PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kremer, L; Dover, LG; Morehouse, C; Hitchin, P; Everett, M; Morris, HR; Dell, A; Brennan, PJ; McNeil, MR; Flaherty, C; Duncan, K; Besra, GS				Kremer, L; Dover, LG; Morehouse, C; Hitchin, P; Everett, M; Morris, HR; Dell, A; Brennan, PJ; McNeil, MR; Flaherty, C; Duncan, K; Besra, GS			Galactan biosynthesis in Mycobacterium tuberculosis - Identification of a bifunctional UDP-galactofuranosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTOCIDA HYALURONAN SYNTHASE; MYCOLIC ACID SYNTHESIS; CAPSULE GENE-CLUSTER; CELL-WALL; ESCHERICHIA-COLI; MASS-SPECTROMETRY; ARABINAN BIOSYNTHESIS; ACTIVE-SITE; ETHAMBUTOL; ARABINOGALACTAN	The cell wall of Mycobacterium tuberculosis and related genera is unique among prokaryotes, consisting of a covalently bound complex of mycolic acids, D-arabinan and D-galactan, which is linked to peptidoglycan via a special linkage unit consisting of Rhap-(1 -->3)-GlcNAc-P. Information concerning the biosynthesis of this entire polymer is now emerging with the promise of new drug targets against tuberculosis. Accordingly, we have developed a galactosyltransferase assay that utilizes the disaccharide neoglycolipid accepters beta -D-Galf-(1 -->5)-beta -Galf-O-C-10:1 and beta -D-Galf-(1 -->6)-beta -D-Galf-O-C-10:1, with UDP-Gal in conjunction with isolated membranes. Chemical analysis of the subsequent reaction products established that the enzymatically synthesized products contained both beta -D-Galf linkages ((1 -->5) and (1 -->6)) found within the mycobacterial cell, as well as in an alternating (1 -->5) and (1 -->6) fashion consistent with the established structure of the cell wall. Furthermore, through a detailed examination of the M. tuberculosis genome, we have shown that the gene product of Rv3808c, now termed glfT is a novel UDP-galactofuranosyltransferase, This enzyme possesses dual functionality in per forming both (1 -->5) and (1 -->6) galactofuranosyltransferase reactions with the above neoglycolipid accepters, using membranes isolated from the heterologous host Escherichia coli expressing Rv3808c, Thus, at a biochemical and genetic level, the polymerization of the galactan region of the mycolyl-arabinogalactan complex has been defined, allowing the possibility of further studies toward substrate recognition and catalysis and assay development. Ultimately, this may also lead to a more rational approach to drug design to be explored in the context of mycobacterial infections.	Newcastle Univ, Dept Microbiol & Immunol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2AZ, England; GlaxoSmithKline Res & Dev Ltd, Stevenage SG1 2NY, Herts, England; Colorado State Univ, Dept Microbiol, Ft Collins, CO 80523 USA	Newcastle University - UK; Imperial College London; GlaxoSmithKline; Colorado State University	Besra, GS (corresponding author), Newcastle Univ, Dept Microbiol & Immunol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	g.s.besra@newcastle.ac.uk	Dover, Lynn George/Q-6778-2019; McNeil, Michael/G-3325-2019; Kremer, Laurent/M-4935-2017; Dover, Lynn G/F-3021-2010	Dover, Lynn George/0000-0002-4776-2665; Kremer, Laurent/0000-0002-6604-4458; Dover, Lynn G/0000-0002-4776-2665; Besra, Gurdyal/0000-0002-5605-0395	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI038087, R22AI018357, R01AI018357, R37AI018357, N01AI075320, R01AI045317] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-45317, AI-38087, N01-AI-75320, AI-18357] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Barlow JN, 2000, CARBOHYD RES, V328, P473, DOI 10.1016/S0008-6215(00)00135-X; Barry CE, 1997, BIOCHEM PHARMACOL, V54, P1165, DOI 10.1016/S0006-2952(97)00163-9; BAULARD A, 1992, NUCLEIC ACIDS RES, V20, P4105, DOI 10.1093/nar/20.15.4105; Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; BESRA GS, 1995, BIOCHEMISTRY-US, V34, P4257, DOI 10.1021/bi00013a015; BESRA GS, 1994, P NATL ACAD SCI USA, V91, P12735, DOI 10.1073/pnas.91.26.12735; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Breton C, 1998, J BIOCHEM, V123, P1000; Cartee RT, 2000, J BIOL CHEM, V275, P3907, DOI 10.1074/jbc.275.6.3907; CLARKE BR, 1995, J BACTERIOL, V177, P5411, DOI 10.1128/jb.177.19.5411-5418.1995; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DAFFE M, 1990, J BIOL CHEM, V265, P6734; DeAngelis PL, 1999, J BIOL CHEM, V274, P26557, DOI 10.1074/jbc.274.37.26557; DELL A, 1994, METHOD ENZYMOL, V230, P108; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Griffiths G, 1998, J BIOL CHEM, V273, P11752, DOI 10.1074/jbc.273.19.11752; Hagen FK, 1999, J BIOL CHEM, V274, P6797, DOI 10.1074/jbc.274.10.6797; HAGOPIAN A, 1968, ARCH BIOCHEM BIOPHYS, V128, P422, DOI 10.1016/0003-9861(68)90048-9; Hoang TT, 1999, GENE, V237, P361, DOI 10.1016/S0378-1119(99)00331-5; Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883; JOZIASSE DH, 1992, GLYCOBIOLOGY, V2, P271, DOI 10.1093/glycob/2.4.271; KILBURN JO, 1981, ANTIMICROB AGENTS CH, V20, P401, DOI 10.1128/AAC.20.3.401; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; KREMER L, 1995, J BACTERIOL, V177, P642, DOI 10.1128/jb.177.3.642-653.1995; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Lee RE, 1997, GLYCOBIOLOGY, V7, P1121, DOI 10.1093/glycob/7.8.1121; Ma YF, 1997, MICROBIOL-SGM, V143, P937, DOI 10.1099/00221287-143-3-937; MCNEIL M, 1990, J BIOL CHEM, V265, P18200; McNeil M, 1999, GENETICS OF BACTERIALS POLYSACCHARIDES, P207; Mdluli K, 1998, SCIENCE, V280, P1607, DOI 10.1126/science.280.5369.1607; Mikusova K, 2000, J BIOL CHEM, V275, P33890, DOI 10.1074/jbc.M006875200; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; Mikusova K, 1996, J BIOL CHEM, V271, P7820, DOI 10.1074/jbc.271.13.7820; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; PETIT C, 1995, MOL MICROBIOL, V17, P611, DOI 10.1111/j.1365-2958.1995.mmi_17040611.x; QUEMARD A, 1991, ANTIMICROB AGENTS CH, V35, P1035, DOI 10.1128/AAC.35.6.1035; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995; Shibayama K, 1998, J BACTERIOL, V180, P5313, DOI 10.1128/JB.180.20.5313-5318.1998; Slayden RA, 2000, MOL MICROBIOL, V38, P514, DOI 10.1046/j.1365-2958.2000.02145.x; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Stern RJ, 1999, MICROBIOL-UK, V145, P663, DOI 10.1099/13500872-145-3-663; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; SUGAWARA F, 1986, AGR BIOL CHEM TOKYO, V50, P1557, DOI 10.1080/00021369.1986.10867583; TAKAYAMA K, 1979, ANTIMICROB AGENTS CH, V16, P240, DOI 10.1128/AAC.16.2.240; TAKAYAMA K, 1989, ANTIMICROB AGENTS CH, V33, P1493, DOI 10.1128/AAC.33.9.1493; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; VEENEMAN GH, 1989, RECL TRAV CHIM PAY B, V108, P344; WARD JB, 1977, FEBS LETT, V78, P151, DOI 10.1016/0014-5793(77)80294-9; WARD JB, 1982, EUR J BIOCHEM, V122, P125; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Weston A, 1998, TUBERCLE LUNG DIS, V78, P123, DOI 10.1016/S0962-8479(98)80005-1; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; WOLFROM ML, 1964, J ORG CHEM, V29, P454, DOI 10.1021/jo01025a052; YOUNG DB, 1995, ANNU REV MICROBIOL, V49, P641, DOI 10.1146/annurev.mi.49.100195.003233; ZUURMOND HM, 1990, RECL TRAV CHIM PAY B, V109, P437	60	141	151	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2001	276	28					26430	26440		10.1074/jbc.M102022200	http://dx.doi.org/10.1074/jbc.M102022200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451VP	11304545	hybrid			2022-12-27	WOS:000169823300104
J	Ito, H; Akiyama, H; Iguchi, H; Iyama, K; Miyamoto, M; Ohsawa, K; Nakamura, T				Ito, H; Akiyama, H; Iguchi, H; Iyama, K; Miyamoto, M; Ohsawa, K; Nakamura, T			Molecular cloning and biological activity of a novel lysyl oxidase-related gene expressed in cartilage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROGENIC EC CELLS; INDIAN HEDGEHOG; CHONDROCYTE DIFFERENTIATION; BONE-GROWTH; ATDC5; COLLAGEN; RECEPTOR; PROTEIN; LINE	We cloned a cDNA encoding a novel lysyl oxidase-related protein, named LOXC, by suppression subtractive hybridization between differentiated and calcified ATDC5 cells, a clonal mouse chondrogenic EC cell line. The deduced amino acid sequence of mouse LOXC consists of 757 amino acids and shows 50% identity with that of mouse lysyl oxidase. Northern blot analysis showed a distinct hybridization band of 5.4 kilobases, and Western blot analysis showed an immunoreactive band at 82 kilodaltons. Expression of LOXC mRNA was detected in osteoblastic MC3T3-E1 cells and embryonic fibroblast C3H10T1/2 cells, whereas none of NIH3T3 fibroblasts and myoblastic C2C12 cells expressed LOXC mRNA in vitro. Moreover, the LOXC mRNA and protein levels dramatically increased throughout a process of chondrogenic differentiation in ATDC5 cells. In vivo, LOXC gene expression was localized in hypertrophic and calcified chondrocytes of growth plates in adult mice. The conditioned media of COS-7 cells transfected with the full-length LOXC cDNA showed the lysyl oxidase activity in both type I and type II collagens derived from chick embryos, and these activities of LOXC were inhibited by P-aminopropionitrile, a specific inhibitor of lysyl oxidase. Our data indicate that LOXC is expressed in cartilage in vivo and modulates the formation of a collagenous extracellular matrix.	Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto 6068507, Japan; Hyogo Coll Med, Dept Hyg, Nishinomiya, Hyogo 6638501, Japan; Kumamoto Univ, Sch Med, Dept Surg Pathol, Kumamoto 8608556, Japan	Kyoto University; Hyogo College of Medicine; Kumamoto University	Akiyama, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto 6068507, Japan.							Akiyama H, 1999, J BIOL CHEM, V274, P32192, DOI 10.1074/jbc.274.45.32192; Akiyama H, 2000, CELL STRUCT FUNCT, V25, P195, DOI 10.1247/csf.25.195; Akiyama H, 1996, J BONE MINER RES, V11, P22; Akiyama H, 1999, BIOCHEM BIOPH RES CO, V257, P814, DOI 10.1006/bbrc.1999.0494; Akiyama H, 1997, BIOCHEM BIOPH RES CO, V235, P142, DOI 10.1006/bbrc.1997.6750; AMIZUKA N, 1994, J CELL BIOL, V126, P1611, DOI 10.1083/jcb.126.6.1611; CASTAGNOLA P, 1988, J CELL BIOL, V106, P461, DOI 10.1083/jcb.106.2.461; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; HARLOW E, 1988, ANTIBODIES LABORATOR, P309; IGUCHI H, 1982, TOXICOL APPL PHARM, V62, P126, DOI 10.1016/0041-008X(82)90109-0; Ito H, 1999, BBA-MOL CELL RES, V1451, P263, DOI 10.1016/S0167-4889(99)00100-7; Ito H, 1999, BIOCHEM BIOPH RES CO, V260, P240, DOI 10.1006/bbrc.1999.0882; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; PINNELL SR, 1968, P NATL ACAD SCI USA, V61, P708, DOI 10.1073/pnas.61.2.708; RESNICK D, 1994, TRENDS BIOCHEM SCI, V19, P5, DOI 10.1016/0968-0004(94)90165-1; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Tsumaki N, 1999, J CELL BIOL, V144, P161, DOI 10.1083/jcb.144.1.161; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	24	53	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24023	24029		10.1074/jbc.M100861200	http://dx.doi.org/10.1074/jbc.M100861200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11292829	hybrid			2022-12-27	WOS:000169531100106
J	Lynch, KW; Weiss, A				Lynch, KW; Weiss, A			A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; SEVERE COMBINED IMMUNODEFICIENCY; POINT MUTATION; COMBINATORIAL CONTROL; CELL MATURATION; SR-PROTEINS; T-CELLS; ENHANCER; ACTIVATION; EXPRESSION	Previous studies have identified a single nucleotide polymorphism that significantly increases the splicing of variable exon 4 in transcripts of the human protein-tyrosine phosphatase CD45. Strikingly, the presence of this polymorphism correlates with susceptibility to the autoimmune disease multiple sclerosis. In this study we investigated the mechanism by which the polymorphism enhances splicing of CD45 exon 4. We found that at least four distinct splicing regulatory elements exist within exon 4 and that the strongest of these elements is an exonic splicing silencer (designated ESS1), which is disrupted by the polymorphism. We show that ESS1 normally functions to repress the weak 5' splice site (ss) of CD45 exon 4. The ESS1 sequence also suppresses the splicing of a heterologous 5' ss and associates with a specific complex in nuclear extracts. We further demonstrate that ESS1 is juxtaposed to a purine-rich enhancer sequence that activates the use of the 5' ss of exon 4. Thus, proper functioning of the immune system is dependent on a complex interplay of regulatory activities that mediate the appropriate splicing of CD45 exon 4.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.				NIGMS NIH HHS [R01-GM39553] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039553] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLACK DL, 1995, RNA, V1, P763; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Bourgeois CF, 1999, MOL CELL BIOL, V19, P7347; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Cale CM, 1997, ARCH DIS CHILD, V76, P163, DOI 10.1136/adc.76.2.163; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; D'Souza I, 2000, J BIOL CHEM, V275, P17700, DOI 10.1074/jbc.M909470199; Del Gatto-Konczak F, 1999, MOL CELL BIOL, V19, P251; EPERON IC, 1994, RNA PROCESSING PRACT, V1, P57; Gooding C, 1998, RNA, V4, P85; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Konig H, 1998, EMBO J, V17, P2904, DOI 10.1093/emboj/17.10.2904; Kung C, 2000, NAT MED, V6, P343; LAVIGUEUR A, 1993, GENE DEV, V7, P2405, DOI 10.1101/gad.7.12a.2405; Lemaire R, 1999, EUR J IMMUNOL, V29, P823, DOI 10.1002/(SICI)1521-4141(199903)29:03<823::AID-IMMU823>3.0.CO;2-C; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Lynch KW, 2000, MOL CELL BIOL, V20, P70, DOI 10.1128/MCB.20.1.70-80.2000; LYNCH KW, 1995, GENE DEV, V9, P284, DOI 10.1101/gad.9.3.284; Lynch KW, 1996, GENE DEV, V10, P2089, DOI 10.1101/gad.10.16.2089; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Maquat LE, 2001, NAT GENET, V27, P5, DOI 10.1038/83759; Matter N, 2000, J BIOL CHEM, V275, P35353, DOI 10.1074/jbc.M004692200; Modafferi EF, 1999, RNA, V5, P687, DOI 10.1017/S1355838299990155; Reed R, 1996, CURR OPIN GENET DEV, V6, P215, DOI 10.1016/S0959-437X(96)80053-0; REED R, 1997, EUKARYOTIC MRNA PROC, P103; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Sarkissian M, 1996, J BIOL CHEM, V271, P31106, DOI 10.1074/jbc.271.49.31106; Schatzmann M, 1999, ENVIRONM POLLUT SER, V1, P261; SCHWINZER R, 1992, EUR J IMMUNOL, V22, P1095, DOI 10.1002/eji.1830220433; SCHWINZER R, 1990, J EXP MED, V171, P1803, DOI 10.1084/jem.171.5.1803; SIEBEL CW, 1992, GENE DEV, V6, P1386, DOI 10.1101/gad.6.8.1386; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; STREULI M, 1989, EMBO J, V8, P787, DOI 10.1002/j.1460-2075.1989.tb03439.x; SUN Q, 1993, GENE DEV, V7, P2598, DOI 10.1101/gad.7.12b.2598; TANAKA K, 1994, MOL CELL BIOL, V14, P1347, DOI 10.1128/MCB.14.2.1347; ten Dam GB, 2000, J IMMUNOL, V164, P5287, DOI 10.4049/jimmunol.164.10.5287; THUDE H, 1995, EUR J IMMUNOL, V25, P2101, DOI 10.1002/eji.1830250745; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Wang HY, 2001, MOL CELL, V7, P331, DOI 10.1016/S1097-2765(01)00181-2; Wang J, 1997, CURR OPIN GENET DEV, V7, P205, DOI 10.1016/S0959-437X(97)80130-X; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; Zilch CF, 1998, EUR J IMMUNOL, V28, P22, DOI 10.1002/(SICI)1521-4141(199801)28:01<22::AID-IMMU22>3.0.CO;2-7	45	97	99	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24341	24347		10.1074/jbc.M102175200	http://dx.doi.org/10.1074/jbc.M102175200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11306584	hybrid			2022-12-27	WOS:000169531100146
J	Qiao, FY; Moss, A; Kupfer, GM				Qiao, FY; Moss, A; Kupfer, GM			Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-D GENE; GROUP-C; GROUP-A; COMPLEX; COMPLEMENTATION; FAC; APOPTOSIS; INTERACT; OVEREXPRESSION; LYMPHOCYTES	Fanconi anemia (FA) is a genetic disease characterized by congenital defects, bone marrow failure, and cancer susceptibility. Cells from patients with FA exhibit genomic instability and hypersensitivity to DNA cross linking agents such as mitomycin C, Despite the identification of seven complementation groups and the cloning of six genes, the function of the encoded gene products remains elusive. The FancA (Fanconi anemia complementation group A), FancC, and FancG proteins have been detected within a nuclear complex, but no change in level, binding, or localization has been reported as a result of drug treatment or cell cycle. We show that in immunofluorescence studies, FancA ap. pears as a non-nucleolar nuclear protein that is excluded from condensed, mitotic chromosomes. Biochemical fractionation reveals that the FA proteins are found in nuclear matrix and chromatin and that treatment with mitomycin C results in increase of the FA proteins in nuclear matrix and chromatin fractions. This induction occurs in wild-type cells and mutant FA-D (Fanconi complementation group D) cells but not in mutant FA-A cells. Immunoprecipitation of FancA protein in chromatin demonstrates the coprecipitation of FancA, FancC, and FancG, showing that the FA proteins move together as a complex. Also, fractionation of mitotic cells confirms the lack of FA proteins in chromatin or the nuclear matrix. Furthermore, phosphorylation of FancG; was found to be temporally correlated with exit of the FA complex from chromosomes at mitosis, Taken together, these findings suggest a role for FA proteins in chromatin and nuclear matrix.	Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Pediat, Charlottesville, VA 22908 USA; Univ Virginia, Hlth Syst, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Kupfer, GM (corresponding author), Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA.				PHS HHS [R01 63776] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; ALTER BP, 1993, HEMATOLOGY INFANCY C, V1, P216; Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; AUERBACH AD, 1997, GENETIC BASIS HUMAN, P317; Brois DW, 1999, CARCINOGENESIS, V20, P1845, DOI 10.1093/carcin/20.9.1845; Burtelow MA, 2000, J BIOL CHEM, V275, P26343, DOI 10.1074/jbc.M001244200; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Christianson TA, 2000, BLOOD, V95, P725, DOI 10.1182/blood.V95.2.725; Cumming RC, 1996, BLOOD, V88, P4558, DOI 10.1182/blood.V88.12.4558.bloodjournal88124558; de Winter JP, 2000, NAT GENET, V24, P15, DOI 10.1038/71626; de Winter JP, 1998, NAT GENET, V20, P281, DOI 10.1038/3093; de Winter JP, 2000, AM J HUM GENET, V67, P1306, DOI 10.1016/S0002-9297(07)62959-0; de Winter JP, 2000, HUM MOL GENET, V9, P2665, DOI 10.1093/hmg/9.18.2665; DUTRILLAUX B, 1982, HUM GENET, V62, P327, DOI 10.1007/BF00304549; Escarceller M, 1997, SOMAT CELL MOLEC GEN, V23, P401, DOI 10.1007/BF02673750; Escarceller M, 1998, J MOL BIOL, V279, P375, DOI 10.1006/jmbi.1998.1784; FANCONI G., 1967, SEMINARS HAMATOL, V4, P233; Fanconi G., 1927, JAHRB KINDERHEILK, V117, P257; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Heinrich MC, 2000, BLOOD, V95, P3970; Hejna JA, 2000, AM J HUM GENET, V66, P1540, DOI 10.1086/302896; Joenje H, 2000, AM J HUM GENET, V67, P759, DOI 10.1086/303067; Joenje H, 1997, AM J HUM GENET, V61, P940, DOI 10.1086/514881; KAISER TN, 1982, CYTOMETRY, V2, P291; Kruyt FAE, 1998, BLOOD, V92, P3050, DOI 10.1182/blood.V92.9.3050.421k56_3050_3056; Kupfer GM, 1997, BLOOD, V90, P1047, DOI 10.1182/blood.V90.3.1047.1047_1047_1054; Kupfer GM, 1997, NAT GENET, V17, P487, DOI 10.1038/ng1297-487; Kupfer GM, 1996, BLOOD, V88, P1019; Laquerbe A, 1999, MUTAT RES-FUND MOL M, V431, P341, DOI 10.1016/S0027-5107(99)00177-3; Li YL, 1997, J CLIN INVEST, V100, P2873, DOI 10.1172/JCI119836; LoTenFoe JR, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; Marathi UK, 1996, BLOOD, V88, P2298, DOI 10.1182/blood.V88.6.2298.bloodjournal8862298; McMahon LW, 1999, J BIOL CHEM, V274, P32904, DOI 10.1074/jbc.274.46.32904; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; Naf D, 1998, MOL CELL BIOL, V18, P5952; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pemov A, 1998, P NATL ACAD SCI USA, V95, P14757, DOI 10.1073/pnas.95.25.14757; Pulsipher M, 1998, MOL MED, V4, P468, DOI 10.1007/BF03401752; Rathbun RK, 1997, BLOOD, V90, P974, DOI 10.1182/blood.V90.3.974.974_974_985; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Ridet A, 1997, CANCER RES, V57, P1722; Sala-Trepat M, 2000, EXP CELL RES, V260, P208, DOI 10.1006/excr.2000.4994; Smith MM, 1991, CURR OPIN CELL BIOL, V3, P429, DOI 10.1016/0955-0674(91)90070-F; STONESIFER KJ, 1987, ACTA CYTOL, V31, P125; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; Waisfisz Q, 1999, P NATL ACAD SCI USA, V96, P10320, DOI 10.1073/pnas.96.18.10320; Wang JX, 1998, CANCER RES, V58, P3538; WHITE RJ, 1995, MOL CELL BIOL, V15, P6653; WHITNEY M, 1995, NAT GENET, V11, P341, DOI 10.1038/ng1195-341; Whitney MA, 1996, BLOOD, V88, P49; Yamashita T, 1998, P NATL ACAD SCI USA, V95, P13085, DOI 10.1073/pnas.95.22.13085	53	88	88	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23391	23396		10.1074/jbc.M101855200	http://dx.doi.org/10.1074/jbc.M101855200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11297559	hybrid			2022-12-27	WOS:000169531100024
J	Tchernov, D; Helman, Y; Keren, N; Luz, B; Ohad, I; Reinhold, L; Ogawa, T; Kaplan, A				Tchernov, D; Helman, Y; Keren, N; Luz, B; Ohad, I; Reinhold, L; Ogawa, T; Kaplan, A			Passive entry of CO2 and its energy-dependent intracellular conversion to HCO3- in cyanobacteria are driven by a photosystem I-generated Delta mu H+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN PCC-6803; STEADY-STATE PHOTOSYNTHESIS; INORGANIC CARBON TRANSPORT; CYCLIC ELECTRON-TRANSFER; SYNECHOCOCCUS UTEX-625; SYNECHOCYSTIS PCC6803; ACTIVE-TRANSPORT; CO2-CONCENTRATING MECHANISM; CONCENTRATING MECHANISM; ANABAENA-VARIABILIS	CO2 entry into Synechococcus sp PCC7942 cells was drastically inhibited by the water channel blocker p-chloromercuriphenylsulfonic acid suggesting that CO2 uptake is, for the most part, passive via aquaporins with subsequent energy-dependent conversion to HCO3-. Dependence of CO2 uptake on photosynthetic electron transport via photosystem I (PSI) was confirmed by experiments with electron transport inhibitors, electron donors and accepters, and a mutant lacking PSI activity. CO2 uptake was drastically inhibited by the uncouplers carbonyl cyanide m-chlorophenylhydrazone (CCCP) and ammonia but substantially less so by the inhibitors of ATP formation arsenate and N, N,-dicyclo-hexylcarbodiimide (DCCD). Thus a Delta muH(+) generated by photosynthetic PSI electron transport apparently serves as the direct source of energy for CO2 uptake. Under low light intensity, the rate of CO2 uptake by a high-CO2-requiring mutant of Synechococcus sp PCC7942, at a CO2 concentration below its threshold for CO2 fixation, was higher than that of the wild type. At saturating light intensity, net CO2 uptake was similar in the wild type and in the mutant IL-3 suggesting common limitation by the rate of conversion of CO2 to HCO3-. These findings are consistent with a model postulating that electron transport-dependent formation of alkaline domains on the thylakoid membrane energizes intracellular conversion of CO2 to HCO3- .	Hebrew Univ Jerusalem, Fac Sci & Math, Dept Plant Sci, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Minerva Ctr Photosynth Stress, IL-91904 Jerusalem, Israel; Nagoya Univ, Biosci Ctr, Nagoya, Aichi 4648601, Japan	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Nagoya University	Kaplan, A (corresponding author), Hebrew Univ Jerusalem, Fac Sci & Math, Dept Plant Sci, IL-91904 Jerusalem, Israel.		Kaplan, Aaron/GLN-5655-2022; Tchernov, Dan/AAE-2545-2021	Tchernov, Dan/0000-0003-1135-8270; Keren, Nir/0000-0002-7356-8831; Kaplan, Aaron/0000-0002-0815-5731				ABE T, 1987, PLANT CELL PHYSIOL, V28, P671; Allakhverdiev SI, 2000, PLANT PHYSIOL, V122, P1201, DOI 10.1104/pp.122.4.1201; BADGER MR, 1994, PHYSIOL PLANTARUM, V90, P529, DOI 10.1111/j.1399-3054.1994.tb08811.x; Bonfil DJ, 1998, FEBS LETT, V430, P236, DOI 10.1016/S0014-5793(98)00662-0; BRECHIGNAC F, 1985, PLANT PHYSIOL, V78, P551, DOI 10.1104/pp.78.3.551; Cooley JW, 2000, J BACTERIOL, V182, P714, DOI 10.1128/JB.182.3.714-722.2000; Cortes P, 2000, BBA-BIOENERGETICS, V1456, P67, DOI 10.1016/S0005-2728(99)00109-7; ESPIE GS, 1991, PLANT PHYSIOL, V97, P943, DOI 10.1104/pp.97.3.943; Fridlyand L, 1996, BIOSYSTEMS, V37, P229, DOI 10.1016/0303-2647(95)01561-2; Hagemann M, 1999, PHYSIOL PLANTARUM, V105, P670, DOI 10.1034/j.1399-3054.1999.105411.x; Huertas IE, 2000, J PHYCOL, V36, P314, DOI 10.1046/j.1529-8817.2000.99142.x; Jeanjean R, 1998, FEMS MICROBIOL LETT, V167, P131, DOI 10.1016/S0378-1097(98)00372-3; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; KAPLAN A, 1987, PLANT PHYSIOL, V84, P210, DOI 10.1104/pp.84.2.210; Klughammer B, 1999, MOL MICROBIOL, V32, P1305, DOI 10.1046/j.1365-2958.1999.01457.x; Letellier L, 1997, J BIOL CHEM, V272, P11109; Li QL, 1998, PLANT PHYSIOL, V116, P1125, DOI 10.1104/pp.116.3.1125; MARCO E, 1993, PLANT PHYSIOL, V101, P1047, DOI 10.1104/pp.101.3.1047; McGinn PJ, 1997, CAN J BOT, V75, P1913, DOI 10.1139/b97-903; MILLER AG, 1988, PLANT PHYSIOL, V86, P677, DOI 10.1104/pp.86.3.677; MILLER AG, 1991, CAN J BOT, V69, P925, DOI 10.1139/b91-119; OGAWA T, 1992, PLANT PHYSIOL, V99, P1604, DOI 10.1104/pp.99.4.1604; OGAWA T, 1985, BIOCHIM BIOPHYS ACTA, V808, P77, DOI 10.1016/0005-2728(85)90029-5; Ohkawa H, 2000, J BIOL CHEM, V275, P31630, DOI 10.1074/jbc.M003706200; Ohkawa H, 1998, CAN J BOT, V76, P1035, DOI 10.1139/b98-076; Ohkawa H, 2000, J BACTERIOL, V182, P2591, DOI 10.1128/JB.182.9.2591-2596.2000; Omata T, 1999, P NATL ACAD SCI USA, V96, P13571, DOI 10.1073/pnas.96.23.13571; Price GD, 1998, CAN J BOT, V76, P973, DOI 10.1139/b98-081; PRICE GD, 1989, PLANT PHYSIOL, V91, P505, DOI 10.1104/pp.91.2.505; REINHOLD L, 1984, PLANT PHYSIOL, V76, P1090, DOI 10.1104/pp.76.4.1090; Ronen-Tarazi M, 1998, CAN J BOT, V76, P942, DOI 10.1139/b98-085; Salon C, 1998, CAN J BOT, V76, P1, DOI 10.1139/b97-154; Salon C, 1996, PLANT CELL ENVIRON, V19, P260, DOI 10.1111/j.1365-3040.1996.tb00249.x; SHERMAN DM, 1994, PLANT PHYSIOL, V106, P251, DOI 10.1104/pp.106.1.251; So AKC, 1998, CAN J BOT, V76, P1084, DOI 10.1139/b98-071; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Sukenik A, 1997, J PHYCOL, V33, P969, DOI 10.1111/j.0022-3646.1997.00969.x; Tchernov D, 1997, CURR BIOL, V7, P723, DOI 10.1016/S0960-9822(06)00330-7; TU CK, 1987, PLANT PHYSIOL, V85, P72, DOI 10.1104/pp.85.1.72; Tyerman SD, 1999, J EXP BOT, V50, P1055, DOI 10.1093/jexbot/50.suppl_1.1055; van Thor JJ, 2000, BBA-BIOENERGETICS, V1457, P129, DOI 10.1016/S0005-2728(00)00072-4; VERMAAS WFJ, 1994, FEBS LETT, V337, P103, DOI 10.1016/0014-5793(94)80638-1; VOLOKITA M, 1984, PLANT PHYSIOL, V76, P599, DOI 10.1104/pp.76.3.599	43	64	69	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23450	23455		10.1074/jbc.M101973200	http://dx.doi.org/10.1074/jbc.M101973200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11297562	hybrid			2022-12-27	WOS:000169531100031
J	Bourette, RP; De Sepulveda, P; Arnaud, S; Dubreuil, P; Rottapel, R; Mouchiroud, G				Bourette, RP; De Sepulveda, P; Arnaud, S; Dubreuil, P; Rottapel, R; Mouchiroud, G			Suppressor of cytokine signaling 1 interacts with the macrophage colony-stimulating factor receptor and negatively regulates its proliferation signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M-CSF RECEPTOR; LEUKEMIA INHIBITORY FACTOR; FACTOR-I RECEPTOR; C-FMS GENE; GROWTH-FACTOR; DIFFERENTIATION SIGNALS; TYROSINE KINASES; FDC-P1 CELLS; BINDING-SITE; PROTEIN	Macrophage colony-stimulating factor receptor (M-CSF-R) is a tyrosine kinase that regulates proliferation, differentiation, and cell survival during monocytic lineage development. Upon activation, M-CSF-R dimerizes and autophosphorylates on specific tyrosines, creating binding sites for several cytoplasmic SH2-containing signaling molecules that relay and modulate the M-CSF signal. Here we show that M-CSF-R interacts with suppressor of cytokine signaling 1 (Socs1), a negative regulator of various cytokine and growth factor signaling pathways. Using the yeast two-hybrid system, in vitro glutathione S-transferase-M-CSF-R pull-down, and in vivo coimmunoprecipitation experiments, we demonstrated a direct interaction between the SH2 domain of Socs1 and phosphorylated tyrosines 697 or 721 of the M CSF-R kinase insert region. Moreover, Socs1 is tyrosine-phosphorylated in response to M-CSF. Ectopic expression of Socs1 in FDC-P1/MAC and EML hematopoietic cell lines decreased their growth rates in the presence of limiting concentrations of M-CSF. However, Socs1 expression did not totally suppress long term cell growth in the presence of saturating M-CSF concentrations, in contrast to other cytokines such as stem cell factor and interleukin 3. Taken together, these results suggest that Socs1 is an M-CSF-R-binding partner involved in negative regulation of proliferation signaling and that it differentially affects cytokine receptor signals.	CNRS, UMR 5534, Ctr Genet Mol & Cellulaire, F-69622 Villeurbanne, France; INSERM, U119, F-13009 Marseille, France; Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Bourette, RP (corresponding author), CNRS, UMR 5534, Ctr Genet Mol & Cellulaire, 43 Blvd 11 Novembre 1918, F-69622 Villeurbanne, France.	bourette@biomserv.univ-lyon1.fr	Bourette, Roland/ABB-3343-2020; Dubreuil, Patrice/V-4816-2019; Mouchiroud, Guy/K-1153-2018; dubreuil, patrice/F-5346-2011; De sepulveda, paulo/K-6043-2015	Dubreuil, Patrice/0000-0003-1155-1150; dubreuil, patrice/0000-0003-1155-1150; De sepulveda, paulo/0000-0001-8295-5414; Rottapel, Robert/0000-0002-6024-5558				Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; Aperlo C, 1998, CELL GROWTH DIFFER, V9, P929; Bourette RP, 2000, GROWTH FACTORS, V17, P155, DOI 10.3109/08977190009001065; Bourette RP, 1998, EMBO J, V17, P7273, DOI 10.1093/emboj/17.24.7273; BOURETTE RP, 1995, CELL GROWTH DIFFER, V6, P631; Bourette RP, 1997, EMBO J, V16, P5880, DOI 10.1093/emboj/16.19.5880; Cohney SJ, 1999, MOL CELL BIOL, V19, P4980; De Sepulveda P, 2000, J BIOL CHEM, V275, P14005, DOI 10.1074/jbc.C000106200; De Sepulveda P, 1999, EMBO J, V18, P904; Dey BR, 1998, J BIOL CHEM, V273, P24095, DOI 10.1074/jbc.273.37.24095; Dey BR, 2000, BIOCHEM BIOPH RES CO, V278, P38, DOI 10.1006/bbrc.2000.3762; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; GLINIAK BC, 1990, CELL, V63, P1073, DOI 10.1016/0092-8674(90)90510-L; Gregorieff A, 2000, J BIOL CHEM, V275, P21596, DOI 10.1074/jbc.M910087199; HOFFMANLIEBERMANN B, 1991, MOL CELL BIOL, V11, P2375, DOI 10.1128/MCB.11.5.2375; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KATO JY, 1990, BLOOD, V75, P1780; Mancini A, 1997, ONCOGENE, V15, P1565, DOI 10.1038/sj.onc.1201518; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Metcalf D, 1999, LEUKEMIA, V13, P926, DOI 10.1038/sj.leu.2401440; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; Metcalf D, 1999, EXP HEMATOL, V27, P1715, DOI 10.1016/S0301-472X(99)00120-4; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Novak U, 1999, GROWTH FACTORS, V16, P305, DOI 10.3109/08977199909069148; Novak U, 1996, ONCOGENE, V13, P2607; Ohya K, 1997, J BIOL CHEM, V272, P27178, DOI 10.1074/jbc.272.43.27178; Pawlak G, 2000, EXP HEMATOL, V28, P1164, DOI 10.1016/S0301-472X(00)00522-1; Pawlak G, 1999, EXP HEMATOL, V27, P797, DOI 10.1016/S0301-472X(99)00013-2; Pawson T, 2000, GENE DEV, V14, P1027; REEDIJK M, 1992, EMBO J, V11, P1365, DOI 10.1002/j.1460-2075.1992.tb05181.x; ROHRSCHNEIDER LR, 1989, MOL CELL BIOL, V9, P5081, DOI 10.1128/MCB.9.11.5081; ROHRSCHNEIDER LR, 1995, GUIDEBOOK CYTOKINES, P168; ROSNET O, 1993, CRIT REV ONCOGENESIS, V4, P595; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; STANDIFER KM, 1994, NEURON, V12, P805, DOI 10.1016/0896-6273(94)90333-6; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Tamura T, 1999, ONCOGENE, V18, P6488, DOI 10.1038/sj.onc.1203062; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; VANDERGEER P, 1993, EMBO J, V12, P5161, DOI 10.1002/j.1460-2075.1993.tb06211.x; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; WIKTORJEDRZEJCZAK W, 1991, EXP HEMATOL, V19, P1049; WOOLFORD J, 1985, MOL CELL BIOL, V5, P3458, DOI 10.1128/MCB.5.12.3458; ZE W, 1993, MOL CELL BIOL, V13, P5348, DOI 10.1128/MCB.13.9.5348	47	38	38	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22133	22139		10.1074/jbc.M101878200	http://dx.doi.org/10.1074/jbc.M101878200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11297560	hybrid			2022-12-27	WOS:000169412700023
J	Gaikwad, A; Long, DJ; Stringer, JL; Jaiswal, AK				Gaikwad, A; Long, DJ; Stringer, JL; Jaiswal, AK			In vivo role of NAD(P)H : quinone oxidoreductase 1 (NQO1) in the regulation of intracellular redox state and accumulation of abdominal adipose tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DT-DIAPHORASE; QUINONE OXIDOREDUCTASE; MUTAGENICITY; GENE; RESISTANCE; REDUCTASE; GLYCOGEN; MUSCLE; CELLS; LEAD	NAD(P)H:quinone oxidoreductase 1 (NQO1) is a flavoprotein that utilizes NAD(P)II as an electron donor, catalyzing the two-electron reduction and detoxification of quinones and their derivatives. NQO1-/- mice deficient in NQO1 activity and protein were generated in our laboratory (Rajendirane, V,, Joseph, P., Lee, Y, H., Kimura, S., Klein-Szanto, A. J. P., Gonzalez, F, J., and Jaiswal, A. R. (1998) J. Biol. Chem. 273, 7382-7389). Mice lacking a functional NQO1 gene (NQO1-/-) were born normal and reproduced adeptly as the wild-type NQO1+/+ mice. In the present report, we show that NQO1-/- mice exhibit significantly lower levels of abdominal adipose tissue as compared with the wild-type mice. The NQO1-/- mice showed lower blood levels of glucose, no change in insulin, and higher levels of triglycerides, P-hydroxy butyrate, pyruvate, lactate, and glucagon as compared with wild-type mice. Insulin tolerance test demonstrated that the NQO1-/- mice are insulin resistant. The NQO1-/- mice livers also showed significantly higher levels of triglycerides, lactate, pyruvate, and glucose. The liver glycogen reserve was found decreased in NQO1-/- mice as compared with mild-type mice, The livers and kidneys from NQO1-/- mice also showed significantly lower levels of pyridine nucleotides but an increase in the reduced/oxidized NAD(P)H: NAD(P) ratio. These results suggested that loss of NQO1 activity alters the intracellular redox status by increasing the concentration of NAD(P)H. This leads to a reduction in pyridine nucleotide synthesis and reduced glucose and fatty acid metabolism. The alterations in metabolism due to redox changes result in a significant reduction in the amount of abdominal adipose tissue.	Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine	Jaiswal, AK (corresponding author), Baylor Coll Med, Dept Pharmacol, 1 Baylor Plaza, Houston, TX 77030 USA.				NIEHS NIH HHS [R01 ES07943] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007943] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BESSHO M, 1989, ANAL BIOCHEM, V182, P304, DOI 10.1016/0003-2697(89)90599-X; Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528; CHESIS PL, 1984, P NATL ACAD SCI-BIOL, V81, P1696, DOI 10.1073/pnas.81.6.1696; CRESTEIL T, 1991, BIOCHEM PHARMACOL, V42, P1021, DOI 10.1016/0006-2952(91)90284-C; DEFLORA S, 1985, CANCER RES, V45, P3188; DUINE JA, 1991, EUR J BIOCHEM, V200, P271, DOI 10.1111/j.1432-1033.1991.tb16183.x; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; JAISWAL AK, 1990, BIOCHEMISTRY-US, V29, P1899, DOI 10.1021/bi00459a034; JOHANN C, 1971, ANAL BIOCHEM, V43, P183, DOI 10.1016/0003-2697(71)90123-0; Joseph P, 1998, BRIT J CANCER, V77, P709, DOI 10.1038/bjc.1998.117; Joseph P, 1998, BRIT J CANCER, V78, P312, DOI 10.1038/bjc.1998.492; JOSEPH P, 1994, P NATL ACAD SCI USA, V91, P8413, DOI 10.1073/pnas.91.18.8413; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Kather B, 2000, J BACTERIOL, V182, P3204, DOI 10.1128/JB.182.11.3204-3209.2000; KLAIDMAN LK, 1995, ANAL BIOCHEM, V228, P312, DOI 10.1006/abio.1995.1356; LAZZARINO G, 1989, ANAL BIOCHEM, V181, P239, DOI 10.1016/0003-2697(89)90236-4; LEHNINGER AL, 1993, PRINCIPLES BIOCH, P598; Mokuda O, 2000, EXP CLIN ENDOCR DIAB, V108, P353, DOI 10.1055/s-2000-8128; Radjendirane V, 1998, J BIOL CHEM, V273, P7382, DOI 10.1074/jbc.273.13.7382; Radjendirane Venugopal, 1997, P441; RILEY RJ, 1992, BIOCHEM PHARMACOL, V43, P1657, DOI 10.1016/0006-2952(92)90694-E; Roy BD, 1998, J APPL PHYSIOL, V84, P890, DOI 10.1152/jappl.1998.84.3.890; RUSHMORE TH, 1993, J BIOL CHEM, V268, P11475; SHAW PM, 1991, EUR J BIOCHEM, V195, P171, DOI 10.1111/j.1432-1033.1991.tb15691.x; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; TAKASHI M, 1998, P NATL ACAD SCI USA, V95, P10402; Talalay P, 1995, TOXICOL LETT, V82-3, P173, DOI 10.1016/0378-4274(95)03553-2	27	162	165	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22559	22564		10.1074/jbc.M101053200	http://dx.doi.org/10.1074/jbc.M101053200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11309386	hybrid			2022-12-27	WOS:000169412700079
J	Ishmael, FT; Norcum, MT; Benkovic, SJ; Bond, JS				Ishmael, FT; Norcum, MT; Benkovic, SJ; Bond, JS			Multimeric structure of the secreted meprin A metalloproteinase and characterization of the functional protomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNIT; MAM DOMAIN; METALLOENDOPEPTIDASES; PROTEINASE; PROTEASOME; PEPTIDASES; FORMS; BETA	Meprin A secreted from kidney and intestinal epithe lial cells is capable of cleaving growth factors, extracellular matrix proteins, and biologically active peptides. The secreted form of meprin A is a homo oligomer com posed of ct subunits, a multidomain protease of 582 amino acids coded for near the major histocompatibility complex of the mouse and human genome. Analyses of the recombinant homo-oligomeric form of mouse meprin A by gel filtration, nondenaturing gel electrophoresis, and cross-linking (with disuccinimidyl suberate or N-(4-azido 2,3,5,6-tetraflourobenzyl)-3-maleimidylpropionamide) indicate that the secreted enzyme forms high molecular weight multimers, with a predominance of decamers, The multimers are composed of disulfide-linked dimers attached noncovalently by interactions involving the meprin, A5 protein, receptor protein-tyrosine phosphatase mu (MAM) domain. The active protomer is the noncovalently linked dimer. Linkage of active protomers by disulfide-bonds results in an oligomer of similar to 900 kDa, which is unique among proteases and distinguishes meprin A as the largest known secreted protease. Electron microscopy revealed that the protein was present in two states, a crescent-shaped structure and a closed ring. It is concluded from this and other data that the covalent attachment of the protomers enables noncovalent associations of the native enzyme to form higher oligomers that are critical for hydrolysis of protein substrates.	Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; Penn State Univ, Eberly Coll Sci, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Mississippi; University of Mississippi Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bond, JS (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK019691, R01DK019691, R37DK019691] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 19691] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alley SC, 2000, J AM CHEM SOC, V122, P6126, DOI 10.1021/ja000591t; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; BEYNON RJ, 1981, BIOCHEM J, V199, P591, DOI 10.1042/bj1990591; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Chestukhin A, 1997, J BIOL CHEM, V272, P3153, DOI 10.1074/jbc.272.6.3153; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; GORBEA CM, 1991, ARCH BIOCHEM BIOPHYS, V290, P549, DOI 10.1016/0003-9861(91)90580-C; Johnson G.S., 1998, HDB PROTEOLYTIC ENZY, P1222; Kadowaki T, 2000, J BIOL CHEM, V275, P25577, DOI 10.1074/jbc.M003521200; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Marchand P, 1996, J BIOL CHEM, V271, P24236, DOI 10.1074/jbc.271.39.24236; MARCHAND P, 1994, J BIOL CHEM, V269, P15388; MARCHAND P, 1995, J BIOL CHEM, V270, P5449, DOI 10.1074/jbc.270.10.5449; METZ G, 1977, Z NATURFORSCH C, V32, P929; NORCUM MT, 1989, J BIOL CHEM, V264, P15043; STOCKER W, 1995, PROTEIN SCI, V4, P823; Tomkinson B, 1999, TRENDS BIOCHEM SCI, V24, P355, DOI 10.1016/S0968-0004(99)01435-8; Tsukuba T, 1998, J BIOL CHEM, V273, P35260, DOI 10.1074/jbc.273.52.35260; ZONDAG GCM, 1995, J BIOL CHEM, V270, P14247, DOI 10.1074/jbc.270.24.14247	20	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23207	23211		10.1074/jbc.M102654200	http://dx.doi.org/10.1074/jbc.M102654200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301339	hybrid			2022-12-27	WOS:000169412700163
J	Ko, YG; Park, H; Kim, T; Lee, JW; Park, SG; Seol, W; Kim, JE; Lee, WH; Kim, SH; Park, JE; Kim, S				Ko, YG; Park, H; Kim, T; Lee, JW; Park, SG; Seol, W; Kim, JE; Lee, WH; Kim, SH; Park, JE; Kim, S			A cofactor of tRNA synthetase, p43, is secreted to up-regulate proinflammatory genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING-POLYPEPTIDE-II; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRANSFER-RNA SYNTHETASE; TUMOR-DERIVED CYTOKINE; EMAP-II; MICROGLIAL CELLS; APOPTOSIS; ATHEROSCLEROSIS; INFLAMMATION; CHEMOKINES	An auxiliary factor of mammalian multi-aminoacyl-tRNA synthetases, p43, is thought to be a precursor of endothelial monocyte-activating polypeptide II (EMAP II) that triggers proinflammation in leukocytes and macrophages. In the present work, however, we have shown that p43 itself is specifically secreted from intact mammalian cells, while EMAP II is released only when the cells are disrupted. Secretion of p43 was also observed when its expression was increased. These results suggest that p43 itself should be a real cytokine secreted by an active mechanism. To determine the cytokine activity and active domain of p43, we investigated tumor necrosis factor (TNF) and interleukin-8 (IL-8) production from human monocytic THP-1 cells treated with various p43 deletion mutants. The full length of p43 showed higher cytokine activity than EMAP II, further supporting p43 as the active cytokine. p43 was also shown to activate MAPKs and NF kappaB, and to induce cytokines and chemokines such as TNF, IL-8, MCP-1, MIP-1 alpha, MIP-1 beta, MIP-2 alpha, IL-1 beta, and RANTES. Interestingly, the high level of p43 was observed in the foam cells of atherosclerotic lesions. Therefore, p43 could be a novel mediator of atherosclerosis development as well as other inflammation-related diseases.	Seoul Natl Univ, Coll Pharm, Natl Creat Res Initiat Ctr ARS Network, Kwanak Ku, Seoul 151742, South Korea; Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; Sungkyunkwan Univ, Coll Med, Samsung Med Ctr, Cardiovasc Inst, Seoul 135710, South Korea	Seoul National University (SNU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, S (corresponding author), Seoul Natl Univ, Coll Pharm, Natl Creat Res Initiat Ctr ARS Network, Kwanak Ku, San 56-1 Shillim Dong, Seoul 151742, South Korea.	sungkim@snu.ac.kr	Kim, Sunghoon/AAE-8314-2020					Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Barnett G, 2000, CANCER RES, V60, P2850; Behrensdorf HA, 2000, FEBS LETT, V466, P143, DOI 10.1016/S0014-5793(99)01777-9; Berger AC, 2000, J IMMUNOTHER, V23, P519, DOI 10.1097/00002371-200009000-00002; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; de Winther MPJ, 2000, J CLIN INVEST, V105, P1039, DOI 10.1172/JCI9919; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; JANEWAY CA, 1999, IMMUNOBIOLOGY IMMUNE, P380; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; KAO J, 1992, J BIOL CHEM, V267, P20239; KAO J, 1994, J BIOL CHEM, V269, P25106; KAO J, 1994, J BIOL CHEM, V269, P9774; Kim Y, 2000, J BIOL CHEM, V275, P27062; Knies UE, 1998, P NATL ACAD SCI USA, V95, P12322, DOI 10.1073/pnas.95.21.12322; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Norcum MT, 2000, J BIOL CHEM, V275, P17921, DOI 10.1074/jbc.C000266200; Park SG, 1999, J BIOL CHEM, V274, P16673, DOI 10.1074/jbc.274.24.16673; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Schluesener HJ, 1999, ACTA NEUROPATHOL, V97, P119, DOI 10.1007/s004010050964; Schluesener HJ, 1997, GLIA, V20, P365, DOI 10.1002/(SICI)1098-1136(199708)20:4<365::AID-GLIA8>3.0.CO;2-4; Schwarz M, 1999, AM J PHYSIOL-LUNG C, V276, pL365, DOI 10.1152/ajplung.1999.276.2.L365; Scott MG, 2000, J IMMUNOL, V165, P3358, DOI 10.4049/jimmunol.165.6.3358; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Tas MPR, 1996, INT J BIOCHEM CELL B, V28, P837, DOI 10.1016/1357-2725(96)00038-6; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wang ZM, 2000, J BIOL CHEM, V275, P20260, DOI 10.1074/jbc.M909168199; Zhang FR, 2000, DEV DYNAM, V218, P490, DOI 10.1002/1097-0177(200007)218:3<490::AID-DVDY1005>3.0.CO;2-C	32	125	142	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23028	23033		10.1074/jbc.M101544200	http://dx.doi.org/10.1074/jbc.M101544200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11292833	hybrid			2022-12-27	WOS:000169412700139
J	Lim, F; Downey, TP; Peabody, DS				Lim, F; Downey, TP; Peabody, DS			Translational repression and specific RNA binding by the coat protein of the Pseudomonas phage PP7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-Q-BETA; CRYSTAL-STRUCTURE; 3.5-ANGSTROM RESOLUTION; SITE; AERUGINOSA; PLASMID; GA	PP7 is a single strand RNA bacteriophage of Pseudomonas aeroginosa and a distant relative to coliphages like MS2 and Q beta. Here we show that PP7 coat protein is a specific RNA-binding protein, capable of repressing the translation of sequences fused to the translation initiation region of PP7 replicase. Its RNA binding activity is specific since it represses the translational operator of PP7, but does not repress the operators of the MS2 or Q beta phages, Conditions for the purification of coat protein and for the reconstitution of its RNA binding activity from disaggregated virus-like particles were established. Its dissociation constant for PP7 operator RNA in vitro was determined to be about 1 nM. Using a genetic system in which coat protein represses translation of a replicase-beta -galactosidase fusion protein, amino acid residues important for binding of PP7 RNA were identified.	Univ New Mexico, Dept Mol Genet & Microbiol, Sch Med, Albuquerque, NM 87131 USA	University of New Mexico	Peabody, DS (corresponding author), Univ New Mexico, Dept Mol Genet & Microbiol, Sch Med, Albuquerque, NM 87131 USA.							CAREY J, 1983, BIOCHEMISTRY-US, V22, P2610, DOI 10.1021/bi00280a003; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991; Golmohammadi R, 1996, STRUCTURE, V4, P543, DOI 10.1016/S0969-2126(96)00060-3; GOLMOHAMMADI R, 1993, J MOL BIOL, V234, P620, DOI 10.1006/jmbi.1993.1616; GOTT JM, 1991, NUCLEIC ACIDS RES, V19, P6499, DOI 10.1093/nar/19.23.6499; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LECUYER KA, 1996, EMBO J, V15, P6487; Licis N, 2000, VIROLOGY, V271, P298, DOI 10.1006/viro.2000.0327; LILJAS L, 1994, J MOL BIOL, V244, P279, DOI 10.1006/jmbi.1994.1729; Lim F, 1996, J BIOL CHEM, V271, P31839, DOI 10.1074/jbc.271.50.31839; LIM F, 1994, J BIOL CHEM, V269, P9006; Miller J. H, 1972, EXPT MOL GENETICS; MOERSCHELL RP, 1990, J BIOL CHEM, V265, P19638; NI CZ, 1995, STRUCTURE, V3, P255, DOI 10.1016/S0969-2126(01)00156-3; OLSTHOORN RCL, 1995, VIROLOGY, V206, P611, DOI 10.1016/S0042-6822(95)80078-6; PEABODY DS, 1990, J BIOL CHEM, V265, P5684; Peabody DS, 1997, MOL GEN GENET, V254, P358, DOI 10.1007/s004380050427; PEABODY DS, 1993, EMBO J, V12, P595, DOI 10.1002/j.1460-2075.1993.tb05691.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Tars K, 2000, ACTA CRYSTALLOGR D, V56, P398, DOI 10.1107/S0907444900001232; Tars K, 2000, VIROLOGY, V272, P331, DOI 10.1006/viro.2000.0373; Tars K, 1997, J MOL BIOL, V271, P759, DOI 10.1006/jmbi.1997.1214; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WITHERELL GW, 1989, BIOCHEMISTRY-US, V28, P71, DOI 10.1021/bi00427a011; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428	25	60	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22507	22513		10.1074/jbc.M102411200	http://dx.doi.org/10.1074/jbc.M102411200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11306589	hybrid			2022-12-27	WOS:000169412700072
J	Petitpas, I; Bhattacharya, AA; Twine, S; East, M; Curry, S				Petitpas, I; Bhattacharya, AA; Twine, S; East, M; Curry, S			Crystal structure analysis of warfarin binding to human serum albumin - Anatomy of drug site I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACIDS; RESOLUTION; FRAGMENTS; INSIGHTS; REVEALS; CELLS	Human serum albumin (HSA) is an abundant transport protein found in plasma that binds a wide variety of drugs in two primary binding sites (I and II) and can have a significant impact on their pharmacokinetics. We have determined the crystal structures at 2.5 Angstrom -resolution of HSA-myristate complexed with the R-(+) and S-(-) enantiomers of warfarin, a widely used anticoagulant that binds to the protein with high affinity. The structures confirm that warfarin binds to drug site I (in subdomain IIA) in the presence of fatty acids and reveal the molecular details of the protein drug interaction. The two enantiomers of warfarin adopt very similar conformations when bound to the protein and make many of the same specific contacts with amino acid side chains at the binding site, thus accounting for the relative lack of stereospecificity of the HSA-warfarin interaction. The conformation of the warfarin binding pocket is significantly altered upon binding of fatty acids, and this can explain the observed enhancement of warfarin binding to HSA at low levels of fatty acid.	Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, London SW7 2BW, England; Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England	Imperial College London; University of Southampton	Curry, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, London SW7 2BW, England.			Curry, Stephen/0000-0002-0552-8870				Beljaars L, 2000, J BIOL CHEM, V275, P12743, DOI 10.1074/jbc.275.17.12743; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; BIRKETT DJ, 1977, MOL PHARMACOL, V13, P987; BOS OJM, 1988, BIOCHEM PHARMACOL, V37, P3905, DOI 10.1016/0006-2952(88)90072-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carter D. C., 1994, ADV PROTEIN CHEM, V45, P152; CARTER DC, 1994, EUR J BIOCHEM, V226, P1049, DOI 10.1111/j.1432-1033.1994.01049.x; Curry S, 1999, BBA-MOL CELL BIOL L, V1441, P131, DOI 10.1016/S1388-1981(99)00148-1; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; DIANA FJ, 1989, J PHARM SCI-US, V78, P195, DOI 10.1002/jps.2600780304; Dockal M, 2000, PROTEIN SCI, V9, P1455, DOI 10.1110/ps.9.8.1455; Esnouf R. M., 1997, J MOL GRAPHICS, V15, P133; FEHSKE KJ, 1982, MOL PHARMACOL, V21, P387; FEHSKE KJ, 1979, MOL PHARMACOL, V16, P778; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; HO JX, 1993, EUR J BIOCHEM, V215, P205, DOI 10.1111/j.1432-1033.1993.tb18024.x; Holford N. H. G., 1998, BASIC CLIN PHARM, P34; KRAGHHANSEN U, 1990, DAN MED BULL, V37, P57; KRAGHHANSEN U, 1988, MOL PHARMACOL, V34, P160; Lindup W. E., 1987, PROGR DRUG METABOLIS, V10, P141; LOUN B, 1994, ANAL CHEM, V66, P3814, DOI 10.1021/ac00093a043; Mao HY, 2000, PROTEIN EXPRES PURIF, V20, P492, DOI 10.1006/prep.2000.1330; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Peters Jr. T., 1995, ALL ALBUMIN BIOCH GE; Petersen CE, 2000, CHEM-BIOL INTERACT, V124, P161, DOI 10.1016/S0009-2797(99)00143-X; PETERSEN CE, 2000, PROGR DRUG METABOLIS, V124, P161; SJOHOLM I, 1979, MOL PHARMACOL, V16, P767; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Tsuchida E, 2000, BIOCONJUGATE CHEM, V11, P46, DOI 10.1021/bc990065v; VALENTE EJ, 1977, J MED CHEM, V20, P1489, DOI 10.1021/jm00221a025; Vorum H, 1996, J PHARM PHARMACOL, V48, P870, DOI 10.1111/j.2042-7158.1996.tb03990.x; WANWIMOLRUK S, 1982, BIOCHIM BIOPHYS ACTA, V709, P247, DOI 10.1016/0167-4838(82)90467-8; WEST BD, 1961, J AM CHEM SOC, V83, P2676, DOI 10.1021/ja01473a020; WILDING G, 1977, SCIENCE, V195, P991, DOI 10.1126/science.841323; WILTING J, 1980, J BIOL CHEM, V255, P3032; Yamasaki K, 1996, BBA-PROTEIN STRUCT M, V1295, P147, DOI 10.1016/0167-4838(96)00013-1	39	670	695	3	101	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22804	22809		10.1074/jbc.M100575200	http://dx.doi.org/10.1074/jbc.M100575200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11285262	hybrid			2022-12-27	WOS:000169412700110
J	Yuste, VJ; Bayascas, JR; Llecha, N; Sanchez-Lopez, I; Boix, J; Comella, JX				Yuste, VJ; Bayascas, JR; Llecha, N; Sanchez-Lopez, I; Boix, J; Comella, JX			The absence of oligonucleosomal DNA fragmentation during apoptosis of IMR-5 neuroblastoma cells - Disappearance of the caspase-activated DNase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED NEURONAL APOPTOSIS; CHROMATIN CONDENSATION; DEATH; CLEAVAGE; STAUROSPORINE; DEGRADATION; INHIBITOR; INVOLVEMENT; MECHANISMS; INDUCTION	Caspase-activated DNase is responsible for the oligonucleosomal DNA degradation during apoptosis, DNA degradation is thought to be important for multicellular organisms to prevent oncogenic transformation or as a mechanism of viral defense, It has been reported that certain cells, including some neuroblastoma cell lines such as IMR-5, enter apoptosis without digesting DNA in such a way, We have analyzed the causes for the absence of DNA laddering in staurosporine-treated IMR-5 cells, and we have found that most of the molecular mechanisms controlling apoptosis are well preserved in this cell line, These include degradation of substrates for caspases, blockade of cell death by antiapoptotic genes such as Bcl-2 or Bcl-X-L, or normal levels and adequate activation of caspase-3. Moreover, these cells display normal levels of caspase-activated DNase and its inhibitory protein, inhibitor of caspase-activated DNase, and their cDNA sequences are identical to those reported previously. Nevertheless, IMR-5 cells lose caspase-activated DNase during apoptosis and recover their ability to degrade DNA when human recombinant caspase-activated DNase is overexpressed, Our results lead to the conclusion that caspase-activated DNase is processed during apoptosis of IMR-5 cells, making these cells a good model to study the relevance of this endonuclease in physiological or pathological conditions.	Univ Lleida, Dept Ciencies Mediques Basiques, Grp Neurobiol Mol, Lleida 25198, Spain	Universitat de Lleida	Comella, JX (corresponding author), Univ Lleida, Dept Ciencies Mediques Basiques, Grp Neurobiol Mol, Lleida 25198, Spain.		Comella, Joan X/D-7333-2012; Comella, Joan/GQA-4279-2022; Yuste, Victor J./C-7071-2008; Bayascas, Jose R/C-9450-2011	Comella, Joan X/0000-0002-6218-0786; Yuste, Victor J./0000-0001-5322-9261; Bayascas, Jose R/0000-0002-6096-2151; Sanchez Lopez, Isabel/0000-0003-1218-3636				Benito A, 1996, BLOOD, V87, P3837, DOI 10.1182/blood.V87.9.3837.bloodjournal8793837; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Boix J, 1997, NEUROPHARMACOLOGY, V36, P811, DOI 10.1016/S0028-3908(97)00030-0; Boix J, 1998, EXP CELL RES, V238, P422, DOI 10.1006/excr.1997.3852; CUVILLIER O, 1996, P NATL ACAD SCI USA, V93, P8395; de la Taille A, 1999, CANCER RES, V59, P5461; Deshmukh M, 2000, CELL DEATH DIFFER, V7, P250, DOI 10.1038/sj.cdd.4400641; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fadeel B, 1999, BIOCHEM BIOPH RES CO, V266, P699, DOI 10.1006/bbrc.1999.1888; Ferri KF, 2000, NAT CELL BIOL, V2, pE63, DOI 10.1038/35008692; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Halenbeck R, 1998, CURR BIOL, V8, P537, DOI 10.1016/S0960-9822(98)79298-X; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; KOH JY, 1995, EXP NEUROL, V135, P153, DOI 10.1006/exnr.1995.1074; LAZEBNIK YA, 1993, J CELL BIOL, V123, P7, DOI 10.1083/jcb.123.1.7; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu XS, 1999, J BIOL CHEM, V274, P13836, DOI 10.1074/jbc.274.20.13836; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; McIlroy D, 2000, GENE DEV, V14, P549; McIlroy D, 1999, ONCOGENE, V18, P4401, DOI 10.1038/sj.onc.1202868; Mukae N, 1998, P NATL ACAD SCI USA, V95, P9123, DOI 10.1073/pnas.95.16.9123; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Peitsch Manuel C., 1994, Trends in Cell Biology, V4, P37, DOI 10.1016/0962-8924(94)90002-7; Posmantur R, 1997, J NEUROCHEM, V68, P2328; Prehn JHM, 1997, J NEUROCHEM, V68, P1679; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; SCHULZEOSTHOFF K, 1994, J CELL BIOL, V127, P15, DOI 10.1083/jcb.127.1.15; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Walker PR, 1999, ANN NY ACAD SCI, V887, P48, DOI 10.1111/j.1749-6632.1999.tb07921.x; Walker PR, 1997, BIOCHEM CELL BIOL, V75, P287, DOI 10.1139/bcb-75-4-287; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Wu YC, 2000, GENE DEV, V14, P536; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480	43	61	64	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22323	22331		10.1074/jbc.M100072200	http://dx.doi.org/10.1074/jbc.M100072200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294834	hybrid			2022-12-27	WOS:000169412700049
J	Delom, F; Mallett, B; Carayon, P; Lejeune, PJ				Delom, F; Mallett, B; Carayon, P; Lejeune, PJ			Role of extracellular molecular chaperones in the folding of oxidized proteins - Refolding of colloidal thyroglobulin by protein disulfide isomerase and immunoglobulin heavy chain-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE SYNTHESIS; SALT-DEPENDENT LIPASE; ENDOPLASMIC-RETICULUM; HEN LYSOZYME; N-GLYCANS; IN-VITRO; BIP; STORAGE; SPECIFICITY; THYROCYTES	The process of thyroid hormone synthesis, which occurs in the lumen of the thyroid follicles, results from an oxidative reaction leading, as side effects, to the multimerization of thyroglobulin (TG), the prothyroid hormone, Although hormone synthesis is a continuous process; the amount of Tg multimers is relatively constant. Here, we investigated the role of two molecular chaperones, protein disulfide isomerase (PDI) and immunoglobulin heavy chain-binding protein (BiP), present in the follicular lumen, on the multimerization process due to oxidation using both native Tg and its N-terminal domain (NTD), In vitro, PDI decreased multimerization of Tg and even suppressed the formation of NTD multimers, Under the same conditions, BiP was able to bind to Tg and NTD multimers but did not affect the process of multimerization, Associating BiP with PDI did not enhance the ability of PDL to limit the formation of multimers produced by oxidation, However, when BiP and PDI were reacted together with the multimeric forms and for a longer time (48 h), BiP greatly increased the efficiency of PDI, Accordingly, these two molecular chaperones probably act sequentially on the reduction of the intermolecular disulfide bridges. In the thyroid, a similar process may also be effective and participate in limiting the amount of Tg multimers present in the colloid. These results suggest that extracellular molecular chaperones play a similar role to that occurring in the endoplasmic reticulum and, furthermore, take part in the control of multimerization and aggregation of proteins formed by oxidation.	Univ Mediterranee, Fac Med, INSERM, U555, F-13385 Marseille 5, France; Univ Mediterranee, Fac Med, Lab Biochim Endocrinienne & Metab, F-13385 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Mallett, B (corresponding author), Univ Mediterranee, Fac Med, INSERM, U555, F-13385 Marseille 5, France.		Delom, Frederic/J-2782-2014	Delom, Frederic/0000-0002-4600-7633				Baudry N, 1996, FEBS LETT, V396, P223, DOI 10.1016/0014-5793(96)01107-6; Baudry N, 1998, BIOCHEM BIOPH RES CO, V242, P292, DOI 10.1006/bbrc.1997.7952; Berndorfer U, 1996, J CLIN ENDOCR METAB, V81, P1918, DOI 10.1210/jc.81.5.1918; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; BRAAKMAN I, 1992, NATURE, V356, P260, DOI 10.1038/356260a0; Brix K, 1996, ENDOCRINOLOGY, V137, P1963, DOI 10.1210/en.137.5.1963; Bruneau N, 1998, J CELL SCI, V111, P2665; BRUNEAU N, 1995, J BIOL CHEM, V270, P13524, DOI 10.1074/jbc.270.22.13524; Delom F, 1999, BIOCHEM BIOPH RES CO, V255, P438, DOI 10.1006/bbrc.1999.0229; DORNER AJ, 1990, P NATL ACAD SCI USA, V87, P7429, DOI 10.1073/pnas.87.19.7429; DUNN JT, 2000, WERNER INGBARS THYRO, P91; FELDTRASMUSSEN U, 1978, J IMMUNOL METHODS, V21, P295, DOI 10.1016/0022-1759(78)90156-4; FRATI L, 1974, ARCH BIOCHEM BIOPHYS, V162, P126, DOI 10.1016/0003-9861(74)90111-8; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; HERZOG V, 1992, J CELL BIOL, V118, P1071, DOI 10.1083/jcb.118.5.1071; KIM PS, 1995, J CELL BIOL, V128, P29, DOI 10.1083/jcb.128.1.29; KIM PS, 1992, J CELL BIOL, V118, P541, DOI 10.1083/jcb.118.3.541; KNITTLER MR, 1992, EMBO J, V11, P1573, DOI 10.1002/j.1460-2075.1992.tb05202.x; KUZNETSOV G, 1994, J BIOL CHEM, V269, P22990; Kuznetsov G, 1997, J BIOL CHEM, V272, P3057, DOI 10.1074/jbc.272.5.3057; LEMANSKY P, 1994, ENDOCRINOLOGY, V135, P1566, DOI 10.1210/en.135.4.1566; MALLET B, 1995, J BIOL CHEM, V270, P29881; MARRIQ C, 1986, FEBS LETT, V207, P302, DOI 10.1016/0014-5793(86)81509-5; Mayer M, 2000, J BIOL CHEM, V275, P29421, DOI 10.1074/jbc.M002655200; McLaughlin SH, 1998, BIOCHEM J, V331, P793, DOI 10.1042/bj3310793; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Mezghrani A, 2000, J BIOL CHEM, V275, P1920, DOI 10.1074/jbc.275.3.1920; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Muresan Z, 1997, J BIOL CHEM, V272, P26095, DOI 10.1074/jbc.272.42.26095; NOIVA R, 1992, J BIOL CHEM, V267, P3553; Primm TP, 1996, J BIOL CHEM, V271, P33664, DOI 10.1074/jbc.271.52.33664; PUIG A, 1994, J BIOL CHEM, V269, P7764; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; RUF J, 1983, EMBO J, V2, P1821, DOI 10.1002/j.1460-2075.1983.tb01664.x; Saber-Lichtenberg Y, 2000, FASEB J, V14, P1005, DOI 10.1096/fasebj.14.7.1005; Tepel C, 2000, J CELL SCI, V113, P4487; TING J, 1988, DNA-J MOLEC CELL BIO, V7, P275, DOI 10.1089/dna.1988.7.275; van den Berg P, 1999, EMBO J, V18, P4794, DOI 10.1093/emboj/18.17.4794; YAMAUCHI K, 1987, BIOCHEM BIOPH RES CO, V146, P1485, DOI 10.1016/0006-291X(87)90817-5	41	40	41	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21337	21342		10.1074/jbc.M101086200	http://dx.doi.org/10.1074/jbc.M101086200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11294872	hybrid			2022-12-27	WOS:000169297900073
J	McManus, DC; Scott, BR; Franklin, V; Sparks, DL; Marcel, YL				McManus, DC; Scott, BR; Franklin, V; Sparks, DL; Marcel, YL			Proteolytic degradation and impaired secretion of an apolipoprotein A-I mutant associated with dominantly inherited hypoalphalipoproteinemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; LECITHIN-CHOLESTEROL-ACYLTRANSFERASE; CORONARY-ARTERY DISEASE; BINDING CASSETTE TRANSPORTER-1; RECONSTITUTED LPA-I; APOA-I; TANGIER-DISEASE; TRANSGENIC MICE; CENTRAL DOMAIN; HEART-DISEASE	We have devised a combined in vivo, ex vivo, and in vitro approach to elucidate the mechanism(s) responsible for the hypoalphalipoproteinemia in heterozygous carriers of a naturally occurring apolipoprotein A-I (apoA-I) variant (Leu(159) to Arg) known as apoA-I Finland (apoA-I-FIN). Adenovirus-mediated expression of apoA-I-FIN decreased apoA-I and high density lipoprotein cholesterol concentrations in both wild-type C57BL/6J mice and in apoA-I-deficient mice expressing native human apoA-I (hapoA-I), Interestingly, apoA-I-FIN was degraded in the plasma, and the extent of proteolysis correlated with the most significant reductions in murine apoA-I concentrations. ApoA-I-FIN had impaired activation of lecithin:cholesterol acyltransferase in vitro compared with hapoA-I, but in a mixed lipoprotein preparation consisting of both hapoA-I and apoA-I-FIN there was only a moderate reduction in the activation of this enzyme. Importantly, secretion of apoA-I was also decreased from primary apoA-I-deficient hepatocytes when hapoA-I was co-expressed with apoA-I-FIN following infection with recombinant adenoviruses, a condition that mimics secretion in heterozygotes. Thus, this is the first demonstration of an apoA-I point mutation that decreases LCAT activation, impairs hepatocyte secretion of apoA-I, and makes apoA-I susceptible to proteolysis leading to dominantly inherited hypoalphalipoproteinemia.	Univ Ottawa, Inst Heart, Lipoprot & Atherosclerosis Res Grp, Dept Pathol & Lab Med, Ottawa, ON K1Y 4W7, Canada; Univ Ottawa, Inst Heart, Lipoprot & Atherosclerosis Res Grp, Dept Biochem, Ottawa, ON K1Y 4W7, Canada; Univ Ottawa, Inst Heart, Lipoprot & Atherosclerosis Res Grp, Dept Microbiol, Ottawa, ON K1Y 4W7, Canada; Univ Ottawa, Inst Heart, Lipoprot & Atherosclerosis Res Grp, Dept Immunol, Ottawa, ON K1Y 4W7, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa Heart Institute	Marcel, YL (corresponding author), Univ Ottawa, Inst Heart, Lipoprot & Atherosclerosis Res Grp, Dept Pathol & Lab Med, Rm H460,40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.			Scott, Brian/0000-0002-7012-4696				Albers J J, 1986, Methods Enzymol, V129, P763; ASSMANN G, 1993, CIRCULATION, V87, P28; BANKA CL, 1991, J BIOL CHEM, V266, P23886; Bergeron J, 1997, BBA-LIPID LIPID MET, V1344, P139, DOI 10.1016/S0005-2760(96)00136-1; BERGERON J, 1995, J BIOL CHEM, V270, P27429, DOI 10.1074/jbc.270.46.27429; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; BRESLOW JL, 1995, METABOLIC MOL BASES, P2031; BRINTON EA, 1989, J CLIN INVEST, V84, P262, DOI 10.1172/JCI114149; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Bruckert E, 1997, ATHEROSCLEROSIS, V128, P121, DOI 10.1016/S0021-9150(96)05982-5; CALABRESI L, 1993, BIOCHEMISTRY-US, V32, P6477, DOI 10.1021/bi00076a023; Calabresi L, 1997, CURR OPIN LIPIDOL, V8, P219, DOI 10.1097/00041433-199708000-00005; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Collet X, 1997, J LIPID RES, V38, P634; Daum U, 1999, J LIPID RES, V40, P486; Daum U, 1999, J MOL MED, V77, P614, DOI 10.1007/s001099900034; DEEB SS, 1991, J BIOL CHEM, V266, P13654; Dhoest A, 1997, J BIOL CHEM, V272, P15967, DOI 10.1074/jbc.272.25.15967; EISENBERG S, 1984, J LIPID RES, V25, P1017; Frank PG, 2000, J LIPID RES, V41, P853; Frank PG, 1998, BIOCHEMISTRY-US, V37, P13902, DOI 10.1021/bi981205b; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Holvoet P, 2000, ARTERIOSCL THROM VAS, V20, P459, DOI 10.1161/01.ATV.20.2.459; Jiang XC, 1999, J CLIN INVEST, V103, P907, DOI 10.1172/JCI5578; Lee M, 2000, J LIPID RES, V41, P975; Lindholm EM, 1998, BIOCHEMISTRY-US, V37, P4863, DOI 10.1021/bi972888i; Lindstedt L, 1999, J BIOL CHEM, V274, P22627, DOI 10.1074/jbc.274.32.22627; Marcil M, 1999, LANCET, V354, P1341, DOI 10.1016/S0140-6736(99)07026-9; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; McLeod RS, 1996, J BIOL CHEM, V271, P18445, DOI 10.1074/jbc.271.31.18445; McManus DC, 2000, J BIOL CHEM, V275, P5043, DOI 10.1074/jbc.275.7.5043; Mendez AJ, 1997, BBA-LIPID LIPID MET, V1346, P285, DOI 10.1016/S0005-2760(97)00031-3; MENG QH, 1993, J BIOL CHEM, V268, P16966; Miettinen HE, 1997, ARTERIOSCL THROM VAS, V17, P3021, DOI 10.1161/01.ATV.17.11.3021; Miettinen HE, 1997, ARTERIOSCL THROM VAS, V17, P83, DOI 10.1161/01.ATV.17.1.83; Miller M, 1998, ARTERIOSCL THROM VAS, V18, P1242, DOI 10.1161/01.ATV.18.8.1242; Pirillo A, 2000, BIOCHEM BIOPH RES CO, V271, P386, DOI 10.1006/bbrc.2000.2649; Qin SC, 2000, J LIPID RES, V41, P269; Roosbeek S, 2001, J LIPID RES, V42, P31; ROSSENEU M, 1995, FASEB J, V9, P768, DOI 10.1096/fasebj.9.9.7601341; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Sakr SW, 1999, BBA-MOL CELL BIOL L, V1438, P85, DOI 10.1016/S1388-1981(99)00041-4; Segrest JP, 2000, CURR OPIN LIPIDOL, V11, P105, DOI 10.1097/00041433-200004000-00002; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Sorci-Thomas MG, 2000, J BIOL CHEM, V275, P12156, DOI 10.1074/jbc.275.16.12156; Sorci-Thomas MG, 1998, J BIOL CHEM, V273, P11776, DOI 10.1074/jbc.273.19.11776; Sparks DL, 1998, BBA-LIPID LIPID MET, V1390, P160, DOI 10.1016/S0005-2760(97)00172-0; SPARKS DL, 1995, J BIOL CHEM, V270, P5151, DOI 10.1074/jbc.270.10.5151; SPARKS DL, 1992, J BIOL CHEM, V267, P25839; SUBRAHMANYAN L, 1988, SCAND J IMMUNOL, V27, P251, DOI 10.1111/j.1365-3083.1988.tb02345.x; Sviridov D, 2000, J BIOL CHEM, V275, P19707, DOI 10.1074/jbc.M000962200; SWANEY JB, 1978, J BIOL CHEM, V253, P7069; THOMAS SS, 1995, BBA-MOL BASIS DIS, V1272, P37, DOI 10.1016/0925-4439(95)00065-C; Uboldi P, 1996, J LIPID RES, V37, P2557; Velez-Carrasco W, 2000, ARTERIOSCL THROM VAS, V20, P801, DOI 10.1161/01.ATV.20.3.801; von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13, DOI 10.1161/01.ATV.21.1.13; VONECKARDSTEIN A, 1989, J CLIN INVEST, V84, P1722, DOI 10.1172/JCI114355; WEISGRABER KH, 1980, J CLIN INVEST, V66, P901, DOI 10.1172/JCI109957; Yamakawa-Kobayashi K, 1999, HUM MOL GENET, V8, P331, DOI 10.1093/hmg/8.2.331	60	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21292	21302		10.1074/jbc.M100463200	http://dx.doi.org/10.1074/jbc.M100463200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11292828	hybrid			2022-12-27	WOS:000169297900067
J	Canicio, J; Ruiz-Lozano, P; Carrasco, M; Palacin, M; Chien, K; Zorzano, A; Kaliman, P				Canicio, J; Ruiz-Lozano, P; Carrasco, M; Palacin, M; Chien, K; Zorzano, A; Kaliman, P			Nuclear factor kappa B-inducing kinase and I kappa B kinase-alpha signal skeletal muscle cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-THREONINE KINASE; NITRIC-OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3-KINASE; IKK-ALPHA; EXPRESSION; MYOGENESIS; ACTIVATION; PHOSPHORYLATION; MYOBLASTS; PROTEIN	Nuclear factor kappaB (NF-kappaB)-inducing kinase (NIK), I kappaB kinase (IKK)-alpha and -beta, and I kappaB alpha are common elements that signal NF-kappaB activation in response to diverse stimuli. In this study, we analyzed the role of this pathway during insulin-like growth factor II. (IGF-II)-induced myoblast differentiation. L6E9 myoblasts differentiated with IGF-II showed an induction of NF-kappaB DNA-binding activity that correlated in time with the activation of IKK alpha. IKK beta, and NIK. Moreover, the activation of IKK alpha, IKK beta, and NIK by IGF-II was dependent on phosphatidylinositol 3-kinase, a key regulator of myogenesis, Adenoviral transduction with the I kappaB alpha (S32A/S36A) mutant severely impaired both IGF-II-dependent NF-kappaB activation and myoblast differentiation, indicating that phosphorylation of I kappaB alpha at Ser-32 and Ser-36 is an essential myogenic step. Adenoviral transfer of wild-type or kinase-deficient forms of IKK alpha or IKK beta revealed that IKK alpha is required for IGF-II-dependent myoblast differentiation, whereas IKK beta is not essential for this process. Finally, overexpression of kinase-proficient wild-type NIK showed that the activation of MK is sufficient to generate signals that trigger myogenin expression and multinucleated myotube formation in the absence of IGF-II.	Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Barcelona; University of California System; University of California San Diego	Kaliman, P (corresponding author), Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Avda Diagonal 645, E-08028 Barcelona, Spain.		Palacín, Manuel/G-9786-2015; Zorzano, Antonio/R-5479-2018	Palacin, Manuel/0000-0002-8670-293X				Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; DENIS C, 1999, MOL CELL BIOL, V19, P5785; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Engert JC, 1996, J CELL BIOL, V135, P431, DOI 10.1083/jcb.135.2.431; EWTON DZ, 1987, ENDOCRINOLOGY, V120, P115, DOI 10.1210/endo-120-1-115; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; GILMORE TD, 1993, TRENDS GENET, V9, P427, DOI 10.1016/0168-9525(93)90106-R; GRAHAM FL, 1995, MOL BIOTECHNOL, V3, P207, DOI 10.1007/BF02789331; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Kaliman P, 1999, J BIOL CHEM, V274, P17437, DOI 10.1074/jbc.274.25.17437; Kaliman P, 1998, MOL ENDOCRINOL, V12, P66, DOI 10.1210/mend.12.1.0047; KALIMAN P, 1996, J BIOL CHEM, V271, P146; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Lee KH, 1997, BIOCHEM J, V324, P237, DOI 10.1042/bj3240237; LEE KH, 1994, J BIOL CHEM, V269, P14371; Lehtinen SK, 1996, BIOCHEM BIOPH RES CO, V229, P36, DOI 10.1006/bbrc.1996.1754; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; Ozes ON, 1999, NATURE, V401, P82; Pinset C, 1997, CR ACAD SCI III-VIE, V320, P367, DOI 10.1016/S0764-4469(97)85024-X; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; ROSENTHAL SM, 1995, P NATL ACAD SCI USA, V92, P10307, DOI 10.1073/pnas.92.22.10307; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1999, MOL CELL BIOL, V19, P4547	39	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20228	20233		10.1074/jbc.M100718200	http://dx.doi.org/10.1074/jbc.M100718200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279241	hybrid			2022-12-27	WOS:000169135100076
J	Lisby, M; Olesen, JR; Skouboe, C; Krogh, BO; Straub, T; Boege, F; Velmurugan, S; Martensen, PM; Andersen, AH; Jayaram, M; Westergaard, O; Knudsen, BR				Lisby, M; Olesen, JR; Skouboe, C; Krogh, BO; Straub, T; Boege, F; Velmurugan, S; Martensen, PM; Andersen, AH; Jayaram, M; Westergaard, O; Knudsen, BR			Residues within the N-terminal domain of human topoisomerase I play a direct role in relaxation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA TOPOISOMERASES; CELL-CYCLE ARREST; CATALYTIC ACTIVITY; BINDING SEQUENCE; SPLICING FACTOR; PURIFICATION; CLEAVAGE; PHOSPHORYLATION; MECHANISM; CAMPTOTHECIN	All eukaryotic forms of DNA topoisomerase I contain an extensive and highly charged N-terminal domain. This domain contains several nuclear localization sequences and is essential for in vivo function of the enzyme. However, so far no direct function of the N-terminal. domain in the in vitro topoisomerase I reaction has been reported. In this study we have compared the in vitro activities of a truncated form of human topoisomerase I lacking amino acids 1-206 (p67) with the full-length enzyme (p91). Using these enzyme forms, we have identified for the first time a direct role of residues within the N-terminal domain in modulating topoisomerase I catalysis, as revealed by significant differences between p67 and p91 in 13NA binding, cleavage, strand rotation, and ligation. A comparison with previously published studies showing no effect of deleting the first 174 or 190 amino acids of topoisomerase I (Stewart, L., Ireton, G. C., and Champoux, J. J. (1999) J. Biol. Chem. 274 32950-32960; Bronstein, I. B., Wynne-Jones, A., Sukhanoua, A., Fleury, F., Ianoul, A., Holden, J. A., Alix, A. J., Dodson, G. G., Jardillier, J. C., Nabiev, I., and Wilkinson, A. J. (1999) Anticancer Res. 19, 317-327) suggests a pivotal role of amino acids 191-206 in catalysis. Taken together the presented data indicate that at least part(s) of the N-terminal domain regulate(s) enzyme/DNA dynamics during relaxation most probably by controlling non-covalent DNA binding downstream of the cleavage site either directly or by coordinating DNA contacts by other parts of the enzyme.	Aarhus Univ, Dept Mol & Struct Biol, DK-8000 Aarhus C, Denmark; Univ Wurzburg, Sch Med, Med Poliklin, D-97070 Wurzburg, Germany; Univ Texas, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	Aarhus University; University of Wurzburg; University of Texas System; University of Texas Austin	Knudsen, BR (corresponding author), Aarhus Univ, Dept Mol & Struct Biol, CF Mollers Alle,Bldg 130, DK-8000 Aarhus C, Denmark.		Martensen, Pia/I-3996-2012; Andersen, Anni/O-1162-2017; Murugan, Vel/AAA-3554-2019; Lisby, Michael/K-9814-2014; Straub, Tobias/B-2023-2009; Murugan, Vel/AAX-9679-2020; Boege, Fritz/H-3261-2019	Lisby, Michael/0000-0002-4830-5247; Straub, Tobias/0000-0002-0547-0453; Murugan, Vel/0000-0002-7368-7742; Olesen, Jes/0000-0002-6712-2702; Martensen, Pia Moller/0000-0002-1259-0226; Knudsen, Birgitta Ruth/0000-0002-3484-3802; Andersen, Anni/0000-0001-7194-3258				ALSNER J, 1992, J BIOL CHEM, V267, P12408; ATTARDI DG, 1981, J BIOL CHEM, V256, P3654; Bharti AK, 1996, J BIOL CHEM, V271, P1993, DOI 10.1074/jbc.271.4.1993; BONVEN BJ, 1985, CELL, V41, P541, DOI 10.1016/S0092-8674(85)80027-1; Bronstein IB, 1999, ANTICANCER RES, V19, P317; CHAMPOUX JJ, 1978, J MOL BIOL, V118, P441, DOI 10.1016/0022-2836(78)90238-3; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; CHRISTIANSEN K, 1994, J BIOL CHEM, V269, P721; DARPA P, 1988, P NATL ACAD SCI USA, V85, P2543, DOI 10.1073/pnas.85.8.2543; ENG WK, 1988, MOL PHARMACOL, V34, P755; Gobert C, 1996, BIOCHEMISTRY-US, V35, P5778, DOI 10.1021/bi952327w; Haluska P, 1998, ADV ENZYME REGUL, V38, P253, DOI 10.1016/S0065-2571(97)00008-3; Haluska P, 1999, NUCLEIC ACIDS RES, V27, P2538, DOI 10.1093/nar/27.12.2538; JAVAHERIAN K, 1983, NUCLEIC ACIDS RES, V11, P461, DOI 10.1093/nar/11.2.461; Jensen AD, 1996, EUR J BIOCHEM, V236, P389, DOI 10.1111/j.1432-1033.1996.00389.x; Knudsen BR, 1996, J CHROMATOGR B, V684, P307, DOI 10.1016/0378-4347(96)00152-1; KORDIYAK GJ, 1994, BIOCHEMISTRY-US, V33, P13484, DOI 10.1021/bi00249a037; Krogh BO, 2000, MOL CELL, V5, P1035, DOI 10.1016/S1097-2765(00)80268-3; Labourier E, 1998, NUCLEIC ACIDS RES, V26, P2955, DOI 10.1093/nar/26.12.2955; LAZARUS GM, 1987, BIOCHEMISTRY-US, V26, P6195, DOI 10.1021/bi00393a036; LEVIN NA, 1993, GENETICS, V133, P799; Lisby M, 1998, BIOCHEMISTRY-US, V37, P10815, DOI 10.1021/bi980757r; LIU LF, 1981, P NATL ACAD SCI-BIOL, V78, P3487, DOI 10.1073/pnas.78.6.3487; MCCONAUGHY BL, 1981, BIOCHIM BIOPHYS ACTA, V655, P1, DOI 10.1016/0005-2787(81)90059-9; Megonigal MD, 1997, J BIOL CHEM, V272, P12801, DOI 10.1074/jbc.272.19.12801; POMMIER Y, 1990, J BIOL CHEM, V265, P9418; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Redinbo MR, 2000, BIOCHEMISTRY-US, V39, P6832, DOI 10.1021/bi992690t; RIGGS AD, 1970, J MOL BIOL, V48, P67, DOI 10.1016/0022-2836(70)90219-6; RIOU JF, 1986, BIOCHEMISTRY-US, V25, P1471, DOI 10.1021/bi00355a001; ROWE TC, 1981, J BIOL CHEM, V256, P354; SAMUELS DS, 1994, BBA-MOL CELL RES, V1223, P77, DOI 10.1016/0167-4889(94)90075-2; SHUMAN S, 1990, J BIOL CHEM, V265, P17826; Staron K, 1998, MOL BIOL REP, V25, P157, DOI 10.1023/A:1006827925817; STEVNSNER T, 1989, J BIOL CHEM, V264, P10110; Stewart L, 1999, J BIOL CHEM, V274, P32950, DOI 10.1074/jbc.274.46.32950; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stewart L, 1996, J BIOL CHEM, V271, P7602, DOI 10.1074/jbc.271.13.7602; Stewart L, 1996, J BIOL CHEM, V271, P7593, DOI 10.1074/jbc.271.13.7593; STIVERS JT, 1994, BIOCHEMISTRY-US, V33, P327, DOI 10.1021/bi00167a043; Straub T, 1998, J BIOL CHEM, V273, P26261, DOI 10.1074/jbc.273.41.26261; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SVEJSTRUP JQ, 1991, J MOL BIOL, V222, P669, DOI 10.1016/0022-2836(91)90503-X; Takata M, 2000, MOL MICROBIOL, V35, P454, DOI 10.1046/j.1365-2958.2000.01722.x	44	45	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20220	20227		10.1074/jbc.M010991200	http://dx.doi.org/10.1074/jbc.M010991200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11283003	hybrid			2022-12-27	WOS:000169135100075
J	Perez-Terzic, C; Gacy, AM; Bortolon, R; Dzeja, PP; Puceat, M; Jaconi, M; Prendergast, FG; Terzic, A				Perez-Terzic, C; Gacy, AM; Bortolon, R; Dzeja, PP; Puceat, M; Jaconi, M; Prendergast, FG; Terzic, A			Directed inhibition of nuclear import in cellular hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE COMPLEX; CARDIAC-HYPERTROPHY; NUCLEOCYTOPLASMIC TRANSPORT; HISTONE H1; GENE-EXPRESSION; PROTEIN EXPORT; HEART-FAILURE; MESSENGER-RNA; LEPTOMYCIN-B; SIGNAL	Each nuclear pore is responsible for both nuclear import and export with a finite capacity for bidirectional transport across the nuclear envelope, It remains poorly understood how the nuclear transport pathway responds to increased demands for nucleocytoplasmic communication. A case in point is cellular hypertrophy in which increased amounts of genetic material need to be transported from the nucleus to the cytosol, Here, we report an adaptive down-regulation of nuclear import supporting such an increased demand for nuclear export, The induction of cardiac cell hypertrophy by phenylephrine or angiotensin II inhibited the nuclear translocation of HI histones. The removal of hypertrophic stimuli reversed the hypertrophic phenotype and restored nuclear import. Moreover, the inhibition of nuclear export by leptomycin B rescued import, Hypertrophic reprogramming increased the intracellular GTP/GDP ratio and promoted the nuclear redistribution of the GTP-binding transport factor Ran, favoring export over import, Further, in hypertrophy, the reduced creatine kinase and adenylate kinase activities Limited energy delivery to the nuclear pore. The reduction of activities was associated with the closure of the cytoplasmic phase of the nuclear pore preventing import at the translocation step. Thus, to overcome the Limited capacity for nucleocytoplasmic transport, cells requiring increased nuclear export regulate the nuclear transport pathway by undergoing a metabolic and structural restriction of nuclear import.	Mayo Clin & Mayo Fdn, Dept Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Phys Med & Rehabil, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Terzic, A (corresponding author), Mayo Clin & Mayo Fdn, Dept Med, Div Cardiovasc Dis, Guggenhiem 7, Rochester, MN 55905 USA.	terzic.andre@mayo.edu	PUCEAT, michel/R-6140-2017; Jaconi, Marisa EE/J-4392-2013	PUCEAT, michel/0000-0001-9055-7563; Jaconi, Marisa/0000-0002-2004-8226	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064822] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL07111, HL64822] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; BISHOPRIC NH, 1987, J CLIN INVEST, V80, P1194, DOI 10.1172/JCI113179; BREEUWER M, 1990, CELL, V60, P999, DOI 10.1016/0092-8674(90)90348-I; Brodsky AS, 1999, NAT CELL BIOL, V1, pE66, DOI 10.1038/11036; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Corbett AH, 1997, MICROBIOL MOL BIOL R, V61, P193, DOI 10.1128/.61.2.193-211.1997; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; DINGWALL C, 1992, SCIENCE, V258, P942, DOI 10.1126/science.1439805; Dzeja PP, 1999, CIRC RES, V84, P1137, DOI 10.1161/01.RES.84.10.1137; Dzeja PP, 1999, MOL CELL BIOCHEM, V201, P33, DOI 10.1023/A:1007016703229; Dzeja PP, 1998, FASEB J, V12, P523, DOI 10.1096/fasebj.12.7.523; Englmeier L, 1999, CURR BIOL, V9, P30, DOI 10.1016/S0960-9822(99)80044-X; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; GREBER UF, 1995, J CELL BIOL, V128, P5, DOI 10.1083/jcb.128.1.5; Hieda M, 1999, J CELL BIOL, V144, P645, DOI 10.1083/jcb.144.4.645; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; IZUMO S, 1987, J CLIN INVEST, V79, P970, DOI 10.1172/JCI112908; Jaconi M, 2000, MOL BIOL CELL, V11, P1845, DOI 10.1091/mbc.11.5.1845; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; Janssen E, 2000, EMBO J, V19, P6371, DOI 10.1093/emboj/19.23.6371; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; McKinsey TA, 1999, CURR OPIN GENET DEV, V9, P267, DOI 10.1016/S0959-437X(99)80040-9; Meyer N, 2000, FEBS LETT, V478, P151, DOI 10.1016/S0014-5793(00)01839-1; MICHAEL WM, 1995, CELL, V83, P415; Moore JD, 2001, BIOESSAYS, V23, P77, DOI 10.1002/1521-1878(200101)23:1<77::AID-BIES1010>3.3.CO;2-5; Moore MS, 1998, J BIOL CHEM, V273, P22857, DOI 10.1074/jbc.273.36.22857; Nachury MV, 1999, P NATL ACAD SCI USA, V96, P9622, DOI 10.1073/pnas.96.17.9622; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Ohno M, 1998, CELL, V92, P327, DOI 10.1016/S0092-8674(00)80926-5; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Pante N, 1996, SCIENCE, V273, P1729, DOI 10.1126/science.273.5282.1729; Pemberton LF, 1998, CURR OPIN CELL BIOL, V10, P392, DOI 10.1016/S0955-0674(98)80016-1; Pennisi E, 1998, SCIENCE, V279, P1129, DOI 10.1126/science.279.5354.1129; Perez-Terzic C, 1999, CIRC RES, V84, P1292, DOI 10.1161/01.RES.84.11.1292; PerezTerzic C, 1997, BIOESSAYS, V19, P787, DOI 10.1002/bies.950190908; PerezTerzic C, 1996, SCIENCE, V273, P1875, DOI 10.1126/science.273.5283.1875; Post GR, 1996, J BIOL CHEM, V271, P8452, DOI 10.1074/jbc.271.14.8452; Pucar D, 2000, J BIOL CHEM, V275, P41424, DOI 10.1074/jbc.M007903200; Puceat M, 1996, BIOCHEM J, V318, P723, DOI 10.1042/bj3180723; Rakowska A, 1998, J MEMBRANE BIOL, V163, P129, DOI 10.1007/s002329900377; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; STEHNOBITTEL L, 1995, SCIENCE, V270, P1835, DOI 10.1126/science.270.5243.1835; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; SWAIN JL, 1982, P NATL ACAD SCI-BIOL, V79, P655, DOI 10.1073/pnas.79.2.655; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; TERZIC A, 1993, PHARMACOL REV, V45, P147; Terzic A, 1996, J PHYSIOL-LONDON, V492, P395, DOI 10.1113/jphysiol.1996.sp021316; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Thomas JO, 1999, CURR OPIN CELL BIOL, V11, P312, DOI 10.1016/S0955-0674(99)80042-8; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4	57	23	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20566	20571		10.1074/jbc.M101950200	http://dx.doi.org/10.1074/jbc.M101950200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11283025	hybrid			2022-12-27	WOS:000169135100120
J	Sapkota, GP; Kieloch, A; Lizcano, JM; Lain, S; Arthur, JSC; Williams, MR; Morrice, N; Deak, M; Alessi, DR				Sapkota, GP; Kieloch, A; Lizcano, JM; Lain, S; Arthur, JSC; Williams, MR; Morrice, N; Deak, M; Alessi, DR			Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser(431) by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; GLYCOGEN-SYNTHASE KINASE-3; SERINE-THREONINE KINASE; EMBRYONIC STEM-CELLS; IN-VIVO; MAPKAP KINASE-1; MOLECULAR-BASIS; BH3 DOMAIN; ACTIVATION; BAD	Peutz-Jeghers syndrome is an inherited cancer syndrome that results in a greatly increased risk of developing tumors in those affected, The causative gene is a protein kinase termed LKB1, predicted to function as a tumor suppressor, The mechanism by which LKB1 is regulated in cells is not known. Here, we demonstrate that stimulation of Rat-a or embryonic stem cells with activators of ERK1/2 or of cAMP-dependent protein kinase induced phosphorylation of endogenously expressed LKB1 at Ser(431), We present pharmacological and genetic evidence that p90(RSK) mediated this phosphorylation in response to agonists that activate ERK1/2 and that cAMP-dependent protein kinase mediated this phosphorylation in response to agonists that activate adenylate cyclase, Ser(431) of LKB1 lies adjacent to a putative prenylation motif, and we demonstrate that full-length LKB1 expressed in 293 cells was prenylated by addition of a farnesyl group to Cys(433). Our data suggest that phosphorylation of LKB1 at Ser(431) does not affect farnesylation and that farnesylation does not affect phosphorylation at Ser(431), Phosphorylation of LKB1 at Ser(431) did not alter the activity of LKB1 to phosphorylate itself or the tumor suppressor protein p53 or alter the amount of LKB1 associated with cell membranes. The reintroduction of wild-type LKB1 into a cancer cell line that lacks LKB1 suppressed growth, but mutants of LKB1 in which Ser(431) was mutated to Ala to prevent phosphorylation of LKB1 were ineffective in inhibiting growth. In contrast, a mutant of LKB1 that cannot be prenylated was still able to suppress the growth of cells.	Univ Dundee, Sch Life Sci, Med Res Council Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; Ninewells Hosp, Canc Res Campaign Cell Transformat Grp, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee	Alessi, DR (corresponding author), Univ Dundee, Sch Life Sci, Med Res Council Prot Phosphorylat Unit, Dow St, Dundee DD1 5EH, Scotland.		Lizcano, Jose M/E-6080-2010; Arthur, J. Simon/B-8058-2010; lizcano, jose m/AAK-3577-2020; Lain, Sonia/B-6980-2014	Lizcano, Jose M/0000-0002-3154-5383; Arthur, J. Simon/0000-0002-8135-1958; lizcano, jose m/0000-0002-3154-5383; Lain, Sonia/0000-0001-9693-5246; Alessi, Dario/0000-0002-2140-9185				ALESSI DR, 1995, METHOD ENZYMOL, V255, P279; Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Balendran A, 1999, J BIOL CHEM, V274, P37400, DOI 10.1074/jbc.274.52.37400; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bornfeldt KE, 1999, CELL SIGNAL, V11, P465, DOI 10.1016/S0898-6568(99)00020-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caivano M, 2000, J IMMUNOL, V164, P3018, DOI 10.4049/jimmunol.164.6.3018; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DAVIS PD, 1992, J MED CHEM, V35, P177, DOI 10.1021/jm00079a024; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Deak M, 1999, FEBS LETT, V451, P220, DOI 10.1016/S0014-5793(99)00556-6; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; DUMONT JE, 1989, TRENDS BIOCHEM SCI, V14, P67, DOI 10.1016/0968-0004(89)90046-7; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Harlow E., 1988, ANTIBODIES LAB MANUA; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hemminki A, 1999, CELL MOL LIFE SCI, V55, P735, DOI 10.1007/s000180050329; HIDAKA H, 1990, NEUROCHEM RES, V15, P431, DOI 10.1007/BF00969929; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; LEIGHTON IA, 1995, FEBS LETT, V375, P289, DOI 10.1016/0014-5793(95)01170-J; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; MAENHAUT C, 1991, BIOCHIMIE, V73, P29, DOI 10.1016/0300-9084(91)90070-H; Mehenni H, 1998, AM J HUM GENET, V63, P1641, DOI 10.1086/302159; MIDGLEY CA, 1992, J CELL SCI, V101, P183; MOORES SL, 1991, J BIOL CHEM, V266, P14603; Nezu J, 1999, BIOCHEM BIOPH RES CO, V261, P750, DOI 10.1006/bbrc.1999.1047; Powis G, 1995, ACTA BIOCHIM POL, V42, P395; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Scheid MP, 1999, J BIOL CHEM, V274, P31108, DOI 10.1074/jbc.274.43.31108; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Shaw M, 1999, FEBS LETT, V461, P120, DOI 10.1016/S0014-5793(99)01434-9; Smith DP, 1999, HUM MOL GENET, V8, P1479, DOI 10.1093/hmg/8.8.1479; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; Su JY, 1996, J BIOL CHEM, V271, P14430, DOI 10.1074/jbc.271.24.14430; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Watts JL, 2000, DEVELOPMENT, V127, P1467; Westerman AM, 1999, LANCET, V353, P1211, DOI 10.1016/S0140-6736(98)08018-0; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhou XM, 2000, J BIOL CHEM, V275, P25046, DOI 10.1074/jbc.M002526200	58	206	212	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19469	19482		10.1074/jbc.M009953200	http://dx.doi.org/10.1074/jbc.M009953200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11297520	hybrid			2022-12-27	WOS:000169091000109
J	Lollike, K; Johnsen, AH; Durussel, I; Borregaard, N; Cox, JA				Lollike, K; Johnsen, AH; Durussel, I; Borregaard, N; Cox, JA			Biochemical characterization of the penta-EF-hand protein grancalcin and identification of L-plastin as a binding partner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	38th Annual Meeting of the American-Society-for-Cell-Biology	DEC 12-16, 1998	SAN FRANCISCO, CALIFORNIA	Amer Soc Cell Biol			CALCIUM-DEPENDENT PROTEASE; HUMAN NEUTROPHILS; POLYACRYLAMIDE GELS; CRYSTAL-STRUCTURE; SMALL-SUBUNIT; CALPAIN; MEMBER; FAMILY; ALG-2; DOMAIN	Grancalcin is a recently described Ca2+-binding protein especially abundant in human neutrophils, Grancalcin belongs to the penta-EF-hand subfamily of EF-hand proteins, which also comprises calpain, sorcin, peflin, and ALG-2. Penta-EF-hand members are typified by two novel types of EF-hands: one that binds Ca2+ although it has an unusual Ca2+ coordination loop and one that does not bind Ca2+ but is directly involved in homodimerization, We have developed a novel method for purification of native grancalcin and found that the N terminus of wild-type grancalcin is acetylated, This posttranslational modification does not affect the secondary structure or conformation of the protein. We found that both native and recombinant grancalcin always exists as a homodimer, regardless of the Ca2+ load. Flow dialysis showed that recombinant grancalcin binds two Ca2+ per subunit with positive cooperativity and moderate affinity ([Ca2+](0.5) of 25 and 83 muM in the presence and absence of octyl glycoside, respectively) and that the sites are of the Ca2+-specific type. Furthermore, we showed, by several independent methods, that grancalcin undergoes important conformational changes upon binding of Ca2+ and subsequently exposes hydrophobic amino acid residues, which direct the protein to hydrophobic surfaces. By affinity chromatography of solubilized human neutrophils on immobilized grancalcin, L-plastin, a leukocyte-specific actin-bundling protein, was found to interact with grancalcin in a negative Ca2+-dependent manner. This was substantiated by co-immunoprecipitation of grancalcin by anti-L-plastin antibodies and vice verse.	Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; Rigshosp, Granulocyte Res Lab, Dept Hematol, DK-2100 Copenhagen, Denmark; Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark	University of Geneva; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Lollike, K (corresponding author), Novo Nordisk AS, Krogshoehvej 53A, DK-2880 Bagsvaerd, Denmark.							ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532; BORREGAARD N, 1992, FEBS LETT, V304, P195, DOI 10.1016/0014-5793(92)80617-P; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; BOYHAN A, 1992, J BIOL CHEM, V267, P2928; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; COLOWICK SP, 1969, J BIOL CHEM, V244, P774; Cox J.A., 1996, GUIDEBOOK CALCIUM BI, P1; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P49; Dutt P, 1998, FEBS LETT, V436, P367, DOI 10.1016/S0014-5793(98)01167-3; Han Q, 2000, ACTA CRYSTALLOGR D, V56, P772, DOI 10.1107/S0907444900005096; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Jia J, 2000, J MOL BIOL, V300, P1271, DOI 10.1006/jmbi.2000.3925; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Jones SL, 1996, J BIOL CHEM, V271, P14623, DOI 10.1074/jbc.271.24.14623; Kitaura Y, 1999, BIOCHEM BIOPH RES CO, V263, P68, DOI 10.1006/bbrc.1999.1189; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin GD, 1997, NAT STRUCT BIOL, V4, P539, DOI 10.1038/nsb0797-539; Lo KWH, 1999, BIOCHEMISTRY-US, V38, P7498, DOI 10.1021/bi990034n; LOLLIKE K, 1995, J IMMUNOL METHODS, V185, P1, DOI 10.1016/0022-1759(95)00099-V; Maki M, 1998, J BIOCHEM, V124, P1170, DOI 10.1093/oxfordjournals.jbchem.a022235; Maki M, 1997, BIOCHEM J, V328, P718; MINAMI Y, 1988, J BIOCHEM-TOKYO, V104, P927, DOI 10.1093/oxfordjournals.jbchem.a122585; Mosior M, 1997, MOL MEMBR BIOL, V14, P65, DOI 10.3109/09687689709068436; NAKAYAMA S, 1994, ANNU REV BIOPH BIOM, V23, P473, DOI 10.1146/annurev.bb.23.060194.002353; Pettit EJ, 1997, HISTOL HISTOPATHOL, V12, P479; TAKEYAMA Y, 1986, FEBS LETT, V194, P110, DOI 10.1016/0014-5793(86)80060-6; Tarabykina S, 2000, J BIOL CHEM, V275, P10514, DOI 10.1074/jbc.275.14.10514; TEAHAN CG, 1992, BIOCHEM J, V286, P549, DOI 10.1042/bj2860549; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang J, 1999, J BIOL CHEM, V274, P24349, DOI 10.1074/jbc.274.34.24349; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; WINSKY L, 1995, J NEUROCHEM, V65, P381; YOSHIZAWA T, 1995, BIOCHEM BIOPH RES CO, V208, P376, DOI 10.1006/bbrc.1995.1348; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569; ZU Y, 1990, BIOCHEMISTRY-US, V29, P1055, DOI 10.1021/bi00456a030	39	42	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17762	17769		10.1074/jbc.M100965200	http://dx.doi.org/10.1074/jbc.M100965200			8	Biochemistry & Molecular Biology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279160	hybrid			2022-12-27	WOS:000168866500021
J	Singh, S; Pandey, K; Chattopadhayay, R; Yazdani, SS; Lynn, A; Bharadwaj, A; Ranjan, A; Chitnis, C				Singh, S; Pandey, K; Chattopadhayay, R; Yazdani, SS; Lynn, A; Bharadwaj, A; Ranjan, A; Chitnis, C			Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax Duffy-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; INTERCELLULAR-ADHESION MOLECULE-1; CHONDROITIN SULFATE; MALARIA; IDENTIFICATION; INVASION; KNOWLESI; ANTIGEN; GLYCOPROTEIN; ANTIBODIES	Invasion of erythrocytes by malaria parasites is mediated by specific molecular interactions. Plasmodium vivax is completely dependent on interaction with the Duffy blood group antigen to invade human erythrocytes, The P, vivax Duffy-binding protein, which binds the Duffy antigen during invasion, belongs to a family of erythrocyte-binding proteins that also includes Plasmodium falciparum sialic acid binding protein and Plasmodium knowlesi Duffy binding protein, The receptor binding domains of these proteins lie in a conserved, N-terminal, cysteine-rich region, region II, found in each of these proteins. Here, we have expressed P. vivax region II (PvRII), the P. vivax Duffy binding domain, in Escherichia coli, Recombinant PvRII is incorrectly folded and accumulates in inclusion bodies. We have developed methods to refold and purify recombinant PvRII in its functional conformation. Biochemical, biophysical, and functional characterization confirms that recombinant PvRII is pure, homogeneous, and functionally active in that it binds Huffy-positive human erythrocytes with specificity. Refolded PvRII is highly immunogenic and elicits high titer antibodies that can inhibit binding of P. vivax Huffy-binding protein to erythrocytes, providing support for its development as a vaccine candidate for P. vivax malaria. Development of methods to produce functionally active recombinant PvRII is an important step for structural studies as well as vaccine development.	Int Ctr Genet Engn & Biotechnol, Malaria Res Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Chitnis, C (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Res Grp, POB 10504,Aruna Asaf Ali Marg, New Delhi 110067, India.	cchitnis@icgeb.res.in	Ranjan, Akash/C-1670-2009	Chitnis, Chetan/0000-0002-8773-9865; Ranjan, Akash/0000-0002-4582-1553				ADAMS JH, 1990, CELL, V63, P141, DOI 10.1016/0092-8674(90)90295-P; ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BREUER WV, 1983, BIOCHIM BIOPHYS ACTA, V755, P263, DOI 10.1016/0304-4165(83)90213-1; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; CHITNIS CE, 1999, MALARIA MOL CLIN ASP, P249; COHEN GH, 1988, J VIROL, V62, P1932, DOI 10.1128/JVI.62.6.1932-1940.1988; DOLAN SA, 1994, MOL BIOCHEM PARASIT, V64, P55, DOI 10.1016/0166-6851(94)90134-1; Dutta S, 2000, MOL BIOCHEM PARASIT, V109, P179, DOI 10.1016/S0166-6851(00)00244-9; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FANG XD, 1991, MOL BIOCHEM PARASIT, V44, P125, DOI 10.1016/0166-6851(91)90228-X; Fraser T, 1997, INFECT IMMUN, V65, P2772, DOI 10.1128/IAI.65.7.2772-2777.1997; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; FRIEDMAN MJ, 1984, J CELL BIOL, V98, P1672, DOI 10.1083/jcb.98.5.1672; HAYNES JD, 1988, J EXP MED, V167, P1873, DOI 10.1084/jem.167.6.1873; Michon P, 2000, INFECT IMMUN, V68, P3164, DOI 10.1128/IAI.68.6.3164-3171.2000; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; MILLER LH, 1977, J EXP MED, V146, P277, DOI 10.1084/jem.146.1.277; MITCHELL GH, 1986, BLOOD, V67, P1519; Narum DL, 2000, INFECT IMMUN, V68, P1964, DOI 10.1128/IAI.68.4.1964-1966.2000; OCKENHOUSE CF, 1992, J EXP MED, V176, P1183, DOI 10.1084/jem.176.4.1183; OCKENHOUSE CF, 1989, SCIENCE, V243, P1469, DOI 10.1126/science.2467377; Okoyeh JN, 1999, INFECT IMMUN, V67, P5784, DOI 10.1128/IAI.67.11.5784-5791.1999; PASVOL G, 1982, NATURE, V297, P64, DOI 10.1038/297064a0; PERKINS ME, 1988, MOL BIOCHEM PARASIT, V27, P23, DOI 10.1016/0166-6851(88)90021-7; Ranjan A, 1999, P NATL ACAD SCI USA, V96, P14067, DOI 10.1073/pnas.96.24.14067; Reeder JC, 1999, P NATL ACAD SCI USA, V96, P5198, DOI 10.1073/pnas.96.9.5198; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; ROWE AJ, 1997, NATURE, V398, P292; SIM BKL, 1990, J CELL BIOL, V111, P1877, DOI 10.1083/jcb.111.5.1877; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Treutiger CJ, 1997, NAT MED, V3, P1405, DOI 10.1038/nm1297-1405; TURNER GDH, 1994, AM J PATHOL, V145, P1057; WERTHEIMER SP, 1989, EXP PARASITOL, V69, P340, DOI 10.1016/0014-4894(89)90083-0	46	79	83	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17111	17116		10.1074/jbc.M101531200	http://dx.doi.org/10.1074/jbc.M101531200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279211	hybrid			2022-12-27	WOS:000168730400069
J	Pallavicini, A; Negrisolo, E; Barbato, R; Dewilde, S; Ghiretti-Magaldi, A; Moens, L; Lanfranchi, G				Pallavicini, A; Negrisolo, E; Barbato, R; Dewilde, S; Ghiretti-Magaldi, A; Moens, L; Lanfranchi, G			The primary structure of globin and linker chains from the chlorocruorin of the polychaete Sabella spallanzanii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WORM RIFTIA-PACHYPTILA; MULTI-HEMOGLOBIN SYSTEM; 3-DIMENSIONAL RECONSTRUCTION; CRYOELECTRON MICROSCOPY; EUDISTYLIA-VANCOUVERII; POLYPEPTIDE-CHAIN; EXTRACELLULAR HEMOGLOBIN; QUATERNARY STRUCTURE; MOLECULAR-WEIGHT; HIERARCHY	Annelid hemoglobins are organized in a very complex supramolecular network of interacting polypeptides, the structure of which is still not wholly resolved. We have separated by two-dimensional electrophoresis the 4-MDa chlorocruorin of Sabella spallanzanii and identified its components by amino-terminal sequencing. This work reveals a high rate of heterogeneity of constituent chains in a single animal as well as in the Sabella population. Using a cDNA library prepared from the hematopoietic tissue of this worm, we have isolated and fully sequenced most globin and linker cDNAs. The primary structure features of these polypeptides have been characterized by comparison with model globin and linker sequences.	Univ Padua, Dipartimento Biol, I-35131 Padua, Italy; Univ Padua, Ctr Ric Interdipartimentale Biotechnol Innovat, Ctr Biotechnol, I-35131 Padua, Italy; Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci & Tecnol Avanzate, I-15100 Alessandria, Italy; Univ Padua, Dipartimento Biol, I-35131 Padua, Italy; Univ Padua, CNR, Ctr Study Metalloprot, I-35131 Padua, Italy; Univ Antwerp, Dept Biochem, B-2020 Antwerp, Belgium	University of Padua; University of Padua; University of Eastern Piedmont Amedeo Avogadro; University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Antwerp	Lanfranchi, G (corresponding author), Univ Padua, Dipartimento Biol, Via Ugo Bassi 58-B, I-35131 Padua, Italy.		Pallavicini, Alberto/H-9281-2019; Negrisolo, Enrico/K-8124-2015; Pallavicini, Alberto/J-4158-2012	Pallavicini, Alberto/0000-0001-7174-4603; Negrisolo, Enrico/0000-0002-6244-805X; Pallavicini, Alberto/0000-0001-7174-4603				ANTONINI E, 1962, ARCH BIOCHEM BIOPHYS, V97, P343, DOI 10.1016/0003-9861(62)90087-5; ANTONINI E, 1962, ARCH BIOCHEM BIOPHYS, V97, P336, DOI 10.1016/0003-9861(62)90086-3; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BARBATO R, 1991, FEBS LETT, V290, P162, DOI 10.1016/0014-5793(91)81250-C; Bjerrum OJ, 1988, CRC HDB IMMUNOBLOTTI; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; deHaas F, 1996, J MOL BIOL, V255, P140, DOI 10.1006/jmbi.1996.0012; deHaas F, 1996, J MOL BIOL, V264, P111, DOI 10.1006/jmbi.1996.0627; deHaas F, 1996, BIOPHYS J, V70, P1973, DOI 10.1016/S0006-3495(96)79762-X; deHaas F, 1996, PROTEINS, V26, P241; deHaas F, 1997, BIOCHEMISTRY-US, V36, P7330, DOI 10.1021/bi970131l; Dewilde S, 1998, J BIOL CHEM, V273, P32467, DOI 10.1074/jbc.273.49.32467; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; Green BN, 1998, BIOCHEMISTRY-US, V37, P6598, DOI 10.1021/bi972644y; Imai K, 1996, COMP BIOCHEM PHYS B, V113, P613, DOI 10.1016/0305-0491(96)83567-X; IMAI K, 1985, EUR J BIOCHEM, V147, P453; KAPP OH, 1995, PROTEIN SCI, V4, P2179, DOI 10.1002/pro.5560041024; Lamy JN, 1996, CHEM REV, V96, P3113, DOI 10.1021/cr9600058; Mezzasalma Vincenza, 1992, Animal Biology, V1, P85; Negrisolo E, 2001, J BIOL CHEM, V276, P26391, DOI 10.1074/jbc.M100557200; QABAR AN, 1991, J MOL BIOL, V222, P1109, DOI 10.1016/0022-2836(91)90596-X; Rashid AK, 1997, J BIOL CHEM, V272, P2992, DOI 10.1074/jbc.272.5.3000; Royer WE, 2000, P NATL ACAD SCI USA, V97, P7107, DOI 10.1073/pnas.97.13.7107; Sambrook J., 2002, MOL CLONING LAB MANU; SUZUKI T, 1995, BBA-PROTEIN STRUCT M, V1252, P189, DOI 10.1016/0167-4838(95)00147-M; SUZUKI T, 1993, J BIOL CHEM, V268, P13548; SUZUKI T, 1990, J BIOL CHEM, V265, P12168; SUZUKI T, 1990, J BIOL CHEM, V265, P1551; TERWILLIGER RC, 1975, BIOCHIM BIOPHYS ACTA, V400, P302, DOI 10.1016/0005-2795(75)90185-3; TERWILLIGER RC, 1976, COMP BIOCHEM PHYS A, V55, P51, DOI 10.1016/0300-9629(76)90122-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vinogradov S.N., 1985, P9; Vinogradov S. N., 1982, ELECTRON MICROS, P135; VINOGRADOV SN, 1991, COMP BIOCHEM PHYS B, V98, P187, DOI 10.1016/0305-0491(91)90165-A; VINOGRADOV SN, 1985, BIOCHIM BIOPHYS ACTA, V828, P43, DOI 10.1016/0167-4838(85)90007-X; Zal F, 1996, J BIOL CHEM, V271, P8875, DOI 10.1074/jbc.271.15.8875; Zal F, 1997, PROTEINS, V29, P562, DOI 10.1002/(SICI)1097-0134(199712)29:4<562::AID-PROT15>3.0.CO;2-K	39	10	10	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 13	2001	276	28					26384	26390		10.1074/jbc.M006939200	http://dx.doi.org/10.1074/jbc.M006939200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451VP	11294828	hybrid			2022-12-27	WOS:000169823300098
J	Nikolopoulos, SN; Turner, CE				Nikolopoulos, SN; Turner, CE			Integrin-linked kinase (ILK) binding to paxillin LD1 motif regulates ILK localization to focal adhesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CELL-ADHESION; IDENTIFICATION; GROWTH; ACTIN; SITES	Paxillin is a focal adhesion adapter protein involved in integrin signaling. Paxillin LD motifs bind several focal adhesion proteins including the focal adhesion kinase, vinculin, the Arf-GTPase-activating protein paxillin-kinase linker, and the newly identified actin-binding protein actopaxin, Microsequencing of peptides derived from a 50-kDa paxillin LD1 motif-binding protein revealed 100% identity with integrin-linked kinase (ILK)-1, a serine/threonine kinase that has been implicated in integrin, growth factor, and Wnt signaling pathways. Cloning of ILK from rat smooth muscle cells generated a cDNA that exhibited 99.6% identity at the amino acid level with human ILK-1. A monoclonal antibody raised against a region of the carboxyl terminus of ILK, which is identical in rat and human ILK-1 protein, recognized a 50-kDa protein in all cultured cells and tissues examined. Binding experiments showed that ILK binds directly to the paxillin LD1 motif in vitro, Coimmunoprecipitation from fibroblasts confirmed that the association between paxillin and ILK occurs in vivo in both adherent cells and cells in suspension. Immunofluorescence microscopy of fibroblasts demonstrated that endogenous ILK as well as transfected green fluorescent protein-ILK co-localizes with paxillin in focal adhesions. Analysis of the deduced amino acid sequence of ILK identified a paxillin-binding subdomain in the carboxyl terminus of ILK. In contrast to wild-type ILK, paxillin-binding subdomain mutants of ILK were unable to bind to the paxillin LD1 motif in vitro and failed to localize to focal adhesions. Thus, paxillin binding is necessary for efficient focal adhesion targeting of ILK and may therefore impact the role of ILK in integrin-mediated signal transduction events.	SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Turner, CE (corresponding author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, 750 E Adams St, Syracuse, NY 13210 USA.	turnerc@mail.upstate.edu			NIGMS NIH HHS [GM47607, R01 GM047607] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047607, R29GM047607] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Brown MC, 1998, MOL BIOL CELL, V9, P1803, DOI 10.1091/mbc.9.7.1803; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Chung DH, 1998, VIRCHOWS ARCH, V433, P113, DOI 10.1007/s004280050225; Cote JF, 1999, J BIOL CHEM, V274, P20550, DOI 10.1074/jbc.274.29.20550; Dedhar S, 1999, TRENDS CELL BIOL, V9, P319, DOI 10.1016/S0962-8924(99)01612-8; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Herreros L, 2000, J BIOL CHEM, V275, P26436, DOI 10.1074/jbc.M003970200; Huang Y, 1999, INT J MOL MED, V3, P563; Janji B, 2000, ONCOGENE, V19, P3069, DOI 10.1038/sj.onc.1203640; Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379; Li FG, 1997, BBA-MOL CELL RES, V1358, P215, DOI 10.1016/S0167-4889(97)00089-X; Li FG, 1999, J CELL SCI, V112, P4589; Liu SC, 2000, J CELL SCI, V113, P3563; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; TACHIBANA K, 1995, J EXP MED, V182, P1089, DOI 10.1084/jem.182.4.1089; Torres MA, 2000, J CELL BIOL, V149, P1433, DOI 10.1083/jcb.149.7.1433; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Turner CE, 1998, INT J BIOCHEM CELL B, V30, P955, DOI 10.1016/S1357-2725(98)00062-4; Turner CE, 1991, CURR OPIN CELL BIOL, V3, P849, DOI 10.1016/0955-0674(91)90059-8; WOOD CK, 1994, J CELL SCI, V107, P709; Wu CY, 1998, J BIOL CHEM, V273, P528, DOI 10.1074/jbc.273.1.528	27	172	181	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23499	23505		10.1074/jbc.M102163200	http://dx.doi.org/10.1074/jbc.M102163200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11304546	hybrid			2022-12-27	WOS:000169531100038
J	Jacobsen, L; Madsen, P; Jacobsen, C; Nielsen, MS; Gliemann, J; Petersen, CM				Jacobsen, L; Madsen, P; Jacobsen, C; Nielsen, MS; Gliemann, J; Petersen, CM			Activation and functional characterization of the mosaic receptor SorLA/LR11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; LIGAND-BINDING; PROTEIN RAP; SORTILIN/NEUROTENSIN RECEPTOR-3; SORTING RECEPTOR; FAMILY MEMBER; HUMAN BRAIN; EXPRESSION; LR11; IDENTIFICATION	We previously isolated and sequenced the similar to 250-kDa type 1 receptor sorLA/LR11, a mosaic protein with elements characterizing the Vps10p domain receptor family as well as the low density lipoprotein receptor family. The N terminus of the Vps10p domain comprises a consensus sequence for cleavage by furin ((RRKR53)-R-50) that precedes a truncation found in sorLA isolated from human brain. Here we show that sorLA, like sortilin-1/neurotensin receptor-3, whose lumenal domain consists of a Vps10p domain only, is synthesized as a proreceptor that is cleaved by furin in late Gels compartments. We show that the truncation conditions the Vps10p domain for propeptide inhibitable binding of neuropeptides and the receptor-associated protein. We further demonstrate that avid binding of the receptor-associated protein, apolipoprotein E, and lipoprotein lipase not inhibited by propeptide occurs to sites located in other lumenal domains. In transfected cells, about 10% of full-length sorLA were expressed on the cell surface capable of mediating endocytosis. However, the major pool of receptors was found in late Gels compartments, suggesting possible interaction with newly synthesized ligands. The results show that sorLA, following activation by truncation, binds multiple ligands and may mediate both endocytosis and sorting.	Univ Aarhus, Dept Biochem Med, DK-8000 Aarhus C, Denmark	Aarhus University	Gliemann, J (corresponding author), Univ Aarhus, Dept Biochem Med, Ole Worms Alle,Bldg 170, DK-8000 Aarhus C, Denmark.	jg@biokemi.au.dk	Nielsen, Morten Schallburg/G-9498-2016	Nielsen, Morten Schallburg/0000-0001-9863-9694; Madsen, Peder Sondergaard/0000-0002-8845-4802				Andersen OM, 2000, J BIOL CHEM, V275, P21017, DOI 10.1074/jbc.M000507200; BENGTSSONOLIVECRONA G, 1991, METHOD ENZYMOL, V197, P345; BODENMULLER H, 1986, EMBO J, V5, P1825, DOI 10.1002/j.1460-2075.1986.tb04433.x; de Chaves EIP, 2000, J BIOL CHEM, V275, P19883, DOI 10.1074/jbc.275.26.19883; Gliemann J, 1998, BIOL CHEM, V379, P951; Hampe W, 1999, DEVELOPMENT, V126, P4077; Hampe W, 2000, J CELL SCI, V113, P4475; Hermans-Borgmeyer I, 1998, MECH DEVELOP, V70, P65, DOI 10.1016/S0925-4773(97)00177-9; Hermey G, 1999, BIOCHEM BIOPH RES CO, V266, P347, DOI 10.1006/bbrc.1999.1822; Hirayama S, 2000, BIOCHEM BIOPH RES CO, V275, P365, DOI 10.1006/bbrc.2000.3312; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Kanaki T, 1999, ARTERIOSCL THROM VAS, V19, P2687, DOI 10.1161/01.ATV.19.11.2687; Kanaki T, 1998, DNA CELL BIOL, V17, P647, DOI 10.1089/dna.1998.17.647; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; LAFLAMME SE, 1994, J CELL BIOL, V126, P1287, DOI 10.1083/jcb.126.5.1287; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Morwald S, 1997, ARTERIOSCL THROM VAS, V17, P996, DOI 10.1161/01.ATV.17.5.996; Motoi Y, 1999, BRAIN RES, V833, P209, DOI 10.1016/S0006-8993(99)01542-5; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; Petersen CM, 1996, EMBO J, V15, P4165, DOI 10.1002/j.1460-2075.1996.tb00791.x; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Savonen R, 1999, J BIOL CHEM, V274, P25877, DOI 10.1074/jbc.274.36.25877; Simmons T, 1997, J BIOL CHEM, V272, P25531, DOI 10.1074/jbc.272.41.25531; SUN Y, 1993, BIOTECHNIQUES, V15, P372; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x; Willnow TE, 1998, BIOL CHEM, V379, P1025; Yamazaki H, 1996, J BIOL CHEM, V271, P24761, DOI 10.1074/jbc.271.40.24761	32	129	134	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22788	22796		10.1074/jbc.M100857200	http://dx.doi.org/10.1074/jbc.M100857200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294867	hybrid			2022-12-27	WOS:000169412700108
J	Koschak, A; Reimer, D; Huber, I; Grabner, M; Glossmann, H; Engel, J; Striessnig, J				Koschak, A; Reimer, D; Huber, I; Grabner, M; Glossmann, H; Engel, J; Striessnig, J			alpha 1D (Cav1.3) subunits can form L-type Ca2+ channels activating at negative voltages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL EXPRESSION; CALCIUM-CHANNELS; BETA-SUBUNIT; ALPHA(1D) SUBUNIT; CLONING; CURRENTS; ALPHA-2-SUBUNIT; ALPHA-1-SUBUNIT; CONTRIBUTE; RECEPTOR	In cochlea inner hair cells (IHCs), L-type Ca2+ channels (LTCCs) formed by alpha 1D subunits (D-LTCCs) possess biophysical and pharmacological properties distinct from those of alpha 1C containing C-LTCCs. We investigated to which extent these differences are determined by alpha 1D itself by analyzing the biophysical and pharmacological properties of cloned human alpha 1D splice variants in tsA-201 cells. Variant alpha 1Ds(8A) containing exon 8A sequence in repeat I, yielded alpha 1D protein and L-type currents, whereas no intact protein and currents were observed after expression with exon 8B. In whole cell patch-clamp recordings (charge carrier 15-20 mM Ba2+), alpha 1D(8A) - mediated currents activated at more negative voltages (activation threshold, -45.7 versus -31.5 mV, p < 0.05) and more rapidly (tau (act) for maximal inward currents 0.8 versus 2.3 ms; p < 0.05) than currents mediated by rabbit cylC, Inactivation during depolarizing pulses was slower than for alpha 1C (current inactivation after 5-s depolarizations by 90 versus 99%, p < 0.05) but faster than for LTCCs in IHCs. The sensitivity for the dihydropyridine (DHP) L type channel blocker isradipine was 8.5-fold lower than for alpha 1C. Radioligand binding experiments revealed that this was not due to a lower affinity for the DHP binding pocket, suggesting that differences in the voltage dependence of DHP block account for decreased sensitivity of D-LTCCs, Our experiments show that alpha 1D(8A) subunits can form slowly inactivating LTCCs activating at more negative voltages than alpha 1C, These properties should allow D-LTCCs to control physiological processes, such as diastolic depolarization in sinoatrial node cells, neurotransmitter release in IHCs and neuronal excitability.	Inst Biochem Pharmakol, A-6020 Innsbruck, Austria; Univ Tubingen, HNO Klin, Inst Physiol 2, Sekt Sensor Biophys, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Striessnig, J (corresponding author), Inst Biochem Pharmakol, Peter Mayr Str 1, A-6020 Innsbruck, Austria.	joerg.striessnig@vibk.ac.at	Striessnig, Joerg/S-9334-2017; Glossmann, Hartmut/AAL-9790-2020; Tuluc, Petronel/C-2527-2011	Striessnig, Joerg/0000-0002-9406-7120; glossmann, hartmut h./0000-0002-7392-3266				Avery RB, 1996, J NEUROSCI, V16, P5567; BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; Bell DC, 2001, J NEUROPHYSIOL, V85, P816, DOI 10.1152/jn.2001.85.2.816; Berjukow S, 2000, J BIOL CHEM, V275, P22114, DOI 10.1074/jbc.M908836199; Bourinet E, 1999, NAT NEUROSCI, V2, P407, DOI 10.1038/8070; Cahill AL, 2000, J NEUROSCI, V20, P1685; Carlin KP, 2000, EUR J NEUROSCI, V12, P1635, DOI 10.1046/j.1460-9568.2000.00055.x; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Garcia-Palomero E, 2000, FEBS LETT, V481, P235, DOI 10.1016/S0014-5793(00)01984-0; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; Gurnett CA, 1996, J BIOL CHEM, V271, P27975, DOI 10.1074/jbc.271.45.27975; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; HOFMANN F, 1994, ANNU REV NEUROSCI, V17, P399, DOI 10.1146/annurev.neuro.17.1.399; Hsiao CF, 1998, J NEUROPHYSIOL, V79, P2847, DOI 10.1152/jn.1998.79.6.2847; Huber I, 2000, BIOCHEM J, V347, P829, DOI 10.1042/0264-6021:3470829; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; IHARA Y, 1995, MOL ENDOCRINOL, V9, P121, DOI 10.1210/me.9.1.121; Kollmar R, 1997, P NATL ACAD SCI USA, V94, P14889, DOI 10.1073/pnas.94.26.14889; Kollmar R, 1997, P NATL ACAD SCI USA, V94, P14883, DOI 10.1073/pnas.94.26.14883; Lee JH, 1999, J NEUROSCI, V19, P1912; Magee JC, 1996, J NEUROPHYSIOL, V76, P3460, DOI 10.1152/jn.1996.76.5.3460; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Safayhi H, 1997, MOL ENDOCRINOL, V11, P619, DOI 10.1210/me.11.5.619; Sinnegger MJ, 2001, BIOPHYS J, V80, p450A; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; Striessnig J, 2001, LANCET, V357, P1294, DOI 10.1016/S0140-6736(00)04440-8; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Takimoto K, 1997, J MOL CELL CARDIOL, V29, P3035, DOI 10.1006/jmcc.1997.0532; Verheijck EE, 1999, AM J PHYSIOL-HEART C, V276, pH1064, DOI 10.1152/ajpheart.1999.276.3.H1064; Welling A, 1997, CIRC RES, V81, P526, DOI 10.1161/01.RES.81.4.526; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; ZIDANIC M, 1995, BIOPHYS J, V68, P1323, DOI 10.1016/S0006-3495(95)80305-X	39	350	355	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22100	22106		10.1074/jbc.M101469200	http://dx.doi.org/10.1074/jbc.M101469200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11285265	hybrid			2022-12-27	WOS:000169412700018
J	Mahoney, DJ; Blundell, CD; Day, AJ				Mahoney, DJ; Blundell, CD; Day, AJ			Mapping the hyaluronan-binding site on the link module from human tumor necrosis factor-stimulated gene-6 by site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARTILAGE PROTEOGLYCAN CORE; HUMAN TSG-6; ESCHERICHIA-COLI; PROTEIN TSG-6; CDNA CLONING; DOMAIN; CD44; IDENTIFICATION; RECEPTOR; AGGRECAN	Link modules are hyaluronan-binding domains found in extracellular proteins involved in matrix assembly, development, and immune cell migration. Previously we have expressed the Link module from the inflammation-associated protein tumor necrosis factor-stimulated gene-g (TSG-6) and determined its tertiary structure in solution, Here we generated 21 Link module mutants, and these were analyzed by nuclear magnetic resonance spectroscopy and a hyaluronan-binding assay, The individual mutation of five amino acids, which form a cluster on one face of the Link module, caused large reductions in functional activity but did not affect the Link module fold. This ligand-binding site in TSG-6 is similar to that determined previously for the hyaluronan receptor, CD44, suggesting that the location of the interaction surfaces may also be conserved in other Link module-containing proteins. Analysis of the sequences of TSG-6 and CD44 indicates that the molecular details of their association with hyaluronan are likely to be significantly different. This comparison identifies key sequence positions that may be important in mediating hyaluronan binding, across the Link module superfamily, The use of multiple sequence alignment and molecular modeling allowed the prediction of functional residues in link protein, and this approach can be extended to all members of the superfamily.	Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England	University of Oxford	Day, AJ (corresponding author), Univ Oxford, Dept Biochem, MRC, Immunochem Unit, S Parks Rd, Oxford OX1 3QU, England.		Day, Anthony/O-1658-2015	Day, Anthony/0000-0002-1415-3134; Blundell, Charles/0000-0002-1439-9126				Bajorath J, 1998, J BIOL CHEM, V273, P338, DOI 10.1074/jbc.273.1.338; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Banerji S, 1998, PROTEIN EXPRES PURIF, V14, P371, DOI 10.1006/prep.1998.0971; Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; BLUNDELL CD, 2001, HYALURONAN; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; CHRISTNER JE, 1977, BIOCHEM J, V167, P711, DOI 10.1042/bj1670711; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Day AJ, 1999, BIOCHEM SOC T, V27, P115, DOI 10.1042/bst0270115; Day AJ, 1998, WENN GR INT, V72, P141; DOEGE K, 1987, J BIOL CHEM, V262, P17757; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; DUDHIA J, 1990, NUCLEIC ACIDS RES, V18, P1292, DOI 10.1093/nar/18.5.1292; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; FOSANG AJ, 1989, BIOCHEM J, V261, P801, DOI 10.1042/bj2610801; Gary SC, 2000, GENE, V256, P139, DOI 10.1016/S0378-1119(00)00362-0; GOETINCK PF, 1987, J CELL BIOL, V105, P2403, DOI 10.1083/jcb.105.5.2403; GOLDSTEIN LA, 1989, CELL, V56, P1063, DOI 10.1016/0092-8674(89)90639-9; GROVER J, 1994, BIOCHEM J, V300, P317, DOI 10.1042/bj3000317; HARDINGHAM TE, 1976, BIOCHEM J, V157, P127, DOI 10.1042/bj1570127; HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5; Hirakawa S, 2000, BIOCHEM BIOPH RES CO, V276, P982, DOI 10.1006/bbrc.2000.3583; Kahmann JD, 1997, PROTEIN EXPRES PURIF, V9, P315, DOI 10.1006/prep.1996.0694; Kahmann JD, 2000, STRUCTURE, V8, P763, DOI 10.1016/S0969-2126(00)00163-5; Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; LYON M, 1986, BIOCHIM BIOPHYS ACTA, V881, P22, DOI 10.1016/0304-4165(86)90092-9; MORGELIN M, 1988, BIOCHEM J, V253, P175; Nagase T, 1998, DNA Res, V5, P31, DOI 10.1093/dnares/5.1.31; Nagase T, 1996, DNA Res, V3, P321, DOI 10.1093/dnares/3.5.321; NEAME PJ, 1986, J BIOL CHEM, V261, P3519; Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; Poveda A, 1998, CHEM SOC REV, V27, P133, DOI 10.1039/a827133z; Prange CK, 1998, GENE, V221, P199, DOI 10.1016/S0378-1119(98)00455-7; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Vyas NK, 1991, CURR OPIN STRUC BIOL, V1, P732, DOI 10.1016/0959-440X(91)90172-P; Watanabe H, 1997, J BIOL CHEM, V272, P28057, DOI 10.1074/jbc.272.44.28057; Wisniewski Hans-Georg, 1997, Cytokine and Growth Factor Reviews, V8, P143, DOI 10.1016/S1359-6101(97)00008-7; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; YU Q, 1995, BIOTECHNIQUES, V19, P122; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	50	78	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22764	22771		10.1074/jbc.M100666200	http://dx.doi.org/10.1074/jbc.M100666200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11287417	hybrid			2022-12-27	WOS:000169412700105
J	Kniemeyer, O; Heider, J				Kniemeyer, O; Heider, J			Ethylbenzene dehydrogenase, a novel hydrocarbon-oxidizing molybdenum/iron-sulfur/heme enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM THAUERA-AROMATICA; DENITRIFYING BACTERIUM; INITIAL REACTIONS; ANAEROBIC METABOLISM; OXIDOREDUCTASE; PURIFICATION; OXIDATION; SELENATIS; REDUCTASE; COENZYME	The initial enzyme of ethylbenzene metabolism in denitrifying Azoarcus strain EbN1, ethylbenzene dehydrogenase, was purified and characterized. The soluble periplasmic enzyme is the first known enzyme oxidizing a nonactivated hydrocarbon without molecular oxygen as cosubstrate, It is a novel molybdenum/iron-sulfur/ heme protein of 155 kDa, which consists of three subunits (96, 43, and 23 kDa) in an alpha beta gamma structure. The N-terminal amino acid sequence of the alpha subunit is similar to that of other molybdenum proteins such as selenate reductase from the related species Thauera selenatis, Ethylbenzene dehydrogenase is unique in that it oxidizes the hydrocarbon ethylbenzene, a compound without functional groups, to (S)-1-phenylethanol. Formation of the product was evident by coupling tot an enantiomer-specific (S)-1-phenylethanol dehydrogenase from the same organism. The apparent K-m of the enzyme for ethylbenzene is very low at <2 <mu>M, Oxygen does not affect ethylbenzene dehydrogenase activity in extracts but inactivates the purified enzyme, if the heme b cofactor is in the reduced state. A variant of ethylbenzene dehydrogenase exhibiting significant activity also with the homolog n-propylbenzene was detected in a related Azoarcus strain (PbN1).	Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany; Max Planck Inst Marine Mikrobiol, D-28359 Bremen, Germany	University of Freiburg; Max Planck Society	Heider, J (corresponding author), Univ Freiburg, Inst Biol 2, Schanzlestr 1, D-79104 Freiburg, Germany.	heiderj@uni-freiburg.de	Heider, Johann/A-1833-2012; Heider, Johann/Y-2291-2018; Kniemeyer, Olaf/K-1253-2013; Heider, Johann/ABA-7877-2021	Heider, Johann/0000-0001-8328-9716; Heider, Johann/0000-0001-8328-9716; Kniemeyer, Olaf/0000-0002-9493-6402; 				Ball HA, 1996, J BACTERIOL, V178, P5755, DOI 10.1128/jb.178.19.5755-5761.1996; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Beller HR, 1997, J BACTERIOL, V179, P670, DOI 10.1128/jb.179.3.670-676.1997; Biegert T, 1996, EUR J BIOCHEM, V238, P661, DOI 10.1111/j.1432-1033.1996.0661w.x; Boll M, 1995, EUR J BIOCHEM, V234, P921, DOI 10.1111/j.1432-1033.1995.921_a.x; Castellano J.A., 1992, HDB DISPLAY TECHNOLO; Champion Kathleen M., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P157; CLARK LJ, 1955, ANAL CHEM, V27, P2000, DOI 10.1021/ac60108a046; Coligan JE, 1999, CURRENT PROTOCOLS PR; Hanlon SP, 1996, EUR J BIOCHEM, V239, P391, DOI 10.1111/j.1432-1033.1996.0391u.x; Heider J, 1998, FEMS MICROBIOL REV, V22, P459, DOI 10.1111/j.1574-6976.1998.tb00381.x; Johnson HA, 1999, J BACTERIOL, V181, P5662, DOI 10.1128/JB.181.18.5662-5668.1999; Krafft T, 2000, DNA Seq, V10, P365, DOI 10.3109/10425170009015604; LEHMAN TC, 1990, ANAL BIOCHEM, V186, P280, DOI 10.1016/0003-2697(90)90080-S; LOVENBERG W, 1963, J BIOL CHEM, V193, P265; MACKAY D, 1981, J PHYS CHEM REF DATA, V10, P1175, DOI 10.1063/1.555654; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MICHEL TA, 1990, J MICROBIOL METH, V11, P37, DOI 10.1016/0167-7012(90)90045-8; Rabus R, 1998, ARCH MICROBIOL, V170, P377, DOI 10.1007/s002030050656; RABUS R, 1995, ARCH MICROBIOL, V163, P96, DOI 10.1007/BF00381782; RECH SA, 1992, J BACTERIOL, V174, P7316, DOI 10.1128/jb.174.22.7316-7320.1992; Rhee SK, 1999, EUR J BIOCHEM, V262, P507, DOI 10.1046/j.1432-1327.1999.00399.x; Schroder I, 1997, J BIOL CHEM, V272, P23765, DOI 10.1074/jbc.272.38.23765; SMITH L, 1978, METHOD ENZYMOL, V23, P202	24	137	148	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21381	21386		10.1074/jbc.M101679200	http://dx.doi.org/10.1074/jbc.M101679200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11294876	hybrid			2022-12-27	WOS:000169297900079
J	Caselli, A; Taddei, ML; Manao, G; Camici, G; Ramponi, G				Caselli, A; Taddei, ML; Manao, G; Camici, G; Ramponi, G			Tyrosine-phosphorylated caveolin is a physiological substrate of the low M-r protein-tyrosine phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-RECEPTOR; AMINO-ACID-SEQUENCE; ROUS-SARCOMA VIRUS; IN-VIVO; SIGNALING COMPLEXES; TRANSFORMED-CELLS; TRAPPING MUTANTS; PLASMA-MEMBRANE; 3T3 CELLS; PTP-PEST	Low phosphotyrosine-protein phosphatase is involved in the regulation of several tyrosine kinase growth factor receptors. The best characterized action of this enzyme is on the signaling pathways activated by platelet-derived growth factor, where it plays multiple roles. In this study we identify tyrosine-phosphorylated caveolin as a new potential substrate for low M-r phosphotyrosine-protein phosphatase. Caveolin is tyrosine-phosphorylated in vivo by Src kinases, recruits into caveolae, and hence regulates the activities of several proteins involved in cellular signaling cascades. Our results demonstrate that caveolin and low M-r phosphotyrosine-protein phosphatase coimmunoprecipitate from cell lysates, and that a fraction of the enzyme localizes in caveolae. Furthermore, in a cell line sensitive to insulin, the overexpression of the C12S dominant negative mutant of low M-r phosphotyrosine-protein phosphatase (a form lacking activity but able to bind substrates) causes the enhancement of tyrosine-phosphorylated caveolin. Insulin stimulation of these cells induces a strong increase of caveolin phosphorylation. The localization of low M-r phosphotyrosine-protein phosphatase in caveolae, the in vivo interaction between this enzyme and caveolin, and the capacity of this enzyme to rapidly dephosphorylate phosphocaveolin, all indicate that tyrosine-phosphorylated caveolin is a relevant substrate for this phosphatase.	Univ Florence, Dipartimento Sci Biochim, I-50134 Florence, Italy	University of Florence	Camici, G (corresponding author), Univ Florence, Dipartimento Sci Biochim, Viale Morgagni 50, I-50134 Florence, Italy.	camici@scibio.unifi.it	Caselli, Anna/O-7512-2014; Camici, Giovanni/H-1631-2018	Caselli, Anna/0000-0001-8140-3415; Camici, Giovanni/0000-0002-0523-0695				ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; BERTI A, 1994, FEBS LETT, V349, P7, DOI 10.1016/0014-5793(94)00620-2; Bugert P, 1997, FEBS LETT, V400, P252, DOI 10.1016/S0014-5793(96)01398-1; Carman CV, 1999, J BIOL CHEM, V274, P8858, DOI 10.1074/jbc.274.13.8858; CASELLI A, 1994, J PROTEIN CHEM, V13, P107, DOI 10.1007/BF01891998; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; Chiarugi P, 1998, J BIOL CHEM, V273, P6776, DOI 10.1074/jbc.273.12.6776; Chiarugi P, 2000, J BIOL CHEM, V275, P4640, DOI 10.1074/jbc.275.7.4640; CHIARUGI P, 1995, FEBS LETT, V372, P49, DOI 10.1016/0014-5793(95)00947-8; Chiarugi P, 1997, BIOCHEM BIOPH RES CO, V238, P676, DOI 10.1006/bbrc.1997.7355; Cote JF, 1998, BIOCHEMISTRY-US, V37, P13128, DOI 10.1021/bi981259l; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DISSING J, 1991, J BIOL CHEM, V266, P20619; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; GLENNEY JR, 1989, J BIOL CHEM, V264, P20163; GOTOH N, 1994, P NATL ACAD SCI USA, V91, P167, DOI 10.1073/pnas.91.1.167; Grangeasse C, 1998, J MOL BIOL, V278, P339, DOI 10.1006/jmbi.1998.1650; HONEGGER AM, 1987, MOL CELL BIOL, V7, P4568, DOI 10.1128/MCB.7.12.4568; Kim YN, 2000, J BIOL CHEM, V275, P7481, DOI 10.1074/jbc.275.11.7481; KLARLUND JK, 1985, CELL, V41, P707, DOI 10.1016/S0092-8674(85)80051-9; Ko YG, 1998, J CELL BIOCHEM, V71, P524, DOI 10.1002/(SICI)1097-4644(19981215)71:4<524::AID-JCB7>3.3.CO;2-2; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P3863; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; Marzocchini R, 1998, FEBS LETT, V426, P52, DOI 10.1016/S0014-5793(98)00308-1; Mastick CC, 1997, J BIOL CHEM, V272, P20706, DOI 10.1074/jbc.272.33.20706; MASTICK CC, 1995, J CELL BIOL, V129, P1523, DOI 10.1083/jcb.129.6.1523; MILARSKI KL, 1994, J BIOL CHEM, V269, P21239; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; MONDESERT O, 1994, J BIOL CHEM, V269, P27996; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; OSTANIN K, 1995, J BIOL CHEM, V270, P18491, DOI 10.1074/jbc.270.31.18491; RIEDEL H, 1988, P NATL ACAD SCI USA, V85, P1477, DOI 10.1073/pnas.85.5.1477; Rigacci S, 1999, FEBS LETT, V459, P191, DOI 10.1016/S0014-5793(99)01234-X; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Rovida E, 1998, BIOCHEM BIOPH RES CO, V253, P300, DOI 10.1006/bbrc.1998.9736; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Sasaoka T, 1996, J BIOL CHEM, V271, P20082, DOI 10.1074/jbc.271.33.20082; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; Vepa S, 1997, FREE RADICAL BIO MED, V22, P25, DOI 10.1016/S0891-5849(96)00241-9; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Walchli S, 2000, J BIOL CHEM, V275, P9792, DOI 10.1074/jbc.275.13.9792; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263	58	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18849	18854		10.1074/jbc.M100705200	http://dx.doi.org/10.1074/jbc.M100705200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279120	hybrid, Green Published			2022-12-27	WOS:000169091000028
J	Li, J; Peet, GW; Balzarano, D; Li, XN; Massa, P; Barton, RW; Marcu, KB				Li, J; Peet, GW; Balzarano, D; Li, XN; Massa, P; Barton, RW; Marcu, KB			Novel NEMO/I kappa B kinase and NF-kappa B target genes at the pre-B to immature B cell transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							LEUKOCYTE PROTEASE INHIBITOR; HELIX-LOOP-HELIX; SIGNAL-TRANSDUCTION; IKK-BETA; IMMUNOGLOBULIN EXPRESSION; TRANSCRIPTION FACTORS; LEUCINE-ZIPPER; C-MYC; MICROFILAMENT REORGANIZATION; METASTASIS SUPPRESSOR	The I kappaB kinase (IKK) signaling complex is responsible for activating NF-kappaB-dependent gene expression programs. Even though NF-kappaB-responsive genes are known to orchestrate stress-like responses, critical gaps in our knowledge remain about the global effects of NF-kappaB activation on cellular physiology. DNA microarrays were used to compare gene expression programs in a model system of 70Z/3 murine pre-B cells versus their IKK signaling-defective 1.3E2 variant with lipopolysaccharide (LPS), interleukin-l (IL-1), or a combination of LPS + phorbol 12-myristate 13-acetate under brief (2 h) or long term (12 h) stimulation. 70Z/3-1.3E2 cells lack expression of NEMO/IKK gamma /IKKAP-1/FIP-3, an essential positive effector of the IKK complex. Some stimulated hits were known NF-kappaB target genes, but remarkably, the vast majority of the up-modulated genes and an unexpected class of repressed genes were all novel targets of this signaling pathway, encoding transcription factors, receptors, extracellular ligands, and intracellular signaling factors. Thirteen stimulated (B-ATF, Pim-2, MyD118, Pea-15/MAT1, CD82, CD40L, Wnt10a, Notch 1, R-ras, Rgs-16, PAC-I, ISG15, and CD36) and five repressed (CCR2, VpreB, lambda5, SLPI, and CMAP/Cystatin7) genes, respectively, were bona fide NF-kappaB targets by virtue of their response to a transdominant I kappaB alpha SR (super repressor). MyD118 and ISG15, although directly induced by LPS stimulation, were unaffected by IL-1, revealing the existence of direct NF-kappaB target genes, which are not coinduced by the LPS and IL-1 Toll-like receptors.	SUNY Stony Brook, Inst Cell & Dev Biol, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Inst Cell & Dev Biol, Grad Program Genet, Stony Brook, NY 11794 USA; Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Boehringer Ingelheim	Marcu, KB (corresponding author), SUNY Stony Brook, Inst Cell & Dev Biol, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.							Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; AHRENS PB, 1990, J GEN VIROL, V71, P1675, DOI 10.1099/0022-1317-71-8-1675; Allen JD, 1997, ONCOGENE, V15, P1133, DOI 10.1038/sj.onc.1201288; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803; Beadling C, 1999, J IMMUNOL, V162, P2677; BERA TK, 1994, P NATL ACAD SCI USA, V91, P9789, DOI 10.1073/pnas.91.21.9789; BRANCOLINI C, 1995, EMBO J, V14, P5179, DOI 10.1002/j.1460-2075.1995.tb00202.x; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; BURGSTAHLER R, 1995, BIOCHEM BIOPH RES CO, V215, P737, DOI 10.1006/bbrc.1995.2525; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Condorelli G, 1999, ONCOGENE, V18, P4409, DOI 10.1038/sj.onc.1202831; Connelly MA, 1995, CELL MOL BIOL RES, V41, P537; Courtois G, 1997, MOL CELL BIOL, V17, P1441, DOI 10.1128/MCB.17.3.1441; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Cyster JG, 1999, J EXP MED, V189, P447, DOI 10.1084/jem.189.3.447; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; DCunha J, 1996, J IMMUNOL, V157, P4100; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Devergne O, 1998, J VIROL, V72, P7900, DOI 10.1128/JVI.72.10.7900-7908.1998; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dorsey MJ, 1995, ONCOGENE, V11, P2255; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; Hsing Y, 1999, J IMMUNOL, V162, P2804; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Ihle JN, 1996, BIOESSAYS, V18, P95, DOI 10.1002/bies.950180204; Janabi M, 2000, ARTERIOSCL THROM VAS, V20, P1953, DOI 10.1161/01.ATV.20.8.1953; Jin FY, 1998, INFECT IMMUN, V66, P2447, DOI 10.1128/IAI.66.6.2447-2452.1998; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kehry M R, 1994, Semin Immunol, V6, P287, DOI 10.1006/smim.1994.1037; Kitsberg D, 1999, J NEUROSCI, V19, P8244; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; KUNIMOTO DY, 1988, J IMMUNOL, V141, P713; Lentsch AB, 1999, AM J PATHOL, V154, P239, DOI 10.1016/S0002-9440(10)65270-4; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li X, 2000, BRAIN RES PROTOC, V5, P211, DOI 10.1016/S1385-299X(00)00015-5; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Liebermann DA, 1998, ONCOGENE, V17, P3319, DOI 10.1038/sj.onc.1202574; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Liu FS, 2000, GYNECOL ONCOL, V78, P10, DOI 10.1006/gyno.2000.5801; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lombardi DP, 1999, CANCER RES, V59, P5724; LOWE DG, 1987, CELL, V48, P137, DOI 10.1016/0092-8674(87)90364-3; Mahadevappa M, 1999, NAT BIOTECHNOL, V17, P1134, DOI 10.1038/15124; MAINS PE, 1983, J BIOL CHEM, V258, P5027; MAINS PE, 1983, SOMAT CELL GENET, V9, P699, DOI 10.1007/BF01539475; Malynn BA, 2000, GENE DEV, V14, P1390; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; MCFARLAND EC, 1994, CHEM IMMUNOL, V59, P40; McKenzie FR, 2000, MOL CELL BIOL, V20, P2635, DOI 10.1128/MCB.20.8.2635-2649.2000; Melchers F, 1999, CELL, V99, P351, DOI 10.1016/S0092-8674(00)81521-4; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Morita M, 1999, CANCER RES, V59, P151; Moriuchi H, 1997, J IMMUNOL, V158, P3483; Muda M, 1996, J BIOL CHEM, V271, P4319; Odintsova E, 2000, CURR BIOL, V10, P1009, DOI 10.1016/S0960-9822(00)00652-7; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; PAIGE CJ, 1978, J IMMUNOL, V121, P641; PAIGE CJ, 1981, NATURE, V292, P631, DOI 10.1038/292631a0; Panetta R, 1999, BIOCHEM BIOPH RES CO, V259, P550, DOI 10.1006/bbrc.1999.0817; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rudolph D, 2000, GENE DEV, V14, P854; SAKAGUCHI N, 1980, J IMMUNOL, V125, P2654; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Sgorbissa A, 1999, J CELL SCI, V112, P4475; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Suzuki R, 1999, LEUKEMIA, V13, P1335, DOI 10.1038/sj.leu.2401485; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; VANDERLUGT NMT, 1995, EMBO J, V14, P2536, DOI 10.1002/j.1460-2075.1995.tb07251.x; VASSALLI JD, 1993, EMBO J, V12, P1871, DOI 10.1002/j.1460-2075.1993.tb05835.x; Wang JW, 1996, ONCOGENE, V13, P1537; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Wang ZY, 1996, GENOMICS, V35, P156, DOI 10.1006/geno.1996.0334; Webster GA, 1999, MOL CELL BIOL, V19, P3485; WEEKS RS, 1987, SOMAT CELL MOLEC GEN, V13, P205, DOI 10.1007/BF01535203; Wolthuis RMF, 1996, ONCOGENE, V13, P353; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	102	133	138	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18579	18590		10.1074/jbc.M100846200	http://dx.doi.org/10.1074/jbc.M100846200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279141	hybrid			2022-12-27	WOS:000168866500128
J	Reinelt, S; Dedier, S; Asuni, G; Folkers, G; Rognan, D				Reinelt, S; Dedier, S; Asuni, G; Folkers, G; Rognan, D			Mutation of Cys-67 alters the thermodynamic stability of the human leukocyte antigen HLA-B*2705	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HLA-B27 TRANSGENIC MICE; CLASS-II MOLECULES; HLA CLASS-I; ANKYLOSING-SPONDYLITIS; PEPTIDE BINDING; INFLAMMATORY DISEASE; HEAVY-CHAINS; MHC; ASSOCIATION; SPONDYLOARTHROPATHIES	The B pocket of the class I major histocompatibility complex-encoded protein HLA-B*2705 has recently been suggested to be responsible for the misfolding of this HLA haplotype and thus to induce susceptibility to autoimmune inflammatory diseases. Four mutants of the B*2705 heavy chain were refolded in the presence of three control peptides, The monitoring of the thermal unfolding of the B*2705-peptide complexes by circular dichroism spectroscopy showed that all heterotrimeric mutants were markedly less stable than the corresponding complexes with the wild-type heavy chain. Among the four heavy chain mutations, the C67S change was investigated for unfolding and peptide binding properties because this position may mediate disulfide pair bridging and alter T-cell recognition of HLA-B*2705. Wild-type heterotrimers completely unfold in a single transition at mild acidic pH whereas increase of the pH to mild basic conditions induce only a partial biphasic unfolding. Cys-67 seems to play a crucial role in controlling the thermodynamic stability of the B*2705-peptide complexes as the C67S mutant unfolds faster and with a single transition, independent of pH. Fluorescence polarization and size exclusion chromatography of unfolding intermediates suggest that the peculiar unfolding of the B*2705 wild-type heavy chain cannot be explained by modified peptide binding properties but more likely by the formation of high molecular weight species.	ULP, Lab Pharmacochim Commun Cellulaire, CNRS, UMR 7081, F-67401 Illkirch Graffenstaden, France; Swiss Fed Inst Technol, Dept Appl Biosci, CH-8057 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rognan, D (corresponding author), ULP, Lab Pharmacochim Commun Cellulaire, CNRS, UMR 7081, 74 Route Rhin, F-67401 Illkirch Graffenstaden, France.		Rognan, Didier/B-9939-2014	Folkers, Gerd/0000-0002-3620-705X				Allen RL, 1999, IMMUNOGENETICS, V50, P220, DOI 10.1007/s002510050596; Allen RL, 1999, J IMMUNOL, V162, P5045; Alvarez I, 2000, CURR OPIN RHEUMATOL, V12, P248, DOI 10.1097/00002281-200007000-00003; Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; BENJAMIN R, 1990, IMMUNOL TODAY, V11, P137, DOI 10.1016/0167-5699(90)90051-A; BREWERTON DA, 1973, LANCET, V1, P904; BUXTON SE, 1992, J EXP MED, V175, P809, DOI 10.1084/jem.175.3.809; CAPPS GG, 1993, J IMMUNOL, V151, P159; Colbert RA, 2000, MOL MED TODAY, V6, P224, DOI 10.1016/S1357-4310(00)01699-3; COLBERT RA, 1993, P NATL ACAD SCI USA, V90, P6879, DOI 10.1073/pnas.90.14.6879; de Castro JAL, 1998, CURR OPIN IMMUNOL, V10, P59, DOI 10.1016/S0952-7915(98)80033-2; Dedier S, 2000, J BIOL CHEM, V275, P27055; Fiorillo MT, 2000, J CLIN INVEST, V106, P47, DOI 10.1172/JCI9295; Gao XM, 1996, EUR J IMMUNOL, V26, P1443, DOI 10.1002/eji.1830260707; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; Khan MA, 2000, J RHEUMATOL, V27, P1110; Khare SD, 1998, J IMMUNOL, V160, P101; KHARE SD, 1995, J EXP MED, V182, P1153, DOI 10.1084/jem.182.4.1153; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; Mear JP, 1999, J IMMUNOL, V163, P6665; Morgan CS, 1997, PROTEIN SCI, V6, P1771, DOI 10.1002/pro.5560060819; Nasir MS, 1999, COMB CHEM HIGH T SCR, V2, P177; Ottenhoff THM, 1997, J IMMUNOL METHODS, V200, P89, DOI 10.1016/S0022-1759(96)00190-1; PACE NC, 1997, PROTEIN STRUCTURE PR, P299; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; Taurog JD, 1999, IMMUNOL REV, V169, P209; URBAN RG, 1994, P NATL ACAD SCI USA, V91, P1534, DOI 10.1073/pnas.91.4.1534; VILLADANGOS JA, 1995, EUR J IMMUNOL, V25, P2370, DOI 10.1002/eji.1830250837; Weiss GA, 1996, P NATL ACAD SCI USA, V93, P10945, DOI 10.1073/pnas.93.20.10945; WHELAN MA, 1993, EUR J IMMUNOL, V23, P3278, DOI 10.1002/eji.1830231233	34	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18472	18477		10.1074/jbc.M101282200	http://dx.doi.org/10.1074/jbc.M101282200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279190	hybrid			2022-12-27	WOS:000168866500114
J	Cremesti, A; Paris, F; Grassme, H; Holler, N; Tschopp, J; Fuks, Z; Gulbins, E; Kolesnick, R				Cremesti, A; Paris, F; Grassme, H; Holler, N; Tschopp, J; Fuks, Z; Gulbins, E; Kolesnick, R			Ceramide enables Fas to cap and kill	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; GPI-ANCHORED PROTEINS; CAVEOLAE-LIKE DOMAINS; ACIDIC SPHINGOMYELINASE; SIGNAL-TRANSDUCTION; MEMBRANE DOMAINS; TYROSINE PHOSPHORYLATION; CD95-MEDIATED APOPTOSIS; HUMAN-LYMPHOCYTES; DEATH DOMAIN	Recent studies suggest that trimerization of Fas is insufficient for apoptosis induction and indicate that super-aggregation of trimerized Fas might be prerequisite. For many cell surface receptors, cross-linking by multivalent ligands or antibodies induces their lateral segregation within the plasma membrane and co-localization into "caps" on one pole of the cell. In this study, we show that capping of Fas is essential for optimal function and that capping is ceramide-dependent. in Jurkat T lymphocytes and in primary cultures of hepatocytes, ceramide elevation was detected as early as 15-30 s and peaked at 1 min after CH-11 and Jo2 anti-Fas antibody treatment, respectively. Capping was detected 30 s after Fas ligation, peaked at 2 min, and was maintained at a lower level for as long as 30 min in both cell types, Ceramide generation appeared essential for capping. Acid sphingomyelinase(-/-) hepatocytes were defective in Jo2-induced ceramide generation, capping, and apoptosis, and nanomolar concentrations of C-16-ceramide restored these events. To further explore the role of ceramide in capping of Fas, we employed FLAG-tagged soluble Fas ligand (sFasL), which binds trimerized Fas but is unable to induce capping or apoptosis in Jurkat cells, Cross-linking of sFasL with M2 anti-FLAG antibody induced both events. Pretreatment of cells with natural C-16-ceramide bypassed the necessity for forced antibody cross-linking and enabled sFasL to cap and kill. The presence of intact sphingolipid-enriched membrane domains may be essential for Fas capping since their disruption with cholesterol-depleting agents abrogated capping and prevented apoptosis, These data suggest, that capping is a ceramide-dependent event required for optimal Fas signaling in some cells.	Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; St Jude Children's Research Hospital; University of Lausanne	Kolesnick, R (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, 1275 York Ave, New York, NY 10021 USA.	r-kolesnick@ski.mskcc.org	Gulbins, Erich/L-6989-2014; Paris, francois E/L-4915-2015	Gulbins, Erich/0000-0002-3117-1342; Paris, francois E/0000-0002-0176-7348	NATIONAL CANCER INSTITUTE [R01CA052462] Funding Source: NIH RePORTER; NCI NIH HHS [CA52462, CA42385] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Belka C, 1998, RADIAT RES, V149, P588, DOI 10.2307/3579905; Bilderback TR, 1997, J BIOL CHEM, V272, P10922; Bilderback TR, 1999, J BIOL CHEM, V274, P257, DOI 10.1074/jbc.274.1.257; Boesen-de Cock JGR, 1998, J BIOL CHEM, V273, P7560, DOI 10.1074/jbc.273.13.7560; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; BOURGUIGNON LYW, 1984, INT REV CYTOL, V87, P195, DOI 10.1016/S0074-7696(08)62443-2; BOURGUIGNON LYW, 1988, J CELL BIOCHEM, V37, P131, DOI 10.1002/jcb.240370202; Brenner B, 1998, CELL DEATH DIFFER, V5, P29, DOI 10.1038/sj.cdd.4400307; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CHATTERJEE S, 1994, J BIOL CHEM, V269, P879; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; De Maria R, 1998, J EXP MED, V187, P897, DOI 10.1084/jem.187.6.897; Deckert M, 1996, J CELL BIOL, V133, P791, DOI 10.1083/jcb.133.4.791; Drzewiecka A, 1999, ACTA BIOCHIM POL, V46, P107, DOI 10.18388/abp.1999_4188; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; GOLDSTEIN P, 2000, SCIENCE, V288, P2328; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; GRAZIADEI L, 1990, NATURE, V347, P396, DOI 10.1038/347396a0; Grullich C, 2000, J BIOL CHEM, V275, P8650, DOI 10.1074/jbc.275.12.8650; GULBINS E, 1995, IMMUNITY, V2, P341, DOI 10.1016/1074-7613(95)90142-6; HOOVER RL, 1983, J CELL BIOL, V97, P73, DOI 10.1083/jcb.97.1.73; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; HUANG H, 1996, EUR BIOPHYS J, V27, P361; Huang J, 2000, EUR J IMMUNOL, V30, P50, DOI 10.1002/1521-4141(200001)30:1<50::AID-IMMU50>3.3.CO;2-9; HUBER R, 1976, NATURE, V264, P415, DOI 10.1038/264415a0; Huby RDJ, 1999, J BIOL CHEM, V274, P22591, DOI 10.1074/jbc.274.32.22591; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Johns DG, 1998, EUR J PHARMACOL, V349, pR9, DOI 10.1016/S0014-2999(98)00299-4; Junge S, 1999, CELL SIGNAL, V11, P301, DOI 10.1016/S0898-6568(98)00068-0; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kirschnek S, 2000, J BIOL CHEM, V275, P27316; Ko YG, 1999, J IMMUNOL, V162, P7217; Kolesnick RN, 2000, J CELL PHYSIOL, V184, P285; Krammer PH, 1998, TOXICOL LETT, V103, P131, DOI 10.1016/S0378-4274(98)00297-5; Lin T, 2000, J BIOL CHEM, V275, P8657, DOI 10.1074/jbc.275.12.8657; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; LURHUMA AZ, 1976, CLIN EXP IMMUNOL, V25, P212; Martin DA, 1998, J BIOL CHEM, V273, P4345, DOI 10.1074/jbc.273.8.4345; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Paris F, 2001, J BIOL CHEM, V276, P8297, DOI 10.1074/jbc.M008732200; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Patra SK, 1999, J LIPOSOME RES, V9, P247, DOI 10.3109/08982109909024788; RATCLIFFE MJH, 1992, J IMMUNOL, V148, P1643; Ridgway ND, 1998, J BIOL CHEM, V273, P31621, DOI 10.1074/jbc.273.47.31621; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Stulnig TM, 1997, J BIOL CHEM, V272, P19242, DOI 10.1074/jbc.272.31.19242; tenGrotenhuis E, 1996, BIOPHYS J, V71, P1389, DOI 10.1016/S0006-3495(96)79341-4; TEPPER CG, 1995, P NATL ACAD SCI USA, V92, P8443, DOI 10.1073/pnas.92.18.8443; Veiga MP, 1999, BIOPHYS J, V76, P342, DOI 10.1016/S0006-3495(99)77201-2; von Reyher U, 1998, CANCER RES, V58, P526; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yasuhara S, 1999, J BURN CARE REHABIL, V20, P462, DOI 10.1097/00004630-199920060-00007; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zundel W, 1998, GENE DEV, V12, P1941, DOI 10.1101/gad.12.13.1941; Zundel W, 2000, MOL CELL BIOL, V20, P1507, DOI 10.1128/MCB.20.5.1507-1514.2000	64	304	322	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23954	23961		10.1074/jbc.M101866200	http://dx.doi.org/10.1074/jbc.M101866200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11287428	hybrid			2022-12-27	WOS:000169531100097
J	Marin, EP; Krishna, AG; Archambault, V; Simuni, E; Fu, WY; Sakmar, TP				Marin, EP; Krishna, AG; Archambault, V; Simuni, E; Fu, WY; Sakmar, TP			The function of interdomain interactions in controlling nucleotide exchange rates in transducin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ACTIVATION; G-PROTEIN; ALPHA-SUBUNIT; PROTEOLYTIC DIGESTION; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; EFFECTOR-BINDING; GDP RELEASE; TURN-ON; RHODOPSIN	The intramolecular contacts in heterotrimeric G proteins that determine the rates of basal and receptor-stimulated nucleotide exchange are not fully understood. The alpha subunit of heterotrimeric G proteins consists of two domains: a Ras-like domain with structural homology to the monomeric G protein Ras and a helical domain comprised of six alpha -helices. The bound nucleotide lies in a deep cleft between the two domains. Exchange of the bound nucleotide may involve opening of this cleft. Thus interactions between the domains may affect the rate of nucleotide exchange in G proteins. We have tested this hypothesis in the alpha subunit of the rod cell G protein transducin (G alpha (t)). Site-directed mutations were prepared in a series of residues located at the interdomain interface. The proteins were expressed in vitro in a reticulocyte lysate system. The rates of basal and rhodopsin-catalyzed nucleotide exchange were determined using a trypsin digestion assay specifically adapted for kinetic measurements, Charge-altering substitutions of two residues at the interdomain interface, Lys(273) and Lys(276), increased basal nucleotide exchange rates modestly (5-10-fold), However, we found no evidence that interactions spanning the two domains in Cat significantly affected either basal or rhodopsin-catalyzed nucleotide exchange rates. These results suggest that opening of the interdomain cleft is not an energetic barrier to nucleotide exchange in G alpha (t). Experiments with Gal, suggest by comparison that the organization and function of the interdomain region differ among various G protein subtypes.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Biol & Biochem, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Sakmar, TP (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave,Box 284, New York, NY 10021 USA.		Sakmar, Thomas P/D-1833-2015	Sakmar, Thomas P/0000-0002-2836-8953; Aradhyam, Gopala Krishna/0000-0001-8232-3935	NIGMS NIH HHS [GM07982, GM07739] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOURNE HR, 1993, NATURE, V366, P628, DOI 10.1038/366628a0; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; FAUROBERT E, 1993, EMBO J, V12, P4191, DOI 10.1002/j.1460-2075.1993.tb06103.x; FUNG BKK, 1983, J BIOL CHEM, V258, P503; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; GARCIA PD, 1995, EMBO J, V14, P4460, DOI 10.1002/j.1460-2075.1995.tb00125.x; Grishina G, 1998, J BIOL CHEM, V273, P15053, DOI 10.1074/jbc.273.24.15053; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Kazmi MA, 2000, BIOCHEMISTRY-US, V39, P3734, DOI 10.1021/bi992354c; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Li QB, 1997, J BIOL CHEM, V272, P21673, DOI 10.1074/jbc.272.35.21673; Marin EP, 2000, J BIOL CHEM, V275, P1930, DOI 10.1074/jbc.275.3.1930; MARIN EP, 2001, IN PRESS J BIOL CHEM, V276; Marsh SR, 1998, MOL PHARMACOL, V53, P981; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; Mazzoni MR, 1996, J BIOL CHEM, V271, P30034, DOI 10.1074/jbc.271.47.30034; MERRITT ERA, METHODS ENZYMOL, V277, P505; Min KC, 2000, PROTEIN EXPRES PURIF, V20, P514, DOI 10.1006/prep.2000.1326; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; NEER EJ, 1994, METHOD ENZYMOL, V237, P226; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Osawa S, 1995, J BIOL CHEM, V270, P31052, DOI 10.1074/jbc.270.52.31052; Posner BA, 1998, J BIOL CHEM, V273, P21752, DOI 10.1074/jbc.273.34.21752; RAMDAS L, 1991, BIOCHEMISTRY-US, V30, P11637, DOI 10.1021/bi00114a005; Remmers AE, 1999, BIOCHEMISTRY-US, V38, P13795, DOI 10.1021/bi990887f; SAKMAR TP, 1988, NUCLEIC ACIDS RES, V16, P6361, DOI 10.1093/nar/16.14.6361; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Warner DR, 1999, P NATL ACAD SCI USA, V96, P4268, DOI 10.1073/pnas.96.8.4268; Warner DR, 1998, J BIOL CHEM, V273, P23976, DOI 10.1074/jbc.273.37.23976	34	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23873	23880		10.1074/jbc.M101197200	http://dx.doi.org/10.1074/jbc.M101197200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11290746	hybrid			2022-12-27	WOS:000169531100087
J	Shalak, V; Kaminska, M; Mitnacht-Kraus, R; Vandenabeele, P; Clauss, M; Mirande, M				Shalak, V; Kaminska, M; Mitnacht-Kraus, R; Vandenabeele, P; Clauss, M; Mirande, M			The EMAPII cytokine is released from the mammalian multisynthetase complex after cleavage of its p43/proEMAPII component	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; ACTIVATING-POLYPEPTIDE-II; CRYSTAL-STRUCTURE; BINDING PROTEIN; CELLS; MONOCYTES; APOPTOSIS; IDENTIFICATION; EXPRESSION; SUBUNIT	Endothelial-monocyte-activating polypeptide II (EMAPII) is an inflammatory cytokine released under apoptotic conditions. Its proEMAPII precursor proved to be identical to the auxiliary p43 component of the aminoacyl-tRNA synthetase complex. We show here that the EMAPII domain of p43 is released readily from the complex after in vitro digestion with caspase 7 and is able to induce migration of human mononuclear phagocytes. The N terminus of in vitro processed EMAPII coincides exactly with that of the mature cytokine isolated from conditioned medium of fibrosarcoma cells. We also show that p43/proEMAPII has a strong tRNA binding capacity (K-D = 0.2 muM) as compared with its isolated N or C domains (7.5 muM and 40 muM, respectively). The potent general RNA binding capacity ascribed to p43/proEMAPII is lost upon the release of the EMAPII domain. This suggests that after onset of apoptosis, the first consequence of the cleavage of p43 is to limit the availability of tRNA for aminoacyl-tRNA synthetases associated within the complex. Translation arrest is accompanied by the release of the EMAPII cytokine that plays a role in the engulfment of apoptotic cells by attracting phagocytes. As a consequence, p43 compares well with a molecular fuse that triggers the irreversible cell growth/ cell death transition induced under apoptotic conditions.	CNRS, Lab Enzymol & Biochim Struct, F-91190 Gif Sur Yvette, France; State Univ Ghent VIB, Dept Mol Biol,Mol Signalling & Cell Death Unit, B-9000 Ghent, Belgium; Max Planck Inst Physiol & Clin Res, Dept Mol Cell Biol, D-61231 Bad Nauheim, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Flanders Institute for Biotechnology (VIB); Ghent University; Max Planck Society	Mirande, M (corresponding author), CNRS, Lab Enzymol & Biochim Struct, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	marc.mirande@lebs.cnrs-gif.fr	Shalak, Vyacheslav F/D-3707-2015; Vandenabeele, Peter/AAD-5793-2022; Vandenabeele, Peter/C-8597-2009	Shalak, Vyacheslav F/0000-0001-6114-6482; Vandenabeele, Peter/0000-0002-6669-8822; Clauss, Matthias/0000-0001-5180-3899				Agou F, 1996, J BIOL CHEM, V271, P29295, DOI 10.1074/jbc.271.46.29295; Barnett G, 2000, CANCER RES, V60, P2850; Behrensdorf HA, 2000, FEBS LETT, V466, P143, DOI 10.1016/S0014-5793(99)01777-9; BOYUM A, 1983, SCAND J IMMUNOL, V17, P429, DOI 10.1111/j.1365-3083.1983.tb00809.x; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; DUNN SD, 1986, ANAL BIOCHEM, V157, P144, DOI 10.1016/0003-2697(86)90207-1; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Kaminska M, 2000, EMBO J, V19, P6908, DOI 10.1093/emboj/19.24.6908; KAO J, 1992, J BIOL CHEM, V267, P20239; KAO J, 1994, J BIOL CHEM, V269, P25106; KELLERMANN O, 1978, EUR J BIOCHEM, V88, P197, DOI 10.1111/j.1432-1033.1978.tb12438.x; KERJAN P, 1992, BIOCHIMIE, V74, P195, DOI 10.1016/0300-9084(92)90046-H; Kim Y, 2000, J BIOL CHEM, V275, P27062; Kleeman TA, 1997, J BIOL CHEM, V272, P14420, DOI 10.1074/jbc.272.22.14420; Knies UE, 1998, P NATL ACAD SCI USA, V95, P12322, DOI 10.1073/pnas.95.21.12322; Kornelyuk Alexander, 1999, Biopolimery i Kletka, V15, P168; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Marissen WE, 2000, J BIOL CHEM, V275, P9314, DOI 10.1074/jbc.275.13.9314; Marissen WE, 1998, MOL CELL BIOL, V18, P7565, DOI 10.1128/MCB.18.12.7565; MIRANDE M, 1985, EUR J BIOCHEM, V147, P281, DOI 10.1111/j.1432-1033.1985.tb08748.x; MIRANDE M, 1991, PROG NUCLEIC ACID RE, V40, P95; MIRANDE M, 1982, J BIOL CHEM, V257, P1056; Morales AJ, 1999, EMBO J, V18, P3475, DOI 10.1093/emboj/18.12.3475; ONESTI S, 1995, STRUCTURE, V3, P163, DOI 10.1016/S0969-2126(01)00147-2; Quevillon S, 1996, FEBS LETT, V395, P63, DOI 10.1016/0014-5793(96)01005-8; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; QUINN MT, 1988, P NATL ACAD SCI USA, V85, P2805, DOI 10.1073/pnas.85.8.2805; Renault L, 2001, EMBO J, V20, P570, DOI 10.1093/emboj/20.3.570; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Schluesener HJ, 1997, GLIA, V20, P365, DOI 10.1002/(SICI)1098-1136(199708)20:4<365::AID-GLIA8>3.0.CO;2-4; Simos G, 1998, MOL CELL, V1, P235, DOI 10.1016/S1097-2765(00)80024-6; Swairjo MA, 2000, EMBO J, V19, P6287, DOI 10.1093/emboj/19.23.6287; Tan M, 1999, GENE, V233, P131, DOI 10.1016/S0378-1119(99)00146-8; Van de Craen M, 1999, CELL DEATH DIFFER, V6, P1117, DOI 10.1038/sj.cdd.4400589; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147	38	109	120	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23769	23776		10.1074/jbc.M100489200	http://dx.doi.org/10.1074/jbc.M100489200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11306575	hybrid			2022-12-27	WOS:000169531100074
J	Basile, JR; Zacny, V; Munger, K				Basile, JR; Zacny, V; Munger, K			The cytokines tumor necrosis factor-alpha (TNF-alpha) and TNF-related apoptosis-inducing ligand differentially modulate proliferation and apoptotic pathways in human keratinocytes expressing the human papillomavirus-16 E7 oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL-CYCLE; DEATH DOMAIN; MITOTIC CHECKPOINTS; MEDIATED APOPTOSIS; SIGNALING PATHWAYS; TRAIL RECEPTOR-1; DNA-REPLICATION; PROTEIN; GENE	Keratinocytes are the natural target cells for infection by human papillomaviruses (HPVs), most of which cause benign epithelial hyperplasias (warts), However, a subset of papillomaviruses, the "high risk" HPVs, cause lesions that can progress to carcinomas. Inflammatory mediators such as tumor necrosis factor-alpha (TNF-alpha) and TNF-related apoptosis-inducing ligand (TRAIL) are produced by cells in response to a viral infection. To determine the effects of TNF-alpha and TRAIL on keratinocytes expressing the high risk HPV-16 oncoprotein E7, human foreskin keratinocytes stably expressing E7 were treated with TNF-alpha and TRAIL. Treatment with TNF-alpha alone, but not TRAIL, induced growth arrest and differentiation in keratinocytes that was almost completely overcome by expression of HPV-16 E7. Both cytokines induced apoptosis when administered in combination with the protein synthesis inhibitor cycloheximide, but the apoptotic response to TRAIL was significantly more rapid and efficient compared with the response seen after TNF-alpha treatment. HPV-16 E7-expressing keratinocytes were more prone to both TNF-alpha- and TRAIL-mediated apoptosis compared with vector-infected controls.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Dent Med, Dept Oral Med & Diagnost Sci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Canc Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Munger, K (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave,D2-544A, Boston, MA 02115 USA.			Munger, Karl/0000-0003-3288-9935	NCI NIH HHS [T32CA72320, R01 CA81135] Funding Source: Medline; NIDCR NIH HHS [K16DE00275] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081135, T32CA072320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K16DE000275] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Alani RM, 1998, MOL CARCINOGEN, V23, P226, DOI 10.1002/(SICI)1098-2744(199812)23:4<226::AID-MC5>3.0.CO;2-N; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Boyer SN, 1996, CANCER RES, V56, P4620; Chang THT, 1997, ONCOGENE, V14, P2383, DOI 10.1038/sj.onc.1201196; Chaturvedi V, 1999, J BIOL CHEM, V274, P23358, DOI 10.1074/jbc.274.33.23358; CHENG S, 1995, GENE DEV, V9, P2335, DOI 10.1101/gad.9.19.2335; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Delhase M, 2000, NATURE, V406, P367, DOI 10.1038/35019154; DETMAR M, 1990, ARCH DERMATOL RES, V282, P238, DOI 10.1007/BF00371643; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090; GEORGE MD, 1990, J BIOL CHEM, V265, P11098; GOTTLIEB E, 1994, EMBO J, V13, P1368, DOI 10.1002/j.1460-2075.1994.tb06390.x; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Griffith TS, 1998, CURR OPIN IMMUNOL, V10, P559, DOI 10.1016/S0952-7915(98)80224-0; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Jiang YL, 1998, BIOCHEM BIOPH RES CO, V245, P691, DOI 10.1006/bbrc.1998.8390; Jones DL, 1996, SEMIN CANCER BIOL, V7, P327, DOI 10.1006/scbi.1996.0042; Jones DL, 1997, VIROLOGY, V239, P97, DOI 10.1006/viro.1997.8851; Jones DL, 1997, GENE DEV, V11, P2101, DOI 10.1101/gad.11.16.2101; Jones DL, 1999, VIROLOGY, V258, P406, DOI 10.1006/viro.1999.9733; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kondo S, 1997, EUR J IMMUNOL, V27, P1713, DOI 10.1002/eji.1830270718; KONO T, 1990, Journal of Dermatology (Tokyo), V17, P409; Kothny-Wilkes G, 1998, J BIOL CHEM, V273, P29247, DOI 10.1074/jbc.273.44.29247; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; KYO S, 1994, VIROLOGY, V200, P130, DOI 10.1006/viro.1994.1171; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Ma Y, 1999, CANCER RES, V59, P5341; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MISSERO C, 1995, P NATL ACAD SCI USA, V92, P5451, DOI 10.1073/pnas.92.12.5451; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NAKANISHI M, 1995, P NATL ACAD SCI USA, V92, P4352, DOI 10.1073/pnas.92.10.4352; Natoli G, 1998, J BIOL CHEM, V273, P31262, DOI 10.1074/jbc.273.47.31262; Natoli G, 1998, BIOCHEM PHARMACOL, V56, P915, DOI 10.1016/S0006-2952(98)00154-3; Ozes ON, 1999, NATURE, V401, P82; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pastorino JG, 1999, J BIOL CHEM, V274, P19411, DOI 10.1074/jbc.274.27.19411; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; PILLAI S, 1989, J CLIN INVEST, V83, P816, DOI 10.1172/JCI113963; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Ruesch MN, 1998, VIROLOGY, V250, P19, DOI 10.1006/viro.1998.9359; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Schneider P, 1997, FEBS LETT, V416, P329, DOI 10.1016/S0014-5793(97)01231-3; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Smith-McCune K, 1999, P NATL ACAD SCI USA, V96, P6999, DOI 10.1073/pnas.96.12.6999; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Stoppler H, 1998, ONCOGENE, V17, P1207, DOI 10.1038/sj.onc.1202053; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; SYMINGTON FW, 1989, J INVEST DERMATOL, V92, P798, DOI 10.1111/1523-1747.ep12696816; Thompson DA, 1997, ONCOGENE, V15, P3025, DOI 10.1038/sj.onc.1201495; VILLA LL, 1992, MOL CARCINOGEN, V6, P5, DOI 10.1002/mc.2940060103; Wajant H, 1998, CURR BIOL, V8, P113, DOI 10.1016/S0960-9822(98)70042-9; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang J, 1996, SCIENCE, V273, P359, DOI 10.1126/science.273.5273.359; WEMESS BA, 1990, SCIENCE, V248, P76; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; WOODWORTH CD, 1990, CANCER RES, V50, P3709; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang YK, 1999, ONCOGENE, V18, P1131, DOI 10.1038/sj.onc.1202426	75	72	78	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22522	22528		10.1074/jbc.M010505200	http://dx.doi.org/10.1074/jbc.M010505200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11306566	hybrid			2022-12-27	WOS:000169412700074
J	Brinkmann, H; Dahler, AL; Popa, C; Serewko, MM; Parsons, PG; Gabrielli, BG; Burgess, AJ; Saunders, NA				Brinkmann, H; Dahler, AL; Popa, C; Serewko, MM; Parsons, PG; Gabrielli, BG; Burgess, AJ; Saunders, NA			Histone hyperacetylation induced by histone deacetylase inhibitors is not sufficient to cause growth inhibition in human dermal fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; DIFFERENTIATION-SPECIFIC GENES; TRANSFORMED-CELL DIFFERENTIATION; CHAIN FATTY-ACIDS; TRANSCRIPTIONAL REPRESSION; ANTITUMOR-ACTIVITY; EPITHELIAL-CELLS; INTERFERON-GAMMA; TRICHOSTATIN-A; RETINOIC ACID	Use of specific histone deacetylase inhibitors has revealed critical roles for the histone deacetylases (HDAC) in controlling proliferation. Although many studies have correlated the function of HDAC inhibitors with the hyperacetylation of histones, few studies have specifically addressed whether the accumulation of acetylated histones, caused by HDAC inhibitor treatment, is responsible for growth inhibition. In the present study we show that HDAC inhibitors cause growth inhibition in normal and transformed keratinocytes but not in normal dermal fibroblasts, This was despite the observation that the HDAC inhibitor, suberic bishydroxamate (SBHA), caused a kinetically similar accumulation of hyperacetylated histones, This cell type-specific response to SBHA was not due to the inactivation of SBHA by fibroblasts, nor was it due to differences in the expression of specific HDAC family members. Remarkably, overexpression of HDACs 1, 4, and 6 in normal human fibroblasts resulted in cells that could be growth-inhibited by SBHA. These data suggest that, although histone acetylation is a major target for HDAC inhibitors, the accumulation of hyperacetylated histones is not sufficient to cause growth inhibition in all cell types, This suggests that growth inhibition, caused by HDAC inhibitors, may be the culmination of histone hyperacetylation acting in concert with other growth regulatory pathways.	Univ Queensland, Princess Alexandra Hosp, Epithelial Pathobiol Grp, Ctr Immunol & Canc Res,Dept Med, Brisbane, Qld 4102, Australia; Queensland Inst Med Res, Canc Unit, Herston, Qld 4006, Australia; Univ Queensland, Dept Pathol, Sch Med, Herston, Qld 4006, Australia; Univ Queensland, Dept Physiol & Pharmacol, St Lucia, Qld 4067, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland	Saunders, NA (corresponding author), Univ Queensland, Princess Alexandra Hosp, Epithelial Pathobiol Grp, Ctr Immunol & Canc Res,Dept Med, Ipswich Rd, Brisbane, Qld 4102, Australia.		saunders, nicholas/AAJ-6101-2020; Burgess, Andrew/C-7952-2009; Gabrielli, Brian G/B-3655-2011; McTaggart, Jill/G-4696-2010; Parsons, Peter G/H-8163-2015; Burgess, Andrew/H-3339-2019	saunders, nicholas/0000-0002-2478-3420; Burgess, Andrew/0000-0003-4536-9226; Gabrielli, Brian G/0000-0003-3933-1651; McTaggart, Jill/0000-0002-9000-8529; Parsons, Peter G/0000-0002-0473-3346; Burgess, Andrew/0000-0003-4536-9226				Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Cai RL, 2000, J BIOL CHEM, V275, P27909; Dahler AL, 1998, J CELL PHYSIOL, V177, P474, DOI 10.1002/(SICI)1097-4652(199812)177:3<474::AID-JCP10>3.3.CO;2-D; Dangond F, 1998, BIOCHEM BIOPH RES CO, V247, P833, DOI 10.1006/bbrc.1998.8891; Dicker AJ, 2000, ONCOGENE, V19, P2887, DOI 10.1038/sj.onc.1203610; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HAGUE A, 1995, INT J CANCER, V60, P400, DOI 10.1002/ijc.2910600322; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Janson W, 1997, ONCOGENE, V15, P1395, DOI 10.1038/sj.onc.1201304; Jones SJ, 1997, J INVEST DERMATOL, V109, P187, DOI 10.1111/1523-1747.ep12319308; Kao HY, 2000, GENE DEV, V14, P55; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Mariadason JM, 2000, CANCER RES, V60, P4561; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nakajima H, 1998, EXP CELL RES, V241, P126, DOI 10.1006/excr.1998.4027; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Parsons PG, 1997, BIOCHEM PHARMACOL, V53, P1719, DOI 10.1016/S0006-2952(97)00016-6; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Qiu L, 2000, MOL BIOL CELL, V11, P2069, DOI 10.1091/mbc.11.6.2069; Qiu L, 1999, BRIT J CANCER, V80, P1252, DOI 10.1038/sj.bjc.6690493; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Richon VM, 1996, P NATL ACAD SCI USA, V93, P5705, DOI 10.1073/pnas.93.12.5705; Richon VM, 1998, P NATL ACAD SCI USA, V95, P3003, DOI 10.1073/pnas.95.6.3003; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Sambucetti LC, 1999, J BIOL CHEM, V274, P34940, DOI 10.1074/jbc.274.49.34940; Saunders, 1999, Expert Opin Investig Drugs, V8, P1611, DOI 10.1517/13543784.8.10.1611; Saunders N, 1999, CANCER RES, V59, P399; Saunders NA, 1999, J INVEST DERMATOL, V112, P977, DOI 10.1046/j.1523-1747.1999.00611.x; Saunders NA, 1998, CANCER RES, V58, P1646; SAUNDERS NA, 1993, MOL ENDOCRINOL, V7, P387, DOI 10.1210/me.7.3.387; SAUNDERS NA, 1994, J BIOL CHEM, V269, P2016; SAUNDERS NA, 1993, BIOCHEM BIOPH RES CO, V197, P46, DOI 10.1006/bbrc.1993.2439; Sowa Y, 1999, CANCER RES, V59, P4266; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Wang AH, 1999, MOL CELL BIOL, V19, P7816; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Wolffe AP, 1997, NATURE, V387, P16, DOI 10.1038/387016a0; Xiao HY, 1999, J CELL BIOCHEM, V73, P291, DOI 10.1002/(SICI)1097-4644(19990601)73:3<291::AID-JCB1>3.0.CO;2-5; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P14329, DOI 10.1073/pnas.250494697	62	67	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22491	22499		10.1074/jbc.M100206200	http://dx.doi.org/10.1074/jbc.M100206200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11304533	hybrid			2022-12-27	WOS:000169412700070
J	Saveanu, L; Daniel, S; van Endert, PM				Saveanu, L; Daniel, S; van Endert, PM			Distinct functions of the ATP binding cassettes of transporters associated with antigen processing - A mutational analysis of Walker A and B sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I MOLECULES; RESISTANCE PROTEIN MRP1; NUCLEOTIDE-BINDING; P-GLYCOPROTEIN; ABC TRANSPORTER; CRYSTAL-STRUCTURE; INSECT CELLS; PEPTIDE; DOMAINS; EXPRESSION	The transporters associated with antigen processing (TAP1/TAP2) provide peptides to MHC class I molecules in the endoplasmic reticulum, Like other ATP-binding cassette proteins, TAP uses ATP hydrolysis to power transport. We have studied peptide binding to as well as translocation by TAP proteins with mutations in the Walker A and B sequences that are known to mediate ATP binding and hydrolysis. We show that a mutation in the TAP1 Walker B sequence reported to abrogate class I expression by a lung tumor does not affect ATP binding affinity, suggesting a defect restricted to ATP hydrolysis, This mutation reduces peptide transport by only 50%, suggesting that TAP function can be highly limiting for antigen presentation in non-lymphoid cells, Single substitutions in Walker A sequences (TAP1K544A, TAP2K509A), or their complete replacements, abrogate nucleotide binding to each subunit, Although all of these mutations abrogate peptide transport, they reveal distinct roles for nucleotide binding to the two transporter subunits in TAP folding and in regulation of peptide substrate affinity, respectively. Alteration of the TAP1 Walker A motif can have strong effects on TAP1 and thereby TAP complex folding. However, TAP1 Walker A mutations compatible with correct folding do not affect peptide binding. In contrast, abrogation of the TAPS nucleotide binding capacity has little or no effect on TAP folding but eliminates peptide binding to TAP at 37 degreesC in the presence of nucleotides. Thus, nucleotide binding to TAPS but not to TAP1 is a prerequisite for peptide binding to TAP, Based on these results, we propose a model in which nucleotide and peptide release from TAP are coupled and followed by ATP binding to TAPS, which induces high peptide affinity and initiates the transport cycle.	INSERM, U25, F-75743 Paris 15, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	van Endert, PM (corresponding author), INSERM, U25, 161 Rue Sevres, F-75743 Paris 15, France.		Saveanu, Loredana/K-6821-2017; SAVEANU, Loredana/Q-1241-2019; van Endert, Peter/R-4606-2017	SAVEANU, Loredana/0000-0003-3138-7968; van Endert, Peter/0000-0003-3782-0750				Algarra I, 2000, HUM IMMUNOL, V61, P65, DOI 10.1016/S0198-8859(99)00156-1; ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; Bach JM, 1997, J AUTOIMMUN, V10, P375, DOI 10.1006/jaut.1997.0143; Chen HL, 1996, NAT GENET, V13, P210, DOI 10.1038/ng0696-210; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Daniel S, 1997, J IMMUNOL, V159, P2350; Daniel S, 1998, J IMMUNOL, V161, P617; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; Elliott T, 1997, ADV IMMUNOL, V65, P47, DOI 10.1016/S0065-2776(08)60741-5; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Garrido F, 1997, IMMUNOL TODAY, V18, P89, DOI 10.1016/S0167-5699(96)10075-X; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Knittler MR, 1999, CURR BIOL, V9, P999, DOI 10.1016/S0960-9822(99)80448-5; Lauvau G, 1999, J BIOL CHEM, V274, P31349, DOI 10.1074/jbc.274.44.31349; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; Nagata K, 2000, J BIOL CHEM, V275, P17626, DOI 10.1074/jbc.M000792200; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Senior AE, 1997, SEMIN CANCER BIOL, V8, P143, DOI 10.1006/scbi.1997.0065; SPIES T, 1991, NATURE, V351, P323, DOI 10.1038/351323a0; Szabo K, 1998, J BIOL CHEM, V273, P10132, DOI 10.1074/jbc.273.17.10132; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Urbatsch IL, 2000, J BIOL CHEM, V275, P25031, DOI 10.1074/jbc.M003962200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; van Endert PM, 1999, J BIOL CHEM, V274, P14632, DOI 10.1074/jbc.274.21.14632; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x	31	43	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22107	22113		10.1074/jbc.M011221200	http://dx.doi.org/10.1074/jbc.M011221200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11290739	hybrid			2022-12-27	WOS:000169412700019
J	Granovsky, AE; Artemyev, NO				Granovsky, AE; Artemyev, NO			Partial reconstitution of photoreceptor cGMP phosphodiesterase characteristics in cGMP phosphodiesterase-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SUBUNIT; CYCLIC-GMP; AMINO-ACIDS; BINDING; INHIBITION; MECHANISM; SITES; IDENTIFICATION; MUTAGENESIS; PROTEINS	Photoreceptor cGMP phosphodiesterases (PDE6) are uniquely qualified to serve as effector enzymes in the vertebrate visual transduction cascade. In the dark-adapted photoreceptors, the activity of PDE6 is blocked via tight association with the inhibitory gamma -subunits (P gamma), The P gamma block is removed in the light-activated PDE6 by the visual G protein, transducin, Transducin-activated PDE6 exhibits an exceptionally high catalytic rate of cGMP hydrolysis ensuring high signal amplification. To identify the structural determinants for the inhibitory interaction with P gamma and the remarkable cGMP hydrolytic ability, we sought to reproduce the PDE6 characteristics by mutagenesis of PDE5, a related cyclic GMP-specific, cGMP-binding PDE, PDE5 is insensitive to P gamma and has a more than 100-fold lower k(cat) for cGMP hydrolysis, Our mutational analysis of chimeric PDE5/PDE6 alpha' enzymes revealed that the inhibitory interaction of cone PDE6 catalytic subunits (PDE6 alpha') with P gamma is mediated primarily by three hydrophobic residues at the entry to the catalytic pocket, Met(758), Phe(777), and Phe(781), The maximal catalytic rate of PDE5 was enhanced by at least 10-fold with substitutions of PDE5-specific glycine residues for the corresponding PDE5 alanine residues, Ala(608) and Ala(612). The Gly residues are adjacent to the highly conserved metal binding motif His-Asn-X-X-His, which is essential for cGMP hydrolysis. Our results suggest that the unique Gly residues allow the PDE6 metal binding site to adopt a more favorable conformation for cGMP hydrolysis.	Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa	Artemyev, NO (corresponding author), Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA.	nikolai-artemyev@uiowa.edu	Alex, Granovsky/EUV-7323-2022	Artemyev, Nikolai/0000-0002-5266-6854	NEI NIH HHS [EY-10843] Funding Source: Medline; NIDDK NIH HHS [DK-25295] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Artemyev NO, 1996, P NATL ACAD SCI USA, V93, P5407, DOI 10.1073/pnas.93.11.5407; Artemyev NO, 1998, METHODS, V14, P93, DOI 10.1006/meth.1997.0568; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN RL, 1992, BIOCHEMISTRY-US, V31, P5918, DOI 10.1021/bi00140a031; CHABRE M, 1989, EUR J BIOCHEM, V179, P255, DOI 10.1111/j.1432-1033.1989.tb14549.x; DUMKE CL, 1994, J GEN PHYSIOL, V103, P1071, DOI 10.1085/jgp.103.6.1071; Francis SH, 2000, BIOCHEMISTRY-US, V39, P9591, DOI 10.1021/bi000392m; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; Granovsky AE, 1998, J BIOL CHEM, V273, P24485, DOI 10.1074/jbc.273.38.24485; Granovsky AE, 1997, J BIOL CHEM, V272, P11686, DOI 10.1074/jbc.272.18.11686; Granovsky AE, 2000, J BIOL CHEM, V275, P41258, DOI 10.1074/jbc.M008094200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; He F, 2000, J BIOL CHEM, V275, P20572, DOI 10.1074/jbc.M000440200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; MCALLISTERLUCAS LM, 1993, J BIOL CHEM, V268, P22863; Mou HM, 1999, J BIOL CHEM, V274, P18813, DOI 10.1074/jbc.274.26.18813; Natochin M, 2000, METHOD ENZYMOL, V315, P539; PIRIEV NI, 1993, P NATL ACAD SCI USA, V90, P9340, DOI 10.1073/pnas.90.20.9340; QIN N, 1994, J BIOL CHEM, V269, P3265; Rost B, 1996, METHOD ENZYMOL, V266, P525; SKIBA NP, 1995, J BIOL CHEM, V270, P13210, DOI 10.1074/jbc.270.22.13210; THOMAS MK, 1990, J BIOL CHEM, V265, P14964; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THOMPSON WJ, 1971, BIOCHEMISTRY-US, V10, P311; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Turko IV, 1999, MOL PHARMACOL, V56, P124, DOI 10.1124/mol.56.1.124; Turko IV, 1996, J BIOL CHEM, V271, P22240, DOI 10.1074/jbc.271.36.22240; Turko IV, 1998, J BIOL CHEM, V273, P6460, DOI 10.1074/jbc.273.11.6460; Xu RX, 2000, SCIENCE, V288, P1822, DOI 10.1126/science.288.5472.1822; YARFITZ S, 1994, J BIOL CHEM, V269, P14329	32	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21698	21703		10.1074/jbc.M100626200	http://dx.doi.org/10.1074/jbc.M100626200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11285263	hybrid			2022-12-27	WOS:000169297900120
J	Grzeszkiewicz, TM; Kirschling, DJ; Chen, NY; Lau, LF				Grzeszkiewicz, TM; Kirschling, DJ; Chen, NY; Lau, LF			CYR61 stimulates human skin fibroblast migration through integrin alpha(v)beta(5) and enhances mitogenesis through integrin alpha(v)beta(3), independent of its carboxyl-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE GROWTH-FACTOR; IMMEDIATE-EARLY GENE; CELL-SURFACE; MATRIX METALLOPROTEINASE; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; CUTANEOUS WOUNDS; TUMOR-GROWTH; CCN FAMILY; EXPRESSION	CYR61, an angiogenic factor and a member of the CCN protein family, is an extracellular matrix-associated, heparin-binding protein that mediates cell adhesion, promotes cell migration, and enhances growth factor-stimulated cell proliferation. CYR61 induces angiogenesis and promotes tumor growth in vivo and is expressed in dermal fibroblasts during cutaneous wound healing. It has been demonstrated recently that adhesion of primary skin fibroblasts to CYR61 is mediated through integrin alpha (6)beta (1) and cell surface heparan sulfate proteoglycans, resulting in adhesive signaling and up-regulation of matrix metalloproteinases 1 and 3, CYR61 is composed of four discrete structural domains that bear sequence similarities to the insulin-like growth factor-binding proteins, von Willebrand factor type C repeat, thrombospondin type 1 repeat, and a carboxyl-terminal (CT) domain that resembles cysteine knots found in some growth factors, In this study, we show that a CYR61 mutant (CYR61 Delta CT) that has the CT domain deleted is unable to support adhesion of primary human skin fibroblasts but is still able to stimulate chemotaxis and enhance basic fibroblast growth factor-induced mitogenesis similar to wild type. In addition, fibroblast migration to CYR61 is mediated through integrin alpha (v)beta (5) but not integrins alpha (6)beta (1) or alpha (v)beta (3). Furthermore, we show that CYR61 binds directly to purified integrin alpha (v)beta (5) in vitro, By contrast, CYR61 enhancement of basic fibroblast growth factor-induced DNA synthesis is mediated through integrin alpha (v)beta (3), a known receptor for CYR61 that mediates CYR61-dependent cell adhesion and chemotaxis in vascular endothelial cells. Thus, CYR61 promotes primary human fibroblast adhesion, migration, and mitogenesis through integrins alpha (6)beta (1), alpha (v)beta (5), and alpha (v)beta (3), respectively. Together, these findings establish CYR61 as a novel ligand for integrin alpha (v)beta (5) and show that CYR61 interacts with distinct integrins to mediate disparate activities in a cell type-specific manner.	Univ Illinois, Coll Med, Dept Mol Genet, Chicago, IL 60607 USA; Munin Corp, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lau, LF (corresponding author), Univ Illinois, Coll Med, Dept Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA.			Lau, Lester/0000-0002-4364-2914	NCI NIH HHS [CA80080, CA78044, CA46565] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA046565, R43CA078044, R44CA078044] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Ball DK, 1998, BIOL REPROD, V59, P828, DOI 10.1095/biolreprod59.4.828; BENNETT NT, 1993, AM J SURG, V165, P728, DOI 10.1016/S0002-9610(05)80797-4; Blaschuk KL, 2000, DEVELOPMENT, V127, P1961; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Brigstock DR, 1997, J BIOL CHEM, V272, P20275, DOI 10.1074/jbc.272.32.20275; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Carron CP, 1998, CANCER RES, V58, P1930; CAVANI A, 1993, J INVEST DERMATOL, V101, P600, DOI 10.1111/1523-1747.ep12366057; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200; CHERESH DA, 1987, J BIOL CHEM, V262, P17703; Clark RAF, 1996, AM J PATHOL, V148, P1407; Clark RAF, 1996, BRIT J DERMATOL, V135, P46; DHANABAL M, 1995, J IMMUNOL METHODS, V182, P165, DOI 10.1016/0022-1759(95)00036-A; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; GAILIT J, 1994, CURR OPIN CELL BIOL, V6, P717, DOI 10.1016/0955-0674(94)90099-X; GAILIT J, 1994, J INVEST DERMATOL, V103, P221, DOI 10.1111/1523-1747.ep12393176; GAN ZR, 1988, J BIOL CHEM, V263, P19827; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; HU DD, 1995, J BIOL CHEM, V270, P26232, DOI 10.1074/jbc.270.44.26232; Hynes RO, 1996, DEV BIOL, V180, P402, DOI 10.1006/dbio.1996.0314; Jedsadayanmata A, 1999, J BIOL CHEM, V274, P24321, DOI 10.1074/jbc.274.34.24321; Kibe Y, 2000, BRIT J DERMATOL, V143, P720, DOI 10.1046/j.1365-2133.2000.03824.x; KIM JP, 1994, J BIOL CHEM, V269, P26926; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548; KLEMKE RL, 1994, J CELL BIOL, V127, P859, DOI 10.1083/jcb.127.3.859; Kothapalli D, 2000, J CELL PHYSIOL, V182, P119, DOI 10.1002/(SICI)1097-4652(200001)182:1<119::AID-JCP13>3.0.CO;2-4; LARJAVA H, 1993, J CLIN INVEST, V92, P1425, DOI 10.1172/JCI116719; LATINKIC BV, 2001, IN PRESS ENDOCRINOLO; LATINKIC BV, 1994, THESIS U ILLINOIS CH; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Milner R, 1999, J CELL SCI, V112, P4271; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Nakanishi T, 2000, ENDOCRINOLOGY, V141, P264, DOI 10.1210/endo.141.1.7267; OBRIEN TP, 1992, CELL GROWTH DIFFER, V3, P645; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; PIALI L, 1995, J CELL BIOL, V130, P451, DOI 10.1083/jcb.130.2.451; Pilcher BK, 1999, ANN NY ACAD SCI, V878, P12, DOI 10.1111/j.1749-6632.1999.tb07671.x; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; RABINOWICH H, 1995, J IMMUNOL, V154, P1124; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shahan TA, 1999, CANCER RES, V59, P4584; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Steffen CL, 1998, GROWTH FACTORS, V15, P199, DOI 10.3109/08977199809002117; Stuiver I, 1996, J CELL PHYSIOL, V168, P521, DOI 10.1002/(SICI)1097-4652(199609)168:3<521::AID-JCP4>3.0.CO;2-R; Sung V, 1998, J CELL PHYSIOL, V176, P482, DOI 10.1002/(SICI)1097-4652(199809)176:3<482::AID-JCP5>3.0.CO;2-K; THERIAULT NY, 1988, BIOTECHNIQUES, V6, P470; Triantafilou M, 2000, HUM IMMUNOL, V61, P453, DOI 10.1016/S0198-8859(00)00103-8; Vaalamo M, 1996, BRIT J DERMATOL, V135, P52; Wong M, 1997, DEV BIOL, V192, P492, DOI 10.1006/dbio.1997.8766; YANG GP, 1991, CELL GROWTH DIFFER, V2, P351; Zhang R, 1998, MOL CELL BIOL, V18, P6131, DOI 10.1128/MCB.18.10.6131	61	136	143	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21943	21950		10.1074/jbc.M100978200	http://dx.doi.org/10.1074/jbc.M100978200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11287419	hybrid			2022-12-27	WOS:000169297900149
J	Liaw, PCY; Becker, DL; Stafford, AR; Fredenburgh, JC; Weitz, JI				Liaw, PCY; Becker, DL; Stafford, AR; Fredenburgh, JC; Weitz, JI			Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor II in the presence of dermatan sulfate but not heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEEP-VEIN THROMBOSIS; TERNARY COMPLEX; ANTITHROMBIN-III; WEIGHT HEPARINS; ALPHA-THROMBIN; INHIBITION; RESIDUES; PREVENTION; BINDING; MONOMER	Although fibrin-bound thrombin is resistant to inactivation by heparin antithrombin and heparin.heparin cofactor II complexes, indirect studies in plasma systems suggest that the dermatan sulfate.heparin cofactor II complex can inhibit fibrin-bound thrombin, Herein we demonstrate that fibrin monomer produces a 240-fold decrease in the heparin-catalyzed rate of thrombin inhibition by heparin cofactor II but reduces the dermatan sulfate-catalyzed rate only 3-fold. The protection of fibrin-bound thrombin from inhibition by heparin.heparin co-factor II reflects heparin-mediated bridging of thrombin to fibrin that results in the formation of a ternary heparin.thrombin.fibrin complex. This compiler, formed as a result of three binary interactions (thrombin. fibrin, thrombin.heparin, and heparin.fibrin), limits accessibility of heparin-catalyzed inhibitors to thrombin and induces conformational changes at the active site of the enzyme, In contrast, dermatan sulfate binds to thrombin but does not bind to fibrin. Although a ternary dermatan sulfate.thrombin.fibrin complex forms, without dermatan sulfate-mediated bridging of thrombin to fibrin, only two binary interactions exist (thrombin.fibrin and thrombin.dermatan sulfate). Consequently, thrombin remains susceptible to inactivation by heparin cofactor II. This study explains why fibrin-bound thrombin is susceptible to inactivation by heparin cofactor II in the presence of dermatan sulfate but not heparin.	Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada; McMaster Univ, Hamilton, ON L8V 1C3, Canada	McMaster University	Weitz, JI (corresponding author), Henderson Res Ctr, 711 Concess St, Hamilton, ON L8V 1C3, Canada.	jweitz@thrombosis.hhscr.org	Weitz, Jeffrey/AAD-1929-2019	Weitz, Jeffrey/0000-0002-1092-7550				AGNELLI G, 1992, THROMB HAEMOSTASIS, V67, P203; Becker DL, 1999, J BIOL CHEM, V274, P6226, DOI 10.1074/jbc.274.10.6226; BENDAYAN P, 1994, THROMB HAEMOSTASIS, V71, P576; CADROY Y, 1993, ARTERIOSCLER THROMB, V13, P1213, DOI 10.1161/01.ATV.13.8.1213; CHURCH FC, 1989, J BIOL CHEM, V264, P18419; Collins R, 1996, BMJ-BRIT MED J, V313, P652; COSMI B, 1993, THROMB HAEMOSTASIS, V70, P443; Di Carlo V, 1999, THROMB HAEMOSTASIS, V82, P30, DOI 10.1055/s-0037-1614625; EISENBERG PR, 1993, J CLIN INVEST, V91, P1877, DOI 10.1172/JCI116404; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; GAN ZR, 1994, J BIOL CHEM, V269, P1301; HOGG PJ, 1990, J BIOL CHEM, V265, P248; HOGG PJ, 1989, P NATL ACAD SCI USA, V86, P3619, DOI 10.1073/pnas.86.10.3619; Hogg PJ, 1996, J BIOL CHEM, V271, P26088, DOI 10.1074/jbc.271.42.26088; HOGG PJ, 1990, J BIOL CHEM, V265, P241; Hogg PJ, 1997, THROMB HAEMOSTASIS, V77, P424; HORTIN GL, 1989, J BIOL CHEM, V264, P13979; HUNT D, 1992, LANCET, V339, P753; JACKMAN MP, 1992, J BIOL CHEM, V267, P15375; KAWASAKI K, 1992, CHEM PHARM BULL, V40, P3253, DOI 10.1248/cpb.40.3253; LANE DA, 1992, LANCET, V339, P334, DOI 10.1016/0140-6736(92)91650-W; Liaw PCY, 1999, J BIOL CHEM, V274, P27597, DOI 10.1074/jbc.274.39.27597; MERTON RE, 1987, THROMB HAEMOSTASIS, V58, P839; NAGASAWA K, 1978, BIOCHIM BIOPHYS ACTA, V544, P430, DOI 10.1016/0304-4165(78)90110-1; NASKI MC, 1990, J BIOL CHEM, V265, P13484; Odrljin TM, 1996, BLOOD, V88, P2050, DOI 10.1182/blood.V88.6.2050.bloodjournal8862050; OKWUSIDI JI, 1991, J LAB CLIN MED, V117, P359; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Popma JJ, 2001, CHEST, V119, p321S, DOI 10.1378/chest.119.1_suppl.321S; PRANDONI P, 1992, BRIT J SURG, V79, P505, DOI 10.1002/bjs.1800790610; ROSENBERG RD, 1987, HAEMOSTASIS THROMBOS, P1377; SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518; SHEEHAN JP, 1994, J BIOL CHEM, V269, P32747; TOLLEFSEN DM, 1995, THROMB HAEMOSTASIS, V74, P1209; VANDEWERF F, 1990, LANCET, V336, P71; VANRYNMCKENNA J, 1989, ANN NY ACAD SCI, V556, P304; Weitz JI, 1999, CIRCULATION, V99, P682, DOI 10.1161/01.CIR.99.5.682; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; YE J, 1994, J BIOL CHEM, V269, P17965	39	84	89	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20959	20965		10.1074/jbc.M010584200	http://dx.doi.org/10.1074/jbc.M010584200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11294849	hybrid			2022-12-27	WOS:000169297900023
J	Nakahata, S; Katsu, Y; Mita, K; Inoue, K; Nagahama, Y; Yamashita, M				Nakahata, S; Katsu, Y; Mita, K; Inoue, K; Nagahama, Y; Yamashita, M			Biochemical identification of Xenopus pumilio as a sequence-specific cyclin B1 mRNA-binding protein that physically interacts with a nanos homolog, Xcat-2, and a cytoplasmic polyadenylation element-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATURATION-PROMOTING FACTOR; GERM PLASM COMPONENT; OOCYTE MATURATION; MEIOTIC MATURATION; C-MOS; MAP KINASE; CELL-CYCLE; TRANSLATIONAL REPRESSION; MOLECULAR-MECHANISMS; DROSOPHILA	Translational activation of dormant cyclin B1 mRNA stored in oocytes is a prerequisite for the initiation or promotion of oocyte maturation in many vertebrates. Using a monoclonal antibody against the domain highly homologous to that of Drosophila Pumilio, we have shown for the first time in any vertebrate that a homolog of Pumilio is expressed in Xenopus oocytes, This 137-kDa protein binds to the region including the sequence UGUA at nucleotides 1335-1338 in the 3'-untranslated region of cyclin B1 mRNA, which is close to but does not overlap the cytoplasmic polyadenylation elements (CPEs). Physical in vitro association of Xenopus Pumilio with a Xenopus homolog of Nanos (Xcat-2) was demonstrated by a protein pull-down assay. The results of immunoprecipitation experiments showed in vivo interaction between Xenopus Pumilio and CPE-binding protein (CPEB), a key regulator of translational repression and activation of mRNAs stared in oocytes, This evidence provides a new insight into the mechanism of translational regulation through the 3'-end of mRNA during oocyte maturation. These results also suggest the generality of the function of Pumilio as a translational regulator of dormant mRNAs in both invertebrates and vertebrates.	Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan; Nara Inst Sci & Technol, Grad Sch Biosci, Ikoma 6300101, Japan; Natl Inst Basic Biol, Ctr Integrat Biol, Okazaki, Aichi 4448585, Japan; Natl Inst Basic Biol, Reprod Biol Lab, Okazaki, Aichi 4448585, Japan	Hokkaido University; Nara Institute of Science & Technology; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Yamashita, M (corresponding author), Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan.	myama@sci.hokudai.ac.jp	Katsu, Yoshinao/F-9122-2012; Yamashita, Masakane/A-4556-2012	Katsu, Yoshinao/0000-0003-2625-4626; Yamashita, Masakane/0000-0002-3696-451X				Abrieu A, 1998, J CELL SCI, V111, P1751; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; Ballantyne S, 1997, MOL BIOL CELL, V8, P1633, DOI 10.1091/mbc.8.8.1633; BARKER DD, 1992, GENE DEV, V6, P2312, DOI 10.1101/gad.6.12a.2312; Barkoff AF, 2000, DEV BIOL, V220, P97, DOI 10.1006/dbio.2000.9613; CYERT MS, 1988, CELL, V53, P185, DOI 10.1016/0092-8674(88)90380-7; DALBY B, 1993, EMBO J, V12, P1219, DOI 10.1002/j.1460-2075.1993.tb05763.x; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; DESCHAMPS S, 1992, J BIOL CHEM, V267, P13799; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; Ferby I, 1999, GENE DEV, V13, P2177, DOI 10.1101/gad.13.16.2177; Forbes A, 1998, DEVELOPMENT, V125, P679; FORRISTALL C, 1995, DEVELOPMENT, V121, P201; Frank-Vaillant M, 1999, MOL BIOL CELL, V10, P3279, DOI 10.1091/mbc.10.10.3279; Gavin AC, 1999, MOL BIOL CELL, V10, P2971, DOI 10.1091/mbc.10.9.2971; GOTOH Y, 1995, J BIOL CHEM, V270, P25898, DOI 10.1074/jbc.270.43.25898; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HACCARD O, 1995, DEV BIOL, V168, P677, DOI 10.1006/dbio.1995.1112; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hake LE, 1997, BBA-REV CANCER, V1332, pM31, DOI 10.1016/S0304-419X(96)00039-X; HAMPL A, 1995, MOL REPROD DEV, V40, P9, DOI 10.1002/mrd.1080400103; HIRAI T, 1992, MOL REPROD DEV, V33, P131, DOI 10.1002/mrd.1080330204; Houston DW, 1998, DEVELOPMENT, V125, P171; Howard EL, 1999, MOL CELL BIOL, V19, P1990; HUANG WD, 1995, MOL BIOL CELL, V6, P237, DOI 10.1091/mbc.6.3.237; Ihara J, 1998, MOL REPROD DEV, V50, P499, DOI 10.1002/(SICI)1098-2795(199808)50:4<499::AID-MRD14>3.0.CO;2-Y; IRISH V, 1989, NATURE, V338, P646, DOI 10.1038/338646a0; Karaiskou A, 1999, J CELL SCI, V112, P3747; Katsu Y, 1997, EUR J BIOCHEM, V249, P854, DOI 10.1111/j.1432-1033.1997.00854.x; Keiper BD, 1999, DEV BIOL, V206, P1, DOI 10.1006/dbio.1998.9131; KOBAYASHI H, 1991, J CELL BIOL, V114, P755, DOI 10.1083/jcb.114.4.755; KOSAKO H, 1994, EMBO J, V13, P2131, DOI 10.1002/j.1460-2075.1994.tb06489.x; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Kuge H, 1998, NUCLEIC ACIDS RES, V26, P3208, DOI 10.1093/nar/26.13.3208; MacArthur H, 1999, MECH DEVELOP, V84, P75, DOI 10.1016/S0925-4773(99)00075-1; MACDONALD PM, 1992, DEVELOPMENT, V114, P221; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; MINSHULL J, 1991, J CELL BIOL, V114, P767, DOI 10.1083/jcb.114.4.767; Mita K, 2000, ZOOL SCI, V17, P365, DOI 10.2108/jsz.17.365; Mita K, 2000, MECH DEVELOP, V94, P251, DOI 10.1016/S0925-4773(00)00295-1; MOSQUERA L, 1993, DEVELOPMENT, V117, P377; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; MURRAY MT, 1992, P NATL ACAD SCI USA, V89, P11, DOI 10.1073/pnas.89.1.11; Nagase T, 1996, DNA Res, V3, P321, DOI 10.1093/dnares/3.5.321; Nagase T, 1995, DNA Res, V2, P37, DOI 10.1093/dnares/2.1.37; Nakahata S, 2001, ZOOL SCI, V18, P337, DOI 10.2108/zsj.18.337; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Parisi M, 2000, CURR BIOL, V10, pR81, DOI 10.1016/S0960-9822(00)00283-9; Polanski Z, 1998, DEVELOPMENT, V125, P4989; Qian YW, 1998, MOL CELL BIOL, V18, P4262, DOI 10.1128/MCB.18.7.4262; Richter JD, 2000, COLD SPRING HARBOR M, V39, P785; SAGATA N, 1989, SCIENCE, V245, P643, DOI 10.1126/science.2474853; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; Sakamoto I, 1998, DEV BIOL, V195, P60, DOI 10.1006/dbio.1997.8835; SAKASHITA E, 1994, NUCLEIC ACIDS RES, V22, P4082, DOI 10.1093/nar/22.20.4082; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; Tadauchi T, 2001, EMBO J, V20, P552, DOI 10.1093/emboj/20.3.552; Taieb F, 1997, MOL REPROD DEV, V48, P397, DOI 10.1002/(SICI)1098-2795(199711)48:3&lt;397::AID-MRD14&gt;3.0.CO;2-T; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; Tay J, 2000, DEV BIOL, V221, P1, DOI 10.1006/dbio.2000.9669; Walker J, 1996, DEV BIOL, V173, P292, DOI 10.1006/dbio.1996.0024; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; Wreden C, 1997, DEVELOPMENT, V124, P3015; Yamashita M, 2000, ZOOL SCI, V17, P841, DOI 10.2108/zsj.17.841; YAMASHITA M, 1991, DEV GROWTH DIFFER, V33, P617; Yamashita M, 2000, Prog Cell Cycle Res, V4, P115; YAMASHITA M, 1992, DEV BIOL, V149, P8, DOI 10.1016/0012-1606(92)90259-J; Yamashita M, 1998, SEMIN CELL DEV BIOL, V9, P569, DOI 10.1006/scdb.1998.0251; YEW N, 1992, NATURE, V355, P649, DOI 10.1038/355649a0; Zamore PD, 1999, BIOCHEMISTRY-US, V38, P596, DOI 10.1021/bi982264s; Zamore PD, 1997, RNA, V3, P1421; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297; Zhou Y, 1996, DEVELOPMENT, V122, P2947	79	135	138	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20945	20953		10.1074/jbc.M010528200	http://dx.doi.org/10.1074/jbc.M010528200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11283000	hybrid			2022-12-27	WOS:000169297900021
J	Silvin, C; Belisle, B; Abo, A				Silvin, C; Belisle, B; Abo, A			A role for Wiskott-Aldrich syndrome protein in T-cell receptor-mediated transcriptional activation independent of actin polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WASP-RELATED PROTEIN; ARP2/3 COMPLEX; BINDING; CYTOSKELETON; DEFECTS; DOMAIN; CDC42; VASP; REORGANIZATION; FAMILY	Wiskott-Aldrich syndrome protein (WASP) plays a key role in cytoskeletal rearrangement and transcriptional activation in T-cells. Recent evidence links WASP and related proteins to actin polymerization by the Arp2/3 complex. To study whether the role of WASP in actin polymerization is coupled to T-cell receptor (TCR)-mediated transcriptional activation, we made a series of WASP deletion mutants and tested them for actin colocalization, actin polymerization, and transcriptional activation of NFAT, A WASP mutant with a deletion in the C-terminal region (WASP DeltaC) that is defective in actin polymerization potentiated NFAT transcription following TCR activation by anti-CD3 and anti-CD3/CD28 antibodies, but not by phorbol 12-myristate 13-acetate/ionomycin, Furthermore, cotransfection of a dominant-active mutant (WASP-WH2-C) for Arp2/3 polymerization did not inhibit NFAT activation. Finally, by analyzing a series of WASP double-domain deletion mutants, we determined that the WASP homology-l domain is responsible for NFAT transcriptional activation. Our results suggest that WASP activates transcription following TCR stimulation in a manner that is independent of its role in Arp2/3-directed actin polymerization.	Onyx Pharmaceut, Richmond, CA 94806 USA		Abo, A (corresponding author), Onyx Pharmaceut, 3031 Res Dr, Richmond, CA 94806 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056478] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM56478-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Abo A, 1998, CELL MOL LIFE SCI, V54, P1145, DOI 10.1007/s000180050242; Bear JE, 1998, J CELL BIOL, V142, P1325, DOI 10.1083/jcb.142.5.1325; Belisle B, 2000, J BIOL CHEM, V275, P26225, DOI 10.1074/jbc.M002743200; Callebaut I, 1998, FEBS LETT, V441, P181, DOI 10.1016/S0014-5793(98)01541-5; Carl UD, 1999, CURR BIOL, V9, P715, DOI 10.1016/S0960-9822(99)80315-7; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Fedorov AA, 1999, NAT STRUCT BIOL, V6, P661, DOI 10.1038/10717; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; Hoffman GR, 2000, CELL, V102, P403, DOI 10.1016/S0092-8674(00)00045-3; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Kato M, 1999, J BIOL CHEM, V274, P27225, DOI 10.1074/jbc.274.38.27225; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; MOLINA IJ, 1992, J EXP MED, V176, P867, DOI 10.1084/jem.176.3.867; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; RemoldODonnell E, 1996, BLOOD, V87, P2621, DOI 10.1182/blood.V87.7.2621.bloodjournal8772621; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Savoy DN, 2000, J IMMUNOL, V164, P2866, DOI 10.4049/jimmunol.164.6.2866; Sechi AS, 2000, J CELL SCI, V113, P3685; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Snapper SB, 1999, ANNU REV IMMUNOL, V17, P905, DOI 10.1146/annurev.immunol.17.1.905; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329	31	48	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21450	21457		10.1074/jbc.M010729200	http://dx.doi.org/10.1074/jbc.M010729200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11283014	hybrid			2022-12-27	WOS:000169297900088
J	Walker, EA; Clark, AM; Hewison, M; Ride, JP; Stewart, PM				Walker, EA; Clark, AM; Hewison, M; Ride, JP; Stewart, PM			Functional expression, characterization, and purification of the catalytic domain of human 11-beta-hydroxysteroid dehydrogenase type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CYTOPLASM; ENZYMATIC-ACTIVITY; GENE; THIOREDOXIN; REDUCTASE; CELLS; FORM; LOCALIZATION; ORIENTATION; SEQUENCES	11-beta -hydroxysteroid dehydrogenase type 1 catalyzes the conversion of cortisone to hormonally active cortisol and has been implicated in the pathogenesis of a number of disorders including insulin resistance and obesity. The enzyme is a glycosylated membrane-bound protein that has proved difficult to purify in an active state. Extracted enzyme typically loses the reductase properties seen in intact cells and shows principally dehydrogenase activity. The C-terminal catalytic domain is known to contain a disulfide bond and is located within the lumen of the endoplasmic reticulum, anchored to the membrane by a single N-terminal transmembrane domain. We report here the functional expression of the catalytic domain of the human enzyme, without the transmembrane domain and the extreme N terminus, in Escherichia coli, Moderate levels of soluble active protein were obtained using an N-terminal fusion with thioredoxin and a 6xHis tag. In contrast, the inclusion of a 6xHis tag at the C terminus adversely affected protein solubility and activity. However, the highest levels of active protein were obtained using a construct expressing the untagged catalytic domain. Nonreducing electrophoresis revealed the presence of both monomeric and dimeric disulfide bonded forms; however, mutation of a nonconserved cysteine residue resulted in a recombinant protein with no intermolecular disulfide bonds but full enzymatic activity. Using the optimal combination of plasmid construct and E, coli host strain, the recombinant protein was purified to apparent homogeneity by single step affinity chromatography, The purified protein possessed both dehydrogenase and reductase activities with a K-m of 1.4 muM for cortisol and 9.5 muM for cortisone. This study indicates that glycosylation, the N-terminal region including the transmembrane helix, and intermolecular disulfide bonds are not essential for enzyme activity and that expression in bacteria can provide active recombinant protein for future structural and functional studies.	Univ Birmingham, Div Med Sci, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham	Stewart, PM (corresponding author), Univ Birmingham, Div Med Sci, POB 363, Birmingham B15 2TT, W Midlands, England.	p.m.stewart@bham.ac.uk						Abdulaev NG, 2000, J BIOL CHEM, V275, P39354, DOI 10.1074/jbc.M005642200; AGARWAL AK, 1995, BBA-PROTEIN STRUCT M, V1248, P70, DOI 10.1016/0167-4838(95)00005-F; AGARWAL AK, 1990, MOL ENDOCRINOL, V4, P1827, DOI 10.1210/mend-4-12-1827; Blum A, 2000, TOXICOLOGY, V144, P113, DOI 10.1016/S0300-483X(99)00197-3; Blum A, 2000, BIOCHEM BIOPH RES CO, V276, P428, DOI 10.1006/bbrc.2000.3491; Bujalska IJ, 1999, ENDOCRINOLOGY, V140, P3188, DOI 10.1210/en.140.7.3188; Bujalska IJ, 1997, LANCET, V349, P1210, DOI 10.1016/S0140-6736(96)11222-8; Bujalska O, 1997, STEROIDS, V62, P77, DOI 10.1016/S0039-128X(96)00163-8; Condon J, 1997, MOL CELL ENDOCRINOL, V127, P121, DOI 10.1016/S0303-7207(97)04000-8; DERMAN AI, 1991, J BACTERIOL, V173, P7719, DOI 10.1128/jb.173.23.7719-7722.1991; Diederich S, 2000, EUR J ENDOCRINOL, V142, P200, DOI 10.1530/eje.0.1420200; Duax WL, 2000, VITAM HORM, V58, P121, DOI 10.1016/S0083-6729(00)58023-6; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Jornvall H, 1999, FEBS LETT, V445, P261, DOI 10.1016/S0014-5793(99)00130-1; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; KROZOWSKI Z, 1994, J STEROID BIOCHEM, V51, P125, DOI 10.1016/0960-0760(94)90084-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; MERCER W, 1993, MOL CELL ENDOCRINOL, V92, P247, DOI 10.1016/0303-7207(93)90015-C; MOORE CCD, 1993, ENDOCRINOLOGY, V133, P368, DOI 10.1210/en.133.1.368; Morris JC, 1996, EXP HEMATOL, V24, P1369; OBEID J, 1993, MOL ENDOCRINOL, V7, P154, DOI 10.1210/me.7.2.154; Odermatt A, 1999, J BIOL CHEM, V274, P28762, DOI 10.1074/jbc.274.40.28762; OZOLS J, 1995, J BIOL CHEM, V270, P2305, DOI 10.1074/jbc.270.5.2305; Pasquarette MM, 1996, J MOL ENDOCRINOL, V16, P269, DOI 10.1677/jme.0.0160269; Phillipov G, 1996, J CLIN ENDOCR METAB, V81, P3855, DOI 10.1210/jc.81.11.3855; Rajan V, 1996, J NEUROSCI, V16, P65; Ribas AV, 2000, BIOTECHNOL APPL BIOC, V31, P91, DOI 10.1042/BA19990084; Ricketts ML, 1998, J CLIN ENDOCR METAB, V83, P1325, DOI 10.1210/jc.83.4.1325; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Stewart PM, 1999, VITAM HORM, V57, P249; Stewart PM, 1996, LANCET, V347, P88, DOI 10.1016/S0140-6736(96)90211-1; STEWART PM, 1994, J CLIN ENDOCR METAB, V79, P480, DOI 10.1210/jc.79.2.480; Tanabe T, 1998, J BIOCHEM, V124, P634, DOI 10.1093/oxfordjournals.jbchem.a022159; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; TANNIN GM, 1991, J BIOL CHEM, V266, P16653; WALKER BR, 1995, J CLIN ENDOCR METAB, V80, P3155, DOI 10.1210/jc.80.11.3155	38	54	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21343	21350		10.1074/jbc.M011142200	http://dx.doi.org/10.1074/jbc.M011142200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11294832	hybrid			2022-12-27	WOS:000169297900074
J	Wood, JL; Russo, AF				Wood, JL; Russo, AF			Autoregulation of cell-specific MAP kinase control of the tryptophan hydroxylase promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CAMP-RESPONSIVE ELEMENT; MESSENGER-RNA LEVELS; BINDING TRANSCRIPTION FACTORS; HELIX-LOOP-HELIX; NF-Y; CCAAT BOX; RAT-BRAIN; SERINE-133 PHOSPHORYLATION; DEVELOPMENTAL REGULATION	The neurotransmitter serotonin controls a wide range of biological systems, including its own synthesis and release. As the rate-limiting enzyme in serotonin biosynthesis, tryptophan hydroxylase (TPH) is a potential target for this autoregulation, Using the serotonergic neuron-like CA77 cell line, we have demonstrated that treatment with a B-hydroxytryptamine autoreceptor agonist, CGS 12066A, can lower TPH mRNA levels and promoter activity. We reasoned that this repression might involve inhibition of MAP kinases, since 5-HT1 receptors can increase mitogen-activated protein (MAP) kinase phosphatase levels. To test this hypothesis, we first showed that the TPH promoter can be activated 20-fold by mitogen-activated extracellular-signal regulated kinase kinase kinase (MEKK), an activator of MAP kinases. This activation was then blocked by CGS 12066A The maximal MAP kinase and CGS repression regulatory region was mapped to between -149 and -45 base pairs upstream of the transcription start site. The activation by MEKK appears to be cell-specific, because MEKK did not activate the TPH promoter in nonneuronal cell lines. At least part, but not all, of the MAP kinase responsiveness was mapped to an inverted CCAAT box that binds the transcription factor NF-Y. These data suggest a model for the autoregulation of serotonin biosynthesis by repression of MAP kinase stimulation of the TPH promoter.	Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Genet PhD Program, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Russo, AF (corresponding author), Univ Iowa, Dept Physiol & Biophys, 5-632 BSB, Iowa City, IA 52242 USA.			Russo, Andrew/0000-0002-8156-5649	NICHD NIH HHS [HD 25969] Funding Source: Medline; NIDDK NIH HHS [DK 25295] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AZMITIA EC, 1991, J CLIN PSYCHIAT, V52, P4; Banik U, 1997, J BIOL CHEM, V272, P26219, DOI 10.1074/jbc.272.42.26219; BOADLEBIBER MC, 1989, BRAIN RES, V482, P306, DOI 10.1016/0006-8993(89)91193-1; BOADLEBIBER MC, 1993, PROG BIOPHYS MOL BIO, V60, P1, DOI 10.1016/0079-6107(93)90009-9; BOESS FG, 1994, NEUROPHARMACOLOGY, V33, P275, DOI 10.1016/0028-3908(94)90059-0; BOULARAND S, 1995, J BIOL CHEM, V270, P3757, DOI 10.1074/jbc.270.8.3757; Chamas F, 1999, NEUROSCI LETT, V267, P157, DOI 10.1016/S0304-3940(99)00340-7; Chang ZF, 1999, J CELL BIOCHEM, V75, P300, DOI 10.1002/(SICI)1097-4644(19991101)75:2<300::AID-JCB12>3.0.CO;2-Z; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; Clark Michael S., 1995, Methods (Orlando), V7, P253, DOI 10.1006/meth.1995.1030; CLARK MS, 1995, J NEUROSCI, V15, P6167; CORTES R, 1993, J NEUROCHEM, V60, P761, DOI 10.1111/j.1471-4159.1993.tb03213.x; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DARMON MC, 1988, J NEUROCHEM, V51, P312, DOI 10.1111/j.1471-4159.1988.tb04871.x; di Silvio A, 1999, NUCLEIC ACIDS RES, V27, P2578; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; Durham PL, 1999, J NEUROSCI, V19, P3423; Durham PL, 1998, MOL ENDOCRINOL, V12, P1002, DOI 10.1210/me.12.7.1002; Durham PL, 1997, J NEUROSCI, V17, P9545; DURHAM PL, 1992, EXP LUNG RES, V18, P775, DOI 10.3109/01902149209031707; Eggers A, 1998, J BIOL CHEM, V273, P18499, DOI 10.1074/jbc.273.29.18499; EHRET M, 1989, J NEUROCHEM, V52, P1886, DOI 10.1111/j.1471-4159.1989.tb07272.x; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Gerhardt CC, 1997, EUR J PHARMACOL, V334, P1, DOI 10.1016/S0014-2999(97)01115-1; Graeff FG, 1996, PHARMACOL BIOCHEM BE, V54, P129, DOI 10.1016/0091-3057(95)02135-3; HOYER D, 1994, PHARMACOL REV, V46, P157; Hu JB, 2001, J BIOL CHEM, V276, P287, DOI 10.1074/jbc.M004885200; HUFTON SE, 1995, BIOCHEM J, V311, P353, DOI 10.1042/bj3110353; Jin SK, 1998, MOL CELL BIOL, V18, P4377, DOI 10.1128/MCB.18.7.4377; JOHANSEN PA, 1995, J NEUROCHEM, V65, P882; Kultz D, 1998, J BIOL CHEM, V273, P13645, DOI 10.1074/jbc.273.22.13645; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LANIGAN TM, 1993, MOL CELL BIOL, V13, P6079, DOI 10.1128/MCB.13.10.6079; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Nankova BB, 1998, STRESS, V2, P289, DOI 10.3109/10253899809167293; OKADA S, 1995, J BIOL CHEM, V270, P20737, DOI 10.1074/jbc.270.35.20737; PARK DH, 1994, MOL BRAIN RES, V22, P20, DOI 10.1016/0169-328X(94)90028-0; REED GE, 1995, BRAIN RES, V682, P1, DOI 10.1016/0006-8993(95)00284-W; Rind HB, 2000, NEUROSCIENCE, V101, P665, DOI 10.1016/S0306-4522(00)00402-4; RUSSO AF, 1992, MOL ENDOCRINOL, V6, P207, DOI 10.1210/me.6.2.207; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Seternes OM, 1999, MOL ENDOCRINOL, V13, P1071, DOI 10.1210/me.13.7.1071; Siuciak JA, 1998, J NEUROSCI RES, V52, P149; STOLL J, 1991, J NEUROSCI RES, V28, P457, DOI 10.1002/jnr.490280402; Teerawatanasuk N, 1999, J NEUROCHEM, V72, P29, DOI 10.1046/j.1471-4159.1999.0720029.x; Teerawatanasuk N, 1998, MOL BRAIN RES, V55, P61, DOI 10.1016/S0169-328X(97)00364-1; THOPMSON JF, 1991, GENE, V103, P171; TVERBERG LA, 1993, J BIOL CHEM, V268, P15965; TYCE GM, 1990, J CARDIOVASC PHARM, V16, pS1, DOI 10.1097/00005344-199000163-00002; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WRIGHT KL, 1994, EMBO J, V13, P4042, DOI 10.1002/j.1460-2075.1994.tb06721.x; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; ZGOMBICK JM, 1993, MOL PHARMACOL, V44, P575	56	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21262	21271		10.1074/jbc.M007520200	http://dx.doi.org/10.1074/jbc.M007520200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11283010	hybrid			2022-12-27	WOS:000169297900063
J	Denecker, G; Declercq, W; Geuijen, CAW; Boland, A; Benabdillah, R; van Gurp, M; Sory, MP; Vandenabeele, P; Cornelis, GR				Denecker, G; Declercq, W; Geuijen, CAW; Boland, A; Benabdillah, R; van Gurp, M; Sory, MP; Vandenabeele, P; Cornelis, GR			Yersinia enterocolitica YopP-induced apoptosis of macrophages involves the apoptotic signaling cascade upstream of Bid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; NF-KAPPA-B; TOLL-LIKE RECEPTOR-2; CELL-DEATH; ALPHA PRODUCTION; TNF RECEPTOR; COMPLEX DISC; ACTIVATION; PROTEIN; INHIBITION	Yersinia enterocolitica induces apoptosis in macrophages by injecting the plasmid-encoded YopP (YopJ in other Yersinia species). Recently it was reported that YopP/J is a member of an ubiquitin-like protein cysteine protease family and that the catalytic core of YopP/J is required for its inhibition of the MAPK and NF-kappaB pathways. Here we analyzed the YopP/J-induced apoptotic signaling pathway. YopP-mediated cell death could be inhibited by addition of the zVAD caspase inhibitor, but not by DEM or YVAD, Generation of truncated Bid (tBid) was the first apoptosis-related event that we observed. The subsequent translocation of tBid to the mitochondria induced the release of cytochrome c, leading to the activation of procaspase-9 and the executioner procaspase-3 and -7. Inhibition of the postmitochondrial executioner caspases-3 and -7 did not affect Bid cleavage. Bid cleavage could not be observed in a yopP-deficient Y. enterocolitica strain, showing that this event requires YopP, Disruption of the catalytic core of YopP abolished the rapid generation of tBid, thereby hampering induction of apoptosis by Y. enterocolitica. This finding supports the idea that YopP/J induces apoptosis by directly acting on cell death pathways, rather than being the mere consequence of gene induction inhibition in combination with microbial stimulation of the macrophage.	Univ Catholique Louvain, Christian de Duve Inst Cellular Pathol, Microbial Pathogenesis Unit, B-1200 Brussels, Belgium; Flanders Interuniv Inst Biotechnol, Dept Mol Biol, B-9000 Ghent, Belgium; State Univ Ghent, B-9000 Ghent, Belgium	Universite Catholique Louvain; Ghent University	Cornelis, GR (corresponding author), Univ Catholique Louvain, Christian de Duve Inst Cellular Pathol, Microbial Pathogenesis Unit, Ave Hippocrate 74, B-1200 Brussels, Belgium.		Denecker, Geertrui/E-8134-2010; Vandenabeele, Peter/C-8597-2009; Vandenabeele, Peter/AAD-5793-2022	Vandenabeele, Peter/0000-0002-6669-8822; Denecker, Geertrui/0000-0002-2515-2911				Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998; BUSCHER D, 1995, MOL CELL BIOL, V15, P466; Cain K, 1999, J BIOL CHEM, V274, P22686, DOI 10.1074/jbc.274.32.22686; Carpentier I, 1999, FEBS LETT, V460, P246, DOI 10.1016/S0014-5793(99)01356-3; Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cornelis GR, 2000, P NATL ACAD SCI USA, V97, P8778, DOI 10.1073/pnas.97.16.8778; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; ICHINOHE H, 1991, J CLIN MICROBIOL, V29, P846, DOI 10.1128/JCM.29.4.846-847.1991; Kim KI, 2000, J BIOL CHEM, V275, P14102, DOI 10.1074/jbc.275.19.14102; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; Monack DM, 1998, J EXP MED, V188, P2127, DOI 10.1084/jem.188.11.2127; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1997, J BIOL CHEM, V272, P2952, DOI 10.1074/jbc.272.5.2952; Navarre WW, 2000, CELL MICROBIOL, V2, P265, DOI 10.1046/j.1462-5822.2000.00056.x; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; Ruckdeschel K, 1998, J EXP MED, V187, P1069, DOI 10.1084/jem.187.7.1069; Ruckdeschel K, 2001, J IMMUNOL, V166, P1823, DOI 10.4049/jimmunol.166.3.1823; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Stennicke HR, 1999, CELL DEATH DIFFER, V6, P1054, DOI 10.1038/sj.cdd.4400599; Van de Craen M, 1999, CELL DEATH DIFFER, V6, P1117, DOI 10.1038/sj.cdd.4400589; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	50	104	110	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19706	19714		10.1074/jbc.M101573200	http://dx.doi.org/10.1074/jbc.M101573200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279213	hybrid			2022-12-27	WOS:000169135100006
J	Lowenson, JD; Kim, E; Young, SG; Clarke, S				Lowenson, JD; Kim, E; Young, SG; Clarke, S			Limited accumulation of damaged proteins in L-isoaspartyl (D-aspartyl) O-methyltransferase-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ASPARTYL; TRANSGENIC MICE; PEPTIDES; DEGRADATION; ASPARAGINYL; EXPRESSION; REPAIR; MODEL; PURIFICATION; DEAMIDATION	L-Isoaspartyl (D-aspartyl) O-methyltransferase (PCMT1) can initiate the conversion of damaged aspartyl and asparaginyl residues to normal L-aspartyl residues. Mice lacking this enzyme (Pcmt1-/- mice) have elevated levels of damaged residues and die at a mean age of 42 days from massive tonic-clonic seizures. To extend the lives of the knockout mice so that the long term effects of damaged residue accumulation could be investigated, we produced transgenic mice with a mouse Pcmt1 cDNA under the control of a neuron specific promoter. Pcmt1 transgenic mice that were homozygous for the endogenous Pcmt1 knockout mutation ("transgenic Pcmt1-/- mice") had brain PCMT1 activity levels that were 6.5-13% those of mild-type mice but had little or no activity in other tissues. The transgenic Pcmt1-/- mice lived, on average, B-fold longer than nontransgenic Pcmt1-/- mice and accumulated only half as many damaged aspartyl residues in their brain proteins. The concentration of damaged residues in heart, testis, and brain proteins in transgenic Pcmt1-/- mice initially increased with age but unexpectedly reached a plateau by 100 days of age. Urine from Pcmt1-/- mice contained increased amounts of peptides with damaged aspartyl residues, apparently enough to account for proteins that were not repaired intracellularly. In the absence of PCMT1, proteolysis may limit the intracellular accumulation of damaged proteins but less efficiently than in wild-type mice having PCMT1-mediated repair.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Clarke, S (corresponding author), 640 Paul D Boyer Hall,611 Charles E Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu	Lowenson, Jonathan/AAN-6768-2020	Young, Stephen/0000-0001-7270-3176	NHLBI NIH HHS [HL41633] Funding Source: Medline; NIA NIH HHS [AG15451, AG18000] Funding Source: Medline; NIGMS NIH HHS [GM26020] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018000, R01AG015451] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andra K, 1996, NEUROBIOL AGING, V17, P183, DOI 10.1016/0197-4580(95)02066-7; Aswad DW, 2000, J PHARMACEUT BIOMED, V21, P1129, DOI 10.1016/S0731-7085(99)00230-7; BONSNES RW, 1945, J BIOL CHEM, V158, P581; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; BUCHANAN DL, 1962, BIOCHEMISTRY-US, V1, P612, DOI 10.1021/bi00910a011; Chain DG, 1999, MOL NEUROBIOL, V20, P125, DOI 10.1007/BF02742438; Clarke S., 1999, S ADENOSYLMETHIONINE, P123; CRISPENS CG, 1975, HDB LAB MOUSE, P131; DORER FE, 1966, BIOCHEMISTRY-US, V5, P3236, DOI 10.1021/bi00874a025; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Friguet B, 2000, ANN NY ACAD SCI, V908, P143; GARY JD, 1995, J BIOL CHEM, V270, P4076, DOI 10.1074/jbc.270.8.4076; GEIGER T, 1987, J BIOL CHEM, V262, P785; HALEY EE, 1966, BIOCHEMISTRY-US, V5, P3229, DOI 10.1021/bi00874a024; HIGGINS LS, 1993, ANN NY ACAD SCI, V695, P224, DOI 10.1111/j.1749-6632.1993.tb23056.x; Hogan B, 1994, MANIPULATING MOUSE E; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; JOHNSON BA, 1990, BIOCHEMISTRY-US, V29, P4373, DOI 10.1021/bi00470a017; Kandel ER, 1991, PRINCIPLES NEURAL SC, P22; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kim E, 1999, J BIOL CHEM, V274, P20671, DOI 10.1074/jbc.274.29.20671; LOEFFLER M, 1989, CELL TISSUE KINET, V22, P13, DOI 10.1111/j.1365-2184.1989.tb00198.x; Lowenson J. D., 1995, DEAMIDATION ISOASPAR, P47; Lowenson JD, 1999, METHOD ENZYMOL, V309, P89; MACLAREN DC, 1995, PROTEIN EXPRES PURIF, V6, P99, DOI 10.1006/prep.1995.1013; Mamula MJ, 1999, J BIOL CHEM, V274, P22321, DOI 10.1074/jbc.274.32.22321; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; PATEL K, 1990, PHARMACEUT RES, V7, P703, DOI 10.1023/A:1015807303766; PISANO JJ, 1966, ARCH BIOCHEM BIOPHYS, V117, P394, DOI 10.1016/0003-9861(66)90427-9; ROMANIK EA, 1992, GENE, V118, P217, DOI 10.1016/0378-1119(92)90191-Q; Rosenquist C, 1998, CLIN CHEM, V44, P2281; Sano H, 1999, MECH AGEING DEV, V107, P333, DOI 10.1016/S0047-6374(99)00011-1; Schiene C, 2000, CURR OPIN STRUC BIOL, V10, P40, DOI 10.1016/S0959-440X(99)00046-9; Shimizu T, 2000, ARCH BIOCHEM BIOPHYS, V381, P225, DOI 10.1006/abbi.2000.1955; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Szymanska G, 1998, J BIOL CHEM, V273, P28516, DOI 10.1074/jbc.273.43.28516; TANAKA T, 1978, J BIOCHEM-TOKYO, V84, P617, DOI 10.1093/oxfordjournals.jbchem.a132166; Tarcsa E, 2000, J BIOL CHEM, V275, P20295, DOI 10.1074/jbc.M001555200; VISICK JE, 1995, MOL MICROBIOL, V16, P835, DOI 10.1111/j.1365-2958.1995.tb02311.x; Volkin DB, 1997, MOL BIOTECHNOL, V8, P105, DOI 10.1007/BF02752255; Yamamoto A, 1998, J NEUROSCI, V18, P2063	43	62	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20695	20702		10.1074/jbc.M100987200	http://dx.doi.org/10.1074/jbc.M100987200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279164	hybrid			2022-12-27	WOS:000169135100136
J	Meddows, E; Le Bourdelles, B; Grimwood, S; Wafford, K; Sandhu, S; Whiting, P; McIlhinney, RAJ				Meddows, E; Le Bourdelles, B; Grimwood, S; Wafford, K; Sandhu, S; Whiting, P; McIlhinney, RAJ			Identification of molecular determinants that are important in the assembly of N-methyl-D-aspartate receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; GLUTAMATE-RECEPTOR; NMDA RECEPTOR; NR1 SUBUNIT; EXPRESSION; SITE; TOPOLOGY; FORM; NR2A	To determine which domains of the N-methyl-D-aspartate (NMDA) receptor are important for the assembly of functional receptors, a number of N- and C-terminal truncations of the NR1a subunit have been produced. Truncations containing a complete ligand binding domain bound glycine antagonist and gave binding constants similar to those of the native subunit, suggesting they were folding to form antagonist binding sites. Since NR2A is not transported to the cell surface unless it is associated with NR1 (McIlhinney, R, A. J,, Le Bourdelles, E,, Tricuad, N,, Molnar, E,, Streit, P,, and Whiting, P, J, (1998) Neuropharmacology 37, 1355-1367), surface expression of NR2A can be used to monitor the association of the subunits, There was progressive loss of NR2A cell surface expression as the N terminus of NR1a was shortened, with complete loss when truncated beyond residue 380, Removal of the C terminus and/or the last transmembrane domain did not affect NR2A surface expression. Similar results were obtained in co-immunoprecipitation experiments. The oligomerization status of the co-expressed NR1a constructs and NR2A subunits was investigated using a non-denaturing gel electrophoresis system (blue native-polyacrylamide gel electrophoresis) and sucrose density gradient centrifugation, The blue native-polyacrylamide gel electrophoresis system also showed that the NR1a subunits could form a homodimer, which was confirmed using soluble constructs of the NR1a subunit, Together these results suggest the residues N-terminal of residue 380 are important for the association of NR2A with NR1a and that the complete N-terminal domain of the NR1a subunit is required for oligomerization with NR2A.	MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; Merck Sharp & Dohme Ltd, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England	Merck & Company	McIlhinney, RAJ (corresponding author), MRC, Anat Neuropharmacol Unit, Mansfield Rd, Oxford OX1 3TH, England.	jeff.mcilhinney@pharm.ox.ac.uk	Schaack, Beatrice/C-1801-2014	Whiting, Paul/0000-0002-4121-1379; Wafford, Keith/0000-0003-4537-4690				Abele R, 1999, BIOCHEMISTRY-US, V38, P10949, DOI 10.1021/bi982928y; Anson LC, 1998, J NEUROSCI, V18, P581; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BEHE P, 1995, P ROY SOC B-BIOL SCI, V262, P205, DOI 10.1098/rspb.1995.0197; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BENVENISTE M, 1991, BRIT J PHARMACOL, V104, P207, DOI 10.1111/j.1476-5381.1991.tb12409.x; Blahos J, 1996, J BIOL CHEM, V271, P15669, DOI 10.1074/jbc.271.26.15669; BROSE N, 1993, J BIOL CHEM, V268, P22663; CHAZOT PL, 1994, J BIOL CHEM, V269, P24403; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; CIK M, 1993, BIOCHEM J, V296, P877, DOI 10.1042/bj2960877; Coleman SK, 2000, EUR J NEUROSCI, V12, P37; Dingledine R, 1999, PHARMACOL REV, V51, P7; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; GRIMWOOD S, 1995, J NEUROCHEM, V64, P525; Hawkins LM, 1999, J BIOL CHEM, V274, P27211, DOI 10.1074/jbc.274.38.27211; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; HOLLMANN M, 1997, INOTROPIC GLUTAMATE; Ivanovic A, 1998, J BIOL CHEM, V273, P19933, DOI 10.1074/jbc.273.32.19933; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Lampinen M, 1998, EMBO J, V17, P4704, DOI 10.1093/emboj/17.16.4704; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Laube B, 1998, J NEUROSCI, V18, P2954; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Miyazaki J, 1999, BIOCHEM J, V340, P687, DOI 10.1042/0264-6021:3400687; MOLNAR E, 1994, J NEUROCHEM, V63, P683; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Nicke A, 1999, J RECEPT SIGNAL TR R, V19, P493, DOI 10.3109/10799899909036667; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Premkumar LS, 1997, J GEN PHYSIOL, V110, P485, DOI 10.1085/jgp.110.5.485; Robbins MJ, 1999, J NEUROCHEM, V72, P2539, DOI 10.1046/j.1471-4159.1999.0722539.x; Sandhu S, 1999, J NEUROCHEM, V72, P1694, DOI 10.1046/j.1471-4159.1999.721694.x; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sutcliffe MJ, 1996, BIOPHYS J, V70, P1575, DOI 10.1016/S0006-3495(96)79724-2; Varney MA, 1996, J PHARMACOL EXP THER, V279, P367; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154	43	98	106	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18795	18803		10.1074/jbc.M101382200	http://dx.doi.org/10.1074/jbc.M101382200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279200	hybrid			2022-12-27	WOS:000169091000021
J	Mullick, J; Anandatheerthavarada, HK; Amuthan, G; Bhagwat, SV; Biswas, G; Camasamudram, V; Bhat, NK; Reddy, SEP; Rao, V; Avadhani, NG				Mullick, J; Anandatheerthavarada, HK; Amuthan, G; Bhagwat, SV; Biswas, G; Camasamudram, V; Bhat, NK; Reddy, SEP; Rao, V; Avadhani, NG			Physical interaction and functional synergy between glucocorticoid receptor and Ets2 proteins for transcription activation of the rat cytochrome P-450c27 promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE AMINOTRANSFERASE GENE; HEPATIC STEROL 27-HYDROXYLASE; BILE-ACID BIOSYNTHESIS; DNA-BINDING DOMAIN; RNA-POLYMERASE-II; NF-KAPPA-B; NUCLEAR FACTOR; MESSENGER-RNA; RESPONSIVE UNITS; C-JUN	We demonstrate that dexamethasone-mediated transcription activation of the cytochrome P-450c27 promoter involves a physical interaction and functional synergy between glucocorticoid receptor (GR) and Ets2 factor. Ets2 protein binding to a "weak" Ets-like site of the promoter is dependent on Oh bound to the adjacent cryptic glucocorticoid response element. Coimmunoprecipitation and chemical cross-linking experiments show physical interaction between GR and Ets2 proteins. Mutational analyses show synergistic effects of Ets2 and GR in dexamethasone-mediated activation of the cytochrome P-450c27 promoter. The DNA-binding domain of GR, lacking the transcription activation and ligand-binding domains, was fully active in synergistic activation of the promoter with intact Ets2. The DNA-binding domain of Ets2 lacking the transcription activation domain showed a dominant negative effect on the transcription activity. Finally, a fusion protein consisting of the GR DNA-binding domain and the transcription activation domain of Ets2 fully supported the transcription activity, suggesting a novel synergy between the two proteins, which does not require the transactivation domain of GR. Our results also provide new insights on the role of putative weak consensus Ets sites in transcription activation, possibly through synergistic interaction with other gene-specific transcription activators.	Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; Sci Applicat Int Corp, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; Med Coll Penn & Hahnemann Univ, Ctr Canc, Program Canc Genet, Philadelphia, PA 19102 USA	University of Pennsylvania; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Drexel University	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 3800 Spruce St, Philadelphia, PA 19104 USA.				NATIONAL CANCER INSTITUTE [R01CA022762, R37CA022762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034883] Funding Source: NIH RePORTER; NCI NIH HHS [CA22762] Funding Source: Medline; NIGMS NIH HHS [GM34883] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anandatheerthavarada HK, 1998, BIOCHEMISTRY-US, V37, P1150, DOI 10.1021/bi972046j; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Basuyaux JP, 1997, J BIOL CHEM, V272, P26188, DOI 10.1074/jbc.272.42.26188; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BJORKHEM I, 1992, J LIPID RES, V33, P455; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; CARTER RS, 1994, J BIOL CHEM, V269, P4381; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CREPIEUX P, 1994, CRIT REV ONCOGENESIS, V5, P615; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUDEK H, 1992, P NATL ACAD SCI USA, V89, P1291, DOI 10.1073/pnas.89.4.1291; DUTERQUECOQUILLAUD M, 1988, ONCOGENE RES, V2, P335; ESPINAS ML, 1994, MOL CELL BIOL, V14, P4116, DOI 10.1128/MCB.14.6.4116; ESPINAS ML, 1995, MOL CELL BIOL, V15, P5346; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; GAUTHIER JM, 1993, EMBO J, V12, P5089, DOI 10.1002/j.1460-2075.1993.tb06203.x; GRANGE T, 1989, NUCLEIC ACIDS RES, V17, P8695, DOI 10.1093/nar/17.21.8695; GRANGE T, 1991, NUCLEIC ACIDS RES, V19, P131, DOI 10.1093/nar/19.1.131; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMARCO K, 1991, SCIENCE, V253, P789, DOI 10.1126/science.1876836; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LEES JA, 1989, NUCLEIC ACIDS RES, V17, P5477, DOI 10.1093/nar/17.14.5477; LEFSTIN JA, 1994, GENE DEV, V8, P2842, DOI 10.1101/gad.8.23.2842; Lenka N, 1996, J BIOL CHEM, V271, P30281, DOI 10.1074/jbc.271.47.30281; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; MAYO KE, 1981, J BIOL CHEM, V256, P2621; MCCAFFREY PG, 1992, J BIOL CHEM, V267, P1864; MULLICK J, 1995, BIOCHEMISTRY-US, V34, P13729, DOI 10.1021/bi00042a003; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; Nagulapalli S, 1998, MOL CELL BIOL, V18, P4639, DOI 10.1128/MCB.18.8.4639; Pearce D, 1998, J BIOL CHEM, V273, P30081, DOI 10.1074/jbc.273.46.30081; PEARCE D, 1993, SCIENCE, V259, P1161, DOI 10.1126/science.8382376; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; Pongubala JMR, 1997, P NATL ACAD SCI USA, V94, P127, DOI 10.1073/pnas.94.1.127; Rao YP, 1999, J STEROID BIOCHEM, V70, P1, DOI 10.1016/S0960-0760(99)00099-0; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; REDDY ESP, 1988, ONCOGENE RES, V3, P239; RIGAUD G, 1991, CELL, V67, P977, DOI 10.1016/0092-8674(91)90370-E; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; ROUX J, 1995, DNA CELL BIOL, V14, P385, DOI 10.1089/dna.1995.14.385; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMID W, 1989, EMBO J, V8, P2257, DOI 10.1002/j.1460-2075.1989.tb08350.x; SCHULE R, 1988, NATURE, V332, P87, DOI 10.1038/332087a0; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SETH A, 1992, CELL GROWTH DIFFER, V3, P327; Sharrocks AD, 1997, INT J BIOCHEM CELL B, V29, P1371, DOI 10.1016/S1357-2725(97)00086-1; SHAYIQ RM, 1992, J BIOL CHEM, V267, P2421; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; STRAHLE U, 1988, EMBO J, V7, P3389, DOI 10.1002/j.1460-2075.1988.tb03212.x; Stravitz RT, 1996, J STEROID BIOCHEM, V57, P337, DOI 10.1016/0960-0760(95)00282-0; SU P, 1990, DNA CELL BIOL, V9, P657, DOI 10.1089/dna.1990.9.657; Sucharov C, 1995, GENE EXPRESSION, V5, P93; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; Vlahcevic ZR, 1996, AM J PHYSIOL-GASTR L, V270, pG646, DOI 10.1152/ajpgi.1996.270.4.G646; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; Zhang ZX, 1997, J BIOL CHEM, V272, P30607, DOI 10.1074/jbc.272.49.30607	65	36	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18007	18017		10.1074/jbc.M100671200	http://dx.doi.org/10.1074/jbc.M100671200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279115	hybrid			2022-12-27	WOS:000168866500053
J	Legare, D; Richard, D; Mukhopadhyay, R; Stierhof, YD; Rosen, BP; Haimeur, A; Papadopoulou, B; Ouellette, M				Legare, D; Richard, D; Mukhopadhyay, R; Stierhof, YD; Rosen, BP; Haimeur, A; Papadopoulou, B; Ouellette, M			The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARSENITE-RESISTANT LEISHMANIA; INCREASED TRYPANOTHIONE LEVELS; GREEN FLUORESCENT PROTEIN; P-GLYCOPROTEIN GENE; GS-X PUMP; DRUG-RESISTANCE; SACCHAROMYCES-CEREVISIAE; ORNITHINE DECARBOXYLASE; VISCERAL LEISHMANIASIS; PENTAVALENT ANTIMONY	The Leishmania ATP-binding cassette (ABC) transporter PGPA is involved in metal resistance (arsenicals and antimony), although the exact mechanism by which PGPA confers resistance to antimony, the first line drug against Leishmania, is unknown. The results of co-transfection experiments, transport assays, and the use of inhibitors suggest that PGPA recognizes metals conjugated to glutathione or trypanothione, a glutathione-spermidine conjugate present in Leishmania, The HA epitope tag of the influenza hemagglutinin as well as the green fluorescent protein were fused at the COOH terminus of PGPA. Immunofluorescence, confocal, and electron microscopy studies of the fully functional tagged molecules clearly indicated that PGPA is localized in membranes that are close to the flagellar pocket, the site of endocytosis and exocytosis in this parasite. Subcellular fractionation of Leishmania tarentolae PG-PAHA transfectants was performed to further characterize this ABC transporter. The basal PGPA ATPase activity was determined to be 115 nmol/mg/min. Transport experiments using radioactive arsenite-glutathione conjugates clearly showed that PGPA recognizes and actively transports thiol-metal conjugates, Overall, the results are consistent with PGPA being an intracellular ABC transporter that confers arsenite and antimonite resistance by sequestration of the metal-thiol conjugates.	CHU Laval, Ctr Rech Infect, St Foy, PQ G1V 4G2, Canada; Univ Laval, Fac Med, Div Microbiol, St Foy, PQ G1V 4G2, Canada; Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; Max Planck Inst Biol, D-72076 Tubingen, Germany	Laval University; Laval University; Wayne State University; Max Planck Society	Ouellette, M (corresponding author), CHU Laval, Ctr Rech Infectiol, 2705 Blvd Laurier, St Foy, PQ G1V 4G2, Canada.		Ouellette, Marc/K-8694-2017	Ouellette, Marc/0000-0002-6743-9646; Rosen, Barry P./0000-0002-5230-4271	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM055425, R01GM052216, R01GM055425] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55425, GM52216] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHFORD RW, 1992, PARASITOL TODAY, V8, P104, DOI 10.1016/0169-4758(92)90249-2; BALBER AE, 1990, CRIT REV IMMUNOL, V10, P177; Berman JD, 1997, CLIN INFECT DIS, V24, P684, DOI 10.1093/clind/24.4.684; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; CALLAHAN HL, 1991, J BIOL CHEM, V266, P18427; CALLAHAN HL, 1994, MOL BIOCHEM PARASIT, V68, P145, DOI 10.1016/0166-6851(94)00154-5; Chang XB, 1997, J BIOL CHEM, V272, P30962, DOI 10.1074/jbc.272.49.30962; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; DETKE S, 1989, EXP CELL RES, V180, P161, DOI 10.1016/0014-4827(89)90220-6; Dey S, 1996, P NATL ACAD SCI USA, V93, P2192, DOI 10.1073/pnas.93.5.2192; DEY S, 1994, MOL BIOCHEM PARASIT, V67, P49, DOI 10.1016/0166-6851(94)90095-7; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; FarautGambarelli F, 1997, ANTIMICROB AGENTS CH, V41, P827, DOI 10.1128/AAC.41.4.827; FerreiraPinto KC, 1996, CAN J MICROBIOL, V42, P944, DOI 10.1139/m96-121; Gatti D, 2000, J BIOL CHEM, V275, P34009, DOI 10.1074/jbc.R000012200; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN, P45; GROGL M, 1992, AM J TROP MED HYG, V47, P117, DOI 10.4269/ajtmh.1992.47.117; Grondin K, 1997, EMBO J, V16, P3057, DOI 10.1093/emboj/16.11.3057; GRONDIN K, 1993, NUCLEIC ACIDS RES, V21, P1895, DOI 10.1093/nar/21.8.1895; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Haimeur A, 1999, MOL MICROBIOL, V34, P726, DOI 10.1046/j.1365-2958.1999.01634.x; Haimeur A, 2000, MOL BIOCHEM PARASIT, V108, P131, DOI 10.1016/S0166-6851(00)00187-0; HARLOW E, 1988, ANTIBODIES LAB MANUA, P377; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Ishikawa T, 1997, BIOSCIENCE REP, V17, P189, DOI 10.1023/A:1027385513483; ISHIKAWA T, 1994, J BIOL CHEM, V269, P29085; JACKSON JE, 1990, AM J TROP MED HYG, V43, P464, DOI 10.4269/ajtmh.1990.43.464; Kundig C, 1999, EMBO J, V18, P2342, DOI 10.1093/emboj/18.9.2342; Legare D, 1997, EXP PARASITOL, V87, P275, DOI 10.1006/expr.1997.4222; LEGARE D, 1994, MOL BIOCHEM PARASIT, V68, P81, DOI 10.1016/0166-6851(94)00156-1; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Lira R, 1999, J INFECT DIS, V180, P564, DOI 10.1086/314896; MCCANN PP, 1992, PHARMACOL THERAPEUT, V54, P195, DOI 10.1016/0163-7258(92)90032-U; Misteli T, 1997, NAT BIOTECHNOL, V15, P961, DOI 10.1038/nbt1097-961; Mukhopadhyay R, 1996, P NATL ACAD SCI USA, V93, P10383, DOI 10.1073/pnas.93.19.10383; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; Ouellette M, 1998, DRUG RESIST UPDATE, V1, P43, DOI 10.1016/S1368-7646(98)80213-6; OUELLETTE M, 1991, EMBO J, V10, P1009, DOI 10.1002/j.1460-2075.1991.tb08035.x; OUELLETTE M, 1990, EMBO J, V9, P1027, DOI 10.1002/j.1460-2075.1990.tb08206.x; PAPADOPOULOU B, 1994, MOL BIOCHEM PARASIT, V65, P39, DOI 10.1016/0166-6851(94)90113-9; Papadopoulou B, 1996, BIOCHEM BIOPH RES CO, V224, P772, DOI 10.1006/bbrc.1996.1098; PAPADOPOULOU B, 1994, J BIOL CHEM, V269, P11980; SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745; SINGH AK, 1994, MOL BIOCHEM PARASIT, V66, P161, DOI 10.1016/0166-6851(94)90049-3; STIERHOF YD, 1991, J ELECTRON MICR TECH, V17, P336, DOI 10.1002/jemt.1060170307; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; Taguchi Y, 1997, FEBS LETT, V401, P11, DOI 10.1016/S0014-5793(96)01421-4; Tommasini R, 1996, P NATL ACAD SCI USA, V93, P6743, DOI 10.1073/pnas.93.13.6743; WEBSTER P, 1993, PARASITOL TODAY, V9, P201, DOI 10.1016/0169-4758(93)90008-4; Weise F, 2000, J CELL SCI, V113, P4587; WHITE TC, 1988, J BIOL CHEM, V263, P16977	57	169	173	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 13	2001	276	28					26301	26307		10.1074/jbc.M102351200	http://dx.doi.org/10.1074/jbc.M102351200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451VP	11306588	hybrid			2022-12-27	WOS:000169823300088
J	Beylot, B; Spassky, A				Beylot, B; Spassky, A			Chemical probing shows that the intron-encoded endonuclease I-SceI distorts DNA through binding in monomeric form to its homing site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL ELECTROPHORESIS; ESCHERICHIA-COLI; RNA-POLYMERASE; 1,10-PHENANTHROLINE-COPPER ION; DEOXYRIBONUCLEASE ACTIVITY; SEQUENCE SPECIFICITY; CRYSTAL-STRUCTURE; NUCLEASE ACTIVITY; MOLECULAR-WEIGHT; PROTEIN	Despite its small size (27.6 kDa), the group I intron-encoded I-SceI endonuclease initiates intron homing by recognizing and specifically cleaving a large intronless DNA sequence. Here, we used gel shift assays and footprinting experiments to analyze the interaction between I-SceI and its target. I-SceI was found to bind to its substrate in monomeric form. Footprinting using DNase I, hydroxyl radical, phenanthroline copper complexes, UV/DH-MePyPs photosensitizer, and base-modifying reagents revealed the asymmetric nature of the interaction and provided a first glimpse into the architecture of the complex. The protein interacts in the minor and major grooves and distorts DNA at three distinct sites: one at the intron insertion site and the other two, respectively, downstream (-8, -9) and upstream (+9, +10) from this site. The protein appears to stabilize the DNA curved around it by bridging the minor groove on one face of the helix. The scissile phosphates would lie on the outside of the bend, facing in the same direction relative to the DNA helical axis, as expected for an endonuclease that generates 3' overhangs. An internally consistent model is proposed in which the protein would take advantage of the concerted flexibility of the DNA sequence to induce a synergistic binding/kinking process, resulting in the correct positioning of the enzyme active site.	Inst Gustave Roussy, Lab Pharmacol Macromol Biol, F-94805 Villejuif, France	UNICANCER; Gustave Roussy	Spassky, A (corresponding author), Inst Gustave Roussy, Lab Pharmacol Macromol Biol, Rue Camille Desmoulins, F-94805 Villejuif, France.							BADING H, 1988, NUCLEIC ACIDS RES, V16, P5241, DOI 10.1093/nar/16.12.5241; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; BENNETT RJ, 1993, CELL, V74, P1021, DOI 10.1016/0092-8674(93)90724-5; BRYAN JK, 1977, ANAL BIOCHEM, V78, P513, DOI 10.1016/0003-2697(77)90111-7; BURKHOFF AM, 1988, NATURE, V331, P455, DOI 10.1038/331455a0; COLLEAUX L, 1986, CELL, V44, P521, DOI 10.1016/0092-8674(86)90262-X; COLLEAUX L, 1988, P NATL ACAD SCI USA, V85, P6022, DOI 10.1073/pnas.85.16.6022; DEMARET JP, 1989, PHOTOCHEM PHOTOBIOL, V50, P7, DOI 10.1111/j.1751-1097.1989.tb04124.x; DESANTIS P, 1990, BIOCHEMISTRY-US, V29, P9269, DOI 10.1021/bi00491a023; DOETSCH PW, 1985, NUCLEIC ACIDS RES, V13, P3285, DOI 10.1093/nar/13.9.3285; Duan XQ, 1997, CELL, V89, P555, DOI 10.1016/S0092-8674(00)80237-8; DUJON B, 1985, ACHIEVEMENTS PERSPEC, V2, P215; FERGUSON KA, 1964, METABOLISM, V13, P985, DOI 10.1016/S0026-0495(64)80018-4; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; FRANTZ B, 1990, BIOCHEMISTRY-US, V29, P4747, DOI 10.1021/bi00472a001; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3037; GUILLO LA, 1995, PHOTOCHEM PHOTOBIOL, V61, P331, DOI 10.1111/j.1751-1097.1995.tb08617.x; Guillo LA, 1996, PHOTOCHEM PHOTOBIOL, V64, P349, DOI 10.1111/j.1751-1097.1996.tb02470.x; Heath PJ, 1997, NAT STRUCT BIOL, V4, P468, DOI 10.1038/nsb0697-468; Jurica NS, 1998, MOL CELL, V2, P469, DOI 10.1016/S1097-2765(00)80146-X; LAHM A, 1991, J MOL BIOL, V222, P645, DOI 10.1016/0022-2836(91)90502-W; LykkeAndersen J, 1997, EMBO J, V16, P3272, DOI 10.1093/emboj/16.11.3272; MCCARTHY JG, 1990, BIOCHEMISTRY-US, V29, P6071, DOI 10.1021/bi00477a027; MONTEILHET C, 1990, NUCLEIC ACIDS RES, V18, P1407, DOI 10.1093/nar/18.6.1407; MUELLER JE, 1995, EMBO J, V14, P5724, DOI 10.1002/j.1460-2075.1995.tb00259.x; MUELLER JE, 1993, NUCLEASES, P111; NEWMAN M, 1994, NATURE, V368, P660, DOI 10.1038/368660a0; Nielsen P E, 1990, J Mol Recognit, V3, P1, DOI 10.1002/jmr.300030102; ORCHARD K, 1993, NUCLEIC ACIDS RES, V21, P3335, DOI 10.1093/nar/21.14.3335; PERRIN A, 1993, EMBO J, V12, P2939, DOI 10.1002/j.1460-2075.1993.tb05956.x; PHILLIPS SEV, 1994, ANNU REV BIOPH BIOM, V23, P671, DOI 10.1146/annurev.bb.23.060194.003323; SAMBROOK J, 1989, MOL CLONING LAB MANU, P1123; SANDERS CM, 1994, NUCLEIC ACIDS RES, V22, P4890, DOI 10.1093/nar/22.23.4890; Schaeffer F, 1996, J MOL BIOL, V260, P523, DOI 10.1006/jmbi.1996.0419; SIGMAN DS, 1989, NUCLEIC ACIDS MOL BI, V3, P13; SIGMAN DS, 1990, BIOCHEMISTRY-US, V29, P9098; Silva GH, 1999, J MOL BIOL, V286, P1123, DOI 10.1006/jmbi.1998.2519; SPASSKY A, 1985, BIOCHEMISTRY-US, V24, P8050, DOI 10.1021/bi00348a032; Spassky A, 1997, BIOCHEMISTRY-US, V36, P6571, DOI 10.1021/bi962761d; SPASSKY A, 1984, EMBO J, V3, P43, DOI 10.1002/j.1460-2075.1984.tb01759.x; SPASSKY A, 1992, BIOCHEMISTRY-US, V31, P10502, DOI 10.1021/bi00158a013; STEITZ TA, 1990, Q REV BIOPHYS, V23, P205, DOI 10.1017/S0033583500005552; THEDERAHN T, 1990, BIOCHEM BIOPH RES CO, V168, P756, DOI 10.1016/0006-291X(90)92386-E; THIERRY A, 1991, NUCLEIC ACIDS RES, V19, P189, DOI 10.1093/nar/19.1.189; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5489; WANG SQ, 1995, BIOCHEMISTRY-US, V34, P13082, DOI 10.1021/bi00040a020; Werner MH, 1996, SCIENCE, V271, P778, DOI 10.1126/science.271.5250.778; WITHERS BE, 1995, NUCLEIC ACIDS RES, V23, P3571, DOI 10.1093/nar/23.17.3571; YANG CC, 1989, CELL, V57, P869, DOI 10.1016/0092-8674(89)90801-5; YOON C, 1990, BIOCHEMISTRY-US, V29, P2116, DOI 10.1021/bi00460a022; ZAYCHIKOV E, 1995, P NATL ACAD SCI USA, V92, P1739, DOI 10.1073/pnas.92.5.1739	52	16	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					25243	25253		10.1074/jbc.M101200200	http://dx.doi.org/10.1074/jbc.M101200200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11279183	hybrid			2022-12-27	WOS:000169800700109
J	Khare, V; Eckert, KA				Khare, V; Eckert, KA			The 3 '-> 5 ' exonuclease of T4 DNA polymerase removes premutagenic alkyl mispairs and contributes to futile cycling at O-6-methylguanine lesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLATING AGENTS; KLENOW FRAGMENT; MISMATCH REPAIR; REPLICATION; DUPLEX; TOLERANCE; DAMAGE; BACTERIOPHAGE-T4; RESISTANCE; DEFECTS	We have studied the processing of O-6-methylguanine (m6G)-containing oligonucleotides and N-methyl-N-nitrosourea (MNU)-treated DNA templates by the 3' --> 5' exonuclease of T4 DNA polymerase. In vitro biochemical analyses demonstrate that the exonuclease can remove bases opposite a defined m6G lesion. The efficiency of excision of a terminal m6G .T was similar to that of m6G .C, and both mere excised as efficiently as a GT substrate. Partitioning assays between the polymerase and exonuclease activities, performed in the presence of dNTPs, resulted in repeated incorporation and excision events opposite the m6G lesion. This idling produces dramatically less full-length product, relative to natural substrates, indicating that the 3' --> 5' exonuclease may contribute to DNA synthesis inhibition by alkylating agents. Genetic data obtained using an in vitro herpes simplex virus-thymidine kinase assay support the inefficiency of the exonuclease as a "proofreading" activity for m6G, since virtually all mutations produced by the native enzyme using MNU-treated templates were G --> A transitions. Comparison of MNU dose-response curves for exonuclease-proficient and -deficient forms of T4 polymerase reveals that the exonuclease efficiently removes 50-86% of total premutagenic alkyl mispairs. We propose that idling of exonuclease-proficient polymerases at m6G lesions during repair DNA synthesis provides the biochemical explanation for cellular cytotoxicity of methylating agents.	Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Pathol,Gittlen Canc Res Inst, Hershey, PA 17033 USA; Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Eckert, KA (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Pathol,Gittlen Canc Res Inst, 500 Univ Dr, Hershey, PA 17033 USA.							Baker RP, 1998, P NATL ACAD SCI USA, V95, P3507, DOI 10.1073/pnas.95.7.3507; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Bignami M, 2000, MUTAT RES-REV MUTAT, V462, P71, DOI 10.1016/S1383-5742(00)00016-8; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; CECCOTTI S, 1993, BIOCHEMISTRY-US, V32, P13644; Eckert KA, 1997, NUCLEIC ACIDS RES, V25, P1450, DOI 10.1093/nar/25.7.1450; Eckert KA, 1998, MUTAT RES-FUND MOL M, V422, P255, DOI 10.1016/S0027-5107(98)00206-1; Elisseeva E, 1999, J BIOL CHEM, V274, P25151, DOI 10.1074/jbc.274.35.25151; GINELL SL, 1990, BIOCHEMISTRY-US, V29, P10461, DOI 10.1021/bi00498a005; Hampson R, 1997, J BIOL CHEM, V272, P28596, DOI 10.1074/jbc.272.45.28596; Haracska L, 2000, MOL CELL BIOL, V20, P8001, DOI 10.1128/MCB.20.21.8001-8007.2000; Kaina B, 1997, MUTAT RES-FUND MOL M, V381, P227, DOI 10.1016/S0027-5107(97)00187-5; KARRAN P, 1992, NUCLEIC ACIDS RES, V20, P2933, DOI 10.1093/nar/20.12.2933; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; KARRAN P, 1993, J BIOL CHEM, V268, P15878; LARSON K, 1985, MUTAT RES, V150, P77, DOI 10.1016/0027-5107(85)90103-4; LEONARD GA, 1990, P NATL ACAD SCI USA, V87, P9573, DOI 10.1073/pnas.87.24.9573; Morales JC, 2000, BIOCHEMISTRY-US, V39, P2626, DOI 10.1021/bi992173a; Mozzherin DJ, 1997, P NATL ACAD SCI USA, V94, P6126, DOI 10.1073/pnas.94.12.6126; PATEL DJ, 1986, BIOCHEMISTRY-US, V25, P1027, DOI 10.1021/bi00353a012; PATEL DJ, 1986, BIOCHEMISTRY-US, V25, P1036, DOI 10.1021/bi00353a013; REBAKRANTZ LJ, 1998, J BIOL CHEM, V273, P22969; RehaKrantz LJ, 1996, J BIOL CHEM, V271, P20088, DOI 10.1074/jbc.271.33.20088; SAFFHILL R, 1985, BIOCHIM BIOPHYS ACTA, V823, P111, DOI 10.1016/0304-419X(85)90009-5; Sattar AKMA, 1996, BIOCHEMISTRY-US, V35, P16621, DOI 10.1021/bi961552q; SINGER B, 1983, MOL BIOL MUTAGENS CA, P67; SNOW ET, 1984, J BIOL CHEM, V259, P8095; SWANN PF, 1990, MUTAT RES, V233, P81, DOI 10.1016/0027-5107(90)90153-U; Tomer G, 1998, P NATL ACAD SCI USA, V95, P14106, DOI 10.1073/pnas.95.24.14106; VOIGT JM, 1990, BIOCHEMISTRY-US, V29, P5012, DOI 10.1021/bi00473a003; ZHUKOVSKAYA N, 1994, CARCINOGENESIS, V15, P2189, DOI 10.1093/carcin/15.10.2189	32	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24286	24292		10.1074/jbc.M011025200	http://dx.doi.org/10.1074/jbc.M011025200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11290737	hybrid			2022-12-27	WOS:000169531100139
J	Gaither, LA; Eide, DJ				Gaither, LA; Eide, DJ			The human ZIP1 transporter mediates zinc uptake in human K562 erythroleukemia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL EXPRESSION; CONFERS RESISTANCE; METAL TRANSPORTER; MAMMALIAN ZINC; GENE ENCODES; PROTEIN; FAMILY; ARABIDOPSIS	The ZIP superfamily of transporters plays important roles in metal ion uptake in diverse organisms. There are 12 ZIP-encoding genes in humans, and we hypothesize that many of these proteins are zinc transporters. In this study, we addressed the role of one human ZIP gene, hZIP1, in zinc transport. First, we examined Zn-65 uptake activity in K562 erythroleukemia cells overexpressing hZIP1. These cells accumulated more zinc than control cells because of increased zinc influx. Moreover, consistent with its role in zinc uptake, hZIP1 protein was localized to the plasma membrane. Our results also demonstrated that hZIP1 is responsible for the endogenous zinc uptake activity in K562 cells, hZIP1 is expressed in untransfected K562 cells, and the increase in mRNA levels found in hZIP1-overexpressing cells correlated with the increased zinc uptake activity. Furthermore, hZIP1-dependent Zn-65 uptake was biochemically indistinguishable from the endogenous activity. Finally, inhibition of endogenous hZIP1 expression with antisense oligonucleotides caused a marked decrease in endogenous Zn-65 uptake activity. The observation that hZIP1 is the major zinc transporter in K562 cells, coupled with its expression in many normal cell types, indicates that hZIP1 plays an important role in zinc uptake in human tissues.	Univ Missouri, Dept Nutr Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Eide, DJ (corresponding author), Univ Missouri, Dept Nutr Sci, 217 Gwynn Hall, Columbia, MO 65211 USA.	eided@missouri.edu			NATIONAL CANCER INSTITUTE [R01CA079903] Funding Source: NIH RePORTER; NCI NIH HHS [CA79903] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Branch AD, 1998, TRENDS BIOCHEM SCI, V23, P45, DOI 10.1016/S0968-0004(97)01155-9; Cleland W W, 1979, Methods Enzymol, V63, P103; Costello LC, 1999, J BIOL CHEM, V274, P17499, DOI 10.1074/jbc.274.25.17499; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Eng BH, 1998, J MEMBRANE BIOL, V166, P1, DOI 10.1007/s002329900442; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; GAITHER LA, 2001, IN PRESS BIOMETALS; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Lioumi M, 1999, GENOMICS, V62, P272, DOI 10.1006/geno.1999.5993; Liuzzi JP, 2001, J NUTR, V131, P46, DOI 10.1093/jn/131.1.46; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; MAGNESON GR, 1987, J BIOL CHEM, V262, P11140; McMahon RJ, 1998, P NATL ACAD SCI USA, V95, P4841, DOI 10.1073/pnas.95.9.4841; McMahon RJ, 1998, J NUTR, V128, P667, DOI 10.1093/jn/128.4.667; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Pence NS, 2000, P NATL ACAD SCI USA, V97, P4956, DOI 10.1073/pnas.97.9.4956; Reyes JG, 1996, AM J PHYSIOL-CELL PH, V270, pC401, DOI 10.1152/ajpcell.1996.270.2.C401; Rogers EE, 2000, P NATL ACAD SCI USA, V97, P12356, DOI 10.1073/pnas.210214197; Yamaguchi S, 1995, Kokubyo Gakkai Zasshi, V62, P78; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; Zhao H, 1996, J BIOL CHEM, V271, P23203, DOI 10.1074/jbc.271.38.23203; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454; Zucker M, 1999, RNA BIOCH BIOTECHNOL	29	210	218	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22258	22264		10.1074/jbc.M101772200	http://dx.doi.org/10.1074/jbc.M101772200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301334	hybrid			2022-12-27	WOS:000169412700040
J	Han, J; Kim, N; Kim, E; Ho, WK; Earm, YE				Han, J; Kim, N; Kim, E; Ho, WK; Earm, YE			Modulation of ATP-sensitive potassium channels by cGMP-dependent protein kinase in rabbit ventricular myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-NATRIURETIC-FACTOR; PANCREATIC BETA-CELLS; NITRIC-OXIDE; K+-CHANNEL; CYCLIC-GMP; PHARMACOLOGICAL EXPLOITATION; XENOPUS-OOCYTES; SMOOTH-MUSCLE; RAT-HEART; ACTIVATION	This investigation used a patch clamp technique to test the hypothesis that protein kinase G (PKG) contributes to the phosphorylation and activation of ATP-sensitive K+ (K-ATP) channels in rabbit ventricular myocytes. Nitric oxide donors and PKG; activators facilitated pinacidil-induced K-ATP channel activities in a concentration-dependent manner, and a selective PKG inhibitor abrogated these effects. In contrast, neither a selective protein kinase A (PKA) activator nor inhibitor had any effect on K-ATP channels at concentrations up to 100 and 10 muM, respectively. Exogenous PKG, in the presence of both cGMP and ATP, increased channel activity, while the catalytic subunit of PKA had no effect. PKG activity was prevented by heat inactivation, replacing ATP with adenosine 5 ' -O-(thiotriphosphate) (a nonhydrolyzable analog of ATP), removing Mg2+ from the internal solution, applying a PKG inhibitor, or by adding exogenous protein phosphatase 2A The effects of cGMP analogs and PKG were observed under conditions in which PKA was repressed by a selective PKA inhibitor. The results suggest that K-ATP channels are regulated by a PKG-signaling pathway that acts via PKG-dependent phosphorylation. This mechanism may, at least in part, contribute to a signaling pathway that induces ischemic preconditioning in rabbit ventricular myocytes.	Seoul Natl Univ, Coll Med, Dept Physiol & Biophys, Chongno Ku, Seoul 110799, South Korea; Seoul Natl Univ, Coll Med, Natl Res Lab Cellular Signaling, Seoul 110799, South Korea; Inje Univ, Coll Med, Dept Physiol & Biophys, Busan 614735, South Korea	Seoul National University (SNU); Seoul National University (SNU); Inje University	Earm, YE (corresponding author), Seoul Natl Univ, Coll Med, Dept Physiol & Biophys, Chongno Ku, Yonkeun Dong, Seoul 110799, South Korea.		Ho, Won-Kyung/J-2798-2012					AHLNER J, 1991, PHARMACOL REV, V43, P351; ASHFORD MLJ, 1994, NATURE, V370, P456, DOI 10.1038/370456a0; AUCHAMPACH JA, 1993, AM J PHYSIOL, V264, pH1327, DOI 10.1152/ajpheart.1993.264.5.H1327; BILLMAN GE, 1990, FASEB J, V4, P1668, DOI 10.1096/fasebj.4.6.2156744; BUTT E, 1992, BIOCHEM PHARMACOL, V43, P2591, DOI 10.1016/0006-2952(92)90148-C; Butt E, 1995, BRIT J PHARMACOL, V116, P3110, DOI 10.1111/j.1476-5381.1995.tb15112.x; CAMERON JS, 1994, CARDIOVASC RES, V28, P788, DOI 10.1093/cvr/28.6.788; COHEN MV, 1993, LANCET, V342, P6, DOI 10.1016/0140-6736(93)91878-P; COLQUHOUN D, 1983, FITTING STAT ANAL SI, P191; Duncker DJ, 2000, CARDIOVASC DRUG THER, V14, P7, DOI 10.1023/A:1007866102585; GANOTE C, 1993, CARDIOVASC RES, V27, P1387, DOI 10.1093/cvr/27.8.1387; GENIESER HG, 1992, CARBOHYD RES, V234, P217, DOI 10.1016/0008-6215(92)85050-A; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han J, 1998, PFLUG ARCH EUR J PHY, V435, P388, DOI 10.1007/s004240050528; HAN J, 1993, PFLUG ARCH EUR J PHY, V425, P546; HAN J, 1995, HEART VESSELS, V9, P94; Iliodromitis EK, 1996, BASIC RES CARDIOL, V91, P234, DOI 10.1007/BF00788909; INAGAKI N, 1995, J BIOL CHEM, V270, P5691, DOI 10.1074/jbc.270.11.5691; KENNETH DC, 1993, J CLIN INVEST, V91, P2446; Kim EY, 1997, AM J PHYSIOL-HEART C, V272, pH325, DOI 10.1152/ajpheart.1997.272.1.H325; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P28777, DOI 10.1074/jbc.270.48.28777; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO M, 1994, CIRC RES, V74, P471, DOI 10.1161/01.RES.74.3.471; Kwak YG, 1996, LIFE SCI, V58, P897, DOI 10.1016/0024-3205(96)00032-X; Light PE, 1996, CIRC RES, V79, P399, DOI 10.1161/01.RES.79.3.399; Maronde E, 1999, J PINEAL RES, V27, P170, DOI 10.1111/j.1600-079X.1999.tb00613.x; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; PARRATT JR, 1995, J MOL CELL CARDIOL, V27, P991, DOI 10.1016/0022-2828(95)90068-3; PARRATT JR, 1995, CAN J PHYSIOL PHARM, V73, P837, DOI 10.1139/y95-114; PARRATT JR, 1994, TRENDS PHARMACOL SCI, V15, P19, DOI 10.1016/0165-6147(94)90129-5; RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1; Rapundalo ST, 1998, CARDIOVASC RES, V38, P559, DOI 10.1016/S0008-6363(98)00063-7; Ropero AB, 1999, J PHYSIOL-LONDON, V521, P397, DOI 10.1111/j.1469-7793.1999.00397.x; SAKUTA H, 1993, JPN J PHARMACOL, V61, P259, DOI 10.1254/jjp.61.259; SAKUTA H, 1994, EUR J PHARM-MOLEC PH, V267, P281, DOI 10.1016/0922-4106(94)90152-X; SANDBERG M, 1991, BIOCHEM J, V279, P521, DOI 10.1042/bj2790521; Shinbo A, 1997, BRIT J PHARMACOL, V120, P1568, DOI 10.1038/sj.bjp.0701069; SOUTHAM E, 1991, NEUROSCI LETT, V130, P107, DOI 10.1016/0304-3940(91)90239-P; TSUURA Y, 1994, J GEN PHYSIOL, V104, P1079, DOI 10.1085/jgp.104.6.1079; VANWINKLE DM, 1994, AM J PHYSIOL, V266, pH829, DOI 10.1152/ajpheart.1994.266.2.H829; Vila-Petroff MG, 1999, CIRC RES, V84, P1020, DOI 10.1161/01.RES.84.9.1020; WAHLER GM, 1995, AM J PHYSIOL-CELL PH, V268, pC45, DOI 10.1152/ajpcell.1995.268.1.C45; Weinbrenner C, 1997, J MOL CELL CARDIOL, V29, P2383, DOI 10.1006/jmcc.1997.0473; Wellman GC, 1998, J PHYSIOL-LONDON, V507, P117, DOI 10.1111/j.1469-7793.1998.117bu.x; Yamaguchi F, 1997, HEART VESSELS, V12, P74, DOI 10.1007/BF02820870; YAO ZH, 1994, CIRCULATION, V89, P1229, DOI 10.1161/01.CIR.89.3.1229; Zhu Z, 2000, PFLUG ARCH EUR J PHY, V439, P808, DOI 10.1007/s004240051008	48	70	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22140	22147		10.1074/jbc.M010103200	http://dx.doi.org/10.1074/jbc.M010103200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11303020	hybrid			2022-12-27	WOS:000169412700024
J	Huby, T; Dachet, C; Lawn, RM; Wickings, J; Chapman, MJ; Thillet, J				Huby, T; Dachet, C; Lawn, RM; Wickings, J; Chapman, MJ; Thillet, J			Functional analysis of the chimpanzee and human apo(a) promoter sequences - Identification of sequence variations responsible for elevated transcriptional activity in chimpanzee	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; APOLIPOPROTEIN(A) GENE; LIPOPROTEIN(A) LEVELS; MYOCARDIAL-INFARCTION; SIZE POLYMORPHISM; PLASMA; LP(A); REGION; RISK; ASSOCIATION	Lp(a) concentrations vary considerably among individuals and are primarily determined by the apo(a) gene locus. We have previously shown that mean plasma Lp(a) levels in the chimpanzee are significantly higher than those observed in humans (Doucet, C,, Huby, T., Chapman, J., and Thillet, J, (1994) J, Lipid Res 35, 263-270). To evaluate the possibility that this difference may result from a high level of expression of chimpanzee apo(a), we cloned and sequenced 1.4 kilobase (kb) of the 5 ' -flanking region of the gene and compared promoter activity to that of its human counterpart. Sequence analysis revealed 98% homology between chimpanzee and human apo(a) 5 ' sequences; among the differences observed, two involved polymorphic sites associated with Lp(a) levels in humans, The TTTTA repeat located 1.3 kb 5 ' of the apo(a) gene, present in a variable number of copies (n = 5-12) in humans, is uniquely present as four copies in the chimpanzee sequence, The second position concerns the +93 C >T polymorphism that creates an additional ATG start codon in the human apo(a) gene, thereby impairing translation efficiency. In chimpanzee, this position did not appear polymorphic, and a base difference at position +94 precluded the presence of an additional ATG. In transient transfection assays, the chimpanzee apo(a) promoter exhibited a 5-fold elevation in transcriptional activity as compared with its human counterpart. This marked difference in activity was maintained with either 1.4 kb of 5 ' sequence or the minimal promoter region -98 to +141 of the human and chimpanzee apo(a) genes, Using point mutational analyses, nucleotides present at positions -3, -2, and +8 (relative to the start site of transcription) were found to be essential for the high transcription efficiency of the chimpanzee apo(a) promoter, High transcriptional activity of the chimpanzee apo(a) gene may therefore rep resent a key factor in the elevated plasma Lp(a) levels characteristic of this non-human primate.	Hop Pitie, INSERM Unite 551, F-75651 Paris 13, France; Int Ctr Med Res, Franceville, Gabon; CV Therapeut, Palo Alto, CA 94304 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Thillet, J (corresponding author), Hop Pitie, INSERM Unite 551, 83 Blvd Hop, F-75651 Paris 13, France.		Huby, Thierry/E-6768-2017; chapman, john/Y-2742-2019; HUBY, Thierry/N-4820-2019	Huby, Thierry/0000-0001-6634-551X; HUBY, Thierry/0000-0001-6634-551X				BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; BOPP S, 1995, J LIPID RES, V36, P1721; Brazier L, 1999, ATHEROSCLEROSIS, V144, P323, DOI 10.1016/S0021-9150(98)00333-5; Chenivesse X, 1998, BIOCHEMISTRY-US, V37, P7213, DOI 10.1021/bi9721546; CREMER P, 1994, EUR J CLIN INVEST, V24, P444, DOI 10.1111/j.1365-2362.1994.tb02373.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOUCET C, 1994, J LIPID RES, V35, P263; GAUBATZ JW, 1983, J BIOL CHEM, V258, P4582; Hiraga T, 1996, ATHEROSCLEROSIS, V122, P29, DOI 10.1016/0021-9150(95)05743-9; Hixson JE, 1996, J LIPID RES, V37, P2324; JURGENS G, 1995, STROKE, V26, P1841, DOI 10.1161/01.STR.26.10.1841; Keene RG, 1999, J BIOL CHEM, V274, P11526, DOI 10.1074/jbc.274.17.11526; Kraft HG, 1996, ARTERIOSCL THROM VAS, V16, P713, DOI 10.1161/01.ATV.16.6.713; Kraft HG, 1996, EUR J HUM GENET, V4, P74; Kraft HG, 1998, HUM MOL GENET, V7, P257, DOI 10.1093/hmg/7.2.257; KRAFT HG, 1992, HUM GENET, V90, P220; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; LACKNER C, 1991, J CLIN INVEST, V87, P2153, DOI 10.1172/JCI115248; LAPLAUD PM, 1988, J LIPID RES, V29, P1157; Lobentanz EM, 1998, BIOCHEMISTRY-US, V37, P5417, DOI 10.1021/bi972761t; MAKINO K, 1989, ATHEROSCLEROSIS, V78, P81, DOI 10.1016/0021-9150(89)90161-5; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; MOOSER V, 1995, HUM MOL GENET, V4, P173, DOI 10.1093/hmg/4.2.173; RAINWATER DL, 1988, ATHEROSCLEROSIS, V73, P23, DOI 10.1016/0021-9150(88)90159-1; SANDHOLZER C, 1991, HUM GENET, V86, P607; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schreiner PJ, 1996, ARTERIOSCL THROM VAS, V16, P471, DOI 10.1161/01.ATV.16.3.471; Suzuki K, 1997, J CLIN INVEST, V99, P1361, DOI 10.1172/JCI119295; TROMMSDORFF M, 1995, J CLIN INVEST, V96, P150, DOI 10.1172/JCI118015; Utermann G, 1999, CURR OPIN LIPIDOL, V10, P133, DOI 10.1097/00041433-199904000-00007; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; UTERMANN G, 1987, J CLIN INVEST, V80, P458, DOI 10.1172/JCI113093; WADE DP, 1994, J BIOL CHEM, V269, P19757; Wade DP, 1997, J BIOL CHEM, V272, P30387, DOI 10.1074/jbc.272.48.30387; WADE DP, 1993, P NATL ACAD SCI USA, V90, P1369, DOI 10.1073/pnas.90.4.1369; White AL, 1997, J BIOL CHEM, V272, P5048, DOI 10.1074/jbc.272.8.5048; Yang ZY, 1998, J BIOL CHEM, V273, P891, DOI 10.1074/jbc.273.2.891; ZYSOW BR, 1995, ARTERIOSCL THROM VAS, V15, P58, DOI 10.1161/01.ATV.15.1.58	38	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22209	22214		10.1074/jbc.M102204200	http://dx.doi.org/10.1074/jbc.M102204200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301336	hybrid			2022-12-27	WOS:000169412700033
J	Knoop, LL; Baker, SJ				Knoop, LL; Baker, SJ			EWS/FLI alters 5 '-splice site selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; EWINGS-SARCOMA TRANSLOCATION; SPLICING IN-VIVO; TRANSCRIPTION FACTOR; CHROMOSOME-TRANSLOCATION; MYXOID LIPOSARCOMA; POLYMERASE-II; GROWTH-FACTOR; GENE FUSION; CELL LINE	The chimeric gene EWS/FLI is present in at least 85% of Ewing's sarcomas as a result of chromosomal translocations, The resulting fusion protein contains the N terminus of the RNA-binding protein EWS and the ETS DNA-binding domain of the transcription factor FLI-1, Although EWS/FLI binds DNA and activates transcription, both EWS and EWS/FLI also interact with SF1 and U1C, essential components of the splicing machinery. Therefore, we tested the ability of EWS and EWS/FLI to alter 5'-splice site selection using an E1A gene in vivo splicing assay. We found that EWS/FLI, but not EWS, interfered with heterogeneous nuclear ribonucleoprotein Al-dependent splice site selection of E1A, Mutational analysis of EWS/FLI revealed that the ability to affect pre-mRNA splicing coincided with transforming activity. Therefore, EWS/FLI has the ability to influence splicing as well as transcription.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Univ Tennessee, Dept Pathol, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Baker, SJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale, Memphis, TN 38105 USA.				NCI NIH HHS [P01-CA-71907, P30 CA21765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA071907, P30CA021765] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENDAVID Y, 1991, CELL, V66, P831, DOI 10.1016/0092-8674(91)90428-2; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; CHOW VTK, 1993, CANCER LETT, V73, P141, DOI 10.1016/0304-3835(93)90256-9; Clark J, 1997, ONCOGENE, V15, P2233, DOI 10.1038/sj.onc.1201394; Croft L, 2000, NAT GENET, V24, P340, DOI 10.1038/74153; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Davies RC, 1998, GENE DEV, V12, P3217, DOI 10.1101/gad.12.20.3217; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hallier M, 1998, J BIOL CHEM, V273, P4838, DOI 10.1074/jbc.273.9.4838; Hallier M, 1996, J BIOL CHEM, V271, P11177, DOI 10.1074/jbc.271.19.11177; Hosokawa Y, 1997, CANCER LETT, V113, P123, DOI 10.1016/S0304-3835(97)04605-3; Jaishankar S, 1999, ONCOGENE, V18, P5592, DOI 10.1038/sj.onc.1202940; Jang JH, 2000, CANCER RES, V60, P4049; JEON IS, 1995, ONCOGENE, V10, P1229; Knoop LL, 2000, J BIOL CHEM, V275, P24865, DOI 10.1074/jbc.M001661200; LABELLE Y, 1995, HUM MOL GENET, V4, P2219, DOI 10.1093/hmg/4.12.2219; LADANYI M, 1994, CANCER RES, V54, P2837; LESSNICK SL, 1995, ONCOGENE, V10, P423; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; McGarvey T, 2000, J CELL BIOL, V150, P309, DOI 10.1083/jcb.150.2.309; Panagopoulos I, 1996, ONCOGENE, V12, P489; Peter M, 1997, ONCOGENE, V14, P1159, DOI 10.1038/sj.onc.1200933; Poleev A, 2000, EUR J BIOCHEM, V267, P4002, DOI 10.1046/j.1432-1327.2000.01431.x; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V32, P229, DOI 10.1016/0165-4608(88)90285-3; Urano F, 1996, BIOCHEM BIOPH RES CO, V219, P608, DOI 10.1006/bbrc.1996.0281; WANG J, 1995, RNA, V1, P335; Yang L, 2000, J BIOL CHEM, V275, P37612, DOI 10.1074/jbc.M005739200; Yang L, 2000, MOL CELL BIOL, V20, P3345, DOI 10.1128/MCB.20.10.3345-3354.2000; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761; YANG XM, 1994, P NATL ACAD SCI USA, V91, P6924, DOI 10.1073/pnas.91.15.6924; Zhang D, 1998, J BIOL CHEM, V273, P18086, DOI 10.1074/jbc.273.29.18086; Zhang HT, 2000, BRIT J CANCER, V83, P63; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341	39	78	94	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22317	22322		10.1074/jbc.M008950200	http://dx.doi.org/10.1074/jbc.M008950200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301318	hybrid			2022-12-27	WOS:000169412700048
J	Kraev, A; Quednau, BD; Leach, S; Li, XF; Dong, H; Winkfein, R; Perizzolo, M; Cai, XJ; Yang, RM; Philipson, KD; Lytton, J				Kraev, A; Quednau, BD; Leach, S; Li, XF; Dong, H; Winkfein, R; Perizzolo, M; Cai, XJ; Yang, RM; Philipson, KD; Lytton, J			Molecular cloning of a third member of the potassium-dependent sodium-calcium exchanger gene family, NCKX3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENTS; NA-CA EXCHANGER; NA+/CA2+ EXCHANGER; NA+-CA2+ EXCHANGER; FUNCTIONAL EXPRESSION; CDNA CLONING; K EXCHANGER; NCX1; ISOFORMS; BRAIN	We describe here the identification and characterization of a novel member of the family of K+-dependent Na+/Ca2+ exchangers, NCKX3 (gene SLC24A3). Human NCKX3 encodes a protein of 644 amino acids that displayed a high level of sequence identity to the other family members, rod NCKX1 and cone/neuronal NCKX2, in the hydrophobic regions surrounding the "alpha -repeat" sequences thought to form the ion binding pocket far transport. Outside of these regions NCKX3 showed no significant identity to other known proteins. As anticipated from this sequence similarity, NCKX3 displayed K+-dependent Na+/Ca2+ exchanger activity when assayed in heterologous expression systems, using digital imaging of fura-2 fluorescence, electrophysiology, or radioactive Ca-45(2+) uptake. The N-terminal region of NCKX3, although not essential for expression, increased functional activity at least 10-fold and may represent a cleavable signal sequence. NCKX3 transcripts were most abundant in brain, with highest levels found in selected thalamic nuclei, in hippocampal CA1 neurons, and in layer IV of the cerebral cortex. Many other tissues also expressed NCKX3 at lower levels, especially aorta, uterus, and intestine, which are rich in smooth muscle. The discovery of NCKX3 thus expands the K+-dependent Na+/Ca2+ exchanger family and suggests this class of transporter has a more widespread role in cellular Ca2+ handling than previously appreciated.	Univ Calgary, Hlth Sci Ctr, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; Univ Calgary, Hlth Sci Ctr, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA	University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lytton, J (corresponding author), Univ Calgary, Hlth Sci Ctr, Dept Biochem & Mol Biol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	jlytton@ucalgary.ca	Cai, Xinjiang/F-4843-2010; Cai, Xinjiang/A-9617-2008	Cai, Xinjiang/0000-0001-8933-7133; Lytton, Jonathan/0000-0003-4770-2512	NHLBI NIH HHS [HL48509] Funding Source: Medline; PHS HHS [L4901] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048509, R37HL048509] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ausubel F. M., 2001, CURRENT PROTOCOLS MO; Barnes KV, 1997, J BIOL CHEM, V272, P11510, DOI 10.1074/jbc.272.17.11550; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; Cooper CB, 1999, BIOCHEMISTRY-US, V38, P6276, DOI 10.1021/bi983068o; DAHAN D, 1991, J BIOL CHEM, V266, P2067; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; Fujioka Y, 2000, J PHYSIOL-LONDON, V523, P339, DOI 10.1111/j.1469-7793.2000.t01-2-00339.x; FURMAN I, 1995, J BIOL CHEM, V270, P19120, DOI 10.1074/jbc.270.32.19120; Haug-Collet K, 1999, J CELL BIOL, V147, P659, DOI 10.1083/jcb.147.3.659; Iwamoto T, 2000, J BIOL CHEM, V275, P38571, DOI 10.1074/jbc.M003788200; Iwamoto T, 1999, FEBS LETT, V446, P264, DOI 10.1016/S0014-5793(99)00218-5; Iwamoto T, 1998, AM J PHYSIOL-CELL PH, V275, pC423, DOI 10.1152/ajpcell.1998.275.2.C423; Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391; KIMURA M, 1993, J BIOL CHEM, V268, P6874; Kimura M, 1999, AM J PHYSIOL-HEART C, V277, pH911, DOI 10.1152/ajpheart.1999.277.3.H911; KOFUJI P, 1992, AM J PHYSIOL, V263, pC1241, DOI 10.1152/ajpcell.1992.263.6.C1241; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Kraev A, 1996, GENOMICS, V37, P105, DOI 10.1006/geno.1996.0526; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEE SL, 1994, J BIOL CHEM, V269, P14849; Li XF, 1999, J BIOL CHEM, V274, P8153, DOI 10.1074/jbc.274.12.8153; LI ZP, 1994, J BIOL CHEM, V269, P17434; Linck B, 1998, AM J PHYSIOL-CELL PH, V274, pC415, DOI 10.1152/ajpcell.1998.274.2.C415; LOO TW, 1995, J BIOL CHEM, V270, P19345, DOI 10.1074/jbc.270.33.19345; MARLIER LNJL, 1993, MOL BRAIN RES, V20, P21, DOI 10.1016/0169-328X(93)90107-Z; Nicholas SB, 1998, AM J PHYSIOL-HEART C, V274, pH217, DOI 10.1152/ajpheart.1998.274.1.H217; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Poon S, 2000, AM J PHYSIOL-CELL PH, V278, pC651, DOI 10.1152/ajpcell.2000.278.4.C651; Prinsen CFM, 2000, J NEUROSCI, V20, P1424; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; QUI Z, 2001, J BIOL CHEM, V276, P194; REILANDER H, 1992, EMBO J, V11, P1689, DOI 10.1002/j.1460-2075.1992.tb05219.x; SAHINTOTH M, 1995, BIOCHEM BIOPH RES CO, V212, P968, DOI 10.1006/bbrc.1995.2064; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Scheller T, 1998, J BIOL CHEM, V273, P7643, DOI 10.1074/jbc.273.13.7643; SCHNETKAMP PPM, 1991, J BIOL CHEM, V266, P22975; SCHNETKAMP PPM, 1989, AM J PHYSIOL, V257, pC153, DOI 10.1152/ajpcell.1989.257.1.C153; SCHNETKAMP PPM, 1995, CELL CALCIUM, V18, P322, DOI 10.1016/0143-4160(95)90028-4; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; Szerencsei RT, 2000, J BIOL CHEM, V275, P669, DOI 10.1074/jbc.275.1.669; Tashiro M, 2000, PFLUG ARCH EUR J PHY, V440, P819, DOI 10.1007/s004240000384; Tsoi M, 1998, J BIOL CHEM, V273, P4155, DOI 10.1074/jbc.273.7.4155; Tucker JE, 1998, HUM GENET, V103, P411, DOI 10.1007/s004390050842; Tucker JE, 1998, INVEST OPHTH VIS SCI, V39, P435; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wakimoto K, 2000, J BIOL CHEM, V275, P36991, DOI 10.1074/jbc.M004035200; WU KD, 1993, AM J PHYSIOL, V264, pC333, DOI 10.1152/ajpcell.1993.264.2.C333	54	84	88	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23161	23172		10.1074/jbc.M102314200	http://dx.doi.org/10.1074/jbc.M102314200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294880	hybrid			2022-12-27	WOS:000169412700157
J	Masumi, A; Ozato, K				Masumi, A; Ozato, K			Coactivator p300 acetylates the interferon regulatory factor-2 in U937 cells following phorbol ester treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLATION; DNA-BINDING; GENE-TRANSCRIPTION; ONCOPROTEIN E1A; FACTOR-II; PCAF; PHOSPHORYLATION; ACTIVATION; CBP; ACETYLTRANSFERASE	Interferon regulatory factor-2 (IRF-2) is at transcription factor of the IRF family that represses interferon-mediated gene expression. In the present study, we show that human monocytic U937 cells express truncated forms of IRF-2 containing the DNA binding do main but lacking much of the C-terminal regulatory domain. U937 cells are shown to respond to phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) to induce expression of histone acetylases p300 and p300/CBP-associated factor (PCAF), In addition, TPA treatment led to the appearance of full-length IRF-2, along with a reduction of the truncated protein. interestingly, full-length IRF-2 in TPA-treated U937 cells occurred as a complex with p300 as well as PCAF and was itself acetylated. Consistent with these results, recombinant IRF-2 was acetylated by p300 and to a lesser degree by PCAF in vitro. Another IRF member, IRF-1, an activator of interferon-mediated transcription, was also acetylated in vitro by these acetylases, Finally, we demonstrate that the addition of IRF-2 but not IRF-1. inhibits core histone acetylation by p300 in vitro, The addition of IRF-2 also inhibited acetylation of nucleosomal histones in TPA-treated U937 cells. Acetylated IRF-2 may affect local chromatin structure in vivo by inhibiting core histone acetylation and may serve as a mechanism by which IRF-2 negatively regulates interferon-inducible transcription.	Natl Inst Infect Dis, Dept Safety Res Biol, Tokyo 2080011, Japan; NICHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA	National Institute of Infectious Diseases (NIID); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Masumi, A (corresponding author), Natl Inst Infect Dis, Dept Safety Res Biol, 4-7-1 Gakuen,Musashimurayama Shi, Tokyo 2080011, Japan.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001310] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Burysek L, 1999, J VIROL, V73, P7334; Carey JO, 1996, BLOOD, V87, P4316, DOI 10.1182/blood.V87.10.4316.bloodjournal87104316; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Colle JH, 1997, J IMMUNOL METHODS, V210, P175, DOI 10.1016/S0022-1759(97)00186-5; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; Jayachandra S, 1999, P NATL ACAD SCI USA, V96, P11566, DOI 10.1073/pnas.96.20.11566; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Li JW, 2000, MOL CELL BIOL, V20, P2031, DOI 10.1128/MCB.20.6.2031-2042.2000; Li M, 2000, MOL CELL BIOL, V20, P8254, DOI 10.1128/MCB.20.21.8254-8263.2000; Li MT, 1998, J VIROL, V72, P5433, DOI 10.1128/JVI.72.7.5433-5440.1998; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Liu L, 1999, MOL CELL BIOL, V19, P1202; Magnaghi-Jaulin L, 1999, SEMIN CELL DEV BIOL, V10, P197, DOI 10.1006/scdb.1999.0301; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Masumi A, 1999, MOL CELL BIOL, V19, P1810; MASUMIFUKAZAWA A, 1995, EUR J BIOCHEM, V232, P134, DOI 10.1111/j.1432-1033.1995.tb20791.x; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PALOMBELLA VJ, 1992, MOL CELL BIOL, V12, P3325, DOI 10.1128/MCB.12.8.3325; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sano Y, 2001, J BIOL CHEM, V276, P3674, DOI 10.1074/jbc.M006896200; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; Taniguchi T, 1997, J CELL PHYSIOL, V173, P128, DOI 10.1002/(SICI)1097-4652(199711)173:2<128::AID-JCP8>3.0.CO;2-P; Taniguchi T, 1997, BBA-REV CANCER, V1333, pM9, DOI 10.1016/S0304-419X(97)00014-0; Tomita A, 2000, ONCOGENE, V19, P444, DOI 10.1038/sj.onc.1203329; TURNER BM, 1995, SEMIN CELL BIOL, V6, P229, DOI 10.1006/scel.1995.0031; Vassilev A, 1998, MOL CELL, V2, P869, DOI 10.1016/S1097-2765(00)80301-9; Vaughan PS, 1998, J BIOL CHEM, V273, P194, DOI 10.1074/jbc.273.1.194; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; WAYS K, 1991, J BIOL CHEM, V266, P1258; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Xi HK, 1999, ONCOGENE, V18, P5889, DOI 10.1038/sj.onc.1202969; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhou Q, 2000, J BIOL CHEM, V275, P35256, DOI 10.1074/jbc.M003106200	51	45	46	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20973	20980		10.1074/jbc.M101707200	http://dx.doi.org/10.1074/jbc.M101707200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11304541	hybrid			2022-12-27	WOS:000169297900025
J	Zambrano, N; Bruni, P; Minopoli, G; Mosca, R; Molino, D; Russo, C; Schettini, G; Sudol, M; Russo, T				Zambrano, N; Bruni, P; Minopoli, G; Mosca, R; Molino, D; Russo, C; Schettini, G; Sudol, M; Russo, T			The beta-amyloid precursor protein APP is tyrosine-phosphorylated in cells expressing a constitutively active form of the Abl protoncogene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; PROLINE-RICH MOTIFS; KINASE C-ABL; SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE; APOPTOTIC RESPONSE; CYTOPLASMIC DOMAIN; FE65 PROTEIN; DNA-DAMAGE; SUBSTRATE	The cytosolic domain of the beta -amyloid precursor protein APP interacts with three PTB (phosphotyrosine binding domain) containing adaptor proteins, Fe65, X11, and mDab1, Through these adaptors, other molecules can be recruited at the cytodomain of APP; one of them is Mena, that binds to the WW domain (a protein module with two conserved tryptophans) of Fe65, The enabled and disabled genes of Drosophila, homologues of the mammalian Mena and mDab1 genes, respectively, are genetic modulators of the phenotype observed in flies null for the Abl tyrosine kinase gene. The involve ment of Mena and mDab1 in the APP-centered protein-protein interaction network suggests the possibility that Abl plays a role in APP biology, We show that Fe65, through its WW domain, binds in vitro and in vivo the active form of Abl, Furthermore, in cells expressing the active form of Abl, APP is tyrosine-phosphorylated, Phosphopeptide analysis and site-directed mutagenesis support the hypothesis that Tyr(682) Of APP(695) is the target of this phosphorylation. Co-immunoprecipitation experiments demonstrate that active Abl and tyrosine-phosphorylated APP also form a stable complex, which could result from the interaction of the pYENP motif of the APP cytodomain with the SH2 domain of Abl, These results suggest that Abl, Mena, and mDabl are involved in a common molecular machinery and that APP can play a role in tyrosine kinase-mediated signaling.	Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy; Univ Genoa, Dept Oncol Biol & Genet, Pharmacol Sect, I-16132 Genoa, Italy; IST, Serv Pharmacol & Neurosci, I-16132 Genoa, Italy; CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	University of Naples Federico II; University of Genoa; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Russo, T (corresponding author), Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Via S Pansini 5, I-80131 Naples, Italy.	russot@dbbm.unina.it	Russo, Claudio/AIA-1429-2022; Zambrano, Nicola/B-9352-2014; Russo, Tommaso/K-1331-2016	Zambrano, Nicola/0000-0001-9395-3481; Russo, Tommaso/0000-0003-4426-0106; russo, claudio/0000-0002-2520-2958				Agami R, 1999, NATURE, V399, P809; Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Borg JP, 1999, J NEUROSCI, V19, P1307; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Bothwell M, 2000, CELL, V102, P271, DOI 10.1016/S0092-8674(00)00032-5; Bressler SL, 1996, HUM MOL GENET, V5, P1589, DOI 10.1093/hmg/5.10.1589; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Cortes JE, 1996, AM J MED, V100, P555, DOI 10.1016/S0002-9343(96)00061-7; DUCLOS B, 1991, METHOD ENZYMOL, V201, P10; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GERTLER FB, 1990, SCIENCE, V248, P857, DOI 10.1126/science.2188361; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; GERTLER FB, 1993, GENE DEV, V7, P441, DOI 10.1101/gad.7.3.441; Gong JG, 1999, NATURE, V399, P806; HENKEMEYER M, 1990, CELL, V63, P949, DOI 10.1016/0092-8674(90)90498-4; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Howell BW, 1999, MOL CELL BIOL, V19, P5179; KAMPS MP, 1991, METHOD ENZYMOL, V201, P21; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; McLoughlin DM, 1996, FEBS LETT, V397, P197; MIAO YJ, 1996, J BIOL CHEM, V272, P8905; Minopoli G, 2001, J BIOL CHEM, V276, P6545, DOI 10.1074/jbc.M007340200; PONZIAK C, 2000, SCIENCE, V289, P304; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shaul Y, 2000, CELL DEATH DIFFER, V7, P10, DOI 10.1038/sj.cdd.4400626; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; SUZUKI T, 1994, EMBO J, V13, P1114, DOI 10.1002/j.1460-2075.1994.tb06360.x; Suzuki T, 1997, BIOCHEMISTRY-US, V36, P4643, DOI 10.1021/bi962618k; Tauchi T, 1997, J BIOL CHEM, V272, P1389, DOI 10.1074/jbc.272.2.1389; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zambrano N, 1998, J BIOL CHEM, V273, P20128, DOI 10.1074/jbc.273.32.20128; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	44	109	117	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19787	19792		10.1074/jbc.M100792200	http://dx.doi.org/10.1074/jbc.M100792200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279131	hybrid			2022-12-27	WOS:000169135100016
J	Howard, PW; Maurer, RA				Howard, PW; Maurer, RA			A point mutation in the LIM domain of Lhx3 reduces activation of the glycoprotein hormone alpha-subunit promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEODOMAIN TRANSCRIPTION FACTOR; DIFFERENTIAL ACTIVATION; PROTEIN INTERACTIONS; BINDING-PROTEIN; PITUITARY; GENE; EXPRESSION; PATHWAY; CELLS; LDB1	Lhx3, a member of the LIM homeodomain family of transcription factors, is required for development of the pituitary in mice. A recent report has described a point mutation in the human LHX3 gene that is associated with a combined pituitary hormone disorder. The mutation is predicted to lead to the replacement of a tyrosine residue with a cysteine in the second LIM domain of LHX3, We have characterized the effects of this point mutation (Y114C) when analyzed in the context of the mouse Lhx3 coding sequence. Mobility shift assays demonstrated that the Lhx3 Y114C mutant is capable of binding DNA, although a decrease in the formation of a specific complex was observed. Transfection assays using an expression vector for either full-length Lhx3 or a GAL4-Lhx3 LIM domain fusion provided evidence that the Lhx3 Y114C mutant has a decreased ability to stimulate transcription. In particular, a GAL4-Lhx3 Y114C LIM mutant was unable to support Ras responsiveness of a modified glycoprotein hormone cu-subunit reporter gene. Protein interaction studies suggest that the Y114C mutation may modestly reduce binding to the POU transcription factor, Pit-1. Interestingly, the Y114C mutation essentially abrogated binding to the putative co-activator/adapter, selective LIM-binding protein. The findings provide insights into the mechanisms mediating transcriptional activation by Lhx3 and suggest that the observed phenotype of the human mutation probably involves reduced transcriptional activity of the mutant LHX3.	Oregon Hlth Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	Oregon Health & Science University	Maurer, RA (corresponding author), Oregon Hlth Sci Univ, Dept Cell & Dev Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036407, R01DK040339] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK40339, DK36407] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; BACH I, 1995, P NATL ACAD SCI USA, V92, P2720, DOI 10.1073/pnas.92.7.2720; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Breen JJ, 1998, J BIOL CHEM, V273, P4712, DOI 10.1074/jbc.273.8.4712; Dawid IB, 1998, TRENDS GENET, V14, P480, DOI 10.1016/S0168-9525(98)01615-1; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; FEUERSTEIN R, 1994, P NATL ACAD SCI USA, V91, P10655, DOI 10.1073/pnas.91.22.10655; Girardin SE, 1998, FEBS LETT, V431, P333, DOI 10.1016/S0014-5793(98)00787-X; Glenn DJ, 1999, J BIOL CHEM, V274, P36159, DOI 10.1074/jbc.274.51.36159; Howard PW, 2000, J BIOL CHEM, V275, P13336, DOI 10.1074/jbc.275.18.13336; IVERSON RA, 1990, MOL ENDOCRINOL, V4, P1564, DOI 10.1210/mend-4-10-1564; Jurata LW, 1998, CURR TOP MICROBIOL, V228, P75; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Meier BC, 1999, MOL CELL ENDOCRINOL, V147, P65, DOI 10.1016/S0303-7207(98)00213-5; Milan M, 1999, MOL CELL, V4, P267, DOI 10.1016/S1097-2765(00)80374-3; MORCILLO P, 1997, GENE DEV, V11, P2720; Netchine I, 2000, NAT GENET, V25, P182, DOI 10.1038/76041; PerezAlvarado GC, 1996, J MOL BIOL, V257, P153, DOI 10.1006/jmbi.1996.0153; ROBERSON MS, 1994, MOL CELL BIOL, V14, P2985, DOI 10.1128/MCB.14.5.2985; SANCHEZGARCIA I, 1994, TRENDS GENET, V10, P315, DOI 10.1016/0168-9525(94)90034-5; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; SCHODERBEK WE, 1993, J BIOL CHEM, V268, P3903; SEIDAH NG, 1994, DNA CELL BIOL, V13, P1163, DOI 10.1089/dna.1994.13.1163; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sheng HZ, 1997, SCIENCE, V278, P1809, DOI 10.1126/science.278.5344.1809; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; Sloop KW, 1999, MOL ENDOCRINOL, V13, P2212, DOI 10.1210/me.13.12.2212; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SUN PQ, 1995, J BIOL CHEM, V270, P7041, DOI 10.1074/jbc.270.13.7041; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; van Meyel DJ, 1999, MOL CELL, V4, P259, DOI 10.1016/S1097-2765(00)80373-1; WINDLE JJ, 1990, MOL ENDOCRINOL, V4, P597, DOI 10.1210/mend-4-4-597	34	32	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19020	19026		10.1074/jbc.M101782200	http://dx.doi.org/10.1074/jbc.M101782200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279219	hybrid			2022-12-27	WOS:000169091000051
J	Koc, EC; Burkhart, W; Blackburn, K; Moseley, A; Spremulli, LL				Koc, EC; Burkhart, W; Blackburn, K; Moseley, A; Spremulli, LL			The small subunit of the mammalian mitochondrial ribosome - Identification of the full complement of ribosomal proteins present	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORRESPONDING GENE-SEQUENCES; INDUCED CELL-DEATH; NUCLEAR GENES; MASS-SPECTROMETRY; YEAST; CHLOROPLAST; MRPS; DAP3; S12; RNA	Identification of all the protein components of the small subunit (28 S) of the mammalian mitochondrial ribosome has been achieved by carrying out proteolytic digestions of whole 28 S subunits followed by analysis of the resultant peptides by liquid chromatography and tandem mass spectrometry (LC/MS/MS). Peptide sequence information was used to search the human EST data bases and complete coding sequences of the proteins were assembled. The human mitochondrial ribosome has 29 distinct proteins in the small subunit, Fourteen of this group of proteins are homologs of the Escherichia coli 30 S ribosomal proteins S2, S5, S6, S7, S9, S10, S11, S12, S14, S15, S16, S17, S18, and S21, All of these proteins have homologs in Drosophila melanogaster, Caenorhabditis elegans, and Saccharomyces cerevisiae mitochondrial ribosomes, Surprisingly, three variants of ribosomal protein S18 are found in the mammalian and D. melanogaster mitochondrial ribosomes while C. elegans has two S18 homologs. The S18 homologs tend to be more closely related to chloroplast S18s than to prokaryotic S18s. No mitochondrial homologs to prokaryotic ribosomal proteins S1, S3, S4, S8, S13, S19, and S20 could be found in the peptides obtained from the whole 28 S subunit digests or by analysis of the available data bases. The remaining 15 proteins present in mammalian mitochondrial 28 S subunits (MRP-S22 through MRP-S36) are specific to mitochondrial ribosomes, Proteins in this group have no apparent homologs in bacterial, chloroplast, archaebacterial, or cytosolic ribosomes, All but two of these proteins have a clear homolog in D. melanogaster while all but three can be found in the genome of C. elegans. Five of the mitochondrial. specific ribosomal proteins have homologs in S. cerevisiae.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; GlaxoSmithKline Res & Dev, Dept Struct Chem, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; GlaxoSmithKline	Spremulli, LL (corresponding author), Univ N Carolina, Dept Chem, Campus Box 3290, Chapel Hill, NC 27599 USA.				NIGMS NIH HHS [GM32734] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032734] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allard P, 2000, STRUCT FOLD DES, V8, P875, DOI 10.1016/S0969-2126(00)00177-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arden SD, 1996, J CLIN INVEST, V97, P551, DOI 10.1172/JCI118448; BEHAL RH, 1994, J BIOL CHEM, V269, P31372; BURKHART W, 1992, TECHNIQUES PROTEIN C, V4, P399; CAHILL A, 1995, ANAL BIOCHEM, V232, P47, DOI 10.1006/abio.1995.9962; CLAROS MG, 1996, EUR J BIOCHEM, V241, P770, DOI DOI 10.1111/J.1432-1033.1996.00779.X; DEVRIES H, 1973, BIOCHEM BIOPH RES CO, V54, P308, DOI 10.1016/0006-291X(73)90924-8; FEARON K, 1992, J BIOL CHEM, V267, P5162; *GEN COMP GROUP, 1999, WISC PACK VERS 10; Goldschmidt-Reisin S, 1998, J BIOL CHEM, V273, P34828, DOI 10.1074/jbc.273.52.34828; Graack HR, 1998, BIOCHEM J, V329, P433, DOI 10.1042/bj3290433; Graack HR, 1999, BIOCHEMISTRY-US, V38, P16569, DOI 10.1021/bi991543s; Jiang XY, 1996, J MASS SPECTROM, V31, P1309, DOI 10.1002/(SICI)1096-9888(199611)31:11<1309::AID-JMS423>3.0.CO;2-R; KANG C, 1979, J BIOL CHEM, V254, P6667; KISSIL JL, 1995, J BIOL CHEM, V270, P27932, DOI 10.1074/jbc.270.46.27932; Kissil JL, 1999, EMBO J, V18, P353, DOI 10.1093/emboj/18.2.353; Koc EC, 2000, J BIOL CHEM, V275, P32585, DOI 10.1074/jbc.M003596200; Koc EC, 1999, BIOCHEM BIOPH RES CO, V266, P141, DOI 10.1006/bbrc.1999.1785; Koc EC, 2001, FEBS LETT, V492, P166, DOI 10.1016/S0014-5793(01)02250-5; Koc EC, 2001, PROTEIN SCI, V10, P471, DOI 10.1110/ps.35301; Koehler CM, 2000, FEBS LETT, V476, P27, DOI 10.1016/S0014-5793(00)01664-1; Lithgow T, 2000, FEBS LETT, V476, P22, DOI 10.1016/S0014-5793(00)01663-X; Mariottini P, 1999, J BIOL CHEM, V274, P31853, DOI 10.1074/jbc.274.45.31853; MATSUSHITA Y, 1989, MOL GEN GENET, V219, P119, DOI 10.1007/BF00261166; MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; O'Brien TW, 2000, J BIOL CHEM, V275, P18153, DOI 10.1074/jbc.M909762199; OBRIEN TW, 1976, GENETICS BIOGENESIS, P741; OSSWALD M, 1995, NUCLEIC ACIDS RES, V23, P4635, DOI 10.1093/nar/23.22.4635; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PEL HJ, 1994, MOL BIOL REP, V19, P183, DOI 10.1007/BF00986960; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PIETROMONACO SF, 1991, BIOCHIMIE, V73, P827, DOI 10.1016/0300-9084(91)90062-6; RAMAKRISHNAN V, 1986, J BIOL CHEM, V261, P5049; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Shah ZH, 1997, GENE, V204, P55, DOI 10.1016/S0378-1119(97)00521-0; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tong W, 1999, ANAL CHEM, V71, P2270, DOI 10.1021/ac9901182; VANACKEN U, 1975, MOL GEN GENET, V140, P61, DOI 10.1007/BF00268989; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yamaguchi K, 2000, J BIOL CHEM, V275, P28455, DOI 10.1074/jbc.M004350200; Yamaguchi K, 2000, J BIOL CHEM, V275, P28466, DOI 10.1074/jbc.M005012200; ZWEIB C, 1981, NUCLEIC ACIDS RES, V9, P3621	44	181	229	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19363	19374		10.1074/jbc.M100727200	http://dx.doi.org/10.1074/jbc.M100727200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279123	Green Submitted			2022-12-27	WOS:000169091000097
J	Chang, NCA; Hung, SI; Hwa, KY; Kato, I; Chen, JE; Liu, CH; Chang, AC				Chang, NCA; Hung, SI; Hwa, KY; Kato, I; Chen, JE; Liu, CH; Chang, AC			A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; SURFACE-PLASMON RESONANCE; SMOOTH-MUSCLE CELLS; TRICHINELLA-SPIRALIS; ACTIVATED MACROPHAGES; HUMAN CHITOTRIOSIDASE; ADHESION MOLECULES; CHITINASE ACTIVITY; IDENTIFICATION; DIFFERENTIATION	Oral infections of mice with Trichinella spiralis induce activation of peritoneal exudate cells to transiently express and secrete a crystallizable protein Ym1, Purification of Ym1 to homogeneity was achieved. It is a single chain polypeptide (45 kDa) with a strong tendency to crystallize at its isoelectric point (PI 5.7). Coexpression of Ym1 with Mac-1 and scavenger receptor pinpoints macrophages as its main producer. Protein microsequencing data provide information required for full-length cDNA cloning from libraries constructed from activated peritoneal exudate cells. A single open reading frame of 398 amino acids with a leader peptide (21 residues) typical of secretory protein was deduced and later deposited in GenBank (TM) (accession number M94584) in 1992, By means of surface plasmon resonance analyses, Ym1 has been shown to exhibit binding specificity to saccharides with a free amine group, such as GlcN, GalN, or GlcN polymers, but it failed to bind to other saccharides, The interaction is pH-dependent but Ca2+ and Mg2+ ion-independent. The binding avidity of Ym1 to GlcN oligosaccharides was enhanced by more than 1000-fold due to the clustering effect. Specific binding of Ym1 to heparin suggests that heparin/heparan sulfate may be its physiological ligand in vivo during inflammation and/or tissue remodeling. Although it shares similar to 30% homology with microbial chitinases, no chitinase activity was found associated with Ym1. Genomic Southern blot analyses suggest that Ym1 may represent a member of a novel lectin gene family.	Natl Yang Ming Univ, Sch Life Sci, Inst Microbiol & Immunol, Taipei 112, Taiwan; Natl Yang Ming Univ, Sch Life Sci, Inst Neurosci, Taipei 112, Taiwan; Natl Yang Ming Univ, Sch Life Sci, Ctr Neurosci, Taipei 112, Taiwan; Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; Takara Shuzo Co Ltd, Biomed Grp, Otsu, Shiga 52021, Japan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Takara Holdings Inc.	Chang, NCA (corresponding author), Natl Yang Ming Univ, Sch Life Sci, Inst Microbiol & Immunol, Taipei 112, Taiwan.		Hung, Shuen-Iu/ABB-2139-2021; Hung, Shuen-Iu/HHS-9012-2022	Hung, Shuen-Iu/0000-0001-6531-5538; Hwa, Kuo-Yuan/0000-0003-1968-7909				ADAMS DO, 1987, IMMUNOL REV, V97, P5, DOI 10.1111/j.1600-065X.1987.tb00514.x; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Bell RG, 1998, ADV PARASIT, V41, P149, DOI 10.1016/S0065-308X(08)60424-8; BERGER SL, 1987, METHOD ENZYMOL, V152, P215; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; BOGDAN C, 1993, ANN NY ACAD SCI, V685, P713, DOI 10.1111/j.1749-6632.1993.tb35934.x; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 1998, J BIOL CHEM, V273, P25680, DOI 10.1074/jbc.273.40.25680; CHANG NC, 1982, FED PROC, V41, P561; CHANG NC, 1989, TRICHINELLOSIS, P604; Clasper S, 1999, J BIOL CHEM, V274, P24113, DOI 10.1074/jbc.274.34.24113; Crocker PR, 1996, CURR OPIN STRUC BIOL, V6, P679, DOI 10.1016/S0959-440X(96)80036-4; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DESPOMMIER DD, 1993, J PARASITOL, V79, P472, DOI 10.2307/3283370; FAGERSTAM LG, 1992, J CHROMATOGR, V597, P397, DOI 10.1016/0021-9673(92)80137-J; GODING JW, 1983, MONOCLONAL ANTIBODIE, P134; GORDON S, 1995, CURR OPIN IMMUNOL, V7, P24, DOI 10.1016/0952-7915(95)80025-5; Gordon S, 1999, IMMUNOL LETT, V65, P5, DOI 10.1016/S0165-2478(98)00116-3; Gordon S, 1998, RES IMMUNOL, V149, P685, DOI 10.1016/S0923-2494(99)80039-X; Gregory CD, 1998, BIOCHEM SOC T, V26, P644, DOI 10.1042/bst0260644; Guo L, 2000, J BIOL CHEM, V275, P8032, DOI 10.1074/jbc.275.11.8032; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; II M, 1990, J BIOL CHEM, V265, P11295; Jin HM, 1998, GENOMICS, V54, P316, DOI 10.1006/geno.1998.5593; JOHNSTONE A, 1987, IMMUNOCYTOCHEMISTRY, P261; Kaltner H, 1998, ACTA ANAT, V161, P162; KARLSSON R, 1995, ANAL BIOCHEM, V228, P274, DOI 10.1006/abio.1995.1350; KARLSSON R, 1994, ANAL BIOCHEM, V221, P142, DOI 10.1006/abio.1994.1390; Kirkpatrick RB, 1997, EXP CELL RES, V237, P46, DOI 10.1006/excr.1997.3764; KIRKPATRICK RB, 1995, GENE, V153, P147, DOI 10.1016/0378-1119(94)00756-I; Koenig A, 1998, J CLIN INVEST, V101, P877, DOI 10.1172/JCI1509; KONDO A, 1990, AGR BIOL CHEM TOKYO, V54, P2169, DOI 10.1080/00021369.1990.10870232; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Krause SW, 1996, J LEUKOCYTE BIOL, V60, P540, DOI 10.1002/jlb.60.4.540; KUDO S, 1992, EXPERIENTIA, V48, P277, DOI 10.1007/BF01930475; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655; Lawson ND, 1998, P NATL ACAD SCI USA, V95, P10129, DOI 10.1073/pnas.95.17.10129; LEE YC, 1992, FASEB J, V6, P3193, DOI 10.1096/fasebj.6.13.1397841; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MartinezPomares L, 1996, IMMUNOBIOLOGY, V195, P407, DOI 10.1016/S0171-2985(96)80012-X; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MILLIS AJT, 1985, J BIOL CHEM, V260, P3754; MOOS M, 1988, J BIOL CHEM, V263, P6005; MORRIS L, 1991, DEVELOPMENT, V112, P517; Morrissette Naomi, 1999, Trends in Cell Biology, V9, P199, DOI 10.1016/S0962-8924(99)01540-8; Mosser DM, 1999, CURR OPIN IMMUNOL, V11, P406, DOI 10.1016/S0952-7915(99)80068-5; Naito M, 1996, J LEUKOCYTE BIOL, V59, P133, DOI 10.1002/jlb.59.2.133; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; NORGARDSUMNICHT K, 1995, J BIOL CHEM, V270, P12012, DOI 10.1074/jbc.270.20.12012; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Owhashi M, 1998, PARASITOL RES, V84, P136, DOI 10.1007/s004360050370; Owhashi M, 2000, J BIOL CHEM, V275, P1279, DOI 10.1074/jbc.275.2.1279; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; RENKEMA GH, 1995, J BIOL CHEM, V270, P2198, DOI 10.1074/jbc.270.5.2198; RICE PA, 1990, PROTEINS, V8, P334, DOI 10.1002/prot.340080407; RUSSELL DG, 1995, CURR OPIN IMMUNOL, V7, P479, DOI 10.1016/0952-7915(95)80092-1; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; SHEPHERD VL, 1984, J BIOL CHEM, V259, P2257; SHINOHARA Y, 1995, J BIOCHEM-TOKYO, V117, P1076; Shinohara Y, 1997, GLYCOBIOLOGY, V7, P1201, DOI 10.1093/glycob/7.8.1201; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; STERNBER.LA, 1970, J HISTOCHEM CYTOCHEM, V18, P315, DOI 10.1177/18.5.315; Sun YJ, 2001, J BIOL CHEM, V276, P17507, DOI 10.1074/jbc.M010416200; TOWBIN H, 1984, J IMMUNOL METHODS, V72, P313, DOI 10.1016/0022-1759(84)90001-2; TRUDEL J, 1989, ANAL BIOCHEM, V178, P362, DOI 10.1016/0003-2697(89)90653-2; Vaday GG, 2000, J LEUKOCYTE BIOL, V67, P149, DOI 10.1002/jlb.67.2.149; WAKELIN D, 1993, J PARASITOL, V79, P488, DOI 10.2307/3283372; WATANABE T, 1993, J BIOL CHEM, V268, P18567; WATANABE T, 1990, J BIOL CHEM, V265, P15659; YEAMAN C, 1993, J CELL BIOL, V122, P941, DOI 10.1083/jcb.122.4.941; Zeisberger E, 1998, ANN NY ACAD SCI, V856, P116, DOI 10.1111/j.1749-6632.1998.tb08320.x	79	202	214	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17497	17506		10.1074/jbc.M010417200	http://dx.doi.org/10.1074/jbc.M010417200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11297523	hybrid			2022-12-27	WOS:000168730400121
J	Tumaney, AW; Shekar, S; Rajasekharan, R				Tumaney, AW; Shekar, S; Rajasekharan, R			Identification, purification, and characterization of monoacylglycerol acyltransferase from developing peanut cotyledons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LYSOPHOSPHATIDIC ACID; DIHYDROXYACETONE PHOSPHATE; TRIACYLGLYCEROL SYNTHESIS; GLYCEROLIPID SYNTHESIS; MIXED MICELLES; FATTY-ACIDS; BIOSYNTHESIS; KINASE; METABOLISM	Biosynthesis of diacylglycerols in plants occurs mainly through the acylation of lysophosphatidic acid in the microsomal membranes. Here we describe the first identification of diacylglycerol biosynthetic activity in the soluble fraction of developing oilseeds. This activity was NaF-insensitive and acyl-CoA-dependent Diacylglycerol formation was catalyzed by monoacylglycerol (MAG) acyltransferase (EC 2.3.1.22) that transferred an acyl moiety from acyl-CoA to MAG. The enzyme was purified by successive chromatographic separations on octyl-Sepharose, blue-Sepharose, Superdex-75, and palmitoyl-CoA-agarose to apparent homogeneity from developing peanut (Arachis hypogaea) cotyledons, The enzyme was purified to 6,608-fold with the final. specific activity of 15.86 nmol min(-1) mg(-1). The purified enzyme was electrophoretically homogeneous, and its molecular mass was 43,000 daltons, The purified MAG acyltransferase was specific for MAG and did not utilize any other acyl acceptor such as glycerol, glycerol-3-phosphate, lysophosphatidic acid, and lysophosphatidylcholine. The K-m values for 1-palmitoylglycerol and 1-oleoylglycerol were 16.39 and 5.65 phn, respectively. The K-m values for 2-monoacylglycerols were 2- to 4-fold higher than that of the corresponding 1-monoacylglycerol, The apparent K-m values for palmitoyl-, stearoyl-, and oleoyl-CoAs were 17.54, 25.66, and 9.35 muM, respectively. Fatty acids, phospholipids, and sphingosine at low concentrations stimulated the enzyme activity. The identification of MAG acyltransferase in oilseeds suggests the presence of a regulatory link between signal transduction and synthesis of complex lipids in plants.	Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rajasekharan, R (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	lipid@biochem.iisc.ernet.in	Rajasekharan, Ram/R-2257-2019; R, Rajasekharan/D-3420-2009	Rajasekharan, Ram/0000-0002-2124-6013; Tumaney, Ajay W./0000-0003-3708-0123				Athenstaedt K, 1999, J BACTERIOL, V181, P1458, DOI 10.1128/JB.181.5.1458-1463.1999; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; BHAT BG, 1995, BIOCHEMISTRY-US, V34, P11237, DOI 10.1021/bi00035a033; BHAT BG, 1994, J BIOL CHEM, V269, P13172; Bischoff KM, 1998, ANAL BIOCHEM, V260, P1, DOI 10.1006/abio.1998.2680; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRISKIN DP, 1987, METHOD ENZYMOL, V148, P542; BROWSE J, 1991, ANNU REV PLANT PHYS, V42, P467, DOI 10.1146/annurev.pp.42.060191.002343; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; COLEMAN RA, 1984, J BIOL CHEM, V259, P8934; COLEMAN RA, 1986, J BIOL CHEM, V261, P224; DELAROCHE IA, 1973, PLANT PHYSIOL, V51, P468, DOI 10.1104/pp.51.3.468; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; FLETCHER MJ, 1968, CLIN CHIM ACTA, V22, P393, DOI 10.1016/0009-8981(68)90041-7; FRITZ PJ, 1986, J BIOL CHEM, V261, P194; GALLAGHER SR, 1982, PLANT PHYSIOL, V70, P1335, DOI 10.1104/pp.70.5.1335; GROSS RW, 1983, BIOCHEMISTRY-US, V22, P5641, DOI 10.1021/bi00293a028; Hiroyama M, 1998, BIOCHEM J, V336, P483, DOI 10.1042/bj3360483; Hiroyama R, 1999, J BIOL CHEM, V274, P29172, DOI 10.1074/jbc.274.41.29172; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; ICHIHARA K, 1990, BIOCHIM BIOPHYS ACTA, V1043, P227, DOI 10.1016/0005-2760(90)90021-O; ICHIHARA K, 1989, PLANT PHYSIOL, V90, P413, DOI 10.1104/pp.90.2.413; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; JALINK K, 1993, P NATL ACAD SCI USA, V90, P1857, DOI 10.1073/pnas.90.5.1857; JAMDAR SC, 1992, ARCH BIOCHEM BIOPHYS, V296, P419, DOI 10.1016/0003-9861(92)90592-K; KANOH H, 1983, J BIOL CHEM, V258, P1767; KENNEDY EP, 1961, FED PROC, V20, P934; Kent C, 1999, TRENDS BIOCHEM SCI, V24, P146, DOI 10.1016/S0968-0004(99)01365-1; KNUDSEN J, 1975, BIOCHEM BIOPH RES CO, V65, P921, DOI 10.1016/S0006-291X(75)80473-6; LAPETINA EG, 1971, BIOCHEM J, V122, P171, DOI 10.1042/bj1220171; Lehner R, 1996, PROG LIPID RES, V35, P169, DOI 10.1016/0163-7827(96)00005-7; MATTSON FH, 1961, J LIPID RES, V2, P58; MURPHY DJ, 1988, LIPIDS, V23, P157, DOI 10.1007/BF02535452; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; PELECH SL, 1989, TRENDS BIOCHEM SCI, V14, P28, DOI 10.1016/0968-0004(89)90086-8; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SPARACE SA, 1979, PLANT PHYSIOL, V63, P963, DOI 10.1104/pp.63.5.963; Stimmel BF, 1934, J AM CHEM SOC, V56, P1724, DOI 10.1021/ja01323a022; SUNDLER R, 1975, J BIOL CHEM, V250, P8585; Tsujita T, 1996, J BIOL CHEM, V271, P2156, DOI 10.1074/jbc.271.4.2156; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; WEBBER KO, 1992, METHOD ENZYMOL, V209, P92; XIA T, 1993, AM J PHYSIOL, V265, pR414, DOI 10.1152/ajpregu.1993.265.2.R414; XIE MS, 1994, ARCH BIOCHEM BIOPHYS, V312, P254, DOI 10.1006/abbi.1994.1307; [No title captured]	45	36	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10847	10852		10.1074/jbc.M100005200	http://dx.doi.org/10.1074/jbc.M100005200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11283027	hybrid			2022-12-27	WOS:000167980900040
J	Stephanou, A; Scarabelli, TM; Brar, BK; Nakanishi, Y; Matsumura, M; Knight, RA; Latchman, DS				Stephanou, A; Scarabelli, TM; Brar, BK; Nakanishi, Y; Matsumura, M; Knight, RA; Latchman, DS			Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CELL-DEATH; SIGNAL-TRANSDUCTION; REPERFUSION INJURY; PHOSPHORYLATION; INVOLVEMENT; INHIBITION; ISCHEMIA; PATHWAY; STRESS	Previously we reported that ischemia results in apoptosis and is accompanied by phosphorylation on Tyr-701 and increased expression and transcriptional activity of the signal transducer and activator of transcription-1 (STAT-1). In the present study, we show that exposure of cardiomyocytes to ischemia induced the phosphorylation of STAT-1 at another site, Ser-727. Moreover, STAT-1 is critical for the induction of Fas receptor and Fas ligand expression by ischemia/reperfusion (I/R). Transcriptional activation of Fas and FasL was dependent on Ser-727 of STAT-1 but was independent of Tyr-701. Similarly, Ser-727 but not Tyr-701 was required for enhancement of cardiomyocyte cell death by STAT-1 during I/R. In addition, inhibition of the p38 pathway prevented the induction and transcriptional activation of Fas and FasL in cardiac cells exposed to I/R, whereas inhibition of p42/p44 MAPK had no effect. Finally, I/R also induced phosphorylation of STAT-1 on Ser-727 and expression of Fas/FasL in ventricular myocytes in the intact heart ex vivo. These results indicate that Fas/FasL genes and apoptosis are activated by STAT-1 in cardiac myocytes exposed to I/R and these effects are dependent on the Ser-727 but not the Tyr-701 phosphorylation sites of STAT-1.	UCL, Inst Child Hlth, Med Mol Biol Unit, London WC1N 1EH, England; Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9200934, Japan; Royal Brompton Hosp, Natl Heart & Lung Inst, London WC1N 1EH, England	University of London; University College London; Kanazawa University; Imperial College London; Royal Brompton Hospital	Stephanou, A (corresponding author), UCL, Inst Child Hlth, Med Mol Biol Unit, 30 Guilford St, London WC1N 1EH, England.	A.Stephanou@ich.ucl.ac.uk	Nakanishi, Yoshinobu/D-4602-2014	Nakanishi, Yoshinobu/0000-0002-8767-3587				Bauer JH, 1998, J BIOL CHEM, V273, P9255, DOI 10.1074/jbc.273.15.9255; BRAR B, 2001, IN PRESS CARDIOVASCU; Brar BK, 2000, J BIOL CHEM, V275, P8508, DOI 10.1074/jbc.275.12.8508; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Cheng W, 1996, EXP CELL RES, V226, P316, DOI 10.1006/excr.1996.0232; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Fliss H, 1996, CIRC RES, V79, P949, DOI 10.1161/01.RES.79.5.949; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; He HP, 1999, CELL DEATH DIFFER, V6, P987, DOI 10.1038/sj.cdd.4400572; Horvath CM, 1997, CURR OPIN CELL BIOL, V9, P233, DOI 10.1016/S0955-0674(97)80067-1; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; ITOH G, 1995, AM J PATHOL, V146, P1325; Jeremias I, 2000, CIRCULATION, V102, P915; Kaneko S, 1997, CLIN EXP IMMUNOL, V109, P185, DOI 10.1046/j.1365-2249.1997.4191324.x; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; Kovarik P, 2001, EMBO J, V20, P91, DOI 10.1093/emboj/20.1.91; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; Mackay K, 1999, J BIOL CHEM, V274, P6272, DOI 10.1074/jbc.274.10.6272; MARBER MS, 1993, CIRCULATION, V88, P1264, DOI 10.1161/01.CIR.88.3.1264; Minami M, 1996, P NATL ACAD SCI USA, V93, P3963, DOI 10.1073/pnas.93.9.3963; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nakano A, 2000, CIRC RES, V86, P144, DOI 10.1161/01.RES.86.2.144; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Scarabelli TM, 1999, J IMMUNOL METHODS, V228, P23, DOI 10.1016/S0022-1759(99)00090-3; Stephanou A, 1998, J MOL CELL CARDIOL, V30, P849, DOI 10.1006/jmcc.1998.0651; Stephanou A, 2000, CELL DEATH DIFFER, V7, P329, DOI 10.1038/sj.cdd.4400656; Stephanou A, 2000, J BIOL CHEM, V275, P10002, DOI 10.1074/jbc.275.14.10002; Stoiber D, 1999, J IMMUNOL, V163, P2640; Sugden PH, 1998, CIRC RES, V83, P345, DOI 10.1161/01.RES.83.4.345; TANAKA M, 1994, CIRC RES, V75, P426, DOI 10.1161/01.RES.75.3.426; UMANSKY SR, 1995, CELL DEATH DIFFER, V2, P235; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; WADA N, 1995, J BIOL CHEM, V270, P18007, DOI 10.1074/jbc.270.30.18007; Walter MJ, 1997, J BIOL CHEM, V272, P28582, DOI 10.1074/jbc.272.45.28582; Xu XL, 1998, CANCER RES, V58, P2832; Zhang J, 2000, J EXP MED, V191, P1017, DOI 10.1084/jem.191.6.1017; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321	40	147	164	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2001	276	30					28340	28347		10.1074/jbc.M101177200	http://dx.doi.org/10.1074/jbc.M101177200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	456QH	11309387	hybrid			2022-12-27	WOS:000170093400080
J	Garner, B; Merry, AH; Royle, L; Harvey, DJ; Rudd, PM; Thillet, J				Garner, B; Merry, AH; Royle, L; Harvey, DJ; Rudd, PM; Thillet, J			Structural elucidation of the N- and O-glycans of human apolipoprotein(a) - Role of O-glycans in conferring protease resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; NEPHRITIS AUTOANTIGEN GP330; HEYMANN NEPHRITIS; ATHEROSCLEROTIC LESIONS; ENDOCYTIC RECEPTOR; HUMAN-PLASMA; IN-VITRO; PLASMINOGEN; FRAGMENTS; ELASTASE	Apolipoprotein(a) (apo(a)) is a multikringle domain glycoprotein that exists covalently linked to apolipoprotein B100 of low density lipoprotein, to form the lipoprotein(a) (Lp(a)) particle, or as proteolytic fragments. Elevated plasma concentrations of apo(a) and its fragments may promote atherosclerosis, but the underlying mechanisms are incompletely understood. The factors influencing apo(a) proteolysis are also uncertain. Here we have used exoglycosidase digestion and mass spectrometry to sequence the Asn (N)-linked and Ser/Thr (O)-linked oligosaccharides of human apo(a). We also assessed the potential role of apo(a) O-glycans in protecting thermolysin sensitive regions of the polypeptide. Apo(a) contained two major N-glycans that accounted for 17% of the total oligosaccharide structures. The N-glycans were complex biantennary structures present in either a mono- or disialylated state. The O glycans were mostly (80%) represented by the mono sialylated core type 1 structure, NeuNAc2 alpha -3Gal beta1-3GalNAc, with smaller amounts of disialylated and non-sialylated O-glycans also detected. Removal of apo(a) O-glycans by sialidase and O-glycosidase treatment dramatically increased the sensitivity of the polypeptide to thermolysin digestion. These studies provide the first direct sequencing data for apo(a) glycans and indicate a novel function for apo(a) O-glycans that is potentially related to the atherogenicity of Lp(a).	Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England; Hop Pitie, INSERM Unite 551, F-75651 Paris, France	University of Oxford; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Garner, B (corresponding author), Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, S Parks Rd, Oxford OX1 3QU, England.		Harvey, David/A-5579-2013	Harvey, David/0000-0003-0544-771X				ASHFORD D, 1987, EUR J BIOCHEM, V166, P311, DOI 10.1111/j.1432-1033.1987.tb13516.x; Bartlett AL, 2000, ATHEROSCLEROSIS, V153, P219, DOI 10.1016/S0021-9150(00)00402-0; Bartlett AL, 1998, ATHEROSCLEROSIS, V138, P237, DOI 10.1016/S0021-9150(97)00288-8; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Bolton EJ, 1997, BBA-MOL CELL RES, V1356, P12, DOI 10.1016/S0167-4889(96)00157-7; BRUNNER C, 1993, P NATL ACAD SCI USA, V90, P11643, DOI 10.1073/pnas.90.24.11643; CHAMOW SM, 1988, CARBOHYD RES, V176, P195, DOI 10.1016/0008-6215(88)80130-7; DOUCET C, 1994, J LIPID RES, V35, P263; Doucet C, 2000, J AM SOC NEPHROL, V11, P507, DOI 10.1681/ASN.V113507; Edelstein C, 1996, J LIPID RES, V37, P1786; Edelstein C, 1997, J BIOL CHEM, V272, P11079; Edelstein C, 1999, J BIOL CHEM, V274, P10019, DOI 10.1074/jbc.274.15.10019; ETINGIN OR, 1991, J BIOL CHEM, V266, P2459; FLESS GM, 1986, J BIOL CHEM, V261, P8712; GALIS ZS, 1995, ANN NY ACAD SCI, V748, P501; GERRITY RG, 1981, AM J PATHOL, V103, P181; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; GUO HC, 1989, J LIPID RES, V30, P23; HAJJAR KA, 1989, NATURE, V339, P303, DOI 10.1038/339303a0; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; HARPEL PC, 1989, P NATL ACAD SCI USA, V86, P3847, DOI 10.1073/pnas.86.10.3847; HARVEY DJ, 1993, RAPID COMMUN MASS SP, V7, P614, DOI 10.1002/rcm.1290070712; HOFF HF, 1994, CHEM PHYS LIPIDS, V67-8, P271, DOI 10.1016/0009-3084(94)90147-3; HUBY T, 1995, BIOCHEMISTRY-US, V34, P7385, DOI 10.1021/bi00022a011; HUBY T, 1994, BIOCHEMISTRY-US, V33, P3335, DOI 10.1021/bi00177a026; KANALAS JJ, 1991, J BIOL CHEM, V266, P10825; KANALAS JJ, 1988, J IMMUNOL, V141, P4152; KANALAS JJ, 1990, J AM SOC NEPHROL, V1, P792; KANAMORI A, 1990, J BIOL CHEM, V265, P21811; KEESLER GA, 1994, ARTERIOSCLER THROMB, V14, P1337, DOI 10.1161/01.ATV.14.8.1337; Klezovitch O, 1998, J BIOL CHEM, V273, P23856, DOI 10.1074/jbc.273.37.23856; Kostner K, 2001, CLIN CHIM ACTA, V304, P29, DOI 10.1016/S0009-8981(00)00394-6; KOUNNAS MZ, 1995, J BIOL CHEM, V270, P13070, DOI 10.1074/jbc.270.22.13070; Kramerov AA, 1996, FEBS LETT, V378, P213, DOI 10.1016/0014-5793(95)01444-6; KRATZIN H, 1987, BIOL CHEM H-S, V368, P1533, DOI 10.1515/bchm3.1987.368.2.1533; Kronenberg F, 1996, CRIT REV CL LAB SCI, V33, P495, DOI 10.3109/10408369609080056; Mattu TS, 2000, BIOCHEMISTRY-US, V39, P15695, DOI 10.1021/bi001367j; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; MERRY AH, 1992, BIOCHEM SOC T, V20, P91; MILES LA, 1989, NATURE, V339, P301, DOI 10.1038/339301a0; Moestrup SK, 1998, J CLIN INVEST, V102, P902, DOI 10.1172/JCI3772; Mooser V, 1996, J CLIN INVEST, V98, P2414, DOI 10.1172/JCI119055; Mooser V, 1996, J CLIN INVEST, V97, P858, DOI 10.1172/JCI118487; Niemeier A, 1999, ARTERIOSCL THROM VAS, V19, P552, DOI 10.1161/01.ATV.19.3.552; OIDA K, 1992, CLIN CHEM, V38, P2244; PHILLIPS ML, 1993, BIOCHEMISTRY-US, V32, P3722, DOI 10.1021/bi00065a026; POWERS JC, 1977, BIOCHIM BIOPHYS ACTA, V485, P156, DOI 10.1016/0005-2744(77)90203-0; Rudd PM, 1997, NATURE, V388, P205, DOI 10.1038/40677; Scanu AM, 1997, J LIPID RES, V38, P2193; SEMAN LJ, 1986, BIOCHEM CELL BIOL, V64, P999, DOI 10.1139/o86-133; Sobenin IA, 1998, J LIPID RES, V39, P2293; STEFANSSON S, 1995, J BIOL CHEM, V270, P19417, DOI 10.1074/jbc.270.33.19417; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Wang J, 1999, BIOCHEM SOC T, V27, P453, DOI 10.1042/bst0270453; WARREN L, 1959, J BIOL CHEM, V234, P1971; White AL, 1999, J LIPID RES, V40, P275; WILLNOW TE, 1992, J BIOL CHEM, V267, P26172	57	70	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22200	22208		10.1074/jbc.M102150200	http://dx.doi.org/10.1074/jbc.M102150200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294842	hybrid			2022-12-27	WOS:000169412700032
J	Keifer, JA; Guttridge, DC; Ashburner, BP; Baldwin, AS				Keifer, JA; Guttridge, DC; Ashburner, BP; Baldwin, AS			Inhibition of NF-kappa B activity by thalidomide through suppression of I kappa B kinase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; COLLAGEN-INDUCED ARTHRITIS; ERYTHEMA-NODOSUM LEPROSUM; TRANSCRIPTION FACTOR; TNF-ALPHA; ACTIVATION; ANGIOGENESIS; CELL; VITRO; PROTEINS	The sedative and anti-nausea drug thalidomide, which causes birth defects in humans, has been shown to have both anti-inflammatory and anti-oncogenic properties. The anti-inflammatory effect of thalidomide is associated with suppression of cytokine expression and the anti-oncogenic effect with inhibition of angio genesis. It is presently unclear whether the teratogenic properties of thalidomide are connected in any way to the beneficial, anti-disease characteristics of this drug. The transcription factor NF-kappaB has been shown to be a key regulator of inflammatory genes such as tumor ne crosis factor-alpha and interleukin-8. Inhibition of NF-kappaB is associated with reduced inflammation in animal models, such as those for rheumatoid arthritis. We show here that thalidomide can block NF-kappaB activation through a mechanism that involves the inhibition of activity of the I kappaB kinase. Consistent with the observed inhibition of NF-kappaB, thalidomide blocked the cytokine-induced expression of NF-kappaB-regulated genes such as those encoding interleukin-8, TRAF1, and c-IAP2. These data indicate that the therapeutic potential for thalidomide may be based on its ability to block NF-kappaB activation through suppression of I kappaB kinase activity.	Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Baldwin, AS (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.			Guttridge, Denis/0000-0002-7276-6609	NATIONAL CANCER INSTITUTE [R01CA072771, R01CA075080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092] Funding Source: NIH RePORTER; NCI NIH HHS [CA72771, CA75080] Funding Source: Medline; NIGMS NIH HHS [T32 GM07092] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashby J, 1997, MUTAT RES-FUND MOL M, V396, P45, DOI 10.1016/S0027-5107(97)00174-7; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Calabrese L, 2000, AM J MED, V108, P487, DOI 10.1016/S0002-9343(99)00408-8; Calderon P, 1997, INT J DERMATOL, V36, P881, DOI 10.1046/j.1365-4362.1997.00298.x; Cheshire JL, 1997, MOL CELL BIOL, V17, P6746, DOI 10.1128/MCB.17.11.6746; Corral LG, 1999, J IMMUNOL, V163, P380; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Eisen T, 2000, BRIT J CANCER, V82, P812, DOI 10.1054/bjoc.1999.1004; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hales BF, 1999, NAT MED, V5, P489, DOI 10.1038/8371; Hauschild A, 1997, CLIN EXP IMMUNOL, V108, P428, DOI 10.1046/j.1365-2249.1997.3781274.x; Joussen AM, 1999, GRAEF ARCH CLIN EXP, V237, P952, DOI 10.1007/s004170050330; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kenyon BM, 1997, EXP EYE RES, V64, P971, DOI 10.1006/exer.1997.0292; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kroger H, 1996, INFLAMMATION, V20, P203, DOI 10.1007/BF01487406; LENZ W, 1988, TERATOLOGY, V38, P203, DOI 10.1002/tera.1420380303; Marriott JB, 1999, IMMUNOL TODAY, V20, P538, DOI 10.1016/S0167-5699(99)01531-5; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Mayo MW, 2000, BBA-REV CANCER, V1470, pM55, DOI 10.1016/S0304-419X(00)00002-0; MCBRIDE WG, 1977, TERATOLOGY, V16, P79, DOI 10.1002/tera.1420160113; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, CURR OPIN CELL BIOL, V11, P226, DOI 10.1016/S0955-0674(99)80030-1; Minchinton AI, 1996, ANTI-CANCER DRUG, V7, P339, DOI 10.1097/00001813-199605000-00015; Moller DR, 1997, J IMMUNOL, V159, P5157; Moreira AL, 1997, AIDS RES HUM RETROV, V13, P857, DOI 10.1089/aid.1997.13.857; Moreira AL, 1999, J NEURO-ONCOL, V43, P109, DOI 10.1023/A:1006202700039; Oliveira RB, 1999, J LEUKOCYTE BIOL, V65, P364, DOI 10.1002/jlb.65.3.364; Oliver SJ, 1998, J RHEUMATOL, V25, P964; Oliver SJ, 1999, CLIN EXP IMMUNOL, V118, P315; Parman T, 1999, NAT MED, V5, P582, DOI 10.1038/8466; Pazin MJ, 1996, GENE DEV, V10, P37, DOI 10.1101/gad.10.1.37; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Rovelli A, 1998, BONE MARROW TRANSPL, V21, P577, DOI 10.1038/sj.bmt.1701138; SAMPAIO EP, 1991, J EXP MED, V173, P699, DOI 10.1084/jem.173.3.699; SAMPAIO EP, 1993, J INFECT DIS, V168, P408, DOI 10.1093/infdis/168.2.408; Sauer H, 2000, AM J PATHOL, V156, P151, DOI 10.1016/S0002-9440(10)64714-1; SCHULER U, 1995, DRUG SAFETY, V12, P364, DOI 10.2165/00002018-199512060-00002; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SHANNON EJ, 1992, LEPROSY REV, V63, P5; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Stylianou E, 1998, INT J BIOCHEM CELL B, V30, P1075, DOI 10.1016/S1357-2725(98)00081-8; Tavares JL, 1997, RESP MED, V91, P31, DOI 10.1016/S0954-6111(97)90134-7; Verma IM, 1997, P NATL ACAD SCI USA, V94, P11758, DOI 10.1073/pnas.94.22.11758; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015	53	388	415	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22382	22387		10.1074/jbc.M100938200	http://dx.doi.org/10.1074/jbc.M100938200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11297551	Green Published, hybrid			2022-12-27	WOS:000169412700056
J	Ren, XQ; Furukawa, T; Aoki, S; Nakajima, T; Sumizawa, T; Haraguchi, M; Chen, ZS; Kobayashi, M; Akiyama, S				Ren, XQ; Furukawa, T; Aoki, S; Nakajima, T; Sumizawa, T; Haraguchi, M; Chen, ZS; Kobayashi, M; Akiyama, S			Glutathione-dependent binding of a photoaffinity analog of agosterol A to the C-terminal half of human multidrug resistance protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUINOLINE-BASED DRUG; P-GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; LEUKOTRIENE C-4; TUMOR-CELLS; PHARMACOLOGICAL CHARACTERIZATION; MEMBRANE-VESICLES; INSECT CELLS; EXPORT PUMP; MRP	MRP1 is a 190-kDa membrane glycoprotein that confers multidrug resistance (MDR) to tumor cells. MRP1 is characterized by an N-terminal transmembrane domain (TMD0), which is connected to a P-glycoprotein-like core region (Delta MRP) by a cytoplasmic Linker domain zero (L-0). It has been demonstrated that GSH plays an important role in MRP1-mediated MDR. However, the mechanism by which GSH mediates MDR and the precise roles of TMD0 and L-0 are not known. We synthesized [I-125]11-azidophenyl agosterol A ([I-125]azidoAG-A), a photoaffinity analog of the MDR-reversing agent, agosterol A (AGA), to photolabel MRP1, and found that the analog photolabeled the C-proximal molecule of MRP1 (C932-1531) in a manner that was GSH-dependent. The photolabeling was inhibited by anticancer agents, reversing agents and leukotriene C-4. Based on photolabeling studies in the presence and absence of GSH using membrane vesicles expressing various truncated, co-expressed, and mutated MRP1s, we found that L-0 is the site on MRP1 that interacts with GSH. This study demonstrated that GSH is required for the binding of an unconjugated agent to MRP1 and suggested that GSH interacts with L-0 of MRP1. The photoanalog of AG-A will be useful for identifying the drug binding site within MRP1, and the role of GSH in transporting substrates by MRP1.	Kagoshima Univ, Fac Med, Canc Res Inst, Dept Canc Chemotherapy, Kagoshima 8908520, Japan; Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	Kagoshima University; Osaka University	Akiyama, S (corresponding author), Kagoshima Univ, Fac Med, Canc Res Inst, Dept Canc Chemotherapy, Sakuragaoka 8-35-1, Kagoshima 8908520, Japan.			Chen, Zhe-Sheng/0000-0002-8289-097X; Furukawa, Tatsuhiko/0000-0003-1655-4123				AKIYAMA SI, 1989, MOL PHARMACOL, V36, P730; Aoki S, 1998, TETRAHEDRON LETT, V39, P6303, DOI 10.1016/S0040-4039(98)01336-7; Bakos E, 1996, J BIOL CHEM, V271, P12322, DOI 10.1074/jbc.271.21.12322; Bakos E, 1998, J BIOL CHEM, V273, P32167, DOI 10.1074/jbc.273.48.32167; Borst P, 1999, BBA-BIOMEMBRANES, V1461, P347, DOI 10.1016/S0005-2736(99)00167-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUGGEMANN EP, 1992, J BIOL CHEM, V267, P21020; Chen ZS, 1999, MOL PHARMACOL, V55, P921; CHEN ZS, 2001, INT J CANC; CHOWDHRY V, 1979, ANNU REV BIOCHEM, V48, P293, DOI 10.1146/annurev.bi.48.070179.001453; COLE SPC, 1994, CANCER RES, V54, P5902; Cole SPC, 1998, BIOESSAYS, V20, P931, DOI 10.1002/(SICI)1521-1878(199811)20:11<931::AID-BIES8>3.0.CO;2-J; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; CORNWELL MM, 1986, P NATL ACAD SCI USA, V83, P3847, DOI 10.1073/pnas.83.11.3847; CORNWELL MM, 1987, J BIOL CHEM, V262, P2166; Daoud R, 2000, BIOCHEMISTRY-US, V39, P6094, DOI 10.1021/bi9922188; DEBENHAM PG, 1982, MOL CELL BIOL, V2, P881, DOI 10.1128/MCB.2.8.881; Deeley RG, 1997, SEMIN CANCER BIOL, V8, P193, DOI 10.1006/scbi.1997.0070; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; FLENS MJ, 1994, CANCER RES, V54, P4557; FOJO A, 1985, CANCER RES, V45, P3002; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Gao M, 1998, J BIOL CHEM, V273, P10733, DOI 10.1074/jbc.273.17.10733; Gao M, 1996, J BIOL CHEM, V271, P27782, DOI 10.1074/jbc.271.44.27782; GEKELER V, 1995, BIOCHEM BIOPH RES CO, V208, P345, DOI 10.1006/bbrc.1995.1344; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Gottesman MM, 1996, CURR OPIN GENET DEV, V6, P610, DOI 10.1016/S0959-437X(96)80091-8; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hipfner DR, 1997, J BIOL CHEM, V272, P23623, DOI 10.1074/jbc.272.38.23623; Hipfner DR, 1998, BRIT J CANCER, V78, P1134, DOI 10.1038/bjc.1998.642; HIPFNER DR, 1994, CANCER RES, V54, P5788; Hipfner DR, 1999, BBA-BIOMEMBRANES, V1461, P359, DOI 10.1016/S0005-2736(99)00168-6; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; JAKOBY WB, 1980, ENZYMATIC BASIS DETO, V2, P63; Jedlitschky G, 1996, CANCER RES, V56, P988; Latli B, 1997, BIOCONJUGATE CHEM, V8, P7, DOI 10.1021/bc960066c; LEIER I, 1994, EUR J BIOCHEM, V220, P599, DOI 10.1111/j.1432-1033.1994.tb18661.x; LEIER I, 1994, J BIOL CHEM, V269, P27807; Loe DW, 1998, CANCER RES, V58, P5130; Nagayama S, 1998, CANCER LETT, V130, P175, DOI 10.1016/S0304-3835(98)00132-3; Oakley AJ, 1997, J MOL BIOL, V274, P84, DOI 10.1006/jmbi.1997.1364; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; Ren XQ, 2000, BIOCHEM BIOPH RES CO, V270, P608, DOI 10.1006/bbrc.2000.2483; Stride BD, 1999, J BIOL CHEM, V274, P22877, DOI 10.1074/jbc.274.32.22877; Stride BD, 1997, MOL PHARMACOL, V52, P344, DOI 10.1124/mol.52.3.344; Sumizawa T, 1997, MOL PHARMACOL, V51, P399; Taguchi Y, 1997, FEBS LETT, V401, P11, DOI 10.1016/S0014-5793(96)01421-4; VERSANTVOORT CHM, 1995, BRIT J CANCER, V72, P82, DOI 10.1038/bjc.1995.281; Vezmar M, 1998, BIOCHEM PHARMACOL, V56, P733, DOI 10.1016/S0006-2952(98)00217-2; Vezmar M, 1997, BIOCHEM BIOPH RES CO, V241, P104, DOI 10.1006/bbrc.1997.7634; ZAMAN GJR, 1994, P NATL ACAD SCI USA, V91, P8822, DOI 10.1073/pnas.91.19.8822	51	62	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23197	23206		10.1074/jbc.M101554200	http://dx.doi.org/10.1074/jbc.M101554200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301332	hybrid			2022-12-27	WOS:000169412700162
J	Bravo, A; Serrano-Heras, G; Salas, M				Bravo, A; Serrano-Heras, G; Salas, M			A single amino acid substitution within a coiled-coil motif changes the assembly of a 53-amino acid protein from two-dimensional sheets to filamentous structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-CELL-DIVISION; ELECTRON CRYSTALLOGRAPHY; INTERMEDIATE FILAMENTS; PROTOFILAMENT SHEETS; CRYSTAL-STRUCTURE; DNA-REPLICATION; NUCLEAR LAMINS; TUBULIN; FTSZ; DIMER	The bacteriophage phi 29 replication protein pi self-interacts in vitro, generating highly ordered structures. Specifically, the 53-amino acid protein p1 Delta N33, which retains the sequence of p1 spanning amino acids Met(34) to Lys(85), assembles into two-dimensional protofilament sheets. The region of protein p1 located between residues Glu(38) and Asn(65) presumably forms an alpha -helical coiled-coil structure. Here we have examined the role of this coiled-coil sequence in the formation of protofilament sheets. Using sedimentation assays and negative-stain electron microscopy analysis, we demonstrate that residues Leu(46), Met(53), and Leu(60), but not Leu(39), are essential for p1 Delta N33 assembly into sheets. Remarkably, replacement of Leu(46) by Val shifts the pathway of molecular assembly, leading to the formation of filamentous polymers similar to 10 nn in diameter. These results show, for the first time, that a short coiled-coil moth can mediate protein assembly into protofilament sheet structures.	Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, SIC, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Salas, M (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, SIC, E-28049 Madrid, Spain.		Salas, Margarita/J-9873-2014; Bravo, Alicia/Y-5060-2019; Garcia, Pedro/L-2808-2017	Salas, Margarita/0000-0001-5939-3441; Bravo, Alicia/0000-0002-4410-3584; Serrano-Heras, Gemma/0000-0001-9368-4832; Garcia, Pedro/0000-0001-6717-8717	NIGMS NIH HHS [2RO1 GM27242-21] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027242] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; BAKER TS, 1978, J MOL BIOL, V123, P86; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; Bravo A, 1997, J MOL BIOL, V269, P102, DOI 10.1006/jmbi.1997.1032; Bravo A, 1998, EMBO J, V17, P6096, DOI 10.1093/emboj/17.20.6096; Bravo A, 2000, EMBO J, V19, P5575, DOI 10.1093/emboj/19.20.5575; CHOU YH, 1990, CELL, V62, P1063, DOI 10.1016/0092-8674(90)90384-Q; Cohen C, 1998, J STRUCT BIOL, V122, P3, DOI 10.1006/jsbi.1998.3975; CROSS RA, 1991, EMBO J, V10, P747, DOI 10.1002/j.1460-2075.1991.tb08006.x; Downing KH, 2000, ANNU REV CELL DEV BI, V16, P89, DOI 10.1146/annurev.cellbio.16.1.89; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; GASKIN F, 1977, J BIOL CHEM, V252, P6918; GOLDMAN AE, 1986, P NATL ACAD SCI USA, V83, P3839, DOI 10.1073/pnas.83.11.3839; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5; Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3; Kohn WD, 1997, J BIOL CHEM, V272, P2583, DOI 10.1074/jbc.272.5.2583; LOVEJOY B, 1993, SCIENCE, V259, P1288, DOI 10.1126/science.8446897; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Moir RD, 2000, J STRUCT BIOL, V129, P324, DOI 10.1006/jsbi.2000.4251; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; NOGALES E, 1995, J STRUCT BIOL, V115, P199, DOI 10.1006/jsbi.1995.1044; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rothfield LI, 1997, CELL, V88, P581, DOI 10.1016/S0092-8674(00)81899-1; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2	30	7	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21250	21256		10.1074/jbc.M011296200	http://dx.doi.org/10.1074/jbc.M011296200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11283004	hybrid, Green Published			2022-12-27	WOS:000169297900061
J	Hirota, K; Semenza, GL				Hirota, K; Semenza, GL			Rac1 activity is required for the activation of hypoxia-inducible factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR-I; TRANSCRIPTIONAL ACTIVITY; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; SMALL GTPASES; DNA-BINDING; EXPRESSION; ALPHA; CDC42	Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that mediates cellular and systemic homeostatic responses (including erythropoiesis, angiogenesis, and glycolysis) to reduced O-2 availability in mammals. Hypoxia induces both the protein expression and transcriptional activity of the HIF-1 alpha subunit. However, the molecular mechanisms of sensing and signal transduction by which changes in O-2 concentration result in changes in HIF-1 activity are poorly understood. We report here that the small GTPase Rad is activated in response to hypoxia and is required for the induction of HIF-1 alpha protein expression and transcriptional activity in hypoxic cells.	Johns Hopkins Univ, Sch Med, Dept Pediat & Med, Inst Med Genet, Baltimore, MD 21287 USA; Kyoto Univ, Kyoto Univ Hosp, Dept Anesthesia, Kyoto 6068507, Japan	Johns Hopkins University; Kyoto University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat & Med, Inst Med Genet, Baltimore, MD 21287 USA.	gsemenza@jhmi.edu	Hirota, Kiichi/E-9181-2010	Hirota, Kiichi/0000-0003-1110-0827	NHLBI NIH HHS [R01-HL55338] Funding Source: Medline; NIDDK NIH HHS [R01-DK39869] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039869] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agani FH, 2000, J BIOL CHEM, V275, P35863, DOI 10.1074/jbc.M005643200; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Ehleben W, 1998, RESP PHYSIOL, V114, P25, DOI 10.1016/S0034-5687(98)00078-4; FANDREY J, 1994, BIOCHEM J, V303, P507, DOI 10.1042/bj3030507; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hirota K, 2000, BIOCHEM BIOPH RES CO, V274, P177, DOI 10.1006/bbrc.2000.3106; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kim KS, 1998, J CLIN INVEST, V101, P1821, DOI 10.1172/JCI1830; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazure NM, 1997, BLOOD, V90, P3322, DOI 10.1182/blood.V90.9.3322; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ozaki M, 2000, J BIOL CHEM, V275, P35377, DOI 10.1074/jbc.M005287200; Ozaki M, 2000, FASEB J, V14, P418, DOI 10.1096/fasebj.14.2.418; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Sodhi A, 2000, CANCER RES, V60, P4873; Sun HY, 2000, CURR BIOL, V10, P281, DOI 10.1016/S0960-9822(00)00359-6; Sutter CH, 2000, P NATL ACAD SCI USA, V97, P4748, DOI 10.1073/pnas.080072497; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; WANG GL, 1993, J BIOL CHEM, V268, P21513; WANG GL, 1995, BIOCHEM BIOPH RES CO, V216, P669, DOI 10.1006/bbrc.1995.2674; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zhong H, 2000, CANCER RES, V60, P1541; Zundel W, 2000, GENE DEV, V14, P391	47	137	147	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21166	21172		10.1074/jbc.M100677200	http://dx.doi.org/10.1074/jbc.M100677200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11283021	hybrid			2022-12-27	WOS:000169297900051
J	Subramaniam, V; Jovin, TM; Rivera-Pomar, RV				Subramaniam, V; Jovin, TM; Rivera-Pomar, RV			Aromatic amino acids are critical for stability of the bicoid homeodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; DNA-BINDING SPECIFICITY; ULTRAVIOLET CIRCULAR-DICHROISM; ANTENNAPEDIA HOMEODOMAIN; ENGRAILED HOMEODOMAIN; ANGSTROM RESOLUTION; DROSOPHILA EMBRYO; RECOGNITION HELIX; BURIED TRYPTOPHAN; CRYSTAL-STRUCTURE	The Drosophila Bicoid (Bcd) protein plays a dual role as a transcription and translation factor dependent on the unique DNA and RNA binding properties of the homeodomain (HD). We have used circular dichroism and fluorescence spectroscopy to probe the structure and stability of the Bcd-HD, for which a high resolution structure is not yet available. The fluorescence from the single tryptophan residue in the HD (Trp-48) is strongly quenched in the native state but is dramatically enhanced (similar to 20-fold) upon denaturation. Similar results were obtained with the Ultrabithorax HD (Ubx-HD), suggesting that the unusual tryptophan fluorescence may be a general phenomenon of HD proteins. We have used site-directed mutagenesis to explore the role of aromatic acids in the structure of the Bcd-HD and to evaluate the proposal that interactions between the strictly conserved Trp residue in HDs and nearby aromatic residues are responsible for the fluorescence quenching in the native state. We determined that both Trp-48 and Phe-8 in the N-terminal region of the HD are individually necessary for structural stability of the Bcd-HD, the latter most likely as a factor coordinating the orientation of the N-terminal helix I and the recognition helix for efficient binding to a DNA target.	Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany	Max Planck Society	Rivera-Pomar, RV (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, Fassberg 11, D-37077 Gottingen, Germany.		Subramaniam, Vinod/B-4197-2010	Subramaniam, Vinod/0000-0001-6712-7266				ADES SE, 1994, BIOCHEMISTRY-US, V33, P9187, DOI 10.1021/bi00197a022; BILLETER M, 1990, J MOL BIOL, V214, P183, DOI 10.1016/0022-2836(90)90155-F; Billeter M, 1996, PROG BIOPHYS MOL BIO, V66, P211, DOI 10.1016/S0079-6107(97)00006-0; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; Burz DS, 1998, EMBO J, V17, P5998, DOI 10.1093/emboj/17.20.5998; Carra JH, 1997, BIOCHEMISTRY-US, V36, P526, DOI 10.1021/bi962206b; CHAKRABARTTY A, 1993, BIOCHEMISTRY-US, V32, P5560, DOI 10.1021/bi00072a010; Chan SK, 1997, NATURE, V388, P634, DOI 10.1038/41692; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; DAMANTE G, 1994, FEBS LETT, V354, P293, DOI 10.1016/0014-5793(94)01145-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; FERNANDO T, 1992, BIOCHEMISTRY, V31; Fraenkel E, 1998, J MOL BIOL, V284, P351, DOI 10.1006/jmbi.1998.2147; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Gryczynski I, 1996, BIOSPECTROSCOPY, V2, P9, DOI 10.1002/(SICI)1520-6343(1996)2:1<9::AID-BSPY2>3.0.CO;2-6; HANES SD, 1994, MOL CELL BIOL, V14, P3364, DOI 10.1128/MCB.14.5.3364; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; Hirsch JA, 1995, EMBO J, V14, P6280, DOI 10.1002/j.1460-2075.1995.tb00318.x; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; LAUGHON A, 1991, BIOCHEMISTRY-US, V30, P11357, DOI 10.1021/bi00112a001; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; Morgan CG, 1996, REV SCI INSTRUM, V67, P41, DOI 10.1063/1.1147228; MORGAN CG, 1995, REV SCI INSTRUM, V66, P48, DOI 10.1063/1.1146325; Nanda V, 1999, BIOPHYS J, V76, pA448; Nanda V, 2000, PROTEINS, V40, P112, DOI 10.1002/(SICI)1097-0134(20000701)40:1<112::AID-PROT130>3.0.CO;2-C; OTTING G, 1990, EMBO J, V9, P3085, DOI 10.1002/j.1460-2075.1990.tb07505.x; OTTING G, 1988, EMBO J, V7, P4305, DOI 10.1002/j.1460-2075.1988.tb03329.x; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; RIVERAPOMAR R, 1995, NATURE, V376, P253, DOI 10.1038/376253a0; RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0; Rouviere N, 1997, BIOCHEMISTRY-US, V36, P7339, DOI 10.1021/bi962289w; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIER AF, 1992, NATURE, V356, P804, DOI 10.1038/356804a0; Subramaniam V, 1999, BIOPHYS J, V76, pA108; SUWAIYAN A, 1989, CHEM PHYS LETT, V159, P244, DOI 10.1016/0009-2614(89)87418-4; TREISMAN J, 1989, CELL, V59, P553; TuckerKellogg L, 1997, STRUCTURE, V5, P1047, DOI 10.1016/S0969-2126(97)00256-6; VANDUUREN B, 1961, J ORG CHEM, V26, P2954, DOI 10.1021/jo01066a079; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; WOODY RW, 1978, BIOPOLYMERS, V17, P1451, DOI 10.1002/bip.1978.360170606; YANG JT, 1986, METHOD ENZYMOL, V130, P208	45	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21506	21511		10.1074/jbc.M102292200	http://dx.doi.org/10.1074/jbc.M102292200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11294843	Green Published, hybrid			2022-12-27	WOS:000169297900095
J	Vilkaitis, G; Merkiene, E; Serva, S; Weinhold, E; Klimasauskas, S				Vilkaitis, G; Merkiene, E; Serva, S; Weinhold, E; Klimasauskas, S			The mechanism of DNA cytosine-5 methylation - Kinetic and mutational dissection of HhaI methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYL-L-METHIONINE; PRE-STEADY-STATE; CRYSTAL-STRUCTURE; TARGET BASE; ESCHERICHIA-COLI; BINDING; ENZYME; PURIFICATION; MISMATCHES; EXPRESSION	Kinetic and binding studies involving a model DNA cytosine-5-methyltransferase, M.HhaI, and a 37-mer DNA duplex containing a single hemimethylated target site were applied to characterize intermediates on the reaction pathway. Stopped-flow fluorescence studies reveal that cofactor S-adenosyl-L-methionine (AdoMet) and product S-adenosyl-L-homocysteine (AdoHcy) form similar rapidly reversible binary complexes with the enzyme in solution. The M.HhaI.AdoMet complex (K-off = 22 s(-1), K-D = 6 muM) is partially converted into products during isotope-partitioning experiments, suggesting that it is catalytically competent. Chemical formation of the product M.HhaI.(Me)DNA.AdoHCy (k(chem) = 0.26 s(-1)) is followed by a slower decay step (k(off) = 0.045 s(-1)), which is the rate-limiting step in the catalytic cycle (k(cat) = 0.04 s(-1)). Analysis of reaction products shows that the hemi-methylated substrate undergoes complete (>95%) conversion into fully methylated product during the initial burst phase, indicating that M.HhaI exerts high binding selectivity toward the target strand. The T250N, T250D, and T250H mutations, which introduce moderate perturbation in the catalytic site, lead to substantially increased K-D(DNA(ternary)), k(off)(DNA(ternary)), k(M)(AdoMet(ternary)) values but small changes in K-D(DNA(binary)), K-D(AdoMet(binary)), k(chem), and k(cat). When the target cytosine is replaced with 5-fluorocytosine, the chemistry step leading to an irreversible covalent M.HhaI.DNA complex is inhibited 400-fold (k(chem)(5FC) = 0.7 x 10(-3) s(-1)), and the Thr-250 mutations confer further dramatic decrease of the rate of the covalent methylation It,,,,. We suggest that activation of the pyrimidine ring via covalent addition at C-6 is a major contributor to the rate of the chemistry step (k(chem)) in the case of cytosine but not 5-fluorocytosine, In contrast to previous reports, our results imply a random substrate binding order mechanism for M.HhaI.	Rhein Westfal TH Aachen, Inst Organ Chem, D-52056 Aachen, Germany; Inst Biotechnol, Lab Biol DNA Modificat, LT-2028 Vilnius, Lithuania	RWTH Aachen University; Vilnius University	Klimasauskas, S (corresponding author), Inst Biotechnol, Lab Biol DNA Modificat, LT-2028 Vilnius, Lithuania.		Klimasauskas, Saulius/M-3053-2016; Vilkaitis, Giedrius/AAI-9157-2021	Klimasauskas, Saulius/0000-0002-1395-2030; Vilkaitis, Giedrius/0000-0003-2427-3997				BERGERAT A, 1989, J BIOL CHEM, V264, P4064; Bhattacharya SK, 1999, J BIOL CHEM, V274, P14743, DOI 10.1074/jbc.274.21.14743; Cal S, 1997, J BIOL CHEM, V272, P490; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; CHEN L, 1993, J AM CHEM SOC, V115, P5318, DOI 10.1021/ja00065a063; CHENG X, 1993, COLD SPRING HARB SYM, V58, P331, DOI 10.1101/SQB.1993.058.01.039; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; CORNISHBOWDEN A, 1999, FUNDAMENTALS ENZYMES, P88; Cousins J., 1997, KINETASYST VERSION 2; Dryden D. S, 1999, BACTERIAL DNA METHYL, P283; DUBEY AK, 1992, NUCLEIC ACIDS RES, V20, P3167, DOI 10.1093/nar/20.12.3167; FERSHT A, 1999, STRUCTURE MECH PROTE, P196; Flynn J, 1996, BIOCHEMISTRY-US, V35, P7308, DOI 10.1021/bi9600512; FRIEDMAN S, 1992, NUCLEIC ACIDS RES, V20, P3241, DOI 10.1093/nar/20.12.3241; GRAVES KL, 1993, BIOCHEMISTRY-US, V31, P10315; HO DK, 1991, ARCH BIOCHEM BIOPHYS, V284, P264, DOI 10.1016/0003-9861(91)90294-S; Holz B, 1998, NUCLEIC ACIDS RES, V26, P1076, DOI 10.1093/nar/26.4.1076; Hurd PJ, 1999, J MOL BIOL, V286, P389, DOI 10.1006/jmbi.1998.2491; Jeltsch A, 1998, J MOL BIOL, V275, P747, DOI 10.1006/jmbi.1997.1492; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; Klimasauskas S, 1998, EMBO J, V17, P317, DOI 10.1093/emboj/17.1.317; KLIMASAUSKAS S, 1995, NUCLEIC ACIDS RES, V23, P1388, DOI 10.1093/nar/23.8.1388; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; KOSSYKH VG, 1995, FEBS LETT, V370, P75, DOI 10.1016/0014-5793(95)00795-B; Kumar S, 1997, NUCLEIC ACIDS RES, V25, P2773, DOI 10.1093/nar/25.14.2773; KUMAR S, 1992, BIOCHEMISTRY-US, V31, P8648, DOI 10.1021/bi00151a035; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LAAYOUN A, 1995, NUCLEIC ACIDS RES, V23, P1584, DOI 10.1093/nar/23.9.1584; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, P243; LEATHERBARROW RJ, 1992, GRAPHIT VERSION 3 0; Lindstrom WM, 2000, J BIOL CHEM, V275, P4912, DOI 10.1074/jbc.275.7.4912; LIU L, 1992, BIOCHEMISTRY-US, V31, P5100, DOI 10.1021/bi00137a002; Malygin EG, 2000, NUCLEIC ACIDS RES, V28, P4207, DOI 10.1093/nar/28.21.4207; O'Gara M, 1998, NAT STRUCT BIOL, V5, P872, DOI 10.1038/2312; O'Gara M, 1999, J MOL BIOL, V287, P201, DOI 10.1006/jmbi.1999.2608; OGara M, 1996, J MOL BIOL, V263, P597, DOI 10.1006/jmbi.1996.0601; OGara M, 1996, J MOL BIOL, V261, P634, DOI 10.1006/jmbi.1996.0489; OSTERMAN DG, 1988, BIOCHEMISTRY-US, V27, P5204, DOI 10.1021/bi00414a039; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Perakyla M, 1998, J AM CHEM SOC, V120, P12895, DOI 10.1021/ja981405a; Pignot M, 2000, EUR J ORG CHEM, V2000, P549; Posnick LM, 1999, J BACTERIOL, V181, P6756, DOI 10.1128/JB.181.21.6756-6762.1999; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; REICH NO, 1993, J BIOL CHEM, V268, P9191; REICH NO, 1991, BIOCHEMISTRY-US, V30, P2933, DOI 10.1021/bi00225a029; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; RENBAUM P, 1995, J MOL BIOL, V248, P19, DOI 10.1006/jmbi.1995.0199; Rose I A, 1980, Methods Enzymol, V64, P47; Sasnauskas G, 1999, BIOCHEMISTRY-US, V38, P4028, DOI 10.1021/bi982456n; SEGEL IH, 1993, ENZYME KINETICS, P651; SEGEL IH, 1993, ENZYME KINETICS, P818; Serva S, 1998, NUCLEIC ACIDS RES, V26, P3473, DOI 10.1093/nar/26.15.3473; Szegedi SS, 2000, NUCLEIC ACIDS RES, V28, P3962, DOI 10.1093/nar/28.20.3962; SZILAK L, 1993, EUR J BIOCHEM, V218, P727, DOI 10.1111/j.1432-1033.1993.tb18427.x; Szyf M, 1998, CANCER METAST REV, V17, P219, DOI 10.1023/A:1006023023787; TAYLOR JD, 1989, BIOCHEMISTRY-US, V28, P6198, DOI 10.1021/bi00441a011; Vertino PM, 1999, S ADENOSYLMETHIONINE, P341; Vilkaitis G, 1999, ANAL BIOCHEM, V271, P116, DOI 10.1006/abio.1999.4116; Vilkaitis G, 2000, J BIOL CHEM, V275, P38722, DOI 10.1074/jbc.M005278200; WU JC, 1987, J BIOL CHEM, V262, P4778; WU JC, 1988, NUCLEIC ACIDS RES, V16, P703, DOI 10.1093/nar/16.2.703	61	99	102	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20924	20934		10.1074/jbc.M101429200	http://dx.doi.org/10.1074/jbc.M101429200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11283006	hybrid			2022-12-27	WOS:000169297900019
J	Sadowski, CL; Choi, TS; Le, M; Wheeler, TT; Wang, LH; Sadowski, HB				Sadowski, CL; Choi, TS; Le, M; Wheeler, TT; Wang, LH; Sadowski, HB			Insulin induction of SOCS-2 and SOCS-3 mRNA expression in C2C12 skeletal muscle cells is mediated by Stat5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL REGULATORY-ELEMENT; EPIDERMAL GROWTH-FACTOR; TRANSCRIPTION FACTOR FKHR; GENE-EXPRESSION; TYROSINE PHOSPHORYLATION; GLUCOCORTICOID RECEPTOR; DIFFERENTIAL REGULATION; SIGNAL-TRANSDUCTION; NEGATIVE REGULATION; BINDING PROTEIN-1C	Previously, by a yeast 2-hybrid screen, we identified signal transducer and activator of transcription 5b (Stat5b) as a substrate of the insulin receptor (IR). We demonstrated that refeeding of fasted mice leads to rapid activation of Stat5 proteins in liver, skeletal muscle, and fat, suggesting that Stat5b is a physiological target of insulin. Here, we show that injection of glucose or insulin into fasted mice leads to robust activation of both Stat5a and Stat5b in skeletal muscle. In C2C12 myotubes, we find that insulin stimulates tyrosine phosphorylation of Stat5a and Stat5b by 3-5-fold. This degree of Stat5 activation in vitro is significantly lower than what we observe in vivo and inversely correlates with IRS-1/2 levels. We can recapitulate robust insulin activation of Stat5 in C2C12 cells by stable overexpression of the human IR (hIR). To identify insulin-activated genes that are Stat5 targets, we also overexpressed an IR mutant (LA-hIR) that signals normally for mitogen-activated protein kinase- and phosphatidylinositol 3-kinase-dependent pathways but is deficient in Stat5 signaling in response to insulin. We demonstrate that insulin induces the expression of SOCS-2 mRNA in the wild type hIR but not in the LA-hIR-overexpressing cells. The induction of SOCS-3 by insulin is reduced but not lost in the LA-hIR cells. Therefore, our results suggest that insulin induction of SOCS-2, and in part SOCS-3 mRNA expression, is mediated by Stat5 and can be independent of mitogen activated protein kinase and phosphatidylinositol 3-kinase-signaling pathways.	Mt Sinai Sch Med, Dept Biochem & Mol Biol, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; AgRes, Dairy Sci Grp, Hamilton, New Zealand	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; AgResearch - New Zealand	Sadowski, HB (corresponding author), Mt Sinai Sch Med, Dept Biochem & Mol Biol, New York, NY 10029 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010499] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK53000] Funding Source: Medline; NINDS NIH HHS [NS10499] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams TE, 1998, J BIOL CHEM, V273, P1285, DOI 10.1074/jbc.273.3.1285; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389; Cella N, 1998, MOL CELL BIOL, V18, P1783, DOI 10.1128/MCB.18.4.1783; Chan JLK, 1997, J BIOL CHEM, V272, P146; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Chen J, 1997, P NATL ACAD SCI USA, V94, P2295, DOI 10.1073/pnas.94.6.2295; Chin H, 1997, BLOOD, V89, P4327, DOI 10.1182/blood.V89.12.4327; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; David M, 1996, J BIOL CHEM, V271, P9185, DOI 10.1074/jbc.271.16.9185; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Heim MH, 1999, J RECEPT SIGNAL TR R, V19, P75, DOI 10.3109/10799899909036638; KELLER SR, 1991, J BIOL CHEM, V266, P12817; Klingmuller U, 1996, P NATL ACAD SCI USA, V93, P8324, DOI 10.1073/pnas.93.16.8324; Latasa MJ, 2000, P NATL ACAD SCI USA, V97, P10619, DOI 10.1073/pnas.180306597; Leaman DW, 1996, MOL CELL BIOL, V16, P369; Lechner J, 1997, J BIOL CHEM, V272, P20954, DOI 10.1074/jbc.272.33.20954; Lopaczynski W, 1999, ACTA BIOCHIM POL, V46, P51, DOI 10.18388/abp.1999_4183; Marine JC, 1999, CELL, V98, P617, DOI 10.1016/S0092-8674(00)80049-5; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Moutoussamy S, 1998, EUR J BIOCHEM, V255, P1, DOI 10.1046/j.1432-1327.1998.2550001.x; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; Naka T, 1999, TRENDS BIOCHEM SCI, V24, P394, DOI 10.1016/S0968-0004(99)01454-1; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; NICHOLSON SE, 1996, J BIOL CHEM, V271, P947; NISHIYAMA M, 1992, BIOCHEM BIOPH RES CO, V183, P280, DOI 10.1016/0006-291X(92)91640-C; OBRIEN RM, 1991, BIOCHEM J, V278, P609, DOI 10.1042/bj2780609; Paukku K, 2000, BIOCHEM J, V345, P759, DOI 10.1042/0264-6021:3450759; SADOWSKI HB, 1993, NATURE, V362, P79, DOI 10.1038/362079a0; Sawka-Verhelle D, 2000, ENDOCRINOLOGY, V141, P1977, DOI 10.1210/en.141.6.1977; SawkaVerhelle D, 1997, EUR J BIOCHEM, V250, P411, DOI 10.1111/j.1432-1033.1997.0411a.x; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stoecklin E, 1997, MOL CELL BIOL, V17, P6708, DOI 10.1128/MCB.17.11.6708; Stoecklin Elisabeth, 1996, Nature (London), V383, P726; Storz P, 1998, FEBS LETT, V440, P41, DOI 10.1016/S0014-5793(98)01421-5; Storz P, 1999, FEBS LETT, V464, P159, DOI 10.1016/S0014-5793(99)01689-0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Verdier F, 1998, MOL CELL BIOL, V18, P5852, DOI 10.1128/MCB.18.10.5852; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; White MF, 1998, RECENT PROG HORM RES, V53, P119; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143	47	57	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20703	20710		10.1074/jbc.M101014200	http://dx.doi.org/10.1074/jbc.M101014200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279166	hybrid			2022-12-27	WOS:000169135100137
J	Streeper, RS; Hornbuckle, LA; Svitek, CA; Goldman, JK; Oeser, JK; O'Brien, RM				Streeper, RS; Hornbuckle, LA; Svitek, CA; Goldman, JK; Oeser, JK; O'Brien, RM			Protein kinase A phosphorylates hepatocyte nuclear factor-6 and stimulates glucose-6-phosphatase catalytic subunit gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-STORAGE-DISEASE; RAT-LIVER GLUCOSE-6-PHOSPHATASE; CUT HOMEODOMAIN PROTEINS; CAMP RESPONSE ELEMENT; GROWTH-HORMONE; DNA-BINDING; GLUCOSE-METABOLISM; MESSENGER-RNA; DIABETIC RATS; FACTOR-I	Glucose-6-phosphatase is a multicomponent system that catalyzes the terminal step in gluconeogenesis. To examine the effect of the cAMP signal transduction pathway on expression of the gene encoding the mouse glucose-6-phosphatase catalytic subunit (G6Pase), the liver-derived HepG2 cell line was transiently co-transfected with a series of G6Pase-chloramphenicol acetyltransferase fusion genes and an expression vector encoding the catalytic subunit of cAMP-dependent protein kinase A (PKA). PKA markedly stimulated G6Pase-chloramphenicol acetyltransferase fusion gene expression, and mutational analysis of the G6Pase promoter revealed that multiple cis-acting elements were required for this response. One of these elements was mapped to the G6Pase promoter region between -114 and -99, and this sequence was shown to bind hepatocyte nuclear factor (HNF)-6. This HNF-6 binding site was able to confer a stimulatory effect of PKA on the expression of a heterologous fusion gene; a mutation that abolished HNF-6 binding also abolished the stimulatory effect of PKA, Further investigation revealed that PKA phosphorylated HNF-6 in vitro. Site-directed mutation of three consensus PKA phosphorylation sites in the HNF-6 carboxyl terminus markedly reduced this phosphorylation. These results suggest that the stimulatory effect of PKA on G6Pase fusion gene transcription in HepG2 cells may be mediated in part by the phosphorylation of HNF-6.	Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	O'Brien, RM (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, 761 MRB 2, Nashville, TN 37232 USA.				NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007563, P60DK020593, R01DK056374] Funding Source: NIH RePORTER; NCI NIH HHS [CA68485] Funding Source: Medline; NIDDK NIH HHS [DK20593, P60 DK20593, DK56374, 5 T 32 DK07563-12] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Argaud D, 1996, DIABETES, V45, P1563, DOI 10.2337/diabetes.45.11.1563; Argaud D, 1997, J BIOL CHEM, V272, P12854, DOI 10.1074/jbc.272.19.12854; BERGLUND L, 1977, J BIOL CHEM, V252, P613; BYUS CV, 1978, J CYCLIC NUCL PROT, V4, P45; Chapman SC, 1999, J BIOL CHEM, V274, P18625, DOI 10.1074/jbc.274.26.18625; Chatelain F, 1998, DIABETES, V47, P882, DOI 10.2337/diabetes.47.6.882; CHEN YT, 1991, PEDIATR NEPHROL, V5, P71, DOI 10.1007/BF00852851; Chou JY, 1999, TRENDS ENDOCRIN MET, V10, P104; CLINE GW, 1994, J CLIN INVEST, V94, P2369, DOI 10.1172/JCI117602; COLBRAN JL, 1992, BIOCHEM CELL BIOL, V70, P1277, DOI 10.1139/o92-174; CONSOLI A, 1992, DIABETES CARE, V15, P430, DOI 10.2337/diacare.15.3.430; Coqueret O, 1996, J BIOL CHEM, V271, P24862, DOI 10.1074/jbc.271.40.24862; Coqueret O, 1998, J BIOL CHEM, V273, P2561, DOI 10.1074/jbc.273.5.2561; Felinski EA, 2001, MOL CELL BIOL, V21, P1001, DOI 10.1128/MCB.21.4.1001-1010.2001; Foster JD, 1997, P SOC EXP BIOL MED, V215, P314; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; HABER BA, 1995, J CLIN INVEST, V95, P832, DOI 10.1172/JCI117733; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hiraiwa H, 1999, J BIOL CHEM, V274, P5532, DOI 10.1074/jbc.274.9.5532; Kim JA, 2000, P NATL ACAD SCI USA, V97, P11292, DOI 10.1073/pnas.97.21.11292; Lahuna O, 1997, P NATL ACAD SCI USA, V94, P12309, DOI 10.1073/pnas.94.23.12309; Lahuna O, 2000, MOL ENDOCRINOL, V14, P285, DOI 10.1210/me.14.2.285; LANGE AJ, 1994, BIOCHEM BIOPH RES CO, V201, P302, DOI 10.1006/bbrc.1994.1702; Lannoy VJ, 2000, J BIOL CHEM, V275, P22098, DOI 10.1074/jbc.M000855200; Lannoy VJ, 1998, J BIOL CHEM, V273, P13552, DOI 10.1074/jbc.273.22.13552; Lemaigre FP, 1996, P NATL ACAD SCI USA, V93, P9460, DOI 10.1073/pnas.93.18.9460; Lin BC, 1999, HUM GENET, V105, P515, DOI 10.1007/s004390051140; Lin BC, 1997, BIOCHEMISTRY-US, V36, P14096, DOI 10.1021/bi9703249; Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160; LIU ZQ, 1994, BIOCHEM BIOPH RES CO, V205, P680, DOI 10.1006/bbrc.1994.2719; LUCAS PC, 1992, ANNU REV BIOCHEM, V61, P1131; Massillon D, 1997, DIABETES, V46, P153, DOI 10.2337/diabetes.46.1.153; Massillon D, 1998, J BIOL CHEM, V273, P228, DOI 10.1074/jbc.273.1.228; Massillon D, 1996, J BIOL CHEM, V271, P9871, DOI 10.1074/jbc.271.17.9871; MAURER RA, 1989, J BIOL CHEM, V264, P6870; Mithieux G, 1996, DIABETES, V45, P891, DOI 10.2337/diabetes.45.7.891; Mithieux G, 1997, EUR J ENDOCRINOL, V136, P137, DOI 10.1530/eje.0.1360137; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Puskas F, 1999, J BIOL CHEM, V274, P117, DOI 10.1074/jbc.274.1.117; Rastegar M, 2000, ENDOCRINOLOGY, V141, P1686, DOI 10.1210/en.141.5.1686; Rastegar M, 1998, BIOCHEM J, V334, P565, DOI 10.1042/bj3340565; Rausa F, 1997, DEV BIOL, V192, P228, DOI 10.1006/dbio.1997.8744; Samadani U, 1996, MOL CELL BIOL, V16, P6273; Sambrook J., 2002, MOL CLONING LAB MANU; Schmoll D, 1999, BIOCHEM J, V338, P457, DOI 10.1042/0264-6021:3380457; Schmoll D, 1996, FEBS LETT, V383, P63, DOI 10.1016/0014-5793(96)00224-4; Seoane J, 1997, J BIOL CHEM, V272, P26972, DOI 10.1074/jbc.272.43.26972; SINGH TJ, 1977, J BIOL CHEM, V252, P625; SINGH TJ, 1984, J BIOL CHEM, V259, P2857; Streeper RS, 1998, P NATL ACAD SCI USA, V95, P9208, DOI 10.1073/pnas.95.16.9208; Streeper RS, 2000, J BIOL CHEM, V275, P12108, DOI 10.1074/jbc.275.16.12108; Streeper RS, 1997, J BIOL CHEM, V272, P11698, DOI 10.1074/jbc.272.18.11698; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Trinh KY, 1998, J BIOL CHEM, V273, P31615, DOI 10.1074/jbc.273.47.31615	54	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19111	19118		10.1074/jbc.M101442200	http://dx.doi.org/10.1074/jbc.M101442200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279202	hybrid			2022-12-27	WOS:000169091000065
J	Dressel, U; Bailey, PJ; Wang, SCM; Downes, M; Evans, RM; Muscat, GEO				Dressel, U; Bailey, PJ; Wang, SCM; Downes, M; Evans, RM; Muscat, GEO			A dynamic role for HDAC7 in MEF2-mediated muscle differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCYTE ENHANCER FACTOR-2; MEF2 TRANSCRIPTION FACTOR; MYOD GENE FAMILY; SKELETAL-MUSCLE; HISTONE DEACETYLASE-4; MOUSE EMBRYOGENESIS; ORPHAN RECEPTOR; BHLH PROTEINS; MADS-BOX; EXPRESSION	The overlapping expression profile of MEF2 and the class-II histone deacetylase, HDAC7, led us to investigate the functional interaction and relationship between these regulatory proteins. HDAC7 expression inhibits the activity of MEF2 (-A, -C, and -D), and in contrast MyoD and Myogenin activities are not affected. Glutathione S-transferase pulldown and immunoprecipitation demonstrate that the repression mechanism involves direct interactions between MEF2 proteins and HDAC7 and is associated with the ability of MEF2 to interact with the N-terminal 121 amino acids of HDAC7 that encode repression domain 1. The MADS domain of MEF2 mediates the direct interaction of MEF2 with HDAC7, MEF2 inhibition by HDAC7 is dependent on the N-terminal repression domain and surprisingly does not involve the C-terminal deacetylase domain. HDAC7 interacts with CtBP and other class-I and -II HDACs suggesting that silencing of MEF2 activity involves corepressor recruitment. Furthermore, we show that induction of muscle differentiation by serum withdrawal leads to the translocation of HDAC7 from the nucleus into the cytoplasm. This work demonstrates that HDAC7 regulates the function of MEF2 proteins and suggests that this class-II HDAC regulates this important transcriptional (and pathophysiological) target in heart and muscle tissue. The nucleocytoplasmic trafficking of HDAC7 and other class-II HDACs during myogenesis provides an ideal mechanism for the regulation of HDAC targets during mammalian development and differentiation.	Univ Queensland, Inst Mol Biosci, Richie Res Lab, Ctr Cellular & Mol Biol, St Lucia, Qld 4072, Australia; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Salk Inst, Howard Hughes Med Inst, Gene Express Lab, San Diego, CA 92186 USA	University of Queensland; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Salk Institute	Muscat, GEO (corresponding author), Univ Queensland, Inst Mol Biosci, Richie Res Lab, Ctr Cellular & Mol Biol, B402A, St Lucia, Qld 4072, Australia.		Evans, Ronald/AAF-4001-2019; Dressel, Uwe/C-1555-2016; Muscat, George/A-6401-2017; Wang, Shu-Ching/C-6082-2017	Evans, Ronald/0000-0002-9986-5965; Dressel, Uwe/0000-0003-4505-7855; Bailey, Peter/0000-0002-0857-2041; Muscat, George/0000-0002-5829-5695; Wang, Shu-Ching/0000-0002-7871-3735				Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Burke L, 1996, NUCLEIC ACIDS RES, V24, P3481, DOI 10.1093/nar/24.18.3481; Burke LJ, 2000, FASEB J, V14, P1876, DOI 10.1096/fj.99-0943rev; Chen SL, 2000, GENE DEV, V14, P1209; Dangond F, 1998, BIOCHEM BIOPH RES CO, V242, P648, DOI 10.1006/bbrc.1997.8033; DOWNES M, 1995, MOL ENDOCRINOL, V9, P1666, DOI 10.1210/me.9.12.1666; Downes M, 2000, P NATL ACAD SCI USA, V97, P10330, DOI 10.1073/pnas.97.19.10330; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; KADESCH T, 1993, CELL GROWTH DIFFER, V4, P49; Kao HY, 2000, GENE DEV, V14, P55; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Ludolph DC, 1995, FASEB J, V9, P1595, DOI 10.1096/fasebj.9.15.8529839; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; MURRE C, 1991, MOL CELL BIOL, V11, P1156, DOI 10.1128/MCB.11.2.1156; Muscat GEO, 2000, NAT MED, V6, P1216, DOI 10.1038/81312; MUSCAT GEO, 1995, NUCLEIC ACIDS RES, V23, P1311, DOI 10.1093/nar/23.8.1311; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; ONATE SA, 1995, SCIENCE, V270, P1354; Ornatsky OI, 1997, J BIOL CHEM, V272, P33271, DOI 10.1074/jbc.272.52.33271; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; Subramanian SV, 1996, MECH DEVELOP, V57, P103, DOI 10.1016/0925-4773(96)00542-4; SUN XH, 1991, CELL, V64, P459, DOI 10.1016/0092-8674(91)90653-G; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Wang AH, 1999, MOL CELL BIOL, V19, P7816; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3; Zhang CL, 2001, J BIOL CHEM, V276, P35, DOI 10.1074/jbc.M007364200	52	156	160	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17007	17013		10.1074/jbc.M101508200	http://dx.doi.org/10.1074/jbc.M101508200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279209	hybrid			2022-12-27	WOS:000168730400054
J	Woodring, PJ; Hunter, T; Wang, JYJ				Woodring, PJ; Hunter, T; Wang, JYJ			Inhibition of c-Abl tyrosine kinase activity by filamentous actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TERMINAL REPEATED DOMAIN; DNA-DAMAGE; CELL-CYCLE; APOPTOTIC RESPONSE; PROTEIN; BINDING; SRC; PHOSPHORYLATION; GROWTH	The catalytic activity of c-Abl tyrosine kinase is reduced in fibroblasts that are detached from the extracellular matrix. We report here that a deletion of the extreme C terminus of c-Abl (DeltaF-actin c-Abl) can partially restore kinase activity to c-Abl from detached cells. Because the extreme C terminus of c-Abl contains a consensus F-actin binding motif, we investigated the effect of F-actin on c-Abl tyrosine kinase activity. We found that F-actin can inhibit the kinase activity of purified c-Abl protein. Mutations of the extreme C-terminal region of c-Abl disrupted both the binding of c-Abl to F-actin and the inhibition of c-Abl by F-actin. Mutations of the SH3, SH2, and DNA binding domains did not abolish the inhibition of c-Abl kinase by F-actin. Catalytic domain substitutions that affect the regulation of c-Abl by the retinoblastoma protein or the ataxia telangiectasia-mutated kinase also did not abolish the inhibition of c-Abl by F-actin. Interestingly, among these c-Abl mutants, only the DeltaF-actin c-Abl retained kinase activity in detached cells. Taken together, the data suggest that F-actin is an inhibitor of the c-Abl tyrosine kinase and that this inhibition contributes in part to the reduced Abl kinase activity in detached cells.	Salk Inst, La Jolla, CA 92037 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Woodring, PJ (corresponding author), Salk Inst, La Jolla, CA 92037 USA.				NATIONAL CANCER INSTITUTE [R37CA043054, F32CA076710, R01CA043054] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057900] Funding Source: NIH RePORTER; NCI NIH HHS [CA82863, R37 CA043054, CA76710, R01 CA043054] Funding Source: Medline; NHLBI NIH HHS [P01 HL057900, HL57900] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agami R, 1999, NATURE, V399, P809; Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Baskaran R, 1996, MOL CELL BIOL, V16, P3361; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; BASKARAN R, 1993, P NATL ACAD SCI USA, V90, P11167, DOI 10.1073/pnas.90.23.11167; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; DUYSTER J, 1995, P NATL ACAD SCI USA, V92, P1555, DOI 10.1073/pnas.92.5.1555; FELLER SM, 1994, TRENDS BIOCHEM SCI, V19, P453, DOI 10.1016/0968-0004(94)90129-5; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; Freeman JLR, 1998, J BIOL CHEM, V273, P20653, DOI 10.1074/jbc.273.32.20653; Gong JG, 1999, NATURE, V399, P806; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hubbard SR, 1999, NAT STRUCT BIOL, V6, P711, DOI 10.1038/11468; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; Juang JL, 1999, ONCOGENE, V18, P5138, DOI 10.1038/sj.onc.1202911; KIPREOS ET, 1992, SCIENCE, V256, P382, DOI 10.1126/science.256.5055.382; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Lewis JM, 1998, J BIOL CHEM, V273, P14225, DOI 10.1074/jbc.273.23.14225; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; MCWHIRTER JR, 1993, EMBO J, V12, P1533, DOI 10.1002/j.1460-2075.1993.tb05797.x; MCWHIRTER JR, 1991, MOL CELL BIOL, V11, P1553, DOI 10.1128/MCB.11.3.1553; Miao YJ, 1996, J BIOL CHEM, V271, P22823, DOI 10.1074/jbc.271.37.22823; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PENDERGAST AM, 1991, P NATL ACAD SCI USA, V88, P5927, DOI 10.1073/pnas.88.13.5927; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; RENSHAW MW, 1995, MOL CELL BIOL, V15, P1286; RENSHAW MW, 1992, EMBO J, V11, P3941, DOI 10.1002/j.1460-2075.1992.tb05488.x; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Shishido T, 2000, P NATL ACAD SCI USA, V97, P6439, DOI 10.1073/pnas.060030697; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Smith JM, 1999, J BIOL CHEM, V274, P27956, DOI 10.1074/jbc.274.39.27956; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; WANG JYJ, 1993, CURR OPIN GENET DEV, V3, P35, DOI 10.1016/S0959-437X(05)80338-7; WELCH PJ, 1995, MOL CELL BIOL, V15, P5542; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704	46	91	93	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 20	2001	276	29					27104	27110		10.1074/jbc.M100559200	http://dx.doi.org/10.1074/jbc.M100559200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	454HJ	11309382	hybrid			2022-12-27	WOS:000169966900051
J	Csar, XF; Wilson, NJ; McMahon, KA; Marks, DC; Beecroft, TL; Ward, AC; Whitty, GA; Kanangasundarum, V; Hamilton, JA				Csar, XF; Wilson, NJ; McMahon, KA; Marks, DC; Beecroft, TL; Ward, AC; Whitty, GA; Kanangasundarum, V; Hamilton, JA			Proteomic analysis of macrophage differentiation - p46/52(Shc) tyrosine phosphorylation is required for CSF-1-mediated macrophage differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; ACTIVATED PROTEIN-KINASE; FOCAL ADHESION KINASE; FACTOR-I RECEPTOR; SIGNAL-TRANSDUCTION; CSF-1 RECEPTOR; NEURONAL DIFFERENTIATION; PHOSPHATIDYLINOSITOL 3-KINASE; GENE-EXPRESSION; HUMAN MONOCYTES	Macrophage colony stimulating factor (M-CSF or CSF-1) acts to regulate the development and function of cells of the macrophage lineage. Murine myeloid FDC-P1 cells transfected with the CSF-1 receptor (FD/WT) adopt a macrophage-like morphology when cultured in CSF-1, This process is abrogated in FDC-P1 cells transfected with the CSF-1 receptor with a tyrosine to phenyalanine substitution at position 807 (PD/807), suggesting that a molecular interaction critical to differentiation signaling is lost (Bourette, R. P., Myles, G. M., Carlberg, K., Chen, A. R., and Rohrschneider, L. R. (1995) Cell Growth Differ, 6, (631-645). A detailed examination of lysates of CSF-1-treated FD/807 cells by two-dimensional SI)S-polyacrylamide gel electrophoresis (PAGE) revealed a number of proteins whose degree of tyrosine phosphorylation was modulated by the Y807F mutation. Included in this category were three phosphorylated proteins that co-migrated with p46/52(Sch), Immunoprecipitation, Western blotting, and in vitro binding studies suggest that they are indeed p46/52(Shc). A key regulator of differentiation in a number of cell systems, ERK was observed to exhibit an activity that correlated with the relative degree of differentiation induced by CSF-1 in the two cell types. Transfection of cells with a non-tyrosine-phosphorylatable form of p46/52(Shc) prevented the normally observed CSF-1-mediated macrophage differentiation as determined by adoption of macrophage-like morphology and expression of the monocyte/macrophage lineage cell surface marker, Mac-1. These results are the first to suggest that p46/52(Shc) may play a role in CSF-1-induced macrophage differentiation. Additionally, a number of proteins were identified by two-dimensional SDS-PAGE whose degree of tyrosine phosphorylation is also modulated by the Y807F substitution. This group of molecules may contain novel signaling molecules important in macrophage differentiation.	Univ Melbourne, Royal Melbourne Hosp, Arthrit & Inflammat Res Ctr, Dept Med, Parkville, Vic 3050, Australia; Peter MacCallum Canc Inst, Trescowthick Res Labs, Cell Cycle Proteolysis Lab, Melbourne, Vic 3006, Australia; Royal Melbourne Hosp, Cooperat Res Ctr Chron Inflammatory Dis, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; University of Melbourne; Peter Maccallum Cancer Center; Royal Melbourne Hospital	Csar, XF (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Arthrit & Inflammat Res Ctr, Dept Med, Parkville, Vic 3050, Australia.	xfc@unimelb.edu.au	Marks, Denese C/A-5267-2018; McMahon, Kerrie-Ann/J-1821-2014	Marks, Denese C/0000-0002-3674-6934; McMahon, Kerrie-Ann/0000-0002-0833-5708; Hamilton, John A/0000-0002-9493-9224; Ward, Alister/0000-0001-7945-7975				Alexander WS, 1996, EMBO J, V15, P6531, DOI 10.1002/j.1460-2075.1996.tb01044.x; ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; Blaikie PA, 1997, J BIOL CHEM, V272, P20671, DOI 10.1074/jbc.272.33.20671; BOURETTE RP, 1995, CELL GROWTH DIFFER, V6, P631; Bourette RP, 1997, EMBO J, V16, P5880, DOI 10.1093/emboj/16.19.5880; Carlberg K, 1997, J BIOL CHEM, V272, P15943, DOI 10.1074/jbc.272.25.15943; Chen HE, 1996, MOL CELL BIOL, V16, P3685, DOI 10.1128/mcb.16.7.3685; Cheng M, 1999, J BIOL CHEM, V274, P6553, DOI 10.1074/jbc.274.10.6553; Cook SJ, 1999, MOL CELL BIOL, V19, P330; Csar XF, 1997, BIOCHEM J, V322, P79, DOI 10.1042/bj3220079; Csar XF, 1997, J INTERF CYTOK RES, V17, P77, DOI 10.1089/jir.1997.17.77; Csar XF, 2001, PROTEOMICS, V1, P435, DOI 10.1002/1615-9861(200103)1:3<435::AID-PROT435>3.3.CO;2-H; Durstin M, 1996, J IMMUNOL, V157, P534; FernandezValle C, 1997, J NEUROSCI, V17, P241, DOI 10.1523/JNEUROSCI.17-01-00241.1997; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HECKER G, 1991, BIOCHEM SOC T, V19, P385, DOI 10.1042/bst0190385; Hill RJ, 1996, CELL GROWTH DIFFER, V7, P1125; Katagiri K, 1996, BLOOD, V87, P4276, DOI 10.1182/blood.V87.10.4276.bloodjournal87104276; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; KHARBANDA S, 1995, P NATL ACAD SCI USA, V92, P6132, DOI 10.1073/pnas.92.13.6132; KIM YR, 1993, LEUKEMIA RES, V15, P409; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; Leventhal PS, 1996, J BIOL CHEM, V271, P5957, DOI 10.1074/jbc.271.11.5957; LIOUBIN MN, 1994, MOL CELL BIOL, V14, P5682, DOI 10.1128/MCB.14.9.5682; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Marks D C, 1999, Mol Cell Biol Res Commun, V1, P144, DOI 10.1006/mcbr.1999.0123; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MOUTHON MA, 1994, BLOOD, V84, P1085; MU SX, 1995, BLOOD, V86, P4532, DOI 10.1182/blood.V86.12.4532.bloodjournal86124532; Novak U, 1996, ONCOGENE, V13, P2607; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; REEDIJK M, 1992, EMBO J, V11, P1365, DOI 10.1002/j.1460-2075.1992.tb05181.x; RIEDEL H, 1986, NATURE, V324, P68, DOI 10.1038/324068a0; ROHRSCHNEIDER LR, 1989, MOL CELL BIOL, V9, P5081, DOI 10.1128/MCB.9.11.5081; ROUSSEL MF, 1990, P NATL ACAD SCI USA, V87, P6738, DOI 10.1073/pnas.87.17.6738; ROUSSEL MF, 1990, ONCOGENE, V5, P25; Roux S, 1997, ENDOCRINOLOGY, V138, P1476, DOI 10.1210/en.138.4.1476; SALEEM A, 1995, J BIOL CHEM, V270, P10380, DOI 10.1074/jbc.270.18.10380; Saragovi HU, 1998, J BIOL CHEM, V273, P34933, DOI 10.1074/jbc.273.52.34933; SHERR CJ, 1990, BLOOD, V75, P1; Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309; TAPLEY P, 1990, MOL CELL BIOL, V10, P2528, DOI 10.1128/MCB.10.6.2528; THOMAS D, 1995, J BIOL CHEM, V270, P28924, DOI 10.1074/jbc.270.48.28924; Ulloa L, 1996, EUR J NEUROSCI, V8, P1441, DOI 10.1111/j.1460-9568.1996.tb01606.x; VANDERGEER P, 1993, EMBO J, V12, P5161, DOI 10.1002/j.1460-2075.1993.tb06211.x; VANDERGEER P, 1990, MOL CELL BIOL, V10, P2991, DOI 10.1128/MCB.10.6.2991; Vijapurkar U, 1998, J BIOL CHEM, V273, P20996, DOI 10.1074/jbc.273.33.20996; Xie B, 1998, J BIOL CHEM, V273, P11576, DOI 10.1074/jbc.273.19.11576; YamamotoYamaguchi Y, 1996, EXP HEMATOL, V24, P682; Yen A, 1998, CANCER RES, V58, P3163; Yeung YG, 1998, J BIOL CHEM, V273, P17128, DOI 10.1074/jbc.273.27.17128	54	27	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2001	276	28					26211	26217		10.1074/jbc.M100213200	http://dx.doi.org/10.1074/jbc.M100213200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451VP	11290743	hybrid, Green Submitted			2022-12-27	WOS:000169823300077
J	Martin, CC; Bischof, LJ; Bergman, B; Hornbuckle, LA; Hilliker, C; Frigeri, C; Wahl, D; Svitek, CA; Wong, R; Goldman, JK; Oeser, JK; Lepretre, F; Froguel, P; O'Brien, RM; Hutton, JC				Martin, CC; Bischof, LJ; Bergman, B; Hornbuckle, LA; Hilliker, C; Frigeri, C; Wahl, D; Svitek, CA; Wong, R; Goldman, JK; Oeser, JK; Lepretre, F; Froguel, P; O'Brien, RM; Hutton, JC			Cloning and characterization of the human and rat islet-specific glucose-8-phosphatase catalytic subunit-related protein (IGRP) genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-6-PHOSPHATASE GENE; MESSENGER-RNA; DIABETIC RATS; GLUCOSE-METABOLISM; PANCREATIC-ISLETS; EXPRESSION; SEQUENCE; INSULIN; LIVER; TRANSCRIPTION	Islet-specific glucose-6-phosphatase (G6Pase) catalytic subunit-related protein (IGRP) is a homolog of the catalytic subunit of G6Pase, the enzyme that catalyzes the terminal step of the gluconeogenic pathway. Its catalytic activity, however, has not been defined, Since IGRP gene expression is restricted to islets, this suggests a possible role in the regulation of islet metabolism and, hence, insulin secretion induced by metabolites. We report here a comparative analysis of the human, mouse, and rat IGRP genes. These studies aimed to identify conserved sequences that may be critical for IGRP function and that specify its restricted tissue distribution. The single copy human IGRP gene has five exons of similar length and coding sequence to the mouse IGRP gene and is located on human chromosome 2q28-32 adjacent to the myosin heavy chain 1B gene. In contrast, the rat IGRP gene does not appear to encode a protein as a result of a series of deletions and insertions in the coding sequence. Moreover, rat IGRP mRNA, unlike mouse and human IGRP mRNA, is not expressed in islets or islet-derived cell lines, an observation that was traced by fusion gene analysis to a mutation of the TATA box motif in the mouse/human IGRP promoters to TGTA in the rat sequence. The results provide a framework for the further analysis of the molecular basis for the tissue-restricted expression of the IGRP gene and the identification of key amino acid sequences that determine its biological activity.	Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA; Inst Pasteur, Inst Biol, CNRS 8090, F-59019 Lille, France	Vanderbilt University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Hutton, JC (corresponding author), Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, 761 MRB 2, Nashville, TN 37232 USA.		FROGUEL, Philippe/O-6799-2017	FROGUEL, Philippe/0000-0003-2972-0784; lepretre, frederic/0000-0002-5249-3930	NATIONAL CANCER INSTITUTE [T32CA009385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, T32DK007563, P30DK057516] Funding Source: NIH RePORTER; NCI NIH HHS [5T32 CA09385-17] Funding Source: Medline; NIDDK NIH HHS [P30 DK 57516, P60 DK 20593, 5T32 DK07563-12] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		An J, 2001, J BIOL CHEM, V276, P10722, DOI 10.1074/jbc.M009525200; Arden SD, 1996, J CLIN INVEST, V97, P551, DOI 10.1172/JCI118448; Arden SD, 1999, DIABETES, V48, P531, DOI 10.2337/diabetes.48.3.531; Argaud D, 1996, DIABETES, V45, P1563, DOI 10.2337/diabetes.45.11.1563; Argaud D, 1997, J BIOL CHEM, V272, P12854, DOI 10.1074/jbc.272.19.12854; Bischof LJ, 2001, DIABETES, V50, P502, DOI 10.2337/diabetes.50.3.502; Bramblett DE, 2000, ADV PHARMACOL, V47, P255; BRESSAN GM, 1987, NUCLEIC ACIDS RES, V15, P10056, DOI 10.1093/nar/15.23.10056; Chou JY, 1999, TRENDS ENDOCRIN MET, V10, P104; CLINE GW, 1994, J CLIN INVEST, V94, P2369, DOI 10.1172/JCI117602; CONSOLI A, 1992, DIABETES CARE, V15, P430, DOI 10.2337/diacare.15.3.430; Ebert DH, 1999, DIABETES, V48, P543, DOI 10.2337/diabetes.48.3.543; Edlund H, 1998, DIABETES, V47, P1817, DOI 10.2337/diabetes.47.12.1817; Foster JD, 1997, P SOC EXP BIOL MED, V215, P314; Gerin I, 1997, FEBS LETT, V419, P235, DOI 10.1016/S0014-5793(97)01463-4; GERMAN M, 2000, DIABETES MELLITUS FU, P11; GRANNER DK, 1992, DIABETES CARE, V15, P369, DOI 10.2337/diacare.15.3.369; GUEST PC, 1989, BIOCHEM J, V264, P503, DOI 10.1042/bj2640503; Habener JF, 1998, P ASSOC AM PHYSICIAN, V110, P12; HABER BA, 1995, J CLIN INVEST, V95, P832, DOI 10.1172/JCI117733; Hemrika W, 1997, P NATL ACAD SCI USA, V94, P2145, DOI 10.1073/pnas.94.6.2145; JACKSON IJ, 1991, NUCLEIC ACIDS RES, V19, P3795; JACOBY DB, 1989, J BIOL CHEM, V264, P17623; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; KHAN A, 1990, DIABETES, V39, P456, DOI 10.2337/diabetes.39.4.456; KHAN A, 1995, ENDOCRINOLOGY, V136, P1934, DOI 10.1210/en.136.5.1934; KOLLMAR R, 1993, P SOC EXP BIOL MED, V203, P127; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Li N, 1998, J BIOL CHEM, V273, P28170, DOI 10.1074/jbc.273.43.28170; Li YZ, 2000, BIOCHEM BIOPH RES CO, V272, P41, DOI 10.1006/bbrc.2000.2734; LIU ZQ, 1994, BIOCHEM BIOPH RES CO, V205, P680, DOI 10.1006/bbrc.1994.2719; Massillon D, 1998, J BIOL CHEM, V273, P228, DOI 10.1074/jbc.273.1.228; Massillon D, 1996, J BIOL CHEM, V271, P9871, DOI 10.1074/jbc.271.17.9871; MILPETZ F, 1995, TRENDS BIOCHEM SCI, V20, P204, DOI 10.1016/S0968-0004(00)89009-X; Mithieux G, 1996, DIABETES, V45, P891, DOI 10.2337/diabetes.45.7.891; Mithieux G, 1997, EUR J ENDOCRINOL, V136, P137, DOI 10.1530/eje.0.1360137; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; PERALES MA, 1991, MOL CELL BIOCHEM, V101, P67; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Sambrook J., 2002, MOL CLONING LAB MANU; Sander M, 1997, J MOL MED, V75, P327, DOI 10.1007/s001090050118; Seoane J, 1997, J BIOL CHEM, V272, P26972, DOI 10.1074/jbc.272.43.26972; STEIN R, 2001, HDB PHYSL 7, V2, P25; Streeper RS, 1998, P NATL ACAD SCI USA, V95, P9208, DOI 10.1073/pnas.95.16.9208; Streeper RS, 1997, J BIOL CHEM, V272, P11698, DOI 10.1074/jbc.272.18.11698; Stukey J, 1997, PROTEIN SCI, V6, P469; TRANDABURU T, 1977, ACTA HISTOCHEM, V59, P246, DOI 10.1016/S0065-1281(77)80046-9; WADDELL ID, 1988, BIOCHEM J, V255, P471, DOI 10.1042/bj2550471; WATANABE A, 1983, ACTA MED OKAYAMA, V37, P463; Winter W E, 2000, Pediatr Diabetes, V1, P88, DOI 10.1034/j.1399-5448.2000.010206.x; WOBBE CR, 1990, MOL CELL BIOL, V10, P3859, DOI 10.1128/MCB.10.8.3859	53	62	72	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					25197	25207		10.1074/jbc.M101549200	http://dx.doi.org/10.1074/jbc.M101549200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11297555	hybrid, Green Published			2022-12-27	WOS:000169800700103
J	Kwan, CP; Venkataraman, G; Shriver, Z; Raman, R; Liu, DF; Qi, YW; Varticovski, L; Sasisekharan, R				Kwan, CP; Venkataraman, G; Shriver, Z; Raman, R; Liu, DF; Qi, YW; Varticovski, L; Sasisekharan, R			Probing fibroblast growth factor dimerization and role of heparin-like glycosaminoglycans in modulating dimerization and signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FGF RECEPTOR DIMERIZATION; NECROSIS-FACTOR RECEPTOR; SULFATE OLIGOSACCHARIDES; CRYSTAL-STRUCTURE; SELF-ASSOCIATION; BINDING; ACTIVATION; COMPLEX; OLIGOMERIZATION; LIGAND	For a number of growth factors and cytokines, ligand dimerization is believed to be central to the formation of an active signaling complex. In the case of fibroblast growth factor-2 (FGF2) signaling, heparin/heparan sulfate-like glycosaminoglycans (HLGAGs) are involved through interaction with both FGF2 and its receptors (FGFRs) in assembling a tertiary complex and modulating FGF2 activity. Biochemical data have suggested different modes of HLGAG-induced FGF2 dimerization involving specific protein-protein contacts. In addition, several recent x-ray crystallography studies of FGF(.)FGFR and FGF(.)FGFR(.)HLGAG complexes have revealed other modes of molecular assemblage, with no FGF-FGF contacts. All these different biochemical and structural findings have clarified less and in fact raised more questions as to which mode of FGF2 dimerization, if any, is essential for signaling. In this study, we address the issue of FGF2 dimerization in signaling using a combination of biochemical, biophysical, and site-directed mutagenesis approaches. Our findings presented here provide direct evidence of FGF2 dimerization in mediating FGF2 signaling.	MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; Harvard Univ, MIT, Div Hlth Sci & Technol, Div Bioengn & Environm Hlth, Cambridge, MA 02139 USA; Tufts Univ, St Elizabeths Med Ctr, Sch Med, Dept Med, Boston, MA 02135 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); St. Elizabeth's Medical Center; Tufts University	Sasisekharan, R (corresponding author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave,Bldg 16-561, Cambridge, MA 02139 USA.			KWAN, CHI-PONG/0000-0002-7654-0826; Varticovski, Lyuba/0000-0002-5105-9008	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059966] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL59966] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ballinger MD, 1998, NAT STRUCT BIOL, V5, P938, DOI 10.1038/2911; Bisaccia F, 1996, BBA-PROTEIN STRUCT M, V1292, P281, DOI 10.1016/0167-4838(95)00215-4; Davis JC, 1999, BIOCHEM J, V341, P613, DOI 10.1042/0264-6021:3410613; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Dowd CJ, 1999, J BIOL CHEM, V274, P5236, DOI 10.1074/jbc.274.8.5236; ERIKSSON AE, 1993, PROTEIN SCI, V2, P1274, DOI 10.1002/pro.5560020810; Ernst S, 1996, BIOCHEM J, V315, P589, DOI 10.1042/bj3150589; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; FLAUMENHAFT R, 1990, J CELL BIOL, V111, P1651, DOI 10.1083/jcb.111.4.1651; Gallagher JT, 1997, BIOCHEM SOC T, V25, P1206, DOI 10.1042/bst0251206; GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95, DOI 10.1210/edrv-8-2-95; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Herr AB, 1997, J BIOL CHEM, V272, P16382, DOI 10.1074/jbc.272.26.16382; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; Moy FJ, 1996, BIOCHEMISTRY-US, V35, P13552, DOI 10.1021/bi961260p; Moy FJ, 1997, BIOCHEMISTRY-US, V36, P4782, DOI 10.1021/bi9625455; Naismith JH, 1996, STRUCTURE, V4, P1251, DOI 10.1016/S0969-2126(96)00134-7; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; Padera R, 1999, FASEB J, V13, P1677, DOI 10.1096/fasebj.13.13.1677; PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Pye DA, 1999, J BIOL CHEM, V274, P13456, DOI 10.1074/jbc.274.19.13456; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Stauber DJ, 2000, P NATL ACAD SCI USA, V97, P49, DOI 10.1073/pnas.97.1.49; Taipale J, 1997, FASEB J, V11, P51, DOI 10.1096/fasebj.11.1.9034166; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Venkataraman G, 1999, P NATL ACAD SCI USA, V96, P3658, DOI 10.1073/pnas.96.7.3658; Venkataraman G, 1996, P NATL ACAD SCI USA, V93, P845, DOI 10.1073/pnas.93.2.845; Venkataraman G, 1999, P NATL ACAD SCI USA, V96, P1892, DOI 10.1073/pnas.96.5.1892; WILKIE AOM, 1995, CURR BIOL, V5, P500; ZHANG JD, 1991, P NATL ACAD SCI USA, V88, P3446, DOI 10.1073/pnas.88.8.3446	50	38	40	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23421	23429		10.1074/jbc.M010786200	http://dx.doi.org/10.1074/jbc.M010786200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11292822	hybrid			2022-12-27	WOS:000169531100028
J	Lukashova, V; Asselin, C; Krolewski, JJ; Rola-Pleszczynski, M; Stankova, J				Lukashova, V; Asselin, C; Krolewski, JJ; Rola-Pleszczynski, M; Stankova, J			G-protein-independent activation of Tyk2 by the platelet-activating factor receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II AT(1) RECEPTOR; NF-KAPPA-B; INTERFERON-ALPHA RECEPTOR; GENE-EXPRESSION; TYROSINE PHOSPHORYLATION; COUPLED RECEPTORS; SIGNAL-TRANSDUCTION; JAK/STAT PATHWAY; CYTOPLASMIC DOMAINS; HUMAN MONOCYTES	Platelet-activating factor (PAF) is a potent pro-inflammatory phospholipid with multiple physiological and pathological effects. PAF exerts its activity through a specific heptohelical G-protein coupled receptor, expressed on a variety of cell types, including leukocytes. In this study, we showed that PAF induced a rapid tyrosine phosphorylation of the Tyk2 kinase in the monocytic cell lines U937 and MonoMac-1. PAF-initiated Tyk2 phosphorylation was also observed in COS-7 cells transiently transfected with the human PAF receptor (PAFR) and Tyk2 cDNAs. In addition, we found that Tyk2 co-immunoprecipitated and co-localized with PAFR, independently of ligand binding. Deletion mutants of Tyk2 indicated that the N terminus of the kinase was important for the binding to PAFR. Activation of Tyk2 was followed by a time-dependent 2-4-fold increase in the level of tyrosine phosphorylation of signal transducers and activators of transcription 1 (STAT1), STAT2, and STAT3 and a sustained 2.5-fold increase in STAT5 tyrosine phosphorylation. In MonoMac-1 cells, STAT1 and STAT3 translocated to the nucleus following PAF stimulation, and their translocation in transiently transfected COS-7 cells was shown to be dependent on the presence of Tyk2. In addition, when COS-7 cells were transfected with PAFR and constructs containing PAFR promoter 1, coupled to the luciferase reporter gene, PAF induced a 3.6-fold increase in promoter activation in the presence of Tyk2. Finally, PAFR mutants that could not couple to G-proteins were found to effectively mediate Tyk2 activation and signaling. Taken together, these findings suggest an important role for the Janus kinase/STAT pathway in PAFR signaling, independent of G-proteins, and in the regulation of PAF receptor expression by its ligand.	Univ Sherbrooke, Fac Med, Div Immunol, Dept Pediat, Sherbrooke, PQ J1H 5N4, Canada; Univ Sherbrooke, Dept Anat & Cell Biol, Sherbrooke, PQ J1H 5N4, Canada; Univ Calif Irvine, Dept Pathol, Irvine, CA 92697 USA	University of Sherbrooke; University of Sherbrooke; University of California System; University of California Irvine	Stankova, J (corresponding author), Univ Sherbrooke, Fac Med, Div Immunol, Dept Pediat, 3001 N 12th Ave, Sherbrooke, PQ J1H 5N4, Canada.							Ali MS, 2000, J BIOL CHEM, V275, P15586, DOI 10.1074/jbc.M908931199; Ali MS, 1997, J BIOL CHEM, V272, P23382, DOI 10.1074/jbc.272.37.23382; Araki T, 1998, EMBO J, V17, P4018, DOI 10.1093/emboj/17.14.4018; BRAQUET P, 1987, PHARMACOL REV, V39, P97; Calcerrada MC, 1999, BRAIN RES, V835, P275, DOI 10.1016/S0006-8993(99)01612-1; CHAO W, 1993, BIOCHEM J, V292, P617, DOI 10.1042/bj2920617; Chaqour B, 1999, J MOL CELL CARDIOL, V31, P1345, DOI 10.1006/jmcc.1999.0967; COLAMONICI OR, 1994, J BIOL CHEM, V269, P3518; Dagenais P, 1997, INFLAMM RES, V46, pS161; Dagenais P, 1997, J LEUKOCYTE BIOL, V61, P106, DOI 10.1002/jlb.61.1.106; DHAR A, 1994, J BIOL CHEM, V269, P9123; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; GuilletDeniau I, 1997, J BIOL CHEM, V272, P14825, DOI 10.1074/jbc.272.23.14825; Herrington J, 1999, J BIOL CHEM, V274, P5138, DOI 10.1074/jbc.274.8.5138; Heuss C, 2000, TRENDS NEUROSCI, V23, P469, DOI 10.1016/S0166-2236(00)01643-X; HUANG SJ, 1988, BIOCHEM J, V249, P839, DOI 10.1042/bj2490839; Hunt RA, 1999, HYPERTENSION, V34, P603, DOI 10.1161/01.HYP.34.4.603; Izumi T, 1995, BBA-LIPID LIPID MET, V1259, P317, DOI 10.1016/0005-2760(95)00171-9; Jiao HY, 1996, MOL CELL BIOL, V16, P6985; KRAVCHENKO VV, 1995, J BIOL CHEM, V270, P14928, DOI 10.1074/jbc.270.25.14928; KURUVILLA A, 1994, J IMMUNOL, V153, P5433; Le Gouill C, 1999, J BIOL CHEM, V274, P12548, DOI 10.1074/jbc.274.18.12548; LeGouill C, 1997, J BIOL CHEM, V272, P21289, DOI 10.1074/jbc.272.34.21289; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Liu KD, 1998, CURR OPIN IMMUNOL, V10, P271, DOI 10.1016/S0952-7915(98)80165-9; MARRERO MB, 1995, NATURE, V375, P247, DOI 10.1038/375247a0; Mellado M, 1998, J IMMUNOL, V161, P805; Mutoh H, 1996, P NATL ACAD SCI USA, V93, P774, DOI 10.1073/pnas.93.2.774; MUTOH H, 1993, FEBS LETT, V322, P129, DOI 10.1016/0014-5793(93)81552-B; MUTOH H, 1994, BIOCHEM BIOPH RES CO, V205, P1130, DOI 10.1006/bbrc.1994.2783; MUTOH H, 1994, BIOCHEM BIOPH RES CO, V205, P1137, DOI 10.1006/bbrc.1994.2784; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; OLIVEIRA L, 1994, TRENDS PHARMACOL SCI, V15, P170, DOI 10.1016/0165-6147(94)90137-6; OUELLET S, 1994, J IMMUNOL, V152, P5092; PANG JHS, 1995, J BIOL CHEM, V270, P14123, DOI 10.1074/jbc.270.23.14123; PARENT JL, 1993, BIOCHEM BIOPH RES CO, V197, P1443, DOI 10.1006/bbrc.1993.2639; Parent JL, 1996, BIOCHEM BIOPH RES CO, V219, P968, DOI 10.1006/bbrc.1996.0341; Parent JL, 1996, J BIOL CHEM, V271, P23298, DOI 10.1074/jbc.271.38.23298; Pellegrini S, 1997, EUR J BIOCHEM, V248, P615, DOI 10.1111/j.1432-1033.1997.00615.x; Rezaul K, 1997, BIOCHEM BIOPH RES CO, V239, P23, DOI 10.1006/bbrc.1997.7419; Rodriguez-Frade JM, 1999, J CELL BIOL, V144, P755, DOI 10.1083/jcb.144.4.755; ROLAPLESZCZYNSKI M, 1993, J LIPID MEDIATOR, V6, P175; Shimizu T, 1996, ADV EXP MED BIOL, V416, P79; SHUKLA SD, 1991, LIPIDS, V26, P1028, DOI 10.1007/BF02536496; Snyder F., 1990, AM J PHYSIOL, V259, P697; Soldi R, 1996, ONCOGENE, V13, P515; THIVIERGE M, 1993, J BIOL CHEM, V268, P17457; vanBiesen T, 1996, J BIOL CHEM, V271, P1266, DOI 10.1074/jbc.271.3.1266; VENABLE ME, 1993, J LIPID RES, V34, P691; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wang H, 1999, IMMUNOLOGY, V97, P447, DOI 10.1046/j.1365-2567.1999.00784.x; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Wong M, 1998, J BIOL CHEM, V273, P309, DOI 10.1074/jbc.273.1.309; Yan H, 1998, J BIOL CHEM, V273, P4046, DOI 10.1074/jbc.273.7.4046; Yang HH, 1997, J IMMUNOL, V158, P2771; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321	58	52	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24113	24121		10.1074/jbc.M100720200	http://dx.doi.org/10.1074/jbc.M100720200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11309383	hybrid			2022-12-27	WOS:000169531100118
J	Guo, YS; Hellmich, MR; Wen, XD; Townsend, CM				Guo, YS; Hellmich, MR; Wen, XD; Townsend, CM			Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase-2 expression in intestinal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIN-RELEASING-PEPTIDE; MESSENGER-RNA STABILITY; HUMAN-BREAST-CANCER; GROWTH-FACTOR; GENE-EXPRESSION; FACTOR-ALPHA; RECEPTOR SUBTYPES; KAPPA-B; KINASE; AP-1	Colorectal carcinogenesis is a complex, multistep process involving genetic alterations and progressive changes in signaling pathways regulating intestinal epithelial cell proliferation, differentiation, and apoptosis, Although cyclooxygenase-2 (COX-2), gastrin-releasing peptide (GRP), and its receptor, GRP-R, are not normally expressed by the epithelial cells lining the human colon, the levels of all three proteins are aberrantly overexpressed in premalignant adenomatous polyps and colorectal carcinomas of humans. Overexpression of these proteins is associated with altered epithelial cell growth, adhesion, and tumor cell invasiveness, both in vitro and in vivo; however, a mechanistic link between GRP-R-mediated signaling pathways and increased COX-2 overexpression has not been established, We report that bombesin, a homolog of GRP, potently stimulates the expression of COX-2 mRNA and protein as well as the release of prostaglandin E-2 from a rat intestinal epithelial cell line engineered to express GRP-R. Bombesin stimulation of COX-2 expression requires an increase in [Ca2+](i), activation of extracellular signal-regulated kinase (ERR)-1 and -2 and p38(MAPK), and increased activation and expression of the transcription factors Elk-1, ATF-S, c-Fos, and c-Jun, These data suggest that the expression of GRP-R in intestinal epithelial cells may play a role in carcinogenesis by stimulating COX-2 overexpression through an activator protein-1-dependent pathway.	Univ Texas, Med Branch, Dept Surg, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Physiol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Biophys, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Townsend, CM (corresponding author), Univ Texas, Med Branch, Dept Surg, 301 Univ Blvd, Galveston, TX 77555 USA.	ctownsen@utmb.edu			NIDDK NIH HHS [P01 DK35608, R01 DK48345] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048345, P01DK035608] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BeazerBarclay Y, 1996, CARCINOGENESIS, V17, P1757, DOI 10.1093/carcin/17.8.1757; BLAY J, 1984, CELL BIOL INT REP, V8, P551, DOI 10.1016/0309-1651(84)90054-7; Boolbol SK, 1996, CANCER RES, V56, P2556; Carroll RE, 1999, AM J PHYSIOL-GASTR L, V276, pG655, DOI 10.1152/ajpgi.1999.276.3.G655; Castano E, 1997, J PHARMACOL EXP THER, V280, P366; Chan G, 1999, CANCER RES, V59, P991; Cheng HF, 2000, J CLIN INVEST, V106, P681, DOI 10.1172/JCI10318; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CUTTITTA F, 1985, NATURE, V316, P823, DOI 10.1038/316823a0; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; EVERS BM, 1995, MOL CELL BIOL, V15, P3870; FRUCHT H, 1992, CANCER RES, V52, P1114; Fujita T, 1998, CANCER RES, V58, P4823; GIACCHETTI S, 1990, INT J CANCER, V46, P293, DOI 10.1002/ijc.2910460226; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Guan ZH, 1998, J BIOL CHEM, V273, P28670, DOI 10.1074/jbc.273.44.28670; GUO YS, 1995, J AM COLL SURGEONS, V181, P145; Guo YS, 1998, J CELL PHYSIOL, V175, P141, DOI 10.1002/(SICI)1097-4652(199805)175:2<141::AID-JCP3>3.0.CO;2-O; Gupta S, 2000, PROSTATE, V42, P73, DOI 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G; HANAZAWA S, 1993, J BIOL CHEM, V268, P9526; Hecht JR, 1997, PROSTAG OTH LIPID M, V54, P757, DOI 10.1016/S0090-6980(97)00162-7; Hellmich MR, 1999, J BIOL CHEM, V274, P23901, DOI 10.1074/jbc.274.34.23901; Hellmich MR, 1997, P NATL ACAD SCI USA, V94, P751, DOI 10.1073/pnas.94.2.751; Jacoby RF, 1996, CANCER RES, V56, P710; Jian XY, 1999, J BIOL CHEM, V274, P11573, DOI 10.1074/jbc.274.17.11573; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KROOG GS, 1995, MED RES REV, V15, P389, DOI 10.1002/med.2610150502; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Lukiw WJ, 1998, P NATL ACAD SCI USA, V95, P3914, DOI 10.1073/pnas.95.7.3914; Matsuura H, 1999, J BIOL CHEM, V274, P29138, DOI 10.1074/jbc.274.41.29138; Miller C, 1998, J CELL BIOCHEM, V69, P392, DOI 10.1002/(SICI)1097-4644(19980615)69:4<392::AID-JCB2>3.3.CO;2-Z; MOGHIMZADEH E, 1983, NEUROSCIENCE, V10, P553, DOI 10.1016/0306-4522(83)90152-5; Mohan R, 2000, J BIOL CHEM, V275, P10405, DOI 10.1074/jbc.275.14.10405; Molina-Holgado E, 2000, BRIT J PHARMACOL, V131, P152, DOI 10.1038/sj.bjp.0703557; Morris JK, 1996, J BIOL CHEM, V271, P16633, DOI 10.1074/jbc.271.28.16633; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murata H, 1999, AM J GASTROENTEROL, V94, P451; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; PANG L, 1993, BIOCHEM J, V289, P283, DOI 10.1042/bj2890283; PENNYPACKER KR, 1994, FASEB J, V8, P475, DOI 10.1096/fasebj.8.8.8181665; Preston SR, 1996, CRIT REV ONCOL HEMAT, V23, P225, DOI 10.1016/1040-8428(96)00204-1; Reddy ST, 2000, J BIOL CHEM, V275, P3107, DOI 10.1074/jbc.275.5.3107; RodriguezFernandez JL, 1996, J BIOL CHEM, V271, P27895, DOI 10.1074/jbc.271.44.27895; ROLLAND PH, 1980, JNCI-J NATL CANCER I, V64, P1061; Rozengurt E, 1998, J CELL PHYSIOL, V177, P507, DOI 10.1002/(SICI)1097-4652(199812)177:4<507::AID-JCP2>3.0.CO;2-K; Sawaoka H, 1999, LAB INVEST, V79, P1469; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Seol DW, 2000, ONCOGENE, V19, P1132, DOI 10.1038/sj.onc.1203404; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; Sheng HM, 2000, J BIOL CHEM, V275, P6628, DOI 10.1074/jbc.275.9.6628; Strakova Z, 1998, AM J PHYSIOL-ENDOC M, V274, pE634, DOI 10.1152/ajpendo.1998.274.4.E634; Sun BD, 2000, PROSTATE, V42, P295; Tomozawa S, 2000, BRIT J CANCER, V83, P324, DOI 10.1054/bjoc.2000.1270; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; von Knethen A, 1999, J IMMUNOL, V163, P2858; von Knethen A, 2000, BIOCHEMISTRY-US, V39, P1532, DOI 10.1021/bi990820s; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Wolff H, 1998, CANCER RES, V58, P4997; XIE WL, 1994, MOL CELL BIOL, V14, P6531, DOI 10.1128/MCB.14.10.6531; Xie WL, 1996, J BIOL CHEM, V271, P31742, DOI 10.1074/jbc.271.49.31742; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; YANG Y, 2000, J BIOL CHEM, V275, P28281; Yip-Schneider MT, 2000, CARCINOGENESIS, V21, P139, DOI 10.1093/carcin/21.2.139; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	68	115	122	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22941	22947		10.1074/jbc.M101801200	http://dx.doi.org/10.1074/jbc.M101801200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11292836	hybrid			2022-12-27	WOS:000169412700128
J	Schotte, P; Schauvliege, R; Janssens, S; Beyaert, R				Schotte, P; Schauvliege, R; Janssens, S; Beyaert, R			The cathepsin B inhibitor z-FA.fmk inhibits cytokine production in macrophages stimulated by lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; PEPTIDYL FLUOROMETHYL KETONES; RHEUMATOID-ARTHRITIS; TRANSCRIPTION FACTOR; DEPENDENT TRANSCRIPTION; ALPHA DEGRADATION; GENE-EXPRESSION; ACTIVATION; CELLS	Cathepsin B has previously been shown to proteolytically activate the proinflammatory caspase-11 in vitro, Here we show that cathepsin B is not involved in activation of caspase-11 induced by lipopolysaccharide (LPS) and subsequent maturation of interleukin (IL)-1 beta in macrophages. Nevertheless, we found that the cathepsin B inhibitor benzyloxycarbonyl-Phe-Ala-fluoromethylketone (z-FA.fmk) prevents LPS-induced production of IL-1 alpha, IL-1 beta, and tumor necrosis factor at the transcriptional level. The latter was not because of cathepsin B inhibition, but was mediated by inhibition of the transactivation potential of the nuclear factor kappaB (NF-kappaB). z-FA.fmk did not prevent LPS-induced activation of p38 mitogen-activated protein kinase, which was shown to be involved in NF-kappaB transactivation in response to LPS. These results suggest that the previously described therapeutic effect of z-FA.fmk in the treatment of rheumatoid arthritis might not only result from inhibition of cathepsin B but also implicates an important contribution from the inhibition of NF-kappaB-dependent gene expression.	Flanders Interuniv Inst Biotechnol, Dept Mol Biol, Unit Mol Signal Transduct Inflammat, B-9000 Ghent, Belgium; State Univ Ghent, B-9000 Ghent, Belgium	Ghent University	Beyaert, R (corresponding author), Flanders Interuniv Inst Biotechnol, Dept Mol Biol, Unit Mol Signal Transduct Inflammat, KL Ledeganckstr 35, B-9000 Ghent, Belgium.		Beyaert, Rudi/B-2589-2009; Janssens, Sophie/HHN-1756-2022	Beyaert, Rudi/0000-0002-5704-582X				AHMED NK, 1992, BIOCHEM PHARMACOL, V44, P1201, DOI 10.1016/0006-2952(92)90385-V; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Bergmann M, 1998, J BIOL CHEM, V273, P6607, DOI 10.1074/jbc.273.12.6607; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Brennan P, 1998, BIOCHEM PHARMACOL, V55, P965, DOI 10.1016/S0006-2952(97)00535-2; Codorean E, 1985, Morphol Embryol (Bucur), V31, P269; Desmedt M, 1998, J IMMUNOL, V160, P5300; EECKHOUT Y, 1977, BIOCHEM J, V166, P21, DOI 10.1042/bj1660021; ESSER RE, 1993, J RHEUMATOL, V20, P1176; Gabay C, 1998, SPRINGER SEMIN IMMUN, V20, P229, DOI 10.1007/s002810050032; Goto M, 1999, CYTOKINE, V11, P16, DOI 10.1006/cyto.1998.0390; HARTH G, 1993, MOL BIOCHEM PARASIT, V58, P17, DOI 10.1016/0166-6851(93)90086-D; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; KOBAYASHI H, 1993, BIOCHIM BIOPHYS ACTA, V1178, P55, DOI 10.1016/0167-4889(93)90109-3; Kordes U, 2000, LEUKEMIA, V14, P399, DOI 10.1038/sj.leu.2401705; Lemaire R, 1997, BRIT J RHEUMATOL, V36, P735; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Means TK, 2000, J LEUKOCYTE BIOL, V67, P885, DOI 10.1002/jlb.67.6.885; Mort J S, 1985, Prog Clin Biol Res, V180, P243; MORT JS, 1984, ARTHRITIS RHEUM, V27, P509, DOI 10.1002/art.1780270505; Nasuhara Y, 1999, J BIOL CHEM, V274, P19965, DOI 10.1074/jbc.274.28.19965; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; RASNICK D, 1985, ANAL BIOCHEM, V149, P461, DOI 10.1016/0003-2697(85)90598-6; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Schotte P, 1998, BIOCHEM BIOPH RES CO, V251, P379, DOI 10.1006/bbrc.1998.9425; SHAW E, 1986, BIOMED BIOCHIM ACTA, V45, P1397; SHINAGAWA T, 1990, P NATL ACAD SCI USA, V87, P1927, DOI 10.1073/pnas.87.5.1927; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; TRABANDT A, 1991, ARTHRITIS RHEUM, V34, P1444; VANDENABEELE P, 1990, J IMMUNOL METHODS, V135, P25, DOI 10.1016/0022-1759(90)90252-Q; VANNOORDEN CJF, 1988, J RHEUMATOL, V15, P1525; Votta BJ, 1997, J BONE MINER RES, V12, P1396, DOI 10.1359/jbmr.1997.12.9.1396; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Watkins LR, 1999, LIFE SCI, V65, P449, DOI 10.1016/S0024-3205(99)00095-8	37	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21153	21157		10.1074/jbc.M102239200	http://dx.doi.org/10.1074/jbc.M102239200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11290751	hybrid			2022-12-27	WOS:000169297900049
J	Sharma, AK; Kuhns, JJ; Yan, SQ; Friedline, RH; Long, B; Tisch, R; Collins, EJ				Sharma, AK; Kuhns, JJ; Yan, SQ; Friedline, RH; Long, B; Tisch, R; Collins, EJ			Class I major histocompatibility complex anchor substitutions alter the conformation of T cell receptor contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE BINDING; STRUCTURAL BASIS; 3-DIMENSIONAL STRUCTURE; REVERSE-TRANSCRIPTASE; ANGSTROM RESOLUTION; ANTITUMOR IMMUNITY; CRYSTAL-STRUCTURES; VIRAL PEPTIDES; HIGH-AFFINITY; ANTIGEN	An immunogenic peptide (GP2) derived from HER-2/neu binds to HLA-A2.1 very poorly. Some altered-peptide ligands (APL) of GP2 have increased binding affinity and generate improved cytotoxic T lymphocyte recognition of GP2-presenting tumor cells, but most do not. Increases in binding affinity of single-substitution APL are not additive in double-substitution APL. A common first assumption about peptide binding to class I major histocompatibility complex is that each residue binds independently. In addition, immunologists interested in immunotherapy frequently assume that anchor substitutions do not affect T cell receptor contact residues. However, the crystal structures of two GP2 APL show that the central residues change position depending on the identity of the anchor residue(s), Thus it is clear that subtle changes in the identity of anchor residues may have significant effects on the positions of the T cell receptor contact residues.	Univ N Carolina, Dept Microbiol & Immunol, CB 7290, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Collins, EJ (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, CB 7290, 804 ME Jones Bldg, Chapel Hill, NC 27599 USA.	edward_collins@med.unc.edu						Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Batalia MA, 1997, BIOPOLYMERS, V43, P281, DOI 10.1002/(SICI)1097-0282(1997)43:4<281::AID-BIP3>3.0.CO;2-R; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Bouvier M, 1998, PROTEINS, V33, P97, DOI 10.1002/(SICI)1097-0134(19981001)33:1<97::AID-PROT9>3.0.CO;2-I; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CHEN WS, 1994, MOL IMMUNOL, V31, P1069; Clay TM, 1999, J IMMUNOL, V162, P1749; COLBERT RA, 1994, IMMUNITY, V1, P121, DOI 10.1016/1074-7613(94)90105-8; Collins EJ, 1999, J IMMUNOL, V162, P331; Dannull J, 2000, CANCER RES, V60, P5522; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; El-Shami KM, 2000, INT J CANCER, V85, P236, DOI 10.1002/(SICI)1097-0215(20000115)85:2<236::AID-IJC14>3.3.CO;2-X; Fong L, 1997, J IMMUNOL, V159, P3113; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garboczi DN, 1999, IMMUNITY, V10, P1, DOI 10.1016/S1074-7613(00)80001-1; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; GUO HC, 1993, P NATL ACAD SCI USA, V90, P8053, DOI 10.1073/pnas.90.17.8053; Harada M, 2001, CANCER RES, V61, P1089; Heukamp LC, 2001, INT J CANCER, V91, P385, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1051>3.0.CO;2-Z; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kessler JH, 2001, J EXP MED, V193, P73, DOI 10.1084/jem.193.1.73; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; Kirksey TJ, 1999, J BIOL CHEM, V274, P37259, DOI 10.1074/jbc.274.52.37259; Kuhns JJ, 1999, J BIOL CHEM, V274, P36422, DOI 10.1074/jbc.274.51.36422; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; Lehner PJ, 1998, CURR BIOL, V8, pR605, DOI 10.1016/S0960-9822(98)70387-2; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Micheletti F, 1999, EUR J IMMUNOL, V29, P2579, DOI 10.1002/(SICI)1521-4141(199908)29:08<2579::AID-IMMU2579>3.0.CO;2-E; Minev B, 2000, P NATL ACAD SCI USA, V97, P4796, DOI 10.1073/pnas.070560797; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ono T, 1998, J IMMUNOL, V161, P5454; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; PARKER KC, 1994, J IMMUNOL, V152, P163; Parkhurst MR, 1996, J IMMUNOL, V157, P2539; PEOPLES GE, 1995, P NATL ACAD SCI USA, V92, P432, DOI 10.1073/pnas.92.2.432; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; POGUE RR, 1995, P NATL ACAD SCI USA, V92, P8166, DOI 10.1073/pnas.92.18.8166; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; SILVER ML, 1992, NATURE, V360, P367, DOI 10.1038/360367a0; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; STUBER G, 1994, EUR J IMMUNOL, V24, P765, DOI 10.1002/eji.1830240341; YOSHINO I, 1994, CANCER RES, V54, P3387; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6	60	50	54	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21443	21449		10.1074/jbc.M010791200	http://dx.doi.org/10.1074/jbc.M010791200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11287414	hybrid, Green Published			2022-12-27	WOS:000169297900087
J	Gmachl, MJS; Wimmer, C				Gmachl, MJS; Wimmer, C			Sequential involvement of P115, SNAREs, and Rab proteins in intra-Golgi protein transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; SENSITIVE FUSION PROTEIN; DISSOCIATION INHIBITOR ISOFORM; HOMOTYPIC VACUOLE FUSION; CELL-FREE SYSTEM; MEMBRANE-FUSION; VESICULAR TRANSPORT; ALPHA-SNAP; MOLECULAR-CLONING; SYNTAXIN FAMILY	Delivery of transport vesicles to their receptor compartment involves tethering, priming, and fusion. Soluble NSF attachment protein-alpha (alpha SNAP) mediates the disruption of SNAREs by N-ethylmaleimide sensitive factor (NSF) and was employed to determine the hierarchy of proteins responsible for intra-Golgi protein transport. The N-terminal 23 amino acids of alpha SNAP are necessary for SNARE binding. The antibody 2F10 recognizes this SNARE interaction domain of alpha SNAP and inhibits intra-Golgi protein transport reversibly. This antibody was applied to modify the transport assay to determine the protein requirements relative to the action of alpha SNAP and NSF. We found that 1) p115 acts independently of alpha SNAP and NSF, 2) SNAREs are required after tethering and interact selectively after activation by alpha SNAP and NSF, and 3) Rab proteins act after SNARE activation and before fusion.	Basel Inst Immunol, CH-4005 Basel, Switzerland; Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Wimmer, C (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.	wimmer@bii.ch						ANTONY C, 1992, J CELL SCI, V103, P785; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P413, DOI 10.1016/0003-9861(85)90046-3; BALCH WE, 1984, CELL, V39, P525, DOI 10.1016/0092-8674(84)90459-8; Banerjee A, 1996, J BIOL CHEM, V271, P20223, DOI 10.1074/jbc.271.34.20223; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; Barr FA, 1999, CURR BIOL, V9, P381, DOI 10.1016/S0960-9822(99)80167-5; BARROSO M, 1995, P NATL ACAD SCI USA, V92, P527, DOI 10.1073/pnas.92.2.527; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennwald P, 2000, J CELL BIOL, V149, P1, DOI 10.1083/jcb.149.1.1; BURTON J, 1993, NATURE, V361, P464, DOI 10.1038/361464a0; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; CHEN YT, 1993, P NATL ACAD SCI USA, V90, P6508, DOI 10.1073/pnas.90.14.6508; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; CLARY DO, 1990, J BIOL CHEM, V265, P10109; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; DEBELLO WM, 1995, NATURE, V373, P626, DOI 10.1038/373626a0; ELAZAR Z, 1994, J BIOL CHEM, V269, P794; ELAZAR Z, 1994, J CELL BIOL, V124, P415, DOI 10.1083/jcb.124.4.415; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; FRIES E, 1980, P NATL ACAD SCI-BIOL, V77, P3870, DOI 10.1073/pnas.77.7.3870; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; Hay JC, 1997, CELL, V89, P149, DOI 10.1016/S0092-8674(00)80191-9; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; JANOUEIXLEROSEY I, 1995, J BIOL CHEM, V270, P14801, DOI 10.1074/jbc.270.24.14801; KEE Y, 1995, NEURON, V14, P991, DOI 10.1016/0896-6273(95)90337-2; Lane J, 1998, BBA-REV BIOMEMBRANES, V1376, P27, DOI 10.1016/S0304-4157(97)00010-5; Lin CC, 1999, J CELL BIOL, V147, P1457, DOI 10.1083/jcb.147.7.1457; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Lowe SL, 1997, NATURE, V389, P881, DOI 10.1038/39923; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; MARTINEZ O, 1994, J CELL BIOL, V127, P1575, DOI 10.1083/jcb.127.6.1575; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Mayer T, 1996, J BIOL CHEM, V271, P16097, DOI 10.1074/jbc.271.27.16097; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A; Morgan A, 1996, NATURE, V382, P680, DOI 10.1038/382680a0; Nagahama M, 1996, J CELL BIOL, V133, P507, DOI 10.1083/jcb.133.3.507; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; NISHIMURA N, 1994, J BIOL CHEM, V269, P14191; OLKKONEN VM, 1993, J CELL SCI, V106, P1249; Orci L, 1998, P NATL ACAD SCI USA, V95, P2279, DOI 10.1073/pnas.95.5.2279; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Pfeffer SR, 1995, COLD SPRING HARB SYM, V60, P221, DOI 10.1101/SQB.1995.060.01.025; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Robinson LJ, 1998, CURR OPIN CELL BIOL, V10, P483, DOI 10.1016/S0955-0674(98)80063-X; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; Sapperstein SK, 1996, J CELL BIOL, V132, P755, DOI 10.1083/jcb.132.5.755; SAPPERSTEIN SK, 1995, P NATL ACAD SCI USA, V92, P522, DOI 10.1073/pnas.92.2.522; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Sato K, 1998, SCIENCE, V281, P700, DOI 10.1126/science.281.5377.700; SEOG DH, 1994, J BIOCHEM-TOKYO, V116, P1341, DOI 10.1093/oxfordjournals.jbchem.a124685; SHISHEVA A, 1994, MOL CELL BIOL, V14, P3459, DOI 10.1128/MCB.14.5.3459; Simonsen A, 1998, EUR J CELL BIOL, V75, P223, DOI 10.1016/S0171-9335(98)80116-7; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Subramaniam VN, 1996, SCIENCE, V272, P1161, DOI 10.1126/science.272.5265.1161; TAGAYA M, 1993, J BIOL CHEM, V268, P2662; Tang BL, 1998, BIOCHEM BIOPH RES CO, V242, P345, DOI 10.1006/bbrc.1997.7966; Tang BL, 1998, BIOCHEM BIOPH RES CO, V242, P673, DOI 10.1006/bbrc.1997.8029; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Ungermann C, 2000, P NATL ACAD SCI USA, V97, P8889, DOI 10.1073/pnas.160269997; WATERS MG, 1992, J CELL BIOL, V118, P1015, DOI 10.1083/jcb.118.5.1015; WATTENBERG BW, 1992, J CELL BIOL, V118, P1321, DOI 10.1083/jcb.118.6.1321; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WEIDMAN PJ, 1989, J CELL BIOL, V108, P1589, DOI 10.1083/jcb.108.5.1589; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247; Wong SH, 1999, MOL BIOL CELL, V10, P119, DOI 10.1091/mbc.10.1.119; Xu Y, 1997, J BIOL CHEM, V272, P20162, DOI 10.1074/jbc.272.32.20162; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	87	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18178	18184		10.1074/jbc.M101513200	http://dx.doi.org/10.1074/jbc.M101513200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279210	hybrid			2022-12-27	WOS:000168866500076
J	Isaacs, JS; Saito, S; Neckers, LM				Isaacs, JS; Saito, S; Neckers, LM			Requirement for HDM2 activity in the rapid degradation of p53 in neuroblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; NUCLEAR EXPORT SIGNAL; RING-FINGER DOMAIN; DNA-DAMAGE; CELL-LINES; MDM2-MEDIATED DEGRADATION; APOPTOTIC FUNCTION; DOUBLE MINUTE-2; ACTIVATES P53; UV-RADIATION	The wild type p53 tumor suppressor protein is rapidly degraded in normal cells by MDM2, the ubiquitin ligase that serves as the key regulator of p53 function by modulating protein stability. Cellular exposure to genotoxic stress triggers the stabilization of p53 by multiple pathways that converge upon interference with MDM2 function. In this study, we first investigated the ability of HDM2 (MDM2 human homologue) to degrade endogenous p53 in neuroblastoma (NB), Although the p53 protein in NE has been reported to be constitutively stabilized, we find that HDM2 in NE is functional and facilitates the rapid turnover of p53 in nonstressed cells via the proteasome pathway. Second, we examined the relationship between p53 and HDM2 in the adriamycin-mediated stabilization of p53 in NE. We demonstrate that while p53 stabilization depends neither upon the phosphorylation of specific N-terminal sites nor upon dissociation from HDM2, it requires inactivation of functional HDM2, In support of this notion, p53 stabilization following adriamycin resulted in an inhibition of both p53 ubiquitination and HDM2 ligase activity. Taken together, these data implicate a requirement for enzymatic inactivation of HDM2 as a novel mechanism for p53 stabilization in the DNA damage response pathway.	NCI, Tumor Cell Biol Sect, Med Branch, NIH, Rockville, MD 20850 USA; NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Neckers, LM (corresponding author), NCI, Tumor Cell Biol Med Branch, NIH, KWC Ste 300,9610 Med Ctr Dr, Rockville, MD 20850 USA.							Alarcon R, 1999, CANCER RES, V59, P6046; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Biedler J L, 1988, Prog Clin Biol Res, V271, P265; Blattner C, 1999, ONCOGENE, V18, P1723, DOI 10.1038/sj.onc.1202480; Bottger V, 1999, ONCOGENE, V18, P189, DOI 10.1038/sj.onc.1202281; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chen F, 2000, CELL GROWTH DIFFER, V11, P239; Chernov MV, 1997, ONCOGENE, V14, P2503, DOI 10.1038/sj.onc.1201104; Craig AL, 1999, BIOCHEM J, V342, P133, DOI 10.1042/0264-6021:3420133; Danks MK, 1998, CELL DEATH DIFFER, V5, P678, DOI 10.1038/sj.cdd.4400408; DAVIDOFF AM, 1992, ONCOGENE, V7, P127; DOVER R, 1994, J CELL SCI, V107, P1181; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Goldman SC, 1996, AM J PATHOL, V148, P1381; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Higashimoto Y, 2000, J BIOL CHEM, V275, P23199, DOI 10.1074/jbc.M002674200; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Isaacs JS, 1998, CELL GROWTH DIFFER, V9, P545; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; KASTAN MB, 1991, CANCER RES, V51, P6304; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; KOMURO H, 1993, CANCER RES, V53, P5284; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Liu GZ, 2000, CANCER RES, V60, P1810; Lohrum MAE, 2000, NAT CELL BIOL, V2, P179, DOI 10.1038/35004057; Lu WG, 2000, ONCOGENE, V19, P232, DOI 10.1038/sj.onc.1203262; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; Maki CG, 1999, J BIOL CHEM, V274, P16531, DOI 10.1074/jbc.274.23.16531; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; McKenzie PP, 1999, CLIN CANCER RES, V5, P4199; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; MOLL UM, 1996, MOL CELL BIOL, V16, P1669; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Ostermeyer AG, 1996, P NATL ACAD SCI USA, V93, P15190, DOI 10.1073/pnas.93.26.15190; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sionov RV, 1999, J BIOL CHEM, V274, P8371, DOI 10.1074/jbc.274.13.8371; Smart P, 1999, ONCOGENE, V18, P7378, DOI 10.1038/sj.onc.1203260; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Unger T, 1999, EMBO J, V18, P1805, DOI 10.1093/emboj/18.7.1805; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; YEARGIN J, 1995, CURR BIOL, V5, P423, DOI 10.1016/S0960-9822(95)00083-2; Zaika A, 1999, J BIOL CHEM, V274, P27474, DOI 10.1074/jbc.274.39.27474	60	24	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18497	18506		10.1074/jbc.M100638200	http://dx.doi.org/10.1074/jbc.M100638200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279110	hybrid			2022-12-27	WOS:000168866500118
J	Lerouge, I; Laeremans, T; Verreth, C; Vanderleyden, J; Van Soom, C; Tobin, A; Carlson, RW				Lerouge, I; Laeremans, T; Verreth, C; Vanderleyden, J; Van Soom, C; Tobin, A; Carlson, RW			Identification of an ATP-binding cassette transporter for export of the O-antigen across the inner membrane in Rhizobium etli based on the genetic, functional, and structural analysis of an lps mutant deficient in O-antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEGUMINOSARUM BV PHASEOLI; ESCHERICHIA-COLI; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; LIPOPOLYSACCHARIDE SYNTHESIS; K-ANTIGENS; LIPID-A; POLYSACCHARIDE; COMPONENT; BIOSYNTHESIS; SALMONELLA	For O-antigen lipopolysaccharide (LPS) synthesis in bacteria, transmembrane migration of undecaprenyl pyrophosphate-bound O-antigen oligosaccharide subunits or polysaccharide occurs before ligation to the core region of the LPS molecule. In this study, we identified by mutagenesis an ATP-binding cassette transporter in Rhizobium etli CE3 that is likely responsible for the translocation of the O-antigen across the inner plasma membrane. Mutant FAJ1200 LPS lacks largely the O-antigen, as shown by SDS-polyacrylamide gel electrophoresis and confirmed by immunoblot analysis. Furthermore, LPS isolated from FAJ1200 is totally devoid of any O-chain glycosyl residues and contains only those glycosyl residues that can be expected for the inner core region. The membrane component and the cytoplasmic ATP-binding component of the ATP-binding cassette transporter are encoded by wzm and wzt, respectively. The Tn5 transposon in mutant FAJ1200 is inserted in the wzm gene. This mutation resulted in an Inf phenotype in bean plants.	Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; Katholieke Univ Leuven, Ctr Microbial & Plant Genet, B-3001 Heverlee, Belgium	University System of Georgia; University of Georgia; KU Leuven	Carlson, RW (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	Jos.Vanderleyden@agr.kuleuven.ac.be; RCARLSON@ccrc.uga.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039583] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM39583] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allaway D, 1996, J BACTERIOL, V178, P6403, DOI 10.1128/jb.178.21.6403-6406.1996; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 1970, MANUAL PRACTICAL STU; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BARLIER I, 1994, P 1 EUR NITR FIX C S, P308; BEYNON JL, 1980, J GEN MICROBIOL, V120, P421; BHAT UR, 1994, J BIOL CHEM, V269, P14402; BRINK BA, 1990, J BACTERIOL, V172, P548, DOI 10.1128/jb.172.2.548-555.1990; BROM S, 1992, J BACTERIOL, V174, P5183, DOI 10.1128/JB.174.16.5183-5189.1992; CARLSON RW, 1995, J BIOL CHEM, V270, P11783, DOI 10.1074/jbc.270.20.11783; CAVA JR, 1990, MOL GEN GENET, V221, P125, DOI 10.1007/BF00280377; CAVA JR, 1989, J BACTERIOL, V171, P8, DOI 10.1128/jb.171.1.8-15.1989; CHU SJ, 1995, P NATL ACAD SCI USA, V92, P5754, DOI 10.1073/pnas.92.12.5754; CORZO J, 1991, ELECTROPHORESIS, V12, P439, DOI 10.1002/elps.1150120611; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; DIEBOLD R, 1989, J BACTERIOL, V171, P4821, DOI 10.1128/jb.171.9.4821-4830.1989; Dombrecht B, 2001, MOL PLANT MICROBE IN, V14, P426, DOI 10.1094/MPMI.2001.14.3.426; Duelli DM, 1997, MOL PLANT MICROBE IN, V10, P903, DOI 10.1094/MPMI.1997.10.7.903; FATH MJ, 1993, MICROBIOL REV, V57, P995, DOI 10.1128/MMBR.57.4.995-1017.1993; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FernandezLopez M, 1996, MOL MICROBIOL, V20, P993, DOI 10.1111/j.1365-2958.1996.tb02540.x; Forsberg LS, 1998, J BIOL CHEM, V273, P2747, DOI 10.1074/jbc.273.5.2747; Forsberg LS, 2000, J BIOL CHEM, V275, P18851, DOI 10.1074/jbc.M001090200; GarciadelosSantos A, 1997, MOL PLANT MICROBE IN, V10, P891, DOI 10.1094/MPMI.1997.10.7.891; Gu K, 1998, ORAL MICROBIOL IMMUN, V13, P150, DOI 10.1111/j.1399-302X.1998.tb00726.x; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; JANN K, 1984, HDB ENDOTOXINS; KANNENBERG EL, 1998, RHIZOBIACEAE, P119; Keenleyside WJ, 1996, J BIOL CHEM, V271, P28581, DOI 10.1074/jbc.271.45.28581; Kereszt A, 1998, J BACTERIOL, V180, P5426, DOI 10.1128/JB.180.20.5426-5431.1998; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LINDBERG B, 1972, ACTA CHEM SCAND, V26, P2231, DOI 10.3891/acta.chem.scand.26-2231; Lucas MM, 1996, J BACTERIOL, V178, P2727, DOI 10.1128/jb.178.10.2727-2733.1996; Lugowski C, 1996, FEMS IMMUNOL MED MIC, V16, P31, DOI 10.1016/S0928-8244(96)00067-3; Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5; MCKAY IA, 1993, APPL ENVIRON MICROB, V59, P3385, DOI 10.1128/AEM.59.10.3385-3392.1993; Michiels J, 1998, J BACTERIOL, V180, P3620, DOI 10.1128/JB.180.14.3620-3628.1998; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Noel KD, 2000, J BACTERIOL, V182, P5317, DOI 10.1128/JB.182.19.5317-5324.2000; PETERSON AA, 1985, J BACTERIOL, V162, P738, DOI 10.1128/JB.162.2.738-745.1985; PIGEON RP, 1994, MOL MICROBIOL, V14, P871, DOI 10.1111/j.1365-2958.1994.tb01323.x; POOLE PS, 1994, MICROBIOL-SGM, V140, P2797, DOI 10.1099/00221287-140-10-2797; PRIEFER UB, 1995, NITROGEN FIXATION FU, P337; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; REUHS BL, 1994, MOL PLANT MICROBE IN, V7, P240, DOI 10.1094/MPMI-7-0240; REUHS BL, 1993, J BACTERIOL, V175, P3570, DOI 10.1128/jb.175.11.3570-3580.1993; Reuhs BL, 1998, APPL ENVIRON MICROB, V64, P4930; Ridley BL, 2000, GLYCOBIOLOGY, V10, P1013, DOI 10.1093/glycob/10.10.1013; SAIER MH, 1994, MOL MICROBIOL, V11, P841, DOI 10.1111/j.1365-2958.1994.tb00362.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SPAINK HP, 1995, J BACTERIOL, V177, P6276, DOI 10.1128/jb.177.21.6276-6281.1995; TAO H, 1992, J BACTERIOL, V174, P2222, DOI 10.1128/JB.174.7.2222-2229.1992; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valverde C, 1997, BIOTECHNIQUES, V22, P230, DOI 10.2144/97222bm07; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Vlassak KM, 1998, MOL GEN GENET, V258, P558, DOI 10.1007/s004380050768; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Whitfield C, 1997, MOL MICROBIOL, V23, P629, DOI 10.1046/j.1365-2958.1997.2571614.x; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; Yoshida Y, 1998, INFECT IMMUN, V66, P107, DOI 10.1128/IAI.66.1.107-114.1998; ZHANG LJ, 1993, MOL MICROBIOL, V9, P309, DOI 10.1111/j.1365-2958.1993.tb01692.x	62	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17190	17198		10.1074/jbc.M101129200	http://dx.doi.org/10.1074/jbc.M101129200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279176	hybrid, Green Published			2022-12-27	WOS:000168730400079
J	Fankhauser, C				Fankhauser, C			The phytochromes, a family of Red/Far-red absorbing photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CHROMOPHORE BIOSYNTHESIS; SEED-GERMINATION; GENE-EXPRESSION; ACTION SPECTRA; STEM GROWTH; WILD-TYPE; ARABIDOPSIS; LIGHT; PROTEIN; PHYB		Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland	University of Geneva	Fankhauser, C (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.	Christian.Fankhauser@molbio.unige.ch	Fankhauser, Christian/ABE-8757-2021; Fankhauser, Christian/C-4291-2018	Fankhauser, Christian/0000-0003-4719-5901; Fankhauser, Christian/0000-0003-4719-5901				Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; Andel F, 1996, BIOCHEMISTRY-US, V35, P15997, DOI 10.1021/bi962175k; Bevan M, 1999, BIOESSAYS, V21, P110, DOI 10.1002/(SICI)1521-1878(199902)21:2&lt;110::AID-BIES5&gt;3.0.CO;2-V; Bognar LK, 1999, P NATL ACAD SCI USA, V96, P14652, DOI 10.1073/pnas.96.25.14652; Bolle C, 2000, GENE DEV, V14, P1269; BORTHWICK HA, 1952, P NATL ACAD SCI USA, V38, P662, DOI 10.1073/pnas.38.8.662; BORTHWICK HA, 1952, P NATL ACAD SCI USA, V38, P929, DOI 10.1073/pnas.38.11.929; Botto JF, 1996, PLANT PHYSIOL, V110, P439, DOI 10.1104/pp.110.2.439; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Buche C, 2000, PLANT CELL, V12, P547, DOI 10.1105/tpc.12.4.547; BUTLER WL, 1959, P NATL ACAD SCI USA, V45, P1703, DOI 10.1073/pnas.45.12.1703; Canton FR, 1999, PLANT PHYSIOL, V121, P1207, DOI 10.1104/pp.121.4.1207; Cashmore AR, 1998, P NATL ACAD SCI USA, V95, P13358, DOI 10.1073/pnas.95.23.13358; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Cerdan PD, 2000, PLANT CELL, V12, P1203, DOI 10.1105/tpc.12.7.1203; Choi G, 1999, NATURE, V401, P610, DOI 10.1038/44176; Clough RC, 1999, PLANT J, V17, P155, DOI 10.1046/j.1365-313X.1999.00360.x; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Davis SJ, 1999, P NATL ACAD SCI USA, V96, P6541, DOI 10.1073/pnas.96.11.6541; DEHESH K, 1993, PLANT CELL, V5, P1081, DOI 10.1105/tpc.5.9.1081; Deng XW, 1999, SEMIN CELL DEV BIOL, V10, P121, DOI 10.1006/scdb.1999.0287; Devlin PF, 1999, PLANT PHYSIOL, V119, P909, DOI 10.1104/pp.119.3.909; Devlin PF, 1998, PLANT CELL, V10, P1479, DOI 10.1105/tpc.10.9.1479; Eichenberg K, 2000, FEBS LETT, V470, P107, DOI 10.1016/S0014-5793(00)01301-6; Elich TD, 1997, PLANT CELL, V9, P2271, DOI 10.1105/tpc.9.12.2271; Fairchild CD, 2000, GENE DEV, V14, P2377; Fankhauser C, 2000, PLANT PHYSIOL, V124, P39, DOI 10.1104/pp.124.1.39; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Goosey L, 1997, PLANT PHYSIOL, V115, P959, DOI 10.1104/pp.115.3.959; Hamazato F, 1997, PLANT PHYSIOL, V115, P1533, DOI 10.1104/pp.115.4.1533; Hennig L, 1999, PLANT PHYSIOL, V121, P571, DOI 10.1104/pp.121.2.571; Hirschfeld M, 1998, GENETICS, V149, P523; Hsieh HL, 2000, GENE DEV, V14, P1958; Hughes J, 1997, NATURE, V386, P663, DOI 10.1038/386663a0; Hughes O, 1999, PLANT PHYSIOL, V121, P1059; Huq E, 2000, P NATL ACAD SCI USA, V97, P9789, DOI 10.1073/pnas.170283997; Huq E, 2000, PLANT J, V23, P461, DOI 10.1046/j.1365-313x.2000.00810.x; Jiang ZY, 1999, SCIENCE, V285, P406, DOI 10.1126/science.285.5426.406; JOHNSON E, 1994, PLANT PHYSIOL, V105, P141, DOI 10.1104/pp.105.1.141; Jordan ET, 1996, PLANT J, V9, P243, DOI 10.1046/j.1365-313X.1996.09020243.x; Kamiya Y, 1999, CURR OPIN PLANT BIOL, V2, P398, DOI 10.1016/S1369-5266(99)00012-6; Karniol B, 2000, CURR OPIN PLANT BIOL, V3, P387, DOI 10.1016/S1369-5266(00)00101-1; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; KENDRICK RE, 1987, PHYTOCHROME PHOTOREG; Kendrick RE, 1994, PHOTOMORPHOGENESIS P; Krall L, 2000, P NATL ACAD SCI USA, V97, P8169, DOI 10.1073/pnas.140520097; Kretsch T, 2000, PLANT J, V22, P177, DOI 10.1046/j.1365-313x.2000.00715.x; Lagarias DM, 1997, PLANT CELL, V9, P675, DOI 10.1105/tpc.9.5.675; LAGARIAS JC, 1980, J AM CHEM SOC, V102, P4821, DOI 10.1021/ja00534a042; Lapko VN, 1999, PROTEIN SCI, V8, P1032, DOI 10.1110/ps.8.5.1032; Lin CT, 2000, PLANT PHYSIOL, V123, P39, DOI 10.1104/pp.123.1.39; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Morelli G, 2000, PLANT PHYSIOL, V122, P621, DOI 10.1104/pp.122.3.621; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; Mustilli AC, 1997, EMBO J, V16, P5801, DOI 10.1038/sj.emboj.7590554; NAGATANI A, 1993, PLANT PHYSIOL, V102, P269, DOI 10.1104/pp.102.1.269; Nagy F, 2000, EMBO J, V19, P157, DOI 10.1093/emboj/19.2.157; Neff MM, 2000, GENE DEV, V14, P257; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Osterlund MT, 1999, TRENDS CELL BIOL, V9, P113, DOI 10.1016/S0962-8924(99)01499-3; PARKER MW, 1949, AM J BOT, V36, P194, DOI 10.2307/2437789; Parks BM, 1999, P NATL ACAD SCI USA, V96, P14142, DOI 10.1073/pnas.96.24.14142; Quail PH, 1997, BIOESSAYS, V19, P571, DOI 10.1002/bies.950190708; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Remberg A, 1998, BIOCHEMISTRY-US, V37, P9983, DOI 10.1021/bi980575x; Robson PRH, 1996, NAT BIOTECHNOL, V14, P995, DOI 10.1038/nbt0896-995; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; SCHNEIDERPOETSCH HAW, 1991, FEBS LETT, V281, P245, DOI 10.1016/0014-5793(91)80403-P; Shinomura T, 1996, P NATL ACAD SCI USA, V93, P8129, DOI 10.1073/pnas.93.15.8129; Shinomura T, 2000, PLANT PHYSIOL, V122, P147, DOI 10.1104/pp.122.1.147; Smith H, 1997, PLANT PHYSIOL, V114, P637, DOI 10.1104/pp.114.2.637; Soh MS, 2000, PLANT CELL, V12, P2061, DOI 10.1105/tpc.12.11.2061; SOMERS DE, 1995, PLANT PHYSIOL, V107, P523, DOI 10.1104/pp.107.2.523; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Song PS, 1999, J BIOCHEM MOL BIOL, V32, P215; Spiegelman JI, 2000, PLANT CELL, V12, P2485, DOI 10.1105/tpc.12.12.2485; STOCKHAUS J, 1992, GENE DEV, V6, P2364, DOI 10.1101/gad.6.12a.2364; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Terry MJ, 1997, PLANT CELL ENVIRON, V20, P740, DOI 10.1046/j.1365-3040.1997.d01-102.x; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; Whitelam GC, 1997, PLANT CELL ENVIRON, V20, P752, DOI 10.1046/j.1365-3040.1997.d01-100.x; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	87	129	138	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11453	11456		10.1074/jbc.R100006200	http://dx.doi.org/10.1074/jbc.R100006200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11279228	hybrid			2022-12-27	WOS:000168081800003
J	Huang, L; Jacob, RJ; Pegg, SCH; Baldwin, MA; Wang, CC; Burlingame, AL; Babbitt, PC				Huang, L; Jacob, RJ; Pegg, SCH; Baldwin, MA; Wang, CC; Burlingame, AL; Babbitt, PC			Functional assignment of the 20 S proteasome from Trypanosoma brucei using mass spectrometry and new bioinformatics approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID SUBSTITUTION MATRICES; PROTEIN IDENTIFICATION; ELECTROSPRAY IONIZATION; RAPID IDENTIFICATION; SEQUENCE DATABASES; ALIGNMENT; INFORMATION; GENERATION; PEPTIDES	As experimental technologies for characterization of proteomes emerge, bioinformatic analysis of the data becomes essential. Separation and identification technologies currently based on two-dimensional gels/mass spectrometry provide the inherent analytical power required. This strategy involves protein spot digestion and accurate mass mapping together with computational interrogation of available data bases for protein functional identification. When either no exact match is found or when the possible matches only partially account for molecular weights actually observed, peptide sequencing by tandem mass spectrometry has emerged as the methodology of choice to provide the basic additional information required. To evaluate the capabilities of bioinformatics methods employed for identifying homologs of a protein of interest, we attempted to identify the major proteins from the 20 S proteasome of Trypanosoma brucei using sequence information determined using mass spectrometry. The results suggest that neither the traditional query engines, BLAST and FASTA, nor specialized software developed for analysis of sequence information obtained by mass spectrometry are able to identify even closely related sequences at statistically significant scores. To address this deficit, new bioinformatics approaches were developed for concomitant use of the multiple fragments of short sequence typically available from methods of tandem mass spectrometry. These approaches rely on the occurrence of congruence across searches of multiple fragments from a single protein. This method resulted in sharply better statistical significance values for correct hits in the data base output relative to that achieved for independent searches using single sequence fragments.	Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Babbitt, PC (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	babbitt@cgl.ucsf.edu	Huang, Lan/C-3618-2011	Jacob, Richard/0000-0003-0910-5282	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060595] Funding Source: NIH RePORTER; NCRR NIH HHS [RR01614] Funding Source: Medline; NIAID NIH HHS [R01 AI21786] Funding Source: Medline; NIGMS NIH HHS [R01 GM60595] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; ALTSCHUL SF, 1991, J MOL BIOL, V219, P555, DOI 10.1016/0022-2836(91)90193-A; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baker AS, 1998, BIOCHEMISTRY-US, V37, P9305, DOI 10.1021/bi972677d; BAKER P, PROTEIN PROSPECTOR V; BIEMANN K, 1990, METHOD ENZYMOL, V193, P455, DOI 10.1016/0076-6879(90)93433-L; Chang WWP, 2000, PLANT PHYSIOL, V122, P295, DOI 10.1104/pp.122.2.295; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Damer CK, 1998, J BIOL CHEM, V273, P24396, DOI 10.1074/jbc.273.38.24396; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FENN JB, 1990, MASS SPECTROM REV, V9, P37, DOI 10.1002/mas.1280090103; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Gygi SP, 2000, CURR OPIN CHEM BIOL, V4, P489, DOI 10.1016/S1367-5931(00)00121-6; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HENZEL WJ, 1993, P NATL ACAD SCI USA, V90, P5011, DOI 10.1073/pnas.90.11.5011; Hua SB, 1996, MOL BIOCHEM PARASIT, V78, P33, DOI 10.1016/S0166-6851(96)02599-6; Huang L, 2000, MASS SPECTROMETRY IN BIOLOGY & MEDICINE, P217; Huang L, 1999, MOL BIOCHEM PARASIT, V102, P211, DOI 10.1016/S0166-6851(99)00096-1; JAMES P, 1993, BIOCHEM BIOPH RES CO, V195, P58, DOI 10.1006/bbrc.1993.2009; JIMENEZ CR, 1998, CURRENT PROTOCOLS PR; Johnson RS, 2000, METH MOL B, V146, P41, DOI 10.1385/1-59259-045-4:41; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Lander ES, 2000, SCIENCE, V287, P1777, DOI 10.1126/science.287.5459.1777; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605; Medzihradszky Katalin F., 1994, Methods (Orlando), V6, P284, DOI 10.1006/meth.1994.1030; Medzihradszky KF, 2000, ANAL CHEM, V72, P552, DOI 10.1021/ac990809y; Medzihradszky KF, 2001, J AM SOC MASS SPECTR, V12, P215, DOI 10.1016/S1044-0305(00)00214-2; Monaco JJ, 1995, ANNU REV GENET, V29, P729, DOI 10.1146/annurev.ge.29.120195.003501; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pegg SCH, 1999, BIOINFORMATICS, V15, P729, DOI 10.1093/bioinformatics/15.9.729; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Qin J, 1997, ANAL CHEM, V69, P3995, DOI 10.1021/ac970488v; Qiu YC, 1998, J BIOL CHEM, V273, P17940, DOI 10.1074/jbc.273.28.17940; QU K, 2000, CURRENTS COMPUTATION, P139; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shevchenko A, 1997, RAPID COMMUN MASS SP, V11, P1015, DOI 10.1002/(SICI)1097-0231(19970615)11:9<1015::AID-RCM958>3.0.CO;2-H; SPENGLER B, 1992, RAPID COMMUN MASS SP, V6, P105, DOI 10.1002/rcm.1290060207; Taylor JA, 1997, RAPID COMMUN MASS SP, V11, P1067, DOI 10.1002/(SICI)1097-0231(19970615)11:9<1067::AID-RCM953>3.0.CO;2-L; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vestal M, 2000, MASS SPECTROMETRY IN BIOLOGY & MEDICINE, P1; Xu L, 1999, BIOCHEMISTRY-US, V38, P7659, DOI 10.1021/bi990103y; YATES JR, 1993, ANAL BIOCHEM, V214, P397, DOI 10.1006/abio.1993.1514	49	68	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2001	276	30					28327	28339		10.1074/jbc.M008342200	http://dx.doi.org/10.1074/jbc.M008342200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	456QH	11309374	hybrid			2022-12-27	WOS:000170093400079
J	Imbriano, C; Bolognese, F; Gurtner, A; Piaggio, G; Mantovani, R				Imbriano, C; Bolognese, F; Gurtner, A; Piaggio, G; Mantovani, R			HSP-CBF is an NF-Y-dependent coactivator of the heat shock promoters CCAAT boxes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE-CELL LINES; BINDING-FACTOR; TRANSCRIPTIONAL ACTIVATION; MOLECULAR CHARACTERIZATION; NUCLEOTIDE-SEQUENCE; REGULATORY ELEMENT; GRP78/BIP PROMOTER; IN-VIVO; C-MYC; GENE	The cellular response to toxic stimuli is elicited through the expression of heat shock proteins, a transcriptional process that relies upon conserved DNA elements in the promoters: the Heat Shock Elements, activated by the heat shock factors, and the CCAAT boxes. The identity of the CCAAT activator(s) is unclear because two distinct entities, NF-Y and HSP-CBF, have been implicated in the HSP70 system, The former is a conserved ubiquitous trimer containing histone-like subunits, the latter a 110-kDa protein with an acidic N-terminal, We analyzed two CCAAT-containing promoters, HSP70 and HSP40, with recombinant NF-Y and HSP-CBF using electrophoretic mobility shift assay, protein-protein interactions, transfections and chromatin immunoprecipitation assays (ChIP) assays. Both recognize a common DNA-binding protein in nuclear extracts, identified in vitro and in vivo as NF-Y, Both CCAAT boxes show high affinity for recombinant NF-Y but not for HSP-CBF, However, HSP-CBF does activate HSP70 and HSP40 transcription under basal and heat shocked conditions; for doing so, it requires an intact NF-Y trimer as judged by cotransfections with a diagnostic NF-YA dominant negative vector. HSP-CBF interacts in solution and on DNA with the NF-Y trimer through an evolutionary conserved region. In yeast two-hybrid assays HSP-CBF interacts with NF-YB, These data implicate HSP-CBF as a non-DNA binding coactivator of heat shock genes that act on a DNA-bound NF-Y.	Univ Modena, Dipartimento Biol Anim, I-41100 Modena, Italy; Univ Milan, Dipartimento Genet & Biol Microorganismi, I-20133 Milan, Italy; Ist Regina Elena, Ctr Ricerca Sperimentale, I-00161 Rome, Italy	Universita di Modena e Reggio Emilia; University of Milan; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Mantovani, R (corresponding author), Univ Modena, Dipartimento Biol Anim, Via Campi 213-D, I-41100 Modena, Italy.		Gurtner, Aymone/J-7217-2018; Imbriano, Carol/C-9376-2015; Piaggio, Giulia/J-7214-2018; Imbriano, Carol/ABD-8204-2021; gurtner, aymone/AAB-8843-2020; Piaggio, Giulia/AAD-7336-2022	Gurtner, Aymone/0000-0002-7661-9059; Imbriano, Carol/0000-0003-2864-4820; Piaggio, Giulia/0000-0003-2114-1892; Imbriano, Carol/0000-0003-2864-4820; gurtner, aymone/0000-0002-7661-9059; 				ABRAVAYA K, 1991, MOL CELL BIOL, V11, P586, DOI 10.1128/MCB.11.1.586; AGOFF SN, 1994, ONCOGENE, V9, P3707; Bi WM, 1997, J BIOL CHEM, V272, P26562, DOI 10.1074/jbc.272.42.26562; BIENZ M, 1986, CELL, V45, P753, DOI 10.1016/0092-8674(86)90789-0; BONNYCASTLE LLC, 1994, GENOMICS, V23, P85, DOI 10.1006/geno.1994.1462; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Caretti G, 1999, MOL CELL BIOL, V19, P8591; Dix DJ, 1996, DEV BIOL, V174, P310, DOI 10.1006/dbio.1996.0076; Edskes HK, 1998, J BIOL CHEM, V273, P28912, DOI 10.1074/jbc.273.44.28912; GORZOWSKI JJ, 1995, J BIOL CHEM, V270, P26940, DOI 10.1074/jbc.270.45.26940; GREENE JM, 1990, MOL CELL BIOL, V10, P1319, DOI 10.1128/MCB.10.4.1319; GREENE JM, 1987, MOL CELL BIOL, V7, P3646, DOI 10.1128/MCB.7.10.3646; Harton JA, 2000, MOL CELL BIOL, V20, P6185, DOI 10.1128/MCB.20.17.6185-6194.2000; Hata M, 1998, BBA-GENE STRUCT EXPR, V1397, P43, DOI 10.1016/S0167-4781(97)00208-X; Hoeppner MA, 1996, NUCLEIC ACIDS RES, V24, P1091, DOI 10.1093/nar/24.6.1091; HUNT C, 1990, GENE, V87, P199, DOI 10.1016/0378-1119(90)90302-8; James P, 1996, GENETICS, V144, P1425; Jayasena SMT, 1999, INT J PARASITOL, V29, P581, DOI 10.1016/S0020-7519(99)00002-8; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; LANDSBERGER N, 1995, MOL CELL BIOL, V15, P6013; LEJOHN HB, 1994, J BIOL CHEM, V269, P4513; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Li Q, 1998, EMBO J, V17, P6300, DOI 10.1093/emboj/17.21.6300; Lis JT, 2000, GENE DEV, V14, P792; LISOWSKA K, 1994, BBA-GENE STRUCT EXPR, V1219, P64, DOI 10.1016/0167-4781(94)90247-X; LUM LSY, 1992, MOL CELL BIOL, V12, P2599, DOI 10.1128/MCB.12.6.2599; LUM LSY, 1990, MOL CELL BIOL, V10, P6709, DOI 10.1128/MCB.10.12.6709; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Mayer MP, 1998, BIOL CHEM, V379, P261; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; MILARSKI KL, 1986, P NATL ACAD SCI USA, V83, P9517, DOI 10.1073/pnas.83.24.9517; Minuzzo M, 2000, P NATL ACAD SCI USA, V97, P6780, DOI 10.1073/pnas.97.12.6780; Molina A, 2000, FEBS LETT, V474, P5, DOI 10.1016/S0014-5793(00)01538-6; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; MORIMOTO RI, 1986, J BIOL CHEM, V261, P2692; Motta MC, 1999, J BIOL CHEM, V274, P1326, DOI 10.1074/jbc.274.3.1326; MULLER FW, 1992, GENE, V111, P165, DOI 10.1016/0378-1119(92)90684-H; Ohtsuka K, 2000, INT J HYPERTHER, V16, P231, DOI 10.1080/026567300285259; OVSENEK N, 1990, DEV GENET, V11, P97, DOI 10.1002/dvg.1020110111; Rachez C, 2000, GENE, V246, P9, DOI 10.1016/S0378-1119(00)00052-4; RIEPING M, 1992, MOL GEN GENET, V231, P226, DOI 10.1007/BF00279795; ROY B, 1995, MOL CELL BIOL, V15, P2263; Roy B, 1996, J BIOL CHEM, V271, P28995, DOI 10.1074/jbc.271.46.28995; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; SINHA S, 1995, P NATL ACAD SCI USA, V92, P1624, DOI 10.1073/pnas.92.5.1624; Taira T, 1999, J BIOL CHEM, V274, P24270, DOI 10.1074/jbc.274.34.24270; Tom M, 1999, BIOCHEM BIOPH RES CO, V262, P103, DOI 10.1006/bbrc.1999.1165; Ubeda M, 2000, NUCLEIC ACIDS RES, V28, P4987, DOI 10.1093/nar/28.24.4987; WILLIAMS GT, 1989, MOL CELL BIOL, V9, P2574, DOI 10.1128/MCB.9.6.2574; WU BJ, 1985, P NATL ACAD SCI USA, V82, P6070, DOI 10.1073/pnas.82.18.6070; WU BJ, 1986, P NATL ACAD SCI USA, V83, P629, DOI 10.1073/pnas.83.3.629; Yasuda K, 1999, BIOCHEM BIOPH RES CO, V256, P75, DOI 10.1006/bbrc.1999.0283; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	59	38	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 13	2001	276	28					26332	26339		10.1074/jbc.M101553200	http://dx.doi.org/10.1074/jbc.M101553200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451VP	11306579	hybrid			2022-12-27	WOS:000169823300092
J	Aro, N; Saloheimo, A; Ilmen, M; Penttila, M				Aro, N; Saloheimo, A; Ilmen, M; Penttila, M			ACEII, a novel transcriptional activator involved in regulation of cellulase and xylanase genes of Trichoderma reesei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPERGILLUS-NIDULANS; SACCHAROMYCES-CEREVISIAE; AFLATOXIN BIOSYNTHESIS; CELLOBIOHYDROLASE I; AMDS GENE; EXPRESSION; NIGER; XLNR; TRANSFORMATION; ENDOGLUCANASE	A novel yeast-based method to isolate transcriptional activators was applied to clone regulators binding to the cellulase promoter cbh1 of the filamentous fungus Trichoderma reesei (Hypocrea jecorina). This led to the isolation of the cellulase activator ace2 encoding for a protein belonging to the class of zinc binuclear cluster proteins found exclusively in fungi. The DNA-binding domain of ACEII was expressed as a glutathione S-transferase fusion protein in Escherichia coli, and ACEII was shown to bind in vitro to the 5'-GGCTAATAA site present in the cbh1 promoter. This site also contains the proposed binding sequence of the xylanase activator XlnR of Aspergillus niger. Mutation of the GGC triplet abolished ACEII binding. The function of ACEII was studied by analyzing the effects of ace2 deletion in the hypercellulolytic T. reesei strain ALKO2221. Deletion of the ace2 gene led to lowered induction kinetics of mRNAs encoding the major cellulases cellobiohydrolases I and II and endoglucanases I and II and to 30-70% reduced cellulase activity when the fungus was grown on medium containing Solka flee cellulose. The expression level of the gene encoding xylanase was also affected. ace2 deletion led to lowered xyn2 expression in cellulose-induced cultivation. Cellulase induction by so. phorose was not affected by ace2 deletion.	VTT Biotechnol, FIN-02044 Espoo, Finland	VTT Technical Research Center Finland	Aro, N (corresponding author), VTT Biotechnol, Tietotie 2,POB 1500, FIN-02044 Espoo, Finland.	nina.aro@vtt.fi	Penttilä, Merja E/A-4710-2013	Penttila, Merja/0000-0002-6929-1032				BAILEY MJ, 1981, ENZYME MICROB TECH, V3, P153, DOI 10.1016/0141-0229(81)90076-4; CHANG PK, 1995, APPL ENVIRON MICROB, V61, P2372, DOI 10.1128/AEM.61.6.2372-2377.1995; DOWZER CEA, 1991, MOL CELL BIOL, V11, P5701, DOI 10.1128/MCB.11.11.5701; DURAND H, 1988, ENZYME MICROB TECH, V10, P341, DOI 10.1016/0141-0229(88)90012-9; Gielkens MMC, 1999, APPL ENVIRON MICROB, V65, P4340; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; Gritzali M., 1979, HYDROLYSIS CELLULOSE, V181, P237, DOI DOI 10.1021/BA-1979-0181.CH012; HenriqueSilva F, 1996, BIOCHEM BIOPH RES CO, V228, P229, DOI 10.1006/bbrc.1996.1646; Ilmen M, 1996, MOL GEN GENET, V251, P451, DOI 10.1007/s004380050189; Ilmen M, 1997, APPL ENVIRON MICROB, V63, P1298; Ilmen M, 1996, MOL GEN GENET, V253, P303, DOI 10.1007/s004380050326; KUBICEK CP, 1998, REGULATION PRODUCTIO; LITTLEJOHN TG, 1992, MOL GEN GENET, V235, P81, DOI 10.1007/BF00286184; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACH RL, 1994, CURR GENET, V25, P567, DOI 10.1007/BF00351679; MANDELS M, 1962, J BACTERIOL, V83, P400, DOI 10.1128/JB.83.2.400-408.1962; MargollesClark E, 1997, J BIOTECHNOL, V57, P167, DOI 10.1016/S0168-1656(97)00097-7; Narendja FM, 1999, MOL CELL BIOL, V19, P6523; NISIZAWA T, 1971, J BIOCHEM-TOKYO, V70, P375, DOI 10.1093/oxfordjournals.jbchem.a129652; PENTTILA M, 1987, GENE, V61, P155, DOI 10.1016/0378-1119(87)90110-7; PENTTILA ME, 1988, GENE, V63, P103, DOI 10.1016/0378-1119(88)90549-5; PENTTILA ME, 1987, YEAST, V3, P175; SAARELAINEN R, 1993, MOL GEN GENET, V241, P497, DOI 10.1007/BF00279891; Saloheimo A, 2000, J BIOL CHEM, V275, P5817, DOI 10.1074/jbc.275.8.5817; SALOHEIMO M, 1988, GENE, V63, P11, DOI 10.1016/0378-1119(88)90541-0; SHERMAN F, 1981, GUIDE YEAST GENETICS; TAO P, 1990, P NATL ACAD SCI USA, V87, P2077, DOI 10.1073/pnas.87.6.2077; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todd RB, 1997, MOL GEN GENET, V254, P495, DOI 10.1007/s004380050444; Todd RB, 1997, FUNGAL GENET BIOL, V21, P388, DOI 10.1006/fgbi.1997.0993; TORRONEN A, 1992, BIO-TECHNOL, V10, P1461, DOI 10.1038/nbt1192-1461; VAHERI M, 1979, BIOTECHNOLOGY, V1, P696; van Peij NNME, 1998, MOL MICROBIOL, V27, P131, DOI 10.1046/j.1365-2958.1998.00666.x; van Peij NNME, 1998, APPL ENVIRON MICROB, V64, P3615; VANHANEN S, 1989, CURR GENET, V15, P181, DOI 10.1007/BF00435504; VANTILBEURGH H, 1982, FEBS LETT, V149, P152, DOI 10.1016/0014-5793(82)81092-2; WOLOSHUK CP, 1994, APPL ENVIRON MICROB, V60, P2408, DOI 10.1128/AEM.60.7.2408-2414.1994; Zeilinger S, 1996, J BIOL CHEM, V271, P25624, DOI 10.1074/jbc.271.41.25624	38	241	293	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24309	24314		10.1074/jbc.M003624200	http://dx.doi.org/10.1074/jbc.M003624200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11304525	hybrid			2022-12-27	WOS:000169531100142
J	Keizer, DW; Slupsky, CM; Kalisiak, M; Campbell, AP; Crump, MP; Sastry, PA; Hazes, B; Irvin, RT; Sykes, BD				Keizer, DW; Slupsky, CM; Kalisiak, M; Campbell, AP; Crump, MP; Sastry, PA; Hazes, B; Irvin, RT; Sykes, BD			Structure of a pilin monomer from Pseudomonas aeruginosa - Implications for the assembly of pili	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING DOMAIN; SYNTHETIC VACCINE DESIGN; NMR SOLUTION STRUCTURE; C-TERMINAL REGION; NEISSERIA-GONORRHOEAE; TWITCHING MOTILITY; NATURAL TRANSFORMATION; BACTERIAL CONJUGATION; MORAXELLA-BOVIS; GENE CONVERSION	Type TV pilin monomers assemble to form fibers called pill that are required far a variety of bacterial functions. Pilin monomers oligomerize due to the interaction of part of their hydrophobic N-terminal alpha -helix. Engineering of a truncated pilin from Pseudomonas aeruginosa strain K122-4, where the first 28 residues are removed from the N terminus, yields a soluble, monomeric protein. This truncated pilin is shown to bind to its receptor and to decrease morbidity and mortality in mice upon administration 15 min before challenge with a heterologous strain of Pseudomonas. The structure of this truncated pilin reveals an alpha -helix at the N terminus that lies across a 4-stranded antiparallel beta -sheet. A model for a pilus is proposed that takes into account both electrostatic and hydrophobic interactions of pilin subunits as well as previously published x-ray fiber diffraction data. Our model indicates that DNA or RNA cannot pass through the center of the pilus, however, the possibility exists for small organic molecules to pass through indicating a potential mechanism for signal transduction.	Univ Alberta, Heritage Med Res Ctr 713, PENCE, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2H7, Canada; Univ Southampton, Dept Biochem, Southampton S016 7PX, Hants, England; Univ Washington, Sch Pharm, Dept Med Chem, Seattle, WA 98195 USA	University of Alberta; University of Alberta; University of Southampton; University of Washington; University of Washington Seattle	Sykes, BD (corresponding author), Univ Alberta, Heritage Med Res Ctr 713, PENCE, Edmonton, AB T6G 2S2, Canada.		Keizer, David/P-9196-2014	Keizer, David/0000-0002-0442-0999; Crump, Matthew/0000-0002-7868-5818				Alonso A, 1999, MICROBIOL-SGM, V145, P2857, DOI 10.1099/00221287-145-10-2857; BEARD MKM, 1990, J BACTERIOL, V172, P2601, DOI 10.1128/jb.172.5.2601-2607.1990; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BODEY GP, 1983, REV INFECT DIS, V5, P279; BRADLEY DE, 1980, CAN J MICROBIOL, V26, P146, DOI 10.1139/m80-022; BRUNGER AT, 1993, XPLOR VERSION 3 1 SY; Cachia PJ, 1998, J PEPT RES, V52, P289; Campbell AP, 1997, J MOL BIOL, V267, P382, DOI 10.1006/jmbi.1996.0871; Campbell AP, 1995, BIOCHEMISTRY-US, V34, P16255, DOI 10.1021/bi00050a005; Campbell AP, 1996, INT J PEPT PROT RES, V48, P539; CRYZ SJ, 1983, INFECT IMMUN, V39, P1072, DOI 10.1128/IAI.39.3.1072-1079.1983; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DURRENBERGER MB, 1991, J STRUCT BIOL, V107, P146, DOI 10.1016/1047-8477(91)90018-R; FARINHA MA, 1994, INFECT IMMUN, V62, P4118, DOI 10.1128/IAI.62.10.4118-4123.1994; FINKE M, 1991, INFECT IMMUN, V59, P1251, DOI 10.1128/IAI.59.4.1251-1254.1991; FOLKHARD W, 1981, J MOL BIOL, V149, P79, DOI 10.1016/0022-2836(81)90261-8; Forest KT, 1997, GENE, V192, P165, DOI 10.1016/S0378-1119(97)00008-5; Fussenegger M, 1997, GENE, V192, P125, DOI 10.1016/S0378-1119(97)00038-3; GAGNE SM, 1994, PROTEIN SCI, V3, P1961, DOI 10.1002/pro.5560031108; HAAS R, 1987, P NATL ACAD SCI USA, V84, P9079, DOI 10.1073/pnas.84.24.9079; HAASE J, 1995, J BACTERIOL, V177, P4779, DOI 10.1128/jb.177.16.4779-4791.1995; Hazes B, 2000, J MOL BIOL, V299, P1005, DOI 10.1006/jmbi.2000.3801; IRVIN RT, 1993, PSEUDOMONAS AERUGINO, P19; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Karaolis DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715; Keizer DW, 2001, J BIOMOL NMR, V19, P385, DOI 10.1023/A:1011285803129; Kim SR, 1997, J BACTERIOL, V179, P3594, DOI 10.1128/jb.179.11.3594-3603.1997; Klimke WA, 1998, J BACTERIOL, V180, P4036, DOI 10.1128/JB.180.16.4036-4043.1998; LEE KK, 1989, MOL MICROBIOL, V3, P1493, DOI 10.1111/j.1365-2958.1989.tb00135.x; LEE KK, 1994, MOL MICROBIOL, V11, P705, DOI 10.1111/j.1365-2958.1994.tb00348.x; Long CD, 1998, INFECT IMMUN, V66, P1918, DOI 10.1128/IAI.66.5.1918-1927.1998; LYDICK E, 1985, J INFECT DIS, V151, P375, DOI 10.1093/infdis/151.2.375; MARRS CF, 1988, J BACTERIOL, V170, P3032, DOI 10.1128/jb.170.7.3032-3039.1988; MARRS CF, 1990, J BACTERIOL, V172, P4370, DOI 10.1128/jb.172.8.4370-4377.1990; Mattick JS, 1996, GENE, V179, P147, DOI 10.1016/S0378-1119(96)00441-6; MCINNES C, 1993, BIOCHEMISTRY-US, V32, P13432, DOI 10.1021/bi00212a008; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; MEYER TF, 1990, ANNU REV MICROBIOL, V44, P451; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; PARANCHYCH W, 1986, CLIN INVEST MED, V9, P113; PARANCHYCH W, 1979, CAN J MICROBIOL, V25, P1175, DOI 10.1139/m79-182; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; PASLOSKE BL, 1989, J BACTERIOL, V171, P2142, DOI 10.1128/jb.171.4.2142-2147.1989; PENNINGTON JE, 1979, J INFECT DIS, V139, P396, DOI 10.1093/infdis/139.4.396; PIER GB, 1983, J INFECT DIS, V148, P206, DOI 10.1093/infdis/148.2.206; PIER GB, 1985, J INFECT DIS, V151, P575, DOI 10.1093/infdis/151.4.575; PUGH GW, 1977, AM J VET RES, V38, P1519; RAMPHAL R, 1984, INFECT IMMUN, V44, P38, DOI 10.1128/IAI.44.1.38-40.1984; RAMPHAL R, 1991, INFECT IMMUN, V59, P700, DOI 10.1128/IAI.59.2.700-704.1991; RINI JM, 1995, ANNU REV BIOPH BIOM, V24, P551, DOI 10.1146/annurev.biophys.24.1.551; RONCERO C, 1990, J BACTERIOL, V172, P1899, DOI 10.1128/jb.172.4.1899-1904.1990; Sheth H B, 1995, Biomed Pept Proteins Nucleic Acids, V1, P141; SHETH HB, 1994, MOL MICROBIOL, V11, P715, DOI 10.1111/j.1365-2958.1994.tb00349.x; Silverman PM, 1997, MOL MICROBIOL, V23, P423, DOI 10.1046/j.1365-2958.1997.2411604.x; Suh JY, 2001, BIOCHEMISTRY-US, V40, P3985, DOI 10.1021/bi002524h; SWANSON J, 1987, J EXP MED, V165, P1016, DOI 10.1084/jem.165.4.1016; Tripet B, 1996, PROTEIN ENG, V9, P1029, DOI 10.1093/protein/9.11.1029; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; WATTS TH, 1982, J BACTERIOL, V151, P1508, DOI 10.1128/JB.151.3.1508-1513.1982; WISHART DS, 1994, COMPUT APPL BIOSCI, V10, P687; Wolfgang M, 1999, MOL MICROBIOL, V31, P1345, DOI 10.1046/j.1365-2958.1999.01269.x; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x; YU L, 1994, INFECT IMMUN, V62, P5213, DOI 10.1128/IAI.62.12.5213-5219.1994	64	90	98	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24186	24193		10.1074/jbc.M100659200	http://dx.doi.org/10.1074/jbc.M100659200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11294863	hybrid			2022-12-27	WOS:000169531100127
J	Muenzner, P; Naumann, M; Meyer, TF; Gray-Owen, SD				Muenzner, P; Naumann, M; Meyer, TF; Gray-Owen, SD			Pathogenic Neisseria trigger expression of their carcinoembryonic antigen-related cellular adhesion molecule 1 (CEACAM1; previously CD66a) receptor on primary endothelial cells by activating the immediate early response transcription factor, nuclear factor-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-2; TUMOR-NECROSIS-FACTOR; GONOCOCCAL OPACITY PROTEINS; CROSS-REACTING ANTIGEN; EPITHELIAL-CELLS; BILIARY GLYCOPROTEIN; SOLUBLE CD14; OPA PROTEINS; C-CAM; GONORRHOEAE	Neisseria gonorrhoeae express opacity-associated (Opa) protein adhesins that mediate binding to various members of the carcinoembryonic antigen-related cellular adhesion molecule (CEACAM; previously CD66) receptor family. Although human umbilical vein endothelial cells express little CEACAM receptor in vitro, we found neisserial infection to induce expression of CEACAM1, CEACAM1-3L, and CECAM1-4L splice variants. This mediates an increased Opa(52)-dependent binding of gonococci by these cells. The induced receptor expression did not require bacterial Opa expression, but it was more rapid with adherent bacteria. Because the time course of induction was similar to that seen for induced proinflammatory cytokines, we tested whether CEACAM1 expression could be controlled by a similar mechanism. Gonococcal infection activated a nuclear factor-kappaB (NF-kappaB) heterodimer consisting of p50 and p65, and inhibitors that prevent the nuclear translocation of activated NF-kappaB complex inhibited CEACAM1 transcript expression. Each of these effects could be mimicked by using culture filtrates or purified lipopolysaccharide instead of intact bacteria. Together, our results support a model whereby the outer membrane "blebs" that are actively released by gonococci trigger a Toll-like receptor-4-dependent activation of NF-kappaB, which up-regulates the expression of CEACAM1 to allow Opa(52)-mediated neisserial binding. The regulation of CEACAM1 expression by MF-kappaB also implies a broader role for this receptor in the general inflammatory response to infection.	Max Planck Inst Biol, Infekt Biol Abt, D-72076 Tubingen, Germany; Max Planck Inst Infekt Biol, Abt Molekulare BIol, D-21122 Berlin, Mitte, Germany; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	Max Planck Society; Max Planck Society; University of Toronto	Meyer, TF (corresponding author), Max Planck Inst Biol, Infekt Biol Abt, Spemannstr 34, D-72076 Tubingen, Germany.	meyer@mpiib-berlin.mpg.de	Gray-Owen, Scott/AAG-7337-2022; Gray-Owen, Scott/AFL-7380-2022; Meyer, Thomas F. F/J-2485-2013; Naumann, Michael/B-5285-2011	Meyer, Thomas F. F/0000-0002-6120-8679; Naumann, Michael/0000-0002-8060-2313; Gray-Owen, Scott D./0000-0002-1477-3616				ACHTMAN M, 1988, J EXP MED, V168, P507, DOI 10.1084/jem.168.2.507; ARDITI M, 1993, INFECT IMMUN, V61, P3149, DOI 10.1128/IAI.61.8.3149-3156.1993; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beauchemin N, 1999, EXP CELL RES, V252, P243; BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; Billker O, 2000, TRENDS MICROBIOL, V8, P258, DOI 10.1016/S0966-842X(00)01771-6; Bos MP, 1997, INFECT IMMUN, V65, P2353, DOI 10.1128/IAI.65.6.2353-2361.1997; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; CHEN T, 1995, J EXP MED, V182, P511, DOI 10.1084/jem.182.2.511; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Dehio C, 1997, J CELL SCI, V110, P2141; Dehio M, 1998, FEBS LETT, V424, P84, DOI 10.1016/S0014-5793(98)00144-6; DELUDE RL, 1994, J BIOL CHEM, V269, P22253; Duensing TD, 1997, INFECT IMMUN, V65, P964, DOI 10.1128/IAI.65.3.964-970.1997; EIDELMAN FJ, 1993, J CELL BIOL, V123, P467, DOI 10.1083/jcb.123.2.467; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GIRARDIN E, 1988, NEW ENGL J MED, V319, P397, DOI 10.1056/NEJM198808183190703; Gray-Owen SD, 1997, MOL MICROBIOL, V26, P971, DOI 10.1046/j.1365-2958.1997.6342006.x; GrayOwen SD, 1997, EMBO J, V16, P3435, DOI 10.1093/emboj/16.12.3435; Hauck CR, 1997, INFECT IMMUN, V65, P1863, DOI 10.1128/IAI.65.5.1863-1869.1997; HEFTA SA, 1990, J BIOL CHEM, V265, P8618; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; HSIEH JT, 1995, CANCER RES, V55, P190; Kammerer R, 1998, EUR J IMMUNOL, V28, P3664, DOI 10.1002/(SICI)1521-4141(199811)28:11<3664::AID-IMMU3664>3.0.CO;2-D; Klein ML, 1996, INFECT IMMUN, V64, P4574, DOI 10.1128/IAI.64.11.4574-4579.1996; Kleinerman DI, 1996, CANCER RES, V56, P3431; KLEINERMAN DI, 1995, CANCER RES, V55, P1215; KUIJPERS TW, 1992, J CELL BIOL, V118, P457, DOI 10.1083/jcb.118.2.457; Kunath T, 1995, ONCOGENE, V11, P2375; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; Lorenzen DR, 1999, J EXP MED, V190, P1049, DOI 10.1084/jem.190.8.1049; Luo WP, 1997, ONCOGENE, V14, P1697, DOI 10.1038/sj.onc.1200999; MAHON TM, 1995, J BIOL CHEM, V270, P28557, DOI 10.1074/jbc.270.48.28557; MAJURI ML, 1994, APMIS, V102, P432, DOI 10.1111/j.1699-0463.1994.tb04895.x; MCGEE ZA, 1983, REV INFECT DIS, V5, pS708; Means TK, 1999, J IMMUNOL, V163, P3920; Muenzner P, 2000, INFECT IMMUN, V68, P3601, DOI 10.1128/IAI.68.6.3601-3607.2000; NASSIF X, 1992, MOL MICROBIOL, V6, P591, DOI 10.1111/j.1365-2958.1992.tb01505.x; Naumann M, 1997, J EXP MED, V186, P247, DOI 10.1084/jem.186.2.247; NEUMAIER M, 1993, P NATL ACAD SCI USA, V90, P10744, DOI 10.1073/pnas.90.22.10744; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; OIKAWA S, 1991, J BIOL CHEM, V266, P7995; Popp A, 1999, CELL MICROBIOL, V1, P169, DOI 10.1046/j.1462-5822.1999.00017.x; Prall F, 1996, J HISTOCHEM CYTOCHEM, V44, P35, DOI 10.1177/44.1.8543780; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Tapping RI, 2000, J IMMUNOL, V165, P5780, DOI 10.4049/jimmunol.165.10.5780; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; ULEVITCH RJ, 1994, CURR OPIN IMMUNOL, V6, P125, DOI 10.1016/0952-7915(94)90043-4; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; VANPUTTEN JPM, 1995, EMBO J, V14, P2144, DOI 10.1002/j.1460-2075.1995.tb07208.x; Virji M, 2000, MOL MICROBIOL, V36, P784, DOI 10.1046/j.1365-2958.2000.01885.x; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; WAAGE A, 1987, LANCET, V1, P355; Wang J, 1998, MOL MICROBIOL, V30, P657, DOI 10.1046/j.1365-2958.1998.01102.x; Zen K, 1998, EXP CELL RES, V243, P425, DOI 10.1006/excr.1998.4162; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611	62	67	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24331	24340		10.1074/jbc.M006883200	http://dx.doi.org/10.1074/jbc.M006883200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11306560	hybrid			2022-12-27	WOS:000169531100145
J	Yamauchi, J; Tsujimoto, G; Kaziro, Y; Itoh, H				Yamauchi, J; Tsujimoto, G; Kaziro, Y; Itoh, H			Parallel regulation of mitogen-activated protein kinase kinase 3 (MKK3) and MKK6 in G(q)-signaling cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; BETA-GAMMA-SUBUNITS; KIDNEY 293 CELLS; C-JUN KINASE; COUPLED RECEPTORS; SIGNALING PATHWAY; TYROSINE KINASE; NH2-TERMINAL KINASES; MAJOR ACTIVATOR; P38	Heterotrimeric G protein G, stimulates the activity of p38 mitogen-activated protein kinase (MAPK) in mammalian cells. To investigate the signaling mechanism whereby ct and py subunits of G,activate p38 MAPK, we introduced kinase-deficient mutants of mitogen-activated protein kinase kinase 3 (MKK3), MKK4, and MKK6 into human embryonal kidney 293 cells. The activation of p38 MAPK. by Get, and G beta gamma was blocked by kinase-deficient MKK3 and MKK6 but not by kinase-deficient MKK4. In addition, G alpha (q) and G beta gamma stimulated MKK3 and MKK6 activities. The MKK3 and MMK6 activations by G alpha (q), but not by G beta gamma, were dependent on phospholipase C and c-Src. G alpha (q) stimulated MKK3 in a Rac- and Cdc42-dependent manner and MKK6 in a Rho-dependent manner. On the other hand, G beta gamma activated MKK3 in a Rac-and Cdc42-dependent manner and MMK6 in a Rho-, Rac-, and Cdc42-dependent manner. G beta gamma -induced MKK3 and MKK6 activations were dependent on a tyrosine kinase other than c-Src. These results suggest that G alpha (q) and G beta gamma stimulate the activity of p38 MAPK by regulating MKK3 and MKK6 through parallel signaling pathways.	Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; Sanyo Gakuen Univ & Coll, Okayama 7038501, Japan; Japan Sci & Technol Corp, Kawasaki, Kanagawa 3320012, Japan; Childrens Natl Med Ctr, Dept Mol Cell Pharmacol, Setagaya Ku, Tokyo 1541809, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Itoh, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.							BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Brenner B, 1997, J BIOL CHEM, V272, P22173, DOI 10.1074/jbc.272.35.22173; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Clerk A, 1998, J CELL BIOL, V142, P523, DOI 10.1083/jcb.142.2.523; COSO OA, 1995, J BIOL CHEM, V270, P5620, DOI 10.1074/jbc.270.10.5620; Coso OA, 1996, J BIOL CHEM, V271, P3963; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Cuenda A, 1996, EMBO J, V15, P4156, DOI 10.1002/j.1460-2075.1996.tb00790.x; Cuenda A, 1998, BIOCHEM J, V333, P11, DOI 10.1042/bj3330011; Deacon K, 1999, J BIOL CHEM, V274, P16604, DOI 10.1074/jbc.274.23.16604; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Felsch JS, 1998, P NATL ACAD SCI USA, V95, P5051, DOI 10.1073/pnas.95.9.5051; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; Heasley LE, 1996, MOL CELL BIOL, V16, P648; Heidenreich O, 1999, J BIOL CHEM, V274, P14434, DOI 10.1074/jbc.274.20.14434; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Ito M, 1999, MOL CELL BIOL, V19, P7539; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; LANGHANSRAJASEKARAN SA, 1995, P NATL ACAD SCI USA, V92, P8601, DOI 10.1073/pnas.92.19.8601; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MITCHELL FM, 1995, BIOCHEM J, V309, P381, DOI 10.1042/bj3090381; Molnar A, 1997, J BIOL CHEM, V272, P13229, DOI 10.1074/jbc.272.20.13229; Moriguchi T, 1996, J BIOL CHEM, V271, P26981, DOI 10.1074/jbc.271.43.26981; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Nagao M, 1998, J BIOL CHEM, V273, P22892, DOI 10.1074/jbc.273.36.22892; New LG, 1998, TRENDS CARDIOVAS MED, V8, P220, DOI 10.1016/S1050-1738(98)00012-7; Pandey P, 1999, J BIOL CHEM, V274, P10140, DOI 10.1074/jbc.274.15.10140; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schafer C, 1998, J BIOL CHEM, V273, P24173, DOI 10.1074/jbc.273.37.24173; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; VAN AL, 1997, GENE DEV, V11, P2295; Venkatakrishnan G, 1996, J BIOL CHEM, V271, P5066; VOJTEK AB, 1995, CELL, V82, P527, DOI 10.1016/0092-8674(95)90023-3; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Yamauchi J, 2000, J BIOL CHEM, V275, P7633, DOI 10.1074/jbc.275.11.7633; Yamauchi J, 1999, J BIOL CHEM, V274, P1957, DOI 10.1074/jbc.274.4.1957; Yamauchi JJ, 1997, J BIOL CHEM, V272, P27771, DOI 10.1074/jbc.272.44.27771; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	59	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23362	23372		10.1074/jbc.M011752200	http://dx.doi.org/10.1074/jbc.M011752200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11304531	hybrid			2022-12-27	WOS:000169531100021
J	Forgues, M; Marrogi, AJ; Spillare, EA; Wu, CG; Yang , Q; Yoshida, M; Wang, XW				Forgues, M; Marrogi, AJ; Spillare, EA; Wu, CG; Yang , Q; Yoshida, M; Wang, XW			Interaction of the hepatitis B virus X protein with the Crm1-dependent nuclear export pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; MESSENGER-RNA; TRANSACTIVATION FUNCTION; SIGNALING PATHWAY; REV PROTEIN; GENE; DNA; ACTIVATION	The leucine-rich nuclear export signal (NES) is used to shuttle large cellular proteins from the nucleus to the cytoplasm. The nuclear export receptor Crm1 is essential in this process by recognizing the NES motif. Here, we show that the oncogenic hepatitis B virus (HBV)X protein (HBx) contains a functional NES motif. We found that the predominant cytoplasmic localization of HBx is sensitive to the drug leptomycin B (LMB), which specifically inactivates Crm1. Mutations at the two con served leucine residues to alanine at the NES motif (L98A,L100A) resulted in a nuclear redistribution of HBx. A recombinant HBx protein binds to Crm1 in vitro. In addition, ectopic expression of HBx sequesters Crm1 in the cytoplasm. Furthermore, HBx activates NF kappaB by inducing its nuclear translocation in a NES-dependent manner. Abnormal cytoplasmic sequestration of Crm1, accompanied by a nuclear localization of NF kappaB, was also observed in hepatocytes from HBV-positive liver samples with chronic active hepatitis. We suggest that Crm1 may play a role in HBx-mediated liver carcinogenesis.	NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA; Univ Tokyo, Dept Biotechnol, Tokyo, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Tokyo	Wang, XW (corresponding author), NCI, Human Carcinogenesis Lab, NIH, 37 Convent Dr,MSC 4255,Bldg 37,Rm 2C07, Bethesda, MD 20892 USA.	xin_wei_wang@nih.gov	Wang, Xin Wei/B-6162-2009; Yoshida, Minoru/C-8049-2014	Wang, Xin Wei/0000-0001-9735-606X; Yoshida, Minoru/0000-0002-4376-5674				ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; Andrisani OM, 1999, INT J ONCOL, V15, P373; Bangs P, 1998, J CELL BIOL, V143, P1801, DOI 10.1083/jcb.143.7.1801; BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; Brechot C, 2000, SEMIN CANCER BIOL, V10, P211, DOI 10.1006/scbi.2000.0321; CHEONG JH, 1995, EMBO J, V14, P143, DOI 10.1002/j.1460-2075.1995.tb06984.x; Chirillo P, 1997, P NATL ACAD SCI USA, V94, P8162, DOI 10.1073/pnas.94.15.8162; CROSS JC, 1993, P NATL ACAD SCI USA, V90, P8078, DOI 10.1073/pnas.90.17.8078; DIBISCEGLIE AM, 1988, ANN INTERN MED, V108, P390, DOI 10.7326/0003-4819-108-3-390; Dobbelstein M, 1997, EMBO J, V16, P4276, DOI 10.1093/emboj/16.14.4276; Elmore LW, 1997, P NATL ACAD SCI USA, V94, P14707, DOI 10.1073/pnas.94.26.14707; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; GANEM D, 1987, ANNU REV BIOCHEM, V56, P651, DOI 10.1146/annurev.biochem.56.1.651; GRECO A, 1992, ONCOGENE, V7, P237; KEKULE AS, 1993, NATURE, V361, P742, DOI 10.1038/361742a0; Kim H, 1998, J BIOL CHEM, V273, P381, DOI 10.1074/jbc.273.1.381; Kim YC, 2001, ONCOGENE, V20, P16, DOI 10.1038/sj.onc.1203840; Kudo N, 1997, J BIOL CHEM, V272, P29742, DOI 10.1074/jbc.272.47.29742; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Kumar V, 1996, P NATL ACAD SCI USA, V93, P5647, DOI 10.1073/pnas.93.11.5647; Lara-Pezzi E, 1998, EMBO J, V17, P7066, DOI 10.1093/emboj/17.23.7066; MEYER M, 1992, EMBO J, V11, P2991, DOI 10.1002/j.1460-2075.1992.tb05369.x; Montesano R, 1997, JNCI-J NATL CANCER I, V89, P1844, DOI 10.1093/jnci/89.24.1844; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; PATERLINI P, 1995, HEPATOLOGY, V21, P313, DOI 10.1002/hep.1840210208; QADRI I, 1995, P NATL ACAD SCI USA, V92, P1003, DOI 10.1073/pnas.92.4.1003; Qadri I, 1996, P NATL ACAD SCI USA, V93, P10578, DOI 10.1073/pnas.93.20.10578; RITTER SE, 1991, VIROLOGY, V182, P841, DOI 10.1016/0042-6822(91)90626-M; Robinson WS, 1999, MICROBES AND MALIGNANCY, P232; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; SOMAN NR, 1991, P NATL ACAD SCI USA, V88, P4892, DOI 10.1073/pnas.88.11.4892; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Su F, 1997, P NATL ACAD SCI USA, V94, P8744, DOI 10.1073/pnas.94.16.8744; TAKADA S, 1990, P NATL ACAD SCI USA, V87, P5628, DOI 10.1073/pnas.87.15.5628; Tam WF, 2000, MOL CELL BIOL, V20, P2269, DOI 10.1128/MCB.20.6.2269-2284.2000; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Ullman KS, 1997, CELL, V90, P967, DOI 10.1016/S0092-8674(00)80361-X; UNSAL H, 1994, P NATL ACAD SCI USA, V91, P822, DOI 10.1073/pnas.91.2.822; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; Wang HD, 1997, MOL CELL BIOL, V17, P6838, DOI 10.1128/MCB.17.12.6838; WANG XW, 1995, CANCER RES, V55, P6012; WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230; Wang XW, 1996, GENE DEV, V10, P1219, DOI 10.1101/gad.10.10.1219; Weil R, 1999, MOL CELL BIOL, V19, P6345; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X	52	76	85	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22797	22803		10.1074/jbc.M101259200	http://dx.doi.org/10.1074/jbc.M101259200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11287420	hybrid			2022-12-27	WOS:000169412700109
J	Mester, T; Ambert-Balay, K; Ciofi-Baffoni, S; Banci, L; Jones, AD; Tien, M				Mester, T; Ambert-Balay, K; Ciofi-Baffoni, S; Banci, L; Jones, AD; Tien, M			Oxidation of a tetrameric nonphenolic lignin model compound by lignin peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; PHANEROCHAETE-CHRYSOSPORIUM BURDS; SUBSTRATE INTERACTION SITES; MANGANESE PEROXIDASE; VERATRYL ALCOHOL; CRYSTAL-STRUCTURE; KINETIC-ANALYSIS; DEGRADATION; ROT; BIODEGRADATION	The present study maps the active site of lignin peroxidase in respect to substrate size using either fungal or recombinant wild type, as well as mutated, recombinant lignin peroxidases. A nonphenolic tetrameric lignin model was synthesized that contains beta -O-4 linkages. The fungal and recombinant wild type lignin peroxidase both oxidized the tetrameric model forming four products, The four products were identified by mass spectral analyses and compared with synthetic standards. They were identified as tetrameric, trimeric, dimeric, and monomeric carbonyl compounds. Ah four of these products were also formed from single turnover experiments. This indicates that lignin peroxidase is able to attack any of the C-alpha-C-beta linkages in the tetrameric compound and that the substrate-binding site is well exposed. Mutation of the recombinant lignin peroxidase (isozyme H8) in the heme access channel, which is relatively restricted and was previously proposed to be the veratryl alcohol-binding site (E146S), had little effect on the oxidation of the tetramer. In contrast, mutation of a Trp residue (W171S) in the alternate proposed substrate-binding site completely inhibited the oxidation of the tetrameric model. These results are consistent with lignin peroxidase having an exposed active site capable of directly interacting with the lignin polymer without the advent of low molecular weight mediators.	Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Penn State Univ, Dept Chem, University Pk, PA 16802 USA; Univ Florence, Dept Chem, I-50121 Florence, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Florence	Tien, M (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.		Jones, Arthur D/C-2670-2013; Ciofi-Baffoni, Simone/AAH-9778-2021	Ciofi Baffoni, Simone/0000-0002-2376-3321; BANCI, LUCIA/0000-0003-0562-5774; Jones, A. Daniel/0000-0002-7408-6690; Ambert-Balay, Katia/0000-0002-2624-712X				Ambert-Balay K, 1998, BIOCHEM BIOPH RES CO, V251, P283, DOI 10.1006/bbrc.1998.9454; Blodig W, 1998, BIOCHEMISTRY-US, V37, P8832, DOI 10.1021/bi9727186; Camarero S, 1999, J BIOL CHEM, V274, P10324, DOI 10.1074/jbc.274.15.10324; CHANCE B, 1952, ARCH BIOCHEM BIOPHYS, V41, P416, DOI 10.1016/0003-9861(52)90470-0; Ciofi-Baffoni S, 1998, J CHEM SOC PERK T 1, P3207, DOI 10.1039/a805027i; Doyle WA, 1998, BIOCHEMISTRY-US, V37, P15097, DOI 10.1021/bi981633h; FENN P, 1984, J WOOD CHEM TECHNOL, V4, P131, DOI 10.1080/02773818408081148; FLOURNOY DS, 1993, HOLZFORSCHUNG, V47, P297, DOI 10.1515/hfsg.1993.47.4.297; GLENN JK, 1986, ARCH BIOCHEM BIOPHYS, V251, P688, DOI 10.1016/0003-9861(86)90378-4; GLENN JK, 1983, BIOCHEM BIOPH RES CO, V114, P1077, DOI 10.1016/0006-291X(83)90672-1; HAMMEL KE, 1993, J BIOL CHEM, V268, P12274; HAMMEL KE, 1991, ENZYME MICROB TECH, V13, P15, DOI 10.1016/0141-0229(91)90182-A; HARVEY PJ, 1986, FEBS LETT, V195, P242, DOI 10.1016/0014-5793(86)80168-5; Johjima T, 1999, P NATL ACAD SCI USA, V96, P1989, DOI 10.1073/pnas.96.5.1989; Khindaria A, 1996, BIOCHEMISTRY-US, V35, P6418, DOI 10.1021/bi9601666; KIRK TK, 1986, BIOCHEM J, V236, P279, DOI 10.1042/bj2360279; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; KIRK TK, 1986, ENZYME MICROB TECH, V8, P27, DOI 10.1016/0141-0229(86)90006-2; KODURI RS, 1994, BIOCHEMISTRY-US, V33, P4225, DOI 10.1021/bi00180a016; KUAN IC, 1993, J BIOL CHEM, V268, P20064; MESSNER K, 1994, FEMS MICROBIOL REV, V13, P351, DOI 10.1111/j.1574-6976.1994.tb00054.x; Mester T, 1998, J BIOL CHEM, V273, P15412, DOI 10.1074/jbc.273.25.15412; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; ORTH AB, 1993, APPL ENVIRON MICROB, V59, P4017, DOI 10.1128/AEM.59.12.4017-4023.1993; PAICE MG, 1995, J PULP PAP SCI, V27, pJ280; PASZCZYNSKI A, 1986, ARCH BIOCHEM BIOPHYS, V244, P750, DOI 10.1016/0003-9861(86)90644-2; PASZCZYNSKI A, 1991, BIOCHEM BIOPH RES CO, V178, P1056, DOI 10.1016/0006-291X(91)90999-N; PIONTEK K, 1993, FEBS LETT, V315, P119, DOI 10.1016/0014-5793(93)81146-Q; POULOS TL, 1993, J BIOL CHEM, V268, P4429; SARKANEN S, 1991, J BIOL CHEM, V266, P3636; Schoemaker HE, 1996, PURE APPL CHEM, V68, P2089, DOI 10.1351/pac199668112089; SUNDARAMOORTHY M, 1994, J BIOL CHEM, V269, P32759; THURSTON CF, 1994, MICROBIOL-SGM, V140, P19, DOI 10.1099/13500872-140-1-19; TIEN M, 1986, J BIOL CHEM, V261, P1687; TIEN M, 1983, SCIENCE, V221, P661, DOI 10.1126/science.221.4611.661; Timofeevski SL, 1999, BIOCHEM BIOPH RES CO, V256, P500, DOI 10.1006/bbrc.1999.0360; Timofeevski SL, 2000, ARCH BIOCHEM BIOPHYS, V373, P147, DOI 10.1006/abbi.1999.1562	37	59	59	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22985	22990		10.1074/jbc.M010739200	http://dx.doi.org/10.1074/jbc.M010739200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11304528	hybrid			2022-12-27	WOS:000169412700134
J	Pagano, M; Anand-Srivastava, MB				Pagano, M; Anand-Srivastava, MB			Cytoplasmic domain of natriuretic peptide receptor C constitutes G(i) activator sequences that inhibit adenylyl cyclase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE REGULATORY PROTEIN; SIGNAL-TRANSDUCTION SYSTEM; GUANYLATE-CYCLASE; CLEARANCE RECEPTOR; SMOOTH-MUSCLE; PORCINE BRAIN; CYCLIC-GMP; NPR-C; ATRIAL; CELLS	We have recently demonstrated that a 37-amino acid peptide corresponding to the cytoplasmic domain of the natriuretic peptide receptor C (NPR-C) inhibited adenylyl cyclase activity via pertussis toxin (PT)-sensitive G(i) protein. In the present studies, we have used seven different peptide fragments of the cytoplasmic domain of the NPR-C receptor with complete, partial, or no G(i) activator sequence to examine their effects on adenylyl cyclase activity. The peptides used were KKYRITIER-RNH (peptide 1), RRNHQEESNIGK (peptide 2), HRELREDSIRSH (peptide 3), RRNHQEESNIGKHRELR (peptide 4), QEESNIGK (peptide X), ITIERRNH (peptide Y), and ITYKRRNHRE (peptide Z). Peptides 1, 3, and 4 have complete G(i) activator sequences, whereas peptides 2 and Y have partial G(i) activator sequences with truncated carboxyl or amino terminus, respectively. Peptide X has no structural specificity, whereas peptide Z is the scrambled peptide control for peptide 1. Peptides 1, 3, and 4 inhibited adenylyl cyclase activity in a concentration-dependent manner with apparent K-i between 0.1 and 1 nm; however, peptide 2 inhibited adenylyl cyclase activity with a higher K-i of about 10 nM, and peptides X, Y, and Z were unable to inhibit adenylyl cyclase activity. The maximal inhibitions observed were between 30 and 40%. The inhibition of adenylyl cyclase activity by peptides 1-4 was absolutely dependent on the presence of guanine nucleotides and was completely attenuated by PT treatment. In addition, the stimulatory effects of isoproterenol, glucagon, and forskolin on adenylyl cyclase activity were inhibited to different degrees by these peptides. These results suggest that the small peptide fragments of the cytoplasmic domain of the NPR-C receptor containing 12 or 17 amino acids were sufficient to inhibit adenylyl cyclase activity through a PT-sensitive G(i) protein. The peptides having complete structural specificity of G(i) activator sequences at both amino and carboxyl termini were more potent to inhibit adenylyl cyclase activity as compared with the peptides having a truncated carboxyl terminus, whereas the truncation of the amino-terminal motif completely attenuates adenylyl cyclase inhibition.	Univ Montreal, Fac Med, Dept Physiol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Anand-Srivastava, MB (corresponding author), Univ Montreal, Fac Med, Dept Physiol, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.							AnandSrivastava MB, 1996, J BIOL CHEM, V271, P19324, DOI 10.1074/jbc.271.32.19324; ANANDSRIVASTAVA MB, 1986, AM J PHYSIOL, V251, pF417, DOI 10.1152/ajprenal.1986.251.3.F417; ANANDSRIVASTAVA MB, 1991, BIOCHEM J, V278, P211, DOI 10.1042/bj2780211; ANANDSRIVASTAVA MB, 1990, J BIOL CHEM, V265, P8566; ANANDSRIVASTAVA MB, 1986, BIOCHEM BIOPH RES CO, V138, P427, DOI 10.1016/0006-291X(86)90299-8; ANANDSRIVASTAVA MB, 1984, BIOCHEM BIOPH RES CO, V121, P855, DOI 10.1016/0006-291X(84)90756-3; ANANDSRIVASTAVA MB, 1985, LIFE SCI, V36, P1873, DOI 10.1016/0024-3205(85)90161-4; ANANDSRIVASTAVA MB, 1987, J BIOL CHEM, V262, P4931; ANANDSRIVASTAVA MB, 1992, BIOCHEM J, V288, P79, DOI 10.1042/bj2880079; ANANDSRIVASTAVA MB, 1985, FEBS LETT, V181, P199, DOI 10.1016/0014-5793(85)80259-3; ANANDSRIVASTAVA MB, 1993, PHARMACOL REV, V45, P455; BIANCHI C, 1986, CURR EYE RES, V5, P283, DOI 10.3109/02713688609020054; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; CHANG M, 1989, NATURE, V341, P68, DOI 10.1038/341068a0; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CLAVELL AL, 1993, AM J PHYSIOL, V264, P290; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; DEBOLD AJ, 1982, P SOC EXP BIOL MED, V170, P133; FULLER F, 1988, J BIOL CHEM, V263, P9395; HAMET P, 1984, BIOCHEM BIOPH RES CO, V123, P515, DOI 10.1016/0006-291X(84)90260-2; HIRATA M, 1989, BIOCHIM BIOPHYS ACTA, V1010, P346, DOI 10.1016/0167-4889(89)90060-8; KAMBAYASHI Y, 1990, FEBS LETT, V259, P341, DOI 10.1016/0014-5793(90)80043-I; Kanwal S, 1999, ENDOCRINOLOGY, V140, P1118, DOI 10.1210/en.140.3.1118; LEITMAN DC, 1988, J BIOL CHEM, V263, P3720; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Murthy KS, 1999, J BIOL CHEM, V274, P17587, DOI 10.1074/jbc.274.25.17587; OKAMOTO T, 1992, J BIOL CHEM, V267, P8342; Palaparti A, 1999, ARCH BIOCHEM BIOPHYS, V365, P113, DOI 10.1006/abbi.1999.1153; RUSKOAHO H, 1992, PHARMACOL REV, V44, P479; SCHENK DB, 1985, J BIOL CHEM, V260, P4887; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; SOLOMON Y, 1974, ANAL BIOCHEM, V58, P541; STINGO AJ, 1992, AM J PHYSIOL, V262, P308; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; SUGA S, 1992, J CLIN INVEST, V90, P1145, DOI 10.1172/JCI115933; WALDMAN S, 1984, J BIOL CHEM, V259, P15332	38	74	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22064	22070		10.1074/jbc.M101587200	http://dx.doi.org/10.1074/jbc.M101587200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11303026	hybrid			2022-12-27	WOS:000169412700012
J	Twining, SS; Goryshin, IY; Bhasin, A; Reznikoff, WS				Twining, SS; Goryshin, IY; Bhasin, A; Reznikoff, WS			Functional characterization of arginine 30, lysine 40, and arginine 62 in Tn5 transposase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEAVAGE SYNAPTIC COMPLEX; DNA-BINDING; RECOGNITION; MULTIMERIZATION; IDENTIFICATION; INTERMEDIATE; DOMAINS; END	Three N-terminal basic residues of Tn5 transposase, which are associated with proteolytic cleavages by Escherichia coli proteinases, were mutated to glutamine residues with the goal of producing more stable transposase molecules. Mutation of either arginine 30 or arginine 62 to glutamine produced transposase molecules that were more stable toward E. coli proteinases than the parent hyperactive Tn5 transposase, however, they were inactive in vivo. In vitro analysis revealed these mutants were inactive, because both Arg(30) and Arg(62) are required for formation of the paired ends complexes when the transposon is attached to the donor backbone. These results suggest Arg(30) and Arg(62) play critical roles in DNA binding and/or synaptic complex formation. Mutation of lysine 40 to glutamine did not increase the overall stability of the transposase to E. coli proteinases. This mutant transposase was only about 1% as active as the parent hyperactive transposase in vivo; however, it retained nearly full activity in vitro, These results suggest that lysine 40 is important for a step in the transposition mechanism that is bypassed in the in vitro assay system, such as the removal of the transposase molecule from DNA following strand transfer.	Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin	Reznikoff, WS (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	reznikoff@biochem.wisc.edu			NEI NIH HHS [EY12931] Funding Source: Medline; NIGMS NIH HHS [GM50692] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhasin A, 1999, J BIOL CHEM, V274, P37021, DOI 10.1074/jbc.274.52.37021; Bhasin A, 2000, J MOL BIOL, V302, P49, DOI 10.1006/jmbi.2000.4048; Braam LAM, 1998, J BIOL CHEM, V273, P10908, DOI 10.1074/jbc.273.18.10908; Braam LAM, 1999, J BIOL CHEM, V274, P86, DOI 10.1074/jbc.274.1.86; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; DERBYSHIRE KM, 1990, P NATL ACAD SCI USA, V87, P4048, DOI 10.1073/pnas.87.11.4048; Goryshin IY, 1998, P NATL ACAD SCI USA, V95, P10716, DOI 10.1073/pnas.95.18.10716; Goryshin IY, 1998, J BIOL CHEM, V273, P7367, DOI 10.1074/jbc.273.13.7367; Goryshin IY, 2000, NAT BIOTECHNOL, V18, P97, DOI 10.1038/72017; Heinrikson R L, 1977, Methods Enzymol, V47, P175; Jilk RA, 1996, J BACTERIOL, V178, P1671, DOI 10.1128/jb.178.6.1671-1679.1996; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; Naumann TA, 2000, P NATL ACAD SCI USA, V97, P8944, DOI 10.1073/pnas.160107997; Reznikoff WS, 1999, BIOCHEM BIOPH RES CO, V266, P729, DOI 10.1006/bbrc.1999.1891; SAKAI J, 1995, EMBO J, V14, P4374, DOI 10.1002/j.1460-2075.1995.tb00112.x; Smith CK, 1999, P NATL ACAD SCI USA, V96, P6678, DOI 10.1073/pnas.96.12.6678; Steiniger-White M, 2000, J BIOL CHEM, V275, P23127, DOI 10.1074/jbc.M003411200; Stellwagen AE, 1998, TRENDS BIOCHEM SCI, V23, P486, DOI 10.1016/S0968-0004(98)01325-5; WEINREICH MD, 1994, J MOL BIOL, V241, P166, DOI 10.1006/jmbi.1994.1486; WEINREICH MD, 1994, GENE DEV, V8, P2363, DOI 10.1101/gad.8.19.2363; Yigit H, 1999, J BACTERIOL, V181, P3185, DOI 10.1128/JB.181.10.3185-3192.1999; York D, 1997, NUCLEIC ACIDS RES, V25, P2153, DOI 10.1093/nar/25.11.2153; York D, 1996, NUCLEIC ACIDS RES, V24, P3790, DOI 10.1093/nar/24.19.3790; York D, 1998, NUCLEIC ACIDS RES, V26, P1927, DOI 10.1093/nar/26.8.1927; Zhou M, 1998, J MOL BIOL, V276, P913, DOI 10.1006/jmbi.1997.1579	25	15	19	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23135	23143		10.1074/jbc.M010748200	http://dx.doi.org/10.1074/jbc.M010748200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11283001	hybrid			2022-12-27	WOS:000169412700154
J	Tian, GC; Haffner, CD				Tian, GC; Haffner, CD			Linear relationships between the ligand binding energy and the activation energy of time-dependent inhibition of steroid 5 alpha-reductase by Delta(l)-4-azasteroids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 HUMAN 5-ALPHA-REDUCTASE; 5 ALPHA-REDUCTASE; FINASTERIDE; MECHANISM; 6-AZASTEROIDS; OPTIMIZATION	The inhibition of steroid 5 alpha -reductase (5AR) by Delta (1)-4-azasteroids is characterized by a two-step time-dependent kinetic mechanism where inhibitor combines with enzyme in a fast equilibrium, defined by the inhibition constant K-i, to form an initial reversible enzyme-inhibitor complex, which subsequently undergoes a time-dependent chemical rearrangement, defined by the rate constant k(3), leading to the formation of an apparently irreversible, tight-binding enzyme-inhibitor complex (Tian, G,, Mook, R, A., Jr,, Moss, M, L,, and Frye, S. V. (1995) Biochemistry 34, 13453-13459). A detailed kinetic analysis of this process with a series of Delta (1)-4-azasteroids having different C-17 substituents was performed to understand the relationships between the rate of time-dependent inhibition and the affinity of the time-dependent inhibitors for the enzyme. A linear correlation was observed between In(1/K-i), which is proportional to the ligand binding energy for the formation of the enzyme-inhibitor complex, and In(1/(k(3)/K-i)), which is proportional to the activation energy for the inhibition reaction under the second order reaction condition, which leads to the formation of the irreversible, tight-binding enzyme-inhibitor complex. The coefficient of the correlation was -0.88 +/- 0.07 for type 1 5AR and -1.0 +/- 0.2 for type 2 5AR, In comparison, there was no obvious correlation between In(1/K-i) and ln(1/k(3)), which is proportional to the activation energy of the second, time-dependent step of the inhibition reaction. These data are consistent with a model where ligand binding energies provided at C-17 of Delta (1)-4-azasteroids is fully expressed to lower the activation energy of k(3)/K-i with little perturbation of the energy barrier of the second, time-dependent step.	GlaxoSmithKlin Res & Dev, Dept Mol Biochem, Res Triangle Pk, NC 27709 USA; GlaxoSmithKlin Res & Dev, Dept Med Chem, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline; GlaxoSmithKline	Tian, GC (corresponding author), Astrazeneca, Dept Lead Discovery, Wilmington, DE 19850 USA.	gaochao.tian@astrazeneca.com						ALBERY WJ, 1977, ANGEW CHEM INT EDIT, V16, P285, DOI 10.1002/anie.197702851; ANDERSSON S, 1990, P NATL ACAD SCI USA, V87, P3640, DOI 10.1073/pnas.87.10.3640; ANDERSSON S, 1991, NATURE, V354, P159, DOI 10.1038/354159a0; BATCHELOR KW, 1993, Patent No. 9507926; BATCHELOR KW, 1993, Patent No. 9507927; Bull HG, 1996, J AM CHEM SOC, V118, P2359, DOI 10.1021/ja953069t; BURBAUM JJ, 1989, BIOCHEMISTRY-US, V28, P9293, DOI 10.1021/bi00450a009; FALLER B, 1993, BIOCHEMISTRY-US, V32, P5705, DOI 10.1021/bi00072a028; Frye S V, 1998, Pharm Biotechnol, V11, P393; FRYE SV, 1994, J MED CHEM, V37, P2352, DOI 10.1021/jm00041a014; FRYE SV, 1995, J MED CHEM, V38, P2621, DOI 10.1021/jm00014a015; FRYE SV, 1993, J MED CHEM, V36, P4313, DOI 10.1021/jm00078a022; GELLER J, 1991, J AM GERIATR SOC, V39, P1208, DOI 10.1111/j.1532-5415.1991.tb03576.x; KALIR A, 1981, ORG SYNTH, V60, P104; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Moss ML, 1996, BIOCHEMISTRY-US, V35, P3457, DOI 10.1021/bi952472+; RASMUSSON GH, 1986, J MED CHEM, V29, P2298, DOI 10.1021/jm00161a028; REETZ MT, 1980, ANGEW CHEM INT EDIT, V19, P901, DOI 10.1002/anie.198009011; THIGPEN AE, 1993, J CLIN INVEST, V92, P903, DOI 10.1172/JCI116665; Tian GC, 1996, J PHARM SCI, V85, P106, DOI 10.1021/js950100g; TIAN GC, 1994, BIOCHEMISTRY-US, V33, P2291, DOI 10.1021/bi00174a041; TIAN GC, 1995, J AM CHEM SOC, V117, P2369, DOI 10.1021/ja00113a034; TIAN GC, 1995, BIOCHEMISTRY-US, V34, P13453, DOI 10.1021/bi00041a024	23	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21359	21364		10.1074/jbc.M100793200	http://dx.doi.org/10.1074/jbc.M100793200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279132	hybrid			2022-12-27	WOS:000169297900076
J	Krueger, A; Schmitz, I; Baumann, S; Krammer, PH; Kirchhoff, S				Krueger, A; Schmitz, I; Baumann, S; Krammer, PH; Kirchhoff, S			Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEIN; FAS-MEDIATED APOPTOSIS; NF-KAPPA-B; C-FLIP; EFFECTOR DOMAINS; UP-REGULATION; IN-VIVO; RECEPTOR; FADD; INTERACTS	Upon stimulation, CD95 (APO-1/Fas) recruits the adapter molecule FADD/MORT1, procaspase-8, and the cellular FLICE-inhibitory proteins (c-FLIP) into the death-inducing signaling complex (DISC), According to the induced proximity model, procaspase-8 is activated in the DISC in an autoproteolytic manner by two subsequent cleavage steps. c-FLIP proteins exist as a long (c-FLIPL) and a short (c-FLIP,) splice variant, both of them capable of protecting cells from death receptor-mediated apoptosis. In stably transfected BJAB cells, both c-FLIPL and c-FLIPS block procaspase-8 activation at the DISC. However, cleavage is blocked at different steps. c-FLIPL allows the first cleavage step of procaspase-8, leading to the generation of the p10 subunit. In contrast, c-FLIPS completely inhibits cleavage of procaspase-8, Interestingly, p43-c-FLIPL lacking the p12 subunit also prevents cleavage of procaspase-8, In contrast, a nonprocessable mutant of c-FLIPL allows the first cleavage of procaspase-8, In conclusion, both c-FLIP proteins prevent caspase-8 activation at different levels of procaspase-8 processing at the DISC. Our results indicate that c-FLIPL induces a conformation of procaspase-8 that allows partial but not complete proteolytical processing, whereas in contrast c-FLIPS even prevents partial procaspase-8 activation at the DISC.	German Canc Res Ctr, Tumor Immunol Program, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Kirchhoff, S (corresponding author), German Canc Res Ctr, Tumor Immunol Program, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Krueger, Andreas/B-9427-2009; Krueger, Andreas/M-9769-2019; Schmitz, Ingo/G-2093-2013	Krueger, Andreas/0000-0001-7873-7334; Krueger, Andreas/0000-0001-7873-7334; Schmitz, Ingo/0000-0002-5360-0419				Algeciras-Schimnich A, 1999, J IMMUNOL, V162, P5205; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Djerbi M, 1999, J EXP MED, V190, P1025, DOI 10.1084/jem.190.7.1025; ENARI M, 1995, NATURE, V375, P78, DOI 10.1038/375078a0; Goltsev YV, 1997, J BIOL CHEM, V272, P19641, DOI 10.1074/jbc.272.32.19641; Han DKM, 1997, P NATL ACAD SCI USA, V94, P11333, DOI 10.1073/pnas.94.21.11333; Hennino A, 2000, J IMMUNOL, V165, P3023, DOI 10.4049/jimmunol.165.6.3023; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Inohara N, 1997, P NATL ACAD SCI USA, V94, P10717, DOI 10.1073/pnas.94.20.10717; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kirchhoff S, 2000, EUR J IMMUNOL, V30, P2765, DOI 10.1002/1521-4141(200010)30:10<2765::AID-IMMU2765>3.0.CO;2-W; Kirchhoff S, 2000, J IMMUNOL, V165, P6293, DOI 10.4049/jimmunol.165.11.6293; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; PETER ME, 1998, APOPTOSIS PROBLEMS D, P25; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schmitz I, 2000, INT J BIOCHEM CELL B, V32, P1123, DOI 10.1016/S1357-2725(00)00048-0; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; SRINIVASULA SM, 1996, J BIOL CHEM, V271, P20799; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Van Parijs L, 1999, IMMUNITY, V11, P763, DOI 10.1016/S1074-7613(00)80150-8; Wajant H, 2000, J BIOL CHEM, V275, P24357, DOI 10.1074/jbc.M000811200; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang J, 2000, EUR J IMMUNOL, V30, P155, DOI 10.1002/1521-4141(200001)30:1<155::AID-IMMU155>3.3.CO;2-O; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9	44	450	468	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20633	20640		10.1074/jbc.M101780200	http://dx.doi.org/10.1074/jbc.M101780200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279218	hybrid			2022-12-27	WOS:000169135100129
J	Talfournier, F; Munro, AW; Basran, J; Sutcliffe, MJ; Daff, S; Chapman, SK; Scrutton, NS				Talfournier, F; Munro, AW; Basran, J; Sutcliffe, MJ; Daff, S; Chapman, SK; Scrutton, NS			alpha Arg-237 in Methylophilus methylotrophus (sp W3A1) electron-transferring flavoprotein affords similar to 200-millivolt stabilization of the FAD anionic semiquinone and a kinetic block on full reduction to the dihydroquinone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-BEIJERINCKII FLAVODOXIN; FLAVIN MONONUCLEOTIDE COFACTOR; TRIMETHYLAMINE DEHYDROGENASE; OXIDATION-REDUCTION; PARACOCCUS-DENITRIFICANS; REDOX POTENTIALS; PIG-LIVER; PURIFICATION; MODULATION; GENES	The midpoint reduction potentials of the FAD cofactor wild-type Methylophilus methylotrophus (sp. W3A1) electron-transferring flavoprotein (ETF) and the alpha R237A mutant were determined by anaerobic redox titration. The FAD reduction potential of the oxidized-semiquinone couple in wild-type ETF (E'(1)) is + 153 +/- 2 mV, indicating exceptional stabilization of the flavin anionic semiquinone species. Conversion to the dihydroquinone is incomplete (E'(2) < -250 mV), because of the presence of both kinetic and thermodynamic blocks on full reduction of the FAD, A structural model of ETF (Chohan, K. K., Scrutton, N. S., and Sutcliffe, M. J. (1998) Protein Pept. Lett. 5, 231-236) suggests that the guanidinium group of Arg-237, which is located over the si face of the flavin isoalloxazine ring, plays a key role in the exceptional stabilization of the anionic semiquinone in wild-type ETF, The major effect of exchanging <alpha>Arg-237 for Ala in M, methylotrophus ETF is to engineer a remarkable similar to 200-mV destabilization of the flavin anionic semiquinone (E'(2) = -31 +/- 2 mV, and E'(1) = -43 +/- 2 mV). In addition, reduction to the FAD dihydroquinone in alpha R237A ETF is relatively facile, indicating that the kinetic block seen in wild-type ETF is substantially removed in the alpha R237A ETF, Thus, kinetic (as well as thermodynamic) considerations are important in populating the redox forms of the protein-bound flavin, Additionally, we show that electron transfer from trimethylamine dehydrogenase to alpha R237A ETF is severely compromised, because of impaired assembly of the electron transfer complex.	Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; Univ Strathclyde, Royal Coll, Dept Pure & Appl Chem, Glasgow G1 1XL, Lanark, Scotland; Univ Edinburgh, Dept Chem, Edinburgh EH9 3JJ, Midlothian, Scotland	University of Leicester; University of Leicester; University of Strathclyde; University of Edinburgh	Scrutton, NS (corresponding author), Univ Leicester, Dept Biochem, Univ Rd, Leicester LE1 7RH, Leics, England.	nss4@le.ac.uk	Munro, Andrew/G-5639-2019	Munro, Andrew/0000-0002-4642-180X				BARBER MJ, 1988, BIOCHEM J, V256, P657, DOI 10.1042/bj2560657; Basran J, 2000, BIOCHEMISTRY-US, V39, P9188, DOI 10.1021/bi0006868; Bradley LH, 1999, BIOCHEMISTRY-US, V38, P12377, DOI 10.1021/bi991172f; BYRON CM, 1989, BIOCHEMISTRY-US, V28, P8582, DOI 10.1021/bi00447a047; Chang FC, 1999, BIOCHEMISTRY-US, V38, P7168, DOI 10.1021/bi982203u; Chohan KK, 1998, PROTEIN PEPTIDE LETT, V5, P231; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; DAVIDSON VL, 1986, J BACTERIOL, V166, P812, DOI 10.1128/jb.166.3.812-817.1986; DUPLESSIS ER, 1994, BIOCHEM MOL BIOL INT, V32, P195; DUTTON PL, 1978, METHOD ENZYMOL, V54, P422; Dwyer TM, 1999, BIOCHEMISTRY-US, V38, P9735, DOI 10.1021/bi9903906; Dwyer TM, 1999, BBA-PROTEIN STRUCT M, V1433, P139, DOI 10.1016/S0167-4838(99)00139-9; EARL CD, 1987, J BACTERIOL, V169, P1127, DOI 10.1128/jb.169.3.1127-1136.1987; EICHLER K, 1995, J BASIC MICROB, V35, P217, DOI 10.1002/jobm.3620350404; GORELICK RJ, 1982, BIOCHEMISTRY-US, V21, P6936, DOI 10.1021/bi00269a049; HUSAIN M, 1985, J BACTERIOL, V163, P709, DOI 10.1128/JB.163.2.709-715.1985; HUSAIN M, 1983, BIOCHEM J, V209, P541, DOI 10.1042/bj2090541; HUSAIN M, 1984, BIOCHEM J, V219, P1043, DOI 10.1042/bj2191043; Jang MH, 2000, J BIOL CHEM, V275, P12546, DOI 10.1074/jbc.275.17.12546; Jones M, 2000, J BIOL CHEM, V275, P21349, DOI 10.1074/jbc.M001564200; Kasim M, 2000, BIOCHEMISTRY-US, V39, P15322, DOI 10.1021/bi001519a; Lostao A, 1997, BIOCHEMISTRY-US, V36, P14334, DOI 10.1021/bi971384h; Ludwig ML, 1997, BIOCHEMISTRY-US, V36, P1259, DOI 10.1021/bi962180o; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; Mayhew S. G., 1992, CHEM BIOCH FLAVOENZY, V3, P389; MULLER F, 1973, BIOCHEMISTRY-US, V12, P4654; O'Farrell PA, 1998, BIOCHEMISTRY-US, V37, P8405, DOI 10.1021/bi973193k; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Roberts DL, 1999, BIOCHEMISTRY-US, V38, P1977, DOI 10.1021/bi9820917; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; SATO K, 1993, J BIOCHEM, V114, P215, DOI 10.1093/oxfordjournals.jbchem.a124157; STEENKAMP DJ, 1978, J BIOL CHEM, V253, P4086; SWENSON RP, 1994, BIOCHEMISTRY-US, V33, P8505, DOI 10.1021/bi00194a015; Thorpe C, 1991, CHEM BIOCH FLAVOENZY, P471; TSAI MH, 1995, RES MICROBIOL, V146, P397, DOI 10.1016/0923-2508(96)80285-3; WATMOUGH NJ, 1992, EUR J BIOCHEM, V205, P1089, DOI 10.1111/j.1432-1033.1992.tb16877.x; Weidenhaupt M, 1996, ARCH MICROBIOL, V165, P169, DOI 10.1007/s002030050312; WHITE SA, 1994, J MOL BIOL, V240, P265, DOI 10.1006/jmbi.1994.1440; WHITFIELD CD, 1974, J BIOL CHEM, V249, P2801; Wilson EK, 1997, BIOCHEMISTRY-US, V36, P41, DOI 10.1021/bi961224q	40	30	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20190	20196		10.1074/jbc.M010853200	http://dx.doi.org/10.1074/jbc.M010853200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11285259	hybrid			2022-12-27	WOS:000169135100071
J	Araki, M; Masutani, C; Takemura, M; Uchida, A; Sugasawa, K; Kondoh, J; Ohkuma, Y; Hanaoka, F				Araki, M; Masutani, C; Takemura, M; Uchida, A; Sugasawa, K; Kondoh, J; Ohkuma, Y; Hanaoka, F			Centrosome protein centrin 2/caltractin 1 is part of the xeroderma pigmentosum group C complex that initiates global genome nucleotide excision repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ORGANIZING CENTER; MITOTIC SPINDLE POLES; UBIQUITIN-LIKE DOMAIN; EF-HAND PROTEIN; DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; CONTRACTILE FIBERS; MOLECULAR-CLONING; HUMAN HOMOLOGS; CDC31 GENE	Nucleotide excision repair (NER) is carried out by xeroderma pigmentosum (XP) factors. Before the excision reaction, DNA damage is recognized by a complex originally thought to contain the XP group C responsible gene product (XPC) and the human homologue of Rad23 B (HR23B). Here, we show that centrin 2/caltractin 1 (CEN2) is also a component of the XPC repair complex. We demonstrate that nearly all XPC complexes contain CEN2, that CEN2 interacts directly with XPC, and that CEN2, in cooperation with HR23B, stabilizes XPC, which stimulates XPC NER activity in vitro. CEN2 has been shown to play an important role in centrosome duplication. Thus, those findings suggest that the XPC-CEN2 interaction may reflect coupling of cell division and NER.	Osaka Univ, Inst Mol & Cellular Biol, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Suita, Osaka 5650871, Japan; Mitsubishi Tokyo Pharmaceut Inc, Yokohama Res Ctr, Aoba Ku, Yokohama, Kanagawa 2278502, Japan; RIKEN, Wako, Saitama 3510198, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST); RIKEN	Hanaoka, F (corresponding author), Osaka Univ, Inst Mol & Cellular Biol, 1-3 Yamada Oka, Suita, Osaka 5650871, Japan.		Masutani, Chikahide/I-6160-2014; Araki, Marito/T-4283-2019	Araki, Marito/0000-0002-3502-5000; Masutani, Chikahide/0000-0002-8600-8227				ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Araki M, 2000, MUTAT RES-DNA REPAIR, V459, P147, DOI 10.1016/S0921-8777(99)00067-1; Araujo SJ, 1999, MUTAT RES-DNA REPAIR, V435, P23, DOI 10.1016/S0921-8777(99)00042-7; BARON AT, 1995, METHOD CELL BIOL, V47, P341, DOI 10.1016/S0091-679X(08)60828-6; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; BAUM P, 1986, P NATL ACAD SCI USA, V83, P5512, DOI 10.1073/pnas.83.15.5512; Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; ERRABOLU R, 1994, J CELL SCI, V107, P9; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES, P634; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; HUANG B, 1988, J CELL BIOL, V107, P133, DOI 10.1083/jcb.107.1.133; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laoukili J, 2000, J CELL SCI, V113, P1355; LEE VD, 1993, P NATL ACAD SCI USA, V90, P11039, DOI 10.1073/pnas.90.23.11039; MANLEY JL, 1980, P NATL ACAD SCI-BIOL, V77, P3855, DOI 10.1073/pnas.77.7.3855; MASAKI T, 1981, BIOCHIM BIOPHYS ACTA, V660, P51, DOI 10.1016/0005-2744(81)90107-8; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Masutani C, 1997, MOL CELL BIOL, V17, P6915, DOI 10.1128/MCB.17.12.6915; MASUTANI C, 1994, EMBO J, V13, P1831, DOI 10.1002/j.1460-2075.1994.tb06452.x; Middendorp S, 1997, P NATL ACAD SCI USA, V94, P9141, DOI 10.1073/pnas.94.17.9141; MIDDENDORP S, 2000, J CELL SCI, V148, P505; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Paoletti A, 1996, J CELL SCI, V109, P3089; Reardon JT, 1996, J BIOL CHEM, V271, P19451, DOI 10.1074/jbc.271.32.19451; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; SALISBURY JL, 1984, J CELL BIOL, V99, P962, DOI 10.1083/jcb.99.3.962; SALISBURY JL, 1995, CURR OPIN CELL BIOL, V7, P39; SALISBURY JL, 1988, J CELL BIOL, V107, P635, DOI 10.1083/jcb.107.2.635; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; SHIVJI MKK, 1994, J BIOL CHEM, V269, P22749; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SPANG A, 1993, J CELL BIOL, V123, P405, DOI 10.1083/jcb.123.2.405; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; SUGASAWA K, 1993, J BIOL CHEM, V268, P9098; Sugasawa K, 1997, MOL CELL BIOL, V17, P6924, DOI 10.1128/MCB.17.12.6924; Sugasawa K, 1996, MOL CELL BIOL, V16, P4852; TAILLON BE, 1992, J CELL BIOL, V119, P1613, DOI 10.1083/jcb.119.6.1613; VALLEN EA, 1994, GENETICS, V137, P407; vanderSpek PJ, 1996, NUCLEIC ACIDS RES, V24, P2551, DOI 10.1093/nar/24.13.2551; Watanabe Y, 2000, GENES CELLS, V5, P407, DOI 10.1046/j.1365-2443.2000.00336.x; WATKINS JF, 1993, MOL CELL BIOL, V13, P7757, DOI 10.1128/MCB.13.12.7757; Wiech H, 1996, J BIOL CHEM, V271, P22453, DOI 10.1074/jbc.271.37.22453; Wolfrum U, 1998, EXP CELL RES, V242, P10, DOI 10.1006/excr.1998.4038; WOOD RD, 1988, CELL, V53, P97, DOI 10.1016/0092-8674(88)90491-6; Yokoi M, 2000, J BIOL CHEM, V275, P9870, DOI 10.1074/jbc.275.13.9870	51	274	288	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18665	18672		10.1074/jbc.M100855200	http://dx.doi.org/10.1074/jbc.M100855200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279143	hybrid			2022-12-27	WOS:000169091000004
J	Nickerson, K; Sisk, TJ; Inohara, N; Yee, CSK; Kennell, J; Cho, MC; Yannie, PJ; Nunez, G; Chang, CH				Nickerson, K; Sisk, TJ; Inohara, N; Yee, CSK; Kennell, J; Cho, MC; Yannie, PJ; Nunez, G; Chang, CH			Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING; GTP-BINDING; CIITA; EXPRESSION; GENES; ACTIVATION; DEFICIENCY; PROMOTERS; MUTANTS; RICH	The MHC class II transactivator (CIITA) is a critical transcription factor that regulates genes involved in antigen presentation function. At least three functional forms of CIITA gene products are transcribed from three different promoters. The CIITA gene expressed in dendritic cells (DC-CIITA) has a unique first exon encoding an extended N-terminal region of CIITA, Here, we show that the N terminus of DC-CIITA has high homology to a caspase recruitment domain (CARD) found in components of apoptosis and nuclear factor-KB signaling pathways. However, DC-CIITA does not regulate cell death, nor does it induce nuclear factor-KB activity. Instead, DC-CIITA is transcriptionally a more potent activator of the MHC class II gene than the form expressed in B cells. A single amino acid substitution in the CARD of DC-CIITA, predicted to disrupt CARD-CARD interactions, diminished the transactivation potential of DC-CIITA, These results indicate that the CARD in the context of CIITA serves as a regulatory domain for transcriptional activity and may function to selectively enhance MHC class II gene expression in dendritic cells.	Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Cellular & Mol Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chang, CH (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.		Nickerson, Kevin M/B-1351-2009; Nuñez, Gabriel/A-7160-2014	Nickerson, Kevin M/0000-0002-0114-2671; Kennell, Jennifer/0000-0001-9793-6259	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI041510, T32AI007413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863, T32GM007544] Funding Source: NIH RePORTER; NIAID NIH HHS [AI41510, T32-AI07413] Funding Source: Medline; NIGMS NIH HHS [T32-GM07863, 5-T32-GM07544] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACCOLLA RS, 1983, J EXP MED, V157, P1053, DOI 10.1084/jem.157.3.1053; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Chen BG, 1998, BLOOD, V91, P4652, DOI 10.1182/blood.V91.12.4652.412a03_4652_4661; Chin KC, 1997, J IMMUNOL, V159, P2789; Chin KC, 1997, P NATL ACAD SCI USA, V94, P2501, DOI 10.1073/pnas.94.6.2501; CHIN KC, 1994, IMMUNITY, V2, P533; Chinnaiyan AM, 1996, CURR BIOL, V6, P555; Gourley T, 1999, IMMUNITY, V10, P377, DOI 10.1016/S1074-7613(00)80037-0; GOURLEY TS, 2001, IN PRESS J IMMUNOL; Hake SB, 2000, MOL CELL BIOL, V20, P7716, DOI 10.1128/MCB.20.20.7716-7725.2000; Harton JA, 1999, SCIENCE, V285, P1402, DOI 10.1126/science.285.5432.1402; Harton JA, 2000, MOL CELL BIOL, V20, P6185, DOI 10.1128/MCB.20.17.6185-6194.2000; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; RILEY JL, 1995, IMMUNITY, V2, P533, DOI 10.1016/1074-7613(95)90033-0; Sisk TJ, 2000, J IMMUNOL, V165, P2511, DOI 10.4049/jimmunol.165.5.2511; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Thery C, 2001, CURR OPIN IMMUNOL, V13, P45, DOI 10.1016/S0952-7915(00)00180-1; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Williams GS, 1998, INT IMMUNOL, V10, P1957, DOI 10.1093/intimm/10.12.1957; Zhou H, 1997, J IMMUNOL, V158, P4741; ZHOU H, 1995, IMMUNITY, V2, P545, DOI 10.1016/1074-7613(95)90034-9; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	31	58	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19089	19093		10.1074/jbc.M101295200	http://dx.doi.org/10.1074/jbc.M101295200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279191	hybrid			2022-12-27	WOS:000169091000062
J	Curman, D; Cinel, B; Williams, DE; Rundle, N; Block, WD; Goodarzi, AA; Hutchins, JR; Clarke, PR; Zhou, BB; Lees-Miller, SP; Andersen, RJ; Roberge, M				Curman, D; Cinel, B; Williams, DE; Rundle, N; Block, WD; Goodarzi, AA; Hutchins, JR; Clarke, PR; Zhou, BB; Lees-Miller, SP; Andersen, RJ; Roberge, M			Inhibition of the G(2) DNA damage checkpoint and of protein kinases Chk1 and Chk2 by the marine sponge alkaloid debromohymenialdisine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CHECKPOINTS; INDUCED MITOTIC DELAY; BHK CELLS; CHROMOSOME CONDENSATION; RADIOSENSITIZING AGENT; H3 PHOSPHORYLATION; CDC25 PHOSPHATASE; DEPENDENT KINASES; MAMMALIAN-CELLS; 14-3-3 BINDING	Cells can respond to DNA damage by activating checkpoints that delay cell cycle progression and allow time for DNA repair. Chemical inhibitors of the G(2) phase DNA damage checkpoint may be used as tools to understand better how the checkpoint is regulated and may be used to sensitize cancer cells to DNA-damaging therapies. However, few inhibitors are known. We used a cell-based assay to screen natural extracts for G(2) checkpoint inhibitors and identified debromohymenialdisine (DBH) from a marine sponge. DBH is distinct structurally from previously known G(2) checkpoint inhibitors. It inhibited the G(2) checkpoint with an IC50 of 8 muM and showed moderate cytotoxicity (IC50 = 25 muM) toward MCF-7 cells. DBH inhibited the checkpoint kinases Chk1 (IC50 = 3 muM) and Chk2 (IC50 = 3.5 muM) but not ataxia-telangiectasia mutated (ATM), ATM-Rads-related protein, or DNA-dependent protein kinase in vitro, indicating that it blocks two major branches of the checkpoint pathway downstream of ATM. It did not cause the activation or inhibition of different signal transduction proteins, as determined by mobility shift analysis in Western blots, suggesting that it inhibits a narrow range of protein kinases in vivo.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; Univ British Columbia, Dept Oceanog Earth & Ocean Sci, Vancouver, BC V6T 1Z1, Canada; Univ Dundee, Biomed Res Ctr, Dundee DD1 9SY, Scotland; SmithKline Beecham Pharmaceut, Dept Oncol Res, King Of Prussia, PA 19406 USA; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of Dundee; GlaxoSmithKline; University of Calgary	Roberge, M (corresponding author), 2146 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.		Clarke, Paul R./AAA-6803-2020; Clarke, Paul/B-1684-2009	Clarke, Paul/0000-0003-3525-2622; Lees-Miller, Susan/0000-0001-5809-2516				AKINAGA S, 1991, CANCER RES, V51, P4888; Anderson HJ, 1997, CANCER CHEMOTH PHARM, V39, P223; Anderson HJ, 1998, EXP CELL RES, V238, P498, DOI 10.1006/excr.1997.3862; ANDREASSEN PR, 1992, P NATL ACAD SCI USA, V89, P2272, DOI 10.1073/pnas.89.6.2272; BARRIOSSOSA AC, 1999, J ORG CHEM, V65, P610; Blasina A, 1999, CURR BIOL, V9, P1, DOI 10.1016/S0960-9822(99)80041-4; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Busby EC, 2000, CANCER RES, V60, P2108; BUSSE PM, 1978, RADIAT RES, V76, P292, DOI 10.2307/3574780; Chan DW, 1996, BIOCHEM CELL BIOL, V74, P67, DOI 10.1139/o96-007; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chehab NH, 2000, GENE DEV, V14, P278; Clarke DJ, 2000, BIOESSAYS, V22, P351, DOI 10.1002/(SICI)1521-1878(200004)22:4<351::AID-BIES5>3.0.CO;2-W; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Gowdy PM, 1998, J CELL SCI, V111, P3401; GRAVES PR, 2000, J BIOL CHEM, P275; GUO XW, 1995, EMBO J, V14, P976, DOI 10.1002/j.1460-2075.1995.tb07078.x; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hutchins JRA, 2000, FEBS LETT, V466, P91, DOI 10.1016/S0014-5793(99)01763-9; Jackson JR, 2000, CANCER RES, V60, P566; Jiang XX, 2000, INT J ONCOL, V16, P971; Kao GD, 1997, CANCER RES, V57, P753; Kawakami K, 1996, BIOCHEM BIOPH RES CO, V219, P778, DOI 10.1006/bbrc.1996.0310; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Liu QH, 2000, GENE DEV, V14, P1448; Lowndes NF, 2000, CURR OPIN GENET DEV, V10, P17, DOI 10.1016/S0959-437X(99)00050-7; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Meijer L, 2000, CHEM BIOL, V7, P51, DOI 10.1016/S1074-5521(00)00063-6; MIZUNO K, 1995, FEBS LETT, V359, P259, DOI 10.1016/0014-5793(95)00042-8; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Nurse P, 1997, CELL, V91, P865, DOI 10.1016/S0092-8674(00)80476-6; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Raleigh JM, 2000, J CELL SCI, V113, P1727; ROBERGE M, 1990, J CELL BIOL, V111, P1753, DOI 10.1083/jcb.111.5.1753; Roberge M, 1998, CANCER RES, V58, P5701; ROWLEY R, 1984, RADIAT RES, V97, P178, DOI 10.2307/3576199; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sausville EA, 2001, J CLIN ONCOL, V19, P2319, DOI 10.1200/JCO.2001.19.8.2319; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SCHLEGEL R, 1986, SCIENCE, V232, P1264, DOI 10.1126/science.2422760; SHARMA GM, 1980, J CHEM SOC CHEM COMM, P435, DOI 10.1039/c39800000435; Shieh SY, 2000, GENE DEV, V14, P289; Takai H, 2000, GENE DEV, V14, P1439; TAM SW, 1992, CELL GROWTH DIFFER, V3, P811; WALTERS RA, 1974, BIOPHYS J, V14, P99, DOI 10.1016/S0006-3495(74)70002-9; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Wang QZ, 1996, J NATL CANCER I, V88, P956, DOI 10.1093/jnci/88.14.956; WEINERT T, 1993, SEMIN CANCER BIOL, V4, P129; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Yang J, 1999, EMBO J, V18, P2174, DOI 10.1093/emboj/18.8.2174; Ye RQ, 2001, J BIOL CHEM, V276, P4828, DOI 10.1074/jbc.M004894200; ZAMPETTIBOSSELER F, 1985, MUTAT RES, V143, P251, DOI 10.1016/0165-7992(85)90089-2; Zeng Y, 1999, MOL CELL BIOL, V19, P7410; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou BBS, 2000, J BIOL CHEM, V275, P10342, DOI 10.1074/jbc.275.14.10342	61	118	127	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17914	17919		10.1074/jbc.M100728200	http://dx.doi.org/10.1074/jbc.M100728200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279124	hybrid			2022-12-27	WOS:000168866500042
J	Fitzpatrick, TB; Killer, P; Thomas, RM; Jelesarov, I; Amrhein, N; Macheroux, P				Fitzpatrick, TB; Killer, P; Thomas, RM; Jelesarov, I; Amrhein, N; Macheroux, P			Chorismate synthase from the hyperthermophile Thermotoga maritima combines thermostability and increased rigidity with catalytic and spectral properties similar to mesophilic counterparts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORYDALIS-SEMPERVIRENS PERS; FLAVIN; PLANT; INTERMEDIATE; PURIFICATION; SUBSTRATE; STABILITY; PROTEINS; SEQUENCE; BINDING	Chorismate synthase, the last enzyme in the shikimate pathway, catalyzes the transformation of 5-enolpyruvylshikimate 3-phosphate to chorismate, a biochemically unique reaction in that it requires reduced FMN as a cofactor. Here we report on the cloning, expression, and characterization of the protein for the first time from an extremophilic organism Thermotoga maritima which is also one of the oldest and most slowly evolving eubacteria, The protein is monofunctional in that it does not have an intrinsic ability to reduce the FMN cofactor and thereby reflecting the nature of the ancestral enzyme. Circular dichroism studies indicate that the melting temperature of the T. maritima protein is above 92 degreesC compared with 54 degreesC for the homologous Escherichia coli protein while analytical ultracentrifugation showed that both proteins have the same quaternary structure, Interestingly, UV-visible spectral studies revealed that the dissociation constants for both oxidized FMN and 5-enolpyruvylshikimate 3-phosphate decrease 46- and 10-fold, respectively, upon heat treatment of the T, maritima protein. The heat treatment also results in the trapping of the flavin cofactor in an apolar environment, a feature which is enhanced by the presence of the substrate 5-enolpyruvylshikimate 3-phosphate, Nevertheless, stopped-flow spectrophotometric evidence suggests that the mechanism of the T. maritima protein is similar to that of the E. coli protein. In essence, the study shows that T. maritima chorismate synthase exhibits considerably higher rigidity and thermostability while it has conserved features relevant to its catalytic function.	Swiss Fed Inst Technol, Inst Pflanzenwissensch, CH-8092 Zurich, Switzerland; Swiss Fed Inst Technol, Inst Polymere, CH-8092 Zurich, Switzerland; Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Macheroux, P (corresponding author), Swiss Fed Inst Technol, Inst Pflanzenwissensch, Univ Str 2, CH-8092 Zurich, Switzerland.	macheroux@ipw.biol.ethz.ch	Macheroux, Peter/AAB-5157-2019	Macheroux, Peter/0000-0002-0242-454X				ACHENBACHRICHTER L, 1987, SYST APPL MICROBIOL, V9, P34, DOI 10.1016/S0723-2020(87)80053-X; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bornemann S, 1996, BIOCHEMISTRY-US, V35, P9907, DOI 10.1021/bi952958q; Dams T, 1999, BIOCHEMISTRY-US, V38, P9169, DOI 10.1021/bi990635e; GAERTNER FH, 1987, METHOD ENZYMOL, V142, P362; GAERTNER FH, 1973, J BIOL CHEM, V248, P4602; HARBURY HA, 1959, P NATL ACAD SCI USA, V45, P1708, DOI 10.1073/pnas.45.12.1708; HILL RK, 1969, J AM CHEM SOC, V91, P5893, DOI 10.1021/ja01049a045; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu NK, 1998, PROTEIN SCI, V7, P1214, DOI 10.1002/pro.5560070517; Macheroux P, 1996, BIOCHEMISTRY-US, V35, P1643, DOI 10.1021/bi951705u; Macheroux P, 1999, PLANTA, V207, P325, DOI 10.1007/s004250050489; Macheroux P, 1998, BIOCHEM J, V335, P319, DOI 10.1042/bj3350319; Macheroux P, 1996, J BIOL CHEM, V271, P25850, DOI 10.1074/jbc.271.42.25850; MORELL H, 1967, J BIOL CHEM, V242, P82; MOUSDALE DM, 1986, FEBS LETT, V205, P328, DOI 10.1016/0014-5793(86)80922-X; MULLER F, 1973, BIOCHEMISTRY-US, V12, P4654; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; ONDERKA DK, 1969, J AM CHEM SOC, V91, P5894, DOI 10.1021/ja01049a046; RAMJEE MN, 1991, J AM CHEM SOC, V113, P8566, DOI 10.1021/ja00022a078; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHALLER A, 1991, PLANT PHYSIOL, V97, P1271, DOI 10.1104/pp.97.4.1271; SCHALLER A, 1991, J BIOL CHEM, V266, P21434; SCHALLER A, 1990, ARCH BIOCHEM BIOPHYS, V282, P437, DOI 10.1016/0003-9861(90)90141-K; WEBER G, 1966, FLAVINS FLAVOPROTEIN, P15; WELCH GR, 1974, ARCH BIOCHEM BIOPHYS, V165, P505, DOI 10.1016/0003-9861(74)90276-8; WHITE PJ, 1988, BIOCHEM J, V251, P313, DOI 10.1042/bj2510313	28	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18052	18059		10.1074/jbc.M100867200	http://dx.doi.org/10.1074/jbc.M100867200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279147	Green Published, hybrid			2022-12-27	WOS:000168866500059
J	Salazar, EP; Rozengurt, E				Salazar, EP; Rozengurt, E			Src family kinases are required for integrin-mediated but not for G protein-coupled receptor stimulation of focal adhesion kinase autophosphorylation at Tyr-397	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 CELLS; PAXILLIN TYROSINE PHOSPHORYLATION; ACTIVATION LOOP PHOSPHORYLATION; STRESS FIBER FORMATION; GROWTH-FACTOR; LYSOPHOSPHATIDIC ACID; SIGNALING PATHWAYS; ACTIN CYTOSKELETON; PHOSPHATIDYLINOSITOL 3'-KINASE; EXTRACELLULAR-MATRIX	Plating suspended Swiss 3T3 cells onto fibronectin-coated dishes promoted phosphorylation of endogenous focal adhesion kinase (FAK) at Tyr-397, the major autophosphorylation site, and at Tyr-577, located in the activation loop, as revealed by site-specific antibodies that recognize the phosphorylated form of these residues. Treatment with the selective Src family kinase inhibitor pyrazolopyrimidine 2 (PP-2) markedly reduced the phosphorylation of both Tyr-397 and Tyr-577 induced by fibronectin, Furthermore, fibronectin-mediated FAK phosphorylation at Tyr-397 was dramatically reduced in SYF cells (deficient in Src, Yes, and Fyn expression). Stimulation of Swiss 3T3 cells with bombesin also induced a rapid increase in the phosphorylation of endogenous FAK at Tyr-397. In contrast to the results obtained with fibronectin, PP-2 did not prevent FAK Tyr-397 phosphorylation stimulated by bombesin at a concentration (10 muM) that suppressed bombesin-induced FAK Tyr-577 phosphorylation, Similarly, PP-2 did not prevent Tyr-397 phosphorylation in Swiss 3T3 cells stimulated with other G protein-coupled receptor agonists including vasopressin, bradykinin, endothelin, and lysophosphatidic acid. Lysophosphatidic acid also induced FAK phosphorylation at Tyr-397 in SYF cells. Our results identify, for first time, the existence of Src-dependent and Src-independent pathways leading to FAK autophosphorylation at Tyr-397 stimulated by adhesion-dependent signals and G protein-coupled receptor agonists in the same cell.	Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Rozengurt, E (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, Warren Hall Rm 11-124,900 Vet Ave, Los Angeles, CA 90095 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056930, R37DK017294, R01DK017294] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 55003, DK 56930, DK 17294] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Casamassima A, 1998, J BIOL CHEM, V273, P26149, DOI 10.1074/jbc.273.40.26149; Casamassima A, 1997, J BIOL CHEM, V272, P9363; Charlesworth A, 1996, ONCOGENE, V12, P1337; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; EIDE BL, 1995, MOL CELL BIOL, V15, P2819; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; Han DC, 1999, J BIOL CHEM, V274, P24425, DOI 10.1074/jbc.274.34.24425; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; Hungerford JE, 1996, J CELL BIOL, V135, P1383, DOI 10.1083/jcb.135.5.1383; Ilic D, 1997, J CELL SCI, V110, P401; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Lacerda HM, 1997, J BIOL CHEM, V272, P9587; Lacerda HM, 1996, J BIOL CHEM, V271, P439, DOI 10.1074/jbc.271.1.439; LEEBLUNDBERG LMF, 1994, J BIOL CHEM, V269, P24328; Leventhal PS, 1997, J BIOL CHEM, V272, P5214, DOI 10.1074/jbc.272.8.5214; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; McLean GW, 2000, J BIOL CHEM, V275, P23333, DOI 10.1074/jbc.M909322199; Ojaniemi M, 1997, J BIOL CHEM, V272, P25993, DOI 10.1074/jbc.272.41.25993; Owen JD, 1999, MOL CELL BIOL, V19, P4806; OWENS LV, 1995, CANCER RES, V55, P2752; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; RANKIN S, 1994, J BIOL CHEM, V269, P704; Rankin S, 1996, J BIOL CHEM, V271, P7829, DOI 10.1074/jbc.271.13.7829; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Rodriguez-Fernandez JL, 1998, J BIOL CHEM, V273, P19321, DOI 10.1074/jbc.273.30.19321; RodriguezFernandez JL, 1996, J BIOL CHEM, V271, P27895, DOI 10.1074/jbc.271.44.27895; Rozengurt E, 1998, AM J PHYSIOL-GASTR L, V275, pG177, DOI 10.1152/ajpgi.1998.275.2.G177; ROZENGURT E, 1995, CANCER SURV, V24, P81; Ruest PJ, 2000, CELL GROWTH DIFFER, V11, P41; Salazar EP, 1999, J BIOL CHEM, V274, P28371, DOI 10.1074/jbc.274.40.28371; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; SCHLAEPFER DD, 1994, NATURE, V372, P786; SEUFFERLEIN T, 1995, CELL GROWTH DIFFER, V6, P383; Seufferlein T, 1996, MOL BIOL CELL, V7, P1865, DOI 10.1091/mbc.7.12.1865; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P27610; SEUFFERLEIN T, 1995, J BIOL CHEM, V270, P24343, DOI 10.1074/jbc.270.41.24343; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P9345; SINNETTSMITH J, 1993, J BIOL CHEM, V268, P14261; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Tsuda T, 1997, BIOCHEMISTRY-US, V36, P16328, DOI 10.1021/bi971448o; WEINER TM, 1993, LANCET, V342, P1024, DOI 10.1016/0140-6736(93)92881-S; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; Xu LH, 1996, CELL GROWTH DIFFER, V7, P413; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P; ZACHARY I, 1992, J BIOL CHEM, V267, P19031; Zhang X, 1999, P NATL ACAD SCI USA, V96, P9021, DOI 10.1073/pnas.96.16.9021	65	110	115	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17788	17795		10.1074/jbc.M100984200	http://dx.doi.org/10.1074/jbc.M100984200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279163	hybrid			2022-12-27	WOS:000168866500024
J	van Holde, KE; Miller, KI; Decker, H				van Holde, KE; Miller, KI; Decker, H			Hemocyanins and invertebrate evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CRYSTAL-STRUCTURE; ARTHROPOD HEMOCYANIN; HALIOTIS-TUBERCULATA; CDNA CLONING; SEQUENCE; SUBUNIT; PLANT; TYROSINASE; RESOLUTION; MECHANISM		Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; Johannes Gutenberg Univ Mainz, Inst Mol Biophys, D-55128 Mainz, Germany	Oregon State University; Johannes Gutenberg University of Mainz	Miller, KI (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	millerk@ucs.orst.edu						Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; ASPAN A, 1995, P NATL ACAD SCI USA, V92, P939, DOI 10.1073/pnas.92.4.939; Burmester T, 2001, MOL BIOL EVOL, V18, P184, DOI 10.1093/oxfordjournals.molbev.a003792; Burmester T, 1996, J MOL EVOL, V42, P713, DOI 10.1007/BF02338804; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; Creighton T.E., 1993, PROTEINS; Cuff ME, 1998, J MOL BIOL, V278, P855, DOI 10.1006/jmbi.1998.1647; Decker H, 1998, J BIOL CHEM, V273, P25889, DOI 10.1074/jbc.273.40.25889; Decker H, 2000, ANGEW CHEM INT EDIT, V39, P1591, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1591::AID-ANIE1591>3.0.CO;2-H; Decker H, 2000, J EXP BIOL, V203, P1777; Decker H, 2000, TRENDS BIOCHEM SCI, V25, P392, DOI 10.1016/S0968-0004(00)01602-9; Durstewitz G, 1997, MOL BIOL EVOL, V14, P266, DOI 10.1093/oxfordjournals.molbev.a025762; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; HAZES B, 1993, PROTEIN SCI, V2, P597; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; Kurtz D.M. Jr, 1992, Advances in Comparative and Environmental Physiology, V13, P151; Lieb B, 2000, J BIOL CHEM, V275, P5675, DOI 10.1074/jbc.275.8.5675; LIEB B, 2001, IN PRESS P NATL ACAD; LOEWE R, 1978, J COMP PHYSIOL, V128, P161, DOI 10.1007/BF00689480; MAGNUS KA, 1994, PROTEINS, V19, P302, DOI 10.1002/prot.340190405; Markl J., 1992, Advances in Comparative and Environmental Physiology, V13, P325; MARKL J, 1986, BIOL BULL, V171, P90, DOI 10.2307/1541909; Meissner U, 2000, J MOL BIOL, V298, P21, DOI 10.1006/jmbi.2000.3631; Miller KI, 1998, J MOL BIOL, V278, P827, DOI 10.1006/jmbi.1998.1648; Morris SC, 2000, P NATL ACAD SCI USA, V97, P4426, DOI 10.1073/pnas.97.9.4426; Salvato B, 1998, BIOCHEMISTRY-US, V37, P14065, DOI 10.1021/bi980879j; SALVATO B, 1983, LIFE CHEM REP S, V1, P313; SVEDBERG T, 1928, J AM CHEM SOC, V50, P1399; VanGelder CWG, 1997, PHYTOCHEMISTRY, V45, P1309, DOI 10.1016/S0031-9422(97)00186-6; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; VANHOLDE KE, 1992, ADV COMP ENV PHYSL, V13, P251; Voit R, 2000, J BIOL CHEM, V275, P39339, DOI 10.1074/jbc.M005442200; VOLBEDA A, 1989, J MOL BIOL, V206, P531, DOI 10.1016/0022-2836(89)90499-3; Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568; Xun G, 1998, J MOL EVOL, V47, P369, DOI 10.1007/PL00013150	36	251	257	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15563	15566		10.1074/jbc.R100010200	http://dx.doi.org/10.1074/jbc.R100010200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279230	hybrid			2022-12-27	WOS:000168623100001
J	Sugiura, N; Patel, RG; Corriveau, RA				Sugiura, N; Patel, RG; Corriveau, RA			N-methyl-D-aspartate receptors regulate a group of transiently expressed genes in the developing brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL NMDA RECEPTORS; LONG-TERM-MEMORY; CLASS-I MHC; APOPTOTIC NEURODEGENERATION; ELECTRICAL-ACTIVITY; NEURONAL PATTERNS; CRITICAL PERIOD; DENTATE GYRUS; MICE; PLASTICITY	Mammalian brain development requires the transmission of electrical signals between neurons via the N-methyl-D-aspartate (NMDA) class of glutamate receptors. However, little is known about how NMDA receptors carry out this role. Here we report the first genes shown to be regulated by physiological levels of NMDA receptor function in developing neurons in vivo: NMDA receptor-regulated gene 1 (NARG1), NARG2, and NARG3. These genes share several striking regulatory features. All three are expressed at high levels in the neonatal brain in regions of neuronal proliferation and migration, are dramatically down-regulated during early postnatal development, and are down-regulated by NMDA receptor function. NARG2 and NARG3 appear to be novel, while NARG1 is the mammalian homologue of a yeast N-terminal acetyltransferase that regulates entry into the G(o) phase of the cell cycle. The results suggest that highly specific NMDA receptor-dependent regulation of gene expression plays an important role in the transition from proliferation of neuronal precursors to differentiation of neurons.	Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48201 USA	Wayne State University	Corriveau, RA (corresponding author), Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48201 USA.							Aparicio SAJR, 2000, NAT GENET, V25, P129, DOI 10.1038/75949; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Buonanno A, 1999, CURR OPIN NEUROBIOL, V9, P110, DOI 10.1016/S0959-4388(99)80014-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Corriveau RA, 1999, J NEUROSCI, V19, P7999, DOI 10.1523/jneurosci.19-18-07999.1999; CORRIVEAU RA, 1993, J NEUROSCI, V13, P2662, DOI 10.1523/JNEUROSCI.13-06-02662.1993; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Corriveau RA, 1999, J NEUROBIOL, V41, P148, DOI 10.1002/(SICI)1097-4695(199910)41:1<148::AID-NEU18>3.0.CO;2-6; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Gall C M, 1997, Adv Neurol, V72, P9; Gendron RL, 2000, DEV DYNAM, V218, P300, DOI 10.1002/(SICI)1097-0177(200006)218:2<300::AID-DVDY5>3.0.CO;2-K; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Gould E, 1997, BEHAV NEUROSCI, V111, P49; GOULD E, 1994, J COMP NEUROL, V340, P551, DOI 10.1002/cne.903400408; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Hubel DH, 1998, NEURON, V20, P401, DOI 10.1016/S0896-6273(00)80984-8; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; Kennedy MB, 1998, BRAIN RES REV, V26, P243, DOI 10.1016/S0165-0173(97)00043-X; KILLACKEY HP, 1995, TRENDS NEUROSCI, V18, P402, DOI 10.1016/0166-2236(95)93937-S; Komuro H, 1998, J NEUROBIOL, V37, P110, DOI 10.1002/(SICI)1097-4695(199810)37:1<110::AID-NEU9>3.3.CO;2-Q; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Messersmith EK, 1997, MOL CELL NEUROSCI, V9, P347, DOI 10.1006/mcne.1997.0646; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Okabe S, 1998, EUR J NEUROSCI, V10, P2192, DOI 10.1046/j.1460-9568.1998.00233.x; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Poon CS, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-09-j0003.2000; PUJIC Z, 1993, NEUROSCI LETT, V162, P67, DOI 10.1016/0304-3940(93)90561-X; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Schulte D, 1999, NEURON, V24, P541, DOI 10.1016/S0896-6273(00)81111-3; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sheng M, 2000, NAT NEUROSCI, V3, P633, DOI 10.1038/76576; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Single FN, 2000, J NEUROSCI, V20, P2558; SQUIRE LR, 1995, COGNITIVE NEUROSCIEN; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yuzaki M, 1996, J NEUROSCI, V16, P4651	52	50	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14257	14263		10.1074/jbc.M100011200	http://dx.doi.org/10.1074/jbc.M100011200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11297529	hybrid			2022-12-27	WOS:000168356600099
J	Minton, AP				Minton, AP			The influence of macromolecular crowding and macromolecular confinement on biochemical reactions in physiological media	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CONCENTRATED HEMOGLOBIN-SOLUTIONS; SELF-ASSOCIATION; ESCHERICHIA-COLI; EXCLUDED-VOLUME; PROTEIN SOLUTIONS; HUMAN SPECTRIN; DNA; CELL; DETERMINANT; REACTIVITY		NIDDK, Sect Phys Biochem, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Minton, AP (corresponding author), NIDDK, Sect Phys Biochem, Lab Biochem & Genet, NIH, Bldg 8,Rm 226, Bethesda, MD 20892 USA.			Minton, Allen/0000-0001-8459-1247	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK024150] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ackers G K, 1970, Adv Protein Chem, V24, P343, DOI 10.1016/S0065-3233(08)60245-4; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Bookchin RM, 1999, J BIOL CHEM, V274, P6689, DOI 10.1074/jbc.274.10.6689; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; COLE N, 1994, INT J BIOCHEM, V26, P799, DOI 10.1016/0020-711X(94)90109-0; Eggers DK, 2001, PROTEIN SCI, V10, P250, DOI 10.1110/ps.36201; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; ELLIS RJ, 1997, CURR BIOL, V7, P531; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; Galan A, 2001, J BIOL CHEM, V276, P957, DOI 10.1074/jbc.M006861200; GARNER MM, 1994, AM J PHYSIOL-CELL PH, V266, P877; GIDDINGS JC, 1968, J PHYS CHEM-US, V72, P4397, DOI 10.1021/j100859a008; GOODSELL D, 1993, MACH LIFE; GUTTMAN HJ, 1995, BIOPHYS J, V68, P835, DOI 10.1016/S0006-3495(95)80260-2; HARRISON B, 1986, NUCLEIC ACIDS RES, V14, P1863, DOI 10.1093/nar/14.4.1863; Kidoaki S, 1999, BIOPHYS CHEM, V76, P133, DOI 10.1016/S0301-4622(98)00231-2; Kornberg A, 2000, J BACTERIOL, V182, P3613, DOI 10.1128/JB.182.13.3613-3618.2000; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; LEBOWITZ JL, 1965, J CHEM PHYS, V43, P774, DOI 10.1063/1.1696842; LINDNER R, 1995, BIOPHYS CHEM, V57, P15, DOI 10.1016/0301-4622(95)00063-4; Lindner RA, 1997, BIOPHYS CHEM, V66, P57, DOI 10.1016/S0301-4622(97)00011-2; Martin J, 1997, P NATL ACAD SCI USA, V94, P1107, DOI 10.1073/pnas.94.4.1107; Minton A. P., 1994, CELLULAR MOL PHYSL C, P181; Minton AP, 1997, CURR OPIN BIOTECH, V8, P65, DOI 10.1016/S0958-1669(97)80159-0; Minton AP, 1998, METHOD ENZYMOL, V295, P127; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; MINTON AP, 1981, BIOCHEMISTRY-US, V20, P4821, DOI 10.1021/bi00520a003; MINTON AP, 1981, BIOPOLYMERS, V20, P2093, DOI 10.1002/bip.1981.360201006; Minton AP, 2000, BIOPHYS J, V78, P101, DOI 10.1016/S0006-3495(00)76576-3; MINTON AP, 1995, BIOPHYS J, V68, P1311, DOI 10.1016/S0006-3495(95)80304-8; MINTON AP, 1992, BIOPHYS J, V63, P1090, DOI 10.1016/S0006-3495(92)81663-6; MURAMATSU N, 1988, P NATL ACAD SCI USA, V85, P2984, DOI 10.1073/pnas.85.9.2984; MURPHY LD, 1995, BIOPHYS CHEM, V57, P71, DOI 10.1016/0301-4622(95)00047-2; MURPHY LD, 1994, BBA-GENE STRUCT EXPR, V1219, P277, DOI 10.1016/0167-4781(94)90049-3; Naimushin AN, 2001, BIOPOLYMERS, V58, P204, DOI 10.1002/1097-0282(200102)58:2<204::AID-BIP90>3.0.CO;2-1; OGSTON AG, 1970, J PHYS CHEM-US, V74, P668, DOI 10.1021/j100698a032; OGSTON AG, 1973, P ROY SOC LOND A MAT, V333, P297, DOI 10.1098/rspa.1973.0064; RALSTON GB, 1990, J CHEM EDUC, V67, P857, DOI 10.1021/ed067p857; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P190, DOI 10.1016/S0968-0004(98)01207-9; Rivas G, 1999, BIOCHEMISTRY-US, V38, P9379, DOI 10.1021/bi990355z; Rivas G, 2001, P NATL ACAD SCI USA, V98, P3150, DOI 10.1073/pnas.051634398; ROSS PD, 1977, J MOL BIOL, V112, P437, DOI 10.1016/S0022-2836(77)80191-5; SOMERO GN, 1992, WATER LIFE; van den Berg B, 2000, EMBO J, V19, P3870, DOI 10.1093/emboj/19.15.3870; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V; ZIMMERMAN SB, 1993, BIOCHIM BIOPHYS ACTA, V1216, P175, DOI 10.1016/0167-4781(93)90142-Z; Zimmerman SB, 1996, FEBS LETT, V390, P245, DOI 10.1016/0014-5793(96)00725-9; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	48	1111	1142	8	159	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10577	10580		10.1074/jbc.R100005200	http://dx.doi.org/10.1074/jbc.R100005200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11279227	hybrid			2022-12-27	WOS:000167980900001
J	Perez-Moreno, MA; Locascio, A; Rodrigo, I; Dhondt, G; Portillo, F; Nieto, MA; Cano, A				Perez-Moreno, MA; Locascio, A; Rodrigo, I; Dhondt, G; Portillo, F; Nieto, MA; Cano, A			A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; INVASION-SUPPRESSOR GENE; LOOP-HELIX PROTEINS; DNA-BINDING; E2A GENE; TUMOR PROGRESSION; CELL-ADHESION; PROMOTER; E47; HEB	Down-regulation of E-cadherin expression is a determinant of tumor cell invasiveness, an event frequently associated with epithelial-mesenchymal transitions. Here we show that the mouse E12/E47 basic helix-loop-helix transcription factor (the E2A gene product) acts as a repressor of E-cadherin expression and triggers epithelial-mesenchymal transitions. The mouse E47 factor was isolated in a one-hybrid system designed to isolate repressors of the mouse E-cadherin promoter. Epithelial cells ectopically expressing E47 adopt a fibroblastic phenotype and acquire tumorigenic and migratory/invasive properties, concomitant with the suppression of E-cadherin expression. Suppression of E-cadherin expression under stable or inducible expression of E47 in epithelial cells occurs at the transcriptional level and is dependent on the E-boxes of the E-cadherin promoter. Interestingly, analysis of endogenous E2A expression in murine and human cell lines illustrated its presence in E-cadherin-deficient, invasive carcinoma cells but its absence from epithelial cell lines. This expression pattern is consistent with that observed in early mouse embryos, where E2A mRNA is absent from epithelia but strongly expressed in the mesoderm. These results implicate E12/E47 as a repressor of E-cadherin expression during both development and tumor progression and indicate its involvement in the acquisition and/or maintenance of the mesenchymal phenotype.	UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain; CSIC, Inst Cajal, E-28002 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Cano, A (corresponding author), UAM, CSIC, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain.		Locascio, Annamaria/E-8714-2015; Perez-Moreno, Mirna/I-3687-2015; Nieto, M. Angela/A-6531-2008	Locascio, Annamaria/0000-0001-6956-2157; Perez-Moreno, Mirna/0000-0002-0170-6406; Nieto, M. Angela/0000-0002-3538-840X; Portillo Perez, Francisco/0000-0003-4922-346X				ARONHEIM A, 1993, P NATL ACAD SCI USA, V90, P8063, DOI 10.1073/pnas.90.17.8063; ARONHEIM A, 1993, NUCLEIC ACIDS RES, V21, P1601, DOI 10.1093/nar/21.7.1601; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BEHRENS J, 1991, P NATL ACAD SCI USA, V88, P11495, DOI 10.1073/pnas.88.24.11495; Behrens J, 1992, Semin Cell Biol, V3, P169; Bellairs R., 1987, P123; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; BLANAR MA, 1995, P NATL ACAD SCI USA, V92, P5870, DOI 10.1073/pnas.92.13.5870; BURGESS R, 1995, DEV BIOL, V168, P296, DOI 10.1006/dbio.1995.1081; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cook DM, 1996, ONCOGENE, V13, P1789; Engel I, 1999, CURR OPIN GENET DEV, V9, P575, DOI 10.1016/S0959-437X(99)00008-8; Engel I, 1999, P NATL ACAD SCI USA, V96, P996, DOI 10.1073/pnas.96.3.996; Faraldo MLM, 1997, MOL CARCINOGEN, V20, P33, DOI 10.1002/(SICI)1098-2744(199709)20:1<33::AID-MC5>3.0.CO;2-J; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hajra KM, 1999, ONCOGENE, V18, P7274, DOI 10.1038/sj.onc.1203336; Hennig G, 1996, J BIOL CHEM, V271, P595, DOI 10.1074/jbc.271.1.595; HENNIG G, 1995, ONCOGENE, V11, P475; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; HU JS, 1992, MOL CELL BIOL, V12, P1031, DOI 10.1128/MCB.12.3.1031; Huber O, 1996, CURR OPIN CELL BIOL, V8, P685, DOI 10.1016/S0955-0674(96)80110-4; Inukai T, 1999, MOL CELL, V4, P343, DOI 10.1016/S1097-2765(00)80336-6; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MAUHIN V, 1993, NUCLEIC ACIDS RES, V21, P3951, DOI 10.1093/nar/21.17.3951; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NAVARRO P, 1991, J CELL BIOL, V115, P517, DOI 10.1083/jcb.115.2.517; NELSON C, 1990, GENE DEV, V4, P1035, DOI 10.1101/gad.4.6.1035; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Ramain P, 2000, MOL CELL, V6, P781, DOI 10.1016/S1097-2765(05)00079-1; RISINGER JI, 1994, NAT GENET, V7, P98, DOI 10.1038/ng0594-98; ROBERTS VJ, 1993, P NATL ACAD SCI USA, V90, P7583, DOI 10.1073/pnas.90.16.7583; Rodrigo I, 1999, EXP CELL RES, V248, P358, DOI 10.1006/excr.1999.4438; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Sefton M, 1998, DEVELOPMENT, V125, P3111; SHEN CP, 1995, MOL CELL BIOL, V15, P4518; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Tamura G, 2000, J NATL CANCER I, V92, P569, DOI 10.1093/jnci/92.7.569; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WALKER MD, 1990, NUCLEIC ACIDS RES, V18, P1159, DOI 10.1093/nar/18.5.1159; WATADA H, 1995, GENE, V153, P255, DOI 10.1016/0378-1119(94)00765-K; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; Zhuang YA, 1998, MOL CELL BIOL, V18, P3340, DOI 10.1128/MCB.18.6.3340	56	362	369	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 20	2001	276	29					27424	27431		10.1074/jbc.M100827200	http://dx.doi.org/10.1074/jbc.M100827200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	454HJ	11309385	hybrid, Green Published			2022-12-27	WOS:000169966900092
J	Guo, FF; Kumahara, E; Saffen, D				Guo, FF; Kumahara, E; Saffen, D			A Ca1DAG-GEFI/Rap1/B-Raf cassette couples M-1 muscarinic acetylcholine receptors to the activation of ERK1/2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; PROTEIN-KINASE-C; LONG-TERM POTENTIATION; NUCLEOTIDE EXCHANGE FACTORS; MAPK SIGNALING PATHWAY; B-RAF; MEMBRANE DEPOLARIZATION; DEPENDENT ACTIVATION; CALCIUM INFLUX; CYCLIC-AMP	In this study we examine signaling pathways linking the M-1 subtype of muscarinic acetylcholine receptor (M-1 mAChR) to activation of extracellular signal-regulated kinases (ERK) 1 and 2 in neuronal PC12D cells. We first show that activation of ERK1/2 by the M-1 mAChR agonist carbachol takes place primarily via a Res-independent pathway that depends largely upon Rap1, another small GTP-binding protein in the Res family. Rap1 in turn activates B-Raf, an upstream activator of ERK1/2. Consistent with these results, carbachol was found to activate Rap1 more potently than Res. Similar to other small GTP-binding proteins, activation of Rap1 requires a guanine nucleotide exchange factor (GEF) to promote its conversion from the GDP- to GTP-bound form. Using specific antibodies, we show that a recently identified Rap1 GEF, (cal) under bar cium- and (d) under bari (a) under bar cylglycerol-regulated guanine nucleotide (e) under bar xchange (f) under bar actor (I) under bar (CalDAG-GEFI), is expressed in PC12D cells and that carbachol stimulates the formation of a complex containing CalDAG-GEFI, Rap1, and activated B-Raf. Finally, we show that expression of CalDAG-GEFI antisense RNA largely blocks carbachol-stimulated activation of hemagglutinin (HA)1-tagged B-Raf and formation of the CalDAG-GEFI/Rap1/HA1-tagged B-Raf complex. Together, these data define a novel signaling pathway for M-1 mAChR, where increases in Ca2+ and diacylglycerol stimulate the sequential activation of CalDAG-GEFI, Rap1, and B-Raf, resulting in the activation of MEK and ERK1/2.	Univ Tokyo, Fac Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Guo, FF (corresponding author), Univ Tokyo, Fac Med, Dept Neurochem, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.							ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; BERG MM, 1992, J BIOL CHEM, V267, P13; BERSTEIN G, 1992, J BIOL CHEM, V267, P8081; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; CHANDLER CE, 1983, J CELL PHYSIOL, V114, P321, DOI 10.1002/jcp.1041140311; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; de Rooij J, 1999, J BIOL CHEM, V274, P38125, DOI 10.1074/jbc.274.53.38125; Ebihara T, 1997, J NEUROCHEM, V68, P1001; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; EYCHENE A, 1995, ONCOGENE, V10, P1159; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FEIG LA, 1994, CURR OPIN CELL BIOL, V6, P204, DOI 10.1016/0955-0674(94)90137-6; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FELDER CC, 1995, FASEB J, V9, P619, DOI 10.1096/fasebj.9.8.7768353; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grewal SS, 2000, J BIOL CHEM, V275, P34433, DOI 10.1074/jbc.M004728200; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; GRIFFITH LC, 1988, J BIOL CHEM, V263, P9542; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Haring R, 1998, J NEUROCHEM, V71, P2094; HARLOW E, 1988, ANTIBODIES LABORATOR, P313; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; JAISWAL RK, 1994, MOL CELL BIOL, V14, P6944, DOI 10.1128/MCB.14.10.6944; KATOHSEMBA R, 1987, J NEUROSCI RES, V17, P36, DOI 10.1002/jnr.490170106; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kedra D, 1997, HUM GENET, V100, P611, DOI 10.1007/s004390050562; Keely SJ, 1998, J BIOL CHEM, V273, P27111, DOI 10.1074/jbc.273.42.27111; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Kumahara E, 1999, J BIOL CHEM, V274, P10430, DOI 10.1074/jbc.274.15.10430; Kumahara E, 1999, J BIOCHEM, V125, P541, DOI 10.1093/oxfordjournals.jbchem.a022319; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LAMBERT DG, 1992, BIOCHEM SOC T, V20, P130, DOI 10.1042/bst0200130; LAPETINA EG, 1985, J BIOL CHEM, V260, P1358; LEVEY AI, 1995, J NEUROSCI, V15, P4077; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Liao YH, 1999, J BIOL CHEM, V274, P37815, DOI 10.1074/jbc.274.53.37815; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MAX SI, 1993, J NEUROSCI, V13, P4293; MCCORMICK F, 1994, CURR OPIN GENET DEV, V4, P71, DOI 10.1016/0959-437X(94)90093-0; MRZLJAK L, 1993, P NATL ACAD SCI USA, V90, P5194, DOI 10.1073/pnas.90.11.5194; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Ohtsuka T, 1999, BIOCHEM BIOPH RES CO, V265, P38, DOI 10.1006/bbrc.1999.1619; Ohtsuka T, 1996, J BIOL CHEM, V271, P1258, DOI 10.1074/jbc.271.3.1258; Orban PC, 1999, TRENDS NEUROSCI, V22, P38, DOI 10.1016/S0166-2236(98)01306-X; Papin C, 1998, J BIOL CHEM, V273, P24939, DOI 10.1074/jbc.273.38.24939; Papin C, 1996, ONCOGENE, V12, P2213; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; QUILLIAM LA, 1995, BIOESSAYS, V17, P395, DOI 10.1002/bies.950170507; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Rosenblum K, 2000, J NEUROSCI, V20, P977, DOI 10.1523/JNEUROSCI.20-03-00977.2000; Rouse ST, 1998, NEUROSCIENCE, V86, P221, DOI 10.1016/S0306-4522(97)00681-7; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TRAVERSE S, 1994, FEBS LETT, V350, P13, DOI 10.1016/0014-5793(94)00723-3; Tsai W, 1997, EMBO J, V16, P4597, DOI 10.1093/emboj/16.15.4597; UI M, 1995, TRENDS BIOCHEM SCI, V20, P303, DOI 10.1016/S0968-0004(00)89056-8; VAILLANCOURT RR, 1994, MOL CELL BIOL, V14, P6522, DOI 10.1128/MCB.14.10.6522; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WESS J, 1993, TRENDS PHARMACOL SCI, V14, P308, DOI 10.1016/0165-6147(93)90049-P; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yao H, 1998, J BIOL CHEM, V273, P8240, DOI 10.1074/jbc.273.14.8240; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zwartkruis FJT, 1999, EXP CELL RES, V253, P157, DOI 10.1006/excr.1999.4695; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905; Zwick E, 1997, J BIOL CHEM, V272, P24767, DOI 10.1074/jbc.272.40.24767	92	64	69	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					25568	25581		10.1074/jbc.M101277200	http://dx.doi.org/10.1074/jbc.M101277200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11292831	hybrid			2022-12-27	WOS:000169800700148
J	Jiang, JG; Johnson, C; Zarnegar, R				Jiang, JG; Johnson, C; Zarnegar, R			Peroxisome proliferator-activated receptor gamma-mediated transcriptional up-regulation of the hepatocyte growth factor gene promoter via a novel composite cis-acting element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SKIN FIBROBLASTS; FACTOR MESSENGER-RNA; PPAR-GAMMA; ORPHAN RECEPTORS; SCATTER FACTOR; RETINOIC ACID; COLON-CANCER; EXPRESSION; LIVER; FAMILY	Hepatocyte growth factor (HGF) is a pleotropic polypeptide that can function as a morphogen, motogen, mitogen, angiogen, carcinogen, and tumor suppressor, depending on the target cell and tissue. Previous studies from our laboratory using transgenic mice have shown that HGF gene expression is tightly regulated at the transcriptional level and that the upstream regulatory elements are crucial for the control of HGF gene transcription, In the present study, we have identified and characterized one of these elements as a peroxisome proliferator-activated receptor gamma (PPAR gamma)-responsive element. This regulatory element was localized at -246 to -233 base pairs upstream from the transcription start site of the HGF gene promoter having the sequence GGGCCAGGTGACCT. Gel mobility shift and supershift assays demonstrated that this cis-acting element strongly binds to the PPAR gamma isoforms as well as to chicken ovalbumin upstream promoter-transcription factor, a member of the orphan nuclear receptor subfamily. Mutational analysis and gel mobility band shift assays indicated that the binding site is an inverted repeat of the AGGTCA motif with two spacers (inverted repeat 2 configuration) and that the two spacers are important for PPAR gamma binding. This binding site overlaps with functional binding sites for activating protein-2, nuclear factor 1, and upstream stimulatory factor, and together, they constitute a multifunctional composite binding site through which these different transcription factors exert their regulatory effects on HGF promoter activity. Functional assays revealed that PPAR gamma, with its ligand, 15-deoxy-prostaglandin J2, strongly stimulates HGF promoter activity. On the other hand, nuclear factor 1, activating protein-2, and chicken ovalbumin upstream promoter-transcription factor transcription factors repress the stimulatory action of PPAR gamma by competing with PPAR gamma for their overlapping binding sites. Furthermore, for the first time, our studies demonstrate that the PPAR gamma ligand, 15-deoxy-prostaglandin J2, induces endogenous HGF mRNA and protein expression in fibroblasts in culture.	Univ Pittsburgh, Sch Med, Dept Pathol, Div Cellular & Mol Pathol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zarnegar, R (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Div Cellular & Mol Pathol, S Biomed Sci Tower,Rm S411A, Pittsburgh, PA 15261 USA.		Jiang, Jie-Gen/K-3845-2019		NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006109] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES 06109] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bell AW, 1998, J BIOL CHEM, V273, P6900, DOI 10.1074/jbc.273.12.6900; GOHDA E, 1994, CYTOKINE, V6, P633, DOI 10.1016/1043-4666(94)90051-5; GREENWEL P, 1991, LAB INVEST, V65, P644; GREENWEL P, 1993, LAB INVEST, V69, P210; Jiang JG, 2000, BIOCHEM BIOPH RES CO, V272, P882, DOI 10.1006/bbrc.2000.2848; Jiang JG, 1997, J BIOL CHEM, V272, P3928, DOI 10.1074/jbc.272.7.3928; Jiang JG, 2000, ONCOGENE, V19, P2786, DOI 10.1038/sj.onc.1203581; Jiang JG, 1997, ONCOGENE, V14, P3039, DOI 10.1038/sj.onc.1201152; Jiang JG, 1997, MOL CELL BIOL, V17, P5758, DOI 10.1128/MCB.17.10.5758; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; KONO S, 1992, BIOCHEM BIOPH RES CO, V186, P991, DOI 10.1016/0006-291X(92)90844-B; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; LIU YH, 1994, J BIOL CHEM, V269, P4152; LIU YH, 1994, MOL CELL ENDOCRINOL, V104, P173, DOI 10.1016/0303-7207(94)90120-1; Lowell BB, 1999, CELL, V99, P239, DOI 10.1016/S0092-8674(00)81654-2; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MATSUMOTO K, 1992, BIOCHEM BIOPH RES CO, V188, P235, DOI 10.1016/0006-291X(92)92375-8; MATSUMOTO K, 1992, J BIOL CHEM, V267, P24917; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; PLASCHKESCHLUTTER A, 1995, J BIOL CHEM, V270, P830, DOI 10.1074/jbc.270.2.830; Rosen ED, 2000, GENE DEV, V14, P1293; RUBIN JS, 1993, BIOCHIM BIOPHYS ACTA, V1155, P357, DOI 10.1016/0304-419X(93)90015-5; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Tamagnone Luca, 1997, Cytokine and Growth Factor Reviews, V8, P129, DOI 10.1016/S1359-6101(97)00007-5; TAMURA M, 1993, J BIOL CHEM, V268, P8140; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Vamecq J, 1999, LANCET, V354, P141, DOI 10.1016/S0140-6736(98)10364-1; Wu Q, 1997, EMBO J, V16, P1656, DOI 10.1093/emboj/16.7.1656; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177; ZARNEGAR R, 1991, BIOCHEM BIOPH RES CO, V177, P559, DOI 10.1016/0006-291X(91)92020-K; ZHU YJ, 1993, J BIOL CHEM, V268, P26817	38	45	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					25049	25056		10.1074/jbc.M101611200	http://dx.doi.org/10.1074/jbc.M101611200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11292834	hybrid			2022-12-27	WOS:000169800700083
J	Jonas-Straube, E; Hutin, C; Hoffman, NE; Schunemann, D				Jonas-Straube, E; Hutin, C; Hoffman, NE; Schunemann, D			Functional analysis of the protein-interacting domains of chloroplast SRP43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; THYLAKOID MEMBRANES; CHROMO DOMAIN; POSTTRANSLATIONAL INTEGRATION; 54-KDA SUBUNIT; ANKYRIN REPEAT; BINDING; HOMOLOG; INSERTION; HP1	The chloroplast signal recognition particle (cpSRP) consists of an evolutionarily conserved 54-kDa subunit (cpSRP54) and a dimer of a unique 43-kDa subunit (cpSRP43), cpSRP binds light-harvesting chlorophyll proteins (LHCPs) to form a cpSRP/LHCP transit complex, which targets LHCP to the thylakoid membrane. Previous studies showed that transit complex formation is mediated through the binding of the L18 domain of LHCP to cpSRP43, cpSRP43 is characterized by a four-ankyrin repeat domain at the N terminus and two chromodomains at the C terminus. in the present study we used the yeast two-hybrid system and in vitro binding assays to analyze the function of different domains of cpSRP43 in protein complex formation. We report here that the first ankyrin repeat binds to the Is-amino acid domain on LHCP that binds to cpSRP43, whereas the third and fourth ankyrin repeats are involved in the dimerization of cpSRP43. We show further that the interaction of cpSRP43 with cpSRP54 is mediated via binding of the methionine-rich domain of cpSRP54 to the C-terminally located chromodomains of cpSRP43, Both chromodomains contain essential elements for binding cpSRP54, indicating that the closely spaced chromodomains together create a single binding site for cpSRP54. In addition, our data demonstrate that the interaction of cpSRP54 with the chromodomains of cpSRP43 is enhanced indirectly by the dimerization motif of cpSRP43.	Rhein Westfal TH Aachen, Inst Biol 2, D-52074 Aachen, Germany; Dept Ecohphysiol Vegetale & Microbiol, F-13108 St Paul Durance, France; Paradigm Genet, Res Triangle Pk, NC 27709 USA	RWTH Aachen University	Schunemann, D (corresponding author), Rhein Westfal TH Aachen, Inst Biol 2, Worringerweg 1, D-52074 Aachen, Germany.			Schuenemann, Danja/0000-0001-8894-7685; Hoffman, Neil/0000-0002-4057-555X				AASLAND R, 1995, NUCLEIC ACIDS RES, V23, P3168; Amin P, 1999, PLANT PHYSIOL, V121, P61, DOI 10.1104/pp.121.1.61; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; CLINE K, 1989, J BIOL CHEM, V264, P14225; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; FRANKLIN AE, 1993, J BIOL CHEM, V268, P22175; HOFFMAN NE, 1994, PLANT PHYSIOL, V105, P295, DOI 10.1104/pp.105.1.295; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kim SJ, 1999, J BIOL CHEM, V274, P4715, DOI 10.1074/jbc.274.8.4715; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Kogata N, 1999, FEBS LETT, V447, P329, DOI 10.1016/S0014-5793(99)00305-1; KOONIN EV, 1995, NUCLEIC ACIDS RES, V23, P4229, DOI 10.1093/nar/23.21.4229; LI XX, 1995, P NATL ACAD SCI USA, V92, P3789, DOI 10.1073/pnas.92.9.3789; Lin JH, 1999, J BIOL CHEM, V274, P14706, DOI 10.1074/jbc.274.21.14706; Matsuno K, 1997, DEVELOPMENT, V124, P4265; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; PARO R, 1991, P NATL ACAD SCI USA, V88, P263, DOI 10.1073/pnas.88.1.263; PARO R, 1990, TRENDS GENET, V6, P416, DOI 10.1016/0168-9525(90)90303-N; PAYAN LA, 1991, J CELL BIOL, V112, P603, DOI 10.1083/jcb.112.4.603; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; ROMISCH K, 1990, J CELL BIOL, V111, P1793, DOI 10.1083/jcb.111.5.1793; Schuenemann D, 1999, BIOCHEM BIOPH RES CO, V254, P253, DOI 10.1006/bbrc.1998.9923; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Tu CJ, 1999, J BIOL CHEM, V274, P27219, DOI 10.1074/jbc.274.38.27219; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	32	47	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					24654	24660		10.1074/jbc.M100153200	http://dx.doi.org/10.1074/jbc.M100153200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11306572	hybrid			2022-12-27	WOS:000169800700033
J	Biemel, KM; Reihl, O; Conrad, J; Lederer, MO				Biemel, KM; Reihl, O; Conrad, J; Lederer, MO			Formation pathways for lysine-arginine cross-links derived from hexoses and pentoses by Maillard processes - Unraveling the structure of a pentosidine precursor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; D-GLUCOSE; PROTEINS; GLYOXAL; METHYLGLYOXAL; MECHANISM; 3-DEOXYGLUCOSONE; IDENTIFICATION; QUANTIFICATION; FLUOROPHORE	Covalently cross-linked proteins are among the major modifications caused by the advanced Maillard reaction. So far, the chemical nature of these aggregates and their formation pathways are largely unknown. Synthesis and unequivocal structural characterization are reported for the lysine-arginine cross-links N-6-{2-{[(4S)-4-ammonio-5-oxido-5-oxopentyl] amino]-5-[(2S,3R)-2,3,4. trihydroxybutyl]-3,5-dihydro-4H-imidazol-4-ylidene}-L-lysinate (DOGIC 12), N-6-{2-{[(4S)-4-ammonio-5-oxido-5-oxopentyl]amino}-5-[(2S)-2,3-dihydroxypropyl] -3-5-dihrdro-4H-imidazol-4-ylidene}-L-lysinate (DOPDIC 13), and 6-((6S)-2-{[(4S)-4-ammonio-5-oxido-5-oxopentyl] amino] 6-hydroxy-5,6,7,7a-tetrahydro-4H-imidazo[4,5-b] pyridin-4-yl)-L-norleucinate (pentosinane 10). For these compounds, as well as for glucosepane 9 and pentosidine 11, the formation pathways could be established by starting from native carbohydrates, Amadori products, and 3-deoxyosones, respectively, Pentosinane 10 was unequivocally proven to be an important precursor of pentosidine 11, which is a well established fluorescent indicator for advanced glycation processes in vivo, The Amadori products are shown to be the pivots in the formation of the various cross-links 9-13. The bicyclic structures 9-11 are directly derived from aminoketoses, whereas 12 and 13 stem from reaction with the 3-deoxyosones, All products 9-13 were identified and quantified from incubations of bovine serum albumin with the respective 3-deoxyosone or carbohydrate, From these results it seems fully justified to expect both glucosepane 9 and DOGDIC 12 to constitute important in vivo cross-links.	Univ Hohenheim, Inst Lebensmittelchem 170, D-70593 Stuttgart, Germany; Univ Hohenheim, Inst Chem 130, D-70593 Stuttgart, Germany	University Hohenheim; University Hohenheim	Lederer, MO (corresponding author), Univ Hohenheim, Inst Lebensmittelchem 170, Garbenstr 28, D-70593 Stuttgart, Germany.							Braun S., 1998, 150 MORE BASIC NMR E; BRINKMANN E, J CHEM SOC P1, P2817; Buettner Ulf, 1997, Carbohydrate Research, V300, P265; Chellan P, 2001, J BIOL CHEM, V276, P3895, DOI 10.1074/jbc.M008626200; DYER DG, 1991, J BIOL CHEM, V266, P11654; Friedman M, 1996, J AGR FOOD CHEM, V44, P631, DOI 10.1021/jf950394r; GLOMB M, 1992, THESIS U STUTTGART G; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; GRANDHEE SK, 1991, J BIOL CHEM, V266, P11649; Henle T, 1997, Z LEBENSM UNTERS F A, V204, P95, DOI 10.1007/s002170050043; KATO H, 1987, AGR BIOL CHEM TOKYO, V51, P2009, DOI 10.1080/00021369.1987.10868313; Lederer MO, 1999, BIOORGAN MED CHEM, V7, P1081, DOI 10.1016/S0968-0896(99)00040-1; Lederer MO, 1999, BIOORGAN MED CHEM, V7, P2499, DOI 10.1016/S0968-0896(99)00212-6; Lederer MO, 1998, BIOORGAN MED CHEM, V6, P993, DOI 10.1016/S0968-0896(98)00058-3; LEDL F, 1990, ANGEW CHEM INT EDIT, V29, P565, DOI 10.1002/anie.199005653; Litchfield JE, 1999, INT J BIOCHEM CELL B, V31, P1297, DOI 10.1016/S1357-2725(99)00091-6; MADSON MA, 1981, CARBOHYD RES, V94, P183, DOI 10.1016/S0008-6215(00)80716-8; MAY PM, 1977, J CHEM SOC DALTON, P588, DOI 10.1039/dt9770000588; MCKAY E, 1964, CLIN CHIM ACTA, V10, P320, DOI 10.1016/0009-8981(64)90062-2; MONNIER VM, 1996, DIABETES, V45, P67; NAGARAJ RH, 1992, BIOCHIM BIOPHYS ACTA, V1116, P34, DOI 10.1016/0304-4165(92)90125-E; Nagaraj RH, 1996, J BIOL CHEM, V271, P19338, DOI 10.1074/jbc.271.32.19338; Nagaraj RH, 1996, ARCH BIOCHEM BIOPHYS, V325, P152, DOI 10.1006/abbi.1996.0019; NISSL J, 1995, CARBOHYD RES, V270, pC1, DOI 10.1016/0008-6215(95)00058-2; Odani H, 1998, FEBS LETT, V427, P381, DOI 10.1016/S0014-5793(98)00416-5; SELL DR, 1991, DIABETES METAB REV, V7, P239, DOI 10.1002/dmr.5610070404; SELL DR, 1989, J BIOL CHEM, V264, P21597; Shamsi FA, 1999, CURR EYE RES, V19, P276, DOI 10.1076/ceyr.19.3.276.5315; Skovsted IC, 1998, CELL MOL BIOL, V44, P1159; Slatter DA, 1998, FEBS LETT, V421, P180, DOI 10.1016/S0014-5793(97)01554-8; Smallcombe SH, 1995, J MAGN RESON SER A, V117, P295, DOI 10.1006/jmra.1995.0759; Tessier F, 1999, J BIOL CHEM, V274, P20796, DOI 10.1074/jbc.274.30.20796; Tyler AN, 1996, ANAL CHEM, V68, P3561, DOI 10.1021/ac9603791; Vasan S, 1996, NATURE, V382, P275, DOI 10.1038/382275a0; WALTER HF, 1991, RUCKSTANDSANALYTIK P, P1; WELLSKNECHT KJ, 1995, BIOCHEMISTRY-US, V34, P3702, DOI 10.1021/bi00011a027; WELLSKNECHT KJ, 1995, J ORG CHEM, V60, P6246, DOI 10.1021/jo00125a001; Yamaguchi M, 1998, DIABETIC MED, V15, P458, DOI 10.1002/(SICI)1096-9136(199806)15:6<458::AID-DIA601>3.0.CO;2-Q	38	116	122	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23405	23412		10.1074/jbc.M102035200	http://dx.doi.org/10.1074/jbc.M102035200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11279247	hybrid			2022-12-27	WOS:000169531100026
J	Krane, CM; Melvin, JE; Nguyen, HV; Richardson, L; Towne, JE; Doetschman, T; Menon, AG				Krane, CM; Melvin, JE; Nguyen, HV; Richardson, L; Towne, JE; Doetschman, T; Menon, AG			Salivary acinar cells from aquaporin 5-deficient mice have decreased membrane water permeability and altered cell volume regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; TARGETED DISRUPTION; CHANNEL; LACKING; SECRETION; PROTEINS; EXCHANGE; CLONING; AQP5	Aquaporins (AQPs) are channel proteins that regulate the movement of water through the plasma membrane of secretory and absorptive cells in response to osmotic gradients. In the salivary gland, AQP5 is the major aquaporin expressed on the apical membrane of acinar cells. Previous studies have shown that the volume of saliva secreted by AQP5-deficient mice is decreased, indicating a role for AQP5 in saliva secretion; however, the mechanism by which AQP5 regulates water transport in salivary acinar cells remains to be determined. Here we show that the decreased salivary flow rate and increased tonicity of the saliva secreted by Aqp5(-/-) mice in response to pilocarpine stimulation are not caused by changes in whole body fluid homeostasis, indicated by similar blood gas and electrolyte concentrations in urine and blood in wild-type and AQPB-deficient mice. In contrast, the water permeability in parotid and sublingual acinar cells isolated from Aqp5(-/-) mice is decreased significantly. Water permeability decreased by 65% in parotid and 77% in sublingual acinar cells from Aqp5(-/-) mice in response to hypertonicity-induced cell shrinkage and hypotonicity-induced cell swelling. These data show that AQP5 is the major pathway for regulating the water permeability in acinar cells, a critical property of the plasma membrane which determines the flow rate and ionic composition of secreted saliva.	Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; Univ Rochester, Sch Med & Dent, Ctr Oral Biol, Rochester, NY 14642 USA	University System of Ohio; University of Cincinnati; University of Rochester	Menon, AG (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Bethesda Ave,3110 MSB,POB 670524, Cincinnati, OH 45267 USA.	Anil.Menon@UC.edu			NHLBI NIH HHS [HL61781] Funding Source: Medline; NIDCR NIH HHS [R01 DE138283, R01 DEO8921] Funding Source: Medline; NIEHS NIH HHS [ES06096] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE008921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ASKEW GR, 1993, MOL CELL BIOL, V13, P4115, DOI 10.1128/MCB.13.7.4115; Astor F C, 1999, Ear Nose Throat J, V78, P476; Bivona P L, 1998, N Y State Dent J, V64, P46; Cook D. I., 1994, P1061; Evans RL, 1999, J BIOL CHEM, V274, P29025, DOI 10.1074/jbc.274.41.29025; Evans RL, 2000, J BIOL CHEM, V275, P26720; Fischer D, 1997, Spec Care Dentist, V17, P58, DOI 10.1111/j.1754-4505.1997.tb00868.x; FOSKETT JK, 1990, AM J PHYSIOL, V259, pC998; FOSKETT JK, 1989, SCIENCE, V244, P1582, DOI 10.1126/science.2500708; Fox PC, 1998, ANN NY ACAD SCI, V842, P132, DOI 10.1111/j.1749-6632.1998.tb09641.x; He XJ, 1997, PFLUG ARCH EUR J PHY, V433, P260; Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413; JUNG JS, 1994, J BIOL CHEM, V269, P14648; King LS, 2000, MOL MED TODAY, V6, P60, DOI 10.1016/S1357-4310(99)01636-6; Krane CM, 1999, MAMM GENOME, V10, P498, DOI 10.1007/s003359901030; Lee MD, 1997, MEDICINE, V76, P141, DOI 10.1097/00005792-199705000-00001; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Matsuzaki T, 1999, CELL TISSUE RES, V295, P513, DOI 10.1007/s004410051257; RAINA S, 1995, J BIOL CHEM, V270, P1908, DOI 10.1074/jbc.270.4.1908; SCHREIBER R, 1999, J BIOL CHEM, V270, P1908; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; SILANIKOVE N, 1989, AM J PHYSIOL, V256, pR809, DOI 10.1152/ajpregu.1989.256.4.R809; Spicer Z, 2000, J BIOL CHEM, V275, P21555, DOI 10.1074/jbc.M001558200; Steward MC, 1998, EUR J MORPHOL, V36, P103; STEWART CL, 1993, METHOD ENZYMOL, V225, P823; TURNER RJ, 1993, CRIT REV ORAL BIOL M, V4, P385, DOI 10.1177/10454411930040031801; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045	30	246	256	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23413	23420		10.1074/jbc.M008760200	http://dx.doi.org/10.1074/jbc.M008760200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11290736	hybrid			2022-12-27	WOS:000169531100027
J	Ramachandran, A; Jain, A; Arora, P; Bashyam, MD; Chatterjee, U; Ghosh, S; Parnaik, VK; Hasnain, SE				Ramachandran, A; Jain, A; Arora, P; Bashyam, MD; Chatterjee, U; Ghosh, S; Parnaik, VK; Hasnain, SE			Novel Sp family-like transcription factors are present in adult insect cells and are involved in transcription from the polyhedrin gene initiator promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; 30-KDA PROTEIN-BINDING; SV40 EARLY PROMOTER; HOST FACTOR; SEQUENCE REQUIREMENTS; MEDIATED EXPRESSION; FUNCTIONAL-ANALYSIS; FIREFLY LUCIFERASE; BACULOVIRUS VECTOR; MOLECULAR-CLONING	We earlier documented the involvement of a cellular factor, polyhedrin (polh) promoter-binding protein, in transcription from the Autographa californica nuclear polyhedrosis virus polh gene promoter. Sequences upstream of the polh promoter were found to influence polh promoter-driven transcription. Analysis of one such region, which could partially compensate for the mutated polh promoter and also activate transcription from the wild-type promoter, revealed a sequence (AcSp) containing a CACCC motif and a loose GC box resembling the binding motifs of the transcription factor Sp1, AcSp and the consensus Spl sequence (cSp) specifically bound factor(s) in HeLa and Spodoptera frugiperda (Sf9) insect cell nuclear extracts to generate identical binding patterns, indicating the similar nature of the factor(s) interacting with these sequences. The AcSp and cSp oligonucleotides enhanced in vivo expression of a polh promoter-driven luciferase gene. In vivo mopping of these factor(s) significantly reduced transcription from the polh promoter. Recombinant viruses carrying deletions in the upstream AcSp sequence confirmed the requirement of these factor(s) in polh promoter-driven transcription in the viral context. We demonstrate for the first time DNA-protein interactions involving novel members of the Sp family of proteins in adult insect cells and their involvement in transcription from the polh promoter.	Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India; Ctr DNA Fingerprinting & Diagnost, Mol & Cellular Biol Lab, Hyderabad 500076, Andhra Pradesh, India; Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Hasnain, SE (corresponding author), Natl Inst Immunol, Eukaryot Gene Express Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	ehtesham@www.cdfd.org.in	HASNAIN, SEYED/C-1492-2009	Hasnain, Seyed/0000-0002-2967-0791				BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BRONNER G, 1994, NATURE, V369, P664, DOI 10.1038/369664a0; BURMA S, 1994, J BIOL CHEM, V269, P2750; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; DYNAN WS, 1983, CELL, V32, P669, DOI 10.1016/0092-8674(83)90053-3; ETKIN E, 1994, VIRUS RES, V31, P343, DOI 10.1016/0168-1702(94)90027-2; GEARING KL, 1990, J GEN VIROL, V71, P251, DOI 10.1099/0022-1317-71-2-251; Ghosh S, 1998, J VIROL, V72, P7484, DOI 10.1128/JVI.72.9.7484-7493.1998; Guarino LA, 1998, J VIROL, V72, P7985, DOI 10.1128/JVI.72.10.7985-7991.1998; Habib S, 1996, J BIOL CHEM, V271, P28250, DOI 10.1074/jbc.271.45.28250; Habib S, 1996, DNA CELL BIOL, V15, P737, DOI 10.1089/dna.1996.15.737; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; HAM J, 1994, EMBO J, V13, P147, DOI 10.1002/j.1460-2075.1994.tb06244.x; Hasnain SE, 1997, GENE, V190, P113, DOI 10.1016/S0378-1119(96)00827-X; Hasnain SE, 1996, METHOD ENZYMOL, V274, P20; HASNAIN SE, 1994, DNA CELL BIOL, V13, P275, DOI 10.1089/dna.1994.13.275; HASNAIN SE, 1990, GENE, V91, P135, DOI 10.1016/0378-1119(90)90175-Q; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; Jain A, 1996, EUR J BIOCHEM, V239, P384, DOI 10.1111/j.1432-1033.1996.0384u.x; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; Krumm A, 1998, P NATL ACAD SCI USA, V95, P13501, DOI 10.1073/pnas.95.23.13501; LU A, 1995, J VIROL, V69, P975, DOI 10.1128/JVI.69.2.975-982.1995; MAOUCHE L, 1995, EUR J BIOCHEM, V233, P793, DOI 10.1111/j.1432-1033.1995.793_3.x; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MCLACHLIN JR, 1994, J VIROL, V68, P7746, DOI 10.1128/JVI.68.12.7746-7756.1994; MORRIS TD, 1994, GENE, V140, P147, DOI 10.1016/0378-1119(94)90538-X; MUKHERJEE B, 1995, DNA CELL BIOL, V14, P7, DOI 10.1089/dna.1995.14.7; MUKHERJEE B, 1995, J BIOL CHEM, V270, P4405, DOI 10.1074/jbc.270.9.4405; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; PASSARELLI AL, 1994, J VIROL, V68, P4673, DOI 10.1128/JVI.68.7.4673-4678.1994; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Prowse DM, 1997, J BIOL CHEM, V272, P1308, DOI 10.1074/jbc.272.2.1308; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; RANKIN C, 1988, GENE, V70, P39, DOI 10.1016/0378-1119(88)90102-3; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SMALE ST, 1990, P NATL ACAD SCI USA, V87, P4509, DOI 10.1073/pnas.87.12.4509; SRIDHAR P, 1994, J BIOSCIENCES, V19, P603; SU W, 1991, GENE DEV, V5, P820, DOI 10.1101/gad.5.5.820; Tanese N, 1996, P NATL ACAD SCI USA, V93, P13611, DOI 10.1073/pnas.93.24.13611; TODD JW, 1995, J VIROL, V69, P968, DOI 10.1128/JVI.69.2.968-974.1995; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Wimmer EA, 1996, MECH DEVELOP, V59, P53, DOI 10.1016/0925-4773(96)00575-8; WIMMER EA, 1995, MECH DEVELOP, V53, P235, DOI 10.1016/0925-4773(95)00439-8; Yang S, 1999, J VIROL, V73, P3404, DOI 10.1128/JVI.73.4.3404-3409.1999; ZENZIEGREGORY B, 1993, MOL CELL BIOL, V13, P3841, DOI 10.1128/MCB.13.7.3841; Zhang SR, 1999, GENE, V227, P231, DOI 10.1016/S0378-1119(98)00590-3	57	19	19	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23440	23449		10.1074/jbc.M101537200	http://dx.doi.org/10.1074/jbc.M101537200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11294840	hybrid			2022-12-27	WOS:000169531100030
J	Bremer, AA; Leeman, SE; Boyd, ND				Bremer, AA; Leeman, SE; Boyd, ND			Evidence for spatial proximity of two distinct receptor regions in the substance P (SP)center dot neurokinin-1 receptor (NK-1R) complex obtained by photolabeling the NK-1R with p-benzoylphenylalanine(3)-SP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOCHEMICAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; FUNCTIONAL CDNA; G-PROTEINS; ANALOG; CELLS; TACHYKININS; SITE	Substance P (SP) belongs to the tachykinin family of bioactive peptides and exerts its many biological effects through functional interaction with its cell-surface, Gr protein-coupled neurokinin-l receptor (NK-1R). Previous studies from our laboratory have shown that I-125-Bolton-Hunter reagent-labeled p-benzoylphenylalanine(8)-SP (Bpa(8)SP) covalently attaches to Met(181), whereas I-125-Bolton-Hunter reagent-labeled Bpa(4)SP covalently attaches to Met(174), both of which are located on the second extracellular loop (EC2) of the NR-1R, In this study, evidence has been obtained that at equilibrium, the photoreactive SP analogue I-125-[D-Tyr(0)]Bpa(3)Sp covalently labels residues in two distinct extracellular regions of the NK-1R, One site of I-125-[D-Tyr(0)]Epa3Sp photoinsertion is located on EC2 within a segment of the receptor extending from residues 173 to 177; a second site of I-125-[D-Tyr(0)]BpaSP photoinsertion is located on the extracellular N terminus within a segment of the receptor extending from residues 11 to 21, a sequence that contains both potential sites for N-linked glycosylation, Since competition binding data presented in this study do not suggest the existence of multiple peptide NK-1R complexes, it is reasonable to assume that the receptor sequences within EC2 and N terminus identified by peptide mapping are in close proximity in the equilibrium complex.	Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	Boston University	Boyd, ND (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, L-611,80 E Concord St, Boston, MA 02118 USA.			Leeman, Susan/0000-0002-0951-5364	NINDS NIH HHS [NS-31346] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031346] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALDWIN JM, 1994, CURR OPIN CELL BIOL, V6, P180, DOI 10.1016/0955-0674(94)90134-1; Bockaert J, 1991, Curr Opin Neurobiol, V1, P32, DOI 10.1016/0959-4388(91)90008-U; BOYD ND, 1991, ANN NY ACAD SCI, V632, P79, DOI 10.1111/j.1749-6632.1991.tb33096.x; BOYD ND, 1991, BIOCHEMISTRY-US, V30, P336, DOI 10.1021/bi00216a005; Boyd ND, 1996, P NATL ACAD SCI USA, V93, P433, DOI 10.1073/pnas.93.1.433; ERSPAMER V, 1971, ANNU REV PHARMACOLOG, V11, P327, DOI 10.1146/annurev.pa.11.040171.001551; ERSPAMER V, 1981, TRENDS NEUROSCI, V4, P267, DOI 10.1016/0166-2236(81)90084-9; GARRET C, 1991, P NATL ACAD SCI USA, V88, P10208, DOI 10.1073/pnas.88.22.10208; HERSHEY AD, 1990, SCIENCE, V247, P958, DOI 10.1126/science.2154852; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; KAGE R, 1993, J NEUROCHEM, V60, P347, DOI 10.1111/j.1471-4159.1993.tb05857.x; Kage R, 1996, J BIOL CHEM, V271, P25797, DOI 10.1074/jbc.271.42.25797; KAGE R, 1995, J NEUROCHEM, V64, P316; Kramer MS, 1998, SCIENCE, V281, P1640, DOI 10.1126/science.281.5383.1640; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li HZ, 2001, J BIOL CHEM, V276, P10589, DOI 10.1074/jbc.M007397200; LI YM, 1995, J BIOL CHEM, V270, P1213, DOI 10.1074/jbc.270.3.1213; MAGGIO JE, 1988, ANNU REV NEUROSCI, V11, P13, DOI 10.1146/annurev.neuro.11.1.13; NAKANISHI S, 1987, PHYSIOL REV, V67, P1117, DOI 10.1152/physrev.1987.67.4.1117; OTSUKA M, 1993, PHYSIOL REV, V73, P229, DOI 10.1152/physrev.1993.73.2.229; Pellegrini M, 2001, J BIOL CHEM, V276, P22862, DOI 10.1074/jbc.M101057200; PERNOW B, 1983, PHARMACOL REV, V35, P85; Quartara L, 1998, NEUROPEPTIDES, V32, P1, DOI 10.1016/S0143-4179(98)90015-4; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; TAKEDA Y, 1992, J NEUROCHEM, V59, P740, DOI 10.1111/j.1471-4159.1992.tb09430.x; TAKEDA Y, 1991, BIOCHEM BIOPH RES CO, V179, P1232, DOI 10.1016/0006-291X(91)91704-G; YOKOTA Y, 1989, J BIOL CHEM, V264, P17649	27	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22857	22861		10.1074/jbc.M100824200	http://dx.doi.org/10.1074/jbc.M100824200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294866	hybrid			2022-12-27	WOS:000169412700117
J	Cram, EJ; Liu, BD; Bjeldanes, LF; Firestone, GL				Cram, EJ; Liu, BD; Bjeldanes, LF; Firestone, GL			Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE CDK6; ESTROGEN-RECEPTOR SP1; CYCLIN D1 ONCOGENE; BINDING PROTEIN; FAMILY; ACTIVATION; CARCINOGENESIS; INDUCTION; COMPLEX; ARREST	Indole-3-carbinol (I3C), a compound naturally occurring in Brassica vegetables, can induce a G(1) cell cycle arrest of human MCF-7 breast cancer cells that is accompanied by the selective inhibition of cyclin-dependent kinase 6 (CDK6) expression. Reverse transcriptase-polymerase chain reaction analysis of CDK6 mRNA de cay rates revealed that I3C had no effect on CDK6 transcript stability. We report the first identification and functional characterization of the CDK6 promoter in order to determine whether I3C inhibits CDK6 transcription. In MCF-7 cells stably transfected with CDK6 promoter-linked luciferase reporter plasmids, I3C inhibited CDK6 promoter activity in an I3C specific response that was not a consequence of the growth-arrested state of the cells. Deletion analysis revealed a 167-base pair I3C-responsive region of the CDK6 promoter between -805 and -638, Site-specific mutations within this region revealed that both Sp1 and Ets-like sites, which are spaced 5 base pairs apart, were necessary for I3C responsiveness in the context of the CDK6 promoter. Electrophoretic mobility shift analysis of protein-DNA complexes formed with nuclear proteins isolated from I3C-treated and -untreated cells, in combination with supershift assays using Spl antibodies, demonstrated that the Sp1-binding site in the CDK6 promoter forms a specific I3C-responsive DNA-protein complex that contains the Sp1 transcription factor. Taken together, our results suggest that I3C down-regulates CDKG transcription by targeting Sp1 at a composite DNA site in the CDK6 promoter.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Nutr & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Firestone, GL (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 591 LSA, Berkeley, CA 94720 USA.	glfire@uclink4.berkeley.edu			NATIONAL CANCER INSTITUTE [R01CA069056] Funding Source: NIH RePORTER; NCI NIH HHS [CA69056-05] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akagi T, 1996, ONCOGENE, V13, P399; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; Badie C, 2000, MOL CELL BIOL, V20, P2358, DOI 10.1128/MCB.20.7.2358-2366.2000; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradlow HL, 1995, ANN NY ACAD SCI, V768, P180, DOI 10.1111/j.1749-6632.1995.tb12121.x; BRADLOW HL, 1994, CANCER EPIDEM BIOMAR, V3, P591; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; Broadbent TA, 1998, CURR MED CHEM, V5, P337; Broadbent TA, 1998, CURR MED CHEM, V5, P469; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Chen I, 1998, CARCINOGENESIS, V19, P1631, DOI 10.1093/carcin/19.9.1631; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cover CM, 1998, J BIOL CHEM, V273, P3838, DOI 10.1074/jbc.273.7.3838; Cover CM, 1999, CANCER RES, V59, P1244; DALTON S, 1992, EMBO J, V11, P1797, DOI 10.1002/j.1460-2075.1992.tb05231.x; Davie JR, 1998, J CELL BIOCHEM, P203; Dean G, 2000, J BIOL CHEM, V275, P32664, DOI 10.1074/jbc.275.42.32664; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Duan R, 1998, ENDOCRINOLOGY, V139, P1981, DOI 10.1210/en.139.4.1981; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; Fry CJ, 1999, J BIOL CHEM, V274, P29583, DOI 10.1074/jbc.274.42.29583; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; GRUBBS CJ, 1995, ANTICANCER RES, V15, P709; Hamel PA, 1997, CANCER INVEST, V15, P143, DOI 10.3109/07357909709115767; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; HORIGUCHIYAMADA J, 1994, MOL CELL BIOCHEM, V132, P31, DOI 10.1007/BF00925672; ISHIDA T, 1995, J IMMUNOL, V155, P5527; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; Kobayashi A, 1996, J BIOL CHEM, V271, P12310, DOI 10.1074/jbc.271.21.12310; Krehan A, 2000, J BIOL CHEM, V275, P18327, DOI 10.1074/jbc.M909736199; Kwon TK, 1996, GENE, V180, P113, DOI 10.1016/S0378-1119(96)00416-7; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; Lu S, 2000, MOL ENDOCRINOL, V14, P753, DOI 10.1210/me.14.5.753; Margana RK, 1997, J BIOL CHEM, V272, P3083, DOI 10.1074/jbc.272.5.3083; Meng QH, 2000, J MOL MED, V78, P155, DOI 10.1007/s001090000088; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Muller C, 1999, J BIOL CHEM, V274, P11220, DOI 10.1074/jbc.274.16.11220; Oyama T, 1998, CANCER RES, V58, P2876; QIN XQ, 1995, MOL CELL BIOL, V15, P742; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rosmarin AG, 1998, J BIOL CHEM, V273, P13097, DOI 10.1074/jbc.273.21.13097; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Saville B, 2000, J BIOL CHEM, V275, P5379, DOI 10.1074/jbc.275.8.5379; SHARMA S, 1994, CANCER RES, V54, P5848; Sharrocks AD, 1997, INT J BIOCHEM CELL B, V29, P1371, DOI 10.1016/S1357-2725(97)00086-1; Sherr CJ, 2000, CANCER RES, V60, P3689; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shiffman D, 1996, J BIOL CHEM, V271, P12199, DOI 10.1074/jbc.271.21.12199; Slansky JE, 1996, CURR TOP MICROBIOL, V208, P1; Srivastava BH, 1998, CANCER LETT, V134, P91, DOI 10.1016/S0304-3835(98)00247-X; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Takahashi Y, 2000, GENE DEV, V14, P804; TANGUAY DA, 1994, MOL IMMUNOL, V31, P643, DOI 10.1016/0161-5890(94)90173-2; Tanner MM, 1998, AM J PATHOL, V153, P191, DOI 10.1016/S0002-9440(10)65560-5; Taya Y, 1997, TRENDS BIOCHEM SCI, V22, P14, DOI 10.1016/S0968-0004(96)10070-0; Thomas JW, 1999, MAMM GENOME, V10, P764, DOI 10.1007/s003359901088; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Wang F, 1998, NUCLEIC ACIDS RES, V26, P3044, DOI 10.1093/nar/26.12.3044; Wang WL, 1999, MOL ENDOCRINOL, V13, P1373, DOI 10.1210/me.13.8.1373; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Xie W, 1999, ENDOCRINOLOGY, V140, P219, DOI 10.1210/en.140.1.219; Zhu XL, 1998, MODERN PATHOL, V11, P1082	70	91	94	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22332	22340		10.1074/jbc.M010539200	http://dx.doi.org/10.1074/jbc.M010539200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11297539	hybrid			2022-12-27	WOS:000169412700050
J	Huang, ZM; Cheng, SL; Slatopolsky, E				Huang, ZM; Cheng, SL; Slatopolsky, E			Sustained activation of the extracellular signal-regulated kinase pathway is required for extracellular calcium stimulation of human osteoblast proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; GROWTH-FACTOR; CA2+-SENSING RECEPTOR; SENSING RECEPTORS; (CA-O(2+))-SENSING RECEPTOR; MC3T3-E1 OSTEOBLASTS; CELL-PROLIFERATION; BONE; INHIBITOR; DIFFERENTIATION	Elevated levels of [Ca2+](o) in bone milieu as a result of the resorptive action of osteoclasts are implicated in promoting proliferation and migration of osteoblasts during bone remodeling. However, mitogenic effects of [Ca2+](o) have only been shown in some, but not all, clonal osteoblast-like cells, and the molecular mechanisms underlying [Ca2+](o)-induced mitogenic signaling are largely unknown. In this study we demonstrated for the first time that [Ca2+](o) stimulated proliferation of primary human osteoblasts and selectively activated extracellular signal-regulated kinases (ERKs), Neither p38 mitogen-activated protein (MAP) kinase nor stress-activated protein kinase was activated by [Ca2+](o). Treatment of human osteoblasts with a MAP kinase kinase inhibitor, PD98059, impaired both basal and [Ca2+](o)-stimulated phosphorylation of ERKs and also reduced both basal and [Ca2+](o)-stimulated proliferation. [Ca2+](o) treatment resulted in two distinctive phases of ERK activation: an acute phase and a sustained phase. An inhibition time course revealed that it was the sustained phase, not the acute phase, that was critical for [Ca2+](o)-stimulated osteoblast proliferation. Our results demonstrate that mitogenic responsiveness to [Ca2+](o) is present in primary human osteoblasts and is mediated via prolonged activation of the MAP kinase kinase/ERK signal pathway.	Washington Univ, Sch Med, Dept Med, Div Renal, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, Div Bone & Mineral Dis, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Huang, ZM (corresponding author), Washington Univ, Sch Med, Dept Med, Div Renal, 660 S Euclid Ave,Box 8126, St Louis, MO 63110 USA.				NIDDK NIH HHS [DK-09976, DK-30178, DK-07126] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007126, R01DK030178, P01DK009976] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bost F, 1997, J BIOL CHEM, V272, P33422, DOI 10.1074/jbc.272.52.33422; Brown EM, 1996, KIDNEY INT, V49, P1042, DOI 10.1038/ki.1996.152; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 1999, VITAM HORM, V55, P1; Chang YH, 1999, ENDOCRINOLOGY, V140, P5883, DOI 10.1210/en.140.12.5883; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; COBB MH, 1994, CELL MOL BIOL RES, V40, P253; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Dikic Ivan, 1999, Cell Biochemistry and Biophysics, V30, P369, DOI 10.1007/BF02738120; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; GARRETT JE, 1995, J BIOL CHEM, V270, P12919, DOI 10.1074/jbc.270.21.12919; Godwin SL, 1997, J BIOL CHEM, V272, P11307; Habel B, 1998, EUR BIOPHYS J BIOPHY, V27, P411, DOI 10.1007/s002490050149; Hartle JE, 1996, J BONE MINER RES, V11, P789; HONDA Y, 1995, J BONE MINER RES, V10, P1660; KAHAN C, 1992, J BIOL CHEM, V267, P13369; KANATANI M, 1991, BIOCHEM BIOPH RES CO, V181, P1425, DOI 10.1016/0006-291X(91)92098-5; Katoh S, 1999, BIOCHEM J, V338, P465, DOI 10.1042/0264-6021:3380465; KIMOTO S, 1994, ENDOCRINOLOGY, V135, P2423, DOI 10.1210/en.135.6.2423; Lopez-Ilasaca M, 1998, BIOCHEM PHARMACOL, V56, P269, DOI 10.1016/S0006-2952(98)00059-8; Luttrell LM, 1997, ADV SEC MESS PHOSPH, V31, P263; Maher P, 1999, J BIOL CHEM, V274, P17491, DOI 10.1074/jbc.274.25.17491; McCawley LJ, 1999, J BIOL CHEM, V274, P4347, DOI 10.1074/jbc.274.7.4347; McNeil SE, 1998, J BIOL CHEM, V273, P1114, DOI 10.1074/jbc.273.2.1114; Orsini MJ, 1999, AM J PHYSIOL-LUNG C, V277, pL479, DOI 10.1152/ajplung.1999.277.3.L479; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Quarles LD, 1997, J BONE MINER RES, V12, P1971, DOI 10.1359/jbmr.1997.12.12.1971; QUARLES LD, 1994, J CELL BIOCHEM, V56, P106, DOI 10.1002/jcb.240560115; Quarles LD, 1997, J BONE MINER RES, V12, P393, DOI 10.1359/jbmr.1997.12.3.393; Racke FK, 1997, J BIOL CHEM, V272, P23366, DOI 10.1074/jbc.272.37.23366; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; SUGIMOTO T, 1994, AM J PHYSIOL, V266, pE709, DOI 10.1152/ajpendo.1994.266.5.E709; Sweeney G, 1999, J BIOL CHEM, V274, P10071, DOI 10.1074/jbc.274.15.10071; Yamaguchi T, 1998, J BONE MINER RES, V13, P1530, DOI 10.1359/jbmr.1998.13.10.1530; Yamaguchi T, 1998, ENDOCRINOLOGY, V139, P3561, DOI 10.1210/en.139.8.3561; Yamaguchi T, 1998, BIOCHEM BIOPH RES CO, V243, P753, DOI 10.1006/bbrc.1998.8178; Yamaguchi T, 2001, AM J PHYSIOL-CELL PH, V280, pC382, DOI 10.1152/ajpcell.2001.280.2.C382; ZAIDI M, 1995, J CLIN INVEST, V96, P1582, DOI 10.1172/JCI118197	39	75	79	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21351	21358		10.1074/jbc.M010921200	http://dx.doi.org/10.1074/jbc.M010921200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11292824	hybrid			2022-12-27	WOS:000169297900075
J	Kang, TB; Yi, J; Guo, A; Wang, X; Overall, CM; Jiang, WP; Elde, R; Borregaard, N; Pei, DQ				Kang, TB; Yi, J; Guo, A; Wang, X; Overall, CM; Jiang, WP; Elde, R; Borregaard, N; Pei, DQ			Subcellular distribution and cytokine- and chemokine-regulated secretion of leukolysin/MT6-MMP/MMP-25 in neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; MATRIX-METALLOPROTEINASES; EXPRESSION; COLLAGENASE; GRANULES; IDENTIFICATION; PROGELATINASE; PURIFICATION; FIBROBLASTS; ACTIVATION	Leukolysin, originally isolated from human leukocytes, is the sixth member of the membrane-type matrix metalloproteinase (MT-MMP) subfamily with a potential glycosylphosphatidylinositol (GPI) anchor. To understand its biological functions, we screened subpopulations of leukocytes and localized the expression of leukolysin at the mRNA level to neutrophils. Polyclonal and mono-specific antisera raised against a synthetic peptide from its hinge region recognized a major protein species at 56 kDa and several minor forms between 38 and 45 kDa in neutrophil lysates, In resting neutrophils, leukolysin is distributed among specific granules (similar to 10%), gelatinase granules (similar to 40%), secretory vesicles (similar to 30%), and the plasma membrane (similar to 20%), a pattern distinct from that of neutrophil MMP-8 and MMP-9. Consistent with its membrane localization and its reported GPI anchor, leukolysin partitions into the detergent phase of Triton X-114 and can be released from intact resting neutrophils by glycosylphosphatidylinositol-specific phospholipase C. Phorbol myristate acetate stimulates neutrophils to discharge 100% of leukolysin from specific and gelatinase granules and similar to 50% from the secretory vesicles and plasma membrane, suggesting that leukolysin can be mobilized by physiological signals to the extracellular milieu as a soluble enzyme. Indeed, interleukin 8, a neutrophil chemoattractant, triggered a release of similar to 85% of cellular leukolysins by a process resistant to a mixture of proteinase inhibitors, including aprotinin, BB-94, pepstatin, and E64. Finally, purified recombinant leukolysin can degrade components of the extracellular matrix. These results not only establish leukolysin as the first neutrophil-specific MT-MMP but also implicate it as a cytokine/chemokine-regulated effector during innate immune responses or tissue injury.	Univ Minnesota, Dept Pharmacol, Sch Med, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurosci, Sch Med, Minneapolis, MN 55455 USA; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; R&D Syst, Minneapolis, MN 55413 USA; Natl Univ Hosp, Finsen Ctr, Dept Hematol, Copenhagen, Denmark	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of British Columbia	Pei, DQ (corresponding author), Univ Minnesota, Dept Pharmacol, Sch Med, 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	peixx003@tc.umn.edu	Wang, Xing/G-2917-2015		NATIONAL CANCER INSTITUTE [R29CA076308, R01CA076308] Funding Source: NIH RePORTER; NCI NIH HHS [CA76308] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Betsuyaku T, 1999, AM J RESP CELL MOL, V20, P1303, DOI 10.1165/ajrcmb.20.6.3558; BIRKEDALHANSEN H, 1993, J PERIODONTOL, V64, P474, DOI 10.1902/jop.1993.64.5s.474; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; BRINCKERHOFF C E, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P145; English WR, 2000, J BIOL CHEM, V275, P14046, DOI 10.1074/jbc.275.19.14046; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hanemaaijer R, 1997, J BIOL CHEM, V272, P31504, DOI 10.1074/jbc.272.50.31504; HASTY KA, 1990, J BIOL CHEM, V265, P11421; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; Horejsi V, 1999, IMMUNOL TODAY, V20, P356, DOI 10.1016/S0167-5699(99)01489-9; Itoh Y, 1999, J BIOL CHEM, V274, P34260, DOI 10.1074/jbc.274.48.34260; Kinoshita T, 1997, J BIOCHEM-TOKYO, V122, P251; KJELDSEN L, 1994, BLOOD, V83, P1640, DOI 10.1182/blood.V83.6.1640.bloodjournal8361640; Kojima S, 2000, FEBS LETT, V480, P142, DOI 10.1016/S0014-5793(00)01919-0; LAZARUS GS, 1968, SCIENCE, V159, P1483, DOI 10.1126/science.159.3822.1483; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; MAINARDI CL, 1984, COLLAGEN REL RES, V4, P479; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; MATRISIAN LM, 1994, MOLECULAR AND CELLULAR BASIS FOR CELL TO CELL INTERACTION: ITS SIGNIFICANCE IN CANCER, P152; MURPHY G, 1977, BIOCHEM J, V162, P195, DOI 10.1042/bj1620195; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Parkos CA, 1997, BIOESSAYS, V19, P865, DOI 10.1002/bies.950191006; Pei DQ, 1998, PROTEIN EXPRES PURIF, V13, P277, DOI 10.1006/prep.1998.0894; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; PEI DQ, 1994, J BIOL CHEM, V269, P25849; Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925; Schonermark M, 1996, ACTA OTO-LARYNGOL, V116, P451, DOI 10.3109/00016489609137872; Sengelov H, 1999, J IMMUNOL METHODS, V232, P145, DOI 10.1016/S0022-1759(99)00172-6; Shlopov BV, 1997, ARTHRITIS RHEUM-US, V40, P2065, DOI 10.1002/art.1780401120; TSCHESCHE H, 1995, METHOD ENZYMOL, V248, P431; Velasco G, 2000, CANCER RES, V60, P877; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang X, 1999, FEBS LETT, V462, P261, DOI 10.1016/S0014-5793(99)01534-3; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705	41	97	98	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21960	21968		10.1074/jbc.M007997200	http://dx.doi.org/10.1074/jbc.M007997200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11282999	hybrid			2022-12-27	WOS:000169297900151
J	Wang, T; Arifoglu, P; Ronai, Z; Tew, KD				Wang, T; Arifoglu, P; Ronai, Z; Tew, KD			Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; H2O2-INDUCED CELL-DEATH; TRANSCRIPTION FACTOR; TRANSDUCTION; APOPTOSIS; PATHWAY; DOMAIN; ATF2; P53	c-Jun N-terminal kinase (JNK)-mediated cell signaling pathways are regulated endogenously in part by protein-protein interactions with glutathione S-transferase P1-1 (GSTP1-1) (1). Using purified recombinant proteins, combined with fluorescence resonance energy transfer technology, we have found that the C terminus of JNK is critical to the interaction with GSTP1-1. The apparent K-d for full-length JNK was 188 nM and for a C-terminal fragment (residues 200-424) 217 nM. An N-terminal fragment (residues 1-206) did not bind to GSTP1-1. Increased expression of the C-terminal JNK fragment in a tetracycline-inducible transfected NIH3T3 cell line produced a concentration-dependent increase in the kinase activity of JNK under normal, unstressed growth conditions indicating a dominant-negative effect. This suggests that the fragment can compete with endogenous full-length functional JNK resulting in dissociation of the GSTP1-1-JNK interaction and concomitant JNK enzyme activation. By using an antibody to hemagglutinin-tagged C-JNK, a concentration-dependent co-immunoprecipitation of GSTP1-1 was achieved. These data provide evidence for direct interactions between the C-terminal of JNK and GSTP1-1 and a rationale for considering GSTP1-1 as a critical ligand-binding protein with a role in regulating kinase pathways.	Fox Chase Canc Ctr, Dept Pharmacol, Philadelphia, PA 19111 USA; CUNY Mt Sinai Sch Med, Ruttenberg Canc Ctr, New York, NY 10029 USA	Fox Chase Cancer Center; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Tew, KD (corresponding author), Fox Chase Canc Ctr, Dept Pharmacol, 7701 Burholme Ave, Philadelphia, PA 19111 USA.			RONAI, ZEEV/0000-0002-3859-0400	NATIONAL CANCER INSTITUTE [R01CA085660, R01CA077389, P30CA006927] Funding Source: NIH RePORTER; NCI NIH HHS [CA06927, CA85660, CA77389] Funding Source: Medline; NCRR NIH HHS [RR05539] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Bernardini S, 2000, J CELL BIOCHEM, V77, P645, DOI 10.1002/(SICI)1097-4644(20000615)77:4<645::AID-JCB12>3.3.CO;2-0; Buschmann T, 2000, J BIOL CHEM, V275, P16590, DOI 10.1074/jbc.M910045199; CHO SG, 2001, IN PRESS J BIOL CHEM; Davis W, 2001, J PHARMACOL EXP THER, V296, P1; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; GARCIASAEZ I, 1994, J MOL BIOL, V237, P298, DOI 10.1006/jmbi.1994.1232; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Janknecht R, 1997, J BIOL CHEM, V272, P4219, DOI 10.1074/jbc.272.7.4219; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; MERELO JJ, 1994, NEUROCOMPUTING, V6, P443, DOI 10.1016/0925-2312(94)90021-3; Meyer CF, 1996, J BIOL CHEM, V271, P8971, DOI 10.1074/jbc.271.15.8971; Monaco R, 1999, J PROTEIN CHEM, V18, P859, DOI 10.1023/A:1020679229110; Morgan AS, 1996, CANCER CHEMOTH PHARM, V37, P363, DOI 10.1007/s002800050398; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; TEW KD, 1994, CANCER RES, V54, P4313; Wang T, 1999, P NATL ACAD SCI USA, V96, P7843, DOI 10.1073/pnas.96.14.7843; Wang TL, 2000, J BIOL CHEM, V275, P7466, DOI 10.1074/jbc.275.11.7466; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Xie XL, 1998, STRUCTURE, V6, P983, DOI 10.1016/S0969-2126(98)00100-2; Yin ZM, 2000, CANCER RES, V60, P4053	24	255	258	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20999	21003		10.1074/jbc.M101355200	http://dx.doi.org/10.1074/jbc.M101355200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279197	hybrid			2022-12-27	WOS:000169297900028
J	Sidis, Y; Schneyer, AL; Sluss, PM; Johnson, LN; Keutmann, HT				Sidis, Y; Schneyer, AL; Sluss, PM; Johnson, LN; Keutmann, HT			Follistatin: Essential role for the N-terminal domain in activin binding and neutralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MORPHOGENETIC PROTEIN; EARLY XENOPUS EMBRYO; CELL-LINE PA-1; II RECEPTORS; HEPARAN-SULFATE; GROWTH-FACTOR; INHIBIN; AGRIN; SITE; IDENTIFICATION	Follistatin is recognized to be an important regulator of cellular differentiation and secretion through its potent ability to bind and bioneutralize activin with which it is colocalized in many tissue systems. The 288-residue follistatin molecule is comprised of a 63-residue N-terminal segment followed by three repeating 10-cysteine "follistatin domains" also represented in several extracellular matrix proteins. We have used chemical modifications and mutational analyses to define structural requirements for follistatin bioactivity that previously have not been investigated systematically. Mutant follistatins were stably expressed fi om Chinese hamster ovary cell cultures and assayed for activin binding in a solid-phase competition assay. Biological activities were determined by inhibition of activin-mediated transcriptional activity and by suppression of follicle-stimulating hormone secretion by cultured anterior pituitary cells. Deletion of the entire N-terminal domain, disruption of N-terminal disulfides, and deletion of the first two residues each reduced activin binding to <5 % of expressed wild-type follistatin and abolished the ability of the respective mutants to suppress activin-mediated responses in both bioassay systems. Hence, the three follistatin domains inherently lack the ability to bind or neutralize activin. Activin binding was impaired after oxidation of at least one tryptophan, at position 4, in FS-288, Mutation of Trp to Ala or Asp at either positions 4 or 36 eliminated activin binding and bioactivity, Mutation of a third hydrophobic residue, Phe-52, reduced binding to 20% whereas substitutions for the individual Lys and Arg residues in the N-terminal region were tolerated. These results establish that hydrophobic residues within the N-terminal domain constitute essential activin-binding determinants in the follistatin molecule. The correlation among the effects of mutation on activin binding, activin transcriptional responses, and follicle-stimulating hormone secretion substantiates the concept that, at least in the pituitary, the biological activity of follistatin is attributable to its ability to bind and bioneutralize activin.	Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Natl Ctr Infertil Res, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Keutmann, HT (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Wellman 501, Boston, MA 02114 USA.	Keutmann@helix.mgh.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053828] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-53828] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLIEL PM, 1993, EUR J BIOCHEM, V214, P347, DOI 10.1111/j.1432-1033.1993.tb17930.x; Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41; Busch E, 2000, J BIOL CHEM, V275, P25508, DOI 10.1074/jbc.M001770200; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Delbaere A, 1999, ENDOCRINOLOGY, V140, P2463, DOI 10.1210/en.140.6.2463; Denzer AJ, 1998, EMBO J, V17, P335, DOI 10.1093/emboj/17.2.335; DePaolo LV, 1997, P SOC EXP BIOL MED, V214, P328; deWinter JP, 1996, MOL CELL ENDOCRINOL, V116, P105, DOI 10.1016/0303-7207(95)03705-5; DYSON HJ, 1992, J MOL BIOL, V226, P795, DOI 10.1016/0022-2836(92)90633-U; Eib DW, 1996, J NEUROCHEM, V67, P1047; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; FEDERMAN S, 2000, P 22 ANN M AM SOC BO; Gamer LW, 1999, DEV BIOL, V208, P222, DOI 10.1006/dbio.1998.9191; Gray PC, 2000, J BIOL CHEM, V275, P3206, DOI 10.1074/jbc.275.5.3206; Greenwald J, 1999, NAT STRUCT BIOL, V6, P18; Haaijman A, 1997, J BONE MINER RES, V12, P1815, DOI 10.1359/jbmr.1997.12.11.1815; Hashimoto O, 1997, J BIOL CHEM, V272, P13835, DOI 10.1074/jbc.272.21.13835; Hayette S, 1998, ONCOGENE, V16, P2949, DOI 10.1038/sj.onc.1201807; Hohenester E, 1997, EMBO J, V16, P3778, DOI 10.1093/emboj/16.13.3778; HUANG HJ, 2001, IN PRESS ENDOCRINOLO; Iemura S, 1999, J BIOL CHEM, V274, P26843, DOI 10.1074/jbc.274.38.26843; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; INOUYE S, 1991, BIOCHEM BIOPH RES CO, V179, P352, DOI 10.1016/0006-291X(91)91377-O; INOUYE S, 1992, MOL CELL ENDOCRINOL, V90, P1, DOI 10.1016/0303-7207(92)90094-M; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; LANE TF, 1990, J CELL BIOL, V111, P3065, DOI 10.1083/jcb.111.6.3065; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; McConnell DS, 1998, J CLIN ENDOCR METAB, V83, P851, DOI 10.1210/jc.83.3.851; MERIGGIOLA MC, 1994, ENDOCRINOLOGY, V134, P1967, DOI 10.1210/en.134.4.1967; MICHEL U, 1993, MOL CELL ENDOCRINOL, V91, P1, DOI 10.1016/0303-7207(93)90248-I; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; NEUMANN NP, 1962, BIOCHEMISTRY-US, V1, P68, DOI 10.1021/bi00907a011; PATTHY L, 1993, TRENDS NEUROSCI, V16, P76, DOI 10.1016/0166-2236(93)90021-D; Peng C, 2000, BIOCHEM CELL BIOL, V78, P261, DOI 10.1139/bcb-78-3-261; PURNANANDA G, 1992, BIOCHEMISTRY-US, V31, P4296; SCHNEYER A, 2001, IN PRESS MOL CELL EN; SCHNEYER AL, 1994, ENDOCRINOLOGY, V135, P667, DOI 10.1210/en.135.2.667; SCOTT RS, 1980, ENDOCRINOLOGY, V107, P1536, DOI 10.1210/endo-107-5-1536; SHIMASAKI S, 1988, P NATL ACAD SCI USA, V85, P4218, DOI 10.1073/pnas.85.12.4218; TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; Uchida T, 1999, BIOCHEM BIOPH RES CO, V266, P593, DOI 10.1006/bbrc.1999.1873; VALE W, 1988, RECENT PROG HORM RES, V44, P1; Wang QF, 2000, ENDOCRINOLOGY, V141, P3183, DOI 10.1210/en.141.9.3183; Wang QF, 1996, J CLIN ENDOCR METAB, V81, P1434, DOI 10.1210/jc.81.4.1434; WANG QF, 2000, INT C BON MORPH PROT, P30; Wozney JM, 1998, CLIN ORTHOP RELAT R, P26; Wuytens G, 1999, J BIOL CHEM, V274, P9821, DOI 10.1074/jbc.274.14.9821; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201	50	57	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17718	17726		10.1074/jbc.M100736200	http://dx.doi.org/10.1074/jbc.M100736200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279126	hybrid			2022-12-27	WOS:000168866500015
J	Vilar, M; Esteve, V; Pallas, V; Marcos, JF; Perez-Paya, E				Vilar, M; Esteve, V; Pallas, V; Marcos, JF; Perez-Paya, E			Structural properties of carnation mottle virus p7 movement protein and its RNA-binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOBACCO MOSAIC-VIRUS; CELL-TO-CELL; ALPHA-HELIX STABILITY; SINGLE-STRANDED-DNA; SUBCELLULAR-LOCALIZATION; VIRAL MOVEMENT; AMINO-ACIDS; ENDOPLASMIC-RETICULUM; CIRCULAR-DICHROISM; TRANSGENIC PLANTS	Plant viral movement proteins (MPs) participate actively in the intra- and intercellular movement of RNA plant viruses to such an extent that MP dysfunction impairs viral infection. However, the molecular mechanism(s) of their interaction with cognate nucleic acids are not well understood, partly due to the lack of structural information. In this work, a protein dissection approach was used to gain information on the structural and RNA-binding properties of this class of proteins, as exemplified by the 61-amino acid residue p7 MP from carnation mottle virus (CarMV). Circular dichroism spectroscopy showed that CarMV p7 is an alpha/beta RNA-binding soluble protein. Using synthetic peptides derived from the p7 sequence, we have identified three distinct putative domains within the protein. EMSA showed that the central region, from residue 17 to 35 (represented by peptide p(17-35)), is responsible for the RNA binding properties of CarMV p7, This binding peptide populates a nascent alpha -helix in water solution that is further stabilized in the presence of either secondary structure inducers, such as trifluoroethanol and monomeric SDS, or RNA (which also changes its conformation upon binding to the peptide). Thus, the RNA recognition appears to occur via an "adaptive binding" mechanism. Interestingly, the amino acid sequence and structural properties of the RNA-binding domain of p7 seem to be conserved among carmoviruses and some other RNA-binding proteins and peptides, The low conserved N terminus of p7 (peptide p7(1-16)) is unstructured in solution. In contrast, the highly conserved C terminus motif (peptide p7(40-61)) adopts a beta -sheet conformation in aqueous solution. Alanine scanning mutagenesis of the RNA-binding motif showed how selected positive charged amino acids are more relevant than others in the RNA binding process and how hydrophobic amino acid side chains would participate in the stabilization of the protein-RNA complex.	Univ Valencia, Dept Bioquim & Biol Mol, E-46100 Valencia, Spain; Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46022 Valencia, Spain; CSIC, Inst Agroquim & Tecnol Alimentos, Dept Ciencia Alimentos, E-46100 Valencia, Spain	University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Perez-Paya, E (corresponding author), Univ Valencia, Dept Bioquim & Biol Mol, E-46100 Valencia, Spain.	paya@uv.es	Marcos, Jose F./A-7121-2011; Pallas, Vicente/N-1317-2014; Vilar, Marçal/B-4581-2016; Esteve, Vicent/I-2728-2015	Marcos, Jose F./0000-0003-3339-2584; Pallas, Vicente/0000-0003-4954-989X; Vilar, Marçal/0000-0002-9376-6544; Esteve, Vicent/0000-0003-4740-0936				Antson AA, 2000, CURR OPIN STRUC BIOL, V10, P87, DOI 10.1016/S0959-440X(99)00054-8; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; BERNA A, 1991, VIROLOGY, V182, P682, DOI 10.1016/0042-6822(91)90609-F; BLONDELLE SE, 1995, BIOPHYS J, V68, P351, DOI 10.1016/S0006-3495(95)80194-3; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Brill LM, 2000, P NATL ACAD SCI USA, V97, P7112, DOI 10.1073/pnas.130187897; Cai ZP, 1998, NAT STRUCT BIOL, V5, P203, DOI 10.1038/nsb0398-203; Carrington JC, 1996, PLANT CELL, V8, P1669, DOI 10.1105/tpc.8.10.1669; CHEN L, 1994, BIOCHEMISTRY-US, V33, P2708, DOI 10.1021/bi00175a046; CITOVSKY V, 1990, CELL, V60, P637, DOI 10.1016/0092-8674(90)90667-4; DALY TJ, 1990, BIOCHEMISTRY-US, V29, P9791, DOI 10.1021/bi00494a005; DEOM CM, 1987, SCIENCE, V237, P389, DOI 10.1126/science.237.4813.389; DEOM CM, 1990, P NATL ACAD SCI USA, V87, P3284, DOI 10.1073/pnas.87.9.3284; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; FRANKEL AD, 1992, P NATL ACAD SCI USA, V89, P11653, DOI 10.1073/pnas.89.24.11653; GIESMANCOOKMEYER D, 1993, PLANT CELL, V5, P973, DOI 10.1105/tpc.5.8.973; HACKER DL, 1992, VIROLOGY, V186, P1, DOI 10.1016/0042-6822(92)90055-T; Hefferon KL, 1997, ARCH VIROL, V142, P425, DOI 10.1007/s007050050089; Heinlein M, 1998, PLANT CELL, V10, P1107, DOI 10.1105/tpc.10.7.1107; HEINLEIN M, 1995, SCIENCE, V270, P1983, DOI 10.1126/science.270.5244.1983; Jackson D, 2000, CURR OPIN PLANT BIOL, V3, P394, DOI 10.1016/S1369-5266(00)00102-3; Jorgensen RA, 1998, SCIENCE, V279, P1486, DOI 10.1126/science.279.5356.1486; Kahn TW, 1998, PLANT J, V15, P15, DOI 10.1046/j.1365-313X.1998.00172.x; KNEALE GG, 1992, CURR OPIN STRUC BIOL, V2, P124; KOONIN EV, 1991, J GEN VIROL, V72, P2895, DOI 10.1099/0022-1317-72-12-2895; LAPIDOT M, 1993, PLANT J, V4, P959, DOI 10.1046/j.1365-313X.1993.04060959.x; Leisner S. M., 1999, MOL BIOL PLANT VIRUS, P161; Li VZ, 1998, VIROLOGY, V244, P405, DOI 10.1006/viro.1998.9125; Marcos JF, 1999, VIROLOGY, V255, P354, DOI 10.1006/viro.1998.9596; Mas P, 1999, J CELL BIOL, V147, P945, DOI 10.1083/jcb.147.5.945; McLean BG, 1995, PLANT CELL, V7, P2101, DOI 10.1105/tpc.7.12.2101; Melcher U, 2000, J GEN VIROL, V81, P257, DOI 10.1099/0022-1317-81-1-257; MESHI T, 1987, EMBO J, V6, P2557, DOI 10.1002/j.1460-2075.1987.tb02544.x; MULLER L, 1979, J AM CHEM SOC, V101, P4481; MUNOZ V, 1994, PROTEINS, V20, P301, DOI 10.1002/prot.340200403; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; MUSHEGIAN AR, 1993, ARCH VIROL, V133, P239, DOI 10.1007/BF01313766; Oliver AW, 1999, BIOCHEM J, V339, P525, DOI 10.1042/0264-6021:3390525; Padidam M, 1999, J VIROL, V73, P1609, DOI 10.1128/JVI.73.2.1609-1616.1999; Pallas V, 1998, METH MOL B, V81, P461; PEREZPAYA E, 1995, J BIOL CHEM, V270, P1048, DOI 10.1074/jbc.270.3.1048; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; PLYTE SE, 1991, PROTEIN ENG, V4, P553, DOI 10.1093/protein/4.5.553; Qu F, 1999, ENCY VIROLOGY, P243; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; ROULEAU M, 1994, VIROLOGY, V204, P254, DOI 10.1006/viro.1994.1530; RUSSO M, 1994, ADV VIRUS RES, V44, P381, DOI 10.1016/S0065-3527(08)60334-6; SERRANO L, 1992, J MOL BIOL, V227, P544, DOI 10.1016/0022-2836(92)90906-Z; SERRANO L, 1989, NATURE, V342, P296, DOI 10.1038/342296a0; Soengas MS, 1997, J BIOL CHEM, V272, P303; Su LL, 1997, BIOCHEMISTRY-US, V36, P12722, DOI 10.1021/bi971408k; TAN RY, 1995, P NATL ACAD SCI USA, V92, P5282, DOI 10.1073/pnas.92.12.5282; TAN RY, 1992, BIOCHEMISTRY-US, V31, P10288, DOI 10.1021/bi00157a016; TAN RY, 1994, BIOCHEMISTRY-US, V33, P14579, DOI 10.1021/bi00252a025; TAN RY, 1993, CELL, V73, P1031, DOI 10.1016/0092-8674(93)90280-4; VANDERGRAAF M, 1992, BIOCHEMISTRY-US, V31, P9177, DOI 10.1021/bi00153a009; Waigmann E, 1995, PLANT CELL, V7, P2069; WAIGMANN E, 1994, P NATL ACAD SCI USA, V91, P1433, DOI 10.1073/pnas.91.4.1433; Weiss MA, 1998, BIOPOLYMERS, V48, P167, DOI 10.1002/(SICI)1097-0282(1998)48:2<167::AID-BIP6>3.0.CO;2-8; Wobbe KK, 1998, J VIROL, V72, P6247, DOI 10.1128/JVI.72.7.6247-6250.1998; WOLF S, 1989, SCIENCE, V246, P377, DOI 10.1126/science.246.4928.377; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xoconostle-Cazares B, 1999, SCIENCE, V283, P94, DOI 10.1126/science.283.5398.94	66	29	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18122	18129		10.1074/jbc.M100706200	http://dx.doi.org/10.1074/jbc.M100706200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279121	hybrid			2022-12-27	WOS:000168866500069
J	Graschopf, A; Stadler, JA; Hoellerer, MK; Eder, S; Sieghardt, M; Kohlwein, SD; Schweyen, RJ				Graschopf, A; Stadler, JA; Hoellerer, MK; Eder, S; Sieghardt, M; Kohlwein, SD; Schweyen, RJ			The yeast plasma membrane protein Alr1 controls Mg2+ homeostasis and is subject to Mg2+-dependent control of its synthesis and degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; INDUCED INACTIVATION; MAGNESIUM TRANSPORT; URACIL PERMEASE; CELLULAR MG2+; BUDDING YEAST; ENDOCYTOSIS; GENE; UBIQUITINATION; LOCALIZATION	The Saccharomyces cerevisiae ALR1 (YOL130w) gene product Alr1p is the first known candidate for a Mg2+ transport system in eukaryotic cells and is distantly related to the bacterial CorA Mg2+ transporter family. Here we provide the first experimental evidence for the location of Alr1p in the yeast plasma membrane and for the tight control of its expression and turnover by Mg2+. Using well characterized npi1 and end3 mutants deficient in the endocytic pathway, we demonstrate that Alr1 protein turnover is dependent on ubiquitination and endocytosis. Furthermore, cells lacking the vacuolar protease Pep4p accumulated Alr1p in the vacuole. Mutants lacking Alr1p (Delta alr1) showed a 60% reduction of total intracellular Mg2+ compared with the wild type and failed to grow in standard media. When starved of Mg2+, mutant and wild-type cells had similar low levels of intracellular Mg2+; but upon addition of Mg2+, wild-type cells replenished the intracellular Mg2+ pool within a few hours, whereas Delta alr1 mutant cells did not. Expression of the bacterial Mg2+ transporter CorA in the yeast Delta alr1 mutant partially restored growth in standard media. The results are discussed in terms of Alr1p being a plasma membrane transporter with high selectivity for Mg2+.	Univ Vienna, Inst Microbiol & Genet, Vienna Bioctr, A-1030 Vienna, Austria; Graz Tech Univ, Dept Biochem, Biomembrane Res Ctr SFB, A-8010 Graz, Austria; Univ Agr Sci, Inst Forest Ecol, A-1180 Vienna, Austria	University of Vienna; Vienna Biocenter (VBC); Graz University of Technology; University of Natural Resources & Life Sciences, Vienna	Schweyen, RJ (corresponding author), Univ Vienna, Inst Microbiol & Genet, Vienna Bioctr, Waehringer Guertel 18, A-1030 Vienna, Austria.		Graschopf, Anton/C-5637-2008	Kohlwein, Sepp Dieter/0000-0002-1030-0598				BEELER T, 1994, J BIOL CHEM, V269, P7279; Beeler T, 1997, BBA-BIOMEMBRANES, V1323, P310, DOI 10.1016/S0005-2736(96)00199-X; BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023, DOI 10.1091/mbc.5.9.1023; BERKOWER C, 1994, MOL BIOL CELL, V5, P1185, DOI 10.1091/mbc.5.11.1185; Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Cefaratti C, 1998, AM J PHYSIOL-CELL PH, V275, pC995, DOI 10.1152/ajpcell.1998.275.4.C995; Cefaratti C, 2000, J BIOL CHEM, V275, P3772, DOI 10.1074/jbc.275.6.3772; Chiang HL, 1996, J BIOL CHEM, V271, P9934, DOI 10.1074/jbc.271.17.9934; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Fatholahi M, 2000, ARCH BIOCHEM BIOPHYS, V374, P395, DOI 10.1006/abbi.1999.1619; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; Gregan J, 2001, MOL GEN GENET, V264, P773, DOI 10.1007/s004380000366; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; GUNTHER T, 1995, BBA-BIOMEMBRANES, V1234, P105, DOI 10.1016/0005-2736(94)00267-S; GUNTHER T, 1993, MINER ELECTROL METAB, V19, P259; Jarosch E, 1996, J BIOL CHEM, V271, P17219, DOI 10.1074/jbc.271.29.17219; JONES EW, 1982, GENETICS, V102, P665; Kohlwein SD, 2000, MICROSC RES TECHNIQ, V51, P511, DOI 10.1002/1097-0029(20001215)51:6<511::AID-JEMT3>3.3.CO;2-P; Liu XF, 1999, J BIOL CHEM, V274, P4863, DOI 10.1074/jbc.274.8.4863; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; MacDiarmid CW, 1998, J BIOL CHEM, V273, P1727, DOI 10.1074/jbc.273.3.1727; Medintz I, 1996, J BACTERIOL, V178, P2245, DOI 10.1128/jb.178.8.2245-2254.1996; Nelson N, 1999, EMBO J, V18, P4361, DOI 10.1093/emboj/18.16.4361; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; RODRIGUEZNAVARRO A, 1979, BIOCHIM BIOPHYS ACTA, V552, P322, DOI 10.1016/0005-2736(79)90286-4; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Schweigel M, 2000, AM J PHYSIOL-GASTR L, V278, pG400, DOI 10.1152/ajpgi.2000.278.3.G400; Shaul O, 1999, EMBO J, V18, P3973, DOI 10.1093/emboj/18.14.3973; SHERMAN F, 1991, METHOD ENZYMOL, V94, P3; Smith RL, 1998, MOL MICROBIOL, V28, P217, DOI 10.1046/j.1365-2958.1998.00810.x; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Tashiro M, 1997, BIOPHYS J, V73, P3371, DOI 10.1016/S0006-3495(97)78361-9; VanDenHazel HB, 1996, YEAST, V12, P1, DOI 10.1002/(SICI)1097-0061(199601)12:1<1::AID-YEA902>3.0.CO;2-N; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WALKER GM, 1986, MAGNESIUM, V5, P9; Wendland B, 1998, CURR OPIN CELL BIOL, V10, P513, DOI 10.1016/S0955-0674(98)80067-7; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Zhao H, 1998, J BIOL CHEM, V273, P28713, DOI 10.1074/jbc.273.44.28713	42	98	101	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16216	16222		10.1074/jbc.M101504200	http://dx.doi.org/10.1074/jbc.M101504200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279208	hybrid			2022-12-27	WOS:000168623100087
J	Mehta, S; Wu, HJ; Garner, CC; Marshall, J				Mehta, S; Wu, HJ; Garner, CC; Marshall, J			Molecular mechanisms regulating the differential association of kainate receptor subunits with SAP90/PSD-95 and SAP97	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPSE-ASSOCIATED PROTEIN; TUMOR-SUPPRESSOR PROTEIN; KINASE-LIKE DOMAIN; POSTSYNAPTIC DENSITY; INTRAMOLECULAR INTERACTION; TYROSINE KINASE; SH3 DOMAINS; PSD-95; BINDING; FAMILY	Recent studies have demonstrated that kainate receptors are associated with members of the SAP90/PSD-95 family (synapse-associated proteins (SAPs)) in neurons and that SAP90 can cluster and modify the electrophysiological properties of GluR6/KA2 kainate receptors when co-expressed in transfected cells. In vivo, SAP90 tightly binds kainate receptor subunits, while SAP97 is only weakly associated, suggesting that this glutamate receptor differentially associates with SAP90/PSD-95 family members. Here, green fluorescent protein (GFP)-tagged chimeras and deletion mutants of SAP97 and SAP90 were employed to define the molecular mechanism underlying their differential association with kainate receptors. Our results show that a weak interaction between GluR6 and the PDZ1 domain of SAP97 can account for the weak association of GluR6 with the full-length SAP97 observed in vivo, Expression studies in HEK293 cells and in vitro binding studies further show that although the individual Src homology 3 and guanylate kinase domains in SAP97 can interact with the C-terminal tail of KA2 subunit, specific intramolecular interactions in SAP97 (e.g. the SAP97 N terminus (S97N) binding to the Src homology 3 domain) interfere with KA2 binding to the full-length molecule. Because receptor subunits are known to segregate to different parts of the neuron, our results imply that differential association of kainate receptors with SAP family proteins may be one mechanism of subcellular localization.	Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA	Brown University; University of Alabama System; University of Alabama Birmingham	Marshall, J (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.			Garner, Craig/0000-0003-1970-5417	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD032901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG006569, R01AG012978] Funding Source: NIH RePORTER; NIA NIH HHS [AG 12978-02, AG 06569-09, AG12978-02] Funding Source: Medline; NICHD NIH HHS [P50 HD32901] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Craven SE, 2000, J BIOL CHEM, V275, P20045, DOI 10.1074/jbc.M910153199; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Kuhlendahl S, 1998, EUR J BIOCHEM, V252, P305, DOI 10.1046/j.1432-1327.1998.2520305.x; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; MAYER BJ, 1995, CURR BIOL, V5, P364, DOI 10.1016/S0960-9822(95)00073-X; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Sheng M, 1999, ANN NY ACAD SCI, V868, P483, DOI 10.1111/j.1749-6632.1999.tb11317.x; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; WENG ZG, 1995, MOL CELL BIOL, V15, P5627; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Wu HJ, 1998, J CELL SCI, V111, P2365	28	60	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16092	16099		10.1074/jbc.M100643200	http://dx.doi.org/10.1074/jbc.M100643200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279111	hybrid			2022-12-27	WOS:000168623100072
J	Xie, D; Miller, CW; O'Kelly, J; Nakachi, K; Sakashita, A; Said, JW; Gornbein, J; Koeffler, HP				Xie, D; Miller, CW; O'Kelly, J; Nakachi, K; Sakashita, A; Said, JW; Gornbein, J; Koeffler, HP			Breast cancer - Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE GROWTH-FACTOR; IMMEDIATE-EARLY GENE; VEIN ENDOTHELIAL-CELLS; INTEGRIN ALPHA(V)BETA(3); NOV PROTOONCOGENE; TUMOR-GROWTH; IN-VIVO; EXPRESSION; ADHESION; PRODUCT	To identify genes involved in breast cancer, polymerase chain reaction-selected cDNA subtraction was utilized to construct a breast cancer-subtracted library. Differential screening of the library isolated the growth factor-inducible immediate-early gene Cyr61, a secreted, cysteine-rich, heparin binding protein that promotes endothelial cell adhesion, migration, and neovascularization, Northern analysis revealed that Cyr61 was expressed highly in the invasive breast cancer cell lines MDA-MB-231, T47D, and MDA-MB-157; very low levels were found in the less tumorigenic MCF-7 and BT-20 breast cancer cells and barely detectable amounts were expressed in the normal breast cells, MCF-12A, Univariate analysis showed a significant or borderline significant association between Cyr61 expression and stage, tumor size, lymph node positivity, age, and estrogen receptor levels. Interestingly, expression of Cyr61 mRNA increased 8- to 12-fold in MCF-12A and 3- to 5-fold in MCF-7 cells after 24 and 48-h exposure to estrogen, respectively. Induction of Cyr61 mRNA was blocked by tamoxifen and ICI182,780, inhibitors of the estrogen receptor. Stable expression of Cyr61 cDNA under the regulation of a constitutive promoter in MCF-7 cells enhanced anchorage independent cell growth in soft agar and significantly increased tumorigenicity and vascularization of these tumors in nude mice. Moreover, overexpression of Cyr61 in MCF-12A normal breast cells induced their tumor formation and vascularization in nude mice. In summary, these results suggest that Cyr61 may play a role in the progression of breast cancer and may be involved in estrogen-mediated tumor development.	Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol Oncol, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Sch Med, Dept Pathol, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Sch Med, Dept Biomath, Los Angeles, CA 90048 USA; Saitama Canc Ctr, Ina, Saitama 362, Japan	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Xie, D (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol Oncol, Los Angeles, CA 90048 USA.			Xie, Dong/0000-0002-1150-8657				ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; FANTL V, 1990, EUR J CANCER, V26, P423, DOI 10.1016/0277-5379(90)90009-I; Frazier KS, 1997, INT J BIOCHEM CELL B, V29, P153, DOI 10.1016/S1357-2725(96)00127-6; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GUSTERSON BA, 1988, BRIT J CANCER, V58, P453, DOI 10.1038/bjc.1988.239; Hartmann A, 1997, TRENDS GENET, V13, P27, DOI 10.1016/S0168-9525(96)10043-3; Hashimoto Y, 1998, J EXP MED, V187, P289, DOI 10.1084/jem.187.3.289; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 1996, DEV BIOL, V180, P402, DOI 10.1006/dbio.1996.0314; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; KLAGSBRUN M, 1991, ANNU REV PHYSIOL, V53, P217, DOI 10.1146/annurev.physiol.53.1.217; Kolesnikova TV, 1998, ONCOGENE, V16, P747, DOI 10.1038/sj.onc.1201572; Kubo M, 1998, BRIT J DERMATOL, V139, P192; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; MARTINERIE C, 1994, ONCOGENE, V9, P2729; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MUNKER R, 1986, J CLIN INVEST, V78, P424, DOI 10.1172/JCI112593; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; RAMACHANDRA S, 1990, J PATHOL, V161, P7, DOI 10.1002/path.1711610104; Rivera-Gonzalez R, 1998, J STEROID BIOCHEM, V64, P13, DOI 10.1016/S0960-0760(97)00142-8; Ross JS, 1999, SEMIN CANCER BIOL, V9, P125, DOI 10.1006/scbi.1998.0083; Scholz G, 1996, MOL CELL BIOL, V16, P481; Tsai MS, 2000, CANCER RES, V60, P5603; Varner J., 1997, REGULATION ANGIOGENE, P361; Wenger C, 1999, ONCOGENE, V18, P1073, DOI 10.1038/sj.onc.1202395; Wong M, 1997, DEV BIOL, V192, P492, DOI 10.1006/dbio.1997.8766; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xu LF, 2000, GENE DEV, V14, P585; Zhang R, 1998, MOL CELL BIOL, V18, P6131, DOI 10.1128/MCB.18.10.6131	39	136	143	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14187	14194		10.1074/jbc.M009755200	http://dx.doi.org/10.1074/jbc.M009755200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11297518	hybrid			2022-12-27	WOS:000168356600091
J	Minic, Z; Simon, V; Penverne, B; Gaill, F; Herve, G				Minic, Z; Simon, V; Penverne, B; Gaill, F; Herve, G			Contribution of the bacterial endosymbiont to the biosynthesis of pyrimidine nucleotides in the deep-sea tube worm Riftia pachyptila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA SEQUENCES; ESCHERICHIA-COLI; GLUTAMINE-SYNTHETASE; CHEMOAUTOTROPHIC SYMBIONTS; ASPARTATE-TRANSCARBAMYLASE; MULTIFUNCTIONAL PROTEIN; NITRATE RESPIRATION; CELLS; JONES; PURIFICATION	The deep-sea tube worm Riftia pachyptila (Vestimentifera) from hydrothermal vents lives in an intimate symbiosis with a sulfur-oxidizing bacterium. That involves specific interactions and obligatory metabolic exchanges between the two organisms. In this work, we analyzed the contribution of the two partners to the biosynthesis of pyrimidine nucleotides through both the "de novo" and "salvage" pathways. The first three enzymes of the de novo pathway, carbamyl-phosphate synthetase, aspartate transcarbamylase, and dihydroorotase, were present only in the trophosome, the symbiont-containing tissue. The study of these enzymes in terms of their catalytic and regulatory properties in both the trophosome and the isolated symbiotic bacteria provided a clear indication of the microbial origin of these enzymes. In contrast, the succeeding enzymes of this de novo pathway, dihydroorotate dehydrogenase and orotate phosphoribosyltransferase, were present in all body parts of the worm. This finding indicates that the animal is fully dependent on the symbiont for the de novo biosynthesis of pyrimidines. In addition, it suggests that the synthesis of pyrimidines in other tissues is possible from the intermediary metabolites provided by the trophosomal tissue and from nucleic acid degradation products since the enzymes of the salvage pathway appear to be present in all tissues of the worm. Analysis of these salvage pathway enzymes in the trophosome strongly suggested that these enzymes belong to the worm. In accordance with this conclusion, none of these enzyme activities was found in the isolated bacteria. The enzymes involved in the production of the precursors of carbamyl phosphate and nitrogen assimilation, glutamine synthetase and nitrate reductase, were also investigated, and it appears that these two enzymes are present in the bacteria.	Univ Paris 06, CNRS, UMR 7631, Lab Biochim Signaux Regulateurs Cellulaires & Mol, F-75006 Paris, France; Univ Paris 06, CNRS UPR Roscoff 9042, Inst Natl Sci Univers, Biol Marine Lab, F-75252 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Herve, G (corresponding author), Univ Paris 06, CNRS, UMR 7631, Lab Biochim Signaux Regulateurs Cellulaires & Mol, 96 Blvd Raspail, F-75006 Paris, France.		Minic, Zoran/AAH-2091-2021					AITKEN DM, 1975, CAN J BIOCHEM CELL B, V53, P721, DOI 10.1139/o75-099; ARP AJ, 1981, SCIENCE, V213, P342, DOI 10.1126/science.213.4505.342; BENDER RA, 1977, J BACTERIOL, V129, P1001, DOI 10.1128/JB.129.2.1001-1009.1977; BOSH C, 1984, C R ACAD SCI 3, V299, P413; BOSH C, 1984, C R ACAD SCI 3, V299, P371; Boza JJ, 2000, EUR J NUTR, V39, P38, DOI 10.1007/s003940050074; Bright M, 2000, MAR BIOL, V136, P621, DOI 10.1007/s002270050722; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; COLEMAN PF, 1977, J BIOL CHEM, V252, P6379; DARROW RA, 1977, BIOCHEM BIOPH RES CO, V78, P554, DOI 10.1016/0006-291X(77)90214-5; De Cian MC, 2000, J EXP BIOL, V203, P2907; DISTEL DL, 1988, J BACTERIOL, V170, P2506, DOI 10.1128/jb.170.6.2506-2510.1988; DISTEL DL, 1987, MAR BIOL, V96, P97; Evans D.R., 1986, MULTIDOMAIN PROTEINS, P283; EVANS DR, 1993, BIOCHEM SOC T, V21, P186, DOI 10.1042/bst0210186; FELBECK H, 1981, SCIENCE, V213, P336, DOI 10.1126/science.213.4505.336; Felbeck Horst, 1988, Oceanologica Acta Special Issue, V8, P131; FOX RM, 1971, ANAL BIOCHEM, V41, P578, DOI 10.1016/0003-2697(71)90180-1; HENTSCHEL U, 1993, MAR ECOL PROG SER, V94, P35, DOI 10.3354/meps094035; HENTSCHEL U, 1993, NATURE, V366, P338, DOI 10.1038/366338a0; HUGUES DS, 1997, APPL ENVIRON MICROB, V63, P3494; IVES DH, 1969, ANAL BIOCHEM, V28, P192, DOI 10.1016/0003-2697(69)90170-5; JARROLL EL, 1983, J PARASITOL, V69, P846, DOI 10.2307/3281043; Jones M.L., 1981, Proceedings of the Biological Society of Washington, V93, P1295; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; Jones Meredith L., 1988, Oceanologica Acta Special Issue, V8, P69; JONES ML, 1981, SCIENCE, V213, P333, DOI 10.1126/science.213.4505.333; KALMAN SM, 1966, J BIOL CHEM, V241, P1871; Kochevar Randall E., 1993, Molecular Marine Biology and Biotechnology, V2, P10; Lee RW, 1999, J EXP BIOL, V202, P289; LEGER D, 1988, BIOCHEMISTRY-US, V27, P4293, DOI 10.1021/bi00412a015; LEVINE RL, 1971, BIOCHEMISTRY-US, V10, P3694; LINDMARK DG, 1982, MOL BIOCHEM PARASIT, V5, P291, DOI 10.1016/0166-6851(82)90036-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lundegaard C, 1999, BIOCHEMISTRY-US, V38, P3327, DOI 10.1021/bi982279q; McCauley R, 1998, JPEN-PARENTER ENTER, V22, P105, DOI 10.1177/0148607198022002105; Miller R W, 1978, Methods Enzymol, V51, P63; Nelson D.C., 1995, DEEP SEA HYDROTHERMA, P125; ODONOVAN GA, 1970, BACTERIOL REV, V34, P278, DOI 10.1128/MMBR.34.3.278-343.1970; Ogawa J, 1995, ARCH MICROBIOL, V164, P353; Orengo A, 1978, Methods Enzymol, V51, P299; PERBAL B, 1972, J MOL BIOL, V70, P511, DOI 10.1016/0022-2836(72)90556-6; ROBIN JP, 1989, EUR J BIOCHEM, V183, P519, DOI 10.1111/j.1432-1033.1989.tb21080.x; ROGERS LE, 1972, EXPERIENTIA, V28, P1258, DOI 10.1007/BF01946211; ROGERS LE, 1968, PEDIATRICS, V42, P423; RUBINO SD, 1986, J BIOL CHEM, V261, P1320; SANDER EG, 1965, J BIOL CHEM, V240, P3628; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Simon V, 2000, MAR BIOL, V136, P115, DOI 10.1007/s002270050014; STAHL DA, 1984, SCIENCE, V224, P409, DOI 10.1126/science.224.4647.409; STEUART CD, 1971, NATURE-NEW BIOL, V233, P109, DOI 10.1038/newbio233109a0; STEWART V, 1994, ANTON LEEUW INT J G, V66, P37, DOI 10.1007/BF00871631; TAYLOR WH, 1976, J BACTERIOL, V127, P863, DOI 10.1128/JB.127.2.863-873.1976; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; TUNNICLIFFE V, 1992, AM SCI, V80, P334; WANG CC, 1984, MOL BIOCHEM PARASIT, V10, P171, DOI 10.1016/0166-6851(84)90005-7; Weinfeld H, 1978, Methods Enzymol, V51, P84	57	19	19	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23777	23784		10.1074/jbc.M102249200	http://dx.doi.org/10.1074/jbc.M102249200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11306586	hybrid			2022-12-27	WOS:000169531100075
J	Cacan, R; Duvet, S; Labiau, O; Verbert, A; Krag, SS				Cacan, R; Duvet, S; Labiau, O; Verbert, A; Krag, SS			Monoglucosylated oligomannosides are released during the degradation process of newly synthesized glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE POLYMANNOSE OLIGOSACCHARIDES; D-GLUCOSAMINIDASE ACTIVITY; RAT-LIVER; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; CYTOSOLIC LOCATION; HEPG2 CELLS; TRANSPORT; LYSOSOMES; CALNEXIN	The Chinese hamster ovary mutant MI8-5 is known to synthesize Man(9)GlcNAc(2)-P-P-dolichol rather than the fully glucosylated lipid intermediate Glc(3)Man(9)GlcNAc(2)-P-P-dolichol. This nonglucosylated oligosaccharide lipid precursor is used as donor for N-glycosylation. In this paper we demonstrate that a significant part of the glycans bound to the newly synthesized glycoproteins in MI8-5 cells are monoglucosylated, The presence of monoglucosylated glycans on glycoproteins determines their binding to calnexin as part of the quality control machinery. Furthermore, we point out the presence of Glc(1)Man(5)GlcNAc(1) in the cytosol of MI8-5 cells. This indicates that part of the monoglucosylated glycoproteins can be directed toward a deglycosylation process that occurs in the cytosol, Besides studies on glycoprotein degradation based on the disappearance of protein moieties, MI8-5 cells can be used as a tool to elucidate the various step leading to glycoprotein degradation by studying the fate of the glycan moieties.	Univ Sci & Technol Lille, CNRS UMR 8576, Chim Biol Lab, F-59655 Villeneuve Dascq, France; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Biochem, Baltimore, MD 21205 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Johns Hopkins University	Cacan, R (corresponding author), Univ Sci & Technol Lille, CNRS UMR 8576, Chim Biol Lab, F-59655 Villeneuve Dascq, France.				NATIONAL CANCER INSTITUTE [R01CA020421] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 20421] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANUMULA KR, 1983, J BIOL CHEM, V258, P5274; Burda P, 1998, J CLIN INVEST, V102, P647, DOI 10.1172/JCI2266; Cacan R, 1999, BIOCHEM BIOPH RES CO, V258, P1, DOI 10.1006/bbrc.1999.0549; Cacan R, 1996, BIOCHEM J, V313, P597, DOI 10.1042/bj3130597; Cannon KS, 1999, J BIOL CHEM, V274, P7537, DOI 10.1074/jbc.274.11.7537; Duvet S, 1998, BIOCHEM J, V335, P389, DOI 10.1042/bj3350389; Grard T, 1996, BIOCHEM J, V316, P787, DOI 10.1042/bj3160787; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Karaivanova VK, 2000, GLYCOBIOLOGY, V10, P727, DOI 10.1093/glycob/10.7.727; KMIECIK D, 1995, GLYCOBIOLOGY, V5, P483, DOI 10.1093/glycob/5.5.483; LIANG CJ, 1979, J BIOL CHEM, V254, P6414; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Moore SEH, 1999, TRENDS CELL BIOL, V9, P441, DOI 10.1016/S0962-8924(99)01648-7; MOORE SEH, 1995, EMBO J, V14, P6034, DOI 10.1002/j.1460-2075.1995.tb00292.x; PIERCE RJ, 1980, BIOCHEM J, V185, P261, DOI 10.1042/bj1850261; PIERCE RJ, 1979, BIOCHEM J, V180, P673, DOI 10.1042/bj1800673; Quellhorst GJ, 1999, GLYCOBIOLOGY, V9, P65, DOI 10.1093/glycob/9.1.65; RAY MK, 1991, J BIOL CHEM, V266, P22818; Saint-Pol A, 1999, J BIOL CHEM, V274, P13547, DOI 10.1074/jbc.274.19.13547; SaintPol A, 1997, J CELL BIOL, V136, P45, DOI 10.1083/jcb.136.1.45; SOUSA M, 1995, EMBO J, V14, P4196, DOI 10.1002/j.1460-2075.1995.tb00093.x; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; SUZUKI T, 1994, J BIOL CHEM, V269, P17611; Verbert A, 1999, BBA-GEN SUBJECTS, V1473, P137, DOI 10.1016/S0304-4165(99)00174-9; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5	26	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22307	22312		10.1074/jbc.M101077200	http://dx.doi.org/10.1074/jbc.M101077200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294837	hybrid			2022-12-27	WOS:000169412700046
J	Estrada, M; Cardenas, C; Liberona, JL; Carrasco, MA; Mignery, GA; Allen, PD; Jaimovich, E				Estrada, M; Cardenas, C; Liberona, JL; Carrasco, MA; Mignery, GA; Allen, PD; Jaimovich, E			Calcium transients in 1B5 myotubes lacking ryanodine receptors are related to inositol trisphosphate receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE CHANNELS; MYOGENIC CELL-LINE; SKELETAL-MUSCLE; 1,4,5-TRISPHOSPHATE RECEPTOR; GENE-EXPRESSION; NUCLEUS; UNITS; MEMBRANES; PATHWAYS; PROTEIN	Potassium depolarization of skeletal myotubes evokes slow calcium waves that are unrelated to contraction and involve the cell nucleus (Jaimovich, E., Reyes, R., Liberona, J. L., and Powell, J. A. (2000) Am. J. Physiol. 278, C998-C1010). Studies were done in both the 1B5 (Ry53-/-) murine "dyspedic" myoblast cell line, which does not express any ryanodine receptor isoforms (Moore, R. A, Nguyen, H., Galceran, J., Pessah, I. N., and Alien, P. D. (1998) J. Cell Biol. 140, 843-851), and C2C12 cells, a myoblast cell line that expresses all three isoforms. Although 1B5 cells lack ryanodine binding, they bind tritiated inositol (1,4,5)-trisphosphate. Both type 1 and type 3 inositol trisphosphate receptors were immune-located in the nuclei of both cell types and were visualized by Western blot analysis. After stimulation with 47 mM K+, inositol trisphosphate mass raised transiently in both cell types. Both fast calcium increase and slow propagated calcium signals were seen in C2C12 myotubes. However, 1B5 myotubes (as well as ryanodine-treated C2C12 myotubes) displayed only a long-lasting, non-propagating calcium increase, particularly evident in the nuclei. Calcium signals in 1B5 myotubes were almost completely blocked by inhibitors of the inositol trisphosphate pathway: U73122, 2-aminoethoxydiphenyl berate, or xestospongin C. Results support the hypothesis that inositol trisphosphate mediates slow calcium signals in muscle cell ryanodine receptors, having a role in their time course and propagation.	Univ Chile, Fac Med, Inst Ciencias Biomed, Santiago 70005, Chile; Loyola Univ, Dept Physiol, Maywood, IL 60153 USA; Brigham & Womens Hosp, Dept Anesthesia, Boston, MA 02115 USA	Universidad de Chile; Loyola University Chicago; Harvard University; Brigham & Women's Hospital	Jaimovich, E (corresponding author), Casilla 70005, Santiago 6530499, Chile.		Estrada, Manuel/C-1269-2014; Estrada, Manuel/AAS-5605-2020; Jaimovich, Enrique/AAY-7632-2020	Estrada, Manuel/0000-0001-7877-8160; Estrada, Manuel/0000-0001-7877-8160; 	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043140] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01AR43140] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bading H, 2000, EUR J BIOCHEM, V267, P5280, DOI 10.1046/j.1432-1327.2000.01565.x; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BREDT DS, 1989, BIOCHEM BIOPH RES CO, V159, P976, DOI 10.1016/0006-291X(89)92204-3; Buck ED, 1997, J BIOL CHEM, V272, P7360, DOI 10.1074/jbc.272.11.7360; CASTLEMAN KR, 1989, DIGITAL IMAGE PROCES; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Estrada M, 2000, AM J PHYSIOL-ENDOC M, V279, pE132, DOI 10.1152/ajpendo.2000.279.1.E132; FERRIS CD, 1992, ANNU REV PHYSIOL, V54, P496; Fessenden JD, 2000, BIOPHYS J, V79, P2509, DOI 10.1016/S0006-3495(00)76492-7; FRANZINIARMSTRONG C, 1994, ANNU REV PHYSIOL, V56, P509, DOI 10.1146/annurev.ph.56.030194.002453; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Gerasimenko OV, 1996, PFLUG ARCH EUR J PHY, V432, P1, DOI 10.1007/s004240050098; Guihard G, 1997, FEBS LETT, V414, P89, DOI 10.1016/S0014-5793(97)00949-6; Humbert JP, 1996, J BIOL CHEM, V271, P478, DOI 10.1074/jbc.271.1.478; JAIMOVICH E, 1994, CELL CALCIUM, V15, P356, DOI 10.1016/0143-4160(94)90011-6; Jaimovich E, 2000, AM J PHYSIOL-CELL PH, V278, pC998, DOI 10.1152/ajpcell.2000.278.5.C998; JAIMOVICH E, 1986, BIOCHIM BIOPHYS ACTA, V855, P89, DOI 10.1016/0005-2736(86)90192-6; Kiselyov KI, 2000, MOL CELL, V6, P421, DOI 10.1016/S1097-2765(00)00041-1; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Liberona JL, 1997, J MUSCLE RES CELL M, V18, P587, DOI 10.1023/A:1018671520294; Liberona JL, 1998, MUSCLE NERVE, V21, P902, DOI 10.1002/(SICI)1097-4598(199807)21:7<902::AID-MUS8>3.0.CO;2-A; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; MELZER W, 1995, BBA-REV BIOMEMBRANES, V1241, P59, DOI 10.1016/0304-4157(94)00014-5; MINTA A, 1989, J BIOL CHEM, V264, P8171; Moore RA, 1998, J CELL BIOL, V140, P843, DOI 10.1083/jcb.140.4.843; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Protasi F, 2000, BIOPHYS J, V79, P2494, DOI 10.1016/S0006-3495(00)76491-5; Protasi F, 1998, J CELL BIOL, V140, P831, DOI 10.1083/jcb.140.4.831; Ramos-Franco J, 1998, BIOPHYS J, V75, P834, DOI 10.1016/S0006-3495(98)77572-1; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; STEHNOBITTEL L, 1995, NEURON, V14, P163, DOI 10.1016/0896-6273(95)90250-3; Ward CW, 2000, J PHYSIOL-LONDON, V525, P91, DOI 10.1111/j.1469-7793.2000.t01-2-00091.x; Wojcikiewicz RJH, 1998, MOL PHARMACOL, V53, P656, DOI 10.1124/mol.53.4.656	34	49	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22868	22874		10.1074/jbc.M100118200	http://dx.doi.org/10.1074/jbc.M100118200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301324	hybrid			2022-12-27	WOS:000169412700119
J	Gombos, Z; Jeromin, A; Mal, TK; Chakrabartty, A; Ikura, M				Gombos, Z; Jeromin, A; Mal, TK; Chakrabartty, A; Ikura, M			Calexcitin B is a new member of the sarcoplasmic calcium binding protein family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; CIRCULAR-DICHROISM; DROSOPHILA-MELANOGASTER; ANGSTROM RESOLUTION; KINASE-C; GTP; MEMORY; DOMAIN; PURIFICATION; CONFORMATION	Calexcitin (CE) is a calcium sensor protein that has been implicated in associative learning. The CE gene was previously cloned from the long-finned squid, Loligo pealei, and the gene product was shown to bind GTP and modulate K+ channels and ryanodine receptors in a Ca2+-dependent manner. We cloned a new gene from L. pealei, which encodes a CE like protein, here named calexcitin B (CEB). CEB has 95% amino acid identity to the original form. Our sequence analyses indicate that CEs are homologous to the sarcoplasmic calcium binding protein subfamily of the EF-hand superfamily. Far and near UV circular dichroism and nuclear magnetic resonance studies demonstrate that CEB binds Ca2+ and undergoes a conformational change. CEB is phosphorylated by protein kinase C, but not by casein kinase II. CEB does not bind GTP. Western blot experiments using polyclonal antibodies generated against CEB showed that CEB is expressed in the L. pealei optic lobe, Taken together, the neuronal protein CE represents the first example of a Ca2+ sensor in the sarcoplasmic calcium-binding protein family.	Ontario Canc Inst, Div Mol & Struct Biol, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Ikura, M (corresponding author), Ontario Canc Inst, Div Mol & Struct Biol, Rm 7-723,610 Univ Ave, Toronto, ON M5G 2M9, Canada.	mikura@uhnres.utoronto.ca	Mal, Tapas K/A-9453-2011	Mal, Tapas K/0000-0002-0625-2095; Ikura, Mitsuhiko/0000-0002-9524-1303; Chakrabartty, Avi/0000-0001-7002-8381				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alkon DL, 1998, TRENDS NEUROSCI, V21, P529, DOI 10.1016/S0166-2236(98)01277-6; Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Ascoli GA, 1997, J BIOL CHEM, V272, P24771, DOI 10.1074/jbc.272.40.24771; BOBAK DA, 1990, BIOCHEMISTRY-US, V29, P855, DOI 10.1021/bi00456a600; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CAMPBELL JA, 1991, BIOCHEM SOC T, V19, pS53, DOI 10.1042/bst019053s; Cavallaro S, 1997, P NATL ACAD SCI USA, V94, P9669, DOI 10.1073/pnas.94.18.9669; CHAKRABARTTY A, 1993, BIOCHEMISTRY-US, V32, P5560, DOI 10.1021/bi00072a010; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; CLOSSET J, 1975, BIOCHIM BIOPHYS ACTA, V405, P228, DOI 10.1016/0005-2795(75)90089-6; COLLINS JH, 1983, BIOCHEMISTRY-US, V22, P341, DOI 10.1021/bi00271a017; COOK WJ, 1993, J MOL BIOL, V229, P461, DOI 10.1006/jmbi.1993.1046; COX JA, 1981, BIOCHIM BIOPHYS ACTA, V670, P441, DOI 10.1016/0005-2795(81)90119-7; COX JA, 1979, BIOCHIMIE, V61, P601, DOI 10.1016/S0300-9084(79)80157-1; COX JA, 1991, NOVEL CALCIUM BINDIN, P447; Craescu CT, 1998, J BIOMOL NMR, V12, P565, DOI 10.1023/A:1008361202496; Cuvillier A, 2000, J CELL SCI, V113, P2065; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; DEVER TE, 1987, P NATL ACAD SCI USA, V84, P1814, DOI 10.1073/pnas.84.7.1814; DEVOS AM, 1988, SCIENCE, V239, P888, DOI 10.1126/science.2448879; DURUSSEL I, 1993, BIOCHEMISTRY-US, V32, P2394, DOI 10.1021/bi00060a034; ETCHEBERRIGARAY R, 1994, ANN NY ACAD SCI, V747, P245; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRAND RJA, 1989, BIOCHEM J, V258, P625, DOI 10.1042/bj2580625; GREASLEY SE, 1995, NAT STRUCT BIOL, V2, P797, DOI 10.1038/nsb0995-797; Greenfield NJ, 1996, ANAL BIOCHEM, V235, P1, DOI 10.1006/abio.1996.0084; Gribenko A, 1998, PROTEIN SCI, V7, P211, DOI 10.1002/pro.5560070123; HERMANN A, 1995, COMP BIOCHEM PHYS B, V111, P337, DOI 10.1016/0305-0491(94)00218-J; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; IKURA M, 1985, BIOCHEMISTRY-US, V24, P4264, DOI 10.1021/bi00337a002; Kato M, 1998, BIOCHEM J, V331, P871, DOI 10.1042/bj3310871; KAWASAKI H, 1994, PROTEIN PROFILE, V1, P343; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Kelly LE, 1997, INSECT BIOCHEM MOLEC, V27, P783, DOI 10.1016/S0965-1748(97)00062-3; KERSCHBAUM HH, 1992, BRAIN RES, V597, P339, DOI 10.1016/0006-8993(92)91491-V; KIM CS, 1995, P NATL ACAD SCI USA, V92, P3060, DOI 10.1073/pnas.92.7.3060; Kjeldgaard M, 1996, FASEB J, V10, P1347, DOI 10.1096/fasebj.10.12.8903506; KOHLER L, 1978, MOL CELL BIOCHEM, V20, P85; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Kuzirian AM, 1998, BIOL BULL, V195, P198, DOI 10.2307/1542837; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; MANSER E, 1995, METHOD ENZYMOL, V256, P130; Mitchell J, 1998, BIOCHEMISTRY-US, V37, P9064, DOI 10.1021/bi972768a; Nelson TJ, 1996, P NATL ACAD SCI USA, V93, P13808, DOI 10.1073/pnas.93.24.13808; NELSON TJ, 1990, SCIENCE, V247, P1479, DOI 10.1126/science.2108498; Nelson TJ, 1999, BIOCHEM J, V341, P423, DOI 10.1042/0264-6021:3410423; NELSON TJ, 1991, J NEUROCHEM, V57, P2065, DOI 10.1111/j.1471-4159.1991.tb06423.x; NELSON TJ, 1994, P NATL ACAD SCI USA, V91, P9287, DOI 10.1073/pnas.91.20.9287; NELSON TJ, 1995, J NEUROCHEM, V65, P2350; PAIN R, 1996, CURRENT PROTOCOLS PR, P761; PAULS TL, 1993, EUR J NEUROSCI, V5, P549, DOI 10.1111/j.1460-9568.1993.tb00520.x; PAULS TL, 1993, J BIOL CHEM, V268, P20897; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Strickland E H, 1974, CRC Crit Rev Biochem, V2, P113, DOI 10.3109/10409237409105445; Sun MK, 1999, P NATL ACAD SCI USA, V96, P7023, DOI 10.1073/pnas.96.12.7023; TAKAGI T, 1990, EUR J BIOCHEM, V192, P387, DOI 10.1111/j.1432-1033.1990.tb19239.x; TAMKUN JW, 1991, P NATL ACAD SCI USA, V88, P3120, DOI 10.1073/pnas.88.8.3120; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; Tanaka T, 1998, NATURE, V396, P88, DOI 10.1038/23968; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VIJAYKUMAR S, 1992, J MOL BIOL, V224, P413, DOI 10.1016/0022-2836(92)91004-9; WILLIAMS TC, 1986, BIOCHEMISTRY-US, V25, P1835, DOI 10.1021/bi00355a057; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	66	15	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22529	22536		10.1074/jbc.M010508200	http://dx.doi.org/10.1074/jbc.M010508200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11306567	Green Published, hybrid			2022-12-27	WOS:000169412700075
J	Hikita, T; Tadano-Aritomi, K; Iida-Tanaka, N; Anand, JK; Ishizuka, I; Hakomori, S				Hikita, T; Tadano-Aritomi, K; Iida-Tanaka, N; Anand, JK; Ishizuka, I; Hakomori, S			A novel plasmal conjugate to glycerol and psychosine ("glyceroplasmalopsychosine") - Isolation and characterization from bovine brain white matter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; MASS-SPECTROMETRIC ANALYSIS; CHAIN CYCLIC ACETALS; PROTEIN KINASE-C; NMR-SPECTROSCOPY; LIQUID-CHROMATOGRAPHY; METHYLATION ANALYSIS; GROWTH-FACTOR; EQUINE BRAIN; RAT-KIDNEY	A novel plasmal conjugate of glycosphingolipid having cationic lipid properties was isolated from the white matter of bovine brain. Linkage analysis of galactosyl residue by methylation, liquid secondary ion, and electrospray ionization mass spectrometry of intact and methylated derivatives, and by H-1- and C-13-NMR spectroscopy, identified the structure unambiguously as an O-acetal conjugate of plasmal to the primary hydroxyl group of glycerol and to the 6-hydroxyl group of galactosyl residue of beta -galactosyl 1 -->1 sphingosine (psycho sine). This novel compound is hereby termed "glyceroplasmalopsychosine"; its structure is shown below.	Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA; Pacific NW Res Inst, Div Biomembrane Res, Seattle, WA 98122 USA; Teikyo Univ, Sch Med, Dept Biochem, Tokyo 1738605, Japan	University of Washington; University of Washington Seattle; Teikyo University	Hakomori, S (corresponding author), Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA.	hakomori@u.washington.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039560] Funding Source: NIH RePORTER; NINDS NIH HHS [NS39560] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BJORNDAL H, 1970, ANGEW CHEM INT EDIT, V9, P610, DOI 10.1002/anie.197006101; DEBUCH H, 1956, H-S Z PHYSIOL CHEM, V304, P109, DOI 10.1515/bchm2.1956.304.1-2.109; Debuch H., 1972, ETHER LIPIDS CHEM BI, P1, DOI [10.1016/b978-0-12-654150-2.50008-7, DOI 10.1016/B978-0-12-654150-2.50008-7]; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Feulgen R, 1929, H-S Z PHYSIOL CHEM, V180, P161, DOI 10.1515/bchm2.1929.180.4-6.161; Feulgen R, 1924, PFLUG ARCH GES PHYS, V206, P389, DOI 10.1007/BF01722779; FOLCH J, 1957, J BIOL CHEM, V226, P497; GRAY GM, 1958, BIOCHEM J, V70, P425, DOI 10.1042/bj0700425; HANAHAN DJ, 1960, LIPIDE CHEM, P92; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; Hikita T, 2000, ANAL BIOCHEM, V281, P193, DOI 10.1006/abio.2000.4561; HOLMGREN J, 1980, P NATL ACAD SCI-BIOL, V77, P1947, DOI 10.1073/pnas.77.4.1947; IGARASHI Y, 1990, J BIOL CHEM, V265, P5385; IGARASHI Y, 1989, BIOCHEMISTRY-US, V28, P6796, DOI 10.1021/bi00443a002; IGARASHI Y, 1989, METHOD ENZYMOL, V179, P521; IIDA N, 1989, J BIOL CHEM, V264, P5974; Iida-Tanaka N, 2000, EUR J BIOCHEM, V267, P6790, DOI 10.1046/j.1432-1327.2000.01773.x; Iida-Tanaka N, 2000, CARBOHYD RES, V324, P218, DOI 10.1016/S0008-6215(99)00291-8; Jansson P-E., 1976, CHEM COMMUN U STOCKH, V8, P1; KOCHANOWSKI B, 1993, EUR J BIOCHEM, V214, P747, DOI 10.1111/j.1432-1033.1993.tb17976.x; Kogelberg H, 1996, BIOCHEMISTRY-US, V35, P1954, DOI 10.1021/bi9521598; LEVERY SB, 1987, METHOD ENZYMOL, V138, P13, DOI 10.1016/0076-6879(87)38004-8; LEVERY SB, 1992, BIOCHEMISTRY-US, V31, P5335, DOI 10.1021/bi00138a013; Martonosi, 1985, ENZYMES BIOL MEMBR, V2, P1; Matsuda K, 1997, BBA-LIPID LIPID MET, V1349, P1, DOI 10.1016/S0005-2760(97)00088-X; Megidish T, 1998, J BIOL CHEM, V273, P21834, DOI 10.1074/jbc.273.34.21834; Megidish T, 1999, BIOCHEMISTRY-US, V38, P3369, DOI 10.1021/bi982548c; MERRILL AH, 1989, BIOCHEMISTRY-US, V28, P3138, DOI 10.1021/bi00434a004; NUDELMAN ED, 1992, J BIOL CHEM, V267, P11007; Orfi L, 1997, LIPIDS, V32, P1035, DOI 10.1007/s11745-997-0133-x; RAPPORT MM, 1957, J BIOL CHEM, V225, P851; SADOZAI KK, 1993, CARBOHYD RES, V241, P301, DOI 10.1016/0008-6215(93)80120-4; Sadozai KK, 1996, J CARBOHYD CHEM, V15, P715, DOI 10.1080/07328309608005687; Sakakura C, 1996, J BIOL CHEM, V271, P946, DOI 10.1074/jbc.271.2.946; SHERMA J, 1974, ANAL LETT, V7, P279, DOI 10.1080/00032717408058188; SNYDER E, 1996, BIOCH LIPIDS LIPOPRO, P183; STROUD MR, 1994, BIOCHEMISTRY-US, V33, P10672, DOI 10.1021/bi00201a015; Tadano-Aritomi K, 1998, GLYCOBIOLOGY, V8, P341, DOI 10.1093/glycob/8.4.341; TADANOARITOMI K, 1995, CARBOHYD RES, V273, P41, DOI 10.1016/0008-6215(95)00106-4; Taketomi T, 1998, ACTA BIOCHIM POL, V45, P987, DOI 10.18388/abp.1998_4356; TAKETOMI T, 1990, J BIOCHEM-TOKYO, V107, P680, DOI 10.1093/oxfordjournals.jbchem.a123107; TAKI T, 1995, ANAL BIOCHEM, V225, P24, DOI 10.1006/abio.1995.1102; THANNHAUSER SJ, 1946, J BIOL CHEM, V166, P669; Yachida Y, 1998, J LIPID RES, V39, P1039; Yachida Y, 1999, J LIPID RES, V40, P2271	45	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23084	23091		10.1074/jbc.M101288200	http://dx.doi.org/10.1074/jbc.M101288200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294874	hybrid			2022-12-27	WOS:000169412700146
J	Leimkuhler, S; Rajagopalan, KV				Leimkuhler, S; Rajagopalan, KV			A sulfurtransferase is required in the transfer of cysteine sulfur in the in vitro synthesis of molybdopterin from precursor Z in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SULFITE OXIDASE; FE-S CLUSTER; MOLYBDENUM COFACTOR; SELENOCYSTEINE LYASE; STRUCTURAL-CHARACTERIZATION; CONVERTING FACTOR; GENE CLONING; NIFS GENE; BIOSYNTHESIS; PROTEIN	It has been shown that conversion of precursor Z to molybdopterin (MPT) by Escherichia coli MPT synthase entails the transfer of the sulfur atom of the C-terminal thiocarboxylate from the small subunit of the synthase to generate the dithiolene group of MPT and that the moeB mutant E. coli contains inactive MPT synthase devoid of the thiocarboxylate. The data presented here demonstrate that L-cysteine can serve as the source of the sulfur for the biosynthesis of MPT in vitro but only in the presence of a persulfide containing sulfurtransferase such as IscS, cysteine sulfinate desulfinase (CSD), or CsdB. A fully defined in vitro system has been developed in which an inactive form of MPT synthase can be activated by incubation with MoeB, Mg ATP, L-cysteine, and one of the NifS-like sulfurtransferases, and the addition of precursor Z to the in vitro system gives rise to MPT formation. The use of radiolabeled L-[S-35]cysteine has demonstrated that both sulfurs of the dithiolene group of MPT originate from L-cysteine. It was found that MPT can be produced from precursor Z in an E. coli iscS mutant strain, indicating that IscS is not required for the in vivo sulfuration of RIFT synthase. A comparison of the ability of the three sulfurtransferases to provide the sulfur for MPT formation showed the highest activity for CSD in the in vitro system.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Rajagopalan, KV (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	raj@biochem.duke.edu		Leimkuhler, Silke/0000-0003-3238-2122	NIGMS NIH HHS [GM44283] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044283] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Flint DH, 1996, J BIOL CHEM, V271, P16068; JOHNSON JL, 1990, P NATL ACAD SCI USA, V87, P3190, DOI 10.1073/pnas.87.8.3190; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; JOHNSON ME, 1987, J BACTERIOL, V169, P117, DOI 10.1128/jb.169.1.117-125.1987; JONES HP, 1977, J BIOL CHEM, V252, P4988; JONES RW, 1977, BIOCHEM J, V164, P199, DOI 10.1042/bj1640199; KRAMER SP, 1987, J BIOL CHEM, V262, P16357; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Leimkuhler S, 2001, J BIOL CHEM, V276, P1837, DOI 10.1074/jbc.M007304200; Menendez C, 1996, FEBS LETT, V391, P101, DOI 10.1016/0014-5793(96)00712-0; Mihara H, 2000, J BIOCHEM-TOKYO, V127, P559, DOI 10.1093/oxfordjournals.jbchem.a022641; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; PITTERLE DM, 1993, J BIOL CHEM, V268, P13499; PITTERLE DM, 1993, J BIOL CHEM, V268, P13506; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; Rajagopalan KV, 1997, BIOCHEM SOC T, V25, P757, DOI 10.1042/bst0250757; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; STEWART V, 1988, MICROBIOL REV, V52, P190, DOI 10.1128/MMBR.52.2.190-232.1988; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; WUEBBENS MM, 1993, J BIOL CHEM, V268, P13493; ZHENG LM, 1994, J BIOL CHEM, V269, P18723; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	24	101	107	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22024	22031		10.1074/jbc.M102072200	http://dx.doi.org/10.1074/jbc.M102072200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11290749	hybrid			2022-12-27	WOS:000169412700007
J	Miranda, M; Allen, KE; Pardo, JP; Slayman, CW				Miranda, M; Allen, KE; Pardo, JP; Slayman, CW			Stalk segment 5 of the yeast plasma membrane H+-ATPase - Mutational evidence for a role in glucose regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; NA,K-ATPASE ALPHA-SUBUNIT; SINGLE-POINT MUTATIONS; SACCHAROMYCES-CEREVISIAE; TRANSMEMBRANE DOMAIN; DIRECTED MUTAGENESIS; CALCIUM-PUMP; SECRETORY VESICLES; TERMINAL REGION; PHOSPHORYLATION	In P-2-type ATPases, a stalk region connects the cytoplasmic part of the molecule, which binds and hydrolyzes ATP, to the membrane-embedded part through which cations are pumped. The present study has used cysteine scanning mutagenesis to examine structure-function relationships within stalk segment 5 (S5) of the yeast plasma-membrane H+-ATPase. Of 29 Cys mutants that were made and examined, two (G670C and R682C) were blocked in biogenesis, presumably due to protein misfolding, In addition, one mutant (S681C) had very low ATPase activity, and another (F685C) displayed a 40-fold decrease in sensitivity to orthovanadate, reflecting a shift in equilibrium from the E-2 conformational state toward E-1. By far the most striking group of mutants (F666C, L671C, I674C, A677C, I684C, R687C, and Y689C) were constitutively activated even in the absence of glucose, with rates of ATP hydrolysis and kinetic properties normally seen only in glucose-metabolizing cells. Previous work has suggested that activation of the wild-type H+-ATPase results from kinase-mediated phosphorylation in the auto-inhibitory C-terminal region of the 100-kDa polypeptide, The seven residues identified in the present study are located on one face of the S5 alpha -helix, consistent with the idea that mutations along this face serve to release the auto inhibition.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Yale University; Yale University	Miranda, M (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06510 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM015761, R01GM015761] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-15761] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambesi A, 2000, J BIOL CHEM, V275, P20545, DOI 10.1074/jbc.M001682200; Ambesi A, 1997, ANAL BIOCHEM, V251, P127, DOI 10.1006/abio.1997.2257; Ambesi A, 1996, J BIOL CHEM, V271, P22999, DOI 10.1074/jbc.271.38.22999; Arguello JM, 1996, J BIOL CHEM, V271, P24610, DOI 10.1074/jbc.271.40.24610; Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; Boxenbaum N, 1998, J BIOL CHEM, V273, P23086, DOI 10.1074/jbc.273.36.23086; Carafoli E, 2000, CURR OPIN CHEM BIOL, V4, P152, DOI 10.1016/S1367-5931(99)00069-1; CHANG A, 1991, J CELL BIOL, V115, P289, DOI 10.1083/jcb.115.2.289; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; CLARKE DM, 1990, J BIOL CHEM, V265, P6262; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Curran AC, 2000, J BIOL CHEM, V275, P30301, DOI 10.1074/jbc.M002047200; Daly SE, 1996, J BIOL CHEM, V271, P23683, DOI 10.1074/jbc.271.39.23683; DeWitt ND, 1998, J BIOL CHEM, V273, P21744, DOI 10.1074/jbc.273.34.21744; Dutra MB, 1998, J BIOL CHEM, V273, P17411, DOI 10.1074/jbc.273.28.17411; ERASO P, 1994, J BIOL CHEM, V269, P10393; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Fiske CH, 1925, J BIOL CHEM, V66, P375; Garnett C, 1996, BIOCHEMISTRY-US, V35, P11019, DOI 10.1021/bi960718k; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Mason AB, 1998, BBA-BIOMEMBRANES, V1372, P261, DOI 10.1016/S0005-2736(98)00065-0; Morsomme P, 1996, EMBO J, V15, P5513, DOI 10.1002/j.1460-2075.1996.tb00936.x; Morsomme P, 2000, BBA-BIOMEMBRANES, V1465, P1, DOI 10.1016/S0005-2736(00)00128-0; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; Nakamoto RK, 1998, J BIOL CHEM, V273, P7338, DOI 10.1074/jbc.273.13.7338; NAKAMOTO RK, 1991, J BIOL CHEM, V266, P7940; Nielsen JM, 1998, BIOCHEMISTRY-US, V37, P1961, DOI 10.1021/bi972524q; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; PERLIN DS, 1989, J BIOL CHEM, V264, P21857; Petrov VV, 2000, J BIOL CHEM, V275, P15709, DOI 10.1074/jbc.M000546200; Portillo F, 2000, BBA-REV BIOMEMBRANES, V1469, P31, DOI 10.1016/S0304-4157(99)00011-8; PORTILLO F, 1991, FEBS LETT, V287, P71, DOI 10.1016/0014-5793(91)80018-X; PORTILLO F, 1989, FEBS LETT, V247, P381, DOI 10.1016/0014-5793(89)81375-4; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Sen Gupta S, 1998, J BIOL CHEM, V273, P34328; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; SERRANO R, 1988, BIOCHIM BIOPHYS ACTA, V947, P1, DOI 10.1016/0304-4157(88)90017-2; SETOYOUNG D, 1992, BIOCHIM BIOPHYS ACTA, V1102, P213, DOI 10.1016/0167-4838(92)90512-C; Sorensen TLM, 2000, J BIOL CHEM, V275, P28954, DOI 10.1074/jbc.M004072200; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Wang GF, 1996, J BIOL CHEM, V271, P25438, DOI 10.1074/jbc.271.41.25438; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959; ZHANG Z, 1995, J BIOL CHEM, V270, P16283	46	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22485	22490		10.1074/jbc.M102332200	http://dx.doi.org/10.1074/jbc.M102332200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11306587	hybrid			2022-12-27	WOS:000169412700069
J	Antoniv, TT; De Val, S; Wells, D; Denton, CP; Rabe, C; de Crombrugghe, B; Ramirez, F; Bou-Gharios, G				Antoniv, TT; De Val, S; Wells, D; Denton, CP; Rabe, C; de Crombrugghe, B; Ramirez, F; Bou-Gharios, G			Characterization of an evolutionarily conserved far-upstream enhancer in the human alpha 2(I) collagen (COL1A2) gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; NECROSIS-FACTOR-ALPHA; TRANSGENIC MICE; REPORTER GENES; EXPRESSION; PROMOTER; CHROMATIN; TRANSCRIPTION; CELLS; ELEMENTS	We have examined the chromatin structure around and upstream of the transcriptional start site of the human alpha2(I) collagen (COL1A2) gene. Four strong DNase I-hypersensitive sites (HS2-5) were only detected in fibroblasts, and a weaker one (HS1) was identified in type I collagen-negative cells. Another hypersensitive site potentially involved in COL1A2 silencing was found in intron 1 (HS(In)), HS1 and HS2 were mapped within conserved promoter sequences and at locations comparable to the mouse gene. HS3, HS4, and HS5 were likewise mapped similar to 20 kilobases upstream of COL1A2 at about the same position as the mouse far-upstream enhancer and within a remarkably homologous genomic segment. DNase I footprinting identified twelve areas of nuclease protection in the far-upstream region (FU1-12) and within stretches nearly identical to the mouse sequence. The region containing HS3-5 was found to confer high and tissue-specific expression in transgenic mice to the otherwise minimally active COL1A2 promoter. Characterization of the human element documented functional differences with the mouse counterpart. Enhancer activity substantially decreased without the segment containing FU1-7 and HS5, and inclusion of AluI repeats located 3' of HS3 augmented position-independent expression of the transgene. Hence, subtle differences may characterize the regulation of mammalian alpha2(I) collagen genes by evolutionarily conserved sequences.	NYU, Mt Sinai Sch Med, Dept Biochem & Mol Biol, Brookdale Ctr, New York, NY 10029 USA; Imperial Coll Sch Med, Ctr Clin Sci, MRC, London W12 0NN, England; Imperial Coll Sch Med, Dept Neuromuscular Dis, Gene Targeting Grp, London W6 4RF, England; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77020 USA	Icahn School of Medicine at Mount Sinai; New York University; Imperial College London; Imperial College London; University of Texas System; UTMD Anderson Cancer Center	Antoniv, TT (corresponding author), NYU, Mt Sinai Sch Med, Dept Biochem & Mol Biol, Brookdale Ctr, 1 Gustave L Levy Pl,Box 1020, New York, NY 10029 USA.	ramirf01@doc.mssm.edu		Wells, Dominic/0000-0002-1425-6344	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR044888] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL41262] Funding Source: Medline; NIAMS NIH HHS [AR44888, AR386481] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BEDALOV A, 1994, J BIOL CHEM, V269, P4903; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; Bonifer C, 1996, J MOL MED, V74, P663, DOI 10.1007/s001090050070; BORNSTEIN P, 1989, PROG NUCLEIC ACID RE, V37, P67; BouGharios G, 1996, J CELL BIOL, V134, P1333, DOI 10.1083/jcb.134.5.1333; Dillon N, 2000, BIOESSAYS, V22, P657, DOI 10.1002/1521-1878(200007)22:7<657::AID-BIES8>3.3.CO;2-U; Droge P, 2001, BIOESSAYS, V23, P179, DOI 10.1002/1521-1878(200102)23:2<179::AID-BIES1025>3.0.CO;2-6; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; Festenstein R, 2000, CURR OPIN GENET DEV, V10, P199, DOI 10.1016/S0959-437X(00)00060-5; Greenwel P, 2000, MOL CELL BIOL, V20, P912, DOI 10.1128/MCB.20.3.912-918.2000; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GROSS DS, 1987, TRENDS BIOCHEM SCI, V12, P293, DOI 10.1016/0968-0004(87)90144-7; Hay E.D., 1991, CELL BIOL EXTRACELLU, P419; Hogan B, 1994, MANIPULATING MOUSE E; HOWARD B H, 1990, New Biologist, V2, P759; INAGAKI Y, 1995, J BIOL CHEM, V270, P3353, DOI 10.1074/jbc.270.7.3353; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Krempen K, 1999, GENE EXPRESSION, V8, P151; LISKA DJ, 1994, J CELL BIOL, V125, P695, DOI 10.1083/jcb.125.3.695; Niederreither K, 1995, MATRIX BIOL, V14, P705, DOI 10.1016/S0945-053X(05)80013-7; NIEDERREITHER K, 1992, J CELL BIOL, V119, P1361, DOI 10.1083/jcb.119.5.1361; PAVLIN D, 1992, J CELL BIOL, V116, P227, DOI 10.1083/jcb.116.1.227; POLJAK L, 1994, NUCLEIC ACIDS RES, V22, P4386, DOI 10.1093/nar/22.21.4386; Poncelet AC, 2001, J BIOL CHEM, V276, P6983, DOI 10.1074/jbc.M006442200; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Rossert JA, 1996, P NATL ACAD SCI USA, V93, P1027, DOI 10.1073/pnas.93.3.1027; ROSSI P, 1988, CELL, V52, P405, DOI 10.1016/S0092-8674(88)80033-3; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SHERWOOD AL, 1990, GENE, V89, P239, DOI 10.1016/0378-1119(90)90011-F; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200	32	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21754	21764		10.1074/jbc.M101397200	http://dx.doi.org/10.1074/jbc.M101397200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279244	hybrid			2022-12-27	WOS:000169297900126
J	Daily, D; Vlamis-Gardikas, A; Offen, D; Mittelman, L; Melamed, E; Holmgren, A; Barzilai, A				Daily, D; Vlamis-Gardikas, A; Offen, D; Mittelman, L; Melamed, E; Holmgren, A; Barzilai, A			Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the Ras-phosphoinositide 3-kinase and jun N-terminal kinase pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DNA-BINDING ACTIVITY; I-KAPPA-B; C-JUN; TRANSCRIPTION FACTOR; REDOX REGULATION; CELL-DEATH; PHOSPHATIDYLINOSITOL 3-KINASE; NUCLEAR TRANSLOCATION; SYMPATHETIC NEURONS; SIGNAL-TRANSDUCTION	Glutaredoxin 2 (Grx2) from Escherichia coli protects cerebellar neurons from dopamine-induced apoptosis via nuclear factor kappa B (NF-kappaB) activation, which is mediated by the expression of redox factor-1 (Ref-1), An analysis of the mechanisms underlying Grx2 protective activity revealed dual activation of signal transduction pathways. Grx2 significantly activated the Ras/phosphoinositide 3-kinase/Akt/NF-kappaB cascade in parallel to the Jun N-terminal kinase (JNK)/AP1 cascade. Dopamine, in comparison, down-regulated both pathways. Treatment of neurons with Ref-1 antisense oligonucleotide reduced the ability of Grx2 to activate Akt and AP-1 but had no effect on the phosphorylation of JNK1/2, suggesting that Akt/NF-kappaB and AP-1 are regulated by Ref-1. Exposure of the neurons to JNK1/2 antisense oligonucleotide in the presence of Grx2 significantly reduced AP-1 and NF-kappaB DNA binding activities and abolished Grx2 protection. These results demonstrate that dual activation of Ras/phosphoinositide 3-kinase and AP-1 cascades, which are mediated by Ref-1, is an essential component of the Grx2 mechanism of action.	Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Dept Neurol, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Rabin Med Ctr, Felsenstein Med Res Inst, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Sch Med, Dept Clin Biochem, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Sch Med, Interdepartmental Core Facil, IL-69978 Tel Aviv, Israel; Karolinska Inst, Med Nobel Inst Biochem, Dept Biochem & Biophys, S-17177 Stockholm, Sweden	Tel Aviv University; Tel Aviv University; Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Karolinska Institutet	Barzilai, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel.	barzilai@post.tau.ac.il	Vlamis, Alexios/AAF-5152-2020	Vlamis, Alexios/0000-0001-5068-6459				ADAMS JD, 1991, FREE RADICAL BIO MED, V10, P161, DOI 10.1016/0891-5849(91)90009-R; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bandyopadhyay S, 1998, J BIOL CHEM, V273, P392, DOI 10.1074/jbc.273.1.392; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; BENSHACHAR D, 1995, J NEUROCHEM, V64, P718, DOI 10.1046/j.1471-4159.1995.64020718.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BUISSON A, 1992, J NEUROCHEM, V59, P1153, DOI 10.1111/j.1471-4159.1992.tb08358.x; BURGERING BMT, 1995, TRENDS BIOCHEM SCI, V20, P18, DOI 10.1016/S0968-0004(00)88944-6; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chang NS, 1999, BIOCHEM BIOPH RES CO, V263, P107, DOI 10.1006/bbrc.1999.1288; Clemens JA, 1997, STROKE, V28, P1073, DOI 10.1161/01.STR.28.5.1073; Crowder RJ, 1998, J NEUROSCI, V18, P2933; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Daily D, 2001, J BIOL CHEM, V276, P1335, DOI 10.1074/jbc.M008121200; Das KC, 2001, J BIOL CHEM, V276, P4662, DOI 10.1074/jbc.M006206200; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DRAGUNOW M, 1995, NEUROSCI LETT, V191, P189, DOI 10.1016/0304-3940(95)11589-O; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; DUGUID JR, 1995, CANCER RES, V55, P6097; EFLER R, 1999, J CELL BIOL, V145, P1049; Eilers A, 1998, J NEUROSCI, V18, P1713; FILLOUX F, 1991, SYNAPSE, V8, P281, DOI 10.1002/syn.890080406; FILLOUX F, 1993, EXP NEUROL, V119, P79, DOI 10.1006/exnr.1993.1008; Foulstone EJ, 1999, NEUROSCI LETT, V264, P125, DOI 10.1016/S0304-3940(99)00166-4; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fritz G, 1999, ONCOGENE, V18, P1033, DOI 10.1038/sj.onc.1202394; Gamaley IA, 1999, INT REV CYTOL, V188, P203; Garcia-Pardo L, 1999, MOL HUM REPROD, V5, P914, DOI 10.1093/molehr/5.10.914; GASDASKA JR, 1995, CELL GROWTH DIFFER, V6, P1643; GRILLI M, 1993, INT REV CYTOL, V143, P1; Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Harlow E., 1988, ANTIBODIES LAB MANUA; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Hirota K, 2000, BIOCHEM BIOPH RES CO, V274, P177, DOI 10.1006/bbrc.2000.3106; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Hunot S, 1997, P NATL ACAD SCI USA, V94, P7531, DOI 10.1073/pnas.94.14.7531; Ikeuchi T, 1998, Hum Cell, V11, P125; INGLESE J, 1995, TRENDS BIOCHEM SCI, V20, P151, DOI 10.1016/S0968-0004(00)88992-6; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jung CH, 1996, ARCH BIOCHEM BIOPHYS, V335, P61, DOI 10.1006/abbi.1996.0482; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Karin M, 1998, P NATL ACAD SCI USA, V95, P9067, DOI 10.1073/pnas.95.16.9067; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; LASHER RS, 1972, BRAIN RES, V41, P482, DOI 10.1016/0006-8993(72)90521-5; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Leonardi A, 2000, P NATL ACAD SCI USA, V97, P10494, DOI 10.1073/pnas.190245697; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Liu YF, 1998, J BIOL CHEM, V273, P28873, DOI 10.1074/jbc.273.44.28873; Luo YQ, 1999, MOL PHARMACOL, V56, P254, DOI 10.1124/mol.56.2.254; Luo YQ, 1998, J BIOL CHEM, V273, P3756, DOI 10.1074/jbc.273.6.3756; Makino Y, 1999, J BIOL CHEM, V274, P3182, DOI 10.1074/jbc.274.5.3182; MASAMI H, 1996, J BIOL CHEM, V271, P13234; Masserano JM, 1996, MOL PHARMACOL, V50, P1309; McLaughlin BA, 1998, J NEUROCHEM, V70, P2406; MICHEL PP, 1990, J NEUROSCI RES, V26, P428, DOI 10.1002/jnr.490260405; MIEYAL JJ, 1991, BIOCHEMISTRY-US, V30, P6088, DOI 10.1021/bi00239a002; MYTILINEOU C, 1993, J NEUROCHEM, V61, P1470, DOI 10.1111/j.1471-4159.1993.tb13642.x; Nakamura H, 1998, FREE RADICAL BIO MED, V24, P1176, DOI 10.1016/S0891-5849(97)00429-2; Nakamura T, 1999, FREE RADICAL RES, V31, P357, DOI 10.1080/10715769900300931; OFFEN D, 1995, BBA-MOL CELL RES, V1268, P171, DOI 10.1016/0167-4889(95)00075-4; OKAZAKI T, 1994, J BIOL CHEM, V269, P27855; OLANOW CW, 1994, CURR OPIN NEUROL, V7, P548, DOI 10.1097/00019052-199412000-00013; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Oo TF, 1999, J NEUROCHEM, V72, P557, DOI 10.1046/j.1471-4159.1999.0720557.x; PADILLA CA, 1992, MOL CELL ENDOCRINOL, V85, P1, DOI 10.1016/0303-7207(92)90119-Q; Perez-Sala D, 1999, CELL DEATH DIFFER, V6, P722, DOI 10.1038/sj.cdd.4400557; POWIS G, 1994, ONCOL RES, V6, P539; PRASAD AV, 1994, NEUROSCI LETT, V170, P145, DOI 10.1016/0304-3940(94)90260-7; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Rong YQ, 1996, J NEUROCHEM, V67, P662; ROSENBERG PA, 1988, J NEUROSCI, V8, P2887, DOI 10.1523/jneurosci.08-08-02887.1988; ROZELL B, 1993, EUR J CELL BIOL, V62, P314; Rubio I, 1997, BIOCHEM J, V326, P891, DOI 10.1042/bj3260891; SALMINEN A, 1995, BIOCHEM BIOPH RES CO, V212, P939, DOI 10.1006/bbrc.1995.2060; Saporito MS, 2000, J NEUROCHEM, V75, P1200, DOI 10.1046/j.1471-4159.2000.0751200.x; SCHRAMM M, 1990, P NATL ACAD SCI USA, V87, P1193, DOI 10.1073/pnas.87.3.1193; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Shan RJ, 1999, BLOOD, V94, P4067, DOI 10.1182/blood.V94.12.4067.424k12_4067_4076; Shi J, 1999, J BIOL CHEM, V274, P36039, DOI 10.1074/jbc.274.51.36039; Shimoke K, 1998, FEBS LETT, V437, P221, DOI 10.1016/S0014-5793(98)01235-6; Shimoke K, 1999, DEV BRAIN RES, V112, P245, DOI 10.1016/S0165-3806(98)00172-2; Shinkai T, 1997, J NEUROSCI RES, V47, P393; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Takagi Y, 1999, BIOCHEM BIOPH RES CO, V258, P390, DOI 10.1006/bbrc.1999.0646; TANAKA M, 1991, J NEUROL SCI, V101, P198, DOI 10.1016/0022-510X(91)90046-A; Terai K, 1996, BRAIN RES, V735, P159; VlamisGardikas A, 1997, J BIOL CHEM, V272, P11236; Watson A, 1998, J NEUROSCI, V18, P751; Wei SJ, 2000, CANCER RES, V60, P6688; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang XY, 1999, J BIOL CHEM, V274, P27981, DOI 10.1074/jbc.274.39.27981; YOSHITAKE S, 1994, J BIOCHEM-TOKYO, V116, P42, DOI 10.1093/oxfordjournals.jbchem.a124500; Zandi E, 1999, MOL CELL BIOL, V19, P4547; Zhang LL, 2000, J NEUROSCI RES, V59, P489, DOI 10.1002/(SICI)1097-4547(20000215)59:4<489::AID-JNR3>3.0.CO;2-9; ZilkhaFalb R, 1997, CELL MOL NEUROBIOL, V17, P101, DOI 10.1023/A:1026333222008; ZIV I, 1994, NEUROSCI LETT, V170, P136, DOI 10.1016/0304-3940(94)90258-5	110	65	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21618	21626		10.1074/jbc.M101400200	http://dx.doi.org/10.1074/jbc.M101400200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11290748	hybrid			2022-12-27	WOS:000169297900109
J	Navdaev, A; Clemetson, JM; Polgar, J; Kehrel, BE; Glauner, M; Magnenat, E; Wells, TNC; Clemetson, KJ				Navdaev, A; Clemetson, JM; Polgar, J; Kehrel, BE; Glauner, M; Magnenat, E; Wells, TNC; Clemetson, KJ			Aggretin, a heterodimeric C-type lectin from Calloselasma rhodostoma (Malayan pit viper), stimulates platelets by binding to alpha(2)beta(1) integrin and glycoprotein Ib, activating Syk and phospholipase C gamma 2, but does not involve the glycoprotein VI/Fc receptor gamma chain collagen receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; TYROSINE PHOSPHORYLATION; AGGREGATION INDUCER; SIGNAL-TRANSDUCTION; MONOCLONAL-ANTIBODY; FLOW CONDITIONS; ADHESION; VI; VENOM; CELLS	Aggretin, a potent platelet activator, was isolated from Calloselasma rhodostoma venom, and 30-amino acid N-terminal sequences of both subunits were determined. Aggretin belongs to the heterodimeric snake C-type lectin family and is thought to activate platelets by binding to platelet glycoprotein alpha (2)beta (1). We now show that binding to glycoprotein (GP) Ib is also required. Aggretin-induced platelet activation was inhibited by a monoclonal antibody to GPIb as well as by antibodies to alpha (2)beta (1). Binding of both of these platelet receptors to aggretin was confirmed by affinity chromatography. No binding of other major platelet membrane glycoproteins, in particular GPVI, to aggretin was detected. Aggretin also activates platelets from Fc receptor gamma chain (Fc gamma)-deficient mice to a greater extent than those from normal control mice, showing that it does not use the GPVI/Fc gamma pathway. Platelets from Fc gamma -deficient mice expressed fibrinogen receptors normally in response to collagen, although they did not aggregate, indicating that these platelets may partly compensate via other receptors including alpha (2)beta (1) or GPIb for the lack of the Fc gamma pathway. Signaling by aggretin involves a dose-dependent lag phase followed by rapid tyrosine phosphorylation of a number of proteins. Among these are p72(SYK), p125(FAK) and PLC gamma2, whereas, in comparison with collagen anc; convulxin, the Fc gamma subunit neither is phosphorylated nor coprecipitates with p72(SYK). This supports an independent, GPIb- and integrin-based pathway for activation of p72(SYK) not involving the Fc gamma receptor.	Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland; Univ Munster, Klin & Polyklin Anasthesiol & Operat Intens Med E, D-48149 Munster, Germany; Serono Pharmaceut Res Inst SA, CH-1228 Geneva, Switzerland	University of Bern; University of Munster	Clemetson, KJ (corresponding author), Univ Bern, Theodor Kocher Inst, Freiestr 1, CH-3012 Bern, Switzerland.			Wells, Timothy/0000-0001-9796-847X				Asazuma N, 1997, BLOOD, V90, P4789, DOI 10.1182/blood.V90.12.4789.4789_4789_4798; Asselin J, 1997, BLOOD, V89, P1235, DOI 10.1182/blood.V89.4.1235; Benda B, 1996, TRANSPLANTATION, V62, P1207, DOI 10.1097/00007890-199611150-00003; Chung CH, 1999, BIOCHEM BIOPH RES CO, V263, P723, DOI 10.1006/bbrc.1999.1457; Eble JA, 2001, J BIOL CHEM, V276, P12274, DOI 10.1074/jbc.M009338200; Gao J, 1997, EMBO J, V16, P6414, DOI 10.1093/emboj/16.21.6414; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; Gibbins JM, 1997, FEBS LETT, V413, P255, DOI 10.1016/S0014-5793(97)00926-5; HUANG TF, 1995, BIOCHEM J, V309, P1021, DOI 10.1042/bj3091021; Ichinohe T, 1997, J BIOL CHEM, V272, P63; Inoue K, 1999, BIOCHEM BIOPH RES CO, V256, P114, DOI 10.1006/bbrc.1999.0295; Jung SM, 1998, J BIOL CHEM, V273, P14827, DOI 10.1074/jbc.273.24.14827; Kato Y, 1998, BIOCHEM BIOPH RES CO, V242, P250, DOI 10.1006/bbrc.1997.7917; Keely PJ, 1996, J BIOL CHEM, V271, P26668, DOI 10.1074/jbc.271.43.26668; Kehrel B, 1998, BLOOD, V91, P491; KEHREL B, 1995, SEMIN THROMB HEMOST, V21, P123, DOI 10.1055/s-2007-1000386; KIEFFER N, 1991, J CELL BIOL, V113, P451, DOI 10.1083/jcb.113.2.451; Lankhof H, 1996, THROMB HAEMOSTASIS, V75, P950; MAZUROV AV, 1991, THROMB RES, V62, P673, DOI 10.1016/0049-3848(91)90371-3; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; Moroi M, 1997, THROMB HAEMOSTASIS, V78, P439; Moroi M, 1997, BLOOD, V90, P4413; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; MORTON LF, 1989, BIOCHEM J, V258, P157, DOI 10.1042/bj2580157; MORTON LF, 1994, BIOCHEM J, V299, P791, DOI 10.1042/bj2990791; MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337; Nakamura T, 1998, J BIOL CHEM, V273, P4338, DOI 10.1074/jbc.273.8.4338; NIEUWENHUIS HK, 1985, NATURE, V318, P470, DOI 10.1038/318470a0; PolanowskaGrabowska R, 1997, BLOOD, V90, P1516, DOI 10.1182/blood.V90.4.1516.1516_1516_1526; POLANOWSKAGRABOWSKA R, 1993, BIOCHEM J, V296, P543, DOI 10.1042/bj2960543; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; Polgar J, 1997, BIOCHEM J, V323, P533, DOI 10.1042/bj3230533; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; SANTORO SA, 1995, THROMB HAEMOSTASIS, V74, P813; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; Shin Y, 1998, BIOCHEM BIOPH RES CO, V245, P741, DOI 10.1006/bbrc.1998.8516; Suzuki-Inoue K, 2001, J BIOL CHEM, V276, P1643, DOI 10.1074/jbc.M006191200; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; TENG CM, 1993, THROMB HAEMOSTASIS, V69, P286; Tsuji M, 1997, J BIOL CHEM, V272, P23528, DOI 10.1074/jbc.272.38.23528; Tuckwell DS, 1996, EUR J BIOCHEM, V241, P732, DOI 10.1111/j.1432-1033.1996.00732.x; WHITE JG, 1993, LAB INVEST, V68, P497; XIA ZM, 1994, BIOPHYS J, V66, P2190, DOI 10.1016/S0006-3495(94)81015-X	43	65	73	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20882	20889		10.1074/jbc.M101585200	http://dx.doi.org/10.1074/jbc.M101585200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11287424	hybrid			2022-12-27	WOS:000169297900014
J	Saint-Dic, D; Chang, SC; Taylor, GS; Provot, MM; Ross, TS				Saint-Dic, D; Chang, SC; Taylor, GS; Provot, MM; Ross, TS			Regulation of the Src homology 2-containing inositol 5-phosphatase SHIP1 in HIP1/PDGF beta R-transformed cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOMONOCYTIC LEUKEMIA; PDGF-BETA-R; POLYPHOSPHATE 5-PHOSPHATASE; MYELOGENOUS LEUKEMIA; RECEPTOR-BETA; FUSION; PROTEIN; GENE; PHOSPHATASE; ACTIVATION	It has been shown previously that the Huntingtin interacting protein 1 gene (HIP1) was fused to the platelet-derived growth factor beta receptor gene (PDGF betaR) in leukemic cells of a patient with chronic myelomonocytic leukemia. This resulted in the expression of the chimeric HIP1/PDGF betaR protein, which oligomerizes, is constitutively tyrosine-phosphorylated, and transforms the Ba/F3 murine hematopoietic cell line to interleukin-3-independent growth. Tyrosine phosphorylation of a 130-kDa protein (p130) correlates with transformation by HIP1/PDGF betaR and related transforming mutants. We report here that the p130 band is immunologically related to the 125-kDa isoform of the Src homology 2-containing inositol B-phosphatase, SHIP1. We have found that SHIP1 associates and colocalizes with the HIP1/ PDGF betaR fusion protein and related transforming mutants, These mutants include a mutant that has eight Src homology 2-binding phosphotyrosines mutated to phenylalanine, In contrast, SHIP1 does not associate with WP(KI), the kinase-dead form of HIP1/PDGF betaR. We also report that phosphorylation of SHIP1 by HIP1/PDGF betaR does not change its 5-phosphatase-specific activity. This suggests that phosphorylation and possible PDGF betaR-mediated sequestration of SHIP1 from its substrates (PtdIns(3,4,5)P-3 and Ins(1,3,4,5)P-4) might alter the levels of these inositol-containing signal transduction molecules, resulting in activation of downstream effecters of cellular proliferation and/or survival.	Univ Michigan, Ctr Canc, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ross, TS (corresponding author), Univ Michigan, Ctr Canc, Sch Med, Dept Internal Med, 4217 CCGC Box 0936,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	tsross@umich.edu		Ross, Theodora/0000-0002-9166-1802	NCI NIH HHS [K08 CA76025-01, R01 CA82363-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082363, K08CA076025] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe A, 1997, BLOOD, V90, P4271, DOI 10.1182/blood.V90.11.4271.4271_4271_4277; Carroll M, 1996, P NATL ACAD SCI USA, V93, P14845, DOI 10.1073/pnas.93.25.14845; Chacko GW, 1996, J IMMUNOL, V157, P2234; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; Damen JE, 1998, BLOOD, V92, P1199, DOI 10.1182/blood.V92.4.1199.416k16_1199_1205; de Groot RP, 1998, CELL SIGNAL, V10, P619, DOI 10.1016/S0898-6568(98)00023-0; delPeso L, 1996, J CELL BIOCHEM, V61, P599, DOI 10.1002/(SICI)1097-4644(19960616)61:4<599::AID-JCB14>3.0.CO;2-B; Geier SJ, 1997, BLOOD, V89, P1876, DOI 10.1182/blood.V89.6.1876; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Lamkin TD, 1997, J BIOL CHEM, V272, P10396; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Liu QR, 1998, BLOOD, V91, P2753, DOI 10.1182/blood.V91.8.2753.2753_2753_2759; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Osborne MA, 1996, J BIOL CHEM, V271, P29271, DOI 10.1074/jbc.271.46.29271; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Phee H, 2000, J BIOL CHEM, V275, P19090, DOI 10.1074/jbc.M001093200; Ross TS, 1999, J BIOL CHEM, V274, P22328, DOI 10.1074/jbc.274.32.22328; Ross TS, 1998, BLOOD, V91, P4419, DOI 10.1182/blood.V91.12.4419.412k43_4419_4426; Sattler M, 1999, MOL CELL BIOL, V19, P7473; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Tomasson MH, 1999, BLOOD, V93, P1707, DOI 10.1182/blood.V93.5.1707.405k24_1707_1714; Tomasson MH, 2000, J CLIN INVEST, V105, P423, DOI 10.1172/JCI8902; Wilbanks AM, 2000, EXP HEMATOL, V28, P584, DOI 10.1016/S0301-472X(00)00138-7; Wisniewski D, 1999, BLOOD, V93, P2707, DOI 10.1182/blood.V93.8.2707.408k17_2707_2720	27	12	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21192	21198		10.1074/jbc.M008336200	http://dx.doi.org/10.1074/jbc.M008336200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11287412	hybrid			2022-12-27	WOS:000169297900054
J	Whittle, E; Shanklin, J				Whittle, E; Shanklin, J			Engineering Delta(9)-16 : 0-acyl carrier protein (ACP) desaturase specificity based on combinatorial saturation mutagenesis and logical redesign of the castor Delta(9)-18 : 0-ACP desaturase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; SUBSTRATE-SPECIFICITY; DIRECTED EVOLUTION; ESCHERICHIA-COLI; SEED; EXPRESSION; PLANTS; GENE; BIOSYNTHESIS; FERREDOXIN	Six amino acid locations in the soluble castor Delta (9)-18:0-acyl carrier protein (ACP) desaturase were identified that can affect substrate specificity. Combinatorial saturation mutagenesis of these six amino acids, in conjunction with selection, using an unsaturated fatty acid auxotroph system, led to the isolation of variants with up to Iii-fold increased specific activity toward 16-carbon substrates. The most improved mutant, com2, contained two substitutions (T117R/G188L) common to five of the 19 complementing variants subjected to further analysis. These changes, when engineered into otherwise wild-type 18:0-ACP desaturase to make mutant 5,2, produced a 35-fold increase in specific activity with respect to le-carbon substrates, Kinetic analysis revealed changes in both k(cat) and K-m that result in an 82-fold improvement in specificity factor for Is-carbon substrate compared with wild-type enzyme. Improved substrate orientation apparently compensated for loss of binding energy that results from the loss of desolvation energy for 16-carbon substrates. Mutant 5.2 had specific activity for 16-carbon substrates 2 orders of magnitude higher than those of known natural 16-carbon specific desaturases. These data support the hypothesis that it should be possible to reengineer archetypal enzymes to achieve substrate specificities characteristic of recently evolved enzymes while retaining the desired stability and/or turnover characteristics of a parental paralog.	Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Shanklin, J (corresponding author), Brookhaven Natl Lab, Dept Biol, Bldg 463,50 Bell Ave, Upton, NY 11973 USA.			Shanklin, John/0000-0002-6774-8043				Aguilar PS, 1998, J BACTERIOL, V180, P2194, DOI 10.1128/JB.180.8.2194-2200.1998; Arnold FH, 1999, CURR OPIN CHEM BIOL, V3, P54, DOI 10.1016/S1367-5931(99)80010-6; BEREMAND PD, 1987, ARCH BIOCHEM BIOPHYS, V256, P90, DOI 10.1016/0003-9861(87)90428-0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Broadwater JA, 1998, FETT-LIPID, V100, P103; Cahoon EB, 1997, PLANT MOL BIOL, V33, P1105, DOI 10.1023/A:1005821007291; Cahoon EB, 1998, PLANT PHYSIOL, V117, P593, DOI 10.1104/pp.117.2.593; Cahoon EB, 2000, P NATL ACAD SCI USA, V97, P12350, DOI 10.1073/pnas.210276297; Cahoon EB, 1997, P NATL ACAD SCI USA, V94, P4872, DOI 10.1073/pnas.94.10.4872; Cahoon EB, 1996, J BACTERIOL, V178, P936, DOI 10.1128/jb.178.3.936-939.1996; CAHOON EB, 1992, P NATL ACAD SCI USA, V89, P11184, DOI 10.1073/pnas.89.23.11184; CAHOON EB, 1994, PROG LIPID RES, V33, P155, DOI 10.1016/0163-7827(94)90018-3; CAHOON EB, 1994, J BIOL CHEM, V269, P27519; Cannon WR, 1996, NAT STRUCT BIOL, V3, P821, DOI 10.1038/nsb1096-821; GIBSON KJ, 1993, BIOCHIM BIOPHYS ACTA, V1169, P231, DOI 10.1016/0005-2760(93)90245-5; GOLDSTEIN RA, 2001, IN PRESS PROTEIN FOL; Govindarajan S, 1998, P NATL ACAD SCI USA, V95, P5545, DOI 10.1073/pnas.95.10.5545; Haas JA, 1999, BIOCHEMISTRY-US, V38, P12833, DOI 10.1021/bi991318a; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Leatherbarrow R. J., 1992, GRAFIT VERSION 3 0; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; MCKEON TA, 1982, J BIOL CHEM, V257, P2141; Minshull J, 1999, CURR OPIN CHEM BIOL, V3, P284, DOI 10.1016/S1367-5931(99)80044-1; Miyazaki K, 1999, J MOL EVOL, V49, P716, DOI 10.1007/PL00006593; POSTBEITTENMILLER D, 1991, J BIOL CHEM, V266, P1858; ROUGHAN G, 1990, ARCH BIOCHEM BIOPHYS, V276, P38, DOI 10.1016/0003-9861(90)90007-L; Schultz DJ, 2000, PLANT PHYSIOL, V124, P681, DOI 10.1104/pp.124.2.681; Schultz DJ, 1996, P NATL ACAD SCI USA, V93, P8771, DOI 10.1073/pnas.93.16.8771; Shanklin J, 2000, CURR OPIN PLANT BIOL, V3, P243, DOI 10.1016/S1369-5266(00)00071-6; SHANKLIN J, 1991, P NATL ACAD SCI USA, V88, P2510, DOI 10.1073/pnas.88.6.2510; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Suh MC, 1999, PLANT J, V17, P679, DOI 10.1046/j.1365-313X.1999.00418.x; WHITTY A, 1995, BIOCHEMISTRY-US, V34, P11678, DOI 10.1021/bi00037a005; YAMAMOTO K, 1991, CHEM PHYS LIPIDS, V60, P39, DOI 10.1016/0009-3084(91)90013-2	36	72	92	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21500	21505		10.1074/jbc.M102129200	http://dx.doi.org/10.1074/jbc.M102129200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11294879	hybrid			2022-12-27	WOS:000169297900094
J	Bannerman, DD; Tupper, JC; Ricketts, WA; Bennett, CF; Winn, RK; Harlan, JM				Bannerman, DD; Tupper, JC; Ricketts, WA; Bennett, CF; Winn, RK; Harlan, JM			A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; DISSEMINATED INTRAVASCULAR COAGULATION; MULTIPLE ORGAN FAILURE; BACTERIAL LIPOPOLYSACCHARIDE; ESCHERICHIA-COLI; CYTOCHROME-C; FACTOR-ALPHA; LUNG INJURY; ANTISENSE OLIGONUCLEOTIDES	Lipopolysaccharide (LPS) has been implicated as the bacterial component responsible for much of the endothelial cell injury/dysfunction associated with Gramnegative bacterial infections. Protein synthesis inhibition is required to sensitize the endothelium to lipopolysaccharide-induced apoptosis, suggesting that a constitutive or inducible cytoprotective protein(s) is required for endothelial survival. We have identified two known endothelial anti-apoptotic proteins, c-FLIP and Mcl-1, the expression of which is decreased markedly in the presence of cycloheximide. Decreased expression of both proteins preceded apoptosis evoked by lipopolysaccharide + cycloheximide, Caspase inhibition protected against apoptosis, but not the decreased expression of c-FLIP and Mcl-1, suggesting that they exert protection upstream of caspase activation. Inhibition of the degradation of these two proteins with the proteasome inhibitor, lactacystin, prevented lipopolysaccharide + cycloheximide-induced apoptosis, Similarly, lactacystin protected against endothelial apoptosis induced by either tumor necrosis factor-alpha or interleukin-1 beta in the presence of cycloheximide. That apoptosis could be blocked in the absence of new protein synthesis by inhibition of the proteasome degradative pathway implicates the requisite involvement of a constitutively expressed protein(s) in the endothelial cytoprotective pathway. Finally, reduction of FLIP expression with antisense oligonucleotides sensitized endothelial cells to LPS killing, demonstrating a definitive role for FLIP in the protection of endothelial cells from LPS-induced apoptosis.	Univ Washington, Div Hematol, Seattle, WA 98104 USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98104 USA; Univ Washington, Sch Med, Dept Surg, Seattle, WA 98104 USA; ISIS Pharmaceut, Dept Mol Pharmacol, Carlsbad, CA 92008 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Isis Pharmaceuticals Inc	Bannerman, DD (corresponding author), Univ Washington, Div Hematol, Box 359756,Harborview R&T Bldg,Rm 521,325 9th Ave, Seattle, WA 98104 USA.	dbannerm@u.washington.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042686] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL03174, HL59969] Funding Source: Medline; NIGMS NIH HHS [GM42686, GM07037] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackermann EJ, 1999, J BIOL CHEM, V274, P11245, DOI 10.1074/jbc.274.16.11245; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Armstrong RC, 1996, J BIOL CHEM, V271, P16850, DOI 10.1074/jbc.271.28.16850; ASHANY D, 1995, P NATL ACAD SCI USA, V92, P11225, DOI 10.1073/pnas.92.24.11225; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bannerman DD, 1999, LAB INVEST, V79, P1181; Bannerman DD, 1998, J BIOL CHEM, V273, P35371, DOI 10.1074/jbc.273.52.35371; BENNETT CF, 1994, J IMMUNOL, V152, P3530; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; BRANDTZAEG P, 1989, J INFECT DIS, V159, P195, DOI 10.1093/infdis/159.2.195; BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913; Choi KB, 1998, J BIOL CHEM, V273, P20185, DOI 10.1074/jbc.273.32.20185; CREASEY AA, 1991, CIRC SHOCK, V33, P84; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Frey EA, 1998, MICROB PATHOGENESIS, V24, P101, DOI 10.1006/mpat.1997.0178; Fujita M, 1998, INT ARCH ALLERGY IMM, V117, P202, DOI 10.1159/000024011; GAYNOR E, 1970, SCIENCE, V170, P986, DOI 10.1126/science.170.3961.986; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; Hinshaw LB, 1996, CRIT CARE MED, V24, P1072, DOI 10.1097/00003246-199606000-00031; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; Hoyt DG, 1996, AM J PHYSIOL-LUNG C, V270, pL689, DOI 10.1152/ajplung.1996.270.4.L689; HOYT DG, 1995, AM J PHYSIOL-LUNG C, V269, pL171, DOI 10.1152/ajplung.1995.269.2.L171; Hu XL, 1998, BLOOD, V92, P2759, DOI 10.1182/blood.V92.8.2759.420k29_2759_2765; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kalogeris TJ, 1999, AM J PHYSIOL-CELL PH, V276, pC856, DOI 10.1152/ajpcell.1999.276.4.C856; Karsan A, 1996, J BIOL CHEM, V271, P27201, DOI 10.1074/jbc.271.44.27201; Karsan A, 1997, AM J PATHOL, V151, P1775; Kawasaki M, 2000, AM J PATHOL, V157, P597, DOI 10.1016/S0002-9440(10)64570-1; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LEVI M, 1993, JAMA-J AM MED ASSOC, V270, P975, DOI 10.1001/jama.270.8.975; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Madge LA, 2000, J BIOL CHEM, V275, P15458, DOI 10.1074/jbc.M001237200; McKay RA, 1999, J BIOL CHEM, V274, P1715, DOI 10.1074/jbc.274.3.1715; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; MONIA BP, 1993, J BIOL CHEM, V268, P14514; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pammer J, 1999, BIOCHEM BIOPH RES CO, V264, P139, DOI 10.1006/bbrc.1999.1436; POHLMAN TH, 1989, CELL IMMUNOL, V119, P41, DOI 10.1016/0008-8749(89)90222-0; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; REIDY MA, 1983, LAB INVEST, V48, P25; Rosse T, 1998, NATURE, V391, P496, DOI 10.1038/35160; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; SAWDEY M, 1989, J BIOL CHEM, V264, P10396; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thijs L G, 1993, Intensive Care Med, V19 Suppl 1, pS8, DOI 10.1007/BF01738944; Thijs LG, 1996, CURR TOP MICROBIOL, V216, P209; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; ULEVITCH RJ, 1975, J EXP MED, V142, P1570, DOI 10.1084/jem.142.6.1570; Vaishnaw AK, 1999, J CLIN INVEST, V103, P355, DOI 10.1172/JCI5121; VAN AD, 1996, SCIENCE, V274, P787; WAKABAYASHI GO, 1991, FASEB J, V5, P338, DOI 10.1096/fasebj.5.3.1825816; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zen K, 1999, J BIOL CHEM, V274, P28808, DOI 10.1074/jbc.274.40.28808; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611; ZHANG XM, 1994, MICROBIOL IMMUNOL, V38, P669, DOI 10.1111/j.1348-0421.1994.tb01838.x; ZIEGLER EJ, 1982, NEW ENGL J MED, V307, P1225, DOI 10.1056/NEJM198211113072001	72	94	102	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14924	14932		10.1074/jbc.M100819200	http://dx.doi.org/10.1074/jbc.M100819200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279137	hybrid			2022-12-27	WOS:000168528800055
J	Fisher, EA; Pan, M; Chen, XL; Wu, XY; Wang, HX; Jamil, H; Sparks, JD; Williams, KJ				Fisher, EA; Pan, M; Chen, XL; Wu, XY; Wang, HX; Jamil, H; Sparks, JD; Williams, KJ			The triple threat to nascent apolipoprotein B - Evidence for multiple, distinct degradative pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; TRIGLYCERIDE TRANSFER PROTEIN; HEPARAN-SULFATE PROTEOGLYCANS; UBIQUITIN-PROTEASOME PATHWAY; PLACEBO-CONTROLLED TRIAL; N-3 FATTY-ACIDS; HEP G2 CELLS; INTRACELLULAR DEGRADATION; INSULIN-RESISTANCE; RAT HEPATOCYTES	We previously showed that Omega -3 fatty acids reduce secretion of apolipoprotein B (apoB) from cultured hepatocytes by stimulating post-translational degradation. In this report, we now characterize this process, particularly in regard to the two known processes that degrade newly synthesized apoB, endoplasmic reticulum (ER)-associated degradation and re-uptake from the cell surface. First, we found that Omega -3-induced degradation preferentially reduces the secretion of large, assembled apoB-lipoprotein particles, and apoB polypeptide length is not a determinant. Second, based on several experimental approaches, ER-associated degradation is not involved. Third, re-uptake, the only process known to destroy fully assembled nascent lipoproteins, was clearly active in primary hepatocytes, but Omega -3-induced degradation of apoB continued even when re-uptake was blocked. Cell fractionation showed that Omega -3 fatty acids induced a striking loss of apoB(100) from the Golgi, while sparing apoB(100) in the ER, indicating a post-ER process. To determine the signaling involved, we used wortmannin, a phosphatidylinositol 3-kinase (PI3K) inhibitor, which blocked most, if not all, of the Omega -3 fatty acid effect. Therefore, nascent apoB is subject to ER-associated degradation, re-uptake, and a third distinct degradative pathway that appears to target lipoproteins after considerable assembly and involves a post-ER compartment and PI3K signaling. Physiologic, pathophysiologic, and pharmacologic regulation of net apoB secretion may involve alterations in any of these three degradative steps.	Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, Lab Lipoprot Res, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; Bristol Myers Squibb Co, Div Metab Dis, Princeton, NJ 08543 USA; Univ Rochester, Sch Med, Dept Pathol & Lab Med, Rochester, NY 14642 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Med,Dorrance H Hamilton Res Labs, Div Endocrinol Diabet & Metab Dis, Philadelphia, PA 19107 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Bristol-Myers Squibb; University of Rochester; Jefferson University	Fisher, EA (corresponding author), Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, Lab Lipoprot Res, 1 Gustave Levy Pl,Box 1269, New York, NY 10029 USA.	edward.fisher@mssm.edu	Fisher, Edward/ABE-7469-2020	Williams, Kevin Jon/0000-0002-0000-2159; Fisher, Edward/0000-0001-9802-143X; Sparks, Janet/0000-0002-0072-766X	NHLBI NIH HHS [HL58884, HL38956, HL22263, HL58541, T32-HL07824] Funding Source: Medline; NIDDK NIH HHS [DK50376] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058884, T32HL007824, R01HL058541, R01HL038956, R29HL038956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050376] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; BAMBERGER MJ, 1990, P NATL ACAD SCI USA, V87, P2390, DOI 10.1073/pnas.87.7.2390; BAMBERGER MJ, 1988, J BIOL CHEM, V263, P11868; BANUELOS S, 1995, J BIOL CHEM, V270, P29910, DOI 10.1074/jbc.270.50.29910; Benoist F, 1997, J BIOL CHEM, V272, P20435, DOI 10.1074/jbc.272.33.20435; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brunzell JD, 1999, DIABETES CARE, V22, pC10; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Cartwright IJ, 1996, BIOCHEM J, V314, P977, DOI 10.1042/bj3140977; Chauhan V, 1998, BIOCHEMISTRY-US, V37, P3735, DOI 10.1021/bi9718853; Chirieac DV, 2000, AM J PHYSIOL-ENDOC M, V279, pE1003, DOI 10.1152/ajpendo.2000.279.5.E1003; Davis RA, 1999, BBA-MOL CELL BIOL L, V1440, P1, DOI 10.1016/S1388-1981(99)00083-9; DIXON JL, 1993, J LIPID RES, V34, P167; DIXON JL, 1991, J BIOL CHEM, V266, P5080; FAZIO S, 1992, J BIOL CHEM, V267, P6941; FAZIO S, 1995, ARTERIOSCL THROM VAS, V15, P593, DOI 10.1161/01.ATV.15.5.593; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607; Fuki IV, 2000, J BIOL CHEM, V275, P25742, DOI 10.1074/jbc.M909173199; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; FURUKAWA S, 1992, J BIOL CHEM, V267, P22630; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; HARRIS WS, 1989, J LIPID RES, V30, P785; HARRISON JC, 1988, J LIPID RES, V29, P1439; HOEG JM, 1988, J LIPID RES, V29, P1215; Horton JD, 1999, J CLIN INVEST, V103, P1067, DOI 10.1172/JCI6246; HUFF MW, 1992, ARTERIOSCLER THROMB, V12, P902, DOI 10.1161/01.ATV.12.8.902; HUSSAIN MM, 1989, BIOCHIM BIOPHYS ACTA, V1001, P90; James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s; JAMIL H, 1995, J BIOL CHEM, V270, P6549, DOI 10.1074/jbc.270.12.6549; Jamil H, 1996, P NATL ACAD SCI USA, V93, P11991, DOI 10.1073/pnas.93.21.11991; Jamil H, 1998, J LIPID RES, V39, P1448; JANERO DR, 1983, J BIOL CHEM, V258, P4496; KAMANNA VS, 1989, BIOCHEM BIOPH RES CO, V162, P1508, DOI 10.1016/0006-291X(89)90845-0; KLEINMAN Y, 1988, J LIPID RES, V29, P729; Liang JS, 1998, J BIOL CHEM, V273, P35216, DOI 10.1074/jbc.273.52.35216; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAGUIRE GF, 1989, J LIPID RES, V30, P757; Mahley RW, 1999, J LIPID RES, V40, P1; Mensenkamp AR, 1999, J BIOL CHEM, V274, P35711, DOI 10.1074/jbc.274.50.35711; Mitchell DM, 1998, P NATL ACAD SCI USA, V95, P14733, DOI 10.1073/pnas.95.25.14733; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Mulligan K, 2000, J ACQ IMMUN DEF SYND, V23, P35, DOI 10.1097/00042560-200001010-00005; NEURATH H, 1989, PROTEOLYTIC ENZYMES, P1; Phung TL, 1997, J BIOL CHEM, V272, P30693, DOI 10.1074/jbc.272.49.30693; Rustaeus S, 1999, J NUTR, V129, p463S, DOI 10.1093/jn/129.2.463S; SALAMERO J, 1990, P NATL ACAD SCI USA, V87, P7717, DOI 10.1073/pnas.87.19.7717; SATO R, 1990, J BIOL CHEM, V265, P11880; Singh RB, 1997, CARDIOVASC DRUG THER, V11, P485, DOI 10.1023/A:1007757724505; SORCITHOMAS M, 1992, J LIPID RES, V33, P1147; SPARKS JD, 1986, ATHEROSCLEROSIS, V61, P205, DOI 10.1016/0021-9150(86)90139-5; SPARKS JD, 1992, J CLIN INVEST, V89, P1418, DOI 10.1172/JCI115731; Sparks JD, 1996, BIOCHEM J, V313, P567, DOI 10.1042/bj3130567; SPARKS JD, 1990, J BIOL CHEM, V265, P8854; SPARKS JD, 1994, BBA-LIPID LIPID MET, V1215, P9, DOI 10.1016/0005-2760(94)90088-4; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Taghibiglou C, 2000, J BIOL CHEM, V275, P8416, DOI 10.1074/jbc.275.12.8416; Tsukamoto K, 2000, J LIPID RES, V41, P253; Twisk J, 2000, J CLIN INVEST, V105, P521, DOI 10.1172/JCI8623; VANCE JE, 1990, ANNU REV NUTR, V10, P337, DOI 10.1146/annurev.nu.10.070190.002005; VENTURA MA, 1989, J CLIN INVEST, V84, P528, DOI 10.1172/JCI114195; VERKADE HJ, 1993, J BIOL CHEM, V268, P24990; Vermeulen PS, 1997, J LIPID RES, V38, P447; Vigouroux C, 1999, DIABETES METAB, V25, P225; von Schacky C, 1999, ANN INTERN MED, V130, P554, DOI 10.7326/0003-4819-130-7-199904060-00003; WANG HX, 1993, J CLIN INVEST, V91, P1380, DOI 10.1172/JCI116340; WANG HX, 1994, J BIOL CHEM, V269, P18514; WETTERAU JR, 1992, SCIENCE, V258, P999; Williams KJ, 1997, CURR OPIN LIPIDOL, V8, P253; WILLIAMS KJ, 1992, J BIOL CHEM, V267, P13284; WILLIAMS KJ, 1990, J BIOL CHEM, V265, P16741; Williams KJ, 1999, CIRCULATION, V100, P109; Williams KJ, 2001, CURR OPIN LIPIDOL, V12, P235, DOI 10.1097/00041433-200104000-00018; WILLIAMS KJ, 1991, J CLIN INVEST, V88, P1300, DOI 10.1172/JCI115434; WONG SH, 1989, ARTERIOSCLEROSIS, V9, P836, DOI 10.1161/01.ATV.9.6.836; YAO ZM, 1988, J BIOL CHEM, V263, P2998; Yao ZM, 1997, J LIPID RES, V38, P1937; Yeung SJ, 1996, BIOCHEMISTRY-US, V35, P13843, DOI 10.1021/bi9618777; Zhao Y, 2000, MOL BIOL CELL, V11, P721, DOI 10.1091/mbc.11.2.721; Zhou MY, 1998, J BIOL CHEM, V273, P24649, DOI 10.1074/jbc.273.38.24649; Ziegler O, 1996, DIABETES METAB, V22, P179	82	158	209	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2001	276	30					27855	27863		10.1074/jbc.M008885200	http://dx.doi.org/10.1074/jbc.M008885200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	456QH	11285257	hybrid			2022-12-27	WOS:000170093400017
J	Berger, CEM; Fagnant, PM; Heizmann, S; Trybus, KM; Geeves, MA				Berger, CEM; Fagnant, PM; Heizmann, S; Trybus, KM; Geeves, MA			ADP binding induces an asymmetry between the heads of unphosphorylated myosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; PHOSPHORYLATION-DEPENDENT REGULATION; HEAVY-MEROMYOSIN; KINESIN ATPASE; 2 HEADS; ACTIN; SUBFRAGMENT-1; TROPOMYOSIN; CONTRACTION; MECHANISM	Light chain phosphorylation is the key event that regulates smooth and non-muscle myosin II ATPase activity. Here we show that both heads of smooth muscle heavy meromyosin (HMM) bind tightly to actin in the absence of nucleotide, irrespective of the state of light chain phosphorylation. In striking contrast, only one of the two heads of unphosphorylated HMM binds to actin in the presence of ADP, and the heads have different affinities for ADP. This asymmetry suggests that phosphorylation alters the mechanical coupling between the heads of HMM. A model that incorporates strain between the two heads is proposed to explain the data, which have implications for how one head of a motor protein can gate the response of the other.	Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England; Univ Vermont, Dept Physiol & Mol Biophys, Burlington, VT 05405 USA	University of Kent; University of Vermont	Geeves, MA (corresponding author), Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England.		Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038113, R01HL038113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR041637] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 38113] Funding Source: Medline; NIAMS NIH HHS [P01-AR41637] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BENNETT AJ, 1986, BIOCHEM J, V233, P179, DOI 10.1042/bj2330179; Conibear PB, 1998, BIOPHYS J, V75, P926, DOI 10.1016/S0006-3495(98)77581-2; CREMO CR, 1995, J BIOL CHEM, V270, P2171, DOI 10.1074/jbc.270.5.2171; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Cross RA, 1999, CURR BIOL, V9, pR854, DOI 10.1016/S0960-9822(00)80045-7; GILBERT SP, 1994, BIOCHEMISTRY-US, V33, P1951, DOI 10.1021/bi00173a044; GREENE LE, 1981, BIOCHEMISTRY-US, V20, P2120, DOI 10.1021/bi00511a008; HACKNEY DD, 1984, P NATL ACAD SCI-BIOL, V81, P5345, DOI 10.1073/pnas.81.17.5345; Kurzawa SE, 1996, J MUSCLE RES CELL M, V17, P669, DOI 10.1007/BF00154061; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; MCKILLOP DFA, 1990, BIOCHEM SOC T, V18, P585, DOI 10.1042/bst0180585; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Rosenfeld SS, 1998, J BIOL CHEM, V273, P28682, DOI 10.1074/jbc.273.44.28682; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Trybus KM, 1997, P NATL ACAD SCI USA, V94, P48, DOI 10.1073/pnas.94.1.48; Wendt T, 1999, J CELL BIOL, V147, P1385, DOI 10.1083/jcb.147.7.1385; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; WOODWARD SKA, 1991, BIOCHEMISTRY-US, V30, P422, DOI 10.1021/bi00216a017	20	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23240	23245		10.1074/jbc.M100524200	http://dx.doi.org/10.1074/jbc.M100524200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11301326	hybrid			2022-12-27	WOS:000169531100005
J	Bahring, R; Milligan, CJ; Vardanyan, V; Engeland, B; Young, BA; Dannenberg, J; Waldschutz, R; Edwards, JP; Wray, D; Pongs, O				Bahring, R; Milligan, CJ; Vardanyan, V; Engeland, B; Young, BA; Dannenberg, J; Waldschutz, R; Edwards, JP; Wray, D; Pongs, O			Coupling of voltage-dependent potassium channel inactivation and oxidoreductase active site of Kv beta subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; K+ CHANNELS; RAT-BRAIN; ALPHA-SUBUNITS; DOMAIN; MUTAGENESIS; EXPRESSION; MODULATION	The accessory beta subunits of voltage-dependent potassium (Kv) channels form tetramers arranged with 4-fold rotational symmetry like the membrane-integral and pore-forming alpha subunits (Gulbis, J. M., Mann, S., and MacKinnon, R. (1999) Cell. 90, 943-952). The crystal structure of the Kv beta2 subunit shows that Kv beta subunits are oxidoreductase enzymes containing an active site composed of conserved catalytic residues, a nicotinamide (NADPH)-cofactor, and a substrate binding site. Also, Kv beta subunits with an N-terminal inactivating do main like Kv beta1.1 (Rettig, J., Heinemann, S. H., Wunder, F., Lorra, C., Parcej, D. N., Dolly, O., and Pongs, O. (1994) Nature 369, 289-294) and Kv beta3.1 (Heinemann, S. H., Rettig, J., Graack, H. R,, and Pongs, O. (1996) J. Physiol. (Lond.) 493, 625-633) confer rapid N-type inactivation to otherwise non-inactivating channels. Here we show by a combination of structural modeling and electrophysiological characterization of structure-based mutations that changes in Kv beta oxidoreductase activity may markedly influence the gating mode of Kv channels. Amino acid substitutions of the putative catalytic residues in the Kv beta1.1 oxidoreductase active site attenuate the inactivating activity of Kv beta1.1 in Xenopus oocytes. Conversely, mutating the substrate binding domain and/or the cofactor binding domain rescues the failure of Kv beta3.1 to confer rapid inactivation to Kv1.5 channels in Xenopus oocytes. We propose that Kv beta oxidoreductase activity couples Kv channel inactivation to cellular redox regulation.	Univ Hamburg, Zentrum Mol Neurobiol, Inst Neurale Signalverarbeit, D-20246 Hamburg, Germany; Univ Leeds, Dept Physiol, Inst Pharmacol, Leeds LS2 9JT, W Yorkshire, England	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Leeds	Pongs, O (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol, Inst Neurale Signalverarbeit, Martinistr 52, D-20246 Hamburg, Germany.		Bähring, Robert/F-7146-2010	Bahring, Robert/0000-0002-0406-5958				Accili EA, 1997, J BIOL CHEM, V272, P25824, DOI 10.1074/jbc.272.41.25824; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; BOHREN KM, 1994, BIOCHEMISTRY-US, V33, P2021, DOI 10.1021/bi00174a007; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Heinemann SH, 1995, FEBS LETT, V377, P383, DOI 10.1016/0014-5793(95)01377-6; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Leicher T, 1998, J BIOL CHEM, V273, P35095, DOI 10.1074/jbc.273.52.35095; Leicher T, 1996, NEUROPHARMACOLOGY, V35, P787, DOI 10.1016/0028-3908(96)00133-5; Levin G, 1996, J BIOL CHEM, V271, P29321, DOI 10.1074/jbc.271.46.29321; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; McCormack T, 1999, J BIOL CHEM, V274, P20123, DOI 10.1074/jbc.274.29.20123; MORALES MJ, 1995, J BIOL CHEM, V270, P6272, DOI 10.1074/jbc.270.11.6272; PAWLOWSKI JE, 1994, J BIOL CHEM, V269, P13502; Peri R, 2001, J BIOL CHEM, V276, P738, DOI 10.1074/jbc.M008445200; PONGS O, 1995, SEMIN NEUROSCI, V7, P137, DOI 10.1006/smns.1995.0015; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Roeper J, 1998, NATURE, V391, P390, DOI 10.1038/34916; Sewing S, 1996, NEURON, V16, P455, DOI 10.1016/S0896-6273(00)80063-X; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Trimmer JS, 1998, CURR OPIN NEUROBIOL, V8, P370, DOI 10.1016/S0959-4388(98)80063-9; Uebele VN, 1998, AM J PHYSIOL-CELL PH, V274, pC1485, DOI 10.1152/ajpcell.1998.274.6.C1485; WILSON GG, 1994, PFLUG ARCH EUR J PHY, V428, P186, DOI 10.1007/BF00374857; Yu WF, 1996, NEURON, V16, P441, DOI 10.1016/S0896-6273(00)80062-8	29	66	68	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22923	22929		10.1074/jbc.M100483200	http://dx.doi.org/10.1074/jbc.M100483200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294861	hybrid			2022-12-27	WOS:000169412700126
J	Bureau, C; Bernad, J; Chaouche, N; Orfila, C; Beraud, M; Gonindard, C; Alric, L; Vinel, JP; Pipy, B				Bureau, C; Bernad, J; Chaouche, N; Orfila, C; Beraud, M; Gonindard, C; Alric, L; Vinel, JP; Pipy, B			Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD MONONUCLEAR-CELLS; NF-KAPPA-B; HUMAN-IMMUNODEFICIENCY-VIRUS; REACTIVE OXYGEN; RESPIRATORY BURST; NS3 PROTEIN; INFECTED PATIENTS; CYCLIC-AMP; KINASE; EXPRESSION	It has been shown that oxidative stress occurs in chronic hepatitis C. Release of reactive oxygen species (ROS) from sequestered phagocytes and activated resident macrophages represents the predominant component of oxidative stress in the liver. However, little is known about the ability of the monocyte to produce ROS in response to protein of hepatitis C virus. In this study, we investigated the ROS production in human monocytes stimulated by several viral proteins of hepatitis C virus. Human monocytes from healthy blood donors were incubated with recombinant viral protein: Core, NS3, NS4, and NS5. ROS production was measured by chemiluminescence. Only NS3 triggered ROS production in human monocytes. Generated ROS were mainly the anion superoxide. NS3 also induced a rapid and transient increase in intracellular calcium concentration measured by a video digital microscopy technique. By using different metabolic inhibitors, we showed that ROS production requires calcium influx, tyrosine kinases, and the stress-activated protein kinase, p38. The study of p47(PHOX) phosphorylation and translocation showed that NADPH oxidase was activated and involved in ROS production induced by NS3. In a second experiment, NS3 inhibited the oxidative burst induced by phorbol 12-myristate 13-acetate. These results indicate that NS3 activates NADPH oxidase and modulates ROS production, which may be involved in the natural history of hepatitis C infection.	Univ Toulouse 3, Inst Louis Bugnard, UPRES EA 2405, CHU Rangueil,IFR31, F-31403 Toulouse 04, France; CHU Purpan, Federat Digest, F-31059 Toulouse, France	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Pipy, B (corresponding author), Univ Toulouse 3, Inst Louis Bugnard, UPRES EA 2405, CHU Rangueil,IFR31, Batiment L1,1 Ave Jean Poulhes, F-31403 Toulouse 04, France.			Pipy, Bernard/0000-0001-8060-7029				ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Barbaro G, 1999, AM J GASTROENTEROL, V94, P2198, DOI 10.1111/j.1572-0241.1999.01294.x; BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993; BIRONAITE DA, 1992, ARCH BIOCHEM BIOPHYS, V297, P253, DOI 10.1016/0003-9861(92)90669-N; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Bonizzi G, 1999, MOL CELL BIOL, V19, P1950; Borowski P, 1997, J VIROL, V71, P2838, DOI 10.1128/JVI.71.4.2838-2843.1997; Borowski P, 1999, J BIOL CHEM, V274, P30722, DOI 10.1074/jbc.274.43.30722; BOUFFARD P, 1992, J INFECT DIS, V166, P1276, DOI 10.1093/infdis/166.6.1276; Boya P, 1999, J HEPATOL, V31, P808, DOI 10.1016/S0168-8278(99)80281-5; CHOO QL, 1991, P NATL ACAD SCI USA, V88, P2451, DOI 10.1073/pnas.88.6.2451; Dang PMC, 1999, J BIOL CHEM, V274, P20704, DOI 10.1074/jbc.274.29.20704; DeMaria N, 1996, FREE RADICAL BIO MED, V21, P291, DOI 10.1016/0891-5849(96)00044-5; El Benna J, 1999, J LEUKOCYTE BIOL, V66, P1014; FENG L, 1995, J CLIN INVEST, V95, P1669, DOI 10.1172/JCI117842; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Fujita T, 1996, BIOCHEM BIOPH RES CO, V229, P825, DOI 10.1006/bbrc.1996.1887; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; GRIFFIN GE, 1989, NATURE, V339, P70, DOI 10.1038/339070a0; Gwack Y, 1996, BIOCHEM BIOPH RES CO, V225, P654, DOI 10.1006/bbrc.1996.1225; Ishido S, 1997, BIOCHEM BIOPH RES CO, V230, P431, DOI 10.1006/bbrc.1996.5980; KAO JPY, 1989, J BIOL CHEM, V264, P8179; Kaul N, 1996, FREE RADICAL BIO MED, V21, P401, DOI 10.1016/0891-5849(96)00178-5; Lachgar A, 1999, J VIROL, V73, P1447, DOI 10.1128/JVI.73.2.1447-1452.1999; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lal AS, 1999, BIOCHEM BIOPH RES CO, V259, P465, DOI 10.1006/bbrc.1999.0759; Larrea E, 1998, FREE RADICAL BIO MED, V24, P1235, DOI 10.1016/S0891-5849(97)00437-1; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MULLER HM, 1993, J GEN VIROL, V74, P669, DOI 10.1099/0022-1317-74-4-669; Muratori L, 1996, BLOOD, V88, P2768, DOI 10.1182/blood.V88.7.2768.bloodjournal8872768; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; ODONNELL VB, 1993, BIOCHEM J, V290, P41, DOI 10.1042/bj2900041; PACE GW, 1995, FREE RADICAL BIO MED, V19, P523, DOI 10.1016/0891-5849(95)00047-2; Rane MJ, 1997, J IMMUNOL, V159, P5070; Robertson B, 1998, ARCH VIROL, V143, P2493, DOI 10.1007/s007050050479; Sansonno D, 1996, CLIN EXP IMMUNOL, V103, P414; SOZZANI P, 1995, J BIOL CHEM, V270, P5084, DOI 10.1074/jbc.270.10.5084; SUNO M, 1984, BIOCHEM BIOPH RES CO, V125, P1046, DOI 10.1016/0006-291X(84)91389-5; Tai DI, 2000, HEPATOLOGY, V31, P656, DOI 10.1002/hep.510310316; TAUBER AI, 1982, BLOOD, V60, P333; TUKEY JW, 1985, BIOMETRICS, V41, P295, DOI 10.2307/2530666; VONJAGOW G, 1981, FEBS LETT, V136, P19, DOI 10.1016/0014-5793(81)81206-9; Yan SR, 1996, J BIOL CHEM, V271, P23464, DOI 10.1074/jbc.271.38.23464	46	130	131	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23077	23083		10.1074/jbc.M100698200	http://dx.doi.org/10.1074/jbc.M100698200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11304537	hybrid			2022-12-27	WOS:000169412700145
J	Chiang, GG; Sefton, BM				Chiang, GG; Sefton, BM			Specific dephosphorylation of the Lck tyrosine protein kinase at Tyr-394 by the SHP-1 protein-tyrosine phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; SEVERE COMBINED IMMUNODEFICIENCY; TCR SIGNALING THRESHOLDS; INTRAMOLECULAR REGULATION; T-CELLS; C-SRC; PHOSPHORYLATION; ACTIVATION; ZAP-70; SUBSTRATE	The protein-tyrosine phosphatase SHP-1 has been shown to be a negative regulator of multiple signaling pathways in hematopoietic cells. In this study, we demonstrate that SHP-1 dephosphorylates the lymphoid-specific Src family kinase Lck at Tyr-394 when both are transiently co-expressed in nonlymphoid cells. We also demonstrate that a GST-SHP-1 fusion protein specifically dephosphorylates Lck at Tyr-394 in vitro. Because phosphorylation of Tyr-394 activates Lck, the fact that SHP-1 specifically dephosphorylates this site suggests that SHP-1 is a negative regulator of Lck. The failure of SHP-1 to inactivate Lck may contribute to some of the lymphoid abnormalities observed in motheaten mice.	Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Div Biol, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego	Chiang, GG (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Chiang, Gary/0000-0003-3004-7400	NCI NIH HHS [T32-CA09435, CA14195, CA42350] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA014195, R01CA042350, T32CA009435] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAHAM N, 1990, MOL CELL BIOL, V10, P5197, DOI 10.1128/MCB.10.10.5197; AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; Baker M, 2000, EMBO J, V19, P4644, DOI 10.1093/emboj/19.17.4644; Berg KL, 1999, J BIOL CHEM, V274, P35855, DOI 10.1074/jbc.274.50.35855; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Binstadt BA, 1998, J BIOL CHEM, V273, P27518, DOI 10.1074/jbc.273.42.27518; Carter JD, 1999, INT IMMUNOL, V11, P1999, DOI 10.1093/intimm/11.12.1999; CASNELLIE JE, 1982, J BIOL CHEM, V257, P3877; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN S, 1987, MOL CELL PROBE, V1, P73, DOI 10.1016/0890-8508(87)90008-9; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; FLIER JS, 1989, NEW ENGL J MED, V321, P1383, DOI 10.1056/NEJM198911163212007; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; HARRISON T, 1977, VIROLOGY, V77, P319, DOI 10.1016/0042-6822(77)90428-7; Hartley DK, 1999, J BIOL CHEM, V274, P20056, DOI 10.1074/jbc.274.29.20056; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; HURLEY TR, 1989, ONCOGENE, V4, P265; Jiao HY, 1996, MOL CELL BIOL, V16, P6985; Johnson KG, 1999, J IMMUNOL, V162, P3802; KAMPS MP, 1988, ONCOGENE RES, V3, P105; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Kozlowski M, 1998, MOL CELL BIOL, V18, P2089, DOI 10.1128/MCB.18.4.2089; Lorenz U, 1996, P NATL ACAD SCI USA, V93, P9624, DOI 10.1073/pnas.93.18.9624; LUO K, 1990, ONCOGENE, V5, P921; Martin A, 1999, J BIOL CHEM, V274, P21725, DOI 10.1074/jbc.274.31.21725; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Neel BG, 1997, CURR OPIN IMMUNOL, V9, P405, DOI 10.1016/S0952-7915(97)80088-X; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; Pani G, 1996, J EXP MED, V184, P839, DOI 10.1084/jem.184.3.839; PEI DH, 1994, BIOCHEMISTRY-US, V33, P15483, DOI 10.1021/bi00255a030; Plas DR, 1999, J IMMUNOL, V162, P5680; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; REINHERZ EL, 1979, P NATL ACAD SCI USA, V76, P4061, DOI 10.1073/pnas.76.8.4061; Shultz LD, 1997, TRENDS BIOTECHNOL, V15, P302, DOI 10.1016/S0167-7799(97)01060-3; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SIEH M, 1993, EMBO J, V12, P315, DOI 10.1002/j.1460-2075.1993.tb05659.x; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; THOMAS JE, 1991, SCIENCE, V254, P568, DOI 10.1126/science.1719633; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; VEILLETTE A, 1992, ONCOGENE, V7, P971; VORONOVA AF, 1984, MOL CELL BIOL, V4, P2705, DOI 10.1128/MCB.4.12.2705; VORONOVA AF, 1986, NATURE, V319, P682, DOI 10.1038/319682a0; WATTS JD, 1993, J BIOL CHEM, V268, P23275; Wu YJ, 1998, CURR BIOL, V8, P1009, DOI 10.1016/S0960-9822(07)00421-6; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yang J, 2000, J BIOL CHEM, V275, P4066, DOI 10.1074/jbc.275.6.4066; Zhang JY, 1999, J IMMUNOL, V163, P3012	53	95	100	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23173	23178		10.1074/jbc.M101219200	http://dx.doi.org/10.1074/jbc.M101219200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294838	hybrid			2022-12-27	WOS:000169412700158
J	Lai, WS; Blackshear, PJ				Lai, WS; Blackshear, PJ			Interactions of CCCH zinc finger proteins with mRNA - Tristetraprolin-mediated Au-rich element-dependent mRNA degradation can occur in the absence of a poly(A) tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; MESSENGER-RNA DECAY; NUCLEOTIDE-SEQUENCE; GENE; DESTABILIZATION; DEADENYLATION; EXPRESSION; STABILITY; BINDING; TIS11	The CCCH family of tandem zinc finger proteins has recently been shown to promote the turnover of certain mRNAs containing class II AU-rich elements (AREs). In the case of one member of this family, tristetraprolin (TTP), absence of the protein in knockout mice leads to stabilization of two mRNAs containing AREs of this type, those encoding tumor necrosis factor alpha (TNF alpha) and granulocyte-macrophage colony-stimulating factor. To bean to decipher the mechanism by which these zinc finger proteins stimulate the breakdown of this class of mRNAs, we co-transfected TTP and its related CCCH proteins into 293 cells with vectors encoding full-length TNF alpha, granulocyte-macrophage colony-stimulating factor, and interleukin-3 mRNAs. Go-expression of the CCCH proteins caused the rapid turnover of these ARE-containing mRNAs and also promoted the accumulation of stable breakdown intermediates that were truncated at the 3'-end of the mRNA, even further 5' than the 5'-end of the poly(A) tail. To determine whether an intact poly(A) tail was necessary for TTP to promote this type of mRNA degradation, we inserted the TNF alpha ARE into a nonpolyadenylated histone mRNA and also attached a histone 3'-end-processing sequence to the 3'-end of nonpolyadenylated interleukin-3 and TNF alpha mRNAs. In all three cases, TTP stimulated the turnover of the ARE-containing mRNAs, despite the demonstrated absence of a poly(A) tail. These studies indicate that members of this class of CCCH proteins can promote class II ARE containing mRNA turnover even in the absence of a poly(A) tail, suggesting that the processive removal of the poly(A) tail may not be required for this type of CCCH protein-stimulated mRNA turnover.	NIEHS A205, Off Clin REs & Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; Duke Univ, Med Ctr, Dept Med & Biochem, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University	Blackshear, PJ (corresponding author), NIEHS A205, Off Clin REs & Lab Signal Transduct, NIH, 111 Alexandre Dr, Res Triangle Pk, NC 27709 USA.		Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080, Z01ES090080] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; De J, 1999, GENE, V228, P133, DOI 10.1016/S0378-1119(98)00617-9; Dominski Z, 1999, GENE, V239, P1, DOI 10.1016/S0378-1119(99)00367-4; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; GOMPERTS M, 1990, ONCOGENE, V5, P1081; HEXIMER SP, 1993, DNA CELL BIOL, V12, P73, DOI 10.1089/dna.1993.12.73; HURT MM, 1989, NUCLEIC ACIDS RES, V17, P8876, DOI 10.1093/nar/17.21.8876; Jarrousse AS, 1999, J BIOL CHEM, V274, P5925, DOI 10.1074/jbc.274.9.5925; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; LAI WS, 1995, J BIOL CHEM, V270, P25266, DOI 10.1074/jbc.270.42.25266; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 1999, MOL CELL BIOL, V19, P4311; MA QF, 1991, ONCOGENE, V6, P1277; Marzluff William F., 1992, Gene Expression, V2, P93; Mitchell P, 2000, CURR OPIN GENET DEV, V10, P193, DOI 10.1016/S0959-437X(00)00063-0; STANLEY E, 1985, EMBO J, V4, P2569, DOI 10.1002/j.1460-2075.1985.tb03972.x; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; THORENS B, 1987, CELL, V48, P671, DOI 10.1016/0092-8674(87)90245-5; VARNUM BC, 1989, ONCOGENE, V4, P119; Wilson GM, 1999, PROG NUCLEIC ACID RE, V62, P257; Xu NH, 1997, MOL CELL BIOL, V17, P4611, DOI 10.1128/MCB.17.8.4611; Yang L, 1996, MOL CELL BIOL, V16, P3300	23	118	123	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23144	23154		10.1074/jbc.M100680200	http://dx.doi.org/10.1074/jbc.M100680200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11279239	hybrid			2022-12-27	WOS:000169412700155
J	Nozawa, K; Maehara, K; Isobe, K				Nozawa, K; Maehara, K; Isobe, K			Mechanism for the reduction of telomerase expression during muscle cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYC MESSENGER-RNA; REVERSE-TRANSCRIPTASE GENE; C-MYC; MOUSE TELOMERASE; CATALYTIC SUBUNIT; MYOGENIC DIFFERENTIATION; MAMMALIAN TELOMERASE; CODING ELEMENTS; SP-FAMILY; ACTIVATION	Telomerase, the reverse transcriptase that maintains telomere DNA, is usually undetectable in adult human tissues, but is positive in embryonic tissues and in cancers. However, in rodents, several organs of normal adult animals express substantial amounts of telomerase activity. To elucidate relevant control mechanisms operating on the tissue specific expression of telomerase in rodents, we examined the transcriptional regulation of telomerase reverse transcriptase (mTERT) gene in muscle cell differentiation. Reverse transcriptase-polymerase chain reaction analysis showed that the reduction of telomerase activity was caused by the decrease of mTERT mRNA level during myogenesis. Transfections of mTERT promoter showed that the proximal 225-base pair region is the core promoter responsible for basal transcriptional activity and also participates in the reduced transcription after muscle differentiation. Electrophoretic mobility shift assays showed that this region contained the GC-boxes, which bind to Spl family proteins, and the E-box, which binds to c-Myc. Furthermore, DNA binding activities of Sp1, Sp3, and c-Myc were down-regulated during myogenesis. These data suggest that Spl, Sp3, and c-Myc have critical roles of TERT transactivation in mouse, and the lack of these transcription factors cause down-regulation of mTERT gene expression in muscle cells differentiation.	Natl Inst Longev Sci, Dept Basic Gerontol, Morioka, Aichi 4748522, Japan		Isobe, K (corresponding author), Natl Inst Longev Sci, Dept Basic Gerontol, 36-3 Gengo, Morioka, Aichi 4748522, Japan.		isobe, ken-ichi/A-6685-2011	isobe, ken-ichi/0000-0002-8150-2496				Baudino TA, 2001, MOL CELL BIOL, V21, P691, DOI 10.1128/MCB.21.3.691-702.2001; Bestilny LJ, 1996, CANCER RES, V56, P3796; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; CHADENEAU C, 1995, ONCOGENE, V11, P893; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; Dang CV, 1999, MOL CELL BIOL, V19, P1; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Fandos C, 1999, J MOL BIOL, V294, P103, DOI 10.1006/jmbi.1999.3216; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Greenberg RA, 1998, ONCOGENE, V16, P1723, DOI 10.1038/sj.onc.1201933; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; HAGEN G, 1995, J BIOL CHEM, V270, P24989, DOI 10.1074/jbc.270.42.24989; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Holt SE, 1996, MOL CELL BIOL, V16, P2932; Horikawa I, 1999, CANCER RES, V59, P826; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Liang YX, 1996, J BIOL CHEM, V271, P11792, DOI 10.1074/jbc.271.20.11792; Maehara K, 2000, J CELL BIOCHEM, V77, P474, DOI 10.1002/(SICI)1097-4644(20000601)77:3<474::AID-JCB12>3.0.CO;2-H; MAJELLO B, 1994, NUCLEIC ACIDS RES, V22, P4914, DOI 10.1093/nar/22.23.4914; Majello B, 1997, J BIOL CHEM, V272, P4021, DOI 10.1074/jbc.272.7.4021; Martin-Rivera L, 1998, P NATL ACAD SCI USA, V95, P10471, DOI 10.1073/pnas.95.18.10471; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakayama JI, 1997, CELL, V88, P875, DOI 10.1016/S0092-8674(00)81933-9; Nozawa K, 1999, J BIOCHEM, V126, P361, DOI 10.1093/oxfordjournals.jbchem.a022458; O'Hagan RC, 2000, NAT GENET, V24, P113, DOI 10.1038/72761; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Parks CL, 1996, J BIOL CHEM, V271, P4417; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Takakura M, 1999, CANCER RES, V59, P551; Takakura M, 1998, CANCER RES, V58, P1558; Taylor RS, 1996, J INVEST DERMATOL, V106, P759, DOI 10.1111/1523-1747.ep12345811; UDVADIA AJ, 1995, P NATL ACAD SCI USA, V92, P3953, DOI 10.1073/pnas.92.9.3953; Vinals F, 1997, J BIOL CHEM, V272, P12913, DOI 10.1074/jbc.272.20.12913; WISDOM R, 1990, J BIOL CHEM, V265, P19015; Wright WE, 1996, DEV GENET, V18, P173; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Xiao HY, 1999, J CELL BIOCHEM, V73, P291, DOI 10.1002/(SICI)1097-4644(19990601)73:3<291::AID-JCB1>3.0.CO;2-5; Yamaguchi Y, 1998, EXP CELL RES, V242, P120, DOI 10.1006/excr.1998.4102; Yeilding NM, 1998, J BIOL CHEM, V273, P15749, DOI 10.1074/jbc.273.25.15749; Yeilding NM, 1997, MOL CELL BIOL, V17, P2698, DOI 10.1128/MCB.17.5.2698; Yeilding NM, 1996, MOL CELL BIOL, V16, P3511; Yin L, 2000, J BIOL CHEM, V275, P36671, DOI 10.1074/jbc.M007378200	52	34	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22016	22023		10.1074/jbc.M011181200	http://dx.doi.org/10.1074/jbc.M011181200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11279234	hybrid			2022-12-27	WOS:000169412700006
J	Shiroishi, M; Yokota, A; Tsumoto, K; Kondo, H; Nishimiya, Y; Horii, K; Matsushima, M; Ogasahara, K; Yutani, K; Kumagai, I				Shiroishi, M; Yokota, A; Tsumoto, K; Kondo, H; Nishimiya, Y; Horii, K; Matsushima, M; Ogasahara, K; Yutani, K; Kumagai, I			Structural evidence for entropic contribution of salt bridge formation to a protein antigen-antibody interaction - The case of hen lysozyme-HyHEL-10 Fv complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTILYSOZYME MONOCLONAL-ANTIBODY; EGG-WHITE LYSOZYME; CRYSTAL-STRUCTURE; BINDING; WATER; RECOGNITION; ASSOCIATION; EXPRESSION; RESIDUES; HYHEL-5	A structural and thermodynamic study of the entropic contribution of salt bridge formation to the interaction between hen egg white lysozyme (HEL) and the variable domain fragment (Fv) of anti-MEL antibody, HyMEL-10, was carried out. Three Fv mutants (HD32A, HD96A, and MD32AD96A) were prepared, and the interactions between the mutant Fvs and HEL were investigated. Crystallography revealed that the overall structures of these mutant complexes were almost identical to that of wildtype Fv, Little structural changes were observed in the HD32AD96A mutant-MEL complex, and two water molecules were introduced into the mutation site, indicating that the two water molecules structurally compensated for the complete removal of the salt bridges. This result suggests that the entropic contribution of the salt bridge originates from dehydration. In the singly mutated complexes, one water molecule was also introduced into the mutated site, bridging the antigen-antibody interface. However, a local structural difference was observed in the MD32A FV-HEL complex, and conformational changes occurred due to changes in the relative orientation of the heavy chain to the light chain upon complexation in HD96A Fv-HEL complexes. The reduced affinity of these single mutants for the antigen originates from the increase in entropy loss, indicating that these structural changes also introduced an increase in entropy loss. These results suggest that salt bridge formation makes an entropic contribution to the protein antigen-antibody interaction through reduction of entropy loss due to dehydration and structural changes.	Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; Hokkaido Natl Ind Res Inst, Sapporo, Hokkaido 0118511, Japan; Rat Drug Design Lab, Fukushima 9601242, Japan; Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Tohoku University; National Institute of Advanced Industrial Science & Technology (AIST); Osaka University	Tsumoto, K (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aoba Ku, Aoba Yama 07, Sendai, Miyagi 9808579, Japan.	tsumoto@mail.cc.tohoku.ac.jp; kmiz@mail.cc.tohoku.ac.jp	Nishimiya, Yoshiyuki/M-4173-2018; Kondo, Hidemasa/M-7465-2018	Nishimiya, Yoshiyuki/0000-0002-0701-7775; Kondo, Hidemasa/0000-0003-2799-1775; Shiroishi, Mitsunori/0000-0002-3133-157X				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker BM, 1997, J MOL BIOL, V268, P557, DOI 10.1006/jmbi.1997.0977; BHAT TN, 1990, NATURE, V347, P483, DOI 10.1038/347483a0; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; BRADEN BC, 1995, FASEB J, V9, P9, DOI 10.1096/fasebj.9.1.7821765; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BRUNGER AT, 1992, XPLOR MANUAL; CHACKO S, 1995, J MOL BIOL, V245, P261, DOI 10.1006/jmbi.1994.0022; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; COLMAN PM, 1988, ADV IMMUNOL, V43, P99; Cordes MHJ, 1999, SCIENCE, V284, P325, DOI 10.1126/science.284.5412.325; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Davis SJ, 1998, P NATL ACAD SCI USA, V95, P5490, DOI 10.1073/pnas.95.10.5490; DUNITZ JD, 1994, SCIENCE, V264, P670, DOI 10.1126/science.264.5159.670; Fischer S, 1999, P NATL ACAD SCI USA, V96, P9613, DOI 10.1073/pnas.96.17.9613; FOX GC, 1966, ACTA CRYSTALLOGR, V20, P886, DOI 10.1107/S0365110X66002007; Goldbaum FA, 1996, J MOL RECOGNIT, V9, P6, DOI 10.1002/(SICI)1099-1352(199601)9:1<6::AID-JMR240>3.3.CO;2-M; Holdgate GA, 1997, BIOCHEMISTRY-US, V36, P9663, DOI 10.1021/bi970294+; Hubbard S, 1996, NACCESS VERSION 2 1; Imoto T., 1972, ENZYMES, V7, P665; JANIN J, 1990, J BIOL CHEM, V265, P16027; KABAT EA, NIH PUBLICATION; KAMMORGAN LNW, 1993, P NATL ACAD SCI USA, V90, P3958, DOI 10.1073/pnas.90.9.3958; Kondo H, 1999, J BIOL CHEM, V274, P27623, DOI 10.1074/jbc.274.39.27623; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MARIUZZA RA, 1993, CURR OPIN IMMUNOL, V5, P50, DOI 10.1016/0952-7915(93)90080-C; Merk H, 1999, J BIOCHEM, V125, P328, DOI 10.1093/oxfordjournals.jbchem.a022290; MURPHY KP, 1995, PROTEINS, V21, P83, DOI 10.1002/prot.340210202; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; NAVAZA J, 1994, ACTA CRYSTALLOGR D, V50, P805; NOVOTNY J, 1989, BIOCHEMISTRY-US, V28, P4735, DOI 10.1021/bi00437a034; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; Padlan EA, 1996, ADV PROTEIN CHEM, V49, P57, DOI 10.1016/S0065-3233(08)60488-X; Perozzo R, 2000, J BIOL CHEM, V275, P16139, DOI 10.1074/jbc.M000509200; Pons J, 1999, PROTEIN SCI, V8, P958, DOI 10.1110/ps.8.5.958; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHWARZ FP, 1995, EUR J BIOCHEM, V228, P388; Sharp KA, 1998, PROTEINS, V33, P39, DOI 10.1002/(SICI)1097-0134(19981001)33:1<39::AID-PROT4>3.3.CO;2-K; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; SMITHGILL SJ, 1984, J IMMUNOL, V133, P384; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; STURTEVANT JM, 1994, CURR OPIN STRUC BIOL, V4, P69, DOI 10.1016/S0959-440X(94)90062-0; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Takano K, 2000, BIOCHEMISTRY-US, V39, P12375, DOI 10.1021/bi000849s; TSUMOTO K, 1995, J BIOL CHEM, V270, P18551, DOI 10.1074/jbc.270.31.18551; TSUMOTO K, 1994, J BIOL CHEM, V269, P28777; TSUMOTO K, 1994, BIOCHEM BIOPH RES CO, V201, P546, DOI 10.1006/bbrc.1994.1736; Tsumoto K, 1996, J BIOL CHEM, V271, P32612, DOI 10.1074/jbc.271.51.32612; Ueda H, 1996, NAT BIOTECHNOL, V14, P1714, DOI 10.1038/nbt1296-1714; UEDA Y, 1993, GENE, V129, P129; Vajda S, 1997, CURR OPIN STRUC BIOL, V7, P222, DOI 10.1016/S0959-440X(97)80029-2; Vaughan CK, 1999, J MOL BIOL, V286, P1487, DOI 10.1006/jmbi.1998.2559; WEBSTER DM, 1994, CURR OPIN STRUC BIOL, V4, P123, DOI 10.1016/S0959-440X(94)90070-1; Wibbenmeyer JA, 1999, J BIOL CHEM, V274, P26838, DOI 10.1074/jbc.274.38.26838; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xavier KA, 1998, BIOPHYS J, V74, P2036; Xavier KA, 1997, BIOPHYS J, V73, P2116, DOI 10.1016/S0006-3495(97)78242-0; Ye H, 2000, P NATL ACAD SCI USA, V97, P8961, DOI 10.1073/pnas.160241997; Ysern X, 1998, NAT STRUCT BIOL, V5, P412, DOI 10.1038/nsb0698-412	66	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23042	23050		10.1074/jbc.M100480200	http://dx.doi.org/10.1074/jbc.M100480200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11297547	hybrid			2022-12-27	WOS:000169412700141
J	Rufo, C; Teran-Garcia, M; Nakamura, MT; Koo, SH; Towle, HC; Clarke, SD				Rufo, C; Teran-Garcia, M; Nakamura, MT; Koo, SH; Towle, HC; Clarke, SD			Involvement of a unique carbohydrate-responsive factor in the glucose regulation of rat liver fatty-acid synthase gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN-1; ACETYL-COA CARBOXYLASE; STEROL REGULATION; PYRUVATE-KINASE; IN-VIVO; EXPRESSION; PROMOTER; IDENTIFICATION; LIPOGENESIS; INDUCTION	Refeeding carbohydrate to fasted rats induces the transcription of genes encoding enzymes of fatty acid biosynthesis, e.g. fatty-acid synthase (FAS). part of this transcriptional induction is mediated by insulin, An insulin response element has been described for the fatty-acid synthase gene region of -600 to +65, but the 2-3-fold increase in fatty-acid synthase promoter activity attributable to this region is small compared with the 20-30-fold induction in fatty-acid synthase gene transcription observed in fasted rats refed carbohydrate. We have previously reported that the fatty-acid synthase gene region between -7382 and -6970 was essential for achieving high in vivo rates of gene transcription. The studies of the current report demonstrate that the region of -7382 to -6970 of the fatty-acid synthase gene contains a carbohydrate response element (CHO-REFAS) with a palindrome sequence (CATGTGn(5)GGCGTG) that is nearly identical to the CHO-RE of the L-type pyruvate kinase and S-14 genes. The glucose responsiveness imparted by CHO-REFAS was independent of insulin. Moreover, CHO-REFAS conferred glucose responsiveness to a heterologous promoter (i.e. L-type pyruvate kinase). Electrophoretic mobility shift assays demonstrated that CHO-RE, readily bound a unique hepatic ChoRF and that CHO-REFAS competed with the CHO-RE of the L-type pyruvate kinase and S-14 genes for ChoRF binding. In vivo footprinting revealed that fasting reduced and refeeding increased ChoRF binding to CHO-RE,. Thus, carbohydrate responsiveness of rat liver fatty-acid synthase appears to require both insulin and glucose signaling pathways. More importantly, a unique hepatic ChoRF has now been shown to recognize glucose responsive sequences that are common to three different genes: fatty-acid synthase, L-type pyruvate kinase, and S-14.	Univ Texas, Div Nutr Sci, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Univ Minnesota, Dept Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Minnesota System; University of Minnesota Twin Cities	Clarke, SD (corresponding author), Univ Texas, Div Nutr Sci, 115 Gearing, Austin, TX 78712 USA.	stevedclarke@mail.utexas.edu	Koo, Seung-Hoi/E-2763-2015; Teran-Garcia, Margarita/B-5344-2009; Rufo, Caterina/O-4602-2017	Koo, Seung-Hoi/0000-0001-8769-2879; Teran-Garcia, Margarita/0000-0002-8196-7605; Rufo, Caterina/0000-0001-9044-8818	NIDDK NIH HHS [DK 09723, DK 26919, DK 53872] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026919, F32DK009723, R01DK053872] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARMSTRONG MK, 1991, BIOCHEM BIOPH RES CO, V177, P1056, DOI 10.1016/0006-291X(91)90645-N; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; Casado M, 1999, J BIOL CHEM, V274, P2009, DOI 10.1074/jbc.274.4.2009; CLARKE BA, 1982, ARCH BIOCHEM BIOPHYS, V218, P92, DOI 10.1016/0003-9861(82)90324-1; CLARKE SD, 1990, J NUTR, V120, P218, DOI 10.1093/jn/120.2.218; Daniel S, 1996, J BIOL CHEM, V271, P14692, DOI 10.1074/jbc.271.25.14692; Foretz M, 1999, MOL CELL BIOL, V19, P3760; FOUFELLE F, 1995, BIOCHEM J, V308, P521, DOI 10.1042/bj3080521; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Hasegawa J, 1999, J BIOL CHEM, V274, P1100, DOI 10.1074/jbc.274.2.1100; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; JUMP DB, 1994, J LIPID RES, V35, P1076; JUMP DB, 1987, J BIOL CHEM, V262, P778; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; JUMP DB, 1990, MOL ENDOCRINOL, V4, P1655, DOI 10.1210/mend-4-11-1655; KATSURADA A, 1990, EUR J BIOCHEM, V190, P427, DOI 10.1111/j.1432-1033.1990.tb15592.x; Kaytor EN, 1997, J BIOL CHEM, V272, P7525, DOI 10.1074/jbc.272.11.7525; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Koo SH, 2000, J BIOL CHEM, V275, P5200, DOI 10.1074/jbc.275.7.5200; Koo SH, 2001, J BIOL CHEM, V276, P9437, DOI 10.1074/jbc.M010029200; Latasa MJ, 2000, P NATL ACAD SCI USA, V97, P10619, DOI 10.1073/pnas.180306597; LIU ZR, 1993, J BIOL CHEM, V268, P12787; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Moon YS, 2000, J BIOL CHEM, V275, P10121, DOI 10.1074/jbc.275.14.10121; MOUSTAID N, 1994, J BIOL CHEM, V269, P5629; MUELLER PR, 1992, CURRENT PROTOCOLS MO; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Rangan VS, 1996, J BIOL CHEM, V271, P2307, DOI 10.1074/jbc.271.4.2307; Roder K, 1997, J BIOL CHEM, V272, P21616, DOI 10.1074/jbc.272.34.21616; Rufo C, 1999, BIOCHEM BIOPH RES CO, V261, P400, DOI 10.1006/bbrc.1999.1034; SALATI LM, 1986, ARCH BIOCHEM BIOPHYS, V246, P82, DOI 10.1016/0003-9861(86)90451-0; SHIH HM, 1995, J BIOL CHEM, V270, P21991, DOI 10.1074/jbc.270.37.21991; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SPENCE JT, 1982, EUR J BIOCHEM, V128, P15; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; WILLIAMS BH, 1982, J NUTR, V112, P534, DOI 10.1093/jn/112.3.534; WILSON MD, 1986, J NUTR, V116, P1511, DOI 10.1093/jn/116.8.1511; Yin DZ, 1998, BIOCHEM J, V331, P815, DOI 10.1042/bj3310815; Zammit VA, 1999, BIOCHEM J, V343, P505, DOI 10.1042/0264-6021:3430505	43	97	98	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21969	21975		10.1074/jbc.M100461200	http://dx.doi.org/10.1074/jbc.M100461200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279238	hybrid			2022-12-27	WOS:000169297900152
J	Tang, J; Lin, YK; Zhang, ZM; Tikunova, S; Birnbaumer, L; Zhu, MX				Tang, J; Lin, YK; Zhang, ZM; Tikunova, S; Birnbaumer, L; Zhu, MX			Identification of common binding sites for calmodulin and inositol 1,4,5-trisphosphate receptors on the carboxyl termini of Trp channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CA2+ STORES; CALCIUM INFLUX FACTOR; TRANSIENT RECEPTOR; PLASMA-MEMBRANE; CATION CHANNEL; CA2+-DEPENDENT INACTIVATION; INSP(3) RECEPTOR; DROSOPHILA TRP; POTENTIAL TRP; ACTIVATION	Homologues of Drosophila Trp (transient receptor potential) form plasma membrane channels that mediate Ca2+ entry following the activation of phospholipase C by cell surface receptors, Among the seven Trp homologous found in mammals, Trp3 has been shown to interact with and respond to IP3 receptors (IP(3)Rs) for activation. Here we show that Trp4 and other Trp proteins also interact with IP(3)Rs. The IP3R-binding domain also interacts with calmodulin (CaM) in a Ca2+-dependent manner with affinities ranging from 10 nM for Trp2 to 290 nM for Trp6, In addition, other binding sites for CaM and IP(3)Rs are present in the alpha but not the beta isoform of Trp4, In the presence of Ca2+, the Trp-IP3R interaction is inhibited by CaM, However, a synthetic peptide representing a Trp-binding domain of IP(3)Rs inhibited the binding of CaM to Trp3, -6, and -7 more effectively than that to Trp1, -2, -4, and -5, In inside-out membrane patches, Trp4 is activated strongly by calmidazolium, an antagonist of CaM, and a high (50 muM) but not a low (5 muM) concentration of the Trp-binding peptide of the IP3R. Our data support the view that both CaM and IP(3)Rs play important roles in controlling the gating of Trp-based channels. However, the sensitivity and responses to CaM and IP(3)Rs differ for each Trp.	Ohio State Univ, Neurobiotechnol Ctr, Columbus, OH 43210 USA; Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Los Angeles, CA 90095 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Zhu, MX (corresponding author), Ohio State Univ, Neurobiotechnol Ctr, 168 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	zhu.55@osu.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042183] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL45198] Funding Source: Medline; NIGMS NIH HHS [GM54235] Funding Source: Medline; NINDS NIH HHS [R01 NS042183] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Csutora P, 1999, P NATL ACAD SCI USA, V96, P121, DOI 10.1073/pnas.96.1.121; ERICKSONVIITANEN S, 1987, METHOD ENZYMOL, V139, P455; FASOLATO C, 1994, TRENDS PHARMACOL SCI, V15, P77, DOI 10.1016/0165-6147(94)90282-8; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; Kiselyov KI, 1999, PFLUG ARCH EUR J PHY, V437, P305, DOI 10.1007/s004240050784; Kiselyov KI, 1997, FEBS LETT, V407, P309, DOI 10.1016/S0014-5793(97)00366-9; Krupp JJ, 1999, J NEUROSCI, V19, P1165; LEE SH, 1995, J BIOL CHEM, V270, P21806, DOI 10.1074/jbc.270.37.21806; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Liu XB, 1998, J BIOL CHEM, V273, P33295, DOI 10.1074/jbc.273.50.33295; Liu XB, 2000, J BIOL CHEM, V275, P3403, DOI 10.1074/jbc.275.5.3403; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Meissner G, 1995, BIOSCIENCE REP, V15, P399, DOI 10.1007/BF01788371; Mery L, 2001, FEBS LETT, V487, P377, DOI 10.1016/S0014-5793(00)02362-0; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Philipp S, 2000, J BIOL CHEM, V275, P23965, DOI 10.1074/jbc.M003408200; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Raghu P, 2000, MOL CELL NEUROSCI, V15, P429, DOI 10.1006/mcne.2000.0846; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; Rosado JA, 2000, BIOCHEM J, V350, P631, DOI 10.1042/0264-6021:3500631; SANFORD J, 1991, J BIOL CHEM, V266, P9570; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Thrower EC, 2000, J BIOL CHEM, V275, P36049, DOI 10.1074/jbc.M000970200; Trepakova ES, 2000, J BIOL CHEM, V275, P26158, DOI 10.1074/jbc.M004666200; Trost C, 1999, FEBS LETT, V451, P257, DOI 10.1016/S0014-5793(99)00588-8; Vaca L, 1996, FEBS LETT, V390, P289, DOI 10.1016/0014-5793(96)00675-8; VACA L, 1995, AM J PHYSIOL-CELL PH, V269, pC733, DOI 10.1152/ajpcell.1995.269.3.C733; Vannier B, 1999, P NATL ACAD SCI USA, V96, P2060, DOI 10.1073/pnas.96.5.2060; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; Warr CG, 1996, BIOCHEM J, V314, P497, DOI 10.1042/bj3140497; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333; Zubov AI, 1999, J BIOL CHEM, V274, P25983, DOI 10.1074/jbc.274.37.25983; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209	56	245	259	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21303	21310		10.1074/jbc.M102316200	http://dx.doi.org/10.1074/jbc.M102316200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11290752	hybrid, Green Accepted			2022-12-27	WOS:000169297900068
J	Rogers, MA; Langbein, L; Winter, H; Ehmann, C; Praetzel, S; Korn, B; Schweizer, J				Rogers, MA; Langbein, L; Winter, H; Ehmann, C; Praetzel, S; Korn, B; Schweizer, J			Characterization of a cluster of human high/ultrahigh sulfur keratin-associated protein genes embedded in the type I keratin gene domain on chromosome 17q12-21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH PROTEINS; HAIR FOLLICLE; DIFFERENTIAL EXPRESSION; SHEEP WOOL; SEQUENCE; FAMILY; LINKAGE; HUMAN-CHROMOSOME-21; ORGANIZATION; CARCINOMAS	Low stringency screening of a human PI artificial chromosome library using a human hair keratin-associated protein (hKAP1. 1A) gene probe resulted in the isolation of six PI artificial chromosome clones. End sequencing and EMBO/GenBank (TM) data base analysis showed these clones to be contained in four previously sequenced human bacterial artificial chromosome clones present on chromosome 17q12-21 and arrayed into two large contigs of 290 and 225 kilobase pairs (kb) in size. A fifth, partially sequenced human bacterial artificial chromosome clone data base sequence overlapped and closed both of these contigs, One end of this 600-kb cluster harbored six gene loci for previously described human type I hair keratin genes. The other end of this cluster contained the human type I cytokeratin K20 and K12 gene loci. The center of the cluster, starting 35 kb downstream of the hHa3-I hair keratin gene, contained 37 genes for high/ultrahigh sulfur hair keratin-associated proteins (KAPs), which could be divided into a total of 7 KAP multigene families based on amino acid homology comparisons with previously identified sheep, mouse, and rabbit KAPs. To date, 26 human KAP cDNA clones have been isolated through screening of an arrayed human scalp cDNA library by means of specific 3'-noncoding region polymerase chain reaction probes derived from the identified KAP gene sequences. This screening also yielded four additional cDNA sequences whose genes were not present on this gene cluster but belonged to specific KAP gene families present on this contig. Hair follicle in situ hybridization data for single members of five different KAP multigene families all showed localization of the respective mRNAs to the upper cortex of the hair shaft.	German Canc Res Ctr, Div Biochem Tissue Specif Regulat, D-69120 Heidelberg, Germany; German Canc Res Ctr, Div Cell Biol, D-69120 Heidelberg, Germany; German Canc Res Ctr, Resource Ctr Human Genome Res, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Rogers, MA (corresponding author), German Canc Res Ctr, Div Biochem Tissue Specif Regulat, 5th Floor,Rm 522,Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Rogers, Michael A./J-9803-2012	Rogers, Michael A./0000-0002-3728-2107				Aoki N, 1997, J BIOL CHEM, V272, P30512, DOI 10.1074/jbc.272.48.30512; Aoki N, 1998, J INVEST DERMATOL, V111, P804, DOI 10.1046/j.1523-1747.1998.00387.x; BOULAY A, 2000, THESIS U STRASSBURG; Cole SE, 1998, GENOMICS, V54, P437, DOI 10.1006/geno.1998.5590; Corden LD, 2000, EXP EYE RES, V70, P41, DOI 10.1006/exer.1999.0769; FRATINI A, 1993, J BIOL CHEM, V268, P4511; FRATINI A, 1994, J INVEST DERMATOL, V102, P178, DOI 10.1111/1523-1747.ep12371759; FRENKEL MJ, 1989, GENOMICS, V4, P182, DOI 10.1016/0888-7543(89)90298-X; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HUH N, 1994, J INVEST DERMATOL, V102, P716, DOI 10.1111/1523-1747.ep12375385; JENKINS BJ, 1994, J INVEST DERMATOL, V103, P310, DOI 10.1111/1523-1747.ep12394770; KUCZEK ES, 1987, EUR J BIOCHEM, V166, P79, DOI 10.1111/j.1432-1033.1987.tb13486.x; Kuhn F, 1999, MECH DEVELOP, V86, P193, DOI 10.1016/S0925-4773(99)00115-X; LANGBEIN L, 1993, DIFFERENTIATION, V55, P57, DOI 10.1111/j.1432-0436.1993.tb00033.x; Langbein L, 1999, J BIOL CHEM, V274, P19874, DOI 10.1074/jbc.274.28.19874; LESSIN SR, 1988, J INVEST DERMATOL, V91, P572, DOI 10.1111/1523-1747.ep12477087; MACKINNON PJ, 1990, J CELL BIOL, V111, P2587, DOI 10.1083/jcb.111.6.2587; MACKINNON PJ, 1995, MAMM GENOME, V1, P53; MCNAB AR, 1990, P NATL ACAD SCI USA, V87, P6848, DOI 10.1073/pnas.87.17.6848; MCNAB AR, 1989, J INVEST DERMATOL, V92, P263, DOI 10.1111/1523-1747.ep12276832; Mitsui S, 1998, GENE, V208, P123, DOI 10.1016/S0378-1119(97)00607-0; MOLL R, 1993, DIFFERENTIATION, V53, P75, DOI 10.1111/j.1432-0436.1993.tb00648.x; PARSONS YM, 1994, GENOMICS, V20, P500, DOI 10.1006/geno.1994.1209; Perez C, 1999, GENE, V227, P137, DOI 10.1016/S0378-1119(98)00616-7; Powell B C, 1997, EXS, V78, P59; POWELL BC, 1983, NUCLEIC ACIDS RES, V11, P5327, DOI 10.1093/nar/11.16.5327; POWELL BC, 1995, DIFFERENTIATION, V58, P227, DOI 10.1046/j.1432-0436.1995.5830227.x; Regnier CH, 1998, BRIT J CANCER, V78, P1640, DOI 10.1038/bjc.1998.736; ROGERS MA, 1995, EXP CELL RES, V220, P357, DOI 10.1006/excr.1995.1326; Rogers MA, 1998, J BIOL CHEM, V273, P26683, DOI 10.1074/jbc.273.41.26683; Rogers MA, 1997, DIFFERENTIATION, V61, P187, DOI 10.1046/j.1432-0436.1997.6130187.x; Rogers MA, 2000, J INVEST DERMATOL, V114, P464, DOI 10.1046/j.1523-1747.2000.00910.x; SWART LS, 1973, BIOCHEM J, V133, P641, DOI 10.1042/bj1330641; SWART LS, 1976, P 5 INT WOOL TEXT RE, P254; Swift JA, 1977, CHEM NATURAL PROTEIN, P81; Takaishi M, 1998, J INVEST DERMATOL, V111, P128, DOI 10.1046/j.1523-1747.1998.00241.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; ZHUMABAEVA BD, 1992, MOL BIOL+, V26, P550	40	84	117	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19440	19451		10.1074/jbc.M100657200	http://dx.doi.org/10.1074/jbc.M100657200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279113	hybrid			2022-12-27	WOS:000169091000106
J	Bienvenu, F; Gascan, H; Coqueret, O				Bienvenu, F; Gascan, H; Coqueret, O			Cyclin D1 represses STAT3 activation through a Cdk4-independent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; ESTROGEN-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; V-SRC; INHIBITION; KINASE; G1; PHOSPHORYLATION; TRANSFORMATION	STAT3 transcription factors are cytoplasmic proteins that induce gene activation in response to cytokine receptor stimulation. Following tyrosine phosphorylation, STAT3 proteins dimerize, translocate into the nucleus, and activate specific target genes. Activation is transient, and down-regulation of STAT3 signaling occurs within a few hours. In this study, we show that cyclin D1 inhibits STAT3 activation. In co-immunoprecipitation and pull-down assays, cyclin D1 was found to associate with the activation domain of STAT3 upon interleukin-6 stimulation. Overexpression of cyclin D1 inhibited transcriptional activation by STAT3 proteins. This effect was not shared by cyclin E, was independent of association with Cdk4, and was unaffected by inhibitors of Cdk4, Whereas cyclin D1 had no effect on the steady-state level of STAT3 proteins in the cytoplasm, it was found to reduce the STAT3 nuclear level in HepG2 cells. These results suggest a model by which cyclin D1 is part of a feedback network controlling the down-regulation of STAT3 activity and highlight a new activity for this cell cycle regulatory protein.	CHU Angers, INSERM, EMI U 9928, F-49033 Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Coqueret, O (corresponding author), CHU Angers, INSERM, EMI U 9928, 4 Rue Larrey, F-49033 Angers, France.		Coqueret, Olivier/K-9660-2015	Coqueret, Olivier/0000-0002-2843-7867				Bernards R, 1999, BBA-REV CANCER, V1424, pM17, DOI 10.1016/S0304-419X(99)00024-4; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Cao XM, 1996, MOL CELL BIOL, V16, P1595; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dynlacht BD, 1997, NATURE, V389, P149, DOI 10.1038/38225; Ganter B, 1998, EMBO J, V17, P255, DOI 10.1093/emboj/17.1.255; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Haspel RL, 1999, P NATL ACAD SCI USA, V96, P10188, DOI 10.1073/pnas.96.18.10188; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; Hoey T, 1998, CURR OPIN GENET DEV, V8, P582, DOI 10.1016/S0959-437X(98)80015-4; Horstmann S, 2000, ONCOGENE, V19, P298, DOI 10.1038/sj.onc.1203302; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; Jeffrey PD, 2000, GENE DEV, V14, P3115, DOI 10.1101/gad.851100; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Robledo O, 1996, J NEUROCHEM, V66, P1391; SHERR CJ, 1994, CELL, V79, P547; SKAPEK SX, 1995, SCIENCE, V267, P1022, DOI 10.1126/science.7863328; Skapek SX, 1996, MOL CELL BIOL, V16, P7043; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Wang YZ, 2000, ONCOGENE, V19, P2075, DOI 10.1038/sj.onc.1203548; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X; Zhang JJ, 1998, EMBO J, V17, P6963, DOI 10.1093/emboj/17.23.6963; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6; Zwijsen RML, 1998, GENE DEV, V12, P3488, DOI 10.1101/gad.12.22.3488	40	104	105	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16840	16847		10.1074/jbc.M100795200	http://dx.doi.org/10.1074/jbc.M100795200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279133	hybrid			2022-12-27	WOS:000168730400034
J	Lalev, AI; Nazar, RN				Lalev, AI; Nazar, RN			A chaperone for ribosome maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTERNAL TRANSCRIBED SPACER; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; STRUCTURAL FEATURES; RNA; PURIFICATION; CLEAVAGE; PROTEINS; SYSTEM	The nascent pre-rRNA of eukaryotic ribosomes is fully transcribed and assembled into an 80-90 S nucleolar particle before being cleaved into mature ribosomal RNA. The interdependence of steps in the processing of this precursor RNA indicates that RNA processing, at least in part, acts as a quality control mechanism that helps ensure that only functional RNA is incorporated into mature ribosomes, In search of structural components that underlie this interdependence using the Schizosaccharomyces pombe internal transcribed spacer 1 (ITS) as a ligand for affinity chromatography of ITS1-specific proteins, we have isolated a large spliceosome-like protein complex, a ribosome assembly chaperone (RAC) of 20 or more polypeptides (Lalev, PL I., Abeyrathne, P, D,, and Nazar, R, N, (2000) J, Mol. Biol, 302, 65-77), When the ITS2 spacer was used in the present study to isolate ITS2-specific proteins, the same proteins were identified consistent with a complex containing multiple specific binding sites, Subsequent competition binding studies indicated that the protein complex actually contains independent binding sites for all four of the transcribed spacers in the pre-rRNA Because disruption of protein-binding sites in these spacer RNAs is known to severely affect rRNA processing, taken together these results suggest that the RAC complex is a chaperone for ribosome maturation acting as a "rack" on which critical structure is organized.	Univ Guelph, Dept Mol Biol & Genet, Guelph, ON N1G 2W1, Canada	University of Guelph	Nazar, RN (corresponding author), Univ Guelph, Dept Mol Biol & Genet, Axelrod Bldg, Guelph, ON N1G 2W1, Canada.							AbouElela S, 1996, CELL, V85, P115, DOI 10.1016/S0092-8674(00)81087-9; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Good L, 1997, J MOL BIOL, V273, P782, DOI 10.1006/jmbi.1997.1351; Hitchen J, 1997, J MOL BIOL, V274, P481, DOI 10.1006/jmbi.1997.1376; HUGHES JMX, 1991, EMBO J, V10, P4231, DOI 10.1002/j.1460-2075.1991.tb05001.x; Intine RVA, 1999, J MOL BIOL, V286, P695, DOI 10.1006/jmbi.1998.2502; KUMAR A, 1972, J MOL BIOL, V63, P233, DOI 10.1016/0022-2836(72)90372-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lalev AI, 1999, NUCLEIC ACIDS RES, V27, P3071, DOI 10.1093/nar/27.15.3071; Lalev AI, 1998, J MOL BIOL, V284, P1341, DOI 10.1006/jmbi.1998.2222; Lalev AI, 2000, J MOL BIOL, V302, P65, DOI 10.1006/jmbi.2000.4015; Liang WQ, 1997, P NATL ACAD SCI USA, V94, P2864, DOI 10.1073/pnas.94.7.2864; MELEKHOVETS YF, 1994, J MOL BIOL, V239, P170, DOI 10.1006/jmbi.1994.1361; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MERRILL CR, ANAL BIOCH, V110, P201; Moore M., 1993, RNA WORLD, P303; MORRISSEY JP, 1995, TRENDS BIOCHEM SCI, V20, P78, DOI 10.1016/S0968-0004(00)88962-8; NAZAR RN, 1996, RNA 96 1 ANN M RNA S; NEUPERT B, 1990, NUCLEIC ACIDS RES, V18, P51, DOI 10.1093/nar/18.1.51; Rotondo G, 1996, NUCLEIC ACIDS RES, V24, P2377, DOI 10.1093/nar/24.12.2377; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; VANNUES RW, 1995, J MOL BIOL, V250, P24, DOI 10.1006/jmbi.1995.0355; VANNUES RW, 1993, TRANSLATIONAL APPARATUS, P151; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261	24	13	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16655	16659		10.1074/jbc.M101157200	http://dx.doi.org/10.1074/jbc.M101157200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279180	hybrid			2022-12-27	WOS:000168730400010
J	Ghosh, N; Gyory, I; Wright, G; Wood, J; Wright, KL				Ghosh, N; Gyory, I; Wright, G; Wood, J; Wright, KL			Positive regulatory domain I binding factor 1 silences class II transactivator expression in multiple myeloma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; GENE-EXPRESSION; PLASMA-CELLS; PR DOMAIN; B-CELLS; TRANSCRIPTIONAL REPRESSION; HISTONE DEACETYLASE; ACTIVE SUPPRESSION; IFN-GAMMA; CIITA	The major histocompatibility complex (MHC) class II transactivator (CIITA) acts as a master switch to activate expression of the genes required for MHC-II antigen presentation. During B-cell to plasma cell differentiation, MHC-II expression is actively silenced, but the mechanism has been unknown. In plasma cell tumors such as multiple myeloma the repression of MHC-II is associated with the loss of CIITA. We have identified that positive regulatory domain I binding factor I (PRDI-BF1), a transcriptional repressor, inhibits CIITA expression in multiple myeloma cell lines. Repression of CIITA depends on the DNA binding activity of PRDI-BF1 and its specific binding site in the CIITA promoter. Deletion of a histone deacetylase recruitment domain in PRDI-BF1 does not inhibit repression of CIITA nor does blocking histone deacetylase activity. This is in contrast to PRDI-BF1 repression of the c-myc promoter. Repression of CIITA requires either the N-terminal acidic and conserved PR motif or the proline-rich domain. PRDI-BF1 has been shown to be a key regulator of B-cell and macrophage differentiation. These findings now indicate that PRDI-BF1 has at least two mechanisms of repression whose function is dependent on the nature of the target promoter. Importantly, PRDI-BF1 is defined as the key molecule in silencing CIITA and thus MHC-II in multiple myeloma cells.	Univ S Florida, H Lee Moffitt Canc Ctr, Interdisciplinary Oncol Program, Tampa, FL 33612 USA; Univ S Florida, Dept Biochem & Mol Biol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Wright, KL (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Interdisciplinary Oncol Program, 12902 Magnolia Dr,MRC 4072, Tampa, FL 33612 USA.				NCI NIH HHS [CA80990-R01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080990] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Burrows P D, 1990, Semin Immunol, V2, P189; BUYSE IM, 1995, P NATL ACAD SCI USA, V92, P4467, DOI 10.1073/pnas.92.10.4467; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; CHANG CH, 1992, J EXP MED, V176, P1465, DOI 10.1084/jem.176.5.1465; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; CHIN KC, 1994, IMMUNITY, V1, P687, DOI 10.1016/1074-7613(94)90039-6; DELLABONA P, 1989, J IMMUNOL, V142, P2902; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fears S, 1996, P NATL ACAD SCI USA, V93, P1642, DOI 10.1073/pnas.93.4.1642; Ghosh N, 1999, J BIOL CHEM, V274, P32342, DOI 10.1074/jbc.274.45.32342; HALPER J, 1978, J IMMUNOL, V120, P1480; Harton JA, 2000, MOL CELL BIOL, V20, P6185, DOI 10.1128/MCB.20.17.6185-6194.2000; Huang S, 1998, J BIOL CHEM, V273, P15933, DOI 10.1074/jbc.273.26.15933; Jayachandra S, 1999, P NATL ACAD SCI USA, V96, P11566, DOI 10.1073/pnas.96.20.11566; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; LATRON F, 1988, P NATL ACAD SCI USA, V85, P2229, DOI 10.1073/pnas.85.7.2229; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; MORISHITA K, 1992, P NATL ACAD SCI USA, V89, P3937, DOI 10.1073/pnas.89.9.3937; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; NUCIFORA G, 1994, P NATL ACAD SCI USA, V91, P4004, DOI 10.1073/pnas.91.9.4004; Piskurich JF, 1998, J IMMUNOL, V160, P233; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Sartoris S, 1996, EUR J IMMUNOL, V26, P2456, DOI 10.1002/eji.1830261028; SILACCI P, 1994, J EXP MED, V180, P1329, DOI 10.1084/jem.180.4.1329; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; VENKITARAMAN AR, 1987, EUR J IMMUNOL, V17, P1441, DOI 10.1002/eji.1830171009; Xie M, 1997, J BIOL CHEM, V272, P26360, DOI 10.1074/jbc.272.42.26360; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000	31	57	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15264	15268		10.1074/jbc.M100862200	http://dx.doi.org/10.1074/jbc.M100862200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279146	hybrid			2022-12-27	WOS:000168528800098
J	Grossman, AR; Bhaya, D; He, QF				Grossman, AR; Bhaya, D; He, QF			Tracking the light environment by cyanobacteria and the dynamic nature of light harvesting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							COMPLEMENTARY CHROMATIC ADAPTATION; SUBUNIT PHYCOCYANOBILIN LYASE; BLUE-GREEN-ALGA; FREMYELLA-DIPLOSIPHON; SYNECHOCOCCUS-SP; RED-LIGHT; MOLECULAR CHARACTERIZATION; ANACYSTIS-NIDULANS; MULTIGENE FAMILY; PHYCOBILISOME		Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA	Carnegie Institution for Science	Grossman, AR (corresponding author), Carnegie Inst Washington, Dept Plant Biol, 260 Panama St, Stanford, CA 94305 USA.							ALLEN MM, 1969, ARCH MIKROBIOL, V69, P114, DOI 10.1007/BF00409755; Appleby JL, 1996, CELL, V86, P845, DOI 10.1016/S0092-8674(00)80158-0; BENNETT A, 1973, J CELL BIOL, V58, P419, DOI 10.1083/jcb.58.2.419; BRUNS BU, 1989, J BACTERIOL, V171, P901, DOI 10.1128/jb.171.2.901-908.1989; BRYANT DA, 1981, EUR J BIOCHEM, V119, P415, DOI 10.1111/j.1432-1033.1981.tb05624.x; CAPUANO V, 1991, J BIOL CHEM, V266, P7239; CASEY ES, 1994, J BACTERIOL, V176, P6362, DOI 10.1128/jb.176.20.6362-6374.1994; Casey ES, 1997, J BACTERIOL, V179, P4599, DOI 10.1128/jb.179.14.4599-4606.1997; CHIANG GG, 1992, P NATL ACAD SCI USA, V89, P9415, DOI 10.1073/pnas.89.20.9415; COBLEY JG, 1983, J BACTERIOL, V153, P1486, DOI 10.1128/JB.153.3.1486-1492.1983; COLLIER JL, 1994, EMBO J, V13, P1039, DOI 10.1002/j.1460-2075.1994.tb06352.x; COLLIER JL, 1994, PHOTOSYNTH RES, V42, P173, DOI 10.1007/BF00018260; CONLEY PB, 1985, SCIENCE, V230, P550, DOI 10.1126/science.3931221; CONLEY PB, 1986, P NATL ACAD SCI USA, V83, P3924, DOI 10.1073/pnas.83.11.3924; Dolganov N, 1999, J BACTERIOL, V181, P610, DOI 10.1128/JB.181.2.610-617.1999; ESCOUBAS JM, 1995, P NATL ACAD SCI USA, V92, P10237, DOI 10.1073/pnas.92.22.10237; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FEDERSPIEL NA, 1992, J BACTERIOL, V174, P5994, DOI 10.1128/jb.174.18.5994-5998.1992; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.bb.14.060185.000403; GLAZER AN, 1983, ANN INST PASTEUR MIC, VB134, P159, DOI 10.1016/S0769-2609(83)80103-3; GREEN LS, 1988, J BACTERIOL, V170, P583, DOI 10.1128/jb.170.2.583-587.1988; Grossman AR, 1997, PHOTOSYNTH RES, V53, P95, DOI 10.1023/A:1005807221560; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; HOUMARD J, 1988, J BACTERIOL, V170, P5512, DOI 10.1128/jb.170.12.5512-5521.1988; Kahn K, 1997, J BACTERIOL, V179, P998, DOI 10.1128/jb.179.4.998-1006.1997; Kehoe DM, 1997, J BACTERIOL, V179, P3914, DOI 10.1128/jb.179.12.3914-3921.1997; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; KEREN N, 1998, CHLAMYDOMONAS; Kim JM, 1997, SCIENCE, V278, P1954, DOI 10.1126/science.278.5345.1954; LOMAX TL, 1987, J BACTERIOL, V169, P2675, DOI 10.1128/jb.169.6.2675-2684.1987; MAZEL D, 1988, MOL GEN GENET, V211, P296, DOI 10.1007/BF00330607; MAZEL D, 1986, NUCLEIC ACIDS RES, V14, P8279, DOI 10.1093/nar/14.21.8279; MAZEL D, 1989, NATURE, V341, P245, DOI 10.1038/341245a0; RAY JM, 1991, J BACTERIOL, V173, P4297, DOI 10.1128/JB.173.14.4297-4309.1991; SCHMIDTGOFF CM, 1993, J BACTERIOL, V175, P1806, DOI 10.1128/JB.175.6.1806-1813.1993; Schwarz R, 1998, P NATL ACAD SCI USA, V95, P11008, DOI 10.1073/pnas.95.18.11008; SHERMAN DM, 1983, J BACTERIOL, V156, P393, DOI 10.1128/JB.156.1.393-401.1983; SOBCZYK A, 1993, EMBO J, V12, P997, DOI 10.1002/j.1460-2075.1993.tb05740.x; STEVENS SE, 1981, PLANT PHYSIOL, V67, P716, DOI 10.1104/pp.67.4.716; Tandeau De Marsac Nicole, 1993, FEMS (Federation of European Microbiological Societies) Microbiology Reviews, V104, P119, DOI 10.1111/j.1574-6968.1993.tb05866.x; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; VOGELMANN TC, 1978, PLANTA, V143, P233, DOI 10.1007/BF00391993; YAMANAKA G, 1980, ARCH MICROBIOL, V124, P39, DOI 10.1007/BF00407026	43	117	130	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11449	11452		10.1074/jbc.R100003200	http://dx.doi.org/10.1074/jbc.R100003200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11279225	Green Published, hybrid			2022-12-27	WOS:000168081800002
J	Goodwin, AJ; McInerney, JM; Glander, MA; Pomerantz, O; Lowrey, CH				Goodwin, AJ; McInerney, JM; Glander, MA; Pomerantz, O; Lowrey, CH			In vivo formation of a human beta-globin locus control region core element requires binding sites for multiple factors including GATA-1, NF-E2, erythroid Kruppel-like factor, and Sp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT CONTROL REGION; CHROMATIN REMODELING COMPLEX; TRANSCRIPTION FACTOR; HYPERSENSITIVE SITES; MINIMAL REQUIREMENTS; FACTOR EKLF; GENE; PROMOTER; ACTIVATION; ENHANCER	The active elements of the beta -globin locus control region (LCR) are located within domains of unique chromatin structure. These nuclease hypersensitive sites (HSs) are characterized by high DNase I sensitivity, erythroid specificity, similar nucleosomal structure, and evolutionarily conserved clusters of cis-acting elements that are required for the formation and function of the core elements. To determine the requirements for HS core formation in the setting of nuclear chromatin, we constructed a series of artificial HS cores containing binding sites for GATA-1, NF-E2, and Sp1, In contrast to the results of previous in vitro experiments, we found that when constructs were stably integrated in mouse erythroleukemia cells the binding sites for NF-E2, GATA-1, or Sp1 alone or in any combination were unable to form core HS structures, We subsequently identified two new cis-acting elements from the LCR HS4 core that, when combined with the NF-ES, Sp1, and tandem inverted GATA elements, result in core structure formation. Both new cis-acting elements bind Sp1, and one binds erythroid Kruppel-like factor (EKLF). We conclude that in vivo beta -globin LCR HS core formation is more complex than previously thought and that several factors are required for this process to occur.	Dartmouth Coll, Sch Med, Dept Med, HB 7650, Hanover, NH 03755 USA; Dartmouth Coll, Sch Med, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Lowrey, CH (corresponding author), Dartmouth Coll, Sch Med, Dept Med, HB 7650, Hanover, NH 03755 USA.	c.lowrey@dartmouth.edu			NHLBI NIH HHS [F32 HL10083, HL 52243] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052243, F32HL010083] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Armstrong JA, 1996, MOL CELL BIOL, V16, P5634; Armstrong JA, 1998, CELL, V95, P93, DOI 10.1016/S0092-8674(00)81785-7; BAIYONG L, 1994, J BIOL CHEM, V269, P7756; Bender MA, 2000, BLOOD, V95, P3600, DOI 10.1182/blood.V95.11.3600.011k42_3600_3604; Boyes J, 1996, EMBO J, V15, P2496, DOI 10.1002/j.1460-2075.1996.tb00607.x; BRESNICK EH, 1994, P NATL ACAD SCI USA, V91, P1314, DOI 10.1073/pnas.91.4.1314; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Bungert J, 1995, GENE DEV, V9, P3083, DOI 10.1101/gad.9.24.3083; COLLIS P, 1990, EMBO J, V9, P233, DOI 10.1002/j.1460-2075.1990.tb08100.x; CUNNINGHAM JM, 1994, BLOOD, V84, P1298; DHAR V, 1990, MOL CELL BIOL, V10, P4324, DOI 10.1128/MCB.10.8.4324; Ding H, 1999, J BIOL CHEM, V274, P19573, DOI 10.1074/jbc.274.28.19573; EMERSON BM, 1987, P NATL ACAD SCI USA, V84, P4786, DOI 10.1073/pnas.84.14.4786; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; Felsenfeld G, 1996, P NATL ACAD SCI USA, V93, P9384, DOI 10.1073/pnas.93.18.9384; FORRESTER WC, 1989, P NATL ACAD SCI USA, V86, P5439, DOI 10.1073/pnas.86.14.5439; FORRESTER WC, 1987, NUCLEIC ACIDS RES, V15, P10159, DOI 10.1093/nar/15.24.10159; Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494; Gong QH, 1996, MOL CELL BIOL, V16, P6055; Grosveld F, 1999, CURR OPIN GENET DEV, V9, P152, DOI 10.1016/S0959-437X(99)80023-9; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GROUDINE M, 1983, P NATL ACAD SCI-BIOL, V80, P7551, DOI 10.1073/pnas.80.24.7551; Hardison R, 1997, GENE, V205, P73, DOI 10.1016/S0378-1119(97)00474-5; HARDISON R, 1995, MOL BIOL HEMOGLOBIN, P405; JONGSTRA J, 1984, NATURE, V307, P708, DOI 10.1038/307708a0; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Krude T, 1996, CURR BIOL, V6, P511, DOI 10.1016/S0960-9822(02)00529-8; LAYON ME, 1998, BLOOD CELL MOL DIS, V24, P499; Lee CH, 1999, P NATL ACAD SCI USA, V96, P12311, DOI 10.1073/pnas.96.22.12311; LEWIN B, 1994, CELL, V79, P397, DOI 10.1016/0092-8674(94)90249-6; LOWREY CH, 1992, P NATL ACAD SCI USA, V89, P1143, DOI 10.1073/pnas.89.3.1143; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; McDowell JC, 1999, MOL CELL BIOL, V19, P7600; MIGNOTTE V, 1989, NUCLEIC ACIDS RES, V17, P37, DOI 10.1093/nar/17.1.37; MIGNOTTE V, 1989, P NATL ACAD SCI USA, V86, P6548, DOI 10.1073/pnas.86.17.6548; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Motohashi H, 1997, NUCLEIC ACIDS RES, V25, P2953, DOI 10.1093/nar/25.15.2953; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; Navas PA, 1998, MOL CELL BIOL, V18, P4188, DOI 10.1128/MCB.18.7.4188; NEY PA, 1990, NUCLEIC ACIDS RES, V18, P6011, DOI 10.1093/nar/18.20.6011; NEY PA, 1990, GENE DEV, V4, P993, DOI 10.1101/gad.4.6.993; PARANJAPE SM, 1994, ANNU REV BIOCHEM, V63, P265, DOI 10.1146/annurev.biochem.63.1.265; PAWLIK KM, 1995, DEV BIOL, V169, P728, DOI 10.1006/dbio.1995.1182; PHILIPSEN S, 1993, EMBO J, V12, P1077, DOI 10.1002/j.1460-2075.1993.tb05749.x; PHILIPSEN S, 1990, EMBO J, V9, P2159, DOI 10.1002/j.1460-2075.1990.tb07385.x; Pomerantz O, 1998, NUCLEIC ACIDS RES, V26, P5684, DOI 10.1093/nar/26.24.5684; PONDEL MD, 1995, P NATL ACAD SCI USA, V92, P7237, DOI 10.1073/pnas.92.16.7237; PRUZINA S, 1991, NUCLEIC ACIDS RES, V19, P1413, DOI 10.1093/nar/19.7.1413; Shelton DA, 1997, BLOOD, V89, P3457, DOI 10.1182/blood.V89.9.3457; Stamatoyannopoulos G., 2000, MOL BASIS BLOOD DIS, P135; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; TALBOT D, 1990, EMBO J, V9, P2169, DOI 10.1002/j.1460-2075.1990.tb07386.x; TAMAKI T, 1995, J BIOL CHEM, V270, P4299, DOI 10.1074/jbc.270.9.4299; Tewari R, 1998, EMBO J, V17, P2334, DOI 10.1093/emboj/17.8.2334; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; Widlak P, 1997, J BIOL CHEM, V272, P17654, DOI 10.1074/jbc.272.28.17654; Wijgerde M, 1996, GENE DEV, V10, P2894, DOI 10.1101/gad.10.22.2894; WOLFFE AP, 1994, TRENDS BIOCHEM SCI, V19, P240, DOI 10.1016/0968-0004(94)90148-1; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10638, DOI 10.1073/pnas.88.23.10638; ZON LI, 1991, J BIOL CHEM, V266, P22948	64	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2001	276	29					26883	26892		10.1074/jbc.M008410200	http://dx.doi.org/10.1074/jbc.M008410200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	454HJ	11304527	hybrid			2022-12-27	WOS:000169966900022
J	Ramamurthy, V; Tucker, C; Wilkie, SE; Daggett, V; Hunt, DM; Hurley, JB				Ramamurthy, V; Tucker, C; Wilkie, SE; Daggett, V; Hunt, DM; Hurley, JB			Interactions within the coiled-coil domain of RetGC-1 guanylyl cyclase are optimized for regulation rather than for high affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONE-ROD DYSTROPHY; ADENYLYL-CYCLASE; CATALYTIC MECHANISM; CA2+-BINDING PROTEINS; MOLECULAR-DYNAMICS; ACTIVATING PROTEIN; ESCHERICHIA-COLI; NUCLEIC-ACIDS; CALCIUM; MUTATIONS	RetGC-1, a member of the membrane guanylyl cyclase family of proteins, is regulated in photoreceptor cells by a Ca2+-binding protein known as GCAP-1, Proper regulation of RetGC-1 is essential in photoreceptor cells for normal light adaptation and recovery to the dark state. In this study we show that cGMP synthesis by RetGC-1 requires dimerization, because critical functions in the catalytic site must be provided by each of the two polypeptide chains of the dimer, We also show that an intact cy-helical coiled-coil structure is required to provide dimerization strength for the catalytic domain of RetGC-1, However, the dimerization strength of this domain must be precisely optimized for proper regulation by GCAP-1, We found that Arg(838) within the dimerization domain establishes the Ca2+ sensitivity of RetGC-1 by determining the strength of the coiled-coil interaction. Arg(838) substitutions dominantly enhance cGMP synthesis even at the highest Ca2+ concentrations that occur in normal dark-adapted photoreceptor cells, Molecular dynamics simulations suggest that Arg(838) substitutions disrupt a small network of salt bridges to allow an abnormal extension of coiled-coil structure. Substitutions at Arg(838) were first identified by linkage to the retinal degenerative disease, autosomal dominant cone rod dystrophy (adCORD). Consistent with the characteristics of this disease, the Arg(898)-substituted RetGC-1 mutants exhibit a dominant biochemical phenotype, We propose that accelerated cGMP synthesis in humans with adCORD is the primary cause of cone-rod degeneration.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; UCL, Inst Ophthalmol, Dept Visual Sci, London EC1V 9EL, England; UCL, Dept Mol Genet, London EC1V 9EL, England; Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of London; University College London; University of London; University College London; University of Washington; University of Washington Seattle	Hurley, JB (corresponding author), Univ Washington, Howard Hughes Med Inst, Box 357370, Seattle, WA 98195 USA.	jbhhh@u.washington.edu	Hunt, David M/K-6024-2012; Tucker, Chandra/F-6842-2011	Hunt, David M/0000-0002-9264-3948; Tucker, Chandra/0000-0003-3033-1786	NEI NIH HHS [EY06641] Funding Source: Medline; NIGMS NIH HHS [GM50789] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050789, R29GM050789] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3; COETZER TL, 1991, J CLIN INVEST, V88, P743, DOI 10.1172/JCI115371; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Dizhoor AM, 1999, METHODS, V19, P521, DOI 10.1006/meth.1999.0894; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; Duda T, 1996, BIOCHEMISTRY-US, V35, P8478, DOI 10.1021/bi960752z; Duda T, 1999, BIOCHEMISTRY-US, V38, P13912, DOI 10.1021/bi9915972; Duda T, 2000, BIOCHEMISTRY-US, V39, P12522, DOI 10.1021/bi001514d; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Frins S, 1996, J BIOL CHEM, V271, P8022, DOI 10.1074/jbc.271.14.8022; GARBERS DL, 1994, J BIOL CHEM, V269, P30741; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; Gregory-Evans K, 2000, OPHTHALMOLOGY, V107, P55, DOI 10.1016/S0161-6420(99)00038-X; He LH, 2000, J BIOL CHEM, V275, P12175, DOI 10.1074/jbc.275.16.12175; Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719; HOVNANIAN A, 1993, NAT GENET, V3, P327, DOI 10.1038/ng0493-327; HU JC, 1990, SCIENCE, V250, P1400, DOI 10.1126/science.2147779; Hu JC, 2000, METHODS, V20, P80, DOI 10.1006/meth.1999.0908; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Jappelli R, 1999, BIOCHEM BIOPH RES CO, V266, P243, DOI 10.1006/bbrc.1999.1806; JOSLYN G, 1993, P NATL ACAD SCI USA, V90, P11109, DOI 10.1073/pnas.90.23.11109; KABSCH W, 1983, FEBS LETT, V155, P179, DOI 10.1016/0014-5793(82)80597-8; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; Laura RP, 1998, BIOCHEMISTRY-US, V37, P11264, DOI 10.1021/bi9809674; LETAI A, 1992, J CELL BIOL, V116, P1181, DOI 10.1083/jcb.116.5.1181; Levitt M, 1997, J PHYS CHEM B, V101, P5051, DOI 10.1021/jp964020s; LEVITT M, 1995, COMPUT PHYS COMMUN, V91, P215, DOI 10.1016/0010-4655(95)00049-L; LEVITT M, 1990, ENCAD COMPUTER PROGR; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Lucas KA, 2000, PHARMACOL REV, V52, P375; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; MARKS PW, 1991, ANAL BIOCHEM, V193, P61, DOI 10.1016/0003-2697(91)90044-T; Miller J.H., 1992, SHORT COURSE BACTERI, P150; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; PABO CO, 1979, P NATL ACAD SCI USA, V76, P1608, DOI 10.1073/pnas.76.4.1608; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X; POTTER LR, 1992, J BIOL CHEM, V267, P14531; Pugh EN, 1997, BIOSCIENCE REP, V17, P429; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Rudnicka-Nawrot M, 1998, BIOCHEMISTRY-US, V37, P248, DOI 10.1021/bi972306x; SHYJAN AW, 1992, NEURON, V9, P727, DOI 10.1016/0896-6273(92)90035-C; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; TANG WJ, 1995, BIOCHEMISTRY-US, V34, P14563, DOI 10.1021/bi00044a035; Tang WJ, 1998, MOL PHARMACOL, V54, P231, DOI 10.1124/mol.54.2.231; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tesmer JJG, 1998, CURR OPIN STRUC BIOL, V8, P713, DOI 10.1016/S0959-440X(98)80090-0; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; van den Akker F, 2000, NATURE, V406, P101, DOI 10.1038/35017602; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Weigell-Weber M, 2000, ARCH OPHTHALMOL-CHIC, V118, P300; WILSON EM, 1995, BIOCHEMISTRY-US, V34, P4696, DOI 10.1021/bi00014a025; Yang JM, 1997, J INVEST DERMATOL, V109, P692, DOI 10.1111/1523-1747.ep12338320; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; YARFITZ S, 1994, J BIOL CHEM, V269, P14329; Yu H, 1999, J BIOL CHEM, V274, P15547, DOI 10.1074/jbc.274.22.15547; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0; Zimmermann G, 1998, J BIOL CHEM, V273, P19650, DOI 10.1074/jbc.273.31.19650	70	81	81	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2001	276	28					26218	26229		10.1074/jbc.M010495200	http://dx.doi.org/10.1074/jbc.M010495200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451VP	11306565	hybrid			2022-12-27	WOS:000169823300078
J	Chen, S; Inamdar, KV; Pfeiffer, P; Feldmann, E; Hannah, MF; Yu, Y; Lee, JW; Zhou, T; Lees-Miller, SP; Povirk, LF				Chen, S; Inamdar, KV; Pfeiffer, P; Feldmann, E; Hannah, MF; Yu, Y; Lee, JW; Zhou, T; Lees-Miller, SP; Povirk, LF			Accurate in vitro end joining of a DNA double strand break with partially cohesive 3 '-overhangs and 3 '-phosphoglycolate termini - Effect of Ku on repair fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; RAY-SENSITIVE MUTANTS; XENOPUS EGG EXTRACTS; CELL-FREE-EXTRACTS; IONIZING-RADIATION; CATALYTIC SUBUNIT; IN-VITRO; MAMMALIAN-CELLS; NUCLEAR FOCI; MECHANISMS	To examine determinants of fidelity in DNA end joining, a substrate containing a model of a staggered free radical-mediated double-strand break, with cohesive phosphoglycolate-terminated 3'-overhangs and a one-base gap in each strand, was constructed. In extracts of Xenopus eggs, human lymphoblastoid cells, hamster CHO-K1 cells, and a Chinese hamster ovary (CHO) derivative lacking the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs), the predominant end joining product was that corresponding to accurate restoration of the original sequence. In extracts of the Ku-deficient CHO derivative xrs6, a shorter product, consistent with 3' --> 5' resection before ligation, was formed. Similar results were seen for a substrate with 5'-overhangs and recessed S'-phosphoglycolate ends. Supplementation of the xrs6 extracts with purified Ku restored accurate end joining. In Xenopus and human extracts, but not in hamster extracts, gap filling and ligation were blocked by wortmannin, consistent with a requirement for DNA-PKcs activity. The results suggest a Ku-dependent pathway, regulated by DNA-PKcs, that can accurately restore the original DNA sequence at sites of free radical-mediated double-strand breaks, by protecting DNA termini from degradation and maintaining the alignment of short partial complementarities during gap filling and ligation.	Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; Univ Essen Gesamthsch Klinikum, Inst Zellbiol, D-45122 Essen, Germany; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	Virginia Commonwealth University; University of Duisburg Essen; University of Calgary	Povirk, LF (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, POB 980230, Richmond, VA 23298 USA.	LPOVIRK@hsc.vcu.edu		Lees-Miller, Susan/0000-0001-5809-2516	NATIONAL CANCER INSTITUTE [R01CA040615] Funding Source: NIH RePORTER; NCI NIH HHS [CA40615] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Bennett RAO, 1996, INT J RADIAT BIOL, V70, P623; Calsou P, 1999, J BIOL CHEM, V274, P7848, DOI 10.1074/jbc.274.12.7848; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; Chan DW, 1996, BIOCHEM CELL BIOL, V74, P67, DOI 10.1139/o96-007; Chan DW, 1996, J BIOL CHEM, V271, P8936, DOI 10.1074/jbc.271.15.8936; Chaudhry MA, 1999, BIOCHEM PHARMACOL, V57, P531, DOI 10.1016/S0006-2952(98)00327-X; CHEN DS, 1991, NUCLEIC ACIDS RES, V19, P5907, DOI 10.1093/nar/19.21.5907; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Chen S, 2001, ANAL BIOCHEM, V289, P274, DOI 10.1006/abio.2000.4936; Chu G, 1997, J BIOL CHEM, V272, P24097, DOI 10.1074/jbc.272.39.24097; Daza P, 1996, BIOL CHEM, V377, P775, DOI 10.1515/bchm3.1996.377.12.775; DEDON PC, 1992, CHEM RES TOXICOL, V5, P311, DOI 10.1021/tx00027a001; Errami A, 1998, NUCLEIC ACIDS RES, V26, P3146, DOI 10.1093/nar/26.13.3146; Featherstone C, 1999, MUTAT RES-DNA REPAIR, V434, P3, DOI 10.1016/S0921-8777(99)00006-3; Feldmann E, 2000, NUCLEIC ACIDS RES, V28, P2585, DOI 10.1093/nar/28.13.2585; FINNIE NJ, 1995, P NATL ACAD SCI USA, V92, P320, DOI 10.1073/pnas.92.1.320; GETTS RC, 1994, J BIOL CHEM, V269, P15981; Gottlich B, 1998, EUR J BIOCHEM, V258, P387, DOI 10.1046/j.1432-1327.1998.2580387.x; Gu XY, 1998, BIOCHEMISTRY-US, V37, P9827, DOI 10.1021/bi980198o; Gu XY, 1996, J BIOL CHEM, V271, P19660, DOI 10.1074/jbc.271.33.19660; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; HENNER WD, 1983, J BIOL CHEM, V258, P711; HUTCHINSON F, 1985, PROG NUCLEIC ACID RE, V32, P115, DOI 10.1016/S0079-6603(08)60347-5; JEGGO PA, 1983, MUTAT RES, V112, P313, DOI 10.1016/0167-8817(83)90026-3; Jeggo PA, 1997, MUTAT RES-DNA REPAIR, V384, P1, DOI 10.1016/S0921-8777(97)00009-8; Labhart P, 1999, MOL CELL BIOL, V19, P2585; LeesMiller SP, 1996, BIOCHEM CELL BIOL, V74, P503, DOI 10.1139/o96-054; LeRomancer M, 1996, J CELL SCI, V109, P3121; Leuther KK, 1999, EMBO J, V18, P1114, DOI 10.1093/emboj/18.5.1114; Lieber MR, 1997, CURR OPIN GENET DEV, V7, P99, DOI 10.1016/S0959-437X(97)80116-5; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; MEUTH M, 1989, MOBILE DNA, P833; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; OBE G, 1992, MUTAGENESIS, V7, P3, DOI 10.1093/mutage/7.1.3; Pang DL, 1997, CANCER RES, V57, P1412; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Paull TT, 2000, P NATL ACAD SCI USA, V97, P6409, DOI 10.1073/pnas.110144297; Petrini JHJ, 1999, AM J HUM GENET, V64, P1264, DOI 10.1086/302391; PFEIFFER P, 1988, NUCLEIC ACIDS RES, V16, P907, DOI 10.1093/nar/16.3.907; PFEIFFER P, 1994, MOL CELL BIOL, V14, P888, DOI 10.1128/MCB.14.2.888; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; Roth D., 1988, GENETIC RECOMBINATIO, P621; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; SCHAAL H, 1993, GENE, V124, P275, DOI 10.1016/0378-1119(93)90405-R; Smith GCM, 1999, BIOCHEM SOC SYMP, P91; Suh D, 1997, NUCLEIC ACIDS RES, V25, P2495, DOI 10.1093/nar/25.12.2495; Sutherland BM, 2000, P NATL ACAD SCI USA, V97, P103, DOI 10.1073/pnas.97.1.103; THODE S, 1990, CELL, V60, P921, DOI 10.1016/0092-8674(90)90340-K; Ting NSY, 1999, RADIAT RES, V151, P414, DOI 10.2307/3579828; WALKER AI, 1985, EMBO J, V4, P139, DOI 10.1002/j.1460-2075.1985.tb02328.x; WARD JF, 1981, RADIAT RES, V86, P185, DOI 10.2307/3575500; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; WHITMORE GF, 1989, INT J RADIAT BIOL, V56, P657, DOI 10.1080/09553008914551881; WINTERS TA, 1992, NUCLEIC ACIDS RES, V20, P2573, DOI 10.1093/nar/20.10.2573; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Yoo S, 1999, NUCLEIC ACIDS RES, V27, P4679, DOI 10.1093/nar/27.24.4679	62	98	101	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24323	24330		10.1074/jbc.M010544200	http://dx.doi.org/10.1074/jbc.M010544200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11309379	hybrid			2022-12-27	WOS:000169531100144
J	Rose, K; Allan, A; Gauldie, S; Stapleton, G; Dobbie, L; Dott, X; Martin, C; Wang, L; Hedlund, E; Seckl, JR; Gustafsson, JA; Lathe, R				Rose, K; Allan, A; Gauldie, S; Stapleton, G; Dobbie, L; Dott, X; Martin, C; Wang, L; Hedlund, E; Seckl, JR; Gustafsson, JA; Lathe, R			Neurosteroid hydroxylase CYP7B - Vivid reporter activity in dentate gyrus of gene-targeted mice and abolition of a widespread pathway of steroid and oxysterol hydroxylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE-SPECIFIC INHIBITION; MOUSE-LIVER MICROSOMES; CENTRAL-NERVOUS-SYSTEM; ADIPOSE STROMAL CELLS; BILE-ACID SYNTHESIS; DEHYDROEPIANDROSTERONE-SULFATE; CYTOCHROME-P450 INHIBITORS; BRAIN CYTOCHROME-P450; PROSTATE MICROSOMES; MOLECULAR-CLONING	The major adrenal steroid dehydroepiandrosterone (DHEA) enhances memory and immune function but has no known dedicated receptor; local metabolism may govern its activity. We described a cytochrome P450 expressed in brain and other tissues, CYP7B, that catalyzes the 7 alpha -hydroxylation of oxysterols and 3 beta -hydroxysteroids including DHEA, We report here that CYP7B mRNA and 7 alpha -hydroxylation activity are widespread in rat tissues. However, steroids related to DHEA are reported to be modified at positions other than 7 alpha, exemplified by prominent 6 alpha -hydroxylation of 5 alpha -androstane-3 beta ,17 beta -diol (A/anediol) in some rodent tissues including brain. To determine whether CYP7B is responsible for these and other activities we disrupted the mouse Cyp7b gene by targeted insertion of an IRES-lacZ reporter cassette, placing reporter enzyme activity (beta -galactosidase) under Cyp7b promoter control. In heterozygous mouse brain, chromogenic detection of reporter activity was strikingly restricted to the dentate gyrus. Staining did not exactly reproduce the in situ hybridization expression pattern; post-transcriptional control is inferred. Lower level staining was detected in cerebellum, liver, and kidney, and which largely paralleled mRNA distribution. Liver and kidney expression was sexually dimorphic. Mice homozygous for the insertion are viable and superficially normal, but ex vivo metabolism of DHEA to 7 alpha -hydroxy-DHEA was abolished in brain, spleen, thymus, heart, lung, prostate, uterus, and mammary gland; lower abundance metabolites were also eliminated. 7 alpha -Hydroxylation of 25-hydroxycholesterol and related substrates was also abolished, as was presumed 6 alpha -hydroxylation of A/anediol. These different enzyme activities therefore derive from the Cyp7b gene. CYP7B is thus a major extrahepatic steroid and oxysterol hydroxylase and provides the predominant route for local metabolism of DHEA and related molecules in brain and other tissues.	Univ Edinburgh, Ctr Genome Res, Edinburgh EH9 3JQ, Midlothian, Scotland; Univ Edinburgh, Ctr Neurosci, Edinburgh EH9 3JQ, Midlothian, Scotland; Huddinge Hosp, Karolinska Inst, S-14186 Huddinge, Sweden; Transgene SA, F-67000 Strasbourg, France; Western Gen Hosp, Mol Med Ctr, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Karolinska Institutet; Transgene SA; University of Edinburgh	Lathe, R (corresponding author), Univ Edinburgh, Ctr Genome Res, Kings Bldgs,W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.	Rlathe@ed.ac.uk	Seckl, Jonathan R/C-3555-2013	Hedlund, Eva/0000-0001-6347-0075; Lathe, Richard/0000-0001-9698-9834				AKWA Y, 1992, BIOCHEM J, V288, P959, DOI 10.1042/bj2880959; AKWA Y, 1993, J CELL BIOL, V121, P135, DOI 10.1083/jcb.121.1.135; Axelson M, 1996, J BIOL CHEM, V271, P12724, DOI 10.1074/jbc.271.22.12724; Baulieu EE, 2000, P NATL ACAD SCI USA, V97, P4279, DOI 10.1073/pnas.97.8.4279; Baulieu EE, 1998, PSYCHONEUROENDOCRINO, V23, P963, DOI 10.1016/S0306-4530(98)00071-7; BAULIEU EE, 1990, J STEROID BIOCHEM, V37, P395, DOI 10.1016/0960-0760(90)90490-C; BJORKHEM I, 1994, SCAND J GASTROENTERO, V29, P68, DOI 10.3109/00365529409103629; Chang HC, 1999, P NATL ACAD SCI USA, V96, P11173, DOI 10.1073/pnas.96.20.11173; CHURCH GM, 1986, P NATL ACAD SCI USA, V81, P1991; Creancier L, 2000, J CELL BIOL, V150, P275, DOI 10.1083/jcb.150.1.275; DANENBERG HD, 1995, VACCINE, V13, P1445, DOI 10.1016/0264-410X(95)00063-7; DAYNES RA, 1990, EUR J IMMUNOL, V20, P793, DOI 10.1002/eji.1830200413; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Dombroski R, 1997, J CLIN ENDOCR METAB, V82, P1338, DOI 10.1210/jc.82.5.1338; Doostzadeh J, 1996, STEROIDS, V61, P613, DOI 10.1016/S0039-128X(96)00122-5; Doostzadeh J, 1997, J NEUROENDOCRINOL, V9, P923, DOI 10.1046/j.1365-2826.1997.00661.x; Doostzadeh J, 1998, STEROIDS, V63, P608, DOI 10.1016/S0039-128X(98)00071-3; Doostzadeh J, 1998, STEROIDS, V63, P383, DOI 10.1016/S0039-128X(98)00012-9; Eggertsen G, 1996, J BIOL CHEM, V271, P32269, DOI 10.1074/jbc.271.50.32269; FLOOD JF, 1988, BRAIN RES, V448, P178, DOI 10.1016/0006-8993(88)91116-X; FLOOD JF, 1995, P NATL ACAD SCI USA, V92, P10806, DOI 10.1073/pnas.92.23.10806; FLOOD JF, 1992, P NATL ACAD SCI USA, V89, P1567, DOI 10.1073/pnas.89.5.1567; GEMZIK B, 1992, ARCH BIOCHEM BIOPHYS, V296, P374, DOI 10.1016/0003-9861(92)90587-M; GEMZIK B, 1992, ARCH BIOCHEM BIOPHYS, V296, P355, DOI 10.1016/0003-9861(92)90585-K; GUIRAUD JM, 1982, STEROIDS, V40, P625, DOI 10.1016/0039-128X(82)90003-4; Hinson JP, 1999, J ENDOCRINOL, V163, P1, DOI 10.1677/joe.0.1630001; ISAACS JT, 1979, STEROIDS, V33, P675, DOI 10.1016/0039-128X(79)90116-8; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; KHALIL MW, 1993, J STEROID BIOCHEM, V46, P585, DOI 10.1016/0960-0760(93)90186-Z; KILLINGER DW, 1995, J STEROID BIOCHEM, V52, P195, DOI 10.1016/0960-0760(94)00164-H; Kurose K, 1999, ARCH BIOCHEM BIOPHYS, V371, P270, DOI 10.1006/abbi.1999.1457; Lane MA, 1997, J CLIN ENDOCR METAB, V82, P2093, DOI 10.1210/jc.82.7.2093; LARDY H, 1995, P NATL ACAD SCI USA, V92, P6617, DOI 10.1073/pnas.92.14.6617; LATHE R, 2001, IN PRESS GENETICS ST; LI K, 1978, STEROIDS, V31, P113; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16543, DOI 10.1074/jbc.M001810200; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARTEL C, 1992, J STEROID BIOCHEM, V41, P597, DOI 10.1016/0960-0760(92)90390-5; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; MORALES AJ, 1994, J CLIN ENDOCR METAB, V78, P1360, DOI 10.1210/jc.78.6.1360; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; ORENTREICH N, 1992, J CLIN ENDOCR METAB, V75, P1002, DOI 10.1210/jc.75.4.1002; Padgett DA, 1998, J NEUROIMMUNOL, V84, P61, DOI 10.1016/S0165-5728(97)00244-0; PAYNE DW, 1995, J BIOL CHEM, V270, P18888, DOI 10.1074/jbc.270.32.18888; PEREIRA B, 1994, BIOCHEM BIOPH RES CO, V203, P59, DOI 10.1006/bbrc.1994.2148; Rose KA, 1997, P NATL ACAD SCI USA, V94, P4925, DOI 10.1073/pnas.94.10.4925; Rosen H, 1998, J BIOL CHEM, V273, P14805, DOI 10.1074/jbc.273.24.14805; SAPOLSKY RM, 1993, J GERONTOL, V48, pB196, DOI 10.1093/geronj/48.5.B196; Schwarz M, 1997, J BIOL CHEM, V272, P23995, DOI 10.1074/jbc.272.38.23995; Setchell KDR, 1998, J CLIN INVEST, V102, P1690, DOI 10.1172/JCI2962; Shi J, 2000, STEROIDS, V65, P124, DOI 10.1016/S0039-128X(99)00094-X; SONDERFAN AJ, 1989, ENDOCRINOLOGY, V125, P857, DOI 10.1210/endo-125-2-857; Song C, 2000, STEROIDS, V65, P423, DOI 10.1016/S0039-128X(00)00127-6; Song W, 1998, J BIOL CHEM, V273, P16223, DOI 10.1074/jbc.273.26.16223; STAPLETON G, 1995, J BIOL CHEM, V270, P29739, DOI 10.1074/jbc.270.50.29739; STAPLETON G, 1994, THESIS U EDINBURGH; Steel M, 1998, HIPPOCAMPUS, V8, P444, DOI 10.1002/(SICI)1098-1063(1998)8:5<444::AID-HIPO5>3.0.CO;2-X; STROMSTEDT M, 1993, MOL PHARMACOL, V44, P1077; SUNDIN M, 1987, J BIOL CHEM, V262, P12293; WARNER M, 1989, ENDOCRINOLOGY, V124, P2699, DOI 10.1210/endo-124-6-2699; Wolf OT, 1998, J GERONTOL A-BIOL, V53, pM385, DOI 10.1093/gerona/53A.5.M385; Wolf OT, 1997, J CLIN ENDOCR METAB, V82, P2363, DOI 10.1210/jc.82.7.2363; Wu ZL, 1999, J LIPID RES, V40, P2195; ZHANG J, 1995, BBA-LIPID LIPID MET, V1256, P353	65	69	76	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23937	23944		10.1074/jbc.M011564200	http://dx.doi.org/10.1074/jbc.M011564200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11290741	hybrid			2022-12-27	WOS:000169531100095
J	Anusaksathien, O; Laplace, C; Li, X; Ren, Y; Peng, L; Goldring, SR; Galson, DL				Anusaksathien, O; Laplace, C; Li, X; Ren, Y; Peng, L; Goldring, SR; Galson, DL			Tissue-specific and ubiquitous promoters direct the expression of alternatively spliced transcripts from the calcitonin receptor gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; MESSENGER-RNA; PEPTIDE RECEPTOR; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; LIGAND-BINDING; TRANSMEMBRANE DOMAIN; EUKARYOTIC RIBOSOMES; SECONDARY STRUCTURE; PHOSPHOLIPASE-C	The gene encoding the murine calcitonin receptor (mCTR) was isolated, and the exon/intron structure was determined. Analysis of transcripts revealed novel cDNA sequences, new alternative exon splicing in the 5'- untranslated region, and three putative promoters (P1, P2, and P3). The longest transcription unit is greater than 67 kilobase pairs, and the location of introns within the coding region of the mCTR gene (exons E3-E14) are identical to those of the porcine and human CTR genes. We have identified novel cDNA sequences that form three new exons as well as others that add 512 base pairs to the 5' side of the previously published cDNA, thereby extending exon El to 682 base pairs. Two of these novel exons are upstream of exon E2 and form a tripartite exon E2 (E2a, E2b, and E2c) in which E2a is utilized by promoter P2 with variable splicing of E2b. The third new exon (E3b') lies between E3a and E3b and is utilized by promoter P3. Analysis of mCTR mRNAs has revealed that the three alternative promoters give rise to at least seven mCTR isoforms in the 5' region of the gene and generate 5'-untranslated regions of very different lengths. Analysis by reverse transcription-polymerase chain reaction shows that promoters P1 and P2 are utilized in osteoclasts, brain, and kidney, whereas promoter P3 appears to be osteoclast-specific. Using transiently transfected reporter constructs, promoter P2 has activity in both a murine kidney cell line (MDCT209) and a chicken osteoclastlike cell line (HD-11EM), whereas promoter P3 is active only in the osteoclast-like cell. line. These transfection data confirm the osteoclast specificity of promoter P3 and provide the first evidence that the CTR gene is regulated in a tissue specific manner by alternative promoter utilization.	Harvard Inst Med, Beth Israel Deaconess Med Ctr, New England Baptist & Bone Joint Inst, Boston, MA 02115 USA; Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; New England Baptist Hospital; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School	Galson, DL (corresponding author), Harvard Inst Med, Beth Israel Deaconess Med Ctr, New England Baptist & Bone Joint Inst, Rm 247,4 Blackfan Circle, Boston, MA 02115 USA.		Galson, Deborah L./E-9370-2010	Galson, Deborah L./0000-0002-2045-8807	NIAMS NIH HHS [R01 AR045421, AR45421] Funding Source: Medline; NIDDK NIH HHS [DK46773] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046773] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBRANDT K, 1995, ENDOCRINOLOGY, V136, P5377, DOI 10.1210/en.136.12.5377; ALBRANDT K, 1993, FEBS LETT, V325, P225, DOI 10.1016/0014-5793(93)81078-E; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antequera F, 1999, CURR BIOL, V9, pR661, DOI 10.1016/S0960-9822(99)80418-7; Antequera F, 1993, MOL BIOL BIOL SIGNIF, P169; Beesley AH, 1999, AM J PHYSIOL-CELL PH, V276, pC585, DOI 10.1152/ajpcell.1999.276.3.C585; Bettoun JD, 1998, J CLIN INVEST, V102, P958, DOI 10.1172/JCI3678; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; CHAKRABORTY M, 1991, SCIENCE, V251, P1078, DOI 10.1126/science.1847755; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11163, DOI 10.1073/pnas.91.23.11163; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Deftos Leonard J., 1996, P82; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIXON M, 1989, MOL CELL BIOL, V9, P4896, DOI 10.1128/MCB.9.11.4896; FEN Z, 1991, ONCOGENE, V6, P953; Foord SM, 1999, TRENDS PHARMACOL SCI, V20, P184, DOI 10.1016/S0165-6147(99)01347-4; FORCE T, 1992, AM J PHYSIOL, V262, pF1110, DOI 10.1152/ajprenal.1992.262.6.F1110; FRIEDMAN J, 1965, SCIENCE, V150, P1465, DOI 10.1126/science.150.3702.1465; GALSON DL, 1997, J BONE MINER RES S1, V12, pS323; GALSON DL, 1996, J BONE MINER RES  S1, V11, pS203; Gebauer F, 1998, RNA, V4, P142; GEHRKE L, 1983, BIOCHEMISTRY-US, V22, P5157, DOI 10.1021/bi00291a015; GESEK FA, 1992, J CLIN INVEST, V90, P429, DOI 10.1172/JCI115878; GOLDRING S, 1996, PRINCIPLES BONE BIOL, P462; GORN AH, 1992, J CLIN INVEST, V90, P1726, DOI 10.1172/JCI116046; GORN AH, 1995, J CLIN INVEST, V95, P2680, DOI 10.1172/JCI117970; HORIUCHI T, 1990, J BIOL CHEM, V265, P6521; Houbaviy HB, 1996, P NATL ACAD SCI USA, V93, P13577, DOI 10.1073/pnas.93.24.13577; HOUSSAMI S, 1994, ENDOCRINOLOGY, V135, P183, DOI 10.1210/en.135.1.183; HSIA YJ, 1995, J BONE MINER RES, V10, pS424; IKEGAME M, 1995, J BONE MINER RES, V10, P59; Inoue D, 1999, ENDOCRINOLOGY, V140, P1060, DOI 10.1210/en.140.3.1060; Jagger C, 1999, ENDOCRINOLOGY, V140, P492, DOI 10.1210/en.140.1.492; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; JOUN H, 1995, J BONE MINER RES, V10, pS488; Kel A, 1999, J MOL BIOL, V288, P353, DOI 10.1006/jmbi.1999.2684; KOZAK M, 1995, P NATL ACAD SCI USA, V92, P2662, DOI 10.1073/pnas.92.7.2662; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Krainer AR, 1988, TRANSCRIPTION SPLICI, P131; KUESTNER RE, 1994, MOL PHARMACOL, V46, P246; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; LEE SK, 1995, ENDOCRINOLOGY, V136, P4572, DOI 10.1210/en.136.10.4572; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; MCCUAIG KA, 1995, NUCLEIC ACIDS RES, V23, P1948, DOI 10.1093/nar/23.11.1948; MCCUAIG KA, 1994, P NATL ACAD SCI USA, V91, P5051, DOI 10.1073/pnas.91.11.5051; MITSUHASHI T, 1989, J BIOL CHEM, V264, P8900; MOORE EE, 1995, MOL ENDOCRINOL, V9, P959, DOI 10.1210/me.9.8.959; Muff R, 1999, ENDOCRINOLOGY, V140, P2924, DOI 10.1210/en.140.6.2924; Naro F, 1998, ENDOCRINOLOGY, V139, P3241, DOI 10.1210/en.139.7.3241; NIELSEN FC, 1990, J BIOL CHEM, V265, P13431; Nishikawa T, 1999, FEBS LETT, V458, P409, DOI 10.1016/S0014-5793(99)01176-X; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RAISZ LG, 1967, AM J MED, V43, P684, DOI 10.1016/0002-9343(67)90110-6; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMIDT EE, 1995, J CELL BIOL, V128, P467, DOI 10.1083/jcb.128.4.467; SEGRE GV, 1993, TRENDS ENDOCRIN MET, V4, P309, DOI 10.1016/1043-2760(93)90071-L; SEXTON PM, 1993, MOL ENDOCRINOL, V7, P815, DOI 10.1210/me.7.6.815; Shyu JF, 1996, J BIOL CHEM, V271, P31127, DOI 10.1074/jbc.271.49.31127; Steinbeck MJ, 1998, J CELL PHYSIOL, V176, P574, DOI 10.1002/(SICI)1097-4652(199809)176:3<574::AID-JCP14>3.0.CO;2-#; STRADER CD, 1995, FASEB J, V9, P745, DOI 10.1096/fasebj.9.9.7601339; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; TETI A, 1995, J BIOL CHEM, V270, P16666, DOI 10.1074/jbc.270.28.16666; THEISEN HJ, 1990, NUCLEIC ACIDS RES, V18, P3202; Turner CW, 1998, BRIT J HAEMATOL, V103, P326, DOI 10.1046/j.1365-2141.1998.01003.x; Usheva A, 1996, P NATL ACAD SCI USA, V93, P13571, DOI 10.1073/pnas.93.24.13571; WARSHAWSKY H, 1980, J CELL BIOL, V85, P682, DOI 10.1083/jcb.85.3.682; Wimalawansa SJ, 1997, CRIT REV NEUROBIOL, V11, P167, DOI 10.1615/CritRevNeurobiol.v11.i2-3.40; YAMIN M, 1994, ENDOCRINOLOGY, V135, P2635, DOI 10.1210/en.135.6.2635; ZOLNIEROWICZ S, 1994, J BIOL CHEM, V269, P19530	75	58	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22663	22674		10.1074/jbc.M007104200	http://dx.doi.org/10.1074/jbc.M007104200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11309373	hybrid			2022-12-27	WOS:000169412700093
J	Cok, SJ; Morrison, AR				Cok, SJ; Morrison, AR			The 3 '-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; JUN NH2-TERMINAL KINASE; 3' UNTRANSLATED REGION; RENAL MESANGIAL CELLS; NECROSIS-FACTOR-ALPHA; UA-RICH SEQUENCES; N-TERMINAL KINASE; GROWTH-FACTOR; TRANSFORMING GROWTH-FACTOR-BETA-1; TRANSCRIPTIONAL REGULATION	Renal mesangial cells regulate their expression of the pro-inflammatory gene cyclooxygenase-2 (COX-2) through mechanisms involving gene transcription and post-transcriptional events. Post-transcriptional regulation of COX-2 is dependent, in part, on sequences within the 3'-untranslated region (3'-UTR) of the COX-2 mRNA Insertion of the entire 3'-UTR of COX-2 into the 3'-UTR of luciferase resulted in a 70% decrease in luciferase enzymatic activity. Measurement of steady-state reporter gene mRNA levels suggested that the loss of activity was due to decreased translational efficiency. Deletion analysis identified the first 60 nucleotides of the 3'-UTR of COX-2 as a major translational control element. This region of the 3'-UTR of COX-2 is highly conserved across species; is AU-rich; and contains multiple repeats of the regulatory sequence AUUUA, reported to confer post-transcriptional control. In addition, we identified regions of the 3'-UTR of COX-2 outside of the first 60 nucleotides that altered message stability. Some of these regions contained AUUUA consensus sequences, whereas others did not, and represent novel control elements. These results suggest that expression of COX-2 in mesangial cells depends on the complex integration of multiple signals derived from the 3'-UTR of the message.	Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Morrison, AR (corresponding author), Barnes Jewish Hosp, 822 Yalem Res Bldg,216 S Kingshighway, St Louis, MO 63110 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050606, P01DK009976] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 50606, DK 09976] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Balmer LA, 2001, MOL CELL BIOL, V21, P2070, DOI 10.1128/MCB.21.6.2070-2084.2001; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Diaz A, 1998, EXP CELL RES, V241, P222, DOI 10.1006/excr.1998.4050; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; FLETCHER BS, 1992, J BIOL CHEM, V267, P4338; Gou Q, 1998, BIOCHEM BIOPH RES CO, V242, P508, DOI 10.1006/bbrc.1997.7994; Guan ZH, 1997, J BIOL CHEM, V272, P8083, DOI 10.1074/jbc.272.12.8083; Guan ZH, 1998, J BIOL CHEM, V273, P12901, DOI 10.1074/jbc.273.21.12901; Guan ZH, 1996, AM J PHYSIOL-RENAL, V270, pF634, DOI 10.1152/ajprenal.1996.270.4.F634; Guan ZH, 1998, J BIOL CHEM, V273, P28670, DOI 10.1074/jbc.273.44.28670; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; HERSCHMAN HR, 1995, BIOESSAYS, V17, P1031, DOI 10.1002/bies.950171207; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; Izquierdo JM, 1997, MOL CELL BIOL, V17, P5255, DOI 10.1128/MCB.17.9.5255; KRUYS V, 1987, P NATL ACAD SCI USA, V84, P6030, DOI 10.1073/pnas.84.17.6030; KRUYS V, 1994, BIOCHIMIE, V76, P862, DOI 10.1016/0300-9084(94)90188-0; KRUYS V, 1989, SCIENCE, V245, P852, DOI 10.1126/science.2672333; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; LAGNADO CA, 1994, MOL CELL BIOL, V14, P7984, DOI 10.1128/MCB.14.12.7984; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Lee NH, 1998, J BIOL CHEM, V273, P22317, DOI 10.1074/jbc.273.35.22317; Mbella EGM, 2000, MOL CELL BIOL, V20, P4572, DOI 10.1128/MCB.20.13.4572-4579.2000; Meade EA, 1999, J BIOL CHEM, V274, P8328, DOI 10.1074/jbc.274.12.8328; Ming XF, 1998, EMBO J, V17, P6039, DOI 10.1093/emboj/17.20.6039; Morris JK, 1996, J BIOL CHEM, V271, P16633, DOI 10.1074/jbc.271.28.16633; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; *PE BIOS, 1997, PE BIOS US B 2; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Reddy ST, 2000, J BIOL CHEM, V275, P3107, DOI 10.1074/jbc.275.5.3107; RISTIMAKI A, 1994, J BIOL CHEM, V269, P11769; Ross J, 1996, TRENDS GENET, V12, P171, DOI 10.1016/0168-9525(96)10016-0; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Sheng HM, 2000, J BIOL CHEM, V275, P6628, DOI 10.1074/jbc.275.9.6628; SIROIS J, 1992, J BIOL CHEM, V267, P11586; SRIVASTAVA SK, 1994, AM J PHYSIOL, V267, pF504, DOI 10.1152/ajprenal.1994.267.3.F504; STANDART N, 1994, BIOCHIMIE, V76, P867, DOI 10.1016/0300-9084(94)90189-9; STOECKLIN G, 1994, J BIOL CHEM, V269, P28591; Subbaramaiah K, 1998, J BIOL CHEM, V273, P32943, DOI 10.1074/jbc.273.49.32943; Wadleigh DJ, 2000, J BIOL CHEM, V275, P6259, DOI 10.1074/jbc.275.9.6259; Wickens M, 1997, CURR OPIN GENET DEV, V7, P220, DOI 10.1016/S0959-437X(97)80132-3; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Xie WL, 1996, J BIOL CHEM, V271, P31742, DOI 10.1074/jbc.271.49.31742; Xu KM, 2000, J BIOL CHEM, V275, P23012, DOI 10.1074/jbc.M001611200; Yang TX, 2000, J BIOL CHEM, V275, P23281, DOI 10.1074/jbc.M910237199; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	48	182	191	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23179	23185		10.1074/jbc.M008461200	http://dx.doi.org/10.1074/jbc.M008461200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294846	hybrid			2022-12-27	WOS:000169412700159
J	Tasken, KA; Collas, P; Kemmners, WA; Witczak, O; Conti, M; Tasken, K				Tasken, KA; Collas, P; Kemmners, WA; Witczak, O; Conti, M; Tasken, K			Phosphodiesterase 4D and protein kinase A type II constitute a signaling unit in the Centrosomal Area	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORING PROTEIN; SUBCELLULAR-LOCALIZATION; DIFFERENTIAL EXPRESSION; CAMP; ASSOCIATION; IDENTIFICATION; ACTIVATION; INTERACTS; SUBUNITS; HORMONE	The mediation of cAMP effects by specific pools of protein kinase A (PRA) targeted to distinct subcellular domains raises the question of how inactivation of the cAMP signal is achieved locally and whether similar targeting of phosphodiesterases (PDEs) to sites of cAMP/PKA action could be observed. Here, we demonstrate that Sertoli cells of the testis contain an insoluble PDE4D3 isoform, which is shown by immunofluorescence to target to centrosomes. Staining of PDE4D and PKA shows co-localization of PDE4D with PKA-RII alpha and RII beta in the centrosomal region. Go-precipitation of RII subunits and PDE4D3 from cytoskeletal extracts indicates a physical association of the two proteins. Distribution of PDE4D overlaps with that of the centrosomal PKA-anchoring protein, AKAP450, and AKAP450, PDE4D3, and PRA-RII alpha co-immunoprecipitate. Finally, both PDE4D8 and PRA co-precipitate with a soluble fragment of AKAP450 encompassing amino acids 1710 to 2872 when co-expressed in 293T cells. Thus, a centrosomal complex that includes PDE4D and PKA constitutes a novel signaling unit that may provide accurate spatiotemporal modulation of cAMP signals.	Univ Oslo, Inst Med Biochem, N-0317 Oslo, Norway; Max Planck Inst Dev Biol, Dept Biochem, D-72076 Tubingen, Germany; Stanford Univ, Med Ctr, Dept Gynecol & Obstet, Stanford, CA 94305 USA	University of Oslo; Max Planck Society; Stanford University	Tasken, K (corresponding author), Univ Oslo, Inst Med Biochem, POB 1112, N-0317 Oslo, Norway.	kjetil.tasken@basalmed.uio.no		Tasken, Kjetil/0000-0003-2841-4697	NICHD NIH HHS [HD20778] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BAILLY E, 1989, EMBO J, V8, P3985, DOI 10.1002/j.1460-2075.1989.tb08581.x; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Collas P, 1996, J CELL BIOL, V135, P1715, DOI 10.1083/jcb.135.6.1715; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Conti M, 2000, PROG NUCLEIC ACID RE, V63, P1; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; DORRINGTON JH, 1975, MOL CELL ENDOCRINOL, V3, P57, DOI 10.1016/0303-7207(75)90031-3; Eide T, 1998, EXP CELL RES, V238, P305, DOI 10.1006/excr.1997.3855; Fernandez A, 1995, Prog Cell Cycle Res, V1, P241; Gavet O, 1998, J CELL SCI, V111, P3333; Gradin HM, 1998, J CELL BIOL, V140, P131, DOI 10.1083/jcb.140.1.131; Iona S, 1998, MOL PHARMACOL, V53, P23, DOI 10.1124/mol.53.1.23; Jin SLC, 1998, J BIOL CHEM, V273, P19672, DOI 10.1074/jbc.273.31.19672; Keryer G, 1999, EXP CELL RES, V249, P131, DOI 10.1006/excr.1999.4447; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; LANDMARK BF, 1991, ENDOCRINOLOGY, V129, P2345, DOI 10.1210/endo-129-5-2345; MARO B, 1980, BIOL CELLULAIRE, V39, P287; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; OYEN O, 1987, BIOL REPROD, V37, P947, DOI 10.1095/biolreprod37.4.947; Reinton N, 2000, DEV BIOL, V223, P194, DOI 10.1006/dbio.2000.9725; Schillace RV, 1999, CURR BIOL, V9, P321, DOI 10.1016/S0960-9822(99)80141-9; Schmidt PH, 1999, J BIOL CHEM, V274, P3055, DOI 10.1074/jbc.274.5.3055; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; TASKEN KA, 1991, MOL ENDOCRINOL, V5, P21, DOI 10.1210/mend-5-1-21; Tassin AM, 1999, BIOL CELL, V91, P343, DOI 10.1016/S0248-4900(99)80095-1; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; Vicini E, 1997, MOL ENDOCRINOL, V11, P839, DOI 10.1210/me.11.7.839; WALTER U, 1983, METHOD ENZYMOL, V99, P154; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Witczak O, 1999, EMBO J, V18, P1858, DOI 10.1093/emboj/18.7.1858; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909	33	185	197	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					21999	22002		10.1074/jbc.C000911200	http://dx.doi.org/10.1074/jbc.C000911200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11285255	hybrid			2022-12-27	WOS:000169412700003
J	Van Valkenburgh, H; Shern, JF; Sharer, JD; Zhu, XJ; Kahn, RA				Van Valkenburgh, H; Shern, JF; Sharer, JD; Zhu, XJ; Kahn, RA			ADP-ribosylation factors (ARFs) and ARF-like 1 (ARL1) have both specific and shared effectors - Characterizing ARL1-binding proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING-PROTEIN; GUANINE-NUCLEOTIDE-EXCHANGE; COILED-COIL PROTEINS; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPASE-D; CHOLERA-TOXIN; GOLGI-COMPLEX; DELTA-SUBUNIT; MOLECULAR CHARACTERIZATION; DOWNSTREAM EFFECTOR	Despite the 40-60% identity between ADP-ribosylation factors (ARFs) and ARE-like (ARL) proteins, distinct functional roles have been inferred from findings that ARLs lack the biochemical or genetic activities characteristic of ARFs. The potential for functional overlap between ARFs and ARLs was examined by com paring effects of expression on intact cells and the ability to bind effecters. Expression of [Q71L]ARL1 in mammalian cells led to altered Golgi structure similar to, but less dramatic than, that reported previously for [Q71L]ARF1 (1). Two previously identified partners of ARFs, MKLP1 and Arfaptin2/POR1, also bind ARL1 but not ARL2 or ARL3. Two-hybrid screens of human cDNA libraries with dominant active mutants of human ARL1, ARL2, and ARL3 identified eight different but overlapping sets of binding partners. Specific interactions between ARL1 and two binding proteins, SCOCO and Golgin-245, are defined and characterized in more detail. Like ARFs and ARL1, the binding of SCOCO to Golgi membranes is rapidly reversed by brefeldin A, suggesting the presence of a brefeldin A-sensitive ARL1 exchange factor. These data reveal a complex network of interactions between GTPases in the ARF family and their effecters and reveal a potential for cross-talk not demonstrated previously.	Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Kahn, RA (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	rkahn@emory.edu	Kahn, Richard/ABD-2666-2020; Shern, Jack/V-4002-2019	Kahn, Richard/0000-0002-0259-0601; 				Barr FA, 1999, CURR BIOL, V9, P381, DOI 10.1016/S0960-9822(99)80167-5; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Boman AL, 1999, CELL MOTIL CYTOSKEL, V44, P119, DOI 10.1002/(SICI)1097-0169(199910)44:2<119::AID-CM4>3.3.CO;2-3; BOMAN AL, 1995, TRENDS BIOCHEM SCI, V20, P147, DOI 10.1016/S0968-0004(00)88991-4; BOTSTEIN D, 1988, COLD SPRING HARB SYM, V53, P629, DOI 10.1101/SQB.1988.053.01.072; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; CHAN EKL, 1998, ELECTRON J BIOTECHN, V1, P1; CLARK J, 1993, P NATL ACAD SCI USA, V90, P8952, DOI 10.1073/pnas.90.19.8952; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; Cullen PJ, 1999, BIOCHEM SOC T, V27, P683, DOI 10.1042/bst0270683; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Florio SK, 1996, J BIOL CHEM, V271, P24036, DOI 10.1074/jbc.271.39.24036; Fritzler MJ, 1995, J BIOL CHEM, V270, P31262, DOI 10.1074/jbc.270.52.31262; GILLESPIE PG, 1989, J BIOL CHEM, V264, P12187; Hall A, 1995, GUIDEBOOK SMALL GTPA, P3; Higashide T, 1996, J BIOL CHEM, V271, P1797, DOI 10.1074/jbc.271.3.1797; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Hong JX, 1998, J BIOL CHEM, V273, P15872, DOI 10.1074/jbc.273.25.15872; Huber I, 1998, J BIOL CHEM, V273, P24786, DOI 10.1074/jbc.273.38.24786; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; JONES TLZ, 1990, P NATL ACAD SCI USA, V87, P568, DOI 10.1073/pnas.87.2.568; KAHN RA, 1984, J BIOL CHEM, V259, P6228; KAHN RA, 1992, J BIOL CHEM, V267, P13039; KAHN RA, 1991, J BIOL CHEM, V266, P2606; KAHN RA, 1986, J BIOL CHEM, V261, P7906; KAHN RA, 1995, J BIOL CHEM, V270, P143, DOI 10.1074/jbc.270.1.143; KAHN RA, 1995, GUIDEBOOK SMALL GTPA, P443; KAHN RA, 1991, METHOD ENZYMOL, V195, P233; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Lee FJS, 1997, J BIOL CHEM, V272, P30998, DOI 10.1074/jbc.272.49.30998; LEE FJS, 1992, J BIOL CHEM, V267, P24441; Li BJ, 1996, J BIOL CHEM, V271, P16813, DOI 10.1074/jbc.271.28.16813; Li N, 1998, GENOMICS, V49, P76, DOI 10.1006/geno.1998.5210; Li N, 1998, FEBS LETT, V440, P454, DOI 10.1016/S0014-5793(98)01501-4; Linari M, 1999, FEBS LETT, V458, P55, DOI 10.1016/S0014-5793(99)01117-5; Lowe SL, 1996, J CELL SCI, V109, P209; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Munro S, 1999, CURR BIOL, V9, P377, DOI 10.1016/S0960-9822(99)80166-3; MURTAGH JJ, 1993, BIOCHEMISTRY-US, V32, P6011, DOI 10.1021/bi00074a012; Nothwang HG, 1998, GENOMICS, V47, P383, DOI 10.1006/geno.1997.5119; Pacheco-Rodriguez G, 1998, J BIOL CHEM, V273, P26543, DOI 10.1074/jbc.273.41.26543; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; Robineau S, 2000, P NATL ACAD SCI USA, V97, P9913, DOI 10.1073/pnas.170290597; ROTH MG, 2000, GTPASES; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHURMANN A, 1994, J BIOL CHEM, V269, P15683; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Sharer JD, 1999, J BIOL CHEM, V274, P27553, DOI 10.1074/jbc.274.39.27553; Sherman F., 1974, METHODS YEAST GENETI; Shin OH, 1999, J BIOL CHEM, V274, P36609, DOI 10.1074/jbc.274.51.36609; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; STEARNS T, 1990, MOL CELL BIOL, V10, P6690, DOI 10.1128/MCB.10.12.6690; Swanson DA, 1998, INVEST OPHTH VIS SCI, V39, P2085; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TAMKUN JW, 1991, P NATL ACAD SCI USA, V88, P3120, DOI 10.1073/pnas.88.8.3120; TRAUB LM, 1995, J BIOL CHEM, V270, P4933, DOI 10.1074/jbc.270.9.4933; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289; ZHANG GF, 1995, J BIOL CHEM, V270, P21, DOI 10.1074/jbc.270.1.21; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418; Zhu XJ, 2000, J BIOL CHEM, V275, P13465, DOI 10.1074/jbc.275.18.13465; Zhu XJ, 2001, BIOCHEMISTRY-US, V40, P4560, DOI 10.1021/bi002628s	71	118	130	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22826	22837		10.1074/jbc.M102359200	http://dx.doi.org/10.1074/jbc.M102359200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11303027	hybrid			2022-12-27	WOS:000169412700113
J	Kleene, R; Yang, HB; Kutsche, M; Schachner, M				Kleene, R; Yang, HB; Kutsche, M; Schachner, M			The neural recognition molecule L1 is a sialic acid-binding lectin for CD24, which induces promotion and inhibition of neurite outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; AXON GUIDANCE; MOUSE CD24; GENE; NEURONS; HOMOLOGY; DOMAINS; PROTEIN; MEMBER; BRAIN	Among the recognition molecules that determine a neuron's interaction with other cells, L1 and CD24 have been suggested to cooperate with each other in neurite outgrowth and signal transduction, Here we report that binding of CD24 to L1 depends on alpha2,3-sialic acid on CD24, which determines the CD24 induced and cell type-specific promotion or inhibition of neurite outgrowth. Using knockout mutants, we could show that the CD24-induced effects on neurite outgrowth are mediated via L1, and not GPI-linked CD24, by trans-interaction of L1 with sialylated CD24, This glycoform is excluded together with L1 from raft microdomains, suggesting that molecular compartmentation in the surface membrane could play a role in signal transduction.	Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Schachner, M (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol, Martinistr 52, D-20246 Hamburg, Germany.							Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; CONSTAM DB, 1994, EUR J NEUROSCI, V6, P766, DOI 10.1111/j.1460-9568.1994.tb00988.x; CROCKER PR, 1998, GLYCOBIOLOGY, V8, P211; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Doherty P, 1996, PERSPECT DEV NEUROBI, V4, P157; Du YZ, 1998, HUM MUTAT, V11, P222, DOI 10.1002/(SICI)1098-1004(1998)11:3<222::AID-HUMU7>3.3.CO;2-M; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; FILBIN MT, 1993, J CELL BIOL, V122, P451, DOI 10.1083/jcb.122.2.451; Finckh U, 2000, AM J MED GENET, V92, P40, DOI 10.1002/(SICI)1096-8628(20000501)92:1<40::AID-AJMG7>3.0.CO;2-R; Fortini ME, 2000, NATURE, V406, P357, DOI 10.1038/35019233; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; Haney CA, 1999, J CELL BIOL, V146, P1173, DOI 10.1083/jcb.146.5.1173; Haspel J, 2000, J NEUROBIOL, V42, P287, DOI 10.1002/(SICI)1097-4695(20000215)42:3<287::AID-NEU1>3.3.CO;2-O; Heiland PC, 1998, EUR J CELL BIOL, V75, P97, DOI 10.1016/S0171-9335(98)80052-6; Henrick K, 1998, GLYCOBIOLOGY, V8, P45, DOI 10.1093/glycob/8.1.45; Holm J, 1996, EUR J NEUROSCI, V8, P1613, DOI 10.1111/j.1460-9568.1996.tb01306.x; HUBER AH, 1994, NEURON, V12, P717, DOI 10.1016/0896-6273(94)90326-3; KADMON G, 1990, J CELL BIOL, V110, P209, DOI 10.1083/jcb.110.1.209; KADMON G, 1995, EUR J NEUROSCI, V7, P993, DOI 10.1111/j.1460-9568.1995.tb01087.x; Kamiguchi H, 1998, MOL CELL NEUROSCI, V12, P48, DOI 10.1006/mcne.1998.0702; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; NEDELEC J, 1992, EUR J BIOCHEM, V203, P433, DOI 10.1111/j.1432-1033.1992.tb16567.x; Nguyen DNT, 1997, DEVELOPMENT, V124, P3303; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; Sammar M, 1997, BBA-PROTEIN STRUCT M, V1337, P287, DOI 10.1016/S0167-4838(96)00177-X; Shewan D, 1996, J NEUROSCI, V16, P2624; Soussi-Yanicostas N, 1998, J CELL SCI, V111, P2953; TANNAHILL L, 1995, EUR J NEUROSCI, V7, P1424, DOI 10.1111/j.1460-9568.1995.tb01136.x; Vinson M, 1996, J BIOL CHEM, V271, P9267, DOI 10.1074/jbc.271.16.9267; WENGER RH, 1995, TRANSGENIC RES, V4, P173, DOI 10.1007/BF01968782	37	113	113	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21656	21663		10.1074/jbc.M101790200	http://dx.doi.org/10.1074/jbc.M101790200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11283023	hybrid			2022-12-27	WOS:000169297900114
J	Paria, BC; Song, H; Wang, X; Schmid, PC; Krebsbach, RJ; Schmid, HHO; Bonner, TI; Zimmer, A; Dey, SK				Paria, BC; Song, H; Wang, X; Schmid, PC; Krebsbach, RJ; Schmid, HHO; Bonner, TI; Zimmer, A; Dey, SK			Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREIMPLANTATION MOUSE EMBRYO; LEUKEMIA INHIBITORY FACTOR; BLASTOCYST IMPLANTATION; CB1 RECEPTOR; UTERUS; EXPRESSION; ANANDAMIDE; PHARMACOLOGY; ACTIVATION; BINDS	The mechanisms by which synchronized embryonic development to the blastocyst stage, preparation of the uterus for the receptive state, and reciprocal embryo-uterine interactions for implantation are coordinated are still unclear. We show in this study that preimplantation embryo development became asynchronous in mice that are deficient in brain-type (CB1) and/or spleen-type (CB2) cannabinoid receptor genes. Furthermore, whereas the levels of uterine anandamide (endocannabinoid) and blastocyst CB1 are coordinately down-regulated with the onset of uterine receptivity and blastocyst activation prior to implantation, these levels remained high in the nonreceptive uterus and in dormant blastocysts during delayed implantation and in pregnant, leukemia inhibitory factor (LIF)-deficient mice with implantation failure. These results suggest that a tight regulation of endocannabinoid signaling is important for synchronizing embryo development with uterine receptivity for implantation. Indeed this is consistent with our finding that while an experimentally induced, sustained level of an exogenously administered, natural cannabinoid inhibited implantation in wild-type mice, it failed to do so in CB1(-/-)/CB2(-/-) double mutant mice. The present study is clinically important because of the widely debated medicinal use of cannabinoids and their reported adverse effects on pregnancy.	Univ Kansas, Med Ctr, Ralph L Smith Res Ctr, Dept Mol & Intergrat Physiol, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Dept Pediat, Kansas City, KS 66160 USA; Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; NIMH, Genet Lab, Bethesda, MD 20892 USA; Univ Bonn, Psychiat Clin, Mol Neurobiol Lab, D-53105 Bonn, Germany	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Minnesota System; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Bonn	Dey, SK (corresponding author), Univ Kansas, Med Ctr, Ralph L Smith Res Ctr, Dept Mol & Intergrat Physiol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.		Zimmer, Andreas/B-8357-2009	Song, Haengseok/0000-0002-5027-7310	NICHD NIH HHS [HD 1 2304, HD 37394, HD 33994, HD 02528, HD 29968] Funding Source: Medline; NIDA NIH HHS [DA 06668] Funding Source: Medline; NIGMS NIH HHS [GM 45741] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002528] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012304, R01HD037394, R37HD012304, U01HD029968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006668, R37DA006668] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BHATT H, 1991, P NATL ACAD SCI USA, V88, P11408, DOI 10.1073/pnas.88.24.11408; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Calignano A, 2000, NATURE, V408, P96, DOI 10.1038/35040576; DAS SK, 1995, P NATL ACAD SCI USA, V92, P4332, DOI 10.1073/pnas.92.10.4332; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; FELDER CC, 1992, MOL PHARMACOL, V42, P838; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; HOWLETT AC, 1995, ANNU REV PHARMACOL, V35, P607, DOI 10.1146/annurev.pharmtox.35.1.607; Maccarrone M, 2000, LANCET, V355, P1326, DOI 10.1016/S0140-6736(00)02115-2; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; PARIA BC, 1995, P NATL ACAD SCI USA, V92, P9460, DOI 10.1073/pnas.92.21.9460; Paria BC, 1996, MOL REPROD DEV, V45, P183, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;183::AID-MRD11&gt;3.0.CO;2-2; Paria BC, 1998, BIOL REPROD, V58, P1490, DOI 10.1095/biolreprod58.6.1490; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Paria BC, 1999, MARIHUANA AND MEDICINE, P393; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; PSYCHOYOS A, 1973, HDB PHYSL, P187; Schmid PC, 1997, P NATL ACAD SCI USA, V94, P4188, DOI 10.1073/pnas.94.8.4188; Schmid PC, 2000, CHEM PHYS LIPIDS, V104, P185, DOI 10.1016/S0009-3084(99)00124-3; Song HS, 2000, MOL ENDOCRINOL, V14, P1147, DOI 10.1210/me.14.8.1147; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Sugiura T, 1999, J BIOL CHEM, V274, P2794, DOI 10.1074/jbc.274.5.2794; Sulcova E, 1998, PHARMACOL BIOCHEM BE, V59, P347, DOI 10.1016/S0091-3057(97)00422-X; Wang J, 1999, BIOL REPROD, V60, P839, DOI 10.1095/biolreprod60.4.839; Yang ZM, 1996, BIOL REPROD, V55, P756, DOI 10.1095/biolreprod55.4.756; Yoshinaga K., 1980, PROGR REPRODUCTIVE B, V7, P189; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	30	148	154	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20523	20528		10.1074/jbc.M100679200	http://dx.doi.org/10.1074/jbc.M100679200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279117	hybrid			2022-12-27	WOS:000169135100114
J	Ho, MWY; Kaetzel, MA; Armstrong, DL; Shears, SB				Ho, MWY; Kaetzel, MA; Armstrong, DL; Shears, SB			Regulation of a human chloride channel - A paradigm for integrating input from calcium, type II calmodulin-dependent protein kinase, and inositol 3,4,5,6-tetrakisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA-2+-DEPENDENT CL CHANNELS; COLONIC CELLS HT-29; CYSTIC-FIBROSIS; CAM KINASE; INS(3,4,5,6)P-4; CONDUCTANCE; ACTIVATION; CLONING; LINE; CA2+	We have studied the regulation of Ca2+-dependent chloride (Cl-Ca) channels in a human pancreatoma epithelial cell line (CFPAC-1), which does not express functional cAMP-dependent cystic fibrosis transmembrane conductance regulator chloride channels. In cell-free patches from these cells, physiological Ca2+ concentrations activated a single class of 1-picosiemens Cl--selective channels. The same channels were also stimulated by a purified type II calmodulin-dependent protein kinase (CaMKII), and in cell-attached patches by purinergic agonists. In whole-cell recordings, both Ca2+- and CaMKII-dependent mechanisms contributed to chloride channel stimulation by Ca2+, but the CaMKII-dependent pathway was selectively inhibited by inositol 3,4,5,6-tetrakisphosphate (Ins(3,4,5,6)P-4). This inhibitory effect of Ins(3,4,5,6)P, on Cl-Ca channel stimulation by CaMKII was reduced by raising [Ca2+] and prevented by inhibition of protein phosphatase activity with 100 nM okadaic acid. These data provide a new context for understanding the physiological relevance of Ins(3,4,5,6)P, in the longer term regulation of Ca2+-dependent Cl- fluxes in epithelial cells.	NIEHS, Inositide Signaling Grp, NIH, Res Triangle Pk, NC 27709 USA; NIEHS, Membrane Signaling Grp, NIH, Res Triangle Pk, NC 27709 USA; NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; Univ Cincinnati, Coll Med, Dept Cellular & Mol Physiol, Cincinnati, OH 45267 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Cincinnati	Ho, MWY (corresponding author), NIEHS, Inositide Signaling Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.		Shears, Stephen B/C-6335-2019	Shears, Stephen B/0000-0001-7309-8916	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES080043, ZIAES080043, ZIAES080046, Z01ES080046] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 46433] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arreola J, 1996, J PHYSIOL-LONDON, V490, P351, DOI 10.1113/jphysiol.1996.sp021149; Bennett WD, 1996, AM J RESP CRIT CARE, V153, P1796, DOI 10.1164/ajrccm.153.6.8665037; BEVAN S, 1984, PROC R SOC SER B-BIO, V222, P349, DOI 10.1098/rspb.1984.0068; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Carew MA, 2000, J BIOL CHEM, V275, P26906; CHAN HC, 1994, J BIOL CHEM, V269, P32464; Collier ML, 1996, CIRC RES, V78, P936, DOI 10.1161/01.RES.78.5.936; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL785, DOI 10.1152/ajplung.1996.271.5.L785; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Fuller CM, 2000, CLIN EXP PHARMACOL P, V27, P906, DOI 10.1046/j.1440-1681.2000.03359.x; FULLER CM, 1994, J BIOL CHEM, V269, P26642; Gotter AL, 1997, COMP BIOCHEM PHYS A, V118, P81, DOI 10.1016/S0300-9629(96)00411-2; Gruber AD, 1999, AM J PHYSIOL-CELL PH, V276, pC1261; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Ho MWY, 1997, AM J PHYSIOL-CELL PH, V272, pC1160, DOI 10.1152/ajpcell.1997.272.4.C1160; HO MWY, 2000, FRONTIERS MOL BIOL B, P298; Ismailov II, 1996, P NATL ACAD SCI USA, V93, P10505, DOI 10.1073/pnas.93.19.10505; Kidd JF, 2000, ANNU REV PHYSIOL, V62, P493, DOI 10.1146/annurev.physiol.62.1.493; Kotlikoff MI, 1998, AM J RESP CRIT CARE, V158, pS109, DOI 10.1164/ajrccm.158.supplement_2.13tac600; LING BN, 1993, J CLIN INVEST, V92, P2141, DOI 10.1172/JCI116815; MORRIS AP, 1993, AM J PHYSIOL, V264, pC968, DOI 10.1152/ajpcell.1993.264.4.C968; MORRIS AP, 1993, AM J PHYSIOL, V264, pC977, DOI 10.1152/ajpcell.1993.264.4.C977; NISHIMOTO I, 1991, NEURON, V6, P547, DOI 10.1016/0896-6273(91)90057-7; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; Schlenker T, 1996, AM J PHYSIOL-GASTR L, V271, pG304, DOI 10.1152/ajpgi.1996.271.2.G304; SCHOUMACHER RA, 1990, P NATL ACAD SCI USA, V87, P4012, DOI 10.1073/pnas.87.10.4012; SCHWIEBERT EM, 1995, CELL, V81, P1063, DOI 10.1016/S0092-8674(05)80011-X; SINGH AK, 1991, AM J PHYSIOL, V260, pC51; TALEB O, 1988, PFLUG ARCH EUR J PHY, V412, P641, DOI 10.1007/BF00583766; VAJANAPHANICH M, 1994, NATURE, V371, P711, DOI 10.1038/371711a0; WAGNER JA, 1991, NATURE, V349, P793, DOI 10.1038/349793a0; WELSH N, 1988, BIOCHEM J, V252, P701, DOI 10.1042/bj2520701; Xie WW, 1998, J PHYSIOL-LONDON, V510, P661, DOI 10.1111/j.1469-7793.1998.661bj.x; Xie WW, 1996, J BIOL CHEM, V271, P14092, DOI 10.1074/jbc.271.24.14092; Yang XN, 2000, BIOCHEM J, V351, P551, DOI 10.1042/0264-6021:3510551	37	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18673	18680		10.1074/jbc.M101128200	http://dx.doi.org/10.1074/jbc.M101128200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279175	hybrid			2022-12-27	WOS:000169091000005
J	Kojima, H; Nemoto, A; Uemura, T; Honma, R; Ogura, M; Liu, YK				Kojima, H; Nemoto, A; Uemura, T; Honma, R; Ogura, M; Liu, YK			rDRAK1, a novel kinase related to apoptosis, is strongly expressed in active osteoclasts and induces apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; BONE-RESORBING ACTIVITY; MATURE OSTEOCLASTS; IN-VITRO; INHIBITORY FACTOR; SERINE/THREONINE KINASE; MEVALONATE PATHWAY; PROTEIN-KINASE; BISPHOSPHONATES INHIBIT; OSTEOPROTEGERIN LIGAND	This is the first report of a novel serine/threonine kinase, rabbit death-associated protein (DAP) kinase-related apoptosis-inducing protein kinase 1 (rDRAK1), involved in osteoclast apoptosis, We searched for osteoclast-specific genes from a cDNA library of highly enriched rabbit osteoclasts cultured on ivory. One of the cloned genes has a high homology with human DRAK1 (hDRAK1), which belongs to the DAP kinase subfamily of serine/threonine kinases, By screening a rabbit osteoclast cDNA library and 5 ' -RACE (rapid amplification of cDNA ends), we obtained a full length of this cDNA, termed rDRAK1. The sequencing data indicated that rDRAK1 has 88.0, 44.6, 38.7, and 42.3% identity with hDRAK1, DAP kinase, DRP-1, and ZIP (zipper-interacting protein) kinase, respectively. To clarify the role of DRAK1 in osteoclasts, we examined the effect of three osteoclast survival factors (interleukin-l, macrophage colony-stimulating factor, and osteoclast differentiation-inducing factor) on rDRAK1 mRNA expression and the effect of rDRAK1 overexpression on osteoclast apoptosis, The results suggested that these three survival factors were proved to inhibit rDRAK1 expression in rabbit osteoclasts. After transfection of a rDRAK1 expression vector into cultured osteoclasts, overexpressed rDRAK1 was localized exclusively to the nuclei and induced apoptosis, Hence, rDRAK1 may play an important role in the core apoptosis program in osteoclast.	Natl Inst Adv Ind Sci & Technol, Tissue Engn Res Ctr, Tsukuba, Ibaraki 3058562, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan; Univ Tokyo, Grad Sch Med, Dept Biomed Engn, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan; Shanghai Med Univ, Liver Canc Inst, Shanghai 200032, Peoples R China	National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); University of Tokyo; University of Tsukuba; Fudan University	Uemura, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Tissue Engn Res Ctr, 1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.							Akatsu T, 1998, BIOCHEM BIOPH RES CO, V250, P229, DOI 10.1006/bbrc.1998.9294; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Anderson P, 1997, MICROBIOL MOL BIOL R, V61, P33, DOI 10.1128/.61.1.33-46.1997; Boissier S, 2000, CANCER RES, V60, P2949; Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998; Cohen O, 1999, J CELL BIOL, V146, P141; Coxon FP, 2000, J BONE MINER RES, V15, P1467, DOI 10.1359/jbmr.2000.15.8.1467; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; FULLER K, 1993, J EXP MED, V178, P1733, DOI 10.1084/jem.178.5.1733; Haertel-Wiesmann M, 2000, J BIOL CHEM, V275, P32046, DOI 10.1074/jbc.M000074200; Hiroi-Furuya E, 1999, CALCIFIED TISSUE INT, V64, P219, DOI 10.1007/s002239900606; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Hughes DE, 1996, NAT MED, V2, P1132, DOI 10.1038/nm1096-1132; Inbal B, 2000, MOL CELL BIOL, V20, P1044, DOI 10.1128/MCB.20.3.1044-1054.2000; Jimi E, 1998, J BIOL CHEM, V273, P8799, DOI 10.1074/jbc.273.15.8799; Jimi E, 1999, EXP CELL RES, V247, P84, DOI 10.1006/excr.1998.4320; Kakudo S, 1996, J BONE MINER METAB, V14, P129, DOI [10.1007/BF02239480, DOI 10.1007/BF02239480]; KAMEDA T, 1995, BIOCHEM BIOPH RES CO, V207, P753, DOI 10.1006/bbrc.1995.1251; Kameda T, 1998, BIOCHEM BIOPH RES CO, V245, P419, DOI 10.1006/bbrc.1998.8448; Kameda T, 1997, J EXP MED, V186, P489, DOI 10.1084/jem.186.4.489; Kawai T, 1998, MOL CELL BIOL, V18, P1642, DOI 10.1128/MCB.18.3.1642; Kobayashi Y, 2000, J BONE MINER RES, V15, P1924, DOI 10.1359/jbmr.2000.15.10.1924; Kogel D, 1998, ONCOGENE, V17, P2645, DOI 10.1038/sj.onc.1202204; Lacey DL, 2000, AM J PATHOL, V157, P435, DOI 10.1016/S0002-9440(10)64556-7; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lorget F, 2000, BIOCHEM BIOPH RES CO, V268, P899, DOI 10.1006/bbrc.2000.2229; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Mano H, 2000, J BIOL CHEM, V275, P8126, DOI 10.1074/jbc.275.11.8126; Mano M, 2000, CALCIFIED TISSUE INT, V67, P85, DOI 10.1007/s00223001102; Miyauchi A, 2000, J BIOL CHEM, V275, P3335, DOI 10.1074/jbc.275.5.3335; Murakami T, 1998, BIOCHEM BIOPH RES CO, V252, P747, DOI 10.1006/bbrc.1998.9723; Murata-Hori M, 1999, FEBS LETT, V451, P81, DOI 10.1016/S0014-5793(99)00550-5; Nakagawa M, 2000, FEBS LETT, V473, P161, DOI 10.1016/S0014-5793(00)01520-9; Okahashi N, 1998, BONE, V23, P33, DOI 10.1016/S8756-3282(98)00069-6; Reszka AA, 1999, J BIOL CHEM, V274, P34967, DOI 10.1074/jbc.274.49.34967; Sakai H, 2000, BIOCHEM BIOPH RES CO, V270, P550, DOI 10.1006/bbrc.2000.2485; SALENDAR KS, 1996, MOL PHARMACOL, V50, P1127; Sanjo H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/jbc.273.44.29066; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; SUDA T, 1995, ENDOCRINE REV MONOGR, V4, P266; Suda Tatsuo, 1996, P87; Tsuda E, 1997, BIOCHEM BIOPH RES CO, V234, P137, DOI 10.1006/bbrc.1997.6603; UEMURA T, 2000, 27 EUR S CALC TISS T, V66, pS103; Vaananen HK, 1998, MAT SCI ENG C-BIO S, V6, P205, DOI 10.1016/S0928-4931(98)00052-6; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yoneda Toshiyuki, 2000, Cancer, V88, P2979, DOI 10.1002/1097-0142(20000615)88:12+<2979::AID-CNCR13>3.0.CO;2-U; Zaidi M, 1999, J BONE MINER RES, V14, P669, DOI 10.1359/jbmr.1999.14.5.669; [No title captured]	52	14	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19238	19243		10.1074/jbc.M101023200	http://dx.doi.org/10.1074/jbc.M101023200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279167	hybrid			2022-12-27	WOS:000169091000081
J	Oakley, RH; Laporte, SA; Holt, JA; Barak, LS; Caron, MG				Oakley, RH; Laporte, SA; Holt, JA; Barak, LS; Caron, MG			Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE PHOSPHORYLATION SITES; GREEN FLUORESCENT PROTEIN; SUBSTANCE-P RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; DEPENDENT ENDOCYTOSIS; ACTIVATED RECEPTOR-2; MEDIATED ENDOCYTOSIS; CLATHRIN ADAPTER; VISUAL ARRESTIN; INTERNALIZATION	beta -Arrestins bind agonist-activated G protein-coupled receptors (GPCRs) and mediate their desensitization and internalization. Although beta -arrestins dissociate from some receptors at the plasma membrane, such as the beta2 adrenergic receptor, they remain associated with other GPCRs and internalize with them into endocytic vesicles. Formation of stable receptor-beta -arrestin complexes that persist inside the cell impedes receptor resensitization, and the aberrant formation of these complexes may play a role in GPCR-based diseases (Barak, L, S., Oakley, R, H,, Laporte, S. A., and Caron, M. G. (2001) Proc. Natl. Acad, Sci, U, S, A. 98, 93-98), Here, we investigate the molecular determinants responsible for sustained receptor/beta -arrestin interactions. We show in real time and in live human embryonic kidney (HEK-293) cells that a beta -arrestin-2-green fluorescent protein conjugate internalizes into endocytic vesicles with agonist-activated neurotensin-1 receptor, oxytocin receptor, angiotensin II type 1A receptor, and substance P receptor. Using receptor mutagenesis, we demonstrate that the ability of beta -arrestin to remain associated with these receptors is mediated by specific clusters of serine and threonine residues located in the receptor carboxyl-terminal tail. These clusters are remarkably conserved in their position within the carboxyl-terminal domain and serve as primary sites of agonist-dependent receptor phosphorylation. In addition, we identify a beta -arrestin mutant with enhanced affinity for the agonist-activated beta -adrenergic receptor that traffics into endocytic vesicles with receptors that lack serine/threonine clusters and normally dissociate from wild-type beta -arrestin at the plasma membrane, By identifying receptor and beta -arrestin residues critical for the formation of stable receptor-beta -arrestin complexes, these studies provide novel targets for regulating GPCR responsiveness and treating diseases resulting from abnormal GPCR/beta -arrestin interactions.	Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Med, Durham, NC 27710 USA	Duke University; Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 3287, Durham, NC 27710 USA.		Laporte, Stephane A/F-3282-2012; Laporte, Stephane/ABC-4228-2021	Laporte, Stephane/0000-0002-0633-543X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 61365] Funding Source: Medline; NINDS NIH HHS [NS 19576] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; BARAK LS, 1994, J BIOL CHEM, V269, P2790; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Botto JM, 1998, BIOCHEM BIOPH RES CO, V243, P585, DOI 10.1006/bbrc.1997.8071; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; KIESELBACH T, 1994, EUR J BIOCHEM, V226, P87, DOI 10.1111/j.1432-1033.1994.tb20029.x; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krueger KM, 1997, J BIOL CHEM, V272, P5; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McConalogue K, 1999, J BIOL CHEM, V274, P16257, DOI 10.1074/jbc.274.23.16257; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; PIPPIG S, 1993, J BIOL CHEM, V268, P3201; Roush ED, 1999, MOL PHARMACOL, V55, P855; Seibold A, 1998, J BIOL CHEM, V273, P7637, DOI 10.1074/jbc.273.13.7637; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; Shiina T, 2000, J BIOL CHEM, V275, P29082, DOI 10.1074/jbc.M909757199; VIGNA SR, 1994, J NEUROSCI, V14, P834; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Walker JKL, 1999, J BIOL CHEM, V274, P31515, DOI 10.1074/jbc.274.44.31515; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	44	346	363	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19452	19460		10.1074/jbc.M101450200	http://dx.doi.org/10.1074/jbc.M101450200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279203	hybrid			2022-12-27	WOS:000169091000107
J	Dermine, JF; Duclos, S; Garin, J; St-Louis, F; Rea, S; Parton, RG; Desjardins, M				Dermine, JF; Duclos, S; Garin, J; St-Louis, F; Rea, S; Parton, RG; Desjardins, M			Flotillin-1-enriched lipid raft domains accumulate on maturing phagosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE-PROTEINS; LEISHMANIA-DONOVANI; FUSION PROPERTIES; PLASMA-MEMBRANE; MACROPHAGES; CAVEOLAE; LIPOPHOSPHOGLYCAN; CELLS; PHAGOLYSOSOMES; PHAGOCYTOSIS	Flotillin-1 was recently shown to be enriched on detergent-resistant domains of the plasma membrane called lipid rafts. These rafts, enriched in sphingolipids and cholesterol, sequester certain proteins while excluding others. Lipid rafts have been implicated in numerous cellular processes including signal transduction, membrane trafficking and molecular sorting. In this study, we demonstrate both morphologically and biochemically that lipid rafts are present on phagosomes, These structures are enriched in flotillin-1 and devoid of the main phagosomes membrane protein lysosomal-associated membrane protein (LAMP1), The flotillin-1 present on phagosomes does not originate from the plasma membrane during phagocytosis but accumulates gradually on maturing phagosomes, Treatment with bafilomycin A1, a compound that inhibits the proton pump ATPase and prevents the fusion of phagosomes with late endocytic organelles, prevents the acquisition of flotillin-1 by phagosomes, indicating that this protein might be recruited on phagosomes from endosomal organelles. A proteomic characterization of the lipid rafts of phagosomes indicates that actin, the alpha- and beta -subunits of heterotrimeric G proteins, as well as subunits of the proton pump V-ATPase are among the constituents of these domains. Remarkably, the intracellular parasite Leishmania donovani can actively inhibit the acquisition of flotillin-1-enriched lipid rafts by phagosomes and the maturation of these organelles. These results indicate that specialized functions required for phagolysosome biogenesis may occur at focal points on the phagosome membrane, and therefore represent a potential target of intracellular pathogens.	Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada; CEA, Lab Chim Prot, F-38054 Grenoble, France; Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; Univ Queensland, Dept Physiol & Pharmacol, Brisbane, Qld 4072, Australia	Universite de Montreal; CEA; University of Queensland; University of Queensland	Desjardins, M (corresponding author), Univ Montreal, Dept Pathol & Biol Cellulaire, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.		Parton, Robert G/C-5673-2009; Rea, Shane/F-4073-2014	Parton, Robert G/0000-0002-7494-5248; Desjardins, Michel/0000-0002-5684-5980				Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; BERTHIAUME EP, 1995, J CELL BIOL, V129, P989, DOI 10.1083/jcb.129.4.989; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Defacque H, 2000, EMBO J, V19, P199, DOI 10.1093/emboj/19.2.199; Dermine JF, 2000, CELL MICROBIOL, V2, P115, DOI 10.1046/j.1462-5822.2000.00037.x; Desjardins M, 1997, J CELL SCI, V110, P2303; DESJARDINS M, 1995, TRENDS CELL BIOL, V5, P183, DOI 10.1016/S0962-8924(00)88989-8; DESJARDINS M, 1994, J BIOL CHEM, V269, P32194; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; DESJARDINS M, 1997, J EXP MED, V185, P206; Duclos S, 2000, J CELL SCI, V113, P3531; Galli T, 1996, J BIOL CHEM, V271, P2193, DOI 10.1074/jbc.271.4.2193; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; MIAO L, 1995, BIOCHEMISTRY-US, V34, P4676, DOI 10.1021/bi00014a022; NANAVATI C, 1992, BIOPHYS J, V63, P1118, DOI 10.1016/S0006-3495(92)81679-X; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; Pasquali C, 1997, ELECTROPHORESIS, V18, P2573, DOI 10.1002/elps.1150181413; Roberts RL, 1999, J CELL SCI, V112, P3667; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Snyers L, 1999, EUR J CELL BIOL, V78, P802, DOI 10.1016/S0171-9335(99)80031-4; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x; TOLSON DL, 1989, MOL BIOCHEM PARASIT, V35, P109, DOI 10.1016/0166-6851(89)90113-8; WANG YL, 1987, J CELL BIOL, V104, P1749, DOI 10.1083/jcb.104.6.1749; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	41	248	255	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18507	18512		10.1074/jbc.M101113200	http://dx.doi.org/10.1074/jbc.M101113200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279173	hybrid			2022-12-27	WOS:000168866500119
J	Mikhailov, V; Mikhailova, M; Pulkrabek, DJ; Dong, Z; Venkatachalam, MA; Saikumar, P				Mikhailov, V; Mikhailova, M; Pulkrabek, DJ; Dong, Z; Venkatachalam, MA; Saikumar, P			Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; CHANNEL-FORMING ACTIVITY; PERMEABILITY TRANSITION; FAMILY PROTEINS; APOPTOSIS; TRANSLOCATION; ACTIVATION; BCL-X(L); CYTOSOL; DEATH	ATP depletion results in Bax translocation from cytosol to mitochondria and release of cytochrome c from mitochondria into cytosol in cultured kidney cells. Overexpression of Bcl-2 prevents cytochrome c release, without ameliorating ATP depletion or Bax translocation, with little or no association between Bcl-2 and Bax as demonstrated by immunoprecipitation (Saikumar, P,, Dong, Z,, Patel, Y,, Hall, K,, Hopfer, U,, Weinberg, J, M,, and Venkatachalam, M, A. (1998) Oncogene 17, 3401-3415). Now we show that translocated Bax forms homooligomeric structures, stabilized as chemical adducts by bifunctional cross-linkers in ATP-depleted wild type cells, but remains monomeric in Bcl-2-overexpressing cells. The protective effects of Bcl-2 did not require Bcl-2/Bax association, at least to a degree of proximity or affinity that was stable to conditions of immunoprecipitation or adduct formation by eight cross-linkers of diverse spacer lengths and chemical reactivities. On the other hand, nonionic detergents readily induced homodimers and heterodimers of Bax and Bcl-2, Moreover, associations between translocated Bax and the voltage-dependent anion channel protein or the adenine nucleotide translocator protein could not be demonstrated by immunoprecipitation of Bax, or by using bifunctional cross-linkers. Our data suggest that the in vivo actions of Bax are at least in part dependent on the formation of homo-oligomers without requiring associations with other molecules and that Bcl-2 cytoprotection involves mechanisms that prevent Bax oligomerization.	Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Saikumar, P (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Pathol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037139, R01DK054472, R37DK037139] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK37139, DK54472] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Cregan SP, 1999, J NEUROSCI, V19, P7860; DURAN MA, 1990, TOXICOL APPL PHARM, V105, P183, DOI 10.1016/0041-008X(90)90180-3; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; FISKUM G, 1980, P NATL ACAD SCI-BIOL, V77, P3430, DOI 10.1073/pnas.77.6.3430; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Haldar S, 1996, CANCER RES, V56, P1253; Hengartner MO, 1999, RECENT PROG HORM RES, V54, P213; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kluck RM, 1999, J CELL BIOL, V147, P809, DOI 10.1083/jcb.147.4.809; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Murphy KM, 2000, CELL DEATH DIFFER, V7, P102, DOI 10.1038/sj.cdd.4400597; Murphy KM, 1999, ONCOGENE, V18, P5991, DOI 10.1038/sj.onc.1203001; Nissim I, 1996, KIDNEY INT, V49, P684, DOI 10.1038/ki.1996.97; Petit PX, 1998, FEBS LETT, V426, P111, DOI 10.1016/S0014-5793(98)00318-4; Poommipanit PB, 1999, J BIOL CHEM, V274, P1033, DOI 10.1074/jbc.274.2.1033; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Reed JC, 1998, BBA-BIOENERGETICS, V1366, P127, DOI 10.1016/S0005-2728(98)00108-X; Saikumar P, 1998, ONCOGENE, V17, P3401, DOI 10.1038/sj.onc.1202590; Saikumar P, 1998, ONCOGENE, V17, P3341, DOI 10.1038/sj.onc.1202579; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Scarlett JL, 1997, FEBS LETT, V418, P282, DOI 10.1016/S0014-5793(97)01391-4; Schendel SL, 1998, CELL DEATH DIFFER, V5, P372, DOI 10.1038/sj.cdd.4400365; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; VENKATACHALAM MA, 1993, SURVIVING HYPOXIA, P473; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Woost PG, 1996, KIDNEY INT, V50, P125, DOI 10.1038/ki.1996.295; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zha HB, 1997, J BIOL CHEM, V272, P31482, DOI 10.1074/jbc.272.50.31482	43	270	292	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18361	18374		10.1074/jbc.M100655200	http://dx.doi.org/10.1074/jbc.M100655200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279112	hybrid			2022-12-27	WOS:000168866500100
J	Dong, JF; Ye, P; Schade, AJ; Gao, S; Romo, GM; Turner, NT; McIntire, LV; Lopez, JA				Dong, JF; Ye, P; Schade, AJ; Gao, S; Romo, GM; Turner, NT; McIntire, LV; Lopez, JA			Tyrosine sulfation of glycoprotein Ib alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; HUMAN-PLATELET MEMBRANE; IX-V COMPLEX; AMINO-ACID-SEQUENCE; VONWILLEBRAND-FACTOR; P-SELECTIN; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; THROMBIN-BINDING; 4TH COMPONENT	Glycoprotein Ib alpha (GP Ib alpha), the ligand binding subunit of the platelet glycoprotein Ib-M-V complex, is sulfated on three tyrosine residues (Tyr-276, Tyr-278, and Tyr-279). This posttranslational modification is known to be critical for von Willebrand factor (VWF) binding; yet it remains unclear whether it provides a specific structure or merely contributes negative charges. To investigate this issue, we constructed cell lines expressing GP Ib alpha polypeptides with the three tyrosine residues converted to either Glu or Phe and studied the ability of these mutants to bind vWF in the presence of modulators or shear stress. The mutants were expressed normally on the cell surface as GP m-M complexes, with the conformation of the ligand-binding domain preserved, as judged by the binding of conformation-sensitive monoclonal antibodies. In contrast to their normal expression, both mutants were functionally abnormal. Cells expressing the Phe mutant failed to bind vWF in the presence of either ristocetin or botrocetin. These cells adhered to and rolled on immobilized vWF only when their surface receptor density was increased to twice the level that supported adhesion of cells expressing the wild-type receptor and even then only 20% as many rolled and rolled significantly faster than wild-type cells. Cells expressing the Glu mutant, on the other hand, were normal with respect to ristocetin-induced vWF binding and adhesion to immobilized VWF but were markedly defective in botrocetin-induced vWF binding. These results indicate that GP Ib alpha tyrosine sulfation influences the interaction of this polypeptide with vWF primarily by contributing negative charges under physiological conditions and when the interaction is induced by ristocetin but contributes a specific structure to the botrocetin-induced interaction.	Baylor Coll Med, Dept Med, Thrombosis Res Sect, Div Thrombosis Res, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Rice Univ, Cox Lab Bioengn, Houston, TX 77005 USA	Baylor College of Medicine; Baylor College of Medicine; Rice University	Lopez, JA (corresponding author), Baylor Coll Med, Dept Med, Thrombosis Res Sect, Div Thrombosis Res, BCM286,N1319,1 Baylor Plaza, Houston, TX 77030 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL002463, R29HL046416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS023327] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL02463, HL46416, HL18673] Funding Source: Medline; NINDS NIH HHS [NS23327] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREWS RK, 1989, BIOCHEMISTRY-US, V28, P8317, DOI 10.1021/bi00447a009; BERNDT MC, 1985, EUR J BIOCHEM, V151, P637, DOI 10.1111/j.1432-1033.1985.tb09152.x; BERNDT MC, 1988, BIOCHEMISTRY-US, V27, P633, DOI 10.1021/bi00402a021; CARDELLI JA, 1990, J BIOL CHEM, V265, P8847; CAREW JA, 1990, BLOOD, V76, P2530; Dong JF, 1997, BIOCHEMISTRY-US, V36, P12421, DOI 10.1021/bi970636b; DONG JF, 1994, BIOCHEMISTRY-US, V33, P13946, DOI 10.1021/bi00250a050; Dong JF, 2001, BLOOD, V97, P162, DOI 10.1182/blood.V97.1.162; Fredrickson BJ, 1998, BLOOD, V92, P3684, DOI 10.1182/blood.V92.10.3684.422k39_3684_3693; HAN KK, 1992, INT J BIOCHEM, V24, P1349, DOI 10.1016/0020-711X(92)90060-E; HICKEY MJ, 1989, P NATL ACAD SCI USA, V86, P6773, DOI 10.1073/pnas.86.17.6773; HORTIN G, 1986, BIOCHEM BIOPH RES CO, V141, P326, DOI 10.1016/S0006-291X(86)80372-2; HORTIN G, 1986, J BIOL CHEM, V261, P1786; HORTIN GL, 1989, P NATL ACAD SCI USA, V86, P1338, DOI 10.1073/pnas.86.4.1338; HORTIN GL, 1990, BLOOD, V76, P946; HUTTNER WB, 1987, TRENDS BIOCHEM SCI, V12, P361, DOI 10.1016/0968-0004(87)90166-6; JONES DA, 1993, BIOPHYS J, V65, P1560, DOI 10.1016/S0006-3495(93)81195-0; Kukreti S, 1997, BLOOD, V89, P4104, DOI 10.1182/blood.V89.11.4104; LANZA F, 1993, J BIOL CHEM, V268, P20801; LEYTE A, 1991, J BIOL CHEM, V266, P740; LI CQ, 1995, J BIOL CHEM, V270, P16302, DOI 10.1074/jbc.270.27.16302; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Lopez J A, 1997, Curr Opin Hematol, V4, P323; LOPEZ JA, 1987, P NATL ACAD SCI USA, V84, P5615, DOI 10.1073/pnas.84.16.5615; LOPEZ JA, 1988, P NATL ACAD SCI USA, V85, P2135, DOI 10.1073/pnas.85.7.2135; LOPEZ JA, 1992, J BIOL CHEM, V267, P12851; LOPEZ JA, 1994, BLOOD COAGUL FIBRIN, V5, P97; MARCHESE P, 1995, J BIOL CHEM, V270, P9571, DOI 10.1074/jbc.270.16.9571; MILLER JL, 1983, J CLIN INVEST, V72, P1532, DOI 10.1172/JCI111112; Romo GM, 1999, J EXP MED, V190, P803, DOI 10.1084/jem.190.6.803; RUAN C, 1981, BRIT J HAEMATOL, V49, P511, DOI 10.1111/j.1365-2141.1981.tb07259.x; RUAN CG, 1987, BLOOD, V69, P570; SAKO D, 1995, CELL, V83, P323, DOI 10.1016/0092-8674(95)90173-6; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193; SLACK SM, 1994, THROMB HAEMOSTASIS, V72, P777; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; TITANI K, 1987, P NATL ACAD SCI USA, V84, P5610, DOI 10.1073/pnas.84.16.5610; Ward CM, 1996, BIOCHEMISTRY-US, V35, P4929, DOI 10.1021/bi952456c; YAMAMOTO K, 1986, THROMB HAEMOSTASIS, V55, P162	40	44	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16690	16694		10.1074/jbc.M101035200	http://dx.doi.org/10.1074/jbc.M101035200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279169	hybrid			2022-12-27	WOS:000168730400015
J	Rout, MP; Aitchison, JD				Rout, MP; Aitchison, JD			The nuclear pore complex as a transport machine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MOLECULAR ARCHITECTURE; NUCLEOPORIN COMPLEX; BINDING-SITES; CELL-CYCLE; PROTEIN; RAN; ENVELOPE; NSP1P; CONFIGURATIONS; VISUALIZATION		Inst Syst Biol, Seattle, WA 98105 USA; Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10021 USA; Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	Institute for Systems Biology (ISB); Rockefeller University; University of Alberta	Aitchison, JD (corresponding author), Inst Syst Biol, 4225 Roosevelt Way,Ste 200, Seattle, WA 98105 USA.	jaitchison@systemsbiology.org	Rout, Michael/Y-7090-2018	Rout, Michael/0000-0003-2010-706X				AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; AKEY CW, 1989, J CELL BIOL, V109, P971, DOI 10.1083/jcb.109.3.971; AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; AKEY CW, 1990, BIOPHYS J, V58, P341, DOI 10.1016/S0006-3495(90)82381-X; Allen TD, 2000, J CELL SCI, V113, P1651; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Blobel G, 1995, COLD SPRING HARB SYM, V60, P1; Bodoor K, 1999, J CELL SCI, V112, P2253; BUSS F, 1994, J CELL SCI, V107, P631; Cole CN, 1998, CURR BIOL, V8, pR368, DOI 10.1016/S0960-9822(98)70239-8; Damelin M, 2000, MOL CELL, V5, P133, DOI 10.1016/S1097-2765(00)80409-8; Del Priore V, 1997, J CELL SCI, V110, P2987; DINGWALL C, 1995, P NATL ACAD SCI USA, V92, P7525, DOI 10.1073/pnas.92.16.7525; DWORETZKY SI, 1988, J CELL BIOL, V107, P1279, DOI 10.1083/jcb.107.4.1279; Enarson P, 1998, CHROMOSOMA, V107, P228, DOI 10.1007/s004120050301; Fabre E, 1997, ANNU REV GENET, V31, P277, DOI 10.1146/annurev.genet.31.1.277; Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577; Favreau C, 1996, BIOCHEMISTRY-US, V35, P8035, DOI 10.1021/bi9600660; Floer M, 1999, J BIOL CHEM, V274, P16279, DOI 10.1074/jbc.274.23.16279; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Gant TM, 1998, CURR OPIN CELL BIOL, V10, P409, DOI 10.1016/S0955-0674(98)80018-5; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; GROTE M, 1995, J CELL SCI, V108, P2963; GUAN TL, 1995, MOL BIOL CELL, V6, P1591, DOI 10.1091/mbc.6.11.1591; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kiseleva E, 1996, J MOL BIOL, V260, P304, DOI 10.1006/jmbi.1996.0401; Kiseleva E, 1998, J CELL SCI, V111, P223; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; MAUL GG, 1971, J CELL BIOL, V51, P405, DOI 10.1083/jcb.51.2.405; Moore MS, 1998, J BIOL CHEM, V273, P22857, DOI 10.1074/jbc.273.36.22857; Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982; Rappsilber J, 2000, ANAL CHEM, V72, P267, DOI 10.1021/ac991081o; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; RICHARDSON WD, 1988, CELL, V52, P655, DOI 10.1016/0092-8674(88)90403-5; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Ryan KJ, 2000, CURR OPIN CELL BIOL, V12, P361, DOI 10.1016/S0955-0674(00)00101-0; Schlaich NL, 1997, MOL BIOL CELL, V8, P33, DOI 10.1091/mbc.8.1.33; Shulga N, 2000, J CELL BIOL, V149, P1027, DOI 10.1083/jcb.149.5.1027; Siniossoglou S, 2000, J CELL BIOL, V149, P41, DOI 10.1083/jcb.149.1.41; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; Wente SR, 2000, SCIENCE, V288, P1374, DOI 10.1126/science.288.5470.1374; Winey M, 1997, MOL BIOL CELL, V8, P2119, DOI 10.1091/mbc.8.11.2119; Wozniak RW, 1998, TRENDS CELL BIOL, V8, P184, DOI 10.1016/S0962-8924(98)01248-3; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Yaseen NR, 1999, P NATL ACAD SCI USA, V96, P5516, DOI 10.1073/pnas.96.10.5516	50	218	221	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16593	16596		10.1074/jbc.R100015200	http://dx.doi.org/10.1074/jbc.R100015200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11283009	hybrid			2022-12-27	WOS:000168730400001
J	Berg, S; Edman, M; Li, L; Wikstrom, M; Wieslander, A				Berg, S; Edman, M; Li, L; Wikstrom, M; Wieslander, A			Sequence properties of the 1,2-diacylglycerol 3-glucosyltransferase from Acholeplasma laidlawaii membranes - Recognition of a large group of lipid glycosyltransferases in eubacteria and archaea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGLUCOSAMINE; ESCHERICHIA-COLI; STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; GENE; SYNTHASE; DIGLUCOSYLDIACYLGLYCEROL; CLASSIFICATION; PHOSPHOLIPIDS; EXPRESSION	Synthesis of the nonbilayer-prone alpha -monoglucosyldiacylglycerol (MGlcDAG) is crucial for bilayer packing properties and the lipid surface charge density in the membrane of Acholeplasma laidlawii. The gene for the responsible, membrane-bound glucosyltransferase (alMGS) (EC 2.4.1.157) was sequenced and functionally cloned in Escherichia coli, yielding MGlcDAG in the re combinants. Similar amino acid sequences were encoded in the genomes of several Gram-positive bacteria (especially pathogens), thermophiles, archaea, and a few eukaryotes. Ah of these contained the typical EX7E catalytic motif of the CAZy family 4 of alpha -glycosyltransferases. The synthesis of MGlcDAG by a close sequence analog from Streptococcus pneumoniae (spMGS) was verified by polymerase chain reaction cloning, corroborating a connection between sequence and functional similarity for these proteins. However, alMGS and spMGS varied in dependence on anionic phospholipid activators phosphatidylglycerol and cardiolipin, suggesting certain regulatory differences. Fold predictions strongly indicated a similarity for alMGS land spMGS) with the two-domain structure of the E. coli MurG cell envelope glycosyltransferase and several amphipathic membrane binding segments in various proteins. On the basis of this structure, the alMGS sequence charge distribution, and anionic phospholipid dependence, a model for the bilayer surface binding and activity is proposed for this regulatory enzyme.	Univ Stockholm, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; Umea Univ, Dept Biochem, S-90187 Umea, Sweden	Stockholm University; Umea University	Wieslander, A (corresponding author), Univ Stockholm, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	ake@dbb.su.se	Berg, Stefan/AAU-6463-2020; Berg, Stefan O/D-3847-2011	Berg, Stefan/0000-0002-3470-7579; 				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; BAKER PJ, 1992, J MOL BIOL, V228, P662, DOI 10.1016/0022-2836(92)90848-E; BRANDEN C, 1998, INTRO PROTEIN STRUCT, P47; Breton C, 1998, J BIOCHEM, V123, P1000; BRUNDISH DE, 1967, BIOCHEM J, V104, P205; BUPP K, 1993, J BACTERIOL, V175, P1841, DOI 10.1128/JB.175.6.1841-1843.1993; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P14993, DOI 10.1021/bi001627x; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Fischetti VA, 2000, GRAM-POSITIVE PATHOGENS, P11; Garner J, 1996, EMBO J, V15, P3477, DOI 10.1002/j.1460-2075.1996.tb00714.x; Grebe T, 1997, J BACTERIOL, V179, P3342, DOI 10.1128/jb.179.10.3342-3349.1997; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guler S, 2000, J BACTERIOL, V182, P543, DOI 10.1128/JB.182.2.543-545.2000; GURR MI, 1971, LIPID BIOCH INTRO, P162; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; HAUKSSON JB, 1995, BBA-LIPID LIPID MET, V1258, P1, DOI 10.1016/0005-2760(95)00074-M; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HJELMSTAD RH, 1991, BIOCHEMISTRY-US, V30, P1731, DOI 10.1021/bi00221a001; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Huynen M, 1998, J MOL BIOL, V280, P323, DOI 10.1006/jmbi.1998.1884; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Karlsson OP, 1997, J BIOL CHEM, V272, P929, DOI 10.1074/jbc.272.2.929; KARLSSON OP, 1994, J BIOL CHEM, V269, P23484; KARLSSON OP, 1997, THESIS UMEA U UMEA; KAUFAM B, 1965, BIOCHEM BIOPH RES CO, V18, P312, DOI 10.1016/0006-291X(65)90705-9; Li L, 1997, J BIOL CHEM, V272, P29602, DOI 10.1074/jbc.272.47.29602; LIVERMORE BP, 1978, INFECT IMMUN, V20, P215, DOI 10.1128/IAI.20.1.215-220.1978; LIVERMORE BP, 1974, J BACTERIOL, V120, P1268, DOI 10.1128/JB.120.3.1268-1273.1974; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; MENGINLECREULX D, 1991, J BACTERIOL, V173, P4625, DOI 10.1128/jb.173.15.4625-4636.1991; Miege C, 1999, EUR J BIOCHEM, V265, P990, DOI 10.1046/j.1432-1327.1999.00801.x; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; OCHSNER UA, 1994, J BIOL CHEM, V269, P19787; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Saha SK, 1996, BIOSCI BIOTECH BIOCH, V60, P111; Salamon Z, 2000, BIOPHYS J, V78, P1400, DOI 10.1016/S0006-3495(00)76693-8; Schaeffer ML, 1999, J BIOL CHEM, V274, P31625, DOI 10.1074/jbc.274.44.31625; Schultz CP, 1998, J BIOL CHEM, V273, P15661, DOI 10.1074/jbc.273.25.15661; Shimojima M, 1997, P NATL ACAD SCI USA, V94, P333, DOI 10.1073/pnas.94.1.333; Soldo B, 1999, MOL MICROBIOL, V31, P795, DOI 10.1046/j.1365-2958.1999.01218.x; SPROTT GD, 1992, J BIOENERG BIOMEMBR, V24, P555, DOI 10.1007/BF00762348; STEINICK LE, 1980, J BACTERIOL, V143, P1200, DOI 10.1128/JB.143.3.1200-1207.1980; TANAKA R, 1991, NUCLEIC ACIDS RES, V19, P6787, DOI 10.1093/nar/19.24.6787; Teichmann SA, 2000, BIOINFORMATICS, V16, P117, DOI 10.1093/bioinformatics/16.2.117; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Umland TC, 1997, NAT STRUCT BIOL, V4, P788, DOI 10.1038/nsb1097-788; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; Vikstrom S, 1999, BIOCHEMISTRY-US, V38, P5511, DOI 10.1021/bi982532m; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wakarchuk WW, 1998, PROTEIN ENG, V11, P295, DOI 10.1093/protein/11.4.295; Wilkinson S., 1988, MICROBIAL LIPIDS; Zheng WD, 2001, EMBO J, V20, P1164, DOI 10.1093/emboj/20.5.1164	58	50	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22056	22063		10.1074/jbc.M102576200	http://dx.doi.org/10.1074/jbc.M102576200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294844	hybrid			2022-12-27	WOS:000169412700011
J	Pierce, KL; Tohgo, A; Ahn, S; Field, ME; Luttrell, LM; Lefkowitz, RJ				Pierce, KL; Tohgo, A; Ahn, S; Field, ME; Luttrell, LM; Lefkowitz, RJ			Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors - A co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN; KINASE ACTIVATION; PHOSPHORYLATION; ENDOCYTOSIS; TRANSACTIVATION; ADHESION; CLATHRIN; DYNAMIN; RELEASE; CASCADE	"Transactivation" of epidermal growth factor receptors (EGFRs) in response to activation of many G protein-coupled receptors (GPCRs) involves autocrine/ paracrine shedding of heparin binding EGF (HB-EGF). HB-EGF shedding involves proteolytic cleavage of a membrane-anchored precursor by incompletely characterized matrix metalloproteases. In COS-7 cells, alpha (2A)-adrenergic receptors (ARs) stimulate ERK phosphorylation via two distinct pathways, a transactivation pathway that involves the release of HB EGF and the EGFR and an alternate pathway that is independent of both HB-EGF and the EGFR. We have developed a mixed culture system to study the mechanism of GPCR-mediated HB-EGF shedding in COS-7 cells. In this system, alpha (2A)AR expressing "donor" cells are co-cultured with "acceptor" cells lacking the alpha (2A)AR. Each population expresses a uniquely epitope-tagged ERK2 protein, allowing the selective measurement of ERK activation in the donor and acceptor cells. Stimulation with the alpha (2)AR selective agonist UK14304 rapidly increases ERK2 phosphorylation in both the donor and the acceptor cells. The acceptor cell response is sensitive to inhibitors of both the EGFR and HB-EGF, indicating that it results from the release of HB EGF from the alpha (2A)AR-expressing donor cells. Experiments with various chemical inhibitors and dominant inhibitory mutants demonstrate that EGFR-dependent activation of the ERK cascade after alpha (2A)AR stimulation requires G beta gamma subunits upstream and dynamin dependent endocytosis downstream of HB-EGF shedding and EGFR activation, whereas Src kinase activity is required both for the release of HB-EGF and for HB-EGF-mediated ERK2 phosphorylation.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med & Biochem, Durham, NC 27710 USA; Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Durham, NC 27705 USA	Duke University; Howard Hughes Medical Institute; Duke University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 3821, Durham, NC 27710 USA.		Lefkowitz, Robert/AAW-2649-2021	Luttrell, Louis/0000-0003-2805-6949	NHLBI NIH HHS [HL16037] Funding Source: Medline; NIDDK NIH HHS [DK55524] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055524, R56DK055524] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; CAO W, 2000, J BIOL CHEM, V275, P15490; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Gechtman Z, 1999, J BIOL CHEM, V274, P28828, DOI 10.1074/jbc.274.40.28828; Gutwein P, 2000, J BIOL CHEM, V275, P15490, DOI 10.1074/jbc.275.20.15490; Kranenburg O, 1999, J BIOL CHEM, V274, P35301, DOI 10.1074/jbc.274.50.35301; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; MITAMURA T, 1995, J BIOL CHEM, V270, P1015, DOI 10.1074/jbc.270.3.1015; Pierce KL, 2000, P NATL ACAD SCI USA, V97, P1489, DOI 10.1073/pnas.97.4.1489; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; RAAB G, 1997, BIOCHIM BIOPHYS ACTA, V1333, pR179; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4	25	196	198	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23155	23160		10.1074/jbc.M101303200	http://dx.doi.org/10.1074/jbc.M101303200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11290747	hybrid			2022-12-27	WOS:000169412700156
J	Rusnati, M; Urbinati, C; Caputo, A; Possati, L; Lortat-Jacob, H; Giacca, M; Ribatti, D; Presta, M				Rusnati, M; Urbinati, C; Caputo, A; Possati, L; Lortat-Jacob, H; Giacca, M; Ribatti, D; Presta, M			Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; IMMUNODEFICIENCY-VIRUS TYPE-1; PHASE-I TRIAL; SULFATED POLYSACCHARIDES; HEPARAN SULFATES; TUMOR-GROWTH; PROTEIN; CELLS; SARCOMA; ANGIOGENESIS	HIV-1 Tat protein, released from HIV-infected cells, may act as a pleiotropic heparin-binding growth factor. From this observation, extracellular Tat has been implicated in the pathogenesis of AIDS and of AIDS-associated pathologies. Here we demonstrate that the heparin analog pentosan polysulfate (PPS) inhibits the interaction of glutathione S-transferase (GST)-Tat protein with heparin immobilized to a BIAcore sensor chip. Competition experiments showed that Tat-PPS interaction occurs with high affinity (K-d = 9.0 nM). Also, GST.Tat prevents the binding of [H-3]heparin to GST Tat immobilized to glutathione-agarose beads. In vitro, PPS inhibits GST Tat internalization and, consequently, HIV-1 long terminal repeat transactivation in HL3T1 cells. Also, PPS inhibits cell surface interaction and mitogenic activity of GST Tat in murine adenocarcinoma T53 Tat-less cells. In all assays, PPS exerts its Tat antagonist activity with an ID50 equal to similar to1.0 nM. In vivo, PPS inhibits the neovascularization induced by GST Tat or by Tat overexpressing T53 cells in the chick embryo chorioallantoic membrane. In conclusion, PPS binds Tat protein and inhibits its cell surface interaction, internalization, and biological activity in vitro and in vivo. PPS may represent a prototypic molecule for the development of novel Tat antagonists with therapeutic implications in AIDS and AIDS-associated pathologies, including Kaposi's sarcoma.	Univ Brescia, Dept Biomed Sci & Biotechnol, Sch Med, I-25123 Brescia, Italy; Univ Ferrara, Dept Expt & Diagnost Med, Microbiol Sect, I-44100 Ferrara, Italy; Inst Biol Struct, F-38027 Grenoble, France; Univ Ancona, Inst Biomed Sci, I-60131 Ancona, Italy; Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; Univ Bari, Inst Anat Histol & Embryol, I-70124 Bari, Italy	University of Brescia; University of Ferrara; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Marche Polytechnic University; International Center for Genetic Engineering & Biotechnology (ICGEB); Universita degli Studi di Bari Aldo Moro	Presta, M (corresponding author), Univ Brescia, Dept Biomed Sci & Biotechnol, Sch Med, Via Valsabbina 19, I-25123 Brescia, Italy.	presta@med.unibs.it	Rusnati, Marco/F-1168-2010; Caputo, Antonella/ABE-7851-2020; Giacca, Mauro/J-9287-2016; Presta, Marco/B-4345-2010	Rusnati, Marco/0000-0001-9968-5908; Caputo, Antonella/0000-0002-1241-0299; Giacca, Mauro/0000-0003-2927-7225; PRESTA, Marco/0000-0002-4398-8376; Urbinati, Chiara Eva/0000-0002-0138-7871				Albini A, 1996, ONCOGENE, V12, P289; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; BABA M, 1990, J ACQ IMMUN DEF SYND, V3, P493; BARILLARI G, 1993, P NATL ACAD SCI USA, V90, P7941, DOI 10.1073/pnas.90.17.7941; Cafaro A, 1999, NAT MED, V5, P643, DOI 10.1038/9488; CAMPIONI D, 1995, AIDS RES HUM RETROV, V11, P1039, DOI 10.1089/aid.1995.11.1039; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Corallini A, 1996, AIDS, V10, P701, DOI 10.1097/00002030-199606001-00003; Corallini A, 1998, AIDS RES HUM RETROV, V14, P1561, DOI 10.1089/aid.1998.14.1561; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Gatignol A, 2000, Adv Pharmacol, V48, P209; HATTON MWC, 1980, ANAL BIOCHEM, V106, P417, DOI 10.1016/0003-2697(80)90542-4; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Marshall JL, 1997, CLIN CANCER RES, V3, P2347; McLeskey SW, 1996, BRIT J CANCER, V73, P1053, DOI 10.1038/bjc.1996.204; MOSCATELLI D, 1992, J BIOL CHEM, V267, P25803; Noonan D, 2000, Adv Pharmacol, V48, P229; PARKER BW, 1993, J NATL CANCER I, V85, P1068, DOI 10.1093/jnci/85.13.1068; Pauza CD, 2000, P NATL ACAD SCI USA, V97, P3515, DOI 10.1073/pnas.070049797; PearcePratt R, 1996, BIOL REPROD, V54, P173, DOI 10.1095/biolreprod54.1.173; Possati L, 1999, CLIN EXP METASTAS, V17, P575, DOI 10.1023/A:1006737029616; Prakash O, 2000, JNCI-J NATL CANCER I, V92, P721, DOI 10.1093/jnci/92.9.721; RIBATTI D, 1995, DEV BIOL, V170, P39, DOI 10.1006/dbio.1995.1193; Ribatti D, 1997, J VASC RES, V34, P455, DOI 10.1159/000159256; Rusnati M, 1997, AIDS, V11, P727, DOI 10.1097/00002030-199706000-00005; Rusnati M, 1998, J BIOL CHEM, V273, P16027, DOI 10.1074/jbc.273.26.16027; Rusnati M, 2000, FASEB J, V14, P1917, DOI 10.1096/fj.99-0902com; Rusnati M, 1999, J BIOL CHEM, V274, P28198, DOI 10.1074/jbc.274.40.28198; Rusnati M, 1997, J BIOL CHEM, V272, P11313, DOI 10.1074/jbc.272.17.11313; Sadir R, 1998, J BIOL CHEM, V273, P10919, DOI 10.1074/jbc.273.18.10919; SCHOLS D, 1990, VIROLOGY, V175, P556, DOI 10.1016/0042-6822(90)90440-3; Schwartsmann G, 1996, TUMORI, V82, P360, DOI 10.1177/030089169608200412; SWAIN SM, 1995, INVEST NEW DRUG, V13, P55, DOI 10.1007/BF02614221; SYDOW G, 1987, BIOMED BIOCHIM ACTA, V46, P527; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Watson K, 1999, BIOCHEM PHARMACOL, V57, P775, DOI 10.1016/S0006-2952(98)00352-9; WELLSTEIN A, 1991, JNCI-J NATL CANCER I, V83, P716, DOI 10.1093/jnci/83.10.716; WITVROUW M, 1994, ANTIVIR CHEM CHEMOTH, V5, P345, DOI 10.1177/095632029400500601; WRIGHT CM, 1986, SCIENCE, V234, P988, DOI 10.1126/science.3490693; Zugmaier G, 1999, ANN NY ACAD SCI, V886, P243, DOI 10.1111/j.1749-6632.1999.tb09427.x; ZUGMAIER G, 1992, J NATL CANCER I, V84, P1716, DOI 10.1093/jnci/84.22.1716	42	71	74	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22420	22425		10.1074/jbc.M010779200	http://dx.doi.org/10.1074/jbc.M010779200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11304529	hybrid			2022-12-27	WOS:000169412700061
J	Soslau, G; Class, R; Morgan, DA; Foster, C; Lord, ST; Marchese, P; Ruggeri, ZM				Soslau, G; Class, R; Morgan, DA; Foster, C; Lord, ST; Marchese, P; Ruggeri, ZM			Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; ALPHA-THROMBIN; CYTOPLASMIC DOMAIN; GPIIB/IIIA ANTAGONISTS; MONOCLONAL-ANTIBODIES; ADHESION RECEPTOR; BINDING-SITES; IX COMPLEX; FIBRINOGEN; ACTIVATION	Thrombin plays a central role in normal and abnormal hemostatic processes. It is assumed that alpha -thrombin activates platelets by hydrolyzing the protease-activated receptor (PAR)-1, thereby exposing a new N-terminal sequence, a tethered ligand, which initiates a cascade of molecular reactions leading to thrombus formation. This process involves cross-linking of adjacent platelets mediated by the interaction of activated glycoprotein (GP) IIb/IIIa with distinct amino acid sequences, LG-GAKQAGDV and/or RGD, at each end of dimeric fibrinogen molecules. We demonstrate here the existence of a second alpha -thrombin-induced platelet-activating pathway, dependent on GP Ib, which does not require hydrolysis of a substrate receptor, utilizes polymerizing fibrin instead of fibrinogen, and can be inhibited by the Fab fragment of the monoclonal antibody LJIb-10 bound to the GP Ib thrombin-binding site or by the cobra venom metalloproteinase, mocarhagin, that hydrolyzes the extracellular portion of GP Ib. This alternative alpha -thrombin pathway is observed when PAR-1 or GP IIb/ IIIa is inhibited. The recognition sites involved in the cross-linking of polymerizing fibrin and surface integrins via the GP Ib pathway are different from those associated with fibrinogen, This pathway is insensitive to RGDS and anti-GP IIb/IIIa antibodies but reactive with a mutant fibrinogen, gamma 407, with a deletion of the gamma -chain sequence, AGDV, The reaction is not due to simple trapping of platelets by the fibrin clot, since ligand binding, signal transduction, and second messenger formation are required. The GP Ib pathway is accompanied by mobilization of internal calcium and the platelet release reaction. This latter aspect is not observed with ristocetin-induced GP m-von Willebrand factor agglutination nor with GP Ib-von Willebrand factor-polymerizing fibrin trapping of platelets. Human platelets also respond to gamma -thrombin, an autoproteolytic product of cu-thrombin, through PAR-4, Go-activation of the GP Ib, PAR-1, and PAR-4 pathways elicit synergistic responses. The presence of the GP Ib pathway may explain why anti-alpha -thrombin/anti-platelet regimens fail to completely abrogate thrombosis/restenosis in the cardiac patient.	Med Coll Penn & Hahnemann Univ, Dept Biochem, Biochem IMS, Philadelphia, PA 19102 USA; Med Coll Penn & Hahnemann Univ, Dept Radiat Oncol, Philadelphia, PA 19102 USA; Med Coll Penn & Hahnemann Univ, Dept Med, Div Hematol Oncol, Philadelphia, PA 19102 USA; Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA; Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA	Drexel University; Drexel University; Drexel University; Merck & Company; Schering Plough Corporation; University of North Carolina; University of North Carolina Chapel Hill; Scripps Research Institute; Scripps Research Institute	Soslau, G (corresponding author), Med Coll Penn & Hahnemann Univ, Dept Biochem, Biochem IMS, Mail Stop 344,245 N 15th St, Philadelphia, PA 19102 USA.		Soslau, Gerald/A-7934-2009					Ahn HS, 1999, BIOORG MED CHEM LETT, V9, P2073, DOI 10.1016/S0960-894X(99)00339-X; ALI MN, 1995, CHEST, V108, P1409, DOI 10.1378/chest.108.5.1409; Andrews RK, 1998, BIOCHEMISTRY-US, V37, P638, DOI 10.1021/bi970893g; ANDREWS RK, 1992, J BIOL CHEM, V267, P18605; BASHEER AR, 1995, BBA-PROTEIN STRUCT M, V1250, P97, DOI 10.1016/0167-4838(95)00050-5; Beguin S, 1997, THROMB HAEMOSTASIS, V78, P590; BENNETT JS, 1988, J BIOL CHEM, V263, P12948; BERLINER LJ, 1985, BIOCHEMISTRY-US, V24, P7005, DOI 10.1021/bi00345a038; BODARY SC, 1989, J BIOL CHEM, V264, P18859; Bode C, 1997, CIRCULATION, V95, P800; BRASS LF, 1992, J BIOL CHEM, V267, P13795; CLEMETSON KJ, 1995, THROMB HAEMOSTASIS, V74, P111; Coller BS, 1997, THROMB HAEMOSTASIS, V78, P730; Coller BS, 1997, J CLIN INVEST, V99, P1467, DOI 10.1172/JCI119307; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; Cunningham JG, 1996, J BIOL CHEM, V271, P11581, DOI 10.1074/jbc.271.19.11581; Curley GP, 1999, CELL MOL LIFE SCI, V56, P427, DOI 10.1007/s000180050443; DEMARCO L, 1994, J BIOL CHEM, V269, P6478; DIMINNO G, 1982, BLOOD, V59, P563; Du XP, 1996, J BIOL CHEM, V271, P7362, DOI 10.1074/jbc.271.13.7362; Faruqi TR, 2000, J BIOL CHEM, V275, P19728, DOI 10.1074/jbc.M909960199; Greco NJ, 1996, BIOCHEMISTRY-US, V35, P915, DOI 10.1021/bi951504q; Greco NJ, 1996, BIOCHEMISTRY-US, V35, P906, DOI 10.1021/bi951503y; GRECO NJ, 1991, P SOC EXP BIOL MED, V198, P792; HANDA M, 1986, J BIOL CHEM, V261, P2579; HANTGAN RR, 1995, BLOOD, V86, P1001, DOI 10.1182/blood.V86.3.1001.bloodjournal8631001; HARMON JT, 1986, J BIOL CHEM, V261, P5928; HAWIGER J, 1989, BIOCHEMISTRY-US, V28, P2909, DOI 10.1021/bi00433a024; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; JANDROTPERRUS M, 1988, EUR J BIOCHEM, V174, P359, DOI 10.1111/j.1432-1033.1988.tb14106.x; JANDROTPERRUS M, 1992, BLOOD, V80, P2781; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Konstantopoulos K, 1997, BIORHEOLOGY, V34, P57, DOI 10.1016/S0006-355X(97)00004-8; Kuijper PHM, 1996, BLOOD, V87, P3271, DOI 10.1182/blood.V87.8.3271.bloodjournal8783271; LOPEZ JA, 1992, J BIOL CHEM, V267, P12851; LOSCALZO J, 1986, J CLIN INVEST, V78, P1112, DOI 10.1172/JCI112668; NIEWIAROWSKI S, 1981, THROMB RES, V23, P457, DOI 10.1016/0049-3848(81)90207-3; NIEWIAROWSKI S, 1972, J CLIN INVEST, V51, P685, DOI 10.1172/JCI106857; NIIYA K, 1987, BLOOD, V70, P475; OKUMURA T, 1978, J BIOL CHEM, V253, P3435; PHILLIPS DR, 1974, THROMB DIATH HAEMOST, V32, P207, DOI 10.1055/s-0038-1647686; Ramakrishnan V, 2001, P NATL ACAD SCI USA, V98, P1823, DOI 10.1073/pnas.98.4.1823; REIDY MA, 1977, ATHEROSCLEROSIS, V26, P181, DOI 10.1016/0021-9150(77)90101-0; RIGEL DF, 1993, CIRC RES, V72, P1091, DOI 10.1161/01.RES.72.5.1091; Rooney MM, 1996, J BIOL CHEM, V271, P8553, DOI 10.1074/jbc.271.15.8553; RUGGERI ZM, 1994, SEMIN HEMATOL, V31, P229; Ruggeri ZM, 1997, J CLIN INVEST, V99, P559, DOI 10.1172/JCI119195; Schafer AI, 1996, AM J MED, V101, P199, DOI 10.1016/S0002-9343(96)80077-5; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Smith RA, 1997, J BIOL CHEM, V272, P22080, DOI 10.1074/jbc.272.35.22080; Smith RD, 1999, BIOCHEMISTRY-US, V38, P8936, DOI 10.1021/bi9827518; SOSLAU G, 1992, THROMB RES, V66, P15, DOI 10.1016/0049-3848(92)90151-Y; SOSLAU G, 1995, BBA-MOL CELL RES, V1268, P73, DOI 10.1016/0167-4889(95)00051-S; Soslau G, 1997, BLOOD, V90, P1251; SOSLAU G, 1982, THROMB RES, V26, P443, DOI 10.1016/0049-3848(82)90316-4; SOSLAU G, 1988, BIOCHEM BIOPH RES CO, V150, P909, DOI 10.1016/0006-291X(88)90715-2; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Ward CM, 1996, BIOCHEMISTRY-US, V35, P4929, DOI 10.1021/bi952456c; WEITZ J, 1994, DRUGS, V48, P485, DOI 10.2165/00003495-199448040-00001; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Zaffran Y, 2000, J BIOL CHEM, V275, P16779, DOI 10.1074/jbc.275.22.16779	62	141	157	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21173	21183		10.1074/jbc.M008249200	http://dx.doi.org/10.1074/jbc.M008249200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11283012	Green Published, hybrid			2022-12-27	WOS:000169297900052
J	Fabini, G; Raijmakers, R; Hayer, S; Fouraux, MA; Pruijn, GJM; Steiner, G				Fabini, G; Raijmakers, R; Hayer, S; Fouraux, MA; Pruijn, GJM; Steiner, G			The heterogeneous nuclear ribonucleoproteins I and K interact with a subset of the Ro ribonucleoprotein-associated Y RNAs in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRACT-BINDING-PROTEIN; POLYMERASE-III TRANSCRIPTS; INTERNAL RIBOSOMAL ENTRY; MESSENGER-RNA; LA PROTEIN; HNRNP-K; INTRACELLULAR-LOCALIZATION; PERINUCLEOLAR COMPARTMENT; SUBCELLULAR-DISTRIBUTION; CAENORHABDITIS-ELEGANS	The hY RNAs are a group of four small cytoplasmic RNAs of unknown function that are stably associated with at least two proteins, Ro60 and La, to form Ro ribonucleoprotein complexes. Here we show that the heterogeneous nuclear ribonucleoproteins (hnRNP) I and K are able to associate with a subset of hY RNAs in vitro and demonstrate these interactions to occur also in vivo in a yeast three-hybrid system. Experiments performed in vitro and in vivo with deletion mutants of hY1 RNA revealed its pyrimidine-rich central loop to be involved in interactions with both hnRNP I and K and clearly showed their binding sites to be different from the Ro60 binding site. Both hY1 and hY3 RNAs coprecipitated with hnRNP I in immunoprecipitation experiments performed with HeLa S100 extracts and cell extracts from COS-l cells transiently transfected with VSV-G-tagged hnRNP-I, respectively. Furthermore, both anti-Ro60 and anti-La antibodies coprecipitated hnRNP I, whereas coprecipitation of hnRNP K was not observed. Taken together, these data strongly suggest that hnRNP I is a stable component of a subpopulation of Ro RNPs, whereas hnRNP K may be transiently bound or interact only with (rare) Y RNAs that are devoid of Ro60 and La. Given that functions related to translation regulation have been assigned to both proteins and also to La, our findings may provide novel clues toward understanding the role of Y RNAs and their respective RNP complexes.	Univ Hosp Vienna, Dept Internal Med 3, Div Rheumatol, A-1090 Vienna, Austria; Univ Vienna, Inst Med Biochem, A-1030 Vienna, Austria; Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands	University Hospital Vienna; University of Vienna; Radboud University Nijmegen	Steiner, G (corresponding author), Univ Hosp Vienna, Dept Internal Med 3, Div Rheumatol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	Guenter.Steiner@akh-wien.ac.at	Raijmakers, Reinout/A-3045-2010; Pruijn, Ger/D-6664-2012	Raijmakers, Reinout/0000-0001-6316-6663; Steiner, Guenter/0000-0002-5089-7405				Anwar A, 2000, J BIOL CHEM, V275, P34231, DOI 10.1074/jbc.M006343200; Belsham GJ, 1995, CURR TOP MICROBIOL, V203, P85; BENCHETRIT E, 1993, BRIT J RHEUMATOL, V32, P396; BENCHETRIT E, 1988, J EXP MED, V167, P1560, DOI 10.1084/jem.167.5.1560; BOIRE G, 1990, J CLIN INVEST, V85, P1182, DOI 10.1172/JCI114551; BOIRE G, 1995, CLIN EXP IMMUNOL, V100, P489; Bomsztyk K, 1997, FEBS LETT, V403, P113, DOI 10.1016/S0014-5793(97)00041-0; Bouffard P, 2000, RNA, V6, P66, DOI 10.1017/S1355838200990277; Broekhuis CHD, 2000, BIOCHEMISTRY-US, V39, P3023, DOI 10.1021/bi992308c; Chen XG, 2000, GENE DEV, V14, P777; Cheng ST, 1996, J IMMUNOL, V156, P4484; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; ELLINGTON AD, 1994, CURR BIOL, V4, P427, DOI 10.1016/S0960-9822(00)00093-2; Fabini G, 2000, EUR J BIOCHEM, V267, P2778, DOI 10.1046/j.1432-1327.2000.01298.x; FARRIS AD, 1995, GENE, V154, P193, DOI 10.1016/0378-1119(94)00823-B; GHETTI A, 1992, NUCLEIC ACIDS RES, V20, P3671, DOI 10.1093/nar/20.14.3671; Gosert R, 2000, MOL CELL BIOL, V20, P1583, DOI 10.1128/MCB.20.5.1583-1595.2000; GOTTLIEB E, 1989, EMBO J, V8, P851, DOI 10.1002/j.1460-2075.1989.tb03446.x; Grossman JS, 1998, RNA, V4, P613, DOI 10.1017/S1355838298971448; HELLEN CUT, 1993, P NATL ACAD SCI USA, V90, P7642, DOI 10.1073/pnas.90.16.7642; Holcik M, 2000, MOL CELL BIOL, V20, P4648, DOI 10.1128/MCB.20.13.4648-4657.2000; Huang S, 1997, J CELL BIOL, V137, P965, DOI 10.1083/jcb.137.5.965; KELEKAR A, 1994, J CLIN INVEST, V93, P1637, DOI 10.1172/JCI117145; Kim JH, 2000, J MOL BIOL, V298, P395, DOI 10.1006/jmbi.2000.3687; Kim YK, 1999, J GEN VIROL, V80, P3159, DOI 10.1099/0022-1317-80-12-3159; Labbe JC, 1999, BIOCHEM CELL BIOL, V77, P349, DOI 10.1139/bcb-77-4-349; Labbe JC, 2000, P NATL ACAD SCI USA, V97, P13233, DOI 10.1073/pnas.230284297; Ladomery M, 1997, BIOESSAYS, V19, P903, DOI 10.1002/bies.950191010; Lee B, 1996, P NATL ACAD SCI USA, V93, P11471, DOI 10.1073/pnas.93.21.11471; Lee MH, 1996, J BIOL CHEM, V271, P3420; Maraia RJ, 1996, P NATL ACAD SCI USA, V93, P3383, DOI 10.1073/pnas.93.8.3383; MATERA AG, 1995, J CELL BIOL, V129, P1181, DOI 10.1083/jcb.129.5.1181; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; McCluskey J, 1998, IMMUNOL REV, V164, P209, DOI 10.1111/j.1600-065X.1998.tb01222.x; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; OBRIEN CA, 1994, GENE DEV, V8, P2891, DOI 10.1101/gad.8.23.2891; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Pannone BK, 1998, EMBO J, V17, P7442, DOI 10.1093/emboj/17.24.7442; PEEK R, 1993, J CELL SCI, V106, P929; PEERY T, 1993, J VIROL, V67, P3534, DOI 10.1128/JVI.67.6.3534-3543.1993; Pellizzoni L, 1996, J MOL BIOL, V259, P904, DOI 10.1006/jmbi.1996.0368; Pellizzoni L, 1998, J MOL BIOL, V281, P593, DOI 10.1006/jmbi.1998.1961; Perez I, 1997, BIOCHEMISTRY-US, V36, P11881, DOI 10.1021/bi9711745; PFEIFLE J, 1987, BIOCHIM BIOPHYS ACTA, V928, P217, DOI 10.1016/0167-4889(87)90124-8; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; PIZER LI, 1983, MOL CELL BIOL, V3, P1235, DOI 10.1128/MCB.3.7.1235; PRUIJN GJM, 1995, EUR J BIOCHEM, V232, P611, DOI 10.1111/j.1432-1033.1995.tb20851.x; Pruijn GJM, 1997, EUR J CELL BIOL, V74, P123; PRUIJN GJM, 1991, NUCLEIC ACIDS RES, V19, P5173, DOI 10.1093/nar/19.19.5173; PRUIJN GJM, 1993, BIOCHIM BIOPHYS ACTA, V1216, P395, DOI 10.1016/0167-4781(93)90006-Y; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Simons FHM, 1996, RNA, V2, P264; SLOBBE RL, 1992, J MOL BIOL, V227, P361, DOI 10.1016/0022-2836(92)90890-V; Svitkin YV, 1996, EMBO J, V15, P7147, DOI 10.1002/j.1460-2075.1996.tb01106.x; Teunissen SWM, 2000, NUCLEIC ACIDS RES, V28, P610, DOI 10.1093/nar/28.2.610; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; TOPPER JN, 1990, J BIOL CHEM, V265, P13254; Valcarcel J, 1997, CURR BIOL, V7, pR705, DOI 10.1016/S0960-9822(06)00361-7; VANGELDER CWG, 1994, NUCLEIC ACIDS RES, V22, P2498, DOI 10.1093/nar/22.13.2498; Varani G, 1998, ANNU REV BIOPH BIOM, V27, P407, DOI 10.1146/annurev.biophys.27.1.407; VELDHOVEN CHA, 1995, CLIN EXP IMMUNOL, V101, P45; Wang DR, 1999, J CLIN INVEST, V104, P1265, DOI 10.1172/JCI8003; Wolin SL, 1999, GENE DEV, V13, P1, DOI 10.1101/gad.13.1.1; WOLIN SL, 1983, CELL, V32, P735, DOI 10.1016/0092-8674(83)90059-4; Xue DH, 2000, EMBO J, V19, P1650, DOI 10.1093/emboj/19.7.1650; Yu YT, 1999, RNA WORLD, P487; Zimmermann C, 1996, J RHEUMATOL, V23, P1897	70	42	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20711	20718		10.1074/jbc.M101360200	http://dx.doi.org/10.1074/jbc.M101360200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279198	Green Published, hybrid			2022-12-27	WOS:000169135100138
J	Yang, RY; Hsu, DK; Yu, L; Ni, J; Liu, FT				Yang, RY; Hsu, DK; Yu, L; Ni, J; Liu, FT			Cell cycle regulation by galectin-12, a new member of the galectin superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTOSIDE-BINDING PROTEIN; LEYDEN CRYSTAL PROTEIN; HUMAN T-LYMPHOCYTES; NUCLEAR-LOCALIZATION; ANIMAL LECTINS; GENE FAMILY; DECREASED EXPRESSION; EPITHELIAL-CELLS; COLON-CARCINOMA; BETA-GBP	Galectins are a family of beta -galactoside-binding animal lectins with conserved carbohydrate recognition domains (CRDs). Here we report the identification and characterization of a new galectin, galectin-12, which contains two domains that are homologous to the galectin CRD. The N-terminal domain contains all of the sequence elements predicted to form the two beta -sheets found in other galectins, as well as conserved carbohydrate-interacting residues. The C-terminal domain shows considerable divergence from the consensus sequence, and many of these conserved residues are not present. Nevertheless, the protein has lactose binding activity, most Likely due to the contribution of the N-terminal domain. The mRNA for galectin-12 contains features coding for proteins with growth-regulatory functions. These include start codons in a context that are suboptimal for translation initiation and AU-rich motifs in the 3'-untranslated region, which are known to confer instability to mRNA. Galectin-12 mRNA is sparingly expressed or undetectable in many tissues and cell lines tested, but it is up-regulated in cells synchronized at the G(1) phase or the G(1)/S boundary of the cell cycle. Ectopic expression of galectin-12 in cancer cells causes cell cycle arrest at the G(1) phase and cell growth suppression. We conclude that galectin-12 is a novel regulator of cellular homeostasis.	La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA; Human Genome Sci Inc, Rockville, MD 20850 USA	La Jolla Institute for Immunology; GlaxoSmithKline; Human Genome Sciences Inc	Liu, FT (corresponding author), La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA.		Liu, FU-TONG/A-5749-2019; Yang, Riyao/R-7593-2019	Liu, FU-TONG/0000-0002-3354-1001; Yang, Riyao/0000-0002-0278-4385	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020958, R01AI039620] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1RR0833] Funding Source: Medline; NIAID NIH HHS [AI39620, R01 AI20958] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS M, 1995, NATURE S, V377, P6547; Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Akahani S, 1997, CANCER RES, V57, P5272; Allione A, 1998, J IMMUNOL, V161, P2114; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BAUM C, 1994, BIOTECHNIQUES, V17, P1058; Bernerd F, 1999, P NATL ACAD SCI USA, V96, P11329, DOI 10.1073/pnas.96.20.11329; Bresalier RS, 1998, GASTROENTEROLOGY, V115, P287, DOI 10.1016/S0016-5085(98)70195-7; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Castronovo V, 1996, J PATHOL, V179, P43, DOI 10.1002/(SICI)1096-9896(199605)179:1<43::AID-PATH541>3.0.CO;2-N; CASTRONOVO V, 1992, JNCI-J NATL CANCER I, V84, P1161, DOI 10.1093/jnci/84.15.1161; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; COFFINO P, 1975, P NATL ACAD SCI USA, V72, P878, DOI 10.1073/pnas.72.3.878; Cooper DNW, 1999, GLYCOBIOLOGY, V9, P979, DOI 10.1093/glycob/9.10.979; COOPER HM, 1995, CURRENT PROTOCOLS IM; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; Dunphy JL, 2000, J BIOL CHEM, V275, P32106, DOI 10.1074/jbc.M003739200; Dyer KD, 1997, GENOMICS, V40, P217, DOI 10.1006/geno.1996.4590; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fernandez PL, 1997, J PATHOL, V181, P80; GIBSON AW, 1995, EXP CELL RES, V218, P351, DOI 10.1006/excr.1995.1166; Gitt MA, 1998, J BIOL CHEM, V273, P2961, DOI 10.1074/jbc.273.5.2961; GITT MA, 1992, J BIOL CHEM, V267, P10601; GITT MA, 1995, J BIOL CHEM, V270, P5032, DOI 10.1074/jbc.270.10.5032; GITT MA, 1991, BIOCHEMISTRY-US, V30, P82, DOI 10.1021/bi00215a013; Goletz S, 1997, J CELL SCI, V110, P1585; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; Hsu DK, 1996, AM J PATHOL, V148, P1661; Hsu DK, 1999, INT J CANCER, V81, P519, DOI 10.1002/(SICI)1097-0215(19990517)81:4<519::AID-IJC3>3.0.CO;2-0; KANDROFSKE MM, 1998, ARCH BIOCHEM BIOPHYS, V349, P7; Kasai K, 1996, J BIOCHEM-TOKYO, V119, P1; Kim HRC, 1999, CANCER RES, V59, P4148; Konstantinov KN, 1996, AM J PATHOL, V148, P25; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Leonidas DD, 1998, BIOCHEMISTRY-US, V37, P13930, DOI 10.1021/bi981056x; Leonidas DD, 1995, STRUCTURE, V3, P1379, DOI 10.1016/S0969-2126(01)00275-1; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIAO DI, 1994, P NATL ACAD SCI USA, V91, P1428, DOI 10.1073/pnas.91.4.1428; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Liu FT, 2000, CLIN IMMUNOL, V97, P79, DOI 10.1006/clim.2000.4912; LOBSANOV YD, 1993, J BIOL CHEM, V268, P27034; LOTZ MM, 1993, P NATL ACAD SCI USA, V90, P3466, DOI 10.1073/pnas.90.8.3466; Magnaldo T, 1998, DIFFERENTIATION, V63, P159, DOI 10.1046/j.1432-0436.1998.6330159.x; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; MOUTSATSOS IK, 1987, P NATL ACAD SCI USA, V84, P6452, DOI 10.1073/pnas.84.18.6452; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Ogden AT, 1998, J BIOL CHEM, V273, P28889, DOI 10.1074/jbc.273.44.28889; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; Perillo NL, 1997, J EXP MED, V185, P1851, DOI 10.1084/jem.185.10.1851; Pesheva P, 1998, J NEUROSCI RES, V54, P639, DOI 10.1002/(SICI)1097-4547(19981201)54:5<639::AID-JNR9>3.0.CO;2-2; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rabinovich GA, 1999, CELL DEATH DIFFER, V6, P711, DOI 10.1038/sj.cdd.4400535; RAZ A, 1990, INT J CANCER, V46, P871, DOI 10.1002/ijc.2910460520; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; SEVE AP, 1993, GLYCOBIOLOGY, V3, P23, DOI 10.1093/glycob/3.1.23; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Su ZZ, 1996, P NATL ACAD SCI USA, V93, P7252, DOI 10.1073/pnas.93.14.7252; Than NG, 1999, PLACENTA, V20, P703, DOI 10.1053/plac.1999.0436; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOBEY RA, 1972, EXP CELL RES, V75, P460, DOI 10.1016/0014-4827(72)90453-3; Tureci O, 1997, J BIOL CHEM, V272, P6416, DOI 10.1074/jbc.272.10.6416; VANDENBRULE FA, 1994, EUR J CANCER, V30A, P1096, DOI 10.1016/0959-8049(94)90464-2; VandenBrule FA, 1996, HUM PATHOL, V27, P1185, DOI 10.1016/S0046-8177(96)90313-5; Vyakarnam A, 1998, EXP CELL RES, V242, P419, DOI 10.1006/excr.1998.4111; Vyakarnam A, 1997, MOL CELL BIOL, V17, P4730, DOI 10.1128/MCB.17.8.4730; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wells V, 1999, EUR J CANCER, V35, P978, DOI 10.1016/S0959-8049(99)00020-9; XU XC, 1995, AM J PATHOL, V147, P815; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yang RY, 1998, BIOCHEMISTRY-US, V37, P4086, DOI 10.1021/bi971409c	75	115	127	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20252	20260		10.1074/jbc.M010914200	http://dx.doi.org/10.1074/jbc.M010914200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11283015	hybrid			2022-12-27	WOS:000169135100080
J	Varrault, A; Bilanges, B; Mackay, DJG; Basyuk, E; Ahr, B; Fernandez, C; Robinson, DO; Bockaert, J; Journot, L				Varrault, A; Bilanges, B; Mackay, DJG; Basyuk, E; Ahr, B; Fernandez, C; Robinson, DO; Bockaert, J; Journot, L			Characterization of the methylation-sensitive promoter of the imprinted ZAC gene supports its role in transient neonatal diabetes mellitus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; LONG ARM; CHROMOSOME 6Q; SOLID TUMORS; CANCER; IDENTIFICATION; DUPLICATION; EXPRESSION; MECHANISMS; LOST	ZAC is a recently isolated zinc finger protein that induces apoptosis and cell cycle arrest. The corresponding gene is imprinted maternally through an unknown mechanism and maps to 6q24-q25, within the minimal interval harboring the gene responsible for transient neonatal diabetes mellitus (TNDM) and a tumor suppressor gene involved in breast cancer, Because of its functional properties, imprinting status, and expression pattern in mammary cell lines and tumors, ZAC is the best candidate so far for both disease conditions. In the present work, we delineated ZAC genomic organization and mapped its transcriptional start site. It is noteworthy that the ZAC promoter localized to the CpG island harboring the methylation imprint associated with TNDM and methylation of this promoter silenced its activity. These data indicate that the methylation mark may have a direct effect on the silencing of the ZAC imprinted allele, Our findings further strengthen the hypothesis that ZAC is the gene responsible for TNDM and suggest a novel mechanism for ZAC inactivation in breast tumors.	UPR 6023 CNRS Ctr, INSERM Pharmacol Endocrinol, F-34094 Montpellier 05, France; Salibury Dist Hosp, Wessex Reg Gen Lab, Salisbury SP2 8BJ, Wilts, England	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Salisbury District Hospital	Varrault, A (corresponding author), UPR 6023 CNRS Ctr, INSERM Pharmacol Endocrinol, 141 Rue Cardonille, F-34094 Montpellier 05, France.	varrault@ccipe.montp.inserm.fr	Bilanges, Benoit/AAP-6078-2020; Journot, Laurent/T-9652-2018; Mackay, Deborah JG/B-2879-2015	Journot, Laurent/0000-0003-3499-8887; Mackay, Deborah JG/0000-0003-3088-4401; Basyuk, Eugenia/0000-0001-9768-4557; Bilanges, Benoit/0000-0003-4400-3716				Abdollahi A, 1997, CANCER RES, V57, P2029; Abdollahi A, 1997, ONCOGENE, V14, P1973, DOI 10.1038/sj.onc.1201034; Arima T, 2000, GENOMICS, V67, P248, DOI 10.1006/geno.2000.6266; Arthur EI, 1997, EUR J HUM GENET, V5, P417, DOI 10.1159/000484801; Barlow DP, 1997, EMBO J, V16, P6899, DOI 10.1093/emboj/16.23.6899; Ben-Porath I, 2000, CURR OPIN GENET DEV, V10, P550, DOI 10.1016/S0959-437X(00)00126-X; Bilanges B, 1999, ONCOGENE, V18, P3979, DOI 10.1038/sj.onc.1202933; Bilanges B, 2001, ONCOGENE, V20, P1246, DOI 10.1038/sj.onc.1204237; Brannan CI, 1999, CURR OPIN GENET DEV, V9, P164, DOI 10.1016/S0959-437X(99)80025-2; Cave H, 2000, DIABETES, V49, P108, DOI 10.2337/diabetes.49.1.108; El Kharroubi A, 2001, J BIOL CHEM, V276, P8674, DOI 10.1074/jbc.M009392200; Falls JG, 1999, AM J PATHOL, V154, P635, DOI 10.1016/S0002-9440(10)65309-6; FERGUSON AW, 1970, ARCH DIS CHILD, V45, P80, DOI 10.1136/adc.45.239.80; Gardner RJ, 1998, CLIN GENET, V54, P522; Gardner RJ, 2000, HUM MOL GENET, V9, P589, DOI 10.1093/hmg/9.4.589; Gardner RJ, 1999, J MED GENET, V36, P192; HAIG D, 1994, NAT GENET, V7, P10, DOI 10.1038/ng0594-10a; Hermann R, 2000, PEDIATRICS, V105, P49, DOI 10.1542/peds.105.1.49; Kamiya M, 2000, HUM MOL GENET, V9, P453, DOI 10.1093/hmg/9.3.453; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; MATHEW PM, 1988, CLIN PEDIATR, V27, P148, DOI 10.1177/000992288802700307; Mertens F, 1997, CANCER RES, V57, P2765; MILNER RDG, 1971, ARCH DIS CHILD, V46, P724, DOI 10.1136/adc.46.249.724; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; NIELSEN F, 1989, ACTA PAEDIATR SCAND, V78, P469, DOI 10.1111/j.1651-2227.1989.tb11114.x; PANDYA A, 1995, AM J MED GENET, V59, P38, DOI 10.1002/ajmg.1320590109; PIVNICK EK, 1990, J MED GENET, V27, P523, DOI 10.1136/jmg.27.8.523; Reik W, 2000, NATURE, V405, P408, DOI 10.1038/35013178; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; SEQUEL A, 1982, AM J DIS CHILD, V136, P626, DOI 10.1001/archpedi.1982.03970430058015; Spengler D, 1997, EMBO J, V16, P2814, DOI 10.1093/emboj/16.10.2814; TEMPLE IK, 1995, NAT GENET, V9, P110, DOI 10.1038/ng0295-110; Temple IK, 2000, DIABETES, V49, P1359, DOI 10.2337/diabetes.49.8.1359; Temple IK, 1996, HUM MOL GENET, V5, P1117, DOI 10.1093/hmg/5.8.1117; Varrault A, 1998, P NATL ACAD SCI USA, V95, P8835, DOI 10.1073/pnas.95.15.8835; Vu TH, 2000, GENOME RES, V10, P1660, DOI 10.1101/gr.166200; Wolffe AP, 2000, CURR BIOL, V10, pR463, DOI 10.1016/S0960-9822(00)00534-0; Zneimer SM, 1998, AM J MED GENET, V80, P133, DOI 10.1002/(SICI)1096-8628(19981102)80:2<133::AID-AJMG8>3.0.CO;2-B	38	53	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18653	18656		10.1074/jbc.C100095200	http://dx.doi.org/10.1074/jbc.C100095200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11297535	hybrid			2022-12-27	WOS:000169091000002
J	Do, TQ; Hsu, AY; Jonassen, T; Lee, PT; Clarke, CF				Do, TQ; Hsu, AY; Jonassen, T; Lee, PT; Clarke, CF			A defect in coenzyme Q biosynthesis is responsible for the respiratory deficiency in Saccharomyces cerevisiae abc1 mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATIONAL ACTIVATOR PROTEINS; MITOCHONDRIAL-MEMBRANE SYSTEM; PERMEABILITY TRANSITION PORE; O-METHYLTRANSFERASE STEPS; CYTOCHROME BC(1) COMPLEX; C OXIDASE BIOGENESIS; UBIQUINONE BIOSYNTHESIS; ESCHERICHIA-COLI; PLASMA-MEMBRANE; FUNCTIONAL COMPLEMENTATION	Ubiquinone (coenzyme Q or Q) is an essential component of the mitochondrial respiratory chain in eukaryotic cells. There are eight complementation groups of Q-deficient Saccharomyces cerevisiae mutants designated coq1-coq8, Here we report that COQ8 is ABC1 (for Activity of be, complex), which was originally isolated as a multicopy suppressor of a cytochrome b mRNA translation defect (Bousquet, I., Dujardin, G,, and Slonimski, P. P. (1991) EIMBO J. 10, 2023-2031), Previous studies of abc1 mutants suggested that the mitochondrial respiratory complexes were thermosensitive and function inefficiently. Although initial characterization of the abc1 mutants revealed characteristics of Q-deficient mutants, levels of Q were reported to be similar to wild type. The suggested function of Abc1p was that it acts as a chaperone-like protein essential for the proper conformation and functioning of the be, and its neighboring complexes (Brasseur, G,, Tron, P,, Dujardin, G,, Slonimski, P, P, (1997) fur. J. Biochem. 246, 103-111). Studies presented here indicate that abc1/coq8 null mutants are defective in Q biosynthesis and accumulate 3-hexaprenyl-4-hydroxybenzoic acid as the predominant intermediate. As observed in other yeast cog mutants, supplementation of growth media with Q, rescues the abc1/coq8 null mutants for growth on nonfermentable carbon sources. Such supplementation also partially restores succinate-cytochrome c reductase activity in the abc1/coq8 null mutants. Abc1/Coq8p localizes to the mitochondria, and is proteolytically processed upon import. The findings presented here indicate that the previously reported thermosensitivity of the respiratory complexes of abc1/coq8 mutants results from the lack of Q and a general deficiency in respiration, rather than a specific phenotype due to dysfunction of the Abc1 polypeptide. These results indicate that ABC1/COQ8 is essential for Q-biosynthesis and that the critical defect of abc1/coq8 mutants is a lack of Q.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, CF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	cathy@mbi.ucla.edu			NIGMS NIH HHS [GM45952] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS A, 1997, METHODS YEAST GENETI, P145; ASHBY MN, 1992, J BIOL CHEM, V267, P4128; ASHBY MN, 1990, J BIOL CHEM, V265, P13157; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; Barkovich RJ, 1997, J BIOL CHEM, V272, P9182; BELOGRUDOV GI, 2001, IN PRESS ARCH BIOCH; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; Bonnefoy N, 1996, MOL GEN GENET, V251, P204; BOUSQUET I, 1991, EMBO J, V10, P2023, DOI 10.1002/j.1460-2075.1991.tb07732.x; Brasseur G, 1997, EUR J BIOCHEM, V246, P103, DOI 10.1111/j.1432-1033.1997.t01-1-00103.x; BROWN GG, 1977, BIOCHEMISTRY-US, V16, P4449, DOI 10.1021/bi00639a019; Cardazzo B, 1998, GENE, V221, P117, DOI 10.1016/S0378-1119(98)00417-X; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CLARKE CF, 1991, J BIOL CHEM, V266, P16636; COX GB, 1969, J BACTERIOL, V99, P450, DOI 10.1128/JB.99.2.450-458.1969; Dibrov E, 1997, J BIOL CHEM, V272, P9175; Do TQ, 1996, P NATL ACAD SCI USA, V93, P7534, DOI 10.1073/pnas.93.15.7534; Dutton P.L., 2001, COENZYME Q OXIDATION, P65; Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; GIBSON F, 1973, Biochemical Society Transactions, V1, P317; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; GomezDiaz C, 1997, J BIOENERG BIOMEMBR, V29, P251, DOI 10.1023/A:1022410127104; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; Hsu AY, 2000, BBA-MOL CELL BIOL L, V1484, P287, DOI 10.1016/S1388-1981(00)00019-6; Hsu AY, 1996, BIOCHEMISTRY-US, V35, P9797, DOI 10.1021/bi9602932; Jonassen T, 2000, J BIOL CHEM, V275, P12381, DOI 10.1074/jbc.275.17.12381; Jonassen T, 1998, J BIOL CHEM, V273, P3351, DOI 10.1074/jbc.273.6.3351; JONASSEN T, 2001, COENZYME Q MOL MECH, P185; KAGAN VE, 1996, HDB ANTIOXIDANTS, P157; KLOECKENERGRUISSEM B, 1987, CURR GENET, V12, P311, DOI 10.1007/BF00405753; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Kroger A, 1978, Methods Enzymol, V53, P579; Lenaz G., 1985, COENZYME Q, P165; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; Macinga DR, 1998, J BACTERIOL, V180, P128, DOI 10.1128/JB.180.1.128-135.1998; Malaney S, 1997, J BIOL CHEM, V272, P17495, DOI 10.1074/jbc.272.28.17495; MARBOIS BN, 1994, GENE, V138, P213; Marbois BN, 1996, J BIOL CHEM, V271, P2995, DOI 10.1074/jbc.271.6.2995; MCEWEN JE, 1986, J BIOL CHEM, V261, P1872; MCMULLIN TW, 1993, J BIOL CHEM, V268, P11737; MEGANATHAN R, 1996, ESCHERICHIA COLI SAL, P642; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; NIMAN HL, 1983, P NATL ACAD SCI-BIOL, V80, P4949, DOI 10.1073/pnas.80.16.4949; OLSON RE, 1983, VITAM HORM, V40, P1, DOI 10.1016/S0083-6729(08)60431-8; PERLMAN PS, 1974, ARCH BIOCHEM BIOPHYS, V162, P248, DOI 10.1016/0003-9861(74)90125-8; Poon WW, 2000, J BACTERIOL, V182, P5139, DOI 10.1128/JB.182.18.5139-5146.2000; Poon WW, 1999, J BIOL CHEM, V274, P21665, DOI 10.1074/jbc.274.31.21665; POON WW, 1995, ARCH BIOCHEM BIOPHYS, V320, P305, DOI 10.1016/0003-9861(95)90014-4; POON WW, 1997, J BIOL CHEM, V18, pS121; Rodel G, 1997, CURR GENET, V31, P375, DOI 10.1007/s002940050219; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Santos-Ocana C, 1998, J BIOENERG BIOMEMBR, V30, P465, DOI 10.1023/A:1020542230308; Santos-Ocana C, 1998, J BIOL CHEM, V273, P8099, DOI 10.1074/jbc.273.14.8099; SIKORSKI RS, 1989, GENETICS, V122, P19; SPAIN BH, 1995, J BIOL CHEM, V270, P25435, DOI 10.1074/jbc.270.43.25435; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; TZAGOLOFF A, 1976, FEBS LETT, V65, P391, DOI 10.1016/0014-5793(76)80154-8; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; Tzschoppe K, 1999, CURR GENET, V36, P201, DOI 10.1007/s002940050491; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; YAFFE MP, 1991, METHOD ENZYMOL, V194, P627	67	101	109	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18161	18168		10.1074/jbc.M100952200	http://dx.doi.org/10.1074/jbc.M100952200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279158	hybrid			2022-12-27	WOS:000168866500074
J	Kim, JH; Lee, JN; Paik, YK				Kim, JH; Lee, JN; Paik, YK			Cholesterol biosynthesis from lanosterol - A concerted role for Sp1 and NF-Y-binding sites for sterol-mediated regulation of rat 7-dehydrocholesterol reductase gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEMLI-OPITZ-SYNDROME; NUCLEAR FACTOR-Y; LIPOPROTEIN RECEPTOR PROMOTER; ACID SYNTHASE PROMOTER; MOLECULAR-CLONING; SYNERGISTIC ACTIVATION; SONIC-HEDGEHOG; DELTA-7-STEROL REDUCTASE; ASSAY-METHOD; ELEMENT	The 7-dehydrocholesterol reductase (Dhcr7) is the terminal enzyme in the pathway of cholesterol biosynthesis. We have previously reported that sterol depletion in vivo caused a significant induction of both liver mRNA and enzyme activity of Dhcr7 (Bae, S.-H., Lee, J. N., Fitzky, B. U., Seong, J., and Paik, Y.-K, (1999) J. Biol. Chem. 274, 14624-14631), In this paper, we also observed liver cell-specific sterol-mediated Dhcr7 gene induction in vitro by sterol depletion in rat hepatoma cells, suggesting the presence of sterol-mediated regulatory elements in the Dhcr7 gene. To understand the mechanisms responsible for regulating Dhcr7 expression, we have isolated the 5'-flanking region of the gene encoding rat Dhcr7 and have characterized the potential regulatory elements of the gene that are responsible for sterol-mediated regulation. The Dhcr7 promoter contains binding sites for Sp1 (at -177, -172, -125, and -20), NF-Y (at -88 and -51), and SREBP-1 or ADD1 (at -33), Deletion analysis of the Dhcr7 gene promoter (-1053/ +31), employing a nested series of Dhcr7-luciferase constructs, demonstrated that the -179 upstream region of the gene is necessary and sufficient for optimal efficient sterol-regulated transcription. DNase I footprinting and electrophoretic mobility shift assay showed that the SRE1/E box (-33/-22) involved in sterol response of many sterol-related enzyme genes was protected specifically by the overexpressed recombinant ADD1. Mutational analysis for the functional relationship between the identified cis-elements in this region indicate that one of the binding sites for Sp1 (GC box at -125) and NF-Y (CCAAT box at -88) plays a cooperative role in the sterol-mediated activation, in which the latter site also acts as a co-regulator for SREBP-activated Dhcr7 promoter activity. We believe that Dhcr7 is the first enzyme characterized with a sterol-regulatory function in the post-lanosterol pathway. This may be important for understanding the coordinated control of cholesterol biosynthesis as well as the molecular mechanism of Smith-Lemli-Opitz syndrome-related protein in mammals.	Yonsei Univ, Dept Biochem, Bioprod Res Ctr, Seoul 120749, South Korea; Yonsei Univ, Yonsei Proteome Res Ctr, Seoul 120749, South Korea	Yonsei University; Yonsei University	Paik, YK (corresponding author), Yonsei Univ, Dept Biochem, Bioprod Res Ctr, 134 Shinchon Dong, Seoul 120749, South Korea.	paikyk@yonsei.ac.kr						ALLEY TL, 1995, AM J HUM GENET, V56, P1411; Anderson AJ, 1998, AM J MED GENET, V78, P413, DOI 10.1002/(SICI)1096-8628(19980806)78:5<413::AID-AJMG4>3.0.CO;2-M; Athanikar JN, 1998, P NATL ACAD SCI USA, V95, P4935, DOI 10.1073/pnas.95.9.4935; Bae SH, 1999, J BIOL CHEM, V274, P14624, DOI 10.1074/jbc.274.21.14624; Bae SH, 1997, BIOCHEM J, V326, P609, DOI 10.1042/bj3260609; Bennett MK, 1999, J BIOL CHEM, V274, P13025, DOI 10.1074/jbc.274.19.13025; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; Ericsson J, 1996, J BIOL CHEM, V271, P24359, DOI 10.1074/jbc.271.40.24359; Fitzky BU, 1998, P NATL ACAD SCI USA, V95, P8181, DOI 10.1073/pnas.95.14.8181; GIBBONS GF, 1971, J BIOL CHEM, V246, P3967; GUAN GM, 1995, J BIOL CHEM, V270, P21958, DOI 10.1074/jbc.270.37.21958; Honda A, 1997, AM J MED GENET, V68, P288, DOI 10.1002/(SICI)1096-8628(19970131)68:3<288::AID-AJMG8>3.0.CO;2-I; IRONS M, 1994, AM J MED GENET, V50, P347, DOI 10.1002/ajmg.1320500409; Jackson SM, 1998, J LIPID RES, V39, P767; Kelley RI, 1996, AM J MED GENET, V66, P478, DOI 10.1002/(SICI)1096-8628(19961230)66:4<478::AID-AJMG22>3.0.CO;2-Q; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Lanoue L, 1997, AM J MED GENET, V73, P24; Lecain E, 1996, J BIOL CHEM, V271, P10866, DOI 10.1074/jbc.271.18.10866; Lee JN, 1997, J BIOCHEM MOL BIOL, V30, P370; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Moebius FF, 1998, P NATL ACAD SCI USA, V95, P1899, DOI 10.1073/pnas.95.4.1899; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; Natarajan R, 1998, BIOCHEM BIOPH RES CO, V243, P349, DOI 10.1006/bbrc.1997.8030; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Roder K, 1999, GENE, V234, P61, DOI 10.1016/S0378-1119(99)00180-8; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Shefer S, 1997, METABOLISM, V46, P844, DOI 10.1016/S0026-0495(97)90133-5; SMITH DW, 1964, J PEDIATR-US, V64, P210, DOI 10.1016/S0022-3476(64)80264-X; SPEAR DH, 1992, J BIOL CHEM, V267, P14462; TINT GS, 1995, J LIPID RES, V36, P89; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; WANG XD, 1993, J BIOL CHEM, V268, P14497; Wassif CA, 1998, AM J HUM GENET, V63, P55, DOI 10.1086/301936; Waterham HR, 1998, AM J HUM GENET, V63, P329, DOI 10.1086/301982; Xiong SB, 2000, P NATL ACAD SCI USA, V97, P3948, DOI 10.1073/pnas.040574197; YIEH L, 1995, P NATL ACAD SCI USA, V92, P6102, DOI 10.1073/pnas.92.13.6102	42	49	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18153	18160		10.1074/jbc.M101661200	http://dx.doi.org/10.1074/jbc.M101661200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279217	hybrid			2022-12-27	WOS:000168866500073
J	Bisaillon, M; Shuman, S				Bisaillon, M; Shuman, S			Structure-function analysis of the active site tunnel of yeast RNA triphosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE TRIPHOSPHATASE; CAPPING APPARATUS; COMPONENT; MECHANISM; 5'-TRIPHOSPHATASE; 5-TRIPHOSPHATASE; POLYMERASE; SUBUNIT	Cet1, the RNA triphosphatase component of the yeast mRNA capping apparatus, catalyzes metal-dependent gamma phosphate hydrolysis within the hydrophilic interior of a topologically closed 8-strand beta barrel (the "triphosphate tunnel"). We used structure-guided alanine scanning to identify 6 side chains within the triphosphate tunnel that are essential for phosphohydrolase activity in vitro and in vivo: Arg(393), Glu(433), Arg(458), Arg(469), Asp(471) and Thr(473). Alanine substitutions at two positions, Asp(377) and Lys(409), resulted in partial catalytic defects and a thermosensitive growth phenotype, Structure-function relationships were clarified by introducing conservative substitutions. Five residues were found to be nonessential: Lys(309), Ser(395), Asp(397), Lys(427), Asn(431), and Lys(474). The present findings, together with earlier mutational analyses, reveal an unusually complex active site in which 15 individual side chains in the tunnel cavity are important for catalysis, and each of the S strands of the beta barrel contributes at least one functional constituent. The active site residues fall into three classes: (i) those that participate directly in catalysis via coordination of the gamma phosphate or the metal; (ii) those that make critical water-mediated contacts with the gamma phosphate or the metal; and (iii) those that function indirectly via interactions with other essential side chains or by stabilization of the tunnel structure.	Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	s-shuman@ski.mskcc.org			NIGMS NIH HHS [GM52470] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052470] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Gross CH, 1998, J VIROL, V72, P10020, DOI 10.1128/JVI.72.12.10020-10028.1998; Ho CK, 2001, P NATL ACAD SCI USA, V98, P3050, DOI 10.1073/pnas.061636198; Ho CK, 1998, J BIOL CHEM, V273, P34151, DOI 10.1074/jbc.273.51.34151; Ho CK, 2001, J VIROL, V75, P1744, DOI 10.1128/JVI.75.4.1744-1750.2001; Ho CK, 1998, MOL CELL BIOL, V18, P5189, DOI 10.1128/MCB.18.9.5189; Ho CK, 2000, J VIROL, V74, P5486, DOI 10.1128/JVI.74.12.5486-5494.2000; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jin JP, 1998, J VIROL, V72, P10011, DOI 10.1128/JVI.72.12.10011-10019.1998; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; Martins A, 2000, J BIOL CHEM, V275, P35070, DOI 10.1074/jbc.M005748200; Pei Y, 2000, NUCLEIC ACIDS RES, V28, P1885, DOI 10.1093/nar/28.9.1885; Pei Y, 1999, J BIOL CHEM, V274, P28865, DOI 10.1074/jbc.274.41.28865; Pei Y, 2001, NUCLEIC ACIDS RES, V29, P387, DOI 10.1093/nar/29.2.387; Rodriguez CR, 1999, NUCLEIC ACIDS RES, V27, P2181, DOI 10.1093/nar/27.10.2181; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Takagi T, 1997, CELL, V89, P867, DOI 10.1016/S0092-8674(00)80272-X; Tsukamoto T, 1997, BIOCHEM BIOPH RES CO, V239, P116, DOI 10.1006/bbrc.1997.7439	18	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17261	17266		10.1074/jbc.M100980200	http://dx.doi.org/10.1074/jbc.M100980200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279161	hybrid			2022-12-27	WOS:000168730400088
J	Christensen, K; Bose, HS; Harris, FM; Miller, WL; Bell, JD				Christensen, K; Bose, HS; Harris, FM; Miller, WL; Bell, JD			Binding of steroidogenic acute regulatory protein to synthetic membranes suggests an active molten globule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOID ADRENAL-HYPERPLASIA; LEYDIG TUMOR-CELLS; PHOSPHOLIPID-VESICLES; ALPHA-LACTALBUMIN; STAR; MECHANISM; MLN64; MITOCHONDRIA; CHOLESTEROL; PRECURSORS	Steroidogenic acute regulatory protein (StAR) mediates cholesterol transport from the outer to the inner mitochondrial membrane during steroid biosynthesis, The mechanism of StAR's action is not established, To address mechanistic issues, we assessed the binding of StAR to artificial membranes by fluorescence resonance energy transfer using endogenous StAR tryptophan residues as the donor and dansyl-phosphatidylethanolamine in the bilayer as the acceptor. Mixing StAR with dansyl-labeled vesicles composed of phosphatidylcholine increased the fluorescence intensity of dansyl emission excited at 280 nm by 10-40%, This interaction was dependent on pH, with a maximum at pH 3.0-3.5 and essentially no change above pH 5, Binding experiments at different temperatures and various combinations of phosphatidylcholine, phosphatidylglycerol, cardiolipin, and cholesterol showed that binding involves an electrostatic step and one or more other steps. Although binding prefers a thermodynamically ordered bilayer, the rate-limiting step occurs either when the bilayer is in a fluid state or when there is cholesterol-induced membrane heterogeneity, Experiments with fluorescence and light scattering indicate that StAR binding promotes ordering and aggregation of anionic membranes. The inactive StAR mutant R182L had lower affinity for the membrane, and the partially active mutant L275P had intermediate affinity. Far-UV CD spectroscopy of StAR in PC membranes show more p-structure than in aqueous buffers, and the presence of cardiolipin or cholesterol in the membrane fosters a molten globule state. Our data suggest that StAR binds to membranes in a partially unfolded molten globule state that is relevant to the activity of the protein.	Brigham Young Univ, Dept Zool, Provo, UT 84602 USA; Univ Calif San Francisco, Metab Res Unit, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	Brigham Young University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Miller, WL (corresponding author), Brigham Young Univ, Dept Zool, Provo, UT 84602 USA.		Miller, Walter L/J-3696-2012		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD034449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK002762, R01DK037922] Funding Source: NIH RePORTER; NICHD NIH HHS [U54 HD 34449] Funding Source: Medline; NIDDK NIH HHS [K01 DK02762, R01 DK37922] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arakane F, 1996, P NATL ACAD SCI USA, V93, P13731, DOI 10.1073/pnas.93.24.13731; Arakane F, 1998, J BIOL CHEM, V273, P16339, DOI 10.1074/jbc.273.26.16339; BANUELOS S, 1995, J BIOL CHEM, V270, P29910, DOI 10.1074/jbc.270.50.29910; Bell JD, 1996, BIOCHEMISTRY-US, V35, P4945, DOI 10.1021/bi952274i; Bose HS, 2000, BIOCHEMISTRY-US, V39, P11722, DOI 10.1021/bi000911l; Bose HS, 1998, BIOCHEMISTRY-US, V37, P9768, DOI 10.1021/bi980588a; Bose HS, 1999, P NATL ACAD SCI USA, V96, P7250, DOI 10.1073/pnas.96.13.7250; Bose HS, 1996, NEW ENGL J MED, V335, P1870, DOI 10.1056/NEJM199612193352503; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; EPSTEIN LF, 1991, J BIOL CHEM, V266, P19739; FASMAN GD, 1995, J PROTEIN CHEM, V14, P595, DOI 10.1007/BF01886885; GREGORY RB, 1986, J BIOL CHEM, V261, P13963; HAUFFA BP, 1985, CLIN ENDOCRINOL, V23, P481, DOI 10.1111/j.1365-2265.1985.tb01107.x; Heimburg T, 1996, BIOPHYS J, V70, P84, DOI 10.1016/S0006-3495(96)79551-6; HEIMBURG T, 1994, BIOCHEMISTRY-US, V33, P9477, DOI 10.1021/bi00198a013; Huang WH, 1997, BIOCHEMISTRY-US, V36, P2860, DOI 10.1021/bi962405v; Kallen CB, 1998, J BIOL CHEM, V273, P26285, DOI 10.1074/jbc.273.41.26285; Kamen DE, 2000, BIOCHEMISTRY-US, V39, P15932, DOI 10.1021/bi001900v; Karlsson OP, 1996, BIOCHEMISTRY-US, V35, P10094, DOI 10.1021/bi9602876; KIM J, 1986, BIOCHEMISTRY-US, V25, P7867, DOI 10.1021/bi00372a012; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; Miller WL, 1999, J STEROID BIOCHEM, V69, P131, DOI 10.1016/S0960-0760(98)00153-8; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; MoogLutz C, 1997, INT J CANCER, V71, P183, DOI 10.1002/(SICI)1097-0215(19970410)71:2<183::AID-IJC10>3.0.CO;2-J; MUDERHWA JM, 1992, J BIOL CHEM, V267, P24184; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Stocco DM, 1999, EXP CLIN ENDOCR DIAB, V107, P229, DOI 10.1055/s-0029-1212105; STOCCO DM, 1991, J BIOL CHEM, V266, P19731; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; VAZ WLC, 1978, EUR J BIOCHEM, V83, P299, DOI 10.1111/j.1432-1033.1978.tb12094.x; Watari H, 1997, P NATL ACAD SCI USA, V94, P8462, DOI 10.1073/pnas.94.16.8462; Worthman LAD, 1997, BIOPHYS J, V72, P2569, DOI 10.1016/S0006-3495(97)78900-8	34	56	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17044	17051		10.1074/jbc.M100903200	http://dx.doi.org/10.1074/jbc.M100903200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279152	hybrid			2022-12-27	WOS:000168730400059
J	Barry, OP; Mullan, B; Sheehan, D; Kazanietz, MG; Shanahan, F; Collins, JK; O'Sullivan, GC				Barry, OP; Mullan, B; Sheehan, D; Kazanietz, MG; Shanahan, F; Collins, JK; O'Sullivan, GC			Constitutive ERK1/2 activation in esophagogastric rib bone marrow micrometastatic cells is MEK-independent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; PROTEIN-TYROSINE PHOSPHATASE; IN-VIVO; ESOPHAGEAL CANCER; PLATELET MICROPARTICLES; RAT-1 FIBROBLASTS; GROWTH-FACTOR; MAP KINASES; RAS; INHIBITOR	In this study, we examined the mitogen-activated protein kinase (MAPK) cascade in micrometastatic cell lines generated from rib bone marrow (RBM) of patients undergoing resection of esophagogastric malignancies, The molecular mechanism(s) involved in esophagogastric MAPK activation have not previously been investigated. Constitutive activation of both ERK1 and -2 isoforms was evident in each of the five RBM cell lines. Elk-1, a transcription factor activated by the ERK1/2 pathway was also found to be constitutively activated. Cell lines generated from metastases of involved lymph nodes (OC2) and ascites (OC1) of patients with esophageal cancer do not display, however, hyperphosphorylation of ERK1/2, Constitutive RBM ERK1/2 activation is protein kinase C and phosphatidylinositol 3-kinase dependent. Surprisingly, constitutive ERK1/2 activation is MEK-independent. Pharmacological inhibition of MEK with two specific inhibitors, PD 98059 and U0126, were both ineffective in blocking ERK activation. Similarly, the use of a dominant negative MEK mutant was without effect. Interestingly, experiments overexpressing two different dominant negative Pak1 mutants significantly reduced RBM ERK1/2 activation, albeit not to the same extent for all cell lines. We also examined the role of three different phosphatases, PAC1, MKP-1, and -2, While RBM ERK1/2 activation was found to be PAC1- and MKP-2-independent, surprisingly, MKP-1 was down-regulated in all five RBM cell lines. In conclusion, we provide evidence for the first time for a MEK-independent constitutive ERK1/2 activation pathway in esophagogastric RBM cell lines. These findings have important implications for drug treatment strategies which currently target MEK in other forms of cancer.	Natl Univ Ireland Univ Coll Cork, Cork Canc Res Ctr, Cork, Ireland; Natl Univ Ireland Univ Coll Cork, Dept Med, Cork, Ireland; Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; Univ Penn, Dept Pharmacol, Ctr Expt Therapeut, Philadelphia, PA 19104 USA	University College Cork; University College Cork; University College Cork; University of Pennsylvania	O'Sullivan, GC (corresponding author), Mercy Hosp, Cork Canc Res Ctr, Cork, Ireland.		Shanahan, Fergus/ABF-2390-2020	Shanahan, Fergus/0000-0003-0467-0936; Barry, Orla/0000-0001-6364-3642				ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Barry OP, 1998, J CLIN INVEST, V102, P136, DOI 10.1172/JCI2592; Barry OP, 1999, J BIOL CHEM, V274, P7545, DOI 10.1074/jbc.274.11.7545; BECKER S, 1991, J IMMUNOL, V147, P4307; BLUMEJENSEN P, 1991, EMBO J, V10, P4121, DOI 10.1002/j.1460-2075.1991.tb04989.x; Bokemeyer D, 1997, J AM SOC NEPHROL, V8, P40; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; EllingerZiegelbauer H, 1997, J BIOL CHEM, V272, P2668, DOI 10.1074/jbc.272.5.2668; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; Finlay GA, 2000, J BIOL CHEM, V275, P27650; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; Guan K L, 1993, Semin Cell Biol, V4, P389, DOI 10.1006/scel.1993.1046; Hu LM, 2000, CLIN CANCER RES, V6, P880; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; KHOSRAVIFAR R, 1994, MOL CELL BIOL, V14, P6848, DOI 10.1128/MCB.14.10.6848; Kim SC, 1999, BLOOD, V93, P3893, DOI 10.1182/blood.V93.11.3893.407k14_3893_3899; LAIRD AD, 1995, J BIOL CHEM, V270, P26742, DOI 10.1074/jbc.270.45.26742; Lenormand P, 1996, J BIOL CHEM, V271, P15762, DOI 10.1074/jbc.271.26.15762; LIU YS, 1995, J BIOL CHEM, V270, P8377, DOI 10.1074/jbc.270.15.8377; Loda M, 1996, AM J PATHOL, V149, P1553; LOWRY DR, 1993, ANNU REV BIOCHEM, V62, P851; MagiGalluzzi C, 1997, LAB INVEST, V76, P37; Manser E, 1999, Prog Mol Subcell Biol, V22, P115; McCawley LJ, 1999, J BIOL CHEM, V274, P4347, DOI 10.1074/jbc.274.7.4347; Montesano R, 1996, INT J CANCER, V69, P225, DOI 10.1002/(SICI)1097-0215(19960621)69:3<225::AID-IJC13>3.0.CO;2-6; Nemoto T, 1997, PATHOBIOLOGY, V65, P195, DOI 10.1159/000164123; NISHIHIRA T, 1993, J CANCER RES CLIN, V119, P441, DOI 10.1007/BF01215923; O'Sullivan GC, 1999, GASTROENTEROLOGY, V116, P543, DOI 10.1016/S0016-5085(99)70175-7; OKA H, 1995, CANCER RES, V55, P4182; OSULLIVAN GC, 1995, GASTROENTEROLOGY, V109, P1535, DOI 10.1016/0016-5085(95)90641-X; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; ROSSOMANDO AJ, 1994, MOL CELL BIOL, V14, P1594, DOI 10.1128/MCB.14.3.1594; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Simon C, 1999, BRIT J CANCER, V80, P1412, DOI 10.1038/sj.bjc.6690537; Sivaraman VS, 1997, J CLIN INVEST, V99, P1478, DOI 10.1172/JCI119309; SUN H, 1994, SCIENCE, V266, P285, DOI 10.1126/science.7939666; Tang Y, 1998, P NATL ACAD SCI USA, V95, P5139, DOI 10.1073/pnas.95.9.5139; Tang Y, 1997, MOL CELL BIOL, V17, P4454, DOI 10.1128/MCB.17.8.4454; Tang Y, 1999, MOL CELL BIOL, V19, P1881; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Towatari M, 1997, LEUKEMIA, V11, P479, DOI 10.1038/sj.leu.2400617; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Welch DR, 2000, CANCER RES, V60, P1552; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; Zhang P, 2000, J BIOL CHEM, V275, P22479, DOI 10.1074/jbc.M910425199; ZHENG CF, 1993, J BIOL CHEM, V268, P11435	55	44	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15537	15546		10.1074/jbc.M010847200	http://dx.doi.org/10.1074/jbc.M010847200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11297525	hybrid			2022-12-27	WOS:000168528800133
J	Negrisolo, E; Pallavicini, A; Barbato, R; Dewilde, S; Ghiretti-Magaldi, A; Moens, L; Lanfranchi, G				Negrisolo, E; Pallavicini, A; Barbato, R; Dewilde, S; Ghiretti-Magaldi, A; Moens, L; Lanfranchi, G			The evolution of extracellular hemoglobins of annelids, vestimentiferans, and pogonophorans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRIC COMPOSITION; AMINO-ACID-SEQUENCE; 2 GLOBIN STRAINS; CHAIN; EARTHWORM; ALIGNMENT; SITE	The evolution of extracellular hemoglobins of annelids, vestimentiferans, and pogonophorans was investigated by applying cladistic and distance-based approaches to reconstruct the phylogenetic relationships of this group of respiratory pigments. We performed this study using the aligned sequences of globin and linker chains that are the constituents of these complex molecules. Three novel globin and two novel linker chains of Sabella spallanzanii described in an accompanying paper (Pallavicini, A., Negrisolo, E., Barbato, R., Dewilde, S., Ghiretti-Magaldi, A., Moens, L., and Lanfranchi, G. (2001) J. Biol. Chem 276, 26384-26390) were also included. Our results allowed us to test previous hypotheses on the evolutionary pathways of these proteins and to formulate a new most parsimonious model of molecular evolution. According to this novel model, the genes coding for the polypeptides forming these composite molecules were already present in the common ancestor of annelids, vestimentiferans, and pogonophorans.	Univ Padua, Dipartimento Biol, I-35131 Padua, Italy; Univ Padua, Ctr Ric Interdipartimentale Biotecnol Innovat, I-35131 Padua, Italy; Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci & Tecnol Avanzate, I-15100 Alessandria, Italy; Univ Padua, CNR, Ctr Study Metalloprot, I-35131 Padua, Italy; Univ Instelling Antwerp, Dept Biochem, B-2610 Wilrijk, Belgium	University of Padua; University of Padua; University of Eastern Piedmont Amedeo Avogadro; Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Antwerp	Lanfranchi, G (corresponding author), Univ Padua, Dipartimento Biol, Via Ugo Bassi 58-B, I-35131 Padua, Italy.		Pallavicini, Alberto/J-4158-2012; Pallavicini, Alberto/H-9281-2019; Negrisolo, Enrico/K-8124-2015	Pallavicini, Alberto/0000-0001-7174-4603; Pallavicini, Alberto/0000-0001-7174-4603; Negrisolo, Enrico/0000-0002-6244-805X				FARIS JF, 1989, CLADISTICS, V5, P417; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GOTOH T, 1987, BIOCHEM J, V241, P441, DOI 10.1042/bj2410441; GOTOH T, 1991, STRUCTURE AND FUNCTION OF INVERTEBRATE OXYGEN CARRIERS, P279; KAPP OH, 1995, PROTEIN SCI, V4, P2179, DOI 10.1002/pro.5560041024; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Lamy JN, 1996, CHEM REV, V96, P3113, DOI 10.1021/cr9600058; Li W. H, 1997, MOL EVOLUTION; MADISON WP, 1992, MACCLADE ANAL PHYLOG; Martin PD, 1996, J MOL BIOL, V255, P154, DOI 10.1006/jmbi.1996.0013; MORRIS SC, 1993, NATURE, V361, P219, DOI 10.1038/361219a0; Pallavicini A, 2001, J BIOL CHEM, V276, P26384, DOI 10.1074/jbc.M006939200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shishikura F, 1997, ZOOL SCI, V14, P923, DOI 10.2108/zsj.14.923; Shishikura F, 1996, ZOOL SCI, V13, P849, DOI 10.2108/zsj.13.849; Shishikura F, 1996, ZOOL SCI, V13, P551, DOI 10.2108/zsj.13.551; SUZUKI T, 1990, BIOCHEM J, V266, P221, DOI 10.1042/bj2660221; SUZUKI T, 1993, J BIOL CHEM, V268, P13548; SWOFFORD DL, 1993, POLYGENETIC ANAL USI; TAKAGI T, 1991, STRUCTURE AND FUNCTION OF INVERTEBRATE OXYGEN CARRIERS, P245; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V3, P227; VINOGRADOV SN, 1985, COMP BIOCHEM PHYS B, V82, P1, DOI 10.1016/0305-0491(85)90120-8; Yuasa HJ, 1996, BBA-PROTEIN STRUCT M, V1296, P235, DOI 10.1016/0167-4838(96)00081-7; Zal F, 1997, PROTEINS, V29, P562, DOI 10.1002/(SICI)1097-0134(199712)29:4<562::AID-PROT15>3.0.CO;2-K	25	12	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 13	2001	276	28					26391	26397		10.1074/jbc.M100557200	http://dx.doi.org/10.1074/jbc.M100557200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451VP	11294835	hybrid, Green Published			2022-12-27	WOS:000169823300099
J	Silver, DL; Wang, N; Xiao, X; Tall, AR				Silver, DL; Wang, N; Xiao, X; Tall, AR			High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SR-BI; TARGETED MUTATION; APOLIPOPROTEIN-E; LDL CHOLESTEROL; APICAL DOMAIN; LIPID UPTAKE; CELLS; RAT; IDENTIFICATION; METABOLISM	High density lipoprotein (HDL) mediates reverse transport of cholesterol from atheroma foam cells to the liver, but the mechanisms of hepatic uptake and trafficking of HDL particles are poorly understood. In contrast to its accepted role as a cell surface receptor, scavenger receptor class B type 1 (SR-BI) is shown to be an endocytic receptor that mediates HDL particle uptake and recycling, but not degradation, in both transfected Chinese hamster ovary cells and hepatocytes. Confocal microscopy of polarized primary hepatocytes shows that HDL particles enter both the endocytic recycling compartment and the apical canalicular region paralleling the movement of SR-BI. In polarized epithelial cells (Madin-Darby canine kidney) expressing SR-BI, HDL protein and cholesterol undergo selective sorting with recycling of HDL protein from the basolateral membrane and secretion of HDL-derived cholesterol through the apical membrane. Thus, HDL particles, internalized via SR-BI, undergo a novel process of selective transcytosis, leading to polarized cholesterol transport. A distinct process not mediated by SR-BI is involved in uptake and degradation of apoE-free HDL in hepatocytes.	Columbia Univ, Dept Med, Div Mol Med, New York, NY 10032 USA; Univ Pittsburgh, Dept Mol Genet & Biochem, Pittsburgh, PA 15219 USA	Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Silver, DL (corresponding author), Columbia Univ, Dept Med, Div Mol Med, New York, NY 10032 USA.	dls51@columbia.edu	Tall, Alan/AAT-8528-2021; Eckhardt, Erik/G-1567-2010	Silver, David/0000-0002-7289-9890	NHLBI NIH HHS [HL22682, HL09928] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL009928, R01HL022682, R37HL022682] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Azhar S, 1998, J LIPID RES, V39, P1616; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; BOYER JL, 1993, ISOLATED RAT HEPATOC, P597; BRAVO E, 1989, BIOCHIM BIOPHYS ACTA, V1003, P315, DOI 10.1016/0005-2760(89)90238-5; BRETSCHER MS, 1988, EMBO J, V7, P4087, DOI 10.1002/j.1460-2075.1988.tb03302.x; CABRAL DJ, 1989, PHYSICAL CHEM BILE H, P621; Daly C, 2000, P NATL ACAD SCI USA, V97, P6120, DOI 10.1073/pnas.97.11.6120; DELAMATRE JG, 1990, J LIPID RES, V31, P191; Fagan AM, 1996, J BIOL CHEM, V271, P30121, DOI 10.1074/jbc.271.47.30121; Fidge NH, 1999, J LIPID RES, V40, P187; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; Glomset J A, 1973, Adv Lipid Res, V11, P1; GOLDSTEIN JL, 1992, EUR HEART J, V13, P34, DOI 10.1093/eurheartj/13.suppl_B.34; Hemery I, 1996, J CELL SCI, V109, P1215; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; KAMBOURIS AM, 1990, ARTERIOSCLEROSIS, V10, P582, DOI 10.1161/01.ATV.10.4.582; KOO C, 1985, J BIOL CHEM, V260, P1934; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Luetterforst R, 1999, J CELL BIOL, V145, P1443, DOI 10.1083/jcb.145.7.1443; McGwire GB, 1999, J BIOL CHEM, V274, P31632, DOI 10.1074/jbc.274.44.31632; MELLMAN I, 1993, J CELL SCI, P1; Miller N. E., 1980, Atherosclerosis 5. Proceedings of the Fifth International Symposium, P500; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; PORTMAN OW, 1980, BIOCHIM BIOPHYS ACTA, V619, P545, DOI 10.1016/0005-2760(80)90106-X; Rao AW, 1998, J BIOL CHEM, V273, P25450, DOI 10.1074/jbc.273.39.25450; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; Roelofsen H, 1998, J CELL SCI, V111, P1137; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; SCHELL MJ, 1992, J CELL BIOL, V119, P1173, DOI 10.1083/jcb.119.5.1173; SCHWARTZ CC, 1978, J CLIN INVEST, V61, P408, DOI 10.1172/JCI108952; Silver DL, 2000, J CLIN INVEST, V105, P151, DOI 10.1172/JCI8087; Silver DL, 1999, J BIOL CHEM, V274, P4140, DOI 10.1074/jbc.274.7.4140; Stangl H, 1999, J BIOL CHEM, V274, P32692, DOI 10.1074/jbc.274.46.32692; Subtil A, 1997, J CELL SCI, V110, P2441; TAKATA K, 1988, J LIPID RES, V29, P1117; Tall AR, 1998, EUR HEART J, V19, pA31; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Vilhardt F, 1999, MOL BIOL CELL, V10, P179, DOI 10.1091/mbc.10.1.179; Wang N, 1998, J BIOL CHEM, V273, P32920, DOI 10.1074/jbc.273.49.32920; Webb NR, 1998, J BIOL CHEM, V273, P15241, DOI 10.1074/jbc.273.24.15241	51	192	196	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					25287	25293		10.1074/jbc.M101726200	http://dx.doi.org/10.1074/jbc.M101726200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11301333	hybrid			2022-12-27	WOS:000169800700114
J	Harris, FM; Smith, SK; Bell, JD				Harris, FM; Smith, SK; Bell, JD			Physical properties of erythrocyte ghosts that determine susceptibility to secretory phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-II PHOSPHOLIPASE-A2; S49 CELL-MEMBRANES; AGKISTRODON-PISCIVORUS; PLASMA-MEMBRANE; PALMITIC ACID; GENERALIZED POLARIZATION; FLUORESCENT-PROBES; VESICLES; CALCIUM; LYSOLECITHIN	Artificial membranes may be resistant or susceptible to catalytic attack by secretory phospholipase A, (sPLA(2)) depending on the physical properties of the membrane. Living cells are normally resistant but become susceptible during trauma, apoptosis, and/or a significant elevation of intracellular calcium. Intact erythrocytes and ghosts were studied to determine whether the principles learned from artificial systems apply to biological membranes. Membrane properties such as phospholipid and/or protein composition, morphology, and microscopic characteristics (e.g, fluidity) were manipulated by preparing ghosts under different experimental conditions such as in the presence or absence of divalent cations with or without ATP. The properties of each membrane preparation were assessed by biochemical and physical means (fluorescence spectroscopy and electron and two-photon microscopy using the membrane probes bis-pyrene and laurdan) and compared with sPLA(2) activity. The properties that appeared most relevant were the degree of phosphatidylserine exposure on the outer face of the membrane and changes to the membrane physical state detected by bis pyrene and laurdan, Specifically, vulnerability to hydrolysis by sPLA(2) was associated with an increase in bilayer order apparently reflective of expansion of membrane regions of diminished fluidity, These results argue that the general principles identified from studies with artificial membranes apply to biological systems.	Brigham Young Univ, Dept Zool, Provo, UT 84602 USA	Brigham Young University	Bell, JD (corresponding author), Brigham Young Univ, Dept Zool, Provo, UT 84602 USA.	john_bell@byu.edu						Abe T, 1997, INT J CANCER, V74, P245, DOI 10.1002/(SICI)1097-0215(19970620)74:3<245::AID-IJC2>3.0.CO;2-Z; ANDERSEN S, 1994, INFLAMMATION, V18, P1, DOI 10.1007/BF01534593; Atsumi G, 1997, BBA-LIPID LIPID MET, V1349, P43, DOI 10.1016/S0005-2760(97)00082-9; BELL JD, 1989, J BIOL CHEM, V264, P225; Bell JD, 1996, BIOCHEMISTRY-US, V35, P4945, DOI 10.1021/bi952274i; BELL JD, 1995, BIOCHEMISTRY-US, V34, P11551, DOI 10.1021/bi00036a031; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURACK WR, 1995, BIOCHEMISTRY-US, V34, P14819, DOI 10.1021/bi00045a024; BURACK WR, 1994, CHEM PHYS LIPIDS, V73, P209, DOI 10.1016/0009-3084(94)90182-1; BUTIKOFER P, 1989, BLOOD, V74, P1481; CHONG PLG, 1993, BIOCHIM BIOPHYS ACTA, V1149, P260, DOI 10.1016/0005-2736(93)90209-I; COMFURIUS P, 1990, BIOCHIM BIOPHYS ACTA, V1026, P153, DOI 10.1016/0005-2736(90)90058-V; CONNOR J, 1994, J BIOL CHEM, V269, P2399; DEJONG K, 1993, FEBS LETT, V334, P183, DOI 10.1016/0014-5793(93)81708-8; DENKAMP JAO, 1979, ANNU REV BIOCHEM, V45, P47; DUMASWALA UJ, 1984, TRANSFUSION, V24, P490, DOI 10.1046/j.1537-2995.1984.24685066807.x; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; FRANCK PF, 1995, J CLIN INVEST, V75, P183; GELB MH, 1995, ANNU REV BIOCHEM, V64, P653; Ghomashchi F, 1998, BIOCHEMISTRY-US, V37, P6697, DOI 10.1021/bi972525i; GRAINGER DW, 1989, FEBS LETT, V252, P73, DOI 10.1016/0014-5793(89)80892-0; GREEN JA, 1991, INFLAMMATION, V15, P355, DOI 10.1007/BF00917352; Haapamaki MM, 1997, GUT, V40, P95, DOI 10.1136/gut.40.1.95; HAGERSTRAND H, 1994, BBA-BIOMEMBRANES, V1190, P409, DOI 10.1016/0005-2736(94)90101-5; Han SK, 1997, J BIOL CHEM, V272, P3573, DOI 10.1074/jbc.272.26.16152; Henshaw JB, 1998, BIOCHEMISTRY-US, V37, P10709, DOI 10.1021/bi9728809; Honger T, 1996, BIOCHEMISTRY-US, V35, P9003, DOI 10.1021/bi960866a; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V980, P23, DOI 10.1016/0005-2736(89)90195-8; Krasnowska EK, 1998, BIOPHYS J, V74, P1984, DOI 10.1016/S0006-3495(98)77905-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839; MELNICK RL, 1981, BIOPHYS J, V34, P499, DOI 10.1016/S0006-3495(81)84864-3; MENASHE M, 1986, J BIOL CHEM, V261, P5328; Murakami M, 1997, CRIT REV IMMUNOL, V17, P225, DOI 10.1615/CritRevImmunol.v17.i3-4.10; NEVALAINEN TJ, 1993, GUT, V34, P1133, DOI 10.1136/gut.34.8.1133; Nielson KH, 2000, BBA-MOL CELL BIOL L, V1484, P163, DOI 10.1016/S1388-1981(00)00004-4; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; RICHIERI GV, 1995, ANAL BIOCHEM, V229, P256, DOI 10.1006/abio.1995.1410; SCOTT DL, 1994, BIOPHYS J, V67, P493, DOI 10.1016/S0006-3495(94)80546-6; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; SHEFFIELD MJ, 1995, BIOCHEMISTRY-US, V34, P7796, DOI 10.1021/bi00024a003; SHUKLA SD, 1982, ARCH BIOCHEM BIOPHYS, V214, P335, DOI 10.1016/0003-9861(82)90038-8; Smith SK, 2001, J BIOL CHEM, V276, P22732, DOI 10.1074/jbc.M010880200; Steck T L, 1974, Methods Enzymol, V31, P172; TEST ST, 1991, BLOOD, V78, P3056; WHATMORE JL, 1994, BBA-BIOMEMBRANES, V1192, P88, DOI 10.1016/0005-2736(94)90146-5; WILLIAMSON P, 1985, J CELL PHYSIOL, V123, P209, DOI 10.1002/jcp.1041230209; Wilson HA, 1997, BBA-LIPID LIPID MET, V1349, P142, DOI 10.1016/S0005-2760(97)00089-1; Wilson HA, 1999, J BIOL CHEM, V274, P11494, DOI 10.1074/jbc.274.17.11494; YU BZ, 1993, BIOCHEMISTRY-US, V32, P6485, DOI 10.1021/bi00076a024; Yu WM, 1996, BIOPHYS J, V70, P626, DOI 10.1016/S0006-3495(96)79646-7; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	53	46	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22722	22731		10.1074/jbc.M010879200	http://dx.doi.org/10.1074/jbc.M010879200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294853	hybrid			2022-12-27	WOS:000169412700100
J	Jahns, P; Wehner, A; Paulsen, H; Hobe, S				Jahns, P; Wehner, A; Paulsen, H; Hobe, S			De-epoxidation of violaxanthin after reconstitution into different carotenoid binding sites of light-harvesting complex II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XANTHOPHYLL-CYCLE; PLANTS; PROTEINS; IDENTIFICATION; DEPENDENCE; DYNAMICS	In higher plants, the de-epoxidation of violaxanthin (Vx) to antheraxanthin and zeaxanthin is required for the pH-dependent dissipation of excess light energy as heat and by that process plays an important role in the protection against photo-oxidative damage. The de epoxidation reaction was investigated in an in vitro system using reconstituted light-harvesting complex II (LHCII) and a thylakoid raw extract enriched in the enzyme Vx de-epoxidase. Reconstitution of LHCII with varying carotenoids was performed to replace lutein and/or neoxanthin, which are bound to the native complex, by Vx. Recombinant LHCII containing either 2 lutein and 1 Vx or 1.6 Vx and 1.1 neoxanthin or 2.8 Vx per monomer were studied. Vx de epoxidation was inducible for all complexes after the addition of Vx de epoxidase but to different extents and with different kinetics in each complex. Analysis of the kinetics indicated that the three possible Vx binding sites have at least two, and perhaps three, specific rate constants for de-epoxidation. In particular, Vx bound to one of the two lutein binding sites of the native complex, most likely L1, was not at all or only at a slow rate convertible to Zx. In reisolated LHCII, newly formed Zx almost stoichiometrically replaced the transformed Vx, indicating that LHCII and Vx de-epoxidase stayed in close contact during the de-epoxidation reactions and that no release of carotenoids occurred.	Univ Dusseldorf, Inst Biochem Pflanzen, D-40225 Dusseldorf, Germany; Johannes Gutenberg Univ Mainz, Inst Allgemeine Bot, D-55128 Mainz, Germany	Heinrich Heine University Dusseldorf; Johannes Gutenberg University of Mainz	Jahns, P (corresponding author), Univ Dusseldorf, Inst Biochem Pflanzen, D-40225 Dusseldorf, Germany.	pjahns@uni-duesseldorf.de	Paulsen, Harald/D-3742-2011					Arvidsson PO, 1996, PHOTOSYNTH RES, V49, P119, DOI 10.1007/BF00117662; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; BASSI R, 1993, EUR J BIOCHEM, V212, P297, DOI 10.1111/j.1432-1033.1993.tb17662.x; Bassi R, 2000, PHOTOSYNTH RES, V64, P243, DOI 10.1023/A:1006409506272; Croce R, 1999, FEBS LETT, V456, P1, DOI 10.1016/S0014-5793(99)00907-2; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Farber A, 1997, PLANT PHYSIOL, V115, P1609, DOI 10.1104/pp.115.4.1609; FRYER MJ, 1992, PLANT CELL ENVIRON, V15, P381, DOI 10.1111/j.1365-3040.1992.tb00988.x; GREEN BR, 1991, TRENDS BIOCHEM SCI, V16, P181, DOI 10.1016/0968-0004(91)90072-4; Hartel H, 1996, PLANT PHYSIOL, V110, P471, DOI 10.1104/pp.110.2.471; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 2000, PLANT PHYSIOL, V124, P273, DOI 10.1104/pp.124.1.273; Hobe S, 2000, EUR J BIOCHEM, V267, P616, DOI 10.1046/j.1432-1327.2000.01060.x; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; JAHNS P, 1995, PLANT PHYSIOL, V108, P149, DOI 10.1104/pp.108.1.149; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; KUHLBRANDT W, 1991, NATURE, V350, P130, DOI 10.1038/350130a0; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; PAULSEN H, 1993, EUR J BIOCHEM, V215, P809, DOI 10.1111/j.1432-1033.1993.tb18096.x; PETER GF, 1991, J BIOL CHEM, V266, P16745; PFUNDEL EE, 1993, PLANT PHYSIOL, V101, P65, DOI 10.1104/pp.101.1.65; Pogson B, 1996, PLANT CELL, V8, P1627, DOI 10.1105/tpc.8.9.1627; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Schmid VHR, 1997, P NATL ACAD SCI USA, V94, P7667, DOI 10.1073/pnas.94.14.7667; SIEFERMANN D, 1974, BIOCHIM BIOPHYS ACTA, V357, P144, DOI 10.1016/0005-2728(74)90119-4; Verhoeven AS, 1999, PLANT PHYSIOL, V120, P727, DOI 10.1104/pp.120.3.727; YAMAMOTO HY, 1996, OXYGENIC PHOTOSYNTHE, P539, DOI DOI 10.1007/0-306-48127-8_30	32	56	57	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22154	22159		10.1074/jbc.M102147200	http://dx.doi.org/10.1074/jbc.M102147200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301335	hybrid			2022-12-27	WOS:000169412700026
J	Lelievre, E; Plun-Favreau, H; Chevalier, S; Froger, J; Guillet, C; Elson, GCA; Gauchat, JF; Gascan, H				Lelievre, E; Plun-Favreau, H; Chevalier, S; Froger, J; Guillet, C; Elson, GCA; Gauchat, JF; Gascan, H			Signaling pathways recruited by the cardiotrophin-like cytokine/cytokine-like factor-1 composite cytokine - Specific requirement of the membrane-bound form of ciliary neurotrophic factor receptor alpha component	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA INHIBITORY FACTOR; TYROSINE-PHOSPHATASE SHP-2; ACTIVATED PROTEIN-KINASE; ONCOSTATIN-M; CNTF RECEPTOR; MICE LACKING; TRANSCRIPTION FACTOR; TARGETED DISRUPTION; MOLECULAR-CLONING; TRANSDUCER GP130	Ciliary neurotrophic factor (CNTF) is a cytokine sup porting the differentiation and survival of a number of neural cell types. Its receptor complex consists of a ligand-binding component, CNTF receptor (CNTFR), associated with two signaling receptor components, gp130 and leukemia inhibitory factor receptor (LIFR), Striking phenotypic differences between CNTF- and CNTFR-deficient mice suggest that CNTFR serves as a receptor for a second developmentally important ligand, We recently demonstrated that cardiotrophin-like cytokine (CLC) associates with the soluble orphan receptor cytokine-like factor-1 (CLF) to form a heterodimeric cytokine that displayed activities only on cells expressing the tripartite CNTF receptor on their surface. In this present study we examined the membrane binding of the CLC/CLF composite cytokine and observed a preferential interaction of the cytokine with the CNTFR subunit. Signaling pathways recruited by the CLC/CLF complex in human neuroblastoma cell lines were also analyzed in detail. The results obtained showed an activation of Janus kinases (JAK1, JAK2, and TYK2) leading to a tyrosine phosphorylation of the gp130 and LIFR, The phosphorylated signaling receptors served in turn as docking proteins for signal transducing molecules such as STAT3 and SHP-2, In vitro analysis revealed that the gp130-LIFR pathway could also stimulate the phosphatidylinositol 3-kinase and the mitogen-activated protein kinase pathways. In contrast to that reported before for CNTF, soluble CNTFR failed to promote the action CLC/CLF, and an absolute requirement of the membrane form of CNTFR was required to generate a functional response to the composite cytokine. This study reinforces the functional similarity between CNTF and the CLC/CLF composite cytokine defining the second ligand for CNTFR.	CHU Angers, INSERM EMI 9928, F-49003 Angers, France; Ctr Immunol Pierre Fabre, F-74164 St Julien En Genevois, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre d'Immunologie Pierre Fabre	Gascan, H (corresponding author), CHU Angers, INSERM E 9928, 4 Rue Larrey, F-49033 Angers, France.		Plun-Favreau, Helene/Q-4111-2016; Lelievre, Eric/M-2878-2015; PLUN-FAVREAU, Helene/C-8513-2009	Plun-Favreau, Helene/0000-0002-1401-9656; lelievre, eric/0000-0002-4132-4023				Alexander WS, 1999, CURR BIOL, V9, P605, DOI 10.1016/S0960-9822(99)80266-8; BAUMANN H, 1993, J BIOL CHEM, V268, P8414; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; BONNI A, 1993, SCIENCE, V262, P1575, DOI 10.1126/science.7504325; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; BOULTON TG, 1995, P NATL ACAD SCI USA, V92, P6915, DOI 10.1073/pnas.92.15.6915; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Elson GCA, 1998, J IMMUNOL, V161, P1371; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; GEARING DP, 1994, P NATL ACAD SCI USA, V91, P1119, DOI 10.1073/pnas.91.3.1119; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; Guillet C, 1999, J NEUROSCI, V19, P1257; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HELGREN ME, 1994, CELL, V76, P493, DOI 10.1016/0092-8674(94)90113-9; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Horejsi V, 1999, IMMUNOL TODAY, V20, P356, DOI 10.1016/S0167-5699(99)01489-9; IP NY, 1991, J NEUROSCI, V11, P3124; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; Kahn MA, 1997, J NEUROCHEM, V68, P1413; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Kim H, 1999, MOL CELL BIOL, V19, P5326; Kim HK, 1998, MOL CELL BIOL, V18, P1525, DOI 10.1128/MCB.18.3.1525; LAI CF, 1995, J BIOL CHEM, V270, P14847, DOI 10.1074/jbc.270.25.14847; LARKFORS L, 1994, EUR J NEUROSCI, V6, P1015, DOI 10.1111/j.1460-9568.1994.tb00596.x; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MITSUMOTO H, 1994, SCIENCE, V265, P1107, DOI 10.1126/science.8066451; Miyakawa Y, 2001, J BIOL CHEM, V276, P2494, DOI 10.1074/jbc.M002633200; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Oh H, 1998, J BIOL CHEM, V273, P9703, DOI 10.1074/jbc.273.16.9703; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Olivier C, 2000, J BIOL CHEM, V275, P5648, DOI 10.1074/jbc.275.8.5648; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Qu CK, 2001, BLOOD, V97, P911, DOI 10.1182/blood.V97.4.911; Robledo O, 1997, J BIOL CHEM, V272, P4855, DOI 10.1074/jbc.272.8.4855; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Schaper F, 1998, BIOCHEM J, V335, P557, DOI 10.1042/bj3350557; SCHIEMANN WP, 1995, P NATL ACAD SCI USA, V92, P5361, DOI 10.1073/pnas.92.12.5361; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; Sendtner M, 1997, J NEUROSCI, V17, P6999; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; SENDTNER M, 1994, J NEUROBIOL, V25, P1436, DOI 10.1002/neu.480251110; Shi Y, 1999, BIOCHEM BIOPH RES CO, V262, P132, DOI 10.1006/bbrc.1999.1181; Simon R, 1995, NEUROREPORT, V7, P153, DOI 10.1097/00001756-199512000-00037; STAHL N, 1993, J BIOL CHEM, V268, P7628; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; TAKAHASHI R, 1994, NAT GENET, V7, P79, DOI 10.1038/ng0594-79; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; THOMA B, 1994, J BIOL CHEM, V269, P6215; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Timmermann A, 2000, FEBS LETT, V468, P120, DOI 10.1016/S0014-5793(00)01205-9; WEGENKA UM, 1994, MOL CELL BIOL, V14, P3186, DOI 10.1128/MCB.14.5.3186; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	74	79	83	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22476	22484		10.1074/jbc.M101681200	http://dx.doi.org/10.1074/jbc.M101681200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294841	hybrid			2022-12-27	WOS:000169412700068
J	Mueller, S; Pantopoulos, K; Hubner, CA; Stremmel, W; Hentze, MW				Mueller, S; Pantopoulos, K; Hubner, CA; Stremmel, W; Hentze, MW			IRP1 activation by extracellular oxidative stress in the perfused rat liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON REGULATORY PROTEIN-1; HYDROGEN-PEROXIDE; FERRITIN SYNTHESIS; NITRIC-OXIDE; METABOLISM; H2O2; INFLAMMATION; CATALASE; PATHOGENESIS; MECHANISM	The expression of several proteins with critical functions in iron metabolism is regulated post-transcriptionally by the binding of iron regulatory proteins, IRP1 and IRP2, to mRNA iron responsive elements (IREs). In iron deficient tissues and cultured cells, both IRP1 and IRP2 are activated for high affinity IRE binding. Previous work showed that IRP1 is also activated when cultured cells are exposed to H2O2. The well established role of iron and H2O2 in tissue injury (based on Fenton chemistry) suggests that this response may have important pathophysiological implications. This is particularly relevant in inflammation, where cytotoxic immune cells release large amounts of reactive oxygen species. Here, we describe a rat liver perfusion model to study IRP1 activation under H2O2 generation conditions that mimic a physiological inflammatory response, using steady-state concentrations of H2O2 produced by a glucose/ glucose oxidase/catalase system. We show first that stimulated neutrophils are able to increase serum levels of H2O2 by a factor of 10, even in the presence of H2O2-degrading erythrocytes. We further show that perfusion of rat liver with glucose oxidase leads to a rapid activation of IRE binding activity in the intact organ. Mobility shift assays with liver extracts and IRP1 or IRP2-specific probes indicate that only IRP1 responds to H2O2. Our study demonstrates a principal existence of iron regulation by oxidative stress at the intact organ level. It also provides a link between iron metabolism and the inflammatory response, as H2O2 is a major product of the oxidative burst of neutrophils and macrophages.	Heidelberg Univ, Dept Internal Med 4, D-69115 Heidelberg, Germany; European Mol Biol Lab, Gene Express Programme, D-699117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Mueller, S (corresponding author), Heidelberg Univ, Dept Internal Med 4, Bergheimer Str 58, D-69115 Heidelberg, Germany.	mueller@urz.uni-heidelberg.de	Hentze, Matthias W/V-3980-2017; Pantopoulos, Kostas/A-9668-2008; Hübner, Christian/A-2950-2017	Hentze, Matthias W/0000-0002-4023-7876; Pantopoulos, Kostas/0000-0002-2305-0057; Hübner, Christian/0000-0002-1030-4943; Stremmel, Wolfgang/0000-0002-8545-1753				AEBI H, 1984, METHOD ENZYMOL, V105, P121; BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205; Barisani D, 1996, DIGEST DIS, V14, P304, DOI 10.1159/000171561; Bartosek I, 1973, ISOLATED LIVER PERFU; BEERS RF, 1952, J BIOL CHEM, V195, P133; BOTHWELL TH, 1995, NUTR REV, V53, P237, DOI 10.1111/j.1753-4887.1995.tb05480.x; BOYUM A, 1991, BLOOD SEPARATION PLA, P217; Brazzolotto X, 1999, J BIOL CHEM, V274, P21625, DOI 10.1074/jbc.274.31.21625; Cairo G, 1996, FASEB J, V10, P1326, DOI 10.1096/fasebj.10.11.8836047; Cairo G, 1998, ANN NY ACAD SCI, V851, P179, DOI 10.1111/j.1749-6632.1998.tb08992.x; Caltagirone A, 2001, J BIOL CHEM, V276, P19738, DOI 10.1074/jbc.M100245200; DASILVA JJR, 1991, BIOL CHEM ELEMENTS I, P319; GREEN JG, 1984, METHOD ENZYMOL, V105, P4; GUO B, 1994, J BIOL CHEM, V269, P24252; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; Henderson ER, 1996, J BIOL CHEM, V271, P4900; HENTZE MW, 1989, SCIENCE, V244, P357, DOI 10.1126/science.2711187; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; KLEBANOFF SJ, 1984, METHOD ENZYMOL, V105, P399; KONIJN AM, 1981, BRIT J HAEMATOL, V49, P361, DOI 10.1111/j.1365-2141.1981.tb07238.x; KONIJN AM, 1977, BRIT J HAEMATOL, V37, P7, DOI 10.1111/j.1365-2141.1977.tb08806.x; MARTINS EAL, 1995, ARCH BIOCHEM BIOPHYS, V316, P128, DOI 10.1006/abbi.1995.1019; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Mueller S, 1997, BIOLUMINESCENCE AND CHEMILUMINESCENCE, P338; Mueller S, 1997, ANAL BIOCHEM, V245, P55, DOI 10.1006/abio.1996.9939; Mueller S, 2000, FREE RADICAL BIO MED, V29, P410, DOI 10.1016/S0891-5849(00)00261-6; MUELLER S, 1995, J BIOLUM CHEMILUM, V10, P229, DOI 10.1002/bio.1170100406; Mueller S, 1997, BLOOD, V90, P4973, DOI 10.1182/blood.V90.12.4973.4973_4973_4978; MUELLER S, 2001, IN PRESS METHODS ENZ; Pantopoulos K, 1998, P NATL ACAD SCI USA, V95, P10559, DOI 10.1073/pnas.95.18.10559; PANTOPOULOS K, 1995, P NATL ACAD SCI USA, V92, P1267, DOI 10.1073/pnas.92.5.1267; PANTOPOULOS K, 1995, EMBO J, V14, P2917, DOI 10.1002/j.1460-2075.1995.tb07291.x; Pantopoulos K, 1996, MOL CELL BIOL, V16, P3781; Pantopoulos K, 1997, J BIOL CHEM, V272, P9802; Pirisi M, 2000, AM J CLIN PATHOL, V113, P546, DOI 10.1309/TRB1-JXUJ-L9R6-9NHX; Rouault T, 1997, CURR TOP CELL REGUL, V35, P1, DOI 10.1016/S0070-2137(97)80001-5; Tacchini L, 1997, GASTROENTEROLOGY, V113, P946, DOI 10.1016/S0016-5085(97)70191-4; TEST ST, 1984, J BIOL CHEM, V259, P399	40	66	69	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23192	23196		10.1074/jbc.M100654200	http://dx.doi.org/10.1074/jbc.M100654200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11297549	hybrid			2022-12-27	WOS:000169412700161
J	Pullar, JM; Vissers, MCM; Winterbourn, CC				Pullar, JM; Vissers, MCM; Winterbourn, CC			Glutathione oxidation by hypochlorous acid in endothelial cells produces glutathione sulfonamide as a major product but not glutathione disulfide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SKIN FIBROBLASTS; PROTEIN S-THIOLATION; REDUCED GLUTATHIONE; GROWTH ARREST; NEUTROPHILS; CHLORIDE; THIOLS; STRESS	Treatment of cells with hypochlorous acid (HOCl) at sublethal doses causes a concentration-dependent loss in reduced glutathione (GSH) levels. We have investigated the products of the reaction of HOCl with GSH in human umbilical vein endothelial cells. Despite a complete loss of GSH, there were only very small increases in intracellular and extracellular glutathione disulfide and glutathione sulfonic acid after exposure to HOCl. S-35 labeling of the GSH pool showed only a minimal increase in protein-bound GSH, suggesting that S-thiolation was not a major contributor to HOCl-mediated loss of GSH in endothelial cells. Rather, the products of the reaction were mostly exported from cells and included a peak that co-eluted with the cyclic sulfonamide that is a product of the reaction of GSH with reagent HOCl. Evidence of this species in endothelial cell supernatants after HOCl treatment was also obtained using electrospray mass spectrometry. In conclusion, expo sure to HOCl causes the irreversible loss of cellular GSH with the formation of novel products that are rapidly exported from the cell, and resynthesis of GSH will be required to restore levels. The loss of GSH would alter the redox state of the cell and compromise its defenses against further oxidative stress.	Christchurch Sch Med, Dept Pathol, Free Rad Res Grp, Christchurch, New Zealand	University of Otago	Pullar, JM (corresponding author), Christchurch Sch Med, Dept Pathol, Free Rad Res Grp, POB 4345, Christchurch, New Zealand.		Vissers, Margreet C M/T-4159-2017					Armesto XL, 2000, TETRAHEDRON, V56, P1103, DOI 10.1016/S0040-4020(99)01066-2; Carr AC, 1997, BIOCHEM J, V327, P275, DOI 10.1042/bj3270275; CHAI YC, 1994, ARCH BIOCHEM BIOPHYS, V310, P264, DOI 10.1006/abbi.1994.1166; CLAIBORNE A, 1993, FASEB J, V7, P1483, DOI 10.1096/fasebj.7.15.8262333; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; FOLKES LK, 1995, ARCH BIOCHEM BIOPHYS, V323, P120, DOI 10.1006/abbi.1995.0017; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; MARTIN J, 1991, J CHROMATOGR-BIOMED, V568, P219, DOI 10.1016/0378-4347(91)80356-H; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Prutz WA, 1996, ARCH BIOCHEM BIOPHYS, V332, P110, DOI 10.1006/abbi.1996.0322; Pullar JM, 1999, AM J PHYSIOL-HEART C, V277, pH1505, DOI 10.1152/ajpheart.1999.277.4.H1505; SCHUPPE I, 1992, BIOCHEM PHARMACOL, V44, P1757, DOI 10.1016/0006-2952(92)90069-U; SILVERSTEIN RM, 1974, BIOCHEMISTRY-US, V13, P5069, DOI 10.1021/bi00722a001; TATSUMI T, 1994, AM J PHYSIOL-HEART C, V267, pH1597, DOI 10.1152/ajpheart.1994.267.4.H1597; THOMAS JA, 1994, METHOD ENZYMOL, V233, P385; Vile GF, 1998, ARCH BIOCHEM BIOPHYS, V359, P51, DOI 10.1006/abbi.1998.0881; Vile GF, 2000, ARCH BIOCHEM BIOPHYS, V377, P122, DOI 10.1006/abbi.2000.1706; VISSERS MCM, 1990, FREE RADICAL BIO MED, V8, P331, DOI 10.1016/0891-5849(90)90098-4; VISSERS MCM, 1991, ARCH BIOCHEM BIOPHYS, V285, P53, DOI 10.1016/0003-9861(91)90327-F; Vissers MCM, 1999, BIOCHEM J, V344, P443, DOI 10.1042/0264-6021:3440443; VISSERS MCM, 1995, BIOCHEM J, V307, P57, DOI 10.1042/bj3070057; Winterbourn CC, 1997, BIOCHEM J, V326, P87, DOI 10.1042/bj3260087; WINTERBOURN CC, 1985, BIOCHIM BIOPHYS ACTA, V840, P204, DOI 10.1016/0304-4165(85)90120-5	23	78	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22120	22125		10.1074/jbc.M102088200	http://dx.doi.org/10.1074/jbc.M102088200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11283008	hybrid			2022-12-27	WOS:000169412700021
J	Abe, MK; Kahle, KT; Saelzler, MP; Orth, K; Dixon, JE; Rosner, MR				Abe, MK; Kahle, KT; Saelzler, MP; Orth, K; Dixon, JE; Rosner, MR			ERK7 is an autoactivated member of the MAPK family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION PATHWAY; GENE-PRODUCT; PROTEIN-KINASE-1 BMK1; DUAL PHOSPHORYLATION; MITOGEN; TYROSINE; AUTOPHOSPHORYLATION; CASCADES; INVITRO	Extracellular signal-regulated kinase 7 (ERK7) shares significant sequence homology with other members of the ERK family of signal transduction proteins, including the signature TEY activation motif. However, ERK7 has several distinguishing characteristics. Unlike other ERKs, ERK7 has been shown to have significant constitutive activity in serum-starved cells, which is not increased further by extracellular stimuli that typically activate other members of the mitogen-activated protein kinase (MAPK) family. On the other hand, ERK7's activation state and kinase activity appear to be regulated by its ability to utilize ATP and the presence of its extended C-terminal region. In this study, we investigated the mechanism of ERK7 activation, The results suggest that 1) MAPK kinase (MEK) inhibitors do not suppress ERK7 kinase activity; 2) intramolecular autophosphorylation is sufficient for activation of ERK7 in the absence of an upstream MEK; and 3) multiple regions of the C-terminal domain of ERK7 regulate its kinase activity. Taken together, these results indicate that autophosphorylation is sufficient for ERK7 activation and that the C-terminal domain regulates its kinase activity through multiple interactions.	Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Michigan System; University of Michigan; University of Chicago	Rosner, MR (corresponding author), Univ Chicago, Ben May Inst Canc Res, 5841 S Maryland Ave,MC 6027, Chicago, IL 60637 USA.		Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018024, R37DK018024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033858] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 03867, HL 56399] Funding Source: Medline; NIDDK NIH HHS [DK 18024] Funding Source: Medline; NINDS NIH HHS [NS 33858] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; Abe MK, 1999, MOL CELL BIOL, V19, P1301; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BROTT BK, 1993, CELL GROWTH DIFFER, V4, P921; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chao TH, 1999, J BIOL CHEM, V274, P36035, DOI 10.1074/jbc.274.51.36035; CHAREST DL, 1993, MOL CELL BIOL, V13, P4679, DOI 10.1128/MCB.13.8.4679; Chesneau V, 2000, PROTEIN EXPRES PURIF, V19, P91, DOI 10.1006/prep.2000.1217; Cobb M H, 1996, Adv Pharmacol, V36, P49, DOI 10.1016/S1054-3589(08)60576-1; CREWS CM, 1991, P NATL ACAD SCI USA, V88, P8845, DOI 10.1073/pnas.88.19.8845; CREWS CM, 1992, P NATL ACAD SCI USA, V89, P8205, DOI 10.1073/pnas.89.17.8205; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; HER JH, 1993, BIOCHEM J, V296, P25, DOI 10.1042/bj2960025; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Lechner C, 1996, P NATL ACAD SCI USA, V93, P4355, DOI 10.1073/pnas.93.9.4355; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; MACDONALD SG, 1993, MOL CELL BIOL, V13, P6615, DOI 10.1128/MCB.13.11.6615; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Palmer LE, 1999, INFECT IMMUN, V67, P708, DOI 10.1128/IAI.67.2.708-716.1999; Peng X, 1996, J NEUROCHEM, V66, P1191; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WU J, 1991, P NATL ACAD SCI USA, V88, P9508, DOI 10.1073/pnas.88.21.9508; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; ZHENG CF, 1993, J BIOL CHEM, V268, P11435; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	40	57	60	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21272	21279		10.1074/jbc.M100026200	http://dx.doi.org/10.1074/jbc.M100026200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11287416	hybrid			2022-12-27	WOS:000169297900064
J	Aicher, LD; Campbell, JS; Yeung, RS				Aicher, LD; Campbell, JS; Yeung, RS			Tuberin phosphorylation regulates its interaction with hamartin - Two proteins involved in tuberous sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TSC2 GENE; PRODUCT; IDENTIFICATION	Hamartin and tuberin are products of the tumor suppressor genes, TSC1 and TSC2, respectively. When mutated, a characteristic spectrum of tumor-like growths develop resulting in the syndrome of tuberous sclerosis complex. The phenotypes associated with TSC1 and TSC2 mutations are largely indistinguishable suggesting a common biochemical pathway. Indeed, hamartin and tuberin have been shown to interact stably in vitro and in vivo. Factors that regulate their interaction are likely critical to the understanding of disease pathogenesis, In this study, we showed that tuberin is phosphorylated at serine and tyrosine residues in response to serum and other factors, and it undergoes serial phosphorylation that can be detected by differences in electrophoretic mobilities. A disease-related TSC2 mutation (Y1571H) nearly abolished tuberin phosphorylation when stimulated with pervanadate, Expression of this mutant tuberin caused a marked reduction in TSC1-TSC2 interaction compared with wild-type protein and significantly curtailed the growth inhibitory effects of tuberin when overexpressed in COS1 cells, consistent with a loss of function mutation. Examination of a second pathologic mutation, P1675L, revealed a similar relationship between limited phosphorylation and reduced interaction with hamartin, Our data show for the first time that 1) tuberin is phosphorylated at tyrosine and serine residues, 2) TSC1-TSC2 interaction is regulated by tuberin phosphorylation, and 3) defective phosphorylation of tuberin is associated with loss of its tumor suppressor activity. These findings suggest that phosphorylation may be a key regulatory mechanism controlling TSC1-TSC2 function.	Univ Washington, Dept Surg, Seattle, WA 98195 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Yeung, RS (corresponding author), Univ Washington, Dept Surg, 1959 NE Pacific St,Box 356410, Seattle, WA 98195 USA.	ryeung@u.washington.edu		Campbell, Jean/0000-0002-9187-2204	NCI NIH HHS [CA77882] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077882] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Gomez M.R., 1999, TUBEROUS SCLEROSIS C, V3rd, P10; Grangeasse C, 1999, BIOTECHNIQUES, V27, P62, DOI 10.2144/99271bm12; Henry KW, 1998, J BIOL CHEM, V273, P20535, DOI 10.1074/jbc.273.32.20535; Hodges AK, 2000, AM J HUM GENET, V67, P406; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Jin F, 1996, P NATL ACAD SCI USA, V93, P9154, DOI 10.1073/pnas.93.17.9154; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; MacKintosh C, 1996, FEBS LETT, V397, P235, DOI 10.1016/S0014-5793(96)01175-1; NELLIST M, 1993, CELL, V75, P1305; Orimoto K, 1996, BIOCHEM BIOPH RES CO, V219, P70, DOI 10.1006/bbrc.1996.0183; Plank TL, 1998, CANCER RES, V58, P4766; Rennebeck G, 1998, P NATL ACAD SCI USA, V95, P15629, DOI 10.1073/pnas.95.26.15629; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; Soucek T, 1998, P NATL ACAD SCI USA, V95, P15653, DOI 10.1073/pnas.95.26.15653; Soucek T, 1997, J BIOL CHEM, V272, P29301, DOI 10.1074/jbc.272.46.29301; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; Xiao GH, 1997, J BIOL CHEM, V272, P6097, DOI 10.1074/jbc.272.10.6097	21	78	80	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21017	21021		10.1074/jbc.C100136200	http://dx.doi.org/10.1074/jbc.C100136200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11290735	hybrid			2022-12-27	WOS:000169297900031
J	Bottero, V; Rossi, F; Samson, M; Mari, M; Hofman, P; Peyron, JF				Bottero, V; Rossi, F; Samson, M; Mari, M; Hofman, P; Peyron, JF			I kappa B-alpha, the NF-kappa B inhibitors subunit, interacts with ANT, the mitochondrial ATP/ADP translocator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION; TRANSCRIPTION FACTORS; INDUCED APOPTOSIS; CELL-SURVIVAL; KINASE IKK; PROTEIN; ACTIVATION; INDUCTION; MEMBRANE; THERAPY	The transcription factor NF-kappaB regulates a wide set of genes involved in the establishment of many cellular processes that control cell activation, proliferation, and apoptosis. I kappaB inhibitory subunits integrate NF-kappaB activation signals through phosphorylation and ubiquitination of its N-terminal domain. Using the two-hybrid system in yeast, we searched for I kappaB-alpha N-terminal domain interactors and therefore potential NF-kappaB regulators. An interaction of I kappaB-alpha with the mitochondrial ATP/ADP translocator ANT was detected in yeast and confirmed in glutathione S-transferase pull-down assays and co-precipitation experiments in transfected cells. Subcellular cell fractionation, resistance to proteinase K treatment, and electron microscopy experiments demonstrated the presence of I kappaB-alpha and associated p65 NF-kappaB in the mitochondrial intermembrane space. I kappaB-. alpha .NF-kappaB appeared to be released from mitochondria upon the induction of apoptosis by engagement of the Fas receptor. These data suggest that the mitochondrial I kappaB-alpha .NF-kappaB pool participates in the regulation of apoptosis.	Fac Med Pasteur, INSERM, U526, F-06107 Nice 2, France; Fac Med Pasteur, INSERM, U364, F-06107 Nice 2, France; Hop Louis Pasteur, Lab Anatomopathol, F-06107 Nice 2, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Peyron, JF (corresponding author), Fac Med Pasteur, INSERM, U526, IFR50, F-06107 Nice 2, France.	peyron@unice.fr	Jean-Francois, Peyron/AAA-9496-2022; Hofman, Paul/P-7654-2018; Peyron, Jean-Francois/M-5682-2016	Jean-Francois, Peyron/0000-0001-6113-916X; Hofman, Paul/0000-0003-0431-9353; Peyron, Jean-Francois/0000-0001-6113-916X				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Ausubel FA, 1990, CURRENT PROTOCOLS MO; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Bertolotto C, 2000, J BIOL CHEM, V275, P37246, DOI 10.1074/jbc.M007732200; BRANDOLIN G, 1993, J BIOENERG BIOMEMBR, V25, P459, DOI 10.1007/BF01108403; Foo SY, 1999, TRENDS GENET, V15, P229; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Harhaj EW, 1999, J BIOL CHEM, V274, P22911, DOI 10.1074/jbc.274.33.22911; Hirsch T, 1998, EXP CELL RES, V241, P426, DOI 10.1006/excr.1998.4084; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; Levkau B, 1999, NAT CELL BIOL, V1, P227, DOI 10.1038/12050; Li F, 1997, J BIOL CHEM, V272, P30299, DOI 10.1074/jbc.272.48.30299; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Martinou JC, 1999, NATURE, V399, P411, DOI 10.1038/20804; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Marzo I, 1998, FEBS LETT, V427, P198, DOI 10.1016/S0014-5793(98)00424-4; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; MORIN PJ, 1993, NUCLEIC ACIDS RES, V21, P2157, DOI 10.1093/nar/21.9.2157; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Ozes ON, 1999, NATURE, V401, P82; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Ragan MT, 1987, MITOCHONDRIA PRACTIC, P79; Reuther JY, 1999, J BIOL CHEM, V274, P20664, DOI 10.1074/jbc.274.29.20664; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Scarlett JL, 1997, FEBS LETT, V418, P282, DOI 10.1016/S0014-5793(97)01391-4; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zamzami N, 1996, J EXP MED, V183, P1533, DOI 10.1084/jem.183.4.1533; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	42	73	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21317	21324		10.1074/jbc.M005850200	http://dx.doi.org/10.1074/jbc.M005850200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11287411	hybrid			2022-12-27	WOS:000169297900070
J	Fierobe, HP; Mechaly, A; Tardif, C; Belaich, A; Lamed, R; Shoham, Y; Belaich, JP; Bayer, EA				Fierobe, HP; Mechaly, A; Tardif, C; Belaich, A; Lamed, R; Shoham, Y; Belaich, JP; Bayer, EA			Design and production of active cellulosome chimeras - Selective incorporation of dockerin-containing enzymes into defined functional complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-THERMOCELLUM CELLULOSOME; SITE-DIRECTED MUTAGENESIS; INTEGRATING PROTEIN CIPA; SCAFFOLDING PROTEIN; CRYSTAL-STRUCTURE; CELLULOLYTICUM CELLULOSOME; COHESIN DOMAIN; ENDOGLUCANASE; GENE; PURIFICATION	Defined chimeric cellulosomes were produced in which selected enzymes were incorporated in specific locations within a multicomponent complex, The molecular building blocks of this approach are based on complementary protein modules from the cellulosomes of two clostridia, Clostridium thermocellum and Clostridium cellulolyticum, wherein cellulolytic enzymes are incorporated into the complexes by means of high-affinity species-specific cohesin-dockerin interactions. To construct the desired complexes, a series of chimeric scaffoldins was prepared by recombinant means. The scaffoldin chimeras were designed to include two cohesin modules from the different species, optionally connected to a cellulose-binding domain. The two divergent cohesins exhibited distinct specificities such that leach recognized selectively and bound strongly to its dockerin counterpart. Using this strategy, appropriate dockerin-containing enzymes could be assembled precisely and by design into a desired complex. Compared with the mixture of free cellulases, the resultant cellulosome chimeras exhibited enhanced synergistic action on crystalline cellulose.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Inst Federatif Rech 1, Inst Biol Struct & Microbiol, CNRS, F-13402 Marseille, France; Univ Aix Marseille 1, F-13331 Marseille, France; Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; Technion Israel Inst Technol, Inst Catalysis Sci & Technol, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel	Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Tel Aviv University; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Bayer, EA (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.		Shoham, Yuval/M-4409-2013; FIEROBE, Henri-Pierre/P-4372-2019					Bayer E.A., 1994, TRENDS BIOTECHNOL, V12, P378; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; BAYER EA, 1990, METHOD ENZYMOL, V184, P138; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; Beguin P, 1996, CRIT REV BIOCHEM MOL, V31, P201, DOI 10.3109/10409239609106584; BHAT MK, 1998, RRD BIOTECH BIOENG 1, V1, P59; BHAT S, 1994, INT J BIOL MACROMOL, V16, P335, DOI 10.1016/0141-8130(94)90066-3; Ciruela A, 1998, FEBS LETT, V422, P221, DOI 10.1016/S0014-5793(97)01590-1; FELIX CR, 1993, ANNU REV MICROBIOL, V47, P791, DOI 10.1146/annurev.micro.47.1.791; FIEROBE HP, 1991, J BACTERIOL, V173, P7956, DOI 10.1128/jb.173.24.7956-7962.1991; Fierobe HP, 1999, BIOCHEMISTRY-US, V38, P12822, DOI 10.1021/bi9911740; GERNGROSS UT, 1993, MOL MICROBIOL, V8, P325, DOI 10.1111/j.1365-2958.1993.tb01576.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kataeva I, 1997, BIOCHEM J, V326, P617, DOI 10.1042/bj3260617; Lytle B, 1996, J BACTERIOL, V178, P1200, DOI 10.1128/jb.178.4.1200-1203.1996; Mechaly A, 2000, PROTEINS, V39, P170, DOI 10.1002/(SICI)1097-0134(20000501)39:2<170::AID-PROT7>3.0.CO;2-H; Mechaly A, 2001, J BIOL CHEM, V276, P9883, DOI 10.1074/jbc.M009237200; Meza R, 1996, FEMS MICROBIOL LETT, V145, P333, DOI 10.1111/j.1574-6968.1996.tb08597.x; Pages S, 1999, J BACTERIOL, V181, P1801; Pages S, 1997, PROTEINS, V29, P517, DOI 10.1002/(SICI)1097-0134(199712)29:4<517::AID-PROT11>3.3.CO;2-I; Pages S, 1996, J BACTERIOL, V178, P2279, DOI 10.1128/jb.178.8.2279-2286.1996; PARK JT, 1949, J BIOL CHEM, V181, P149; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; ReverbelLeroy C, 1996, MICROBIOL-SGM, V142, P1013, DOI 10.1099/00221287-142-4-1013; ReverbelLeroy C, 1997, J BACTERIOL, V179, P46, DOI 10.1128/jb.179.1.46-52.1997; REVERBELLEROY C, 1996, THESIS U PROVENCE AI; Shimon LJW, 1997, STRUCTURE, V5, P381, DOI 10.1016/S0969-2126(97)00195-0; Shoham Y, 1999, TRENDS MICROBIOL, V7, P275, DOI 10.1016/S0966-842X(99)01533-4; Spinelli S, 2000, J MOL BIOL, V304, P189, DOI 10.1006/jmbi.2000.4191; Tavares GA, 1997, J MOL BIOL, V273, P701, DOI 10.1006/jmbi.1997.1326; WANG WK, 1993, J BACTERIOL, V175, P1293, DOI 10.1128/JB.175.5.1293-1302.1993; WU JHD, 1988, BIOCHEMISTRY-US, V27, P1703, DOI 10.1021/bi00405a048; YARON S, 1995, FEBS LETT, V360, P121, DOI 10.1016/0014-5793(95)00074-J	33	162	178	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21257	21261		10.1074/jbc.M102082200	http://dx.doi.org/10.1074/jbc.M102082200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11290750	hybrid			2022-12-27	WOS:000169297900062
J	Kato, M; Frick, DN; Lee, J; Tabor, S; Richardson, CC; Ellenberger, T				Kato, M; Frick, DN; Lee, J; Tabor, S; Richardson, CC; Ellenberger, T			A complex of the bacteriophage T7 primase-helicase and DNA polymerase directs primer utilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID REPLICATION INVITRO; GENE 4 PROTEIN; DEOXYRIBONUCLEIC-ACID; CRYSTAL-STRUCTURE; DUPLEX DNA; RNA PRIMER; DOMAIN; BINDING; GENE-4-PROTEIN; HYDROLYSIS	The lagging strand of the replication fork is initially copied as short Okazaki fragments produced by the coupled activities of two template-dependent enzymes, a primase that synthesizes RNA primers and a DNA polymerase that elongates them. Gene 4 of bacteriophage T7 encodes a bifunctional primase-helicase that assembles into a ring-shaped hexamer with both DNA unwinding and primer synthesis activities. The primase is also required for the utilization of RNA primers by T7 DNA polymerase, It is not known how many subunits of the primase-helicase hexamer participate directly in the priming of DNA synthesis. In order to determine the minimal requirements for RNA primer utilization by T7 DNA polymerase, we created an altered gene 4 protein that does not form functional hexamers and consequently lacks detectable DNA unwinding activity. Remarkably, this monomeric primase readily primes DNA synthesis by T7 DNA polymerase on single-stranded templates. The monomeric gene 4 protein forms a specific and stable complex with T7 DNA polymerase and thereby delivers the RNA primer to the polymerase for the onset of DNA synthesis. These results show that a single subunit of the primase-helicase hexamer contains all of the residues required for primer synthesis and for utilization of primers by T7 DNA polymerase.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Ellenberger, T (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	tome@hms.harvard.edu		Frick, David/0000-0002-2434-7223				Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; Augustin MA, 2001, NAT STRUCT BIOL, V8, P57, DOI 10.1038/83060; BAKER TA, 1992, DNA REPLICATION, P471; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Bird LE, 1997, NUCLEIC ACIDS RES, V25, P2620, DOI 10.1093/nar/25.13.2620; Boyer PD, 2000, BBA-BIOENERGETICS, V1458, P252, DOI 10.1016/S0005-2728(00)00077-3; BROWN WC, 1989, J BIOL CHEM, V264, P6748; Chowdhury K, 2000, P NATL ACAD SCI USA, V97, P12469, DOI 10.1073/pnas.230448397; DEBYSER Z, 1994, CELL, V77, P157, DOI 10.1016/0092-8674(94)90243-7; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Frick DN, 1999, J BIOL CHEM, V274, P35889, DOI 10.1074/jbc.274.50.35889; Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957; Frick DN, 1999, J BIOL CHEM, V274, P35899, DOI 10.1074/jbc.274.50.35899; FULLER CW, 1982, COLD SPRING HARB SYM, V47, P669, DOI 10.1101/SQB.1983.047.01.078; GUO LH, 1982, NUCLEIC ACIDS RES, V10, P2065, DOI 10.1093/nar/10.6.2065; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Hacker KJ, 1997, BIOCHEMISTRY-US, V36, P14080, DOI 10.1021/bi971644v; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; Hingorani MM, 1997, P NATL ACAD SCI USA, V94, P5012, DOI 10.1073/pnas.94.10.5012; Hingorani MM, 1996, BIOCHEMISTRY-US, V35, P2218, DOI 10.1021/bi9521497; ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243; Keck JL, 2000, SCIENCE, V287, P2482, DOI 10.1126/science.287.5462.2482; KENNARD O, 1985, J BIOMOL STRUCT DYN, V3, P205, DOI 10.1080/07391102.1985.10508412; KIM YT, 1994, J BIOL CHEM, V269, P5270; KIM YT, 1992, J BIOL CHEM, V267, P15032; KOLODNER R, 1977, P NATL ACAD SCI USA, V74, P1525, DOI 10.1073/pnas.74.4.1525; Kusakabe T, 1997, J BIOL CHEM, V272, P12446, DOI 10.1074/jbc.272.19.12446; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Leslie AGW, 2000, PHILOS T ROY SOC B, V355, P465, DOI 10.1098/rstb.2000.0588; Lohman TM, 1998, CELL, V93, P9, DOI 10.1016/S0092-8674(00)81139-3; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; MENDELMAN LV, 1992, P NATL ACAD SCI USA, V89, P10638, DOI 10.1073/pnas.89.22.10638; NAKAI H, 1986, J BIOL CHEM, V261, P5217; NAKAI H, 1986, J BIOL CHEM, V261, P5208; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; NOTARNICOLA SM, 1993, J BIOL CHEM, V268, P27198; NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215; Pan H, 2000, STRUCTURE, V8, P231, DOI 10.1016/S0969-2126(00)00101-5; PATEL SS, 1992, J BIOL CHEM, V267, P15013; PATEL SS, 1993, J BIOL CHEM, V268, P10668; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; Rogers S G, 1980, Methods Enzymol, V65, P201; ROMANO LJ, 1979, J BIOL CHEM, V254, P483; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; SCHERZINGER E, 1977, EUR J BIOCHEM, V72, P543, DOI 10.1111/j.1432-1033.1977.tb11278.x; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; TABOR S, 1981, P NATL ACAD SCI-BIOL, V78, P205, DOI 10.1073/pnas.78.1.205; TABOR S, 1987, J BIOL CHEM, V262, P16212; Tougu K, 1996, J BIOL CHEM, V271, P21398, DOI 10.1074/jbc.271.35.21398; Waksman G, 2000, NAT STRUCT BIOL, V7, P20, DOI 10.1038/71215; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825; Yu X, 1996, NAT STRUCT BIOL, V3, P740, DOI 10.1038/nsb0996-740	55	34	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21809	21820		10.1074/jbc.M101470200	http://dx.doi.org/10.1074/jbc.M101470200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279245	Green Published, hybrid			2022-12-27	WOS:000169297900132
J	Perumal, K; Sinha, K; Henning, D; Reddy, R				Perumal, K; Sinha, K; Henning, D; Reddy, R			Purification, characterization, and cloning of the cDNA of human signal recognition particle RNA 3 '-adenylating enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A) POLYMERASE; PROTEIN; DOMAIN; ADENYLATION; SEQUENCE; BINDING; GUANYLYLTRANSFERASE; PHOSPHORYLATION; IDENTIFICATION; CONSERVATION	The 3'-terminal adenylic acid residue in several human small RNAs including signal recognition particle (SRP) RNA, nuclear 7SK RNA, U2 small nuclear RNA, and ribosomal 5S RNA is caused by a post-transcriptional adenylation event (Sinha, K., Gu, J., Chen, Y., and Reddy, R. (1998) J. Biol. Chem. 273, 6853-6859), Using the Alu portion of the SRP RNA as a substrate in an in vitro adenylation assay, we purified an adenylating enzyme that adds adenylic acid residues to SRP/Alu RNA from the HeLa cell nuclear extract. All the peptide sequences obtained by microsequencing of the purified enzyme matched a unique human cDNA corresponding to a new adenylating enzyme having homologies to the well characterized mRNA poly(A) polymerase, The amino terminus region of the human SRP RNA adenylating enzyme showed similar to 75% homology to the amino terminus of the human mRNA poly(A) polymerase that includes the catalytic domain. The carboxyl terminus of the human SRP RNA adenylating enzyme showed less than 25% homology to the carboxyl terminus of poly(A) polymerase, which interacts with other factors and provides specificity. The SRP RNA adenylating enzyme is coded far by a gene located on chromosome 2 in contrast to the poly(A) polymerase gene, which is located on chromosome 14, A recombinant protein for the SRP RNA adenylating enzyme was prepared, and its activity was compared with the purified enzyme from HeLa cells. The data indicate that in addition to the SRP RNA adenylating enzyme, other factors may be required to carry out accurate 3'-end adenylation of SRP RNA.	Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine	Reddy, R (corresponding author), Baylor Coll Med, Dept Pharmacol, 1 Baylor Plaza, Houston, TX 77030 USA.	rreddy@bcm.tmc.edu						BLACK DL, 1985, CELL, V42, P737, DOI 10.1016/0092-8674(85)90270-3; Bond GL, 2000, MOL CELL BIOL, V20, P5310, DOI 10.1128/MCB.20.14.5310-5320.2000; Chen YH, 1998, J BIOL CHEM, V273, P35023, DOI 10.1074/jbc.273.52.35023; Chen YH, 2000, RNA, V6, P1277, DOI 10.1017/S1355838200000285; Colgan DF, 1996, NATURE, V384, P282, DOI 10.1038/384282a0; Colgan DF, 1998, EMBO J, V17, P1053, DOI 10.1093/emboj/17.4.1053; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Jacobson MR, 1998, P NATL ACAD SCI USA, V95, P7981, DOI 10.1073/pnas.95.14.7981; LI WY, 1982, J BIOL CHEM, V257, P5136; LINGNER J, 1991, NATURE, V354, P496, DOI 10.1038/354496a0; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; MARTIN SA, 1976, J BIOL CHEM, V251, P7313; MAXWELL ES, 1995, ANNU REV BIOCHEM, V64, P897, DOI 10.1146/annurev.bi.64.070195.004341; MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672; OBRIEN CA, 1994, GENE DEV, V8, P2891, DOI 10.1101/gad.8.23.2891; PARKER R, 1987, CELL, V49, P229, DOI 10.1016/0092-8674(87)90564-2; Perumal K, 2000, MOL CELL BIOCHEM, V208, P99, DOI 10.1023/A:1007098122583; RAABE T, 1994, MOL CELL BIOL, V14, P2946, DOI 10.1128/MCB.14.5.2946; REDDY R, 1984, J BIOL CHEM, V259, P2265; SHUMAN S, 1982, J BIOL CHEM, V257, P7237; SHUMYATSKY G, 1993, NUCLEIC ACIDS RES, V21, P4756, DOI 10.1093/nar/21.20.4756; Sinha KM, 1998, J BIOL CHEM, V273, P6853, DOI 10.1074/jbc.273.12.6853; Sinha R, 1999, J BIOL CHEM, V274, P30826, DOI 10.1074/jbc.274.43.30826; STEITZ JA, 1998, STRUCTURE FUNCTION M, P115; STRUB K, 1991, MOL CELL BIOL, V11, P3949, DOI 10.1128/MCB.11.8.3949; TING J, 1988, DNA-J MOLEC CELL BIO, V7, P275, DOI 10.1089/dna.1988.7.275; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; ULLU E, 1984, EMBO J, V3, P3303, DOI 10.1002/j.1460-2075.1984.tb02294.x; ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0; WAHLE E, 1991, EMBO J, V10, P4251, DOI 10.1002/j.1460-2075.1991.tb05003.x; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; Weichenrieder O, 1997, RNA, V3, P1262; Zhao WQ, 1998, MOL CELL BIOL, V18, P5010, DOI 10.1128/MCB.18.9.5010; Zhao WQ, 1996, MOL CELL BIOL, V16, P2378; ZHELKOVSKY AM, 1995, J BIOL CHEM, V270, P26715, DOI 10.1074/jbc.270.44.26715	36	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21791	21796		10.1074/jbc.M101905200	http://dx.doi.org/10.1074/jbc.M101905200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11287430	hybrid			2022-12-27	WOS:000169297900130
J	Shackelford, RE; Innes, CL; Sieber, SO; Heinloth, AN; Leadon, SA; Paules, RS				Shackelford, RE; Innes, CL; Sieber, SO; Heinloth, AN; Leadon, SA; Paules, RS			The Ataxia telangiectasia gene product is required for oxidative stress-induced G(1) and G(2) checkpoint function in human fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XERODERMA-PIGMENTOSUM; IONIZING-RADIATION; HYDROGEN-PEROXIDE; SKIN FIBROBLASTS; CELL; ATM; DAMAGE; CANCER; REPAIR; P53	Ataxia telangiectasia (AT) is an autosomal recessive disorder characterized by neuronal degeneration accompanied by ataxia, telangiectasias, acute cancer predisposition, and sensitivity to ionizing radiation (IR). Cells from individuals with AT show unusual sensitivity to IR, severely attenuated cell cycle checkpoint functions, and poor p53 induction in response to IR compared with normal human fibroblasts (NHFs), The gene mutated in AT (ATM) has been cloned, and its product, pATM, has IR-inducible kinase activity. The AT phenotype has been suggested to be a consequence, at least in part, of an inability to respond appropriately to oxidative damage. To test this hypothesis, we examined the ability of NHFs and AT dermal fibroblasts to respond to t-butyl hydroperoxide and IR treatment. Ar fibroblasts exhibit, in comparison to NHFs, increased sensitivity to the toxicity of t-butyl hydroperoxide, as measured by colony-forming efficiency assays. Unlike NHFs, AT fibroblasts fail to show G(1) and G(2) phase checkpoint functions or to induce p53 in response to t-butyl hydroperoxide. Treatment of NHFs with t-butyl hydroperoxide activates pATM-associated kinase activity. Our results indicate that pATM is involved in responding to certain aspects of oxidative damage and in signaling this information to downstream effecters of the cell cycle checkpoint functions. Our data further suggest that some of the pathologies seen in AT could arise as a consequence of an inability to respond normally to oxidative damage.	NIEHS, Growth Control & Canc Grp, NIH, Res Triangle Pk, NC 27709 USA; Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Paules, RS (corresponding author), NIEHS, Growth Control & Canc Grp, NIH, Mail Drop F1-05,111 Alexander Dr,POB 12233, Res Triangle Pk, NC 27709 USA.	paules@niehs.nih.gov		Paules, Richard S/0000-0001-9106-7486	NCI NIH HHS [CA40453] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES021157, ZIAES021157] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915; BEAMISH H, 1994, INT J RADIAT BIOL, V65, P175, DOI 10.1080/09553009414550211; BEAMISH H, 1994, RADIAT RES, V138, pS130, DOI 10.2307/3578780; Boder E, 1970, Psychiatr Neurol Med Psychol Beih, V13-14, P8; BODER E, 1985, ATAXIA TELANGIECTASI, V19, P1; BOYER JC, 1990, CANCER RES, V50, P2593; Broeks A, 2000, AM J HUM GENET, V66, P494, DOI 10.1086/302746; CANMAN CE, 1994, CANCER RES, V54, P5054; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; CONGER AD, 1952, P NATL ACAD SCI USA, V38, P289, DOI 10.1073/pnas.38.4.289; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; EASTON DF, 1994, INT J RADIAT BIOL, V66, pS177, DOI 10.1080/09553009414552011; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Flattery-O'Brien JA, 1998, J BIOL CHEM, V273, P8564, DOI 10.1074/jbc.273.15.8564; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; Gilad S, 1996, HUM MOL GENET, V5, P2033, DOI 10.1093/hmg/5.12.2033; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Green MHL, 1997, FREE RADICAL BIO MED, V22, P343, DOI 10.1016/S0891-5849(96)00336-X; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; KAUFMANN WK, 1995, CANCER RES, V55, P7; Kaufmann WK, 1997, CELL GROWTH DIFFER, V8, P1105; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Le XC, 1998, SCIENCE, V280, P1066, DOI 10.1126/science.280.5366.1066; MCKINNON PJ, 1987, HUM GENET, V75, P197, DOI 10.1007/BF00281059; MEREDITH MJ, 1987, CANCER RES, V47, P4576; MEYN MS, 1993, SCIENCE, V260, P1327, DOI 10.1126/science.8493577; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; PAINTER RB, 1976, BIOCHIM BIOPHYS ACTA, V418, P146, DOI 10.1016/0005-2787(76)90063-0; PAULES RS, 1995, CANCER RES, V55, P1763; Regoli F, 1999, TOXICOL APPL PHARM, V156, P96, DOI 10.1006/taap.1999.8637; Rotman G, 1997, BIOESSAYS, V19, P911, DOI 10.1002/bies.950191011; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; SCOTT D, 1994, INT J RADIAT BIOL, V66, pS157, DOI 10.1080/09553009414551991; Sedgwick R, 1991, HDB CLIN NEUROLOGY, P347; Shackelford RE, 1999, ENVIRON HEALTH PERSP, V107, P5, DOI 10.2307/3434468; SHILOH Y, 1982, EXP CELL RES, V140, P191, DOI 10.1016/0014-4827(82)90169-0; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; VUILLAUME M, 1987, MUTAT RES, V186, P43, DOI 10.1016/0165-1110(87)90014-5; VUILLAUME M, 1989, CARCINOGENESIS, V10, P1375, DOI 10.1093/carcin/10.8.1375; VUILLAUME M, 1986, CANCER RES, V46, P538; WARD AJ, 1994, ENVIRON MOL MUTAGEN, V24, P103, DOI 10.1002/em.2850240205; Watters D, 1999, J BIOL CHEM, V274, P34277, DOI 10.1074/jbc.274.48.34277; WINSTON GW, 1983, BIOCHEM J, V216, P415, DOI 10.1042/bj2160415; Xie GF, 1998, ONCOGENE, V16, P721, DOI 10.1038/sj.onc.1201793; ZAMPETTIBOSSELER F, 1981, INT J RADIAT BIOL, V39, P547, DOI 10.1080/09553008114550651	50	101	101	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21951	21959		10.1074/jbc.M011303200	http://dx.doi.org/10.1074/jbc.M011303200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11290740	Green Published, hybrid			2022-12-27	WOS:000169297900150
J	Chang, BY; Chiang, ML; Cartwright, CA				Chang, BY; Chiang, ML; Cartwright, CA			The interaction of Src and RACK1 is enhanced by activation of protein kinase C and tyrosine phosphorylation of RACK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; ADRENERGIC-RECEPTOR KINASE; MIDDLE TUMOR-ANTIGEN; NIH 3T3 CELLS; WD-REPEAT; SIGNAL-TRANSDUCTION; SH2 DOMAIN; MONOCLONAL-ANTIBODIES; ANCHORING PROTEINS; SCAFFOLD PROTEIN	RACK1 is an intracellular receptor for the serine/threonine protein kinase C. Previously, we demonstrated that RACK1 also interacts with the Src protein-tyrosine kinase. RACK1, via its association with these protein kinases, may play a key role in signal transduction. To further characterize the Src-RACK1 interaction and to analyze mechanisms by which cross-talk occurs between the two RACK1-linked signaling kinases, we identified sites on Src and RACK1 that mediate their binding, and factors that regulate their interaction. We found that the interaction of Src and RACK1 is mediated, in part, by the SH2 domain of Src and by phosphotyrosines in the sixth WD repeat of RACK1, and is enhanced by serum or platelet-derived growth factor stimulation, protein kinase C activation, and tyrosine phosphorylation of RACK1. To the best of our knowledge, this is the first report of tyrosine phosphorylation of a member of the WD repeat family of proteins. We think that tyrosine phosphorylation of these proteins is an important mechanism of signal transduction in cells.	Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA	Stanford University	Cartwright, CA (corresponding author), Stanford Univ, Sch Med, Dept Med, CCSR Bldg,Rm 3115C,269 Campus Dr, Stanford, CA 94305 USA.				NCI NIH HHS [CA69810] Funding Source: Medline; NIDDK NIH HHS [R01 DK43743] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA069810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043743] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; BOLEN JB, 1984, CELL, V38, P767, DOI 10.1016/0092-8674(84)90272-1; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CARTWRIGHT CA, 1985, MOL CELL BIOL, V5, P2647, DOI 10.1128/MCB.5.10.2647; CARTWRIGHT CA, 1986, MOL CELL BIOL, V6, P1562, DOI 10.1128/MCB.6.5.1562; CARTWRIGHT CA, 1990, P NATL ACAD SCI USA, V87, P558, DOI 10.1073/pnas.87.2.558; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; CHEN RH, 1995, NATURE, V377, P548, DOI 10.1038/377548a0; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; COOPER JA, 1984, J BIOL CHEM, V259, P7835; COURTNEIDGE SA, 1983, NATURE, V303, P435, DOI 10.1038/303435a0; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; DISTNIK MH, 1994, P NATL ACAD SCI USA, V91, P559; Emkey R, 1997, J BIOL CHEM, V272, P31172, DOI 10.1074/jbc.272.49.31172; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; GarciaHiguera I, 1996, BIOCHEMISTRY-US, V35, P13985, DOI 10.1021/bi9612879; Gekeler V, 1996, BRIT J CANCER, V74, P897, DOI 10.1038/bjc.1996.454; GLENNEY JR, 1988, J IMMUNOL METHODS, V109, P277, DOI 10.1016/0022-1759(88)90253-0; HARDIE DG, 1993, PROTEIN PHOSPHORYLAT, P231; Jou TS, 1998, J CELL BIOL, V142, P85, DOI 10.1083/jcb.142.1.85; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; LIAO J, 1995, J CELL BIOL, V131, P1291, DOI 10.1083/jcb.131.5.1291; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; LIU XQ, 1993, ONCOGENE, V8, P1119; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mochly-Rosen D, 1998, ADV PHARMACOL, V44, P91, DOI 10.1016/S1054-3589(08)60126-X; Mochly-Rosen D, 1998, FASEB J, V12, P35; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; MOCHLYROSEN D, 1992, BIOCHEMISTRY-US, V31, P8120, DOI 10.1021/bi00150a003; MOYERS JS, 1993, MOL CELL BIOL, V13, P2391, DOI 10.1128/MCB.13.4.2391; MULLER F, 1995, MOL GEN GENET, V248, P162, DOI 10.1007/BF02190797; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Neer EJ, 1996, CELL, V84, P175, DOI 10.1016/S0092-8674(00)80969-1; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; PARK J, 1995, MOL CELL BIOL, V15, P2374; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; RodriguezFernandez JL, 1996, J BIOL CHEM, V271, P27895, DOI 10.1074/jbc.271.44.27895; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1994, J BIOL CHEM, V269, P21395; Ron D, 1999, J BIOL CHEM, V274, P19003, DOI 10.1074/jbc.274.27.19003; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Shanmugam M, 1998, ONCOGENE, V16, P1649, DOI 10.1038/sj.onc.1201684; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; Walter AO, 1999, ONCOGENE, V18, P1911, DOI 10.1038/sj.onc.1202513; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; Zang Q, 1997, J BIOL CHEM, V272, P13275, DOI 10.1074/jbc.272.20.13275; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZHOU SY, 1995, METHOD ENZYMOL, V254, P523; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	61	144	149	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20346	20356		10.1074/jbc.M101375200	http://dx.doi.org/10.1074/jbc.M101375200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279199	hybrid			2022-12-27	WOS:000169135100092
J	Grassme, H; Jekle, A; Riehle, A; Schwarz, H; Berger, J; Sandhoff, K; Kolesnick, R; Gulbins, E				Grassme, H; Jekle, A; Riehle, A; Schwarz, H; Berger, J; Sandhoff, K; Kolesnick, R; Gulbins, E			CD95 signaling via ceramide-rich membrane rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACIDIC SPHINGOMYELINASE; RECEPTOR; ASSOCIATION; CAVEOLAE; TNF; LOCALIZATION; CHOLESTEROL; PATHWAYS; PROTEINS; LIGAND	Clustering seems to be employed by many receptors for transmembrane signaling. Here, we show that acid sphingomyelinase (ASM)-released ceramide is essential for clustering of CD95, In vitro and in vivo, extracellularly orientated ceramide, released upon CD95-triggered translocation of ASM to the plasma membrane outer surface, enabled clustering of CD95 in sphingo lipid-rich membrane rafts and apoptosis induction. Whereas ASM deficiency, destruction of rafts, or neutralization of surface ceramide prevented CD95 clustering and apoptosis, natural ceramide only rescued ASM-deficient cells. The data suggest CD95-mediated clustering by ceramide is prerequisite for signaling and death.	St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; Max Planck Inst Dev Biol, D-72076 Teubingen, Germany; Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA	St Jude Children's Research Hospital; University of Bonn; Max Planck Society; Memorial Sloan Kettering Cancer Center	Gulbins, E (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale, Memphis, TN 38105 USA.	erich.gulbins@stjude.org	Gulbins, Erich/L-6989-2014	Gulbins, Erich/0000-0002-3117-1342; Jekle, Andreas/0000-0001-9416-2622	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; Bilderback TR, 1997, J BIOL CHEM, V272, P10922; BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; BOUCHER LM, 1995, J EXP MED, V181, P2059, DOI 10.1084/jem.181.6.2059; Brenner B, 1998, CELL DEATH DIFFER, V5, P29, DOI 10.1038/sj.cdd.4400307; Brenner B, 1998, EXP CELL RES, V243, P123, DOI 10.1006/excr.1998.4146; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; Drzewiecka A, 1999, ACTA BIOCHIM POL, V46, P107, DOI 10.18388/abp.1999_4188; Gijon MA, 1997, SEMIN CELL DEV BIOL, V8, P297, DOI 10.1006/scdb.1997.0151; Grassme H, 1997, CELL, V91, P605, DOI 10.1016/S0092-8674(00)80448-1; Grassme H, 2000, SCIENCE, V290, P527, DOI 10.1126/science.290.5491.527; GRAZIADEI L, 1990, NATURE, V347, P396, DOI 10.1038/347396a0; Gulbins E, 2000, AM J PHYSIOL-RENAL, V279, pF605, DOI 10.1152/ajprenal.2000.279.4.F605; Holopainen JM, 1998, BIOCHEMISTRY-US, V37, P17562, DOI 10.1021/bi980915e; Huang HW, 1999, BIOPHYS J, V77, P1489, DOI 10.1016/S0006-3495(99)76996-1; Ko YG, 1999, J IMMUNOL, V162, P7217; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Maxfield FR, 1997, ADV EXP MED BIOL, V419, P355; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Murakami M, 1999, J BIOL CHEM, V274, P29927, DOI 10.1074/jbc.274.42.29927; Natoli G, 1998, BIOCHEM PHARMACOL, V56, P915, DOI 10.1016/S0006-2952(98)00154-3; Ni HT, 1999, J IMMUNOL, V162, P5183; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; ROSENMAN SJ, 1993, J LEUKOCYTE BIOL, V53, P1; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; Shin JS, 2000, SCIENCE, V289, P785, DOI 10.1126/science.289.5480.785; Simarro M, 1999, J IMMUNOL, V162, P5149; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; tenGrotenhuis E, 1996, BIOPHYS J, V71, P1389, DOI 10.1016/S0006-3495(96)79341-4; Veiga MP, 1999, BIOPHYS J, V76, P342, DOI 10.1016/S0006-3495(99)77201-2; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456	35	493	508	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20589	20596		10.1074/jbc.M101207200	http://dx.doi.org/10.1074/jbc.M101207200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279185	hybrid			2022-12-27	WOS:000169135100123
J	Seitz, C; Muller, P; Krieg, RC; Mannel, DN; Hehlgans, T				Seitz, C; Muller, P; Krieg, RC; Mannel, DN; Hehlgans, T			A novel p75TNF receptor isoform mediating NF kappa B activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; TNF RECEPTOR; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; VIRAL-PROTEINS; EXPRESSION; PROLIFERATION; CYTOTOXICITY; FAMILY; CELLS	We report the identification of a novel p75TNF receptor isoform termed icp75TNFR, which is generated by the use of an alternative transcriptional start site within the p75TNFR gene and characterized by regulated intracellular expression. The icp75TNFR protein has an apparent molecular mass of similar to 50 kDa and is recognized by antibodies generated against the transmembrane form of p75TNFR. The icp75TNFR binds the tumor necrosis factor(TNF) and mediates intracellular signaling. Overexpression of the icp75TNFR cDNA results in TNF-induced activation of NF kappaB in a TNF receptor-associated factor 2 (TRAF2)-dependent manner. Thus, our results provide an example for intracellular cytokine receptor activation.	Univ Regensburg, Dept Pathol Tumor Immunol, D-93042 Regensburg, Germany	University of Regensburg	Mannel, DN (corresponding author), Univ Regensburg, Dept Pathol Tumor Immunol, Franz Josef Str Allee, D-93042 Regensburg, Germany.							Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93; ERIKSTEIN BK, 1991, EUR J IMMUNOL, V21, P1033, DOI 10.1002/eji.1830210426; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Grell M, 1998, EUR J IMMUNOL, V28, P257, DOI 10.1002/(SICI)1521-4141(199801)28:01<257::AID-IMMU257>3.0.CO;2-G; Haridas V, 1998, J IMMUNOL, V160, P3152; HELLER RA, 1992, CELL, V70, P47; Ledgerwood EC, 1998, LAB INVEST, V78, P1583; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; MASON AT, 1995, J LEUKOCYTE BIOL, V58, P249, DOI 10.1002/jlb.58.2.249; PFIZENMAIER K, 1992, TUMOR NECROSIS FACTO; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; Seitz C, 1998, GENOMICS, V48, P111, DOI 10.1006/geno.1997.5161; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; TARTAGLIA LA, 1993, J IMMUNOL, V151, P4637; TSUJIMOTO M, 1985, P NATL ACAD SCI USA, V82, P7626, DOI 10.1073/pnas.82.22.7626; VANDENABEELE P, 1992, J EXP MED, V176, P1015, DOI 10.1084/jem.176.4.1015; VERCAMMEN D, 1995, CYTOKINE, V7, P463, DOI 10.1006/cyto.1995.0063	20	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19390	19395		10.1074/jbc.M101336200	http://dx.doi.org/10.1074/jbc.M101336200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279196	hybrid			2022-12-27	WOS:000169091000100
J	Chen, JL; Tsai, LC; Wen, TN; Tang, JB; Yuan, HS; Shyur, LF				Chen, JL; Tsai, LC; Wen, TN; Tang, JB; Yuan, HS; Shyur, LF			Directed mutagenesis of specific active site residues on Fibrobacter succinogenes 1,3-1,4-beta-D-glucanase significantly affects catalysis and enzyme structural stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOSTABLE BETA-GLUCANASE; ACID-SEQUENCE SIMILARITIES; BACILLUS-LICHENIFORMIS; ESCHERICHIA-COLI; ENDO-1,3-1,4-BETA-D-GLUCAN 4-GLUCANOHYDROLASE; CLOSTRIDIUM-THERMOCELLUM; PROTEIN STRUCTURES; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; GENE	The functional and structural significance of amino acid residues Met(39), Glu(56), Asp(58), Glu(601) and Gly(63) Of Fibrobacter succinogenes 1,3-1,4-beta -D-glucanase was explored by the approach of site-directed mutagenesis, initial rate kinetics, fluorescence spectroscopy, and CD spectrometry, Glu(56), Asp(58), Glu(60), and Gly(63) residues are conserved among known primary sequences of the bacterial and fungal enzymes. Kinetic analyses revealed that 240-, 540-, 570-, and 880-fold decreases in K-cat were observed for the E56D, E60D, D58N, and D58E mutant enzymes, respectively, with a similar substrate affinity relative to the wild type enzyme. In contrast, no detectable enzymatic activity was observed for the E56A, E56Q, D58A, E60A, and E60Q mutants. These results indicated that the carboxyl side chain at positions 56 and 60 is mandatory for enzyme catalysis, M39F, unlike the other mutants, exhibited a 5-fold increase in K-m value. Lower thermostability was found with the G63A mutant when compared with wild type or other mutant forms of F. succinogenes 1,3-1,4-beta -D-glucanase. Denatured wild type and mutant enzymes were, however, recoverable as active enzymes when 8 M urea was employed as the denaturant. Structural modeling and kinetic studies suggest that Glu(56), Asp(58) and Glu(60) residues apparently play important role(s) in the catalysis off. succinogenes 1,3-1,4-beta -D-glucanase.	Acad Sinica, Inst Bioagr Sci, Taipei 115, Taiwan; Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; Acad Sinica, Inst Bot, Taipei 115, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Shyur, LF (corresponding author), Acad Sinica, Inst Bioagr Sci, Taipei 11529, Taiwan.		Yuan, Hanna S./AAA-4005-2021; Chia, linda/B-3406-2011	Yuan, Hanna S./0000-0001-9671-6967; 				BORRISS R, 1990, MOL GEN GENET, V222, P278, DOI 10.1007/BF00633829; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen HZ, 1997, J BACTERIOL, V179, P6028, DOI 10.1128/jb.179.19.6028-6034.1997; Cheng YS, 2000, J MOL BIOL, V302, P1139, DOI 10.1006/jmbi.2000.4123; DAKHOVA ON, 1993, BIOCHEM BIOPH RES CO, V194, P1359, DOI 10.1006/bbrc.1993.1974; GOSALBES MJ, 1991, J BACTERIOL, V173, P7705, DOI 10.1128/jb.173.23.7705-7710.1991; Gueguen Y, 1997, J BIOL CHEM, V272, P31258, DOI 10.1074/jbc.272.50.31258; HAHN M, 1995, J BIOL CHEM, V270, P3081, DOI 10.1074/jbc.270.7.3081; HAHN M, 1995, EUR J BIOCHEM, V232, P849, DOI 10.1111/j.1432-1033.1995.tb20883.x; HAHN M, 1994, P NATL ACAD SCI USA, V91, P10417, DOI 10.1073/pnas.91.22.10417; Heinemann U, 1996, BIOL CHEM, V377, P447; HEINEMANN U, 1995, TRENDS BIOCHEM SCI, V20, P349, DOI 10.1016/S0968-0004(00)89073-8; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HOFEMEISTER J, 1986, GENE, V49, P177, DOI 10.1016/0378-1119(86)90278-7; HOJ PB, 1992, J BIOL CHEM, V267, P25059; JUNCOSA M, 1994, J BIOL CHEM, V269, P14530; KEITEL T, 1993, P NATL ACAD SCI USA, V90, P5287, DOI 10.1073/pnas.90.11.5287; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LLOBERAS J, 1991, EUR J BIOCHEM, V197, P337, DOI 10.1111/j.1432-1033.1991.tb15916.x; LOUW ME, 1993, APPL MICROBIOL BIOT, V38, P507, DOI 10.1007/BF00242946; MALET C, 1993, BIOCHEM J, V296, P753, DOI 10.1042/bj2960753; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; NELSON M, 1992, METHOD ENZYMOL, V216, P279; Parrado J, 1996, BBA-PROTEIN STRUCT M, V1296, P145, DOI 10.1016/0167-4838(96)00062-3; Piruzian ES, 1998, MOL GEN GENET, V257, P561, DOI 10.1007/s004380050682; SANCHEZ R, 1997, T AM CRYST ASS, V32, P81; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sauer RT, 1996, FASEB J, V10, P42, DOI 10.1096/fasebj.10.1.8566546; SCHIMMING S, 1992, EUR J BIOCHEM, V204, P13, DOI 10.1111/j.1432-1033.1992.tb16600.x; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SPILLIAERT R, 1994, EUR J BIOCHEM, V224, P923, DOI 10.1111/j.1432-1033.1994.00923.x; STEWART CS, 1989, APPL MICROBIOL BIOT, V30, P433; TEATHER RM, 1990, J BACTERIOL, V172, P3837, DOI 10.1128/jb.172.7.3837-3841.1990; Viladot JL, 1998, BIOCHEMISTRY-US, V37, P11332, DOI 10.1021/bi980586q; WOLF M, 1995, MICROBIOL-UK, V141, P281, DOI 10.1099/13500872-141-2-281	39	24	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17895	17901		10.1074/jbc.M100843200	http://dx.doi.org/10.1074/jbc.M100843200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279139	hybrid			2022-12-27	WOS:000168866500039
J	Hamm, JK; Park, BH; Farmer, SR				Hamm, JK; Park, BH; Farmer, SR			A role for C/EBP beta in regulating peroxisome proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1 preadipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTES ADIPOCYTE DIFFERENTIATION; PPAR-GAMMA; TRANSCRIPTION FACTORS; BINDING-PROTEINS; GENE-EXPRESSION; MESSENGER-RNA; FATTY-ACIDS; ALPHA; ISOFORMS; FIBROBLASTS	The differentiation of 3T3-L1 preadipocytes is regulated in part by a cascade of transcriptional events involving activation of the CCAAT/enhancer-binding proteins (C/EBPs) and peroxisome proliferator-activated receptor gamma (PPAR gamma) by dexamethasone (DEX), 3-isobutyl-1-methylxanthine (MIX), and insulin. In this study, we demonstrate that exposure of 3T3-L1 preadipocytes to DEX and insulin fails to induce adipogenesis as indicated by a lack of C/EBP alpha, PPAR gamma2, and adipose protein 2/fatty acid-binding protein expression; however, PPAR gamma1 is expressed. Treatment of these MM-deficient cells with a PPAR gamma ligand, troglitazone, induces C/EBP alpha expression and rescues the block in adipogenesis, In this regard, we also show that induction of C/EBP alpha gene expression by troglitazone in C3H10T1/2 cells ectopically expressing PPAR gamma occurs in the absence of ongoing protein synthesis, suggesting a direct transactivation of the C/EBP alpha gene by PPAR gamma, Furthermore, ectopic expression of a dominant negative isoform of C/EBP beta (liver-enriched transcriptional inhibitory protein (LIP)) inhibits the induction of C/EBP alpha, PPAR gamma2, and adipose protein 2/fatty acid-binding protein by DEX, MM, and insulin in 3T3-L1 cells without affecting the induction of PPAR gamma1 by DEX, Exposure of LIP-expressing preadipocytes to troglitazone along with DEX, MM, and insulin induces differentiation into adipocytes. Additionally, we show that sustained expression of C/EBP alpha in these LIP-expressing adipocytes requires constant exposure to troglitazone. Taken together, these observations suggest that inhibition of C/EBP beta activity not only blocks C/EBP alpha and PPAR gamma2 expression, but it also renders the preadipocytes dependent on an exogenous PPAR gamma ligand for their differentiation into adipocytes, We propose, therefore, an additional role for C/EBP beta in regulating PPAR gamma activity during adipogenesis, and we suggest an alternative means of inducing preadipocyte differentiation that relies on the dexamethasone-associated induction of PPAR gamma1 expression.	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Farmer, SR (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St, Boston, MA 02118 USA.	farmer@biochem.bumc.bu.edu		Farmer, Stephen/0000-0003-2483-2795	NIDDK NIH HHS [DK51586] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK051586, R01DK051586] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; El-Jack AK, 1999, J BIOL CHEM, V274, P7946, DOI 10.1074/jbc.274.12.7946; Elberg G, 2000, J BIOL CHEM, V275, P27815; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Fajas L, 1998, FEBS LETT, V438, P55, DOI 10.1016/S0014-5793(98)01273-3; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; Morrison RF, 1999, J CELL BIOCHEM, P59; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; RANA B, 1995, J BIOL CHEM, V270, P18123, DOI 10.1074/jbc.270.30.18123; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Welm AL, 1999, MOL CELL BIOL, V19, P1695; Wu ZD, 1999, CURR OPIN CELL BIOL, V11, P689, DOI 10.1016/S0955-0674(99)00037-X; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	39	204	212	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18464	18471		10.1074/jbc.M100797200	http://dx.doi.org/10.1074/jbc.M100797200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279134	hybrid			2022-12-27	WOS:000168866500113
J	Jaiswal, AS; Narayan, S				Jaiswal, AS; Narayan, S			p53-dependent transcriptional regulation of the APC promoter in colon cancer cells treated with DNA alkylating agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; DAMAGE-INDUCED PHOSPHORYLATION; CYCLIN-DEPENDENT KINASES; BETA-CATENIN; COLORECTAL-CANCER; HUMAN P53; MESSENGER-RNA; LUNG-CANCER; C-MYC; BINDING	The APC (adenomatous polyposis coli) gene product is involved in cell cycle arrest and in apoptosis, The loss of APC function is associated with the development of colorectal carcinogenesis. In previous studies, we have shown that the APC gene is inducible and that the DNA damage-induced level of APC mRNA requires p53, In the present study, we examined the role of p53 in the transcriptional regulation of APC promoter and characterized two p53-binding sites on the cloned APC promoter (pAPCP), Results of electrophoretic mobility shift assay showed specific interactions of p53 protein with p53-binding site oligonucleotides. The DNA-protein complex formed in electrophoretic mobility shift assay was competed with unlabeled excess of p53-binding site oligonucleotide, unaffected with p53-binding site mutant or Spl-binding site oligonucleotides, and supershifted with anti-p53 antibodies. In a transient transfection assay, the pAPCP promoter activity was lower in HCT-116(p53(+/+)) cells versus HCT-116(p53(-/-)) cells. p53-dependent down-regulation was further confirmed after co-transfection of pAPCP plasmid with pCMV-p53 into HCT-116(p53(-/-)) and SAOS-S (p53-negative) cells. However, the treatment of cells with DNA alkylating agents methylmethane sulfonate and N-methyl-N'-nitro-N-nitrosoguanidine, which cause phosphorylation of p53 at Ser(15) and Ser(392), induced pAPCP promoter activity in HCT-116(p53(+/+)) cells. Other than p53-binding sites, using deletion mutation constructs, we have shown that N-methyl-N'-nitro-N-nitrosoguanidine-induced transcriptional activation of the pAPCP promoter in HCT-116(p53(+/+)) cells depended upon the Sp1-binding: site and the E-box B site. From these results, we conclude that unphosphorylated p53 can down-regulate and phosphorylated p53 can up-regulate the pAPCP promoter activity involving the p53, Sp1, or E-box B elements. These studies are important to understanding the role of p53 and APC in DNA damage-induced cell cycle arrest and/or apoptosis of cancer cells.	Univ Florida, Coll Med, Shands Canc Ctr, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Narayan, S (corresponding author), Univ Florida, Coll Med, Shands Canc Ctr, Acad Res Bldg,Rm R4-216,POB 100232, Gainesville, FL 32610 USA.				NATIONAL CANCER INSTITUTE [R01CA077721] Funding Source: NIH RePORTER; NCI NIH HHS [CA77721] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; BAEG GH, 1995, EMBO J, V14, P5618, DOI 10.1002/j.1460-2075.1995.tb00249.x; Bargonetti J, 1997, CELL MOL BIOL, V43, P935; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Blaydes JP, 1998, ONCOGENE, V17, P1045, DOI 10.1038/sj.onc.1202014; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Duckett DR, 1999, P NATL ACAD SCI USA, V96, P12384, DOI 10.1073/pnas.96.22.12384; EIBNER M, 1994, MED GENET, V6, P155; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FUCHS B, 1995, EUR J BIOCHEM, V228, P625, DOI 10.1111/j.1432-1033.1995.0625m.x; Furuuchi K, 2000, AM J PATHOL, V156, P1997, DOI 10.1016/S0002-9440(10)65072-9; Goss KH, 2000, J CLIN ONCOL, V18, P1967, DOI 10.1200/JCO.2000.18.9.1967; GOYETTE MC, 1992, MOL CELL BIOL, V12, P1387, DOI 10.1128/MCB.12.3.1387; GRODEN J, 1995, CANCER RES, V55, P1531; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; HARGEST R, 1995, GUT, V37, P826, DOI 10.1136/gut.37.6.826; HARPER JW, 1993, CELL, V75, P805; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hecker D, 1996, ONCOGENE, V12, P953; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Hoeijmakers JHJ, 1996, CURR OPIN GENET DEV, V6, P26, DOI 10.1016/S0959-437X(96)90006-4; Ichii Shigetoshi, 1992, Human Molecular Genetics, V1, P387, DOI 10.1093/hmg/1.6.387; Ikeda S, 2000, ONCOGENE, V19, P537, DOI 10.1038/sj.onc.1203359; Ilyas M, 1999, EUR J CANCER, V35, P1986, DOI 10.1016/S0959-8049(99)00298-1; Jaiswal AS, 1998, INT J ONCOL, V13, P733; Jaiswal AS, 1999, ONCOL REP, V6, P1253; Jaiswal AS, 2001, J CELL BIOCHEM, V81, P262, DOI 10.1002/1097-4644(20010501)81:2<262::AID-JCB1041>3.0.CO;2-R; Karuppayil SM, 1998, J BIOL CHEM, V273, P17303, DOI 10.1074/jbc.273.28.17303; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Ljungman M, 2000, NEOPLASIA, V2, P208, DOI 10.1038/sj.neo.7900073; MACK DH, 1993, NATURE, V363, P281, DOI 10.1038/363281a0; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; MEDIROS AC, 1994, CANCER EPIDEM BIOMAR, V3, P331; Meek DW, 2000, PATHOL BIOL, V48, P246; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nakagawa K, 1999, MOL CELL BIOL, V19, P2828; Narayan S, 1997, J BIOL CHEM, V272, P30619, DOI 10.1074/jbc.272.49.30619; Neufeld KL, 2000, P NATL ACAD SCI USA, V97, P12085, DOI 10.1073/pnas.220401797; Neufeld KL, 1997, P NATL ACAD SCI USA, V94, P3034, DOI 10.1073/pnas.94.7.3034; Ohlsson C, 1998, ENDOCRINOLOGY, V139, P1101, DOI 10.1210/en.139.3.1101; Oreffo VIC, 1998, MOL CARCINOGEN, V21, P37, DOI 10.1002/(SICI)1098-2744(199801)21:1<37::AID-MC6>3.0.CO;2-M; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Prives C, 1999, J PATHOL, V187, P112; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sanz-Ortega J, 1999, PATHOL RES PRACT, V195, P677; Sawaya BE, 1998, J BIOL CHEM, V273, P20052, DOI 10.1074/jbc.273.32.20052; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; THLIVERIS A, 1994, CANCER RES, V54, P2991; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	65	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18193	18199		10.1074/jbc.M101298200	http://dx.doi.org/10.1074/jbc.M101298200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279192	hybrid			2022-12-27	WOS:000168866500078
J	Kumar, R; Lee, JC; Bolen, DW; Thompson, EB				Kumar, R; Lee, JC; Bolen, DW; Thompson, EB			The conformation of the glucocorticoid receptor AF1/tau1 domain induced by osmolyte binds co-regulatory proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; TRANSACTIVATION DOMAIN; GENE-EXPRESSION; COMPLEX; COACTIVATORS; FRAGMENT; SEQUENCE; REGION	The activation domains of many transcription factors appear to exist naturally in an unfolded or only partially folded state. This seems to be the case for AF1/tau1, the major transactivation domain of the human glucocorticoid receptor. We show here that in buffers containing the natural osmolyte trimethylamine N-oxide (TMAO), recombinant AF1 folds into more a compact structure, as evidenced by altered fluorescence emission, circular dichroism spectra, and ultracentrifugal analysis. This conformational transition is cooperative, a characteristic of proteins folding to natural structures. The structure resulting from incubation in TMAO causes the peptide to resist proteolysis by trypsin, chymotrypsin, endoproteinase Arg-C and endoproteinase Gluc-C. Ultracentrifugation studies indicate that AF1/tau1 exists as a monomer in aqueous solution and that the presence of TMAO does not lead to oligomerization or aggregation. It has been suggested that recombinant AF1 binds both the ubiquitous coactivator CBP and the TATA box-binding protein, TBP, Interactions with both of these are greatly enhanced in the presence of TMAO. Co-immunoadsorption experiments indicate that in TMAO each of these and the coactivator SRC-1 are found complexed with AF1. These data indicate that TMAO induces a conformation in AF1/tau1 that is important for its interaction with certain co-regulatory proteins.	Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Thompson, EB (corresponding author), Univ Texas, Med Branch, Dept Human Biol Chem & Genet, 301 Univ Blvd,605 Basic Sci Bldg, Galveston, TX 77555 USA.		Lee, James C/A-7849-2009		NATIONAL CANCER INSTITUTE [R01CA041407] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR008961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058829] Funding Source: NIH RePORTER; NCI NIH HHS [5RO1 CA 41407] Funding Source: Medline; NCRR NIH HHS [RR 08961] Funding Source: Medline; NIDDK NIH HHS [1RO1 DK58829-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Almlof T, 1998, BIOCHEMISTRY-US, V37, P9586, DOI 10.1021/bi973029x; BACK JF, 1979, BIOCHEMISTRY-US, V18, P5191, DOI 10.1021/bi00590a025; Bain DL, 2000, J BIOL CHEM, V275, P7313, DOI 10.1074/jbc.275.10.7313; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831; Baskakov I, 1998, BIOPHYS J, V74, P2666, DOI 10.1016/S0006-3495(98)77972-X; Baskakov IV, 1999, J BIOL CHEM, V274, P10693, DOI 10.1074/jbc.274.16.10693; BURG MB, 1995, AM J PHYSIOL-RENAL, V268, pF983, DOI 10.1152/ajprenal.1995.268.6.F983; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; Chen H, 1997, J BIOL CHEM, V272, P25873, DOI 10.1074/jbc.272.41.25873; CHERVENKA CH, 1969, MANUAL METHODS ANALY, P45; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; DAHLMANWRIGHT K, 1995, P NATL ACAD SCI USA, V92, P1699, DOI 10.1073/pnas.92.5.1699; DAHLMANWRIGHT K, 1994, P NATL ACAD SCI USA, V91, P1619, DOI 10.1073/pnas.91.5.1619; Dalby PA, 1998, J MOL BIOL, V276, P625, DOI 10.1006/jmbi.1997.1546; Ford J, 1997, MOL ENDOCRINOL, V11, P1467, DOI 10.1210/me.11.10.1467; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Henriksson A, 1997, MOL CELL BIOL, V17, P3065, DOI 10.1128/MCB.17.6.3065; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; JOHNSON ML, 1985, METHOD ENZYMOL, V117, P301; Kumar R, 1999, J BIOL CHEM, V274, P24737, DOI 10.1074/jbc.274.35.24737; LEE JC, 1981, J BIOL CHEM, V256, P7193; LIU YF, 1995, BIOCHEMISTRY-US, V34, P12884, DOI 10.1021/bi00039a051; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; McEwan IJ, 1997, BIOESSAYS, V19, P153, DOI 10.1002/bies.950190210; McEwan IJ, 1996, BIOCHEMISTRY-US, V35, P9584, DOI 10.1021/bi960793v; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; ONATE SA, 1995, SCIENCE, V270, P1354; Qu YX, 1998, P NATL ACAD SCI USA, V95, P9268, DOI 10.1073/pnas.95.16.9268; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Shen F, 1996, J BIOL CHEM, V271, P4827; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; TSAI SY, 1990, J BIOL CHEM, V265, P17055; Van Holde K., 1971, PHYSICAL BIOCH, P98; Warnmark A, 2000, J BIOL CHEM, V275, P15014, DOI 10.1074/jbc.M001007200; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	42	111	112	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18146	18152		10.1074/jbc.M100825200	http://dx.doi.org/10.1074/jbc.M100825200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279138	hybrid			2022-12-27	WOS:000168866500072
J	Minogue, S; Anderson, JS; Waugh, MG; dos Santos, M; Corless, S; Cramer, R; Hsuan, JJ				Minogue, S; Anderson, JS; Waugh, MG; dos Santos, M; Corless, S; Cramer, R; Hsuan, JJ			Cloning of a human type II phosphatidylinositol 4-kinase reveals a novel lipid kinase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE KINASES; CELLULAR-REGULATION; MOLECULAR-CLONING; PURIFICATION; MEMBRANES; GROWTH; PROTEIN; PHOSPHORYLATION; POLYPHOSPHOINOSITIDES; RECEPTOR	Phosphoinositide lipids regulate numerous cellular processes in all eukaryotes, The versatility of this phospholipid is provided by combinations of phosphorylation on the 3 ', 4 ', and 5 ' positions of the inositol head group. Two distinct structural families of phosphoinositide (PI) kinases have so far been identified and named after their prototypic members, the pi 3-kinase and phosphatidylinositol (PtdIns) phosphate kinase families, both of which have been found to contain structural homologues possessing PI 4-kinase activity. Nevertheless, the prevalent PtdIns 4-kinase activity in many mammalian cell types is conferred by the widespread type II PtdIns 4-kinase, which has so far resisted molecular characterization. We have partially purified the human type II isoform from plasma membrane rafts of human A431 epidermoid carcinoma cells and obtained peptide mass and sequence data. The results allowed the cDNA containing the full open reading frame to, be cloned. The predicted amino acid sequence revealed that the type II enzyme is the prototypic member of a novel, third family of PI kinases, We have named the purified protein type II alpha and a second human isoform, type II beta. The type II alpha mRNA appears to be expressed ubiquitously in human tissues, and homologues appear to be expressed in all eukaryotes.	UCL Royal Free & Univ Coll Med Sch, Dept Med, Ctr Mol Cell Biol, London NW3 2PF, England; Ludwig Inst Canc Res, London W1P 8BT, England	University of London; University College London; UCL Medical School; Ludwig Institute for Cancer Research	Hsuan, JJ (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Med, Ctr Mol Cell Biol, Rowland Hill St, London NW3 2PF, England.	j.hsuan@rfc.ucl.ac.uk	dos Santos, Maria/B-7426-2012; Hsuan, Justin/C-8825-2009; Waugh, Mark/K-5232-2013	Hsuan, Justin/0000-0001-6083-7564; Cramer, Rainer/0000-0002-8037-2511; Waugh, Mark/0000-0002-7241-3168				Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Balla T, 1997, J BIOL CHEM, V272, P18358, DOI 10.1074/jbc.272.29.18358; COCHET C, 1991, J BIOL CHEM, V266, P637; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; deNeef RS, 1996, EUR J BIOCHEM, V235, P549; ENDEMANN GC, 1991, BIOCH J; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Hsuan JJ, 1998, ADV CANCER RES, V74, P167, DOI 10.1016/S0065-230X(08)60767-8; KAUFFMANNZEH A, 1994, J BIOL CHEM, V269, P31243; KAUFFMANNZEH A, 1995, SCIENCE, V268, P1188, DOI 10.1126/science.7761838; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Loijens JC, 1996, ADV ENZYME REGUL, V36, P115, DOI 10.1016/0065-2571(95)00005-4; Meyers R, 1997, J BIOL CHEM, V272, P4384, DOI 10.1074/jbc.272.7.4384; Nakagawa T, 1996, J BIOL CHEM, V271, P12088, DOI 10.1074/jbc.271.20.12088; Nakagawa T, 1996, BIOCHEM J, V320, P643, DOI 10.1042/bj3200643; NICKELS JT, 1992, J BIOL CHEM, V267, P16297; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; PIKE LJ, 1987, J BIOL CHEM, V262, P1644; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; PIKE LJ, 1992, ENDOCR REV, V13, P692, DOI 10.1210/er.13.4.692; PORTER FD, 1988, J BIOL CHEM, V263, P8989; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Waugh MG, 1998, J BIOL CHEM, V273, P17115, DOI 10.1074/jbc.273.27.17115; WETZKER R, 1991, EUR J BIOCHEM, V200, P179, DOI 10.1111/j.1432-1033.1991.tb21065.x; WHITMAN M, 1987, BIOCHEM J, V247, P165, DOI 10.1042/bj2470165; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; WONG K, 1994, J BIOL CHEM, V269, P28878; YAMAKAWA A, 1991, J BIOL CHEM, V266, P17580; Zvelebil MJ, 1996, PHILOS T R SOC B, V351, P217, DOI 10.1098/rstb.1996.0019	37	80	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16635	16640		10.1074/jbc.M100982200	http://dx.doi.org/10.1074/jbc.M100982200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279162	hybrid			2022-12-27	WOS:000168730400007
J	Davies, SS; Pontsler, AV; Marathe, GK; Harrison, KA; Murphy, RC; Hinshaw, JC; Prestwich, GD; St Hilaire, A; Prescott, SM; Zimmerman, GA; McIntyre, TM				Davies, SS; Pontsler, AV; Marathe, GK; Harrison, KA; Murphy, RC; Hinshaw, JC; Prestwich, GD; St Hilaire, A; Prescott, SM; Zimmerman, GA; McIntyre, TM			Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; PPAR-GAMMA; HUMAN PLASMA; ANTIDIABETIC THIAZOLIDINEDIONE; ATHEROSCLEROTIC LESIONS; MONONUCLEAR PHAGOCYTES; MASS-SPECTROMETRY; GENE-EXPRESSION; FATTY-ACIDS; ALPHA	Synthetic high affinity peroxisome proliferator-activated receptor (PPAR) agonists are known, but biologic ligands are of low affinity. Oxidized low density lipoprotein (oxLDL) is inflammatory and signals through PPARs. We showed, by phospholipase A(1) digestion, that PPAR gamma agonists in oxLDL arise from the small pool of alkyl phosphatidylcholines in LDL. We identified an abundant oxidatively fragmented alkyl phospholipid in oxLDL, hexadecyl azelaoyl phosphatidylcholine (azPC), as a high affinity ligand and agonist for PPAR gamma. [H-3]azPC bound recombinant PPAR gamma with an affinity (K-d(app) approximate to 40 nM) that was equivalent to rosiglitazone (BRL49653), and competition with rosiglitazone showed that binding occurred in the ligand-binding pocket. azPC induced PPRE reporter gene expression, as did rosiglitazone, with a half-maximal effect at 100 nM. Over-expression of PPAR alpha or PPAR gamma revealed that azPC was a specific PPAR gamma agonist. The scavenger receptor CD36 is encoded by a PPRE-responsive gene, and azPC enhanced expression of CD36 in primary human monocytes. We found that anti-CD36 inhibited azPC uptake, and it inhibited PPRE reporter induction. Results with a small molecule phospholipid flippase mimetic suggest azPC acts intracellularly and that cellular azPC accumulation was efficient. Thus, certain alkyl phospholipid oxidation products in oxLDL are specific, high affinity extracellular ligands and agonists for PPAR gamma that induce PPAR-responsive genes.	Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; Univ Utah, Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Natl Jewish Med & Res Ctr, Dept Pediat, Denver, CO 80206 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; National Jewish Health	McIntyre, TM (corresponding author), Univ Utah, Dept Pathol, 4130 EIHG,15 North 2030 East, Salt Lake City, UT 84112 USA.		Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515; Marathe, Gopal/0000-0002-0025-6677; Davies, Sean/0000-0001-9879-8062	NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044525, R01HL044513, P01HL034303, R37HL044525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029632] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA 42014] Funding Source: Medline; NHLBI NIH HHS [HL34303, HL 44525, HL 35217, HL44513] Funding Source: Medline; NINDS NIH HHS [NS29632] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMES BN, 1960, J BIOL CHEM, V235, P769; ARMESILLA AL, 1994, J BIOL CHEM, V269, P18985; Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; BECKMAN JK, 1994, CARCINOGENESIS, V15, P2937, DOI 10.1093/carcin/15.12.2937; Boon JM, 1999, J AM CHEM SOC, V121, P11924, DOI 10.1021/ja9933285; Delerive P, 2000, FEBS LETT, V471, P34, DOI 10.1016/S0014-5793(00)01364-8; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; DIAGNE A, 1984, BIOCHIM BIOPHYS ACTA, V793, P221, DOI 10.1016/0005-2760(84)90324-2; DuBois RN, 1998, CARCINOGENESIS, V19, P49, DOI 10.1093/carcin/19.1.49; ELSTAD MR, 1988, J IMMUNOL, V140, P1618; Feng JW, 2000, J LIPID RES, V41, P688; FOLCIK VA, 1994, J LIPID RES, V35, P1570; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fruchart JC, 1999, CURR OPIN LIPIDOL, V10, P245, DOI 10.1097/00041433-199906000-00007; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; GLAVIND J, 1952, ACTA PATHOL MIC SC, V30, P1; HEERY JM, 1995, J CLIN INVEST, V96, P2322, DOI 10.1172/JCI118288; HOFF HF, 1991, ARTERIOSCLER THROMB, V11, P1209, DOI 10.1161/01.ATV.11.5.1209; KAYGANICHHARRISON KA, 1994, ANAL BIOCHEM, V221, P16, DOI 10.1006/abio.1994.1372; Kessel JM, 1998, J IMMUNOL, V160, P5579; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Lee H, 2000, CIRC RES, V87, P516; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehr HA, 1997, J CLIN INVEST, V99, P2358, DOI 10.1172/JCI119417; LENZ ML, 1990, J LIPID RES, V31, P1043; Marathe GK, 1999, J BIOL CHEM, V274, P28395, DOI 10.1074/jbc.274.40.28395; Marx N, 1998, AM J PATHOL, V153, P17, DOI 10.1016/S0002-9440(10)65540-X; Maxey KM, 2000, PROSTAG OTH LIPID M, V62, P15, DOI 10.1016/S0090-6980(00)00072-1; McIntyre TM, 1999, J BIOL CHEM, V274, P25189, DOI 10.1074/jbc.274.36.25189; Meade EA, 1999, J BIOL CHEM, V274, P8328, DOI 10.1074/jbc.274.12.8328; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833; Reginato MJ, 1998, J BIOL CHEM, V273, P32679, DOI 10.1074/jbc.273.49.32679; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Schlame M, 1996, J LIPID RES, V37, P2608; Schulman IG, 1997, GENE DEV, V11, P299, DOI 10.1101/gad.11.3.299; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Spiegelman BM, 1998, CELL, V93, P153, DOI 10.1016/S0092-8674(00)81567-6; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Tokumura A, 1996, LIPIDS, V31, P1251, DOI 10.1007/BF02587909; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; VALIYAYEETTIL S, 1993, ANGEW CHEM INT EDIT, V32, P900, DOI 10.1002/anie.199309001; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; YAGI K, 1984, BIOESSAYS, V1, P58, DOI 10.1002/bies.950010205; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P5252, DOI 10.1073/pnas.88.12.5252; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; Young PW, 1998, J PHARMACOL EXP THER, V284, P751	53	206	234	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16015	16023		10.1074/jbc.M100878200	http://dx.doi.org/10.1074/jbc.M100878200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279149	hybrid			2022-12-27	WOS:000168623100061
J	Chong, YH; Sung, JH; Shin, SA; Chung, JH; Suh, YH				Chong, YH; Sung, JH; Shin, SA; Chung, JH; Suh, YH			Effects of the beta-amyloid and carboxyl-terminal fragment of Alzheimer's amyloid precursor protein on the production of the tumor necrosis factor-alpha and matrix metalloproteinase-9 by human monocytic THP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-GAMMA; 92-KDA GELATINASE; INTERFERON-GAMMA; NEURONAL CELLS; TNF-ALPHA; DISEASE; EXPRESSION; MICROGLIA; NEUROTOXICITY; PEPTIDE	To explore the direct role of beta -amyloid (A beta) and carboxyl-terminal fragments of amyloid precursor protein in the inflammatory processes possibly linked to neurodegeneration associated with Alzheimer's disease, the effects of the 105-amino acid carboxyl-terminal fragment (CT105) of amyloid precursor protein on the production of tumor necrosis factor-cu (TNF-alpha) and matrix metalloproteinase.9 (MMP-9) were examined in a human monocytic THP-1 cell line and compared with that of A beta. CT105 elicited a marked increase in TMF-alpha and MMP-9 production in the presence of interferon-gamma in a dose- and time-dependent manner. Similar patterns were obtained with A beta despite its low magnitude of induction. Autocrine TNF-alpha is likely to be a main mediator of the induction of MMP-9 because the neutralizing antibody to TNF-alpha inhibits MMP-9 production. Genistein, a specific inhibitor of tyrosine kinase, dramatically diminished both TNF-alpha secretion and subsequent MMP-9 release in response to CT105 or A beta. Furthermore, PD98059 and SB202190, specific inhibitors of ERK or p38 MAPK respectively, efficiently suppressed CT105-induced effects whereas only PD98059 was effective at reducing A beta -induced effects. Our results suggest that CT105 in combination withinterferon-gamma might serve as a more potent activator than A beta in triggering inflammatory processes and that both tyrosine kinase and MAPK signaling pathways may represent potential therapeutic targets for the control of Alzheimer's disease progression.	Ewha Womans Univ, Coll Med, Dept Microbiol, Yangcheon Ku, Seoul 158056, South Korea; Ewha Womans Univ, Coll Med, Dept Ophthalmol, Yangcheon Ku, Seoul 158056, South Korea; Ewha Womans Univ, Med Res Ctr, Div Mol Biol & Neurosci, Yangcheon Ku, Seoul 158056, South Korea; Seoul Natl Univ, Coll Med, Natl Creat Res Initiat Ctr Alzheimers Dementia, Dept Pharmacol, Seoul 110799, South Korea; Seoul Natl Univ, Neurosci Res Inst, MRC, Seoul 110799, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University; Seoul National University (SNU); Seoul National University (SNU)	Chong, YH (corresponding author), Ewha Womans Univ, Coll Med, Dept Microbiol, Yangcheon Ku, 911-1 Mok 6 Dong, Seoul 158056, South Korea.		Suh, Yoo-Hun/J-2761-2012					Aloisi F, 1999, J NEUROSCI RES, V56, P571; Backstrom JR, 1996, J NEUROSCI, V16, P7910; Blasko I, 1999, FASEB J, V13, P63, DOI 10.1096/fasebj.13.1.63; BUEE L, 1997, ANN NY ACAD SCI, V26, P7; CAPUTO CB, 1992, BIOCHEM BIOPH RES CO, V185, P1034, DOI 10.1016/0006-291X(92)91730-E; CHAO CC, 1994, DEV NEUROSCI-BASEL, V16, P172, DOI 10.1159/000112104; CHAPEL C, 1994, BIOCHEM BIOPH RES CO, V204, P1272, DOI 10.1006/bbrc.1994.2600; CHONG YH, 1994, LIFE SCI, V54, P1259; Chong YH, 1997, LIFE SCI, V61, P2323, DOI 10.1016/S0024-3205(97)00936-3; Deb S, 1996, J NEUROCHEM, V66, P1641; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; DYRKS T, 1992, J BIOL CHEM, V267, P18210; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Fiala M, 1998, MOL MED, V4, P480, DOI 10.1007/BF03401753; FILLIT H, 1991, NEUROSCI LETT, V129, P318, DOI 10.1016/0304-3940(91)90490-K; Fraser SP, 1996, J NEUROCHEM, V66, P2034; FUKUCHI KI, 1994, EXP NEUROL, V127, P253, DOI 10.1006/exnr.1994.1101; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOODWIN JL, 1995, BRAIN RES, V692, P207, DOI 10.1016/0006-8993(95)00646-8; Gottschall PE, 1996, NEUROREPORT, V7, P3077, DOI 10.1097/00001756-199611250-00057; Griffin WST, 1998, BRAIN PATHOL, V8, P65; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Hardy J, 1998, NAT NEUROSCI, V1, P355, DOI 10.1038/1565; Hartell NA, 2000, J NEUROCHEM, V74, P1112; Hensley K, 1999, J NEUROCHEM, V72, P2053, DOI 10.1046/j.1471-4159.1999.0722053.x; Jensen MB, 2000, J NEUROSCI, V20, P3612, DOI 10.1523/JNEUROSCI.20-10-03612.2000; Kim HS, 2000, FASEB J, V14, P1508, DOI 10.1096/fj.14.11.1508; Kim SH, 1996, J NEUROCHEM, V67, P1172; KLEGERIS A, 1997, BRAIN RES, V74, P7114; KOO EH, 1994, J BIOL CHEM, V269, P17386; KOZLOWSKI MR, 1992, J NEUROSCI, V12, P1679; Lee JP, 2000, J NEUROSCI RES, V60, P565, DOI 10.1002/(SICI)1097-4547(20000515)60:4<565::AID-JNR16>3.0.CO;2-I; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; MATSUMOTO A, 1994, EUR J BIOCHEM, V225, P1055, DOI 10.1111/j.1432-1033.1994.1055b.x; MATSUMOTO A, 1994, BIOCHEM BIOPH RES CO, V175, P361; Mattson MP, 1997, BRAIN RES REV, V23, P47, DOI 10.1016/S0165-0173(96)00014-8; McDonald DR, 1997, J NEUROSCI, V17, P2284; McDonald DR, 1998, J NEUROSCI, V18, P4451; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; McPhie DL, 1997, J BIOL CHEM, V272, P24743, DOI 10.1074/jbc.272.40.24743; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; MURPHY M, 1992, J IMMUNOL, V149, P2506; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; OsterGranite ML, 1996, J NEUROSCI, V16, P6732; PADGETT EL, 1992, BIOCHEM BIOPH RES CO, V186, P775, DOI 10.1016/0006-291X(92)90813-Z; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; POLISNY MB, 1993, AM J PATHOL, V142, P17; PONTE P, 1984, NUCLEIC ACIDS RES, V12, P1687, DOI 10.1093/nar/12.3.1687; PRIETO J, 1994, CELL IMMUNOL, V156, P191, DOI 10.1006/cimm.1994.1164; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Saren P, 1996, J IMMUNOL, V157, P4159; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; Solerte SB, 2000, NEUROBIOL AGING, V21, P271, DOI 10.1016/S0197-4580(00)00105-6; Song DK, 1998, J NEUROCHEM, V71, P875; TAMAOKA A, 1992, P NATL ACAD SCI USA, V89, P1345, DOI 10.1073/pnas.89.4.1345; TOKUDA T, 1995, NEUROSCI LETT, V186, P149, DOI 10.1016/0304-3940(95)11307-I; TORRE D, 1995, INFECTION, V23, P66, DOI 10.1007/BF01710065; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201	61	51	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23511	23517		10.1074/jbc.M009466200	http://dx.doi.org/10.1074/jbc.M009466200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11306564	hybrid			2022-12-27	WOS:000169531100040
J	Alvarez-Tejado, M; Naranjo-Suarez, S; Jimenez, C; Carrera, AC; Landazuri, MO; del Peso, L				Alvarez-Tejado, M; Naranjo-Suarez, S; Jimenez, C; Carrera, AC; Landazuri, MO; del Peso, L			Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells - Protective role in apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR-I; SIGNAL-TRANSDUCTION; REGULATED KINASES; GENE-EXPRESSION; DNA-BINDING; PROTEIN; PHOSPHORYLATION; RESPONSES; DEATH; ERYTHROPOIETIN	Hypoxia is a common environmental stress that influences signaling pathways and cell function. Several cell types, including neuroendocrine chromaffin cells, have evolved to sense oxygen levels and initiate specific adaptive responses to hypoxia. Here we report that under hypoxic conditions, rat pheochromocytoma PC12 cells are resistant to apoptosis induced by serum withdrawal and chemotherapy treatment. This effect is also observed after treatment with deferoxamine, a compound that mimics many of the effects of hypoxia, The hypoxia-dependent protection from apoptosis correlates with activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway, which is detected after 3-4 h of hypoxic or deferoxamine treatment and is sustained while hypoxic conditions are maintained. Hypoxia-induced Akt activation can be prevented by treatment with cycloheximide or actinomycin D, suggesting that de novo protein synthesis is required. Finally, inhibition of PI3K impairs both the protection against apoptosis and the activation of Akt in response to hypoxia, suggesting a functional link between these two phenomena. Thus, reduced oxygen tension regulates apoptosis in PC12 cells through activation of the PI3K/Akt survival pathway.	Univ Autonoma Madrid, Hosp de la Princesa, Serv Inmunol, Madrid 28006, Spain; CSIC, Dept Immunol & Oncol, Ctr Nacl Biotecnol, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	del Peso, L (corresponding author), Univ Autonoma Madrid, Hosp de la Princesa, Serv Inmunol, Madrid 28006, Spain.		Suarez, Salvador Naranjo/K-8450-2017; del Peso, Luis/K-9391-2014	Suarez, Salvador Naranjo/0000-0002-7038-0753; del Peso, Luis/0000-0003-4014-5688; Jimenez, Maria Concepcion/0000-0002-7011-9328; Carrera, Ana/0000-0002-3999-5434				Beitner-Johnson D, 1998, J BIOL CHEM, V273, P19834, DOI 10.1074/jbc.273.31.19834; Beitner-Johnson D, 1998, BIOCHEM BIOPH RES CO, V242, P61, DOI 10.1006/bbrc.1997.7907; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Conrad PW, 1999, J BIOL CHEM, V274, P33709, DOI 10.1074/jbc.274.47.33709; Conrad PW, 2000, ADV EXP MED BIOL, V475, P293; CZYZYKKRZESKA MF, 1994, J BIOL CHEM, V269, P760; DEL PL, 1997, SCIENCE, V278, P687; Downward J, 1998, SCIENCE, V279, P673, DOI 10.1126/science.279.5351.673; ERICKSON JT, 1994, J COMP NEUROL, V348, P161, DOI 10.1002/cne.903480202; GonzalezGarcia A, 1997, J BIOL CHEM, V272, P10220; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KOONG AC, 1994, CANCER RES, V54, P1425; Lachyankar MB, 2000, J NEUROSCI, V20, P1404; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; LINDENBOIM L, 1995, CANCER RES, V55, P1242; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; NORRIS ML, 1995, J BIOL CHEM, V270, P23774, DOI 10.1074/jbc.270.40.23774; Nunez G, 1998, CURR OPIN NEUROBIOL, V8, P613, DOI 10.1016/S0959-4388(98)80089-5; Parrizas M, 1997, J BIOL CHEM, V272, P154; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Robinson J.P., 1997, CURRENT PROTOCOLS CY; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Schmaltz C, 1998, MOL CELL BIOL, V18, P2845, DOI 10.1128/MCB.18.5.2845; Semenza GL, 2000, J CLIN INVEST, V106, P809, DOI 10.1172/JCI11223; TEICHER BA, 1994, CANCER METAST REV, V13, P139, DOI 10.1007/BF00689633; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; WANG GL, 1993, BLOOD, V82, P3610; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Williams RS, 2000, J CLIN INVEST, V106, P813, DOI 10.1172/JCI11205; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Yoshimura S, 1998, J BIOL CHEM, V273, P6921, DOI 10.1074/jbc.273.12.6921; Zaman K, 1999, J NEUROSCI, V19, P9821; Zundel W, 2000, GENE DEV, V14, P391	36	197	200	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22368	22374		10.1074/jbc.M011688200	http://dx.doi.org/10.1074/jbc.M011688200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294857	hybrid			2022-12-27	WOS:000169412700054
J	Boulay, A; Regnier, CH; Anglard, P; Stoll, I; Tomasetto, C; Rio, MC				Boulay, A; Regnier, CH; Anglard, P; Stoll, I; Tomasetto, C; Rio, MC			Transcription regulation and protein subcellular localization of the truncated basic hair keratin hHb1-Delta N in human breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MOUSE SKIN; LEUKOSIALIN CD43 GENE; HUMAN TYPE-I; INTERMEDIATE FILAMENTS; CHROMOSOMAL LOCALIZATION; EXPRESSION; FOLLICLE; HHB1; IDENTIFICATION; STROMELYSIN-3	An aberrant truncated hHb1 hair keratin transcript, named hHb1-DeltaN, was previously identified in breast carcinomas. No normal tissue tested so far, including hairy skin, expressed hHb1-DeltaN, indicating that hHb1-DeltaN is related to carcinogenesis. In the present study, we investigated the mechanism by which such truncated transcript was generated in breast cancer cell lines. We found that hHb1-DeltaN transcription is initiated at an unusual cryptic promoter within the fourth intron of the hHb1 gene and is dependent on two proximal Spl binding sites for its baseline activity, Moreover, hHb1-DeltaN transcription is increased in response to DNA demethylation by the 5-aza-2 ' -deoxycytidine drug. This induction is dependent on protein neosynthesis, indicating that an additional factor is required, In addition, we showed that the hHb1-DeltaN transcript is translated in vivo as a truncated hHb1 protein that is missing the 270 amino-terminal residues. The hHb1-DeltaN protein exhibits a filament pattern throughout the cytoplasm and partially co-localizes with cytokeratin filaments, indicating its participation in the cytoskeleton network, hHb1-DeltaN might alter the adhesive properties of cancer cells.	Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM U184, ULP, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Rio, MC (corresponding author), Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM U184, ULP, BP 163, F-67404 Illkirch Graffenstaden, France.	rio@igbmc.u-strasbg.fr	Tomasetto, Catherine Laure/J-2783-2014; Anglard, Patrick/M-6618-2019	Tomasetto, Catherine Laure/0000-0002-1811-5848; Anglard, Patrick/0000-0001-5701-441X; Regnier, Catherine/0000-0002-4386-1324				ALBERS K, 1987, J CELL BIOL, V105, P791, DOI 10.1083/jcb.105.2.791; ALBERS K, 1989, J CELL BIOL, V108, P1477, DOI 10.1083/jcb.108.4.1477; Ammanamanchi S, 1998, J BIOL CHEM, V273, P16527, DOI 10.1074/jbc.273.26.16527; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; BERNARD O, 1992, J EXP MED, V176, P919, DOI 10.1084/jem.176.4.919; BLOEMENDAL H, 1989, BIOCHIM BIOPHYS ACTA, V1007, P245, DOI 10.1016/0167-4781(89)90144-9; Bowden PE, 1998, J INVEST DERMATOL, V110, P158, DOI 10.1046/j.1523-1747.1998.00097.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COULOMBE PA, 1990, J CELL BIOL, V111, P3049, DOI 10.1083/jcb.111.6.3049; Cribier B, 1999, BRIT J DERMATOL, V140, P600; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Fuchs E, 1997, MOL BIOL CELL, V8, P189, DOI 10.1091/mbc.8.2.189; Galou M, 1997, BIOL CELL, V89, P85, DOI 10.1016/S0248-4900(99)80068-9; Hutton E, 1998, J CELL BIOL, V143, P487, DOI 10.1083/jcb.143.2.487; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Korge BP, 1999, J INVEST DERMATOL, V113, P607, DOI 10.1046/j.1523-1747.1999.00722.x; KUDO S, 1994, EUR J BIOCHEM, V223, P319, DOI 10.1111/j.1432-1033.1994.tb18997.x; KUDO S, 1995, J BIOL CHEM, V270, P13298, DOI 10.1074/jbc.270.22.13298; Luo DC, 1999, J BIOL CHEM, V274, P37177, DOI 10.1074/jbc.274.52.37177; MILLER RK, 1993, J CELL BIOL, V122, P123, DOI 10.1083/jcb.122.1.123; MULLER D, 1993, CANCER RES, V53, P165; NATHRATH WBJ, 1994, INT CONGR SER, V1050, P57; NOEL A, 1995, J BIOL CHEM, V270, P22866, DOI 10.1074/jbc.270.39.22866; Paladini RD, 1999, J CELL BIOL, V146, P1185, DOI 10.1083/jcb.146.5.1185; Paladini RD, 1998, J CELL BIOL, V142, P1035, DOI 10.1083/jcb.142.4.1035; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Regnier CH, 1998, BRIT J CANCER, V78, P1640, DOI 10.1038/bjc.1998.736; Regnier CH, 1997, EXP DERMATOL, V6, P87, DOI 10.1111/j.1600-0625.1997.tb00152.x; ROGERS GE, 1993, J INVEST DERMATOL, V101, pS50, DOI 10.1111/1523-1747.ep12362626; ROGERS MA, 1995, EXP CELL RES, V220, P357, DOI 10.1006/excr.1995.1326; Rogers MA, 1998, J BIOL CHEM, V273, P26683, DOI 10.1074/jbc.273.41.26683; Rogers MA, 2000, J INVEST DERMATOL, V114, P464, DOI 10.1046/j.1523-1747.2000.00910.x; SHIN TH, 1992, MOL CELL BIOL, V12, P3998, DOI 10.1128/MCB.12.9.3998; TAKAHASHI K, 1994, J CELL BIOL, V127, P505, DOI 10.1083/jcb.127.2.505; TOMASETTO C, 1995, GENOMICS, V28, P367, DOI 10.1006/geno.1995.1163; VANDEVEN WJM, 1995, GENE CHROMOSOME CANC, V12, P296; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Windoffer R, 1999, J CELL SCI, V112, P4521; Winter H, 1997, HUM GENET, V101, P165, DOI 10.1007/s004390050607; Winter H, 1997, NAT GENET, V16, P372, DOI 10.1038/ng0897-372; YU DW, 1991, J INVEST DERMATOL, V97, P354, DOI 10.1111/1523-1747.ep12480706; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	42	5	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22954	22964		10.1074/jbc.M101687200	http://dx.doi.org/10.1074/jbc.M101687200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11304540	hybrid			2022-12-27	WOS:000169412700130
J	Chang, SH; Low, PS				Chang, SH; Low, PS			Regulation of the glycophorin C-protein 4.1 membrane-to-skeleton bridge and evaluation of its contribution to erythrocyte membrane stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-CELL MEMBRANES; KINASE-C; HEREDITARY SPHEROCYTOSIS; CALCIUM; BINDING; DEFORMABILITY; ACTIVATION; SPECTRIN; ANKYRIN; BAND-3	The band 3-ankyrin-spectrin bridge and the glycophorin C protein 4.1-spectrin/actin bridge constitute the two major tethers between the erythrocyte membrane and its spectrin skeleton, Although a structural requirement for the band 3-ankyrin bridge is well established, the contribution of the glycophorin C-protein 4.1 bridge to red cell function remains to be defined, In order to explore this latter bridge further, we have identified and/or characterized five stimuli that sever the linkage in intact erythrocytes and have examined the impact of this rupture on membrane mechanical properties. We report here that elevation of cytosolic 2,3-bisphosphoglycerate, an increase in intracellular Ca2+, removal of cell O-2, a decrease in intracellular pH, and activation of erythrocyte protein kinase C all promote dissociation of protein 4.1 from glycophorin C, leading to reduced retention of glycophorin C in detergent-extracted spectrin/actin skeletons. Significantly, where mechanical studies could be performed, we also observe that rupture of the membrane-to-skeleton bridge has little or no impact on the mechanical properties of the cell, as assayed by ektacytometry and nickel mesh filtration, We, therefore, suggest that, although regulation of the glycophorin C-protein 4.1-spectrin/actin bridge likely occurs physiologically, the role of the tether and the associated regulatory changes remain to be established.	Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Low, PS (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	plow@purdue.edu		Low, Philip/0000-0001-9042-5528	NIGMS NIH HHS [GM24417] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024417, R01GM024417] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGRE P, 1992, CLIN RES, V40, P176; AGRE P, 1985, NATURE, V314, P380, DOI 10.1038/314380a0; ALLOISIO N, 1993, BLOOD, V82, P1323, DOI 10.1182/blood.V82.4.1323.bloodjournal8241323; ANDERSON RA, 1985, NATURE, V318, P295, DOI 10.1038/318295a0; ARAI K, 1990, BIORHEOLOGY, V27, P47; BREWER GJ, 1971, SCIENCE, V171, P1205, DOI 10.1126/science.171.3977.1205; CHAO TS, 1991, BIOCHEMISTRY-US, V30, P10529, DOI 10.1021/bi00107a023; COETZER TL, 1988, NEW ENGL J MED, V318, P230, DOI 10.1056/NEJM198801283180407; COHEN CM, 1986, J BIOL CHEM, V261, P7701; COSTA FF, 1990, NEW ENGL J MED, V323, P1046, DOI 10.1056/NEJM199010113231507; DALEKE DL, 1994, ANAL BIOCHEM, V217, P33, DOI 10.1006/abio.1994.1080; DANILOV YN, 1990, J BIOL CHEM, V265, P2556; DISCHER D, 1993, J BIOL CHEM, V268, P7186; FAQUIN WC, 1986, BIOCHIM BIOPHYS ACTA, V887, P142, DOI 10.1016/0167-4889(86)90048-0; GARDOS G, 1958, BIOCHIM BIOPHYS ACTA, V30, P653, DOI 10.1016/0006-3002(58)90124-0; GASCARD P, 1994, BLOOD, V83, P1102; Gedde MM, 1997, BIOPHYS J, V72, P1220, DOI 10.1016/S0006-3495(97)78769-1; Han BG, 2000, ACTA CRYSTALLOGR D, V56, P187, DOI 10.1107/S090744499901495X; HORNE WC, 1985, J BIOL CHEM, V260, P9073; IMANISHI H, 1981, HEMOGLOBIN, V5, P453, DOI 10.3109/03630268108991820; INOUE H, 1987, J BIOL CHEM, V262, P7635; Jarolim P, 1996, BLOOD, V88, P4366; JOHNSON RM, 1989, METHOD ENZYMOL, V173, P35; JONES B, 1987, EXP CELL RES, V168, P309, DOI 10.1016/0014-4827(87)90003-6; KANIEWSKI WS, 1994, BIORHEOLOGY, V31, P91; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDE WM, 1982, J CLIN INVEST, V70, P1273, DOI 10.1172/JCI110726; LEW VL, 1978, CURR TOP MEMBR TRANS, V10, P217; Lijnen P, 1998, AM J HYPERTENS, V11, P81, DOI 10.1016/S0895-7061(97)00368-3; LOMBARDO CR, 1994, BBA-BIOMEMBRANES, V1196, P139, DOI 10.1016/0005-2736(94)00233-9; LORAND L, 1983, J BIOL CHEM, V258, P5300; LOW PS, 1991, BLOOD, V77, P1581; Lux SE, 1995, BLOOD PRINCIPLES PRA, P1701; MCPHERSON RA, 1992, BIOCHEMISTRY-US, V31, P512, DOI 10.1021/bi00117a030; MOHANDAS N, 1993, SEMIN HEMATOL, V30, P171; MOHANDAS N, 1982, BLOOD, V59, P768; MORIYAMA R, 1993, J BIOL CHEM, V268, P10990; MORROW SJ, 1997, HDB PHYSL, P485; Nunomura W, 2000, J BIOL CHEM, V275, P24540, DOI 10.1074/jbc.M002492200; Nunomura W, 2000, J BIOL CHEM, V275, P6360, DOI 10.1074/jbc.275.9.6360; Nunomura W, 1997, J BIOL CHEM, V272, P30322, DOI 10.1074/jbc.272.48.30322; PERRIN DD, 1979, BUFFERS PH METAL ION, P94; Peters LL, 1996, CELL, V86, P917, DOI 10.1016/S0092-8674(00)80167-1; PINDER JC, 1995, BIOCHEM BIOPH RES CO, V210, P478, DOI 10.1006/bbrc.1995.1685; PONNAPPA BC, 1980, BIOCHIM BIOPHYS ACTA, V598, P494, DOI 10.1016/0005-2736(80)90030-9; REID ME, 1987, BLOOD, V69, P1068; Sakashita K, 1999, JPN J PHYSIOL, V49, P113, DOI 10.2170/jjphysiol.49.113; Sauvage M, 2000, EUR J BIOCHEM, V267, P955, DOI 10.1046/j.1432-1327.2000.01084.x; SAVVIDES P, 1993, BLOOD, V82, P2953; TAKAI Y, 1979, J BIOL CHEM, V254, P3692; TAKAKUWA Y, 1986, J CLIN INVEST, V78, P80, DOI 10.1172/JCI112577; Tse WT, 1999, BRIT J HAEMATOL, V104, P2, DOI 10.1111/j.1365-2141.1999.01130.x; Wandersee NJ, 2001, BLOOD, V97, P543, DOI 10.1182/blood.V97.2.543; WHITE JG, 1978, AM J PATHOL, V91, P571; Yi SJ, 1997, BIOCHEMISTRY-US, V36, P9596, DOI 10.1021/bi9704966; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240	56	41	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22223	22230		10.1074/jbc.M100604200	http://dx.doi.org/10.1074/jbc.M100604200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294862	hybrid			2022-12-27	WOS:000169412700035
J	Danielson, PB; Hoversten, MT; Fitzpatrick, M; Schreck, C; Akil, H; Dores, RM				Danielson, PB; Hoversten, MT; Fitzpatrick, M; Schreck, C; Akil, H; Dores, RM			Sturgeon orphanin, a molecular "fossil" that bridges the gap between the opioids and orphanin FQ/nociceptin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FQ PRECURSOR; GENE FAMILY; RECEPTOR; NOCICEPTIN; HYPERALGESIA; NEUROPEPTIDE; GENERATION; EVOLUTION; PEPTIDES; BINDING	The elucidation of the cDNA sequence for sturgeon proorphanin provides a unique window for interpreting the evolutionary history of the opioid/orphanin gene family. The molecular "fossil" status of this precursor can be seen in several ancestral sequence characteristics that point to its origin as a duplication of either a prodynorphin- or proenkephalin-like gene. The sturgeon proorphanin cDNA encodes a precursor protein of 194 residues, and the orphanin heptadecapeptide itself binds not only the opioid receptor-like 1 (ORL1) receptor but also the classical (mu, kappa, and delta) opioid receptors with near equal affinity. Allowing for this broad receptor specificity are several amino acid substitutions at key positions in the heptadecapeptide sequence, relative to its mammalian orthologs, that have been linked by amino acid scans and site directed mutagenic studies to the exclusion of mammalian orphanin FQ/nociceptin from classic opioid ligands (i.e. F1Y and L14W). The unique receptor binding profile of sturgeon orphanin not only provides insight into the evolutionary history of the opioid and opioid-related peptides but also provides an ideal context in which to investigate the under lying mechanisms by which novel and often divergent physiological functions arise in receptor-ligand systems.	Univ Denver, Dept Sci Biol, Denver, CO 80210 USA; Univ Michigan, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA; Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; Oregon State Univ, Oregon Cooperat Fish & Wildlife Res Unit, US Geol Survey, Biol Resources Div, Corvallis, OR 97331 USA	University of Denver; University of Michigan System; University of Michigan; Oregon State University; Oregon State University; United States Department of the Interior; United States Geological Survey	Danielson, PB (corresponding author), Univ Denver, Dept Sci Biol, 2101 E Wesley Ave,Rm 211, Denver, CO 80210 USA.				NIDA NIH HHS [R01 DA 08920] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008920] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Akil H, 1998, DRUG ALCOHOL DEPEN, V51, P127, DOI 10.1016/S0376-8716(98)00071-4; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Danielson PB, 1999, GEN COMP ENDOCR, V113, P169, DOI 10.1006/gcen.1998.7206; DawsonBasoa M, 1997, BRAIN RES, V750, P48, DOI 10.1016/S0006-8993(96)01334-0; DELSAL G, 1989, BIOTECHNIQUES, V7, P514; DOUGLASS J, 1984, ANNU REV BIOCHEM, V53, P665; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GOLDSTEIN A, 1989, MOL PHARMACOL, V36, P265; Hara N, 1997, BRIT J PHARMACOL, V121, P401, DOI 10.1038/sj.bjp.0701146; Houtani T, 1996, BIOCHEM BIOPH RES CO, V219, P714, DOI 10.1006/bbrc.1996.0300; HRUBY VJ, 1989, MED RES REV, V9, P343, DOI 10.1002/med.2610090306; HUGGENVIK JI, 1991, MOL ENDOCRINOL, V5, P921, DOI 10.1210/mend-5-7-921; JAKOBSEN KS, 1994, ADV BIOMAGNETIC SEPA, P61; MARTIN FH, 1985, NUCLEIC ACIDS RES, V13, P8927, DOI 10.1093/nar/13.24.8927; Meng F, 1996, J BIOL CHEM, V271, P32016, DOI 10.1074/jbc.271.50.32016; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; Mogil JS, 1996, NEUROSCIENCE, V75, P333, DOI 10.1016/0306-4522(96)00338-7; Nothacker HP, 1996, P NATL ACAD SCI USA, V93, P8677, DOI 10.1073/pnas.93.16.8677; OHTA T, 1991, J MOL EVOL, V33, P34, DOI 10.1007/BF02100193; Okuda-Ashitaka E, 1998, NATURE, V392, P286, DOI 10.1038/32660; OkudaAshitaka E, 1996, MOL BRAIN RES, V43, P96, DOI 10.1016/S0169-328X(96)00165-9; Paterson S. J., 1984, PEPTIDES ANAL SYNTHE, P147; PATERSON SJ, 1984, NEUROPEPTIDES, V5, P177, DOI 10.1016/0143-4179(84)90056-8; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Reinscheid RK, 1996, J BIOL CHEM, V271, P14163, DOI 10.1074/jbc.271.24.14163; Reinscheid RK, 1998, J BIOL CHEM, V273, P1490, DOI 10.1074/jbc.273.3.1490; Rossi GC, 1997, J PHARMACOL EXP THER, V282, P858; ROSSI GC, 1996, EUR J PHARMACOL, V311, P7; Stanley S.M., 1998, MACROEVOLUTION PATTE, P332; Tian JH, 1998, BRIT J PHARMACOL, V124, P21, DOI 10.1038/sj.bjp.0701788; WANG JB, 1994, FEBS LETT, V348, P75, DOI 10.1016/0014-5793(94)00557-5; Yamamoto T, 1997, NEUROSCIENCE, V81, P249, DOI 10.1016/S0306-4522(97)00166-8; Yuferov VP, 1996, DNA CELL BIOL, V15, P1105, DOI 10.1089/dna.1996.15.1105	35	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22114	22119		10.1074/jbc.M011741200	http://dx.doi.org/10.1074/jbc.M011741200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11290742	hybrid			2022-12-27	WOS:000169412700020
J	Ficzycz, A; Eskiw, C; Meyer, D; Marley, KE; Hurt, M; Ovsenek, N				Ficzycz, A; Eskiw, C; Meyer, D; Marley, KE; Hurt, M; Ovsenek, N			Expression, activity, and subcellular localization of the Yin Yang 1 transcription factor in Xenopus oocytes and embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; EPSILON-GLOBIN GENE; MAJOR DEVELOPMENTAL TRANSITION; RIBOSOMAL-PROTEIN GENES; C-MYC; FACTOR YY1; ADENOVIRUS E1A; FIRST EXON; PROMOTER; BINDING	Yin Yang 1 (YY1) is a multifunctional transcription factor that acts as an activator, repressor, or initiator of transcription of numerous cellular and viral genes. Previous studies in tissue culture model systems suggest YY1 plays a role in development and differentiation in multiple cell types, but the biological role of YY1 in vertebrate oocytes and embryos is not well understood, Here we analyzed expression, activity, and subcellular localization profiles of YY1 during Xenopus laevis development. Abundant levels of YY1 mRNA and protein were detected in early stage oocytes and in all subsequent stages of oocyte and embryonic development through to swimming larval stages. The DNA binding activity of YY1 was detected only in early oocytes (stages I and II) and in embryos after the midblastula transition (MBT), which suggested that its potential to modulate gene expression may be specifically repressed in the intervening period of development. Experiments to determine transcriptional activity showed that addition of YY1 recognition sites upstream of the thymidine kinase promoter had no stimulatory or repressive effect on basal transcription in oocytes and post-MET embryos. Although the apparent transcriptional inactivity of YY1 in oocytes could be explained by the absence of DNA binding activity at this stage of development, the lack of transcriptional activity in post-MET embryos was not expected given the ability of WI to bind its recognition elements. Subsequent Western blot and immuno cytochemical analyses showed that YY1 is localized in the cytoplasm in oocytes and in cells of developing embryos well past the MET. These findings suggest a novel mode of YY1 regulation during early development in which the potential transcriptional function of the maternally expressed factor is repressed by cytoplasmic localization.	Univ Saskatchewan, Dept Anat & Cell Biol, Coll Med, Saskatoon, SK S7N 5E5, Canada; Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	University of Saskatchewan; State University System of Florida; Florida State University	Ovsenek, N (corresponding author), Univ Saskatchewan, Dept Anat & Cell Biol, Coll Med, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.							Adrian GS, 1996, J GERONTOL A-BIOL, V51, pB66, DOI 10.1093/gerona/51A.1.B66; Ali A, 1998, MOL CELL BIOL, V18, P4949, DOI 10.1128/MCB.18.9.4949; Austen M, 1997, CURR TOP MICROBIOL, V224, P123; Brzostowski J, 2000, EMBO J, V19, P3683, DOI 10.1093/emboj/19.14.3683; BUSHMEYER S, 1995, J BIOL CHEM, V270, P30213; Chen CY, 1997, MOL ENDOCRINOL, V11, P812, DOI 10.1210/me.11.6.812; DARASCH S, 1988, BIOCHEM CELL BIOL, V66, P862, DOI 10.1139/o88-098; De Rinaldis E, 1998, EUR J BIOCHEM, V255, P563, DOI 10.1046/j.1432-1327.1998.2550563.x; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Eliassen KA, 1998, MOL CELL BIOL, V18, P7106, DOI 10.1128/MCB.18.12.7106; Ficzycz A, 1997, DEV BIOL, V182, P21, DOI 10.1006/dbio.1996.8459; FLANAGAN JR, 1992, MOL CELL BIOL, V12, P38, DOI 10.1128/MCB.12.1.38; Galvagni F, 1998, J BIOL CHEM, V273, P33708, DOI 10.1074/jbc.273.50.33708; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; Gordon S, 1997, DEV BIOL, V181, P47, DOI 10.1006/dbio.1996.8441; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GUMUCIO DL, 1993, P NATL ACAD SCI USA, V90, P6018, DOI 10.1073/pnas.90.13.6018; Guo B, 1997, P NATL ACAD SCI USA, V94, P121, DOI 10.1073/pnas.94.1.121; GUO B, 1995, P NATL ACAD SCI USA, V92, P10526, DOI 10.1073/pnas.92.23.10526; LEE JS, 1995, NUCLEIC ACIDS RES, V23, P925, DOI 10.1093/nar/23.6.925; LEE TC, 1992, P NATL ACAD SCI USA, V89, P9814, DOI 10.1073/pnas.89.20.9814; LEE TC, 1994, ONCOGENE, V9, P1047; LEMAITRE JM, 1995, MOL CELL BIOL, V15, P5054; MACLELLAN WR, 1994, J BIOL CHEM, V269, P16754; Martin KA, 1997, DNA CELL BIOL, V16, P653, DOI 10.1089/dna.1997.16.653; McNeil S, 1998, J CELL BIOCHEM, V68, P500, DOI 10.1002/(SICI)1097-4644(19980315)68:4<500::AID-JCB9>3.3.CO;2-T; MELTON DA, 1979, CELL, V18, P1165, DOI 10.1016/0092-8674(79)90229-0; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; OConnor MJ, 1996, J VIROL, V70, P6529, DOI 10.1128/JVI.70.10.6529-6539.1996; Oei SL, 1997, BIOCHEM BIOPH RES CO, V240, P108, DOI 10.1006/bbrc.1997.7621; OVSENEK N, 1988, DEV BIOL, V129, P582, DOI 10.1016/0012-1606(88)90403-4; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; Patten M, 1996, J BIOL CHEM, V271, P21134, DOI 10.1074/jbc.271.35.21134; PETERS B, 1993, J BIOL CHEM, V268, P3430; PISANESCHI G, 1994, BIOCHEM BIOPH RES CO, V205, P1236, DOI 10.1006/bbrc.1994.2797; RAICH N, 1995, EMBO J, V14, P801, DOI 10.1002/j.1460-2075.1995.tb07058.x; Reizis B, 1999, J EXP MED, V189, P1669, DOI 10.1084/jem.189.10.1669; Schulten HJ, 1999, BIOCHEM BIOPH RES CO, V257, P871, DOI 10.1006/bbrc.1999.0556; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Shrivastava A, 1996, P NATL ACAD SCI USA, V93, P10638, DOI 10.1073/pnas.93.20.10638; SHRIVASTAVA A, 1993, SCIENCE, V262, P1889, DOI 10.1126/science.8266081; WALLACE RA, 1973, J EXP ZOOL, V184, P321, DOI 10.1002/jez.1401840305; Walowitz JL, 1998, J BIOL CHEM, V273, P6656, DOI 10.1074/jbc.273.12.6656; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; ZHOU QJ, 1995, J VIROL, V69, P7402, DOI 10.1128/JVI.69.12.7402-7409.1995; Zhu W, 1999, BLOOD, V93, P3540, DOI 10.1182/blood.V93.10.3540.410k28_3540_3549	47	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22819	22825		10.1074/jbc.M011188200	http://dx.doi.org/10.1074/jbc.M011188200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294833	hybrid			2022-12-27	WOS:000169412700112
J	Floyd, ZE; Trausch-Azar, JS; Reinstein, E; Ciechanover, A; Schwartz, AL				Floyd, ZE; Trausch-Azar, JS; Reinstein, E; Ciechanover, A; Schwartz, AL			The nuclear ubiquitin-proteasome system degrades MyoD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; SUBCELLULAR-LOCALIZATION; CONJUGATING ENZYME; PROTEIN-DEGRADATION; ACTIVATING ENZYME; RAPID DEGRADATION; 26-S PROTEASOME; DNA-BINDING; IN-VIVO; CELLS	Many short-lived nuclear proteins are targeted for degradation by the ubiquitin-proteasome pathway. The role of the nucleus in regulating the turnover of these proteins is not well defined, although many components of the ubiquitin-proteasome system are localized in the nucleus. We have used nucleoplasm from highly purified HeLa nuclei to examine the degradation of a physiological substrate of the ubiquitin-proteasome system (MyoD). lit vitro studies using inhibitors of the system demonstrate MyoD is degraded via the ubiquitin-proteasome pathway in HeLa nucleoplasm. Purified nucleoplasm in vitro also supports the generation of high molecular mass MyoD-ubiquitin adducts. In addition, in vivo studies, using leptomycin B to inhibit nuclear export, demonstrate that MyoD is degraded in HeLa cells by the nuclear ubiquitin-proteasome system.	Washington Univ, Sch Med, Edward Mallinckrodt Dept Pediat & Mol Biol & Phar, St Louis, MO 63110 USA; St Louis Childrens Hosp, Div Pediat Hematol Oncol, St Louis, MO 63110 USA; Technion Israel Inst Technol, Fac Med, Rappaport Inst Res Med Sci, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Fac Med, Dept Biochem, IL-31096 Haifa, Israel	Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Schwartz, AL (corresponding author), Washington Univ, Sch Med, Edward Mallinckrodt Dept Pediat & Mol Biol & Phar, St Louis, MO 63110 USA.	schwartz@kids.wustl.edu	Floyd, Elizabeth/N-1962-2017; Ciechanover, Aaron J/C-9166-2017; Floyd, Elizabeth/W-2758-2019	Floyd, Elizabeth/0000-0002-3002-6186; Floyd, Elizabeth/0000-0002-3002-6186				Abu Hatoum O, 1998, MOL CELL BIOL, V18, P5670, DOI 10.1128/MCB.18.10.5670; Anton LC, 1999, J CELL BIOL, V146, P113, DOI 10.1083/jcb.146.1.113; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Blondel M, 2000, EMBO J, V19, P6085, DOI 10.1093/emboj/19.22.6085; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Brooks P, 2000, BIOCHEM J, V346, P155, DOI 10.1042/0264-6021:3460155; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; CRESCENZI M, 1990, P NATL ACAD SCI USA, V87, P8442, DOI 10.1073/pnas.87.21.8442; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; GILMORE TD, 1986, CELL, V44, P791, DOI 10.1016/0092-8674(86)90845-7; GOEBL MG, 1994, MOL CELL BIOL, V14, P3022, DOI 10.1128/MCB.14.5.3022; GRENFELL SJ, 1994, BIOCHEM J, V300, P701, DOI 10.1042/bj3000701; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JOHNSTON NL, 1991, BIOCHEMISTRY-US, V30, P7514, DOI 10.1021/bi00244a021; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Kitzmann M, 1999, MOL CELL BIOL, V19, P3167; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lisztwan J, 1998, EMBO J, V17, P368, DOI 10.1093/emboj/17.2.368; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Nasmyth K, 1999, TRENDS BIOCHEM SCI, V24, P98, DOI 10.1016/S0968-0004(99)01358-4; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; PETERS JM, 1994, J BIOL CHEM, V269, P7709; Raymond F, 2000, J CELL SCI, V113, P1687; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Roberts BJ, 1999, J BIOL CHEM, V274, P36351, DOI 10.1074/jbc.274.51.36351; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Rouillon A, 2000, EMBO J, V19, P282, DOI 10.1093/emboj/19.2.282; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Sachdev S, 2000, MOL CELL BIOL, V20, P1571, DOI 10.1128/MCB.20.5.1571-1582.2000; SCHWARTZ AL, 1988, EMBO J, V7, P2961, DOI 10.1002/j.1460-2075.1988.tb03158.x; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Song A, 1998, MOL CELL BIOL, V18, P4994, DOI 10.1128/MCB.18.9.4994; SORRENTINO V, 1990, NATURE, V345, P813, DOI 10.1038/345813a0; Stephen AG, 1996, J BIOL CHEM, V271, P15608, DOI 10.1074/jbc.271.26.15608; Tansey WP, 1999, MOL MED, V5, P773, DOI 10.1007/BF03401990; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; THAYER MJ, 1993, P NATL ACAD SCI USA, V90, P6483, DOI 10.1073/pnas.90.14.6483; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; TRAUSCH JS, 1993, AM J PHYSIOL, V264, pC93, DOI 10.1152/ajpcell.1993.264.1.C93; WATKINS JF, 1993, GENE DEV, V7, P250, DOI 10.1101/gad.7.2.250; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Wilkinson CRM, 1998, EMBO J, V17, P6465, DOI 10.1093/emboj/17.22.6465	63	61	63	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22468	22475		10.1074/jbc.M009388200	http://dx.doi.org/10.1074/jbc.M009388200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11309375	hybrid			2022-12-27	WOS:000169412700067
J	Tartare-Deckert, S; Chavey, C; Monthouel, MN; Gautier, N; Van Obberghen, E				Tartare-Deckert, S; Chavey, C; Monthouel, MN; Gautier, N; Van Obberghen, E			The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; ADIPOSE-TISSUE; INSULIN-RESISTANCE; VASCULAR-DISEASE; GROWTH-FACTOR; VISCERAL FAT; BODY-WEIGHT; SPARC	Alterations in the expression level of genes may contribute to the development and pathophysiology of obesity. To find genes differentially expressed in adipose tissue during obesity, we performed suppression subtractive hybridization on epididymal fat mRNA from goldthioglucose (GTG) obese mice and from their lean littermates. We identified the secreted protein acidic and rich in cysteine (SPARC), a protein that mediates cell-matrix interactions and plays a role in modulation of cell adhesion, differentiation, and angiogenesis. SPARC mRNA expression in adipose tissue was markedly increased (between 3- and B fold) in three different models of obesity, i.e, G;TG mice, ob/ob mice, and AKR mice, after 6 weeks of a high fat diet. Immunoblotting of adipocyte extracts revealed a similar increase in protein level, Using a SPARC-specific ELISA, we demonstrated that SPARC is secreted by isolated adipocytes, We found that insulin administration to mice increased SPARC mRNA in the adipose tissue. Food deprivation had no effect on SPARC expression, but after high fat refeeding SPARC mRNA levels were significantly increased. Our results reveal both hormonal and nutritional regulation of SPARC expression in the adipocyte, and importantly, its alteration in obesity. Finally, we show that purified SPARC increased mRNA levels of plasminogen activator inhibitor 1 (PAI-1) in cultured rat adipose tissue suggesting that elevated adipocyte expression of SPARC might contribute to the abnormal expression of PAI-1 observed in obesity, We propose that SPARC is a newly identified autocrine/paracrine factor that could affect key functions in adipose tissue physiology and pathology.	INSERM U145, IFR 50, F-06107 Nice 2, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Tartare-Deckert, S (corresponding author), INSERM U145, IFR 50, Ave Valombrose, F-06107 Nice 2, France.		TARTARE-DECKERT, Sophie/P-6057-2015	TARTARE-DECKERT, Sophie/0000-0001-8680-5720; Chavey, Carine/0000-0002-5267-5638				AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; Alessi MC, 1997, DIABETES, V46, P860, DOI 10.2337/diabetes.46.5.860; Ausubel FM, 1992, CURRENT PROTOCOLS MO; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; CLAFFEY KP, 1992, J BIOL CHEM, V267, P16317; CORMONT M, 1991, ENDOCRINOLOGY, V129, P3343, DOI 10.1210/endo-129-6-3343; Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786; Diatchenko L, 1999, METHOD ENZYMOL, V303, P349; Francki A, 1999, J BIOL CHEM, V274, P32145, DOI 10.1074/jbc.274.45.32145; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; GIRARD JP, 1995, IMMUNITY, V2, P113, DOI 10.1016/1074-7613(95)90083-7; HASSELAAR P, 1991, J BIOL CHEM, V266, P13178; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; JuhanVague I, 1997, THROMB HAEMOSTASIS, V78, P656; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; LANE TF, 1992, J BIOL CHEM, V267, P16736; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; MARCHANDBRUSTEL YL, 1978, AM J PHYSIOL, V234, pE348; MASON IJ, 1986, EMBO J, V5, P1465, DOI 10.1002/j.1460-2075.1986.tb04383.x; Montague CT, 1998, DIABETES, V47, P1384, DOI 10.2337/diabetes.47.9.1384; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Peraldi P, 1998, MOL CELL BIOCHEM, V182, P169, DOI 10.1023/A:1006865715292; Renz M, 2000, J BIOL CHEM, V275, P10429, DOI 10.1074/jbc.275.14.10429; Sage EH, 1997, NAT MED, V3, P144; SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; Samad F, 1998, P NATL ACAD SCI USA, V95, P7591, DOI 10.1073/pnas.95.13.7591; Samad F, 1999, P NATL ACAD SCI USA, V96, P6902, DOI 10.1073/pnas.96.12.6902; Samad F, 1996, MOL MED, V2, P568, DOI 10.1007/BF03401641; Shankavaram UT, 1997, J CELL PHYSIOL, V173, P327, DOI 10.1002/(SICI)1097-4652(199712)173:3<327::AID-JCP4>3.3.CO;2-R; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Soukas A, 2000, GENE DEV, V14, P963; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; TREMBLE PM, 1993, J CELL BIOL, V121, P1433, DOI 10.1083/jcb.121.6.1433; Vicent D, 1998, DIABETES, V47, P1451, DOI 10.2337/diabetes.47.9.1451; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Wiman B, 1996, Curr Opin Hematol, V3, P372; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	47	75	80	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22231	22237		10.1074/jbc.M010634200	http://dx.doi.org/10.1074/jbc.M010634200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294850	hybrid			2022-12-27	WOS:000169412700036
J	Cyert, MS				Cyert, MS			Regulation of nuclear localization during signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							KAPPA-B-ALPHA; ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR NFAT1; OSMOTIC-STRESS RESPONSE; MAP KINASE; OXIDATIVE STRESS; FISSION YEAST; BUDDING YEAST; NF-ATC; SUBCELLULAR-LOCALIZATION		Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Cyert, MS (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.			Cyert, Martha/0000-0003-3825-7437				Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Ben-Levy R, 1998, CURR BIOL, V8, P1049, DOI 10.1016/S0960-9822(98)70442-7; Bhaskar V, 2000, J BIOL CHEM, V275, P4033, DOI 10.1074/jbc.275.6.4033; Blanco-Aparicio C, 1999, J CELL BIOL, V147, P1129, DOI 10.1083/jcb.147.6.1129; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; del Arco PG, 2000, J BIOL CHEM, V275, P13872, DOI 10.1074/jbc.275.18.13872; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Drier EA, 1999, GENE DEV, V13, P556, DOI 10.1101/gad.13.5.556; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Gaits F, 1999, MOL BIOL CELL, V10, P1395, DOI 10.1091/mbc.10.5.1395; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Jacoby T, 1997, J BIOL CHEM, V272, P17749, DOI 10.1074/jbc.272.28.17749; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Johnson C, 1999, EMBO J, V18, P6682, DOI 10.1093/emboj/18.23.6682; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kudo N, 1999, J BIOL CHEM, V274, P15151, DOI 10.1074/jbc.274.21.15151; Kuge S, 1998, GENES CELLS, V3, P521, DOI 10.1046/j.1365-2443.1998.00209.x; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Luo C, 1996, P NATL ACAD SCI USA, V93, P8907, DOI 10.1073/pnas.93.17.8907; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; Mattison CP, 2000, GENE DEV, V14, P1229; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Nern A, 2000, J CELL BIOL, V148, P1115, DOI 10.1083/jcb.148.6.1115; Park S, 2000, P NATL ACAD SCI USA, V97, P7130, DOI 10.1073/pnas.97.13.7130; Porter CM, 2000, J BIOL CHEM, V275, P3543, DOI 10.1074/jbc.275.5.3543; Posas F, 1998, CURR OPIN MICROBIOL, V1, P175, DOI 10.1016/S1369-5274(98)80008-8; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Shimada Y, 2000, NAT CELL BIOL, V2, P117, DOI 10.1038/35000073; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Tam WF, 2000, MOL CELL BIOL, V20, P2269, DOI 10.1128/MCB.20.6.2269-2284.2000; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Wesselborg S, 1996, J BIOL CHEM, V271, P1274, DOI 10.1074/jbc.271.3.1274; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zhang XT, 2000, MOL MICROBIOL, V36, P618, DOI 10.1046/j.1365-2958.2000.01877.x; Zhu JY, 1999, NATURE, V398, P256, DOI 10.1038/18473; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2; Zuniga A, 1999, J BIOL CHEM, V274, P21900, DOI 10.1074/jbc.274.31.21900	67	143	153	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20805	20808		10.1074/jbc.R100012200	http://dx.doi.org/10.1074/jbc.R100012200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11303030	hybrid			2022-12-27	WOS:000169297900001
J	Katsamba, PS; Myszka, DG; Laird-Offringa, IA				Katsamba, PS; Myszka, DG; Laird-Offringa, IA			Two functionally distinct steps mediate high affinity binding of U1A protein to U1 hairpin II RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEAR RIBONUCLEOPROTEIN; A-PROTEIN; MACROMOLECULAR INTERACTIONS; MOLECULAR-DYNAMICS; KINETIC-ANALYSIS; STRUCTURAL BASIS; RECOGNITION; SEQUENCE; COMPLEX; DOMAIN	Binding of the U1A protein to its RNA target U1A.U1 hairpin II has been extensively studied as a model for a high affinity RNA/protein interaction. However, the mechanism and kinetics by which this complex is formed remain largely unknown. Here we use real-time biomolecular interaction analysis to dissect the roles various protein and RNA structural elements play in the formation of the U1A.U1 hairpin II complex. We show that neutralization of positive charges on the protein or increasing the salt concentration slows the association rate, suggesting that electrostatic interactions play an important role in bringing RNA and protein together. In contrast, removal of hydrogen bonding or stacking interactions within the RNA/protein interface, or reducing the size of the RNA loop, dramatically destabilizes the complex, as seen by a strong increase in the dissociation rate. Our data support a binding mechanism consisting of a rapid initial association based on electrostatic interactions and a subsequent locking step based on close-range interactions that occur during the induced fit of RNA and protein. Remarkably, these two steps can be clearly distinguished using U1A mutants containing single amino acid substitutions. Our observations explain the extraordinary affinity of U1A for its target and may suggest a general mechanism for high affinity RNA/protein interactions.	Univ So Calif, Keck Sch Med, Norris Canc Ctr, Los Angeles, CA 90089 USA; Univ Utah, Sch Med, Ctr Biomol Interact Anal, Salt Lake City, UT 84132 USA	University of Southern California; Utah System of Higher Education; University of Utah	Laird-Offringa, IA (corresponding author), Univ So Calif, Keck Sch Med, Norris Canc Ctr, Los Angeles, CA 90089 USA.	ilaird@hsc.usc.edu	Offringa, Ite/R-4101-2019	Katsamba, Phinikoula/0000-0003-3981-1604				Allain FHT, 1996, NATURE, V380, P646, DOI 10.1038/380646a0; Allain FHT, 1997, EMBO J, V16, P5764, DOI 10.1093/emboj/16.18.5764; Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Avis JM, 1996, J MOL BIOL, V257, P398, DOI 10.1006/jmbi.1996.0171; BENNETT MM, 1993, NUCLEIC ACIDS RES, V21, P4404, DOI 10.1093/nar/21.18.4404; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; BOELENS W, 1991, NUCLEIC ACIDS RES, V19, P4611, DOI 10.1093/nar/19.17.4611; BOELENS WC, 1993, CELL, V72, P881, DOI 10.1016/0092-8674(93)90577-D; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Christensen LLH, 1997, ANAL BIOCHEM, V249, P153, DOI 10.1006/abio.1997.2182; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991; FLICKINGER TW, 1994, GENE DEV, V8, P914, DOI 10.1101/gad.8.8.914; HALL KB, 1992, NUCLEIC ACIDS RES, V20, P4283, DOI 10.1093/nar/20.16.4283; HALL KB, 1994, BIOCHEMISTRY-US, V33, P10076, DOI 10.1021/bi00199a035; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; HOWE PWA, 1994, EMBO J, V13, P3873, DOI 10.1002/j.1460-2075.1994.tb06698.x; JESSEN TH, 1991, EMBO J, V10, P3447, DOI 10.1002/j.1460-2075.1991.tb04909.x; Kranz JK, 1998, J MOL BIOL, V275, P465, DOI 10.1006/jmbi.1997.1441; LAIRDOFFRINGA IA, 1995, P NATL ACAD SCI USA, V92, P11859, DOI 10.1073/pnas.92.25.11859; LUTZFREYERMUTH C, 1990, P NATL ACAD SCI USA, V87, P6393, DOI 10.1073/pnas.87.16.6393; Mittermaier A, 1999, J MOL BIOL, V294, P967, DOI 10.1006/jmbi.1999.3311; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Myszka DG, 1999, J MOL RECOGNIT, V12, P390, DOI 10.1002/(SICI)1099-1352(199911/12)12:6<390::AID-JMR482>3.0.CO;2-8; Myszka DG, 1998, BIOPHYS J, V75, P583, DOI 10.1016/S0006-3495(98)77549-6; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; NAGAI K, 1995, TRENDS BIOCHEM SCI, V20, P235, DOI 10.1016/S0968-0004(00)89024-6; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Park SM, 2000, MOL CELL BIOL, V20, P4765, DOI 10.1128/MCB.20.13.4765-4772.2000; Reyes CM, 2000, J MOL BIOL, V297, P1145, DOI 10.1006/jmbi.2000.3629; Rich RL, 2000, CURR OPIN BIOTECH, V11, P54, DOI 10.1016/S0958-1669(99)00054-3; SCHERLY D, 1989, EMBO J, V8, P4163, DOI 10.1002/j.1460-2075.1989.tb08601.x; SCHERLY D, 1990, NATURE, V345, P502, DOI 10.1038/345502a0; SILLEKENS PTG, 1987, EMBO J, V6, P3841, DOI 10.1002/j.1460-2075.1987.tb02721.x; SIMPSON GG, 1995, EMBO J, V14, P4540, DOI 10.1002/j.1460-2075.1995.tb00133.x; STUMP WT, 1995, RNA, V1, P55; Tang Y, 1999, BIOPHYS J, V77, P1284, DOI 10.1016/S0006-3495(99)76979-1; TSAI DE, 1991, NUCLEIC ACIDS RES, V19, P4931, DOI 10.1093/nar/19.18.4931; VANGELDER CWG, 1993, EMBO J, V12, P5191, DOI 10.1002/j.1460-2075.1993.tb06214.x; Varani G, 1998, ANNU REV BIOPH BIOM, V27, P407, DOI 10.1146/annurev.biophys.27.1.407; Williams DJ, 1996, J MOL BIOL, V257, P265; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575	45	65	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21476	21481		10.1074/jbc.M101624200	http://dx.doi.org/10.1074/jbc.M101624200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11297556	hybrid			2022-12-27	WOS:000169297900091
J	Zhang, YG; Dong, ZM; Nomura, M; Zhong, SP; Chen, NY; Bode, AM; Dong, ZG				Zhang, YG; Dong, ZM; Nomura, M; Zhong, SP; Chen, NY; Bode, AM; Dong, ZG			Signal transduction pathways involved in phosphorylation and activation of p70(S6K) following exposure to UVA irradiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; EPIDERMAL GROWTH-FACTOR; NONMELANOMA SKIN-CANCER; N-TERMINAL KINASE; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; MUSCLE-CELLS; IN-VIVO; AP-1 TRANSACTIVATION; REGULATED KINASE	Ultraviolet light A (WA) plays an important role in the etiology of human skin cancer, and WA-induced signal transduction has a critical role in WA-induced skin carcinogenesis. The upstream signaling pathways leading to p70(S6K) phosphorylation and activation are not well understood. Here, we observed that WA induces phosphorylation and activation of p70(S6K). Further, UVA-stimulated p70(S6K) activity and phosphorylation at Thr(389) were blocked by wortmannin, rapamycin, PD98059, SB202190, and dominant negative mutants of phosphatidylinositol (PI) 3-kinase p85 subunit (DNM-Delta p85), ERK2 (DNM-ERK2), p38 kinase (DNM-p38), and JNK1 (DNM-JNK1) and were absent in Jnk1-/- or Jnk2-/- knockout cells. The p70(S6K) phosphorylation at Ser(411) and Thr(421)/Ser(424) was inhibited by rapamycin, PD98059, or DNM-ERK2 but not by wortmannin, SB202190, DNM-Delta p85, or DNM-p38. However, Ser(411), but not Thr(421)/Ser(424) phosphorylation, was suppressed in DNM-JNK1 and abrogated in Jnk1-/- or Jnk2-/- cells. In vitro assays indicated that Ser(411) on immunoprecipitated p70(S6K) proteins is phosphorylated by active JNKs and ERKs, but not p38 kinase, and Thr(421)/Ser(424) is phosphorylated by ERK1, but not ERK2, JNKs, or p38 kinase, Moreover, p70(S6K) co-immunoprecipitated with PI 3-kinase and possibly PDK1, The complex possibly possessed a partial basal level of phosphorylation, but not at MAPK sites, which was available for its activation by MAPKs in vitro. Thus, these results suggest that activation of MAPKs, like PI 3-kinase/mTOR, may be involved in WA-induced phosphorylation and activation of p70(S6K).	Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; Henan Med Univ, Dept Pathophysiol, Zhengzhou 450052, Peoples R China	University of Minnesota System; Zhengzhou University	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.			Zhang, Yiguo/0000-0003-3910-2779	NATIONAL CANCER INSTITUTE [R01CA077646, R01CA081064, R37CA081064] Funding Source: NIH RePORTER; NCI NIH HHS [CA77646, CA81064] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Assefa Z, 1999, J BIOL CHEM, V274, P8788, DOI 10.1074/jbc.274.13.8788; Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Bae GU, 1999, J BIOL CHEM, V274, P32596, DOI 10.1074/jbc.274.46.32596; Balendran A, 1999, J BIOL CHEM, V274, P37400, DOI 10.1074/jbc.274.52.37400; Band CJ, 1999, ENDOCRINOLOGY, V140, P5626, DOI 10.1210/en.140.12.5626; Begum N, 1996, J BIOL CHEM, V271, P31166, DOI 10.1074/jbc.271.49.31166; Bender K, 1997, J PHOTOCH PHOTOBIO B, V37, P1, DOI 10.1016/S1011-1344(96)07459-3; Blair AS, 1999, J BIOL CHEM, V274, P36293, DOI 10.1074/jbc.274.51.36293; Brenneisen P, 2000, J BIOL CHEM, V275, P4336, DOI 10.1074/jbc.275.6.4336; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chauhan D, 1997, ONCOGENE, V15, P837, DOI 10.1038/sj.onc.1201253; CHOU MM, 1995, CURR OPIN CELL BIOL, V7, P806, DOI 10.1016/0955-0674(95)80064-6; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; DeLaat JMT, 1996, CANCER SURV, V26, P173; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Eguchi S, 1999, J BIOL CHEM, V274, P36843, DOI 10.1074/jbc.274.52.36843; ENDEMANN G, 1990, J BIOL CHEM, V265, P396; Foncea R, 1997, J BIOL CHEM, V272, P19115, DOI 10.1074/jbc.272.31.19115; FRANCO R, 1990, J BIOL CHEM, V265, P4321; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; GretherBeck S, 1997, BIOL CHEM, V378, P1231; Gu MF, 2000, J BIOL CHEM, V275, P11389, DOI 10.1074/jbc.275.15.11389; HAN JW, 1995, J BIOL CHEM, V270, P21396, DOI 10.1074/jbc.270.36.21396; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; Huang CS, 1999, J BIOL CHEM, V274, P14595, DOI 10.1074/jbc.274.21.14595; Huang CS, 1997, J BIOL CHEM, V272, P4187, DOI 10.1074/jbc.272.7.4187; Huang CS, 1996, MOL CELL BIOL, V16, P6427; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Iwasaki H, 1999, ENDOCRINOLOGY, V140, P4659, DOI 10.1210/en.140.10.4659; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; KIMBALL SR, 1994, ANNU REV PHYSIOL, V56, P321, DOI 10.1146/annurev.ph.56.030194.001541; Koh H, 1999, ONCOGENE, V18, P5115, DOI 10.1038/sj.onc.1202895; Kummer JL, 1997, J BIOL CHEM, V272, P20490, DOI 10.1074/jbc.272.33.20490; KUO CJ, 1992, NATURE, V358, P70, DOI 10.1038/358070a0; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; LEIGHTON IA, 1995, FEBS LETT, V375, P289, DOI 10.1016/0014-5793(95)01170-J; Loo DT, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 1, P65; MING XF, 1994, NATURE, V371, P426, DOI 10.1038/371426a0; Moser BA, 1997, MOL CELL BIOL, V17, P5648, DOI 10.1128/MCB.17.9.5648; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Papst PJ, 1998, J BIOL CHEM, V273, P15077, DOI 10.1074/jbc.273.24.15077; Parrott LA, 1999, J BIOL CHEM, V274, P24731, DOI 10.1074/jbc.274.35.24731; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Peterson RT, 1998, CURR BIOL, V8, pR248, DOI 10.1016/S0960-9822(98)70152-6; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; REINHARD C, 1992, P NATL ACAD SCI USA, V89, P4052, DOI 10.1073/pnas.89.9.4052; REINHARD C, 1994, EMBO J, V13, P1557, DOI 10.1002/j.1460-2075.1994.tb06418.x; Romanelli A, 1999, MOL CELL BIOL, V19, P2921; Runger TM, 1999, PHOTODERMATOL PHOTO, V15, P212; Sajan MP, 1999, J BIOL CHEM, V274, P30495, DOI 10.1074/jbc.274.43.30495; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; SEGER R, 1995, J BIOL CHEM, V270, P28325; Sehgal SN, 1998, CLIN BIOCHEM, V31, P335, DOI 10.1016/S0009-9120(98)00045-9; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; STEWART MJ, 1994, BIOESSAYS, V16, P809, DOI 10.1002/bies.950161107; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; TYRRELL RM, 1996, STRESS INDUCIBLE CEL, P255; Wang XM, 1997, BIOCHEM BIOPH RES CO, V238, P207, DOI 10.1006/bbrc.1997.7273; Watts RG, 1998, ONCOGENE, V17, P3493, DOI 10.1038/sj.onc.1202259; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; WENG QP, 1995, P NATL ACAD SCI USA, V92, P5744, DOI 10.1073/pnas.92.12.5744; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Zhao Y, 1996, J BIOL CHEM, V271, P29773, DOI 10.1074/jbc.271.47.29773	73	86	87	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20913	20923		10.1074/jbc.M009047200	http://dx.doi.org/10.1074/jbc.M009047200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279232	hybrid			2022-12-27	WOS:000169297900018
J	Ling, P; Meyer, CF; Redmond, LP; Shui, JW; Davis, B; Rich, RR; Hu, MCT; Wange, RL; Tan, TH				Ling, P; Meyer, CF; Redmond, LP; Shui, JW; Davis, B; Rich, RR; Hu, MCT; Wange, RL; Tan, TH			Involvement of hematopoietic progenitor kinase 1 in T cell receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; GERMINAL CENTER KINASE; STE20-RELATED PROTEIN-KINASE; ADAPTER PROTEINS; ANTIGEN-RECEPTOR; GENETIC-EVIDENCE; TYROSINE KINASE; ACTIVATION; PATHWAY; HPK1	Hematopoietic progenitor kinase 1 (HPK1), a mammalian Ste20-related serine/threonine protein kinase, is a hematopoietic-specific upstream activator of the c-Jun N-terminal kinase. Here, we provide evidence to demonstrate the involvement of HPK1 in T cell receptor (TCR) signaling. HPK1 was activated and tyrosine-phosphorylated with similar kinetics following TCR/CD3 or pervanadate stimulation. Co-expression of protein-tyrosine kinases, Lck and Zap70, with HPK1 led to HPK1 activation and tyrosine phosphorylation in transfected mammalian cells. Upon TCR/CD3 stimulation, HPK1 formed inducible complexes with the adapters Nck and Grk with different kinetics, whereas it constitutively interacted with the adapters Grb2 and CrkL in Jurkat T cells. Interestingly, HPK1 also inducibly associated with linker for activation of T cells (LAT) through its proline-rich motif and translocated into glycolipid-enriched microdomains (also called lipid rafts) following TCR/CD3 stimulation, suggesting a critical role for LAT in the regulation of HPK1, Together, these results identify HPK1 as a new component of TCR signaling. T cell-specific signaling molecules Lck, Zap70, and LAT play roles in the regulation of HPK1 during TCR signaling. Differential complex formation between HPK1 and adapters highlights the possible involvement of HPK1 in multiple signaling pathways in T cells.	Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; NIA, Biol Chem Lab, NIH, Baltimore, MD 21224 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Tan, TH (corresponding author), Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA.		Shui, Jr-Wen/Q-2617-2018; Tan, Tse-Hua/ABD-7080-2021; Wange, Ronald/AAI-2505-2021; Tan, Tse-Hua/E-3983-2010	Shui, Jr-Wen/0000-0002-5243-3727; Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; Wange, Ronald/0000-0001-9593-3572	NIAID NIH HHS [R01-AI38649, R01-AI42532] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042532, R01AI038649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000509] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anafi M, 1997, J BIOL CHEM, V272, P27804, DOI 10.1074/jbc.272.44.27804; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; BRYAN RG, 1994, MOL CELL BIOL, V14, P7933, DOI 10.1128/MCB.14.12.7933; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Chen Y. R., 1999, GENE THER MOL BIOL, V4, P83; Chen YR, 2000, INT J ONCOL, V16, P651; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Gelkop S, 1999, J BIOL CHEM, V274, P21519, DOI 10.1074/jbc.274.31.21519; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Ito Y, 2001, J BIOL CHEM, V276, P18130, DOI 10.1074/jbc.M007294200; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Ling P, 1999, MOL CELL BIOL, V19, P1359; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; Liu SK, 2000, J IMMUNOL, V165, P1417, DOI 10.4049/jimmunol.165.3.1417; Ma WB, 2001, ONCOGENE, V20, P1703, DOI 10.1038/sj.onc.1204224; Myung PS, 2000, CURR OPIN IMMUNOL, V12, P256, DOI 10.1016/S0952-7915(00)00085-6; Oehrl W, 1998, ONCOGENE, V17, P1893, DOI 10.1038/sj.onc.1202108; POMBO CM, 1995, NATURE, V377, P750, DOI 10.1038/377750a0; Rudd CE, 1996, IMMUNITY, V4, P527, DOI 10.1016/S1074-7613(00)80479-3; SECRIST JP, 1993, J BIOL CHEM, V268, P5886; Shi CS, 1997, J BIOL CHEM, V272, P32102, DOI 10.1074/jbc.272.51.32102; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Su YC, 1997, EMBO J, V16, P1279, DOI 10.1093/emboj/16.6.1279; Tung RM, 1997, ONCOGENE, V14, P653, DOI 10.1038/sj.onc.1200877; van Leeuwen JEM, 1999, MOL CELL BIOL, V19, P6652; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Xavier R, 1999, CURR OPIN IMMUNOL, V11, P265, DOI 10.1016/S0952-7915(99)80043-0; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Yao ZB, 1997, J BIOL CHEM, V272, P32378, DOI 10.1074/jbc.272.51.32378; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 2000, SEMIN IMMUNOL, V12, P35, DOI 10.1006/smim.2000.0205; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	41	53	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18908	18914		10.1074/jbc.M101485200	http://dx.doi.org/10.1074/jbc.M101485200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279207	hybrid			2022-12-27	WOS:000169091000036
J	Sweet, CR; Lin, S; Cotter, RJ; Raetz, CRH				Sweet, CR; Lin, S; Cotter, RJ; Raetz, CRH			A Chlamydia trachomatis UDP-N-acetylglucosamine acyltransferase selective for myristoyl-acyl carrier protein - Expression in Escherichia coli and formation of hybrid lipid A species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; ENDOTOXIN BIOSYNTHESIS; SALMONELLA-TYPHIMURIUM; DISACCHARIDE SYNTHASE; MULTICOPY SUPPRESSOR; ANTIBACTERIAL AGENTS; GENOME SEQUENCE; MSBB GENE; HOST-CELL; 1ST STEP	Chlamydia trachomatis lipid A is unusual in that it is acylated with myristoyl chains at the glucosamine 3 and 3' positions, We have cloned and expressed the gene encoding UDP-N-acetylglucosamine 3-O-acyltransferase of C, trachomatis (CtlpxA), the first enzyme of lipid A biosynthesis. C. trachomatis LpxA displays similar to 20-fold selectivity for myristoyl-ACP over R/S-3-hydroxymyristoyl-ACP under standard assay conditions, consistent with the proposed structure of C, trachomatis lipid A. CtLpxA is the first reported UDP-N-acetylglucosamine acyltransferase that prefers a non-hydroxylated acyl-ACP to a hydroxyacyl-ACP. When CtlpxA was expressed in RO138, a temperature-sensitive lpxA mutant of Escherichia coli, five new hybrid lipid A species were made in vivo after 2 h at 42 degreesC, in place of Escherichia coli lipid A. These compounds were purified and analyzed by matrix-assisted laser desorption ionization/time of flight mass spectrometry. In each case, a myristoyl chain replaced one or both of the ester linked 3-hydroxymyristoyl residues of E. coli lipid A. With prolonged growth at 42 degreesC, all the ester-linked 3-hydroxymyristoyl residues were replaced with myristate chains. Re-engineering the structure of E. coli lipid A should facilitate the microbiological production of novel agonists or antagonists of the innate immunity receptor TLR-4, with possible uses as adjuvants or anti-inflammatory agents.	Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Duke Univ, Dept Biochem, Durham, NC 27710 USA	Johns Hopkins University; Duke University	Raetz, CRH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	raetz@biochem.duke.edu			NIGMS NIH HHS [GM-51310, GM08558, GM54882] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008558, R01GM054882, R01GM051310] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; Ausubel FM, 1988, MOL REPROD DEV; Babinski KJ, 1998, FASEB J, V12, pA1288; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brade H, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P229; Brade H., 1999, ENDOTOXIN HLTH DIS; Clementz T, 1997, J BIOL CHEM, V272, P10353; COLEMAN J, 1988, J BACTERIOL, V170, P1268, DOI 10.1128/jb.170.3.1268-1274.1988; COSTELLO CE, 1990, METHOD ENZYMOL, V193, P738, DOI 10.1016/0076-6879(90)93448-T; CROWELL DN, 1987, J BACTERIOL, V169, P5727, DOI 10.1128/jb.169.12.5727-5734.1987; Dotson GD, 1998, J BACTERIOL, V180, P330, DOI 10.1128/JB.180.2.330-337.1998; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hatch GM, 1998, INFECT IMMUN, V66, P3727, DOI 10.1128/IAI.66.8.3727-3735.1998; Hoshino K, 1999, J IMMUNOL, V162, P3749; INGALLS RR, 1995, INFECT IMMUN, V63, P3125, DOI 10.1128/IAI.63.8.3125-3130.1995; Jackman JE, 2000, J BIOL CHEM, V275, P11002, DOI 10.1074/jbc.275.15.11002; KARIMI ST, 1989, INFECT IMMUN, V57, P1780, DOI 10.1128/IAI.57.6.1780-1785.1989; KAROW M, 1992, J BACTERIOL, V174, P702, DOI 10.1128/jb.174.3.702-710.1992; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Low KB, 1999, NAT BIOTECHNOL, V17, P37, DOI 10.1038/5205; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Odegaard TJ, 1997, J BIOL CHEM, V272, P19688, DOI 10.1074/jbc.272.32.19688; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi N, 1997, J BIOL CHEM, V272, P10594; RADIKA K, 1988, J BIOL CHEM, V263, P14859; Raetz C. R. H., 1996, ESCHERICHIA COLI SAL, V1, P1035; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; RAETZ CRH, 1973, J BIOL CHEM, V248, P1098; RAY BL, 1984, J BIOL CHEM, V259, P4852; Rietschel E. T., 1992, BACTERIAL ENDOTOXIC, V1, P3; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rund S, 1999, J BIOL CHEM, V274, P16819, DOI 10.1074/jbc.274.24.16819; Sambrook J., 2002, MOL CLONING LAB MANU; SCHACHTER J, 1980, ANNU REV MICROBIOL, V34, P285, DOI 10.1146/annurev.mi.34.100180.001441; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; VAARA M, 1993, ANTIMICROB AGENTS CH, V37, P2255, DOI 10.1128/AAC.37.11.2255; VUORIO R, 1992, ANTIMICROB AGENTS CH, V37, P354; WILLIAMSON JM, 1991, J BACTERIOL, V173, P3591, DOI 10.1128/jb.173.11.3591-3596.1991; Wyckoff TJO, 1998, TRENDS MICROBIOL, V6, P154, DOI 10.1016/S0966-842X(98)01230-X; Wyckoff TJO, 1998, J BIOL CHEM, V273, P32369, DOI 10.1074/jbc.273.49.32369; Wyckoff TJO, 1999, J BIOL CHEM, V274, P27047, DOI 10.1074/jbc.274.38.27047; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	54	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19565	19574		10.1074/jbc.M101868200	http://dx.doi.org/10.1074/jbc.M101868200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279221	hybrid			2022-12-27	WOS:000169091000120
J	An, JP; Tzagarakis-Foster, C; Scharschmidt, TC; Lomri, N; Leitman, DC				An, JP; Tzagarakis-Foster, C; Scharschmidt, TC; Lomri, N; Leitman, DC			Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE REPLACEMENT THERAPY; BREAST-CANCER; POSTMENOPAUSAL WOMEN; BONE LOSS; SOY PROTEIN; RALOXIFENE; BINDING; ALPHA; RISK; COACTIVATOR	Estrogens used in hormone replacement therapy regimens may increase the risk of developing breast cancer. Paradoxically, high consumption of plant-derived phytoestrogens, particularly soybean isoflavones, is associated with a low incidence of breast cancer. To explore the molecular basis for these potential different clinical outcomes, we investigated whether soybean isoflavones elicit distinct transcriptional actions from estrogens, Our results demonstrate that the estrogen 17 beta -estradiol effectively triggers the transcriptional activation and repression pathways with both estrogen receptors (ERs) ER alpha and ER beta. In contrast, soybean isoflavones (genistein, daidzein, and biochanin A) are ER beta -selective agonists of transcriptional repression and activation at physiological levels. The molecular mechanism for ER beta selectivity by isoflavones involves their capacity to create an activation function-2 surface of ER beta that has a greater affinity for coregulators than ER alpha. Phytoestrogens may act as natural selective estrogen receptor modulators that elicit distinct clinical effects from estrogens used for hormone replacement by selectively recruiting coregulatory proteins to ER beta that trigger transcriptional pathways.	Univ Calif San Francisco, Ctr Reprod Sci, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Leitman, DC (corresponding author), Univ Calif San Francisco, Ctr Reprod Sci, Dept Obstet Gynecol & Reprod Sci, HSE 1619,POB 0556, San Francisco, CA 94143 USA.	leitmand@obgyn.ucsf.edu		Scharschmidt, Tiffany/0000-0001-5517-089X				Adlercreutz M, 1998, BAILLIERE CLIN ENDOC, V12, P605, DOI 10.1016/S0950-351X(98)80007-4; Albertazzi P, 1998, OBSTET GYNECOL, V91, P6, DOI 10.1016/S0029-7844(97)00597-8; Alekel DL, 2000, AM J CLIN NUTR, V72, P844; An JP, 1999, P NATL ACAD SCI USA, V96, P15161, DOI 10.1073/pnas.96.26.15161; Anthony MS, 1997, ARTERIOSCL THROM VAS, V17, P2524, DOI 10.1161/01.ATV.17.11.2524; Arjmandi BH, 1996, J NUTR, V126, P161, DOI 10.1093/jn/126.1.161; Baker VL, 2000, OBSTET GYNECOL SURV, V55, pS21, DOI 10.1097/00006254-200007001-00001; Barkhem T, 1998, MOL PHARMACOL, V54, P105, DOI 10.1124/mol.54.1.105; Barnes S, 1996, ADV EXP MED BIOL, V401, P87; Barnes S, 1998, BAILLIERE CLIN ENDOC, V12, P559, DOI 10.1016/S0950-351X(98)80004-9; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Bush TL, 2000, J REPROD MED, V45, P259; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Clarkson TB, 1998, P SOC EXP BIOL MED, V217, P365; Clemett D, 2000, DRUGS, V60, P379, DOI 10.2165/00003495-200060020-00013; Colditz GA, 1999, J WOMENS HEALTH, V8, P347, DOI 10.1089/jwh.1999.8.347; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Davies GC, 1999, OBSTET GYNECOL, V93, P558, DOI 10.1016/S0029-7844(98)00476-1; Davis SR, 1999, RECENT PROG HORM RES, V54, P185; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Duncan AM, 1999, J CLIN ENDOCR METAB, V84, P3479, DOI 10.1210/jc.84.10.3479; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Foth D, 1998, AM J CLIN NUTR, V68, p1413S, DOI 10.1093/ajcn/68.6.1413S; Gee AC, 1999, MOL ENDOCRINOL, V13, P1912, DOI 10.1210/me.13.11.1912; Glass CK, 2000, GENE DEV, V14, P121; Goodman MT, 1997, AM J EPIDEMIOL, V146, P294, DOI 10.1093/oxfordjournals.aje.a009270; GREEN S, 1986, J STEROID BIOCHEM, V24, P77, DOI 10.1016/0022-4731(86)90035-X; Grodstein F, 1999, AM J MED, V106, P574, DOI 10.1016/S0002-9343(99)00063-7; Hofseth LJ, 1999, J CLIN ENDOCR METAB, V84, P4559, DOI 10.1210/jc.84.12.4559; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Ingram D, 1997, LANCET, V350, P990, DOI 10.1016/S0140-6736(97)01339-1; Johnson SR, 1998, MED CLIN N AM, V82, P297, DOI 10.1016/S0025-7125(05)70608-8; Katzenellenbogen BS, 2000, RECENT PROG HORM RES, V55, P163; Kenny AM, 2000, RHEUM DIS CLIN N AM, V26, P569, DOI 10.1016/S0889-857X(05)70157-5; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lamartiniere CA, 1998, P SOC EXP BIOL MED, V217, P358, DOI 10.3181/00379727-217-44245; Lee MM, 2000, J NATL CANCER I, V92, P42, DOI 10.1093/jnci/92.1.42; LEITMAN DC, 1992, MOL CELL BIOL, V12, P1352, DOI 10.1128/MCB.12.3.1352; LEITMAN DC, 1991, J BIOL CHEM, V266, P9343; Makela S, 1999, P NATL ACAD SCI USA, V96, P7077, DOI 10.1073/pnas.96.12.7077; McDonnell DP, 2000, J SOC GYNECOL INVEST, V7, pS10, DOI 10.1177/1071557600007001S05; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Murkies AL, 1998, J CLIN ENDOCR METAB, V83, P297, DOI 10.1210/jc.83.2.297; Nickelsen T, 1999, PSYCHONEUROENDOCRINO, V24, P115, DOI 10.1016/S0306-4530(98)00041-9; Pacifici R, 1996, J BONE MINER RES, V11, P1043; Picherit C, 2000, J NUTR, V130, P1675, DOI 10.1093/jn/130.7.1675; Pickar JH, 1998, AM J OBSTET GYNECOL, V178, P1087, DOI 10.1016/S0002-9378(98)70553-8; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Sato M, 1996, FASEB J, V10, P905, DOI 10.1096/fasebj.10.8.8666168; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; Setchell KDR, 1998, AM J CLIN NUTR, V68, p1333S, DOI 10.1093/ajcn/68.6.1333S; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Speroff L, 1998, MATURITAS, V31, P9, DOI 10.1016/S0378-5122(98)00104-2; Taylor AH, 2000, J MOL ENDOCRINOL, V24, P145, DOI 10.1677/jme.0.0240145; Tham DM, 1998, J CLIN ENDOCR METAB, V83, P2223, DOI 10.1210/jc.83.7.2223; Upmalis DH, 2000, MENOPAUSE, V7, P236, DOI 10.1097/00042192-200007040-00005; van Duijn CM, 1999, MATURITAS, V31, P201, DOI 10.1016/S0378-5122(99)00005-5; Webb P, 1999, MOL ENDOCRINOL, V13, P1672, DOI 10.1210/me.13.10.1672; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605	64	261	292	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17808	17814		10.1074/jbc.M100953200	http://dx.doi.org/10.1074/jbc.M100953200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279159	hybrid			2022-12-27	WOS:000168866500027
J	Varela, N; Munoz-Pinedo, C; Ruiz-Ruiz, C; Robledo, G; Pedroso, M; Lopez-Rivas, A				Varela, N; Munoz-Pinedo, C; Ruiz-Ruiz, C; Robledo, G; Pedroso, M; Lopez-Rivas, A			Interferon-gamma sensitizes human myeloid leukemia cells to death receptor-mediated apoptosis by a pleiotropic mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; FADD-DEPENDENT APOPTOSIS; TRAIL-INDUCED APOPTOSIS; ANTI-FAS ANTIBODY; CYTOCHROME-C; TNF-ALPHA; TUMORICIDAL ACTIVITY; MOLECULAR-CLONING; SURFACE ANTIGEN; CD95 FAS/APO-1	The role of interferon (IFN)-gamma as a sensitizing agent in apoptosis induced by ligation of death receptors has been evaluated in human myeloid leukemia cells. Incubation of U937 cells with IFN-gamma sensitized these cells to apoptosis induced by tumor necrosis factor-alpha, agonistic CD95 antibody, and tumor necrosis factor-related apoptosis-inducing ligand, Other human myeloid leukemic cells were also sensitized by IFN-gamma to death receptor-mediated apoptosis. Treatment of U937 cells with IFN-gamma up-regulated the expression of caspase-8 and potently synergized with death receptor ligation in the processing of caspase-8 and BID cleavage. Concomitantly, a marked down-regulation of BCL-2 protein was also observed in cells incubated with IFN-gamma, Furthermore, the caspase-dependent generation of a 23-kDa fragment of BCL-2 protein, the release of cytochrome c from mitochondria and the activation of caspase-9 were also enhanced upon death receptor ligation in IFN-gamma -treated cells. Ectopically expressed Bcl-2 protein inhibited IFN-gamma -induced sensitization to apoptosis. In summary, these results indicate that IFN-gamma sensitizes human myeloid leukemic cells to a death receptor-induced, mitochondria-mediated pathway of apoptosis.	CSIC, Inst Parasitol & Biomed, Granada 18001, Spain; Ctr Nacl Sanidad Agropecuaria, Havana, Cuba	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Lopez-Rivas, A (corresponding author), CSIC, Inst Parasitol & Biomed, Calle Ventanilla 11, Granada 18001, Spain.	alrivas@ipb.csic.es	Munoz-Pinedo, Cristina/B-6118-2008; Ruiz-Ruiz, Carmen/I-8792-2017; Hernández, Nieves Yaquelin Varela/E-4280-2018; Lopez-Rivas, Abelardo/E-5115-2015	Munoz-Pinedo, Cristina/0000-0002-9120-664X; Ruiz-Ruiz, Carmen/0000-0002-6243-6227; Hernández, Nieves Yaquelin Varela/0000-0003-3328-4751; Lopez-Rivas, Abelardo/0000-0002-9351-9690				Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baker SJ, 1996, ONCOGENE, V12, P1; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Chandra J, 1998, BLOOD, V92, P4220, DOI 10.1182/blood.V92.11.4220.423k49_4220_4229; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chen P, 1998, J BIOL CHEM, V273, P5815, DOI 10.1074/jbc.273.10.5815; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Chow SC, 1999, EXP CELL RES, V246, P491, DOI 10.1006/excr.1998.4333; Dai CH, 1999, BLOOD, V93, P3309, DOI 10.1182/blood.V93.10.3309.410k04_3309_3316; Deiss LP, 1996, EMBO J, V15, P3861, DOI 10.1002/j.1460-2075.1996.tb00760.x; Dirks W, 1997, BRIT J HAEMATOL, V96, P584, DOI 10.1046/j.1365-2141.1997.d01-2048.x; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Gabriele L, 1999, J EXP MED, V190, P411, DOI 10.1084/jem.190.3.411; Gamen S, 1998, CELL DEATH DIFFER, V5, P241, DOI 10.1038/sj.cdd.4400344; GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Green WB, 1999, LEUKEMIA, V13, P1960, DOI 10.1038/sj.leu.2401596; Griffith TS, 1998, J IMMUNOL, V161, P2833; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Hadden JW, 1999, INT J IMMUNOPHARMACO, V21, P79, DOI 10.1016/S0192-0561(98)00077-0; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Iwase S, 1999, FEBS LETT, V450, P263, DOI 10.1016/S0014-5793(99)00515-3; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jo M, 2000, NAT MED, V6, P564, DOI 10.1038/75045; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; Keane MM, 1996, CANCER RES, V56, P4791; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Koshiji M, 1997, BIOCHEM BIOPH RES CO, V240, P376, DOI 10.1006/bbrc.1997.7657; Koshiji M, 1998, CLIN EXP IMMUNOL, V111, P211; Lee SB, 1997, VIROLOGY, V231, P81, DOI 10.1006/viro.1997.8494; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Muhlenbeck F, 1998, J BIOL CHEM, V273, P33091, DOI 10.1074/jbc.273.49.33091; Munker R, 1996, CYTOKINES MOL THER, V2, P147; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NOGUCHI K, 1995, CELL GROWTH DIFFER, V6, P1271; OEHM A, 1992, J BIOL CHEM, V267, P10709; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Ossina NK, 1997, J BIOL CHEM, V272, P16351, DOI 10.1074/jbc.272.26.16351; OWENSCHAUB LB, 1994, CANCER RES, V54, P1580; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Ruiz-Ruiz C, 2000, CANCER RES, V60, P5673; RUIZRUIZ MD, 1995, MOL IMMUNOL, V32, P947; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sato T, 1997, BRIT J HAEMATOL, V97, P356, DOI 10.1046/j.1365-2141.1997.562704.x; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Smith DJ, 1997, J IMMUNOL, V158, P163; Spanaus KS, 1998, EUR J IMMUNOL, V28, P4398, DOI 10.1002/(SICI)1521-4141(199812)28:12<4398::AID-IMMU4398>3.0.CO;2-Y; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stephanou A, 2000, CELL DEATH DIFFER, V7, P329, DOI 10.1038/sj.cdd.4400656; STRANDER H, 1986, ADV CANCER RES, V46, pR9; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; SUMIMOTO SI, 1994, CELL IMMUNOL, V153, P184, DOI 10.1006/cimm.1994.1016; Tamura T, 1996, BIOCHEM BIOPH RES CO, V229, P21, DOI 10.1006/bbrc.1996.1752; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; WADLER S, 1990, CANCER RES, V50, P3473; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yeh JH, 1998, J EXP MED, V188, P1795, DOI 10.1084/jem.188.10.1795; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	79	54	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17779	17787		10.1074/jbc.M100815200	http://dx.doi.org/10.1074/jbc.M100815200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279136	hybrid			2022-12-27	WOS:000168866500023
J	Xu, YQ; Liu, YL; Ridgway, ND; McMaster, CR				Xu, YQ; Liu, YL; Ridgway, ND; McMaster, CR			Novel members of the human oxysterol-binding protein family bind phospholipids and regulate vesicle transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN-HOMOLOGY-DOMAIN; HAMSTER OVARY CELLS; YEAST GOLGI; MEMBRANE TRAFFICKING; KINASE-C; PATHWAY; ENCODES; DEFECTS; SAC1; IDENTIFICATION	Oxysterol-binding proteins (OSBPs) are a family of eukaryotic intracellular lipid receptors. Mammalian OSBP1 binds oxygenated derivatives of cholesterol and mediates sterol and phospholipid synthesis through as yet poorly undefined mechanisms. The precise cellular roles for the remaining members of the oxysterol-binding protein family remain to be elucidated. In yeast, a family of OSBPs has been identified based on primary sequence similarity to the ligand binding domain of mammalian OSBP1, Yeast Kes1p, an oxysterol-binding protein family member that consists of only the ligand binding domain, has been demonstrated to regulate the Sec14p pathway for Golgi-derived vesicle transport. Specifically, inactivation of the KES1 gene resulted in the ability of yeast to survive in the absence of Sec14p, a phosphatidylinositol/phosphatidylcholine transfer protein that is normally required for cell viability due to its essential requirement in transporting vesicles from the Golgi, We cloned the two human members of the OSBP family, ORP1 and ORP2, with the highest degree of similarity to yeast Kes1p, We expressed ORP1 and ORP2 in yeast lacking Sec14p and Kes1p function and found that ORP1 complemented Kes1p function with respect to cell growth and Golgi vesicle transport, whereas ORP2 was unable to do so. Phenotypes associated with overexpression of ORP2 in yeast were a dramatic decrease in cell growth and a block in Golgi-derived vesicle transport distinct from that of ORP1. Purification of ORP1 and ORP2 for ligand binding studies demonstrated ORP1 and ORP2 did not bind 25-hydroxycholesterol but instead bound phospholipids with both proteins exhibiting strong binding to phosphatidic acid and weak binding to phosphatidylinositol 3-phosphate. In Chinese hamster ovary cells, ORP1 localized to a cytosolic location, whereas ORP2 was associated with the Golgi apparatus, consistent with our vesicle transport studies that indicated ORP1 and ORP2 function at different steps in the regulation of vesicle transport.	Dalhousie Univ, IWK Hlth Ctr, Dept Pediat, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, IWK Hlth Ctr, Dept Biochem, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, IWK Hlth Ctr, Dept Mol Biol, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada	Dalhousie University; Dalhousie University; Dalhousie University	McMaster, CR (corresponding author), Dalhousie Univ, IWK Hlth Ctr, Dept Pediat, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada.			McMaster, Christopher/0000-0003-0822-5776; Ridgway, Neale/0000-0002-0441-6228				BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Bi K, 1997, CURR BIOL, V7, P301, DOI 10.1016/S0960-9822(06)00153-9; CLEVES AE, 1989, J CELL BIOL, V109, P2939, DOI 10.1083/jcb.109.6.2939; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; DAWSON PA, 1991, J BIOL CHEM, V266, P9128; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Fang M, 1996, EMBO J, V15, P6447, DOI 10.1002/j.1460-2075.1996.tb01036.x; Gaynor EC, 1997, J CELL BIOL, V136, P789, DOI 10.1083/jcb.136.4.789; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; HANNUN YA, 1985, J BIOL CHEM, V260, P39; HELMKAMP GM, 1986, J BIOENERG BIOMEMBR, V18, P71, DOI 10.1007/BF00743477; Hughes WE, 2000, J BIOL CHEM, V275, P801, DOI 10.1074/jbc.275.2.801; JIANG B, 1994, YEAST, V10, P341, DOI 10.1002/yea.320100307; Kaiser C., 1994, METHODS YEAST GENETI; Lagace TA, 1997, BIOCHEM J, V326, P205, DOI 10.1042/bj3260205; Lagace TK, 2000, J BIOL CHEM, V275, P14367, DOI 10.1074/jbc.275.19.14367; LEE MH, 1991, BIOCHEMISTRY-US, V30, P1041, DOI 10.1021/bi00218a023; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Maniatis T., 1989, MOL CLONING LAB MANU; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; MCGEE TP, 1994, J CELL BIOL, V124, P273, DOI 10.1083/jcb.124.3.273; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; Phillips SE, 1999, MOL CELL, V4, P187, DOI 10.1016/S1097-2765(00)80366-4; Ridgway ND, 1998, J BIOL CHEM, V273, P31621, DOI 10.1074/jbc.273.47.31621; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; RIDGWAY ND, 1995, J BIOL CHEM, V270, P8023, DOI 10.1074/jbc.270.14.8023; Roth MG, 1997, CURR OPIN CELL BIOL, V9, P519, DOI 10.1016/S0955-0674(97)80028-2; SCHMALIX WA, 1994, BBA-GENE STRUCT EXPR, V1219, P205, DOI 10.1016/0167-4781(94)90273-9; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; TAYLOR FR, 1985, CHEM PHYS LIPIDS, V38, P187, DOI 10.1016/0009-3084(85)90066-0; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; WIRTZ KWA, 1974, BIOCHIM BIOPHYS ACTA, V344, P95, DOI 10.1016/0304-4157(74)90001-X; Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129; Xie ZG, 1998, P NATL ACAD SCI USA, V95, P12346, DOI 10.1073/pnas.95.21.12346	38	83	88	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18407	18414		10.1074/jbc.M101204200	http://dx.doi.org/10.1074/jbc.M101204200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279184	hybrid			2022-12-27	WOS:000168866500105
J	Radaev, S; Sun, PD				Radaev, S; Sun, PD			Recognition of IgG by Fc gamma receptor - The role of Fc glycosylation and the binding of peptide inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY RECEPTOR; EFFECTOR FUNCTIONS; CRYSTAL-STRUCTURE; IMMUNOGLOBULIN-G; IN-VIVO; FRAGMENT; COMPLEX; RIII; IDENTIFICATION; SUBCLASSES	Recently determined crystal structures of the complex between immunoglobulin constant regions (Fc) and their Fc-respective receptors (FcR) have revealed the detailed molecular interactions of this receptor-ligand pair. Of particular interest is the contribution of a glycosylation at Asn(297) of the C(H)2 domain of IgG to receptor recognition. The carbohydrate moieties are found outside the receptor Fe interface in all receptor Fe complex structures. To understand the role of glycosylation in FcR recognition, the receptor affinities of a deglycosylated IgG1 and its Fc fragment were determined by solution binding studies using surface plasmon resonance. The removal of carbohydrates resulted in a non-detectable receptor binding to the Fc alone and a 15- to 20-fold reduction of the receptor binding to IgG1, suggesting that the carbohydrates are important in the function of the Fc gamma RIII. Structurally, the carbohydrates attached to Asn(297) fill the cavity between the C(H)2 domains of Fc functioning equivalently as a hydrophobic core. This may stabilize a favorable lower hinge conformation for the receptor binding, The structure of the complex also revealed the dominance of the lower hinge region in receptor.Fc recognition, To evaluate the potential of designing small molecular ligands to inhibit the receptor function, four lower hinge peptides were investigated for their ability to bind to the receptor Fc gamma RIII, These peptides bind specifically to Fc gamma RIII with affinities 20- to 100-fold lower than IgG1 and are able to compete with Fc in receptor binding. The results of peptide binding illustrate new ways of designing therapeutic compounds to block Fc receptor activation.	NIAID, Struct Biol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sun, PD (corresponding author), NIAID, Struct Biol Sect, Immunogenet Lab, NIH, 12441 Parklawn Dr, Rockville, MD 20852 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000853, Z01AI000853] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], TXB RHEUMATOLOGY; BASU M, 1993, J BIOL CHEM, V268, P13118; BURTON DR, 1985, MOL IMMUNOL, V22, P161, DOI 10.1016/0161-5890(85)90151-8; CHAPPEL MS, 1991, P NATL ACAD SCI USA, V88, P9036, DOI 10.1073/pnas.88.20.9036; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Fossati-Jimack L, 2000, J EXP MED, V191, P1293, DOI 10.1084/jem.191.8.1293; Galon J, 1997, EUR J IMMUNOL, V27, P1928, DOI 10.1002/eji.1830270816; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; HARRIS LJ, 1992, NATURE, V360, P369, DOI 10.1038/360369a0; HUIZINGA TWJ, 1989, J IMMUNOL, V142, P2359; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Kato K, 2000, IMMUNOL TODAY, V21, P310, DOI 10.1016/S0167-5699(00)01666-2; KULCZYCKI A, 1981, MOL IMMUNOL, V18, P723, DOI 10.1016/0161-5890(81)90064-X; LEATHERBARROW RJ, 1985, MOL IMMUNOL, V22, P407, DOI 10.1016/0161-5890(85)90125-7; LUND J, 1990, MOL IMMUNOL, V27, P1145, DOI 10.1016/0161-5890(90)90103-7; McDonnell JM, 1996, NAT STRUCT BIOL, V3, P419, DOI 10.1038/nsb0596-419; POUND JD, 1993, MOL IMMUNOL, V30, P233, DOI 10.1016/0161-5890(93)90052-D; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; ROUSSEAUX J, 1983, J IMMUNOL METHODS, V64, P141, DOI 10.1016/0022-1759(83)90392-7; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; TAKIZAWA F, 1992, J EXP MED, V176, P469, DOI 10.1084/jem.176.2.469; Tamm A, 1997, Int Rev Immunol, V16, P57, DOI 10.3109/08830189709045703; VAUGHAN JH, 1993, ARTHRITIS RHEUM, V36, P1, DOI 10.1002/art.1780360102	26	108	162	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16478	16483		10.1074/jbc.M100351200	http://dx.doi.org/10.1074/jbc.M100351200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11297533	hybrid			2022-12-27	WOS:000168623100121
J	Saito, K; Scharenberg, AM; Kinet, JP				Saito, K; Scharenberg, AM; Kinet, JP			Interaction between the Btk PH domain and phosphatidylinositol-3,4,5-trisphosphate directly regulates Btk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUTONS TYROSINE KINASE; PLECKSTRIN HOMOLOGY DOMAINS; B-CELL; CALCIUM SIGNALS; ACTIVATION; RECEPTOR; MICE; PTDINS-3,4,5-P-3; PHOSPHORYLATION; SPECIFICITY	Bruton's tyrosine kinase (Btk) binds to phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P-3) through the Btk pleckstrin homology (PH) domain, an interaction thought to be required for Btk membrane translocation during B cell receptor signaling. Here, we report that interaction of PtdIns-3,4,5-P-3, with the PH domain of Btk directly induces Btk enzymatic activation in an in vitro kinase assay. A point mutation that reduces interaction of PtdIns-3,4,5-B, with the Btk PH domain blocks in vitro PtdIns-3,4,5-P-3-dependent Btk activation, whereas the PH domain deletion enhances Btk basal activity but eliminates the PtdIns-3,4,5-P-3-dependent stimulation. Btk kinase activity and the Btk activation loop phosphorylation site are both required for the PtdIns-3,4,5-P-3-mediated stimulation of Btk kinase activity. Together, these results suggest that the Btk PH domain is positioned such that it normally suppresses both Btk kinase activity and access to substrates; when interacting with PtdIns-3,4,5-P-3, this suppression is relieved, producing apparent Btk activation. In addition, using Src family kinase inhibitors and Btk catalytically inactive mutants, we demonstrate that in vivo, the activation of Btk is due to both Lyn phosphorylation and PtdIns-3,4,5-P-3-mediated direct activation. Thus, the Btk-PtdIns-3,4,5-P-3 interaction serves to translocate Btk to the membrane and directly regulate its signaling function.	Beth Israel Deaconess Med Ctr, Dept Pathol, Div Allergy & Immunol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kinet, JP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, Div Allergy & Immunol, 330 Brookline Ave, Boston, MA 02215 USA.							Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; EARL PL, 1987, EXPRESSION PROTEINS; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kojima T, 1997, BIOCHEM BIOPH RES CO, V236, P333, DOI 10.1006/bbrc.1997.6947; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Rawlings D J, 1995, Semin Immunol, V7, P237, DOI 10.1006/smim.1995.0028; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Scharenberg AM, 1996, CELL, V87, P961, DOI 10.1016/S0092-8674(00)81790-0; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; SCHARENBERG AM, 1995, EMBO J, V14, P3385, DOI 10.1002/j.1460-2075.1995.tb07344.x; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; TOKER A, 1994, J BIOL CHEM, V269, P32358; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4	25	104	107	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16201	16206		10.1074/jbc.M100873200	http://dx.doi.org/10.1074/jbc.M100873200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279148	hybrid			2022-12-27	WOS:000168623100085
J	Sotomaru, Y; Kawase, Y; Ueda, T; Obata, Y; Suzuki, H; Domeki, I; Hatada, I; Kono, T				Sotomaru, Y; Kawase, Y; Ueda, T; Obata, Y; Suzuki, H; Domeki, I; Hatada, I; Kono, T			Disruption of imprinted expression of U2afbp-rs/U2af1-rs1 gene in mouse parthenogenetic fetuses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLELE-SPECIFIC METHYLATION; CHROMATIN STRUCTURE; SCANNING METHOD; H19 GENE; CHROMOSOME-11; PROTEIN; EMBRYOS; IDENTIFICATION; EMBRYOGENESIS; OSCILLATIONS	The present study shows that the U2afbp-rs gene, a paternally expressed imprinted gene, is activated and expressed in a biallelic manner from maternal alleles in parthenogenetic mouse fetuses on day 9.5 of gestation. The mean expression was detected to be 88% (31-134%) of that in control biparental fetuses, using real-time quantitative reverse transcription and polymerase chain reaction. This disrupted expression of the gene was associated with changes in the chromatin structure but not with the methylation pattern in the regulation region. The present results show that parental specific expression of imprinted genes is not always maintained in uniparental embryos. This suggests that both parental genomes are necessary to establish parental specific expression of the U2afbp-rs gene.	Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1568502, Japan; Tokyo Univ Agr, Dept Anim Sci, Kanagawa 2430034, Japan; Niigata Univ, Mol Genet Res Lab, Niigata 9518510, Japan; Chugai Pharmaceut Co Ltd, Pharmaceut Technol Lab, Shizuoka 4128513, Japan; Gunma Univ, Ctr Gene Res, Maebashi, Gumma 3718511, Japan	Tokyo University of Agriculture; Tokyo University of Agriculture; Niigata University; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Gunma University	Kono, T (corresponding author), Tokyo Univ Agr, Dept Biosci, Setagaya Ku, 1-1-1,Sakauragaoka, Tokyo 1568502, Japan.	tomohiro@nodai.ac.jp						BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; BosMikich A, 1997, DEV BIOL, V182, P172, DOI 10.1006/dbio.1996.8468; BOSMIKICH A, 1995, MOL REPROD DEV, V41, P84, DOI 10.1002/mrd.1080410113; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; CHAILLET JR, 1991, GENOMICS, V11, P773, DOI 10.1016/0888-7543(91)90090-2; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; FERI R, 1997, J BIOL CHEM, V271, P14390; HATADA I, 1993, NUCLEIC ACIDS RES, V21, P5577, DOI 10.1093/nar/21.24.5577; HATADA I, 1991, P NATL ACAD SCI USA, V88, P9523, DOI 10.1073/pnas.88.21.9523; HAYASHIZAKI Y, 1994, NAT GENET, V6, P33, DOI 10.1038/ng0194-33; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; Kono T, 1996, J CELL BIOL, V132, P915, DOI 10.1083/jcb.132.5.915; KONO T, 1993, MOL REPROD DEV, V34, P43, DOI 10.1002/mrd.1080340107; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Miyoshi N, 1998, P NATL ACAD SCI USA, V95, P1102, DOI 10.1073/pnas.95.3.1102; MONK M, 1988, GENE DEV, V2, P921, DOI 10.1101/gad.2.8.921; MOORE T, 1995, REV REPROD, V2, P73; Obata Y, 1998, DEVELOPMENT, V125, P1553; Sasaki H, 1995, DEVELOPMENT, V121, P4195; SASAKI H, 1992, GENE DEV, V6, P1843, DOI 10.1101/gad.6.10.1843; Shemer R, 1996, P NATL ACAD SCI USA, V93, P6371, DOI 10.1073/pnas.93.13.6371; Shibata H, 1996, GENOMICS, V35, P248, DOI 10.1006/geno.1996.0348; Shibata H, 1997, GENOMICS, V44, P171, DOI 10.1006/geno.1997.4877; Sotomaru Yusuke, 2001, Journal of Reproduction and Development, V47, P139, DOI 10.1262/jrd.47.139; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; SURANI MA, 1990, DEVELOPMENT, P89; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; WALSH C, 1994, MECH DEVELOP, V46, P55, DOI 10.1016/0925-4773(94)90037-X; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; WU C, 1979, CELL, V16, P797, DOI 10.1016/0092-8674(79)90095-3	39	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2001	276	28					26694	26698		10.1074/jbc.M101367200	http://dx.doi.org/10.1074/jbc.M101367200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451VP	11306578	hybrid			2022-12-27	WOS:000169823300136
J	Ishmael, FT; Alley, SC; Benkovic, SJ				Ishmael, FT; Alley, SC; Benkovic, SJ			Identification and mapping of protein-protein interactions between gp32 and gp59 by cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; REPLICATION FORK; BINDING-PROTEIN; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; GENE-41 PROTEIN; BACTERIOPHAGE-T4; HELICASE; PARAMETERS	The bacteriophage T4 59 protein (gp59) plays a vital role in recombination and replication by promoting the assembly of the gene 41 helicase (gp41) onto DNA, thus enabling replication as well as strand exchange in recombination, Loading of the helicase onto gp32 (the T4 single strand binding protein)-coated single-stranded DNA requires gp59 to remove gp32 and replace it with gp41. Cross-linking studies between gp32 and gp59 reveal an interaction between Cys-166 of gp32 and Cys-42 of gp59, Since Cys-166 lies in the DNA binding core domain of gp32, this interaction may affect the association of gp32 with DNA. In the presence of gp32 or DNA, gp59 is capable of forming a multimer consisting of at least five gp59 subunits, Kinetics studies suggest that gp59 and gp41 exist in a one-to-one ratio, predicting that gp59 is capable of forming a hexamer (Raney, K, D,, Carver, T, E,, and Benkovic, S. J. (1996) J. Biol. Chem. 271, 14074-14081), The C-terminal A-domain of gp32 is needed for gp59 oligomer formation. Cross-linking has established that gp59 can interact with gp32-A (a truncated form of gp32 lacking the A-domain) but cannot form higher species. The results support a model in which gp59 binds to gp32 on a replication fork, destabilizing the gp32-single-stranded DNA interaction concomitant with the oligomerization of gp59 that results in a switching of gp41 for gp32 at the replication fork.	Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, 414 Wart Lab, University Pk, PA 16802 USA.							Alley SC, 2000, J AM CHEM SOC, V122, P6126, DOI 10.1021/ja000591t; CUNNINGHAM RP, 1977, VIROLOGY, V80, P67, DOI 10.1016/0042-6822(77)90381-6; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Jones CE, 2000, J BIOL CHEM, V275, P27145; Kreuzer Kenneth N., 1994, P89; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; Lefebvre SD, 1997, J MOL BIOL, V272, P312, DOI 10.1006/jmbi.1997.1264; Lefebvre SD, 1999, J BIOL CHEM, V274, P22830, DOI 10.1074/jbc.274.32.22830; MORRICAL SW, 1994, J BIOL CHEM, V269, P33069; Morrical SW, 1996, J BIOL CHEM, V271, P20198, DOI 10.1074/jbc.271.33.20198; Mosig G, 1997, VIROLOGY, V230, P72, DOI 10.1006/viro.1997.8464; MOSIG G, 1994, MOL BIOL BACTERIOP T, V4, P54; Mueser TC, 2000, J MOL BIOL, V296, P597, DOI 10.1006/jmbi.1999.3438; Raney KD, 1996, J BIOL CHEM, V271, P14074, DOI 10.1074/jbc.271.24.14074; San Martin C, 1998, STRUCTURE, V6, P501; Sexton DJ, 1996, J BIOL CHEM, V271, P28045, DOI 10.1074/jbc.271.45.28045; Sexton DJ, 1998, BIOCHEMISTRY-US, V37, P7749, DOI 10.1021/bi980088h; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; SHAMOO Y, 1986, P NATL ACAD SCI USA, V83, P8844, DOI 10.1073/pnas.83.23.8844; Shier VK, 2001, J BIOL CHEM, V276, P14744, DOI 10.1074/jbc.M010688200; TARUMI K, 1995, J BIOL CHEM, V270, P2614, DOI 10.1074/jbc.270.6.2614; YONESAKI T, 1994, J BIOL CHEM, V269, P1284; YOUNG MC, 1994, J MOL BIOL, V235, P1447, DOI 10.1006/jmbi.1994.1100	23	45	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					25236	25242		10.1074/jbc.M100783200	http://dx.doi.org/10.1074/jbc.M100783200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11309384	hybrid			2022-12-27	WOS:000169800700108
J	Olsen, DR; Leigh, SD; Chang, R; McMullin, H; Ong, W; Tai, E; Chisholm, G; Birk, DE; Berg, RA; Hitzeman, RA; Toman, PD				Olsen, DR; Leigh, SD; Chang, R; McMullin, H; Ong, W; Tai, E; Chisholm, G; Birk, DE; Berg, RA; Hitzeman, RA; Toman, PD			Production of human type I collagen in yeast reveals unexpected new insights into the molecular assembly of collagen trimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COOH-TERMINAL REGION; SACCHAROMYCES-CEREVISIAE; TRIPLE-HELIX; FIBRILLOGENESIS INVITRO; III COLLAGEN; PROCOLLAGEN; EXPRESSION; CELLS; SECRETION; CHAIN	Substantial evidence supports the role of the procollagen C-propeptide in the initial association of procollagen polypeptides and for triple helix formation. To evaluate the role of the propeptide domains on triple helix formation, human recombinant type I procollagen, pN-collagen (procollagen without the C-propeptides), pC-collagen (procollagen without the N-propeptides), and collagen (minus both propeptide domains) heterotrimers were expressed in Saccharomyces cerevisiae. Deletion of the N- or C-propeptide, or both propeptide domains, from both pro alpha -chains resulted in correctly aligned triple helical type I collagen. Protease digestion assays demonstrated folding of the triple helix in the absence of the N- and C-propeptides from both pro alpha -chains. This result suggests that sequences required for folding of the triple helix are located in the helical/telopeptide domains of the collagen molecule. Using a strain that does not contain prolyl hydroxylase, the same folding mechanism was shown to be operative in the absence of prolyl hydroxylase, Normal collagen fibrils were generated showing the characteristic banding pattern using this recombinant collagen. This system offers new opportunities for the study of collagen expression and maturation.	Cohes Technol Inc, Palo Alto, CA 94303 USA; Genotypes Inc, San Francisco, CA 94080 USA; Thomas Jefferson Univ, Jefferson Med Sch, Philadelphia, PA 19107 USA	Jefferson University	Toman, PD (corresponding author), Cohes Technol Inc, 2500 Faber Pl, Palo Alto, CA 94303 USA.	dtoman@cson.com	Birk, David/I-4072-2012	Birk, David/0000-0002-4865-9088				BECKER DM, 1991, METHOD ENZYMOL, V194, P182; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; BIRK DE, 1995, DEV DYNAM, V202, P229, DOI 10.1002/aja.1002020303; BIRK DE, 1990, J CELL SCI, V95, P649; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; Bulleid NJ, 1997, EMBO J, V16, P6694, DOI 10.1093/emboj/16.22.6694; Bulleid NJ, 1998, MATRIX BIOL, V17, P233, DOI 10.1016/S0945-053X(98)90062-2; BYRNE MH, 1993, MATRIX, V13, P30; CHEN CY, 1984, NUCLEIC ACIDS RES, V12, P8951, DOI 10.1093/nar/12.23.8951; Doyle SA, 1998, J CELL BIOCHEM, V71, P233; Fields G B, 1992, Matrix Suppl, V1, P68; GELMAN RA, 1979, J BIOL CHEM, V254, P1741; Haralson MA, 1995, EXTRACELLULAR MATRIX, P1; HIGHBERGER JH, 1979, BIOCHEM BIOPH RES CO, V89, P202, DOI 10.1016/0006-291X(79)90964-1; HITZEMAN RA, 1990, METHOD ENZYMOL, V185, P421; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; KADLER K, 1994, PROTEIN PROFILE, V1, P519; KAO WWY, 1979, J BIOL CHEM, V254, P2234; LEE ST, 1992, J BIOL CHEM, V267, P24126; LEE ST, 1988, J BIOL CHEM, V263, P13414; Lees JF, 1997, EMBO J, V16, P908, DOI 10.1093/emboj/16.5.908; Lim AL, 1998, J CELL BIOCHEM, V71, P216, DOI 10.1002/(SICI)1097-4644(19981101)71:2<216::AID-JCB7>3.3.CO;2-K; McLaughlin SH, 1998, MATRIX BIOL, V16, P369, DOI 10.1016/S0945-053X(98)90010-5; MCPHERSON JM, 1985, COLLAGEN REL RES, V5, P119; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; Myllyharju J, 1997, J BIOL CHEM, V272, P21824, DOI 10.1074/jbc.272.35.21824; ROSENBLOOM J, 1976, J BIOL CHEM, V251, P2070; SCHOFIELD JD, 1974, BIOCHEMISTRY-US, V13, P1801, DOI 10.1021/bi00706a004; Toman PD, 2000, J BIOL CHEM, V275, P23303, DOI 10.1074/jbc.M002284200; UITTO J, 1979, ARCH BIOCHEM BIOPHYS, V192, P371, DOI 10.1016/0003-9861(79)90105-X; UITTO VJ, 1981, ARCH BIOCHEM BIOPHYS, V210, P445, DOI 10.1016/0003-9861(81)90208-3; Vaughan PR, 1998, DNA CELL BIOL, V17, P511, DOI 10.1089/dna.1998.17.511; Vuorela A, 1997, EMBO J, V16, P6702, DOI 10.1093/emboj/16.22.6702; WU H, 1990, P NATL ACAD SCI USA, V87, P5888, DOI 10.1073/pnas.87.15.5888	34	42	50	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24038	24043		10.1074/jbc.M101613200	http://dx.doi.org/10.1074/jbc.M101613200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11279215	hybrid			2022-12-27	WOS:000169531100108
J	de Marco, MD; Kremer, L; Albar, JP; Martinez-Menarguez, JA; Ballesta, J; Garcia-Lopez, MA; Marazuela, M; Puertollano, R; Alonso, MA				de Marco, MD; Kremer, L; Albar, JP; Martinez-Menarguez, JA; Ballesta, J; Garcia-Lopez, MA; Marazuela, M; Puertollano, R; Alonso, MA			BENE, a novel raft-associated protein of the MAL proteolipid family, interacts with caveolin-1 in human endothelial-like ECV304 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; DARBY CANINE KIDNEY; APICAL TRANSPORT; PLASMA-MEMBRANE; MDCK CELLS; ANCHORED PROTEINS; CHOLESTEROL; EXPRESSION; COMPONENT; VESICLES	The MAL proteolipid, an integral protein present in glycolipid- and cholesterol-enriched membrane (GEM) rafts, is an element of the machinery necessary for apical sorting in polarized epithelial Madin-Darby canine kidney cells. MAL was the first member identified of an extended family of proteins that have significant overall sequence identity. In this study we have used a newly generated monoclonal antibody to investigate an unedited member of this family, named BENE, which was found to be expressed in endothelial-like ECV304 cells and normal human endothelium, Human BENE was characterized as a proteolipid protein predominantly present in GEM rafts in ECV304 cells, Coimmunoprecipitation experiments revealed that BENE interacted with caveolin-1, Confocal immunofluorescence and electron microscopic analyses indicated that BENE mainly accumulated into intracellular vesicular/tubular structures that partially colocalize with internal caveolin-1, In response to cell surface cholesterol oxidation, BENE redistributed to the dilated vesicular structures that concentrate most of the caveolin-1 originally on the cell surface, After cessation of cholesterol oxidation, a detectable fraction of the BENE molecules migrated to the plasmalemma accompanying caveolin-1 and then returned progressively to its steady state distribution. Together, these features highlight the BENE proteolipid as being an element of the machinery for raft-mediated trafficking in endothelial cells.	Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain; Univ Murcia, Fac Med, Dept Cellular Biol, E-30071 Murcia, Spain; Hosp Princesa, Dept Endocrinol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Murcia; Hospital de La Princesa	Alonso, MA (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.		García-López, Maria Angeles/AAB-5755-2019; Alonso, Miguel A/J-3945-2016; Kremer, Leonor/L-5445-2015	García-López, Maria Angeles/0000-0002-1417-9385; Alonso, Miguel A/0000-0002-7001-8826; Kremer, Leonor/0000-0002-2235-2010; ballesta, Jose/0000-0001-7965-5277				ALONSO MA, 1987, P NATL ACAD SCI USA, V84, P1997, DOI 10.1073/pnas.84.7.1997; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown J, 2000, LAB INVEST, V80, P37, DOI 10.1038/labinvest.3780006; Cheong KH, 1999, P NATL ACAD SCI USA, V96, P6241, DOI 10.1073/pnas.96.11.6241; CONRAD PA, 1995, J CELL BIOL, V131, P1421, DOI 10.1083/jcb.131.6.1421; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P8; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; GAUSEPOHL H, 1992, PEPTIDE RES, V5, P315; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN; Harlow E., 1988, ANTIBODIES LAB MANUA; Hughes SE, 1996, EXP CELL RES, V225, P171, DOI 10.1006/excr.1996.0168; KIM T, 1995, J NEUROSCI RES, V42, P413, DOI 10.1002/jnr.490420316; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; LAUTNERRIESKE A, 1995, GENE, V159, P199, DOI 10.1016/0378-1119(95)00161-X; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; Li SW, 1996, J BIOL CHEM, V271, P28647, DOI 10.1074/jbc.271.45.28647; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Magyar JP, 1997, GENE, V189, P269, DOI 10.1016/S0378-1119(96)00861-X; MARAZUELA M, 1995, CLIN EXP IMMUNOL, V102, P328; Martin-Belmonte F, 1998, ENDOCRINOLOGY, V139, P2077, DOI 10.1210/en.139.4.2077; Martin-Belmonte F, 2000, MOL BIOL CELL, V11, P2033, DOI 10.1091/mbc.11.6.2033; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; MartinezMenarguez JA, 1996, EUR J CELL BIOL, V71, P137; Millan J, 1997, BIOCHEM BIOPH RES CO, V233, P707, DOI 10.1006/bbrc.1997.6530; Millan J, 1998, EUR J IMMUNOL, V28, P3675, DOI 10.1002/(SICI)1521-4141(199811)28:11<3675::AID-IMMU3675>3.3.CO;2-X; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Perez P, 1997, BIOCHEM BIOPH RES CO, V232, P618, DOI 10.1006/bbrc.1997.6338; PONTE P, 1983, MOL CELL BIOL, V3, P1783, DOI 10.1128/MCB.3.10.1783; Puertollano R, 1999, MOL BIOL CELL, V10, P3435, DOI 10.1091/mbc.10.10.3435; Puertollano R, 1999, J CELL BIOL, V145, P141, DOI 10.1083/jcb.145.1.141; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; SCHLESINGER MJ, 1981, ANNU REV BIOCHEM, V50, P193, DOI 10.1146/annurev.bi.50.070181.001205; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; SMART EJ, 1994, J CELL BIOL, V127, P1185, DOI 10.1083/jcb.127.5.1185; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; Zacchetti D, 1995, FEBS LETT, V377, P465, DOI 10.1016/0014-5793(95)01396-2	45	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23009	23017						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294831				2022-12-27	WOS:000169412700137
J	Finazzi, G; Barbagallo, RP; Bergo, E; Barbato, R; Forti, G				Finazzi, G; Barbagallo, RP; Bergo, E; Barbato, R; Forti, G			Photoinhibition of Chlamydomonas reinhardtii in State 1 and State 2 - Damages to the photosynthetic apparatus under linear and cyclic electron flow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN DAMAGE; PHOTOSYSTEM-II; D1 PROTEIN; IN-VIVO; PLASTOQUINONE COMPARTMENTATION; CHLOROPLAST MEMBRANES; ENERGY-DISTRIBUTION; Q(B) SITE; LIGHT; PHOSPHORYLATION	The relationship between state transitions and photoinhibition has been studied in Chlamydomonas reinhardtii cells. In State 2, photosystem II activity was more inhibited by light than in State 1. In State 2, however, the D1 subunit was not degraded, whereas a substantial degradation was observed in State 1, These results suggest that photoinhibition occurs via the generation of an intermediate state in which photosystem II is inactive but the D1 protein is still intact. The accumulation of this state is enhanced in State 2, be cause in this State only cyclic photosynthetic electron transport is active, whereas there is no electron flow between photosystem II and the cytochrome b(6)f complex (Finazzi, G., Furia, A., Barbagallo, R, P,, and Forti, G, (1999) Biochim. Biophys. Acta 1413, 117-129). The activity of photosystem I and of cytochrome b(6)f as well as the coupling of thylakoid membranes was not affected by illumination under the same conditions. This allows repairing the damages to photosystem II thanks to cell capacity to maintain a high rate of ATP synthesis (via photosystem I-driven cyclic electron flow). This capacity might represent an important physiological tool in protecting the photosynthetic apparatus from excess of light as well. as from other a-biotic stress conditions.	CNR, Ctr Studio Biol Cellulare & Mol Piante, I-20133 Milan, Italy; Univ Padua, Dipartimento Biol, I-35100 Padua, Italy; Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci & Tecnol Avanzate, I-15100 Alessandria, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Eastern Piedmont Amedeo Avogadro	Finazzi, G (corresponding author), CNR, Ctr Studio Biol Cellulare & Mol Piante, Via Celoria 26, I-20133 Milan, Italy.							ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; BARBATO R, 1991, FEBS LETT, V290, P162, DOI 10.1016/0014-5793(91)81250-C; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BARENYI B, 1985, PLANTA, V163, P218, DOI 10.1007/BF00393510; BENDALL DS, 1982, BIOCHIM BIOPHYS ACTA, V683, P119, DOI 10.1016/0304-4173(82)90008-8; BENNETT J, 1991, ANNU REV PLANT PHYS, V42, P281, DOI 10.1146/annurev.pp.42.060191.001433; BENNOUN P, 1970, BIOCHIM BIOPHYS ACTA, V216, P357, DOI 10.1016/0005-2728(70)90227-6; BENNOUN P, 1994, BBA-BIOENERGETICS, V1186, P59, DOI 10.1016/0005-2728(94)90135-X; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; BRACHT E, 1994, Z NATURFORSCH C, V49, P439; BULTE L, 1990, BIOCHIM BIOPHYS ACTA, V1020, P72, DOI 10.1016/0005-2728(90)90095-L; BUTLER WL, 1978, ANNU REV PLANT PHYS, V29, P345, DOI 10.1146/annurev.pp.29.060178.002021; Chow WS, 1998, AUST J PLANT PHYSIOL, V25, P775, DOI 10.1071/PP97160; CHYLLA RA, 1989, PLANT PHYSIOL, V90, P765, DOI 10.1104/pp.90.2.765; DELOSME R, 1994, BBA-BIOENERGETICS, V1185, P56, DOI 10.1016/0005-2728(94)90193-7; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Endo T, 1996, PLANT CELL PHYSIOL, V37, P551, DOI 10.1093/oxfordjournals.pcp.a028979; Finazzi G, 1997, BIOCHEMISTRY-US, V36, P2867, DOI 10.1021/bi962717y; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; FORTI G, 1963, BIOCHIM BIOPHYS ACTA, V71, P1, DOI 10.1016/0006-3002(63)90979-X; Forti G, 1999, PHOTOSYNTH RES, V59, P215, DOI 10.1023/A:1006164017455; FRANK K, 1995, PHOTOCHEM PHOTOBIOL, V61, P2, DOI 10.1111/j.1751-1097.1995.tb09237.x; Fulgosi H, 1998, EMBO J, V17, P1577, DOI 10.1093/emboj/17.6.1577; Gal A, 1997, PHYSIOL PLANTARUM, V100, P869, DOI 10.1034/j.1399-3054.1997.1000413.x; GONG HS, 1994, BIOCHIM BIOPHYS ACTA, V1118, P422; GORMAN DS, 1960, P NATL ACAD SCI USA, V46, P83; Heber U, 1995, PLANT CELL PHYSIOL, V36, P1639; HERZIG R, 1989, J PHYCOL, V25, P462, DOI 10.1111/j.1529-8817.1989.tb00251.x; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; HOWARD B, 1983, FEBS LETT, V153, P221; JANSEN MAK, 1993, J BIOL CHEM, V268, P21246; Jegerschold C, 1996, BIOCHEMISTRY-US, V35, P7794, DOI 10.1021/bi960083p; JOLIOT P, 1974, BIOCHIM BIOPHYS ACTA, V357, P267, DOI 10.1016/0005-2728(74)90066-8; JOLIOT P, 1980, J CHIM PHYS PCB, V77, P209, DOI 10.1051/jcp/1980770209; JOLIOT P, 1992, BIOCHIM BIOPHYS ACTA, V1101, P1, DOI 10.1016/0167-4838(92)90460-U; JUNGE W, 1968, Z NATURFORSCH B, V24, P1038; KIRILOVSKY D, 1994, BIOCHEMISTRY-US, V33, P3087, DOI 10.1021/bi00176a043; KIRILOVSKY DL, 1990, BIOCHEMISTRY-US, V29, P8100, DOI 10.1021/bi00487a016; KOMENDA J, 1995, BIOCHEMISTRY-US, V34, P9625, DOI 10.1021/bi00029a040; KYLE DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4070, DOI 10.1073/pnas.81.13.4070; LAVERGNE J, 1991, TRENDS BIOCHEM SCI, V16, P129, DOI 10.1016/0968-0004(91)90054-Y; LAVERGNE J, 1992, BIOCHIM BIOPHYS ACTA, V1101, P13, DOI 10.1016/0167-4838(92)90461-L; MATOO AK, 1984, P NATL ACAD SCI USA, V81, P1380; MISHRA NP, 1994, BBA-BIOENERGETICS, V1187, P296, DOI 10.1016/0005-2728(94)90003-5; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V172, P242, DOI 10.1016/0005-2728(69)90067-X; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; OHAD I, 1984, J CELL BIOL, V99, P481, DOI 10.1083/jcb.99.2.481; PELTIER G, 1991, P NATL ACAD SCI USA, V88, P4791, DOI 10.1073/pnas.88.11.4791; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; Sonoike K, 1996, PLANT CELL PHYSIOL, V37, P239, DOI 10.1093/oxfordjournals.pcp.a028938; SUEOKA N, 1965, P NATL ACAD SCI USA, V54, P1665; TANNER W, 1969, PROGRESS PHOTOSYNTHE, V3, P1217; TREBST A, 1988, PHOTOSYNTH RES, V18, P163, DOI 10.1007/BF00042983; VALLON O, 1991, P NATL ACAD SCI USA, V88, P8262, DOI 10.1073/pnas.88.18.8262; VASS I, 1992, P NATL ACAD SCI USA, V89, P1408, DOI 10.1073/pnas.89.4.1408; Vener AV, 1998, CURR OPIN PLANT BIOL, V1, P217, DOI 10.1016/S1369-5266(98)80107-6; Wykoff DD, 1998, PLANT PHYSIOL, V117, P129, DOI 10.1104/pp.117.1.129; ZER H, 1994, J BIOL CHEM, V269, P17670; ZER H, 1995, EUR J BIOCHEM, V231, P448, DOI 10.1111/j.1432-1033.1995.tb20718.x	61	44	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22251	22257		10.1074/jbc.M011376200	http://dx.doi.org/10.1074/jbc.M011376200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294855	hybrid			2022-12-27	WOS:000169412700039
J	Hu, G; Jang, GF; Cowan, CW; Wensel, TG; Palczewski, K				Hu, G; Jang, GF; Cowan, CW; Wensel, TG; Palczewski, K			Phosphorylation of RGS9-1 by an endogenous protein kinase in rod outer segments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACCELERATING PROTEIN; CYCLIN-DEPENDENT PROTEIN-KINASE-5; HETEROTRIMERIC G-PROTEINS; PHOTOTRANSDUCTION CASCADE; SIGNALING PROTEINS; REGULATORY SUBUNIT; RHODOPSIN KINASE; ACTIVATION; IDENTIFICATION; KINETICS	Inactivation of the visual Gr protein transducin, during recovery from photoexcitation, is regulated by RGS9-1, a GTPase-accelerating protein of the ubiquitous RGS protein family. Incubation of dark-adapted bovine rod outer segments with [gamma-P-32]ATP led to RGS9-1 phosphorylation by an endogenous kinase in rod outer segment membranes, with an average stoichiometry of 0.2-0.45 mol of phosphates/mol of RGS9-1. Mass spectrometry revealed a single major site of phosphorylation, Ser(475). The kinase responsible catalyzed robust phosphorylation of recombinant RGS9-1 and not of an S(475)A mutant. A synthetic peptide corresponding to the region surrounding Ser(475) was also phosphorylated, and a similar peptide with the S(475)A substitution inhibited RGS9-1 phosphorylation. The RGS9-1 kinase is a peripheral membrane protein that co-purifies with rhodopsin in sucrose gradients and can be extracted in buffers of high ionic strength. It is not inhibited or activated significantly by a panel of inhibitors or activators of protein kinase A, protein kinase G, rhodopsin kinase, CaM kinase II, casein kinase II, or cyclin dependent kinase 5, at concentrations 50 or more times higher than their reported IC50 or K-i values. It was inhibited by the protein kinase C inhibitor bisindolylmaleimide I and by lowering Ca2+ to nanomolar levels with EGTA however, it was not stimulated by the addition of phorbol ester, under conditions that significantly enhanced rhodopsin phosphorylation, A monoclonal antibody specific for the Ser475 phosphorylated form of RGS9-1 recognized RGS9-1 in immunoblots of dark-adapted mouse retina. Retinas from light-adapted mice had much lower levels of RGS9-1 phosphorylation. Thus, RGS9-1 is phosphorylated on Ser(475) in vivo, and the phosphorylation level is regulated by light and by [Ca2+], suggesting the importance of the modification in light adaptation.	Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Baylor College of Medicine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wensel, TG (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	twensel@bcm.tmc.edu	Hu, Guang/E-7474-2016; Cowan, Christopher W/I-2497-2014	Hu, Guang/0000-0003-0437-4723; Wensel, Theodore/0000-0003-3518-9352	NEI NIH HHS [EY07001, F32 EY007001, T32 EY007001, R01 EY011900, R01 EY008061, EY11900, EY08061] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008061, R29EY008061, R01EY011900] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arshavsky VY, 1998, NEURON, V20, P11, DOI 10.1016/S0896-6273(00)80430-4; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Baylor DA, 1998, EYE, V12, P521, DOI 10.1038/eye.1998.140; Bell MW, 2000, J NEUROCHEM, V75, P2006, DOI 10.1046/j.1471-4159.2000.0752006.x; Benzing T, 2000, J BIOL CHEM, V275, P28167; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BUCZYLKO J, 1991, P NATL ACAD SCI USA, V88, P2568, DOI 10.1073/pnas.88.6.2568; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Cowan CW, 2001, PROG NUCLEIC ACID RE, V65, P341; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; Cunningham ML, 2001, J BIOL CHEM, V276, P5438, DOI 10.1074/jbc.M007699200; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; De Vries L, 1999, TRENDS CELL BIOL, V9, P138, DOI 10.1016/S0962-8924(99)01515-9; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; Fischer T, 2000, P NATL ACAD SCI USA, V97, P4040, DOI 10.1073/pnas.97.8.4040; Garrison TR, 1999, J BIOL CHEM, V274, P36387, DOI 10.1074/jbc.274.51.36387; Gaudet R, 1999, MOL CELL, V3, P649, DOI 10.1016/S1097-2765(00)80358-5; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GLASS DB, 1978, ANAL BIOCHEM, V87, P566, DOI 10.1016/0003-2697(78)90707-8; GrayKeller MP, 1996, NEURON, V17, P323, DOI 10.1016/S0896-6273(00)80163-4; GREENE NM, 1995, J BIOL CHEM, V270, P6710, DOI 10.1074/jbc.270.12.6710; Harlow E, 1988, ANTIBODIES LABORATOR, P471; Hayashi F, 2000, J BIOL CHEM, V275, P32958, DOI 10.1074/jbc.M000703200; He W, 2000, J BIOL CHEM, V275, P37093, DOI 10.1074/jbc.M006982200; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; HE W, 2001, THESIS BAYLOR COLL M; Hepler JR, 1999, TRENDS PHARMACOL SCI, V20, P376, DOI 10.1016/S0165-6147(99)01369-3; Hollander BA, 1999, CELL MOTIL CYTOSKEL, V43, P114, DOI 10.1002/(SICI)1097-0169(1999)43:2<114::AID-CM3>3.3.CO;2-D; IDO M, 1991, BRIT J CANCER, V64, P1103, DOI 10.1038/bjc.1991.472; INAGAKI M, 1986, MOL PHARMACOL, V29, P577; JAMES P, 1995, TRENDS BIOCHEM SCI, V20, P38, DOI 10.1016/S0968-0004(00)88949-5; KELLEHER DJ, 1985, J CYCLIC NUCL PROT, V10, P579; KUCHERA S, 1993, AGENTS ACTIONS, V39, pC169, DOI 10.1007/BF01972756; LIEBMAN PA, 1980, NATURE, V287, P734, DOI 10.1038/287734a0; Lyubarsky A, 1996, J GEN PHYSIOL, V107, P19, DOI 10.1085/jgp.107.1.19; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; MATESIC DF, 1992, J CELL SCI, V103, P157; Matsuura I, 2000, J BIOL CHEM, V275, P32950, DOI 10.1074/jbc.M000702200; NEWTON AC, 1991, J BIOL CHEM, V266, P17725; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; Palczewski K, 1997, CURR OPIN NEUROBIOL, V7, P500, DOI 10.1016/S0959-4388(97)80029-3; PALCZEWSKI K, 1993, J BIOL CHEM, V268, P6004; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Pedram A, 2000, J BIOL CHEM, V275, P7365, DOI 10.1074/jbc.275.10.7365; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P245, DOI 10.1016/S0968-0004(96)30027-3; Posewitz MC, 1999, ANAL CHEM, V71, P2883, DOI 10.1021/ac981409y; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Rahman Z, 1999, J NEUROSCI, V19, P2016; Sagoo MS, 1997, NATURE, V389, P392, DOI 10.1038/38750; SANDBERG M, 1991, BIOCHEM J, V279, P521, DOI 10.1042/bj2790521; SATHER WA, 1987, P NATL ACAD SCI USA, V84, P9290, DOI 10.1073/pnas.84.24.9290; Siderovski DP, 1999, CRIT REV BIOCHEM MOL, V34, P215, DOI 10.1080/10409239991209273; Smith JK, 2000, J BIOL CHEM, V275, P154, DOI 10.1074/jbc.275.1.154; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; WALTER U, 1984, ADV CYCLIC NUCL PROT, V17, P249; WELLER M, 1975, P NATL ACAD SCI USA, V72, P381, DOI 10.1073/pnas.72.1.381; WILLIAMS TP, 1990, EXP EYE RES, V51, P739, DOI 10.1016/0014-4835(90)90060-8; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Womack KB, 2000, J NEUROSCI, V20, P2792; Zhang K, 1999, GENE, V240, P23, DOI 10.1016/S0378-1119(99)00393-5; Zhang XL, 1998, ANAL CHEM, V70, P2050, DOI 10.1021/ac971207m; Zheng B, 1999, TRENDS BIOCHEM SCI, V24, P411, DOI 10.1016/S0968-0004(99)01474-7	65	35	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22287	22295		10.1074/jbc.M011539200	http://dx.doi.org/10.1074/jbc.M011539200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11292825	Green Accepted, hybrid			2022-12-27	WOS:000169412700044
J	Kuntziger, T; Gavet, O; Sobel, A; Bornens, M				Kuntziger, T; Gavet, O; Sobel, A; Bornens, M			Differential effect of two stathmin/Op18 phosphorylation mutants on Xenopus embryo development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-DESTABILIZING ACTIVITY; CYCLE-REGULATED PHOSPHORYLATION; CELL-CYCLE; MITOTIC SPINDLE; SIGNAL-TRANSDUCTION; CYTOPLASMIC DYNEIN; DISTAL ENDS; TUBULIN; ONCOPROTEIN-18; DYNAMICS	Stathmin/Op18 destabilizes microtubules in vitro and regulates microtubule polymerization in vivo. Both a microtubule catastrophe-promoting activity and a tubulin sequestering activity were demonstrated for stathlin in vitro, and both could contribute to microtubule depolymerization in vivo. Stathmin activity can be turned down by extensive phosphorylation on its four phosphorylatable serines, and down-regulation of stathmin activity by phosphorylation is necessary for cells to proceed through mitosis. Tire show here that microinjection of a nonphosphorylatable Ser to Ala (4A) quadruple mutant in Xenopus two-cell stage embryos results in cell cleavage arrest in the injected blastomeres and aborted development, whereas injection of a pseudo-phosphorylated Ser to Glu quadruple mutant (4E) does not prevent normal development. Addition of these mutants to mitotic cytostatic factor-arrested extracts in which spindle assembly was induced led to a dramatic reduction of spindle size with 4A stathmin, and to a moderate increase with 4E stathmin, but both localized to spindle poles, interestingly the microtubule assembly-dependent phosphorylation of endogenous stathmin was abolished in the presence of 4A stathmin, but not of 4E stathmin. Altogether, this shows that the phosphorylation-mediated regulation of stathmin activity during the cell cycle is essential for early Xenopus embryonic development.	Inst Curie, CNRS, UMR 144, Sect Rech, F-75248 Paris 05, France; Inst Fer Moulin, INSERM, U440, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Bornens, M (corresponding author), Inst Curie, CNRS, UMR 144, Sect Rech, 26 Rue Ulm, F-75248 Paris 05, France.		Küntziger, Thomas M/E-7286-2012; Küntziger, Thomas/H-5252-2019	Küntziger, Thomas/0000-0003-3074-9509				Amayed P, 2000, BIOCHEMISTRY-US, V39, P12295, DOI 10.1021/bi000279w; Andersen SSL, 1997, NATURE, V389, P640, DOI 10.1038/39382; BAILLY E, 1989, EMBO J, V8, P3985, DOI 10.1002/j.1460-2075.1989.tb08581.x; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bobinnec Y, 1998, CELL MOTIL CYTOSKEL, V39, P223, DOI 10.1002/(SICI)1097-0169(1998)39:3<223::AID-CM5>3.3.CO;2-3; BRATTSAND G, 1994, EUR J BIOCHEM, V220, P359, DOI 10.1111/j.1432-1033.1994.tb18632.x; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; CURMI PA, 1994, BIOCHEM J, V300, P331, DOI 10.1042/bj3000331; DiPaolo G, 1997, FEBS LETT, V416, P149, DOI 10.1016/S0014-5793(97)01188-5; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; Gavet O, 1998, J CELL SCI, V111, P3333; Gradin HM, 1998, J CELL BIOL, V140, P131, DOI 10.1083/jcb.140.1.131; Gradin HM, 1997, MOL CELL BIOL, V17, P3459, DOI 10.1128/MCB.17.6.3459; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Holmfeldt P, 2001, MOL BIOL CELL, V12, P73, DOI 10.1091/mbc.12.1.73; Horwitz SB, 1997, J BIOL CHEM, V272, P8129, DOI 10.1074/jbc.272.13.8129; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; KOPPEL J, 1990, J BIOL CHEM, V265, P3703; Kuntziger T, 2001, MOL BIOL CELL, V12, P437, DOI 10.1091/mbc.12.2.437; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; Larsson NL, 1999, MOL CELL BIOL, V19, P2242; Lawler S, 1998, FEBS LETT, V421, P55, DOI 10.1016/S0014-5793(97)01519-6; Lawler S, 1998, CURR BIOL, V8, pR212, DOI 10.1016/S0960-9822(98)70128-9; LUO XN, 1994, J BIOL CHEM, V269, P10312; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; McNally FJ, 1998, MOL BIOL CELL, V9, P1847, DOI 10.1091/mbc.9.7.1847; McNally FJ, 1996, J CELL SCI, V109, P561; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Paoletti A, 1996, J CELL SCI, V109, P3089; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Popov AV, 2001, EMBO J, V20, P397, DOI 10.1093/emboj/20.3.397; Saunders W, 1997, J CELL BIOL, V137, P417, DOI 10.1083/jcb.137.2.417; SAWIN KE, 1991, J CELL BIOL, V112, P941, DOI 10.1083/jcb.112.5.941; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; STRAHLER JR, 1992, BIOCHEM BIOPH RES CO, V185, P197, DOI 10.1016/S0006-291X(05)80975-1; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vaughan KT, 1999, J CELL SCI, V112, P1437	43	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22979	22984		10.1074/jbc.M101466200	http://dx.doi.org/10.1074/jbc.M101466200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11297553	hybrid			2022-12-27	WOS:000169412700133
J	Matsuoka, T; Zhao, L; Stein, R				Matsuoka, T; Zhao, L; Stein, R			The DNA binding activity of the RIPE3b1 transcription factor of insulin appears to be influenced by tyrosine phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; TYPE-2 DIABETES-MELLITUS; GENE-TRANSCRIPTION; PROTEIN PHOSPHATASE; HOMEODOMAIN PROTEIN; ACID-PHOSPHATASE; PHOSPHOTYROSYL-PROTEIN; ALKALINE-PHOSPHATASE; ISLET DEVELOPMENT; GROWTH-HORMONE	The RIPE3b1 DNA binding factor plays a critical role in pancreatic islet beta cell-specific and glucose-regulated transcription of the insulin gene, Recently it was shown that RIPE3b1 binding activity in beta cell nuclear extracts is reduced by treatment with either calf intestinal alkaline phosphatase (CIAP) or a brain-enriched phosphatase preparation (BPP) (Zhao, L., Cissell, M. A., Henderson, E., Colbran, R., and Stein, R, (2000) J. Biol. Chem. 275, 10532-10537). Evidence is presented here suggesting that a tyrosine phosphatase(s) influences the ability of RIPE3b1 to bind to the insulin C1 element in beta cells. We found that RIPE3b1 binding was inhibited upon incubating beta cell nuclear extracts at 30 degreesC, In contrast, PDX-1 and MLTF-1 transcription factor binding activity was unaffected under these conditions. The loss in RIPE3b1 binding activity was prevented by inhibitors of tyrosine phosphatases (sodium orthovanadate and sodium molybdate) but not by inhibitors of serine/threonine phosphatases (sodium fluoride, okadaic acid, and microcystin LR). CIAP- and BPP-catalyzed inhibition of RIPE3b1 binding was also blocked by these tyrosine phosphatase inhibitors. Collectively, the data suggested that removal of a tyrosine(s) within RIPE3b1 prevented activator binding to insulin C1 control element sequences. The presence of a key phosphorylated tyrosine(s) within this transcription factor was further supported by the ability of the 4G10 anti-phosphotyrosine monoclonal antibody to immunoprecipitate RIPE3b1 DNA binding activity. We discuss how tyrosine phosphorylation, a very rare and highly significant regulatory modification, may control RIPE3b1 activator function.	Vanderbilt Univ, Ctr Med, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA	Vanderbilt University	Stein, R (corresponding author), Vanderbilt Univ, Ctr Med, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA.	Roland.Stein@mcmail.vanderbilt.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042505, P60DK020593] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 42505, P60 DK20593] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Aspinwall CA, 1999, J BIOL CHEM, V274, P6360, DOI 10.1074/jbc.274.10.6360; Bramblett DE, 2000, ADV PHARMACOL, V47, P255; Chatterjee-Kishore M, 2000, TRENDS CELL BIOL, V10, P106, DOI 10.1016/S0962-8924(99)01709-2; Cousin SP, 1999, BIOCHEM J, V344, P649, DOI 10.1042/0264-6021:3440649; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; FOULKES JG, 1983, J BIOL CHEM, V258, P431; GERMAN M, 1995, DIABETES, V44, P1002, DOI 10.2337/diab.44.8.1002; GERMAN MS, 1994, MOL CELL BIOL, V14, P4067, DOI 10.1128/MCB.14.6.4067; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; HALLBERG E, 1994, CELL BIOL LAB HDB, V1, P613; Hani EH, 1999, J CLIN INVEST, V104, pR41, DOI 10.1172/JCI7469; Harrison KA, 1999, NAT GENET, V23, P71, DOI 10.1038/12674; HATCH GM, 1990, BIOCHIM BIOPHYS ACTA, V1042, P374, DOI 10.1016/0005-2760(90)90167-V; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; KARLSSON O, 1987, P NATL ACAD SCI USA, V84, P8819, DOI 10.1073/pnas.84.24.8819; KESSLER DS, 1991, J BIOL CHEM, V266, P23471; KREMERSKOTHEN J, 1993, MOL CELL BIOCHEM, V125, P1, DOI 10.1007/BF00926828; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LAU KHW, 1985, J BIOL CHEM, V260, P4653; Leaman DW, 1996, FASEB J, V10, P1578, DOI 10.1096/fasebj.10.14.9002549; Leibiger B, 1998, P NATL ACAD SCI USA, V95, P9307, DOI 10.1073/pnas.95.16.9307; Li H, 1999, NAT GENET, V23, P67; MACFARLANE WM, 1994, BIOCHEM J, V303, P625, DOI 10.1042/bj3030625; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; Macfarlane WM, 1997, J BIOL CHEM, V272, P20936, DOI 10.1074/jbc.272.33.20936; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; Malecki MT, 1999, NAT GENET, V23, P323, DOI 10.1038/15500; Marshak S, 1996, P NATL ACAD SCI USA, V93, P15057, DOI 10.1073/pnas.93.26.15057; MELLOUL D, 1993, P NATL ACAD SCI USA, V90, P3865, DOI 10.1073/pnas.90.9.3865; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Odagiri H, 1996, J BIOL CHEM, V271, P1909, DOI 10.1074/jbc.271.4.1909; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; OKADA M, 1986, BIOCHEM J, V239, P155, DOI 10.1042/bj2390155; Peshavaria M, 1997, MOL CELL BIOL, V17, P3987, DOI 10.1128/MCB.17.7.3987; PESHAVARIA M, 1994, MOL ENDOCRINOL, V8, P806, DOI 10.1210/me.8.6.806; PETERSEN HV, 1994, P NATL ACAD SCI USA, V91, P10465, DOI 10.1073/pnas.91.22.10465; Ram PA, 1996, J BIOL CHEM, V271, P5929, DOI 10.1074/jbc.271.10.5929; REIFELMILLER AE, 1994, J BIOL CHEM, V269, P23861; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHACTERNOIMAN E, 1983, J BIOL CHEM, V258, P4214; SHARMA A, 1994, MOL CELL BIOL, V14, P871, DOI 10.1128/MCB.14.2.871; SHARMA A, 1995, MOL ENDOCRINOL, V9, P1127, DOI 10.1210/me.9.9.1127; SHIEH SY, 1991, J BIOL CHEM, V266, P16708; SHINOZAKI T, 1995, EUR J BIOCHEM, V227, P367, DOI 10.1111/j.1432-1033.1995.tb20398.x; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; STEIN R, 1993, TRENDS ENDOCRIN MET, V122, P1409; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Sussel L, 1998, DEVELOPMENT, V125, P2213; TONKS NK, 1988, J BIOL CHEM, V263, P6731; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; WHELAN J, 1990, MOL CELL BIOL, V10, P1564, DOI 10.1128/MCB.10.4.1564; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; Zhao L, 2000, J BIOL CHEM, V275, P10532, DOI 10.1074/jbc.275.14.10532	64	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22071	22076		10.1074/jbc.M010321200	http://dx.doi.org/10.1074/jbc.M010321200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11309378	hybrid			2022-12-27	WOS:000169412700013
J	May, AP; Whiteheart, SW; Weis, WI				May, AP; Whiteheart, SW; Weis, WI			Unraveling the mechanism of the vesicle transport ATPase NSF, the N-ethylmaleimide-sensitive factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FUSION PROTEIN NSF; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGE; MEMBRANE-FUSION; TERMINAL DOMAIN; AAA ATPASE; COMPLEX; EXOCYTOSIS; REVEALS; BINDING		Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Chandler Med Ctr, Lexington, KY 40536 USA	Stanford University; Stanford University; University of Kentucky	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	bilI.weis@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Whiteheart, Sidney/0000-0001-5577-0473	NIMH NIH HHS [MH58570] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Babor SM, 1999, P NATL ACAD SCI USA, V96, P14759, DOI 10.1073/pnas.96.26.14759; Barnard RJO, 1996, MOL BIOL CELL, V7, P693, DOI 10.1091/mbc.7.5.693; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Coles M, 1999, CURR BIOL, V9, P1158, DOI 10.1016/S0960-9822(00)80017-2; Egelman EH, 1998, J STRUCT BIOL, V124, P123, DOI 10.1006/jsbi.1998.4050; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; GONZALEZ LC, 2001, IN PRESS J BIOL CHEM, V276; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HOHFELD J, 1992, MEMBRANE BIOGENESIS, P185; Hohl TM, 1998, MOL CELL, V2, P539, DOI 10.1016/S1097-2765(00)80153-7; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; LAMB JR, 2001, IN PRESS J BIOL CHEM, V276; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Matveeva E, 1998, FEBS LETT, V435, P211, DOI 10.1016/S0014-5793(98)01071-0; Matveeva EA, 1997, J BIOL CHEM, V272, P26413, DOI 10.1074/jbc.272.42.26413; May AP, 1999, NAT CELL BIOL, V1, P175, DOI 10.1038/11097; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MORGAN A, 1994, J BIOL CHEM, V269, P29347; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Neuwald AF, 1999, GENOME RES, V9, P27; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Rice LM, 1999, MOL CELL, V4, P85, DOI 10.1016/S1097-2765(00)80190-2; Rockel B, 1999, FEBS LETT, V451, P27, DOI 10.1016/S0014-5793(99)00431-7; Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1; Schmidt M, 1999, CURR OPIN CHEM BIOL, V3, P584, DOI 10.1016/S1367-5931(99)00013-7; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Steel GJ, 2000, MOL BIOL CELL, V11, P1345, DOI 10.1091/mbc.11.4.1345; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Swanton E, 2000, J CELL SCI, V113, P1783; TAGAYA M, 1993, J BIOL CHEM, V268, P2662; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531; Yu RC, 1999, MOL CELL, V4, P97, DOI 10.1016/S1097-2765(00)80191-4; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	43	79	84	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					21991	21994		10.1074/jbc.R100013200	http://dx.doi.org/10.1074/jbc.R100013200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301340	hybrid			2022-12-27	WOS:000169412700001
J	van Spaendonk, RML; Ramesar, J; van Wigcheren, A; Eling, W; Beetsma, AL; van Gemert, GJ; Hooghof, J; Janse, CJ; Waters, AP				van Spaendonk, RML; Ramesar, J; van Wigcheren, A; Eling, W; Beetsma, AL; van Gemert, GJ; Hooghof, J; Janse, CJ; Waters, AP			Functional equivalence of structurally distinct ribosomes in the malaria parasite, Plasmodium berghei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA GENES; SACCHAROMYCES-CEREVISIAE; PEPTIDYL TRANSFERASE; PROTEIN; IDENTIFICATION; FALCIPARUM; TRANSCRIPTION; SEQUENCES; TRANSFECTION; SPOROZOITES	Unlike most eukaryotes, many apicomplexan parasites contain only a few unlinked copies of ribosomal RNA (rRNA) genes. Based on stage-specific expression of these genes and structural differences among the rRNA molecules it has been suggested that Plasmodium spp. produce functionally different ribosomes in different developmental stages. This hypothesis was investigated through comparison of the structure of the large sub unit rRNA molecules of the rodent malaria parasite, Plasmodium berghei, and by disruption of both of the rRNA gene units that are transcribed exclusively during development of this parasite in the mosquito (S type rRNA gene units). In contrast to the human parasite, Plasmodium falciparum, we did not find evidence of structural differences in core regions of the distinct large subunit rRNAs which are known to be associated with catalytic activity including the GTPase site that varies in P. falciparum. Knockout P. berghei parasites lacking either of the S-type gene units were able to complete development in both the vertebrate and mosquito hosts. These results formally exclude the hypothesis that two functionally different ribosome types distinct from the predominantly blood stage-expressed A-type ribosomes, are required for development of all Plasmodium species in the mosquito. The maintenance of two functionally equivalent rRNA genes might now be explained as a gene dosage phenomenon.	Leiden Univ, Med Ctr, Dept Parasitol, NL-2300 RC Leiden, Netherlands; Univ Nijmegen St Radboud Hosp, Dept Med Microbiol, Sect Parasitol, NL-6525 ED Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	Waters, AP (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, Postbus 9600, NL-2300 RC Leiden, Netherlands.	Waters@lumc.nl	Waters, Andy P/C-9377-2009	Waters, Andy P/0000-0001-8900-2982; Janse, Chris J/0000-0002-6410-6205; Vervenne, Resie/0000-0002-6077-8725				ABOVICH N, 1985, MOL CELL BIOL, V5, P3429, DOI 10.1128/MCB.5.12.3429; Bishop R, 2000, GENE, V257, P299, DOI 10.1016/S0378-1119(00)00386-3; DAHLBERG AE, 1989, CELL, V57, P525, DOI 10.1016/0092-8674(89)90122-0; DALRYMPLE BP, 1990, MOL BIOCHEM PARASIT, V43, P117, DOI 10.1016/0166-6851(90)90136-A; DAME JB, 1983, J BIOL CHEM, V258, P6984; DAME JB, 1984, MOL BIOCHEM PARASIT, V11, P301, DOI 10.1016/0166-6851(84)90074-4; DAME JB, 1984, NUCLEIC ACIDS RES, V12, P5943, DOI 10.1093/nar/12.14.5943; DAME JB, 1983, MOL BIOCHEM PARASIT, V8, P263, DOI 10.1016/0166-6851(83)90048-8; ENEA V, 1991, J MOL EVOL, V32, P183, DOI 10.1007/BF02515391; Gagnon S, 1996, EXP PARASITOL, V83, P346, DOI 10.1006/expr.1996.0082; GODA SK, 1995, NUCLEIC ACIDS RES, V23, P3357, DOI 10.1093/nar/23.16.3357; GUNDERSON JH, 1987, SCIENCE, V238, P933, DOI 10.1126/science.3672135; GUNDERSON JH, 1986, J PROTOZOOL, V33, P525, DOI 10.1111/j.1550-7408.1986.tb05656.x; GUTELL RR, 1993, NUCLEIC ACIDS RES, V21, P3055, DOI 10.1093/nar/21.13.3055; GUTELL RR, 1988, NUCLEIC ACIDS RES, V16, pR175, DOI 10.1093/nar/16.suppl.r175; HOLMBERG L, 1994, NUCLEIC ACIDS RES, V22, P2776, DOI 10.1093/nar/22.14.2776; JANSE CJ, 1985, PARASITOLOGY, V91, P19, DOI 10.1017/S0031182000056481; JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2; Le Blancq SM, 1997, MOL BIOCHEM PARASIT, V90, P463, DOI 10.1016/S0166-6851(97)00181-3; Li J, 1997, J MOL BIOL, V269, P203, DOI 10.1006/jmbi.1997.1038; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; LUCIOLI A, 1988, MOL CELL BIOL, V8, P4792, DOI 10.1128/MCB.8.11.4792; MCCUTCHAN TF, 1988, MOL BIOCHEM PARASIT, V28, P63, DOI 10.1016/0166-6851(88)90181-8; MCCUTCHAN TF, 1995, PARASITOL TODAY, V11, P134, DOI 10.1016/0169-4758(95)80132-4; Menard R, 1997, METHODS, V13, P148, DOI 10.1006/meth.1997.0507; MITCHELL P, 1992, BIOCHEMISTRY-US, V31, P3004, DOI 10.1021/bi00126a023; MONS B, 1985, PARASITOLOGY, V91, P423, DOI 10.1017/S0031182000062673; NOLLER HF, 1990, RIBOSOME, P73; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; NOLLER HF, 1991, ANNU REV BIOCHEM, V60, P191, DOI 10.1146/annurev.biochem.60.1.191; PATON MG, 1993, MOL BIOCHEM PARASIT, V59, P263, DOI 10.1016/0166-6851(93)90224-L; PONZI M, 1990, MOL BIOCHEM PARASIT, V41, P73, DOI 10.1016/0166-6851(90)90098-7; Rogers MJ, 1996, RNA, V2, P134; SHIPPENLENTZ D, 1990, MOL BIOCHEM PARASIT, V22, P223; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Thompson J, 1999, MOL MICROBIOL, V31, P253, DOI 10.1046/j.1365-2958.1999.01167.x; van Spaendonk RML, 2000, MOL BIOCHEM PARASIT, V105, P169, DOI 10.1016/S0166-6851(99)00175-9; van Spaendonk RML, 1999, MOL BIOCHEM PARASIT, V99, P193, DOI 10.1016/S0166-6851(99)00016-X; VANDIJK MR, 1995, SCIENCE, V268, P1358, DOI 10.1126/science.7761856; Velichutina IV, 1998, RNA, V4, P594, DOI 10.1017/S1355838298980049; Vinkenoog R, 1998, MOL BIOCHEM PARASIT, V94, P1, DOI 10.1016/S0166-6851(98)00035-8; WATERS AP, 1989, NATURE, V342, P438, DOI 10.1038/342438a0; Waters AP, 1997, METHODS, V13, P134, DOI 10.1006/meth.1997.0506; WATERS AP, 1994, ADV PARASIT, V34, P33, DOI 10.1016/S0065-308X(08)60136-0; Waters AP, 1997, J BIOL CHEM, V272, P3583, DOI 10.1074/jbc.272.6.3583; WELLEMS TE, 1987, CELL, V49, P633, DOI 10.1016/0092-8674(87)90539-3; Woodson SA, 1998, CURR OPIN STRUC BIOL, V8, P294, DOI 10.1016/S0959-440X(98)80061-4	48	66	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22638	22647		10.1074/jbc.M101234200	http://dx.doi.org/10.1074/jbc.M101234200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11292830	Green Published, hybrid			2022-12-27	WOS:000169412700090
J	Aphasizhev, R; Simpson, L				Aphasizhev, R; Simpson, L			Isolation and characterization of a U-specific 3 '-5 '-exonuclease from mitochondria of Leishmania tarentolae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYMATIC EDITING COMPLEX; PRECURSOR MESSENGER-RNA; SMALL NUCLEAR-RNA; IN-VITRO; URIDINE INSERTION; EXONUCLEASE; MECHANISM; 3'-END; ENDONUCLEASE; PURIFICATION	We have purified a 3'-5'-exoribonuclease from mitochondrial extract of Leishmania tarentolae over 4000-fold through six column fractionations. This enzyme digested RNA in a distributive manner, showed a high level of specificity for 3'-terminal Us, and was blocked by a terminal dU; there was slight exonucleolytic activity on a S'-terminal A or C but no activity on a 3'-terminal G residue. The enzyme preferred single-stranded 3'-oligo(U) overhangs and did not digest duplex RNA. Two other 3'-5'-exoribonuclease activities were also detected in the mitochondrial extract, one of which was stimulated by a 3'-phosphate and the other of which degraded RNAs with a 3'-OH to mononucleotides in a processive manner. The properties of the distributive U-specific 3'-5'-exoribonuclease suggest an involvement in the U-deletion RNA editing reaction that occurs in the mitochondrion of these cells.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Simpson, L (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, 6780 MacDonald Res Labs,675 Charles Young Dr S, Los Angeles, CA 90095 USA.			Afasizhev, Ruslan/0000-0002-4595-6618	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI009102, R01AI009102] Funding Source: NIH RePORTER; NIAID NIH HHS [AI09102] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Booth BL, 1997, J BIOL CHEM, V272, P984, DOI 10.1074/jbc.272.2.984; BRALY P, 1974, J PROTOZOOL, V21, P782, DOI 10.1111/j.1550-7408.1974.tb03752.x; Burgess MLK, 2000, RNA, V6, P1492, DOI 10.1017/S1355838200000066; Byrne EM, 1996, EMBO J, V15, P6758, DOI 10.1002/j.1460-2075.1996.tb01065.x; Cruz-Reyes J, 1998, NUCLEIC ACIDS RES, V26, P3634, DOI 10.1093/nar/26.16.3634; CruzReyes J, 1996, P NATL ACAD SCI USA, V93, P8901, DOI 10.1073/pnas.93.17.8901; Frech GC, 1996, MOL CELL BIOL, V16, P4584; Huang HJ, 1998, NATURE, V391, P99, DOI 10.1038/34219; Kable ML, 1996, SCIENCE, V273, P1189, DOI 10.1126/science.273.5279.1189; Kapushoc ST, 1999, RNA, V5, P656, DOI 10.1017/S1355838299982250; Korner CG, 1997, J BIOL CHEM, V272, P10448; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Mitchell P, 1996, GENE DEV, V10, P502, DOI 10.1101/gad.10.4.502; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; Papadimitriou A, 1996, EUR J BIOCHEM, V242, P747, DOI 10.1111/j.1432-1033.1996.0747r.x; Piller KJ, 1996, J BIOL CHEM, V271, P4613, DOI 10.1074/jbc.271.9.4613; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; SEIWERT SD, 1994, SCIENCE, V266, P114, DOI 10.1126/science.7524149; Seiwert SD, 1996, CELL, V84, P831, DOI 10.1016/S0092-8674(00)81062-4; Simpson L, 1998, NUCLEIC ACIDS RES, V26, P170, DOI 10.1093/nar/26.1.170; STURM NR, 1992, CELL, V70, P469, DOI 10.1016/0092-8674(92)90171-8; Trippe R, 1998, NUCLEIC ACIDS RES, V26, P3119, DOI 10.1093/nar/26.13.3119	24	29	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21280	21284		10.1074/jbc.M100297200	http://dx.doi.org/10.1074/jbc.M100297200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279235	hybrid			2022-12-27	WOS:000169297900065
J	Crawford, BE; Olson, SK; Esko, JD; Pinhal, MAS				Crawford, BE; Olson, SK; Esko, JD; Pinhal, MAS			Cloning, Golgi localization, and enzyme activity of the full-length heparin/heparan sulfate-glucuronic acid C5-epimerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; URONOSYL C-5 EPIMERASE; HEPARAN-SULFATE; CRYSTAL-STRUCTURE; BIOSYNTHESIS; BINDING; PROTEOGLYCANS; PURIFICATION; MECHANISM; SEQUENCES	While studying the cellular localization and activity of enzymes involved in heparan sulfate biosynthesis, we discovered that the published sequence for the glucuronic acid C5-epimerase responsible for the interconversion of D-glucuronic acid and L-iduronic acid residues encodes a truncated protein. Genome analysis and 5'-rapid amplification of cDNA ends was used to clone the full-length cDNA from a mouse mastocytoma cell line. The extended cDNA encodes for an additional 174 amino acids at the amino terminus of the protein. The murine sequence is 95% identical to the human epimerase identified from genomic sequences and fits with the general size and structure of the gene from Drosophila melanogaster and Caenorhabditis elegans, Full-length epimerase is predicted to have a type II transmembrane topology with a 17-amino acid transmembrane domain and an 11-amino acid cytoplasmic tail. An assay with increased sensitivity was devised that detects enzyme activity in extracts prepared from cultured cells and in recombinant proteins. Unlike other enzymes involved in glycosaminoglycan biosynthesis, the addition of a c-myc tag or green fluorescent protein to the highly conserved COOH-terminal portion of the protein inhibits its activity. The amino-terminally truncated epimerase does not localize to any cellular compartment, whereas the full-length enzyme is in the Golgi, where heparan sulfate synthesis is thought to occur.	Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Pinhal, MAS (corresponding author), Univ Fed Sao Paulo, BR-04044020 Sao Paulo, Brazil.		Pinhal, Maria Aparecida Silva/J-1797-2012	Pinhal, Maria Aparecida Silva/0000-0003-4001-1663	NATIONAL CANCER INSTITUTE [T32CA067754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033063] Funding Source: NIH RePORTER; NCI NIH HHS [CA67754] Funding Source: Medline; NIGMS NIH HHS [R37GM33063, GM08666] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ATHA DH, 1985, BIOCHEMISTRY-US, V24, P6723, DOI 10.1021/bi00344a063; Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BJORK I, 1982, MOL CELL BIOCHEM, V48, P161, DOI 10.1007/BF00421226; CAMPBELL P, 1994, J BIOL CHEM, V269, P26953; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Hagner-McWhirter A, 2000, BIOCHEM J, V347, P69, DOI 10.1042/0264-6021:3470069; Hagner-McWhirter A, 2000, GLYCOBIOLOGY, V10, P159, DOI 10.1093/glycob/10.2.159; JACOBSSON I, 1984, J BIOL CHEM, V259, P1056; JACOBSSON I, 1979, J BIOL CHEM, V254, P2975; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Li JP, 1997, J BIOL CHEM, V272, P28158, DOI 10.1074/jbc.272.44.28158; LINDAHL U, 1976, BIOCHEM BIOPH RES CO, V70, P492, DOI 10.1016/0006-291X(76)91073-1; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; MALMSTROM A, 1980, J BIOL CHEM, V255, P3878; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; MONTGOMERY RI, 1992, P NATL ACAD SCI USA, V89, P11327, DOI 10.1073/pnas.89.23.11327; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1	26	44	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21538	21543		10.1074/jbc.M100880200	http://dx.doi.org/10.1074/jbc.M100880200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279150	hybrid			2022-12-27	WOS:000169297900099
J	Kaplan, MH; Zong, RT; Herrscher, RF; Scheuermann, RH; Tucker, PW				Kaplan, MH; Zong, RT; Herrscher, RF; Scheuermann, RH; Tucker, PW			Transcriptional activation by a matrix associating region-binding protein - Contextual requirements for the function of Bright	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN ENHANCER; SCAFFOLD-ASSOCIATED REGIONS; IMMUNOGLOBULIN-MU ENHANCER; B-CELL SPECIFICITY; NUCLEAR MATRIX; ATTACHMENT REGIONS; CHROMATIN STRUCTURE; TOPOISOMERASE-II; DNA; GENE	Bright (B cell regulator of IgH transcription) is a B cell-specific, matrix associating region-binding protein that transactivates gene expression from the IgH intronic enhancer (E mu). We show here that Bright has multiple contextual requirements to function as a transcriptional activator. Bright cannot transactivate via out of context, concatenated binding sites. Transactivation is maximal on integrated substrates. Two of: the three previously identified binding sites in E mu are required for full Bright transactivation, The Bright DNA binding domain defined a new family, which includes SWI1, a component of the SWI.SNF complex shown to have high mobility group-like DNA binding characteristics. Similar to one group of high mobility group box proteins, Bright distorts E mu binding site-containing DNA on binding, supporting the concept that it mediates E mu remodeling. Transfection studies further implicate Bright in facilitating spatially separated promoter-enhancer interactions in both transient and stable assays. Finally, we show that overexpression of Bright leads to enhanced DNase I sensitivity of the endogenous E mu matrix associating regions. These data further suggest that Bright may contribute to increased gene expression by remodeling the immunoglobulin locus during B cell development.	Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75235 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Tucker, PW (corresponding author), Univ Texas, Inst Mol & Cellular Biol, 100 W 24th St,ESB-534, Austin, TX 78712 USA.			Scheuermann, Richard H./0000-0003-1355-892X	NCI NIH HHS [CA31534] Funding Source: Medline; NIAID NIH HHS [AI18016] Funding Source: Medline; NIGMS NIH HHS [GM50329] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA031534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI018016, R01AI018016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM050329, R01GM050329] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI Y, 1989, EMBO J, V8, P3997, DOI 10.1002/j.1460-2075.1989.tb08582.x; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ARIIZUMI K, 1993, MOL CELL BIOL, V13, P5629, DOI 10.1128/MCB.13.9.5629; ARTANDI SE, 1994, MOL CELL BIOL, V14, P7704, DOI 10.1128/MCB.14.12.7704; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; BLASQUEZ VC, 1992, J BIOL CHEM, V267, P23888; COCKERILL PN, 1987, J BIOL CHEM, V262, P5394; Dallas PB, 1998, MOL CELL BIOL, V18, P3596, DOI 10.1128/MCB.18.6.3596; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; ERNST P, 1995, IMMUNITY, V2, P427, DOI 10.1016/1074-7613(95)90024-1; Fernandez LA, 2001, MOL CELL BIOL, V21, P196, DOI 10.1128/MCB.21.1.196-208.2001; Fernandez LA, 1998, COLD SPRING HARB SYM, V63, P515, DOI 10.1101/sqb.1998.63.515; FORRESTER WC, 1994, SCIENCE, V265, P1221, DOI 10.1126/science.8066460; GENETTA T, 1994, MOL CELL BIOL, V14, P6153, DOI 10.1128/MCB.14.9.6153; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; Herrscher RF, 1995, GENE DEV, V9, P3067, DOI 10.1101/gad.9.24.3067; HOFMANN JFX, 1989, CELL, V57, P725, DOI 10.1016/0092-8674(89)90788-5; IMLER JL, 1987, MOL CELL BIOL, V7, P2558, DOI 10.1128/MCB.7.7.2558; IZAURRALDE E, 1989, J MOL BIOL, V210, P573, DOI 10.1016/0022-2836(89)90133-2; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; KAS E, 1993, EMBO J, V12, P115, DOI 10.1002/j.1460-2075.1993.tb05637.x; KILEDJIAN M, 1988, MOL CELL BIOL, V8, P145, DOI 10.1128/MCB.8.1.145; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; Li S, 1999, J BIOL CHEM, V274, P7803, DOI 10.1074/jbc.274.12.7803; LUDERUS MEE, 1992, CELL, V70, P949, DOI 10.1016/0092-8674(92)90245-8; NAKAGOMI K, 1994, MOL CELL BIOL, V14, P1852, DOI 10.1128/MCB.14.3.1852; Pemov A, 1998, P NATL ACAD SCI USA, V95, P14757, DOI 10.1073/pnas.95.25.14757; Peterson CL, 1998, COLD SPRING HARB SYM, V63, P545, DOI 10.1101/sqb.1998.63.545; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Roque MC, 1996, MOL CELL BIOL, V16, P3138; SCHEUERMANN RH, 1989, GENE DEV, V3, P1255, DOI 10.1101/gad.3.8.1255; Scheuermann RH, 1999, CRIT REV EUKAR GENE, V9, P295, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.140; SCHNITZER GR, 1988, COLD SPRING HARB SYM, V63, P535; SINGH L, 1994, NUCLEIC ACIDS RES, V22, P2289, DOI 10.1093/nar/22.12.2289; Stein GS, 1998, J CELL BIOCHEM, V70, P200; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; TSUTSUI K, 1993, J BIOL CHEM, V268, P12886; Wang ZY, 1999, MOL CELL BIOL, V19, P284; Webb C, 1999, COLD SPRING HARB SYM, V64, P109, DOI 10.1101/sqb.1999.64.109; Webb CF, 1998, J IMMUNOL, V160, P4747; WEBB CF, 1991, MOL CELL BIOL, V11, P5206, DOI 10.1128/MCB.11.10.5206; WEBB CF, 1991, MOL CELL BIOL, V11, P5197, DOI 10.1128/MCB.11.10.5197; WEBB CF, 1989, J IMMUNOL, V143, P3934; Webb CF, 2000, J IMMUNOL, V165, P6956, DOI 10.4049/jimmunol.165.12.6956; WEINBERGER J, 1988, MOL CELL BIOL, V8, P988, DOI 10.1128/MCB.8.2.988; ZHAO K, 1993, EMBO J, V12, P3237, DOI 10.1002/j.1460-2075.1993.tb05993.x; ZONG RT, 1995, J BIOL CHEM, V270, P24010, DOI 10.1074/jbc.270.41.24010; Zong RT, 2000, EMBO J, V19, P4123, DOI 10.1093/emboj/19.15.4123	52	27	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21325	21330		10.1074/jbc.M100836200	http://dx.doi.org/10.1074/jbc.M100836200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11294836	hybrid			2022-12-27	WOS:000169297900071
J	Wang, CG; Fu, MF; Angeletti, RH; Siconolfi-Baez, L; Reutens, AT; Albanese, C; Lisanti, MP; Katzenellenbogen, BS; Kato, S; Hopp, T; Fuqua, SAW; Lopez, GN; Kushner, PJ; Pestell, RG				Wang, CG; Fu, MF; Angeletti, RH; Siconolfi-Baez, L; Reutens, AT; Albanese, C; Lisanti, MP; Katzenellenbogen, BS; Kato, S; Hopp, T; Fuqua, SAW; Lopez, GN; Kushner, PJ; Pestell, RG			Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; ACTIVATION FUNCTION 1; CYCLIN D1; HISTONE ACETYLATION; ACETYLTRANSFERASE ACTIVITY; COACTIVATORS P300; GENE ACTIVATION; RNA HELICASE; N-COR; CBP	Regulation of nuclear receptor gene expression involves dynamic and coordinated interactions with histone acetyl transferase (HAT) and deacetylase complexes. The estrogen receptor (ER alpha) contains two transactivation domains regulating ligand-independent and -dependent gene transcription (AF-1 and AF-2 (activation functions 1 and 2)). ER alpha -regulated gene expression involves interactions with cointegrators (e.g. p300/ CBP, P/CAF) that have the capacity to modify core histone acetyl groups. Here we show that the ER alpha is acetylated in vivo, p300, but not P/CAF, selectively and directly acetylated the ER alpha at lysine residues within the ER alpha hinge/ligand binding domain. Substitution of these residues with charged or polar residues dramatically enhanced ER alpha hormone sensitivity without affecting induction by MAPK signaling, suggesting that direct ER alpha acetylation normally suppresses ligand sensitivity. These ER alpha lysine residues also regulated transcriptional activation by histone deacetylase inhibitors and p300, The conservation of the ER alpha acetylation motif in a phylogenetic subset of nuclear receptors suggests that direct acetylation of nuclear receptors may contribute to additional signaling pathways involved in metabolism and development.	Albert Einstein Coll Med, Albert Einstein Canc Ctr, Dept Dev & Mol Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Pharmacol, Bronx, NY 10461 USA; Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Illinois, Coll Med, Urbana, IL 61801 USA; Univ Tokyo, Bunkyo Ku, Tokyo 1130032, Japan; Japan Sci & Technol, CREST, Kawaguchi, Saitama 3320012, Japan; Baylor Coll Med, Breast Ctr, Houston, TX 77030 USA; Univ Calif San Francisco, Sch Med, Metab Res Unit, San Francisco, CA 94143 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Tokyo; Japan Science & Technology Agency (JST); Baylor College of Medicine; University of California System; University of California San Francisco	Pestell, RG (corresponding author), Albert Einstein Coll Med, Albert Einstein Canc Ctr, Dept Dev & Mol Biol, Chanin 302,1300 Morris Pk Ave, Bronx, NY 10461 USA.	pestell@aecom.yu.edu	Lisanti, Michael/B-6131-2018; Lisanti, Michael P/C-6866-2013	Lisanti, Michael/0000-0003-2034-1382; 	NCI NIH HHS [R01-CA72038-01, CA60514, R01CA70897, R01-CA-80250, 5-P30-CA13330-26, R01CA75503] Funding Source: Medline; NHLBI NIH HHS [NIHCA18119] Funding Source: Medline; NIDDK NIH HHS [DK20541] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072038, R01CA060514, R01CA070897, R01CA080250, R01CA075503, P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albanese C, 1999, J BIOL CHEM, V274, P34186, DOI 10.1074/jbc.274.48.34186; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Auwerx J, 1999, CELL, V97, P161; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Berger SL, 1999, CURR OPIN CELL BIOL, V11, P336, DOI 10.1016/S0955-0674(99)80046-5; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Espinos E, 1999, MOL CELL BIOL, V19, P3474; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; Fuqua SAW, 2000, CANCER RES, V60, P4026; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Glass CK, 2000, GENE DEV, V14, P121; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Hanstein B, 1996, P NATL ACAD SCI USA, V93, P11540, DOI 10.1073/pnas.93.21.11540; Henttu PMA, 1997, MOL CELL BIOL, V17, P1832, DOI 10.1128/MCB.17.4.1832; Hung HL, 1999, MOL CELL BIOL, V19, P3496; JACKSON RH, 2000, SCIENCE, V288, P1422; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kobayashi Y, 2000, J BIOL CHEM, V275, P15645, DOI 10.1074/jbc.M000042200; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kraus WL, 1999, MOL CELL BIOL, V19, P8123; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Liu L, 1999, MOL CELL BIOL, V19, P1202; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McMahon C, 1999, P NATL ACAD SCI USA, V96, P5382, DOI 10.1073/pnas.96.10.5382; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Schlegel A, 1999, J BIOL CHEM, V274, P33551, DOI 10.1074/jbc.274.47.33551; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tremblay A, 1999, MOL CELL, V3, P513, DOI 10.1016/S1097-2765(00)80479-7; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; Wang L, 1998, GENE DEV, V12, P640, DOI 10.1101/gad.12.5.640; Watanabe G, 1998, MOL CELL BIOL, V18, P3212, DOI 10.1128/MCB.18.6.3212; Watanabe G, 1996, P NATL ACAD SCI USA, V93, P12861, DOI 10.1073/pnas.93.23.12861; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855	58	278	285	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18375	18383		10.1074/jbc.M100800200	http://dx.doi.org/10.1074/jbc.M100800200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279135	hybrid			2022-12-27	WOS:000168866500101
J	Kumar, BRP; Swaminathan, V; Banerjee, S; Kundu, TK				Kumar, BRP; Swaminathan, V; Banerjee, S; Kundu, TK			p300-mediated acetylation of human transcriptional coactivator PC4 is inhibited by phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE ACTIVITY; C-TERMINAL DOMAIN; ACTIVATOR-DEPENDENT TRANSCRIPTION; DNA-BINDING; P300; CBP; REPRESSION; COMPONENTS; PROTEINS; PROMOTER	The human positive coactivator 4 (PC4) acts as a general coactivator for activator-dependent transcription, the activity of which is regulated negatively by phosphorylation, We report here that PC4 can be acetylated specifically by another coactivator, p300, Interestingly, phosphorylation of PC4 by casein kinase II inhibits the p300-mediated acetylation, Mass spectral analysis revealed that there are at least two lysine residues acetylated in PC4, as a result of which its DNA binding activity is stimulated.	Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Transcript & Dis Lab, Bangalore 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Kundu, TK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Transcript & Dis Lab, Bangalore 560064, Karnataka, India.	tapas@jncasr.ac.in	Banerjee, Sourav/AAB-7829-2022; Kumar, B R Prashantha/AAK-2805-2020	Kundu, Tapas/0000-0001-7790-214X; Venkatesh, Swaminathan/0000-0001-9837-1501; Banerjee, Sourav/0000-0002-2636-0157				Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; ALEXANDER CR, 1998, J BIOL CHEM, V273, P1430; Barlev NA, 1998, MOL CELL BIOL, V18, P1349, DOI 10.1128/MCB.18.3.1349; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; Brandsen J, 1997, NAT STRUCT BIOL, V4, P900, DOI 10.1038/nsb1197-900; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Ge H, 1996, METHOD ENZYMOL, V274, P57; GE H, 1994, P NATL ACAD SCI USA, V91, P12691, DOI 10.1073/pnas.91.26.12691; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guermah M, 1998, MOL CELL BIOL, V18, P3234, DOI 10.1128/MCB.18.6.3234; Herrera JE, 1999, MOL CELL BIOL, V19, P3466; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; KAISER K, 1995, EMBO J, V14, P3520, DOI 10.1002/j.1460-2075.1995.tb07358.x; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; Kundu TK, 1999, MOL CELL BIOL, V19, P1605; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Werten S, 1998, EMBO J, V17, P5103, DOI 10.1093/emboj/17.17.5103; Werten S, 1998, J MOL BIOL, V276, P367, DOI 10.1006/jmbi.1997.1534; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0	30	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16804	16809		10.1074/jbc.M100934200	http://dx.doi.org/10.1074/jbc.M100934200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279157	hybrid			2022-12-27	WOS:000168730400029
J	Christie, JM; Briggs, WR				Christie, JM; Briggs, WR			Blue light sensing in higher plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DNA PHOTOLYASE; RECEPTOR CRYPTOCHROME-2; CIRCADIAN CLOCK; PROTEIN-KINASE; ARABIDOPSIS CRYPTOCHROMES; PHOTORECEPTOR FAMILY; SIGNAL-TRANSDUCTION; FLOWERING TIME; PHYTOCHROME-B; GREEN LIGHT		Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	Carnegie Institution for Science	Briggs, WR (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 260 Panama St, Stanford, CA 94305 USA.	briggs@andrew2.stanford.edu		Christie, John/0000-0002-9976-0055				AHMAD M, 1995, PLANT J, V8, P653, DOI 10.1046/j.1365-313X.1995.08050653.x; Ahmad M, 1999, CURR OPIN PLANT BIOL, V2, P230, DOI 10.1016/S1369-5266(99)80040-5; Ahmad M, 1998, PLANT CELL, V10, P197, DOI 10.1105/tpc.10.2.197; Ahmad M, 1998, NATURE, V392, P720, DOI 10.1038/33701; Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Batschauer A, 1999, CELL MOL LIFE SCI, V55, P153, DOI 10.1007/s000180050282; Baum G, 1999, P NATL ACAD SCI USA, V96, P13554, DOI 10.1073/pnas.96.23.13554; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Casal JJ, 2000, PHOTOCHEM PHOTOBIOL, V71, P1, DOI 10.1562/0031-8655(2000)071&lt;0001:PCPPII&gt;2.0.CO;2; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Cho MH, 1996, P NATL ACAD SCI USA, V93, P8134, DOI 10.1073/pnas.93.15.8134; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Eisinger W, 2000, PLANT PHYSIOL, V122, P99, DOI 10.1104/pp.122.1.99; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Frechilla S, 2000, PLANT CELL PHYSIOL, V41, P171, DOI 10.1093/pcp/41.2.171; GRESSEL J, 1979, PHOTOCHEM PHOTOBIOL, V30, P749, DOI 10.1111/j.1751-1097.1979.tb07209.x; Guo HW, 1999, PLANT J, V19, P279, DOI 10.1046/j.1365-313X.1999.00525.x; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hoffman PD, 1996, MOL GEN GENET, V253, P259, DOI 10.1007/s004380050321; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; JACKSON JA, 1995, PLANTA, V197, P233, DOI 10.1007/BF00202642; JANOUDI AK, 1997, PLANT PHYSIOL, V110, P155; Jarillo JA., 1998, PLANT PHYSIOL, V117, P719; Jenkins GI, 1995, PLANT SCI, V112, P117, DOI 10.1016/0168-9452(95)04260-1; Kanegae H, 2000, PLANT CELL PHYSIOL, V41, P415, DOI 10.1093/pcp/41.4.415; Kanegae T, 1998, MOL GEN GENET, V259, P345, DOI 10.1007/s004380050821; Khurana JP, 1998, CRIT REV PLANT SCI, V17, P465, DOI 10.1080/07352689891304258; Kleiner O, 1999, PLANT J, V19, P289, DOI 10.1046/j.1365-313X.1999.00535.x; Lasceve G, 1999, PLANT PHYSIOL, V120, P605, DOI 10.1104/pp.120.2.605; LIN C, 1995, P NATL ACAD SCI USA, V92, P8423, DOI 10.1073/pnas.92.18.8423; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; Lin CT, 2000, PLANT PHYSIOL, V123, P39, DOI 10.1104/pp.123.1.39; Lin CT, 2000, TRENDS PLANT SCI, V5, P337, DOI 10.1016/S1360-1385(00)01687-3; Liscum E, 2000, PHOTOCHEM PHOTOBIOL, V72, P273, DOI 10.1562/0031-8655(2000)072&lt;0273:PASPRM&gt;2.0.CO;2; LISCUM E, 1995, PLANT CELL, V7, P473, DOI 10.1105/tpc.7.4.473; MAHESHAWARI SC, 2000, J BIOSCIENCE, V24, P499; MALHOTRA K, 1995, BIOCHEMISTRY-US, V34, P6892, DOI 10.1021/bi00020a037; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Mockler TC, 1999, DEVELOPMENT, V126, P2073; Motchoulski A, 1999, SCIENCE, V286, P961, DOI 10.1126/science.286.5441.961; Neff MM, 2000, GENE DEV, V14, P257; Nozue K, 1998, P NATL ACAD SCI USA, V95, P15826, DOI 10.1073/pnas.95.26.15826; NOZUE K, 2000, PLANT PHYSIOL, V122, P1457; Parks BM, 1998, PLANT PHYSIOL, V118, P609, DOI 10.1104/pp.118.2.609; REYMOND P, 1992, PLANT PHYSIOL, V100, P655, DOI 10.1104/pp.100.2.655; Sakai T, 2000, PLANT CELL, V12, P225, DOI 10.1105/tpc.12.2.225; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; SANCAR A, 1994, BIOCHEMISTRY-US, V33, P2, DOI 10.1021/bi00167a001; SHORT TW, 1994, ANNU REV PLANT PHYS, V45, P143, DOI 10.1146/annurev.pp.45.060194.001043; SMALL GD, 1995, PLANT MOL BIOL, V28, P443, DOI 10.1007/BF00020393; Somers DE, 1999, PLANT PHYSIOL, V121, P9, DOI 10.1104/pp.121.1.9; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Spalding EP, 2000, PLANT CELL ENVIRON, V23, P665, DOI 10.1046/j.1365-3040.2000.00594.x; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Todo T, 1996, SCIENCE, V272, P109, DOI 10.1126/science.272.5258.109; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Zeiger E, 1998, J EXP BOT, V49, P433, DOI 10.1093/jexbot/49.suppl_1.433; ZHOA S, 1997, PHOTOCHEM PHOTOBIOL, V66, P727	67	144	158	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11457	11460		10.1074/jbc.R100004200	http://dx.doi.org/10.1074/jbc.R100004200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11279226	hybrid			2022-12-27	WOS:000168081800004
J	Makdessi, K; Andreesen, JR; Pich, A				Makdessi, K; Andreesen, JR; Pich, A			Tungstate uptake by a highly specific ABC transporter in Eubacterium acidaminophilum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDATE-BINDING-PROTEIN; CRYSTAL-STRUCTURE; FORMYLMETHANOFURAN DEHYDROGENASE; ARTHROBACTER NICOTINOVORANS; CLOSTRIDIUM-THERMOACETICUM; FERREDOXIN OXIDOREDUCTASE; FORMATE DEHYDROGENASE; MOLYBDENUM COFACTOR; GLYCINE REDUCTASE; MEMBRANE-PROTEINS	The Gram-positive anaerobe Eubacterium acidaminophilum contains at least two tungsten-dependent enzymes: viologen-dependent formate dehydrogenase and aldehyde dehydrogenase, W-185-Labeled tungstate was taken up by this organism with a maximum rate of 0.53 pmol min(-1) mg(-1) of protein at 36 degreesC, The uptake was not affected by equimolar amounts of molybdate, The genes tupABC coding for an ABC transporter specific for tungstate were cloned in the downstream region of genes encoding a tungsten-containing formate dehydrogenase, The substrate-binding protein, TupA, of this putative transporter was overexpressed in Escherichia coli, and its binding properties toward oxyanions were determined by a native polyacrylamide gel retardation assay. Only tungstate induced a shift of TupA mobility, suggesting that only this anion was specifically bound by TupA If molybdate and sulfate were added in high molar excess (> 1000-fold), they were also slightly bound by TupA. The K-d, value for tungstate was determined to be 0.5 muM, The genes encoding the tungstate-specific ABC transporter exhibited highest similarities to putative transporters from Methanobacterium thermoautotrophicun, Haloferax volcanii, Vibrio cholerae, and Campylobacter jejuni. These five transporters represent a separate phylogenetic group of oxyanion ABC transporters as evident from analysis of the deduced amino acid sequences of the binding proteins. Downstream of the tupABC genes, the genes moeA, moeA-1, moaA, and a truncated moaC have been identified by sequence comparison of the deduced amino acid sequences. They should participate in the biosynthesis of the pterin cofactor that is present in molybdenum- and tungsten-containing enzymes except nitrogenase.	Univ Halle Wittenberg, Inst Mikrobiol, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg	Pich, A (corresponding author), Univ Halle Wittenberg, Inst Mikrobiol, Kurt Mothes Str 3, D-06120 Halle, Germany.	a.pich@mikrobiologie.uni-halle.de						Allen RM, 1999, J BIOL CHEM, V274, P15869, DOI 10.1074/jbc.274.22.15869; Anderson LA, 1997, EUR J BIOCHEM, V246, P119, DOI 10.1111/j.1432-1033.1997.00119.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chambaud I, 1999, TRENDS MICROBIOL, V7, P493, DOI 10.1016/S0966-842X(99)01641-8; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Graentzdoerffer A, 2001, ARCH MICROBIOL, V175, P8, DOI 10.1007/s002030000232; GRAENTZDOERFFER A, 2000, THESIS U HALLE; GRANDERATH K, 1993, THESIS U GOTTINGEN; Grunden AM, 1997, ARCH MICROBIOL, V168, P345, DOI 10.1007/s002030050508; Hasona A, 1998, FEMS MICROBIOL LETT, V169, P111, DOI 10.1111/j.1574-6968.1998.tb13306.x; Hasona A, 1998, J BACTERIOL, V180, P1466, DOI 10.1128/JB.180.6.1466-1472.1998; HERZIG AJ, 1968, ENCY CHEM ELEMENTS, P412; Hochheimer A, 1995, EUR J BIOCHEM, V234, P910, DOI 10.1111/j.1432-1033.1995.910_a.x; Hu YL, 1999, J MOL BIOL, V286, P899, DOI 10.1006/jmbi.1998.2488; Hu YL, 1997, NAT STRUCT BIOL, V4, P703, DOI 10.1038/nsb0997-703; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Imperial J, 1998, BBA-BIOMEMBRANES, V1370, P337, DOI 10.1016/S0005-2736(98)00003-0; Johnson MK, 1996, CHEM REV, V96, P2817, DOI 10.1021/cr950063d; Kletzin A, 1996, FEMS MICROBIOL REV, V18, P5, DOI 10.1016/0168-6445(95)00025-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawson DM, 1998, STRUCTURE, V6, P1529, DOI 10.1016/S0969-2126(98)00151-8; Lawson DM, 1997, J CHEM SOC DALTON, P3981, DOI 10.1039/a704006g; LEONHARDT U, 1977, ARCH MICROBIOL, V115, P277, DOI 10.1007/BF00446453; LJUNGDAHL LG, 1976, TRENDS BIOCHEM SCI, V1, P63, DOI 10.1016/S0968-0004(76)80193-4; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; Meckenstock RU, 1999, EUR J BIOCHEM, V264, P176, DOI 10.1046/j.1432-1327.1999.00600.x; Menendez C, 1996, FEBS LETT, V391, P101, DOI 10.1016/0014-5793(96)00712-0; MENENDEZ C, 1995, ARCH MICROBIOL, V164, P142, DOI 10.1007/s002030050246; MEYER M, 1995, EUR J BIOCHEM, V234, P184, DOI 10.1111/j.1432-1033.1995.184_c.x; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; MUKUND S, 1995, J BIOL CHEM, V270, P8389, DOI 10.1074/jbc.270.15.8389; Nikaido H, 1998, METHOD ENZYMOL, V292, P3; Pau RN, 1997, TRANSITION METALS IN MICROBIAL METABOLISM, P217; RAUH D, 2000, THESIS U HALLE; Rech S, 1996, J BIOL CHEM, V271, P2557, DOI 10.1074/jbc.271.5.2557; RIVERS SL, 1993, MOL MICROBIOL, V8, P1071, DOI 10.1111/j.1365-2958.1993.tb01652.x; ROSENTEL JK, 1995, J BACTERIOL, V177, P4857, DOI 10.1128/jb.177.17.4857-4864.1995; Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775; SAITO H, 1963, BIOCHIM BIOPHYS ACTA, V72, P619, DOI 10.1016/0926-6550(63)90386-4; Sambrook J, 1998, MOL CLONING LAB MANU, V2nd; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shan SO, 1996, SCIENCE, V272, P97, DOI 10.1126/science.272.5258.97; SUTCLIFFE IC, 1995, J BACTERIOL, V177, P1123, DOI 10.1128/jb.177.5.1123-1128.1995; Towbin H, 1992, Biotechnology, V24, P145; Vorholt JA, 1997, MOL MICROBIOL, V23, P1033, DOI 10.1046/j.1365-2958.1997.2931653.x; WAGNER R, 1987, ARCH MICROBIOL, V147, P295, DOI 10.1007/BF00463491; Wagner UG, 2000, STRUCTURE, V8, P1127, DOI 10.1016/S0969-2126(00)00525-6; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wanner C, 1999, GENETICS, V152, P1417; WHITE H, 1992, ARCH MICROBIOL, V158, P81, DOI 10.1007/BF00245209; Williams CEM, 1999, ACTA CRYSTALLOGR D, V55, P1356, DOI 10.1107/S0907444999005375; YAMAMOTO I, 1983, J BIOL CHEM, V258, P1826; ZINDEL U, 1988, ARCH MICROBIOL, V150, P254, DOI 10.1007/BF00407789	55	45	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					24557	24564		10.1074/jbc.M101293200	http://dx.doi.org/10.1074/jbc.M101293200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11292832	hybrid			2022-12-27	WOS:000169800700020
J	Albert, CJ; Crowley, JR; Hsu, FF; Thukkani, AK; Ford, DA				Albert, CJ; Crowley, JR; Hsu, FF; Thukkani, AK; Ford, DA			Reactive chlorinating species produced by myeloperoxidase target the vinyl ether bond of plasmalogens - Identification of 8-chlorohexadecanal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXIDE-CHLORIDE SYSTEM; OXIDANT MEMBRANE INJURY; HYPOCHLOROUS ACID; HYDROGEN-PEROXIDE; HUMAN-NEUTROPHILS; PANCREATIC-ISLETS; ARACHIDONIC-ACID; ANIMAL-CELLS; PLASMENYLCHOLINE; PHAGOCYTES	Plasmalogens contain a vinyl ether bond linking the sn-l aliphatic chain to the glycerol backbone of this predominant phospholipid molecular subclass, which is found in many mammalian tissues. The present study demonstrates that the vinyl ether bond of plasmalogens is a molecular target of the reactive chlorinating species produced by myeloperoxidase, Analysis by thin layer chromatography revealed that reactive chlorinating species produced by myeloperoxidase target the vinyl ether bond of the plasmalogen, lysoplasmenylcholine (1-O-hexadec-1 ''-enyl-sn-glycero3-phosphorylcholine), resulting in the production of a neutral lipid. Capillary gas chromatographic analyses demonstrated that the neutral lipid generated from lysoplasmenylcholine was neither hexadecanal nor did it contain masked hexadecanal (Le. the vinyl ether) because the dimethyl acetal of hexadecanal produced by acid methanolysis derivatization was no longer present. Electrospray ionization mass spectrometry of the myeloperoxidase-generated neutral Lipid product was consistent with the production of a 16-carbon fatty aldehyde containing one chlorine atom. Furthermore, proton NMR analysis indicated that this neutral lipid product was a 8-chloro-fatty aldehyde. Additional structural analysis of this neutral lipid by gas chromatography-mass spectrometry of the underivatized product as well as its pentafluorobenzyl oxime-derivative product was consistent with the neutral lipid being 2-chlorohexadecanal. The reactive chlorinating species, hypochlorous acid and chlorine gas, both attacked the vinyl ether bond of lysoplasmenylcholine resulting in the production of 2-chlorohexadecanal, The production of 2-chlorohexadecanal was dependent on the presence of the plasmalogen masked aldehyde (ae. the vinyl ether) in the substrate because the free fatty aldehyde, hexadecanal, was not converted to 2-chlorohexadecanal by the reactive chlorinating species generated by myeloperoxidase. Taken together, the present studies demonstrate for the first time the targeting of the vinyl ether bond of plasmalogens by the reactive chlorinating species produced by myeloperoxidase resulting in the production of novel chlorinated fatty aldehydes.	St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; Washington Univ, Med Ctr, St Louis, MO 63110 USA	Saint Louis University; Washington University (WUSTL)	Ford, DA (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, 1402 S Grand Blvd, St Louis, MO 63104 USA.		Ford, David/D-1819-2018	Ford, David/0000-0002-0029-1560; Hsu, Fong-Fu/0000-0001-5368-0183	NCRR NIH HHS [RR00954] Funding Source: Medline; NHLBI NIH HHS [K04 HL 03316-05, HL 42665-11] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL042665, K04HL003316, R01HL042665] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBRICH JM, 1981, P NATL ACAD SCI-BIOL, V78, P210, DOI 10.1073/pnas.78.1.210; ARTHUR G, 1986, BIOCHEM J, V236, P475, DOI 10.1042/bj2360475; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHILTON FH, 1988, J BIOL CHEM, V263, P5260; CLARKSON CW, 1983, CIRC RES, V52, P543, DOI 10.1161/01.RES.52.5.543; Dittmer J, 1969, METHOD ENZYMOL, V14, P482, DOI [DOI 10.1016/S0076-6879(69)14055-0, 10.1016/S0076-6879(69)14055-0]; FORD DA, 1991, J CLIN INVEST, V88, P331, DOI 10.1172/JCI115296; FORD DA, 1989, P NATL ACAD SCI USA, V86, P3479, DOI 10.1073/pnas.86.10.3479; Ford DA, 1996, FEBS LETT, V394, P99, DOI 10.1016/0014-5793(96)00930-1; GROSS RW, 1985, BIOCHEMISTRY-US, V24, P1662, DOI 10.1021/bi00328a014; GROSS RW, 1984, BIOCHEMISTRY-US, V23, P158, DOI 10.1021/bi00296a026; HAN XL, 1992, ANAL BIOCHEM, V200, P119, DOI 10.1016/0003-2697(92)90286-G; HAN XL, 1994, P NATL ACAD SCI USA, V91, P10635, DOI 10.1073/pnas.91.22.10635; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; Hazen SL, 1996, J BIOL CHEM, V271, P23080, DOI 10.1074/jbc.271.38.23080; Hazen SL, 1996, J CLIN INVEST, V98, P1283, DOI 10.1172/JCI118914; HAZEN SL, 1993, J CLIN INVEST, V91, P2513, DOI 10.1172/JCI116487; HEINECKE JW, 1994, BIOCHEMISTRY-US, V33, P10127, DOI 10.1021/bi00199a041; IGARASHI Y, 1990, BIOCHEM BIOPH RES CO, V172, P77, DOI 10.1016/S0006-291X(05)80175-5; KLEBANOFF SJ, 1980, ANN INTERN MED, V93, P480, DOI 10.7326/0003-4819-93-3-480; KLEBANOFF SJ, 1978, NEUTROPHIL FUNCTION, P447; LAMPERT MB, 1983, BLOOD, V62, P645; MCMASTER CR, 1992, LIPIDS, V27, P945, DOI 10.1007/BF02535569; MORAND OH, 1988, J BIOL CHEM, V263, P11597; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; PAK JH, 1987, BIOCHEMISTRY-US, V26, P4824, DOI 10.1021/bi00389a033; POST JA, 1988, FEBS LETT, V240, P78, DOI 10.1016/0014-5793(88)80343-0; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P5339, DOI 10.1021/bi00071a009; RAMANADHAM S, 1994, BIOCHEMISTRY-US, V33, P7442, DOI 10.1021/bi00189a052; SASAKI Y, 1993, FEBS LETT, V320, P47, DOI 10.1016/0014-5793(93)81655-J; SEDLIS SP, 1983, AM J PHYSIOL, V244, pH32, DOI 10.1152/ajpheart.1983.244.1.H32; SEPE SM, 1985, J IMMUNOL, V134, P1888; SEPE SM, 1985, J IMMUNOL, V134, P1896; Thomas E L, 1986, Methods Enzymol, V132, P569; THOMAS EL, 1982, BIOCHEMISTRY-US, V21, P6299, DOI 10.1021/bi00267a040; VENABLE ME, 1991, J BIOL CHEM, V266, P18691; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; WINTERBOURN CC, 1992, ARCH BIOCHEM BIOPHYS, V296, P547, DOI 10.1016/0003-9861(92)90609-Z; Zeng YC, 1998, BIOCHEMISTRY-US, V37, P2346, DOI 10.1021/bi9725172; ZOELLER RA, 1988, J BIOL CHEM, V263, P11590	41	92	95	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23733	23741		10.1074/jbc.M101447200	http://dx.doi.org/10.1074/jbc.M101447200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11301330	hybrid			2022-12-27	WOS:000169531100069
J	Jullig, M; Eriksson, S				Jullig, M; Eriksson, S			Apoptosis induces efflux of the mitochondrial matrix enzyme deoxyguanosine kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLASE-DEFICIENT MICE; CELL-FREE-EXTRACTS; CYTOCHROME-C; NUCLEOSIDE ANALOGS; ACTIVATION; INDUCTION; PROGRAM; DATP; DNA	Deoxyguanosine kinase (dGK) initiates the salvage of purine deoxynucleosides in mitochondria and is a key enzyme in mitochondrial DNA precursor synthesis. The active form of the enzyme is a 60-kDa protein normally located in the mitochondrial matrix. Here we describe the subcellular distribution of dGK during apoptosis in human epithelial kidney 293 cells and human lymphoblast Molt-4 cells. Immunological methods were used to monitor dGK as well as other mitochondrial proteins. Surprisingly, dGK was found to relocate to the cytosolic compartment at a similar rate as cytochrome c, a mitochondrial intermembraneous enzyme known to enter the cytosol early in apoptosis. The redistribution of dGK from the mitochondria to the cytosol may be of importance for the activation of apoptotic purine nucleoside cofactors such as dATP and demonstrates that mitochondrial matrix proteins may selectively leak out during apoptosis.	Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Vet Med Chem, S-75123 Uppsala, Sweden	Swedish University of Agricultural Sciences	Jullig, M (corresponding author), Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Vet Med Chem, Box 575, S-75123 Uppsala, Sweden.							ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Arpaia E, 2000, J EXP MED, V191, P2197, DOI 10.1084/jem.191.12.2197; CARSON DA, 1980, P NATL ACAD SCI-BIOL, V77, P6865, DOI 10.1073/pnas.77.11.6865; CASTRO J, 1993, CYTOMETRY, V14, P793, DOI 10.1002/cyto.990140712; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Csapo Z, 2001, BIOCHEM PHARMACOL, V61, P191, DOI 10.1016/S0006-2952(00)00534-7; Dolce V, 2001, P NATL ACAD SCI USA, V98, P2284, DOI 10.1073/pnas.031430998; Genini D, 2000, J BIOL CHEM, V275, P29, DOI 10.1074/jbc.275.1.29; GOWER WR, 1979, J BIOL CHEM, V254, P2180; HAMADA T, 1994, NEPHRON, V68, P104, DOI 10.1159/000188227; Hamada T, 1996, BIOCHEM BIOPH RES CO, V219, P829, DOI 10.1006/bbrc.1996.0318; Jullig M, 2000, EUR J BIOCHEM, V267, P5466, DOI 10.1046/j.1432-1327.2000.01607.x; Kim CN, 1997, CANCER RES, V57, P3115; Kohler C, 1999, FEBS LETT, V447, P10, DOI 10.1016/S0014-5793(99)00251-3; Leoni LM, 1998, P NATL ACAD SCI USA, V95, P9567, DOI 10.1073/pnas.95.16.9567; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; PARK I, 1988, ARCH BIOCHEM BIOPHYS, V266, P51, DOI 10.1016/0003-9861(88)90235-4; Petrakis TG, 1999, J BIOL CHEM, V274, P24726, DOI 10.1074/jbc.274.35.24726; RICHARD K, 1982, J BIOL CHEM, V257, P9300; Shepherd D., 1969, METHODS ENZYMOL, V13, P11, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]; Sjoberg AH, 1998, MOL PHARMACOL, V53, P270, DOI 10.1124/mol.53.2.270; SNYDER FF, 1994, BBA-MOL BASIS DIS, V1227, P33, DOI 10.1016/0925-4439(94)90103-1; THORNBERRY NA, 1994, METHOD ENZYMOL, V244, P615; WANG LY, 1993, J BIOL CHEM, V268, P22847; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Zhu CY, 2000, J BIOL CHEM, V275, P26727; Zhu CY, 1998, J BIOL CHEM, V273, P14707, DOI 10.1074/jbc.273.24.14707; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	29	10	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24000	24004		10.1074/jbc.M100435200	http://dx.doi.org/10.1074/jbc.M100435200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11294860	hybrid			2022-12-27	WOS:000169531100103
J	Soref, CM; Di, YP; Hayden, L; Zhao, YH; Satre, MA; Wu, R				Soref, CM; Di, YP; Hayden, L; Zhao, YH; Satre, MA; Wu, R			Characterization of a novel airway epithelial cell specific short chain alcohol dehydrogenase/reductase gene whose expression is up-regulated by retinoids and is involved in the metabolism of retinol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALL-TRANS-RETINOL; CDNA CLONING; 13-CIS-RETINOIC ACID; ESCHERICHIA-COLI; MESSENGER-RNA; VITAMIN-A; IDENTIFICATION; RECEPTORS; TISSUE; MOUSE	Multiple retinoic acid responsive cDNAs were isolated from a high density cDNA microarray membrane, which was developed from a cDNA Library of human tracheobronchial epithelial cells. Five selected cDNA clones encoded the sequence of the same novel gene. The predicted open reading frame of the novel gene encoded a protein of 319 amino acids. The deduced amino acid sequence contains four motifs that are conserved in the short-chain alcohol dehydrogenase/reductase (SDR) family of proteins. The novel gene shows the greatest homology to a group of dehydrogenases that can oxidize retinol (retinol dehydrogenases), The mRNA of the novel gene was found in trachea, colon, tongue, and esophagus. In situ hybridization of airway tissue sections demonstrated epithelial cell-specific gene expression, especially in the ciliated cell type. Both all-trans-retinoic acid and g-cis-retinoic acid were able to elevate the expression of the novel gene in primary human tracheobronchial epithelial cells in vitro. This elevation coincided with an enhanced retinol metabolism in these cultures. COS cells transfected with an expression construct of the novel gene were also elevated in the metabolism of retinol. The results suggested that the novel gene represents a new member of the SDR family that may play a critical role in retinol metabolism in airway epithelia as well as in other epithelia of colon, tongue, and esophagus.	Univ Calif Davis, Ctr Comparat Resp Biol & Med, Davis, CA 95616 USA; Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Wu, R (corresponding author), Univ Calif Davis, Ctr Comparat Resp Biol & Med, Surge 1 Bldg,Rm 1121,1 Shields Ave, Davis, CA 95616 USA.		Di, Yuanpu Peter/H-4191-2016	Di, Yuanpu Peter/0000-0003-2028-2087	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL009573, R37HL035635, F32HL010324, R01HL035635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006230, R01ES009701] Funding Source: NIH RePORTER; NHLBI NIH HHS [F32 HL10324, F32 HL009573, HL35635, F32 HL09573] Funding Source: Medline; NIEHS NIH HHS [ES09701, ES06230, ES00628] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; AUSUBEL FM, 1994, CURRENT PROTOCOLS MO, V2; Bhat PV, 1998, BIOCHEM CELL BIOL, V76, P59, DOI 10.1139/bcb-76-1-59; BOERMAN MHEM, 1995, BIOCHEMISTRY-US, V34, P7027, DOI 10.1021/bi00021a014; Booth SL, 1997, J NUTR, V127, P587, DOI 10.1093/jn/127.4.587; Chai XY, 1996, GENE, V169, P219, DOI 10.1016/0378-1119(95)00833-0; CHAI XY, 1995, J BIOL CHEM, V270, P3900, DOI 10.1074/jbc.270.8.3900; CHAI XY, 1995, J BIOL CHEM, V270, P28408, DOI 10.1074/jbc.270.47.28408; Chai XY, 1997, J BIOL CHEM, V272, P33125, DOI 10.1074/jbc.272.52.33125; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chen JJW, 1998, GENOMICS, V51, P313, DOI 10.1006/geno.1998.5354; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CONNOR MJ, 1987, BIOCHEM PHARMACOL, V36, P919, DOI 10.1016/0006-2952(87)90185-7; De Luca L M, 1985, Acta Vitaminol Enzymol, V7 Suppl, P13; DELEENHEER AP, 1982, J LIPID RES, V23, P1362; DRIESSEN CAGG, 1995, INVEST OPHTH VIS SCI, V36, P1988; Duester G, 1996, BIOCHEMISTRY-US, V35, P12221, DOI 10.1021/bi961176+; ECKHOFF C, 1990, J LIPID RES, V31, P1445; FELL HB, 1953, J PHYSIOL-LONDON, V119, P470, DOI 10.1113/jphysiol.1953.sp004860; Furr Harold C., 1994, P179; Gamble MV, 1999, J LIPID RES, V40, P2279; Gamble MV, 2000, BBA-PROTEIN STRUCT M, V1476, P3, DOI 10.1016/S0167-4838(99)00232-0; Gough WH, 1998, J BIOL CHEM, V273, P19778, DOI 10.1074/jbc.273.31.19778; GROENENDIJK GWT, 1979, ANAL BIOCHEM, V99, P304, DOI 10.1016/S0003-2697(79)80011-1; GROENENDIJK GWT, 1980, BIOCHIM BIOPHYS ACTA, V617, P430, DOI 10.1016/0005-2760(80)90009-0; Haselbeck RJ, 1999, DEV GENET, V25, P353, DOI 10.1002/(SICI)1520-6408(1999)25:4<353::AID-DVG9>3.0.CO;2-G; HUANG TH, 1989, DIFFERENTIATION, V41, P78, DOI 10.1111/j.1432-0436.1989.tb00735.x; HUANG TH, 1994, AM J RESP CELL MOL, V10, P192, DOI 10.1165/ajrcmb.10.2.7509163; Jetten A M, 1992, J Natl Cancer Inst Monogr, P93; JETTEN AM, 1986, BIOCHEM SOC T, V14, P930, DOI 10.1042/bst0140930; Jurukovski V, 1999, MOL GENET METAB, V67, P62, DOI 10.1006/mgme.1999.2840; Koo JS, 1999, BIOCHEM J, V338, P351, DOI 10.1042/0264-6021:3380351; KURLANDSKY SB, 1994, J BIOL CHEM, V269, P32821; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mertz JR, 1997, J BIOL CHEM, V272, P11744, DOI 10.1074/jbc.272.18.11744; NAPOLI JL, 1991, BIOMED PHARMACOTHER, V45, P131, DOI 10.1016/0753-3322(91)90101-X; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Penzes P, 1997, GENE, V191, P167, DOI 10.1016/S0378-1119(97)00054-1; Penzes P, 1997, BBA-PROTEIN STRUCT M, V1342, P175, DOI 10.1016/S0167-4838(97)00102-7; PERSSON B, 1995, ADV EXP MED BIOL, V372, P383; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Ribaya-Mercado JD, 1999, AM J CLIN NUTR, V69, P278; ROBINSON CB, 1991, J TISSUE CULTURE MET, V13, P95; Rossman M.G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; Simon A, 1996, GENOMICS, V36, P424, DOI 10.1006/geno.1996.0487; Simon A, 1999, J CELL SCI, V112, P549; Su J, 1998, J BIOL CHEM, V273, P17910, DOI 10.1074/jbc.273.28.17910; Su J, 1999, ENDOCRINOLOGY, V140, P5275, DOI 10.1210/endo.140.11.7137; Ulven SM, 2000, DEV BIOL, V220, P379, DOI 10.1006/dbio.2000.9634; Vogel S, 2000, J LIPID RES, V41, P882; Wang J, 1999, BIOCHEM J, V338, P23, DOI 10.1042/0264-6021:3380023; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; WU R, 1986, J CELL PHYSIOL, V127, P73, DOI 10.1002/jcp.1041270110; WU R, 1997, GROWTH DEV LUNG, P211; WU YJ, 1982, CELL, V31, P693, DOI 10.1016/0092-8674(82)90324-5; Zhao D, 1996, EUR J BIOCHEM, V240, P15, DOI 10.1111/j.1432-1033.1996.0015h.x	58	42	43	3	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24194	24202		10.1074/jbc.M100332200	http://dx.doi.org/10.1074/jbc.M100332200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11304534	hybrid			2022-12-27	WOS:000169531100128
J	Tse, WT; Tang, J; Jin, O; Korsgren, C; John, KM; Kung, AL; Gwynn, B; Peters, LL; Lux, SE				Tse, WT; Tang, J; Jin, O; Korsgren, C; John, KM; Kung, AL; Gwynn, B; Peters, LL; Lux, SE			A new spectrin, beta IV, has a major truncated isoform that associates with promyelocytic leukemia protein nuclear bodies and the nuclear matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENTATION GROUP-A; PORE COMPLEX PROTEIN; FANCONI-ANEMIA; ERYTHROCYTE-MEMBRANE; PREMATURE SENESCENCE; BINDING PROTEINS; ONCOGENIC RAS; CELL-GROWTH; PML GENE; IN-VITRO	We isolated cDNAs that encode a 77-kDa peptide similar to repeats 10-16 of beta -spectrins, Its gene localizes to human chromosome 19q13.13-q13.2 and mouse chromosome 7, at 7.5 centimorgans, A 289-kDa isoform, similar to full-length beta -spectrins, was partially assembled from sequences in the human genomic DNA data base and completely cloned and sequenced. RNA transcripts are seen predominantly in the brain, and Western analysis shows a major peptide that migrates as a 72-kDa band. This new gene, spectrin beta IV, thus encodes a full-length minor isoform (Sp beta IV Sigma1) and a truncated major isoform (Sp beta IV Sigma5), Immunostaining of cells shows a micropunctate pattern in the cytoplasm and nucleus. In mesenchymal stem cells, the staining concentrates at nuclear dots that stain positively for the promyelocytic leukemia protein (PML). Expression of Sp beta IV Sigma5 fused to green fluorescence protein in cells produces nuclear dots that include all PML bodies, which double in number in transfected cells. Deletion analysis shows that partial repeats 10 and 16 of Sp beta IV Sigma5 are necessary for nuclear dot formation. Immunostaining of whole-mount nuclear matrices reveals diffuse positivity with accentuation at PML bodies, Spectrin beta IV is the first beta -spectrin associated with a subnuclear structure and may be part of a nuclear scaffold to which gene regulatory machinery binds.	Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Jackson Lab, Bar Harbor, ME 04609 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Jackson Laboratory	Tse, WT (corresponding author), Childrens Hosp, Div Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	william.tse@tch.harvard.edu	Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; Peters, Luanne/0000-0002-0784-0534	NCI NIH HHS [CA34196] Funding Source: Medline; NHLBI NIH HHS [HL64885, R01 HL064885, HL33262, HL55321, R01 HL055321] Funding Source: Medline; NICHD NIH HHS [P30-HD18655] Funding Source: Medline; NIDDK NIH HHS [DK34083] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033262, R01HL064885, R01HL055321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034083, R37DK034083] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alcalay M, 1998, MOL CELL BIOL, V18, P1084, DOI 10.1128/MCB.18.2.1084; AMIN KM, 1993, GENOMICS, V18, P118, DOI 10.1006/geno.1993.1434; BACHS O, 1990, J BIOL CHEM, V265, P18595; BECK KA, 1994, J CELL BIOL, V127, P707, DOI 10.1083/jcb.127.3.707; BEREZNEY R, 1975, SCIENCE, V189, P291, DOI 10.1126/science.1145202; BEREZNEY R, 1974, BIOCHEM BIOPH RES CO, V60, P1410, DOI 10.1016/0006-291X(74)90355-6; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; BLENCOWE BJ, 1994, J CELL BIOL, V127, P593, DOI 10.1083/jcb.127.3.593; Boddy MN, 1996, ONCOGENE, V13, P971; Brois DW, 1999, CARCINOGENESIS, V20, P1845, DOI 10.1093/carcin/20.9.1845; BURRIDGE K, 1982, J CELL BIOL, V95, P478, DOI 10.1083/jcb.95.2.478; CHANG KS, 1995, BLOOD, V85, P3646, DOI 10.1182/blood.V85.12.3646.bloodjournal85123646; CONLON RA, 1992, DEVELOPMENT, V116, P357; Corcoran Stacey L., 1997, Biochemical Society Transactions, V25, p483S; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; DAVIS LH, 1994, J BIOL CHEM, V269, P4409; De Matteis MA, 1998, CURR OPIN CELL BIOL, V10, P542, DOI 10.1016/S0955-0674(98)80071-9; De Matteis MA, 2000, J CELL SCI, V113, P2331; de Ruijter NCA, 2000, CELL BIOL INT, V24, P427, DOI 10.1006/cbir.2000.0508; DeCarcer G, 1995, BIOCHEM J, V312, P871, DOI 10.1042/bj3120871; Devarajan P, 1996, J CELL BIOL, V133, P819, DOI 10.1083/jcb.133.4.819; Doucas V, 1999, P NATL ACAD SCI USA, V96, P2627, DOI 10.1073/pnas.96.6.2627; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; EMIG S, 1995, J BIOL CHEM, V270, P13787, DOI 10.1074/jbc.270.23.13787; EVERETT RD, 1994, EMBO J, V13, P5062, DOI 10.1002/j.1460-2075.1994.tb06835.x; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; Ferbeyre G, 2000, GENE DEV, V14, P2015; GIBB S, 1981, GENET RES, V37, P95, DOI 10.1017/S0016672300020048; GLENNEY JR, 1983, CELL, V34, P503, DOI 10.1016/0092-8674(83)90383-5; Goodman RH, 2000, GENE DEV, V14, P1553; Harborth J, 1999, EMBO J, V18, P1689, DOI 10.1093/emboj/18.6.1689; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Hoock TC, 1997, J CELL BIOL, V136, P1059, DOI 10.1083/jcb.136.5.1059; HOZAK P, 1995, J CELL SCI, V108, P635; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jiang WQ, 1996, EXP CELL RES, V229, P289, DOI 10.1006/excr.1996.0374; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; KENNEDY SP, 1991, J CELL BIOL, V115, P267, DOI 10.1083/jcb.115.1.267; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Krauss SW, 1997, J CELL BIOL, V137, P275, DOI 10.1083/jcb.137.2.275; Kumaresan KR, 2000, CARCINOGENESIS, V21, P741, DOI 10.1093/carcin/21.4.741; Lallena MJ, 1998, J CELL SCI, V111, P1963; LAVAU C, 1995, ONCOGENE, V11, P871; Lippincott-Schwartz J, 1998, CURR OPIN CELL BIOL, V10, P52, DOI 10.1016/S0955-0674(98)80086-0; MALCHIODIALBEDI F, 1993, J CELL SCI, V106, P67; MARCHESI V. T., 1968, SCIENCE, V159, P203, DOI 10.1126/science.159.3811.203; Matera AG, 1999, TRENDS CELL BIOL, V9, P302, DOI 10.1016/S0962-8924(99)01606-2; Mattagajasingh SN, 1999, J CELL BIOL, V145, P29, DOI 10.1083/jcb.145.1.29; Mattern KA, 1996, J CELL BIOCHEM, V62, P275, DOI 10.1002/(SICI)1097-4644(199608)62:2<275::AID-JCB15>3.0.CO;2-K; Maul GG, 2000, J STRUCT BIOL, V129, P278, DOI 10.1006/jsbi.2000.4239; McMahon LW, 1999, J BIOL CHEM, V274, P32904, DOI 10.1074/jbc.274.46.32904; Michaely P, 1999, J BIOL CHEM, V274, P35908, DOI 10.1074/jbc.274.50.35908; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Nagase T, 2000, DNA RES, V7, P273; Nickerson JA, 1997, P NATL ACAD SCI USA, V94, P4446, DOI 10.1073/pnas.94.9.4446; Odorizzi G, 1998, TRENDS CELL BIOL, V8, P282, DOI 10.1016/S0962-8924(98)01295-1; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Pederson T, 2000, MOL BIOL CELL, V11, P799, DOI 10.1091/mbc.11.3.799; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quignon F, 1998, NAT GENET, V20, P259, DOI 10.1038/3068; Rando OJ, 2000, TRENDS CELL BIOL, V10, P92, DOI 10.1016/S0962-8924(99)01713-4; REPASKY EA, 1982, CELL, V29, P821, DOI 10.1016/0092-8674(82)90444-5; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; SAITO F, 1995, CYTOGENET CELL GENET, V71, P179, DOI 10.1159/000134102; SCHEER U, 1984, CELL, V39, P111, DOI 10.1016/0092-8674(84)90196-X; Seeler JS, 1999, CURR OPIN GENET DEV, V9, P362, DOI 10.1016/S0959-437X(99)80054-9; Seeler JS, 1998, P NATL ACAD SCI USA, V95, P7316, DOI 10.1073/pnas.95.13.7316; SMITH PR, 1993, AM J PHYSIOL, V264, pC63, DOI 10.1152/ajpcell.1993.264.1.C63; Stabach PR, 2000, J BIOL CHEM, V275, P21385, DOI 10.1074/jbc.C000159200; Stankewich MC, 1998, P NATL ACAD SCI USA, V95, P14158, DOI 10.1073/pnas.95.24.14158; Sternsdorf T, 1997, J CELL BIOL, V139, P1621, DOI 10.1083/jcb.139.7.1621; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; STUURMAN N, 1992, J CELL SCI, V101, P773; SUKEGAWA J, 1993, CELL, V72, P29, DOI 10.1016/0092-8674(93)90047-T; SZOSTECKI C, 1990, J IMMUNOL, V145, P4338; TERRIS B, 1995, CANCER RES, V55, P1590; Tse WT, 1999, BRIT J HAEMATOL, V104, P2, DOI 10.1111/j.1365-2141.1999.01130.x; TURNER BM, 1986, FEBS LETT, V197, P41, DOI 10.1016/0014-5793(86)80294-0; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; WINKELMANN JC, 1990, J BIOL CHEM, V265, P20449; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Ye KQ, 1999, J NEUROSCI, V19, P10747, DOI 10.1523/JNEUROSCI.19-24-10747.1999; YOUSSOUFIAN H, 1990, AM J HUM GENET, V47, P62; Zeng CM, 1998, P NATL ACAD SCI USA, V95, P1585, DOI 10.1073/pnas.95.4.1585; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367	91	46	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23974	23985		10.1074/jbc.M009307200	http://dx.doi.org/10.1074/jbc.M009307200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11294830	hybrid			2022-12-27	WOS:000169531100100
J	Honey, K; Duff, M; Beers, C; Brissette, WH; Elliott, EA; Peters, C; Maric, M; Cresswell, P; Rudensky, A				Honey, K; Duff, M; Beers, C; Brissette, WH; Elliott, EA; Peters, C; Maric, M; Cresswell, P; Rudensky, A			Cathepsin S regulates the expression of cathepsin L and the turnover of gamma-interferon-inducible lysosomal thiol reductase in B lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; INVARIANT-CHAIN; ANTIGEN PRESENTATION; DENDRITIC CELLS; SURFACE EXPRESSION; DISULFIDE BONDS; COMPLEX; MOLECULES; INHIBITION; PROTEINASES	Loading of antigenic peptide fragments on major histocompatibility complex class II molecules is essential for generation of CD4(+) T cell responses and occurs after cathepsin mediated degradation of the invariant chain chaperone molecule. Cathepsins are expressed differentially in antigen presenting cells, and mice deficient in cathepsin S or cathepsin L exhibit severely impaired antigen presentation in peripheral lymphoid organs and the thymus, respectively. To determine whether these defects are due solely to the block in invariant chain cleavage, we used cathepsin-deficient B cells to examine the role of cathepsins S and E in the degradation of other molecules important in the class II presentation pathway. Our data indicate that neither cathepsin S nor B is critical for H-2M degradation or processing of precursor gamma -interferon inducible lysosomal thiol reductase (GILT) to a mature thiol reductase, but suggest a role for cathepsin S in the turnover of mature GILT and in regulating levels of mature cathepsin L protein in E cells. Despite the presence of mature cathepsin L protein, no enzyme activity could be detected in B cells or dendritic cells. These experiments suggest a novel mechanism by which these functionally important enzymes may be regulated.	Univ Washington, Dept Immunol, Seattle, WA 98115 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98115 USA; Pfizer Inc, Dept Immunol, Groton, CT 06340 USA; Univ Freiburg, Inst Mol Med & Zellforsch, D-76106 Freiburg, Germany; Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Pfizer; University of Freiburg; Howard Hughes Medical Institute; Yale University	Rudensky, A (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98115 USA.							ANDERSON MS, 1992, P NATL ACAD SCI USA, V89, P2282, DOI 10.1073/pnas.89.6.2282; Antoniou AN, 2000, IMMUNITY, V12, P391, DOI 10.1016/S1074-7613(00)80191-0; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Arunachalam B, 1998, J IMMUNOL, V160, P5797; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BENNETT K, 1992, EUR J IMMUNOL, V22, P1519, DOI 10.1002/eji.1830220626; Bevec T, 1996, J EXP MED, V183, P1331, DOI 10.1084/jem.183.4.1331; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carmona E, 1996, BIOCHEMISTRY-US, V35, P8149, DOI 10.1021/bi952736s; Cimerman N, 1999, J ENZYM INHIB, V14, P167, DOI 10.3109/14756369909036552; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; FOX T, 1992, BIOCHEMISTRY-US, V31, P12571, DOI 10.1021/bi00165a005; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Guay J, 2000, EUR J BIOCHEM, V267, P6311, DOI 10.1046/j.1432-1327.2000.01730.x; Guncar G, 1999, EMBO J, V18, P793, DOI 10.1093/emboj/18.4.793; Jensen P E, 1995, Semin Immunol, V7, P347, DOI 10.1006/smim.1995.0039; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; Leonardi A, 1996, BIOL CHEM H-S, V377, P319; Liuzzo JP, 1999, MOL MED, V5, P320, DOI 10.1007/BF03402068; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; Mach N, 2000, CANCER RES, V60, P3239; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; MARIC MA, 1994, P NATL ACAD SCI USA, V91, P2171, DOI 10.1073/pnas.91.6.2171; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; MASON RW, 1989, BIOCHEM J, V263, P945, DOI 10.1042/bj2630945; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; MERKEL BJ, 1995, J IMMUNOL, V154, P128; MORKOWSKI S, 1995, J EXP MED, V182, P1403, DOI 10.1084/jem.182.5.1403; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Nakagawa TY, 1999, IMMUNOL REV, V172, P121, DOI 10.1111/j.1600-065X.1999.tb01361.x; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; Pierre P, 2000, J EXP MED, V191, P1057, DOI 10.1084/jem.191.6.1057; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; PORTNOY DA, 1986, J BIOL CHEM, V261, P4697; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; ROWAN AD, 1992, J BIOL CHEM, V267, P15993; SALMINEN A, 1990, BIOCHEM J, V272, P39, DOI 10.1042/bj2720039; Shachar I, 1996, SCIENCE, V274, P106, DOI 10.1126/science.274.5284.106; Shi GP, 2000, J EXP MED, V191, P1177, DOI 10.1084/jem.191.7.1177; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0	52	44	45	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22573	22578		10.1074/jbc.M101851200	http://dx.doi.org/10.1074/jbc.M101851200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11306582	hybrid			2022-12-27	WOS:000169412700081
J	Nicolas, M; Noe, V; Jensen, KB; Ciudad, CJ				Nicolas, M; Noe, V; Jensen, KB; Ciudad, CJ			Cloning and characterization of the 5 '-flanking region of the human transcription factor Sp1 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROFOLATE-REDUCTASE; FUNCTIONAL-ANALYSIS; ACTIVATION DOMAINS; O-GLYCOSYLATION; CELL-GROWTH; SP-FAMILY; PROMOTER; BINDING; PHOSPHORYLATION; EXPRESSION	The 5 ' -flanking region of the human Sp1 gene was cloned and characterized. Sequence analysis of this region showed the absence of both CAAT and TATA boxes and an initiator element. The proximal promoter of the Sp1 gene is a GC-rich region that contains multiple GC boxes and Ap2 binding sites. The major transcription start site is located 63 base pairs upstream of the translation start site. Transfection experiments demonstrate that all the elements necessary to achieve significant basal transcription activity are located between positions -443 and -20 relative to the translational start. Sp1 and Sp3 proteins bind to the downstream GC box located in the progimal promoter of Sp1. Furthermore, we demonstrate that the Sp1 protein activates Sp1 transcription activity; thus the Sp1 gene is autoregulated.	Univ Barcelona, Fac Farm, Dept Bioquim & Biol Mol, Div 4,Sch Pharm, Barcelona 08028, Spain; Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA	University of Barcelona; Rockefeller University	Ciudad, CJ (corresponding author), Univ Barcelona, Fac Farm, Dept Bioquim & Biol Mol, Div 4,Sch Pharm, Avda Diagonal 643, Barcelona 08028, Spain.	Cciudad@farmacia.far.ub.es	Noe, Veronique/K-3615-2014; Jensen, Kirk/B-4756-2008; Jensen, Kirk/AAL-5883-2020; Ciudad, Carlos J./D-7917-2014	Noe, Veronique/0000-0001-7937-8038; Jensen, Kirk/0000-0002-2084-1734; Jensen, Kirk/0000-0002-2084-1734; Ciudad, Carlos J./0000-0002-7855-392X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apt D, 1996, VIROLOGY, V224, P281, DOI 10.1006/viro.1996.0530; Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; BERGER I, 1994, DNA CELL BIOL, V13, P249, DOI 10.1089/dna.1994.13.249; Black AR, 1999, J BIOL CHEM, V274, P1207, DOI 10.1074/jbc.274.3.1207; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; CIUDAD CJ, 1992, J BIOL CHEM, V267, P3650; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DATTA PK, 1995, MOL CELL BIOL, V15, P5444; Discher DJ, 1998, J BIOL CHEM, V273, P26087, DOI 10.1074/jbc.273.40.26087; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; EMILI A, 1994, MOL CELL BIOL, V14, P1582, DOI 10.1128/MCB.14.3.1582; GAYNOR RB, 1993, CYTOGENET CELL GENET, V64, P210, DOI 10.1159/000133578; GIDONI D, 1984, NATURE, V312, P409, DOI 10.1038/312409a0; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; JANSON L, 1990, P NATL ACAD SCI USA, V87, P4732, DOI 10.1073/pnas.87.12.4732; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; LEE JS, 1993, P NATL ACAD SCI USA, V90, P6145, DOI 10.1073/pnas.90.13.6145; LEGGETT RW, 1995, J BIOL CHEM, V270, P25879, DOI 10.1074/jbc.270.43.25879; LIPTAY S, 1994, MOL CELL BIOL, V14, P7695, DOI 10.1128/MCB.14.12.7695; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; MASTRANGELO IA, 1991, P NATL ACAD SCI USA, V88, P5670, DOI 10.1073/pnas.88.13.5670; MATERA AG, 1993, GENOMICS, V17, P793, DOI 10.1006/geno.1993.1413; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; MEYER TE, 1993, ENDOCRINOLOGY, V132, P770, DOI 10.1210/en.132.2.770; MURATA Y, 1994, J BIOL CHEM, V269, P20674; Noe V, 1998, ONCOGENE, V16, P1931, DOI 10.1038/sj.onc.1201718; Noe V, 1997, EUR J BIOCHEM, V249, P13, DOI 10.1111/j.1432-1033.1997.00013.x; Novina CD, 1996, TRENDS GENET, V12, P351, DOI 10.1016/0168-9525(96)10034-2; Osoegawa K, 1998, GENOMICS, V52, P1, DOI 10.1006/geno.1998.5423; PARK K, 1994, J BIOL CHEM, V269, P6083; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Roder K, 1999, GENE, V234, P61, DOI 10.1016/S0378-1119(99)00180-8; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; SALTZMAN AG, 1989, FASEB J, V3, P1723, DOI 10.1096/fasebj.3.6.2649403; SEHGAL A, 1988, MOL CELL BIOL, V8, P3160, DOI 10.1128/MCB.8.8.3160; SETO E, 1993, NATURE, V365, P462, DOI 10.1038/365462a0; Strom AC, 1996, NUCLEIC ACIDS RES, V24, P1981, DOI 10.1093/nar/24.11.1981; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Takahara T, 2000, J BIOL CHEM, V275, P38067, DOI 10.1074/jbc.M002010200; Vinals F, 1997, J BIOL CHEM, V272, P12913, DOI 10.1074/jbc.272.20.12913; Xiao HY, 1999, J CELL BIOCHEM, V73, P291, DOI 10.1002/(SICI)1097-4644(19990601)73:3<291::AID-JCB1>3.0.CO;2-5; Xiao HY, 2000, J BIOL CHEM, V275, P1371, DOI 10.1074/jbc.275.2.1371; Yajima S, 1998, DNA CELL BIOL, V17, P471, DOI 10.1089/dna.1998.17.471	54	76	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22126	22132		10.1074/jbc.M010740200	http://dx.doi.org/10.1074/jbc.M010740200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294852	hybrid			2022-12-27	WOS:000169412700022
J	Ritz, H; Schramek, N; Bracher, A; Herz, S; Eisenreich, W; Richter, G; Bacher, A				Ritz, H; Schramek, N; Bracher, A; Herz, S; Eisenreich, W; Richter, G; Bacher, A			Biosynthesis of riboflavin - Studies on the mechanism of GTP cyclohydrolase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; REDUCTASE; SYNTHASE; GENE	GTP cyclohydrolase II catalyzes the first committed reaction in the biosynthesis of the vitamin riboflavin, The recombinant enzyme from Escherichia coli is shown to pro duce 2,5 diamino-6-beta -ribosylamino 4(3H)-pyrimidinone 5'-phosphate and GMP at an approximate molar ratio of 10:1. The main product is subject to spontaneous isomerization affording the alpha -anomer. O-18 from solvent water is incorporated by the enzyme into the phosphate group of the 5-aminopyrimidine derivative as well as GMP. These data are consistent with the transient formation of a covalent phosphoguanosyl derivative of the enzyme. Subsequent ring opening of the covalently bound nucleotide followed by hydrolysis of the phosphodiester bond could then afford the pyrimidine type product. The hydrolysis of the phosphodiester bond without prior ring opening could afford GMP. The enzyme reaction is cooperative with a Hill coefficient of 1.3, Inhibition by pyrophosphate is competitive. Inhibition by orthophosphate is partially uncompetitive at low concentration and competitive at concentrations above 6 mM.	Tech Univ Munich, Lehrstuhl Organ Chem & Biochem, D-85747 Garching, Germany	Technical University of Munich	Bacher, A (corresponding author), Tech Univ Munich, Lehrstuhl Organ Chem & Biochem, Lichtenbergstr 4, D-85747 Garching, Germany.		Eisenreich, Wolfgang/A-1258-2013; Richter, Gerald/F-3642-2011	Eisenreich, Wolfgang/0000-0002-9832-8279; 				Auerbach G, 2000, P NATL ACAD SCI USA, V97, P13567, DOI 10.1073/pnas.240463497; Bacher A, 1997, METHOD ENZYMOL, V280, P382; Bacher A., 1993, BIOORGANIC CHEM FRON, P147, DOI [10.1007/978-3-642-78110-0, DOI 10.1007/978-3-642-78110-0]; BLAU N, 1982, BIOCH CLIN ASPECTS P, V1, P103; Bracher A, 1998, J BIOL CHEM, V273, P28132, DOI 10.1074/jbc.273.43.28132; Bracher A, 1999, J BIOL CHEM, V274, P16727, DOI 10.1074/jbc.274.24.16727; Brown G. M., 1987, ESCHERICHIA COLI SAL, V1, P521; BURG AW, 1968, J BIOL CHEM, V243, P2349; DIETRICH R, 1979, J AM CHEM SOC, V101, P6144, DOI 10.1021/ja00514a059; FOOR F, 1975, J BIOL CHEM, V250, P3545; Foor F, 1980, Methods Enzymol, V66, P303; Herz S, 2000, PHYTOCHEMISTRY, V53, P723, DOI 10.1016/S0031-9422(00)00013-3; Kobayashi M, 1998, J BIOL CHEM, V273, P26394, DOI 10.1074/jbc.273.41.26394; NAR H, 1995, STRUCTURE, V3, P459, DOI 10.1016/S0969-2126(01)00179-4; NAR H, 1996, BIOCH SOC T S, V24, P37; NICHOL CA, 1985, ANNU REV BIOCHEM, V54, P729, DOI 10.1146/annurev.biochem.54.1.729; RICHTER G, 1993, J BACTERIOL, V175, P4045, DOI 10.1128/JB.175.13.4045-4051.1993; Schramek N, 2001, J BIOL CHEM, V276, P2622, DOI 10.1074/jbc.M004912200; SHIOTA T, 1965, J BIOL CHEM, V240, P4449	19	37	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22273	22277		10.1074/jbc.M100752200	http://dx.doi.org/10.1074/jbc.M100752200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301327	hybrid			2022-12-27	WOS:000169412700042
J	Yamaguchi, N; Xin, CL; Meissner, G				Yamaguchi, N; Xin, CL; Meissner, G			Identification of apocalmodulin and Ca2+-calmodulin regulatory domain in skeletal muscle Ca2+ release channel, ryanodine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-BINDING SITES; SARCOPLASMIC-RETICULUM; CALCIUM RELEASE; PROTEIN; SENSITIVITY; MODULATION; EXPRESSION; CLONING; CA-2+; RYR1	Fusion proteins and full-length mutants were generated to identify the Ca2(+)-free (apoCaM) and Ca2(+)bound (CaCaM) calmodulin binding sites of the skeletal muscle Ca2+ release channel/ryanodine receptor (RyR1). [S-35]Calmodulin (CaM) overlays of fusion proteins revealed one potential Ca2+-dependent (aa 3553-3662) and one Ca2+-independent (aa 4302-4430) CaM binding domain. W3620A or L3624D substitutions almost abolished completely, whereas V3619A or L3624A substitutions reduced [S-35]CaM binding to fusion protein (aa 3553-3662). Three full-length RyR1 single-site mutants (V3619A, W3620A,L3624D) and one deletion mutant (Delta 4274-4535) were generated and expressed in human embryonic kidney 293 cells. L3624D exhibited greatly reduced [35S]CaM binding affinity as indicated by a lack of noticeabIe binding of apoCaM and CaCaM (nanomolar) and the requirement of CaCaM (micromolar) for the inhibition of RyR1 activity. W3620A bound CaM (nanomolar) only in the absence of Ca2+ and did not show inhibition of RyR1 activity by 3 muM CaCaM. V3619A and the deletion mutant bound apoCaM and CaCaM at levels compared with wild type. V3619A activity was inhibited by CaM with IC50 similar to 200 nM, as compared with IC50 similar to 50 nM for wild type and the deletion mutant. [S-35]CaM binding experiments with sarcoplasmic reticulum vesicles suggested that apoCaM and CaCaM bind to the same region of the native RyR1 channel complex. These results indicate that the intact RyR1 has a single CaM binding domain that is shared by apoCaM and CaCaM.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Yamaguchi, N (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	meissner@med.unc.edu			NIAMS NIH HHS [AR18687] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR018687, R37AR018687] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BALSHAW DM, 2001, IN PRESS J BIOL CHEM; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Chen SRW, 1997, J BIOL CHEM, V272, P24234, DOI 10.1074/jbc.272.39.24234; CHEN SRW, 1994, J BIOL CHEM, V269, P22698; CORONADO R, 1994, AM J PHYSIOL, V266, pC1485, DOI 10.1152/ajpcell.1994.266.6.C1485; Du GC, 2000, J BIOL CHEM, V275, P11778, DOI 10.1074/jbc.275.16.11778; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Fruen BR, 2000, AM J PHYSIOL-CELL PH, V279, pC724, DOI 10.1152/ajpcell.2000.279.3.C724; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; Gao L, 1997, FEBS LETT, V412, P223, DOI 10.1016/S0014-5793(97)00781-3; GUERRINI R, 1995, BIOCHEMISTRY-US, V34, P5120, DOI 10.1021/bi00015a024; KOERNER TJ, 1991, METHOD ENZYMOL, V194, P477; Mackrill JJ, 1999, BIOCHEM J, V337, P345, DOI 10.1042/0264-6021:3370345; MEISSNER G, 1986, BIOCHEMISTRY-US, V25, P244, DOI 10.1021/bi00349a034; MEISSNER G, 1987, J BIOL CHEM, V262, P3065; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; MENEGAZZI P, 1994, BIOCHEMISTRY-US, V33, P9078, DOI 10.1021/bi00197a008; Moore CP, 1999, BIOCHEMISTRY-US, V38, P8532, DOI 10.1021/bi9907431; Moore CP, 1999, J BIOL CHEM, V274, P36831, DOI 10.1074/jbc.274.52.36831; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Rodney GG, 2000, BIOCHEMISTRY-US, V39, P7807, DOI 10.1021/bi0005660; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Samso M, 2000, BIOPHYS J, V78, p149A; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; Yamaguchi N, 2001, BIOPHYS J, V80, p385A; YANG HC, 1994, BIOCHEMISTRY-US, V33, P518, DOI 10.1021/bi00168a017; Zhang JZ, 1999, AM J PHYSIOL-CELL PH, V276, pC46; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	29	88	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22579	22585		10.1074/jbc.M102729200	http://dx.doi.org/10.1074/jbc.M102729200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11306590	hybrid, Green Published			2022-12-27	WOS:000169412700082
J	Chishti, MA; Yang, DS; Janus, C; Phinney, AL; Horne, P; Pearson, J; Strome, R; Zuker, N; Loukides, J; French, J; Turner, S; Lozza, G; Grilli, M; Kunicki, S; Morissette, C; Paquette, J; Gervais, F; Bergeron, C; Fraser, PE; Carlson, GA; St George-Hyslop, P; Westaway, D				Chishti, MA; Yang, DS; Janus, C; Phinney, AL; Horne, P; Pearson, J; Strome, R; Zuker, N; Loukides, J; French, J; Turner, S; Lozza, G; Grilli, M; Kunicki, S; Morissette, C; Paquette, J; Gervais, F; Bergeron, C; Fraser, PE; Carlson, GA; St George-Hyslop, P; Westaway, D			Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; A-BETA PEPTIDE; MOUSE MODEL; NEURONAL LOSS; NEUROFIBRILLARY TANGLES; PLAQUES; GENE; PRESENILIN-1; CELLS; BRAIN	We have created early-onset transgenic (Tg) models by exploiting the synergistic effects of familial Alzheimer's disease mutations on amyloid P-peptide (Ap) biogenesis. TgCRND8 mice encode a double mutant form of amyloid precursor protein 695 (KM670/671NL+V717F) under the control of the PrP gene promoter. Thioflavine S-positive AP amyloid deposits are present at 3 months, with dense-cored plaques and neuritic pathology evident from 5 months of age. TgCRND8 mice exhibit 3,200-4,600 pmol of A beta 42 per g brain at age 6 months, with an excess of A beta 42 over A beta 40. High level production of the pathogenic A beta 42 form of A beta peptide was associated with an early impairment in TgCRND8 mice in acquisition and learning reversal in the reference memory version of the Morris water maze, present by 3 months of age. Notably, learning impairment in young mice was offset by immunization against A beta 42 (Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., Mount, H. T. J., Nixon, R. A., Mercken, M., Bergeron, C., Fraser, P. E., St. George-Hyslop, P., and Westaway, D. (2000) Nature 408, 979-982). Amyloid deposition in TgCRND8 mice was enhanced by the expression of presenilin 1 transgenes including familial Alzheimer's disease mutations; for mice also expressing a M146L+L286V presenilin 1 transgene, amyloid deposits were apparent by 1 month of age. The Tg mice described here suggest a potential to investigate aspects of Alzheimer's disease pathogenesis, prophylaxis, and therapy within short time frames.	Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 3H2, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 3H2, Canada; Univ Toronto, Dept Med, Div Neurol, Toronto, ON M5S 3H2, Canada; Univ Toronto, Univ Hlth Network, Toronto, ON M5S 3H2, Canada; McLaughlin Res Inst, Great Falls, MT 59405 USA; Schering Plough Res Inst, Milan, Italy; Neurochem Inc, Montreal, PQ H4S 2A1, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McLaughlin Research Institute for Biomedical Sciences, Inc.; Merck & Company	Westaway, D (corresponding author), Univ Toronto, Ctr Res Neurodegenerat Dis, Tanz Neurosci Bldg,6 Queens Pk Crescent W, Toronto, ON M5S 3H2, Canada.		grilli, mariagrazia/ABF-1542-2020; French, Jacqueline/G-6795-2013	grilli, mariagrazia/0000-0001-9165-5827; St George-Hyslop, Peter/0000-0003-0796-7209; French, Jacqueline/0000-0003-2242-8027				Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bartoo GT, 1997, J NEUROPATH EXP NEUR, V56, P531, DOI 10.1097/00005072-199705000-00009; Beach TG, 2000, J NEUROPATH EXP NEUR, V59, P308, DOI 10.1093/jnen/59.4.308; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Capell A, 1997, J NEUROCHEM, V69, P2432; Carlson GA, 1997, HUM MOL GENET, V6, P1951, DOI 10.1093/hmg/6.11.1951; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Citron M, 1998, NEUROBIOL DIS, V5, P107, DOI 10.1006/nbdi.1998.0183; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crook R, 1998, NAT MED, V4, P452, DOI 10.1038/nm0498-452; Cummings BJ, 1996, NEUROBIOL AGING, V17, P921, DOI 10.1016/S0197-4580(96)00170-4; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; Dewachter I, 2000, J NEUROSCI, V20, P6452, DOI 10.1523/JNEUROSCI.20-17-06452.2000; Dodart JC, 2000, NEUROBIOL DIS, V7, P71, DOI 10.1006/nbdi.1999.0278; Dodart JC, 1999, BEHAV NEUROSCI, V113, P982, DOI 10.1037/0735-7044.113.5.982; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gass P, 1998, LEARN MEMORY, V5, P274; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; HACCOU P, 1995, STAT ANAL BEHAV DATA, P120; Harkany T, 2000, REV NEUROSCIENCE, V11, P329; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1998, EXP GERONTOL, V33, P883, DOI 10.1016/S0531-5565(98)00045-X; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Janus C, 2000, NEUROBIOL AGING, V21, P541, DOI 10.1016/S0197-4580(00)00107-X; Janus C, 2000, BBA-MOL BASIS DIS, V1502, P63, DOI 10.1016/S0925-4439(00)00033-8; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; JOHNSTON JA, 1994, FEBS LETT, V354, P274, DOI 10.1016/0014-5793(94)01137-0; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; MASLIAH E, 1991, AM J PATHOL, V138, P235; Masliah E, 1996, J NEUROSCI, V16, P5795; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; ROHER AE, 1993, J BIOL CHEM, V268, P3072; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SPILLANTINI MG, 1990, P NATL ACAD SCI USA, V87, P3947, DOI 10.1073/pnas.87.10.3947; Storey E, 1999, NEUROPATH APPL NEURO, V25, P81; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WEHNER JM, 1990, BRAIN RES, V523, P181, DOI 10.1016/0006-8993(90)91485-Y; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531	73	736	782	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21562	21570		10.1074/jbc.M100710200	http://dx.doi.org/10.1074/jbc.M100710200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279122	hybrid			2022-12-27	WOS:000169297900102
J	Mahadev, K; Zilbering, A; Zhu, L; Goldstein, BJ				Mahadev, K; Zilbering, A; Zhu, L; Goldstein, BJ			Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1B in vivo and enhances the early insulin action cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE; ACTIVATION; GENERATION; CATALYSIS; H2O2; DEPHOSPHORYLATION; INACTIVATION; SENSITIVITY; MECHANISM; COMPLEX	The insulin signaling pathway is activated by tyrosine phosphorylation of the insulin receptor and key postreceptor substrate proteins and balanced by the action of specific protein-tyrosine phosphatases (PTPases), PTPase activity, in turn, is highly regulated in vivo by oxidation/reduction reactions involving the cysteine thiol moiety required for catalysis, Here we show that insulin stimulation generates a burst of intracellular H2O2 in insulin-sensitive hepatoma and adipose cells that is associated with reversible oxidative inhibition of up to 62% of overall cellular PTPase activity, as measured by a novel method using strictly anaerobic conditions. The specific activity of immunoprecipitated PTP1B, a PTPase homolog implicated in the regulation of insulin signaling, was also strongly inhibited by up to 88% following insulin stimulation, Catalase pretreatment abolished the insulin-stimulated production of H2O2 as well as the inhibition of cellular PTPases, including PTP1B, and was associated with reduced insulin-stimulated tyrosine phosphorylation of its receptor and high M-r insulin receptor substrate (IRS) proteins. These data provide compelling new evidence for a redox signal that enhances the early insulin-stimulated cascade of tyrosine phosphorylation by oxidative inactivation of PTP1B and possibly other tyrosine phosphatases.	Thomas Jefferson Univ, Jefferson Med Coll, Dept Med,Div Endocrinol & Metab Dis, Dorrance H Hamilton Res Labs, Philadelphia, PA 19107 USA	Jefferson University	Goldstein, BJ (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Med,Div Endocrinol & Metab Dis, Dorrance H Hamilton Res Labs, Rm 349 Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.	Barry.Goldstein@mail.tju.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043396, R01DK053388] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK43396, DK53388] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHMAD F, 1995, J BIOL CHEM, V270, P20503, DOI 10.1074/jbc.270.35.20503; Bae GU, 1999, J BIOL CHEM, V274, P32596, DOI 10.1074/jbc.274.46.32596; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; BERNIER M, 1994, BIOCHEMISTRY-US, V33, P4343, DOI 10.1021/bi00180a031; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calera MR, 2000, J BIOL CHEM, V275, P6308, DOI 10.1074/jbc.275.9.6308; Cheung A, 1999, J LAB CLIN MED, V134, P115, DOI 10.1016/S0022-2143(99)90115-4; CICIRELLI MF, 1990, P NATL ACAD SCI USA, V87, P5514, DOI 10.1073/pnas.87.14.5514; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; CZECH MP, 1974, J BIOL CHEM, V249, P1001; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; ELBERG G, 1995, BBA-MOL CELL RES, V1269, P299, DOI 10.1016/0167-4889(95)00124-8; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Gagnon AM, 1998, OBES RES, V6, P157, DOI 10.1002/j.1550-8528.1998.tb00330.x; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; GOLDSTEIN BJ, 2000, DIABETES MELLITUS FU, P206; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; HASHIMOTO N, 1992, J BIOL CHEM, V267, P13811; Herrlich P, 2000, BIOCHEM PHARMACOL, V59, P35, DOI 10.1016/S0006-2952(99)00298-1; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Kennedy BP, 2000, BIOCHEM PHARMACOL, V60, P877, DOI 10.1016/S0006-2952(00)00305-1; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; KOZMA L, 1993, P NATL ACAD SCI USA, V90, P4460, DOI 10.1073/pnas.90.10.4460; KriegerBrauer HI, 1997, J BIOL CHEM, V272, P10135; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Malamas MS, 2000, J MED CHEM, V43, P995, DOI 10.1021/jm990476x; MEYEROVITCH J, 1992, BIOCHEMISTRY-US, V31, P10338, DOI 10.1021/bi00157a023; Mooney RA, 1997, BIOCHEM BIOPH RES CO, V235, P709, DOI 10.1006/bbrc.1997.6889; Rao GN, 1996, ONCOGENE, V13, P713; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; Venable CL, 2000, J BIOL CHEM, V275, P18318, DOI 10.1074/jbc.M908392199; Withers DJ, 2000, ENDOCRINOLOGY, V141, P1917, DOI 10.1210/en.141.6.1917; Zhang ZY, 1998, CRIT REV BIOCHEM MOL, V33, P1, DOI 10.1080/10409239891204161; ZHU L, 2001, IN PRESS FASEB J	41	410	424	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21938	21942		10.1074/jbc.C100109200	http://dx.doi.org/10.1074/jbc.C100109200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11297536	hybrid			2022-12-27	WOS:000169297900148
J	Zhu, XL; Hadhazy, M; Groh, ME; Wheeler, MT; Wollmann, R; McNally, EM				Zhu, XL; Hadhazy, M; Groh, ME; Wheeler, MT; Wollmann, R; McNally, EM			Overexpression of gamma-sarcoglycan induces severe muscular dystrophy - Implications for the regulation of sarcoglycan assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOVIRUS-MEDIATED TRANSFER; GENE-TRANSFER; MDX MICE; TRANSGENE EXPRESSION; MINIDYSTROPHIN GENE; BETA-SARCOGLYCAN; MUSCLE-FIBERS; DEFICIENCY; PROTEIN; MOUSE	The sarcoglycan complex is found normally at the plasma membrane of muscle. Disruption of the sarcoglycan complex, through primary gene mutations in dystrophin or sarcoglycan subunits, produces membrane instability and muscular dystrophy, Restoration of the sarcoglycan complex at the plasma membrane requires reintroduction of the mutant sarcoglycan subunit in a manner that will permit normal assembly of the entire sarcoglycan complex. To study sarcoglycan gene replacement, we introduced transgenes expressing murine gamma -sarcoglycan into muscle of normal mice. Mice expressing high levels of gamma -sarcoglycan, under the control of the muscle-specific creatine kinase promoter, developed a severe muscular dystrophy with greatly reduced muscle mass and early lethality. Marked gamma -sarcoglycan overexpression produced cytoplasmic aggregates that interfered with normal membrane targeting of gamma -sarcoglycan, Overexpression of gamma -sarcoglycan lead to the up-regulation of alpha- and beta -sarcoglycan. These data suggest that increased gamma -sarcoglycan and/or mislocalization of gamma -sarcoglycan to the cytoplasm is sufficient to induce muscle damage and provides a new model of muscular dystrophy that highlights the importance of this protein in the assembly, function, and downstream signaling of the sarcoglycan complex. Most importantly, gene dosage and promoter strength should be given serious consideration in replacement gene therapy to ensure safety in human clinical trials.	Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	McNally, EM (corresponding author), Univ Chicago, Dept Med, Cardiol Sect, 5841 S Maryland,MC 6088, Chicago, IL 60637 USA.		McNally, Elizabeth/W-4909-2019	Groh, Margaret/0000-0002-7473-597X; Wheeler, Matthew/0000-0001-8721-3022; McNally, Elizabeth/0000-0002-1221-719X	NHLBI NIH HHS [HL10288, HL61322] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010288, R01HL061322] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; Cordier L, 2000, MOL THER, V1, P119, DOI 10.1006/mthe.1999.0019; COX GA, 1993, NATURE, V364, P725, DOI 10.1038/364725a0; Crosbie RH, 2000, HUM MOL GENET, V9, P2019, DOI 10.1093/hmg/9.13.2019; Hack AA, 2000, J CELL SCI, V113, P2535; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; Hack AA, 1999, P NATL ACAD SCI USA, V96, P10723, DOI 10.1073/pnas.96.19.10723; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOGAN B, 1994, MANIPULATING MOUSE E, P115; Holt KH, 1998, MOL CELL, V1, P841, DOI 10.1016/S1097-2765(00)80083-0; Kim S, 1997, J CLIN INVEST, V100, P1006, DOI 10.1172/JCI119611; Larochelle N, 1997, GENE THER, V4, P465, DOI 10.1038/sj.gt.3300414; LEE CC, 1993, HUM GENE THER, V4, P273, DOI 10.1089/hum.1993.4.3-273; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; MATSUDA R, 1995, J BIOCHEM-TOKYO, V118, P959, DOI 10.1093/jb/118.5.959; MATSUMURA K, 1993, J CLIN INVEST, V92, P866, DOI 10.1172/JCI116661; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; PUNKT K, 1987, ACTA HISTOCHEM, V82, P109, DOI 10.1016/S0065-1281(87)80061-2; RAGOT T, 1993, NATURE, V361, P647, DOI 10.1038/361647a0; Stedman Hansell, 2000, Human Gene Therapy, V11, P777; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Thompson TG, 2000, J CELL BIOL, V148, P115, DOI 10.1083/jcb.148.1.115; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; VINCENT N, 1993, NAT GENET, V5, P130, DOI 10.1038/ng1093-130; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Zatz M, 2000, CURR OPIN NEUROL, V13, P511, DOI 10.1097/00019052-200010000-00002; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2	29	48	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21785	21790		10.1074/jbc.M101877200	http://dx.doi.org/10.1074/jbc.M101877200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11287429	hybrid			2022-12-27	WOS:000169297900129
J	Fujishiro, M; Gotoh, Y; Katagiri, H; Sakoda, H; Ogihara, T; Anai, M; Onishi, Y; Ono, H; Funaki, M; Inukai, K; Fukushima, Y; Kikuchi, M; Oka, Y; Asano, T				Fujishiro, M; Gotoh, Y; Katagiri, H; Sakoda, H; Ogihara, T; Anai, M; Onishi, Y; Ono, H; Funaki, M; Inukai, K; Fukushima, Y; Kikuchi, M; Oka, Y; Asano, T			MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE-B; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION; SIGNAL-TRANSDUCTION PATHWAYS; SKELETAL-MUSCLE CELLS; 3T3-L1 ADIPOCYTES; GLUT4 TRANSLOCATION; OSMOTIC SHOCK; RECEPTOR SUBSTRATE-1; GENE-TRANSCRIPTION	p38 mitogen-activated protein kinase (MAPK), which is situated downstream of MAPK kinase (MKK) 6 and MKK3, is activated by mitogenic or stress-inducing stimuli, as well as by insulin. To clarify the role of the MKK6/3-p38 MAPK pathway in the regulation of glucose transport, dominant negative p38 MAPK and MKK6 mutants and constitutively active MKK6 and MKK3 mutants were overexpressed in 3T3-L1 adipocytes and L6 myotubes using an adenovirus-mediated transfection procedure. Constitutively active MKK6/3 mutants up-regulated GLUT1 expression and down-regulated GLUT4 expression, thereby significantly increasing basal glucose transport but diminishing transport induced by insulin. Similar effects were elicited by chronic (24 h) exposure to tumor necrosis factor alpha, interleukin-1 beta, or 200 mM sorbitol, all activate the MKK6/3-p38 MAPK pathway. SB203580, a specific p38 MAPK inhibitor, attenuated these effects, further confirming that both MMK6 and MMK3 act via p38 MAPK,whereas they had no effect on the increase in glucose transport induced by a constitutively active MAPK kinase 1 (MEK1) mutant or by myristoylated Akt, In addition, suppression of p38 MAPK activation by overexpression of a dominant negative p38 MAPK or MKK6 mutant did not diminish insulin-induced glucose uptake by 3T3-L1 adipocytes, It is thus apparent that activation of p38 MAPK is not essential for insulin-induced increases in glucose uptake. Rather, p38 MAPK activation leads to a marked down-regulation of insulin-induced glucose uptake via GLUT4, which may underlie cellular stress-induced insulin resistance caused by tumor necrosis factor alpha and other factors.	Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Dept Mol Biol, Bunkyo Ku, Tokyo 1130032, Japan; Asahi Life Fdn, Inst Adult Dis, Shinjuku Ku, Tokyo 1600023, Japan; Yamaguchi Univ, Sch Med, Dept Internal Med 3, Yamaguchi 7550067, Japan	University of Tokyo; University of Tokyo; Asahi Life Foundation; Yamaguchi University	Asano, T (corresponding author), Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	asano-tky@umin.ac.jp	Onishi, Yukiko/AAU-9057-2021	Onishi, Yukiko/0000-0003-1180-5982				Anai M, 1998, DIABETES, V47, P13, DOI 10.2337/diabetes.47.1.13; ASANO T, 1992, J BIOL CHEM, V267, P19636; Battelino T, 1999, J LAB CLIN MED, V133, P583, DOI 10.1016/S0022-2143(99)90188-9; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; BIRNBAUM MJ, 1987, SCIENCE, V235, P1495, DOI 10.1126/science.3029870; BURANT CF, 1991, RECENT PROG HORM RES, V47, P349; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; Chen D, 1999, MOL CELL BIOL, V19, P4684; Chen D, 1997, J BIOL CHEM, V272, P27401, DOI 10.1074/jbc.272.43.27401; CLARKE JF, 1994, BIOCHEM J, V300, P631, DOI 10.1042/bj3000631; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Davis RJ, 1999, BIOCHEM SOC SYMP, P1; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642; GOULD GW, 1994, CELL SIGNAL, V6, P313, DOI 10.1016/0898-6568(94)90036-1; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hansen LL, 1999, J BIOL CHEM, V274, P25078, DOI 10.1074/jbc.274.35.25078; Hansen PA, 1998, J BIOL CHEM, V273, P18173, DOI 10.1074/jbc.273.29.18173; Hausdorff SF, 1999, J BIOL CHEM, V274, P24677, DOI 10.1074/jbc.274.35.24677; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; KAESTNER KH, 1990, P NATL ACAD SCI USA, V87, P251, DOI 10.1073/pnas.87.1.251; KAHN B B, 1985, Diabetes Metabolism Reviews, V1, P203; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Katagiri H, 1996, J BIOL CHEM, V271, P16987, DOI 10.1074/jbc.271.29.16987; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; KONO T, 1983, METHOD ENZYMOL, V98, P431; Long SD, 1996, BIOCHEM J, V319, P179, DOI 10.1042/bj3190179; Martin SS, 1996, J BIOL CHEM, V271, P17605, DOI 10.1074/jbc.271.30.17605; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Moriguchi T, 1997, EMBO J, V16, P7045, DOI 10.1093/emboj/16.23.7045; Moriguchi T, 1996, J BIOL CHEM, V271, P26981, DOI 10.1074/jbc.271.43.26981; Moxham CM, 1996, J BIOL CHEM, V271, P30765, DOI 10.1074/jbc.271.48.30765; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MURAKAMI T, 1992, J BIOL CHEM, V267, P9300; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Ogihara T, 1997, J BIOL CHEM, V272, P12868, DOI 10.1074/jbc.272.19.12868; OKA Y, 1988, J BIOL CHEM, V263, P13432; OKA Y, 1984, J BIOL CHEM, V259, P8125; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; Qi C, 2000, P SOC EXP BIOL MED, V223, P128, DOI 10.1046/j.1525-1373.2000.22318.x; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; RICHARDSON JM, 1993, J BIOL CHEM, V268, P21021; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Rudich A, 1997, AM J PHYSIOL-ENDOC M, V272, pE935, DOI 10.1152/ajpendo.1997.272.5.E935; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; Sakoda H, 1999, DIABETES, V48, P1365, DOI 10.2337/diabetes.48.7.1365; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Storz P, 1999, EUR J BIOCHEM, V266, P17, DOI 10.1046/j.1432-1327.1999.00809.x; Sweeney G, 1999, J BIOL CHEM, V274, P10071, DOI 10.1074/jbc.274.15.10071; Taha C, 1997, AM J PHYSIOL-ENDOC M, V273, pE68, DOI 10.1152/ajpendo.1997.273.1.E68; Wang CN, 1998, DIABETES, V47, P24, DOI 10.2337/diabetes.47.1.24; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360	62	97	103	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19800	19806		10.1074/jbc.M101087200	http://dx.doi.org/10.1074/jbc.M101087200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279172	hybrid			2022-12-27	WOS:000169135100018
J	Wojnar, P; Lechnar, M; Merschak, P; Redl, B				Wojnar, P; Lechnar, M; Merschak, P; Redl, B			Molecular cloning of a novel lipocalin-1 interacting human cell membrane receptor using phage display	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOL-BINDING-PROTEIN; EBNERS GLAND PROTEIN; CDNA CLONING; ALPHA(1)-ACID GLYCOPROTEIN; GENE; EXPRESSION; FAMILY; MEMBER; SUPERFAMILY; MEGALIN	Human lipocalin-1 (Lcn-1, also called tear lipocalin), a member of the lipocalin structural superfamily, is produced by a number of glands and tissues and is known to bind an unusually large array of hydrophobic ligands, Apart from its specific function in stabilizing the lipid film of human tear fluid, it is suggested to act as a physiological scavenger of potentially harmful lipophilic compounds, in general, To characterize proteins involved in the reception, detoxification, or degradation of these ligands, a cDNA phage-display library from human pituitary gland was constructed and screened for proteins interacting with Lcn-1, Using this method an Lcn-1 interacting phage was isolated that expressed a novel human protein, Molecular cloning and analysis of the entire cDNA indicated that it encodes a 55-kDa protein, lipocalin-1 interacting membrane receptor (LIMR), with nine putative transmembrane domains. The cell membrane location of this protein was confirmed by immunocytochemistry and Western blot analysis of membrane fractions of human NT2 cells. Independent biochemical investigations using a recombinant N-terminal fragment of LIMR also demonstrated a specific interaction with Lcn-1 in vitro, Eased on these data, we suggest LIMR to be a receptor of Lcn-1 ligands, These findings constitute the first report of cloning of a lipocalin interacting plasma membrane-located receptor, in general, In addition, a sequence comparison supports the biological relevance of this novel membrane protein, because genes with significant nucleotide sequence similarity are present in Takifugu rubripes, Drosophila melanogaster, Caenorhabditis elegans, Mus musculus, Bos taurus, and Sus scrofa, According to data derived from the human genome sequencing project, the LIMR-encoding gene has to be mapped on human chromosome 12, and its intron/exon organization could be established. The entire LIMR-encoding gene consists of about 13.7 kilobases in length and contains 16 introns with a length between 91 and 3438 base pairs.	Univ Innsbruck, Sch Med, Dept Microbiol, A-6020 Innsbruck, Austria	University of Innsbruck	Redl, B (corresponding author), Univ Innsbruck, Sch Med, Dept Microbiol, Fritz Pregl Str 3, A-6020 Innsbruck, Austria.	bernard.redl@uribk.ac.at						Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Andersen UO, 1996, J MOL RECOGNIT, V9, P364, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<364::AID-JMR266>3.0.CO;2-6; Andersen UO, 1999, ACTA HISTOCHEM, V101, P113, DOI 10.1016/S0065-1281(99)80011-7; BAVIK CO, 1992, J BIOL CHEM, V267, P23035; BAVIK CO, 1993, J BIOL CHEM, V268, P20540; BLAKER M, 1993, BIOCHIM BIOPHYS ACTA, V1172, P131, DOI 10.1016/0167-4781(93)90279-M; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; Boudjelal M, 1996, BIOCHEM J, V317, P23, DOI 10.1042/bj3170023; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRAMERI R, 1993, GENE, V137, P69, DOI 10.1016/0378-1119(93)90253-Y; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P327, DOI 10.1016/S0167-4838(00)00169-2; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; GLASGOW BJ, 1995, CURR EYE RES, V14, P363, DOI 10.3109/02713689508999934; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holzfeind P, 1996, FEBS LETT, V395, P95, DOI 10.1016/0014-5793(96)01008-3; KANG AS, 1991, P NATL ACAD SCI USA, V88, P4363, DOI 10.1073/pnas.88.10.4363; KORENBERG JR, 1994, GENOMICS, V22, P88, DOI 10.1006/geno.1994.1348; Lacazette E, 2000, HUM MOL GENET, V9, P289, DOI 10.1093/hmg/9.2.289; LASSAGNE H, 1993, EXP EYE RES, V56, P605, DOI 10.1006/exer.1993.1075; Leheste JR, 1999, AM J PATHOL, V155, P1361, DOI 10.1016/S0002-9440(10)65238-8; LUGDBERG L, 2000, BIOCHIM BIOPHYS ACTA, V1482, P284; Miller RE, 1998, FEBS LETT, V436, P455, DOI 10.1016/S0014-5793(98)01184-3; MITTERDORFER J, 1994, FEBS LETT, V352, P141, DOI 10.1016/0014-5793(94)00938-4; Moebius FF, 1998, P NATL ACAD SCI USA, V95, P1899, DOI 10.1073/pnas.95.4.1899; NICOLETTI A, 1995, HUM MOL GENET, V4, P641, DOI 10.1093/hmg/4.4.641; NOY N, 1990, BIOCHEMISTRY-US, V29, P3613; PAPIZ MZ, 1986, NATURE, V324, P383, DOI 10.1038/324383a0; REDL B, 1992, J BIOL CHEM, V267, P20282; Redl B, 1998, LAB INVEST, V78, P1121; Redl B, 2000, BBA-PROTEIN STRUCT M, V1482, P241, DOI 10.1016/S0167-4838(00)00142-4; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; ROBINSON GW, 1993, MOL CELL BIOL, V13, P2706, DOI 10.1128/MCB.13.5.2706; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Scalfari F, 1997, COMP BIOCHEM PHYS B, V118, P819, DOI 10.1016/S0305-0491(97)00218-6; SENOO H, 1993, P NATL ACAD SCI USA, V90, P3616, DOI 10.1073/pnas.90.8.3616; Silve S, 1996, J BIOL CHEM, V271, P22434, DOI 10.1074/jbc.271.37.22434; SIVAPRASADARAO A, 1994, BIOCHEM J, V302, P245, DOI 10.1042/bj3020245; SMELAND S, 1995, BIOCHEM J, V305, P419, DOI 10.1042/bj3050419; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sundaram M, 1998, J BIOL CHEM, V273, P3336, DOI 10.1074/jbc.273.6.3336; vantHof W, 1997, J BIOL CHEM, V272, P1837; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wester L, 1998, SCAND J IMMUNOL, V48, P1; XU S, 2000, BIOCHIM BIOPHYS ACTA, V1482, P289; Yusifov TN, 2000, BIOCHEM J, V347, P815, DOI 10.1042/0264-6021:3470815	46	57	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20206	20212		10.1074/jbc.M101762200	http://dx.doi.org/10.1074/jbc.M101762200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11287427	hybrid			2022-12-27	WOS:000169135100073
J	Ikushiro, H; Hayashi, H; Kagamiyama, H				Ikushiro, H; Hayashi, H; Kagamiyama, H			A water-soluble homodimeric serine palmitoyltransferase from Sphingomonas paucimobilis EY2395(T) strain - Purification, characterization, cloning, and overproduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOLIPID SYNTHESIS; BACILLUS-SPHAERICUS; ESCHERICHIA-COLI; BASE SYNTHESIS; ENZYME; LCB1; SACCHAROMYCES; SEQUENCE; GENE; BIOSYNTHESIS	Serine palmitoyltransferase (SPT, EC 2.3.1.50) is a key enzyme in sphingolipid biosynthesis and catalyzes the decarboxylative condensation of L-serine and palmitoylcoenzyme A to 3-ketodihydrosphingosine. We found that the Gram-negative obligatory aerobic bacteria Sphingomonas paucimobilis EY2395(T) have significant SPT activity and purified SPT to homogeneity. This enzyme is a water-soluble homodimeric protein unlike eukaryotic enzymes, known as heterodimers composed of tightly membrane-bound subunits, named LCB1 and LCB2. The purified SPT shows an absorption spectrum characteristic of a pyridoxal 5'-phosphate-dependent enzyme. The substrate specificity of the Sphingomonas SPT is less strict than the SPT complex from Chinese hamster ovary cells. We isolated the SPT gene encoding 420 amino acid residues (M-r 45,041) and succeeded in overproducing the SPT protein in Escherichia coli, in which the product amounted to about 10-20% of the total protein of the cell extract. Sphingomonas SPT shows about 30% homology with the enzymes of the alpha -oxamine synthase family, and amino acid residues supposed to be involved in catalysis are conserved. The recombinant SPT was catalytically and spectrophotometrically indistinguishable from the native enzyme. This is the first successful overproduction of an active enzyme in the sphingolipid biosynthetic pathway. Sphingomonas SPT is a prototype of the eukaryotic enzyme and would be a useful model to elucidate the reaction mechanism of SPT.	Osaka Med Coll, Dept Biochem, Osaka 5698686, Japan	Osaka Medical College	Kagamiyama, H (corresponding author), Osaka Med Coll, Dept Biochem, Osaka 5698686, Japan.							Alexeev D, 1998, J MOL BIOL, V284, P401, DOI 10.1006/jmbi.1998.2086; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AUSUBEL FM, 1994, CURRENT PROTOCOLS S, V27; Batrakov SG, 1999, BBA-MOL CELL BIOL L, V1440, P163, DOI 10.1016/S1388-1981(99)00119-5; BATRAKOV SG, 2000, BIOCHIM BIOPHYS ACTA, V148, P225; BUEDE R, 1991, J BACTERIOL, V173, P4325, DOI 10.1128/JB.173.14.4325-4332.1991; DROLET M, 1991, MOL GEN GENET, V226, P250, DOI 10.1007/BF00273610; GLOECKLER R, 1990, GENE, V87, P63, DOI 10.1016/0378-1119(90)90496-E; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; Hanada K, 2000, J BIOL CHEM, V275, P8409, DOI 10.1074/jbc.275.12.8409; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Huwiler A, 2000, BBA-MOL CELL BIOL L, V1485, P63, DOI 10.1016/S1388-1981(00)00042-1; Ikushiro H, 2000, BIOCHEMISTRY AND MOLECULAR BIOLOGY OF VITAMIN B6 AND PQQ-DEPENDENT PROTEINS, P251; KALLEN RG, 1985, TRANSAMINASES, P37; KAWASAKI S, 1994, J BACTERIOL, V176, P284, DOI 10.1128/JB.176.2.284-290.1994; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEV M, 1981, ARCH BIOCHEM BIOPHYS, V212, P424, DOI 10.1016/0003-9861(81)90384-2; MANDON EC, 1992, J BIOL CHEM, V267, P11144; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; MUKHERJEE JJ, 1987, J BIOL CHEM, V262, P14441; Nagiec MM, 1996, GENE, V177, P237, DOI 10.1016/0378-1119(96)00309-5; NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; PLOUX O, 1992, BIOCHEM J, V283, P327, DOI 10.1042/bj2830327; Segel I. H., 1975, ENZYME KINETICS BEHA, P505; SNELL EE, 1970, CHEM PHYS LIPIDS, V5, P116, DOI 10.1016/0009-3084(70)90013-7; Weiss B, 1997, EUR J BIOCHEM, V249, P239, DOI 10.1111/j.1432-1033.1997.00239.x; WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9; YABUUCHI E, 1979, J GEN APPL MICROBIOL, V25, P95, DOI 10.2323/jgam.25.95; YAMAMOTO A, 1978, J BIOCHEM-TOKYO, V83, P1213, DOI 10.1093/oxfordjournals.jbchem.a132015; YAMAMOTO A, 1982, J OSAKA CITY MED, V31, P201; YANO I, 1982, FEMS MICROBIOL LETT, V15, P303, DOI 10.1111/j.1574-6968.1982.tb00239.x	33	68	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18249	18256		10.1074/jbc.M101550200	http://dx.doi.org/10.1074/jbc.M101550200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279212	hybrid			2022-12-27	WOS:000168866500086
J	Liu, Y; MacDonald, RJ; Swift, GH				Liu, Y; MacDonald, RJ; Swift, GH			DNA binding and transcriptional activation by a PDX1 center dot PBX1b center dot MEIS2b trimer and cooperation with a pancreas-specific basic helix-loop-helix complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELASTASE-I ENHANCER; HOX PROTEINS; HOMEODOMAIN PROTEIN; CELL-LINES; INSULIN PROMOTER; TRANSGENIC MICE; PBX PROTEINS; SOMATOSTATIN PROMOTER; HOMEOBOX FACTOR; FACTOR STF-1	In pancreatic acinar cells, the HOX-like factor PDX1 acts as part of a trimeric complex with two TALE class homeodomain factors, PBX1b and MEIS2b, The complex binds to overlapping half-sites for PDX1 and PBX, The trimeric complex activates transcription in cells to a level about an order of magnitude greater than PDX1 alone. The N-terminal PDX1 activation domain is required for detectable transcriptional activity of the complex, even though PDX1 truncations bearing only the PDX1 C-terminal homeodomain and pentapeptide motifs can still participate in forming the trimeric complex. The conserved N-terminal PBC-B domain of PBX, as well as its homeodomain, is required for both complex formation and transcriptional activity. Only the N-terminal region of MEIS2, including the conserved MEIS domains, is required for formation of a trimer on DNA and transcriptional activity: the MEIS homeodomain is dispensable. The activity of the pancreas-specific ELA1 enhancer requires the cooperation of the trimer-binding element and a nearby element that binds the pancreatic transcription factor PTF1, We show that the PDX1 PBX1b. MEIS2b complex cooperates with the PTF1 basic helix-loop-helix complex to activate an ELA1 minienhancer in HeLa cells and that this cooperation requires all three homeoprotein subunits, including the PDX1 activation domain.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Swift, GH (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		MacDonald, Ray/AAA-1290-2022; Liu, Ying/C-2734-2008		NIDDK NIH HHS [DK-55266] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055266] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Berthelsen J, 1998, EMBO J, V17, P1423, DOI 10.1093/emboj/17.5.1423; Berthelsen J, 1998, EMBO J, V17, P1434, DOI 10.1093/emboj/17.5.1434; Bischof LJ, 1998, J BIOL CHEM, V273, P7941, DOI 10.1074/jbc.273.14.7941; Bromleigh VC, 2000, GENE DEV, V14, P2581, DOI 10.1101/gad.817100; Brooke NM, 1998, NATURE, V392, P920, DOI 10.1038/31933; BURGLIN TR, 1992, NAT GENET, V1, P319, DOI 10.1038/ng0892-319; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; Carty MD, 1997, J BIOL CHEM, V272, P11986, DOI 10.1074/jbc.272.18.11986; Chan SK, 1996, P NATL ACAD SCI USA, V93, P5223, DOI 10.1073/pnas.93.11.5223; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; Chang CP, 1997, MOL CELL BIOL, V17, P5679, DOI 10.1128/MCB.17.10.5679; COCKELL M, 1989, MOL CELL BIOL, V9, P2464, DOI 10.1128/MCB.9.6.2464; DiRocco G, 1997, EMBO J, V16, P3644, DOI 10.1093/emboj/16.12.3644; Dutta S, 2001, P NATL ACAD SCI USA, V98, P1065, DOI 10.1073/pnas.031561298; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Ferretti E, 2000, DEVELOPMENT, V127, P155; Goudet G, 1999, J BIOL CHEM, V274, P4067, DOI 10.1074/jbc.274.7.4067; GUZ Y, 1995, DEVELOPMENT, V121, P11; Jacobs Y, 1999, MOL CELL BIOL, V19, P5134, DOI 10.1128/mcb.19.7.5134; JESSOP NW, 1980, IN VITRO CELL DEV B, V16, P212; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Knoepfler PS, 1999, NUCLEIC ACIDS RES, V27, P3752, DOI 10.1093/nar/27.18.3752; Knoepfler PS, 1997, P NATL ACAD SCI USA, V94, P14553, DOI 10.1073/pnas.94.26.14553; Krapp A, 1996, EMBO J, V15, P4317, DOI 10.1002/j.1460-2075.1996.tb00806.x; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; KRUSE F, 1995, MOL CELL BIOL, V15, P4385; LAWRENCE PA, 1994, CELL, V78, P181, DOI 10.1016/0092-8674(94)90289-5; Lu M, 1996, ENDOCRINOLOGY, V137, P2959, DOI 10.1210/en.137.7.2959; Lu Q, 1996, P NATL ACAD SCI USA, V93, P470, DOI 10.1073/pnas.93.1.470; Lu Q, 1996, MOL CELL BIOL, V16, P1632; MacDonald RJ, 1998, INT J DEV BIOL, V42, P983; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Neuteboom STC, 1997, MOL CELL BIOL, V17, P4696, DOI 10.1128/MCB.17.8.4696; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Ohneda K, 2000, MOL CELL BIOL, V20, P900, DOI 10.1128/MCB.20.3.900-911.2000; ORNITZ DM, 1987, SCIENCE, V238, P188, DOI 10.1126/science.2821617; OuladAbdelghani M, 1997, DEV DYNAM, V210, P173, DOI 10.1002/(SICI)1097-0177(199710)210:2<173::AID-AJA9>3.0.CO;2-D; PEERS B, 1994, MOL ENDOCRINOL, V8, P1798, DOI 10.1210/me.8.12.1798; PEERS B, 1995, MOL CELL BIOL, V15, P7091; Peshavaria M, 1997, MOL CELL BIOL, V17, P3987, DOI 10.1128/MCB.17.7.3987; PHILIPPE J, 1987, J CLIN INVEST, V79, P351, DOI 10.1172/JCI112819; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; ROSE SD, 1994, MOL CELL BIOL, V14, P2048, DOI 10.1128/MCB.14.3.2048; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; Serup P, 1996, P NATL ACAD SCI USA, V93, P9015, DOI 10.1073/pnas.93.17.9015; Sharkey M, 1997, TRENDS GENET, V13, P145, DOI 10.1016/S0168-9525(97)01096-2; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; SWIFT GH, 1989, GENE DEV, V3, P687, DOI 10.1101/gad.3.5.687; SWIFT GH, 1994, J BIOL CHEM, V269, P12809; Swift GH, 1998, MOL CELL BIOL, V18, P5109, DOI 10.1128/MCB.18.9.5109; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Watada H, 1996, DIABETES, V45, P1478, DOI 10.2337/diabetes.45.11.1478	55	56	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17985	17993		10.1074/jbc.M100678200	http://dx.doi.org/10.1074/jbc.M100678200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279116	hybrid			2022-12-27	WOS:000168866500050
J	Verrecchia, F; Chu, ML; Mauviel, A				Verrecchia, F; Chu, ML; Mauviel, A			Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TRANSCRIPTION FACTOR SP1; HUMAN SKIN FIBROBLASTS; TERMINAL KINASE JNK; COLLAGEN GENE; FUNCTIONAL-CHARACTERIZATION; PROMOTER ACTIVITY; HUMAN ALPHA-1(I); COL7A1 PROMOTER; EXPRESSION	Despite major advances in the understanding of the intimate mechanisms of transforming growth factor-beta (TGF-beta) signaling through the Smad pathway, little progress has been made in the identification of direct target genes. In this report, using cDNA microarrays, we have focussed our attention on the characterization of extracellular matrix-related genes rapidly induced by TGF-beta in human dermal fibroblasts and attempted to identify the ones whose up-regulation by TGF-beta is Smad-mediated. For a gene to qualify as a direct Smad target, we postulated that it had to meet the following criteria: (1) rapid (30 min) and significant (at least S-fold) elevation of steady-state mRNA levels upon TGF-beta stimulation, (2) activation of the promoter by both exogenous TGF-beta and co-transfected Smad3 expression vector, (3) up-regulation of promoter activity by TGF-beta blocked by both dominant-negative Smad3 and inhibitory Smad7 expression vectors, and (4) promoter transactivation by TGF-beta not possible in Smad3(-/-) mouse embryo fibroblasts. Using this stringent approach, we have identified COL1A2, COL3A1, COL6A1, COL6A3, and tissue inhibitor of metalloproteases-1 as definite TGF-beta /Smad3 targets. Extrapolation of this approach to other extracellular matrix-related gene promoters also identified COL1A1 and COL5A2, but not COL6A2, as novel Smad targets. Together, these results represent a significant step toward the identification of novel, early-induced Smad-dependent TGF-beta target genes in fibroblasts.	Hop St Louis, INSERM U532, Inst Rech Peau, F-75475 Paris 10, France; Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Jefferson University	Mauviel, A (corresponding author), Hop St Louis, INSERM U532, Inst Rech Peau, Pavillon Bazin,1 Ave Claude Vellefaux, F-75475 Paris 10, France.	mauviel@chu-stlouis.fr	MAUVIEL, Alain/F-6251-2013; Verrecchia, Franck/G-5535-2018	Verrecchia, Franck/0000-0003-4920-2554; Mauviel, Alain/0000-0002-0438-2793	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038912] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR38912] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Border WA, 1997, KIDNEY INT, V51, P1388, DOI 10.1038/ki.1997.190; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Chen YR, 1998, ONCOGENE, V17, P173, DOI 10.1038/sj.onc.1201941; Chung KY, 1996, J BIOL CHEM, V271, P3272, DOI 10.1074/jbc.271.6.3272; Clark IM, 1997, BIOCHEM J, V324, P611, DOI 10.1042/bj3240611; COCKAYNE D, 1988, BIOCHEMISTRY-US, V27, P2736, DOI 10.1021/bi00408a013; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; HATA RI, 1995, CELL BIOL INT, V19, P735, DOI 10.1006/cbir.1995.1124; HECKMANN M, 1992, FEBS LETT, V310, P79, DOI 10.1016/0014-5793(92)81151-B; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Iozzo RV, 1997, J BIOL CHEM, V272, P5219, DOI 10.1074/jbc.272.8.5219; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kardassis D, 2000, J BIOL CHEM, V275, P41405, DOI 10.1074/jbc.M007896200; KHALIL N, 1991, CIBA F SYMP, V157, P194; Lai CF, 2000, J BIOL CHEM, V275, P36400, DOI 10.1074/jbc.M002131200; Letterio JJ, 1997, CLIN IMMUNOL IMMUNOP, V84, P244, DOI 10.1006/clin.1997.4409; LI LY, 1995, GENE, V164, P229, DOI 10.1016/0378-1119(95)00508-4; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MAUVIEL A, 1995, J BIOL CHEM, V270, P11692, DOI 10.1074/jbc.270.19.11692; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; MUDRYJ M, 1988, NUCLEIC ACIDS RES, V16, P7513, DOI 10.1093/nar/16.15.7513; MURDOCH AD, 1992, J BIOL CHEM, V267, P8544; Nagarajan RP, 1999, J BIOL CHEM, V274, P33412, DOI 10.1074/jbc.274.47.33412; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Pardali E, 2000, J BIOL CHEM, V275, P3552, DOI 10.1074/jbc.275.5.3552; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; SAITTA B, 1995, EUR J BIOCHEM, V234, P542, DOI 10.1111/j.1432-1033.1995.542_b.x; SAITTA B, 1994, EUR J BIOCHEM, V223, P675, DOI 10.1111/j.1432-1033.1994.tb19040.x; SANDMEYER S, 1981, J BIOL CHEM, V256, P5022; Taylor LM, 2000, J BIOL CHEM, V275, P16709, DOI 10.1074/jbc.275.22.16709; TRUTER S, 1992, J BIOL CHEM, V267, P25389; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Vindevoghel L, 1998, J BIOL CHEM, V273, P13053, DOI 10.1074/jbc.273.21.13053; Vindevoghel L, 1997, J BIOL CHEM, V272, P10196; Vindevoghel L, 1998, P NATL ACAD SCI USA, V95, P14769, DOI 10.1073/pnas.95.25.14769; Wong C, 1999, MOL CELL BIOL, V19, P1821; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	50	518	553	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17058	17062		10.1074/jbc.M100754200	http://dx.doi.org/10.1074/jbc.M100754200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279127	hybrid			2022-12-27	WOS:000168730400061
J	Keshvara, L; Benhayon, D; Magdaleno, S; Curran, T				Keshvara, L; Benhayon, D; Magdaleno, S; Curran, T			Identification of reelin-induced sites of tyrosyl phosphorylation on disabled 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; LAMINAR ORGANIZATION; NEURONAL MIGRATION; CYTOSOLIC ADAPTER; BIPOLAR DISORDER; VLDL RECEPTOR; MUTANT MOUSE; PROTEIN; KINASES; BRAIN	The study of mice with spontaneous and targeted mutations has uncovered a signaling pathway that controls neuronal positioning during mammalian brain development. Mice with disruptions in reelin, dab1, or both vldlr and apoER2 are ataxic, and they exhibit severe lamination defects within several brain structures. Reelin is a secreted extracellular protein that binds to the very low density lipoprotein receptor and the apolipoprotein E receptor 2 on the surface of neurons. Disabled-1 (Dab1), an intracellular adapter protein containing a PTB (phosphotyrosine binding) domain, is tyrosyl-phosphorylated during embryogenesis, but it accumulates in a hypophosphorylated form in mice lacking Reelin or both very low density lipoprotein receptor and apolipoprotein E receptor 2, Dab1 is rapidly phosphorylated when neurons isolated from embryonic brains are stimulated with Reelin, and several tyrosines have been implicated in this response. Mice with phenylalanine substitutions of all five tyrosines (Tyr(185), Tyr(198), Tyr(200), Tyr(220), and Tyr(232)) exhibit a reeler phenotype, implying that tyrosine phosphorylation is critical for Dab1 function. Here we report that, although Src can phosphorylate all five tyrosines in vitro, Tyr(198) and Tyr(220) represent the major sites of Reelin-induced Dab1 phosphorylation in embryonic neurons.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Univ Tennessee, Dept Anat & Neurobiol, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Curran, T (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	fos1@aol.com	Curran, Tom/D-7515-2011; Curran, Thomas/AAE-7631-2019; Curran, Tom/C-1164-2008; Curran, Tom/F-5234-2018	Curran, Thomas/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036558] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA21765] Funding Source: Medline; NINDS NIH HHS [R01-NS36558] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHEN WJ, 1990, J BIOL CHEM, V265, P3116; D'Arcangelo G, 1998, BIOESSAYS, V20, P235, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;235::AID-BIES7&gt;3.0.CO;2-Q; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; LUO KX, 1991, METHOD ENZYMOL, V201, P149; MORI S, 1993, EMBO J, V12, P2257, DOI 10.1002/j.1460-2075.1993.tb05879.x; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Rice DS, 1998, DEVELOPMENT, V125, P3719; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; WEST MHP, 1984, ELECTROPHORESIS, V5, P133, DOI 10.1002/elps.1150050302; Yoneshima H, 1997, NEUROSCI RES, V29, P217, DOI 10.1016/S0168-0102(97)00088-6; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	32	106	115	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16008	16014		10.1074/jbc.M101422200	http://dx.doi.org/10.1074/jbc.M101422200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279201	hybrid			2022-12-27	WOS:000168623100060
J	Radaev, S; Motyka, S; Fridman, WH; Sautes-Fridman, C; Sun, PD				Radaev, S; Motyka, S; Fridman, WH; Sautes-Fridman, C; Sun, PD			The structure of a human type III Fc gamma receptor in complex with Fc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VARIANT ANTIDANSYL ANTIBODIES; LOW-AFFINITY RECEPTOR; EPSILON-RI-ALPHA; IGG BINDING-SITE; CRYSTAL-STRUCTURE; MOLECULAR REPLACEMENT; MONOCLONAL-ANTIBODY; DOMAIN; FRAGMENT; IDENTIFICATION	Fc gamma receptors mediate antibody-dependent inflammatory responses and cytotoxicity as well as certain autoimmune dysfunctions. Here we report the crystal structure of a human Fc receptor (Fc gamma RIIIB) in complex with an Fc fragment of human IgG1 determined from orthorhombic and hexagonal crystal forms at 3.0- and 3.5-Angstrom resolution, respectively. The refined structures from the two crystal forms are nearly identical with no significant discrepancies between the coordinates. Regions of the C-terminal domain of Fc gamma RIII, including the BC, C'E, FG loops, and the C' beta -strand, bind asymmetrically to the lower hinge region, residues Leu(234)-Pro(238), Of both Fe chains creating a 1:1 receptor-ligand stoichiometry. Minor conformational changes are observed in both the receptor and Fc upon complex formation. Hydrophobic residues, hydrogen bonds, and salt bridges are distributed throughout the receptor le interface. Sequence comparisons of the receptor-ligand interface residues suggest a conserved binding mode common to all members of immunoglobulin-like Fc receptors, Structural comparison between Fc gamma RIII.Fc and Fc epsilon RI.Fc complexes highlights the differences in ligand recognition between the high and low affinity receptors, Although not in direct contact with the receptor, the carbohydrate attached to the conserved glycosylation residue Asn(297) On Fc may stabilize the conformation of the receptor-binding epitope on Fc. An antibody-Fc gamma RIII model suggests two possible ligand-induced receptor aggregations.	NIAID, Struct Biol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; Johns Hopkins Univ, Sch Med, Biochem Cellular & Mol Biol Program, Baltimore, MD 21205 USA; Inst Curie, INSERM, U255, Lab Cellular & Clin Immunol, F-75005 Paris, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Sun, PD (corresponding author), NIAID, Struct Biol Sect, Immunogenet Lab, NIH, 12441 Parklawn Dr, Rockville, MD 20852 USA.			fridman, wolf herman/0000-0002-1332-0973; sautes-fridman, catherine/0000-0003-1735-8722	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000853, ZIAAI000853] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOROS P, 1994, J IMMUNOL, V152, P302; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; CHAPPEL MS, 1991, P NATL ACAD SCI USA, V88, P9036, DOI 10.1073/pnas.88.20.9036; Cook JPD, 1997, BIOCHEMISTRY-US, V36, P15579, DOI 10.1021/bi9713005; Corper AL, 1997, NAT STRUCT BIOL, V4, P374, DOI 10.1038/nsb0597-374; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Galon J, 1997, EUR J IMMUNOL, V27, P1928, DOI 10.1002/eji.1830270816; Galon J, 1996, J IMMUNOL, V157, P1184; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; HARRIS LJ, 1992, NATURE, V360, P369, DOI 10.1038/360369a0; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; Henry AJ, 1997, BIOCHEMISTRY-US, V36, P15568, DOI 10.1021/bi971299+; HIBBS ML, 1994, J IMMUNOL, V152, P4466; HULETT MD, 1995, J BIOL CHEM, V270, P21188, DOI 10.1074/jbc.270.36.21188; HULETT MD, 1994, J BIOL CHEM, V269, P15287; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; JEFFERIS R, 1995, IMMUNOL LETT, V44, P111, DOI 10.1016/0165-2478(94)00201-2; KATO K, 1991, BIOCHEMISTRY-US, V30, P6604, DOI 10.1021/bi00240a033; KATO K, 1991, BIOCHEMISTRY-US, V30, P270, DOI 10.1021/bi00215a037; Kato K, 2000, J MOL BIOL, V295, P213, DOI 10.1006/jmbi.1999.3351; KIMBERLY RP, 1990, J EXP MED, V171, P1239, DOI 10.1084/jem.171.4.1239; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LUND J, 1991, J IMMUNOL, V147, P2657; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Powell MS, 1999, IMMUNOL LETT, V68, P17, DOI 10.1016/S0165-2478(99)00025-5; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Sondermann P, 1999, EMBO J, V18, P1095, DOI 10.1093/emboj/18.5.1095; Tamm A, 1997, Int Rev Immunol, V16, P57, DOI 10.3109/08830189709045703; Tamm A, 1996, J BIOL CHEM, V271, P3659; Unkeless J C, 1995, Semin Immunol, V7, P37, DOI 10.1016/1044-5323(95)90006-3; ZHAN GY, 2000, IMMUNITY, V13, P387	46	293	378	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16469	16477		10.1074/jbc.M100350200	http://dx.doi.org/10.1074/jbc.M100350200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11297532	hybrid			2022-12-27	WOS:000168623100120
J	Stuehr, D; Pou, S; Rosen, GM				Stuehr, D; Pou, S; Rosen, GM			Oxygen reduction by nitric-oxide synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ELECTRON FLOW-THROUGH; SUPEROXIDE GENERATION; L-ARGININE; CHROMOSOMAL LOCALIZATION; HEME; TETRAHYDROBIOPTERIN; DOMAIN; BRAIN; PEROXYNITRITE; MECHANISM		Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA; Univ Maryland, Ctr Med Biotechnol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Cleveland Clinic Foundation; University System of Maryland; University of Maryland Baltimore	Rosen, GM (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 725 W Lombard St, Baltimore, MD 21201 USA.	grosen@umaryland.edu			NCI NIH HHS [CA-53914, CA-69538] Funding Source: Medline; NCRR NIH HHS [RR-12257] Funding Source: Medline; NIGMS NIH HHS [GM-51491] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA053914, R29CA053914, R01CA069538] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abu-Soud HM, 2000, J BIOL CHEM, V275, P17349, DOI 10.1074/jbc.M000050200; AbuSoud HM, 1997, J BIOL CHEM, V272, P17349, DOI 10.1074/jbc.272.28.17349; ABUSOUD HM, 1994, J BIOL CHEM, V269, P32318; ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Adak S, 2000, J BIOL CHEM, V275, P33554, DOI 10.1074/jbc.M004337200; Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; BIELSKI BHJ, 1977, J PHYS CHEM-US, V81, P1048, DOI 10.1021/j100526a005; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; CHARTRAIN NA, 1994, J BIOL CHEM, V269, P6765; Chen PF, 2000, J BIOL CHEM, V275, P13155, DOI 10.1074/jbc.275.17.13155; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; CULCASI M, 1994, J BIOL CHEM, V269, P12589; Daff S, 1999, J BIOL CHEM, V274, P30589, DOI 10.1074/jbc.274.43.30589; DAWSON TM, 1991, P NATL ACAD SCI USA, V88, P7797, DOI 10.1073/pnas.88.17.7797; Day BJ, 1999, P NATL ACAD SCI USA, V96, P12760, DOI 10.1073/pnas.96.22.12760; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; FINKELSTEIN E, 1980, J AM CHEM SOC, V102, P4994, DOI 10.1021/ja00535a029; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Gorren ACF, 2000, BIOCHEMISTRY-US, V39, P11763, DOI 10.1021/bi0007775; Grisham MB, 1998, FREE RADICAL BIO MED, V25, P404, DOI 10.1016/S0891-5849(98)00094-X; GUENGERICH FP, 1984, ACCOUNTS CHEM RES, V17, P9, DOI 10.1021/ar00097a002; Haber F., 1934, P R SOC LOND A, V147, P332, DOI [10.1098/rspa.1934.0221, DOI 10.1098/RSPA.1934.0221, DOI 10.1098/rspa.1934.0221]; HALL AV, 1994, J BIOL CHEM, V269, P33082; HEINZEL B, 1992, BIOCHEM J, V281, P627, DOI 10.1042/bj2810627; HEVEL JM, 1991, J BIOL CHEM, V266, P22789; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; Kaufman S., 1974, MOL MECH OXYGEN ACTI, P285; KLATT P, 1992, J BIOL CHEM, V267, P11374; Lane P, 1999, SEMIN NEPHROL, V19, P215; List BM, 1997, BIOCHEM J, V323, P159, DOI 10.1042/bj3230159; Margolis AS, 2000, BBA-GEN SUBJECTS, V1524, P253, DOI 10.1016/S0304-4165(00)00167-7; MARLETTA MA, 1993, ADV EXP MED BIOL, V338, P281; MARSDEN PA, 1994, GENOMICS, V19, P183, DOI 10.1006/geno.1994.1039; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; Martasek P, 1996, BIOCHEM BIOPH RES CO, V219, P359, DOI 10.1006/bbrc.1996.0238; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Massey V., 1973, OXIDASES RELATED RED, P25; Masters BSS, 1996, FASEB J, V10, P552, DOI 10.1096/fasebj.10.5.8621055; Matsuda H, 1999, BBA-GEN SUBJECTS, V1473, P345, DOI 10.1016/S0304-4165(99)00193-2; Miller RT, 1999, BIOCHEM BIOPH RES CO, V265, P184, DOI 10.1006/bbrc.1999.1643; Miller RT, 1997, BIOCHEMISTRY-US, V36, P15277, DOI 10.1021/bi972022c; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; Nishida CR, 1998, J BIOL CHEM, V273, P5566, DOI 10.1074/jbc.273.10.5566; Noble MA, 1999, BIOCHEMISTRY-US, V38, P16413, DOI 10.1021/bi992150w; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; POU S, 1995, BBA-GEN SUBJECTS, V1244, P62, DOI 10.1016/0304-4165(94)00197-6; POU S, 1992, J BIOL CHEM, V267, P24173; Pou S, 1999, J BIOL CHEM, V274, P9573, DOI 10.1074/jbc.274.14.9573; Presta A, 1998, BIOCHEMISTRY-US, V37, P298, DOI 10.1021/bi971944c; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; Richeson CE, 1998, J AM CHEM SOC, V120, P7211, DOI 10.1021/ja980871x; ROBINSON LJ, 1994, GENOMICS, V19, P350, DOI 10.1006/geno.1994.1068; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Roman LJ, 2000, J BIOL CHEM, V275, P21914, DOI 10.1074/jbc.M002449200; Rosen GM, 1995, NEUROLOGIST, V1, P311; ROSEN GM, 1984, P NATL ACAD SCI-BIOL, V81, P7269, DOI 10.1073/pnas.81.23.7269; Rusche KM, 2001, J BIOL CHEM, V276, P421, DOI 10.1074/jbc.M006860200; Santolini J, 2001, J BIOL CHEM, V276, P1233, DOI 10.1074/jbc.M006858200; Sato H, 1998, BIOCHEM BIOPH RES CO, V253, P845, DOI 10.1006/bbrc.1998.9851; SCHMIDT HHHW, 1991, P NATL ACAD SCI USA, V88, P365, DOI 10.1073/pnas.88.2.365; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; STUEHR DJ, 1991, J BIOL CHEM, V266, P6259; Tantillo DJ, 2000, J AM CHEM SOC, V122, P536, DOI 10.1021/ja991876c; VANDERVLIET A, 1994, FEBS LETT, V339, P89, DOI 10.1016/0014-5793(94)80391-9; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vasquez-Vivar J, 1999, J BIOL CHEM, V274, P26736, DOI 10.1074/jbc.274.38.26736; VasquezVivar J, 1997, BIOCHEMISTRY-US, V36, P11293, DOI 10.1021/bi971475e; VasquezVivar J, 1997, FEBS LETT, V403, P127, DOI 10.1016/S0014-5793(97)00036-7; Wei CC, 2001, J BIOL CHEM, V276, P315, DOI 10.1074/jbc.M008441200; WHITE RE, 1994, CYTOCHROME P450, P333; Witteveen CFB, 1998, BIOCHEM BIOPH RES CO, V250, P36, DOI 10.1006/bbrc.1998.8807; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Xia Y, 1998, J BIOL CHEM, V273, P22635, DOI 10.1074/jbc.273.35.22635; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954; XU WM, 1993, CYTOGENET CELL GENET, V64, P62, DOI 10.1159/000133562	81	322	332	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14533	14536		10.1074/jbc.R100011200	http://dx.doi.org/10.1074/jbc.R100011200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279231	hybrid			2022-12-27	WOS:000168528800001
J	Yada, T; Sugiura, R; Kita, A; Itoh, Y; Lu, YB; Hong, YJ; Kinoshita, T; Shuntoh, H; Kuno, T				Yada, T; Sugiura, R; Kita, A; Itoh, Y; Lu, YB; Hong, YJ; Kinoshita, T; Shuntoh, H; Kuno, T			Its8, a fission yeast homolog of Mcd4 and Pig-n, is involved in GPI anchor synthesis and shares an essential function with calcineurin in cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; CELL INTEGRITY; CYCLOSPORINE-A; FIRST STEP; GENE; GLYCOSYLPHOSPHATIDYLINOSITOL; BIOSYNTHESIS; EXPRESSION	In fission yeast, calcineurin is required for cytokinesis and ion homeostasis; however, most of its physiological roles remain obscure. To identify genes that share an essential function with calcineurin, we screened for mutations that confer sensitivity to the calcineurin inhibitor FK506 and high temperature and isolated the mutant its8-1. its8(+) encodes a homolog of the budding yeast MCD4 and human Pig-n that are involved in glycosylphosphatidylinositol (GPI) anchor synthesis. Consistently, reduced inositol labeling of proteins suggested impaired GPI anchor synthesis in its8-1 mutants. The temperature upshift induced a further decrease in inositol labeling and caused dramatic increases in the frequency of septation in its8-1 mutants. BE49385A, an inhibitor of MCD4 and Pig-n, also increased the septation index of the wild-type cell. Osmotic stabilization suppressed these morphological defects, indicating that cell wall weakness caused by impaired GPI anchor synthesis resulted in abnormal cytokinesis. Furthermore, calcineurin-deleted cells exhibited hypersensitivity to BE49385A, and FK506 exacerbated the cytokinesis defects of the its8-1 mutant, Thus, calcineurin and Its8 may share an essential function in cytokinesis and cell viability through the regulation of cell wall integrity.	Kobe Univ, Sch Med, Dept Pharmacol, Chuo Ku, Kobe, Hyogo 6500017, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, Suita, Osaka 5650871, Japan; Kobe Univ, Sch Med, Fac Hlth Sci, Kobe, Hyogo 6540142, Japan	Kobe University; Osaka University; Kobe University	Kuno, T (corresponding author), Kobe Univ, Sch Med, Dept Pharmacol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	tkuno@kobe-u.ac.jp	Kinoshita, Taroh/C-7353-2009					Arellano M, 1999, J CELL SCI, V112, P3569; BENGHEZAL M, 1995, J CELL BIOL, V130, P1333, DOI 10.1083/jcb.130.6.1333; Canivenc-Gansel E, 1998, GLYCOBIOLOGY, V8, P761, DOI 10.1093/glycob/8.8.761; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; CONZELMANN A, 1988, EMBO J, V7, P2233, DOI 10.1002/j.1460-2075.1988.tb03063.x; CONZELMANN A, 1990, EMBO J, V9, P653, DOI 10.1002/j.1460-2075.1990.tb08157.x; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; Gaynor EC, 1999, MOL BIOL CELL, V10, P627, DOI 10.1091/mbc.10.3.627; HAMBURGER D, 1995, J CELL BIOL, V129, P629, DOI 10.1083/jcb.129.3.629; HELM R, 1995, NATURE, V373, P663; HIROSE S, 1992, J BIOL CHEM, V267, P16968; Hong YJ, 1999, J BIOL CHEM, V274, P35099, DOI 10.1074/jbc.274.49.35099; Ishiguro J, 1997, J BACTERIOL, V179, P7653, DOI 10.1128/jb.179.24.7653-7662.1997; LEIDICH SD, 1995, METHOD ENZYMOL, V250, P560; LEIDICH SD, 1994, J BIOL CHEM, V269, P10193; Leidich SD, 1996, J BIOL CHEM, V271, P27829, DOI 10.1074/jbc.271.44.27829; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LIU Y, 1991, MOL GEN GENET, V227, P52, DOI 10.1007/BF00260706; LU CF, 1995, J CELL BIOL, V128, P333, DOI 10.1083/jcb.128.3.333; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MAZUR P, 1995, MOL CELL BIOL, V15, P5671; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; Mondesert G, 1996, J CELL BIOL, V132, P137, DOI 10.1083/jcb.132.1.137; Mondesert G, 1997, GENETICS, V147, P421; MORENO S, 1991, METHOD ENZYMOL, V194, P795; PLOCHOCKAZULINSKA D, 1995, J BIOL CHEM, V270, P24794, DOI 10.1074/jbc.270.42.24794; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SCHONBACHLER M, 1995, EMBO J, V14, P1637, DOI 10.1002/j.1460-2075.1995.tb07152.x; Sugiura R, 1999, NATURE, V399, P479, DOI 10.1038/20951; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; Sutterlin C, 1998, BIOCHEM J, V332, P153; Sutterlin C, 1997, EMBO J, V16, P6374, DOI 10.1093/emboj/16.21.6374; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tiede A, 1999, BIOL CHEM, V380, P503, DOI 10.1515/BC.1999.066; Toda T, 1996, MOL CELL BIOL, V16, P6752; Tujioka H, 1998, BIOCHEM BIOPH RES CO, V251, P737, DOI 10.1006/bbrc.1998.9542; VANDENKAPTEYN JC, 1999, BIOCHIM BIOPHYS ACTA, V1426, P373; Wang YX, 1996, MOL BIOL CELL, V7, P1375, DOI 10.1091/mbc.7.9.1375; YAMAGUCHI H, 1982, J ANTIBIOT, V35, P210, DOI 10.7164/antibiotics.35.210; YOSHIDA T, 1994, J CELL SCI, V107, P1725; Zhao C, 1998, MOL CELL BIOL, V18, P1013, DOI 10.1128/MCB.18.2.1013	41	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13579	13586		10.1074/jbc.M009260200	http://dx.doi.org/10.1074/jbc.M009260200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11297516	hybrid			2022-12-27	WOS:000168356600012
J	Biagini, GA; Knodler, LA; Saliba, KJ; Kirk, K; Edwards, MR				Biagini, GA; Knodler, LA; Saliba, KJ; Kirk, K; Edwards, MR			Na+-dependent pH regulation by the amitochondriate protozoan parasite Giardia intestinalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; H+-ATPASE; INTRACELLULAR PH; PLASMA-MEMBRANE; CYTOPLASMIC PH; GASTROINTESTINAL PH; LEISHMANIA-DONOVANI; CRITHIDIA-LUCILIAE; TRYPANOSOMA-CRUZI; TRANSIT TIMES	Giardia intestinalis is a pathogenic fermentative parasite, which inhabits the gastrointestinal tract of animals and humans. G. intestinalis trophozoites are exposed to acidic fluctuations in vivo and must also cope with acidic metabolic endproducts. In this study, a combination of independent techniques (UP NMR spectroscopy, distribution of the weak acid pH marker 5,5-dimethyl-2,4-oxazolidinedione (DMO) and the fluorescent pH indicator 2 ' ,7 ' -bis (carboxyethyl)-5,6-carboxyfluorescein (BCECF)) were used to show that G. intestinalis trophozoites exposed to an extracellular pH range of 6.0-7.5 maintain their cytosolic pH (pH(i)) within the range 6.7-7.1. Maintenance of the resting pH(i) was Na+-dependent but unaffected by amiloride (or analogs thereof). Recovery of pH, from an intracellular acidosis was also Na+-dependent, with the rate of recovery varying with the extracellular Na+ concentration in a saturable manner (K-m = 18 mm; V-max = 10 mM H+ min(-1)). The recovery of pH. from an acid load was inhibited by amiloride but unaffected by a number of its analogs. The postulated involvement of one or more Na+/H+ exchanger(s) in the regulation of pH(i) in G. intestinalis is discussed.	Univ New S Wales, Sch Biochem & Mol Genet, Sydney, NSW 2052, Australia; Australian Natl Univ, Fac Sci, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia	University of New South Wales Sydney; Australian National University	Biagini, GA (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.		Saliba, Kevin J/C-9166-2009; Biagini, Giancarlo A/F-3449-2011; Kirk, Kiaran/C-8299-2009	Saliba, Kevin J/0000-0003-3345-8440; Biagini, Giancarlo A/0000-0001-6356-6595; Kirk, Kiaran/0000-0002-5613-2622; Knodler, Leigh/0000-0002-3028-2198				ADAM RD, 1991, MICROBIOL REV, V55, P706, DOI 10.1128/MMBR.55.4.706-732.1991; Benchimol M, 1998, BIOCHEM J, V332, P695, DOI 10.1042/bj3320695; BOSIA A, 1993, J CELL PHYSIOL, V154, P527, DOI 10.1002/jcp.1041540311; Brown DM, 1998, INT J PARASITOL, V28, P149, DOI 10.1016/S0020-7519(97)00172-0; DuBose TD, 1999, CURR OPIN NEPHROL HY, V8, P597, DOI 10.1097/00041552-199909000-00011; EDWARDS MR, 1989, MOL BIOCHEM PARASIT, V37, P19, DOI 10.1016/0166-6851(89)90098-4; Embley TM, 1998, CURR OPIN GENET DEV, V8, P624, DOI 10.1016/S0959-437X(98)80029-4; FALLINGBORG J, 1990, J PEDIATR GASTR NUTR, V11, P211, DOI 10.1097/00005176-199008000-00010; FALLINGBORG J, 1990, ALIMENT PHARM THERAP, V4, P247, DOI 10.1111/j.1365-2036.1990.tb00469.x; FARTHING MJG, 1994, GIARDIA: FROM MOLECULES TO DISEASE, P15; Forgac M, 1999, J BIOENERG BIOMEMBR, V31, P57, DOI 10.1023/A:1005496530380; GLASER TA, 1988, P NATL ACAD SCI USA, V85, P7602, DOI 10.1073/pnas.85.20.7602; GRINSTEIN S, 1984, J GEN PHYSIOL, V83, P341, DOI 10.1085/jgp.83.3.341; GROTE R, 1990, MOL BIOCHEM PARASIT, V42, P109, DOI 10.1016/0166-6851(90)90118-6; IGARASHI P, 1987, J BIOL CHEM, V262, P860; JIANG SP, 1994, J CELL PHYSIOL, V159, P60, DOI 10.1002/jcp.1041590109; KINSELLA JL, 1987, J BIOL CHEM, V262, P7092; KIRK K, 1986, J MAGN RESON, V70, P484, DOI 10.1016/0022-2364(86)90141-1; KNODLER LA, 1994, EXP PARASITOL, V79, P117, DOI 10.1006/expr.1994.1071; Lanfredi-Rangel A, 1999, PARASITOL RES, V85, P951, DOI 10.1007/s004360050665; Moreno SNJ, 1998, BIOCHEM J, V330, P853; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; ORLOWSKI J, 1996, NAPLUS HPLUS EXCHANG; PADAN E, 1981, BIOCHIM BIOPHYS ACTA, V650, P151, DOI 10.1016/0304-4157(81)90004-6; RINDLER MJ, 1981, J BIOL CHEM, V256, P820; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; SCHOFIELD PJ, 1991, MOL BIOCHEM PARASIT, V45, P39, DOI 10.1016/0166-6851(91)90025-2; SERRANO R, 1988, BIOCHIM BIOPHYS ACTA, V947, P1, DOI 10.1016/0304-4157(88)90017-2; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; TERKUILE BH, 1992, MOL BIOCHEM PARASIT, V55, P21, DOI 10.1016/0166-6851(92)90123-2; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; THOMAS JA, 1982, INTRACELLULAR PH ITS; Vanderheyden N, 1996, BIOCHEM J, V318, P103, DOI 10.1042/bj3180103; VIEIRA L, 1994, J BIOL CHEM, V269, P16254; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; Warren K. S., 1989, New strategies in parasitology. Proceedings of an international symposium sponsored by Glaxo Research, Brocket Hall, Hertfordshire, UK, 22-25 April 1989, P217; WEINMAN SA, 1982, J GEN PHYSIOL, V80, P299, DOI 10.1085/jgp.80.2.299; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	39	11	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					29157	29162		10.1074/jbc.M102728200	http://dx.doi.org/10.1074/jbc.M102728200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11297564	hybrid			2022-12-27	WOS:000170346000071
J	Yamamoto, H; Hinoi, T; Michiue, T; Fukui, A; Usui, H; Janssens, V; Van Hoof, C; Goris, J; Asashima, M; Kikuchi, A				Yamamoto, H; Hinoi, T; Michiue, T; Fukui, A; Usui, H; Janssens, V; Van Hoof, C; Goris, J; Asashima, M; Kikuchi, A			Inhibition of the Wnt signaling pathway by the PR61 subunit of protein phosphatase 2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOMATOUS POLYPOSIS-COLI; GLYCOGEN-SYNTHASE KINASE-3-BETA; APC TUMOR-SUPPRESSOR; F-BOX PROTEIN; BETA-CATENIN; NEGATIVE REGULATOR; AXIS FORMATION; GSK-3-BETA-DEPENDENT PHOSPHORYLATION; FUNCTIONAL INTERACTION; CATALYTIC SUBUNIT	Axin, a negative regulator of the Wnt signaling pathway, forms a complex with glycogen synthase kinase-3 beta (GSK-3 beta), beta -catenin, adenomatous polyposis coli (APC) gene product, and Dvl, and it regulates GSK-3 beta -dependent phosphorylation in the complex and the stability of beta -catenin. Using yeast two-hybrid screening, we found that regulatory subunits of protein phosphatase 2A, PR61 beta and -gamma, interact with Axin. PR61 beta or -gamma formed a complex with Axin in intact cells, and their interaction was direct. The binding site of PR61 beta on Axin was different from those of GSK-3 beta, beta -catenin, APC, and Dvl. Although PR61 beta did not affect the stability of beta -catenin, it inhibited Dvl- and beta -catenin-dependent T cell factor activation in mammalian cells. Moreover, it suppressed beta -catenin-induced axis formation and expression of siamois, a Wnt target gene, in Xenopus embryos, suggesting that PR61 beta acts either at the level of beta -catenin or downstream of it. Taken together with the previous observations that PR61 interacts with APC and functions upstream of beta -catenin, these results demonstrate that PR61 regulates the Wnt signaling pathway at various steps.	Hiroshima Univ, Fac Med, Dept Biochem, Minami Ku, Hiroshima 7348551, Japan; Univ Tokyo, Dept Life Sci Biol, Meguro Ku, Tokyo 1538902, Japan; Univ Tokyo, Crest Project, Meguro Ku, Tokyo 1538902, Japan; Katholieke Univ Leuven, Fac Geneeskunde, Afdeling Biochem, B-3000 Louvain, Belgium	Hiroshima University; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; KU Leuven	Kikuchi, A (corresponding author), Hiroshima Univ, Fac Med, Dept Biochem, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	akikuchi@hiroshima-u.ac.jp	Janssens, Veerle/I-7059-2016; Fukui, Akimasa/F-5284-2011	Janssens, Veerle/0000-0002-6772-8448; 				Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Brannon M, 1999, DEVELOPMENT, V126, P3159; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Dale TC, 1998, BIOCHEM J, V329, P209; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Hino SI, 2001, MOL CELL BIOL, V21, P330, DOI 10.1128/MCB.21.1.330-342.2001; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ikeda S, 2000, ONCOGENE, V19, P537, DOI 10.1038/sj.onc.1203359; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jho EH, 1999, BIOCHEM BIOPH RES CO, V266, P28, DOI 10.1006/bbrc.1999.1760; Kadoya T, 2000, J BIOL CHEM, V275, P37030, DOI 10.1074/jbc.M005984200; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; Kikuchi A, 1999, CELL SIGNAL, V11, P777, DOI 10.1016/S0898-6568(99)00054-6; Kikuchi A, 1999, CYTOKINE GROWTH F R, V10, P255, DOI 10.1016/S1359-6101(99)00017-9; Kikuchi A, 1996, J BIOL CHEM, V271, P588, DOI 10.1074/jbc.271.1.588; Kishida M, 1999, ONCOGENE, V18, P979, DOI 10.1038/sj.onc.1202388; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Okazaki M, 1996, CANCER RES, V56, P2387; Ratcliffe MJ, 2000, J BIOL CHEM, V275, P35680, DOI 10.1074/jbc.C000639200; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sakamoto I, 2000, J BIOL CHEM, V275, P32871, DOI 10.1074/jbc.M004089200; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; SCHARF SR, 1980, DEV BIOL, V79, P181, DOI 10.1016/0012-1606(80)90082-2; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Shibamoto S, 1998, GENES CELLS, V3, P659; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Tago K, 2000, GENE DEV, V14, P1741; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; USUI H, 1988, J BIOL CHEM, V263, P3752; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamamoto H, 1998, MOL CELL BIOL, V18, P2867, DOI 10.1128/MCB.18.5.2867; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; Zolnierowicz S, 1996, BIOCHEM J, V317, P187, DOI 10.1042/bj3170187	67	54	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2001	276	29					26875	26882		10.1074/jbc.M100443200	http://dx.doi.org/10.1074/jbc.M100443200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	454HJ	11297546	hybrid			2022-12-27	WOS:000169966900021
J	Dai, KS; Liew, CC				Dai, KS; Liew, CC			A novel human striated muscle RING zinc finger protein, SMRZ, interacts with SMT3b via its RING domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEINS; HEPATOCELLULAR CARCINOMAS; FREQUENT REARRANGEMENTS; CENTROMERE PROTEIN; CHROMOSOME 1P; GENE; MOTIF; MUTATIONS; PML; EXPRESSION	The RING domain is a conserved zinc finger motif, which serves as a protein-protein interaction interface. Searches of a human heart expressed sequence tag data base for genes encoding the RING domain identified a novel cDNA, named striated muscle RING zinc finger protein (SMRZ). The SMRZ cDNA is 1.9 kilobase pairs in length and encodes a polypeptide of 288 amino acid residues; analysis of the peptide sequence demonstrated an N-terminal RING domain. Fluorescence in situ hybridization localized SMRZ to chromosome 1p33-34. Northern blots demonstrated that SMRZ is expressed exclusively in striated muscle. In the cardiovascular system, SMRZ is more highly expressed in the fetal heart than in the adult heart (slightly higher expression in the ventricle than in the atrium), suggesting that SMRZ is developmentally regulated. SMRZ was found to interact with SMT3b, a ubiquitin-like protein, through the SMRZ-RING domain. This interaction was abolished by mutagenesis of conserved RING domain residues. Transient transfection of SMRZ into C2C12 myoblasts showed localization of SMRZ to the nucleus. These data suggest that SMRZ may play an important role in striated muscle cell embryonic development and perhaps in cell cycle regulation.	Univ Toronto, Inst Med Sci, Toronto, ON M5G 1L5, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada	University of Toronto; University of Toronto	Liew, CC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Cardiovasc Genome Unit, Sch Med, 75 Francis St,Thorn 1326, Boston, MA 02115 USA.	liewcc@tcgu.med.utoronto.ca						Ahn JH, 1998, MOL CELL BIOL, V18, P4899, DOI 10.1128/MCB.18.8.4899; Alkema MJ, 1997, ONCOGENE, V15, P899, DOI 10.1038/sj.onc.1201262; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; BROWN MT, 1993, J CELL BIOL, V123, P387, DOI 10.1083/jcb.123.2.387; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; Cigudosa JC, 1999, GENE CHROMOSOME CANC, V25, P123, DOI 10.1002/(SICI)1098-2264(199906)25:2<123::AID-GCC8>3.0.CO;2-4; Cohen KJ, 1996, MOL CELL BIOL, V16, P5527; Copps K, 1998, EMBO J, V17, P5409, DOI 10.1093/emboj/17.18.5409; COVEY SN, 1986, NUCLEIC ACIDS RES, V14, P623, DOI 10.1093/nar/14.2.623; Dai KS, 1999, J MOL CELL CARDIOL, V31, P1749, DOI 10.1006/jmcc.1999.1011; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; DING SF, 1992, BRIT J CANCER, V65, P809, DOI 10.1038/bjc.1992.173; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; ELBARADI T, 1991, MECH DEVELOP, V35, P155, DOI 10.1016/0925-4773(91)90015-X; EVERETT R, 1995, J VIROL, V69, P7339, DOI 10.1128/JVI.69.11.7339-7344.1995; Everett RD, 1999, J CELL SCI, V112, P4581; Ezaki T, 1996, BRIT J CANCER, V73, P424, DOI 10.1038/bjc.1996.76; Farnebo F, 1999, J CLIN ENDOCR METAB, V84, P3775, DOI 10.1210/jc.84.10.3775; FREEMONT PS, 1993, ANN NY ACAD SCI, V684, P174, DOI 10.1111/j.1749-6632.1993.tb32280.x; FREEMONT PS, 1991, CELL, V64, P483, DOI 10.1016/0092-8674(91)90229-R; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; HENG HHQ, 1993, CHROMOSOMA, V102, P325, DOI 10.1007/BF00661275; HENG HHQ, 1992, P NATL ACAD SCI USA, V89, P9509, DOI 10.1073/pnas.89.20.9509; HWANG DM, 1995, GENOMICS, V30, P293, DOI 10.1006/geno.1995.9874; Hwang DM, 1997, CIRCULATION, V96, P4146; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; Kaplanski C, 1997, INT J CANCER, V72, P248, DOI 10.1002/(SICI)1097-0215(19970717)72:2<248::AID-IJC8>3.0.CO;2-R; KLUG A, 1987, TRENDS BIOCHEM SCI, V12, P464, DOI 10.1016/0968-0004(87)90231-3; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Krause AK, 1997, CANCER GENET CYTOGEN, V94, P138, DOI 10.1016/S0165-4608(96)00223-3; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; LIEW CC, 1994, P NATL ACAD SCI USA, V91, P10645, DOI 10.1073/pnas.91.22.10645; Mannen H, 1996, BIOCHEM BIOPH RES CO, V222, P178, DOI 10.1006/bbrc.1996.0717; Martinez-Noel G, 1999, FEBS LETT, V454, P257, DOI 10.1016/S0014-5793(99)00823-6; MAZEN A, 1989, NUCLEIC ACIDS RES, V17, P4689, DOI 10.1093/nar/17.12.4689; MEEKSWAGNER D, 1986, CELL, V44, P53, DOI 10.1016/0092-8674(86)90484-8; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Nishida T, 2000, EUR J BIOCHEM, V267, P6423, DOI 10.1046/j.1432-1327.2000.01729.x; Okumoto K, 1998, MOL CELL BIOL, V18, P4324, DOI 10.1128/MCB.18.7.4324; Okura T, 1996, J IMMUNOL, V157, P4277; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; Parada LA, 1998, GENE CHROMOSOME CANC, V23, P26; Prikhodko EA, 1998, J VIROL, V72, P684; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; QIAN XQ, 1993, NATURE, V365, P277, DOI 10.1038/365277a0; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sakakura C, 1999, BRIT J CANCER, V80, P2034, DOI 10.1038/sj.bjc.6690638; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; SCHWABE JWR, 1991, TRENDS BIOCHEM SCI, V16, P291, DOI 10.1016/0968-0004(91)90121-B; Schwarz SE, 1998, P NATL ACAD SCI USA, V95, P560, DOI 10.1073/pnas.95.2.560; Tsukamoto K, 1998, CANCER-AM CANCER SOC, V82, P317, DOI 10.1002/(SICI)1097-0142(19980115)82:2<323::AID-CNCR11>3.3.CO;2-P; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; YULUG IG, 1995, GENOMICS, V27, P544, DOI 10.1006/geno.1995.1090; Zimonjic DB, 1999, HEPATOLOGY, V29, P1208, DOI 10.1002/hep.510290410	64	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23992	23999		10.1074/jbc.M011208200	http://dx.doi.org/10.1074/jbc.M011208200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11283016	hybrid			2022-12-27	WOS:000169531100102
J	Lin, HH; Stacey, M; Saxby, C; Knott, V; Chaudhry, Y; Evans, D; Gordon, S; McKnight, AJ; Handford, P; Lea, S				Lin, HH; Stacey, M; Saxby, C; Knott, V; Chaudhry, Y; Evans, D; Gordon, S; McKnight, AJ; Handford, P; Lea, S			Molecular analysis of the epidermal growth factor-like short consensus repeat domain-mediated protein-protein interactions - Dissection of the CD97-CD55 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DECAY-ACCELERATING FACTOR; TRANSMEMBRANE RECEPTOR CD97; ACTIVATION ANTIGEN CD97; EPSTEIN-BARR-VIRUS; EGF-LIKE DOMAINS; MARFAN-SYNDROME; LIGAND CD55; FACTOR-IX; BINDING; CALCIUM	Epidermal growth factor-like (EGF) and short consensus repeat (SCR) domains are commonly found in cell sill-face and soluble proteins that mediate specific protein-protein recognition events. Unlike the immunoglobulin (Ig) superfamily, very Little is known about the general properties of intermolecuIar interactions encoded by these common modules, and in particular, how specificity of binding is achieved. We have dissected the binding of CD97 (a member of the EGF-TM7 family) to the complement regulator CD55, two cell surface modular proteins that contain EGF and SCR domains, respectively. We demonstrate that the interaction is mediated solely by these domains and is characterized by a low affinity (86 mum) and rapid off-rate (at least 0.6 s(-1)). The interaction is Ca2+-dependent but is unaffected by glycosylation of the EGF domains. Using biotinylated multimerized peptides in cell binding assays and surface plasmon resonance, we show that a CD97-related EGF-TM7 molecule (termed EMR2), differing by only three amino acids within the EGF domains, binds CD55 with a K-D at least an order of magnitude weaker than that of CD97, These results suggest that low affinity cell-cell interactions may be a general feature of highly expressed cell surface proteins and that specificity of SCR-EGF binding can be finely tuned by a small number of amino acid changes on the EGF module surface.	Univ Oxford, Dept Biochem, Mol Biophys Lab, Oxford OX1 3QU, England; Univ Oxford, Dept Biochem, Div Mol & Cellular Biochem, Oxford OX1 3QU, England; Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; Kings Coll London Hosp, Inst Liver Studies, Dept Clin Sci, London WC2R 2LS, England	University of Oxford; University of Oxford; University of Oxford; University of Glasgow; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Lea, S (corresponding author), Univ Oxford, Dept Biochem, Mol Biophys Lab, S Parks Rd, Oxford OX1 3QU, England.	susan@biop.ox.ac.uk	Evans, David/C-7553-2012; LIN, Hsi-Hsien/N-1488-2015; Lea, Susan M/B-7678-2009	Lea, Susan M/0000-0001-9287-8053; Evans, David J./0000-0002-1315-4258				Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Brown MH, 1995, EUR J IMMUNOL, V25, P3222, DOI 10.1002/eji.1830251204; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Casasnovas JM, 1999, EMBO J, V18, P2911, DOI 10.1093/emboj/18.11.2911; CHARREAU B, 1994, TRANSPLANTATION, V58, P1222, DOI 10.1097/00007890-199412150-00015; DAVIS SJ, 1995, J BIOL CHEM, V270, P369, DOI 10.1074/jbc.270.1.369; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; DYKMAN TR, 1984, J EXP MED, V159, P691, DOI 10.1084/jem.159.3.691; EICHLER W, 1994, SCAND J IMMUNOL, V39, P111, DOI 10.1111/j.1365-3083.1994.tb03348.x; Eichler W, 1997, TISSUE ANTIGENS, V50, P429, DOI 10.1111/j.1399-0039.1997.tb02897.x; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; Gray JX, 1996, J IMMUNOL, V157, P5438; Hamann J, 1999, ARTHRITIS RHEUM-US, V42, P650, DOI 10.1002/1529-0131(199904)42:4<650::AID-ANR7>3.0.CO;2-S; HAMANN J, 1995, J IMMUNOL, V155, P1942; Hamann J, 1998, EUR J IMMUNOL, V28, P1701, DOI 10.1002/(SICI)1521-4141(199805)28:05<1701::AID-IMMU1701>3.0.CO;2-2; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; KUTT H, 1989, BIOCHIM BIOPHYS ACTA, V1009, P229, DOI 10.1016/0167-4781(89)90107-3; Lea SM, 1998, J BIOL CHEM, V273, P30443, DOI 10.1074/jbc.273.46.30443; Lin HH, 2000, GENOMICS, V67, P188, DOI 10.1006/geno.2000.6238; LOWELL CA, 1989, J EXP MED, V170, P1931, DOI 10.1084/jem.170.6.1931; MAYHEW M, 1992, PROTEIN ENG, V5, P489, DOI 10.1093/protein/5.6.489; McGettrick AJ, 2000, HUM MOL GENET, V9, P1987, DOI 10.1093/hmg/9.13.1987; McKnight AJ, 1996, IMMUNOL TODAY, V17, P283, DOI 10.1016/0167-5699(96)80546-9; McKnight AJ, 1998, J LEUKOCYTE BIOL, V63, P271, DOI 10.1002/jlb.63.3.271; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; MOORE MD, 1991, J VIROL, V65, P3559, DOI 10.1128/JVI.65.7.3559-3565.1991; POST TW, 1990, J IMMUNOL, V144, P740; Powell RM, 1997, J VIROL, V71, P9306, DOI 10.1128/JVI.71.12.9306-9312.1997; RAO Z, 1995, CELL, V82, P131, DOI 10.1016/0092-8674(95)90059-4; REES DJG, 1988, EMBO J, V7, P2053, DOI 10.1002/j.1460-2075.1988.tb03045.x; Reinhardt DP, 2000, J BIOL CHEM, V275, P12339, DOI 10.1074/jbc.275.16.12339; Reinhardt DP, 1997, J BIOL CHEM, V272, P1231, DOI 10.1074/jbc.272.2.1231; Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104; Smallridge RS, 1999, J MOL BIOL, V286, P661, DOI 10.1006/jmbi.1998.2536; SUZUKI K, 1989, J BIOL CHEM, V264, P4872; Werner JM, 2000, J MOL BIOL, V296, P1065, DOI 10.1006/jmbi.1999.3513; Whiteman P, 1998, J BIOL CHEM, V273, P7807, DOI 10.1074/jbc.273.14.7807; WONG WW, 1983, J CLIN INVEST, V72, P685, DOI 10.1172/JCI111018	41	96	98	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24160	24169		10.1074/jbc.M101770200	http://dx.doi.org/10.1074/jbc.M101770200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11297558	hybrid			2022-12-27	WOS:000169531100124
J	Shi, CS; Lee, SB; Sinnarajah, S; Dessauer, CW; Rhee, SG; Kehrl, JH				Shi, CS; Lee, SB; Sinnarajah, S; Dessauer, CW; Rhee, SG; Kehrl, JH			Regulator of G-protein signaling 3 (RGS3) inhibits G beta(1)gamma(2)-induced inositol phosphate production, mitogen-activated protein kinase activation, and Akt activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; HETEROTRIMERIC G-PROTEINS; ALPHA-SUBUNIT; B-LYMPHOCYTES; BINDING; RECEPTORS; PHOSDUCIN; CHEMOTAXIS; PATHWAY; COMPLEX	Regulator of G-protein signaling 3 (RGS3) enhances the intrinsic rate at which G alpha (i) and G alpha (q) hydrolyze GTP to GDP, thereby limiting the duration in which GTP-G alpha (i) and GTP-G alpha (q) can activate effecters. Since GDP-G alpha subunits rapidly combine with free G beta gamma subunits to reform inactive heterotrimeric G-proteins, RGS3 and other RGS proteins may also reduce the amount of G beta gamma subunits available for effector interactions. Although RGS6, RGS7, and RGS11 bind GP, in the absence of a Gy subunit, RGS proteins are not known to directly influence G beta gamma signaling. Here we show that RGS3 binds G beta (1)gamma (2) subunits and limits their ability to trigger the production of inositol phosphates and the activation of Akt and mitogen-activated protein kinase. Go-expression of RGS3 with G beta (1)beta (2) inhibits G beta (1)gamma (2) induced inositol phosphate production and Akt activation in COS-7 cells and mitogen-activated protein kinase activation in HEK 293 cells. The inhibition of G beta (1)gamma (2) signaling does not require an intact RGS domain but depends upon two regions in RGS3 located between acids 313 and 390 and between 391 and 458. Several other RGS proteins do not affect G beta (1)gamma (2) signaling in these assays. Consistent with the in vivo results, RGS3 inhibits G beta gamma -mediated activation of phospholipase C beta in vitro. Thus, RGS3 may limit G beta gamma signaling not only by virtue of its GTPase-activating protein activity for G alpha subunits, but also by directly interfering with the activation of effecters.	NIAID, Immunoregulat Lab, Cell Mol Immunol Sect B, NIH, Bethesda, MD 20892 USA; Univ Texas, Sch Med, Dept Integrat BIol & Pharmacol, Houston, TX 77030 USA; NHLBI, Lab Cell Signaling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kehrl, JH (corresponding author), NIAID, Immunoregulat Lab, Cell Mol Immunol Sect B, NIH, Bldg 10,Rm 11B08, Bethesda, MD 20892 USA.		Kehrl, John/AAE-6292-2019; Dessauer, Carmen/N-6933-2018	Dessauer, Carmen/0000-0003-1210-4280; Kehrl, John/0000-0002-6526-159X	NIGMS NIH HHS [R01 GM060419, R01 GM060419-02, GM 60419] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arai H, 1997, P NATL ACAD SCI USA, V94, P14495, DOI 10.1073/pnas.94.26.14495; Bluml K, 1997, EMBO J, V16, P4908, DOI 10.1093/emboj/16.16.4908; Bowman EP, 1998, J BIOL CHEM, V273, P28040, DOI 10.1074/jbc.273.43.28040; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; CHO HS, 2000, CURR T BIOCHEM RES, V2, P161; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Craft CM, 1998, BIOCHEMISTRY-US, V37, P15758, DOI 10.1021/bi980921a; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Druey KM, 1997, P NATL ACAD SCI USA, V94, P12851, DOI 10.1073/pnas.94.24.12851; Dulin NO, 1999, MOL CELL BIOL, V19, P714; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Hepler JR, 1999, TRENDS PHARMACOL SCI, V20, P376, DOI 10.1016/S0165-6147(99)01369-3; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073/pnas.94.4.1512; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hirschman JE, 1997, J BIOL CHEM, V272, P240; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; Kasahara S, 2000, P NATL ACAD SCI USA, V97, P412, DOI 10.1073/pnas.97.1.412; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; LEE SB, 1993, J BIOL CHEM, V268, P25952; Lin HC, 1998, P NATL ACAD SCI USA, V95, P5057, DOI 10.1073/pnas.95.9.5057; Ma JY, 1997, NEURON, V19, P443, DOI 10.1016/S0896-6273(00)80952-6; Mao JH, 1998, P NATL ACAD SCI USA, V95, P12973, DOI 10.1073/pnas.95.22.12973; Moratz C, 2000, J IMMUNOL, V164, P1829, DOI 10.4049/jimmunol.164.4.1829; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Neill JD, 1997, ENDOCRINOLOGY, V138, P843, DOI 10.1210/en.138.2.843; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Panchenko MP, 1998, J BIOL CHEM, V273, P28298, DOI 10.1074/jbc.273.43.28298; POMBO CM, 1995, NATURE, V377, P750, DOI 10.1038/377750a0; Reif K, 2000, J IMMUNOL, V164, P4720, DOI 10.4049/jimmunol.164.9.4720; Scheschonka A, 2000, MOL PHARMACOL, V58, P719, DOI 10.1124/mol.58.4.719; Srinivasa SP, 1998, J BIOL CHEM, V273, P1529, DOI 10.1074/jbc.273.3.1529; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; Wang TL, 1999, BIOCHEMISTRY-US, V38, P1517, DOI 10.1021/bi982008f; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; YOSHIDA T, 1994, J BIOL CHEM, V269, P24050	42	40	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24293	24300		10.1074/jbc.M100089200	http://dx.doi.org/10.1074/jbc.M100089200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11294858	hybrid			2022-12-27	WOS:000169531100140
J	Haruta, I; Kato, Y; Hashimoto, E; Minjares, C; Kennedy, S; Uto, H; Yamauchi, K; Kobayashi, M; Yusa, S; Muller, U; Hayashi, N; Miyazaki, T				Haruta, I; Kato, Y; Hashimoto, E; Minjares, C; Kennedy, S; Uto, H; Yamauchi, K; Kobayashi, M; Yusa, S; Muller, U; Hayashi, N; Miyazaki, T			Association of AIM, a novel apoptosis inhibitory factor, with hepatitis via supporting macrophage survival and enhancing phagocytotic function of macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; CD8(+) T-CELLS; FAS LIGAND; NOD MICE; DEATH; FAMILY; SUSCEPTIBILITY; PATHOGENESIS; REQUIREMENT; THYMOCYTES	A hallmark of many inflammatory diseases is the destruction of tissue cells by infiltrating hematopoietic cells including lymphocytes, neutrophils, and macrophages. The regulation of apoptosis of both target tissue cells and the infiltrating cells is one of the key events that defines the initiation and the progression of inflammation. However, the precise picture of the apoptosis regulation of the cells at the inflammatory sites is still unclear. We recently isolated a novel apoptosis inhibitory factor, termed AIM, which is secreted exclusively by tissue macrophages. In this report, we present unique characteristics of AIM associated with liver inflammation (hepatitis), identified by introducing an experimental hepatitis in both AIM transgenic mice, which overexpress AIM in the body, and normal mice. First, endogenous AIM expression in macrophages is rapidly increased in response to inflammatory stimuli. Second, AIM appears to inhibit the death of macrophages in the inflammatory regions, judging by the remarkably increased number of macrophages observed in the liver from transgenic mice. In addition, we show that AIM also enhances the phagocytosis by macrophages, which emphasizes the multifunctional character of ATM. All these findings strongly provoke an idea that ATM may play an important role in hepatitis pathogenesis in a sequential manner; first AIM expression is up-regulated by inflammatory stimuli, and then in an autocrine fashion, AIM supports the survival of infiltrating macrophages as well as enhances phagocytosis by macrophages, which may result in an efficient clearance of dead cells and infectious or toxic reagents.	Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75235 USA; Tokyo Womens Med Univ, Inst Gastroenterol, Shinjuku Ku, Tokyo 1628666, Japan; Tokyo Womens Med Univ, Dept Pathol, Shinjuku Ku, Tokyo 1628666, Japan; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Basel Inst Immunol, CH-4005 Basel, Switzerland	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Tokyo Women's Medical University; Tokyo Women's Medical University; Fox Chase Cancer Center	Miyazaki, T (corresponding author), Univ Texas, SW Med Ctr, Ctr Immunol, 6000 Harry Hines Blvd,NA7200, Dallas, TX 75235 USA.	toru.miyazaki@UTSouthwestern.edu						Andre I, 1996, P NATL ACAD SCI USA, V93, P2260, DOI 10.1073/pnas.93.6.2260; Benoist C, 1997, CELL, V89, P1, DOI 10.1016/S0092-8674(00)80174-9; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; CORY S, 1995, ANNU REV IMMUNOL, V13, P513, DOI 10.1146/annurev.iy.13.040195.002501; Crispe IN, 2000, IMMUNOL REV, V174, P47, DOI 10.1034/j.1600-0528.2002.017412.x; Grzybowski J, 1999, Postepy Hig Med Dosw, V53, P75; Hahn CS, 2000, VIROLOGY, V276, P127, DOI 10.1006/viro.2000.0541; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jun HS, 1999, DIABETES, V48, P34, DOI 10.2337/diabetes.48.1.34; Jun HS, 1999, J EXP MED, V189, P347, DOI 10.1084/jem.189.2.347; KAWAGUCHI M, 1988, ACTA OTO-LARYNGOL, P108; Kim S, 2000, J IMMUNOL, V164, P2931, DOI 10.4049/jimmunol.164.6.2931; Kim YH, 1999, EUR J IMMUNOL, V29, P455, DOI 10.1002/(SICI)1521-4141(199902)29:02<455::AID-IMMU455>3.0.CO;2-A; Kondo T, 1997, NAT MED, V3, P409, DOI 10.1038/nm0497-409; LIU W, 2000, CHUNG HUA KAN TSANG, V8, P269; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Miyazaki T, 1999, J EXP MED, V189, P413, DOI 10.1084/jem.189.2.413; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ogawa S, 2000, J GASTROEN HEPATOL, V15, P69, DOI 10.1046/j.1440-1746.2000.02044.x; Papaccio G, 1998, J CELL BIOCHEM, V71, P479, DOI 10.1002/(SICI)1097-4644(19981215)71:4<479::AID-JCB3>3.0.CO;2-6; POMBO CM, 1994, J BIOL CHEM, V269, P26546; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Reed John C., 1995, Current Opinion in Oncology, V7, P541, DOI 10.1097/00001622-199511000-00012; Rosmalen JGM, 2000, LAB INVEST, V80, P23, DOI 10.1038/labinvest.3780004; Rothstein TL, 1996, CURR OPIN IMMUNOL, V8, P362, DOI 10.1016/S0952-7915(96)80126-9; Smith ME, 1998, J NEUROSCI RES, V54, P68, DOI 10.1002/(SICI)1097-4547(19981001)54:1<68::AID-JNR8>3.0.CO;2-F; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Strasser A, 1997, BIOCHIM BIOPHYS ACTA, V1333, P151; TANIDA N, 1992, J BIOCHEM-TOKYO, V112, P616, DOI 10.1093/oxfordjournals.jbchem.a123949; Taya N, 2000, BRIT J HAEMATOL, V110, P89, DOI 10.1046/j.1365-2141.2000.01945.x; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tsuji H, 1999, J IMMUNOL, V162, P1049; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wang B, 1996, EUR J IMMUNOL, V26, P1762, DOI 10.1002/eji.1830260815; WESTWICK JK, 1995, J BIOL CHEM, V270, P22689, DOI 10.1074/jbc.270.39.22689; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yoon JW, 1999, ARCH PHARM RES, V22, P437, DOI 10.1007/BF02979150; Yusa S, 1999, EUR J IMMUNOL, V29, P1086, DOI 10.1002/(SICI)1521-4141(199904)29:04<1086::AID-IMMU1086>3.3.CO;2-O; 季伟, 1999, [中华肝脏病杂志, Chinese Journal of Hepatology], V7, P77	43	46	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22910	22914		10.1074/jbc.M100324200	http://dx.doi.org/10.1074/jbc.M100324200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294859	hybrid			2022-12-27	WOS:000169412700124
J	Nagano, Y; Inaba, T; Furuhashi, H; Sasaki, Y				Nagano, Y; Inaba, T; Furuhashi, H; Sasaki, Y			Trihelix DNA-binding protein with specificities for two distinct cis-elements - Both important for light down-regulated and dark-inducible gene expression in higher plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; DOMAIN; MOTIF; GT-1	The DE1 sequence is a cis-regulatory element necessary and sufficient for light down-regulated and dark-inducible expression of the pea GTPase pra2 gene. This sequence does not show any sequence similarity to the previously reported ones involved in light regulated gene expression. A one-hybrid screen isolated a cDNA encoding a DNA-binding protein, named DF1, with specificity for the DE1 sequence 5'-TACAGT. DF1 has domains similar to the trihelix DNA-binding domain found in the GT-1 and GT-2 proteins, which are plant transcription factors. The DE1-binding domain of DF1 is most similar to the carboxyl-terminal trihelix domain of the rice GT-2 protein with specificity for the GT2 sequence 5'-GGTAATT, which is also necessary for dark-inducible expression of the rice phyA gene. An electrophoretic mobility shift assay showed that this DNA-binding domain specifically binds to two types of DNA sequences, DE1 and GT2. Additionally, using DF1/GT-1 chimeras, we show that the second and third helices of the trihelix DNA-binding domain of DF1 are responsible for this dual DNA binding specificity. Our results show that DF1 has specificity for the two distinct cis-regulatory elements, both important for light down-regulated and dark-inducible gene expression in higher plants.	Nagoya Univ, Grad Sch Agr Sci, Nagoya, Aichi 4648601, Japan	Nagoya University	Nagano, Y (corresponding author), Nagoya Univ, Grad Sch Agr Sci, Nagoya, Aichi 4648601, Japan.	nagano@agr.nagoya-u.ac.jp	Nagano, Yukio/H-8734-2019	Nagano, Yukio/0000-0001-5030-676X; Inaba, Takehito/0000-0003-1750-454X				DEHESH K, 1990, SCIENCE, V250, P1397, DOI 10.1126/science.2255908; DEHESH K, 1992, EMBO J, V11, P4131, DOI 10.1002/j.1460-2075.1992.tb05506.x; GILMARTIN PM, 1992, PLANT CELL, V4, P839, DOI 10.1105/tpc.4.7.839; HIRATSUKA K, 1994, PLANT CELL, V6, P1805, DOI 10.1105/tpc.6.12.1805; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Inaba T, 1999, PLANT PHYSIOL, V120, P491, DOI 10.1104/pp.120.2.491; Inaba T, 2000, J BIOL CHEM, V275, P19723, DOI 10.1074/jbc.M001337200; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Nagano Y, 2000, PLANT PHYSIOL, V124, P491, DOI 10.1104/pp.124.2.491; NAGANO Y, 1995, P NATL ACAD SCI USA, V92, P6314, DOI 10.1073/pnas.92.14.6314; NAGANO Y, 1993, PLANT CELL PHYSIOL, V34, P447; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; PERISIC O, 1992, PLANT CELL, V4, P831, DOI 10.1105/tpc.4.7.831; Smalle J, 1998, P NATL ACAD SCI USA, V95, P3318, DOI 10.1073/pnas.95.6.3318; Solano R, 1997, J BIOL CHEM, V272, P2889, DOI 10.1074/jbc.272.5.2889; TERZAGHI WB, 1995, ANNU REV PLANT PHYS, V46, P445, DOI 10.1146/annurev.pp.46.060195.002305; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; YOSHIDA K, 1993, P NATL ACAD SCI USA, V90, P6636, DOI 10.1073/pnas.90.14.6636; Zhou DX, 1999, TRENDS PLANT SCI, V4, P210, DOI 10.1016/S1360-1385(99)01418-1	19	33	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22238	22243		10.1074/jbc.M102474200	http://dx.doi.org/10.1074/jbc.M102474200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301338	hybrid			2022-12-27	WOS:000169412700037
J	Nakamura, K; Miyamoto, H; Suzuma, S; Sakamoto, T; Kawai, G; Yamane, K				Nakamura, K; Miyamoto, H; Suzuma, S; Sakamoto, T; Kawai, G; Yamane, K			Minimal functional structure of Escherichia coli 4.5 S RNA required for binding to elongation factor G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION-PARTICLE; SMALL CYTOPLASMIC RNA; EF-G; CRYSTAL-STRUCTURE; BACILLUS-SUBTILIS; 23S RNA; SRP RNA; PROTEIN; DOMAIN; COMPLEX	Escherichia coli cells contain abundant amounts of metabolically stable 4.5 S RNA. Consisting of 114 nucleotides, 4.5 S RNA is structurally homologous to mammalian 7 S RNA, and it plays an essential role in targeting proteins containing signal peptide to the secretory apparatus by forming an signal recognition-like particle with Ffh protein. It also binds independently to protein elongation factor G (EF-G) and functions in the translation process. This RNA contains a phylogenetically conserved RNA domain, the predicted secondary structure of which consists of a hairpin motif with two bulges. We examined the binding activity of mutants with systematic deletions to define the minimal functional interaction domain of 4.5 S RNA that interacts with EF-G. This domain consisted of 35-nucleotides extending from 36 to 70 nucleotides of mature 4.5 S RNA and contained two conserved bulges in which mutations of A47, A60, G61, C62, A63, and A67 diminished binding to EF-G, whereas those at A39, C40, C41, A42, G48, and G49 did not affect binding. These data suggested that the 10 nucleotides in 4.5 S RNA, which are conserved between 4.5 S RNA and 23 S rRNA, have a key role for EF-G: binding. Based on the NMR derived structure of mutant A47U, we further verified that substituting U at A47 causes striking structural changes and the loss of the symmetrical bulge. These results indicate the mechanism by which EF-G interacts with 4.5 S RNA and the importance of the bulge structure for EF-G binding.	Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan; Chiba Inst Technol, Dept Ind Chem, Narashino, Chiba 2750016, Japan	University of Tsukuba; Chiba Institute of Technology	Nakamura, K (corresponding author), Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan.		Sakamoto, Taiichi/V-2389-2019	Sakamoto, Taiichi/0000-0002-1450-9372				Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; BOURGAIZE DB, 1990, J BACTERIOL, V172, P1151, DOI 10.1128/jb.172.2.1151-1154.1990; BOURGAIZE DB, 1987, NATURE, V325, P281, DOI 10.1038/325281a0; BROWN S, 1989, J MOL BIOL, V209, P79, DOI 10.1016/0022-2836(89)90171-X; BROWN S, 1984, J MOL BIOL, V178, P533, DOI 10.1016/0022-2836(84)90237-7; BROWN S, 1987, CELL, V49, P825, DOI 10.1016/0092-8674(87)90620-9; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; ERNST RR, 1987, PRINCIPLES NUCL MAGN, P516; Gowda K, 1997, NUCLEIC ACIDS RES, V25, P2835, DOI 10.1093/nar/25.14.2835; HEUS HA, 1991, SCIENCE, V253, P191, DOI 10.1126/science.1712983; Jovine L, 2000, STRUCTURE, V8, P527, DOI 10.1016/S0969-2126(00)00137-4; Larsen N, 1998, NUCLEIC ACIDS RES, V26, P177, DOI 10.1093/nar/26.1.177; Lentzen G, 1996, RNA, V2, P244; Liljas A, 1995, CURR OPIN STRUC BIOL, V5, P721, DOI 10.1016/0959-440X(95)80003-4; LUIRINK J, 1992, NATURE, V359, P741, DOI 10.1038/359741a0; LUTCKE H, 1995, EUR J BIOCHEM, V228, P531, DOI 10.1111/j.1432-1033.1995.0531m.x; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; NAKAMURA K, 1992, J BACTERIOL, V174, P2185, DOI 10.1128/JB.174.7.2185-2192.1992; Nakamura K, 1999, EUR J BIOCHEM, V259, P543, DOI 10.1046/j.1432-1327.1999.00077.x; NAKAMURA K, 1995, MICROBIOL-SGM, V141, P2965, DOI 10.1099/13500872-141-11-2965; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; PORITZ MA, 1988, CELL, V55, P4, DOI 10.1016/0092-8674(88)90003-7; RIBES V, 1990, CELL, V63, P591, DOI 10.1016/0092-8674(90)90454-M; Schmitz U, 1996, RNA, V2, P1213; Schmitz U, 1999, NAT STRUCT BIOL, V6, P634, DOI 10.1038/10683; Schmitz U, 1999, RNA, V5, P1419, DOI 10.1017/S1355838299991458; SELINGER D, 1993, MOL CELL BIOL, V13, P1353, DOI 10.1128/MCB.13.3.1353; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; Shibata T, 1996, J BIOL CHEM, V271, P13162, DOI 10.1074/jbc.271.22.13162; SKOLD SE, 1983, NUCLEIC ACIDS RES, V11, P4923, DOI 10.1093/nar/11.14.4923; STRUCK JCR, 1988, NUCLEIC ACIDS RES, V16, P2720, DOI 10.1093/nar/16.6.2720; Suzuma S, 1999, FEMS MICROBIOL LETT, V180, P271, DOI 10.1016/S0378-1097(99)00498-X; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; WOOD H, 1992, NUCLEIC ACIDS RES, V20, P5919, DOI 10.1093/nar/20.22.5919	34	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22844	22849		10.1074/jbc.M101376200	http://dx.doi.org/10.1074/jbc.M101376200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294875	hybrid			2022-12-27	WOS:000169412700115
J	Karthikeyan, S; Leung, T; Ladias, JAA				Karthikeyan, S; Leung, T; Ladias, JAA			Structural basis of the Na+/H+ exchanger regulatory factor PDZ1 interaction with the carboxyl-terminal region of the cystic fibrosis transmembrane conductance regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; LIGAND INTERACTIONS; CRYSTAL-STRUCTURE; CHLORIDE CHANNEL; DOMAIN; IDENTIFICATION; RECOGNITION; ASSOCIATION; MEMBRANE; PEPTIDE	The PDZ1 domain of the Na+/H+ exchanger regulatory factor (NHERF) binds with nanomolar affinity to the carboxyl-terminal sequence QDTRL of the cystic fibrosis transmembrane conductance regulator (CFTR) and plays a central role in the cellular localization and physiological regulation of this chloride channel. The crystal structure of human NHERF PDZ1 bound to the carboxyl-terminal peptide QDTRL has been determined at 1.7-(A) over circle resolution. The structure reveals the specificity and affinity determinants of the PDZ1-CFTR interaction and provides insights into carboxyl-terminal leucine recognition by class I PDZ domains. The peptide ligand inserts into the PDZ1 binding pocket forming an additional antiparallel beta -strand to the PDZ1 beta -sheet, and an extensive network of hydrogen bonds and hydrophobic interactions stabilize the complex. Remarkably, the guanido group of arginine at position -1 of the CFTR peptide forms two salt bridges and two hydrogen bonds with PDZ1 residues Glu(43) and Asn(22), respectively, providing the structural basis for the contribution of the penultimate amino acid of the peptide ligand to the affinity of the interaction.	Harvard Univ, Sch Med, Inst Med, Div Expt Med,Mol Med Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Inst Med, Div Expt Med,Macromol Crystallog Unit, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Leung, T (corresponding author), Harvard Univ, Sch Med, Inst Med, Div Expt Med,Mol Med Lab, Rm 354,4 Blackfan Circle, Boston, MA 02115 USA.		Karthikeyan, Subramanian/F-8808-2010					Akabas MH, 2000, J BIOL CHEM, V275, P3729, DOI 10.1074/jbc.275.6.3729; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Fuh G, 2000, J BIOL CHEM, V275, P21486, DOI 10.1074/jbc.275.28.21486; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karthikeyan S, 2001, J MOL BIOL, V308, P963, DOI 10.1006/jmbi.2001.4634; Kocher O, 1998, LAB INVEST, V78, P117; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Kozlov G, 2000, BIOCHEMISTRY-US, V39, P2572, DOI 10.1021/bi991913c; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Milewski MI, 2001, J CELL SCI, V114, P719; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murthy A, 1998, J BIOL CHEM, V273, P1273, DOI 10.1074/jbc.273.3.1273; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; RIORDAN JR, 1989, SCIENCE, V245, P1066; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Shenolikar S, 2001, AM J PHYSIOL-RENAL, V280, pF389, DOI 10.1152/ajprenal.2001.280.3.F389; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Tochio H, 1999, NAT STRUCT BIOL, V6, P417; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903	40	105	107	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19683	19686		10.1074/jbc.C100154200	http://dx.doi.org/10.1074/jbc.C100154200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11304524	hybrid			2022-12-27	WOS:000169135100002
J	Kridel, SJ; Chen, E; Kotra, LP; Howard, EW; Mobashery, S; Smith, JM				Kridel, SJ; Chen, E; Kotra, LP; Howard, EW; Mobashery, S; Smith, JM			Substrate hydrolysis by matrix metalloproteinase-9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN BASIC-PROTEIN; GELATINASE-B; CLEAVAGE SITE; SEQUENCE SPECIFICITIES; PLASMINOGEN-ACTIVATOR; EXTRACELLULAR-MATRIX; CEREBROSPINAL-FLUID; TISSUE INHIBITOR; TERMINAL DOMAIN; IV COLLAGENASES	The catalytic clefts of all matrix metalloproteinases (MMPs) have a similar architecture, raising questions about the redundancy in substrate recognition across the protein family. In the present study, an unbiased phage display strategy was applied to define the substrate recognition profile of MMP-9. Three groups of substrates were identified, each occupying a distinct set of subsites within the catalytic pocket. The most prevalent motif contains the sequence Pro-X-X-Hy-(Ser/Thr) at P-3 through P-2'. This sequence is similar to the MMP cleavage sites within the collagens and is homologous to substrates the have been selected for other MMPs. Despite this similarity, most of the substrates identified here are selective for MMP-9 over MMP-7 and MMP-13. This observation indicates that substrate selectivity is conferred by key subsite interactions at positions other than P-3 and P-1'. This study shows that MMP-9 has a unique preference for Arg at both P-2 and P-1, and a preference for Ser/Thr at P-2'. Substrates containing the consensus MMP-9 recognition motif were used to query the protein data bases. A surprisingly limited List of putative physiologic substrates was identified. The functional implications of these proteins lead to testable hypotheses regarding physiologic substrates for MMP-9.	Burnham Inst, Program Cell Adhes, La Jolla, CA 92037 USA; Burnham Inst, Canc Res Ctr, La Jolla, CA 92037 USA; Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; Wayne State Univ, Inst Drug Design, Detroit, MI 48202 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Wayne State University; Wayne State University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Smith, JM (corresponding author), Burnham Inst, Program Cell Adhes, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Kotra, Lakshmi P./0000-0002-7071-4637	NCI NIH HHS [CA69036, CA30199] Funding Source: Medline; NIAMS NIH HHS [AR42750, AR08505] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042750] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; BARRETT AJ, 1998, HDB PROTEOLYTIC ENZY, P1199; Basbaum CB, 1996, CURR OPIN CELL BIOL, V8, P731, DOI 10.1016/S0955-0674(96)80116-5; Belaaouaj AA, 2000, J BIOL CHEM, V275, P27123; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; Bode W, 1999, CELL MOL LIFE SCI, V55, P639, DOI 10.1007/s000180050320; BODE W, 1994, EMBO J, V13, P1263, DOI 10.1002/j.1460-2075.1994.tb06378.x; CASE DA, 1997, AMBER 5; Conant K, 1999, ANN NEUROL, V46, P391, DOI 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0; Coombs GS, 1998, CHEM BIOL, V5, P475, DOI 10.1016/S1074-5521(98)90004-7; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Deng SJ, 2000, J BIOL CHEM, V275, P31422, DOI 10.1074/jbc.M004538200; DING L, 1995, P NATL ACAD SCI USA, V92, P7627, DOI 10.1073/pnas.92.17.7627; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; FIELDS GB, 1987, J BIOL CHEM, V262, P6221; FOSANG AJ, 1992, J BIOL CHEM, V267, P19470; GALARDY RE, 1994, ANN NY ACAD SCI, V732, P315, DOI 10.1111/j.1749-6632.1994.tb24746.x; GIJBELS K, 1993, J NEUROSCI RES, V36, P432, DOI 10.1002/jnr.490360409; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Karas M, 1996, BIOCHEM SOC T, V24, P897, DOI 10.1042/bst0240897; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Koivunen E, 1999, NAT BIOTECHNOL, V17, P768, DOI 10.1038/11703; Landry F, 2000, ANAL BIOCHEM, V279, P1, DOI 10.1006/abio.1999.4468; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Leppert D, 1998, BRAIN, V121, P2327, DOI 10.1093/brain/121.12.2327; Lin ECK, 1997, J BIOL CHEM, V272, P23912, DOI 10.1074/jbc.272.38.23912; Liu Z, 1998, J EXP MED, V188, P475, DOI 10.1084/jem.188.3.475; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; MADISON EL, 1995, J BIOL CHEM, V270, P7558, DOI 10.1074/jbc.270.13.7558; Marinkovich MP, 1996, J INVEST DERMATOL, V106, P734, DOI 10.1111/1523-1747.ep12345782; Massova I, 1997, J MOL MODEL, V3, P17, DOI 10.1007/s008940050021; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; MCGEEHAN GM, 1994, J BIOL CHEM, V269, P32814; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; NETZELARNETT S, 1991, J BIOL CHEM, V266, P6747; NETZELARNETT S, 1993, BIOCHEMISTRY-US, V32, P6427, DOI 10.1021/bi00076a016; NGUYEN Q, 1993, BIOCHEM J, V295, P595, DOI 10.1042/bj2950595; NIYIBIZI C, 1994, BIOCHEM BIOPH RES CO, V202, P328, DOI 10.1006/bbrc.1994.1931; OCHIENG J, 1994, BIOCHEMISTRY-US, V33, P14109, DOI 10.1021/bi00251a020; OCONNELL JP, 1994, J BIOL CHEM, V269, P14967; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; PROOST P, 1993, BIOCHEM BIOPH RES CO, V192, P1175, DOI 10.1006/bbrc.1993.1540; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SELTZER JL, 1990, J BIOL CHEM, V265, P20409; SENIOR RM, 1991, J BIOL CHEM, V266, P7870; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; SMITH GP, 1993, GENE, V128, P1, DOI 10.1016/0378-1119(93)90145-S; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; STOCKER W, 1995, PROTEIN SCI, V4, P823; VORM O, 1994, ANAL CHEM, V66, P3281, DOI 10.1021/ac00091a044; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wong NC, 1998, CLIN EXP METASTAS, V16, P50; Xia T, 1996, BBA-PROTEIN STRUCT M, V1293, P259, DOI 10.1016/0167-4838(95)00259-6	58	149	167	3	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20572	20578		10.1074/jbc.M100900200	http://dx.doi.org/10.1074/jbc.M100900200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279151	hybrid			2022-12-27	WOS:000169135100121
J	Mohamed, MR; Niles, EG				Mohamed, MR; Niles, EG			The viral RNA polymerase H4L subunit is required for vaccinia virus early gene transcription termination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE TRIPHOSPHATE PHOSPHOHYDROLASES; TEMPERATURE-SENSITIVE MUTANTS; MESSENGER-RNA; TERNARY COMPLEXES; CELLULAR PROTEIN; STAGE GENES; NASCENT RNA; IN-VITRO; PURIFICATION; PROMOTER	Vaccinia virus early gene transcription is catalyzed by a multisubunit virion form of RNA polymerase that possesses a unique subunit, H4L. Prior studies from this laboratory showed that the NH2-terminal domain of H4L, containing amino acids 1-195, interacts with the COOH-terminal end of nucleoside triphosphate phosphohydrolase I (NPH I), an ATPase that is employed in early gene transcription termination, Carboxyl-terminal deletion mutations of NPH I lose both the ability to mediate transcription termination and binding to H4L, providing evidence that the interaction between NPN I and H4L is required for termination, In order to test this model further, antibodies raised against segments of H4L mere tested for their ability to inhibit transcription termination in vitro. A bead-bound template was employed. in these studies, which permitted us to separate transcription initiation from elongation and termination. Antibodies raised against H4L amino acids 1-256 inhibited termination in an in vitro assay using virus-infected cell extracts lacking NPH I, but antibodies raised against H4L amino acids 568-795 did not. Preincubation of anti-H4L(1-256) antibodies with H4L fragments 1-256 or 1-195 prevented antibody inhibition of termination, demonstrating that inhibition was mediated by antibody binding to one or more epitopes in the NH2-terminal end of H4L, Antibody inhibition of termination is reduced in wild type virus-infected cell extracts containing NPH I. Furthermore, preincubation of a NPH I minus cell extract with NPH I prior to antibody addition, or readdition of NPH I to isolated ternary complexes prepared in the absence of NPH I, prevented antibody inhibition of transcription termination, These data show that NPH I and the inhibitory antibodies compete for a binding site(s) on H4L, providing further evidence that the H4L subunit of the vaccinia virus RNA polymerase plays a direct, role in transcription termination.	SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol, Buffalo, NY 14214 USA; SUNY Buffalo, Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14214 USA; SUNY Buffalo, Sch Med & Biomed Sci, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Niles, EG (corresponding author), SUNY Buffalo, Dept Microbiol & Biochem, 138 Farber Hall, Buffalo, NY 14214 USA.		Mohamed, Mohamed Ragaa/V-9143-2019	Mohamed, Mohamed Ragaa/0000-0002-9269-3128	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043933] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43933] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHN BY, 1992, P NATL ACAD SCI USA, V89, P3536, DOI 10.1073/pnas.89.8.3536; AHN BY, 1994, J BIOL CHEM, V269, P7552; BROYLES SS, 1988, J BIOL CHEM, V263, P10754; Christen LM, 1998, VIROLOGY, V245, P360, DOI 10.1006/viro.1998.9177; CONDIT RC, 1983, VIROLOGY, V128, P429, DOI 10.1016/0042-6822(83)90268-4; CONDIT RC, 1981, VIROLOGY, V113, P224, DOI 10.1016/0042-6822(81)90150-1; Condit RC, 1996, VIROLOGY, V218, P169, DOI 10.1006/viro.1996.0177; Deng L, 1996, J BIOL CHEM, V271, P29386, DOI 10.1074/jbc.271.46.29386; DENG L, 1994, J BIOL CHEM, V269, P14323; Deng L, 1998, GENE DEV, V12, P538, DOI 10.1101/gad.12.4.538; Deng L, 1996, J BIOL CHEM, V271, P19556, DOI 10.1074/jbc.271.32.19556; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; Gunasinghe SK, 1998, J BIOL CHEM, V273, P27524, DOI 10.1074/jbc.273.42.27524; HAGLER J, 1994, J BIOL CHEM, V269, P10050; HAGLER J, 1993, J BIOL CHEM, V268, P2166; KANE EM, 1992, J VIROL, V66, P5752, DOI 10.1128/JVI.66.10.5752-5762.1992; KATES JR, 1967, P NATL ACAD SCI USA, V58, P134, DOI 10.1073/pnas.58.1.134; LI J, 1993, J BIOL CHEM, V268, P20016; LI J, 1993, J BIOL CHEM, V268, P2773; Mohamed MR, 2000, J BIOL CHEM, V275, P25798, DOI 10.1074/jbc.M002250200; MOSS B, 1996, VIROLOGY, P2637; MUNYON W, 1967, P NATL ACAD SCI USA, V58, P2280, DOI 10.1073/pnas.58.6.2280; PAOLETTI E, 1974, J BIOL CHEM, V249, P3273; PAOLETTI E, 1974, J BIOL CHEM, V249, P3281; ROHRMANN G, 1986, CELL, V46, P1029, DOI 10.1016/0092-8674(86)90702-6; ROSALES R, 1994, P NATL ACAD SCI USA, V91, P3794, DOI 10.1073/pnas.91.9.3794; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1989, J BIOL CHEM, V264, P21356; SPRINGER T, 1987, CURRENT TOPICS MOL B; WEI CM, 1975, P NATL ACAD SCI USA, V72, P318, DOI 10.1073/pnas.72.1.318; WITTEK R, 1980, CELL, V21, P487, DOI 10.1016/0092-8674(80)90485-7; YUEN L, 1986, J VIROL, V60, P320, DOI 10.1128/JVI.60.1.320-323.1986; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417; Zhu M, 1998, J VIROL, V72, P3893, DOI 10.1128/JVI.72.5.3893-3899.1998	34	12	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20758	20765		10.1074/jbc.M101641200	http://dx.doi.org/10.1074/jbc.M101641200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279216	hybrid			2022-12-27	WOS:000169135100144
J	Michell, BJ; Chen, ZP; Tiganis, T; Stapleton, D; Katsis, F; Power, DA; Sim, AT; Kemp, BE				Michell, BJ; Chen, ZP; Tiganis, T; Stapleton, D; Katsis, F; Power, DA; Sim, AT; Kemp, BE			Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; CELLS; DEPHOSPHORYLATION; GROWTH; AKT; IDENTIFICATION; ISOFORMS; PATHWAY; SITES	Endothelial nitric-oxide synthase (eNOS) is an important regulatory enzyme in the cardiovascular system catalyzing the production of NO from arginine. Multiple protein kinases including Akt/PKB, cAMP-dependent protein kinase (PKA), and the AMP-activated protein kinase (AMPK) activate eNOS by phosphorylating Ser-1177 in response to various stimuli. During VEGF signaling in endothelial cells, there is a transient increase in Ser-1177 phosphorylation coupled with a decrease in Thr-495 phosphorylation that reverses over 10 min. PKC signaling in endothelial cells inhibits eNOS activity by phosphorylating Thr-495 and dephosphorylating Ser-1177 whereas PKA signaling acts in reverse by increasing phosphorylation of Ser-1177 and dephosphorylation of Thr-495 to activate eNOS. Both phosphatases PP1 and PP2A are associated with eNOS, PP1 is responsible for dephosphorylation of Thr-495 based on its specificity for this site in both eNOS and the corresponding synthetic phosphopeptide whereas PP2A is responsible for dephosphorylation of Ser-1177. Treatment of endothelial cells with calyculin selectively blocks PKA-mediated dephosphorylation of Thr-495 whereas okadaic acid selectively blocks PKC-mediated dephosphorylation of Ser-1177, These results show that regulation of eNOS activity involves coordinated signaling through Ser-1177 and Thr-495 by multiple protein kinases and phosphatases.	St Vincents Hosp, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia; Austin & Repatriat Med Ctr, Dept Nephrol, Heidelberg, Vic 3084, Australia; Univ Newcastle, Sch Biomed Sci, Newcastle, NSW 2308, Australia	St Vincent's Hospital Melbourne; St. Vincent's Institute of Medical Research; Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Newcastle	Kemp, BE (corresponding author), St Vincents Inst Med Res, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.		Tiganis, Tony/AAV-3495-2020; Kemp, Bruce E/L-2633-2014; Kemp, Bruce/G-9602-2019; Power, David/AAM-6012-2021	Tiganis, Tony/0000-0002-8065-9942; Kemp, Bruce E/0000-0001-6735-5082; Kemp, Bruce/0000-0001-6735-5082; Power, David/0000-0003-3983-0581				Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4; Bernier SG, 2000, J BIOL CHEM, V275, P30707, DOI 10.1074/jbc.M005116200; Beullens M, 1999, J BIOL CHEM, V274, P14053, DOI 10.1074/jbc.274.20.14053; BREDT DS, 1992, J BIOL CHEM, V267, P10976; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; DAVDA RK, 1994, EUR J PHARM-MOLEC PH, V266, P237, DOI 10.1016/0922-4106(94)90132-5; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; HARRIS MB, 2001, J BIOL CHEM; Haynes MP, 2000, CIRC RES, V87, P677, DOI 10.1161/01.RES.87.8.677; HIRATA K, 1995, HYPERTENSION, V25, P180, DOI 10.1161/01.HYP.25.2.180; Hisamoto K, 2001, J BIOL CHEM, V276, P3459, DOI 10.1074/jbc.M005036200; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Ludowyke RI, 2000, J BIOL CHEM, V275, P6144, DOI 10.1074/jbc.275.9.6144; MacKenzie S, 1997, BIOCHEM J, V324, P159, DOI 10.1042/bj3240159; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Mitchelhill KI, 1997, J BIOL CHEM, V272, P24475, DOI 10.1074/jbc.272.39.24475; Oliver C.J., 1998, FRONT BIOSCI, V3, P961; Potter LR, 1998, BIOCHEMISTRY-US, V37, P2422, DOI 10.1021/bi972303k; Ratcliffe MJ, 1999, BIOCHEM J, V338, P471, DOI 10.1042/0264-6021:3380471; Ratcliffe MJ, 1997, J BIOL CHEM, V272, P31894, DOI 10.1074/jbc.272.50.31894; Schoenthal Axel H., 1998, Frontiers in Bioscience, V3, pD1262; Seymour LW, 1996, LAB INVEST, V75, P427; Sim ATR, 1998, NEUROCHEM RES, V23, P487, DOI 10.1023/A:1022422332404; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006	27	450	471	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17625	17628		10.1074/jbc.C100122200	http://dx.doi.org/10.1074/jbc.C100122200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11292821	hybrid			2022-12-27	WOS:000168866500002
J	Qu, ZQ; Hartzell, HC				Qu, ZQ; Hartzell, HC			Functional geometry of the permeation pathway of Ca2+-activated Cl- channels inferred from analysis of voltage-dependent block	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; RABBIT VENTRICULAR MYOCYTES; XENOPUS OOCYTES; ANTIARRHYTHMIC APPROACH; ANION MANIPULATION; AIRWAY EPITHELIA; CHLORIDE; CURRENTS; SECRETION; CALCIUM	We examined the voltage-dependent block of Ca2+- activated Cl- channels by anthacene-9-carboxylic acid (A9C), diphenylamine-2-carboxylic acid (DPC), 4,4'-diisothiocyanostilbene-2,2 '-disulfonic acid (DIDS), and niflumic acid (NFA) in excised inside-out and outside-out patches from Xenopus oocytes, The fraction of the voltage field (delta) experienced by the blocking drug was determined from the voltage dependence of block. All the drugs blocked by entering the channel from the outside. delta was 0.6 for A9C, 0.3 for DPC and BIBS, and <0.1 for NFA. Because the voltage dependence of the drugs differed, the order of potency was also voltage-dependent. At +100 mV the order of potency was NFA > A9C > DIDS > DPC (K-i (muM) = 10.1, 18.3, 48, and 11.1, respectively). Because the drugs are hydrophobic, they can cross the bilayer when applied from the inside and block the channel from the outside. The equilibrium geometries of the blockers were determined by molecular modeling and compared with their blocking positions (delta), This analysis suggests that the channel is an elliptical cone with the largest opening facing the extracellular space. The selectivity filter has an apparent size of 0.33 x 0.75 nm, because C(CN)(3)(-), which has these dimensions, permeates. The external opening is at least 0.60 x 0.94 nm, because DPC has these dimensions and penetrates the channel similar to 30%.	Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	Emory University	Hartzell, HC (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	criss@cellbio.emory.edu			NIGMS NIH HHS [GM 60448] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060448] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Begenisich T, 1998, J MEMBRANE BIOL, V163, P77, DOI 10.1007/s002329900372; BOUCHER RC, 1989, J CLIN INVEST, V84, P1424, DOI 10.1172/JCI114316; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; CURTIS MJ, 1993, J MOL CELL CARDIOL, V25, P417, DOI 10.1006/jmcc.1993.1048; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; Freeman LC, 1997, J CARDIOVASC ELECTR, V8, P872, DOI 10.1111/j.1540-8167.1997.tb00848.x; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Greger R, 1996, PFLUG ARCH EUR J PHY, V432, P579, DOI 10.1007/s004240050173; GRUBB BR, 1994, AM J PHYSIOL, V266, pC1478, DOI 10.1152/ajpcell.1994.266.5.C1478; Han XQ, 1996, J MOL CELL CARDIOL, V28, P2069, DOI 10.1006/jmcc.1996.0200; Hartzell HC, 1997, MOL PHARMACOL, V51, P683, DOI 10.1124/mol.51.4.683; Hehre W. J., 1998, BRIEF GUIDE MOL MECH; Hille B., 1992, ION CHANNELS EXCITAB; HIRAOKA M, 1989, J PHYSIOL-LONDON, V410, P187, DOI 10.1113/jphysiol.1989.sp017528; Hiraoka M, 1998, CARDIOVASC RES, V40, P23, DOI 10.1016/S0008-6363(98)00173-4; JAFFE LA, 1986, ANNU REV PHYSIOL, V48, P191, DOI 10.1146/annurev.ph.48.030186.001203; JANUARY CT, 1988, PHARMACOL REV, V40, P219; JOHNSON LG, 1995, J CLIN INVEST, V95, P1377, DOI 10.1172/JCI117789; KAWANO S, 1991, J MOL CELL CARDIOL, V23, P681, DOI 10.1016/0022-2828(91)90978-U; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Large WA, 1996, AM J PHYSIOL-CELL PH, V271, pC435; Linsdell P, 1996, J PHYSIOL-LONDON, V496, P687, DOI 10.1113/jphysiol.1996.sp021719; Machaca K, 1999, J GEN PHYSIOL, V113, P249, DOI 10.1085/jgp.113.2.249; Machaca K, 1998, BIOPHYS J, V74, P1286, DOI 10.1016/S0006-3495(98)77842-7; Machaca K, 1999, J BIOL CHEM, V274, P4824, DOI 10.1074/jbc.274.8.4824; MCCARTY NA, 1993, J GEN PHYSIOL, V102, P1, DOI 10.1085/jgp.102.1.1; PAPP Z, 1995, J PHYSIOL-LONDON, V483, P319, DOI 10.1113/jphysiol.1995.sp020588; Qu ZQ, 2000, J GEN PHYSIOL, V116, P825, DOI 10.1085/jgp.116.6.825; RIDLEY PD, 1992, CIRC RES, V70, P617, DOI 10.1161/01.RES.70.4.617; Schultz BD, 1999, PHYSL REV S, V79, P109; Tanaka H, 1996, J PHARMACOL EXP THER, V278, P854; WHITE MM, 1990, MOL PHARMACOL, V37, P720; WILLUMSEN NJ, 1989, AM J PHYSIOL, V256, pC226, DOI 10.1152/ajpcell.1989.256.2.C226; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; ZYGMUNT AC, 1994, AM J PHYSIOL-HEART C, V267, pH1984, DOI 10.1152/ajpheart.1994.267.5.H1984; Zygmunt AC, 1998, AM J PHYSIOL-HEART C, V275, pH1979, DOI 10.1152/ajpheart.1998.275.6.H1979; Zygmunt AC, 1997, AM J PHYSIOL-HEART C, V273, pH1096, DOI 10.1152/ajpheart.1997.273.3.H1096	37	55	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18423	18429		10.1074/jbc.M101264200	http://dx.doi.org/10.1074/jbc.M101264200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279188	hybrid			2022-12-27	WOS:000168866500107
J	Angus, LM; Chan, RYY; Jasmin, BJ				Angus, LM; Chan, RYY; Jasmin, BJ			Role of intronic E- and N-box motifs in the transcriptional induction of the acetylcholinesterase gene during myogenic differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GA-BINDING-PROTEIN; SKELETAL-MUSCLE FIBERS; DELTA-SUBUNIT GENE; MESSENGER-RNA; NEUROMUSCULAR-JUNCTION; SYNAPTIC EXPRESSION; NEURAL REGULATION; UTROPHIN GENE; RECEPTOR GENE; PROMOTER	In this study, we examined whether an intronic N-box motif is involved in the expression of acetylchollinesterase (AChE) during myogenesis, We determined that AChE transcripts are barely detectable in cultured myoblasts and that their levels increase dramatically in myotubes, Nuclear run-on assays revealed that this increase was accompanied by a parallel induction in the transcriptional activity of the AChE gene, These changes in transcription were also observed in transfection experiments using AChE promoter-reporter gene constructs. Mutation of the intronic N-box at position +755 base pairs (bp) reduced by more than 70% expression of the reporter gene in myotubes, Disruption of an adjacent E-box, at position +767 bp, also reduced expression of the reporter gene following myogenic differentiation. Co-transfection experiments using AChE promoter-reporter gene constructs and a myogenin expression vector showed that expression of this regulatory factor increased expression of the reporter gene in myotubes. Although the AChE promoter contains multiple E-boxes, mutation of this intronic one was sufficient to prevent the myogenin-induced increase in reporter gene expression. Together, these results indicate that changes in AChE gene transcription occur during myogenesis and highlight the contribution of the intronic Nand E-box motifs in the developmental regulation of the AChE gene in skeletal muscle.	Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; Univ Ottawa, Fac Med, Ctr Neuromuscular Dis, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa	Jasmin, BJ (corresponding author), Univ Ottawa, Fac Med, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.							Arnold HH, 1998, CURR OPIN GENET DEV, V8, P539, DOI 10.1016/S0959-437X(98)80008-7; BALDWIN TJ, 1988, J CELL BIOL, V107, P2271, DOI 10.1083/jcb.107.6.2271; Bannert N, 1999, P NATL ACAD SCI USA, V96, P1541, DOI 10.1073/pnas.96.4.1541; BELANGER G, 2000, SOC NEUR ABSTR, V26, P1089; Biederer CH, 2000, J BIOL CHEM, V275, P26245, DOI 10.1074/jbc.M001430200; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Boudreau-Lariviere C, 2000, J NEUROCHEM, V74, P2250, DOI 10.1046/j.1471-4159.2000.0742250.x; Buckingham M, 1996, BIOCHEM SOC T, V24, P506, DOI 10.1042/bst0240506; BUONANNO A, 1986, J BIOL CHEM, V261, P1452; Chan RYY, 1998, J BIOL CHEM, V273, P9727, DOI 10.1074/jbc.273.16.9727; Chan RYY, 1999, P NATL ACAD SCI USA, V96, P4627, DOI 10.1073/pnas.96.8.4627; CRESNAR B, 1994, J NEUROSCI RES, V38, P294, DOI 10.1002/jnr.490380307; Culetto E, 1999, J MOL BIOL, V290, P951, DOI 10.1006/jmbi.1999.2937; Curcic D, 1997, J CELL BIOCHEM, V65, P287; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Duclert A, 1996, J BIOL CHEM, V271, P17433, DOI 10.1074/jbc.271.29.17433; EDMONDSON DG, 1991, J BIOL CHEM, V266, P21343; EVANS S, 1987, J BIOL CHEM, V262, P4911; FONTAINE B, 1989, J CELL BIOL, V108, P1025, DOI 10.1083/jcb.108.3.1025; FORSTER E, 1993, NEUROSCI LETT, V155, P216, DOI 10.1016/0304-3940(93)90711-S; Fromm L, 1998, GENE DEV, V12, P3074, DOI 10.1101/gad.12.19.3074; FUENTES ME, 1993, NEURON, V10, P679, DOI 10.1016/0896-6273(93)90169-R; Gramolini AO, 1999, NUCLEIC ACIDS RES, V27, P3603, DOI 10.1093/nar/27.17.3603; Gramolini AO, 1998, J BIOL CHEM, V273, P736, DOI 10.1074/jbc.273.2.736; Gramolini AO, 1999, P NATL ACAD SCI USA, V96, P3223, DOI 10.1073/pnas.96.6.3223; GRUBIC Z, 1995, NEURON, V14, P317, DOI 10.1016/0896-6273(95)90288-0; JANKNECHT R, 1993, BIOCHIM BIOPHYS ACTA, V1155, P346, DOI 10.1016/0304-419X(93)90014-4; JASMIN BJ, 1993, NEURON, V11, P467, DOI 10.1016/0896-6273(93)90151-G; JBILO O, 1994, EUR J BIOCHEM, V225, P115, DOI 10.1111/j.1432-1033.1994.00115.x; Khurana TS, 1999, MOL BIOL CELL, V10, P2075, DOI 10.1091/mbc.10.6.2075; KLARSFELD A, 1987, BIOCHIMIE, V69, P433, DOI 10.1016/0300-9084(87)90080-0; KOIKE S, 1995, P NATL ACAD SCI USA, V92, P10624, DOI 10.1073/pnas.92.23.10624; Legay C, 2000, MICROSC RES TECHNIQ, V49, P56, DOI 10.1002/(SICI)1097-0029(20000401)49:1<56::AID-JEMT7>3.0.CO;2-R; LEGAY C, 1995, EUR J NEUROSCI, V7, P1803, DOI 10.1111/j.1460-9568.1995.tb00699.x; Luo ZD, 1999, MOL PHARMACOL, V56, P886, DOI 10.1124/mol.56.5.886; Luo ZD, 1998, J BIOL CHEM, V273, P28486, DOI 10.1074/jbc.273.43.28486; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MERLIE JP, 1985, NATURE, V317, P66, DOI 10.1038/317066a0; MICHEL RN, 1994, J CELL BIOL, V127, P1061, DOI 10.1083/jcb.127.4.1061; MUTERO A, 1995, J BIOL CHEM, V270, P1866, DOI 10.1074/jbc.270.40.23511; Ou XM, 2000, J BIOL CHEM, V275, P8161, DOI 10.1074/jbc.275.11.8161; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; RAY A, 1995, J BIOL CHEM, V270, P25837, DOI 10.1074/jbc.270.43.25837; Rimer M, 1999, BIOCHEM BIOPH RES CO, V260, P251, DOI 10.1006/bbrc.1999.0893; Rossi SG, 2000, J NEUROSCI, V20, P919, DOI 10.1523/JNEUROSCI.20-03-00919.2000; ROSSI SG, 2000, SOC NEUR ABSTR, V26, P1090; Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078; SETH A, 1990, ONCOGENE, V5, P1761; SVEISTRUP H, 1995, AM J PHYSIOL, V269, pC756; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; TOUTANT JP, 1987, MAMMALIAN ECTOENZYME, P289; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0	53	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17603	17609		10.1074/jbc.M100916200	http://dx.doi.org/10.1074/jbc.M100916200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279154	hybrid			2022-12-27	WOS:000168730400134
J	Siegel, G; Sternfeld, L; Gonzalez, A; Schulz, I; Schmid, A				Siegel, G; Sternfeld, L; Gonzalez, A; Schulz, I; Schmid, A			Arachidonic acid modulates the spatiotemporal characteristics of agonist-evoked Ca2+ waves in mouse pancreatic acinar cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); ACTIVATED PROTEIN-KINASE; EXOCRINE PANCREAS; MAP KINASE; PHAS-I; CHOLECYSTOKININ; PHOSPHORYLATION; RELEASE; OSCILLATIONS; MOBILIZATION	In pancreatic acinar cells analysis of the propagation speed of secretagogue-evoked Ca2+ waves can be used to examine coupling of hormone receptors to intracellular signal cascades that cause activation of protein kinase C or production of arachidonic acid (AA), In the present study we have investigated the role of cytosolic phospholipase A(2) (cPLA(2)) and AA in acetylcholine (ACh)- and bombesin-induced Ca2+ signaling. Inhibition of cPLA(2) caused acceleration of ACh-induced Ca2+ waves, whereas bombesin-evoked Ca2+ waves were unaffected. When enzymatic metabolization of AA was prevented with the cyclooxygenase inhibitor indomethacin or the lipoxygenase inhibitor nordihydroguaiaretic acid, ACh-induced Ca2+ waves were slowed down. Agonist-induced activation of cPLA(2) involves mitogen-activated protein kinase (MAPK) activation. An increase in phosphorylation of p38(MAPK) and p42/44(MAPK) within 10 a after stimulation could be demonstrated for ACh but was absent for bombesin, Rapid phosphorylation of p38(MAPK) and p42/44MAPK could also be observed in the presence of cholecystokinin (CCK), which also causes activation of cPLA(2). ACh-and CCK-induced Ca2+ waves were slowed down when p38MAPK Wag inhibited with SE 203580, whereas inhibition of p42/44MAPK With PD 98059 caused acceleration of ACh- and CCK-induced Ca2+ waves. The spreading of bombesin-evoked Ca2+ waves was affected neither by PD 98059 nor by SE 203580. Our data indicate that in mouse pancreatic acinar cells both ACh and CCK receptors couple to the cPLA(2) pathway. cPLA(2) activation occurs within 1-2 s after hormone application and is promoted by p42/44MAPK and inhibited by p38MAPK. Furthermore, the data demonstrate that secondary (Ca2+-induced) Ca2+ release, which supports Ca2+ wave spreading, is inhibited by AA. itself and not by a metabolite of AA.	Univ Saarland, Dept Physiol 2, D-66421 Homburg, Germany	Saarland University	Schmid, A (corresponding author), Univ Saarland, Dept Physiol 2, D-66421 Homburg, Germany.		Gonzalez, Antonio/C-5428-2018	Gonzalez, Antonio/0000-0001-8380-0270				Balsinde J, 2000, J IMMUNOL, V164, P5398, DOI 10.4049/jimmunol.164.10.5398; Blinman TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1993, DOI 10.1152/ajpcell.2000.279.6.C1993; Bragado MJ, 1998, GASTROENTEROLOGY, V115, P733, DOI 10.1016/S0016-5085(98)70153-2; Bragado MJ, 2000, GASTROENTEROLOGY, V119, P1731, DOI 10.1053/gast.2000.20242; Fonteh AN, 2000, J IMMUNOL, V165, P2773, DOI 10.4049/jimmunol.165.5.2773; Gonzalez A, 1999, BIOCHEM BIOPH RES CO, V261, P726, DOI 10.1006/bbrc.1999.1106; Gonzalez A, 2000, J BIOL CHEM, V275, P38680, DOI 10.1074/jbc.M005667200; HAYSTEAD TAJ, 1994, J BIOL CHEM, V269, P23185; Hiller G, 1999, CELL SIGNAL, V11, P863, DOI 10.1016/S0898-6568(99)00058-3; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Lin WW, 1998, BRIT J PHARMACOL, V125, P1601, DOI 10.1038/sj.bjp.0702219; MARUYAMA Y, 1993, J PHYSIOL-LONDON, V463, P729, DOI 10.1113/jphysiol.1993.sp019619; Pfeiffer F, 1998, AM J PHYSIOL-CELL PH, V274, pC663; Rowles SJ, 1996, BIOCHEM J, V319, P913, DOI 10.1042/bj3190913; Schafer C, 1998, J BIOL CHEM, V273, P24173, DOI 10.1074/jbc.273.37.24173; Schulz I, 1999, BIOL CHEM, V380, P903, DOI 10.1515/BC.1999.111; Singh RP, 1999, J BIOL CHEM, V274, P19593, DOI 10.1074/jbc.274.28.19593; Straub SV, 2000, J GEN PHYSIOL, V116, P547, DOI 10.1085/jgp.116.4.547; Syrbu SI, 1999, J IMMUNOL, V162, P2334; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; TSUNODA Y, 1995, AM J PHYSIOL-GASTR L, V269, pG435, DOI 10.1152/ajpgi.1995.269.3.G435; Wheeler-Jones C, 1997, FEBS LETT, V420, P28, DOI 10.1016/S0014-5793(97)01481-6	24	6	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16986	16991		10.1074/jbc.M101136200	http://dx.doi.org/10.1074/jbc.M101136200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279177	hybrid			2022-12-27	WOS:000168730400051
J	Ishikawa, T; Uematsu, N; Mizukoshi, T; Iwai, S; Iwasaki, H; Masutani, C; Hanaoka, F; Ueda, R; Ohmori, H; Todo, T				Ishikawa, T; Uematsu, N; Mizukoshi, T; Iwai, S; Iwasaki, H; Masutani, C; Hanaoka, F; Ueda, R; Ohmori, H; Todo, T			Mutagenic and nonmutagenic bypass of DNA lesions by Drosophila DNA polymerases dpol eta and dpol iota	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMINE-THYMINE DIMER; ESCHERICHIA-COLI; CIS-SYN; CYCLOBUTANE DIMER; GENE ENCODES; 6-4 ADDUCT; PHOTOPRODUCT; FIDELITY; PROTEIN; REPAIR	cDNA sequences were identified and isolated that encode Drosophila homologues of human Rad30A and Rad30B called drad30A and drad30B, Here we show that the C-terminal-truncated forms of the drad30A and drad30B gene products, designated dpol eta DeltaC and dpol iota DeltaC, respectively, exhibit DNA polymerase activity, dpol eta DeltaC and dpol iota DeltaC efficiently bypass a cis syn.-cyclobutane thymine-thymine (TT) dimer in a mostly error-free manner. dpol eta DeltaC shows limited ability to bypass a 6-4-photoproduct ((6-4)PP) at thymine-thymine (TT-(6-4)PP) or at thymine-cytosine (TC-(6-4)PP) in an error-prone manner. dpol iota DeltaC scarcely bypasses these lesions. Thus, the fidelity of translesion synthesis depends on the identity of the lesion and on the polymerase. The human XPV gene product, hpol eta, bypasses cis-syn-cyclobutane thymine-thymine dimer efficiently in a mostly error-free manner but does not bypass TT-(6-4)PP, whereas Escherichia coli DNA polymerase V (UmuD'C-2 complex) bypasses both lesions, especially TT-(6-4)PP, in an error prone manner (Tang, M., Pham, P., Shen, X, Taylor, J. S., O'Donnell, M., Woodgate, R., and Goodman, M, F. (2000) Nature 404, 1014-1018); Both dpol eta DeltaC and DNA polymerase V preferentially incorporate GA opposite TT-(6-4)PP. The chemical structure of the lesions and the similarity in the nucleotides incorporated suggest that structural information in the altered bases contribute to nucleotide selection during incorporation opposite these lesions by these polymerases.	Kyoto Univ, Ctr Radiat Biol, Sakyo Ku, Kyoto 6068501, Japan; Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; Osaka Univ, Inst Mol & Cellular Biol, Suita, Osaka 5650871, Japan; Biomol Engn Res Inst, Osaka 5650874, Japan; Mitsubishi Kasei Inst Life Sci, Tokyo 1948511, Japan; Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan	Kyoto University; Osaka University; Osaka University; Kyoto University	Todo, T (corresponding author), Kyoto Univ, Ctr Radiat Biol, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.	todo@house.rbc.kyoto-u.ac.jp	Iwasaki, Hiroshi/Y-7946-2018; Masutani, Chikahide/I-6160-2014	Iwasaki, Hiroshi/0000-0002-0153-6873; Masutani, Chikahide/0000-0002-8600-8227				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BANERJEE SK, 1988, P NATL ACAD SCI USA, V85, P8141, DOI 10.1073/pnas.85.21.8141; Friedberg EC, 2000, P NATL ACAD SCI USA, V97, P5681, DOI 10.1073/pnas.120152397; Friedberg EC, 1995, DNA REPAIR MUTAGENES, P24; Fujiwara Y, 1997, BIOCHEMISTRY-US, V36, P1544, DOI 10.1021/bi9619942; Hitomi K, 1997, J BIOL CHEM, V272, P32591, DOI 10.1074/jbc.272.51.32591; HORSFALL MJ, 1994, J MOL BIOL, V235, P465, DOI 10.1006/jmbi.1994.1006; Horsfall MJ, 1997, J BACTERIOL, V179, P2835, DOI 10.1128/jb.179.9.2835-2839.1997; Iwai S, 1996, J AM CHEM SOC, V118, P7642, DOI 10.1021/ja9603158; Jing YQ, 1998, NUCLEIC ACIDS RES, V26, P3845, DOI 10.1093/nar/26.16.3845; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Johnson RE, 1999, P NATL ACAD SCI USA, V96, P12224, DOI 10.1073/pnas.96.22.12224; Johnson RE, 1999, J BIOL CHEM, V274, P15975, DOI 10.1074/jbc.274.23.15975; KEMMINK J, 1987, NUCLEIC ACIDS RES, V15, P4645, DOI 10.1093/nar/15.11.4645; KIM JK, 1995, PHOTOCHEM PHOTOBIOL, V62, P44, DOI 10.1111/j.1751-1097.1995.tb05236.x; Kulaeva OI, 1996, MUTAT RES-FUND MOL M, V357, P245, DOI 10.1016/0027-5107(96)00164-9; LAWRENCE CW, 1990, MOL GEN GENET, V222, P166, DOI 10.1007/BF00283040; LECLERC JE, 1991, P NATL ACAD SCI USA, V88, P9685, DOI 10.1073/pnas.88.21.9685; Lee JH, 1999, P NATL ACAD SCI USA, V96, P6632, DOI 10.1073/pnas.96.12.6632; Lin WS, 1999, NUCLEIC ACIDS RES, V27, P4468, DOI 10.1093/nar/27.22.4468; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Masutani C, 1999, EMBO J, V18, P3491, DOI 10.1093/emboj/18.12.3491; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; McDonald JP, 1999, GENOMICS, V60, P20, DOI 10.1006/geno.1999.5906; Mizukoshi T, 1998, J AM CHEM SOC, V120, P10634, DOI 10.1021/ja982004y; MURATA T, 1990, NUCLEIC ACIDS RES, V18, P7279, DOI 10.1093/nar/18.24.7279; Ogi T, 1999, GENES CELLS, V4, P607, DOI 10.1046/j.1365-2443.1999.00289.x; Ohashi E, 2000, GENE DEV, V14, P1589; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; Otoshi E, 2000, CANCER RES, V60, P1729; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; TAYLOR JS, 1990, BIOCHEMISTRY-US, V29, P8858, DOI 10.1021/bi00489a049; Tissier A, 2000, GENE DEV, V14, P1642; Tissier A, 2000, EMBO J, V19, P5259, DOI 10.1093/emboj/19.19.5259; TODO T, 1993, NATURE, V361, P371, DOI 10.1038/361371a0; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Washington MT, 1999, J BIOL CHEM, V274, P36835, DOI 10.1074/jbc.274.52.36835; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191; Yuan FH, 2000, J BIOL CHEM, V275, P8233, DOI 10.1074/jbc.275.11.8233; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000	46	31	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15155	15163		10.1074/jbc.M009822200	http://dx.doi.org/10.1074/jbc.M009822200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11297519	hybrid			2022-12-27	WOS:000168528800084
J	Singh, SK; Matsuno, K; LaPorte, DC; Banaszak, LJ				Singh, SK; Matsuno, K; LaPorte, DC; Banaszak, LJ			Crystal structure of Bacillus subtilis isocitrate dehydrogenase at 1.55 angstrom - Insights into the nature of substrate specificity exhibited by Escherichia coli isocitrate dehydrogenase kinase/phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; X-RAY-DIFFRACTION; MOLECULAR-DYNAMICS; ACTIVE-SITE; PHOSPHORYLATION; ENZYME; PHOSPHATASE; REFINEMENT; MECHANISM; MAPS	Isocitrate dehydrogenase from Bacillus subtilis (BsIDH) is a member of a family of metal-dependent decarboxylating dehydrogenases, Its crystal structure was solved to 1.55 Angstrom and detailed comparisons with the homologue from Escherichia coli (EcIDH), the founding member of this family, were made. Although the two IDHs are structurally similar, there are three notable differences between them. First, a mostly nonpolar P-strand and two connecting loops in the small domain of EcIDH are replaced by two polar alpha -helices in BsIDH. Because of a 13-residue insert in this region of BsIDH, these helices protrude over the active site cleft of the opposing monomer, Second, a coil leading into this cleft, the so-called "phosphorylation" loop, is bent inward in the B, subtilis enzyme, narrowing the entrance to the active site from about 12 to 4 Angstrom. Third, although BsIDH is a homodimer, the two unique crystallographic subunits of BsIDH are not structurally identical. The two monomers appear to differ by a domain shift of the large domain relative to the small domain/clasp region, reminiscent of what has been observed in the open/closed conformations of EcIDH. In Escherichia coli, IDH is regulated by reversible phosphorylation by the bifunctional enzyme IDH kinase/phosphatase (IDH-K/P), The site of phosphorylation is Ser(113), which lies deep within the active site crevice. Structural differences between EcIDH and BsIDH may explain disparities in their abilities to act as substrates for IDH-K/P.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	University of Minnesota System; University of Minnesota Twin Cities; Tufts University	Banaszak, LJ (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	len_b@dcmir.med.umn.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036718] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 36718] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585, DOI 10.1107/S0108767390002355; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BRUNGER AT, 1990, XPLOR VERSION 3 1 SY; DEAN AM, 1990, SCIENCE, V249, P1044, DOI 10.1126/science.2204110; DEAN AM, 1989, J BIOL CHEM, V264, P20482; DEAN AM, 1993, BIOCHEMISTRY-US, V32, P9302, DOI 10.1021/bi00087a007; Duret L, 1996, COMPUT APPL BIOSCI, V12, P507; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FinerMoore J, 1997, BIOCHEMISTRY-US, V36, P13890, DOI 10.1021/bi9711691; FUJINAGA M, 1987, J APPL CRYSTALLOGR, V20, P517, DOI 10.1107/S0021889887086102; HOWARD A, 1978, J APPL CRYSTALLOGR, V20, P383; HUBER R, 1965, ACTA CRYSTALLOGR, V19, P353, DOI 10.1107/S0365110X65003444; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026; HURLEY JH, 1990, SCIENCE, V249, P1012, DOI 10.1126/science.2204109; HURLEY JH, 1990, J BIOL CHEM, V265, P3599; JIANG JS, 1994, J MOL BIOL, V243, P100, DOI 10.1006/jmbi.1994.1633; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JONES TA, 1992, MOL REPLACEMENT, P91; KEMP BE, 1977, J BIOL CHEM, V252, P4888; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KORNBERG HL, 1966, BIOCHEM J, V99, P1; LAPORTE DC, 1984, J BIOL CHEM, V259, P4068; LAPORTE DC, 1985, J BIOL CHEM, V260, P563; LAPORTE DC, 1982, NATURE, V300, P458, DOI 10.1038/300458a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEVITT DG, 1993, J APPL CRYSTALLOGR, V26, P736, DOI 10.1107/S0021889893003279; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Matsuno K, 1999, J BACTERIOL, V181, P3382, DOI 10.1128/JB.181.11.3382-3391.1999; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCKEE JS, 1989, BIOCHIMIE, V71, P1059, DOI 10.1016/0300-9084(89)90111-9; Miller SP, 2000, J BIOL CHEM, V275, P833, DOI 10.1074/jbc.275.2.833; NIMMO GA, 1984, EUR J BIOCHEM, V141, P409, DOI 10.1111/j.1432-1033.1984.tb08206.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; SPRANG SR, 1988, NATURE, V336, P215, DOI 10.1038/336215a0; SRIDHARAN S, 1995, J COMPUT CHEM, V16, P1038, DOI 10.1002/jcc.540160810; STEIGEMANN W, 1974, THESIS TU MUENCHEN; STODDARD BL, 1993, BIOCHEMISTRY-US, V32, P9310, DOI 10.1021/bi00087a008; Stroud RM, 1991, CURR OPIN STRUC BIOL, V1, P826, DOI 10.1016/0959-440X(91)90186-W; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; 1996, KALEIDAGRAPH SYNERGY	48	52	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2001	276	28					26154	26163		10.1074/jbc.M101191200	http://dx.doi.org/10.1074/jbc.M101191200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451VP	11290745	hybrid			2022-12-27	WOS:000169823300070
J	Wright, MM; Henneberry, AL; Lagace, TA; Ridgway, ND; McMaster, CR				Wright, MM; Henneberry, AL; Lagace, TA; Ridgway, ND; McMaster, CR			Uncoupling farnesol-induced apoptosis from its inhibition of phosphatidylcholine synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLINEPHOSPHOTRANSFERASE ACTIVITY; CELL-DEATH; BIOSYNTHESIS; INDUCTION; CANCER; FARNESYLTRANSFERASE; TOXICITY; CLONING; CHOLINE	Genetic inactivation of the synthesis of phosphatidylcholine, the most abundant membrane lipid in eukaryotic cells, induces apoptosis, Administration of farnesol, a catabolite within the isoprenoid/cholesterol pathway, also induces apoptosis, The mechanism by which farnesol induces apoptosis is currently believed to be by direct competitive inhibition with diacylglycerol for cholinephosphotransferase, the final step in the phosphatidylcholine biosynthetic pathway. Our recent isolation of the first mammalian cholinephosphotransferase cDNA has enabled us to more precisely assess how farnesol affects phosphatidylcholine synthesis and the induction of apoptosis, Induced over-expression of cholinephosphotransferase in Chinese hamster ovary cells prevented the block in phosphatidylcholine biosynthesis associated with exposure to farnesol, However, induced over-expression of cholinephosphotransferase was not sufficient for the prevention of farnesol-induced apoptosis, In addition, exogenous administration of diacylglycerol prevented farnesol-induced apoptosis but did not relieve the farnesol-induced block in phosphatidylcholine synthesis. We also developed an in vitro lipid mixed micelle cholinephosphotransferase enzyme assay, as opposed to the delivery of the diacylglycerol substrate in a detergent emulsion, and demonstrated that there was no direct inhibition of cholinephosphotransferase by farnesol or its phosphorylated metabolites. The execution of apoptosis by farnesol appears to be a separate and distinct event from farnesol-induced inhibition of phosphatidylcholine biosynthesis and instead likely occurs through a diacylglycerol-mediated process that is downstream of phosphatidylcholine synthesis.	Dalhousie Univ, Atlantic Res Ctr, IWK Hlth Ctr, Dept Pediat, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Atlantic Res Ctr, IWK Hlth Ctr, Dept Biochem & Mol Biol, Halifax, NS B3H 4H7, Canada	Dalhousie University; Dalhousie University	McMaster, CR (corresponding author), Dalhousie Univ, Atlantic Res Ctr, IWK Hlth Ctr, Dept Pediat, Halifax, NS B3H 4H7, Canada.			McMaster, Christopher/0000-0003-0822-5776; Ridgway, Neale/0000-0002-0441-6228				ADANY I, 1994, CANCER LETT, V79, P175, DOI 10.1016/0304-3835(94)90257-7; AMES BN, 1960, J BIOL CHEM, V235, P769; Anthony ML, 1999, J BIOL CHEM, V274, P19686, DOI 10.1074/jbc.274.28.19686; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; Henneberry AL, 1999, BIOCHEM J, V339, P291, DOI 10.1042/0264-6021:3390291; Henneberry AL, 2000, J BIOL CHEM, V275, P29808, DOI 10.1074/jbc.M005786200; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; KOLESNICK RN, 1990, BIOCHEM J, V267, P17, DOI 10.1042/bj2670017; Law BK, 2000, J BIOL CHEM, V275, P10796, DOI 10.1074/jbc.275.15.10796; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mangues R, 1998, CANCER RES, V58, P1253; Meigs TE, 1996, J BIOL CHEM, V271, P7916, DOI 10.1074/jbc.271.14.7916; MELNYKOVYCH G, 1992, BIOCHEM BIOPH RES CO, V186, P543, DOI 10.1016/S0006-291X(05)80842-3; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; Miquel K, 1998, J BIOL CHEM, V273, P26179, DOI 10.1074/jbc.273.40.26179; O KM, 1993, BIOCHEM J, V289, P727, DOI 10.1042/bj2890727; Park HW, 1997, CURR OPIN STRUC BIOL, V7, P873; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Rioja A, 2000, FEBS LETT, V467, P291, DOI 10.1016/S0014-5793(00)01168-6; Sellers WR, 1999, J CLIN INVEST, V104, P1655, DOI 10.1172/JCI9053; Sinensky M, 2000, BBA-MOL CELL BIOL L, V1484, P93, DOI 10.1016/S1388-1981(00)00009-3; TANIGUCHI S, 1986, J BIOCHEM-TOKYO, V100, P485, DOI 10.1093/oxfordjournals.jbchem.a121737; VANCE DE, 1996, BIOCH LIPIDS LIPOPRO, P153; VOZIYAN PA, 1995, BIOCHEM BIOPH RES CO, V212, P479, DOI 10.1006/bbrc.1995.1995; VOZIYAN PA, 1993, BIOCHEM J, V295, P757, DOI 10.1042/bj2950757; Williams SNO, 1998, MAGNET RESON MED, V40, P411, DOI 10.1002/mrm.1910400311; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; YAZLOVITSKAYA EM, 1995, CANCER LETT, V88, P179, DOI 10.1016/0304-3835(94)03635-V	37	48	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					25254	25261		10.1074/jbc.M011552200	http://dx.doi.org/10.1074/jbc.M011552200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11306571	hybrid			2022-12-27	WOS:000169800700110
J	Romeo, AM; Christen, L; Niles, EG; Kosman, DJ				Romeo, AM; Christen, L; Niles, EG; Kosman, DJ			Intracellular chelation of iron by bipyridyl inhibits DNA virus replication - Ribonucleotide reductase maturation as a probe of intracellular iron pools	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; VACCINIA VIRUS; SMALL-SUBUNIT; FERRITIN; PROTEIN; ACQUISITION; BINDING; YEAST; GENE; SIDEROPHORES	The efficient replication of large DNA viruses requires dNTPs supplied by a viral ribonucleotide reductase, Viral ribonucleotide reductase is an early gene product of both vaccinia and herpes simplex virus. For productive infection, the apoprotein must scavenge iron from the endogenous, labile iron pool(s), The membrane-permeant, intracellular Fe2+ chelator, 2,2'-bipyridine (bipyridyl, BIP), is known to sequester iron from this pool. We show here that BIP strongly inhibits the replication of both vaccinia and herpes simplex virus, type 1, In a standard plaque assay, 50 muM BIP caused a 50% reduction in plaque-forming units with either virus, Strong inhibition was observed only when BIP was added within 3 h post-infection. This time dependence was observed also in regards to inhibition of viral late protein and DNA synthesis by BIP, BIP did not inhibit the activity of vaccinia ribonucleotide reductase (RR), its synthesis, nor its stability indicating that BIP blocked the activation of the apoprotein, In parallel with its inhibition of vaccinia RR activation, BIP treatment increased the RNA binding activity of the endogenous iron-response protein, IRP1, by 1.9-fold. The data indicate that the diiron prosthetic group in vaccinia RR is assembled from iron taken from the BIP-accessible, labile iron pool that is sampled also by ferritin and the iron-regulated protein found in the cytosol of mammalian cells.	SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kosman, DJ (corresponding author), SUNY Buffalo, Dept Biochem, 140 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	camkos@acsu.buffalo.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053820] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43933] Funding Source: Medline; NIDDK NIH HHS [DK53820] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aisen P, 1999, CURR OPIN CHEM BIOL, V3, P200, DOI 10.1016/S1367-5931(99)80033-7; BREUER W, 1995, J BIOL CHEM, V270, P24209, DOI 10.1074/jbc.270.41.24209; Britigan BE, 2000, INFECT IMMUN, V68, P1271, DOI 10.1128/IAI.68.3.1271-1275.2000; Cabantchik ZI, 1999, FEMS IMMUNOL MED MIC, V26, P289, DOI 10.1111/j.1574-695X.1999.tb01401.x; CAMERON JM, 1988, J GEN VIROL, V69, P2607, DOI 10.1099/0022-1317-69-10-2607; Chabes A, 2000, P NATL ACAD SCI USA, V97, P2474, DOI 10.1073/pnas.97.6.2474; Cinatl J, 1996, ANTIVIR RES, V31, P23, DOI 10.1016/0166-3542(95)00833-0; CONDIT RC, 1981, VIROLOGY, V113, P224, DOI 10.1016/0042-6822(81)90150-1; Cooper CE, 1996, J BIOL CHEM, V271, P20291, DOI 10.1074/jbc.271.34.20291; CORNELISSEN CN, 1994, MOL MICROBIOL, V14, P843, DOI 10.1111/j.1365-2958.1994.tb01320.x; Darnell G, 1999, BLOOD, V94, P781, DOI 10.1182/blood.V94.2.781.414k32_781_792; Eisenstein RS, 1997, CH MICROBIOL SER, P157; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Hanson ES, 1998, J BIOL CHEM, V273, P7588, DOI 10.1074/jbc.273.13.7588; Harrison MD, 1999, J BIOL INORG CHEM, V4, P145, DOI 10.1007/s007750050297; Hassett RF, 1998, J BIOL CHEM, V273, P7628, DOI 10.1074/jbc.273.13.7628; HILL HAO, 1983, BIOL ASPECTS METALS, P15; Howard DH, 1999, CLIN MICROBIOL REV, V12, P394, DOI 10.1128/CMR.12.3.394; HOWELL ML, 1992, J BIOL CHEM, V267, P1705; HOWELL ML, 1993, J BIOL CHEM, V268, P7155; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; IDOWU AD, 1992, ANTIVIR RES, V17, P145, DOI 10.1016/0166-3542(92)90048-A; JACOBSON JG, 1989, VIROLOGY, V173, P276, DOI 10.1016/0042-6822(89)90244-4; Konijn AM, 1999, BLOOD, V94, P2128, DOI 10.1182/blood.V94.6.2128.418k20_2128_2134; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamarche N, 1996, BIOCHEM J, V320, P129, DOI 10.1042/bj3200129; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Mabeza GF, 1999, PHARMACOL THERAPEUT, V81, P53, DOI 10.1016/S0163-7258(98)00037-0; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Nguyen HHT, 1999, P NATL ACAD SCI USA, V96, P12339, DOI 10.1073/pnas.96.22.12339; NILES EG, 1989, VIROLOGY, V172, P513, DOI 10.1016/0042-6822(89)90194-3; NYHOLM S, 1993, J BIOL CHEM, V268, P26200; Picard V, 1998, J BIOL CHEM, V273, P15382, DOI 10.1074/jbc.273.25.15382; Polla BS, 1999, BIOCHEM PHARMACOL, V57, P1345, DOI 10.1016/S0006-2952(99)00017-9; PRICHARD MN, 1995, CHEMOTHERAPY, V41, P384, DOI 10.1159/000239371; RAGUZZI F, 1988, FEBS LETT, V231, P253, DOI 10.1016/0014-5793(88)80742-7; Richardson DR, 1997, CAN J PHYSIOL PHARM, V75, P1164, DOI 10.1139/cjpp-75-10-11-1164; SLABAUGH MB, 1986, J VIROL, V60, P506, DOI 10.1128/JVI.60.2.506-514.1986; SLABAUGH MB, 1993, J BIOL CHEM, V268, P17803; SLABAUGH MB, 1984, J VIROL, V52, P507, DOI 10.1128/JVI.52.2.507-514.1984; SWENSON GR, 1991, BIOL MET, V4, P48, DOI 10.1007/BF01135557; Taramelli D, 2000, INFECT IMMUN, V68, P1724, DOI 10.1128/IAI.68.3.1724-1726.2000; Thomas F, 1999, J BIOL CHEM, V274, P13375, DOI 10.1074/jbc.274.19.13375; Urbanowski JL, 1999, J BIOL CHEM, V274, P38061, DOI 10.1074/jbc.274.53.38061; WALDEN WE, 1988, P NATL ACAD SCI USA, V85, P9503, DOI 10.1073/pnas.85.24.9503; Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114; WEINBERG ED, 1995, CURR OPIN INFECT DIS, V8, P164, DOI 10.1097/00001432-199506000-00004; Wessling-Resnick M, 1999, CRIT REV BIOCHEM MOL, V34, P285, DOI 10.1080/10409239991209318; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x	51	52	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24301	24308		10.1074/jbc.M010806200	http://dx.doi.org/10.1074/jbc.M010806200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11301321	hybrid			2022-12-27	WOS:000169531100141
J	Ginsberg, MH; Yaspan, B; Forsyth, J; Ulmer, TS; Campbell, ID; Slepak, M				Ginsberg, MH; Yaspan, B; Forsyth, J; Ulmer, TS; Campbell, ID; Slepak, M			A membrane-distal segment of the integrin alpha(IIb) cytoplasmic domain regulates integrin activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUT SIGNAL-TRANSDUCTION; PLATELET GPIIB-IIIA; BETA-SUBUNIT; PROXIMAL REGION; CELL-ADHESION; TALIN-BINDING; TAIL; MODULATION; RECEPTOR; AFFINITY	Previous evidence suggests that interactions between integrin cytoplasmic domains regulate integrin activation. We have constructed and validated recombinant structural mimics of the heterodimeric alpha (IIb)beta (3) cytoplasmic domain. The mimics elicited polyclonal antibodies that recognize a combinatorial epitope(s) formed in mixtures of the alpha (.)(IIb) and beta (3) cytoplasmic domains but not present in either isolated tail. This epitope(s) is present within intact alpha (IIb)beta (3), indicating that interaction between the tails can occur in the native integrin. Furthermore, the combinatorial epitope(s) is also formed by introducing the activation-blocking beta (3)(Y747A) mutation into the beta (3) tail. A membrane-distal heptapeptide sequence in the alpha (IIb) tail ((RPPLEED)-R-997) is responsible for this effect on beta (3). Membrane-permeant palmitoylated peptides, containing this alpha (IIb) sequence, specifically blocked alpha (IIb)beta (3) activation in platelets. Thus, this region of the alpha (IIb) tail causes the beta (3) tail to resemble that of beta (3)(Y747A) and suppresses activation of the integrin.	Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Scripps Research Institute; University of Oxford	Ginsberg, MH (corresponding author), Scripps Res Inst, Dept Vasc Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Yaspan, Brian/0000-0002-3787-2510				BOYD J, 1992, J MAGN RESON, V98, P660, DOI 10.1016/0022-2364(92)90021-X; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; CHEN YP, 1994, J BIOL CHEM, V269, P18307; CROWE DT, 1994, J BIOL CHEM, V269, P14411; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Haas TA, 1996, J BIOL CHEM, V271, P6017, DOI 10.1074/jbc.271.11.6017; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; HIBBS ML, 1991, SCIENCE, V251, P1611, DOI 10.1126/science.1672776; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JOHN M, 1994, J BIOL CHEM, V269, P16247; Kaapa A, 1999, EXP CELL RES, V250, P524, DOI 10.1006/excr.1999.4533; Laplantine E, 2000, J CELL SCI, V113, P1167; Leisner TM, 1999, J BIOL CHEM, V274, P12945, DOI 10.1074/jbc.274.18.12945; LEONG L, 1995, J CELL SCI, V108, P3817; Lu CF, 1997, J IMMUNOL, V159, P268; Lu CF, 2001, J BIOL CHEM, V276, P14642, DOI 10.1074/jbc.M100600200; Margolis B, 1999, KIDNEY INT, V56, P1230, DOI 10.1046/j.1523-1755.1999.00700.x; MUIR TW, 1994, BIOCHEMISTRY-US, V33, P7701, DOI 10.1021/bi00190a025; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; OTOOLE TE, 1991, SCIENCE, V254, P854; Patil S, 1999, J BIOL CHEM, V274, P28575, DOI 10.1074/jbc.274.40.28575; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; PLOW EF, 1984, J BIOL CHEM, V259, P5388; RABB H, 1993, J IMMUNOL, V151, P990; RESZKA AA, 1992, J CELL BIOL, V117, P1321, DOI 10.1083/jcb.117.6.1321; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Stephens G, 1998, J BIOL CHEM, V273, P20317, DOI 10.1074/jbc.273.32.20317; Tahiliani PD, 1997, J BIOL CHEM, V272, P7892, DOI 10.1074/jbc.272.12.7892; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Wang RG, 1997, J CLIN INVEST, V100, P2393, DOI 10.1172/JCI119780; Williams Michael J., 1994, Trends in Cell Biology, V4, P109, DOI 10.1016/0962-8924(94)90059-0; Wuthrich K, 1986, NMR PROTEINS NUCL AC; YLANNE J, 1995, J BIOL CHEM, V270, P9550; YLANNE J, 1993, J CELL BIOL, V122, P223, DOI 10.1083/jcb.122.1.223	42	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22514	22521		10.1074/jbc.M101915200	http://dx.doi.org/10.1074/jbc.M101915200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11304543	hybrid			2022-12-27	WOS:000169412700073
J	Knudsen, C; Wieden, HJ; Rodnina, MV				Knudsen, C; Wieden, HJ; Rodnina, MV			The importance of structural transitions of the switch II region for the functions of elongation factor Tu on the ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; FACTOR-EF-TU; ESCHERICHIA-COLI RIBOSOME; GTPASE-ACTIVATING-PROTEIN; CRYSTAL-STRUCTURE; CONFORMATIONAL CHANGE; RAS P21; ANGSTROM-RESOLUTION; BINDING DOMAIN; COMPLEX	Elongation factor Tu (EF-Tu) undergoes a large con formational transition when switching from the GTP to GDP forms. Structural changes in the switch I and II regions in the G domain are particularly important for this rearrangement. In the snitch II region, helix alpha2 is flanked by two glycine residues: Gly(83) in the consensus element DXXG at the N terminus and Gly(94) the C terminus. The role of helix alpha2 was studied by pre-steady state kinetic experiments using Escherichia coli EF-Tu mutants where either Gly(83), Gly(94), Or both were replaced with alanine. The G83A mutation slows down the association of the ternary complex EF-Tu.GTP.aminoacyl-tRNA with the ribosome and abolishes the ribosome-induced GTPase activity of EF-Tu. The G94A mutation strongly impairs the conformational change of EF-Tu from the GTP- to the GDP-bound form and decelerates the dissociation of EF-Tu GDP from the ribosome. The behavior of the double mutant is dominated by the G83A mutation. The results directly relate structural transitions in the switch II region to specific functions of EF-Tu on the ribosome.	Univ Witten Herdecke, Inst Phys Biochem, D-58448 Witten, Germany; Aarhus Univ, Inst Mol & Struct Biol, DK-8000 Aarhus C, Denmark	Witten Herdecke University; Aarhus University	Rodnina, MV (corresponding author), Univ Witten Herdecke, Inst Phys Biochem, D-58448 Witten, Germany.		Rodnina, Marina V./AAD-4667-2019	Rodnina, Marina V./0000-0003-0105-3879; Wieden, Hans-Joachim/0000-0001-5181-6059; Knudsen, Charlotte/0000-0003-2356-4821				Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Abel K, 1996, STRUCTURE, V4, P1153, DOI 10.1016/S0969-2126(96)00123-2; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; Berghuis AM, 1996, STRUCTURE, V4, P1277, DOI 10.1016/S0969-2126(96)00136-0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; KJAERSGARD IVH, 1995, EUR J BIOCHEM, V228, P184; KJELDGAARD M, 1992, J MOL BIOL, V223, P721, DOI 10.1016/0022-2836(92)90986-T; Kjeldgaard M, 1996, FASEB J, V10, P1347, DOI 10.1096/fasebj.10.12.8903506; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; KNUDSEN CR, 1995, EUR J BIOCHEM, V228, P176; LEE E, 1992, J BIOL CHEM, V267, P1212; Ma JP, 1997, P NATL ACAD SCI USA, V94, P11905, DOI 10.1073/pnas.94.22.11905; MILLER RT, 1988, NATURE, V334, P712, DOI 10.1038/334712a0; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Pape T, 2000, NAT STRUCT BIOL, V7, P104; Piepenburg O, 2000, BIOCHEMISTRY-US, V39, P1734, DOI 10.1021/bi992331y; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; RODNINA MV, 1995, EMBO J, V14, P2613, DOI 10.1002/j.1460-2075.1995.tb07259.x; Rodnina MV, 1996, J BIOL CHEM, V271, P646, DOI 10.1074/jbc.271.2.646; RODNINA MV, 1994, BIOCHEMISTRY-US, V33, P12267, DOI 10.1021/bi00206a033; Sasaki N, 1998, J BIOL CHEM, V273, P20334, DOI 10.1074/jbc.273.32.20334; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SCHLICHTING I, 1990, NATURE, V345, P309, DOI 10.1038/345309a0; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; SUNG YJ, 1995, BIOCHEMISTRY-US, V34, P3470, DOI 10.1021/bi00010a040; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; Vorstenbosch E, 1996, EMBO J, V15, P6766, DOI 10.1002/j.1460-2075.1996.tb01066.x	39	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22183	22190		10.1074/jbc.M102186200	http://dx.doi.org/10.1074/jbc.M102186200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11304547	hybrid			2022-12-27	WOS:000169412700030
J	Neudecker, P; Schweimer, K; Nerkamp, J; Scheurer, S; Vieths, S; Sticht, H; Rosch, P				Neudecker, P; Schweimer, K; Nerkamp, J; Scheurer, S; Vieths, S; Sticht, H; Rosch, P			Allergic cross-reactivity made visible - Solution structure of the major cherry allergen Pru av 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIRCH POLLEN ALLERGEN; PATHOGENESIS-RELATED PROTEINS; INTERPROTON DISTANCE DATA; PULSED-FIELD GRADIENTS; 3-DIMENSIONAL STRUCTURES; NMR DATA; BET-V-1; PROGRAM; CLONING; SPECTROSCOPY	Birch pollinosis is often accompanied by hypersensitivity to fruit as a consequence of the cross-reaction of pollen allergen-specific IgE antibodies with homologous food proteins. To provide a basis for examining the cross-reactivity on a structural level, we used heteronuclear multidimensional NMR spectroscopy to determine the high-resolution three dimensional structure of the major cherry allergen, Pru av 1, in solution. Based on a detailed comparison of the virtually identical structures of Pru av 1 and Bet v 1, the major birch pollen allergen, we propose an explanation for a significant aspect of the observed cross-reactivity pattern among the family of allergens under consideration. The large hydrophobic cavity expected to be important for the still unknown physiological function of Bet v 1 is conserved in Pru av 1. Structural homology to a domain of human MLN64 associated with cholesterol transport suggests phytosteroids as putative ligands for Pru av 1, NMR spectroscopy provides experimental evidence that Pru av 1 interacts with phytosteroids, and molecular modeling shows that the hydrophobic cavity is large enough to accommodate two such molecules.	Univ Bayreuth, Lehrstuhl Biopolymere, D-95440 Bayreuth, Germany; Paul Ehrlich Inst, Abt Allergol, D-63225 Langen, Germany	University of Bayreuth; Paul Ehrlich Institute	Rosch, P (corresponding author), Univ Bayreuth, Lehrstuhl Biopolymere, Univ Str 30, D-95447 Bayreuth, Germany.	paul.roesch@uni-bayreuth.de	Neudecker, Philipp/G-5265-2013; Rösch, Paul/I-5445-2014; Neudecker, Philipp/AAP-9005-2020; Scheurer, Stephan/A-6509-2019	Neudecker, Philipp/0000-0002-0557-966X; Rösch, Paul/0000-0003-3330-2446; Neudecker, Philipp/0000-0002-0557-966X; Scheurer, Stephan/0000-0002-2859-562X; Sticht, Heinrich/0000-0001-5644-045X; Schweimer, Kristian/0000-0002-3837-8442				BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Beissinger M, 1998, EMBO J, V17, P27, DOI 10.1093/emboj/17.1.27; Boehm M, 1997, BIOL CHEM, V378, P687, DOI 10.1515/bchm.1997.378.7.687; BREITENEDER H, 1995, EUR J BIOCHEM, V233, P484, DOI 10.1111/j.1432-1033.1995.484_2.x; BREITENEDER H, 1989, EMBO J, V8, P1935, DOI 10.1002/j.1460-2075.1989.tb03597.x; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; BRUNGER AT, 1993, SCIENCE, V261, P328, DOI 10.1126/science.8332897; Bufe A, 1996, PLANTA, V199, P413, DOI 10.1007/BF00195733; Cavanagh J., 1996, PROTEIN NMR SPECTROS, P447; DAYIE KT, 1994, J MAGN RESON SER A, V111, P121, DOI 10.1006/jmra.1994.1236; Diercks T, 1999, J BIOMOL NMR, V15, P177, DOI 10.1023/A:1008367912535; Faber C, 1996, J BIOL CHEM, V271, P19243, DOI 10.1074/jbc.271.32.19243; Ferreira F, 1998, FASEB J, V12, P231, DOI 10.1096/fasebj.12.2.231; FRENKIEL T, 1990, J MAGN RESON, V90, P420, DOI 10.1016/0022-2364(90)90152-Y; Fujioka S, 1999, BRASSINOSTEROIDS, P21; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; GHOSH D, 1995, STRUCTURE, V3, P279, DOI 10.1016/S0969-2126(01)00158-7; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hoffmann-Sommergruber K, 2000, INT ARCH ALLERGY IMM, V122, P155, DOI 10.1159/000024392; HOLAK TA, 1989, FEBS LETT, V242, P218, DOI 10.1016/0014-5793(89)80473-9; HOLM J, 2000, ALLERGY, V55, P21; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; IKURA M, 1990, J AM CHEM SOC, V112, P9020, DOI 10.1021/ja00180a080; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KARAMLOO F, 2000, IN PRESS J CHROMAT B; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuszewski J, 2000, J MAGN RESON, V146, P249, DOI 10.1006/jmre.2000.2142; Kuszewski J, 1996, PROTEIN SCI, V5, P1067; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Neudecker P, 2000, J BIOMOL NMR, V18, P71, DOI 10.1023/A:1008357100592; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; POWELL MJD, 1977, MATH PROGRAM, V12, P241, DOI 10.1007/BF01593790; Scheurer S, 1997, MOL IMMUNOL, V34, P619, DOI 10.1016/S0161-5890(97)00072-2; Scheurer S, 1999, MOL IMMUNOL, V36, P155, DOI 10.1016/S0161-5890(99)00033-4; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; SCHONING B, 1995, J SCI FOOD AGR, V67, P431, DOI 10.1002/jsfa.2740670403; Schweimer K, 1999, APPL MAGN RESON, V17, P449, DOI 10.1007/BF03162177; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; SLUYTERMAN LAA, 1978, J CHROMATOGR, V150, P17, DOI 10.1016/S0021-9673(01)92092-8; Sticht H, 1998, J MOL BIOL, V276, P177, DOI 10.1006/jmbi.1997.1528; SWOBODA I, 1995, PLANT CELL ENVIRON, V18, P865, DOI 10.1111/j.1365-3040.1995.tb00595.x; Talluri S, 1996, J MAGN RESON SER B, V112, P200, DOI 10.1006/jmrb.1996.0132; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Valenta R, 1999, BIOL CHEM, V380, P815, DOI 10.1515/BC.1999.101; VANEKKREBITZ M, 1995, BIOCHEM BIOPH RES CO, V214, P538, DOI 10.1006/bbrc.1995.2320; Vieths S., 1992, Food and Agricultural Immunology, V4, P181, DOI 10.1080/09540109209354767; VIETHS S, 2000, ARBEITEN P EHRLICH I, V93, P159; VIETHS S, 1997, HDB PLANT FUNGAL TOX, P157	56	139	148	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22756	22763		10.1074/jbc.M101657200	http://dx.doi.org/10.1074/jbc.M101657200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11287426	hybrid			2022-12-27	WOS:000169412700104
J	Usacheva, A; Smith, R; Minshall, R; Baida, G; Seng, SH; Croze, E; Colamonici, O				Usacheva, A; Smith, R; Minshall, R; Baida, G; Seng, SH; Croze, E; Colamonici, O			The WD motif-containing protein receptor for activated protein kinase C (RACK1) is required for recruitment and activation of signal transducer and activator of transcription 1 through the type I interferon receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE RECEPTOR; BETA-SUBUNIT; TYROSINE PHOSPHORYLATION; CYTOKINE RECEPTORS; CYTOPLASMIC DOMAIN; STAT-PATHWAY; ALPHA; INTERACTS; COMMON; CHAIN	An obligatory step in the activation of Signal Transducers and Activators of Transcription (STATs) by cytokines is their docking to specific receptors via phosphotyrosines. However, this model does not address whether STATs pre-associate with their corresponding receptor or exist free in the cytoplasm before receptor activation. In this report, we demonstrate that pre-association of STAT1 with the receptor is required for type I interferon (IFN) signaling. Interestingly, the interaction between the human type I IFN receptor and STAT1 is not direct but mediated by the adapter protein receptor for activated protein kinase C (RACK1). Disruption of the IFN alpha receptor-RACK1 interaction abolishes not only IFN alpha -induced tyrosine phosphorylation of STAT1 but also activation of STATE, indicating that RACK1 plays a central role in early signaling through the Jak-STAT pathway. These findings demonstrate the involvement of RACK1 in STAT1 activation and raise the possibility that other STATs may pre-associate with cytokine receptors through similar adapter-STAT-mediated interactions.	Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; Berlex Biosci, Dept Immunol, Richmond, CA 94804 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colamonici, O (corresponding author), Univ Illinois, Dept Pharmacol, 835 S Wolcott Ave,M-C868 Rm E403, Chicago, IL 60612 USA.		Usacheva, Anna/J-7543-2018	Usacheva, Anna/0000-0001-7508-6513	NIGMS NIH HHS [GM54709] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054709] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; CHEUNG SC, 1991, J IMMUNOL, V146, P121; COLAMONICI OR, 1993, J BIOL CHEM, V268, P10895; Collum RG, 2000, P NATL ACAD SCI USA, V97, P10120, DOI 10.1073/pnas.170192197; Croze E, 2000, J IMMUNOL, V165, P5127, DOI 10.4049/jimmunol.165.9.5127; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Domanski P, 1997, J BIOL CHEM, V272, P26388, DOI 10.1074/jbc.272.42.26388; GarciaHiguera I, 1996, BIOCHEMISTRY-US, V35, P13985, DOI 10.1021/bi9612879; Geijsen N, 1999, ONCOGENE, V18, P5126, DOI 10.1038/sj.onc.1202896; GHISLAIN J, 1995, J BIOL CHEM, V270, P21785, DOI 10.1074/jbc.270.37.21785; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; GREENLUND AC, 1995, IMMUNITY, V2, P677, DOI 10.1016/1074-7613(95)90012-8; HACKETT RH, 1995, J BIOL CHEM, V270, P21326, DOI 10.1074/jbc.270.36.21326; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; MOCHLYROSEN D, 1995, BIOCHEM SOC T, V23, P596, DOI 10.1042/bst0230596; MOCHLYROSEN D, 1991, J BIOL CHEM, V266, P14866; Nadeau OW, 1999, J BIOL CHEM, V274, P4045, DOI 10.1074/jbc.274.7.4045; Neer EJ, 1996, CELL, V84, P175, DOI 10.1016/S0092-8674(00)80969-1; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Schindler C, 1999, EXP CELL RES, V253, P7, DOI 10.1006/excr.1999.4670; SCHINDLER S, 1995, ANNU REV BIOCHEM, V64, P621; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Stancato LF, 1996, J BIOL CHEM, V271, P4134; Uddin S, 1997, J IMMUNOL, V158, P2390; Uddin S, 1997, BLOOD, V90, P2574; Uddin S, 1997, BIOCHEM BIOPH RES CO, V235, P83, DOI 10.1006/bbrc.1997.6741; WANG YD, 1995, J BIOL CHEM, V270, P7021, DOI 10.1074/jbc.270.13.7021; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; Zhu MH, 1998, J BIOL CHEM, V273, P10719, DOI 10.1074/jbc.273.17.10719	36	64	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22948	22953		10.1074/jbc.M100087200	http://dx.doi.org/10.1074/jbc.M100087200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301323	hybrid			2022-12-27	WOS:000169412700129
J	White, PW; Pelletier, A; Brault, K; Titolo, S; Welchner, E; Thauvette, L; Fazekas, M; Cordingley, MG; Archambault, J				White, PW; Pelletier, A; Brault, K; Titolo, S; Welchner, E; Thauvette, L; Fazekas, M; Cordingley, MG; Archambault, J			Characterization of recombinant HPV6 and 11 E1 helicases - Effect of ATP on the interaction of E1 with E2 and mapping of a minimal helicase domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAPILLOMAVIRUS TYPE-1 E1; LARGE T-ANTIGEN; DNA-POLYMERASE-ALPHA; NUCLEAR-LOCALIZATION SIGNAL; SEDIMENTATION-VELOCITY DATA; REPLICATION PROTEIN-A; LARGE TUMOR-ANTIGEN; BOVINE PAPILLOMAVIRUS; BINDING DOMAIN; VIRAL E1	To better characterize the enzymatic activities required for human papillomavirus (HPV) DNA replication, the El helicases of HPV types 6 and 11 were produced using a baculovirus expression system. The purified wild type proteins and a version of HPV11 El lacking the N-terminal 71 amino acids, which was better expressed, were found to be hexameric over a wide range of concentrations and to have helicase and ATPase activities with relatively low values for K-m(ATP) of 12 muM for HPV6 El and 6 muM for HPV11 El. Interestingly, the value of K-m(ATP) was increased 7-fold in the presence of the E2 transactivation domain. In turn, ATP was found to perturb the co-operative binding of El and E2 to DNA. Mutant and truncated versions of in vitro translated El were used to identify a minimal ATPase domain composed of the C-terminal 297 amino acids. This fragment was expressed, purified, and found to be fully active in ATP hydrolysis, single-stranded DNA binding, and unwinding assays, despite lacking the minimal origin-binding domain.	Boehringer Ingelheim Canada Ltd, Dept Sci Biol, Laval, PQ H7S 2G5, Canada	Boehringer Ingelheim	White, PW (corresponding author), Boehringer Ingelheim Canada Ltd, Dept Sci Biol, 2100 Cunard St, Laval, PQ H7S 2G5, Canada.	pwhite@lav.boehringer-ingelheim.com		Archambault, Jacques/0000-0001-8107-3428				Amin AA, 2000, VIROLOGY, V272, P137, DOI 10.1006/viro.2000.0328; BENSON JD, 1995, J VIROL, V69, P4364, DOI 10.1128/JVI.69.7.4364-4372.1995; Berg M, 1997, J VIROL, V71, P3853, DOI 10.1128/JVI.71.5.3853-3863.1997; Bird LE, 1997, NUCLEIC ACIDS RES, V25, P2620, DOI 10.1093/nar/25.13.2620; BISHOP EO, 1981, BIOCHIM BIOPHYS ACTA, V635, P63, DOI 10.1016/0005-2728(81)90007-4; Biswas EE, 1999, BIOCHEMISTRY-US, V38, P10919, DOI 10.1021/bi990048t; BISWAS SB, 1994, BIOCHEMISTRY-US, V33, P11307, DOI 10.1021/bi00203a028; BLITZ IL, 1991, J VIROL, V65, P649, DOI 10.1128/JVI.65.2.649-656.1991; BONNEANDREA C, 1995, J VIROL, V69, P2341, DOI 10.1128/JVI.69.4.2341-2350.1995; Chen G, 1998, J VIROL, V72, P2567, DOI 10.1128/JVI.72.4.2567-2576.1998; CLARK R, 1981, J BIOL CHEM, V256, P1854; CLERTANT P, 1984, NATURE, V311, P276, DOI 10.1038/311276a0; Conger KL, 1999, J BIOL CHEM, V274, P2696, DOI 10.1074/jbc.274.5.2696; Cooper CS, 1998, VIROLOGY, V241, P312, DOI 10.1006/viro.1997.8941; Cueille N, 1998, J VIROL, V72, P7255, DOI 10.1128/JVI.72.9.7255-7262.1998; DEAN FB, 1992, J BIOL CHEM, V267, P14129; FERSHT A, 1999, STRUCTURE MECH PROTE, P126; Fouts ET, 1999, J BIOL CHEM, V274, P4447, DOI 10.1074/jbc.274.7.4447; FRATTINI MG, 1994, P NATL ACAD SCI USA, V91, P12398, DOI 10.1073/pnas.91.26.12398; GIACHERIO D, 1979, J BIOL CHEM, V254, P8113; GILLETTE TG, 1994, P NATL ACAD SCI USA, V91, P8846, DOI 10.1073/pnas.91.19.8846; GOETZ GS, 1988, J BIOL CHEM, V263, P383; GORBALENYA AE, 1990, FEBS LETT, V262, P145, DOI 10.1016/0014-5793(90)80175-I; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Han YF, 1999, J VIROL, V73, P4899, DOI 10.1128/JVI.73.6.4899-4907.1999; HOWLEY PM, 1996, FIELDS VIROLOGY, P2045; Huang SG, 1998, BIOCHEMISTRY-US, V37, P15336, DOI 10.1021/bi981094g; HUGHES FJ, 1998, NUCLEIC ACIDS RES, V21, P5817; ITAYA K, 1966, CLIN CHIM ACTA, V14, P361, DOI 10.1016/0009-8981(66)90114-8; Jenkins O, 1996, J GEN VIROL, V77, P1805, DOI 10.1099/0022-1317-77-8-1805; KUO SR, 1994, J BIOL CHEM, V269, P24058; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leng X, 1997, J VIROL, V71, P848, DOI 10.1128/JVI.71.1.848-852.1997; LENTZ MR, 1993, J VIROL, V67, P1414, DOI 10.1128/JVI.67.3.1414-1423.1993; Liu JS, 1998, J BIOL CHEM, V273, P30704, DOI 10.1074/jbc.273.46.30704; LUSKY M, 1994, P NATL ACAD SCI USA, V91, P8895, DOI 10.1073/pnas.91.19.8895; LUSKY M, 1991, P NATL ACAD SCI USA, V88, P6363, DOI 10.1073/pnas.88.14.6363; LUSKY M, 1993, J BIOL CHEM, V268, P15795; Ma TL, 1999, P NATL ACAD SCI USA, V96, P382, DOI 10.1073/pnas.96.2.382; MACPHERSON P, 1994, VIROLOGY, V204, P403, DOI 10.1006/viro.1994.1544; Masterson PJ, 1998, J VIROL, V72, P7407, DOI 10.1128/JVI.72.9.7407-7419.1998; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; McShan GD, 1997, J GEN VIROL, V78, P171, DOI 10.1099/0022-1317-78-1-171; MOHR IJ, 1990, SCIENCE, V250, P1694, DOI 10.1126/science.2176744; Muller F, 1996, VIROLOGY, V219, P247, DOI 10.1006/viro.1996.0242; NAKAYAMA N, 1984, J BIOL CHEM, V259, P88; PARK P, 1994, P NATL ACAD SCI USA, V91, P8700, DOI 10.1073/pnas.91.18.8700; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Phelps WC, 1998, ANTIVIR CHEM CHEMOTH, V9, P359, DOI 10.1177/095632029800900501; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Philo JS, 1997, BIOPHYS J, V72, P435, DOI 10.1016/S0006-3495(97)78684-3; RAJ K, 1995, J GEN VIROL, V76, P2949, DOI 10.1099/0022-1317-76-12-2949; Rocque WJ, 2000, PROTEIN EXPRES PURIF, V18, P148, DOI 10.1006/prep.1999.1182; Sakai H, 1996, J VIROL, V70, P1602, DOI 10.1128/JVI.70.3.1602-1611.1996; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanders CM, 1998, EMBO J, V17, P7044, DOI 10.1093/emboj/17.23.7044; SANTUCCI S, 1995, J GEN VIROL, V76, P1129, DOI 10.1099/0022-1317-76-5-1129; SARAFI TR, 1995, VIROLOGY, V211, P385, DOI 10.1006/viro.1995.1421; Scherzinger E, 1997, J BIOL CHEM, V272, P30228, DOI 10.1074/jbc.272.48.30228; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; Sedman J, 1998, J VIROL, V72, P6893, DOI 10.1128/JVI.72.8.6893-6897.1998; Sedman J, 1995, EMBO J, V14, P6218, DOI 10.1002/j.1460-2075.1995.tb00312.x; Sedman T, 1997, J VIROL, V71, P2887, DOI 10.1128/JVI.71.4.2887-2896.1997; SEO YS, 1993, P NATL ACAD SCI USA, V90, P2865, DOI 10.1073/pnas.90.7.2865; SEO YS, 1993, P NATL ACAD SCI USA, V90, P702, DOI 10.1073/pnas.90.2.702; SHAH KV, 1996, FIELDS VIROLOGY, P2077; Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; STAHL H, 1986, EMBO J, V5, P1939, DOI 10.1002/j.1460-2075.1986.tb04447.x; Sun YN, 1998, J GEN VIROL, V79, P1651, DOI 10.1099/0022-1317-79-7-1651; THORNER LK, 1993, J VIROL, V67, P6000, DOI 10.1128/JVI.67.10.6000-6014.1993; Titolo S, 1999, J VIROL, V73, P5282, DOI 10.1128/JVI.73.7.5282-5293.1999; Titolo S, 2000, J VIROL, V74, P7349, DOI 10.1128/JVI.74.16.7349-7361.2000; USTAV M, 1991, EMBO J, V10, P4321, DOI 10.1002/j.1460-2075.1991.tb05010.x; USTAV M, 1991, EMBO J, V10, P449, DOI 10.1002/j.1460-2075.1991.tb07967.x; Valle M, 2000, MOL CELL BIOL, V20, P34, DOI 10.1128/MCB.20.1.34-41.2000; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Walker SL, 1997, J VIROL, V71, P6996, DOI 10.1128/JVI.71.9.6996-7004.1997; WEBER K, 1969, J BIOL CHEM, V244, P4406; WILSON VG, 1991, J VIROL, V65, P5314, DOI 10.1128/JVI.65.10.5314-5322.1991; WINOKUR PL, 1992, EMBO J, V11, P4111, DOI 10.1002/j.1460-2075.1992.tb05504.x; Wu CX, 1998, J VIROL, V72, P10256, DOI 10.1128/JVI.72.12.10256-10259.1998; XIAO XL, 1994, J GEN VIROL, V75, P2463, DOI 10.1099/0022-1317-75-9-2463; YANG L, 1993, P NATL ACAD SCI USA, V90, P5086, DOI 10.1073/pnas.90.11.5086; YANG L, 1991, NATURE, V353, P628, DOI 10.1038/353628a0	85	54	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22426	22438		10.1074/jbc.M101932200	http://dx.doi.org/10.1074/jbc.M101932200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11304544	hybrid			2022-12-27	WOS:000169412700062
J	Arozarena, I; Matallanas, D; Crespo, P				Arozarena, I; Matallanas, D; Crespo, P			Maintenance of Cdc42 GDP-bound state by Rho-GDI inhibits MAP kinase activation by the exchange factor Ras-GRF - Evidence for Ras-GRF function being inhibited by Cdc42-GDP but unaffected by Cdc42-GTP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEINS RAC1; DEPENDENT ACTIVATION; TYROSINE KINASE; MOLECULAR-CLONING; IDENTIFICATION; FAMILY; PHOSPHORYLATION; PATHWAY; CDC25; DBL	The function of the Pas guanine nucleotide exchange factor Ras-GRF/cdc25(Mn) is subject to tight regulatory processes. We have recently shown that the activation of the Ras/MAPK pathway by Ras-GRF is controlled by the Rho family GTPase Cdc42 through still unknown mechanisms. Here, we report that retaining Cdc42 in its GDP-bound state by overexpressing Rho-GDI inhibits Ras-GRF-mediated MAPK activation. Conversely, Ras-GRF basal and LPA- or ionomycin-stimulated activities were unaffected by a constitutively active GTP-bound Cdc42, Moreover, the Cdc42 downstream effecters MLK3, ACK1, PAK1, and WASP had no detectable influence on Ras-GRF-mediated MAPK activation. In contrast, promoting GDP release from Cdc42 with the Rho family GEF Dbl or with ionomycin suppressed the restraint exerted by Cdc42 on Ras-GRF activity. We conclude that Cdc42-GDP inhibits Ras-GRF-induced MAPK activation, but neither Cdc42-GTP nor the Cdc42 downstream effecters affect Ras-GRF performance, Interestingly, the loss of the GDP-bound state by Cdc42 abolishes its inhibitory effects on Ras-GRF function. These results suggest that the Cdc42 mechanism of action may not be solely restricted to activation of downstream signaling cascades when GTP-loaded, Furthermore, the GDP-bound form may be acting as an inhibitory molecule down-modulating parallel signaling routes such as the Ras/MAPK pathway.	CSIC, Inst Invest Biomed, E-28029 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Crespo, P (corresponding author), CSIC, Inst Invest Biomed, Arturo Duperier 4, E-28029 Madrid, Spain.	pcrespo@iib.uam.es	gomez, david/U-9465-2019; Crespo, Piero/M-3273-2014; Arozarena, Imanol/A-5981-2017	gomez, david/0000-0002-2360-3141; Crespo, Piero/0000-0003-2825-7783; Arozarena, Imanol/0000-0001-6349-2442				Ajenjo N, 2000, J BIOL CHEM, V275, P7189, DOI 10.1074/jbc.275.10.7189; Arozarena I, 2000, J BIOL CHEM, V275, P26441, DOI 10.1074/jbc.M002992200; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Buchsbaum R, 1996, MOL CELL BIOL, V16, P4888; CEN H, 1992, EMBO J, V11, P4007, DOI 10.1002/j.1460-2075.1992.tb05494.x; CHENEY RE, 1994, MOL BIOL CELL, V5; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Gosser YQ, 1997, NATURE, V387, P814, DOI 10.1038/42961; HART MJ, 1994, J BIOL CHEM, V269, P62; HART MJ, 1991, J BIOL CHEM, V266, P20840; HORII Y, 1994, EMBO J, V13, P4776, DOI 10.1002/j.1460-2075.1994.tb06803.x; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kiyono M, 2000, J BIOL CHEM, V275, P5441, DOI 10.1074/jbc.275.8.5441; Kiyono M, 1999, P NATL ACAD SCI USA, V96, P4826, DOI 10.1073/pnas.96.9.4826; Kiyono M, 2000, J BIOL CHEM, V275, P29788, DOI 10.1074/jbc.M001378200; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; LEONARD D, 1992, J BIOL CHEM, V267, P22860; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MARTEGANI E, 1992, EMBO J, V11, P2151, DOI 10.1002/j.1460-2075.1992.tb05274.x; MARTTINGLY RR, 1996, NATURE, V382, P268; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MORII N, 1991, J BIOL CHEM, V266, P7646; Nomanbhoy TK, 1999, BIOCHEMISTRY-US, V38, P1744, DOI 10.1021/bi982198u; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; SASAKI T, 1993, J BIOL CHEM, V268, P23959; Sasaki T, 1998, BIOCHEM BIOPH RES CO, V245, P641, DOI 10.1006/bbrc.1998.8253; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; SHOU CC, 1995, ONCOGENE, V10, P1887; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tang Y, 1997, MOL CELL BIOL, V17, P4454, DOI 10.1128/MCB.17.8.4454; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; VAN AL, 1997, GENE DEV, V11, P2295; WEI W, 1992, P NATL ACAD SCI USA, V89, P7100, DOI 10.1073/pnas.89.15.7100; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Zippel R, 1996, ONCOGENE, V12, P2697	44	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21878	21884		10.1074/jbc.M011383200	http://dx.doi.org/10.1074/jbc.M011383200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11285260	hybrid			2022-12-27	WOS:000169297900140
J	Levin, MH; Haggie, PM; Vetrivel, L; Verkman, AS				Levin, MH; Haggie, PM; Vetrivel, L; Verkman, AS			Diffusion in the endoplasmic reticulum of an aquaporin-2 mutant causing human nephrogenic diabetes insipidus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; WATER CHANNELS; PHOTOBLEACHING RECOVERY; CHEMICAL CHAPERONES; MEMBRANE; MOBILITY; DISTRIBUTIONS; TRAFFICKING; MUTATIONS; DYNAMICS	Mutations in the aquaporin-2 (AQP2) water channel cause the hereditary renal disease nephrogenic diabetes insipidus (NDI), The missense mutation PIQP2-T126M causes human recessive NDI by retention at the endoplasmic reticulum (ER) of renal epithelial cells, To determine whether the ER retention of AQP2-T126M is due to relative immobilization in the ER, we measured by fluorescence recovery after photobleaching the intramembrane mobility of green fluorescent protein (GFP) chimeras containing human wild-type and mutant AQP2, In transfected LLC-PK1 renal epithelial cells, GFP-labeled AQP2-T126M was localized to the ER, and wild-type AQP2 to endosomes and the plasma membrane; both were localized to the ER after brefeldin A treatment. Photobleaching with image detection indicated that the GFP-AQP2 chimeras were freely mobile throughout the ER, Quantitative spot photobleaching revealed a diffusion-dependent irreversible process whose recovery depended on spot size and was abolished by paraformaldehyde fixation, In addition, a novel slow reversible fluorescence recovery (t(1/2) similar to2 s) was characterized whose recovery was independent of: spot size and not affected by fixation, AQP2 translational diffusion in the ER was not slowed by the T126M mutation; diffusion coefficients were (in cm(2)/s x 10(-10)) 2.6 +/- 0.5 (wild-type) and 3.0 +/- 0.4 (T126M), Much faster diffusion was found for a lipid probe (diOC(4)(3), 2.7 x 10(-8) cm(2)/s) in the ER membrane and for unconjugated GFP in the aqueous ER lumen (6 x 10(-8) cm(2)/s). ER diffusion of GFP-T126M was not significantly affected by up-regulation of molecular chaperones, cAMP activation, or actin filament disruption. ATP depletion by S-deoxyglucose and azide resulted in comparable slowing/immobilization of wild-type and T126M AQP2, These results indicate that the ER retention of AQP2-T126M does not result from restricted or slowed mobility and suggest that the majority of AQP2-T126M is not aggregated or bound to slowly moving membrane proteins.	Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, 1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.				NHLBI NIH HHS [HL60288, HL59198] Funding Source: Medline; NIDDK NIH HHS [DK43840, DK35124] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060288, R01HL059198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035124, R01DK035124, R01DK043840] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Bichet DG, 1998, AM J MED, V105, P431, DOI 10.1016/S0002-9343(98)00301-5; Canfield MC, 1997, HUM MOL GENET, V6, P1865, DOI 10.1093/hmg/6.11.1865; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; DEEN PMT, 1995, J CLIN INVEST, V95, P2291, DOI 10.1172/JCI117920; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; Gustafson CE, 1998, HISTOCHEM CELL BIOL, V110, P377, DOI 10.1007/s004180050298; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; KAO HP, 1993, J CELL BIOL, V120, P175, DOI 10.1083/jcb.120.1.175; Kao HP, 1996, BIOPHYS CHEM, V59, P203; Klumperman J, 2000, CURR OPIN CELL BIOL, V12, P445, DOI 10.1016/S0955-0674(00)00115-0; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; LEE GM, 1993, J CELL BIOL, V120, P25, DOI 10.1083/jcb.120.1.25; LEE GM, 1991, P NATL ACAD SCI USA, V88, P6274, DOI 10.1073/pnas.88.14.6274; Mulders SM, 1997, J AM SOC NEPHROL, V8, P242; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Olveczky BP, 1997, BIOPHYS J, V73, P2836, DOI 10.1016/S0006-3495(97)78312-7; Partikian A, 1998, J CELL BIOL, V140, P821, DOI 10.1083/jcb.140.4.821; Periasamy N, 1998, BIOPHYS J, V75, P557, DOI 10.1016/S0006-3495(98)77545-9; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Szczesna-Skorupa E, 1998, P NATL ACAD SCI USA, V95, P14793, DOI 10.1073/pnas.95.25.14793; Tamarappoo BK, 1998, J CLIN INVEST, V101, P2257, DOI 10.1172/JCI2303; Tamarappoo BK, 1999, J BIOL CHEM, V274, P34825, DOI 10.1074/jbc.274.49.34825; Umenishi F, 2000, BIOPHYS J, V78, P1024, DOI 10.1016/S0006-3495(00)76661-6; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; Yang Baoxue, 2000, Journal of the American Society of Nephrology, V11, p23A; Yang BX, 2001, J BIOL CHEM, V276, P2775, DOI 10.1074/jbc.M008216200	29	25	25	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21331	21336		10.1074/jbc.M101901200	http://dx.doi.org/10.1074/jbc.M101901200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11297561	hybrid			2022-12-27	WOS:000169297900072
J	Mignen, O; Shuttleworth, TJ				Mignen, O; Shuttleworth, TJ			Permeation of monovalent cations through the non-capacitative arachidonate-regulated Ca2+ Channels in HEK293 cells - Comparison with endogenous store-operated channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CALCIUM CURRENT; JURKAT T-LYMPHOCYTES; <CA2+>(I) OSCILLATIONS; FROG-MUSCLE; MAST-CELLS; ENTRY; RECEPTOR; CONDUCTANCE; SELECTIVITY; DEPLETION	In a manner similar to voltage-gated Ca2+ channels and Ca2+ release-activated Ca2+ (CRAC) channels, the recently identified arachidonate-regulated Ca2+ (ARC) channels display a large monovalent conductance upon removal of external divalent cations. Using whole-cell patch-clamp recording, we have characterized the properties of these monovalent currents in HEK293 cells stably transfected with the m3 muscarinic receptor and compared them with the corresponding currents through the endogenous store-operated Ca2+ (SOC) channels in the same cells. Although the monovalent currents seen through these two channels displayed certain similarities, several marked differences were also apparent, including the magnitude of the monovalent current/Ca2+ current ratio, the rate and nature of the spontaneous decline in the currents, and the effects of external monovalent cation substitutions and removal of internal Mg2+. Moreover, monovalent ARC currents could be activated after the complete spontaneous inactivation of the corresponding SOC current :in the same cell. We conclude that the non-capacitative ARC channels share, with voltage-gated Ca2+ channels and store-operated Ca2+ channels (e.g, SOC and CRAC the general property of monovalent ion permeation in the nominal absence of extracellular divalent ions. However, the clear differences between the properties of these currents through ARC and SOC channels in the same cell confirm that these represent distinct conductances.	Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester	Shuttleworth, TJ (corresponding author), Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Sch Med & Dent, POB 711,601 Elmwood Ave, Rochester, NY 14642 USA.		MIGNEN, Olivier/M-3258-2019	MIGNEN, Olivier/0000-0001-7913-6119	NIGMS NIH HHS [GM 40457] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALMERS W, 1984, J PHYSIOL-LONDON, V353, P565, DOI 10.1113/jphysiol.1984.sp015351; ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Braun FJ, 2001, J BIOL CHEM, V276, P1063, DOI 10.1074/jbc.M008348200; Broad LM, 1999, J BIOL CHEM, V274, P32881, DOI 10.1074/jbc.274.46.32881; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESS P, 1984, NATURE, V309, P453, DOI 10.1038/309453a0; HESS P, 1986, J GEN PHYSIOL, V88, P293, DOI 10.1085/jgp.88.3.293; Hille B., 1992, IONIC CHANNELS EXCIT; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Kerschbaum HH, 1998, J GEN PHYSIOL, V111, P521, DOI 10.1085/jgp.111.4.521; Kerschbaum HH, 1999, SCIENCE, V283, P836, DOI 10.1126/science.283.5403.836; LeppleWienhues A, 1996, BIOPHYS J, V71, P787, DOI 10.1016/S0006-3495(96)79278-0; Lewis RS, 1999, ADV SEC MESS PHOSPH, V33, P279; McCleskey EW, 1999, J GEN PHYSIOL, V113, P765, DOI 10.1085/jgp.113.6.765; Mignen O, 2000, J BIOL CHEM, V275, P9114, DOI 10.1074/jbc.275.13.9114; Munaron L, 1997, CELL CALCIUM, V22, P179, DOI 10.1016/S0143-4160(97)90011-7; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Shuttleworth TJ, 1999, J BIOL CHEM, V274, P31174, DOI 10.1074/jbc.274.44.31174; Shuttleworth TJ, 1998, J BIOL CHEM, V273, P32636, DOI 10.1074/jbc.273.49.32636; Shuttleworth TJ, 1999, CELL CALCIUM, V25, P237, DOI 10.1054/ceca.1999.0022; Shuttleworth TJ, 1996, J BIOL CHEM, V271, P21720, DOI 10.1074/jbc.271.36.21720; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6259	27	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21365	21374		10.1074/jbc.M102311200	http://dx.doi.org/10.1074/jbc.M102311200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11285268	hybrid			2022-12-27	WOS:000169297900077
J	Wu, Y; Dowbenko, D; Pisabarro, MT; Dillard-Telm, L; Koeppen, H; Lasky, LA				Wu, Y; Dowbenko, D; Pisabarro, MT; Dillard-Telm, L; Koeppen, H; Lasky, LA			PTEN 2, a Golgi-associated testis-specific homologue or the PTEN tumor suppressor lipid phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE; PROSTATE-CANCER; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; GLIOBLASTOMA CELLS; 3-KINASE ACTIVITY; GENE; KINASE; PTEN/MMAC1; GROWTH; INACTIVATION	The tumor suppressor PTEN is a phosphatidylinositol phospholipid phosphatase, which indirectly down-regulates the activity of the protein kinase B/Akt survival kinases. Examination of sequence data bases revealed the existence of a highly conserved homologue of PTEN, This homologue, termed PTEN 2, contained an extended amino-terminal domain having four potential transmembrane motifs, a lipid phosphatase domain, and a potential lipid-binding C2 domain. Transcript analysis demonstrated that PTEN 2 is expressed only in testis and specifically in secondary spermatocytes, In contrast to PTEN, PTEN 2 was localized to the Golgi apparatus via the amino-terminal membrane-spanning regions. Molecular modeling suggested that PTEN 2 is a phospholipid phosphatase with potential specificity for the phosphate at the 3 position of inositol phosphates, Enzymatic analysis of PTEN 2 revealed substrate specificity that is similar to PTEN, with a preference for the dephosphorylation of the phosphatidylinositol 3,5-phosphate phospholipid, a known mediator of vesicular trafficking. Together, these data suggest that PTEN 2 is a Golgi-localized, testis-specific phospholipid phosphatase, which may contribute to the terminal stages of spermatocyte differentiation.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Lasky, LA (corresponding author), Genentech Inc, Dept Mol Oncol, 460 Pt San Bruno Blvd, San Francisco, CA 94080 USA.	lal@gene.com	Pisabarro, M. Teresa/D-4270-2012					BROWN WJ, 1995, J CELL BIOL, V130, P781, DOI 10.1083/jcb.130.4.781; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cairns P, 1997, CANCER RES, V57, P4997; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chen HM, 1999, HUM GENET, V105, P399, DOI 10.1007/s004390051122; Cheney IW, 1998, CANCER RES, V58, P2331; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Eng C, 1998, NAT GENET, V19, P223, DOI 10.1038/897; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Gaullier JM, 1999, BIOCHEM SOC T, V27, P666, DOI 10.1042/bst0270666; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; KERR JB, 1995, MICROSC RES TECHNIQ, V32, P364, DOI 10.1002/jemt.1070320503; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Rasheed BKA, 1997, CANCER RES, V57, P4187; Reaves BJ, 1996, J CELL SCI, V109, P749; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Tashiro H, 1997, CANCER RES, V57, P3935; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199	33	76	79	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21745	21753		10.1074/jbc.M101480200	http://dx.doi.org/10.1074/jbc.M101480200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279206	hybrid			2022-12-27	WOS:000169297900125
J	Vo, N; Goodman, RH				Vo, N; Goodman, RH			CREB-binding protein and p300 in transcriptional regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							IFN-BETA ENHANCEOSOME; HISTONE ACETYLTRANSFERASE ACTIVITY; ACTIVATES TRANSCRIPTION; DEPENDENT KINASES; COACTIVATORS P300; GENE ACTIVATION; HMG I(Y); IN-VIVO; CBP; ACETYLATION		Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Goodman, RH (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.							Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; Bergel M, 2000, J BIOL CHEM, V275, P11514, DOI 10.1074/jbc.275.15.11514; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Fondell JD, 1999, P NATL ACAD SCI USA, V96, P1959, DOI 10.1073/pnas.96.5.1959; Goodman RH, 2000, GENE DEV, V14, P1553; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Ito T, 2000, GENE DEV, V14, P1899; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; Jayachandra S, 1999, P NATL ACAD SCI USA, V96, P11566, DOI 10.1073/pnas.96.20.11566; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Kim TK, 1998, P NATL ACAD SCI USA, V95, P12191, DOI 10.1073/pnas.95.21.12191; Kingston RE, 1999, NATURE, V399, P199, DOI 10.1038/20302; Kraus WL, 1999, MOL CELL BIOL, V19, P8123; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Kung AL, 2000, GENE DEV, V14, P272; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Lorch Y, 2000, MOL CELL, V6, P197, DOI 10.1016/S1097-2765(00)00021-6; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Nakajima T, 1996, CELL, V86, P465, DOI 10.1016/S0092-8674(00)80119-1; Partanen M, 1999, INT J DEV BIOL, V43, P487; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; ROEDER RG, 1999, TRANSCRIPTION REGULA, P106; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Swope DL, 1996, J BIOL CHEM, V271, P28138, DOI 10.1074/jbc.271.45.28138; Ugai H, 1999, J MOL MED, V77, P481, DOI 10.1007/s001099900021; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; YACIUK P, 1991, MOL CELL BIOL, V11, P2116, DOI 10.1128/MCB.11.4.2116; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yie JM, 1999, P NATL ACAD SCI USA, V96, P13108, DOI 10.1073/pnas.96.23.13108; Yie JM, 1999, EMBO J, V18, P3074, DOI 10.1093/emboj/18.11.3074; Zanger K, 1999, MOL ENDOCRINOL, V13, P268, DOI 10.1210/me.13.2.268; Zhang QH, 2000, MOL CELL BIOL, V20, P4970, DOI 10.1128/MCB.20.14.4970-4978.2000	53	671	685	4	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13505	13508		10.1074/jbc.R000025200	http://dx.doi.org/10.1074/jbc.R000025200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11279224	hybrid			2022-12-27	WOS:000168356600001
J	Lundberg, M; Johansson, C; Chandra, J; Enoksson, M; Jacobsson, G; Ljung, J; Johansson, M; Holmgren, A				Lundberg, M; Johansson, C; Chandra, J; Enoksson, M; Jacobsson, G; Ljung, J; Johansson, M; Holmgren, A			Cloning and expression of a novel human glutaredoxin (Grx2) with mitochondrial and nuclear isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI GLUTAREDOXIN; PROTEIN DISULFIDE-ISOMERASE; RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE; GLUTATHIONE-DEPENDENT SYNTHESIS; OXYR TRANSCRIPTION FACTOR; HYDROGEN DONOR SYSTEM; HIGH-LEVEL EXPRESSION; DNA-BINDING ACTIVITY; AMINO-ACID-SEQUENCE; THIOLTRANSFERASE GLUTAREDOXIN	Glutaredoxin (Grx) is a glutathione-dependent hydrogen donor for ribonucleotide reductase, Today glutaredoxins are known as a multifunctional family of GSH-disulfide-oxidoreductases belonging to the thioredoxin fold superfamily, In contrast to Escherichia coli and yeast, a single human glutaredoxin is known. We have identified and cloned a novel 18-kDa human dithiol glutaredoxin, named glutaredoxin-2 (Grx2), which is 34% identical to the previously known cytosolic 12-kDa human Grx1. The human Grx2 sequence contains three characteristic regions of the glutaredoxin family: the dithiol/disulfide active site, CSYC, the GSH binding site, and a hydrophobic surface area. The human Grx2 gene, located at chromosome 1q31.2-31.3, consisted of five exons that were transcribed to a 0.9-kilobase human Grx2 mRNA ubiquitously expressed in several tissues. Two alternatively spliced Grx2 mRNA isoforms that differed in their 5 ' region were identified. These corresponded to alternative proteins with a common 125-residue C-terminal Grx domain but with different N-terminal extensions of 39 and 40 residues, respectively. The 125-residue Grx domain and the two full-length variants were expressed in E. coli and exhibited GSH-dependent hydroxyethyl disulfide and dehydroascorbate reducing activities. Western blot analysis of subcellular fractions from Jurkat cells with a specific anti-Grx2 antibody showed that human Grx2 was predominantly located in the nucleus but also present in the mitochondria, We further showed that one of the mRNA isoforms corresponding to Grx2a encoded a functional N-terminal mitochondrial translocation signal.	Karolinska Inst, Med Nobel Inst Biochem, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; Karolinska Hosp, Dept Med, Unit Clin Allergy Res, S-17176 Stockholm, Sweden; Huddinge Univ, Div Clin Virol, S-14186 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Holmgren, A (corresponding author), Karolinska Inst, Med Nobel Inst Biochem, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.							APONTOWEIL P, 1975, BIOCHIM BIOPHYS ACTA, V399, P10, DOI 10.1016/0304-4165(75)90206-8; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; ASLUND F, 1994, P NATL ACAD SCI USA, V91, P9813, DOI 10.1073/pnas.91.21.9813; Bandyopadhyay S, 1998, J BIOL CHEM, V273, P392, DOI 10.1074/jbc.273.1.392; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; BELLOMO G, 1992, P NATL ACAD SCI USA, V89, P4412, DOI 10.1073/pnas.89.10.4412; BUSHWELLER JH, 1992, BIOCHEMISTRY-US, V31, P9288, DOI 10.1021/bi00153a023; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; Daily D, 2001, J BIOL CHEM, V276, P1335, DOI 10.1074/jbc.M008121200; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Fernandez-Checa JC, 1998, BIOFACTORS, V8, P7, DOI 10.1002/biof.5520080102; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; GREENBERG JT, 1986, J BACTERIOL, V168, P1026, DOI 10.1128/jb.168.2.1026-1029.1986; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; HOLMGREN A, 1979, J BIOL CHEM, V254, P3664; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; HOOG JO, 1983, EUR J BIOCHEM, V136, P223, DOI 10.1111/j.1432-1033.1983.tb07730.x; Jung CH, 1996, ARCH BIOCHEM BIOPHYS, V335, P61, DOI 10.1006/abbi.1996.0482; KLINTROT IM, 1984, EUR J BIOCHEM, V144, P417, DOI 10.1111/j.1432-1033.1984.tb08481.x; Ladner RD, 1997, J BIOL CHEM, V272, P19072, DOI 10.1074/jbc.272.30.19072; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lillig CH, 1999, J BIOL CHEM, V274, P7695, DOI 10.1074/jbc.274.12.7695; Lind C, 1998, BIOCHEM BIOPH RES CO, V247, P481, DOI 10.1006/bbrc.1998.8695; Liu SS, 1999, J BIOENERG BIOMEMBR, V31, P367; LUTHMAN M, 1982, J BIOL CHEM, V257, P6686; LUTHMAN M, 1979, P NATL ACAD SCI USA, V76, P2158, DOI 10.1073/pnas.76.5.2158; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; MARTINEZGALISTEO E, 1995, COMP BIOCHEM PHYS B, V111, P17, DOI 10.1016/0305-0491(94)00235-M; MirandaVizuete A, 1996, J BIOL CHEM, V271, P19099, DOI 10.1074/jbc.271.32.19099; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Nakamura T, 1999, FREE RADICAL RES, V31, P357, DOI 10.1080/10715769900300931; NEWMEYER DD, 1991, METHOD CELL BIOL, V36, P607; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637; Padilla CA, 1996, FEBS LETT, V378, P69; PADILLA CA, 1995, EUR J BIOCHEM, V227, P27, DOI 10.1111/j.1432-1033.1995.tb20356.x; Padilla CA, 1996, GENOMICS, V32, P455, DOI 10.1006/geno.1996.0141; Prieto-Alamo MJ, 2000, J BIOL CHEM, V275, P13398, DOI 10.1074/jbc.275.18.13398; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; ROZELL B, 1993, EUR J CELL BIOL, V62, P314; Ruoppolo M, 1997, BIOCHEMISTRY-US, V36, P12259, DOI 10.1021/bi970851s; SCHULZEOSTHOFF K, 1993, EMBO J, V12, P3095, DOI 10.1002/j.1460-2075.1993.tb05978.x; Shi J, 1999, J BIOL CHEM, V274, P36039, DOI 10.1074/jbc.274.51.36039; Shi ZZ, 2000, P NATL ACAD SCI USA, V97, P5101, DOI 10.1073/pnas.97.10.5101; SODANO P, 1991, J MOL BIOL, V221, P1311; Spector D, 2001, J BIOL CHEM, V276, P7011, DOI 10.1074/jbc.M009814200; Sun CH, 1998, J MOL BIOL, V280, P687, DOI 10.1006/jmbi.1998.1913; Takashima Y, 1999, IMMUNOL LETT, V68, P397, DOI 10.1016/S0165-2478(99)00087-5; VlamisGardikas A, 1997, J BIOL CHEM, V272, P11236; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WELLS WW, 1990, J BIOL CHEM, V265, P15361; WU AL, 1994, MOL CELL BIOL, V14, P5832, DOI 10.1128/MCB.14.9.5832; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zhivotovsky B, 1999, CELL DEATH DIFFER, V6, P644, DOI 10.1038/sj.cdd.4400536	65	253	268	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 13	2001	276	28					26269	26275		10.1074/jbc.M011605200	http://dx.doi.org/10.1074/jbc.M011605200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451VP	11297543	hybrid			2022-12-27	WOS:000169823300084
J	van Kempen, LCLT; Nelissen, JMDT; Degen, WGJ; Torensma, R; Weidle, UH; Bloemers, HPJ; Figdor, CG; Swart, GWM				van Kempen, LCLT; Nelissen, JMDT; Degen, WGJ; Torensma, R; Weidle, UH; Bloemers, HPJ; Figdor, CG; Swart, GWM			Molecular basis for the hemophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN SUPERFAMILY; HUMAN-MELANOMA; TUMOR PROGRESSION; LIGAND-BINDING; CD6 LIGAND; DM-GRASP; DOMAIN; EXPRESSION; CLONING; ANTIGEN	Activated leukocyte cell adhesion molecule (ALCAM/ CD166), a member of the immunoglobulin superfamily with five extracellular immunoglobulin-like domains, facilitates heterophilic (ALCAM-CD6) and hemophilic (ALCAM-ALCAM) cell-cell interactions, While expressed in a wide variety of tissues and cells, ALCAM is restricted to subsets of cells usually involved in dynamic growth and/or migration processes. A structure-function analysis, using two monoclonal anti-ALCAM antibodies and a series of amino-terminally deleted ALCAM constructs, revealed that hemophilic cell adhesion depended on ligand binding mediated by the membrane-distal amino-terminal immunoglobulin domain and on avidity controlled by ALCAM clustering at the cell surface involving membrane-proximal immunoglobulin domains. Go-expression of a transmembrane ALCAM. deletion mutant, which lacks the ligand binding domain, and endogenous wild-type ALCAM inhibited hemophilic cell-cell interactions by interference with ALCAM avidity, while hemophilic, soluble ligand binding remained unaltered. The extracellular structures of ALCAM thus provide two structurally and functionally distinguishable modules, one involved in ligand binding and the other in avidity. Functionality of both modules is required for stable hemophilic ALCAM-ALCAM cell-cell adhesion.	Univ Nijmegen, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; Univ Med Ctr St Radboud, Dept Tumor Immunol, Nijmegen, Netherlands; Roche Diagnost GmbH, D-82372 Penzberg, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Roche Holding	Swart, GWM (corresponding author), Univ Nijmegen, Dept Biochem, POB 9101, NL-6500 HB Nijmegen, Netherlands.		Figdor, Carl G/A-4232-2010; van Kempen, Léon/AAX-5866-2021; van Kempen, Leon/ABG-6815-2020; Torensma, Ruurd/C-2853-2009; van kempen, leon/A-8598-2012	Figdor, Carl G/0000-0002-2366-9212; van Kempen, Léon/0000-0003-0646-0705; Torensma, Ruurd/0000-0002-0555-7903; 				Aruffo A, 1997, IMMUNOL TODAY, V18, P498, DOI 10.1016/S0167-5699(97)01130-4; Bodian DL, 1997, BIOCHEMISTRY-US, V36, P2637, DOI 10.1021/bi962560+; Bowen MA, 1997, EUR J IMMUNOL, V27, P1469, DOI 10.1002/eji.1830270625; Bowen MA, 1996, J BIOL CHEM, V271, P17390, DOI 10.1074/jbc.271.29.17390; BOWEN MA, 1995, J EXP MED, V181, P2213, DOI 10.1084/jem.181.6.2213; Bowen MA, 2000, PROTEINS, V40, P420; Bruder SP, 1998, J BONE MINER RES, V13, P655, DOI 10.1359/jbmr.1998.13.4.655; BURNS FR, 1991, NEURON, V7, P209, DOI 10.1016/0896-6273(91)90259-3; Cortes F, 1999, BLOOD, V93, P826, DOI 10.1182/blood.V93.3.826.403k28_826_837; Degen WGJ, 1998, AM J PATHOL, V152, P805; ETZIONI A, 1994, CELL ADHES COMMUN, V2, P257, DOI 10.3109/15419069409004445; FEIZI T, 1994, TRENDS BIOCHEM SCI, V19, P233, DOI 10.1016/0968-0004(94)90144-9; Heffron DS, 2000, J NEUROSCI, V20, P2287; Kasper C, 2000, NAT STRUCT BIOL, V7, P389; LEHMANN JM, 1989, P NATL ACAD SCI USA, V86, P9891, DOI 10.1073/pnas.86.24.9891; Levesque MC, 1998, ARTHRITIS RHEUM, V41, P2221, DOI 10.1002/1529-0131(199812)41:12<2221::AID-ART18>3.0.CO;2-I; Li G, 2000, MOL MED TODAY, V6, P163, DOI 10.1016/S1357-4310(00)01692-0; Matsumoto A, 1997, J BIOL CHEM, V272, P16778, DOI 10.1074/jbc.272.27.16778; Nelissen JMDT, 2000, MOL BIOL CELL, V11, P2057, DOI 10.1091/mbc.11.6.2057; PATEL DD, 1995, J EXP MED, V181, P1563, DOI 10.1084/jem.181.4.1563; POURQUIE O, 1992, P NATL ACAD SCI USA, V89, P5261, DOI 10.1073/pnas.89.12.5261; Sekine-Aizawa Y, 1998, EUR J NEUROSCI, V10, P2810, DOI 10.1111/j.1460-9568.1998.00288.x; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Skonier JE, 1997, PROTEIN ENG, V10, P943, DOI 10.1093/protein/10.8.943; TANAKA H, 1991, NEURON, V7, P535, DOI 10.1016/0896-6273(91)90366-8; Uchida N, 1997, BLOOD, V89, P2706, DOI 10.1182/blood.V89.8.2706; van Kempen LCLT, 2000, AM J PATHOL, V156, P769, DOI 10.1016/S0002-9440(10)64943-7; VANMUIJEN GNP, 1991, CLIN EXP METASTAS, V9, P259, DOI 10.1007/BF01753729	28	123	130	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 13	2001	276	28					25783	25790		10.1074/jbc.M011272200	http://dx.doi.org/10.1074/jbc.M011272200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451VP	11306570	Green Published, hybrid			2022-12-27	WOS:000169823300021
J	Basran, J; Sutcliffe, MJ; Scrutton, NS				Basran, J; Sutcliffe, MJ; Scrutton, NS			Deuterium isotope effects during carbon-hydrogen bond cleavage by trimethylamine dehydrogenase - Implications for mechanism and vibrationally assisted hydrogen tunneling in wild-type and mutant enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON TRANSFERRING FLAVOPROTEIN; ALCOHOL-DEHYDROGENASE; PROTON-TRANSFER; COUPLED MOTION; CATALYSIS; SUBSTRATE; OXIDASE; OXIDATION; DYNAMICS; KINETICS	His-172 and Tyr-169 are components of a triad in the active site of trimethylamine dehydrogenase (TMADH) comprising Asp-267, His-172, and Tyr-169, Stopped-flow kinetic studies with trimethylamine as substrate have indicated that mutation of His-172 to Gin reduces the limiting rate constant for flavin reduction similar to 10-fold (Basran, J,, Sutcliffe, M. J,, Hille, R,, and Scrutton, N, S, (1999) Biochem, J, 341, 397-314), A kinetic isotope effect (KIE = k(H)/K-D) accompanies flavin reduction by H172Q TIMADH, the magnitude of which varies significantly with solution pH, With trimethylamine, flavin reduction by H172Q TMADH is controlled by a single macroscopic ionization (pK(a) = 6.8 +/- 0.1), This ionization is perturbed (pK(a) = 7.4 +/- 0.1) in reactions with perdeuterated trimethylamine and is responsible for the apparent variation in the KIE with solution pH, At pH 9.5, where the functional group controlling flavin reduction is fully ionized, the KIE is independent of temperature in the range 277-297 K, consistent with vibrationally assisted hydrogen tunneling during breakage of the substrate C-H bond. Y169F TMADH is similar to4-fold more compromised than H172Q TMADH for hydrogen transfer, which occurs non-classically. Studies with Y169F TMADH suggest partial thermal excitation of substrate prior to hydrogen tunneling by a vibrationally assisted mechanism. Our studies illustrate the varied effects of compromising mutations on tunneling regimes in enzyme molecules.	Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England	University of Leicester; University of Leicester	Scrutton, NS (corresponding author), Univ Leicester, Dept Biochem, Univ Rd, Leicester LE1 7RH, Leics, England.			Sutcliffe, Mike/0000-0003-0414-1700				Abad JL, 2000, ANGEW CHEM INT EDIT, V39, P3279, DOI 10.1002/1521-3773(20000915)39:18<3279::AID-ANIE3279>3.0.CO;2-G; Alhambra C, 2000, J AM CHEM SOC, V122, P8197, DOI 10.1021/ja001476l; Alston WC, 1996, BIOCHEMISTRY-US, V35, P12873, DOI 10.1021/bi960831a; Antoniou D, 1997, P NATL ACAD SCI USA, V94, P12360, DOI 10.1073/pnas.94.23.12360; Bahnson BJ, 1997, P NATL ACAD SCI USA, V94, P12797, DOI 10.1073/pnas.94.24.12797; Basran J, 1999, J BIOL CHEM, V274, P13155, DOI 10.1074/jbc.274.19.13155; Basran J, 2000, BIOCHEMISTRY-US, V39, P9188, DOI 10.1021/bi0006868; Basran J, 1999, BIOCHEM J, V341, P307, DOI 10.1042/0264-6021:3410307; Basran J, 1997, BIOCHEMISTRY-US, V36, P1989, DOI 10.1021/bi962623o; Basran J, 2001, J BIOL CHEM, V276, P6234, DOI 10.1074/jbc.M008141200; Basran J, 1999, BIOCHEMISTRY-US, V38, P3218, DOI 10.1021/bi982719d; Bell R. P., 1980, TUNNEL EFFECT CHEM, P51; BORGIS D, 1991, J CHEM PHYS, V94, P3619, DOI 10.1063/1.459733; BRUNO WJ, 1992, BIOPHYS J, V63, P689, DOI 10.1016/S0006-3495(92)81654-5; CHA Y, 1989, SCIENCE, V243, P1325, DOI 10.1126/science.2646716; Colby TD, 1998, BIOCHEMISTRY-US, V37, P9295, DOI 10.1021/bi973184b; Harris RJ, 2000, BIOCHEMISTRY-US, V39, P1189, DOI 10.1021/bi991941v; HUANG LX, 1995, J BIOL CHEM, V270, P23958, DOI 10.1074/jbc.270.41.23958; Jang MH, 1999, J BIOL CHEM, V274, P13147, DOI 10.1074/jbc.274.19.13147; Jonsson T, 1996, J AM CHEM SOC, V118, P10319, DOI 10.1021/ja961827p; JONSSON T, 1994, BIOCHEMISTRY-US, V33, P14871, DOI 10.1021/bi00253a026; Karsten WE, 1999, BIOCHEMISTRY-US, V38, P4398, DOI 10.1021/bi982439y; Kohen A, 2000, J AM CHEM SOC, V122, P10738, DOI 10.1021/ja002229k; Kohen A, 1999, CHEM BIOL, V6, pR191, DOI 10.1016/S1074-5521(99)80058-1; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Kohen A, 1997, BIOCHEMISTRY-US, V36, P2603, DOI 10.1021/bi962492r; KRAUT J, 1988, SCIENCE, V242, P533, DOI 10.1126/science.3051385; Kuznetsov AM, 1999, CAN J CHEM, V77, P1085, DOI 10.1139/cjc-77-5-6-1085; LIM LW, 1986, J BIOL CHEM, V261, P5140; Miller JR, 1999, BIOCHEMISTRY-US, V38, P13670, DOI 10.1021/bi990920y; NAGY J, 1979, J BIOL CHEM, V254, P2684; Nesheim JC, 1996, BIOCHEMISTRY-US, V35, P10240, DOI 10.1021/bi960596w; Northrop DB, 2000, BIOCHEMISTRY-US, V39, P2406, DOI 10.1021/bi992537z; ROHLFS RJ, 1994, J BIOL CHEM, V269, P30869; Scrutton NS, 1999, EUR J BIOCHEM, V264, P666, DOI 10.1046/j.1432-1327.1999.00645.x; SINGER TP, 1980, FLAVINS FLAVOPROTEIN, P277; STEENKAMP DJ, 1982, BIOCHEM J, V207, P241, DOI 10.1042/bj2070241; STEENKAMP DJ, 1978, BIOCHEM J, V169, P361, DOI 10.1042/bj1690361; STEENKAMP DJ, 1976, BIOCHIM BIOPHYS ACTA, V429, P705, DOI 10.1016/0005-2744(76)90319-3; STEENKAMP DJ, 1978, MECHANISMS OXIDIZING, P127; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Sutcliffe MJ, 2000, TRENDS BIOCHEM SCI, V25, P405, DOI 10.1016/S0968-0004(00)01642-X; Sutcliffe MJ, 2000, PHILOS T ROY SOC A, V358, P367, DOI 10.1098/rsta.2000.0536; Trickey P, 2000, BIOCHEMISTRY-US, V39, P7678, DOI 10.1021/bi9927181; Whittaker MM, 1998, BIOCHEMISTRY-US, V37, P8426, DOI 10.1021/bi980328t; WILSON EK, 1995, BIOCHEMISTRY-US, V34, P2584, DOI 10.1021/bi00008a024	46	73	73	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					24581	24587		10.1074/jbc.M101178200	http://dx.doi.org/10.1074/jbc.M101178200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11304539	hybrid			2022-12-27	WOS:000169800700023
J	Bahring, R; Dannenberg, J; Peters, HC; Leicher, T; Pongs, O; Isbrandt, D				Bahring, R; Dannenberg, J; Peters, HC; Leicher, T; Pongs, O; Isbrandt, D			Conserved Kv4 N-terminal domain critical for effects of Kv channel-interacting protein 2.2 on channel expression and gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIENT OUTWARD CURRENT; K+ CHANNEL; POTASSIUM CHANNELS; SUBTHRESHOLD POTENTIALS; ALPHA-SUBUNIT; RAT-HEART; INACTIVATION; NEURONS; CLONING; SIGNAL	Association of Kv channel-interacting proteins (KChIPs) with Kv4 channels leads to modulation of these A-type potassium channels (An, W, F,, Bowlby, M, R, Petty, M., Cao, J,, Ling, RP,, Mendoza, G., Hinson, J, W., Mattsson, R. I., Strassle, B, ni., Trimmer, J, S., and Rhodes, K. J, (2000) Nature 403, 553-556), We cloned a KChIP2 splice variant (KChIP2.2) from human ventricle. In comparison with RChIP2.1, coexpression of KChIP2.2 with human Kv4 channels in mammalian cells slowed the onset of Kv4 current inactivation (23-fold), accelerated the recovery from inactivation (5-7-fold), and shifted Kv4 steady-state inactivation curves by 8-29 mV to more positive potentials. The features of Kv4.2/KChIP2.2 currents closely resemble those of cardiac rapidly inactivating transient outward currents, KChIP2.2 stimulated the Kv4 current density in Chinese hamster ovary cells by similar to 55-fold. This correlated with a redistribution of immunoreactivity hom perinuclear areas to the plasma membrane. Increased Kv4 cell-surface expression and current density were also obtained in the absence of KChIP2.2 when the highly conserved proximal Kv4 N terminus was deleted. The same domain is required for association of RChIP2.2 with Kv4 alpha -subunits. We propose that an efficient transport of Kv4 channels to the cell surface depends on KChIP binding to the Kv4 N-terminal domain. Our data suggest that the binding is necessary, but not sufficient, for the functional activity of KChIPs.	Univ Hamburg, Inst Neurale Signalverarbeitung, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Pongs, O (corresponding author), Univ Hamburg, Inst Neurale Signalverarbeitung, Zentrum Mol Neurobiol, Martinistr 52, D-20246 Hamburg, Germany.		Bähring, Robert/F-7146-2010	Bahring, Robert/0000-0002-0406-5958; Isbrandt, Dirk/0000-0002-4720-1016				An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; BARRY DM, 1995, CIRC RES, V77, P361, DOI 10.1161/01.RES.77.2.361; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Isbrandt D, 2000, GENOMICS, V64, P144, DOI 10.1006/geno.2000.6117; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Jerng HH, 1997, BIOPHYS J, V72, P163, DOI 10.1016/S0006-3495(97)78655-7; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; PAK MD, 1991, P NATL ACAD SCI USA, V88, P4386, DOI 10.1073/pnas.88.10.4386; Petersen KR, 1999, PFLUG ARCH EUR J PHY, V437, P381, DOI 10.1007/s004240050792; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; ROBERDS SL, 1991, P NATL ACAD SCI USA, V88, P1798, DOI 10.1073/pnas.88.5.1798; Roeper J, 1997, J NEUROSCI, V17, P3379; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; SERODIO P, 1994, J NEUROPHYSIOL, V72, P1516, DOI 10.1152/jn.1994.72.4.1516; Serodio P, 1996, J NEUROPHYSIOL, V75, P2174, DOI 10.1152/jn.1996.75.5.2174; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Yuste R, 1997, NATURE, V387, P851, DOI 10.1038/43063; Zhu XR, 1999, RECEPTOR CHANNEL, V6, P387	23	169	173	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23888	23894		10.1074/jbc.M101320200	http://dx.doi.org/10.1074/jbc.M101320200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11287421	hybrid			2022-12-27	WOS:000169531100089
J	Fan, GF; Shumay, E; Wang, HY; Malbon, CC				Fan, GF; Shumay, E; Wang, HY; Malbon, CC			The scaffold protein gravin (cAMP-dependent protein kinase-anchoring protein 250) binds the beta(2)-adrenergic receptor via the receptor cytoplasmic Arg-329 to Leu-413 domain and provides a mobile scaffold during desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-INDUCED DESENSITIZATION; BETA-ADRENERGIC-RECEPTOR; PHOSPHORYLATION; COMPLEXES; ROLES	The cyclic AMP-dependent kinase-anchoring proteins (AKAPs) function as scaffolds for a wide-range of protein-protein interactions. The 250-kDa AKAP known as gravin plays a central role in organizing G-protein-coupled receptors to the protein kinases and phosphatases that regulate receptor function in desensitization, resensitization, and sequestration. Although gravin is critical for G-protein-linked receptor biology, the molecular features of the receptor necessary for interaction with this scaffold are not known. Herein, we map the regions of the beta (2)-adrenergic receptor that are required for binding to gravin, Intracellular loops 1, 2, and 3 appear not to participate in the binding of the receptor to the scaffold. In contrast, the C-terminal cytoplasmic region of the receptor (Arg-329 to Leu-413) competes readily for the binding of the beta (2)-adrenergic receptor by gravin, both using in vitro and in vivo assays. C-terminally truncated peptides with sequences ranging from Arg-329 to Leu-342 (13 aminoacyl residues), to Asn-352 (23 residues), to Tyr-366 (37 residues), to Asp-380 (51 residues), or to His-390 (61 residues), as well as N-terminally truncated peptides from Gln-391 to Leu-413 (23 residues) or Leu-381 to Leu-413 (33 residues) displayed no ability to block binding of receptor to gravin, The combination of Arg-329 to His-390 peptide and Gln-391 to Leu-413 peptide, however, reconstitutes a fragmented but full-length C-terminal region and also potently blocks the ability of gravin to bind the beta (2)-adrenergic receptor. The gravin-receptor interaction was examined in response to agonist by confocal microscopy, Remarkably, the association of the receptor with gravin was not disrupted during agonist-induced sequestration. The receptor-scaffold complex was maintained during agonist-induced sequestration. These data, in agreement with the biochemical data, reveal that gravin binds the receptor through the beta2-adrenergic receptor C-terminal cytoplasmic domain and that this interaction is maintained as the receptor is internalized. This is the first report of an AKAP scaffold protein translocating with its receptor, in this case a G-protein-coupled receptor.	SUNY Stony Brook, Pharmacol HSC, Dept Mol Pharmacol, Diabet & Metab Dis Res Program,Med Ctr, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Physiol & Biophys, Diabet & Metab Dis Res Program, Med Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Malbon, CC (corresponding author), SUNY Stony Brook, Pharmacol HSC, Dept Mol Pharmacol, Diabet & Metab Dis Res Program,Med Ctr, Stony Brook, NY 11794 USA.		malbon, craig/ABF-3604-2020					Bahouth SW, 1996, RECEPT SIGNAL TRANS, V6, P141; Dodge K, 2000, FEBS LETT, V476, P58, DOI 10.1016/S0014-5793(00)01671-9; Doronin S, 2000, PROTEIN EXPRES PURIF, V20, P451, DOI 10.1006/prep.2000.1322; Faux MC, 1996, CELL, V85, P9, DOI 10.1016/S0092-8674(00)81075-2; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Lin FB, 2000, J BIOL CHEM, V275, P19025, DOI 10.1074/jbc.275.25.19025; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Shih ML, 1996, J BIOL CHEM, V271, P21478, DOI 10.1074/jbc.271.35.21478; SHIH ML, 1994, P NATL ACAD SCI USA, V91, P12193, DOI 10.1073/pnas.91.25.12193; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; WANG HY, 1989, J BIOL CHEM, V264, P14424	14	79	83	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24005	24014		10.1074/jbc.M011199200	http://dx.doi.org/10.1074/jbc.M011199200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11309381	hybrid			2022-12-27	WOS:000169531100104
J	Hara, KY; Kato-Yamada, Y; Kikuchi, Y; Hisabori, T; Yoshida, M				Hara, KY; Kato-Yamada, Y; Kikuchi, Y; Hisabori, T; Yoshida, M			The role of the beta DELSEED motif of F-1-ATPase - Propagation of the inhibitory effect of the epsilon subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F1-ATPASE; ATP SYNTHASE; GAMMA-SUBUNIT; ENDOGENOUS INHIBITOR; ROTATION; COMPLEX; DOMAIN; RESOLUTION; CATALYSIS; MOVEMENT	In F-1-ATPase, a rotary motor enzyme, the region of the conserved DELSEED motif in the beta subunit moves and contacts the rotor gamma subunit when the nucleotide fills the catalytic site, and the acidic nature of the motif was previously assumed to play a critical role in rotation. Our previous work, however, disproved the assumption (Hara, K. Y., Noji, H., Bald, D., Yasuda, R., Kinosita, K., Jr., and Yoshida, M. (2000) J. Biol. Chem. 275, 14260-14263), and the role of this motif remained unknown. Here, we found that the E subunit, an intrinsic inhibitor, was unable to inhibit the ATPase activity of a mutant thermophilic F-1-ATPase in which all of the five acidic residues in the DELSEED motif were replaced with alanines, although the epsilon subunit in the mutant F-1-ATPase assumed the inhibitory form. In addition, the replacement of basic residues in the C-terminal region of the epsilon subunit by alanines caused a decrease of the inhibitory effect. Partial replacement of the acidic residues in the DELSEED motif of the beta subunit or of the basic residues in the C-terminal alpha -helix of the epsilon subunit induced a partial effect. We here conclude that the epsilon subunit exerts its inhibitory effect through the electrostatic interaction with the DELSEED motif of the beta subunit.	Tokyo Inst Technol, Chem Res Lab, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology	Yoshida, M (corresponding author), Tokyo Inst Technol, Chem Res Lab, R-1,Nagatsuta 4259, Yokohama, Kanagawa 2268503, Japan.	myoshida@res.titech.ac.jp	Hisabori, Toru/E-5205-2014	Hisabori, Toru/0000-0003-2046-0277				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Aggeler R, 1997, J BIOL CHEM, V272, P19621, DOI 10.1074/jbc.272.31.19621; Aggeler R, 1996, J BIOL CHEM, V271, P13888, DOI 10.1074/jbc.271.23.13888; AGGELER R, 1995, J BIOL CHEM, V270, P9185, DOI 10.1074/jbc.270.16.9185; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulygin VV, 1998, J BIOL CHEM, V273, P31765, DOI 10.1074/jbc.273.48.31765; DALLMANN HG, 1992, J BIOL CHEM, V267, P18953; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Fillingame RH, 1998, BBA-BIOENERGETICS, V1365, P135, DOI 10.1016/S0005-2728(98)00053-X; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Hara KY, 2000, J BIOL CHEM, V275, P14260, DOI 10.1074/jbc.275.19.14260; Hisabori T, 1999, FEBS LETT, V463, P35, DOI 10.1016/S0014-5793(99)01602-6; Hisabori T, 1997, EUR J BIOCHEM, V247, P1158, DOI 10.1111/j.1432-1033.1997.01158.x; Kato Y, 1997, J BIOL CHEM, V272, P24906, DOI 10.1074/jbc.272.40.24906; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; Kato-Yamada Y, 1998, J BIOL CHEM, V273, P19375, DOI 10.1074/jbc.273.31.19375; Kato-Yamada Y, 2000, J BIOL CHEM, V275, P35746, DOI 10.1074/jbc.M006575200; Ketchum CJ, 1998, BIOCHEM J, V330, P707; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LAGET PP, 1979, ARCH BIOCHEM BIOPHYS, V197, P83, DOI 10.1016/0003-9861(79)90222-4; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 1999, BIOCHEM BIOPH RES CO, V260, P597, DOI 10.1006/bbrc.1999.0885; Pedersen PL, 1996, J BIOENERG BIOMEMBR, V28, P389, DOI 10.1007/BF02113979; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; STERNWEIS PC, 1980, BIOCHEMISTRY-US, V19, P526, DOI 10.1021/bi00544a021; Stiggall D L, 1979, Methods Enzymol, V55, P308; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Tang CL, 1996, J BIOL CHEM, V271, P3018, DOI 10.1074/jbc.271.6.3018; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961; Wilkens S, 1998, J BIOL CHEM, V273, P26645, DOI 10.1074/jbc.273.41.26645; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7	36	68	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23969	23973		10.1074/jbc.M009303200	http://dx.doi.org/10.1074/jbc.M009303200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11279233	hybrid			2022-12-27	WOS:000169531100099
J	Takahashi, N; Khoo, KH; Suzuki, N; Johnson, JR; Lee, YC				Takahashi, N; Khoo, KH; Suzuki, N; Johnson, JR; Lee, YC			N-glycan structures from the major glycoproteins of pigeon egg white - Predominance of terminal Gal alpha (1-4)Gal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED SUGAR CHAINS; ESCHERICHIA-COLI; MAPPING TECHNIQUE; CELL-LINE; OLIGOSACCHARIDES; GLYCOPEPTIDES; IDENTIFICATION; SPECIFICITY; SIALYLATION; OVALBUMIN	N-Glycans from major glycoproteins of pigeon egg white (ovotransferrin, ovomucoid, and ovalbumins) were enzymatically released and were reductively aminated with 2-aminopyridine, separated, and structurally characterized by mass spectrometry and a three-dimensional mapping technique using three different columns of high performance liquid chromatography (HPLC) (Takahashi, N., Nakagawa, H., Fujikawa, K., Kawamura, Y., and Tomiya,N. (1995) Anal Biochem. 226, 139-146). Twenty-five major N-glycan structures, all of them hitherto unknown, were identified as pyridylamino derivatives. Of these, 13 were neutral, 10 were monosialyl, and 2 were disialyl oligosaccharides. All N-glycans contain from one to four Gal(YC1,4)GalP(1,4) sequences at the nonreducing terminal positions and are devoid of fucose residues. NAcetylneuraminic acids were alpha (2,6)-linked only to beta -galactose. The HPLC profiles of the N-glycans from four different glycoproteins were qualitatively very similar to each other, but not identical in the peak distributions. Monosialyl glycans were most abundant in all four glycoproteins, followed by neutral glycans, Disialyl glycans were lowest in ovotransferrin, and highest in ovomucoid. Triantennary structures with bisecting GlcNAc were predominant in ovotransferrin, and tetra-antennary (with and without bisecting GlcNAc-containing) structures were predominant in other glycoproteins. Penta-antennary structures (with a sialic acid and without bisecting GlcNAc residue) were also found in small quantities in all four glycoproteins. In contrast to the chicken egg white counterparts, which contain mostly high mannose and hybrid types, all N-glycan structures in the major pigeon egg white glycoproteins are complex type.	Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Nagoya City Univ, Fac Pharmaceut Sci, Nagoya, Aichi 4678603, Japan; Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; Univ Minnesota, Dept Med, Minneapolis, MN 55417 USA; Univ Minnesota, Med Ctr, Minneapolis, MN 55417 USA	Johns Hopkins University; Nagoya City University; Academia Sinica - Taiwan; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lee, YC (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.		Khoo, Kay-Hooi/E-1989-2019	Khoo, Kay-Hooi/0000-0003-2906-406X	NIDDK NIH HHS [DKO9970, DK-47504] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047504, R01DK009970, R37DK009970] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		DELL A, 1994, METHOD ENZYMOL, V230, P108; FRANCOIS C, 1962, J BIOCHEM-TOKYO, V257, P335; FRANCOISGERARD C, 1980, REV FR TRANSFUS IMMU, V23, P579, DOI 10.1016/S0338-4535(80)80161-9; JOHNSON JR, 1994, AM J MED SCI, V307, P335, DOI 10.1097/00000441-199405000-00004; JOHNSON JR, 1993, INFECT IMMUN, V61, P4902, DOI 10.1128/IAI.61.11.4902-4905.1993; JOHNSON JR, 1992, INFECT IMMUN, V60, P578, DOI 10.1128/IAI.60.2.578-583.1992; JOZIASSE DH, 1987, J BIOL CHEM, V262, P2025; Lopez M, 1998, J BIOL CHEM, V273, P33644, DOI 10.1074/jbc.273.50.33644; NAKAGAWA H, 1995, ANAL BIOCHEM, V226, P130, DOI 10.1006/abio.1995.1200; SHIMODA N, 1987, J BIOCHEM-TOKYO, V102, P657, DOI 10.1093/oxfordjournals.jbchem.a122101; SHOJI H, 1992, EUR J BIOCHEM, V207, P631, DOI 10.1111/j.1432-1033.1992.tb17090.x; Suzuki N, 2001, J BIOL CHEM, V276, P23221, DOI 10.1074/jbc.M101379200; TAI T, 1975, J BIOL CHEM, V250, P8569; TAKAHASHI N, 1977, BIOCHEM BIOPH RES CO, V76, P1194, DOI 10.1016/0006-291X(77)90982-2; TAKAHASHI N, 1995, ANAL BIOCHEM, V226, P139, DOI 10.1006/abio.1995.1201; TAKAHASHI N, 1995, ANAL BIOCHEM, V230, P333, DOI 10.1006/abio.1995.1483; TAKAHASHI N, 1992, HDB ENDOGLYCOSIDASES, P209; Tomiya N, 1998, ANAL BIOCHEM, V264, P204, DOI 10.1006/abio.1998.2849; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; WIERUSZESKI JM, 1987, J BIOL CHEM, V262, P6650; YAMAMOTO S, 1989, J BIOCHEM-TOKYO, V105, P547, DOI 10.1093/oxfordjournals.jbchem.a122703; YAMASHITA K, 1983, J BIOL CHEM, V258, P3099; YAMASHITA K, 1978, J BIOL CHEM, V253, P3862; YAMASHITA K, 1982, J BIOL CHEM, V257, P2809; [No title captured]	25	51	53	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23230	23239		10.1074/jbc.M101380200	http://dx.doi.org/10.1074/jbc.M101380200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11285264	hybrid			2022-12-27	WOS:000169531100004
J	Lu, CX; Schwartzbauer, G; Sperling, MA; Devaskar, SU; Thamotharan, S; Robbins, PD; McTiernan, CF; Liu, JL; Jiang, J; Frank, SJ; Menon, RK				Lu, CX; Schwartzbauer, G; Sperling, MA; Devaskar, SU; Thamotharan, S; Robbins, PD; McTiernan, CF; Liu, JL; Jiang, J; Frank, SJ; Menon, RK			Demonstration of direct effects of growth hormone on neonatal cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPROVES CARDIAC-FUNCTION; FACTOR-I; TYROSINE PHOSPHORYLATION; GLUCOSE TRANSPORTERS; DISULFIDE LINKAGE; GENE-EXPRESSION; ACID-TRANSPORT; RECEPTOR; INSULIN; RAT	The cellular and molecular basis of growth hormone (GH) actions on the heart remain poorly defined, and it is unclear whether GH effects on the myocardium are direct or mediated at least in part via insulin-like growth factor (IGF-1). Here, we demonstrate that the cultured neonatal cardiomyocyte is not an appropriate model to study the effects of GH because of artifactual loss of GH receptors (GHRs). To circumvent this problem, rat neonatal cardiomyocytes were infected with a recombinant adenovirus expressing the murine GHR, Functional integrity of GHR was suggested by GH-induced activation of the cognate JAK2/STAT5, MAPK, and Akt intracellular pathways in the cells expressing GHR. Although exposure to GH resulted in a significant increase in the size of the cardiomyocyte and increased expression of c fos, myosin light chain 2, and skeletal a-actin mRNAs, there were no significant changes in IGF-1 or atrial natriuretic factor mRNA levels in response to GH stimulation. In this model, GH increased incorporation of leucine, uptake of palmitic acid, and abundance of fatty acid transport protein mRNA. In contrast, GH decreased uptake of a-deoxy-D-glucose and levels of Glut1 protein. Thus, in isolated rat neonatal cardiomyocytes expressing GHR, GH induces hypertrophy and causes alterations in cellular metabolic profile in the absence of demonstrable changes in IGF-1 mRNA, suggesting that these effects may be independent of IGF-1.	Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Cardiol, Pittsburgh, PA 15213 USA; Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA; McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; McGill University	Menon, RK (corresponding author), Childrens Hosp Pittsburgh, Dept Pediat, Div Endocrinol, 3705 5th Ave, Pittsburgh, PA 15213 USA.	menonr@chplink.chp.edu	Liu, Jun-Li/A-1501-2008; liu, jun-li/O-2115-2019	Liu, Jun-Li/0000-0001-6251-6406; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD025024, R01HD025024, R01HD033997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046395, R01DK049845, R56DK046395, T32DK007729, R29DK046395, R56DK049845, R29DK049845] Funding Source: NIH RePORTER; NICHD NIH HHS [HD25024, HD33997] Funding Source: Medline; NIDDK NIH HHS [DK49845, DK46395, T32DK07729] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMATO G, 1993, J CLIN ENDOCR METAB, V77, P1671, DOI 10.1210/jc.77.6.1671; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Argetsinger LS, 1996, PHYSIOL REV, V76, P1089, DOI 10.1152/physrev.1996.76.4.1089; BILLESTRUP N, 1995, P NATL ACAD SCI USA, V92, P2725, DOI 10.1073/pnas.92.7.2725; Camarillo IG, 1998, ENDOCRINOLOGY, V139, P3585, DOI 10.1210/en.139.8.3585; Carter-Su C, 1998, RECENT PROG HORM RES, V53, P61; CarterSu C, 1996, ANNU REV PHYSIOL, V58, P187, DOI 10.1146/annurev.ph.58.030196.001155; Cittadini A, 1996, CIRCULATION, V93, P800, DOI 10.1161/01.CIR.93.4.800; Cittadini A, 1997, ENDOCRINOLOGY, V138, P5161, DOI 10.1210/en.138.12.5161; Cittadini A, 1997, J AM COLL CARDIOL, V29, P1109, DOI 10.1016/S0735-1097(97)00010-7; CLAYCOMB WC, 1983, ADV EXP MED BIOL, V161, P249; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; Das UG, 1999, AM J PHYSIOL-REG I, V276, pR809, DOI 10.1152/ajpregu.1999.276.3.R809; DONATH MY, 1994, P NATL ACAD SCI USA, V91, P1686, DOI 10.1073/pnas.91.5.1686; Duerr RL, 1996, CIRCULATION, V93, P2188, DOI 10.1161/01.CIR.93.12.2188; Fazio S, 1996, NEW ENGL J MED, V334, P809, DOI 10.1056/NEJM199603283341301; Foncea R, 1997, J BIOL CHEM, V272, P19115, DOI 10.1074/jbc.272.31.19115; Frank SJ, 1999, ADV MOL CELL ENDOCR, V3, P1; FRANK SJ, 1994, ENDOCRINOLOGY, V135, P148, DOI 10.1210/en.135.1.148; FRUSTACI A, 1992, AM J CLIN PATHOL, V97, P503, DOI 10.1093/ajcp/97.4.503; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; GLATZ JFC, 1982, BIOCHIM BIOPHYS ACTA, V711, P327, DOI 10.1016/0005-2760(82)90042-X; GLENNON PE, 1995, BRIT HEART J, V73, P496; HAMLIN G, 1999, DIABETES, V48, P2255; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Harvey S., 1995, GROWTH HORMONE; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HJALMARSON A, 1969, AM J PHYSIOL, V217, P1795, DOI 10.1152/ajplegacy.1969.217.6.1795; Isgaard J, 1997, EUR J CLIN INVEST, V27, P517, DOI 10.1046/j.1365-2362.1997.1430692.x; ITO H, 1993, CIRCULATION, V87, P1715, DOI 10.1161/01.CIR.87.5.1715; Jiang J, 1998, BIOCHEM BIOPH RES CO, V253, P774, DOI 10.1006/bbrc.1998.9793; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KILGOUR E, 1995, J ENDOCRINOL, V145, P27, DOI 10.1677/joe.0.1450027; Kim SO, 1998, J BIOL CHEM, V273, P2344, DOI 10.1074/jbc.273.4.2344; Kirshenbaum LA, 1997, MOL CELL BIOCHEM, V172, P13, DOI 10.1023/A:1006853824044; KRISHENBAUM LA, 1993, J CLIN INVEST, V92, P381, DOI 10.1172/JCI116577; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730; Liang L, 1999, ENDOCRINOLOGY, V140, P1972, DOI 10.1210/en.140.5.1972; LONG CS, 1991, CELL REGUL, V2, P1081, DOI 10.1091/mbc.2.12.1081; LOWE WL, 1988, MOL ENDOCRINOL, V2, P528, DOI 10.1210/mend-2-6-528; MEROLA B, 1993, J CLIN ENDOCR METAB, V77, P1658, DOI 10.1210/jc.77.6.1658; MORVAN D, 1991, EUR HEART J, V12, P666; Napoli R, 1996, BIOCHEM J, V315, P959, DOI 10.1042/bj3150959; NIEUWENHOVEN FA, 1999, INT J BIOCHEM CELL B, V31, P489; ODriscoll JG, 1997, LANCET, V349, P1068, DOI 10.1016/S0140-6736(05)62290-8; Osterziel KJ, 1998, LANCET, V351, P1233, DOI 10.1016/S0140-6736(97)11329-0; *PERK APPL BIOS, 1997, US B, V2; *PERK APPL BIOS, 1998, US B, V5; Ross J, 1999, CIRCULATION, V99, P15, DOI 10.1161/01.CIR.99.1.15; SACCA L, 1994, ENDOCR REV, V15, P555, DOI 10.1210/er.15.5.555; Schaap FG, 1997, BBA-GENE STRUCT EXPR, V1354, P29, DOI 10.1016/S0167-4781(97)00121-8; Schaub MC, 1997, J MOL MED, V75, P901, DOI 10.1007/s001090050182; Shen YT, 1996, AM J PHYSIOL-HEART C, V271, pH1721, DOI 10.1152/ajpheart.1996.271.5.H1721; SIMPSON P, 1982, CIRC RES, V50, P101, DOI 10.1161/01.RES.50.1.101; TAI PKK, 1990, J BIOL CHEM, V265, P21828; Tanaka N, 1998, AM J PHYSIOL-HEART C, V275, pH393, DOI 10.1152/ajpheart.1998.275.2.H393; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; VICK GW, 1998, SCI PRACTICE PEDIAT, P155; Wang J, 1999, ENDOCRINOLOGY, V140, P3391, DOI 10.1210/en.140.7.3391; WERNER H, 1989, P NATL ACAD SCI USA, V86, P7451, DOI 10.1073/pnas.86.19.7451; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; YANG RH, 1995, CIRCULATION, V92, P262, DOI 10.1161/01.CIR.92.2.262; Yi WS, 1996, MOL ENDOCRINOL, V10, P1425, DOI 10.1210/me.10.11.1425; Zhang Y, 1999, J BIOL CHEM, V274, P33072, DOI 10.1074/jbc.274.46.33072	67	63	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22892	22900		10.1074/jbc.M011647200	http://dx.doi.org/10.1074/jbc.M011647200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11303022	hybrid			2022-12-27	WOS:000169412700122
J	Smith, SK; Farnbach, AR; Harris, FM; Hawes, AC; Jackson, LR; Judd, AM; Vest, RS; Sanchez, S; Bell, JD				Smith, SK; Farnbach, AR; Harris, FM; Hawes, AC; Jackson, LR; Judd, AM; Vest, RS; Sanchez, S; Bell, JD			Mechanisms by which intracellular calcium induces susceptibility to secretory phospholipase A(2) in human erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-CELL DEFORMABILITY; PALMITIC ACID; RED-CELLS; GENERALIZED POLARIZATION; SIGNAL-TRANSDUCTION; FLUORESCENT-PROBE; MEMBRANE; ASYMMETRY; VESICLES; DIPALMITOYLPHOSPHATIDYLCHOLINE	Exposure of human erythrocytes to the calcium ionophore ionomycin rendered them susceptible to the action of secretory phospholipase A(2) (sPLA(2)). Analysis of erythrocyte phospholipid metabolism by thin-layer chromatography revealed significant hydrolysis of both phosphatidylcholine and phosphatidylethanolamine during incubation with ionomycin and sPLA(2). Several possible mechanisms for the effect of ionomycin were considered. Involvement of intracellular phospholipases A, was excluded since inhibitors of these enzymes had no effect. Assessment of membrane oxidation by cis-parinaric acid fluorescence and comparison to the oxidants diamide and phenylhydrazine revealed that oxidation does not participate in the effect of iono- mycin. Incubation with ionomycin caused classical physical changes to the erythrocyte membrane such as morphological alterations (spherocytosis), translocation of aminophospholipids to the outer leaflet of the membrane, and release of microvesicles. Experiments with phenylhydrazine, KCI, quinine, merocyanine 540, the calpain inhibitor E-64d, and the scramblase inhibitor R5421 revealed that neither phospholipid translocation nor vesicle release was required to induce susceptibility. Results from fluorescence spectroscopy and two-photon excitation scanning microscopy using the membrane probe laurdan argued that susceptibility to sPLA(2) is a consequence of increased order of membrane lipids.	Brigham Young Univ, Dept Zool, Provo, UT 84602 USA; Univ Illinois, Lab Flourescence Dynam, Urbana, IL 61801 USA	Brigham Young University; University of Illinois System; University of Illinois Urbana-Champaign	Bell, JD (corresponding author), Brigham Young Univ, Dept Zool, Provo, UT 84602 USA.	john_bell@byu.edu						ALLAN D, 1981, BIOCHEM J, V198, P433, DOI 10.1042/bj1980433; ALLAN D, 1989, BIOCHIM BIOPHYS ACTA, V986, P115, DOI 10.1016/0005-2736(89)90279-4; Allan D, 1987, Folia Haematol Int Mag Klin Morphol Blutforsch, V114, P499; ARDUINI A, 1989, ARCH BIOCHEM BIOPHYS, V273, P112, DOI 10.1016/0003-9861(89)90168-9; ARDUINI A, 1986, BIOCHIM BIOPHYS ACTA, V862, P65, DOI 10.1016/0005-2736(86)90469-4; Atsumi G, 1997, BBA-LIPID LIPID MET, V1349, P43, DOI 10.1016/S0005-2760(97)00082-9; Balsinde J, 1998, P NATL ACAD SCI USA, V95, P7951, DOI 10.1073/pnas.95.14.7951; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; BARTLETT GR, 1959, J BIOL CHEM, V273, P6830; BASSE F, 1994, BBA-BIOMEMBRANES, V1190, P217, DOI 10.1016/0005-2736(94)90077-9; BELL JD, 1989, J BIOL CHEM, V264, P225; Bell JD, 1996, BIOCHEMISTRY-US, V35, P4945, DOI 10.1021/bi952274i; BELL JD, 1995, BIOCHEMISTRY-US, V34, P11551, DOI 10.1021/bi00036a031; Bell JD, 2001, BIOPHYS J, V80, p46A; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLUMENFELD N, 1991, BLOOD, V77, P849; BURACK WR, 1995, BIOCHEMISTRY-US, V34, P14819, DOI 10.1021/bi00045a024; BURACK WR, 1994, CHEM PHYS LIPIDS, V73, P209, DOI 10.1016/0009-3084(94)90182-1; Chukhlovin Alexei B., 1996, Scanning Microscopy, V10, P795; Das Choudhury T, 1999, POL J PHARMACOL, V51, P341; deJong K, 1997, BIOCHEMISTRY-US, V36, P6768, DOI 10.1021/bi962973a; Dekkers DWC, 1998, BLOOD, V91, P2133, DOI 10.1182/blood.V91.6.2133; EATON JW, 1973, NATURE, V246, P105, DOI 10.1038/246105a0; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; FRIEDERICHS E, 1994, BIORHEOLOGY, V31, P207; GELB MH, 1995, ANNU REV BIOCHEM, V64, P653; GRAINGER DW, 1990, BIOCHIM BIOPHYS ACTA, V1023, P365, DOI 10.1016/0005-2736(90)90128-B; HARA S, 1991, J BIOCHEM, V110, P163, DOI 10.1093/oxfordjournals.jbchem.a123550; Harris FM, 2001, J BIOL CHEM, V276, P22722, DOI 10.1074/jbc.M010879200; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Henshaw JB, 1998, BIOCHEMISTRY-US, V37, P10709, DOI 10.1021/bi9728809; HOFFMAN JF, 1987, BLOOD CELLS, V12, P565; Honger T, 1996, BIOCHEMISTRY-US, V35, P9003, DOI 10.1021/bi960866a; Inomata M, 1996, ARCH BIOCHEM BIOPHYS, V328, P129, DOI 10.1006/abbi.1996.0152; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V980, P23, DOI 10.1016/0005-2736(89)90195-8; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P217, DOI 10.1016/0005-2760(93)90003-R; KUYPERS FA, 1987, BIOCHIM BIOPHYS ACTA, V921, P266, DOI 10.1016/0005-2760(87)90027-0; LEW VL, 1985, NATURE, V315, P586, DOI 10.1038/315586a0; MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839; MENASHE M, 1986, J BIOL CHEM, V261, P5328; MOHANDAS N, 1993, SEMIN HEMATOL, V30, P171; MORTENSEN AM, 1991, TOXICOL APPL PHARM, V110, P435, DOI 10.1016/0041-008X(91)90045-G; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; Nielson KH, 2000, BBA-MOL CELL BIOL L, V1484, P163, DOI 10.1016/S1388-1981(00)00004-4; Okafor MC, 1997, AM J PHYSIOL-CELL PH, V272, pC1365, DOI 10.1152/ajpcell.1997.272.4.C1365; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; Reddy ST, 1997, J BIOL CHEM, V272, P3231, DOI 10.1074/jbc.272.6.3231; REICHSTEIN E, 1981, J MEMBRANE BIOL, V59, P57, DOI 10.1007/BF01870821; REINHART WH, 1986, BLOOD, V68, P1376; RICHIERI GV, 1995, ANAL BIOCHEM, V229, P256, DOI 10.1006/abio.1995.1410; RUNGEMORRIS MA, 1988, TOXICOL APPL PHARM, V94, P414, DOI 10.1016/0041-008X(88)90282-7; SCHLEGEL RA, 1987, METHOD ENZYMOL, V149, P281; SCHNEIDER GB, 1976, AM J ANAT, V146, P93, DOI 10.1002/aja.1001460105; SHEFFIELD MJ, 1995, BIOCHEMISTRY-US, V34, P7796, DOI 10.1021/bi00024a003; SWEETMAN LL, 1995, ARCH BIOCHEM BIOPHYS, V323, P97, DOI 10.1006/abbi.1995.0014; TSUDA K, 1990, AM J HYPERTENS, V3, P714, DOI 10.1093/ajh/3.9.714; WILLIAMSON P, 1992, BIOCHEMISTRY-US, V31, P6355, DOI 10.1021/bi00142a027; Wilson HA, 1997, BBA-LIPID LIPID MET, V1349, P142, DOI 10.1016/S0005-2760(97)00089-1; Wilson HA, 1999, J BIOL CHEM, V274, P11494, DOI 10.1074/jbc.274.17.11494; YU BZ, 1993, BIOCHEMISTRY-US, V32, P6485, DOI 10.1021/bi00076a024; Yu WM, 1996, BIOPHYS J, V70, P626, DOI 10.1016/S0006-3495(96)79646-7; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121; ZWAAL RFA, 1989, MOL CELL BIOCHEM, V91, P23, DOI 10.1007/BF00228075	64	51	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22732	22741		10.1074/jbc.M010880200	http://dx.doi.org/10.1074/jbc.M010880200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294854	hybrid			2022-12-27	WOS:000169412700101
J	King, ND; O'Brian, MR				King, ND; O'Brian, MR			Evidence for direct interaction between enzyme I-Ntr and aspartokinase to regulate bacterial oligopeptide transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOLEVULINIC-ACID UPTAKE; ESCHERICHIA-COLI; PHOSPHOTRANSFERASE SYSTEM; BRADYRHIZOBIUM-JAPONICUM; SALMONELLA-TYPHIMURIUM; DIPEPTIDE PERMEASE; 5-AMINOLEVULINIC ACID; BACILLUS-SUBTILIS; BINDING PROTEIN; GENE	Bradyrhizobium japonicum transports olgopeptides and the heme precursor delta -aminolevulinic acid (ALA) by a common mechanism. Two Tn5-induced mutants disrupted in the lysC and ptsP genes were identified based on the inability to use prolyl-glycyl-glycine as a proline source and were defective in [C-14]ALA uptake activity. lysC and ptsP were shown to be proximal genes in the B, japonicum genome. However, RNase protection and in trans complementation analysis showed that lysC and ptsP are transcribed separately, and that both genes are involved in oligopeptide transport. Aspartokinase, encoded by lysC, catalyzes the phosphorylation of aspartate for synthesis of three amino acids, but the lysC strain is not an amino acid auxotroph, The ptsP gene encodes Enzyme I-Ntr (EINtr), a paralogue of Enzyme I of the phosphoenolpyruvate:sugar phosphotransferase (PTS) system. In vitro pull-down experiments indicated that purified recombinant aspartokinase and EINtr interact directly with each other. Expression of ptsP in trans from a multicopy plasmid complemented the lysC mutant, suggesting that aspartokinase normally affects Enzyme I-Ntr in a manner that can be compensated for by increasing the copy number of the ptsP gene. ATP was not a phosphoryl donor to purified EINtr, but it was phosphorylated by ATP in the presence of cell extracts. This phosphorylation was inhibited in the presence of aspartokinase. The findings demonstrate a role for a PTS protein in the transport of a non-sugar solute and suggest an unusual regulatory function for aspartokinase in regulating the phosphorylation state of EINtr.	SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; SUNY Buffalo, Ctr Microbial Pathogenesis, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	O'Brian, MR (corresponding author), SUNY Buffalo, Dept Biochem, 140 Farber Hall, Buffalo, NY 14214 USA.							ABOUHAMAD WN, 1994, MOL MICROBIOL, V14, P1077, DOI 10.1111/j.1365-2958.1994.tb01340.x; ABOUHAMAD WN, 1991, MOL MICROBIOL, V5, P1035, DOI 10.1111/j.1365-2958.1991.tb01876.x; AUSTIN S, 1994, J BACTERIOL, V176, P3460, DOI 10.1128/JB.176.12.3460-3465.1994; Ausubel FM, 1994, CURRENT PROTOCOLS MO; BONDARYK RP, 1985, J BIOL CHEM, V260, P592; Cases I, 1999, J BIOL CHEM, V274, P15562, DOI 10.1074/jbc.274.22.15562; Cases I, 2001, J BACTERIOL, V183, P1032, DOI 10.1128/JB.183.3.1032-1037.2001; Chauhan S, 1997, J BACTERIOL, V179, P3706, DOI 10.1128/jb.179.11.3706-3710.1997; Dannelly HK, 1996, J BIOL CHEM, V271, P15285, DOI 10.1074/jbc.271.25.15285; ELLIOTT T, 1993, J BACTERIOL, V175, P325, DOI 10.1128/JB.175.2.325-331.1993; FOX DK, 1986, J BIOL CHEM, V261, P3498; FRUSTACI JM, 1991, J BACTERIOL, V173, P1145, DOI 10.1128/jb.173.3.1145-1150.1991; FRUSTACI JM, 1992, J BACTERIOL, V174, P4223, DOI 10.1128/JB.174.13.4223-4229.1992; HIGGINS C, 1987, NATURE, V327, P655, DOI 10.1038/327655a0; HILES ID, 1987, J MOL BIOL, V195, P125, DOI 10.1016/0022-2836(87)90332-9; HILES ID, 1986, EUR J BIOCHEM, V158, P561, DOI 10.1111/j.1432-1033.1986.tb09791.x; KALINOWSKI J, 1991, MOL MICROBIOL, V5, P1197, DOI 10.1111/j.1365-2958.1991.tb01893.x; Kikuchi Y, 1999, FEMS MICROBIOL LETT, V173, P211, DOI 10.1111/j.1574-6968.1999.tb13504.x; King ND, 1997, J BACTERIOL, V179, P1828, DOI 10.1128/jb.179.5.1828-1831.1997; King ND, 2000, APPL ENVIRON MICROB, V66, P5469, DOI 10.1128/AEM.66.12.5469-5471.2000; KULLIK I, 1991, J BACTERIOL, V173, P1125, DOI 10.1128/jb.173.3.1125-1138.1991; Lazazzera BA, 1997, CELL, V89, P917, DOI 10.1016/S0092-8674(00)80277-9; MCGINNIS SD, 1995, PLANT PHYSIOL, V108, P1547, DOI 10.1104/pp.108.4.1547; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Merrick M.J., 1992, BIOL NITROGEN FIXATI, P835; Michiels J, 1998, J BACTERIOL, V180, P1729, DOI 10.1128/JB.180.7.1729-1740.1998; OLSON ER, 1991, J BACTERIOL, V173, P234, DOI 10.1128/jb.173.1.234-244.1991; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; POWELL BS, 1995, J BIOL CHEM, V270, P4822, DOI 10.1074/jbc.270.9.4822; Rabus R, 1999, J BIOL CHEM, V274, P26185, DOI 10.1074/jbc.274.37.26185; Reizer J, 1996, GENE, V181, P103, DOI 10.1016/S0378-1119(96)00481-7; ROOSSIEN FF, 1983, BIOCHIM BIOPHYS ACTA, V760, P185, DOI 10.1016/0304-4165(83)90141-1; SAIER MH, 1994, MOL MICROBIOL, V13, P755; SAMBROOK J, 1989, MOL CLONING LAB MANJ; SANGWAN I, 1991, SCIENCE, V251, P1220, DOI 10.1126/science.251.4998.1220; Segura D, 1998, J BACTERIOL, V180, P4790, DOI 10.1128/JB.180.18.4790-4798.1998; STADTMAN ER, 1961, J BIOL CHEM, V236, P2033; THEZE J, 1974, J BACTERIOL, V117, P133; VERKAMP E, 1993, J BACTERIOL, V175, P1452, DOI 10.1128/JB.175.5.1452-1456.1993	40	26	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21311	21316		10.1074/jbc.M101982200	http://dx.doi.org/10.1074/jbc.M101982200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11287431	hybrid			2022-12-27	WOS:000169297900069
J	Knowles, VL; Smith, CS; Smith, CR; Plaxton, WC				Knowles, VL; Smith, CS; Smith, CR; Plaxton, WC			Structural and regulatory properties of pyruvate kinase from the cyanobacterium Synechococcus PCC 6301	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASTOR BEAN ENDOSPERM; GREEN-ALGA; SELENASTRUM-MINUTUM; IMMUNOLOGICAL CHARACTERIZATION; ANACYSTIS-NIDULANS; COMPUTER-PROGRAM; PURIFICATION; ISOZYMES; ASSIMILATION; ISOENZYMES	Pyruvate kinase (PK) from the cyanobacterium Synechococcus PCC 6301 was purified 1,300-fold to electrophoretic homogeneity and a final specific activity of 222 mu mol of pyruvate produced/min/mg of protein. The enzyme was shown to have a pi of 5.7 and to exist as a 280-kDa homotetramer composed of 66-kDa subunits, This PK appears to be immunologically related to Bacillus PK and a green algal chloroplast PK, but not to rabbit muscle PK, or vascular plant cytosolic and plastidic PKs, The N-terminal amino acid sequence of the Synechococcus PK exhibited maximal (67%) identity with the corresponding region of a putative Ph-A sequence deduced from the genome of the cyanobacterium, Synechocystis PCC 6803, Synechococcus PK was relatively heat-labile and displayed a broad pH optimum around pH 7.0. Its activity was not influenced by K+, but required high concentrations of Mg2+ and was relatively nonspecific with respect to the nucleoside diphosphate substrate. Potent allosteric regulation by various effecters was observed (activators: hexose monophosphates, ribose 5-phosphate, glycerol 3-phosphate, and AMP; inhibitors: fructose 1,6-bisphosphate, inorganic phosphate, ATP, and several Krebs' cycle intermediates). The enzyme exhibited marked positive cooperativity for phosphoenolpyruvate, which was eliminated or reduced by the presence of the allosteric activators. The results are discussed in terms of the phylogeny and probable central role of PK in the control of cyanobacterial glycolysis.	Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Plaxton, WC (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	plaxton@biology.queensu.ca	Plaxton, William C/O-3353-2013	Plaxton, William C/0000-0002-8447-7249				ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BIGGINS J, 1969, J BACTERIOL, V99, P570, DOI 10.1128/JB.99.2.570-575.1969; BOLLAG DM, 1996, PROTEIN METHODS, P62; BROOKS SPJ, 1992, BIOTECHNIQUES, V13, P906; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; CHUANG DT, 1979, J BIOL CHEM, V254, P8434; Dixon M., 1979, ENZYMES, Vthird; Douglas SE, 1998, CURR OPIN GENET DEV, V8, P655, DOI 10.1016/S0959-437X(98)80033-6; FALKNER G, 1976, PLANT PHYSIOL, V58, P717, DOI 10.1104/pp.58.6.717; GARCIAOLALLA C, 1987, BIOCHEM J, V241, P573, DOI 10.1042/bj2410573; GOLDEN SS, 1989, J BACTERIOL, V171, P24, DOI 10.1128/jb.171.1.24-29.1989; GUY RD, 1989, PLANT PHYSIOL, V89, P1150, DOI 10.1104/pp.89.4.1150; HANDELMAN SL, 1973, J DENT RES, V52, P651, DOI 10.1177/00220345730520040301; Hattori J, 1995, BIOCHEM SYST ECOL, V23, P773, DOI 10.1016/0305-1978(95)00061-5; IHLENFELDT MJA, 1975, ARCH MICROBIOL, V102, P13, DOI 10.1007/BF00428339; IRELAND RJ, 1980, PLANT PHYSIOL, V65, P1188, DOI 10.1104/pp.65.6.1188; Kaneko T, 1996, DNA Res, V3, P109; KNOWLES VL, 1989, FEBS LETT, V259, P130, DOI 10.1016/0014-5793(89)81511-X; Liaud MF, 2000, MOL BIOL EVOL, V17, P213, DOI 10.1093/oxfordjournals.molbev.a026301; LIN M, 1989, ARCH BIOCHEM BIOPHYS, V269, P228, DOI 10.1016/0003-9861(89)90104-5; LIN M, 1989, ARCH BIOCHEM BIOPHYS, V269, P219, DOI 10.1016/0003-9861(89)90103-3; MALCOVATI M, 1982, METHOD ENZYMOL, V90, P170; Mattevi A, 1996, FEBS LETT, V389, P15, DOI 10.1016/0014-5793(96)00462-0; MERTENS E, 1992, MOL BIOCHEM PARASIT, V54, P13, DOI 10.1016/0166-6851(92)90090-7; MUIRHEAD H, 1999, BIOCHEM SOC T, V18, P193; PAWLUK A, 1986, BIOCHEM J, V238, P275, DOI 10.1042/bj2380275; PLAXTON WC, 1990, PLANT PHYSIOL, V94, P1528, DOI 10.1104/pp.94.4.1528; PLAXTON WC, 1989, EUR J BIOCHEM, V181, P443, DOI 10.1111/j.1432-1033.1989.tb14745.x; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; SAKAI H, 1986, J BIOCHEM-TOKYO, V99, P1157, DOI 10.1093/oxfordjournals.jbchem.a135579; Schramm A, 2000, J BACTERIOL, V182, P2001, DOI 10.1128/JB.182.7.2001-2009.2000; Smith CR, 2000, EUR J BIOCHEM, V267, P4477, DOI 10.1046/j.1432-1327.2000.01494.x; Stal LJ, 1997, FEMS MICROBIOL REV, V21, P179, DOI 10.1016/S0168-6445(97)00056-9; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001	35	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20966	20972		10.1074/jbc.M008878200	http://dx.doi.org/10.1074/jbc.M008878200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11294847	hybrid			2022-12-27	WOS:000169297900024
J	Bolhuis, A; Mathers, JE; Thomas, JD; Barrett, CML; Robinson, C				Bolhuis, A; Mathers, JE; Thomas, JD; Barrett, CML; Robinson, C			TatB and TatC form a functional and structural unit of the twin-arginine translocase from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEC-INDEPENDENT PROTEIN; EXPORT PATHWAY; PEPTIDE; PURIFICATION; EXPRESSION; MEMBRANE; AFFINITY; COMPLEX; SYSTEM	In Escherichia coli, a subset of periplasmic proteins is exported via the twin-arginine translocation (Tat) pathway. In the present study, we have purified the Tat complex from E. coli, and we show that it contains only TatA, TatB, and TatC, Within the purified complex, TatB and TatC are present in a strict 1:1 ratio, suggesting a functional association. This has been confirmed by expression of a translational fusion between TatB and TatC, This Tat(BC) chimera supports efficient Tat-dependent export, indicating that TatB and TatC act as a unit in both structural and functional terms. The purified Tat complex contains varying levels of TatA, suggesting a gradual loss during isolation and a looser association. The molecular mass of the complex is similar to 600 kDa, demonstrating the presence of multiple copies of TatA, B, and C, Co-immunoprecipitation experiments show that TatC is required for the interaction of TatA with TatB, suggesting that TatA may interact with the complex via binding to TatC.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Robinson, C (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	crobinson@bio.warwick.ac.uk	Bolhuis, Albert/E-9932-2010	Bolhuis, Albert/0000-0001-9307-0515; Smith, Joanna/0000-0003-4234-6686				Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2000, FEBS LETT, V472, P88, DOI 10.1016/S0014-5793(00)01428-9; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Dalbey RE, 1999, TRENDS BIOCHEM SCI, V24, P17, DOI 10.1016/S0968-0004(98)01333-4; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Manting EH, 2000, MOL MICROBIOL, V37, P226, DOI 10.1046/j.1365-2958.2000.01980.x; RANDALL LL, 1986, CELL, V46, P921, DOI 10.1016/0092-8674(86)90074-7; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; SCHMIDT TGM, 1993, PROTEIN ENG, V6, P109, DOI 10.1093/protein/6.1.109; SILVESTRO A, 1989, BIOCHIM BIOPHYS ACTA, V999, P208, DOI 10.1016/0167-4838(89)90220-3; Voss S, 1997, PROTEIN ENG, V10, P975, DOI 10.1093/protein/10.8.975; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200	17	220	228	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20213	20219		10.1074/jbc.M100682200	http://dx.doi.org/10.1074/jbc.M100682200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279240	hybrid			2022-12-27	WOS:000169135100074
J	Sung, YH; Shin, J; Chang, HJ; Cho, JM; Lee, W				Sung, YH; Shin, J; Chang, HJ; Cho, JM; Lee, W			Solution structure, backbone dynamics, and stability of a double mutant single-chain monellin - Structural origin of sweetness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; SIMULATED ANNEALING CALCULATIONS; INTERPROTON DISTANCE DATA; AMINO-ACID-SEQUENCE; 3-DIMENSIONAL STRUCTURES; HETERONUCLEAR NMR; PROTEIN MONELLIN; N-15 NMR; SPECTROSCOPY; GEOMETRY	Single-chain monellin (SCM), which is an engineered 94-residue polypeptide, has been characterized as being as sweet as native two-chain monellin, Data from gelfiltration high performance liquid chromatography and NMR has proven that SCM exists as a monomer in aqueous solution. In order to determine the structural origin of the taste of sweetness, we engineered several mutant SCM proteins by mutating Glu(2), Asp(7), and Arg(39) residues, which are responsible for sweetness. In this study, we present the solution structure, backbone dynamics, and stability of mutant SCM proteins using circular dichroism, fluorescence, and NMR spectroscopy. Based on the NMR data, a stable alpha -helix and five-stranded antiparallel beta -sheet were identified for double mutant SCM, Strands beta1 and beta2 are connected by a small bulge, and the disruption of the first beta -strand were observed with SCMDR comprising residues of IIe(38)-Cys(41). The dynamical and folding characteristics from circular dichroism, fluorescence, and backbone dynamics studies revealed that both wild type and mutant proteins showed distinct dynamical as well as stability differences, suggesting the important role of mutated residues in the sweet taste of SCM. Our results will provide an insight into the structural origin of sweet taste as well as the mutational effect in the stability of the engineered sweet protein SCM.	Yonsei Univ, Coll Sci, Dept Biochem, Seodaemoon Gu, Seoul 120740, South Korea; Yonsei Univ, Coll Sci, Prot Network Res Ctr, Seodaemoon Gu, Seoul 120740, South Korea; LG Chem, Biotech Res Inst, Taejon 305380, South Korea	Yonsei University; Yonsei University; LG Chem	Lee, W (corresponding author), Yonsei Univ, Coll Sci, Dept Biochem, Seodaemoon Gu, Seoul 120740, South Korea.	wlee@biochem.yonsei.ac.kr	LEE, WEON TAE/AAQ-9088-2021					AGASHE VR, 1995, BIOCHEMISTRY-US, V34, P3286, DOI 10.1021/bi00010a019; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BROUWER JN, 1973, ACTA PHYSIOL SCAND, V89, P550, DOI 10.1111/j.1748-1716.1973.tb05549.x; CLORE GM, 1987, BIOCHEMISTRY-US, V26, P8012, DOI 10.1021/bi00398a069; DRISCOLL PC, 1989, BIOCHEMISTRY-US, V28, P2188, DOI 10.1021/bi00431a033; FAN P, 1993, BIOCHEMISTRY-US, V32, P1573, DOI 10.1021/bi00057a023; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; HELLEKANT G, 1976, ACTA PHYSIOL SCAND, V97, P241, DOI 10.1111/j.1748-1716.1976.tb10257.x; HOUGH CAM, 1978, NATURE, V271, P381, DOI 10.1038/271381a0; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KIM SH, 1989, PROTEIN ENG, V2, P571, DOI 10.1093/protein/2.8.571; KRISHNAGOPAL M, 1985, BIOCHIM BIOPHYS ACTA, V832, P156; KRISHNAMURTHY VV, 1995, J MAGN RESON SER B, V106, P170, DOI 10.1006/jmrb.1995.1028; KURIHARA K, 1968, SCIENCE, V161, P1241, DOI 10.1126/science.161.3847.1241; Lee SY, 1999, BIOCHEMISTRY-US, V38, P2340, DOI 10.1021/bi9822731; LEE W, 1994, EUR J BIOCHEM, V219, P89, DOI 10.1111/j.1432-1033.1994.tb19918.x; LIU XZ, 1993, EUR J BIOCHEM, V211, P281, DOI 10.1111/j.1432-1033.1993.tb19896.x; LOMIZE AL, 1990, BIOORG KHIM+, V16, P179; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MORRIS JA, 1972, BIOCHIM BIOPHYS ACTA, V261, P114, DOI 10.1016/0304-4165(72)90320-0; MORRIS JA, 1976, LLOYDIA, V39, P25; MURZIN AG, 1993, J MOL BIOL, V230, P689, DOI 10.1006/jmbi.1993.1186; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; OGATA C, 1987, NATURE, V328, P739, DOI 10.1038/328739a0; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; SKELTON NJ, 1993, J MAGN RESON SER B, V102, P253, DOI 10.1006/jmrb.1993.1095; SURI AK, 1995, J MAGN RESON SER B, V106, P24, DOI 10.1006/jmrb.1995.1004; TOMIC MT, 1992, J BIOMOL NMR, V2, P557, DOI 10.1007/BF02192845; VANDERWEL H, 1972, EUR J BIOCHEM, V31, P221; VANDERWEL H, 1976, BIOCH SENSORY FUNCT, V197, P235; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; WAGNER G, 1987, J MOL BIOL, V196, P611, DOI 10.1016/0022-2836(87)90037-4; WOODY RW, 1978, BIOPOLYMERS, V17, P1451, DOI 10.1002/bip.1978.360170606; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; YAMASHITA H, 1990, J BIOL CHEM, V265, P15770	39	30	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19624	19630		10.1074/jbc.M100930200	http://dx.doi.org/10.1074/jbc.M100930200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279156	hybrid			2022-12-27	WOS:000169091000128
J	Li, YH; Lu, WY; Marzolo, MP; Bu, GJ				Li, YH; Lu, WY; Marzolo, MP; Bu, GJ			Differential functions of members of the low density lipoprotein receptor family suggested by their distinct endocytosis rates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-E RECEPTOR-2; DEPENDENT LIGAND DISSOCIATION; AMYLOID PRECURSOR PROTEIN; LDL-RECEPTOR; CYTOSOLIC ADAPTER; MOLECULAR CHAPERONE; VLDL RECEPTOR; MESSENGER-RNA; GENE FAMILY; IN-VITRO	The low density lipoprotein receptor (LDLR) family is composed of a class of cell surface endocytic receptors that recognize extracellular ligands and internalize them for degradation by lysosomes, In addition to LDLR, mammalian members of this family include the LDLR-related protein (LRP), the very low density lipoprotein receptor (VLDLR), the apolipoprotein E receptor-2 (apoER2), and megalin. Herein we have analyzed the endocytic functions of the cytoplasmic tails of these receptors using LRP minireceptors, its chimeric receptor constructs, and full-length VLDLR and apoER2 stably expressed in LRP-null Chinese hamster ovary cells. We find that the initial endocytosis rates mediated by different cytoplasmic tails are significantly different, with half-times of ligand internalization ranging from less than 30 s to more than 8 min. The tail of LRP mediates the highest rate of endocytosis, whereas those of the VLDLR and apoER2 exhibit least endocytosis function. Compared with the tail of LRP, the tails of the LDLR and megalin display significantly lower levels of endocytosis rates. Ligand degradation analyses strongly support differential endocytosis rates initiated by these receptors. Interestingly apoER2, which has recently been shown to mediate intracellular signal transduction, exhibited the lowest level of ligand degradation efficiency. These results thus suggest that the endocytic functions of members of the LDLR family are distinct and that certain receptors in this family may play their main roles in areas other than receptor-mediated endocytosis.	Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Univ Chile, Dept Biol, Santiago, Chile; St Louis Childrens Hosp, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Universidad de Chile; St. Louis Children's Hospital; Washington University (WUSTL)	Bu, GJ (corresponding author), Washington Univ, Sch Med, Dept Pediat, CB 8208,660 S Euclid Ave, St Louis, MO 63110 USA.				NHLBI NIH HHS [HL59150] Funding Source: Medline; NIDDK NIH HHS [DK56783] Funding Source: Medline; NINDS NIH HHS [NS37525] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037525] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BATTEY FD, 1994, J BIOL CHEM, V269, P23268; Bu GJ, 1998, CURR OPIN LIPIDOL, V9, P149, DOI 10.1097/00041433-199804000-00012; BU GJ, 1992, J BIOL CHEM, V267, P15595; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; BU GJ, 1994, J BIOL CHEM, V269, P29874; BU GJ, 1993, J BIOL CHEM, V268, P13002; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; FITZGERALD DJ, 1995, J CELL BIOL, V129, P1533, DOI 10.1083/jcb.129.6.1533; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Herz J, 2000, CURR OPIN LIPIDOL, V11, P161, DOI 10.1097/00041433-200004000-00009; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hjalm G, 1996, EUR J BIOCHEM, V239, P132, DOI 10.1111/j.1432-1033.1996.0132u.x; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Kim DH, 1997, J BIOL CHEM, V272, P8498, DOI 10.1074/jbc.272.13.8498; Kim DH, 1996, J BIOL CHEM, V271, P8373, DOI 10.1074/jbc.271.14.8373; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; LAI A, 1995, J BIOL CHEM, V270, P3565, DOI 10.1074/jbc.270.8.3565; Li YH, 2001, MOL CELL BIOL, V21, P1185, DOI 10.1128/MCB.21.4.1185-1195.2001; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Mikhailenko I, 1999, J CELL SCI, V112, P3269; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; Obermoeller LM, 1998, J BIOL CHEM, V273, P22374, DOI 10.1074/jbc.273.35.22374; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Oleinikov AV, 2000, BIOCHEM J, V347, P613, DOI 10.1042/0264-6021:3470613; SAKAI J, 1994, J BIOL CHEM, V269, P2173; Savonen R, 1999, J BIOL CHEM, V274, P25877, DOI 10.1074/jbc.274.36.25877; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; STRICKLAND DK, 1995, FASEB J, V9, P890, DOI 10.1096/fasebj.9.10.7615159; Sun XM, 1999, EUR J BIOCHEM, V262, P230, DOI 10.1046/j.1432-1327.1999.00394.x; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; VASSILIOU G, 1994, J BIOL CHEM, V269, P15172; WARSHAWSKY I, 1993, J BIOL CHEM, V268, P22046; Willnow TE, 1996, BIOCHEM J, V313, P71, DOI 10.1042/bj3130071; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0	41	122	127	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18000	18006		10.1074/jbc.M101589200	http://dx.doi.org/10.1074/jbc.M101589200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279214	hybrid			2022-12-27	WOS:000168866500052
J	Yan, Z; Serrano, AL; Schiaffino, S; Bassel-Duby, R; Williams, RS				Yan, Z; Serrano, AL; Schiaffino, S; Bassel-Duby, R; Williams, RS			Regulatory elements governing transcription in specialized myofiber subtypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE FIBER-TYPE; HUMAN MYOGLOBIN PROMOTER; SLOW SKELETAL-MUSCLE; GENE-EXPRESSION; SONIC-HEDGEHOG; E-BOX; NERVE-ACTIVITY; IN-VIVO; MYOGENIN; DIFFERENTIATION	Skeletal myofibers of vertebrates acquire specialized metabolic and physiological properties as a consequence of developmental cues in the embryo and different patterns of contractile activity in the adult. The myoglobin gene is regulated stringently in muscle fibers, such that high myoglobin expression is observed in mitochondria-rich, oxidative myofibers (Types I and IIa) compared with glycolytic fibers (Type IIb). Using germline transgenesis and somatic cell gene transfer methods, we defined discrete regions of the murine and human genes encoding myoglobin that are sufficient to confer muscle- and fiber type-specific expression to reporter genes. Mutational analysis confirms the importance of APT-rich, MEF2-binding motifs in myoglobin gene regulation, as suggested by previous studies using different experimental approaches. In addition, we demonstrated a previously unsuspected role for an intragenic E-box motif as a negative regulatory element contributing to the tightly regulated variation in myoglobin gene expression among particular myofiber subtypes.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; Univ Padua, CNR, Ctr Muscle Biol & Physiopathol, I-35121 Padua, Italy	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua	Williams, RS (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, 6000 Harry Hines Blvd,NB11-200, Dallas, TX 75390 USA.		Serrano, A/I-9198-2014	Schiaffino, Stefano/0000-0002-5607-6421; Yan, Zhen/0000-0002-4826-9813				BASSELDUBY R, 1992, MOL CELL BIOL, V12, P5024, DOI 10.1128/MCB.12.11.5024; BASSELDUBY R, 1993, CIRC RES, V73, P360, DOI 10.1161/01.RES.73.2.360; Bigard X, 2000, J BIOL CHEM, V275, P19653, DOI 10.1074/jbc.M000430200; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Cann GM, 1999, ANAT EMBRYOL, V200, P239, DOI 10.1007/s004290050276; Ceccarelli E, 1999, DEV BIOL, V213, P217, DOI 10.1006/dbio.1999.9345; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; DEVLIN BH, 1989, J BIOL CHEM, V264, P13896; Dunn SE, 2000, J CELL BIOL, V151, P663, DOI 10.1083/jcb.151.3.663; Duprez D, 1999, MECH DEVELOP, V82, P151, DOI 10.1016/S0925-4773(99)00040-4; Garry DJ, 1996, DEV GENET, V19, P146, DOI 10.1002/(SICI)1520-6408(1996)19:2<146::AID-DVG6>3.0.CO;2-9; GRAYSON J, 1995, MOL CELL BIOL, V15, P1870; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; Hughes SM, 1999, J CELL BIOL, V145, P633, DOI 10.1083/jcb.145.3.633; HUGHES SM, 1993, DEVELOPMENT, V118, P1137; Jerkovic R, 1997, CELL STRUCT FUNCT, V22, P147, DOI 10.1247/csf.22.147; Kanatous SB, 1999, J APPL PHYSIOL, V86, P1247, DOI 10.1152/jappl.1999.86.4.1247; Kraner SD, 1999, J BIOL CHEM, V274, P8129, DOI 10.1074/jbc.274.12.8129; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Murgia M, 2000, NAT CELL BIOL, V2, P142, DOI 10.1038/35004013; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Neufer PD, 1998, AM J PHYSIOL-CELL PH, V274, pC341, DOI 10.1152/ajpcell.1998.274.2.C341; Norris W, 2000, J CELL SCI, V113, P2695; O'Mahoney JV, 1998, MOL CELL BIOL, V18, P6641, DOI 10.1128/MCB.18.11.6641; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; Postigo AA, 1997, EMBO J, V16, P3935, DOI 10.1093/emboj/16.13.3935; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; SIMON AM, 1993, MOL CELL BIOL, V13, P5133, DOI 10.1128/MCB.13.9.5133; Spitz F, 1999, J MOL BIOL, V289, P893, DOI 10.1006/jmbi.1999.2821; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Swoap SJ, 2000, AM J PHYSIOL-CELL PH, V279, pC915, DOI 10.1152/ajpcell.2000.279.4.C915; UNDERWOOD LE, 1987, AM J PHYSIOL, V252, pC450, DOI 10.1152/ajpcell.1987.252.4.C450; Williams RS, 1996, HDB PHYSL EXERCISE R, P1124; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Yang Q, 1997, MOL CELL BIOL, V17, P5236, DOI 10.1128/MCB.17.9.5236; Zhang CL, 2001, J BIOL CHEM, V276, P35, DOI 10.1074/jbc.M007364200; [No title captured]	42	39	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17361	17366		10.1074/jbc.M101251200	http://dx.doi.org/10.1074/jbc.M101251200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279187	hybrid			2022-12-27	WOS:000168730400102
J	Utkin, YN; Kukhtina, VV; Kryukova, EV; Chiodini, F; Bertrand, D; Methfessel, C; Tsetlin, VI				Utkin, YN; Kukhtina, VV; Kryukova, EV; Chiodini, F; Bertrand, D; Methfessel, C; Tsetlin, VI			"Weak toxin" from Naja kaouthia is a nontoxic antagonist of alpha 7 and muscle-type nicotinic acetylcholine receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	XIIIth World Congress of the International-Society-on-Toxinology	SEP 18-22, 2000	PARIS, FRANCE	Int Soc Toxinol			SNAKE-VENOM TOXINS; CONOTOXIN IMI; CURAREMIMETIC TOXINS; HOMOMERIC ALPHA-7; LY-6 FAMILY; NEUROTOXINS; BUNGAROTOXIN; IDENTIFICATION; COBRATOXIN; PROTEINS	A novel "weak toxin" (WTX) from Naja kaouthia snake venom competes with [I-125]alpha -bungarotoxin for binding to the membrane-bound Torpedo californica acetylcholine receptor (AChR), with an IC50 of similar to2.2 muM. In this respect, it is similar to 300 times less potent than neurotoxin II from Naja oxiana and alpha -cobratoxin from N. kaouthia, representing short-type and long-type alpha -neurotoxins, respectively. WTX and alpha -cobratoxin displaced [I-125]alpha -bungarotoxin from the Escherichia coli-expressed fusion protein containing the rat alpha7 AChR N-terminal domain 1-208 preceded by glutathione S-transferase with IC50 values of 4.3 and 9.1 muM, respectively, whereas for neurotoxin II the IC50 value was >100 muM. Micromolar concentrations of WTX inhibited acetylcholine-activated currents in Xenopus oocyte-expressed rat muscle AChR and human and rat alpha7 AChRs, inhibiting the latter most efficiently (IC50 of similar to8.3 muM). Thus, a virtually nontoxic "three-fingered" protein WTX, although differing from alpha -neurotoxins by an additional disulfide in the N-terminal loop, can be classified as a weak alpha -neurotoxin. It differs from the short chain alpha -neurotoxins, which potently block the muscle-type but not the alpha7 AChRs, and is closer to the long alpha -neurotoxins, which have comparable potency against the above-mentioned AChR types.	Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; Ctr Med Univ Geneva, Dept Physiol, CH-1211 Geneva 4, Switzerland; Bayer AG, Cent Res Biophys, D-51368 Leverkusen, Germany	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; University of Geneva; Bayer AG	Tsetlin, VI (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, 16-10 Miklukho Maklaya Str,V-437,GSP-7, Moscow 117997, Russia.	vits@ibch.ru	Tsetlin, Victor/X-2491-2018; Utkin, Yuri/L-2952-2019; Utkin, Yuri N./F-1958-2014	Utkin, Yuri/0000-0002-4609-970X; Utkin, Yuri N./0000-0002-4609-970X				Ackermann EJ, 1998, J BIOL CHEM, V273, P10958, DOI 10.1074/jbc.273.18.10958; Aird SD, 1999, TOXICON, V37, P609, DOI 10.1016/S0041-0101(98)00199-8; Antil S, 1999, J BIOL CHEM, V274, P34851, DOI 10.1074/jbc.274.49.34851; Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; Ariel S, 1998, ANN NY ACAD SCI, V841, P93, DOI 10.1111/j.1749-6632.1998.tb10912.x; BERTRAND D, 1992, NEUROSCI LETT, V146, P87, DOI 10.1016/0304-3940(92)90179-B; Bertrand D, 1991, METHODS NEUROSCIENCE, V4, P174; BETZEL C, 1991, J BIOL CHEM, V266, P21530; Buisson B, 1998, J PHYSIOL-PARIS, V92, P89, DOI 10.1016/S0928-4257(98)80144-7; CARLSSON FHH, 1975, BIOCHIM BIOPHYS ACTA, V400, P310, DOI 10.1016/0005-2795(75)90186-5; Chang LS, 2000, BBA-PROTEIN STRUCT M, V1480, P293, DOI 10.1016/S0167-4838(00)00082-0; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; Cordero-Erausquin M, 2000, TRENDS PHARMACOL SCI, V21, P211, DOI 10.1016/S0165-6147(00)01489-9; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Eletskii A V, 2001, Bioorg Khim, V27, P89; GERZANICH V, 1994, MOL PHARMACOL, V45, P212; Grant GA, 1998, BIOCHEMISTRY-US, V37, P12166, DOI 10.1021/bi981227y; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Gullick W J, 1994, Methods Mol Biol, V32, P389; GUMLEY TP, 1995, IMMUNOL CELL BIOL, V73, P277, DOI 10.1038/icb.1995.45; Hucho F, 1996, EUR J BIOCHEM, V239, P539, DOI 10.1111/j.1432-1033.1996.0539u.x; JOHNSON DS, 1995, MOL PHARMACOL, V48, P194; JOUBERT FJ, 1980, H-S Z PHYSIOL CHEM, V361, P425, DOI 10.1515/bchm2.1980.361.1.425; JOUBERT FJ, 1975, H-S Z PHYSIOL CHEM, V356, P1901; KIEFFER B, 1994, BIOCHEMISTRY-US, V33, P4471, DOI 10.1021/bi00181a006; KLUKAS O, 1995, BIOORG KHIM+, V21, P152; Kuhn P, 2000, ACTA CRYSTALLOGR D, V56, P1401, DOI 10.1107/S0907444900011501; Kukhtina VV, 2000, BIOORG KHIM+, V26, P803; Maslennikov IV, 1999, FEBS LETT, V444, P275, DOI 10.1016/S0014-5793(99)00069-1; Menez A, 1998, TOXICON, V36, P1557, DOI 10.1016/S0041-0101(98)00148-2; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; MOORE MA, 1995, BBA-BIOMEMBRANES, V1235, P336, DOI 10.1016/0005-2736(95)80022-8; NIRTHANAN S, 2000, 13 WORLD C INT SOC T, pL108; Osaka H, 2000, J BIOL CHEM, V275, P5478, DOI 10.1074/jbc.275.8.5478; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; Quiram PA, 1998, J BIOL CHEM, V273, P11007, DOI 10.1074/jbc.273.18.11007; RICHARDS D, 1988, ELISA OTHER SOLID PH, P345; Servent D, 1997, J BIOL CHEM, V272, P24279, DOI 10.1074/jbc.272.39.24279; SHAFQAT J, 1991, FEBS LETT, V284, P70, DOI 10.1016/0014-5793(91)80764-T; TREMEAU O, 1995, J BIOL CHEM, V270, P9362, DOI 10.1074/jbc.270.16.9362; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; UTKIN Y, 2000, 13 WORLD C INT SOC T, pP162; Utkin YN, 1998, EUR J BIOCHEM, V253, P229, DOI 10.1046/j.1432-1327.1998.2530229.x; Utkin YN, 1999, TOXICON, V37, P1683, DOI 10.1016/S0041-0101(99)00111-7; Utkin YN, 2001, TOXICON, V39, P921, DOI 10.1016/S0041-0101(00)00223-3; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Wonnacott S., 1993, METHODS NEUROSCI, P263	47	101	106	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15810	15815		10.1074/jbc.M100788200	http://dx.doi.org/10.1074/jbc.M100788200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	431GH	11279130	hybrid			2022-12-27	WOS:000168623100033
J	Deb, TB; Su, L; Wong, L; Bonvini, E; Wells, A; David, M; Johnson, GR				Deb, TB; Su, L; Wong, L; Bonvini, E; Wells, A; David, M; Johnson, GR			Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TYROSINE KINASE; MICE LACKING; EXPRESSION; PHOSPHORYLATION; HETERODIMERIZATION; TRANSDUCTION; REQUIREMENT; SPECIFICITY; MUTATION	The ErbB family of receptors, which includes the epidermal growth factor receptor (EGFR), ErbB2, ErbB3, and ErbB4, mediate signaling by EGF-like polypeptides, To better understand the role of the EGFR tyrosine kinase, we analyzed signaling by a kinase-inactive EGFR (K721M) in ErbB-devoid 32D cells. K721M alone exhibited no detectable signaling capacity, whereas coexpression of K721M with ErbB2, but not ErbB3 or ErbB4, resulted in EGF-dependent mitogen-activated protein kinase (MAPK) activation. The kinase activity, but not tyrosine phosphorylation, of ErbB2 was required for EGF-induced MAPK activation. The presence of tyrosine phosphorylation sites in K721M was not a requisite for signaling, indicating that transphosphorylation of K721M by ErbB2 was not an essential mechanism of receptor activation. Conversely, the mutated kinase domain of K721M (residues 648-973) and tyrosine phosphorylation of at least one of the receptors were necessary. EGF was found to activate the pro-survival protein kinase Akt in stable cell lines expressing K721M and ErbB2 but, unlike cells expressing wild-type EGFR, was incapable of activating signal transducers and activators of transcription (STAT) or driving cell proliferation. These results demonstrate that EGFR-ErbB2 oligomers are potent activators of MAPK and Akt, and this signaling does not require EGFR kinase activity.	US FDA, Ctr Biol Evaluat & Res, Div Therapeut Prot, Bethesda, MD 20892 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; US FDA, Ctr Biol Evaluat & Res, Div Monoclonal Antibodies, Bethesda, MD 20892 USA; Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA	US Food & Drug Administration (FDA); University of California System; University of California San Diego; University of California System; University of California San Diego; US Food & Drug Administration (FDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Johnson, GR (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Therapeut Prot, Bldg 29A,Rm 3B-16,8800 Rockville Pike, Bethesda, MD 20892 USA.	Johnsong@cber.fda.gov		Su, Leon/0000-0001-7654-9997; Wells, Alan/0000-0002-1637-8150				Alimandi M, 1997, EMBO J, V16, P5608, DOI 10.1093/emboj/16.18.5608; ASKEW DS, 1991, ONCOGENE, V6, P1915; Brennan PJ, 2000, ONCOGENE, V19, P6093, DOI 10.1038/sj.onc.1203967; CAMPOSGONZALEZ R, 1992, J BIOL CHEM, V267, P14535; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; COKER KJ, 1994, P NATL ACAD SCI USA, V91, P6967, DOI 10.1073/pnas.91.15.6967; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; David M, 1996, J BIOL CHEM, V271, P9185, DOI 10.1074/jbc.271.16.9185; DIFIORE PP, 1990, SCIENCE, V248, P79, DOI 10.1126/science.2181668; ELDREDGE ER, 1994, MOL CELL BIOL, V14, P7527, DOI 10.1128/MCB.14.11.7527; Ferguson KM, 2000, EMBO J, V19, P4632, DOI 10.1093/emboj/19.17.4632; FOWLER KJ, 1995, P NATL ACAD SCI USA, V92, P1465, DOI 10.1073/pnas.92.5.1465; Gamett DC, 1997, J BIOL CHEM, V272, P12052, DOI 10.1074/jbc.272.18.12052; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; HACK N, 1993, J BIOL CHEM, V268, P26441; HONEGGER AM, 1987, MOL CELL BIOL, V7, P4568, DOI 10.1128/MCB.7.12.4568; Huang GC, 1998, BIOCHEM J, V331, P113, DOI 10.1042/bj3310113; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Ilaria RL, 1999, BLOOD, V93, P4154, DOI 10.1182/blood.V93.12.4154.412k15_4154_4166; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Nakamura N, 1996, J BIOL CHEM, V271, P19483, DOI 10.1074/jbc.271.32.19483; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; PIERCE JH, 1988, SCIENCE, V239, P628, DOI 10.1126/science.3257584; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; SCHLESSINGER J, 1993, TRENDS BIOCHEM SCI, V18, P273, DOI 10.1016/0968-0004(93)90031-H; SELVA E, 1993, J BIOL CHEM, V268, P2250; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Tzahar E, 1998, BBA-REV CANCER, V1377, pM25, DOI 10.1016/S0304-419X(97)00032-2; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Walker F, 1998, GROWTH FACTORS, V16, P53, DOI 10.3109/08977199809017491; Walker F, 1998, MOL CELL BIOL, V18, P7192, DOI 10.1128/MCB.18.12.7192; WRIGHT JD, 1995, J BIOL CHEM, V270, P12085, DOI 10.1074/jbc.270.20.12085	38	55	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15554	15560		10.1074/jbc.M100928200	http://dx.doi.org/10.1074/jbc.M100928200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279155	hybrid			2022-12-27	WOS:000168528800135
J	Wang, LH; Tsai, AL; Hsu, PY				Wang, LH; Tsai, AL; Hsu, PY			Substrate binding is the rate-limiting step in thromboxane synthase catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN ENDOPEROXIDES; LIPID-PEROXIDATION; ARACHIDONIC-ACID; HUMAN-PLATELETS; ENZYME; CYTOCHROME-P-450; MALONDIALDEHYDE; PURIFICATION; MECHANISM; IDENTIFICATION	Thromboxane synthase (TXAS) is "non-classical" cytochrome P450. Without any need for an external electron donor, or for a reductase or molecular oxygen, it uses prostaglandin H-2 (PGrH(2)) to catalyze either an isomerization reaction to form thromboxane A(2) (TXA(2)) or a fragmentation reaction to form 12-L-hydroxy-5,8,10-heptadecatrienoic acid and malondialdehyde (MDA) at a ratio of 1:1:1 (TXA(2):heptadecatrienoic acid:MDA), We report here kinetics of TXAS with heme ligands in binding study and with PGH, in enzymatic study. We determined that 1) binding of U44069, an oxygen-based ligand, is a two-step process; U44069 first binds TXAS, then ligates the heme-iron with a maximal rate constant of 105-130 s(-1); 2) binding of cyanide, a carbon-based ligand, is a one-step process with k(on) of 2.4 M-1 s(-1) and k(off) of 0.112 s(-1); and 3) both imidazole and clotrimazole (nitrogen-based ligands) bind TXAS in a two-step process; an initial binding to the heme-iron with on-rate constants of 8.4 x 10(4) M-1 s(-1) and 1.5 x 10(5) M-1 s(-1) for imidazole and clotrimazole, respectively, followed by a slow conformational change with off-rate constants of 8.8 s(-1) and 0.53 s(-1), respectively. The results of our binding study indicate that the TXAS active site is hydrophobic and spacious. In addition, steady-state kinetic study revealed that; TXAS consumed PGH(2) at a rate of 3,800 min(-1) and that the k(cat)/K-m for PGH(2) consumption was 3 x 10(6) M-1 s(-1). Based on these data, TXAS appears to be a very efficient catalyst. Surprisingly, rapid-scan stopped-flow experiments revealed marginal absorbance changes upon mixing TXAS with PGH(2), indicating minimal accumulation of any heme-derived intermediates, Freeze-quench EPR measurements for the same reaction showed minimal change of heme redox state, Further kinetic analysis using a combination of rapid-mixing chemical quench and computer simulation showed that the kinetic parameters of TXAS-catalyzed reaction are: PGH(2) bound TXAS at a rate of 1.2-2.0 x 10(7) M-1 s(-1): the rate of catalytic conversion of PGH(2) to TXA(2) or MDA was at least 15,000 s(-1) and the lower limit of the rates for products release was 4,000-6,000 s(-1). Given that the cellular PGH(2) concentration is quite low, we concluded that under physiological conditions, the substrate-binding step is the rate-limiting step of the TXAS-catalyzed reaction, in sharp contrast with "classical" P450 enzymes.	Univ Texas, Dept Internal Med, Div Hematol, Houston, TX 77030 USA	University of Texas System	Wang, LH (corresponding author), Univ Texas, Dept Internal Med, Div Hematol, 6431 Fannin, Houston, TX 77030 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056818] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-60625] Funding Source: Medline; NIGMS NIH HHS [GM-44911, GM-56818] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHAUDHARY AK, 1994, SCIENCE, V265, P1580, DOI 10.1126/science.8079172; Chilton FH, 1996, BBA-LIPID LIPID MET, V1299, P1, DOI 10.1016/0005-2760(95)00169-7; FIERKE CA, 1995, METHOD ENZYMOL, V249, P3; GERBER NC, 1994, J BIOL CHEM, V269, P4260; GrahamLorence S, 1996, FASEB J, V10, P206, DOI 10.1096/fasebj.10.2.8641554; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P345, DOI 10.1073/pnas.71.2.345; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; HARA S, 1994, J BIOL CHEM, V269, P19897; HAURAND M, 1985, J BIOL CHEM, V260, P5059; HECKER M, 1987, ARCH BIOCHEM BIOPHYS, V254, P124, DOI 10.1016/0003-9861(87)90088-9; HECKER M, 1987, BIOCHEM PHARMACOL, V36, P851, DOI 10.1016/0006-2952(87)90175-4; HECKER M, 1989, J BIOL CHEM, V264, P141; Hsu PY, 1999, J BIOL CHEM, V274, P762, DOI 10.1074/jbc.274.2.762; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; LEDERGERBER D, 1995, J ENZYM INHIB, V9, P253, DOI 10.3109/14756369509036554; LINDSKOG S, 1984, ANN NY ACAD SCI, V429, P61, DOI 10.1111/j.1749-6632.1984.tb12315.x; Mueller Ernest J., 1995, P83; NAHRI LO, 1986, J BIOL CHEM, V261, P7160; PETERSON JA, 1975, CYTOCHROMES P450 B5, P311; Plastaras JP, 2000, J BIOL CHEM, V275, P11784, DOI 10.1074/jbc.275.16.11784; RUAN KH, 1993, J BIOL CHEM, V268, P19483; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; SHIRO Y, 1995, J BIOL CHEM, V270, P1617, DOI 10.1074/jbc.270.4.1617; SONG WC, 1991, SCIENCE, V253, P781, DOI 10.1126/science.1876834; TRIGGIANI M, 1995, J EXP MED, V182, P1181, DOI 10.1084/jem.182.5.1181; Uchida K, 1999, TRENDS CARDIOVAS MED, V9, P109, DOI 10.1016/S1050-1738(99)00016-X; VANE J, 1987, FASEB J, V1, P89, DOI 10.1096/fasebj.1.2.3111928; Wang LH, 1996, J BIOL CHEM, V271, P19970, DOI 10.1074/jbc.271.33.19970; WATANABE Y, 1992, ENZYMES, V20, P405; WOLF BA, 1991, BIOCHEMISTRY-US, V30, P6372, DOI 10.1021/bi00240a004; WU KK, 1981, J CLIN INVEST, V67, P1801, DOI 10.1172/JCI110221	33	37	37	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14737	14743		10.1074/jbc.M009177200	http://dx.doi.org/10.1074/jbc.M009177200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11297515	hybrid			2022-12-27	WOS:000168528800029
J	Garrigue-Antar, L; Barker, C; Kadler, KE				Garrigue-Antar, L; Barker, C; Kadler, KE			Identification of amino acid residues in bone morphogenetic protein-1 important for procollagen C-proteinase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY CRYSTAL-STRUCTURE; ZINC-PEPTIDASES; ASTACIN FAMILY; MEPRIN-A; SPECIFICITY; EXPRESSION; PROTEASE; COLLAGENASES; PURIFICATION; INHIBITORS	Bone morphogenetic protein (BMP)-1, which belongs to the tolloid subgroup of astacin-like zinc metalloproteinases, cleaves the C-propeptides of procollagen at the physiologic site and is, therefore, a procollagen C-proteinase (PCP), Cleavage occurs between a specific alanine or glycine residue (depending on the procollagen chain) and an invariant aspartic acid residue in each of the three chains of procollagen. To learn more about how BMP-1 exhibits PCP activity we mapped the primary structure of BMP-I onto the x-ray crystal structure of astacin and identified residues in the metalloproteinase domain of BMP-1 for subsequent site-directed mutagenesis studies. Recombinant wild-type and mutant BMP-1 were expressed in COS-7 cells and assayed for PCP activity using type I procollagen as the substrate. We showed that substitution of alanine for Glu(94), which occurs in the HEXXH zinc-binding motif of BMP-1, abolishes PCP activity. Furthermore, mutation of residues Lys(87) and Lys(176), Which are located in the S1 ' pocket of the enzyme and are therefore adjacent to the P1 ' residue in the substrate, reduced the proteolytic activity of BMP-1 by similar to 50%. A surprising observation was that mutation of Cys(66) reduced the activity to 20%, suggesting that this residue is crucial for activity, Further experiments showed that Cys(66) and Cys(63) which are located in the tolloid-specific sequence Cys(63)-Gly(64)-Cys(65)-Cys(66) in the active site, most likely form a disulfide bridge.	Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Manchester	Kadler, KE (corresponding author), Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, 2-205 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.		KADLER, KARL/ABI-2403-2020	KADLER, KARL/0000-0003-4977-4683; Garrigue-Antar, Laure/0000-0001-6331-8882				Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; BODE W, 1994, EMBO J, V13, P1263, DOI 10.1002/j.1460-2075.1994.tb06378.x; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Chestukhin A, 1997, J BIOL CHEM, V272, P3153, DOI 10.1074/jbc.272.6.3153; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; GOMISRUTH FX, 1993, J MOL BIOL, V229, P945, DOI 10.1006/jmbi.1993.1098; Grams F, 1996, NAT STRUCT BIOL, V3, P671, DOI 10.1038/nsb0896-671; HOJIMA Y, 1985, J BIOL CHEM, V260, P5996; Horton R M, 1993, Methods Mol Biol, V15, P251, DOI 10.1385/0-89603-244-2:251; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; KESSLER E, 1986, COLLAGEN REL RES, V6, P249; LEPAGE T, 1992, DEVELOPMENT, V114, P147; MAENO M, 1993, GENE, V134, P257, DOI 10.1016/0378-1119(93)90103-A; Mullins MC, 1998, TRENDS GENET, V14, P127, DOI 10.1016/S0168-9525(98)01431-0; Ovens A, 2000, J PEPT SCI, V6, P489, DOI 10.1002/1099-1387(200009)6:9<489::AID-PSC282>3.3.CO;2-B; Panchenko MV, 1996, J BIOL CHEM, V271, P7113, DOI 10.1074/jbc.271.12.7113; REYNOLDS SD, 1992, DEVELOPMENT, V114, P769; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Scott IC, 2000, J BIOL CHEM, V275, P30504, DOI 10.1074/jbc.M004846200; SHIMELL MJ, 1991, CELL, V67, P469, DOI 10.1016/0092-8674(91)90522-Z; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; STOCKER W, 1990, BIOCHEMISTRY-US, V29, P10418; STOCKER W, 1993, EUR J BIOCHEM, V214, P215, DOI 10.1111/j.1432-1033.1993.tb17915.x; STOCKER W, 1995, PROTEIN SCI, V4, P823; Suzuki N, 1996, DEVELOPMENT, V122, P3587; TERLINK T, 1989, CLIN CHIM ACTA, V183, P309; TITANI K, 1987, BIOCHEMISTRY-US, V26, P222, DOI 10.1021/bi00375a029; Trojanowska M, 1998, J MOL MED, V76, P266, DOI 10.1007/s001090050216; WOLZ RL, 1991, BIOCHEMISTRY-US, V30, P8488, DOI 10.1021/bi00098a029; WOLZ RL, 1995, METHOD ENZYMOL, V248, P325; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yiallouros I, 2000, FEBS LETT, V484, P224, DOI 10.1016/S0014-5793(00)02163-3; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	35	29	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 13	2001	276	28					26237	26242		10.1074/jbc.M010814200	http://dx.doi.org/10.1074/jbc.M010814200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451VP	11283002	hybrid			2022-12-27	WOS:000169823300080
J	Ikonomov, OC; Sbrissa, D; Shisheva, A				Ikonomov, OC; Sbrissa, D; Shisheva, A			Mammalian cell morphology and endocytic membrane homeostasis require enzymatically active phosphoinositide 6-kinase PIKfyve	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-PHOSPHATE; MULTIVESICULAR BODY; LYSOSOMAL-ENZYMES; GLUCOSE-TRANSPORT; 3-KINASE ACTIVITY; VACUOLE FUNCTION; FAB1P; KINASE; YEAST; PATHWAY	The dual specificity mammalian enzyme PIKfyve phosphorylates in vitro position D-5 in phosphatidylinositol (PtdIns) and PtdIns 3-P, itself or exogenous protein substrates, Here we have addressed the crucial questions for the identity of the lipid products and the role of PIKfyve enzymatic activity in mammalian cells. CHO, HEK293, and COS cells expressing PIKfyve(WT) at high levels and > 90% efficiencies increased selectively the intracellular PtdIns 3,5-P-2 production by 30-55%. In these cell types PtdIns 5-P was undetectable. A kinase-deficient point mutant, pIKfyve(K1831E), transiently transfected into these or other cells elicited a dramatic dominant phenotype, Subsequent to a dilation of the PIKfyve-containing vesicles, PIKfyve(K1831E)-expressing cells progressively accumulated multiple swollen lucent vacuoles of endosomal origin, first in the perinuclear cytoplasm and then toward the cell periphery. Despite their drastically altered morphology, the PIKfyve(K1831E)-expressing cells were viable and functionally active, evidenced by several criteria. This phenotype was completely reversed by introducing PIKfyveW(T) into the PIKfyve(K1831E)-transfected cells. Disruptions of the localization signal in the PIKfyve kinase-deficient mutant yielded a pIKfyve(K1831E Delta fyve) protein, incompetent to vacuolate cells, implying that an active PIKfyve enzyme at distinct late endocytic membranes is crucial for normal cell morphology, This was further substantiated by examining the vacuolation-induced potency of several pharmacological stimuli in cells expressing high PIKfyve(WT) levels. Together, the results indicate that PIKfyve enzymatic activity, possibly through the generation of PtdIns 3,5-P-2, and/or yet to be identified endogenous phosphoproteins, is critical for cell morphology and endomembrane homeostasis.	Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA	Wayne State University	Shisheva, A (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, 540 E Canfield, Detroit, MI 48201 USA.							BROWN WJ, 1986, J CELL BIOL, V103, P1235, DOI 10.1083/jcb.103.4.1235; BROWN WJ, 1995, J CELL BIOL, V130, P781, DOI 10.1083/jcb.130.4.781; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; Corvera S, 1999, CURR OPIN CELL BIOL, V11, P460, DOI 10.1016/S0955-0674(99)80066-0; Cover TL, 1999, GASTROENTEROLOGY, V117, P257, DOI 10.1016/S0016-5085(99)70575-5; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; GROVE RI, 1981, LIPIDS, V16, P691, DOI 10.1007/BF02535065; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Henics T, 1999, BIOL CELL, V91, P485, DOI 10.1016/S0248-4900(00)88205-2; Jones DR, 1999, J BIOL CHEM, V274, P18407, DOI 10.1074/jbc.274.26.18407; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; McEwen RK, 1999, J BIOL CHEM, V274, P33905, DOI 10.1074/jbc.274.48.33905; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Nave BT, 1996, BIOCHEM J, V318, P203, DOI 10.1042/bj3180203; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Reaves BJ, 1996, J CELL SCI, V109, P749; Reyrat JM, 1999, MOL MICROBIOL, V34, P197, DOI 10.1046/j.1365-2958.1999.01592.x; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2000, BIOCHEMISTRY-US, V39, P15980, DOI 10.1021/bi001897f; SBRISSA D, 2000, DIABETES S1, V49, pA1902; Shisheva A, 2001, J BIOL CHEM, V276, P11859, DOI 10.1074/jbc.M008437200; Shisheva A, 1999, MOL CELL BIOL, V19, P623; Shpetner H, 1996, J CELL BIOL, V132, P595, DOI 10.1083/jcb.132.4.595; Stenmark H, 1999, J CELL SCI, V112, P4175; STEPHENS L, 1994, CURR BIOL, V4, P203, DOI 10.1016/S0960-9822(00)00049-X; Tombola F, 1999, BIOPHYS J, V76, P1401, DOI 10.1016/S0006-3495(99)77301-7; Whiteford CC, 1997, BIOCHEM J, V323, P597, DOI 10.1042/bj3230597; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525; YAMAUCHI K, 1994, J BIOL CHEM, V269, P31107	36	181	187	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 13	2001	276	28					26141	26147		10.1074/jbc.M101722200	http://dx.doi.org/10.1074/jbc.M101722200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451VP	11285266	hybrid			2022-12-27	WOS:000169823300068
J	Sun, CT; Lo, WY; Wang, IH; Lo, YH; Shiou, SR; Lai, CK; Ting, LP				Sun, CT; Lo, WY; Wang, IH; Lo, YH; Shiou, SR; Lai, CK; Ting, LP			Transcription repression of human hepatitis B virus genes by negative regulatory element-binding protein/SON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PLATELET DISORDER; DNA-BINDING; CORE PROMOTER; 2ND ENHANCER; NUCLEOCAPSID PROMOTER; ACTIVE REPRESSION; CELL SPECIFICITY; THYROID-HORMONE; DOWN-SYNDROME; MECHANISM	A negative regulatory element (NRE) is located immediately upstream of the upstream regulatory sequence of core promoter and second enhancer of human hepatitis B virus (HBV), NRE represses the transcription activation function of the upstream regulatory sequence of core promoter and the second enhancer. In this study, we described the cloning and characterization of an NRE-binding protein (NREBP) through expression cloning. NREBP cDNA is 8266 nucleotides in size and encodes a protein of 2386 amino acids with a predicted molecular mass of 262 kDa, Three previously described cDNAs, DBP-5, SONB, and SONA, are partial sequence and/or alternatively spliced forms of NREBP, The genomic locus of the NREBP/SON gene is composed of 13 exons and 12 introns, The endogenous NREBP protein is localized in the nucleus of human hepatoma HuH-7 cells. Antibody against NREBP protein can specifically block the NRE binding activity present in fractionated nuclear extracts in gel shifting assays, indicating that NREBP is the endogenous nuclear protein that binds to NRE sequence. By polymerase chain reaction-assisted binding site selection assay, we determined that the consensus sequence for NREBP binding is GA(GPT)AN(C/G)(A/G)CC, Overexpression of NREBP enhances the repression of the HBV core promoter activity via NRE. Overexpression of NREBP can also repress the transcription of HBV genes and the production of HBV virions in a transient transfection system that mimics the viral infection in vivo.	Natl Yang Ming Univ, Sch Life Sci, Inst Microbiol & Immunol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University	Ting, LP (corresponding author), Natl Yang Ming Univ, Sch Life Sci, Inst Microbiol & Immunol, Taipei 112, Taiwan.							Arepally G, 1998, BLOOD, V92, P2600, DOI 10.1182/blood.V92.7.2600; AUWERX J, 1991, CELL, V64, P983, DOI 10.1016/0092-8674(91)90322-P; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BARSOUM J, 1992, J VIROL, V66, P3941, DOI 10.1128/JVI.66.6.3941-3945.1992; BERDICHEVSKII F B, 1988, Molekulyarnaya Biologiya (Moscow), V22, P794; Bliskovskii V. V., 1992, Molekulyarnaya Biologiya (Moscow), V26, P793; Bliskovskii V. V., 1992, Molekulyarnaya Biologiya (Moscow), V26, P807; Buckwold VE, 1997, VIROLOGY, V227, P515, DOI 10.1006/viro.1996.8360; CHEN M, 1995, VIROLOGY, V214, P198, DOI 10.1006/viro.1995.9940; CHUMAKOV I M, 1991, Molekulyarnaya Biologiya (Moscow), V25, P731; COONEY AJ, 1993, J BIOL CHEM, V268, P4152; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; DONG G, 1994, J VIROL, V68, P1115, DOI 10.1128/JVI.68.2.1115-1127.1994; DOWTON SB, 1985, BLOOD, V65, P557; Fondell JD, 1996, MOL CELL BIOL, V16, P281; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; GAUBATZ S, 1995, EMBO J, V14, P1508, DOI 10.1002/j.1460-2075.1995.tb07137.x; GENETTA T, 1994, MOL CELL BIOL, V14, P6153, DOI 10.1128/MCB.14.9.6153; Gilbert S, 2000, J VIROL, V74, P5032, DOI 10.1128/JVI.74.11.5032-5039.2000; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; GRAY S, 1994, GENE DEV, V8, P1829, DOI 10.1101/gad.8.15.1829; Gray S, 1996, CURR OPIN CELL BIOL, V8, P358; GUO WT, 1993, MOL CELL BIOL, V13, P443, DOI 10.1128/MCB.13.1.443; HannaRose W, 1996, TRENDS GENET, V12, P229, DOI 10.1016/0168-9525(96)10022-6; HERSCHBACH BM, 1993, ANNU REV CELL BIOL, V9, P479, DOI 10.1146/annurev.cellbio.9.1.479; Ho CY, 1996, BLOOD, V87, P5218, DOI 10.1182/blood.V87.12.5218.bloodjournal87125218; Huang CJ, 2000, J BIOMED SCI, V7, P160, DOI 10.1159/000025442; Ikeda K, 1998, MOL CELL BIOL, V18, P10, DOI 10.1128/MCB.18.1.10; Ishida H, 2000, J VIROL, V74, P1241, DOI 10.1128/JVI.74.3.1241-1251.2000; JOHNSON AD, 1995, CELL, V81, P655, DOI 10.1016/0092-8674(95)90524-3; JOHNSON JL, 1995, VIROLOGY, V208, P147, DOI 10.1006/viro.1995.1138; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KHAN IM, 1994, ANN HUM GENET, V58, P25, DOI 10.1111/j.1469-1809.1994.tb00723.x; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Lai CK, 1999, J VIROL, V73, P3197, DOI 10.1128/JVI.73.4.3197-3209.1999; Lee KC, 1999, MOL CELL BIOL, V19, P1279; LEHMING N, 1994, NATURE, V371, P175, DOI 10.1038/371175a0; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li C, 1998, MOL CELL BIOL, V18, P3771, DOI 10.1128/MCB.18.7.3771; Li M, 1995, VIROLOGY, V214, P371, DOI 10.1006/viro.1995.0046; Li M, 1998, J BIOL CHEM, V273, P29022, DOI 10.1074/jbc.273.44.29022; LO WY, 1994, J VIROL, V68, P1758, DOI 10.1128/JVI.68.3.1758-1764.1994; LO WY, 1997, THESIS NATL YANG MIN; LOPEZCABRERA M, 1991, VIROLOGY, V183, P825, DOI 10.1016/0042-6822(91)91019-D; LOPEZCABRERA M, 1990, P NATL ACAD SCI USA, V87, P5069, DOI 10.1073/pnas.87.13.5069; MATTIONI T, 1992, CHROMOSOMA, V101, P618, DOI 10.1007/BF00360539; MCBRIDE AA, 1991, J BIOL CHEM, V266, P18411; MCCORMICK MK, 1989, GENOMICS, V5, P325, DOI 10.1016/0888-7543(89)90065-7; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; Olave I, 1998, GENE DEV, V12, P1621, DOI 10.1101/gad.12.11.1621; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; POLLOCK R, 1990, NUCLEIC ACIDS RES, V18, P6197, DOI 10.1093/nar/18.21.6197; Raney AK, 1997, J VIROL, V71, P1058, DOI 10.1128/JVI.71.2.1058-1071.1997; RANEY AK, 1991, J VIROL, V65, P5774, DOI 10.1128/JVI.65.11.5774-5781.1991; RIO D, 1980, P NATL ACAD SCI-BIOL, V77, P5706, DOI 10.1073/pnas.77.10.5706; Ross JF, 1999, MOL CELL, V3, P195, DOI 10.1016/S1097-2765(00)80310-X; Sommer A, 1998, J BIOL CHEM, V273, P6632, DOI 10.1074/jbc.273.12.6632; STENLUND A, 1990, GENE DEV, V4, P123, DOI 10.1101/gad.4.1.123; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Tao YX, 1997, MOL CELL BIOL, V17, P6994, DOI 10.1128/MCB.17.12.6994; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Wang WX, 1998, RES VIROLOGY, V149, P99, DOI 10.1016/S0923-2516(98)80085-X; Wolffe AP, 1997, NATURE, V387, P16, DOI 10.1038/387016a0; YUH CH, 1991, MOL CELL BIOL, V11, P5044, DOI 10.1128/MCB.11.10.5044; YUH CH, 1993, J VIROL, V67, P142, DOI 10.1128/JVI.67.1.142-149.1993; YUH CH, 1992, J VIROL, V66, P4073, DOI 10.1128/JVI.66.7.4073-4084.1992; YUH CH, 1990, J VIROL, V64, P4281, DOI 10.1128/JVI.64.9.4281-4287.1990	69	46	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24059	24067		10.1074/jbc.M101330200	http://dx.doi.org/10.1074/jbc.M101330200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11306577	hybrid			2022-12-27	WOS:000169531100111
J	Qian, ZJ; Lin, C; Espinosa, R; LeBeau, M; Rosner, MR				Qian, ZJ; Lin, C; Espinosa, R; LeBeau, M; Rosner, MR			Cloning and characterization of MST4, a novel Ste20-like kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; ACTIVATED PROTEIN-KINASE; STE20-RELATED KINASE; SIGNAL-TRANSDUCTION; SAPK/JNK PATHWAY; APOPTOSIS; IDENTIFICATION; CASCADE; DOMAIN; DICTYOSTELIUM	MST4, a novel member of the germinal center kinase subfamily of human Ste20-like kinases, was cloned and characterized. Composed of a C-terminal regulatory domain and an N-terminal kinase domain, MST4 is most closely related to mammalian Ste20 kinase family member MST3. Both the kinase and C-terminal regulatory domains of MST4 are required for full activation of the kinase. Northern blot analysis indicates that MST4 is ubiquitously distributed, and the MST4 gene is localized to chromosome Xq26, a disease-rich region, by fluorescence in situ hybridization. Although some members of the MST4 family function as upstream regulators of mitogen-activated protein kinase cascades, expression of MST4 in 293 cells was not sufficient to activate or potentiate extracellular signal-regulated kinase, c-Jun N-terminal kinase, or p38 kinase. An alternatively spliced isoform of MST4 (MST4a) was isolated by yeast two-hybrid interaction with the catalytic domain of Raf from a human fetal brain cDNA library and also found in a variety of human fetal and adult tissues. MST4a lacks an exon encoding kinase subdomains M-XI that stabilizes substrate binding. The existence of both MST4 isoforms suggests that the MST4 kinase activity is highly regulated, and MST4a may function as a dominant-negative regulator of the MST4 kinase.	Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Rosner, MR (corresponding author), Univ Chicago, Ben May Inst Canc Res, 5841 S Maryland Ave,MC 6027, Chicago, IL 60637 USA.	mrosner@ben-may.bsd.uchicago.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033858] Funding Source: NIH RePORTER; NCI NIH HHS [CA40046] Funding Source: Medline; NIGMS NIH HHS [T32 GM07151] Funding Source: Medline; NINDS NIH HHS [NS 33858] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE MK, 1994, AM J RESP CELL MOL, V11, P577, DOI 10.1165/ajrcmb.11.5.7946386; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Camoretti-Mercado B, 1998, GENOMICS, V49, P452, DOI 10.1006/geno.1998.5267; Chung CY, 1998, GENE DEV, V12, P3564, DOI 10.1101/gad.12.22.3564; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Gaskins C, 1996, GENE DEV, V10, P118, DOI 10.1101/gad.10.1.118; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HATZ P, 1994, J BIOL CHEM, V269, P16802; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kuramochi S, 1997, J BIOL CHEM, V272, P22679, DOI 10.1074/jbc.272.36.22679; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEBERER E, 1992, EMBO J, V11, P4815, DOI 10.1002/j.1460-2075.1992.tb05587.x; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Ling P, 1999, MOL CELL BIOL, V19, P1359; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARTIN GA, 1995, EMBO J, V14, P1970, DOI 10.1002/j.1460-2075.1995.tb07189.x; Pombo CM, 1996, EMBO J, V15, P4537, DOI 10.1002/j.1460-2075.1996.tb00831.x; RAMER SW, 1993, P NATL ACAD SCI USA, V90, P452, DOI 10.1073/pnas.90.2.452; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Sabourin LA, 1999, ONCOGENE, V18, P7566, DOI 10.1038/sj.onc.1203119; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schinkmann K, 1997, J BIOL CHEM, V272, P28695, DOI 10.1074/jbc.272.45.28695; Su YC, 1997, EMBO J, V16, P1279, DOI 10.1093/emboj/16.6.1279; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; TEO M, 1995, J BIOL CHEM, V270, P26690, DOI 10.1074/jbc.270.44.26690; Tung RM, 1997, ONCOGENE, V14, P653, DOI 10.1038/sj.onc.1200877; WISHART MJ, 1995, J BIOL CHEM, V270, P26782, DOI 10.1074/jbc.270.45.26782; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Yustein JT, 2000, ONCOGENE, V19, P710, DOI 10.1038/sj.onc.1203342; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zhou TH, 2000, J BIOL CHEM, V275, P2513, DOI 10.1074/jbc.275.4.2513	45	58	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22439	22445		10.1074/jbc.M009323200	http://dx.doi.org/10.1074/jbc.M009323200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11306563	hybrid			2022-12-27	WOS:000169412700063
J	Hammond, PW; Alpin, J; Rise, CE; Wright, M; Kreider, BL				Hammond, PW; Alpin, J; Rise, CE; Wright, M; Kreider, BL			In vitro selection and characterization of Bcl-X-L-binding proteins from a mix of tissue-specific mRNA display libraries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTION MAP; BH3 DOMAIN; FAMILY; CHANNEL; YEAST; EXPRESSION; BCL-X(L); CLONING; SYSTEM; GENE	The covalent coupling of an mRNA to the protein that it encodes (mRNA display) provides a powerful tool for analysis of protein function in the post-genomic era. This coupling allows the selective enrichment of individual members from libraries of displayed proteins and the subsequent regeneration of an enriched library using the RNA moiety, Tissue-specific libraries from poly(A)(+) mRNA were prepared by priming first and second strand cDNA synthesis with oligonucleotides containing nine random 3' nucleotides, the fixed regions of which encoded the requisite sequences for formation of mRNA display constructs and a library-specific sequence tag. Starting with a pool of uniquely tagged libraries from different tissues, an iterative selection was performed for binding partners of the anti-apoptotic protein Bcl-X-L. After four rounds of selection, the pool was deconvoluted by polymerase chain reaction amplification with library-specific primers. Subsequent clonal sequence analysis revealed the selection of three members of the Bcl-2 family known to bind to Bcl-X-L. In addition, several proteins not previously demonstrated to interact with Bcl-X-L were identified. The relative binding affinities of individual selected peptides were determined, as was their susceptibility to competition with a BH3 domain peptide. Based on these data, a putative BH3 domain was identified in most peptides.	Phylos Inc, Lexington, MA 02421 USA		Hammond, PW (corresponding author), Phylos Inc, 128 Spring St, Lexington, MA 02421 USA.	phammond@phylos.com						BLACHLYDYSON E, 1993, J BIOL CHEM, V268, P1835; Diaz JL, 1997, J BIOL CHEM, V272, P11350; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Kawamoto S, 2000, GENOME RES, V10, P1817, DOI 10.1101/gr.151500; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; KURZ M, 2000, NUCLEIC ACIDS RES, V28, P83; Luban Jeremy, 1995, Current Opinion in Biotechnology, V6, P59, DOI 10.1016/0958-1669(95)80010-7; Mayer BJ, 1999, MOL BIOTECHNOL, V13, P201, DOI 10.1385/MB:13:3:201; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Rahmani Z, 1998, EUR J HUM GENET, V6, P337, DOI 10.1038/sj.ejhg.5200198; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Scorilas A, 2001, GENOMICS, V72, P217, DOI 10.1006/geno.2000.6455; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Simonen M, 1997, EUR J BIOCHEM, V249, P85, DOI 10.1111/j.1432-1033.1997.t01-1-00085.x; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Wong C, 1997, ANAL BIOCHEM, V252, P33, DOI 10.1006/abio.1997.2284; Xie ZH, 1998, BIOCHEMISTRY-US, V37, P6410, DOI 10.1021/bi973052i; ZHANG HC, 1995, BIOCHEM BIOPH RES CO, V208, P950, DOI 10.1006/bbrc.1995.1426; Zozulya S, 1999, NAT BIOTECHNOL, V17, P1193, DOI 10.1038/70736	26	75	94	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20898	20906		10.1074/jbc.M011641200	http://dx.doi.org/10.1074/jbc.M011641200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11283018	hybrid			2022-12-27	WOS:000169297900016
J	Houde, M; Laprise, P; Jean, D; Blais, M; Asselin, C; Rivard, N				Houde, M; Laprise, P; Jean, D; Blais, M; Asselin, C; Rivard, N			Intestinal epithelial cell differentiation involves activation of p38 mitogen-activated protein kinase that regulates the homeobox transcription factor CDX2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUCRASE-ISOMALTASE EXPRESSION; GENE-EXPRESSION; POSTNATAL-DEVELOPMENT; 3T3-L1 ADIPOGENESIS; MESSENGER-RNA; CACO-2 CELLS; MAP KINASES; E-CADHERIN; PROMOTER; COMPLEX	The intracellular signaling pathways responsible for cell cycle arrest and differentiation along the crypt-villus axis of the human small intestine remain largely unknown. p38 mitogen-activated protein kinases (MAPKs) have recently emerged as key modulators of various vertebrate cell differentiation processes. In order to elucidate further the mechanism(s) responsible for the loss of proliferative potential once committed intestinal cells begin to differentiate, the role and regulation of p38 MAPK with regard to differentiation were analyzed in both intact epithelium as well as in well established intestinal cell models recapitulating the crypt-villus axis in vitro. Results show that phosphorylated and active forms of p38 were detected primarily in the nuclei of differentiated villus cells. Inhibition of p38 MAPK signaling by 2-20 muM SB203580 did not affect E2F-dependent transcriptional activity in subconfluent Caco-2/15 or HIEC cells. p38 MAPK activity dramatically increased as soon as Caco-2/15 cells reached confluence, whereas addition of SB203580 during differentiation of Caco-2/15 cells strongly attenuated sucrase-isomaltase gene and protein expression as well as protein expression of villin and alkaline phosphatase. The binding of CDX2 to the sucrase-isomaltase promoter and its transcriptional activity were significantly reduced by SB203580. Pull-down glutathione S-transferase and immunoprecipitation experiments demonstrated a direct interaction of CDX3 with p38, Finally, p38-dependent phosphorylation of CDX3 was observed in differentiating Caco-2/15 cells. Taken together, our results indicate that p38 MAPK may be involved in the regulation of CDX2/3 function and intestinal cell differentiation.	Univ Sherbrooke, Fac Med, Dept Anat & Biol Cellulaire, CIHR Grp Funct Dev & Physiopathol Digest Tract, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Rivard, N (corresponding author), Univ Sherbrooke, Fac Med, Dept Anat & Biol Cellulaire, CIHR Grp Funct Dev & Physiopathol Digest Tract, Sherbrooke, PQ J1H 5N4, Canada.							Aliaga JC, 1999, AM J PHYSIOL-GASTR L, V277, pG631, DOI 10.1152/ajpgi.1999.277.3.G631; [Anonymous], 1920, CONTRIBUTIONS EMBRYO; BABYATSKY MW, 1999, GROWTH DEV GASTROINT, P547; Basora N, 1997, GASTROENTEROLOGY, V113, P1510, DOI 10.1053/gast.1997.v113.pm9352853; BEAULIEU JF, 1989, J BIOL CHEM, V264, P20000; BEAULIEU JF, 1991, BIOCHEM J, V280, P599, DOI 10.1042/bj2800599; CAIRNIE AB, 1965, EXP CELL RES, V39, P539, DOI 10.1016/0014-4827(65)90056-X; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; Chailler P, 1999, FRONT BIOSCI, V4, P87; CHENG H, 1985, ANAT REC, V211, P420, DOI 10.1002/ar.1092110408; CROSS HS, 1991, AM J PHYSIOL, V261, pC1173; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deschenes C, 2001, GASTROENTEROLOGY, V120, P423, DOI 10.1053/gast.2001.21199; DOELL RG, 1965, P NATL ACAD SCI USA, V54, P1268, DOI 10.1073/pnas.54.4.1268; EICHHOLZ A, 1967, BIOCHIM BIOPHYS ACTA, V135, P475, DOI 10.1016/0005-2736(67)90037-5; Engelman JA, 1999, J BIOL CHEM, V274, P35630, DOI 10.1074/jbc.274.50.35630; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; Engle MJ, 1998, J CELL PHYSIOL, V174, P362, DOI 10.1002/(SICI)1097-4652(199803)174:3<362::AID-JCP10>3.0.CO;2-B; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Evers BM, 1996, AM J PHYSIOL-GASTR L, V271, pG722, DOI 10.1152/ajpgi.1996.271.4.G722; Fang RX, 2000, GASTROENTEROLOGY, V118, P115, DOI 10.1016/S0016-5085(00)70420-3; Freund JN, 1998, BIOCHEM CELL BIOL, V76, P957, DOI 10.1139/bcb-76-6-957; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; GORDON JI, 1994, CURR OPIN CELL BIOL, V6, P795, DOI 10.1016/0955-0674(94)90047-7; Guay J, 1997, J CELL SCI, V110, P357; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hermiston ML, 1996, GENE DEV, V10, P985, DOI 10.1101/gad.10.8.985; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; JAMES R, 1994, J BIOL CHEM, V269, P15229; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; Jin TR, 1997, MOL ENDOCRINOL, V11, P203, DOI 10.1210/me.11.2.203; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; Karam Sherif M., 1999, Frontiers in Bioscience, V4, pD286, DOI 10.2741/Karam; Lambert M, 1996, EUR J BIOCHEM, V236, P778, DOI 10.1111/j.1432-1033.1996.00778.x; LATHANGUE NB, 1994, CURR OPIN CELL BIOL, V6, P443, DOI 10.1016/0955-0674(94)90038-8; LEMISCHKA IR, 1981, J MOL BIOL, V151, P101, DOI 10.1016/0022-2836(81)90223-0; Lorentz O, 1997, J CELL BIOL, V139, P1553, DOI 10.1083/jcb.139.6.1553; MENARD D, 1985, GASTROENTEROLOGY, V88, P691, DOI 10.1016/0016-5085(85)90139-8; Menard D., 1994, MEMBRANE PHYSIOPATHO, P319; MENARD D, 1989, GROWTH PROMOTING FAC, P123; Montgomery RK, 1999, GASTROENTEROLOGY, V116, P702, DOI 10.1016/S0016-5085(99)70193-9; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; Pageot LP, 2000, MICROSC RES TECHNIQ, V49, P394; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Pelletier N, 1998, FEBS LETT, V439, P275, DOI 10.1016/S0014-5793(98)01388-X; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Perreault N, 1998, EXP CELL RES, V245, P34, DOI 10.1006/excr.1998.4221; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PINTO M, 1983, BIOL CELL, V47, P323; QUARONI A, 1985, DEV BIOL, V111, P280, DOI 10.1016/0012-1606(85)90483-X; QUARONI A, 1985, DEV BIOL, V111, P267, DOI 10.1016/0012-1606(85)90482-8; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; RONCARI G, 1969, INT J PROT RES, V1, P45; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; SADOWSKI I, 1992, GENE, V118, P137, DOI 10.1016/0378-1119(92)90261-M; Silberg DG, 1997, GASTROENTEROLOGY, V113, P478, DOI 10.1053/gast.1997.v113.pm9247467; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; Soubeyran P, 1999, GASTROENTEROLOGY, V117, P1326, DOI 10.1016/S0016-5085(99)70283-0; STEIN B, 1989, MOL CELL BIOL, V9, P5169, DOI 10.1128/MCB.9.11.5169; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Suh E, 1996, MOL CELL BIOL, V16, P619; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; Taupin D, 1999, GASTROENTEROLOGY, V116, P1072, DOI 10.1016/S0016-5085(99)70010-7; Taylor JK, 1997, DNA CELL BIOL, V16, P1419, DOI 10.1089/dna.1997.16.1419; Traber PG, 1996, ANNU REV PHYSIOL, V58, P275, DOI 10.1146/annurev.physiol.58.1.275; TRABER PG, 1992, MOL CELL BIOL, V12, P3614, DOI 10.1128/MCB.12.8.3614; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Trinh KY, 1999, J BIOL CHEM, V274, P6011, DOI 10.1074/jbc.274.9.6011; VACHON PH, 1992, GASTROENTEROLOGY, V103, P414, DOI 10.1016/0016-5085(92)90829-N; VACHON PH, 1995, AM J PHYSIOL, V268, P857; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P795; WU GD, 1994, J BIOL CHEM, V269, P17080; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Yang SH, 1999, MOL CELL BIOL, V19, P4028; Zavitz KH, 1997, CURR OPIN CELL BIOL, V9, P773, DOI 10.1016/S0955-0674(97)80077-4; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhou J, 1998, J BIOL CHEM, V273, P33367, DOI 10.1074/jbc.273.50.33367	82	125	143	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21885	21894		10.1074/jbc.M100236200	http://dx.doi.org/10.1074/jbc.M100236200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11283019	hybrid			2022-12-27	WOS:000169297900141
J	Akileswaran, L; Taraska, JW; Sayer, JA; Gettemy, JM; Coghlan, VM				Akileswaran, L; Taraska, JW; Sayer, JA; Gettemy, JM; Coghlan, VM			A-kinase-anchoring protein AKAP95 is targeted to the nuclear matrix and associates with p68 RNA helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; POLYMERASE-II; IDENTIFICATION; CLONING; ORGANIZATION; COACTIVATOR; ACTIVATION; SCAFFOLD; SUBUNIT; CAMP	The cell nucleus is structurally and functionally organized by the nuclear matrix. We have examined whether the nuclear cAMP-dependent protein kinase-anchoring protein AKAP95 contains specific signals for targeting to the subnuclear compartment and for interaction with other proteins. AKAP95 was expressed in mammalian cells and found to localize exclusively to the nuclear matrix. Mutational analysis was used to identify determinants for nuclear localization and nuclear matrix targeting of AKAP95, These sites were found to be distinct from previously identified DNA and protein kinase A binding domains. The nuclear matrix-targeting site is unique but conserved among members of the AKAP95 family. Direct binding of AKAP95 to isolated nuclear matrix was demonstrated in situ and found to be dependent on the nuclear matrix-targeting site. Moreover, Far Western blot analysis identified at least three AKAP95-binding proteins in nuclear matrix isolated from rat brain. Yeast two-hybrid cloning identified one binding partner as p68 RNA helicase, The helicase and AKAP95 co-localized in the nuclear matrix of mammalian cells, associated in vitro, and were precipitated as a complex from solubilized cell extracts. The results define novel protein-protein interactions among nuclear matrix proteins and suggest a potential role of AKAP95 as a scaffold for coordinating assembly of hormonally responsive transcription complexes.	Oregon Hlth & Sci Univ, Inst Neurol Sci, Beaverton, OR 97006 USA	Oregon Health & Science University	Coghlan, VM (corresponding author), Oregon Hlth & Sci Univ, Inst Neurol Sci, 505 NW 185th Ave, Beaverton, OR 97006 USA.	coghlanv@ohsu.edu	Taraska, Justin/H-8876-2016	Taraska, Justin/0000-0001-5355-9535	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052491] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK52491] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; BEREZNEY R, 1974, BIOCHEM BIOPH RES CO, V60, P1410, DOI 10.1016/0006-291X(74)90355-6; BEREZNEY R, 1977, J CELL BIOL, V73, P616, DOI 10.1083/jcb.73.3.616; Berezney R, 1995, INT REV CYTOL, V162A, P1; Bushmeyer SM, 1998, J CELL BIOCHEM, V68, P484, DOI 10.1002/(SICI)1097-4644(19980315)68:4<484::AID-JCB8>3.3.CO;2-F; COGHLAN VM, 1994, J BIOL CHEM, V269, P7658; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; COGHLAN VM, 1998, GEL ELECTROPHORESIS, P293; Collas P, 1999, J CELL BIOL, V147, P1167, DOI 10.1083/jcb.147.6.1167; Duttweiler HM, 1996, TRENDS GENET, V12, P340, DOI 10.1016/S0168-9525(96)80008-4; DWORETZKY SI, 1992, P NATL ACAD SCI USA, V89, P4178, DOI 10.1073/pnas.89.9.4178; Eide T, 1998, EXP CELL RES, V238, P305, DOI 10.1006/excr.1997.3855; Endoh H, 1999, MOL CELL BIOL, V19, P5363; ENGELHARDT P, 1982, P NATL ACAD SCI-BIOL, V79, P6937, DOI 10.1073/pnas.79.22.6937; FEY EG, 1986, J CELL BIOL, V102, P1654, DOI 10.1083/jcb.102.5.1654; FEY EG, 1988, P NATL ACAD SCI USA, V85, P121, DOI 10.1073/pnas.85.1.121; GASSER SM, 1986, EMBO J, V5, P511, DOI 10.1002/j.1460-2075.1986.tb04240.x; Grondin B, 1997, J BIOL CHEM, V272, P27877, DOI 10.1074/jbc.272.44.27877; HAKES DJ, 1991, J BIOL CHEM, V266, P11131; Hausken ZE, 1996, J BIOL CHEM, V271, P29016, DOI 10.1074/jbc.271.46.29016; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; Hicks GR, 1995, ANNU REV CELL DEV BI, V11, P155, DOI 10.1146/annurev.cb.11.110195.001103; Hughes JH, 1999, AM J CLIN PATHOL, V111, P267; JACKSON DA, 1981, NATURE, V292, P552, DOI 10.1038/292552a0; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lee JY, 1998, DNA CELL BIOL, V17, P849, DOI 10.1089/dna.1998.17.849; LEWIS CD, 1984, J CELL SCI, P103; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nardozza TA, 1996, J CELL BIOCHEM, V61, P467, DOI 10.1002/(SICI)1097-4644(19960601)61:3<467::AID-JCB14>3.3.CO;2-W; NELSON WG, 1986, ANNU REV BIOPHYS BIO, V15, P457, DOI 10.1146/annurev.bb.15.060186.002325; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PETERS KE, 1980, J CELL BIOL, V86, P135, DOI 10.1083/jcb.86.1.135; ReplogleSchwab TS, 1996, CRIT REV EUKAR GENE, V6, P103, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.10; Seki N, 2000, J HUM GENET, V45, P31, DOI 10.1007/s100380070040; VANDRIEL R, 1991, J CELL BIOCHEM, V47, P311, DOI 10.1002/jcb.240470405; Vo NK, 1998, BIOCHEM BIOPH RES CO, V246, P831, DOI 10.1006/bbrc.1998.8722; Westberg C, 2000, J BIOL CHEM, V275, P21396, DOI 10.1074/jbc.M909887199; Zeng CM, 1997, P NATL ACAD SCI USA, V94, P6746, DOI 10.1073/pnas.94.13.6746	38	57	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17448	17454		10.1074/jbc.M101171200	http://dx.doi.org/10.1074/jbc.M101171200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279182	hybrid			2022-12-27	WOS:000168730400114
J	Lee, SY; Cho, HS; Pelton, JG; Yan, DL; Berry, EA; Wemmer, DE				Lee, SY; Cho, HS; Pelton, JG; Yan, DL; Berry, EA; Wemmer, DE			Crystal structure of activated CheY - Comparison with other activated receiver domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE REGULATOR PROTEIN; SIGNAL-TRANSDUCTION; BACTERIAL CHEMOTAXIS; ESCHERICHIA-COLI; Y-PROTEIN; PHOSPHORYLATION; BINDING; SWITCH; NTRC; MUTANTS	The crystal structure of BeF3--activated CheY, with manganese in the magnesium binding site, was determined at 2.4-Angstrom resolution. BeF3- bonds to Asp(57), the normal site of phosphorylation, forming a hydrogen bond and salt bridge with Thr(87) and Lys(109), respectively. The six coordination sites for manganese are satisfied by a fluorine of BeF3-, the side chain oxygens of Asp(13) and Asp(57), the carbonyl oxygen of Asn(59), and two water molecules. All of the active site interactions seen for BeF3-- CheY are also observed in P-Spo0A(r), Thus, BeF3- activates CheY as well as other receiver domains by mimicking both the tetrahedral geometry and electrostatic potential of a phosphoryl group. The aromatic ring of Tyr(106) is found buried within a hydrophobic pocket formed by beta -strand beta4 and helix H4, The tyrosine side chain is stabilized in this conformation by a hydrogen bond between the hydroxyl group and the backbone carbonyl oxygen of Glu(89). This hydrogen bond appears to stabilize the active conformation of the beta4/H4 loop. Comparison of the backbone coordinates for the active and inactive states of CheY reveals that only modest changes occur upon activation, except in the loops, with the largest changes occurring in the beta4/H4 loop. This region is known to be conformationally flexible in inactive CheY and is part of the surface used by activated CheY for binding its target, FliM, The pattern of activation-induced backbone coordinate changes is similar to that seen in FixJ(r). A common feature in the active sites of BeF3--CheY, P-Spo0A(r) P-FixJ(r), and phosphono-CheY is a salt bridge between Lys(109) N zeta and the phosphate or its equivalent, beryllofluoride, This suggests that, in addition to the concerted movements of Thr(87) and Tyr(106) (Thr-Tyr coupling), formation of the Lys(109)-PO3- salt bridge is directly involved in the activation of receiver domains generally.	Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Grad Grp Biophys, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wemmer, DE (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA.							Appleby JL, 1998, J BACTERIOL, V180, P3563, DOI 10.1128/JB.180.14.3563-3569.1998; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bellsolell L, 1996, J MOL BIOL, V257, P116, DOI 10.1006/jmbi.1996.0151; Birck C, 1999, STRUCTURE, V7, P1505, DOI 10.1016/S0969-2126(00)88341-0; BRUIX M, 1993, EUR J BIOCHEM, V215, P573, DOI 10.1111/j.1432-1033.1993.tb18068.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cho HS, 2000, J MOL BIOL, V297, P543, DOI 10.1006/jmbi.2000.3595; Djordjevic S, 1998, J STRUCT BIOL, V124, P189, DOI 10.1006/jsbi.1998.4034; Feher VA, 1999, NATURE, V400, P289, DOI 10.1038/22357; Gouet P, 1999, STRUCTURE, V7, P1517, DOI 10.1016/S0969-2126(00)88342-2; Grebe TW, 1999, ADV MICROB PHYSIOL, V41, P139, DOI 10.1016/S0065-2911(08)60167-8; Halkides CJ, 2000, BIOCHEMISTRY-US, V39, P5280, DOI 10.1021/bi9925524; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAR L, 1992, BIOCHEM J, V287, P521, DOI 10.1042/bj2870521; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SY, 2001, NAT STRUCT BIOL, V8, P52; Lewis RJ, 2000, J MOL BIOL, V297, P757, DOI 10.1006/jmbi.2000.3598; Lewis RJ, 1999, J MOL BIOL, V294, P9, DOI 10.1006/jmbi.1999.3261; LUKAT GS, 1991, J BIOL CHEM, V266, P8348; LUKAT GS, 1990, BIOCHEMISTRY-US, V29, P5436, DOI 10.1021/bi00475a004; McEvoy MM, 1999, J MOL BIOL, V289, P1423, DOI 10.1006/jmbi.1999.2830; MOY FJ, 1994, BIOCHEMISTRY-US, V33, P10731, DOI 10.1021/bi00201a022; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEEDHAM JV, 1993, BIOCHEMISTRY-US, V32, P3363, DOI 10.1021/bi00064a020; NIXON BT, 1986, P NATL ACAD SCI USA, V83, P7850, DOI 10.1073/pnas.83.20.7850; Nohaile M, 1997, J MOL BIOL, V273, P299, DOI 10.1006/jmbi.1997.1296; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; SANDERS DA, 1989, J BIOL CHEM, V264, P21770; Sola M, 2000, J MOL BIOL, V303, P213, DOI 10.1006/jmbi.2000.4507; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOCK AM, 1993, BIOCHEMISTRY-US, V32, P13375, DOI 10.1021/bi00212a001; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; VOLKMAN BF, 1995, BIOCHEMISTRY-US, V34, P1413, DOI 10.1021/bi00004a036; VOLZ K, 1991, J BIOL CHEM, V266, P15511; VOLZ K, 1993, BIOCHEMISTRY-US, V32, P11741, DOI 10.1021/bi00095a001; WEINSTEIN M, 1992, MOL MICROBIOL, V6, P2041, DOI 10.1111/j.1365-2958.1992.tb01377.x; WELCH M, 1994, BIOCHEMISTRY-US, V33, P10470, DOI 10.1021/bi00200a031; Yan D, 1999, P NATL ACAD SCI USA, V96, P14789, DOI 10.1073/pnas.96.26.14789; Zhu XY, 1996, J BACTERIOL, V178, P4208, DOI 10.1128/jb.178.14.4208-4215.1996; Zhu XY, 1997, J BIOL CHEM, V272, P5000, DOI 10.1074/jbc.272.8.5000	47	128	129	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16425	16431		10.1074/jbc.M101002200	http://dx.doi.org/10.1074/jbc.M101002200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279165	hybrid			2022-12-27	WOS:000168623100114
J	Tosello-Trampont, AC; Brugnera, E; Ravichandran, KS				Tosello-Trampont, AC; Brugnera, E; Ravichandran, KS			Evidence for a conserved role for CrkII and Rac in engulfment of apoptotic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; DENDRITIC CELLS; PROTEIN CED-6; PHAGOCYTOSIS; PHOSPHATIDYLSERINE; RECOGNITION; BINDING; DOCK180; DEATH	Apoptosis or programmed cell death occurs in multicellular organisms throughout life. The removal of apoptotic cells by phagocytes prevents secondary necrosis and inflammation and also plays a key role in tissue remodeling and regulating immune responses. The molecular mechanisms that regulate the engulfment of apoptotic cells are just beginning to be elucidated. Recent genetic studies in the nematode Caenorhabditis elegans have implicated at least six genes in the removal of apoptotic cell corpses. The gene products of ced-2 ced-5, and ced-10 are thought to be part of a pathway that regulates the reorganization of the cytoskeleton during engulfment. The adapter proteins CrkII and Dock180 and the small GTPase Rac represent the mammalian orthologues of the ced-5 ced-5 and ced-10 gene products, respectively. It is not known whether CrkII, Dock180, or Rac proteins have any role during engulfment in mammalian cells. Here we show, using stable cell lines and transient transfections, that overexpression of wild-type CrkII or an activated form of Rad enhances engulfment. Mutants of CrkII failed to mediate this increased engulfment. The higher CrkII-mediated uptake was inhibited by coexpression of a dominant negative form of Rad but not by a dominant a negative Rho protein; this suggested that Rac functions downstream of CrkII in this process, which is consistent with genetic studies in the worm that place ced-10 (rac) downstream of ced-2 (crh) in cell corpse removal, Taken together, these data suggest that CED 2/CrkII and CED-10/Rac are part of an evolutionarily conserved pathway in engulfment of apoptotic cells.	Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Beirne Carter Ctr Immunol Res, MR4,Rm 4012F,HSC, Charlottesville, VA 22908 USA.							Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; da Silva RP, 1999, BIOCHEM J, V338, P687, DOI 10.1042/bj3380687; ELLIS RE, 1991, GENETICS, V129, P79; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Fadok VA, 1998, CURR BIOL, V8, pR693, DOI 10.1016/S0960-9822(98)70438-5; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Green DR, 2000, NATURE, V405, P28, DOI 10.1038/35011175; Greenberg S, 1999, J LEUKOCYTE BIOL, V66, P712, DOI 10.1002/jlb.66.5.712; Gregory CD, 2000, CURR OPIN IMMUNOL, V12, P27, DOI 10.1016/S0952-7915(99)00047-3; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kiyokawa E, 1997, CRIT REV ONCOGENESIS, V8, P329, DOI 10.1615/CritRevOncog.v8.i4.30; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Liu QA, 1999, CURR BIOL, V9, P1347, DOI 10.1016/S0960-9822(00)80061-5; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Luciani MF, 1996, EMBO J, V15, P226, DOI 10.1002/j.1460-2075.1996.tb00353.x; Marguet D, 1999, NAT CELL BIOL, V1, P454, DOI 10.1038/15690; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Ravichandran KS, 1997, MOL CELL BIOL, V17, P5540, DOI 10.1128/MCB.17.9.5540; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Schlegel RA, 1999, CELL DEATH DIFFER, V6, P583, DOI 10.1038/sj.cdd.4400529; Smits E, 1999, CURR BIOL, V9, P1351, DOI 10.1016/S0960-9822(00)80062-7; Su HP, 2000, J BIOL CHEM, V275, P9542, DOI 10.1074/jbc.275.13.9542; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5	37	64	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13797	13802		10.1074/jbc.M011238200	http://dx.doi.org/10.1074/jbc.M011238200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11297528	hybrid			2022-12-27	WOS:000168356600042
J	Wu, YJ; Zhang, Y; Cao, L; Chen, LW; Lee, V; Zheng, PS; Kiani, C; Adams, ME; Ang, LC; Paiwand, F; Yang, BB				Wu, YJ; Zhang, Y; Cao, L; Chen, LW; Lee, V; Zheng, PS; Kiani, C; Adams, ME; Ang, LC; Paiwand, F; Yang, BB			Identification of the motif in versican G3 domain that plays a dominant-negative effect on astrocytoma cell proliferation through inhibiting versican secretion and binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; PG-M; G1 DOMAIN; LINK PROTEIN; TENASCIN-R; ADHESION; CHONDROGENESIS; EXPRESSION; OUTGROWTH; AGGRECAN	This study was designed to investigate the mechanisms by which mutant versican constructs play a dominant-negative effect on astrocytoma cell proliferation. Although a mini-versican or a versican G3 construct promoted growth of U87 astrocytoma cells, a mini-versican lacking epidermal growth factor (EGF) motifs (versican Delta EGF) and a G3 mutant (G3 Delta EGF) exerted a dominant-negative effect on cell proliferation. G3 Delta EGF-transfected cells formed smaller colonies, arrested cell cycle at G(1) phase, inhibited expression of cell cycle proteins cdk4 and cyclin D1, and contained multiple nucleoli, In cell surface binding assays, G3 products expressed in COS-7 cells and bacteria bound to U87 cell surface. G3 Delta EGF products exhibited decreased binding activity, but higher levels of G3 Delta EGF products were able to inhibit the binding of G3 to the cell surface, G3 Delta EGF expression inhibited secretion of endogenous versican in astrocytoma cells and also inhibited the secretion of mini-versican in COS-7 cells co-transfected with the mini-versican and G3 Delta EGF constructs. The effect seems to depend on the expression efficiency of G3 Delta EGF, and it occurred via the carbohydrate recognition domain.	Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M4N 3M5, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Yang, BB (corresponding author), Sunnybrook & Womens Coll, Hlth Sci Ctr, Res Bldg,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.							Ang LC, 1999, J NEUROPATH EXP NEUR, V58, P597, DOI 10.1097/00005072-199906000-00004; ASPBERG A, 1995, P NATL ACAD SCI USA, V92, P10590, DOI 10.1073/pnas.92.23.10590; Aspberg A, 1997, P NATL ACAD SCI USA, V94, P10116, DOI 10.1073/pnas.94.19.10116; BINETTE F, 1994, J BIOL CHEM, V269, P19116; BRAUNEWELL KH, 1995, EUR J NEUROSCI, V7, P805, DOI 10.1111/j.1460-9568.1995.tb00683.x; DEAK F, 1986, P NATL ACAD SCI USA, V83, P3766, DOI 10.1073/pnas.83.11.3766; DOURSZIMMERMANN MT, 1994, J BIOL CHEM, V269, P32992; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Giese A, 1996, NEUROSURGERY, V39, P235, DOI 10.1097/00006123-199608000-00001; ITO K, 1995, J BIOL CHEM, V270, P958, DOI 10.1074/jbc.270.2.958; Kawashima H, 2000, J BIOL CHEM, V275, P35448, DOI 10.1074/jbc.M003387200; Kiani C, 2001, BIOCHEM J, V354, P199, DOI 10.1042/0264-6021:3540199; KIMATA K, 1986, J BIOL CHEM, V261, P3517; KRUSIUS T, 1987, J BIOL CHEM, V262, P13120; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; LEBARON RG, 1992, J BIOL CHEM, V267, P10003; MARGOLIS RU, 1994, METHOD ENZYMOL, V245, P105; NASO MF, 1994, J BIOL CHEM, V269, P32999; NASO MF, 1995, GENOMICS, V29, P297, DOI 10.1006/geno.1995.1251; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; Paulus W, 1996, J NEUROPATH EXP NEUR, V55, P528, DOI 10.1097/00005072-199605000-00005; PERIDES G, 1993, ANAT EMBRYOL, V188, P467; SHINOMURA T, 1990, ANAT EMBRYOL, V181, P227; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; Tiedemann K, 1997, MATRIX BIOL, V15, P469, DOI 10.1016/S0945-053X(97)90020-2; VONSTRANDMANN EP, 1995, PROTEIN ENG, V8, P732; YAMAGATA M, 1993, ANAT EMBRYOL, V187, P433; Yang BL, 2000, J BIOL CHEM, V275, P21255, DOI 10.1074/jbc.M001443200; Yang BL, 1999, J CELL BIOCHEM, V72, P210, DOI 10.1002/(SICI)1097-4644(19990201)72:2<210::AID-JCB5>3.0.CO;2-E; Zako M, 1997, J BIOL CHEM, V272, P9325, DOI 10.1074/jbc.272.14.9325; Zhang Y, 1999, J CELL BIOCHEM, V73, P445, DOI 10.1002/(SICI)1097-4644(19990615)73:4<445::AID-JCB3>3.0.CO;2-D; Zhang Y, 1998, J BIOL CHEM, V273, P33054, DOI 10.1074/jbc.273.49.33054; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342; Zhang Y, 2001, EXP CELL RES, V263, P33, DOI 10.1006/excr.2000.5095; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x; ZIMMERMANN DR, 1994, J CELL BIOL, V124, P817, DOI 10.1083/jcb.124.5.817	36	49	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14178	14186		10.1074/jbc.M100618200	http://dx.doi.org/10.1074/jbc.M100618200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11297534	hybrid			2022-12-27	WOS:000168356600090
J	Ichihashi, K; Osawa, T; Toyokuni, S; Uchida, K				Ichihashi, K; Osawa, T; Toyokuni, S; Uchida, K			Endogenous formation of protein adducts with carcinogenic aldehydes - Implications for oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-CELL CARCINOMA; FERRIC NITRILOTRIACETATE; LIPID-PEROXIDATION; CATALYZED OXIDATION; MODEL; INDUCTION; PRODUCT; RATS; CROTONALDEHYDE; NEPHROTOXICITY	In the present study, we characterize the covalent modification of a protein by crotonaldehyde, a representative carcinogenic aldehyde, and describe the endogenous production of this aldehyde in vivo, The crotonaldehyde preferentially reacted with the lysine and histidine residues of bovine serum albumin and generated a protein-linked carbonyl derivative. Upon incubation with the histidine and lysine derivatives, crotonaldehyde predominantly generated beta -substituted butanal adducts of histidine and lysine and N-epsilon-(2,5-dimethyl-3-formyl-3,4-dehydropiperidino)lysine (dimethyl-FDP-lysine) as the putative carbonyl derivatives generated in the crotonaldehyde-modified protein. To verify the endogenous formation of crotonaldehyde in vivo, we raised the monoclonal antibody (mAb82D3) against the crotonaldehyde-modified protein and found that it cross-reacted with the protein-bound 2-alkenals, such as crotonaldehyde, 2-pentenal, and 2-hexenal. The anti-2-alkenal antibody recognized multiple crotonaldehyde-lysine adducts, including dimethyl-FDP-lysine and an unknown product, which showed the greatest immunoreactivity with the antibody. On the basis of the chemical and spectroscopic evidence, the major antigenic product was determined to be a novel Schiff base-derived crotonaldehyde-lysine adduct, N-epsilon- (5-ethyl-2-methylpyridinium)lysine (EMP-lysine), It was found that the lysine residues that had disappeared in the protein treated with crotonaldehyde were partially recovered by EMP-lysine. The presence of immunoreactive materials with mAb82D3 in vivo was demonstrated in the kidney of rats exposed to the renal carcinogen, ferric nitrilotriacetate. In addition, the observations that the metal-catalyzed oxidation of polyunsaturated fatty acids in the presence of proteins resulted in an increase in the antigenicity of the protein indicated that lipid peroxidation represents a potential pathway for the formation of crotonalde-hyde/2-alkenals in vivo, These data suggest that the formation of carcinogenic aldehydes during lipid peroxidation may be causally involved in the pathophysiological effects associated with oxidative stress.	Nagoya Univ, Lab Food & Biodynam, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 606, Japan	Nagoya University; Kyoto University	Uchida, K (corresponding author), Nagoya Univ, Lab Food & Biodynam, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.		Toyokuni, Shinya/ABE-7714-2021; Toyokuni, Shinya/C-1358-2010	Toyokuni, Shinya/0000-0002-5757-1109; Toyokuni, Shinya/0000-0002-5757-1109; Uchida, Koji/0000-0003-3894-5299				ALAIZ M, 1995, CHEM PHYS LIPIDS, V75, P43, DOI 10.1016/0009-3084(94)02399-P; AWAI M, 1979, AM J PATHOL, V95, P663; Baker A, 1998, CHEM RES TOXICOL, V11, P730, DOI 10.1021/tx970167e; Baker AG, 1999, J AM SOC MASS SPECTR, V10, P613, DOI 10.1016/S1044-0305(99)00029-X; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; Burcham PC, 1996, BIOCHEM BIOPH RES CO, V220, P996, DOI 10.1006/bbrc.1996.0521; CHUNG FL, 1986, CANCER RES, V46, P1285; Chung FL, 1999, MUTAT RES-FUND MOL M, V424, P71, DOI 10.1016/S0027-5107(99)00009-3; Chung FL, 1996, CARCINOGENESIS, V17, P2105, DOI 10.1093/carcin/17.10.2105; EBINA Y, 1986, J NATL CANCER I, V76, P107; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; ESTERBAUER H, 1976, TETRAHEDRON, V32, P285, DOI 10.1016/0040-4020(76)87015-9; GLADSTONE IM, 1994, PEDIATRICS, V93, P764; International Agency for Research on Cancer, 1995, IARC MON EV CARC RIS, V63, P373; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; LI JL, 1987, CANCER RES, V47, P1867; NADKARNI DV, 1995, CHEM RES TOXICOL, V8, P284, DOI 10.1021/tx00044a014; OLIVER CN, 1987, J BIOL CHEM, V262, P5488; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255; STADTMAN ER, 1986, TRENDS BIOCHEM SCI, V11, P11, DOI 10.1016/0968-0004(86)90221-5; STADTMAN ER, 1991, J BIOL CHEM, V266, P2005; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; STEINBERG D, 1995, ADV EXP MED BIOL, V369, P39; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; TOYOKUNI S, 1990, CANCER RES, V50, P5574; Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P553, DOI 10.1016/0891-5849(95)02111-6; Toyokuni S, 1997, LAB INVEST, V76, P365; TOYOKUNI S, 1994, P NATL ACAD SCI USA, V91, P2616, DOI 10.1073/pnas.91.7.2616; UCHIDA K, 1993, P NATL ACAD SCI USA, V90, P8742, DOI 10.1073/pnas.90.18.8742; UCHIDA K, 1995, ARCH BIOCHEM BIOPHYS, V317, P405, DOI 10.1006/abbi.1995.1181; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; UCHIDA K, 1993, J BIOL CHEM, V268, P6388; WANG MY, 1988, CHEM RES TOXICOL, V1, P28, DOI 10.1021/tx00001a005; Wang MY, 2000, CHEM RES TOXICOL, V13, P1065, DOI 10.1021/tx000095i	38	91	96	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23903	23913		10.1074/jbc.M101947200	http://dx.doi.org/10.1074/jbc.M101947200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11283024	hybrid			2022-12-27	WOS:000169531100091
J	Rudolph, MG; Linnemann, T; Grunewald, P; Wittinghofer, A; Vetter, IR; Herrmann, C				Rudolph, MG; Linnemann, T; Grunewald, P; Wittinghofer, A; Vetter, IR; Herrmann, C			Thermodynamics of Ras/effector and Cdc42/effector interactions probed by isothermal titration calorimetry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAS-BINDING DOMAIN; WISKOTT-ALDRICH-SYNDROME; HEAT-CAPACITY; SYNDROME PROTEIN; TARGET PROTEINS; TIGHT-BINDING; KINASE; COMPLEX; GTPASES; WATER	Proliferation, differentiation, and morphology of eucaryotic cells is regulated by a large network of signaling molecules, Among the major players are members of the Ras and Rho/Rac subfamilies of small GTPases that bind to different sets of effector proteins. Recognition of multiple effecters is important for communicating signals into different pathways, leading to the question of how an individual GTPase achieves tight binding to diverse targets. To understand the observed specificity, detailed information about binding energetics is expected to complement the information gained from the three-dimensional structures of GTPase/effector protein complexes. Here, the thermodynamics of the interaction of four closely related members of the Ras subfamily with four different effecters and, additionally, the more distantly related Cdc42/WASP couple were quantified by means of isothermal titration calorimetry. The heat capacity changes upon complex formation were rationalized in light of the GTPase/effector complex structures. Changes in enthalpy, entropy, and heat capacity of association with various Ras proteins are similar for the same effector. In contrast, although the structures of the Ras-binding domains are similar, the thermodynamics of the Ras/Raf and Ras/Ral guanine nucleotide dissociation stimulator interactions are quite different, The energy profile of the Cdc42/WASP interaction is similar to Ras/Ral guanine nucleotide dissociation stimulator, despite largely different structures and interface areas of the complexes. Water molecules in the interface cannot fully account for the observed discrepancy but may explain the large range of Ras/effector binding specificity. The differences in the thermodynamic parameters, particularly the entropy changes, could help in the design of effector-specific inhibitors that selectively block a single pathway.	Max Planck Inst Mol Physiol, Abt Strukturelle Biol, D-44227 Dortmund, Germany	Max Planck Society	Herrmann, C (corresponding author), Max Planck Inst Mol Physiol, Abt Strukturelle Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.			Rudolph, Markus/0000-0003-0447-1101				Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1; BOKOCH GM, 1994, CURR OPIN CELL BIOL, V6, P212, DOI 10.1016/0955-0674(94)90138-4; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradshaw JM, 1998, BIOCHEMISTRY-US, V37, P15400, DOI 10.1021/bi9814991; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Carlier MF, 1999, CHEM BIOL, V6, pR235, DOI 10.1016/S1074-5521(99)80107-0; Doyle ML, 1995, METHOD ENZYMOL, V259, P183; DUNITZ JD, 1994, SCIENCE, V264, P670, DOI 10.1126/science.264.5159.670; EMERSON SD, 1995, BIOCHEMISTRY-US, V34, P6911, DOI 10.1021/bi00021a001; FERSHT AR, 1987, TRENDS BIOCHEM SCI, V12, P301, DOI 10.1016/0968-0004(87)90146-0; Fukada H, 1998, PROTEINS, V33, P159, DOI 10.1002/(SICI)1097-0134(19981101)33:2<159::AID-PROT2>3.0.CO;2-E; Geyer M, 1997, NAT STRUCT BIOL, V4, P694, DOI 10.1038/nsb0997-694; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOMEZ J, 1995, PROTEINS, V22, P404, DOI 10.1002/prot.340220410; Habermann SM, 1996, PROTEIN SCI, V5, P1229, DOI 10.1002/pro.5560050702; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Herrmann C, 1996, PROG BIOPHYS MOL BIO, V66, P1, DOI 10.1016/S0079-6107(96)00015-6; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Huang L, 1997, NAT STRUCT BIOL, V4, P609, DOI 10.1038/nsb0897-609; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Huber F, 2000, J BIOMOL NMR, V16, P355, DOI 10.1023/A:1008335420475; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; LIVINGSTONE JR, 1991, BIOCHEMISTRY-US, V30, P4237, DOI 10.1021/bi00231a019; MARSHALL MS, 1995, FASEB J, V9, P1311, DOI 10.1096/fasebj.9.13.7557021; Martell A. E., 1974, CRITICAL STABILITY C; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; MURPHY KP, 1990, SCIENCE, V247, P559, DOI 10.1126/science.2300815; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ochs HD, 1998, SPRINGER SEMIN IMMUN, V19, P435, DOI 10.1007/BF00792601; Parsegian VA, 1995, METHOD ENZYMOL, V259, P43; Ridley A J, 1999, Prog Mol Subcell Biol, V22, P1; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Steiner G, 2000, J BIOMOL NMR, V18, P73, DOI 10.1023/A:1008373529242; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Tu H, 1997, MOL CELL BIOL, V17, P5876, DOI 10.1128/MCB.17.10.5876; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785	53	65	66	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23914	23921		10.1074/jbc.M011600200	http://dx.doi.org/10.1074/jbc.M011600200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11292826	hybrid			2022-12-27	WOS:000169531100092
J	Bigger, BW; Tolmachov, O; Collombet, JM; Fragkos, M; Palaszewski, I; Coutelle, C				Bigger, BW; Tolmachov, O; Collombet, JM; Fragkos, M; Palaszewski, I; Coutelle, C			An araC-controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; MUTANT LOX SITES; ESCHERICHIA-COLI; INFLAMMATORY RESPONSE; PLASMID DNA; CPG MOTIFS; GENOME; INTEGRATION; DELIVERY; PROMOTER	The presence of CpG motifs and their associated sequences in bacterial DNA causes an immunotoxic response following the delivery of these plasmid vectors into mammalian hosts. We describe a biotechnological approach to the elimination of this problem by the creation of a bacterial ore recombinase expression system, tightly controlled by the arabinose regulon, This permits the Cre-mediated and -directed excision of the entire bacterial vector sequences from plasmid constructs to create supercoiled gene expression minicircles for gene therapy. Minicircle yields using standard culture volumes are sufficient for most in vitro and in vivo ap plications whereas minicircle expression in vitro is significantly increased over standard plasmid transfection. By the simple expedient of removing the bacterial DNA complement, we significantly reduce the size and CpG content of these expression vectors, which should also reduce DNA-induced inflammatory responses in a dose dependent manner. We further describe the generation of minicircle expression vectors for mammalian mitochondrial gene therapy, for which no other vector systems currently exist. The removal of bacterial vector sequences should permit appropriate transcription and correct transcriptional cleavage from the mitochondrial minicircle constructs in a mitochondrial environment and brings the realization of mitochondrial gene therapy a step closer.	Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, Cyst Fibrosis Gene Therapy Grp, London SW7 2AZ, England	Imperial College London	Bigger, BW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, Cyst Fibrosis Gene Therapy Grp, SAF Bldg,Exhibit Rd, London SW7 2AZ, England.	b.bigger@ic.ac.uk	Fragkos, Michalis/GQQ-1030-2022; Bigger, Brian/I-3553-2012	Fragkos, Michalis/0000-0003-2721-4327; Tolmachov, Oleg/0000-0002-6926-4229; Bigger, Brian/0000-0002-9708-1112				ABREMSKI K, 1984, J BIOL CHEM, V259, P1509; ABREMSKI K, 1983, CELL, V32, P1301, DOI 10.1016/0092-8674(83)90311-2; ALBERT H, 1995, PLANT J, V7, P649, DOI 10.1046/j.1365-313X.1995.7040649.x; Araki K, 1997, NUCLEIC ACIDS RES, V25, P868, DOI 10.1093/nar/25.4.868; Aristidou AA, 1999, BIOTECHNOL PROGR, V15, P140, DOI 10.1021/bp980115v; Bigger B, 2000, ANAL BIOCHEM, V277, P236, DOI 10.1006/abio.1999.4382; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P3118, DOI 10.1093/nar/24.15.3118; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P4256, DOI 10.1093/nar/24.21.4256; Collombet JM, 1997, J BIOL CHEM, V272, P5342, DOI 10.1074/jbc.272.8.5342; Darquet AM, 1997, GENE THER, V4, P1341, DOI 10.1038/sj.gt.3300540; Darquet AM, 1999, GENE THER, V6, P209, DOI 10.1038/sj.gt.3300816; Gschaedler A, 1999, BIOTECHNOL BIOENG, V63, P712, DOI 10.1002/(SICI)1097-0290(19990620)63:6<712::AID-BIT9>3.0.CO;2-R; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HAHN S, 1984, J MOL BIOL, V180, P61, DOI 10.1016/0022-2836(84)90430-3; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; HIRSH J, 1973, J MOL BIOL, V80, P433, DOI 10.1016/0022-2836(73)90414-2; KAZAKOVA TB, 1983, GENETIKA+, V19, P381; KOSIBA BE, 1982, J MOL BIOL, V156, P53, DOI 10.1016/0022-2836(82)90458-2; Kreiss P, 1998, APPL MICROBIOL BIOT, V49, P560, DOI 10.1007/s002530051213; Krieg AM, 2000, MOL THER, V1, P209, DOI 10.1006/mthe.2000.0041; Krieg AM, 1999, J GENE MED, V1, P56, DOI 10.1002/(SICI)1521-2254(199901/02)1:1<56::AID-JGM5>3.3.CO;2-Y; Krieg AM, 1996, J LAB CLIN MED, V128, P128, DOI 10.1016/S0022-2143(96)90004-9; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Leahy P, 1997, NUCLEIC ACIDS RES, V25, P449, DOI 10.1093/nar/25.2.449; McLachlan G, 2000, GENE THER, V7, P384, DOI 10.1038/sj.gt.3301097; NEIDHARDT FC, 1987, ESCHERICHIA COLI SAL, V2; Norman J, 2000, GENE THER, V7, P1425, DOI 10.1038/sj.gt.3301240; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OJALA D, 1980, CELL, V22, P393, DOI 10.1016/0092-8674(80)90350-5; RADLOFF R, 1967, P NATL ACAD SCI USA, V57, P1514, DOI 10.1073/pnas.57.5.1514; Sambrook J., 2002, MOL CLONING LAB MANU; STERNBERG N, 1986, J MOL BIOL, V187, P197, DOI 10.1016/0022-2836(86)90228-7; SWARTZ MN, 1962, J BIOL CHEM, V237, P1961; TOLMACHOV OE, 1990, BIOTEKHNOLOGIYA, V1, P25; Wheeler VC, 1996, GENE, V169, P251, DOI 10.1016/0378-1119(95)00812-8; Wheeler VC, 1997, GENE, V198, P203, DOI 10.1016/S0378-1119(97)00315-6; Yew NS, 2000, MOL THER, V1, P255, DOI 10.1006/mthe.2000.0036; Yew NS, 1999, HUM GENE THER, V10, P223, DOI 10.1089/10430349950019011	38	116	136	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23018	23027		10.1074/jbc.M010873200	http://dx.doi.org/10.1074/jbc.M010873200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11304530	hybrid			2022-12-27	WOS:000169412700138
J	Opitz, B; Schroder, NWJ; Spreitzer, I; Michelsen, KS; Kirschning, CJ; Hallatschek, W; Zahringer, U; Hartung, T; Gobel, UB; Schumann, RR				Opitz, B; Schroder, NWJ; Spreitzer, I; Michelsen, KS; Kirschning, CJ; Hallatschek, W; Zahringer, U; Hartung, T; Gobel, UB; Schumann, RR			Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappa B translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL COMPONENTS; BORRELIA-BURGDORFERI LIPOPROTEINS; ACTIVATED PROTEIN-KINASES; HUMAN MONOCYTIC CELLS; INNATE IMMUNE-SYSTEM; CUTTING EDGE; DROSOPHILA TOLL; STAPHYLOCOCCUS-AUREUS; SIGNAL-TRANSDUCTION; PATTERN-RECOGNITION	Recently Toll-like receptors (TLRs) have been found to be involved in cellular activation by microbial products, including lipopolysaccharide, lipoproteins, and peptidoglycan. Although for these ligands the specific transmembrane signal transducers TLR4, TLR-2, or TLR-2 and 6 have now been identified, the molecular basis of recognition of lipoteichoic acids (LTAs) and related glycolipids has not been completely understood. In order to determine the role of TLRs in immune cell activation by these stimuli, experiments involving TLR-2-negative cell lines, TLR-expression plasmids, macrophages from TLR-4-deficient C3H/HeJ-mice, and inhibitory TLR-4/MD-2 antibodies were performed. Glycolipids from Treponema maltophilum and Treponema brennaborense, as well as highly purified LTAs from Staphylococcus aureus and Bacillus subtilis exhibited TLR-2 dependence in nuclear factor KB activation and cytokine induction; however, T. brennaborense additionally appeared to signal via TLR-4. Fractionation of the T. brennaborense glycolipids by hydrophobic interaction chromatography and subsequent cell stimulation experiments revealed two peaks of activity, one exhibiting TLR-2-, and a second TLR-4-dependence. Furthermore, we show involvement of the signaling molecules MyD88 and NIK in cell stimulation by LTAs and glycolipids by dominant negative overexpression experiments. In summary, the results presented here indicate that TLR-2 is the main receptor for Treponema glycolipid and LTA-mediated inflammatory response.	Humboldt Univ, Fak Med, Charite Med Ctr, Inst Mikrobiol & Hyg, D-10117 Berlin, Germany; Univ Konstanz, Dept Biochem Pharmacol, D-78457 Constance, Germany; Tech Univ, Inst Microbiol Immunol & Hyg, D-81657 Munich, Germany; Forschungszentrum Borstel, Dept Immunochem, D-23845 Borstel, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Konstanz; Technical University of Munich; Forschungszentrum Borstel	Schumann, RR (corresponding author), Humboldt Univ, Fak Med, Klinikum Charite, Inst Mikrobiol & Hyg, Dorotheenstr 96, D-10117 Berlin, Germany.			Opitz, Bastian/0000-0003-1276-836X				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akashi S, 2000, BIOCHEM BIOPH RES CO, V268, P172, DOI 10.1006/bbrc.2000.2089; Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BHAKDI S, 1991, INFECT IMMUN, V59, P4614, DOI 10.1128/IAI.59.12.4614-4620.1991; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; CHOI BK, 1994, INFECT IMMUN, V62, P1889, DOI 10.1128/IAI.62.5.1889-1895.1994; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; DEKIMPE SJ, 1995, P NATL ACAD SCI USA, V92, P10359, DOI 10.1073/pnas.92.22.10359; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; FISCHER W, 1980, FEBS LETT, V119, P224, DOI 10.1016/0014-5793(80)80257-2; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Greenberg JW, 1996, INFECT IMMUN, V64, P3318, DOI 10.1128/IAI.64.8.3318-3325.1996; Gupta D, 1996, J BIOL CHEM, V271, P23310, DOI 10.1074/jbc.271.38.23310; Hashimoto M, 2000, BIOCHEM BIOPH RES CO, V273, P164, DOI 10.1006/bbrc.2000.2921; Heine H, 1999, J IMMUNOL, V162, P6971; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; IWASAKI H, 1989, J BACTERIOL, V171, P424, DOI 10.1128/jb.171.1.424-429.1989; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; LAMBERT PA, 1977, BIOCHIM BIOPHYS ACTA, V472, P1, DOI 10.1016/0304-4157(77)90012-0; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEOPOLD K, 1992, ANAL BIOCHEM, V201, P350, DOI 10.1016/0003-2697(92)90350-G; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Means TK, 1999, J IMMUNOL, V163, P3920; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; MULLER JM, 1993, IMMUNOBIOLOGY, V187, P233; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Norgard MV, 1996, INFECT IMMUN, V64, P3845, DOI 10.1128/IAI.64.9.3845-3852.1996; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Polotsky VY, 1996, INFECT IMMUN, V64, P380, DOI 10.1128/IAI.64.1.380-383.1996; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Schrank K, 1999, INT J SYST BACTERIOL, V49, P43, DOI 10.1099/00207713-49-1-43; Schroder NWJ, 2000, J IMMUNOL, V165, P2683, DOI 10.4049/jimmunol.165.5.2683; Schultz CP, 1998, J BIOL CHEM, V273, P15661, DOI 10.1074/jbc.273.25.15661; Schumann RR, 1998, GLIA, V22, P295, DOI 10.1002/(SICI)1098-1136(199803)22:3<295::AID-GLIA8>3.0.CO;2-4; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Sellati TJ, 1999, J IMMUNOL, V163, P2049; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Williams MJ, 1997, EMBO J, V16, P6120, DOI 10.1093/emboj/16.20.6120; Wyss C, 1996, INT J SYST BACTERIOL, V46, P745, DOI 10.1099/00207713-46-3-745; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yang H, 2000, J BIOL CHEM, V275, P20861, DOI 10.1074/jbc.M002896200; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yoshimura A, 1999, J IMMUNOL, V163, P1	68	185	192	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22041	22047		10.1074/jbc.M010481200	http://dx.doi.org/10.1074/jbc.M010481200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11285258	hybrid			2022-12-27	WOS:000169412700009
J	Ogura, Y; Yoshida, Y; Yabe, N; Hasunuma, K				Ogura, Y; Yoshida, Y; Yabe, N; Hasunuma, K			A point mutation in nucleoside diphosphate kinase results in a deficient light response for perithecial polarity in Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHITE-COLLAR MUTANTS; X-RAY STRUCTURE; BLUE-LIGHT; SIGNAL-TRANSDUCTION; SCHIZOSACCHAROMYCES-POMBE; TUMOR-METASTASIS; GENETIC-ANALYSIS; HIGHER-PLANTS; IN-VITRO; PROTEIN	In Neurospora crassa, the phosphorylation of nucleoside diphosphate kinase (NDK)-1 is rapidly enhanced after blue light irradiation. We have investigated the function of NDK-1 in the blue light signal transduction pathway. A mutant called psp (phosphorylation of small protein) shows undetectable phosphorylation of NDK-1 and is defective in light-responsive regulation of perithecial polarity. Sequencing analysis of ndk-1 cDNA by reverse transcription-polymerase chain reaction revealed that proline 72 of ndk-1 was replaced with histidine in psp. The mutation ndk-1(P72H) resulted in accumulation of normal levels of mRNA and of about 25% of NDK-1(P72H) protein compared with that of wild type as determined by Western blot analysis. The ectopic expression of cDNA and introduction of genomic DNA of wild type ndk-1 in psp (ndk-1(P72H)) suppressed the reduction in accumulation and phosphorylation of NDK-1 and the light-insensitive phenotype. These findings demonstrated that the phenotype of psp was caused by the ndk-1(P72H) mutation. Biochemical analysis using recombinant NDK-1 and NDK-1P72H indicated that the P72H substitution in NDK-1 was responsible for the decrease in phosphotransfer activities, 5% of autophosphorylation activity, and 2% of V-max for protein kinase activity phosphorylating myelin basic protein, compared with those of wild type NDK-1, respectively.	Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan; Yokohama City Univ, Grad Sch Integrated Sci, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan	Yokohama City University; Yokohama City University	Hasunuma, K (corresponding author), Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, 641-12 Maioka Cho, Yokohama, Kanagawa 2440813, Japan.	kohji@yokohama-cu.ac.jp						Agarwal R P, 1978, Methods Enzymol, V51, P376; Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; Arpaia G, 1999, MOL GEN GENET, V262, P314, DOI 10.1007/s004380051089; Ballario P, 1998, MOL MICROBIOL, V29, P719, DOI 10.1046/j.1365-2958.1998.00955.x; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; Batschauer A, 1998, PLANTA, V206, P479, DOI 10.1007/s004250050425; BELOZERSKAYA TA, 1993, EXP MYCOL, V17, P157, DOI 10.1006/emyc.1993.1015; BIGGS J, 1990, CELL, V63, P933, DOI 10.1016/0092-8674(90)90496-2; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Choi G, 1999, NATURE, V401, P610, DOI 10.1038/44176; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; DEGLIINNOCENTI F, 1984, J BACTERIOL, V159, P757, DOI 10.1128/JB.159.2.757-761.1984; DUMAS C, 1992, EMBO J, V11, P3203, DOI 10.1002/j.1460-2075.1992.tb05397.x; Freije JMP, 1997, J BIOL CHEM, V272, P5525, DOI 10.1074/jbc.272.9.5525; HARDING RW, 1983, PLANT PHYSIOL, V72, P996, DOI 10.1104/pp.72.4.996; HARDING RW, 1981, PLANT PHYSIOL, V68, P745, DOI 10.1104/pp.68.3.745; Horwitz BA, 1997, BOT ACTA, V110, P360, DOI 10.1111/j.1438-8677.1997.tb00651.x; IZUMIYA H, 1995, J BIOL CHEM, V270, P27859, DOI 10.1074/jbc.270.46.27859; Kendrick RE, 1994, PHOTOMORPHOGENESIS P; KIMURA N, 1983, J BIOL CHEM, V258, P2278; Lasceve G, 1999, PLANT PHYSIOL, V120, P605, DOI 10.1104/pp.120.2.605; LAUTER FR, 1991, NUCLEIC ACIDS RES, V19, P6883, DOI 10.1093/nar/19.24.6883; Leung SM, 1997, J BIOL CHEM, V272, P2607, DOI 10.1074/jbc.272.5.2607; Linden H, 1997, EMBO J, V16, P98, DOI 10.1093/emboj/16.1.98; MEYEROWITZ EM, 1994, ARABIDOPSIS; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MORERA S, 1994, J MOL BIOL, V243, P873, DOI 10.1006/jmbi.1994.1689; MULLANEY EJ, 1985, MOL GEN GENET, V199, P37, DOI 10.1007/BF00327506; NELSON MA, 1989, MOL CELL BIOL, V9, P1271, DOI 10.1128/MCB.9.3.1271; Oda K, 1997, MOL GEN GENET, V256, P593, DOI 10.1007/s004380050607; ODA K, 1994, FEBS LETT, V345, P162, DOI 10.1016/0014-5793(94)00436-6; Ogura T, 1999, PHOTOCHEM PHOTOBIOL, V69, P397, DOI 10.1562/0031-8655(1999)069<0397:COPCCN>2.3.CO;2; Ogura Y, 1999, EUR J BIOCHEM, V266, P709, DOI 10.1046/j.1432-1327.1999.00783.x; Otero ADS, 1999, BBA-MOL CELL RES, V1449, P157, DOI 10.1016/S0167-4889(99)00009-9; Pall ML, 1993, FUNGAL GENET NEWSL, V40, P59, DOI DOI 10.4148/1941-4765.1413; PARKS RE, 1973, ENZYMES; PERKINS DD, 1982, MICROBIOL REV, V46, P426, DOI 10.1128/MMBR.46.4.426-570.1982; POSTEL EH, 1993, SCIENCE, V261, P478, DOI 10.1126/science.8392752; POTAPOVA TV, 1984, ARCH MICROBIOL, V137, P262, DOI 10.1007/BF00414555; Quail PH, 1997, BIOESSAYS, V19, P571, DOI 10.1002/bies.950190708; Sokolovsky V., 1990, FUNGAL GENET NEWSLET, V37, P41; STEEG PS, 1988, CANCER RES, V48, P6550; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Tanaka N, 1998, J PHOTOCH PHOTOBIO B, V45, P113, DOI 10.1016/S1011-1344(98)00169-9; VOLLMER SJ, 1986, P NATL ACAD SCI USA, V83, P4869, DOI 10.1073/pnas.83.13.4869; Whitelam GC, 1998, PLANT PHYSIOL BIOCH, V36, P125, DOI 10.1016/S0981-9428(98)80097-1; Zimmermann S, 1999, J BIOL CHEM, V274, P17017, DOI 10.1074/jbc.274.24.17017	47	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21228	21234		10.1074/jbc.M011381200	http://dx.doi.org/10.1074/jbc.M011381200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11287415	hybrid			2022-12-27	WOS:000169297900058
J	Schneider, S; Schwer, B				Schneider, S; Schwer, B			Functional domains of the yeast splicing factor Prp22p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; MUTATIONAL ANALYSIS; DEPENDENT ATPASE; NUCLEOSIDE TRIPHOSPHATASE; HELICASE DOMAIN; PROTEIN PRP22; FACTOR PRP16; NPH-II; BOX; SPLICEOSOME	The essential Saccharomyces cerevisiae PRP22 gene encodes a 1145-amino acid DEXH box RNA helicase. Prp22p plays two roles during pre-mRNA splicing as follows: it is required for the second transesterification step and for the release of mature mRNA from the spliceosome, Whereas the step 2 function of Prp22p does not require ATP hydrolysis, spliceosome disassembly is dependent on the ATPase and helicase activities. Here we delineate a minimal functional domain, Prp22(262-1145), that suffices for the activity of Prp22p in vivo when expressed under the natural PRP22 promoter and for pre-mRNA splicing activity in vitro, The biologically active domain lacks an S1 motif (residues 177-256) that had been proposed to play a role in RNA binding by Prp22p. The deletion mutant Prp22(351-1145) can function in vivo when provided at a high gene dosage, We suggest that the segment from residues 262 to 350 enhances Prp22p function in vivo, presumably by targeting Prp22p to the spliceosome. We characterize an even smaller catalytic domain, Prp22(466-1145) that suffices for ATP hydrolysis, RNA binding, and RNA unwinding in vitro and for nuclear localization in vivo but cannot by itself support cell growth. However, the ATPase/helicase domain can function in vivo if the N-terminal region Prp22(1-480) is co-expressed in trans.	Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Cornell University	Schwer, B (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.	bschwer@mail.med.cornell.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050288] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50288] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arenas JE, 1997, P NATL ACAD SCI USA, V94, P11798, DOI 10.1073/pnas.94.22.11798; Brys A, 1996, RNA, V2, P707; BURGESS S, 1990, CELL, V60, P705, DOI 10.1016/0092-8674(90)90086-T; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; Chang SC, 2000, J VIROL, V74, P9732, DOI 10.1128/JVI.74.20.9732-9737.2000; CHEN JH, 1990, NUCLEIC ACIDS RES, V18, P6447, DOI 10.1093/nar/18.21.6447; COMPANY M, 1991, NATURE, V349, P487, DOI 10.1038/349487a0; Gross CH, 1998, J VIROL, V72, P4729, DOI 10.1128/JVI.72.6.4729-4736.1998; Gross CH, 1996, J VIROL, V70, P1706, DOI 10.1128/JVI.70.3.1706-1713.1996; GROSS CH, 1995, J VIROL, V69, P4727, DOI 10.1128/JVI.69.8.4727-4736.1995; Heilek GM, 1997, J VIROL, V71, P6264, DOI 10.1128/JVI.71.8.6264-6266.1997; Hotz HR, 1998, GENETICS, V149, P807; Kaufer NF, 2000, NUCLEIC ACIDS RES, V28, P3003, DOI 10.1093/nar/28.16.3003; Kim DW, 1997, J VIROL, V71, P9400, DOI 10.1128/JVI.71.12.9400-9409.1997; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; KIM SH, 1993, P NATL ACAD SCI USA, V90, P888, DOI 10.1073/pnas.90.3.888; KIM SH, 1992, EMBO J, V11, P2319, DOI 10.1002/j.1460-2075.1992.tb05291.x; LEE CG, 1992, J BIOL CHEM, V267, P4398; Martins A, 1999, J VIROL, V73, P1302, DOI 10.1128/JVI.73.2.1302-1308.1999; McPheeters DS, 2000, NUCLEIC ACIDS RES, V28, P1313, DOI 10.1093/nar/28.6.1313; ONO W, 1994, MOL CELL BIOL, V14, P7611, DOI 10.1128/MCB.14.11.7611; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Puoti A, 2000, P NATL ACAD SCI USA, V97, P3276, DOI 10.1073/pnas.97.7.3276; SCHENA M, 1991, METHOD ENZYMOL, V194, P389; Schwer B, 1998, EMBO J, V17, P2086, DOI 10.1093/emboj/17.7.2086; SCHWER B, 1991, NATURE, V349, P494, DOI 10.1038/349494a0; Schwer B, 2000, EMBO J, V19, P6582, DOI 10.1093/emboj/19.23.6582; SUBRAMANIAN AR, 1983, PROG NUCLEIC ACID RE, V28, P101, DOI 10.1016/S0079-6603(08)60085-9; TEIGELKAMP S, 1994, EMBO J, V13, P888, DOI 10.1002/j.1460-2075.1994.tb06332.x; Wagner JDO, 1998, EMBO J, V17, P2926, DOI 10.1093/emboj/17.10.2926; Wang Y, 1998, RNA, V4, P1216, DOI 10.1017/S1355838298980992; Wang Y, 1998, CURR BIOL, V8, P441, DOI 10.1016/S0960-9822(98)70178-2; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; Zhang XP, 1997, NUCLEIC ACIDS RES, V25, P2146, DOI 10.1093/nar/25.11.2146	35	46	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21184	21191		10.1074/jbc.M101964200	http://dx.doi.org/10.1074/jbc.M101964200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11283007	hybrid			2022-12-27	WOS:000169297900053
J	Camacho, LR; Constant, P; Raynaud, C; Laneelle, MA; Triccas, JA; Gicquel, B; Daffe, M; Guilhot, C				Camacho, LR; Constant, P; Raynaud, C; Laneelle, MA; Triccas, JA; Gicquel, B; Daffe, M; Guilhot, C			Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis - Evidence that this lipid is involved in the cell wall permeability barrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOCEROSIC ACID SYNTHASE; GENE-CLUSTER; IDENTIFICATION; VIRULENCE; ATTENUATION; MYCOSIDES; ENVELOPE; FLUIDITY; COMPLEX; ENZYME	Among the few characterized genes that have products involved in the pathogenicity of Mycobacterium tuberculosis, the etiological agent of tuberculosis, are those of the phthiocerol dimycocerosate (DIM) locus. Genes involved in biosynthesis of these compounds are grouped on a 50-kilobase fragment of the chromosome containing 13 genes. Analysis of mRNA produced from this 50-kilobase fragment in the wild type strain showed that this region is subdivided into three transcriptional units. Biochemical characterization of five mutants with transposon insertions in this region demonstrated that (i) the complete DIM molecules are synthesized in the cytoplasm of M. tuberculosis before being translocated into the cell wall; (ii) the genes fadD26 and fadD28 are directly involved in their biosynthesis; and (iii) both the drrC and mmpL7 genes are necessary for the proper localization of DIMs. Insertional mutants unable to synthesize or translocate DIMs exhibit higher cell. wall permeability and are more sensitive to detergent than the wild type strain, indicating for the first time that, in addition to being important virulence factors, extractable lipids of M. tuberculosis play a role in the cell envelope architecture and permeability. This function may represent one of the molecular mechanisms by which DIMs are involved in the virulence of M. tuberculosis.	UPS, Inst Pharmacol & Biol Struct, CNRS, UMR 5089, F-31077 Toulouse, France; Inst Pasteur, Unite Genet Mycobacterienne, F-75725 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Guilhot, C (corresponding author), UPS, Inst Pharmacol & Biol Struct, CNRS, UMR 5089, 205 Route Narbonne, F-31077 Toulouse, France.	guilhot@ipbs.fr	Triccas, Jamie/AAD-7629-2020	Triccas, James/0000-0003-3730-2339				Asselineau J, 1982, Indian J Chest Dis Allied Sci, V24, P143; Azad AK, 1997, J BIOL CHEM, V272, P16741, DOI 10.1074/jbc.272.27.16741; Azad AK, 1996, P NATL ACAD SCI USA, V93, P4787, DOI 10.1073/pnas.93.10.4787; Berthet FX, 1998, SCIENCE, V282, P759, DOI 10.1126/science.282.5389.759; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; CHAMBERS HF, 1995, ANTIMICROB AGENTS CH, V39, P2620, DOI 10.1128/AAC.39.12.2620; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; DAFFE M, 1987, EUR J BIOCHEM, V167, P155, DOI 10.1111/j.1432-1033.1987.tb13317.x; DAFFE M, 1988, J GEN MICROBIOL, V134, P2049; DAFFE M, 1989, EUR J BIOCHEM, V185, P157, DOI 10.1111/j.1432-1033.1989.tb15097.x; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Draper P, 1998, Front Biosci, V3, pD1253; FERNANDEZMORENO MA, 1991, CELL, V66, P769, DOI 10.1016/0092-8674(91)90120-N; Fitzmaurice AM, 1998, J BIOL CHEM, V273, P8033, DOI 10.1074/jbc.273.14.8033; GASTAMBIDEODIER M, 1967, B SOC CHIM BIOL, V49, P849; GOREN MB, 1974, INFECT IMMUN, V9, P150, DOI 10.1128/IAI.9.1.150-158.1974; Jackson M, 1999, INFECT IMMUN, V67, P2867, DOI 10.1128/IAI.67.6.2867-2873.1999; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; JARLIER V, 1990, J BACTERIOL, V172, P1418, DOI 10.1128/jb.172.3.1418-1423.1990; KONDO E, 1976, JPN J MED SCI BIOL, V29, P199, DOI 10.7883/yoken1952.29.199; LEMASSU A, 1994, BIOCHEM J, V297, P351, DOI 10.1042/bj2970351; Liu J, 1996, J BIOL CHEM, V271, P29545, DOI 10.1074/jbc.271.47.29545; LIU J, 1995, P NATL ACAD SCI USA, V92, P11254, DOI 10.1073/pnas.92.24.11254; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; MATHUR M, 1992, J BIOL CHEM, V267, P19388; MURPHY CK, 1996, ESCHERICHIA COLI SAL, V1, P967; NATHAN CF, 1992, MONONUCLEAR PHAGOCYT; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; OrtaloMagne A, 1996, J BACTERIOL, V178, P456, DOI 10.1128/jb.178.2.456-461.1996; Pelicic V, 1998, MOL MICROBIOL, V28, P413, DOI 10.1046/j.1365-2958.1998.00807.x; Raynaud C, 1998, MICROBIOL-SGM, V144, P577, DOI 10.1099/00221287-144-2-577; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Yuan Y, 1997, J BIOL CHEM, V272, P10041	35	285	305	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19845	19854		10.1074/jbc.M100662200	http://dx.doi.org/10.1074/jbc.M100662200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279114	Green Submitted, hybrid			2022-12-27	WOS:000169135100024
J	Schneider, P; Street, SL; Gaide, O; Hertig, S; Tardivel, A; Tschopp, J; Runkel, L; Alevizopoulos, K; Ferguson, BM; Zonana, J				Schneider, P; Street, SL; Gaide, O; Hertig, S; Tardivel, A; Tschopp, J; Runkel, L; Alevizopoulos, K; Ferguson, BM; Zonana, J			Mutations leading to X-linked hypohidrotic ectodermal dysplasia affect three major functional domains in the tumor necrosis factor family member ectodysplasin-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR; CRYSTAL-STRUCTURE; JAPANESE FAMILY; CELL GROWTH; EDA1 GENE; LIGAND; HOMOLOG; PROTEIN; FORM; MORPHOGENESIS	Mutations in the epithelial morphogen ectodysplasin-A (EDA), a member of the tumor necrosis factor (TNF) family, are responsible for the human disorder X-linked hypohidrotic ectodermal dysplasia (XLHED) characterized by impaired development of hair, eccrine sweat glands, and teeth. EDA-A1 and EDA-A2 are two splice variants of EDA, which bind distinct EDA-A1 and X-linked EDA-A2 receptors. We identified a series of novel EDA mutations in families with XLHED, allowing the identification of the following three functionally important regions in EDA: a C-terminal TNF homology domain, a collagen domain, and a furin protease recognition sequence. Mutations in the TNF homology domain impair binding of both splice variants to their receptors, Mutations in the collagen domain can inhibit multimerization of the TNF homology region, whereas those in the consensus furin recognition sequence prevent proteolytic cleavage of EDA. Finally, a mutation affecting an intron splice donor site is predicted to eliminate specifically the EDA-A1 but not the EDA-A2 splice variant. Thus a proteolytically processed, oligomeric form of EDA-A1 is required in vivo for proper morphogenesis.	Univ Lausanne, Inst Biochem, BIL Biomed Res Ctr, CH-1066 Epalinges, Switzerland; Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; ApoTech, CH-1066 Epalinges, Switzerland; Biogen Inc, Dept Inflammat, Cambridge, MA 02142 USA	University of Lausanne; Oregon Health & Science University; Biogen	Schneider, P (corresponding author), Univ Lausanne, Inst Biochem, BIL Biomed Res Ctr, Ch Boveresses 155, CH-1066 Epalinges, Switzerland.			Schneider, Pascal/0000-0003-0677-9409	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011311] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE11311] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aoki N, 2000, J INVEST DERMATOL, V115, P329, DOI 10.1046/j.1523-1747.2000.00065-1.x; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bayes M, 1998, HUM MOL GENET, V7, P1661, DOI 10.1093/hmg/7.11.1661; Cassiano Linda, 2000, Scandinavian Journal of Immunology, V51, P22; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Eby MT, 2000, J BIOL CHEM, V275, P15336, DOI 10.1074/jbc.275.20.15336; Eggleton P, 1998, TRENDS CELL BIOL, V8, P428, DOI 10.1016/S0962-8924(98)01373-7; Ferguson BM, 1998, J MED GENET, V35, P112, DOI 10.1136/jmg.35.2.112; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Hertz JM, 1998, CLIN GENET, V53, P205; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kishore U, 1999, IMMUNOPHARMACOLOGY, V42, P15, DOI 10.1016/S0162-3109(99)00011-9; Kojima T, 2000, J BIOL CHEM, V275, P20742, DOI 10.1074/jbc.M002691200; Martinez F, 1999, J INVEST DERMATOL, V113, P285, DOI 10.1046/j.1523-1747.1999.00656.x; Mikkola ML, 1999, MECH DEVELOP, V88, P133, DOI 10.1016/S0925-4773(99)00180-X; Monreal AW, 1998, AM J HUM GENET, V63, P380, DOI 10.1086/301984; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; ORTH U, 1998, AM J HUM GENET, V63, P377; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Schneider P, 1997, J BIOL CHEM, V272, P18827, DOI 10.1074/jbc.272.30.18827; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Tucker AS, 2000, DEVELOPMENT, V127, P4691; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; Yotsumoto S, 1998, J INVEST DERMATOL, V111, P1246, DOI 10.1046/j.1523-1747.1998.00443.x; Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914	31	178	197	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18819	18827		10.1074/jbc.M101280200	http://dx.doi.org/10.1074/jbc.M101280200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279189	Green Published, hybrid			2022-12-27	WOS:000169091000024
J	Mayer, MR; Stone, MJ				Mayer, MR; Stone, MJ			Identification of receptor binding and activation determinants in the N-terminal and N-loop regions of the CC chemokine eotaxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOTACTIC PROTEIN-1; MOLECULAR-CLONING; HUMAN EOSINOPHIL; MCP-1 RECEPTOR; CHEMOATTRACTANT; RECRUITMENT; MIP-1-BETA; EXPRESSION; RESIDUES; DYNAMICS	Eotaxin is a CC chemokine that specifically activates the receptor CCR3 causing accumulation of eosinophils in allergic diseases and parasitic infections. Twelve amino acid residues in the N-terminal (residues 1-8) and N-loop (residues 11-20) regions of eotaxin have been individually mutated to alanine, and the ability of the mutants to bind and activate CCR3 has been determined in cell-based assays, The alanine mutants at positions Thr(7), Asn(12), Leu(13), and Leu(20) show near wild type binding affinity and activity. The mutants T8A, N15A, and K17A have near wild type binding affinity for CCR3 but reduced receptor activation. A third class of mutants, S4A, V5A, R16A, and I18A, display significantly perturbed binding affinity for CCR3 while retaining the ability to activate or partially activate the receptor. Finally, the mutant Phe(11) has little detectable activity and 20-fold reduced binding affinity relative to wild type eotaxin, the most dramatic effect observed in both assays but less dramatic than the effect of mutating the corresponding residue in some other chemokines, Taken together, the results indicate that residues contributing to receptor binding affinity and those required for triggering receptor activation are distributed throughout the N-terminal and N-loop regions. This conclusion is in contrast to the separation of binding and activation functions between N-loop and N-terminal regions, respectively, that has been observed previously for some other chemokines.	Indiana Univ, Dept Chem, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Stone, MJ (corresponding author), Indiana Univ, Dept Chem, 800 E Kirkwood Ave, Bloomington, IN 47405 USA.	mastone@indiana.edu	Stone, Martin/C-2492-2012	Stone, Martin/0000-0002-6468-4427	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM055055, R01GM055055] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-55055] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali S, 2000, J BIOL CHEM, V275, P11721, DOI 10.1074/jbc.275.16.11721; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; CLUBB RT, 1994, FEBS LETT, V338, P93, DOI 10.1016/0014-5793(94)80123-1; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Crump MP, 1998, J BIOL CHEM, V273, P22471, DOI 10.1074/jbc.273.35.22471; Daugherty BL, 1996, J EXP MED, V183, P2349, DOI 10.1084/jem.183.5.2349; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Forssmann U, 1997, J EXP MED, V185, P2171, DOI 10.1084/jem.185.12.2171; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; GRIFFITHSJOHNSON DA, 1993, BIOCHEM BIOPH RES CO, V197, P1167, DOI 10.1006/bbrc.1993.2599; HE JL, 1995, J VIROL, V69, P4587, DOI 10.1128/JVI.69.7.4587-4592.1995; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; Kitaura M, 1999, J BIOL CHEM, V274, P27975, DOI 10.1074/jbc.274.39.27975; Kitaura M, 1996, J BIOL CHEM, V271, P7725, DOI 10.1074/jbc.271.13.7725; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Mayer KL, 2000, BIOCHEMISTRY-US, V39, P8382, DOI 10.1021/bi000523j; Mizoue LS, 1999, BIOCHEMISTRY-US, V38, P1402, DOI 10.1021/bi9820614; Murdoch C, 2000, BLOOD, V95, P3032; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Pakianathan DR, 1997, BIOCHEMISTRY-US, V36, P9642, DOI 10.1021/bi970593z; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; Rankin SM, 2000, MOL MED TODAY, V6, P20, DOI 10.1016/S1357-4310(99)01635-4; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rothenberg ME, 1997, J EXP MED, V185, P785, DOI 10.1084/jem.185.4.785; Shinkai A, 1999, J IMMUNOL, V163, P1602; SICILIANO SJ, 1994, P NATL ACAD SCI USA, V91, P1214, DOI 10.1073/pnas.91.4.1214; Stone MJ, 2000, CHEMOKINES IN ALLERGIC DISEASE, P67; Struyf S, 1999, J IMMUNOL, V162, P4903; Wells TNC, 1996, J LEUKOCYTE BIOL, V59, P53, DOI 10.1002/jlb.59.1.53; White JR, 1997, J LEUKOCYTE BIOL, V62, P667, DOI 10.1002/jlb.62.5.667; Ye JP, 2000, J BIOL CHEM, V275, P27250; Ye JQ, 1999, J BIOMOL NMR, V15, P115, DOI 10.1023/A:1008376728947	37	33	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13911	13916		10.1074/jbc.M011202200	http://dx.doi.org/10.1074/jbc.M011202200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11297526	hybrid			2022-12-27	WOS:000168356600057
J	Aramli, LA; Teschke, CM				Aramli, LA; Teschke, CM			Alleviation of a defect in protein folding by increasing the rate of subunit assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUBSTITUTIONS; PHAGE-P22 COAT PROTEIN; INCLUSION-BODY FORMATION; P22 TAILSPIKE PROTEIN; TEMPERATURE-SENSITIVE MUTATIONS; TAIL SPIKE PROTEIN; IN-VITRO; SCAFFOLDING PROTEIN; POLYPEPTIDE-CHAINS; ESCHERICHIA-COLI	Understanding the nature of protein grammar is critical because amino acid substitutions in some proteins cause misfolding and aggregation of the mutant protein resulting in a disease state. Amino acid substitutions in phage P22 coat protein, known as tsf (temperature-sensitive folding) mutations, cause folding defects that result in aggregation at high temperatures. We have isolated global su (suppressor) amino acid substitutions that alleviate the tsf phenotype in coat protein (Aramli, L. A. and Teschke, C. M. (1999) J. Biol. Chem. 274, 22217-22224). Unexpectedly, we found that a global su amino acid substitution in tsf coat proteins made aggregation worse and that the tsf phenotype was suppressed by increasing the rate of subunit assembly, thereby decreasing the concentration of aggregation-prone folding intermediates.	Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Teschke, CM (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, U-3125,75 N Eagleville Rd, Storrs, CT 06269 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053567, R29GM053567] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53567] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREWS AT, 1986, ELECTROPHORESIS THEO, P5; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Aramli LA, 1999, J BIOL CHEM, V274, P22217, DOI 10.1074/jbc.274.32.22217; Betts S, 1999, STRUCT FOLD DES, V7, pR131, DOI 10.1016/S0969-2126(99)80078-1; Betts SD, 1998, PROTEIN SCI, V7, P1516, DOI 10.1002/pro.5560070704; BREMS DN, 1988, BIOCHEMISTRY-US, V27, P4541, DOI 10.1021/bi00412a048; Capen CM, 2000, BIOCHEMISTRY-US, V39, P1142, DOI 10.1021/bi991956t; CHRUNYK BA, 1993, J BIOL CHEM, V268, P18053; EARNSHAW W, 1980, J MOL BIOL, V134, P575; FANE B, 1991, GENETICS, V127, P263; FANE B, 1991, J BIOL CHEM, V266, P11640; FOGUEL D, 1995, BIOCHEMISTRY-US, V34, P1120, DOI 10.1021/bi00004a003; FULLER MT, 1981, VIROLOGY, V112, P529, DOI 10.1016/0042-6822(81)90300-7; FULLER MT, 1980, BIOPHYS J, V32, P381, DOI 10.1016/S0006-3495(80)84963-0; GALISTEO ML, 1995, J BIOL CHEM, V270, P16595, DOI 10.1074/jbc.270.28.16595; GOLDENBERG DP, 1981, J MOL BIOL, V145, P633, DOI 10.1016/0022-2836(81)90307-7; GOLDENBERG DP, 1988, ANNU REV BIOPHYS BIO, V17, P481; GOLDENBERG DP, 1983, P NATL ACAD SCI-BIOL, V80, P7060, DOI 10.1073/pnas.80.23.7060; GORDON CL, 1994, J BIOL CHEM, V269, P27941; GORDON CL, 1993, J BIOL CHEM, V268, P9358; GORDON CL, 1994, GENETICS, V136, P427; Greene B, 1999, J BIOL CHEM, V274, P16135, DOI 10.1074/jbc.274.23.16135; HAASEPETTINGELL CA, 1988, J BIOL CHEM, V263, P4977; Huang WZ, 1997, P NATL ACAD SCI USA, V94, P8801, DOI 10.1073/pnas.94.16.8801; James EL, 1999, J BIOL CHEM, V274, P9482, DOI 10.1074/jbc.274.14.9482; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kelly JW, 1997, STRUCTURE, V5, P595, DOI 10.1016/S0969-2126(97)00215-3; Kelly JW, 1997, ADV PROTEIN CHEM, V50, P161, DOI 10.1016/S0065-3233(08)60321-6; KING J, 1974, NATURE, V251, P112, DOI 10.1038/251112a0; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lanman J, 1999, BIOCHEMISTRY-US, V38, P14614, DOI 10.1021/bi9915420; MARSTON FAO, 1986, BIOCHEM J, V240, P1, DOI 10.1042/bj2400001; McGee WA, 1998, PROTEIN SCI, V7, P1071, DOI 10.1002/pro.5560070501; MITRAKI A, 1993, J BIOL CHEM, V268, P20071; MITRAKI A, 1991, SCIENCE, V253, P54, DOI 10.1126/science.1648264; MITRAKI A, 1989, BIO-TECHNOL, V7, P690, DOI 10.1038/nbt0789-690; Nakonechny WS, 1998, J BIOL CHEM, V273, P27236, DOI 10.1074/jbc.273.42.27236; PRASAD BVV, 1993, J MOL BIOL, V231, P65, DOI 10.1006/jmbi.1993.1257; PREVELIGE PE, 1988, J MOL BIOL, V202, P743, DOI 10.1016/0022-2836(88)90555-4; PREVELIGE PE, 1993, BIOPHYS J, V64, P824, DOI 10.1016/S0006-3495(93)81443-7; PREVELIGE PE, 1993, PROG MED VIROL, V40, P206; RABILLOUD T, 1988, ELECTROPHORESIS, V9, P288, DOI 10.1002/elps.1150090608; Schuler B, 1998, J MOL BIOL, V281, P227, DOI 10.1006/jmbi.1998.1944; Sideraki V, 2001, P NATL ACAD SCI USA, V98, P283, DOI 10.1073/pnas.011454198; Speed MA, 1996, NAT BIOTECHNOL, V14, P1283, DOI 10.1038/nbt1096-1283; SPEED MA, 1995, PROTEIN SCI, V4, P900; Teschke Carolyn M., 1992, Current Opinion in Biotechnology, V3, P468, DOI 10.1016/0958-1669(92)90073-R; Teschke CM, 1999, BIOCHEMISTRY-US, V38, P2873, DOI 10.1021/bi982739f; TESCHKE CM, 1993, BIOCHEMISTRY-US, V32, P10839, DOI 10.1021/bi00091a040; Teschke CM, 1996, BIOCHEMISTRY-US, V35, P14831, DOI 10.1021/bi960860l; THATCHER DR, 1992, MECH PROTEIN FOLDING, P229; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; TSAI AYM, 1991, J BIOL CHEM, V266, P10534; Van der Schueren J, 1998, PROTEIN ENG, V11, P1211, DOI 10.1093/protein/11.12.1211; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; WINSTON F, 1979, J BACTERIOL, V137, P433, DOI 10.1128/JB.137.1.433-439.1979	57	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					25372	25377		10.1074/jbc.M101759200	http://dx.doi.org/10.1074/jbc.M101759200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11304542	hybrid			2022-12-27	WOS:000169800700125
J	Lee, SH; Eom, M; Lee, SD; Kim, S; Park, HJ; Park, D				Lee, SH; Eom, M; Lee, SD; Kim, S; Park, HJ; Park, D			beta Pix-enhanced p38 activation by Cdc42/Rac/PAK/MKK3/6-mediated pathway - Implication in the regulation of membrane ruffling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; RHO-FAMILY PROTEINS; ACTIN REORGANIZATION; KINASE ACTIVATION; SIGNALING PATHWAY; BINDING PROTEINS; CELL-MIGRATION; LIM-KINASE; PAK; RAC	beta Pix (PAK-interacting exchange factor) is a recently identified guanine nucleotide exchange factor for Rho family small G protein Cdc42/Rac, The protein interacts with p21-activated protein kinase (PAK) through its SH3 domain. We examined the effect of beta Pix on MAP kinase signaling and cytoskeletal rearrangement in NIH3T3 fibroblast cells. Overexpression of beta Pix enhanced the activation of p38 in the absence of other stimuli and also induced translocation of p38 to the nucleus. This beta Pix-induced p38 activation was blocked by coexpression of dominant-negative Cdc42/Rac or kinase-inactive PAK, indicating that the effect of beta Pix on p38 is exerted through the Cdc42/Rac-PAK pathway and requires PAK kinase activity. The essential role of beta Pix in growth factor-stimulated p38 activation was evidenced by the blocking of platelet-derived growth factor-induced p38 activation in the cells expressing beta Pix SH3m (W43K) and beta Pix DHm (L238R,L239R). In addition, SB203580, a p38 inhibitor, and kinase-inactive p38 (T180A;Y182F) blocked membrane ruffling induced by beta Pix, suggesting that p38 might be involved in mediating beta Pix-induced membrane ruffling. The results in this study suggest that beta Pix might have a role in nuclear signaling, as well as in actin cytoskeleton regulation, and that some part of these cellular functions is possibly mediated by p38 MAP kinase.	Seoul Natl Univ, Sch Biol Sci, Kwanak Gu, Seoul 151742, South Korea	Seoul National University (SNU)	Park, D (corresponding author), Seoul Natl Univ, Sch Biol Sci, Kwanak Gu, Seoul 151742, South Korea.		Kim, Seyun/B-3387-2012	Lee, Seung Joon/0000-0001-6690-2830				Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Aspenstrom P, 1999, EXP CELL RES, V246, P20, DOI 10.1006/excr.1998.4300; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Hout J, 1998, J CELL BIOL, V143, P1361; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kim S, 2000, BIOCHEM BIOPH RES CO, V272, P721, DOI 10.1006/bbrc.2000.2845; Leung T, 1996, MOL CELL BIOL, V16, P5313; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Matsumoto T, 1999, J BIOL CHEM, V274, P13954, DOI 10.1074/jbc.274.20.13954; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Obermeier A, 1998, EMBO J, V17, P4328, DOI 10.1093/emboj/17.15.4328; Oh WK, 1997, BIOCHEM BIOPH RES CO, V235, P794, DOI 10.1006/bbrc.1997.6875; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Philip A, 2000, J BIOL CHEM, V275, P5911, DOI 10.1074/jbc.275.8.5911; Salojin KV, 1999, J IMMUNOL, V163, P844; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yoshii S, 1999, ONCOGENE, V18, P5680, DOI 10.1038/sj.onc.1202936; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zhou KM, 1998, J BIOL CHEM, V273, P16782, DOI 10.1074/jbc.273.27.16782; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	33	59	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					25066	25072		10.1074/jbc.M010892200	http://dx.doi.org/10.1074/jbc.M010892200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11309380	hybrid			2022-12-27	WOS:000169800700085
J	Kasahara, J; Fukunaga, K; Miyamoto, E				Kasahara, J; Fukunaga, K; Miyamoto, E			Activation of calcium/calmodulin-dependent protein kinase IV in long term potentiation in the rat hippocampal CA1 region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; SYNAPTIC PLASTICITY; BINDING PROTEIN; PHOSPHATASE 2A; LATE-PHASE; NEURONS; LTP; PHOSPHORYLATION; IDENTIFICATION; INDUCTION	The importance of well characterized calcium/calmodulin-dependent protein kinase (CaMK) II in hippocampal long term potentiation (LTP) is widely well established; however, several CaMKs other than CaMKII are not yet clearly characterized and understood, Here we report the activation of CaMKIV, which is phosphorylated by CaMK kinase and localized predominantly in neuronal nuclei, and its functional role as a cyclic AMP-responsive element-binding protein (CREB) kinase in high frequency stimulation (HFS)-induced LTP in the rat hippocampal CA1 region, CaMKIV was transiently activated in neuronal nuclei after HFS, and the activation returned to the basal level within 30 min. Phosphorylation of CREB, which is a CaMKIV substrate, and expression of c-Fos protein, which is regulated by CREE, increased during LTP. This increase was inhibited mainly by CaMK inhibitors and also by an inhibitor for mitogen-activated protein kinase cascade, although to a lesser extent. Our results suggest that CaMKIV functions as a CREB kinase and controls CREB-regulated gene expression during HFS-induced LTP in the rat hippocampal CA1 region.	Kumamoto Univ, Sch Med, Dept Pharmacol, Kumamoto 8600811, Japan	Kumamoto University	Miyamoto, E (corresponding author), Kumamoto Univ, Sch Med, Dept Pharmacol, 2-2-1 Honjo, Kumamoto 8600811, Japan.		Fukunaga, Kohji/AAI-8811-2021	Fukunaga, Kohji/0000-0001-8526-2824				Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Fukunaga K, 2000, J NEUROCHEM, V74, P807, DOI 10.1046/j.1471-4159.2000.740807.x; FUKUNAGA K, 1992, J BIOL CHEM, V267, P22527; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; FUKUNAGA K, 1995, J BIOL CHEM, V270, P6119, DOI 10.1074/jbc.270.11.6119; Fukunaga K, 2000, NEUROSCI RES, V38, P3, DOI 10.1016/S0168-0102(00)00139-5; GOTO S, 1985, J NEUROCHEM, V45, P276, DOI 10.1111/j.1471-4159.1985.tb05504.x; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P2850, DOI 10.1073/pnas.88.7.2850; Kasahara J, 1999, J BIOL CHEM, V274, P9061, DOI 10.1074/jbc.274.13.9061; Kasahara J, 2000, J NEUROSCI RES, V59, P594, DOI 10.1002/(SICI)1097-4547(20000301)59:5<594::AID-JNR2>3.3.CO;2-H; Liu J, 1999, J NEUROSCI, V19, P8292; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MIYANO O, 1992, J BIOL CHEM, V267, P1198; NAIRN AC, 1987, J BIOL CHEM, V262, P7273; NAIRN AC, 1985, P NATL ACAD SCI USA, V82, P7939, DOI 10.1073/pnas.82.23.7939; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; Park IK, 1995, J BIOL CHEM, V270, P30464, DOI 10.1074/jbc.270.51.30464; Qi M, 1996, P NATL ACAD SCI USA, V93, P1571, DOI 10.1073/pnas.93.4.1571; RIBER TJ, 2000, J NERUOSCI, V20, P1; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; SERBERT MA, 1995, J BIOL CHEM, V270, P17616; SIKELA JM, 1987, P NATL ACAD SCI USA, V84, P3038, DOI 10.1073/pnas.84.9.3038; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Tokuda M, 1997, BRAIN RES, V755, P162, DOI 10.1016/S0006-8993(97)00189-3; TOKUMITSU H, 1994, J BIOL CHEM, V269, P28640; Wang Y, 1996, MOL CELL BIOL, V16, P5915; Watabe AM, 2000, J NEUROSCI, V20, P5924, DOI 10.1523/JNEUROSCI.20-16-05924.2000; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	47	98	103	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24044	24050		10.1074/jbc.M100247200	http://dx.doi.org/10.1074/jbc.M100247200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11306573	hybrid			2022-12-27	WOS:000169531100109
J	Warnmark, A; Almlof, T; Leers, J; Gustafsson, JA; Treuter, E				Warnmark, A; Almlof, T; Leers, J; Gustafsson, JA; Treuter, E			Differential recruitment of the mammalian mediator subunit TRAP220 by estrogen receptors ER alpha and ER beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; NUCLEAR HORMONE RECEPTORS; LIGAND-BINDING DOMAIN; COACTIVATOR COMPLEX; TRANSCRIPTIONAL ACTIVATION; FUNCTIONAL DIFFERENCES; CONFORMATIONAL-CHANGES; PEPTIDE ANTAGONISTS; DRIP COMPLEX; F-DOMAIN	Estrogen receptors (ERs) associate with distinct transcriptional coactivators to mediate activation of target genes in response to estrogens. Previous work has provided multiple evidence for a critical role of p160 coactivators and associated histone acetyltransferases in estrogen signaling. In contrast, the involvement of the mammalian mediator complex remains to be established. Further, although the two subtypes ER alpha and ER beta appear to be similar in regard to principles of LXXLL-mediated coactivator binding to the AF-2 activation domain, there are indications that the context-dependent transcriptional activation profiles of the two ERs can be quite distinct. Potentially, this could be attributed to differences with regard to coregulator recruitment. We have here studied the interactions of the nuclear receptor-binding subunit of the mammalian mediator complex, referred to as TRAP220, with ER alpha and ER beta. In comparison to the p160 coactivator TIF2, we find that TRAP220 displays ERP preference. Here, we show that this is a feature of the binding specificity of the TRAP220 LXXLL motifs and demonstrate that the ER subtype-specific F-domain influences TRAP220 interaction. Such differences with regard to coactivator recruitment indicate that the relative importance of individual coregulators in estrogen signaling could depend on the dominant ER subtype.	Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden	Karolinska Institutet	Treuter, E (corresponding author), Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden.			Treuter, Eckardt/0000-0002-4147-8989				Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Burakov D, 2000, J BIOL CHEM, V275, P20928, DOI 10.1074/jbc.M002013200; Caira F, 2000, J BIOL CHEM, V275, P5308, DOI 10.1074/jbc.275.8.5308; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chiba N, 2000, J BIOL CHEM, V275, P10719, DOI 10.1074/jbc.275.15.10719; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Cowley SM, 1999, J STEROID BIOCHEM, V69, P165, DOI 10.1016/S0960-0760(99)00055-2; Cowley SM, 1997, J BIOL CHEM, V272, P19858, DOI 10.1074/jbc.272.32.19858; DAIMONT BD, 1998, GENE DEV, V12, P3343; Delaunay F, 2000, MOL PHARMACOL, V58, P584, DOI 10.1124/mol.58.3.584; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; Gee AC, 1999, MOL ENDOCRINOL, V13, P1912, DOI 10.1210/me.13.11.1912; Glass CK, 2000, GENE DEV, V14, P121; Gustafsson JA, 2000, SEMIN PERINATOL, V24, P66, DOI 10.1016/S0146-0005(00)80059-2; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Johansson L, 2000, MOL CELL BIOL, V20, P1124, DOI 10.1128/MCB.20.4.1124-1133.2000; Johansson L, 1999, J BIOL CHEM, V274, P345, DOI 10.1074/jbc.274.1.345; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Kobayashi Y, 2000, J BIOL CHEM, V275, P15645, DOI 10.1074/jbc.M000042200; Kraichely DM, 2000, ENDOCRINOLOGY, V141, P3534, DOI 10.1210/en.141.10.3534; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Leers J, 1998, MOL CELL BIOL, V18, P6001, DOI 10.1128/MCB.18.10.6001; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Llopis J, 2000, P NATL ACAD SCI USA, V97, P4363, DOI 10.1073/pnas.97.8.4363; Mak HY, 1999, MOL CELL BIOL, V19, P3895; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; McInerney EM, 1998, ENDOCRINOLOGY, V139, P4513, DOI 10.1210/en.139.11.4513; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; MONTANO MM, 1995, MOL ENDOCRINOL, V9, P814, DOI 10.1210/me.9.7.814; Nichols M, 1998, EMBO J, V17, P765, DOI 10.1093/emboj/17.3.765; Norris JD, 1999, SCIENCE, V285, P744, DOI 10.1126/science.285.5428.744; Northrop JP, 2000, MOL ENDOCRINOL, V14, P605, DOI 10.1210/me.14.5.605; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Paige LA, 1999, P NATL ACAD SCI USA, V96, P3999, DOI 10.1073/pnas.96.7.3999; Peters GA, 1999, MOL ENDOCRINOL, V13, P286, DOI 10.1210/me.13.2.286; Pettersson K, 1997, MOL ENDOCRINOL, V11, P1486, DOI 10.1210/me.11.10.1486; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rachez C, 2000, MOL CELL BIOL, V20, P2718, DOI 10.1128/MCB.20.8.2718-2726.2000; Rachez C, 1998, GENE DEV, V12, P1787, DOI 10.1101/gad.12.12.1787; Ren YS, 2000, MOL CELL BIOL, V20, P5433, DOI 10.1128/MCB.20.15.5433-5446.2000; Schaufele F, 2000, MOL ENDOCRINOL, V14, P2024, DOI 10.1210/me.14.12.2024; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sharma D, 2000, MOL ENDOCRINOL, V14, P2001, DOI 10.1210/me.14.12.2001; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Treuter E, 1999, J BIOL CHEM, V274, P6667, DOI 10.1074/jbc.274.10.6667; Treuter E, 1998, MOL ENDOCRINOL, V12, P864, DOI 10.1210/me.12.6.864; Warner M, 1999, CURR OPIN OBSTET GYN, V11, P249, DOI 10.1097/00001703-199906000-00003; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Yang W, 2000, MOL CELL BIOL, V20, P8008, DOI 10.1128/MCB.20.21.8008-8017.2000; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhang H, 2000, J BIOL CHEM, V275, P39855, DOI 10.1074/jbc.C000567200; Zhu YJ, 2000, J BIOL CHEM, V275, P14779, DOI 10.1074/jbc.C000121200; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500; Zhu YJ, 1999, P NATL ACAD SCI USA, V96, P10848, DOI 10.1073/pnas.96.19.10848	67	106	108	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23397	23404		10.1074/jbc.M011651200	http://dx.doi.org/10.1074/jbc.M011651200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11303023	hybrid			2022-12-27	WOS:000169531100025
J	Bennett, TA; Key, TA; Gurevich, VV; Neubig, R; Prossnitz, ER; Sklar, LA				Bennett, TA; Key, TA; Gurevich, VV; Neubig, R; Prossnitz, ER; Sklar, LA			Real-time analysis of G protein-coupled receptor reconstitution in a solubilized system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMYL PEPTIDE RECEPTOR; CHEMOATTRACTANT RECEPTORS; PHOSPHOLIPID-VESICLES; HUMAN NEUTROPHIL; TERNARY COMPLEX; ARRESTIN; BINDING; CELLS; FLUORESCENCE; ASSOCIATION	Receptor based signaling mechanisms are the primary source of cellular regulation. The superfamily of G protein-coupled receptors is the largest and most ubiquitous of the receptor mediated processes. We describe here the analysis in real-time of the assembly and disassembly of soluble G protein-coupled receptor a protein complexes. A fluorometric method was utilized to determine the dissociation of a fluorescent ligand from the receptor solubilized in detergent. The ligand dissociation rate differs between a receptor coupled to a G protein and the receptor alone. By observing the sensitivity of the dissociation of a fluorescent ligand to the presence of guanine nucleotide, we have shown a time- and concentration-dependent reconstitution of the N-formyl peptide receptor with endogenous G proteins. Furthermore, after the clearing of endogenous G proteins, purified G alpha subunits premixed with bovine brain G beta gamma subunits were also able to reconstitute with the solubilized receptors. The solubilized N-formyl peptide receptor and G(alpha i3) protein interacted with an affinity of similar to 10(-6) M with other alpha subunits exhibiting lower affinities (G(alpha i3) > G(alpha i2) > G(alpha i1) much greater than G(alphao)). The N-formyl peptide receptor-G protein interactions were inhibited by peptides corresponding to the G(alphai) C-terminal regions, by G(alphai) mAbs, and by a truncated form of arrestin-3. This system should prove useful for the analysis of the specificity of receptor a protein interactions, as well as for the elucidation and characterization of receptor molecular assemblies and signal transduction complexes.	Univ New Mexico, Ctr Canc, Ctr Hlth Sci, Dept Pathol, Albuquerque, NM 87131 USA; Univ New Mexico, Ctr Canc, Ctr Hlth Sci, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA; Sun Hlth Res Inst, Ralph & Muriel Roberts Lab Vis Sci, Sun City, AZ 85351 USA; Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; Natl Flow Cytometry Resource, Los Alamos, NM 87545 USA	University of New Mexico; University of New Mexico; Banner Research; Banner Health; Banner Sun Health Research Institute; University of Michigan System; University of Michigan	Sklar, LA (corresponding author), Univ New Mexico, Ctr Canc, Ctr Hlth Sci, Dept Pathol, 2325 Camino de Salud,CRF219A, Albuquerque, NM 87131 USA.		Prossnitz, Eric/I-4599-2019; Prossnitz, Eric R./B-4543-2008; Gurevich, Vsevolod/A-3236-2008	Prossnitz, Eric/0000-0001-9190-8302; Gurevich, Vsevolod/0000-0002-3950-5351; Neubig, Richard/0000-0003-0501-0008	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001315] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036357, R29AI036357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM060799] Funding Source: NIH RePORTER; NCRR NIH HHS [RR01315] Funding Source: Medline; NEI NIH HHS [EY11500] Funding Source: Medline; NIAID NIH HHS [AI36357] Funding Source: Medline; NIGMS NIH HHS [GM60799] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bennett TA, 2000, J BIOL CHEM, V275, P24590, DOI 10.1074/jbc.C000314200; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BOMMAKANTI RK, 1994, BBA-PROTEIN STRUCT M, V1209, P69, DOI 10.1016/0167-4838(94)90138-4; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; CUPO JF, 1989, BIOCHIM BIOPHYS ACTA, V982, P31, DOI 10.1016/0005-2736(89)90170-3; DE LA, 1980, J BIOL CHEM, V255, P7108; Draganescu A, 2000, J BIOL CHEM, V275, P4555, DOI 10.1074/jbc.275.7.4555; FAY SP, 1991, BIOCHEMISTRY-US, V30, P5066, DOI 10.1021/bi00234a033; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; GIERSCHIK P, 1989, J BIOL CHEM, V264, P21470; Gilbert TL, 2001, BIOCHEMISTRY-US, V40, P3467, DOI 10.1021/bi001320y; GUDERMANN T, 1995, J MOL MED, V73, P51, DOI 10.1007/BF00270578; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Kew RR, 1997, J LEUKOCYTE BIOL, V61, P329, DOI 10.1002/jlb.61.3.329; KLOTZ KN, 1994, J IMMUNOL, V152, P801; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; KUROSE H, 1991, BIOCHEMISTRY-US, V30, P3335, DOI 10.1021/bi00227a024; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; MCEWEN DP, 2001, IN PRESS METHODS ENZ; MURPHY PM, 1987, FEBS LETT, V221, P81, DOI 10.1016/0014-5793(87)80356-3; NEUBIG RR, 1994, FEBS LETT, V355, P251, DOI 10.1016/0014-5793(94)01212-1; Nolan John P., 1998, P19; POSNER RG, 1994, MOL PHARMACOL, V45, P65; PROSSNITZ ER, 1995, J BIOL CHEM, V270, P10686, DOI 10.1074/jbc.270.18.10686; PROSSNITZ ER, 1993, BIOCHEM J, V294, P581, DOI 10.1042/bj2940581; Prossnitz ER, 1997, PHARMACOL THERAPEUT, V74, P73, DOI 10.1016/S0163-7258(96)00203-3; SKLAR LA, 1984, J BIOL CHEM, V259, P5661; Sklar LA, 2000, BIOTECHNIQUES, V28, P976, DOI 10.2144/00285rr03; SKLAR LA, 1989, J BIOL CHEM, V264, P8483; Wenzel-Seifert K, 1999, J BIOL CHEM, V274, P33259, DOI 10.1074/jbc.274.47.33259; Ye R D, 1997, Adv Pharmacol, V39, P221, DOI 10.1016/S1054-3589(08)60073-3	32	28	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22453	22460		10.1074/jbc.M009679200	http://dx.doi.org/10.1074/jbc.M009679200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11309376	hybrid			2022-12-27	WOS:000169412700065
J	Heritage, D; Wonderlin, WF				Heritage, D; Wonderlin, WF			Translocon pores in the endoplasmic reticulum are permeable to a neutral, polar molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE MAMMARY-GLAND; GLUCOSIDASE-II; PROTEIN TRANSLOCATION; ER MEMBRANE; GLYCOPROTEIN; PURIFICATION; SUBUNIT; MICROSOMES; CHANNEL; CHAIN	The pore of the translocon complex in the endoplasmic reticulum (ER) is large enough to be permeated by small molecules, but it is generally believed that permeation is prevented by a barrier at the luminal end of the pore. We tested the hypothesis that 4-methylumbel-liferyl alpha -D-glucopyranoside (4M alphaG), a small, neutral dye molecule, cannot permeate an empty translocon pore by measuring its activation by an ER resident alpha -glucosidase, which is dependent on entry into the ER, The basal entry of dye into the ER of broken Chinese hamster ovary-S cells was remarkably high, and it was increased by the addition of puromycin, which purges translocon pores of nascent polypeptides, creating additional empty pores. The basal and puromycin-dependent entries of 4M alphaG were mediated by a common, salt-sensitive pathway that was partially blocked by spermine. A similar activation of 4M alphaG was observed in nystatin-perforated cells, indicating that the entry of 4MaG into the ER did not result simply from the loss of cytosolic factors in broken cells. We reject the hypothesis and conclude that a small, neutral molecule can permeate the empty pore of a translocon complex, and we propose that translationally inactive, ribosome-bound translocons could provide a pathway for small molecules to cross the ER membrane.	W Virginia Univ, Robert C Byrd Hlth Sci Ctr, Dept Biochem & Mol Pharmacol, Morgantown, WV 26506 USA	West Virginia University	Wonderlin, WF (corresponding author), W Virginia Univ, Robert C Byrd Hlth Sci Ctr, Dept Biochem & Mol Pharmacol, Morgantown, WV 26506 USA.	wonder@wvu.edu						ADELMAN MR, 1973, J CELL BIOL, V56, P206, DOI 10.1083/jcb.56.1.206; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; BRADA D, 1984, EUR J BIOCHEM, V141, P149, DOI 10.1111/j.1432-1033.1984.tb08169.x; BURNS DM, 1982, J BIOL CHEM, V257, P9991; COHEN BE, 1975, J MEMBRANE BIOL, V20, P235, DOI 10.1007/BF01870638; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Gillece P, 2000, P NATL ACAD SCI USA, V97, P4609, DOI 10.1073/pnas.090083497; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; HINO Y, 1985, BIOCHEMISTRY-US, V24, P800, DOI 10.1021/bi00324a040; Johnson CH, 1999, YEAST, V15, P799, DOI 10.1002/(SICI)1097-0061(19990630)15:9&lt;799::AID-YEA419&gt;3.0.CO;2-N; KAUSHAL GP, 1990, J BIOL CHEM, V265, P16271; LUCOCQ JM, 1986, J CELL BIOL, V102, P2137, DOI 10.1083/jcb.102.6.2137; MEISSNER G, 1981, J BIOL CHEM, V256, P6413; Morgan DG, 2000, J MOL BIOL, V301, P301, DOI 10.1006/jmbi.2000.3947; Pestka S, 1974, Methods Enzymol, V30, P261; Potter MD, 2001, TRENDS CELL BIOL, V11, P112, DOI 10.1016/S0962-8924(00)01905-X; Romisch K, 1999, J CELL SCI, V112, P4185; SAXENA S, 1987, BIOCHEM J, V247, P563, DOI 10.1042/bj2470563; Seiser RM, 2000, J BIOL CHEM, V275, P33820, DOI 10.1074/jbc.M004462200; SHAILUBHAI K, 1991, J BIOL CHEM, V266, P16587; SHAILUBHAI K, 1987, BIOCHEM J, V247, P555, DOI 10.1042/bj2470555; SKOGERSON L, 1968, ARCH BIOCHEM BIOPHYS, V125, P497, DOI 10.1016/0003-9861(68)90607-3; SOLOMON AK, 1972, BIOCHIM BIOPHYS ACTA, V255, P1019, DOI 10.1016/0005-2736(72)90416-6; STROUS GJ, 1987, J BIOL CHEM, V262, P3620; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; VanHove JLK, 1996, P NATL ACAD SCI USA, V93, P65, DOI 10.1073/pnas.93.1.65	27	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22655	22662		10.1074/jbc.M102409200	http://dx.doi.org/10.1074/jbc.M102409200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11303028	Green Published, hybrid			2022-12-27	WOS:000169412700092
J	Liberati, NT; Moniwa, M; Borton, AJ; Davie, JR; Wang, XF				Liberati, NT; Moniwa, M; Borton, AJ; Davie, JR; Wang, XF			An essential role for Mad homology domain 1 in the association of Smad3 with histone deacetylase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; N-COR; INDUCED PHOSPHORYLATION; INDUCED TRANSCRIPTION; TUMOR-SUPPRESSOR; DIRECT BINDING; DNA-BINDING; SKI ACTS; COMPLEX; PROTEINS	The Smads are a family of sequence-specific DNA-binding proteins that modulate transcription in response to transforming growth factor beta (TGF beta) by recruiting transcriptional activators like the histone acetyltransferase, p300/CBP, or repressors like the his tone deacetylase, HDAC1, to TGF beta target genes. The association of Smads and HDAC1 is mediated in part by direct binding of Smads to the HDAC1-associated proteins, TG-interacting factor, c-ski, and SnoN. Although ectopic expression of these proteins inhibits Smad-activated transcription, the contribution of histone deacetylase enzymatic activity to transcriptional repression by TGF beta is unknown. Here, the biological requirements for the interaction between Smads and endogenous histone deacetylase activity are investigated. We identify residues in Mad homology domain I of Smad3 that are required for association with histone deacetylase activity. An amino acid change at one of these critical residues does not disrupt the association of Smad3 with c-ski, SnoN, and transforming growth-interacting factor but does abrogate the ability of Smad3 to repress transcription, These findings indicate that the association of Smad3 and histone deacetylase activity relies on additional protein mediators that make contact with Smad3 at its amino terminus. Moreover, these data suggest that the suppressive effect of Smad3 on transcription is dependent upon its association with histone deacetylase enzymatic activity.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB R3E 0W3, Canada; Univ Manitoba, Dept Biochem & Mol Biol, Winnipeg, MB R3E 0W3, Canada	Duke University; University of Manitoba; University of Manitoba	Wang, XF (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27708 USA.	wang0011@mc.duke.edu		Davie, James/0000-0002-0420-6888	NATIONAL CANCER INSTITUTE [R01CA075368] Funding Source: NIH RePORTER; NCI NIH HHS [CA75368] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Ayer DE, 1996, MOL CELL BIOL, V16, P5772; BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116; Datta PK, 2000, J BIOL CHEM, V275, P40014, DOI 10.1074/jbc.C000508200; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; Davie JR, 1998, CURR OPIN GENET DEV, V8, P173, DOI 10.1016/S0959-437X(98)80138-X; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Downes M, 2000, P NATL ACAD SCI USA, V97, P10330, DOI 10.1073/pnas.97.19.10330; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HENDZEL MJ, 1991, J BIOL CHEM, V266, P21936; Hu PPC, 1998, ENDOCR REV, V19, P349, DOI 10.1210/er.19.3.349; Hua XX, 1999, P NATL ACAD SCI USA, V96, P13130, DOI 10.1073/pnas.96.23.13130; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Kasten MM, 1997, MOL CELL BIOL, V17, P4852, DOI 10.1128/MCB.17.8.4852; KERR LD, 1988, J BIOL CHEM, V263, P16999; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Nishihara A, 1998, GENES CELLS, V3, P613, DOI 10.1046/j.1365-2443.1998.00217.x; NODA M, 1989, ENDOCRINOLOGY, V124, P612, DOI 10.1210/endo-124-2-612; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; PIETENPOL JA, 1990, P NATL ACAD SCI USA, V87, P3758, DOI 10.1073/pnas.87.10.3758; PIRSKANEN A, 1994, J BONE MINER RES, V9, P1635; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Qing J, 2000, J BIOL CHEM, V275, P38802, DOI 10.1074/jbc.M004731200; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Song CZ, 1998, J BIOL CHEM, V273, P29287, DOI 10.1074/jbc.273.45.29287; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Stroschein SL, 1999, J BIOL CHEM, V274, P9431, DOI 10.1074/jbc.274.14.9431; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10321, DOI 10.1073/pnas.93.19.10321; Wotton D, 1999, J BIOL CHEM, V274, P37105, DOI 10.1074/jbc.274.52.37105; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu RY, 1997, MOL CELL BIOL, V17, P2521, DOI 10.1128/MCB.17.5.2521; Xu WD, 2000, P NATL ACAD SCI USA, V97, P5924, DOI 10.1073/pnas.090097797; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	66	32	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22595	22603		10.1074/jbc.M010778200	http://dx.doi.org/10.1074/jbc.M010778200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11306568	hybrid			2022-12-27	WOS:000169412700084
J	Pellegrini, M; Bremer, AA; Ulfers, AL; Boyd, ND; Mierke, DF				Pellegrini, M; Bremer, AA; Ulfers, AL; Boyd, ND; Mierke, DF			Molecular characterization of the substance P center dot neurokinin-1 receptor complex - Development of an experimentally based model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY BINDING; NEUROKININ-1 RECEPTOR; NK-1 RECEPTOR; EXTRACELLULAR DOMAIN; ANTAGONIST-BINDING; NK1 RECEPTOR; SITE; RHODOPSIN; PEPTIDE; ANALOG	Molecular models for the interaction of substance P (SP) with its G protein-coupled receptor, the neurokinin-l receptor (NK-1R), have been developed. The ligand receptor complex is based on experimental data from a series of photoaffinity labeling experiments and spectroscopic structural studies of extracellular domains of the NK-1R. Using the ligand/receptor contact points derived from incorporation of photolabile probes (p-benzoylphenylalanine (Bpa)) into SP at positions 3, 4, and 8 and molecular dynamics simulations, the topological arrangement of SP within the NK-1R is explored. The model incorporates the structural features, determined by high resolution NMR studies, of the second extracellular loop (EC2), containing contact points Met(174) and Met(181), providing important experimentally based conformational preferences for the simulations. Extensive molecular dynamics simulations mere carried out to probe the nature of the two contact points identified for the Bpa(3)SP analogue (Bremer, A. A., Leeman, S. E., and Boyd, N. D. (2001) J. Biol. Chem. 276, 22857-22861), examining modes of ligand binding in which the contact points are fulfilled sequentially or simultaneously. The resulting ligand receptor complex has the N terminus of SP projecting toward transmembrane helix (TM) 1 and TM2, exposed to the solvent. The C terminus of SP is located in proximity to TM5 and TM6, deeper into the central core of the receptor. The central portion of the ligand, adopting a helical loop conformation, is found to align with the helices of the central regions EC2 and EC3, forming important interactions with both of these extracellular domains. The model developed here allows for atomic insight into the biochemical data currently available and guides targeting of future experiments to probe specific ligand/receptor interactions and thereby furthers our understanding of the functioning of this important neuropeptide system.	Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; Brown Univ, Dept Mol Pharmacol, Div Biol & Med, Providence, RI 02912 USA	Boston University; Brown University	Boyd, ND (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, L-611,80 E Concord St, Boston, MA 02118 USA.	nboyd@bu.edu; dale_mierke@brown.edu	Pellegrini, Maria/W-6005-2019	Pellegrini, Maria/0000-0003-3817-4412	NIGMS NIH HHS [GM-54082] Funding Source: Medline; NINDS NIH HHS [NS-31346] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054082, R29GM054082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031346] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auge S, 2000, BIOPOLYMERS, V54, P297, DOI 10.1002/1097-0282(20001015)54:5<297::AID-BIP10>3.0.CO;2-9; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Boyd ND, 1996, P NATL ACAD SCI USA, V93, P433, DOI 10.1073/pnas.93.1.433; Bremer AA, 2000, FEBS LETT, V486, P43, DOI 10.1016/S0014-5793(00)02228-6; Bremer AA, 2001, J BIOL CHEM, V276, P22857, DOI 10.1074/jbc.M100824200; Elling CE, 1997, ANN NY ACAD SCI, V814, P142, DOI 10.1111/j.1749-6632.1997.tb46152.x; Elling CE, 2000, BIOCHEMISTRY-US, V39, P667, DOI 10.1021/bi991777b; ELLING CE, 1995, NATURE, V374, P74, DOI 10.1038/374074a0; Elling CE, 1996, EMBO J, V15, P6213, DOI 10.1002/j.1460-2075.1996.tb01011.x; FONG TM, 1994, J BIOL CHEM, V269, P2728; FONG TM, 1995, CAN J PHYSIOL PHARM, V73, P860, DOI 10.1139/y95-118; FONG TM, 1992, BIOCHEMISTRY-US, V31, P11806, DOI 10.1021/bi00162a019; FONG TM, 1993, NATURE, V362, P350; FONG TM, 1993, REGUL PEPTIDES, V46, P43, DOI 10.1016/0167-0115(93)90010-6; FONG TM, 1992, BIOPHYS J, V62, P59, DOI 10.1016/S0006-3495(92)81778-2; Hastrup H, 1996, FEBS LETT, V399, P264, DOI 10.1016/S0014-5793(96)01337-3; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Holst B, 2000, MOL PHARMACOL, V58, P263, DOI 10.1124/mol.58.2.263; Huang RRC, 1995, BIOCHEMISTRY-US, V34, P16467, DOI 10.1021/bi00050a030; Kage R, 1996, J BIOL CHEM, V271, P25797, DOI 10.1074/jbc.271.42.25797; KAGE R, 1995, J NEUROCHEM, V64, P316; Li HZ, 2001, J BIOL CHEM, V276, P10589, DOI 10.1074/jbc.M007397200; Macdonald D, 2001, BIOCHEMISTRY-US, V40, P2530, DOI 10.1021/bi001880x; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Paterlini G, 1997, J MED CHEM, V40, P3254; Prado GN, 1998, J BIOL CHEM, V273, P33548, DOI 10.1074/jbc.273.50.33548; RENSDOMIANO S, 1991, J BIOL CHEM, V266, P20094; Rolz C, 1999, BIOCHEMISTRY-US, V38, P6397, DOI 10.1021/bi9829276; Sagan S, 1997, MOL PHARMACOL, V52, P120, DOI 10.1124/mol.52.1.120; Seelig A, 1996, BIOCHEMISTRY-US, V35, P4365, DOI 10.1021/bi952434q; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Takeuchi Y, 1998, J MED CHEM, V41, P3609, DOI 10.1021/jm9700171; TALLON M, 1993, BIOPOLYMERS, V33, P915, DOI 10.1002/bip.360330607; Turcatti G, 1997, J BIOL CHEM, V272, P21167, DOI 10.1074/jbc.272.34.21167; Unger VM, 1997, NATURE, V389, P203, DOI 10.1038/38316; VANBUUREN AR, 1993, J PHYS CHEM-US, V97, P9206, DOI 10.1021/j100138a023; Vedani A, 2000, J MED CHEM, V43, P4416, DOI 10.1021/jm000986n; Whitehead TL, 1998, J MED CHEM, V41, P1497, DOI 10.1021/jm970789x; WINNIK MA, 1981, CHEM REV, V81, P491, DOI 10.1021/cr00045a004; WOOLLEY GA, 1987, BIOPOLYMERS, V26, pS109, DOI 10.1002/bip.360260012	42	38	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22862	22867		10.1074/jbc.M101057200	http://dx.doi.org/10.1074/jbc.M101057200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294871	hybrid			2022-12-27	WOS:000169412700118
J	Rozenvayn, N; Flaumenhaft, R				Rozenvayn, N; Flaumenhaft, R			Phosphatidylinositol 4,5-bisphosphate mediates Ca2+-induced platelet alpha-granule secretion - Evidence for type II phosphatidylinositol 5-phosphate 4-kinase function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PERMEABILIZED HUMAN PLATELETS; GTP-GAMMA-S; PHOSPHOLIPASE-C; MEMBRANE-FUSION; PHOSPHOINOSITIDE 3-KINASE; CA2+-ACTIVATED SECRETION; INOSITOL PHOSPHOLIPIDS; MOLECULAR MECHANISMS; THROMBIN STIMULATION	To understand the molecular basis of granule release from platelets, we examined the role of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) in alpha -granule secretion. Streptolysin O-permeabilized platelets synthesized PtdIns(4,5)P-2 when incubated in the presence of ATP. Incubation of streptolysin O permeabilized platelets with phosphatidylinositol-specific phospholipase C reduced PtdIns(4,5)P-2 levels and resulted in a dose and time-dependent inhibition of Ca2+-induced alpha -granule secretion. Exogenously added PtdIns(4,5)P-2 inhibited alpha -granule secretion, with 80% inhibition at 50 muM PtdIns(4,5)P-2. Nanomolar concentrations of wortmannin, 33.3 muM LY294002, and antibodies directed against PtdIns 3-kinase did not inhibit Ca2+-induced alpha -granule secretion, suggesting that PtdIns 3-kinase is not involved in alpha -granule secretion. However, micromolar concentrations of wortmannin inhibited both PtdIns(4,5)P-2 synthesis and alpha -granule secretion by similar to 50%. Antibodies directed against type II phosphatidylinositol-phosphate kinase (phosphatidylinositol 5-phosphate 4-kinase) also inhibited both PtdIns(4,5)P-2 synthesis and Ca2+-induced alpha -granule secretion by similar to 50%. These antibodies inhibited alpha -granule secretion only when added prior to ATP exposure and not when added following ATP exposure, prior to Ca2+-mediated triggering. The inhibitory effects of micromolar wortmannin and anti-type II phosphatidylinositol-phosphate kinase antibodies were additive, These results show that PtdIns(4,5)P-2 mediates platelet alpha -granule secretion and that PtdIns(4,5)P-2 synthesis required for Ca2+-induced alpha -granule secretion involves the type II phosphatidylinositol 5-phosphate 4-kinase-dependent pathway.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hemostasis & Thrombosis Res, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Flaumenhaft, R (corresponding author), RE 319,Res East,POB 15732, Boston, MA 02215 USA.				NHLBI NIH HHS [HL63250] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063250] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; Avery J, 1999, ANNU REV PHYSIOL, V61, P777, DOI 10.1146/annurev.physiol.61.1.777; BENISTANT C, 1990, BIOCHEM J, V269, P489, DOI 10.1042/bj2690489; Bernstein AM, 1999, BLOOD, V93, P571, DOI 10.1182/blood.V93.2.571.402k05_571_579; BONNEMA JD, 1994, J EXP MED, V180, P1427, DOI 10.1084/jem.180.4.1427; BRASS LF, 1920, HEMATOLOGY BASIC PRI; Chen D, 2000, BLOOD, V95, P921, DOI 10.1182/blood.V95.3.921.003k17_921_929; Chung SH, 2000, J BIOL CHEM, V275, P25286, DOI 10.1074/jbc.M004204200; Coorssen JR, 1996, AM J PHYSIOL-CELL PH, V270, pC1153, DOI 10.1152/ajpcell.1996.270.4.C1153; COORSSEN JR, 1993, FEBS LETT, V316, P170, DOI 10.1016/0014-5793(93)81209-I; DIVECHA N, 1995, BIOCHEM J, V309, P715, DOI 10.1042/bj3090715; EBERHARD DA, 1990, BIOCHEM J, V268, P15, DOI 10.1042/bj2680015; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Fensome A, 1996, CURR BIOL, V6, P730, DOI 10.1016/S0960-9822(09)00454-0; Flaumenhaft R, 1999, J CELL PHYSIOL, V179, P1; Flaumenhaft R, 1999, J BIOL CHEM, V274, P2492, DOI 10.1074/jbc.274.4.2492; GINSBERG MH, 1980, BLOOD, V55, P661; GRONDIN P, 1991, J BIOL CHEM, V266, P15705; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; HASLAM RJ, 1993, ADV EXP MED BIOL, V344, P149; HASLAM RJ, 1984, BIOCHEM J, V222, P351, DOI 10.1042/bj2220351; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Heraud JM, 1998, J BIOL CHEM, V273, P17817, DOI 10.1074/jbc.273.28.17817; Hinchliffe KA, 1996, EMBO J, V15, P6516, DOI 10.1002/j.1460-2075.1996.tb01042.x; Hinchliffe KA, 1999, BIOCHEM SOC T, V27, P657, DOI 10.1042/bst0270657; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; KAIBUCHI K, 1983, J BIOL CHEM, V258, P6701; KOVACSOVICS TJ, 1995, J BIOL CHEM, V270, P11358, DOI 10.1074/jbc.270.19.11358; LAPETINA EG, 1985, J BIOL CHEM, V260, P7078; LASSING I, 1990, FEBS LETT, V262, P231, DOI 10.1016/0014-5793(90)80197-Q; LEFEBVRE P, 1993, EUR J CELL BIOL, V62, P194; Lemons PP, 1997, BLOOD, V90, P1490, DOI 10.1182/blood.V90.4.1490.1490_1490_1500; Lemons PP, 2000, BIOCHEM BIOPH RES CO, V267, P875, DOI 10.1006/bbrc.1999.2039; LISCOVITCH M, 1994, J BIOL CHEM, V269, P21403; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; Martin TFJ, 1997, CURR OPIN NEUROBIOL, V7, P331, DOI 10.1016/S0959-4388(97)80060-8; Martin TFJ, 1997, BIOCHEM SOC T, V25, P1137, DOI 10.1042/bst0251137; Morris JB, 2000, FEBS LETT, V475, P57, DOI 10.1016/S0014-5793(00)01625-2; Nakagawa T, 1996, BIOCHEM J, V320, P643, DOI 10.1042/bj3200643; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Nickel W, 1999, P NATL ACAD SCI USA, V96, P12571, DOI 10.1073/pnas.96.22.12571; Padfield PJ, 1996, BIOCHEM J, V314, P123, DOI 10.1042/bj3140123; PATEL S, 1991, BIOCHEM J, V273, P561, DOI 10.1042/bj2730561; PIKE LJ, 1992, ENDOCR REV, V13, P692, DOI 10.1210/er.13.4.692; PLOW EF, 2000, HEMATOLOGY BASIC PRI; Polgar J, 1999, BLOOD, V94, P1313, DOI 10.1182/blood.V94.4.1313.416k27_1313_1318; RACAUDSULTAN C, 1993, FEBS LETT, V330, P347, DOI 10.1016/0014-5793(93)80902-7; RASMUSSEN UB, 1993, J BIOL CHEM, V268, P14322; SANCHEZ A, 1985, FEBS LETT, V191, P283, DOI 10.1016/0014-5793(85)80025-9; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; SHATTIL SJ, 1992, J BIOL CHEM, V267, P18424; Shisheva A, 1999, MOL CELL BIOL, V19, P623; Sloan DC, 1997, BIOCHEM J, V328, P13; SueAQuan AK, 1997, J CELL PHYSIOL, V172, P94, DOI 10.1002/(SICI)1097-4652(199707)172:1<94::AID-JCP11>3.0.CO;2-O; Way G, 2000, BIOCHEM J, V346, P63, DOI 10.1042/0264-6021:3460063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WHEELERJONES CPD, 1992, BIOCHEM J, V281, P465, DOI 10.1042/bj2810465; WHITE JG, 1983, AM J PATHOL, V112, P207; WHITE JG, 1982, BLOOD, V60, P474; White JG, 1999, BLOOD, V93, P2422, DOI 10.1182/blood.V93.7.2422.407a36c_2422_2425; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; YANO H, 1993, J BIOL CHEM, V268, P25846	63	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22410	22419		10.1074/jbc.M008184200	http://dx.doi.org/10.1074/jbc.M008184200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11304526	hybrid			2022-12-27	WOS:000169412700060
J	Elholm, M; Dam, I; Jorgensen, C; Krogsdam, AM; Holst, D; Kratchmarova, I; Gottlicher, M; Gustafsson, JA; Berge, R; Flatmark, T; Knudsen, J; Mandrup, S; Kristiansen, K				Elholm, M; Dam, I; Jorgensen, C; Krogsdam, AM; Holst, D; Kratchmarova, I; Gottlicher, M; Gustafsson, JA; Berge, R; Flatmark, T; Knudsen, J; Mandrup, S; Kristiansen, K			Acyl-CoA esters antagonize the effects of ligands on peroxisome proliferator-activated receptor alpha conformation, DNA binding, and interaction with co-factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-HORMONE RECEPTOR; RETINOID-X-RECEPTOR; COENZYME-A THIOESTERS; FATTY-ACIDS; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL ACTIVITY; PROGESTERONE-RECEPTOR; HYPOLIPIDEMIC DRUGS; ESTROGEN-RECEPTOR; NUCLEAR RECEPTORS	The peroxisome proliferator-activated receptor alpha (PPAR alpha) is a ligand-activated transcription factor and a key regulator of lipid homeostasis. Numerous fatty acids and eicosanoids serve as ligands and activators for PPAR. Here we demonstrate that S-hexadecyl-CoA, a nonhydrolyzable palmitoyl-CoA analog, antagonizes the effects of agonists on PPAR alpha conformation and function in vitro, In electrophoretic mobility shift assays, S-hexadecyl-CoA prevented agonist-induced binding of the PPAR alpha -retinoid X receptor alpha heterodimer to the acyl-CoA oxidase peroxisome proliferator response element. PPAR alpha bound specifically to immobilized palmitoyl-CoA and Wy14643, but not BRL49653, abolished binding. S-Hexadecyl-CoA increased in a dose-dependent and reversible manner the sensitivity of PPAR alpha to chymotrypsin digestion, and the S-hexadecyl-CoA-induced sensitivity required a functional PPAR alpha ligand-binding pocket. S-Hexadecyl-CoA prevented ligand-induced interaction between the co-activator SRC-1 and PPAR alpha but increased recruitment of the nuclear receptor corepressor NCoR, In cells, the concentration of free acyl-CoA esters is kept in the low nanomolar range due to the buffering effect of high affinity acyl-CoA-binding proteins, especially the acyl-CoA-binding protein. By using PPAR alpha expressed in Sf21 cells for electrophoretic mobility shift assays, we demonstrate that S-hexadecyl-CoA was able to increase the mobility of the PPAR alpha -containing heterodimer even in the presence of a molar excess of acyl-CoA-binding protein, mimicking the conditions found in vivo.	Univ So Denmark, Dept Biochem & Mol Biol, DK-5320 Odense M, Denmark; Univ So Denmark, Ctr Expt Bioinformat, DK-5320 Odense, Denmark; Karolinska Inst, Dept Med Nutr, S-14157 Huddinge, Sweden; Univ Bergen, Inst Clin Biochem, N-5021 Bergen, Norway; Univ Bergen, Dept Biochem & Mol Biol, N-5021 Bergen, Norway	University of Southern Denmark; University of Southern Denmark; Karolinska Institutet; University of Bergen; University of Bergen	Kristiansen, K (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Campusvej 55, DK-5320 Odense M, Denmark.		Göttlicher, Martin/M-7342-2014; Kristiansen, Karsten/J-5148-2014; Krogsdam, Anne/AAM-7278-2020; Mandrup, Susanne/B-6693-2008	Göttlicher, Martin/0000-0003-0619-2181; Kristiansen, Karsten/0000-0002-6024-0917; Krogsdam, Anne/0000-0002-5478-0511; Kratchmarova, Irina/0000-0001-6613-7315; Jorgensen, Claus/0000-0002-7841-943X; Mandrup, Susanne/0000-0002-0961-5787				AARSLAND A, 1991, BIOCHEM PHARMACOL, V41, P53, DOI 10.1016/0006-2952(91)90010-3; Auwerx J, 1999, CELL, V97, P161; BERGE RK, 1985, BIOCHIM BIOPHYS ACTA, V837, P141, DOI 10.1016/0005-2760(85)90237-1; BERGE RK, 1989, BIOCHIM BIOPHYS ACTA, V1004, P343; Bogan AA, 2000, J MOL BIOL, V302, P831, DOI 10.1006/jmbi.2000.4099; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; BRONFMAN M, 1986, BIOCHEM J, V239, P781, DOI 10.1042/bj2390781; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; CONSTANTINIDES PP, 1985, J BIOL CHEM, V260, P7573; DEMCZUK S, 1993, P NATL ACAD SCI USA, V90, P2574, DOI 10.1073/pnas.90.7.2574; Dowell P, 1997, J BIOL CHEM, V272, P2013, DOI 10.1074/jbc.272.3.2013; Dowell P, 1999, J BIOL CHEM, V274, P15901, DOI 10.1074/jbc.274.22.15901; Dowell P, 1997, J BIOL CHEM, V272, P33435, DOI 10.1074/jbc.272.52.33435; Elholm M, 2000, J LIPID RES, V41, P538; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; GEARING KL, 1993, P NATL ACAD SCI USA, V90, P1440, DOI 10.1073/pnas.90.4.1440; Glass CK, 2000, GENE DEV, V14, P121; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; HERTZ R, 1994, EUR J BIOCHEM, V221, P611, DOI 10.1111/j.1432-1033.1994.tb18773.x; Hertz R, 1996, J BIOL CHEM, V271, P218, DOI 10.1074/jbc.271.1.218; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; HERTZ R, 1995, J BIOL CHEM, V270, P13470, DOI 10.1074/jbc.270.22.13470; HORLEIN AJ, 1995, NATURE, V377, P379; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; KALB VF, 1977, ANAL BIOCHEM, V82, P362, DOI 10.1016/0003-2697(77)90173-7; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kussmann-Gerber S, 1999, ANAL BIOCHEM, V271, P102, DOI 10.1006/abio.1999.4117; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Leers J, 1998, MOL CELL BIOL, V18, P6001, DOI 10.1128/MCB.18.10.6001; Lin QO, 1999, BIOCHEMISTRY-US, V38, P185, DOI 10.1021/bi9816094; LYGRE T, 1986, J CHROMATOGR, V38, P95; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Murakami K, 2001, BIOCHEM J, V353, P231, DOI 10.1042/0264-6021:3530231; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; NILSSON A, 1984, LIPIDS, V19, P187, DOI 10.1007/BF02534796; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Nordhoff E, 1999, NAT BIOTECHNOL, V17, P884, DOI 10.1038/12873; Norris JD, 1999, SCIENCE, V285, P744, DOI 10.1126/science.285.5428.744; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; ONATE SA, 1995, SCIENCE, V270, P1354; ORCHARD K, 1993, NUCLEIC ACIDS RES, V21, P3335, DOI 10.1093/nar/21.14.3335; ORO AE, 1990, NATURE, V347, P298, DOI 10.1038/347298a0; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V175, P866, DOI 10.1016/0006-291X(91)91645-S; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Rodriguez JC, 1998, BIOCHEM BIOPH RES CO, V242, P692, DOI 10.1006/bbrc.1997.8032; ROSENDAL J, 1993, BIOCHEM J, V290, P321, DOI 10.1042/bj2900321; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; Treuter E, 1998, MOL ENDOCRINOL, V12, P864, DOI 10.1210/me.12.6.864; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Uppenberg J, 1998, J BIOL CHEM, V273, P31108, DOI 10.1074/jbc.273.47.31108; Wagner BL, 1998, MOL CELL BIOL, V18, P1369, DOI 10.1128/MCB.18.3.1369; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu JM, 1996, P NATL ACAD SCI USA, V93, P12195, DOI 10.1073/pnas.93.22.12195; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zhang JS, 1999, MOL CELL BIOL, V19, P6448; Zhang X, 1998, MOL ENDOCRINOL, V12, P513, DOI 10.1210/me.12.4.513	65	38	38	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21410	21416		10.1074/jbc.M101073200	http://dx.doi.org/10.1074/jbc.M101073200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279171	hybrid			2022-12-27	WOS:000169297900083
J	Riedel, C; Levy, O; Carrasco, N				Riedel, C; Levy, O; Carrasco, N			Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID NA+/I SYMPORTER; SODIUM-IODIDE SYMPORTER; GENE-EXPRESSION; FRTL-5 CELLS; PHOSPHORYLATION; TRANSPORTER; VESICLES; CLONING; DOMAIN; CANCER	The Na+/I- symporter (NIS) is a key plasma membrane glycoprotein that mediates active I- transport in the thyroid gland (Dai, G., Levy, O., and Carrasco, N. (1996) Nature 379, 458-460), the first step in thyroid hormone biogenesis, Whereas relatively little is known about the mechanisms by which thyrotropin (TSH), the main hormonal regulator of thyroid function, regulates NIS activity, post-transcriptional events have been suggested to play a role (Kaminsky, S. M., Levy, O., Salvador, C., Dai, G., and Carrasco, N. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 3789-3793), Here we show that TSH induces de novo NIS biosynthesis and modulates the long NIS half-life (similar to5 days). In addition, we demonstrate that TSH is required for NIS targeting to or retention in the plasma membrane. We further show that NIS is a phosphoprotein and that TSH modulates its phosphorylation pattern. These results provide strong evidence of the major role played by post-transcriptional events in the regulation of NIS by TSH. Beyond their inherent interest, it is also of medical significance that these TSH-dependent regulatory mechanisms may be altered in the large proportion of thyroid cancers in which NIS is predominantly expressed in intracellular compartments, instead of being properly targeted to the plasma membrane.	Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Carrasco, N (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	carrasco@aecom.yu.edu	Carrasco, Nancy/AAH-1053-2019	Carrasco, Nancy/0000-0003-4137-6162; Riedel, Claudia/0000-0001-6168-8601	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041544] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-41544, DK-07218] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arturi F, 2000, EUR J ENDOCRINOL, V143, P623, DOI 10.1530/eje.0.1430623; BAGCHI N, 1973, BIOCHIM BIOPHYS ACTA, V318, P235, DOI 10.1016/0005-2736(73)90117-X; Blakely RD, 2000, CURR OPIN NEUROBIOL, V10, P328, DOI 10.1016/S0959-4388(00)00088-X; Bradbury NA, 1999, PHYSL REV S, V79, P175, DOI DOI 10.1152/physrev.1999.79.1.S175; Brown D, 2000, AM J PHYSIOL-RENAL, V278, pF192, DOI 10.1152/ajprenal.2000.278.2.F192; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; DE la Vieja A, 2000, PHYSIOL REV, V80, P1083, DOI 10.1152/physrev.2000.80.3.1083; Eskandari S, 1997, J BIOL CHEM, V272, P27230, DOI 10.1074/jbc.272.43.27230; Glavy JS, 2000, J BIOL CHEM, V275, P1479, DOI 10.1074/jbc.275.2.1479; KAMINSKY SM, 1994, P NATL ACAD SCI USA, V91, P3789, DOI 10.1073/pnas.91.9.3789; Kogai T, 1997, ENDOCRINOLOGY, V138, P2227, DOI 10.1210/en.138.6.2227; Kogai T, 2000, J ENDOCRINOL, V167, P125, DOI 10.1677/joe.0.1670125; KOPITO RR, 1999, PHYSIOL REV, V79, P167; Krantz DE, 2000, J CELL BIOL, V149, P379, DOI 10.1083/jcb.149.2.379; Krantz DE, 1997, J BIOL CHEM, V272, P6752, DOI 10.1074/jbc.272.10.6752; Law RM, 2000, J BIOL CHEM, V275, P23986, DOI 10.1074/jbc.M910283199; Levy O, 1997, P NATL ACAD SCI USA, V94, P5568, DOI 10.1073/pnas.94.11.5568; Levy O, 1998, J BIOL CHEM, V273, P22657, DOI 10.1074/jbc.273.35.22657; LUO KX, 1991, METHOD ENZYMOL, V201, P149; MARCOCCI C, 1984, ENDOCRINOLOGY, V115, P2123, DOI 10.1210/endo-115-6-2123; MARTINO E, 2000, THYROID FUNDMENTAL C, P762; MAZAFERRI EL, 2000, THYROID FUNDAMENTAL, P904; Mehrens T, 2000, J AM SOC NEPHROL, V11, P1216, DOI 10.1681/ASN.V1171216; Ohno M, 1999, MOL CELL BIOL, V19, P2051; ORR GA, 1993, J BIOL CHEM, V268, P25054; Paire A, 1997, J BIOL CHEM, V272, P18245, DOI 10.1074/jbc.272.29.18245; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Ramamoorthy S, 1999, SCIENCE, V285, P763, DOI 10.1126/science.285.5428.763; Saito T, 1997, J CLIN ENDOCR METAB, V82, P3331, DOI 10.1210/jc.82.10.3331; Saito T, 1998, J CLIN INVEST, V101, P1296, DOI 10.1172/JCI1259; Schmutzler C, 2000, THYROID, V10, P393, DOI 10.1089/thy.2000.10.393; Smanik PA, 1996, BIOCHEM BIOPH RES CO, V226, P339, DOI 10.1006/bbrc.1996.1358; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Venkataraman GM, 1999, J CLIN ENDOCR METAB, V84, P2449, DOI 10.1210/jc.84.7.2449; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1099, DOI 10.1210/endo-114-4-1099; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1108, DOI 10.1210/endo-114-4-1108; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090	39	202	214	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21458	21463		10.1074/jbc.M100561200	http://dx.doi.org/10.1074/jbc.M100561200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11290744	hybrid			2022-12-27	WOS:000169297900089
J	Baskakov, IV; Legname, G; Prusiner, SB; Cohen, FE				Baskakov, IV; Legname, G; Prusiner, SB; Cohen, FE			Folding of prion protein to its native alpha-helical conformation is under kinetic control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRIL FORMATION; 106 RESIDUES; DOMAIN; STABILITY; DISEASES; PH	The recombinant mouse prion protein (MoPrP) can be folded either to a monomeric alpha -helical or oligomeric beta -sheet-rich isoform. By using circular dichroism spectroscopy and size-exclusion chromatography, we show that the beta -rich isoform of MoPrP is thermodynamically more stable than the native alpha -helical isoform. The conformational transition from the alpha -helical to beta -rich isoform is separated by a large energetic barrier that is associated with unfolding and with a higher order kinetic process related to oligomerization. Under partially denaturing acidic conditions, MoPrP avoids the kinetic trap posed by the alpha -helical isoform and folds directly to the thermodynamically more stable beta -rich isoform. Our data demonstrate that the folding of the prion protein to its native alpha -helical monomeric conformation is under kinetic control.	Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol Pharmaceut Chem & M, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cohen, FE (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, Box 0450, San Francisco, CA 94143 USA.		Legname, Giuseppe/C-1723-2012	Legname, Giuseppe/0000-0003-0716-4393	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS014069, P50NS014069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER; NIA NIH HHS [AG10770, AG0Z132] Funding Source: Medline; NINDS NIH HHS [NS14069] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BAKER D, 1994, BIOCHEMISTRY-US, V33, P7505, DOI 10.1021/bi00190a002; Baskakov IV, 2000, BIOCHEMISTRY-US, V39, P2792, DOI 10.1021/bi9923353; Broome BM, 2000, J MOL BIOL, V296, P961, DOI 10.1006/jmbi.2000.3514; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2000, EMBO J, V19, P1441, DOI 10.1093/emboj/19.7.1441; Cohen FE, 1999, J MOL BIOL, V293, P313, DOI 10.1006/jmbi.1999.2990; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; GROB M, 1999, PROTEIN SCI, V8, P1350; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; Mehlhorn I, 1996, BIOCHEMISTRY-US, V35, P5528, DOI 10.1021/bi952965e; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Ramirez-Alvarado M, 2000, P NATL ACAD SCI USA, V97, P8979, DOI 10.1073/pnas.150091797; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; Wildegger G, 1999, NAT STRUCT BIOL, V6, P550, DOI 10.1038/9323; Yutani K, 2000, BIOCHEMISTRY-US, V39, P2769, DOI 10.1021/bi991406v; ZHANG H, 1995, J MOL BIOL, V250, P514, DOI 10.1006/jmbi.1995.0395	23	194	196	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19687	19690		10.1074/jbc.C100180200	http://dx.doi.org/10.1074/jbc.C100180200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11306559	hybrid			2022-12-27	WOS:000169135100003
J	Sun, JX; Kamei, CN; Layne, MD; Jain, MK; Liao, JK; Lee, ME; Chin, MT				Sun, JX; Kamei, CN; Layne, MD; Jain, MK; Liao, JK; Lee, ME; Chin, MT			Regulation of myogenic terminal differentiation by the hairy-related transcription factor CHF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX REPRESSOR; DNA-BINDING; DROSOPHILA HAIRY; GENE-EXPRESSION; BHLH PROTEINS; ENHANCER; SPLIT; DOMAIN; MYOD; SOMITOGENESIS	We have recently cloned a novel basic helix-loop-helix factor, CHF2, that functions as a transcriptional repressor. To address its role in the regulation of myogenic terminal differentiation, we analyzed its expression pattern during C2C12 mouse myotube formation. In undifferentiated myoblasts, CHF2 is expressed at high levels. After induction of myotube formation in low serum, CHF2 expression is barely detectable at 3 days after induction, Myogenin expression, in contrast, peaks at 3 days. In transiently transfected 10T1/2 embryonic fibroblasts, CHF2 inhibited MyoD-dependent activation of the myogenin promoter in a dose-dependent fashion. Electrophoretic mobility shift analysis indicated that CHF2 inhibits the binding of the MyoD.E47 heterodimer to the E-box binding site. CHF2 also inhibited myogenic conversion of 10T1/2 cells by MyoD, as measured by skeletal myosin heavy chain protein expression. Coimmunoprecipitation analysis indicated that CHF2 forms a protein complex with MyoD. Mutational analysis of CHF2 indicated that the repression activity for both transcription and myogenic conversion mapped to a hydrophobic carboxyl-terminal region and did not require either the basic helix-loop-helix or YRPW motifs, Our data indicate that CHF2 functions as a transcriptional repressor of myogenesis by formation of an inactive heterodimeric complex with MyoD and likely plays an important role in muscle development.	Brigham & Womens Hosp, Vasc Med Unit, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Chin, MT (corresponding author), Brigham & Womens Hosp, Vasc Med Unit, Div Cardiovasc, 221 Longwood Ave, Boston, MA 02115 USA.			Layne, Matthew/0000-0003-0007-4870	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057664, F32HL010113, P01HL048743] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 03745, HL 03747, HL 10113, HL 48743, HL 57664] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Chen CMA, 1996, CELL, V86, P731, DOI 10.1016/S0092-8674(00)80148-8; Chin MT, 2000, J BIOL CHEM, V275, P6381, DOI 10.1074/jbc.275.9.6381; Chin MT, 1998, J BIOL CHEM, V273, P9755, DOI 10.1074/jbc.273.16.9755; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; Fisher A, 1998, BIOESSAYS, V20, P298, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;298::AID-BIES6&gt;3.0.CO;2-M; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Holley SA, 2000, GENE DEV, V14, P1678; Jain MK, 1996, J BIOL CHEM, V271, P10194, DOI 10.1074/jbc.271.17.10194; Kokubo H, 1999, BIOCHEM BIOPH RES CO, V260, P459, DOI 10.1006/bbrc.1999.0880; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; NADALGINARD B, 1978, CELL, V15, P855, DOI 10.1016/0092-8674(78)90270-2; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; OHSAKO S, 1994, GENE DEV, V8, P2743, DOI 10.1101/gad.8.22.2743; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; PEVERALI FA, 1994, EMBO J, V13, P4291, DOI 10.1002/j.1460-2075.1994.tb06749.x; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; VANDOREN M, 1994, GENE DEV, V8, P2729, DOI 10.1101/gad.8.22.2729; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	26	61	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18591	18596		10.1074/jbc.M101163200	http://dx.doi.org/10.1074/jbc.M101163200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279181	hybrid			2022-12-27	WOS:000168866500129
J	Roseman, DS; Baenziger, JU				Roseman, DS; Baenziger, JU			The mannose/N-acetylgalactosamine-4-SO4 receptor displays greater specificity for multivalent than monovalent ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; BETA 1,4GLCNAC BETA; MANNOSE RECEPTOR; OLIGOSACCHARIDES; BINDING; LECTIN; PROTEIN; ELECTROPHORESIS; RECOGNITION	Recognition of carbohydrates on glycosylated molecules typically requires multivalent interactions with receptors, Monovalent forms of terminal saccharides engaged by the receptor binding sites typically display weak affinities in the mM range and poor specificity, In contrast, multivalent forms of the same saccharides are bound with strong affinity (10(-7)-10(-9) M) and significantly greater specificity. Although multivalency can readily account for increased affinity, the molecular basis for enhanced specificity is not well understood. We have examined the specificity of the cysteine-rich domain of the mannose/GalNAc-4-SO4 receptor using monovalent and multivalent forms of the trisaccharide GalNAc beta1,4GlcNAc beta1,2Man alpha (GGnM) sulfated at either the C4 (S4GGnM) or C3 (S3GGnM) hydroxyl of the terminal GalNAc. Monovalent S4GGnM and S3GGnM have K-i values Of 25.8 and 16.2 muM, respectively. Multivalent conjugates of the same GalNAc-4-SO4- and GalNAc-3SO(4)-bearing trisaccharides (6.7 mol of trisaccharide/mol of bovine serum albumin) have Ki values of 0.013 and 0.170 mum, respectively. The 2000-fold versus 95-fold change in affinity seen for the multivalent forms of these 4-sulfated and 3-sulfated trisaccharides reflects a difference in the impact of conformational entropy, A large fraction of the SO4-3-GalNAc structures exists in a form that is not favorable for binding to the Cys-rich domain. This reduces the effective concentration of SO4-3-GalNAc as compared with SO4-4-GalNAc under the same conditions and results in a markedly lower association rate. This difference in association rate accounts for the 12-fold difference in the rate of clearance from the blood seen with S4GGnM-BSA and S3GGnM-BSA in vivo.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Washington University (WUSTL)	Baenziger, JU (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.	Baenziger@Pathology.WUSTL.EDU	Baenziger, Jacques U/E-9430-2012		NATIONAL CANCER INSTITUTE [R37CA021923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041738] Funding Source: NIH RePORTER; NCI NIH HHS [R37-CA21923] Funding Source: Medline; NIDDK NIH HHS [R01-DK41738] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADLER P, 1995, J BIOL CHEM, V270, P5164, DOI 10.1074/jbc.270.10.5164; BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; BAENZIGER JU, 1980, CELL, V22, P611, DOI 10.1016/0092-8674(80)90371-2; BAENZIGER JU, 1980, J BIOL CHEM, V255, P4607; Chen FTA, 1998, GLYCOBIOLOGY, V8, P1045, DOI 10.1093/glycob/8.11.1045; CHEN FTA, 1995, ANAL BIOCHEM, V230, P273, DOI 10.1006/abio.1995.1474; Dam TK, 2000, J BIOL CHEM, V275, P14223, DOI 10.1074/jbc.275.19.14223; Fiete D, 1997, J BIOL CHEM, V272, P14629, DOI 10.1074/jbc.272.23.14629; Fiete D, 1997, P NATL ACAD SCI USA, V94, P11256, DOI 10.1073/pnas.94.21.11256; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Guttman A, 1996, ANAL BIOCHEM, V233, P234, DOI 10.1006/abio.1996.0034; HINDSGAUL V, 1987, CAN J CHEM, V65, P1645; Horan N, 1999, P NATL ACAD SCI USA, V96, P11782, DOI 10.1073/pnas.96.21.11782; LEE YC, 1995, ACCOUNTS CHEM RES, V28, P321, DOI 10.1021/ar00056a001; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Liang R, 1997, P NATL ACAD SCI USA, V94, P10554, DOI 10.1073/pnas.94.20.10554; Liu Y, 2000, J EXP MED, V191, P1105, DOI 10.1084/jem.191.7.1105; Liu Y, 2001, J MOL BIOL, V305, P481, DOI 10.1006/jmbi.2000.4326; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Martinez-Pomares L, 1998, J BIOL CHEM, V273, P23376, DOI 10.1074/jbc.273.36.23376; MELLIS SJ, 1981, ANAL BIOCHEM, V114, P276, DOI 10.1016/0003-2697(81)90480-2; Mortell KH, 1996, J AM CHEM SOC, V118, P2297, DOI 10.1021/ja953574q; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597	24	31	33	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17052	17057		10.1074/jbc.M101027200	http://dx.doi.org/10.1074/jbc.M101027200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279168	hybrid			2022-12-27	WOS:000168730400060
J	Sengupta, SM; VanKanegan, M; Persinger, J; Logie, C; Cairns, BR; Peterson, CL; Bartholomew, B				Sengupta, SM; VanKanegan, M; Persinger, J; Logie, C; Cairns, BR; Peterson, CL; Bartholomew, B			The interactions of yeast SWI/SNF and RSC with the nucleosome before and after chromatin remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; HISTONE OCTAMER; TRANSCRIPTION COMPLEX; NUCLEAR-PROTEIN; DNA; GENE; BINDING; SUBUNITS; ENCODES; ATPASE	Interactions of the yeast chromatin-remodeling complexes SWI/SNF and RSC with nucleosomes were probed using site-specific DNA photoaffinity labeling. 5 S rDNA was engineered with photoreactive nucleotides incorporated at different sites in DNA to scan for the subunits of SWI/SNF in close proximity to DNA when SWI/SNF is bound to the 5 S nucleosome or to the free 5 S rDNA The Swi2/Snf2 and Snf6 subunits of SWI/SNF were efficiently cross-linked at several positions in the nucleosome, whereas only Snf6 was efficiently cross-linked when SWI/SNF was bound to free DNA DNA photoaffinity labeling of RSC showed that the Reel subunit is in close proximity to nucleosomal DNA and not when RSC is bound to free DNA After remodeling, the Swi2/Snf2 and Rsc4 subunits are no longer detected near the nucleosomal DNA and are evidently displaced from the surface of the nucleosome, indicating significant changes in SWI/SNF and RSC contacts with DNA after remodeling.	So Illinois Univ, Sch Med, Program Mol Biol Microbiol & Mol Biol, Carbondale, IL 62901 USA; So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01605 USA; Univ Utah, Sch Med, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Bartholomew, B (corresponding author), So Illinois Univ, Sch Med, Program Mol Biol Microbiol & Mol Biol, Carbondale, IL 62901 USA.		Logie, Colin/A-1528-2010; Logie, Colin/L-9833-2019	Logie, Colin/0000-0002-8534-6582; Logie, Colin/0000-0002-8534-6582	NIGMS NIH HHS [GM48413, R01 GM049650, R37 GM049650] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048413, R29GM048413, R01GM049650, R37GM049650] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cairns BR, 1998, MOL CELL, V2, P639, DOI 10.1016/S1097-2765(00)80162-8; Cairns BR, 1996, GENE DEV, V10, P2131, DOI 10.1101/gad.10.17.2131; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; CAIRNS BR, 1994, P NATL ACAD SCI USA, V91, P1950, DOI 10.1073/pnas.91.5.1950; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; DONG F, 1990, P NATL ACAD SCI USA, V87, P5724, DOI 10.1073/pnas.87.15.5724; Du J, 1998, GENETICS, V150, P987; ESTRUCH F, 1990, MOL CELL BIOL, V10, P2544, DOI 10.1128/MCB.10.6.2544; Grant PA, 1999, SEMIN CELL DEV BIOL, V10, P169, DOI 10.1006/scdb.1999.0298; Guyon JR, 1999, MOL CELL BIOL, V19, P2088; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; HAYES JJ, 1990, P NATL ACAD SCI USA, V87, P7405, DOI 10.1073/pnas.87.19.7405; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; HENRY NR, COMMUNICATION; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jaskelioff M, 2000, MOL CELL BIOL, V20, P3058, DOI 10.1128/MCB.20.9.3058-3068.2000; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lannutti BJ, 1996, BIOCHEMISTRY-US, V35, P9821, DOI 10.1021/bi960525x; LAURENT BC, 1992, GENE DEV, V6, P1707, DOI 10.1101/gad.6.9.1707; LAURENT BC, 1992, MOL CELL BIOL, V12, P1893, DOI 10.1128/MCB.12.4.1893; Logie C, 1999, METHOD ENZYMOL, V304, P726; Logie C, 1999, BIOCHEMISTRY-US, V38, P2514, DOI 10.1021/bi982109d; Lorch Y, 1998, CELL, V94, P29, DOI 10.1016/S0092-8674(00)81218-0; MEERSSEMAN G, 1992, EMBO J, V11, P2951, DOI 10.1002/j.1460-2075.1992.tb05365.x; Ornaghi P, 1999, J MOL BIOL, V287, P1, DOI 10.1006/jmbi.1999.2577; Panetta G, 1998, J MOL BIOL, V282, P683, DOI 10.1006/jmbi.1998.2087; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Peterson CL, 1998, J BIOL CHEM, V273, P23641, DOI 10.1074/jbc.273.37.23641; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Pruss D, 1996, SCIENCE, V274, P614, DOI 10.1126/science.274.5287.614; Quinn J, 1996, NATURE, V379, P844, DOI 10.1038/379844a0; RENART J, 1984, METHOD ENZYMOL, V104, P455; Richmond E, 1996, NUCLEIC ACIDS RES, V24, P3685, DOI 10.1093/nar/24.19.3685; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Sengupta SM, 1999, METHODS, V19, P434, DOI 10.1006/meth.1999.0880; SZERLONG H, UNPUB; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; TSUCHIYA E, 1992, EMBO J, V11, P4017, DOI 10.1002/j.1460-2075.1992.tb05495.x; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; WOLFFE AP, 1986, CELL, V47, P217, DOI 10.1016/0092-8674(86)90444-7; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	51	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12636	12644		10.1074/jbc.M010470200	http://dx.doi.org/10.1074/jbc.M010470200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11304548	Green Published, hybrid			2022-12-27	WOS:000168198600024
J	Fago, A; Giangiacomo, L; D'Avino, R; Carratore, V; Romano, M; Boffi, A; Chiancone, E				Fago, A; Giangiacomo, L; D'Avino, R; Carratore, V; Romano, M; Boffi, A; Chiancone, E			Hagfish hemoglobins - Structure, function, and oxygen-linked association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYXINE-GLUTINOSA; CRYSTAL-STRUCTURE; LIGAND-BINDING; TRANSPORT; COOPERATIVITY; HAEMOGLOBIN; MYOGLOBIN; PROTEINS	Cyclostomes, hagfishes and lampreys, contain hemoglobins that are monomeric when oxygenated and polymerize to dimers or tetramers when deoxygenated. The three major hemoglobin components (HbI, HbII, and HbIII) from the hagfish Myxine glutinosa have been characterized and compared with lamprey Petromyzon marinus HbV, whose x-ray crystal structure has been solved in the deoxygenated, dimeric state (Heaslet, H. A., and Royer, W. E., Jr. (1999) Structure 7, 517-526). Of these three, HbII bears the highest sequence similarity to P. marinus HbV. In HbI and HbIII the distal histidine is substituted by a glutamine residue and additional substitutions occur in residues located at the deoxy dimer interface of P. marinus HbV. Infrared spectroscopy of the CO derivatives, used to probe the distal pocket fine structure, brings out a correlation between the CO stretching frequencies and the rates of CO combination. Ultracentrifugation studies show that HbI and HbIII are monomeric in both the oxygenated and deoxygenated states under all conditions studied, whereas deoxy HbII forms dimers at acidic pH values, like P. marinus HbV. Accordingly, the oxygen affinities of HbI and HbIII are independent of pH, whereas HbII displays a Bohr effect below pH 7.2. HbII also forms heterodimers with HbIII and heterotetramers with HbI. The functional counterparts of heteropolymer formation are cooperativity in oxygen binding and the oxygen-linked binding of protons and bicarbonate. The observed effects are explained on the basis of the x-ray structure of P. marinus HbV and the association behavior of site-specific mutants.	Univ Roma La Sapienza, CNR, Ctr Mol Biol, I-00185 Rome, Italy; Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; Univ Aarhus, Dept Zoophysiol, DK-8000 Aarhus C, Denmark; CNR, Inst Prot Biochem & Enzymol, I-80125 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; Sapienza University Rome; Aarhus University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Chiancone, E (corresponding author), Univ Roma La Sapienza, CNR, Ctr Mol Biol, Ple Aldo Moro 5, I-00185 Rome, Italy.	emilia.chiancone@uniroma1.it	Fago, Angela/J-5946-2013	Fago, Angela/0000-0001-7315-2628				ACKERS GK, 1976, BIOCHEM BIOPH RES CO, V69, P135, DOI 10.1016/S0006-291X(76)80283-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANTONINI E, 1965, J MOL BIOL, V12, P375, DOI 10.1016/S0022-2836(65)80261-3; BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; BANNAI S, 1972, J BIOL CHEM, V247, P505; BAUER C, 1975, NATURE, V256, P66, DOI 10.1038/256066a0; BRIEHL RW, 1963, J BIOL CHEM, V238, P2361; BRITTAIN T, 1991, COMP BIOCHEM PHYS B, V99, P731, DOI 10.1016/0305-0491(91)90136-2; CHIANCONE E, 1981, J MOL BIOL, V152, P577, DOI 10.1016/0022-2836(81)90270-9; ELLORY JC, 1987, J EXP BIOL, V129, P377; Fago A, 1999, RESP PHYSIOL, V115, P309, DOI 10.1016/S0034-5687(98)00102-9; FAGO A, 1995, BBA-PROTEIN STRUCT M, V1249, P109, DOI 10.1016/0167-4838(95)00031-O; FANELLI AR, 1958, ARCH BIOCHEM BIOPHYS, V77, P478; FRIEDMAN M, 1970, J BIOL CHEM, V245, P3868; GOODMAN M, 1981, J MOL EVOL, V17, P114, DOI 10.1007/BF01732683; GROSS E, 1961, J AM CHEM SOC, V83, P1510, DOI 10.1021/ja01467a052; Heaslet HA, 1999, STRUCT FOLD DES, V7, P517, DOI 10.1016/S0969-2126(99)80068-9; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; KELLETT GL, 1970, NATURE, V227, P921, DOI 10.1038/227921a0; Kussmann M, 1997, J MASS SPECTROM, V32, P593; Landon, 1977, Methods Enzymol, V47, P145; LI SL, 1972, BIOCHIM BIOPHYS ACTA, V278, P344, DOI 10.1016/0005-2795(72)90239-5; LI TS, 1994, BIOCHEMISTRY-US, V33, P1433, DOI 10.1021/bi00172a021; LILJEQVIST G, 1982, J MOL EVOL, V18, P102, DOI 10.1007/BF01810828; Martini FH, 1998, SCI AM, V279, P70, DOI 10.1038/scientificamerican1098-70; MAXWELL JC, 1976, BIOCHEMISTRY-US, V15, P388, DOI 10.1021/bi00647a023; NIKINMAA M, 1993, VERTEBRATE GAS TRANSPORT CASCADE, P179; OHNO S, 1966, SCIENCE, V154, P1034, DOI 10.1126/science.154.3752.1034; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; PALEUS S, 1971, COMP BIOCHEM PHYSIOL, V39, P551, DOI 10.1016/0305-0491(71)90199-4; PARK KD, 1991, BIOCHEMISTRY-US, V30, P2333, DOI 10.1021/bi00223a007; PERRY SF, 1993, J EXP BIOL, V183, P165; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; Peters T, 1998, BIOLOGY OF HAGFISHES, P307; Qiu Y, 2000, J BIOL CHEM, V275, P13517, DOI 10.1074/jbc.275.18.13517; ROYER WE, 1989, J BIOL CHEM, V264, P21052; RUMEN NM, 1963, ACTA CHEM SCAND, V17, P222, DOI 10.3891/acta.chem.scand.17s-0222; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WELLS RMG, 1986, J EXP BIOL, V123, P43; WELLS RMG, 1989, SOC EXPT BIOL SERIES; [No title captured]	42	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2001	276	29					27415	27423		10.1074/jbc.M100759200	http://dx.doi.org/10.1074/jbc.M100759200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	454HJ	11294865	hybrid			2022-12-27	WOS:000169966900091
J	Barnes, BJ; Moore, PA; Pitha, PM				Barnes, BJ; Moore, PA; Pitha, PM			Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I INTERFERON; TRANSCRIPTION FACTORS; FUNCTIONAL-ANALYSIS; MEDIATED INDUCTION; POSITIVE FEEDBACK; PROMOTER REGION; PROTEIN; CELLS; IDENTIFICATION; EXPRESSION	Interferon regulatory factor (IRF) genes encode DNA-binding proteins that are involved in the innate immune response to infection. Two of these proteins, IRF-3 and IRF-7, serve as direct transducers of virus-mediated signaling and play critical roles in the induction of type I interferon genes. We have now shown that another factor, IRF-5, participates in the induction of interferon A (IFNA) and IFNB genes and can replace the requirement for IRF-7 in the induction of IFNA genes, We demonstrate that, despite the functional similarity, IRF-5 possesses unique characteristics and does not have a redundant role. Thus, 1) activation of IRF-5 by phosphorylation is virus-specific, and its in vivo association with the IFNA promoter can be detected only in cells infected with NDV, not Sendai virus, while both viruses activate IRF-3 and IRF-7, and 2) NDV infection of IFNA8 overexpressing cells preferentially induced the IFNA8 subtype, while IFNA1 was primarily induced in IRF-7 expressing cells. These data indicate that multiple signaling pathways induced by infection may be differentially recognized by members of the IRF family and modulate transcription of individual IFNA genes in a virus and cell type-specific manner.	Johns Hopkins Univ, Sch Med, Ctr Oncol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21231 USA; Human Genome Sci Inc, Rockville, MD 20850 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; GlaxoSmithKline; Human Genome Sciences Inc	Pitha, PM (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Oncol, 1650 Orleans St, Baltimore, MD 21231 USA.				NIAID NIH HHS [AII937] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; AU WC, 1993, J BIOL CHEM, V268, P24032; AU WC, 1992, NUCLEIC ACIDS RES, V20, P2877, DOI 10.1093/nar/20.11.2877; Au WC, 1998, J BIOL CHEM, V273, P29210, DOI 10.1074/jbc.273.44.29210; AU WC, 1995, P NATL ACAD SCI USA, V92, P11657, DOI 10.1073/pnas.92.25.11657; Au WC, 2001, VIROLOGY, V280, P273, DOI 10.1006/viro.2000.0782; Burysek L, 1999, J VIROL, V73, P7334; DEMAEYER E, 1988, INTERFERONS OTHER RE, P364; Dent CL, 1996, J INTERF CYTOK RES, V16, P99, DOI 10.1089/jir.1996.16.99; DIAZ MO, 1995, SEMIN VIROL, V6, P143, DOI 10.1006/smvy.1995.0019; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; FITZGERALDBOCAR.PA, 2000, EUR CYTOKINE NETW, V11, P33; Foster GR, 1996, J INTERF CYTOK RES, V16, P1027, DOI 10.1089/jir.1996.16.1027; Hayashida S, 2000, GENOMICS, V66, P221, DOI 10.1006/geno.2000.6206; Hibbert L, 1999, J INTERF CYTOK RES, V19, P309, DOI 10.1089/107999099314009; HO M, 1973, INTERFERONS INTERFER, P29; ITOH S, 1991, GENOMICS, V10, P1097, DOI 10.1016/0888-7543(91)90208-V; Juang YT, 1998, P NATL ACAD SCI USA, V95, P9837, DOI 10.1073/pnas.95.17.9837; Juang YT, 1999, J BIOL CHEM, V274, P18060, DOI 10.1074/jbc.274.25.18060; Kim T, 1999, J BIOL CHEM, V274, P30686, DOI 10.1074/jbc.274.43.30686; Kim T, 2000, J BIOL CHEM, V275, P16910, DOI 10.1074/jbc.M000524200; Kumar KP, 2000, MOL CELL BIOL, V20, P4159, DOI 10.1128/MCB.20.11.4159-4168.2000; Lin RT, 1999, MOL CELL BIOL, V19, P959; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Lopez SB, 2000, MOL CELL BIOL, V20, P7527, DOI 10.1128/MCB.20.20.7527-7540.2000; Lowther WJ, 1999, DNA CELL BIOL, V18, P685, DOI 10.1089/104454999314962; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; Lubyova B, 2000, J VIROL, V74, P8194, DOI 10.1128/JVI.74.17.8194-8201.2000; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Nonkwelo C, 1997, J VIROL, V71, P6887, DOI 10.1128/JVI.71.9.6887-6897.1997; RAJ NBK, 1991, J BIOL CHEM, V266, P11360; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Slifka MK, 2000, IMMUNITY, V12, P451, DOI 10.1016/S1074-7613(00)80197-1; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Suhara W, 2000, J BIOCHEM-TOKYO, V128, P301, DOI 10.1093/oxfordjournals.jbchem.a022753; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; THANOS D, 1995, MOL CELL BIOL, V15, P152, DOI 10.1128/MCB.15.1.152; Touchman JW, 1997, GENOME RES, V7, P281, DOI 10.1101/gr.7.3.281; WATHELET MG, 1998, MOL CELL, V1, P1359; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Yeow WS, 2000, J BIOL CHEM, V275, P6313, DOI 10.1074/jbc.275.9.6313; Yeow WS, 2001, J VIROL, V75, P3021, DOI 10.1128/JVI.75.6.3021-3027.2001; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748	54	300	307	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23382	23390		10.1074/jbc.M101216200	http://dx.doi.org/10.1074/jbc.M101216200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11303025	hybrid			2022-12-27	WOS:000169531100023
J	Goda, M; Hashimoto, Y; Shimizu, S; Kobayashi, M				Goda, M; Hashimoto, Y; Shimizu, S; Kobayashi, M			Discovery of a novel enzyme, isonitrile hydratase, involved in nitrogen-carbon triple bond cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOCOCCUS-RHODOCHROUS J1; MASS NITRILE HYDRATASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; PSEUDOMONAS-CHLORORAPHIS B23; DNA-BASE COMPOSITION; REACTION-PRODUCT; GENE-CLUSTER; PURIFICATION; IDENTIFICATION; AMIDASE	Isonitrile containing an N equivalent toC triple bond was degraded by microorganism sp N19-2, which was isolated from soil through a 2-month acclimatization culture in the presence of this compound. The isonitrile-degrading microorganism was identified as Pseudomonas putida The microbial degradation was found to proceed through an enzymatic reaction, the isonitrile being hydrated to the corresponding N-substituted formamide. The enzyme, named isonitrile hydratase, was purified and characterized. The native enzyme had a molecular mass of about 59 kDa and consisted of two identical subunits. The enzyme stoichiometrically catalyzed the hydration of cyclohexyl isocyanide tan isonitrile) to N-cyclohexylformamide, but no formation of other compounds was detected. The apparent K-m value for cyclohexyl isocyanide mas 16.2 mM. Although the enzyme acted on various isonitriles, no nitriles or amides were accepted as substrates.	Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan; Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan	University of Tsukuba; Kyoto University	Kobayashi, M (corresponding author), Univ Tsukuba, Inst Appl Biochem, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.							ACHENBAC.H, 1972, CHEM BER-RECL, V105, P784, DOI 10.1002/cber.19721050307; ACHENBACH H, 1965, Z NATURFORSCH PT B, VB 20, P137, DOI 10.1515/znb-1965-0209; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURRESON BJ, 1975, J AM CHEM SOC, V97, P4763, DOI 10.1021/ja00849a053; CAFIERI F, 1973, TETRAHEDRON, V29, P4259, DOI 10.1016/0040-4020(73)80267-4; EDENBOROUGH MS, 1988, NAT PROD REP, V5, P229, DOI 10.1039/np9880500229; HAGADONE MR, 1984, J AM CHEM SOC, V106, P2447, DOI 10.1021/ja00320a044; HAGEDORN J, 1957, PHARMAZIE, V12, P567; KATAYAMAFUJIMURA Y, 1984, AGR BIOL CHEM TOKYO, V48, P3169, DOI 10.1080/00021369.1984.10866660; KATOH K, 1983, REPT NATL FOOD RES I, V43, P79; KELLY M, 1967, BIOCHEM J, V102, pC1, DOI 10.1042/bj1020001C; Kobayashi M, 1998, FEBS LETT, V439, P325, DOI 10.1016/S0014-5793(98)01406-9; KOBAYASHI M, 1995, P NATL ACAD SCI USA, V92, P714, DOI 10.1073/pnas.92.3.714; KOBAYASHI M, 1989, EUR J BIOCHEM, V182, P349, DOI 10.1111/j.1432-1033.1989.tb14837.x; Kobayashi M, 2000, CURR OPIN CHEM BIOL, V4, P95, DOI 10.1016/S1367-5931(99)00058-7; Kobayashi M, 1997, P NATL ACAD SCI USA, V94, P11986, DOI 10.1073/pnas.94.22.11986; KOBAYASHI M, 1993, EUR J BIOCHEM, V217, P327, DOI 10.1111/j.1432-1033.1993.tb18250.x; Kobayashi M, 1999, EUR J BIOCHEM, V261, P1, DOI 10.1046/j.1432-1327.1999.00186.x; KOBAYASHI M, 1993, P NATL ACAD SCI USA, V90, P247, DOI 10.1073/pnas.90.1.247; KOBAYASHI M, 1992, BIOCHEMISTRY-US, V31, P9000, DOI 10.1021/bi00152a042; KOBAYASHI M, 1992, J BIOL CHEM, V267, P20746; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; KOBAYASHI M, 1992, TRENDS BIOTECHNOL, V10, P402, DOI 10.1016/0167-7799(92)90283-2; KOBAYASHI M, 1994, FEMS MICROBIOL LETT, V120, P217, DOI 10.1016/0378-1097(94)90474-X; KOBAYASHI M, 1990, J BACTERIOL, V172, P4807, DOI 10.1128/jb.172.9.4807-4815.1990; Komeda H, 1996, P NATL ACAD SCI USA, V93, P4267, DOI 10.1073/pnas.93.9.4267; Komeda H, 1996, J BIOL CHEM, V271, P15796, DOI 10.1074/jbc.271.26.15796; Komeda H, 1996, P NATL ACAD SCI USA, V93, P10572, DOI 10.1073/pnas.93.20.10572; Komeda H, 1997, P NATL ACAD SCI USA, V94, P36, DOI 10.1073/pnas.94.1.36; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; NAGASAWA T, 1987, EUR J BIOCHEM, V162, P691, DOI 10.1111/j.1432-1033.1987.tb10692.x; NAGASAWA T, 1986, BIOCHEM BIOPH RES CO, V139, P1305, DOI 10.1016/S0006-291X(86)80320-5; NISHIYAMA M, 1991, J BACTERIOL, V173, P2465, DOI 10.1128/jb.173.8.2465-2472.1991; PFEIFER S, 1972, PHARMAZIE, V27, P536; RUBINSON JF, 1983, BIOCHEMISTRY-US, V22, P6260, DOI 10.1021/bi00295a034; SCHEUER PJ, 1992, ACCOUNTS CHEM RES, V25, P433, DOI 10.1021/ar00022a001; SUGIURA Y, 1987, J AM CHEM SOC, V109, P5848, DOI 10.1021/ja00253a046; TAMAOKA J, 1984, FEMS MICROBIOL LETT, V25, P125, DOI 10.1016/0378-1097(84)90059-4; Yamada H, 1996, BIOSCI BIOTECH BIOCH, V60, P1391, DOI 10.1271/bbb.60.1391	39	37	45	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23480	23485		10.1074/jbc.M007856200	http://dx.doi.org/10.1074/jbc.M007856200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11306561	hybrid			2022-12-27	WOS:000169531100035
J	Nulton-Persson, AC; Szweda, LI				Nulton-Persson, AC; Szweda, LI			Modulation of mitochondrial function by hydrogen peroxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-KETOGLUTARATE DEHYDROGENASE; TYROSINE-PHOSPHATASE 1B; FREE-RADICAL GENERATION; SIGNAL-TRANSDUCTION; HEART-MITOCHONDRIA; REVERSIBLE INACTIVATION; CARDIAC REPERFUSION; ALZHEIMERS-DISEASE; PROTEIN OXIDATION; REDOX REGULATION	During normal cellular metabolism, mitochondrial electron transport results in the formation of superox ide anion (O-2) and subsequently hydrogen peroxide (H2O2). Because H2O2 increases in concentration under certain physiologic and pathophysiologic conditions and can oxidatively modify cellular components, it is critical to understand the response of mitochondria to H2O2. In the present study, treatment of isolated rat heart mitochondria with H2O2 resulted in a decline and subsequent recovery of state 3 NADH-linked respiration. Alterations in NADH levels induced by H2O2 closely paralleled changes in the rate of state 3 respiration. Assessment of electron transport chain complexes and Krebs cycle enzymes revealed that alpha -ketoglutarate dehydrogenase (KGDH), succinate dehydrogenase (SDH), and aconitase were susceptible to H2O2 inactivation. Of particular importance, KGDH and SDH activity returned to control levels, concurrent with the recovery of state 3 respiration. Inactivation is not because of direct interaction of H2O2 with KGDH and SDH. In addition, removal of H2O2 alone is not sufficient for reactivation, Enzyme activity does not recover unless mitochondria remain intact. The sensitivity of KGDH and SDH to H2O2-mediated inactivation and the reversible nature of inactivation suggest a potential role for H2O2 in the regulation of KGDH and SDH.	Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Szweda, LI (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA.				NATIONAL INSTITUTE ON AGING [R01AG016339] Funding Source: NIH RePORTER; NIA NIH HHS [AG-16339] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BOLLI R, 1988, J CLIN INVEST, V82, P476, DOI 10.1172/JCI113621; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; CADENAS E, 1980, BIOCHEM J, V188, P31, DOI 10.1042/bj1880031; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; EMPTAGE MH, 1983, J BIOL CHEM, V258, P1106; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Gabbita SP, 2000, ARCH BIOCHEM BIOPHYS, V376, P1, DOI 10.1006/abbi.1999.1685; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; Janero DR, 1996, AM J PHYSIOL-CELL PH, V270, pC1735, DOI 10.1152/ajpcell.1996.270.6.C1735; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; Kish SJ, 1997, ANN NY ACAD SCI, V826, P218, DOI 10.1111/j.1749-6632.1997.tb48473.x; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; LOSCHEN G, 1973, FEBS LETT, V33, P84, DOI 10.1016/0014-5793(73)80165-6; Lucas DT, 1998, P NATL ACAD SCI USA, V95, P510, DOI 10.1073/pnas.95.2.510; Lucas DT, 1999, P NATL ACAD SCI USA, V96, P6689, DOI 10.1073/pnas.96.12.6689; MASTROGIACOMO F, 1993, J NEUROCHEM, V61, P2007, DOI 10.1111/j.1471-4159.1993.tb07436.x; MIZUNO Y, 1995, BBA-MOL BASIS DIS, V1271, P265, DOI 10.1016/0925-4439(95)00038-6; NOHL H, 1978, EUR J BIOCHEM, V90, P385, DOI 10.1111/j.1432-1033.1978.tb12615.x; NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x; OTANI H, 1984, CIRC RES, V55, P168, DOI 10.1161/01.RES.55.2.168; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; ROKUTAN K, 1987, J BIOCHEM-TOKYO, V101, P415, DOI 10.1093/oxfordjournals.jbchem.a121926; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; TONG JJ, 1994, J BIOL CHEM, V269, P24920; TRIMM JL, 1986, J BIOL CHEM, V261, P6092; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; UETA H, 1990, J MOL CELL CARDIOL, V22, P893, DOI 10.1016/0022-2828(90)90120-Q; Vasquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064; VERNIQUET F, 1991, BIOCHEM J, V276, P643, DOI 10.1042/bj2760643; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168	48	324	338	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23357	23361		10.1074/jbc.M100320200	http://dx.doi.org/10.1074/jbc.M100320200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11283020	hybrid			2022-12-27	WOS:000169531100020
J	Lambert, C; Prange, R				Lambert, C; Prange, R			Dual topology of the hepatitis B virus large envelope protein - Determinants influencing post-translational pre-S translocatton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE SURFACE PROTEIN; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE TOPOLOGY; PARTICLE MORPHOGENESIS; MEMBRANE-PROTEIN; ANTIGEN; GLYCOPROTEIN; SEQUENCE; DOMAIN; INSERTION	The large (L) envelope protein of the hepatitis B virus (HBV) has the peculiar capacity to form two transmembrane topologies via an as yet uncharacterized process of partial post-translational translocation of its pre-S domain across membranes. In view of a current model that predicts an HBV-specific channel generated during virion envelope assembly to enable pre-S translocation, we have examined parameters influencing L topogenesis by using protease protection analysis of wild-type and mutant L proteins synthesized in transfected cells. We demonstrate that contrary to expectation, all determinants, thought to be responsible for channel formation, are dispensable for pre-S reorientation. In particular, we observed that this process does not require (i) the helper function of the HBV S (small) and M (middle) envelope proteins, (ii) covalent dimer formation of envelope chains, or (iii) either of the three amphipathic transmembrane segments of L. Rather, the most hydro phobic transmembrane segment 2 of L was identified as a vital topogenic determinant, essential and sufficient for post-translational pre-S translocation. Cell fractionation studies revealed that pre-S refolding and thus the dual topology of L is established at the endoplasmic reticulum (ER) membrane rather than at a post-ER compartment as originally supposed. Together our data pro vide evidence to suggest that the topological reorientation of L is facilitated by a host cell transmembrane transport machinery such as the ER translocon.	Univ Mainz, Inst Med Microbiol & Hyg, D-55101 Mainz, Germany	Johannes Gutenberg University of Mainz	Prange, R (corresponding author), Univ Mainz, Inst Med Microbiol & Hyg, Augustuspl, D-55101 Mainz, Germany.							Andrews DW, 1996, TRENDS BIOCHEM SCI, V21, P365; Berting A, 1995, INTERVIROLOGY, V38, P8, DOI 10.1159/000150409; Borel AC, 1996, CELL, V85, P379, DOI 10.1016/S0092-8674(00)81116-2; BRUSS V, 1994, EMBO J, V13, P2273, DOI 10.1002/j.1460-2075.1994.tb06509.x; BRUSS V, 1995, J VIROL, V69, P6652, DOI 10.1128/JVI.69.11.6652-6657.1995; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; DUNLOP J, 1995, EMBO J, V14, P3609, DOI 10.1002/j.1460-2075.1995.tb00030.x; EBLE BE, 1987, MOL CELL BIOL, V7, P3591, DOI 10.1128/MCB.7.10.3591; EBLE BE, 1990, J VIROL, V64, P1414, DOI 10.1128/JVI.64.3.1414-1419.1990; Foster W, 2000, J BIOL CHEM, V275, P34157, DOI 10.1074/jbc.M000165200; GERHARDT E, 1995, J VIROL, V69, P1201, DOI 10.1128/JVI.69.2.1201-1208.1995; Grgacic EVL, 2000, J VIROL, V74, P2455, DOI 10.1128/JVI.74.5.2455-2458.2000; Guo JT, 1997, J VIROL, V71, P1107, DOI 10.1128/JVI.71.2.1107-1114.1997; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; HEDGE RS, 1999, TRENDS CELL BIOL, V9, P132; HEDGE RS, 1998, MOL CELL, V2, P85; Hildt E, 1996, VIROLOGY, V225, P235, DOI 10.1006/viro.1996.0594; HUOVILA APJ, 1992, J CELL BIOL, V118, P1305, DOI 10.1083/jcb.118.6.1305; KRIJNSELOCKER J, 1992, J BIOL CHEM, V267, P21911; Le Seyec J, 1998, J VIROL, V72, P5573, DOI 10.1128/JVI.72.7.5573-5578.1998; Le Seyec J, 1999, J VIROL, V73, P2052, DOI 10.1128/JVI.73.3.2052-2057.1999; Levy D, 1996, Essays Biochem, V31, P49; LIPP J, 1989, J CELL BIOL, V109, P2013, DOI 10.1083/jcb.109.5.2013; Loffler-Mary H, 2000, VIROLOGY, V270, P358, DOI 10.1006/viro.2000.0268; LofflerMary H, 1997, VIROLOGY, V235, P144, DOI 10.1006/viro.1997.8689; Lu XY, 1996, J VIROL, V70, P2277, DOI 10.1128/JVI.70.4.2277-2285.1996; Lu Y, 2000, MOL BIOL CELL, V11, P2973, DOI 10.1091/mbc.11.9.2973; Mitchell DM, 1998, P NATL ACAD SCI USA, V95, P14733, DOI 10.1073/pnas.95.25.14733; Mothes W, 1997, CELL, V89, P523, DOI 10.1016/S0092-8674(00)80234-2; Nassal M, 1996, CURR TOP MICROBIOL, V214, P297; Oess S, 2000, GENE THER, V7, P750, DOI 10.1038/sj.gt.3301154; OSTAPCHUK P, 1994, EMBO J, V13, P1048, DOI 10.1002/j.1460-2075.1994.tb06353.x; PASTAN I, 1991, ANNU REV MED, V42, P277, DOI 10.1146/annurev.med.42.1.277; PRANGE R, 1992, J VIROL, V66, P5832, DOI 10.1128/JVI.66.10.5832-5841.1992; PRANGE R, 1995, EMBO J, V14, P247, DOI 10.1002/j.1460-2075.1995.tb06998.x; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Sansom MSP, 1998, BIOESSAYS, V20, P992, DOI 10.1002/(SICI)1521-1878(199812)20:12<992::AID-BIES5>3.0.CO;2-7; Satoh O, 2000, J BIOCHEM-TOKYO, V127, P543, DOI 10.1093/oxfordjournals.jbchem.a022639; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; STIRK HJ, 1992, INTERVIROLOGY, V33, P148, DOI 10.1159/000150244; Swameye I, 1997, J VIROL, V71, P9434, DOI 10.1128/JVI.71.12.9434-9441.1997; WESSELS HP, 1988, CELL, V55, P61, DOI 10.1016/0092-8674(88)90009-8; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; ZHANG JT, 1993, J BIOL CHEM, V268, P15101	44	74	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22265	22272		10.1074/jbc.M100956200	http://dx.doi.org/10.1074/jbc.M100956200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301328	hybrid			2022-12-27	WOS:000169412700041
J	Lardinois, OM; de Montellano, PRO				Lardinois, OM; de Montellano, PRO			H2O2-mediated cross-linking between lactoperoxidase and myoglobin - Elucidation of protein-protein radical transfer reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERM WHALE MYOGLOBIN; HYDROGEN-PEROXIDE; COMPOUND-I; HEME; METMYOGLOBIN; REDUCTION; SITE; IDENTIFICATION; DITYROSINE; OXIDATION	The H2O2-dependent reaction of lactoperoxidase (LPO) with sperm whale myoglobin (SwMb) or horse myoglobin (HoMb) produces LPO-Mb cross linked species, in addition to LPO and SwMb homodimers. The HoMb products are a LPO(HoMb) dimer and LPO(HoMb), trimer. Dityrosine cross-links are shown by their fluorescence to be present in the oligomeric products. Addition of H2O2 to myoglobin (Mb), followed by catalase to quench excess H2O2 before the addition of LPO, still yields LPO cross-linked products. LPO oligomerization therefore requires radical transfer from Rib to LPO. In contrast to native LPO, recombinant LPO undergoes little self-dimerization in the absence of Mb but occurs normally in its presence. Simultaneous addition of 3,5-dibromo-4-nitrosobenzenesulfonic acid (DBNBS) and LPO to activated Mb produces a spin-trapped radical electron paramagnetic resonance signal located primarily on LPO, confirming the radical transfer. Mutation of Tyr-103 or Tyr-151 in SwMb decreased cross-linking with LPO, but mutation of Tyr-146, Trp-7, or Trp-14 did not. However, because DBNBS-trapped LPO radicals were observed with all the mutants, DBNBS traps LPO radicals other than those involved in protein oligomerization. The results clearly establish that radical transfer occurs from Mb to LPO and suggest that intermolecularly transferred radicals may reside on residues other than those that are generated by intramolecular reactions.	Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ortiz@cgl.ucsf.edu			NIGMS NIH HHS [GM32488] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032488] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMADO R, 1984, METHOD ENZYMOL, V107, P377; ANDERSEN SO, 1966, ACTA PHYSL SCAND S, V66, P263; ANTONINI E, 1971, HEMOGLOBIN MYOGLOBIN, P44; CATALANO CE, 1989, J BIOL CHEM, V264, P10534; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; COURTIN F, 1984, BIOCHEM BIOPH RES CO, V121, P463, DOI 10.1016/0006-291X(84)90205-5; Davies MJ, 1999, FREE RADICAL BIO MED, V27, P1151, DOI 10.1016/S0891-5849(99)00206-3; DeGray JA, 1997, J BIOL CHEM, V272, P2359; DePillis GD, 1997, J BIOL CHEM, V272, P8857; DUNFORD HB, 1999, HEME PEROXIDASES, P20; Egawa T, 2000, J BIOL CHEM, V275, P34858, DOI 10.1074/jbc.M004026200; Fancy DA, 1998, BIOCHEM BIOPH RES CO, V247, P420, DOI 10.1006/bbrc.1998.8558; Fenwick CW, 1996, J AM CHEM SOC, V118, P12236, DOI 10.1021/ja962764d; FOERDER CA, 1977, P NATL ACAD SCI USA, V74, P4214, DOI 10.1073/pnas.74.10.4214; GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006; GIULIVI C, 1993, J BIOL CHEM, V268, P8752; GROSS AJ, 1959, J BIOL CHEM, V234, P1611; Irwin JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P94, DOI 10.1006/abbi.1998.0987; KING NK, 1967, BIOCHIM BIOPHYS ACTA, V133, P65; KING NK, 1963, J BIOL CHEM, V238, P1520; KOOSER RG, 1969, J CHEM PHYS, V50, P5243, DOI 10.1063/1.1671041; Lardinois OM, 1999, J BIOL CHEM, V274, P35441, DOI 10.1074/jbc.274.50.35441; Matsui T, 1999, J AM CHEM SOC, V121, P9952, DOI 10.1021/ja9914846; MIKI H, 1989, ARCH BIOCHEM BIOPHYS, V275, P354, DOI 10.1016/0003-9861(89)90382-2; OHLSSON PI, 1983, ACTA CHEM SCAND B, V37, P917, DOI 10.3891/acta.chem.scand.37b-0917; Ostdal H, 1997, FREE RADICAL BIO MED, V23, P754, DOI 10.1016/S0891-5849(97)00023-3; Ostdal H, 1999, ARCH BIOCHEM BIOPHYS, V362, P105, DOI 10.1006/abbi.1998.0988; RAO S, 1998, J BIOL CHEM, V268, P803; RICE RH, 1983, ARCH BIOCHEM BIOPHYS, V221, P417, DOI 10.1016/0003-9861(83)90160-1; SAHLIN M, 1987, BIOCHEMISTRY-US, V26, P5541, DOI 10.1021/bi00391a049; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; SPANGLER BD, 1986, BIOCHIM BIOPHYS ACTA, V872, P155; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; TEW D, 1988, J BIOL CHEM, V263, P17880; Thomas EL, 1985, LACTOPEROXIDASE SYST, P31; Tsai AL, 1999, J BIOL CHEM, V274, P21695, DOI 10.1074/jbc.274.31.21695; VOLKER V, 1992, P NATL ACAD SCI USA, V89, P996; WHITTAKER MM, 1990, J BIOL CHEM, V265, P9610; WILKS A, 1992, J BIOL CHEM, V267, P8827; Witting PK, 2000, J BIOL CHEM, V275, P20391, DOI 10.1074/jbc.M000373200; YONETANI T, 1967, J BIOL CHEM, V242, P1974	41	22	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23186	23191		10.1074/jbc.M102084200	http://dx.doi.org/10.1074/jbc.M102084200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11297563	hybrid			2022-12-27	WOS:000169412700160
J	Li, DL; Randhawa, VK; Patel, N; Hayashi, M; Klip, A				Li, DL; Randhawa, VK; Patel, N; Hayashi, M; Klip, A			Hyperosmolarity reduces GLUT4 endocytosis and increases its exocytosis from a VAMP2-independent pool in L6 muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SKELETAL-MUSCLE; RESPONSIVE GLUCOSE-TRANSPORTER; PROTEIN-KINASE-B; 3T3-L1 ADIPOCYTES; PHOSPHATIDYLINOSITOL 3-KINASE; PLASMA-MEMBRANE; OSMOTIC SHOCK; ADIPOSE-CELLS; SUBCELLULAR-DISTRIBUTION; POTASSIUM-DEPLETION	The intracellular traffic of the glucose transporter 4 (GLUT4) in muscle cells remains largely unexplored. Here we make use of L6 myoblasts stably expressing GLUT4 with an exofacially directed Myc-tag (GLUT4myc) to determine the exocytic and endocytic rates of the transporter. Insulin caused a rapid (t(1)/(2) = 4 min) gain, whereas hyperosmolarity (0.45 BI sucrose) caused a slow (t(1)/(2) = 20 min) gain in surface GLUT4myc molecules. With prior insulin stimulation followed by addition of hypertonic sucrose, the increase in surface GLUT4myc was partly additive. Unlike the effect of insulin, the GLUT4myc gain caused by hyperosmolarity was insensitive to wortmannin or to tetanus toxin cleavage of VAMP2 and VAMP3, Disappearance of GLUT4myc from the cell surface was rapid (t(1)/(2) = 1.5 min). Insulin had no effect on the initial rate of GLUT4myc internalization. In contrast, hyperosmolarity almost completely abolished GLUT4myc internalization. Surface GLUT4myc accumulation in response to hyperosmolarity was only partially blocked by inhibition of tyrosine kinases with erbstatin analog (erbstatin A) and genistein. However, neither inhibitor interfered with the ability of hyperosmolarity to block GLUT4myc internalization. We propose that hyperosmolarity increases surface GLUT4myc by preventing GLUT4 endocytosis and stimulating its exocytosis via a pathway independent of phosphatidylinositol 3-kinase activity and of VAMP2 or VAMP3. A tetanus toxin-insensitive v-SNARE such as TI-VAMP detected in these cells, might mediate mem brane fusion of the hyperosmolarity-sensitive pool.	Hosp Sick Children, Program Cell Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Klip, A (corresponding author), Hosp Sick Children, Program Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	amira@sickkids.on.ca						Al-Hasani H, 1998, J BIOL CHEM, V273, P17504, DOI 10.1074/jbc.273.28.17504; Aledo JC, 1997, BIOCHEM J, V325, P727, DOI 10.1042/bj3250727; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; CAIN CC, 1992, J BIOL CHEM, V267, P11681; Cheatham B, 1996, P NATL ACAD SCI USA, V93, P15169, DOI 10.1073/pnas.93.26.15169; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; Chen D, 1999, MOL CELL BIOL, V19, P4684; Chen D, 1997, J BIOL CHEM, V272, P27401, DOI 10.1074/jbc.272.43.27401; CZECH MP, 1993, J BIOL CHEM, V268, P9187; DELUCAFLAHERTY C, 1990, CELL, V62, P875, DOI 10.1016/0092-8674(90)90263-E; DOUEN AG, 1990, J BIOL CHEM, V265, P13427; Fletcher LM, 1999, BIOCHEM SOC T, V27, P677, DOI 10.1042/bst0270677; Foran PGP, 1999, J BIOL CHEM, V274, P28087, DOI 10.1074/jbc.274.40.28087; Foster LJ, 2000, AM J PHYSIOL-CELL PH, V279, pC877, DOI 10.1152/ajpcell.2000.279.4.C877; Foster LJ, 1999, AM J PHYSIOL-CELL PH, V276, pC1108, DOI 10.1152/ajpcell.1999.276.5.C1108; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Garza LA, 2000, J BIOL CHEM, V275, P2560, DOI 10.1074/jbc.275.4.2560; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; HARUTA T, 1995, J BIOL CHEM, V270, P27991; Hashiramoto M, 2000, MOL CELL BIOL, V20, P416, DOI 10.1128/MCB.20.1.416-427.2000; HEUSER J, 1989, J CELL BIOL, V108, P855, DOI 10.1083/jcb.108.3.855; HIRSHMAN MF, 1990, J BIOL CHEM, V265, P987; Hresko RC, 2000, J BIOL CHEM, V275, P18114, DOI 10.1074/jbc.M001937200; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Janez A, 2000, J BIOL CHEM, V275, P26870; JHUN BH, 1992, J BIOL CHEM, V267, P17710; KANAI F, 1993, BIOCHEM BIOPH RES CO, V195, P762, DOI 10.1006/bbrc.1993.2111; KANAI F, 1993, J BIOL CHEM, V268, P14523; Khayat ZA, 2000, J CELL SCI, V113, P279; KLIP A, 1990, BIOCHEM BIOPH RES CO, V172, P728, DOI 10.1016/0006-291X(90)90735-6; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; Lee W, 1999, J BIOL CHEM, V274, P37755, DOI 10.1074/jbc.274.53.37755; MITSUMOTO Y, 1992, J BIOL CHEM, V267, P4957; NISHIMURA H, 1993, J BIOL CHEM, V268, P19246; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; QUON MJ, 1995, MOL CELL BIOL, V15, P5403; RAMLAL T, 1988, BIOCHEM BIOPH RES CO, V157, P1329, DOI 10.1016/S0006-291X(88)81020-9; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Rao AW, 1998, J BIOL CHEM, V273, P25450, DOI 10.1074/jbc.273.39.25450; Rea S, 1998, J BIOL CHEM, V273, P18784, DOI 10.1074/jbc.273.30.18784; Rice JE, 1996, BIOCHEM SOC T, V24, P540, DOI 10.1042/bst0240540; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; SATOH S, 1993, J BIOL CHEM, V268, P17820; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Tonello F, 1996, ADV EXP MED BIOL, V389, P251; TSAKIRIDIS T, 1995, ENDOCRINOLOGY, V136, P4315, DOI 10.1210/en.136.10.4315; Ueyama A, 1999, AM J PHYSIOL-ENDOC M, V277, pE572, DOI 10.1152/ajpendo.1999.277.3.E572; VOLCHUK A, 1994, BIOCHEM J, V304, P139, DOI 10.1042/bj3040139; Volchuk A, 1998, J BIOL CHEM, V273, P8169, DOI 10.1074/jbc.273.14.8169; Volchuk A, 1996, MOL BIOL CELL, V7, P1075, DOI 10.1091/mbc.7.7.1075; VOLCHUK A, 1995, J BIOL CHEM, V270, P8233, DOI 10.1074/jbc.270.14.8233; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; YANG J, 1993, J BIOL CHEM, V268, P4600	56	82	85	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22883	22891		10.1074/jbc.M010143200	http://dx.doi.org/10.1074/jbc.M010143200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11297538	hybrid			2022-12-27	WOS:000169412700121
J	Schmitz, U; Thommes, K; Beier, I; Wagner, W; Sachinidis, A; Dusing, R; Vetter, H				Schmitz, U; Thommes, K; Beier, I; Wagner, W; Sachinidis, A; Dusing, R; Vetter, H			Angiotensin II-induced stimulation of p21-activated kinase and c-Jun NH2-terminal kinase is mediated by Rac1 and Nck	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; SIGNAL-REGULATED KINASE; ADAPTER PROTEIN; DIFFERENTIAL ACTIVATION; MEMBRANE LOCALIZATION; INDUCED HYPERTROPHY; CARDIAC MYOCYTES; TERMINAL KINASE	p21-activated kinase (PAK) has been shown to be an upstream mediator of JNK in angiotensin II (AngII) signaling. Little is known regarding other signaling molecules involved in activation of PAR and JNK by AngII. Rho family GTPases Pac and Cdc42 have been shown to enhance PAR activity by binding to pal-binding domain of PAR (PAK-PBD), In vascular smooth muscle cells (VSMC) AngII stimulated Rad binding to GST-PAK-PBD fusion protein. Pretreatment of VSMC by genistein inhibited AngII-induced Rad activation, whereas Src inhibitor PP1 had no effect. Inhibition of protein kinase C by phorbol 12,13-dibutyrate pretreatment also decreased AngII-mediated activation of Rac1. The adaptor molecule Nck has been shown previously to mediate PAR activation by facilitating translocation of PAR to the plasma membrane. In VSMC AngII stimulated translocation of Nck and PAK to the membrane fraction. Overexpression of dominant-negative Nck in Chinese hamster ovary (CHO) cells, stably expressing the AngII type I receptor (CHO-AT1), inhibited both PAK and JNK activation by AngII, whereas it did not affect ERK1/2. Finally, dominant-negative Nck inhibited AngII-induced DNA synthesis in CHO-AT1 cells. Our data provide evidence for Rad and Nck as upstream mediators of PAR and JNK in AngII signaling and implicate JNK in AngII-induced growth responses.	Med Univ Poliklin, D-53111 Bonn, Germany	University of Bonn	Schmitz, U (corresponding author), Med Univ Poliklin, Wilhelmstr 35-37, D-53111 Bonn, Germany.		Sachinidis, Agapios/AAD-4178-2020; Sachinidis, Agapios/AAM-7988-2020					BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Becker E, 2000, MOL CELL BIOL, V20, P1537, DOI 10.1128/MCB.20.5.1537-1545.2000; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BERK BC, 1989, HYPERTENSION, V13, P305, DOI 10.1161/01.HYP.13.4.305; Bokemeyer D, 2000, KIDNEY INT, V58, P549, DOI 10.1046/j.1523-1755.2000.t01-1-00201.x; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Dimmeler S, 1997, CIRC RES, V81, P970; DUFF JL, 1992, BIOCHEM BIOPH RES CO, V188, P257, DOI 10.1016/0006-291X(92)92378-B; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Eguchi S, 1996, J BIOL CHEM, V271, P14169, DOI 10.1074/jbc.271.24.14169; Eguchi S, 2001, J BIOL CHEM, V276, P7957, DOI 10.1074/jbc.M008570200; Force T, 1996, CIRC RES, V78, P947, DOI 10.1161/01.RES.78.6.947; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Haendeler J, 2000, CIRC RES, V86, P729, DOI 10.1161/01.RES.86.7.729; Heeneman S, 2000, J BIOL CHEM, V275, P15926, DOI 10.1074/jbc.M909616199; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Kim S, 1998, CIRCULATION, V97, P1731, DOI 10.1161/01.CIR.97.17.1731; Kusuhara M, 1998, CIRC RES, V83, P824, DOI 10.1161/01.RES.83.8.824; LEHMANN JM, 1990, NUCLEIC ACIDS RES, V18, P1048, DOI 10.1093/nar/18.4.1048; Lu WG, 1999, ONCOGENE, V18, P797, DOI 10.1038/sj.onc.1202361; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Marrero MB, 1997, J BIOL CHEM, V272, P24684, DOI 10.1074/jbc.272.39.24684; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Murasawa S, 1998, CIRC RES, V82, P1338, DOI 10.1161/01.RES.82.12.1338; Murasawa S, 2000, J BIOL CHEM, V275, P26856; NISHIMURA R, 1993, MOL CELL BIOL, V13, P6889, DOI 10.1128/MCB.13.11.6889; PARK D, 1992, MOL CELL BIOL, V12, P5816, DOI 10.1128/MCB.12.12.5816; Pyles JM, 1997, CIRC RES, V81, P904; Sachinidis A, 1999, ARTERIOSCL THROM VAS, V19, P2412, DOI 10.1161/01.ATV.19.10.2412; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Schieffer B, 1996, J BIOL CHEM, V271, P10329, DOI 10.1074/jbc.271.17.10329; Schmitz U, 1997, TRENDS ENDOCRIN MET, V8, P261, DOI 10.1016/S1043-2760(97)00101-X; Schmitz U, 1998, CIRC RES, V82, P1272, DOI 10.1161/01.RES.82.12.1272; Schmitz U, 1997, CIRC RES, V81, P550, DOI 10.1161/01.RES.81.4.550; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Servant MJ, 1996, J BIOL CHEM, V271, P16047, DOI 10.1074/jbc.271.27.16047; Stein E, 1998, J BIOL CHEM, V273, P1303, DOI 10.1074/jbc.273.3.1303; TANAKA M, 1995, MOL CELL BIOL, V15, P6829; TEO M, 1995, J BIOL CHEM, V270, P26690, DOI 10.1074/jbc.270.44.26690; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Viedt C, 2000, ARTERIOSCL THROM VAS, V20, P940, DOI 10.1161/01.ATV.20.4.940; Wen Y, 2000, BIOCHEM J, V349, P481, DOI 10.1042/0264-6021:3490481; Wilkie N, 1996, J BIOL CHEM, V271, P32447, DOI 10.1074/jbc.271.50.32447; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yano P, 1998, CIRC RES, V83, P752, DOI 10.1161/01.RES.83.7.752; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhao ZS, 2000, MOL CELL BIOL, V20, P3906, DOI 10.1128/MCB.20.11.3906-3917.2000	55	53	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22003	22010		10.1074/jbc.M102450200	http://dx.doi.org/10.1074/jbc.M102450200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11279250	hybrid			2022-12-27	WOS:000169412700004
J	Beutner, G; Sharma, VK; Giovannucci, DR; Yule, DI; Sheu, SS				Beutner, G; Sharma, VK; Giovannucci, DR; Yule, DI; Sheu, SS			Identification of a ryanodine receptor in rat heart mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CARDIAC SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE CHANNEL; CA2+ RELEASE; ADENINE-NUCLEOTIDE; SKELETAL; BINDING; MODULATION; DANTROLENE; PHOSPHORYLATION	Recent studies have shown that, in a wide variety of cells, mitochondria respond dynamically to physiological changes in cytosolic Ca2+ concentrations ([Ca2+](c)). Mitochondrial Ca2+ uptake occurs via a ruthenium red-sensitive calcium uniporter and a rapid mode of Ca2+ uptake. Surprisingly, the molecular identity of these Ca2+ transport proteins is still unknown. Using electron microscopy and Western blotting, we identified a ryanodine receptor in the inner mitochondrial membrane with a molecular mass of approximately 600 kDa in mitochondria isolated from the rat heart. [H-3]Ryanodine binds to this mitochondrial ryanodine receptor with high affinity. This binding is modulated by Ca2+ but not caffeine and is inhibited by Mg2+ and ruthenium red in the assay medium. In the presence of ryanodine, Ca2+ uptake into isolated heart mitochondria is suppressed, In addition, ryanodine inhibited mitochondrial swelling induced by Ca2+ overload. This swelling effect was not observed when Ca2+ was applied to the cytosolic fraction containing sarcoplasmic reticulum. These results are the first to identify a mitochondrial Ca2+ transport protein that has characteristics similar to the ryanodine receptor. This mitochondrial ryanodine receptor is likely to play an essential role in the dynamic uptake of Ca2+ into mitochondria during Ca2+ oscillations.	Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester	Sheu, SS (corresponding author), Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Box 711,601 Elmwood Ave, Rochester, NY 14642 USA.	sheyshing_sheu@urmc.rochester.edu	Giovannucci, David R/A-5657-2018; Sheu, Shey-Shing/Y-4009-2019	Sheu, Shey-Shing/0000-0003-3838-3601	NHLBI NIH HHS [HL-33333] Funding Source: Medline; NIDDK NIH HHS [DK-54568] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK054568, R01DK054568] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833; Beal MF, 1996, CURR OPIN NEUROBIOL, V6, P661, DOI 10.1016/S0959-4388(96)80100-0; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Chacon E, 1996, FEBS LETT, V382, P31, DOI 10.1016/0014-5793(96)00138-X; Duchen MR, 1998, J CELL BIOL, V142, P975, DOI 10.1083/jcb.142.4.975; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Fratea S, 1997, ANESTHESIOLOGY, V86, P205, DOI 10.1097/00000542-199701000-00025; Fruen BR, 1997, J BIOL CHEM, V272, P26965, DOI 10.1074/jbc.272.43.26965; Giovannucci DR, 2000, J BIOL CHEM, V275, P33704, DOI 10.1074/jbc.M004278200; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HAKAMATA Y, 1994, FEBS LETT, V352, P206, DOI 10.1016/0014-5793(94)00955-4; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; HERRERA GA, 1989, ULTRASTRUCT PATHOL, V13, P485, DOI 10.3109/01913128909074532; HOLMBERG SRM, 1990, BIOCHIM BIOPHYS ACTA, V1022, P187, DOI 10.1016/0005-2736(90)90113-3; Huser J, 2000, J BIOENERG BIOMEMBR, V32, P27, DOI 10.1023/A:1005556227425; INUI M, 1987, J BIOL CHEM, V262, P15637; JENSEN KLD, 1992, ULTRASTRUCT PATHOL, V16, P51, DOI 10.3109/01913129209074550; KIJIMA Y, 1993, J BIOL CHEM, V268, P3499; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; LINDSAY ARG, 1991, BIOCHIM BIOPHYS ACTA, V1064, P89, DOI 10.1016/0005-2736(91)90415-5; Liu W, 1998, AM J PHYSIOL-CELL PH, V274, pC120, DOI 10.1152/ajpcell.1998.274.1.C120; MAK DOD, 1994, J BIOL CHEM, V269, P29375; MCCORMACK JG, 1993, BIOCHEM SOC T, V21, P793, DOI 10.1042/bst0210793; MCGREW SG, 1989, BIOCHEMISTRY-US, V28, P1686, DOI 10.1021/bi00430a039; Meissner A, 1999, EUR J HEART FAIL, V1, P177, DOI 10.1016/S1388-9842(99)00017-3; MEISSNER G, 1986, BIOCHEMISTRY-US, V25, P236, DOI 10.1021/bi00349a033; MEISSNER G, 1987, J BIOL CHEM, V262, P3065; Munger SD, 2000, J BIOL CHEM, V275, P20450, DOI 10.1074/jbc.M001989200; Nassar A, 2000, J BIOL CHEM, V275, P23661, DOI 10.1074/jbc.M000457200; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Ogata T, 1997, ANAT REC, V248, P214; OHLENDIECK K, 1986, BIOCHIM BIOPHYS ACTA, V860, P672, DOI 10.1016/0005-2736(86)90567-5; PESSAH IN, 1985, BIOCHEM BIOPH RES CO, V128, P449, DOI 10.1016/0006-291X(85)91699-7; PESSAH IN, 1987, MOL PHARMACOL, V31, P232; PETRONILLI V, 1993, J BIOL CHEM, V268, P21939; Putney JW, 1997, CELL CALCIUM, V21, P257, DOI 10.1016/S0143-4160(97)90050-6; REHNCRONA S, 1979, STROKE, V10, P437, DOI 10.1161/01.STR.10.4.437; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Sharma VK, 2000, J BIOENERG BIOMEMBR, V32, P97, DOI 10.1023/A:1005520714221; SHEU SS, 1994, J BIOENERG BIOMEMBR, V26, P487, DOI 10.1007/BF00762733; Simpson PB, 1996, J BIOL CHEM, V271, P33493, DOI 10.1074/jbc.271.52.33493; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; Szalai G, 2000, J BIOL CHEM, V275, P15305, DOI 10.1074/jbc.275.20.15305; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Xu L, 1999, J BIOL CHEM, V274, P32680, DOI 10.1074/jbc.274.46.32680; Yamaki H, 1998, J DENT RES, V77, P1807, DOI 10.1177/00220345980770100801; ZIMANYI I, 1991, J PHARMACOL EXP THER, V256, P938	50	191	199	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21482	21488		10.1074/jbc.M101486200	http://dx.doi.org/10.1074/jbc.M101486200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11297554	hybrid			2022-12-27	WOS:000169297900092
J	Legaigneur, P; Breton, C; El Battari, A; Guillemot, JC; Auge, C; Malissard, M; Berger, EG; Ronin, C				Legaigneur, P; Breton, C; El Battari, A; Guillemot, JC; Auge, C; Malissard, M; Berger, EG; Ronin, C			Exploring the acceptor substrate recognition of the human beta-galactoside alpha 2,6-sialyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; GOLGI LOCALIZATION; HUMAN THYROTROPIN; POLYSIALIC ACID; GLYCOSYLTRANSFERASES; EXPRESSION; GLYCOPROTEIN; ALPHA-2,3-SIALYLTRANSFERASE; SIALYLTRANSFERASES; FAMILY	Human beta1,4-galactoside alpha2,6-sialyltransferase I (ST6GalI) recognition of glycoprotein accepters has been investigated using various soluble forms of the enzyme deleted to a variable extent in the N-terminal half of the polypeptide. Full-length and truncated forms of the enzyme have been investigated with respect to their specificity for a variety of desialylated glycoproteins of known complex glycans as well as related proteins with different carbohydrate chains. Differences in transfer efficiency have been observed between membrane and soluble enzymatic forms, indicating that deletion of the transmembrane fragment induces loss of acceptor preference. No difference in substrate recognition could be observed when soluble enzymes of similar peptide sequence were produced in yeast or mammalian cells, confirming that removal of the membrane anchor and heterologous expression do not alter enzyme folding and activity. When tested on free oligosaccharides, soluble ST6GalI displayed full ability to sialylate free N-glycans as well as various N-acetyllactosaminyl substrates. Progressive truncation of the N terminus demonstrated that the catalytic domain can proceed with sialic acid transfer with increased efficiency until 80 amino acids are deleted. Fusion of the ST6GalI catalytic domain to the N-terminal half of an unrelated transferase (core 2 beta1,6-N-acetylglucosaminyltransferase) further showed that a chimeric form of broad acceptor specificity and high activity could also be engineered in vivo, These findings therefore delineate a peptide region of similar to 50 amino acids within the ST6GalI stem region that governs both the preference for glycoprotein accepters and catalytic activity, thereby suggesting that it may exert a steric control on the catalytic domain.	CNRS, UPR 9024, F-13402 Marseille 20, France; CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble 9, France; INSERM, U260, F-13335 Marseille 5, France; Univ Paris 11, UMR 8614, Inst Chim Mol & Organ, F-91405 Orsay, France; Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Zurich	Ronin, C (corresponding author), CNRS, UPR 9024, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	ronin@irlnb.cnrs-mrs.fr						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Burger PC, 1998, GLYCOBIOLOGY, V8, P245, DOI 10.1093/glycob/8.3.245; CANONNE C, 1995, GLYCOBIOLOGY, V5, P473, DOI 10.1093/glycob/5.5.473; Cho SK, 1997, J BIOL CHEM, V272, P13622, DOI 10.1074/jbc.272.21.13622; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; DATTA AK, 1995, J BIOL CHEM, V270, P1497, DOI 10.1074/jbc.270.4.1497; Datta AK, 1998, J BIOL CHEM, V273, P9608, DOI 10.1074/jbc.273.16.9608; Datta AK, 1997, INDIAN J BIOCHEM BIO, V34, P157; Dupuy F, 1999, J BIOL CHEM, V274, P12257, DOI 10.1074/jbc.274.18.12257; FENOUILLET E, 1986, J BIOL CHEM, V261, P5153; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; GEREMIA RA, 1997, GLYCOBIOLOGY, V2, pR5; Grossmann M, 1997, ENDOCR REV, V18, P476, DOI 10.1210/er.18.4.476; GRUNDMANN U, 1990, NUCLEIC ACIDS RES, V18, P667, DOI 10.1093/nar/18.3.667; HarduinLepers A, 1995, GLYCOBIOLOGY, V5, P741, DOI 10.1093/glycob/5.8.741; Ikehara Y, 1999, FEBS LETT, V463, P92, DOI 10.1016/S0014-5793(99)01605-1; JOZIASSE DH, 1992, J BIOL CHEM, V267, P5534; Kiss JZ, 1997, CURR OPIN NEUROBIOL, V7, P640, DOI 10.1016/S0959-4388(97)80083-9; KITAGAWA H, 1993, BIOCHEM BIOPH RES CO, V194, P375, DOI 10.1006/bbrc.1993.1830; KITAZUMEKAWAGUC.S, 1999, GLYCOBIOLOGY, V9, P841; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; KOJIMA N, 1994, BIOCHEMISTRY-US, V33, P5772, DOI 10.1021/bi00185a014; Kurosawa N, 1996, J BIOL CHEM, V271, P15109, DOI 10.1074/jbc.271.25.15109; KUROSAWA N, 1994, J BIOL CHEM, V269, P1402; Lee YC, 1999, J BIOL CHEM, V274, P11958, DOI 10.1074/jbc.274.17.11958; LEGAULT DJ, 1995, J BIOL CHEM, V270, P20987, DOI 10.1074/jbc.270.36.20987; Ma JY, 1997, J BIOL CHEM, V272, P672; Malissard M, 2000, BIOCHEM BIOPH RES CO, V267, P169, DOI 10.1006/bbrc.1999.1946; MATTOX S, 1992, ANAL BIOCHEM, V206, P430, DOI 10.1016/0003-2697(92)90389-O; NEMANSKY M, 1995, EUR J BIOCHEM, V227, P880, DOI 10.1111/j.1432-1033.1995.tb20214.x; PAULSON JC, 1977, J BIOL CHEM, V252, P2363; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Ronin C, 1998, CLIN CHEM LAB MED, V36, P373, DOI 10.1515/CCLM.1998.063; Sjoberg ER, 1996, J BIOL CHEM, V271, P7450, DOI 10.1074/jbc.271.13.7450; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuji S, 1996, J BIOCHEM-TOKYO, V120, P1; Tsuji S, 1996, GLYCOBIOLOGY, V6, pR5; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; VanDorst JALM, 1996, EUR J BIOCHEM, V242, P674; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Warner TG, 1999, GLYCOBIOLOGY, V9, P841, DOI 10.1093/glycob/9.9.841; WLASICHUK KB, 1993, J BIOL CHEM, V268, P13971; Xu XH, 1996, J BIOL CHEM, V271, P8818, DOI 10.1074/jbc.271.15.8818; Yeh JC, 1997, GLYCOBIOLOGY, V7, P241, DOI 10.1093/glycob/7.2.241; Zerfaoui M, 2000, EUR J BIOCHEM, V267, P53, DOI 10.1046/j.1432-1327.2000.00958.x; Zhu GF, 1998, GLYCOBIOLOGY, V8, P831, DOI 10.1093/glycob/8.8.831	50	46	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21608	21617		10.1074/jbc.M100860200	http://dx.doi.org/10.1074/jbc.M100860200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279145	hybrid			2022-12-27	WOS:000169297900108
J	Shih, SF; Wu, YH; Hung, CH; Yang, HY; Lin, JY				Shih, SF; Wu, YH; Hung, CH; Yang, HY; Lin, JY			Abrin triggers cell death by inactivating a thiol-specific antioxidant protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PEROXIDE REDUCTASE; INDUCED APOPTOSIS; PHASE-I; CONTINUOUS-INFUSION; ENDOTHELIAL-CELLS; HYDROGEN-PEROXIDE; A-CHAIN; RICIN; IMMUNOTOXIN; ACTIVATION	Abrin A-chain (ABRA) inhibits protein synthesis by its N-glycosidase activity as well as induces apoptosis, but the molecular mechanism of ABRA-induced cell death has been obscure. Using an ABRA mutant that lacks N-glycosidase activity as bait in a yeast two-hybrid system, a 30-kDa antioxidant protein-1 (AOP-1) was found to be an ABRA(E164Q)-interacting protein. The interaction was further confirmed in vitro by a glutathione S-transferase pull-down assay. The colocalization of endogenous AOP-1 and exogenous ABR proteins in the cell was demonstrated by confocal immunofluorescence, We also demonstrated that ABRA attenuates AOP-1 antioxidant activity in a dose-dependent manner and the intracellular level of reactive oxygen species (ROS) increases in ABR-treated cells. Moreover, ROS scavengers N-acetylcysteine and 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl delayed programmed cell death. This indicates that ROS are important mediators of ABR-induced apoptosis, When ectopically expressed, AOP-1 blocked the release of cytochrome c and prevented apoptosis in ABR-treated cells. These findings suggest that the binding of ABRA to AOP-1 promotes apoptosis by inhibiting the mitochondrial antioxidant protein AOP-1, resulting in the increase of intracellular ROS and the release of cytochrome c from the mitochondria to the cytosol, which activates caspase-9 and caspase-3.	Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10081, Taiwan	National Taiwan University	Lin, JY (corresponding author), Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10081, Taiwan.	jylin@ha.mc.ntu.edu.tw	Lin, Jung-Yaw/AGW-9336-2022	Lin, Jung-Yaw/0000-0002-6341-1160				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMLOT PL, 1993, BLOOD, V82, P2624; Araki M, 1999, J BIOL CHEM, V274, P2271, DOI 10.1074/jbc.274.4.2271; BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; Baluna R, 1999, P NATL ACAD SCI USA, V96, P3957, DOI 10.1073/pnas.96.7.3957; Baluna R, 2000, EXP CELL RES, V258, P417, DOI 10.1006/excr.2000.4954; BASS DA, 1983, J IMMUNOL, V130, P1910; Bohler T, 2000, CYTOKINE, V12, P986, DOI 10.1006/cyto.1999.0633; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chen JK, 1997, PROTEIN ENG, V10, P827, DOI 10.1093/protein/10.7.827; Constantini P., 1996, J BIOL CHEM, V271, P6746; COSSARIZZA A, 1995, EXP CELL RES, V220, P232, DOI 10.1006/excr.1995.1311; Geier A, 1996, CANCER INVEST, V14, P435, DOI 10.3109/07357909609018901; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; GROSSBARD ML, 1993, J CLIN ONCOL, V11, P726, DOI 10.1200/JCO.1993.11.4.726; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; Hughes JN, 1996, HUM EXP TOXICOL, V15, P443, DOI 10.1177/096032719601500513; Ivanov VN, 1999, J BIOL CHEM, V274, P14079, DOI 10.1074/jbc.274.20.14079; Jacobson MD, 1996, TRENDS BIOCHEM SCI, V21, P83, DOI 10.1016/0968-0004(96)20008-8; Jaschke A, 1998, J MOL BIOL, V277, P763, DOI 10.1006/jmbi.1998.1644; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Karbowski M, 1999, BBA-MOL CELL RES, V1449, P25, DOI 10.1016/S0167-4889(98)00167-0; Keppler-Hafkemeyer A, 1998, BIOCHEMISTRY-US, V37, P16934, DOI 10.1021/bi980995m; Kessel D, 1999, CELL DEATH DIFFER, V6, P28, DOI 10.1038/sj.cdd.4400446; KIM KW, 1988, J BIOL CHEM, V263, P4704; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; Komatsu N, 1998, J BIOCHEM-TOKYO, V124, P1038, DOI 10.1093/oxfordjournals.jbchem.a022197; Li PF, 1999, FEBS LETT, V448, P206, DOI 10.1016/S0014-5793(99)00370-1; LIN JY, 1970, NATURE, V227, P292, DOI 10.1038/227292a0; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Miller J. H, 1972, EXPT MOL GENETICS; Nett JH, 1998, J BIOL CHEM, V273, P8652, DOI 10.1074/jbc.273.15.8652; Parrizas M, 1997, J BIOL CHEM, V272, P154; Pedrajas JR, 2000, J BIOL CHEM, V275, P16296, DOI 10.1074/jbc.275.21.16296; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; SAUSVILLE EA, 1995, BLOOD, V85, P3457, DOI 10.1182/blood.V85.12.3457.bloodjournal85123457; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Stone MJ, 1996, BLOOD, V88, P1188, DOI 10.1182/blood.V88.4.1188.bloodjournal8841188; Tanudji M, 1999, J BIOL CHEM, V274, P1286, DOI 10.1074/jbc.274.3.1286; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TSUJI K, 1995, BIOCHEM J, V307, P377, DOI 10.1042/bj3070377; VITETTA ES, 1993, IMMUNOL TODAY, V14, P252, DOI 10.1016/0167-5699(93)90041-I; VITETTA ES, 1991, CANCER RES, V51, P4052; Watabe S, 1997, EUR J BIOCHEM, V249, P52, DOI 10.1111/j.1432-1033.1997.t01-1-00052.x; Ye JP, 1999, J BIOL CHEM, V274, P34974, DOI 10.1074/jbc.274.49.34974; Zhuang LH, 1999, J IMMUNOL, V162, P1440; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	51	77	82	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21870	21877		10.1074/jbc.M100571200	http://dx.doi.org/10.1074/jbc.M100571200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11285261	hybrid			2022-12-27	WOS:000169297900139
J	Tagliarino, C; Pink, JJ; Dubyak, GR; Nieminen, AL; Boothman, DA				Tagliarino, C; Pink, JJ; Dubyak, GR; Nieminen, AL; Boothman, DA			Calcium is a key signaling molecule in beta-lapachone-mediated cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; MITOCHONDRIAL PERMEABILITY TRANSITION; CYTOSOLIC CA-2+ CONCENTRATION; BCL-X-L; DT-DIAPHORASE; INDUCED APOPTOSIS; OXIDATIVE STRESS; LYMPHOMA-CELLS; CYTO-TOXICITY; CYTOCHROME-C	beta -Lapachone (beta -Lap) triggers apoptosis in a number of human breast and prostate cancer cell lines through a unique apoptotic pathway that is dependent upon NQO1, a two-electron reductase. Downstream signaling pathway(s) that initiate apoptosis following treatment with beta -Lap have not been elucidated, Since calpain activation was suspected in beta -Lap-mediated apoptosis, we examined alterations in Ca2+ homeostasis using NQO1-expressing MCF-7 cells. beta -Lap-exposed MCF-7 cells exhibited an early increase in intracellular cytosolic Ca2+, from endoplasmic reticulum Ca2+ stores, comparable to thapsigargin exposures. 1,2-Bis-(2-aminophenoxy) ethane-N,N,N ' ,N ' -tetraacetic acid-acetoxymethyl ester, an intracellular Ca2+ chelator, blocked early increases in Ca2+ levels and inhibited beta -Lap-mediated mitochondrial membrane depolarization, intracellular ATP depletion, specific and unique substrate proteolysis, and apoptosis, The extracellular Ca2+ chelator, EGTA, inhibited later apoptotic end points (observed >8 h, e.g. substrate proteolysis and DNA fragmentation), suggesting that later execution events were triggered by Ca2+ influxes from the extracellular milieu. Collectively, these data suggest a critical, but not sole, role for Ca2+ in the NQO1-dependent cell death pathway initiated by beta -Lap. Use of beta -Lap to trigger an apparently novel, calpain like-mediated apoptotic cell death could be useful for breast and prostate cancer therapy.	Case Western Reserve Univ, Dept Radiat Oncol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Anat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Boothman, DA (corresponding author), Case Western Reserve Univ, Dept Radiat Oncol, 10900 Euclid Ave,BRB-326 E, Cleveland, OH 44106 USA.		Boothman, David/Q-7776-2019	Dubyak, George/0000-0001-9720-4226	NATIONAL CANCER INSTITUTE [R01CA102792, R01CA092250] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA102792, R01 CA092250] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKERMAN KEO, 1978, BIOCHIM BIOPHYS ACTA, V502, P359, DOI 10.1016/0005-2728(78)90056-7; AKMAN SA, 1987, J PHARMACOL EXP THER, V240, P486; Beigi RD, 2000, J IMMUNOL, V165, P7189, DOI 10.4049/jimmunol.165.12.7189; BELLOMO G, 1982, J BIOL CHEM, V257, P1558; Budd SL, 2000, P NATL ACAD SCI USA, V97, P6161, DOI 10.1073/pnas.100121097; CHOI MSK, 1995, EUR J IMMUNOL, V25, P1352, DOI 10.1002/eji.1830250533; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; DIMONTE D, 1984, ARCH BIOCHEM BIOPHYS, V235, P343, DOI 10.1016/0003-9861(84)90207-8; Distelhorst CW, 1996, CELL CALCIUM, V19, P473, DOI 10.1016/S0143-4160(96)90056-1; Distelhorst CW, 1998, BLOOD, V91, P731, DOI 10.1182/blood.V91.3.731.731_731_734; Eguchi Y, 1999, CANCER RES, V59, P2174; Fang M, 1998, CANCER LETT, V127, P113, DOI 10.1016/S0304-3835(98)00023-8; FREI B, 1986, BIOCHEMISTRY-US, V25, P4438, DOI 10.1021/bi00363a040; Froelich CJ, 1996, BIOCHEM BIOPH RES CO, V227, P658, DOI 10.1006/bbrc.1996.1565; GAIDO ML, 1991, J BIOL CHEM, V266, P18580; GERSCHENSON LE, 1992, FASEB J, V6, P2450, DOI 10.1096/fasebj.6.7.1563596; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HOLLANDER PM, 1975, ARCH BIOCHEM BIOPHYS, V169, P560, DOI 10.1016/0003-9861(75)90200-3; HOSODA S, 1974, J BIOL CHEM, V249, P6416; Inai Y, 1997, CELL STRUCT FUNCT, V22, P555, DOI 10.1247/csf.22.555; IYANAGI T, 1970, BIOCHIM BIOPHYS ACTA, V216, P282, DOI 10.1016/0005-2728(70)90220-3; Jackisch C, 2000, CLIN CANCER RES, V6, P2844; JEWELL SA, 1982, SCIENCE, V217, P1257, DOI 10.1126/science.7112127; JIANG S, 1994, EXP CELL RES, V212, P84, DOI 10.1006/excr.1994.1121; KANEKO Y, 1994, CANCER LETT, V79, P147, DOI 10.1016/0304-3835(94)90253-4; Kim JE, 1999, J NEUROCHEM, V72, P2456, DOI 10.1046/j.1471-4159.1999.0722456.x; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Kurokawa H, 1999, ONCOL REP, V6, P33; LEVICK V, 1995, BRAIN RES, V676, P325, DOI 10.1016/0006-8993(95)00115-7; Li CJ, 1999, P NATL ACAD SCI USA, V96, P13369, DOI 10.1073/pnas.96.23.13369; LI CJ, 1995, CANCER RES, V55, P3712; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li YZ, 1999, MOL MED, V5, P232, DOI 10.1007/BF03402120; Lotem J, 1998, P NATL ACAD SCI USA, V95, P4601, DOI 10.1073/pnas.95.8.4601; Manna SK, 1999, BIOCHEM PHARMACOL, V57, P763, DOI 10.1016/S0006-2952(98)00354-2; Marin A, 1997, BRIT J CANCER, V76, P923, DOI 10.1038/bjc.1997.485; Marks AR, 1997, AM J PHYSIOL-HEART C, V272, pH597, DOI 10.1152/ajpheart.1997.272.2.H597; MARTIKAINEN P, 1990, PROSTATE, V17, P175, DOI 10.1002/pros.2990170302; McColl KS, 1998, MOL CELL ENDOCRINOL, V139, P229, DOI 10.1016/S0303-7207(98)00051-3; McConkey David J., 1996, Scanning Microscopy, V10, P777; MCCONKEY DJ, 1989, J IMMUNOL, V143, P1801; McConkey DJ, 1997, BIOCHEM BIOPH RES CO, V239, P357, DOI 10.1006/bbrc.1997.7409; MCCONKEY DJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P365, DOI 10.1016/0003-9861(89)90119-7; MEHENDALE HM, 1985, EUR J BIOCHEM, V149, P201, DOI 10.1111/j.1432-1033.1985.tb08912.x; MIRABELLI F, 1988, ARCH BIOCHEM BIOPHYS, V264, P261, DOI 10.1016/0003-9861(88)90593-0; NICOTERA P, 1988, TOXICOLOGY, V52, P55, DOI 10.1016/0300-483X(88)90196-5; Pariat M, 1997, MOL CELL BIOL, V17, P2806, DOI 10.1128/MCB.17.5.2806; Patel T, 1996, FASEB J, V10, P587, DOI 10.1096/fasebj.10.5.8621058; Petersen A, 2000, BRAIN RES, V857, P20, DOI 10.1016/S0006-8993(99)02320-3; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Pink JJ, 2000, EXP CELL RES, V255, P144, DOI 10.1006/excr.1999.4790; PLANCHON SM, 1995, CANCER RES, V55, P3706; Qi XM, 1997, ONCOGENE, V15, P1207, DOI 10.1038/sj.onc.1201290; REDEGELD FAM, 1989, ARCH BIOCHEM BIOPHYS, V273, P215, DOI 10.1016/0003-9861(89)90181-1; REDEGELD FAM, 1990, ARCH BIOCHEM BIOPHYS, V280, P130, DOI 10.1016/0003-9861(90)90527-6; RICHTER C, 1993, FEBS LETT, V325, P104, DOI 10.1016/0014-5793(93)81423-W; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; SAXENA K, 1995, ARCH BIOCHEM BIOPHYS, V317, P79, DOI 10.1006/abbi.1995.1138; SMITH PF, 1987, TOXICOL APPL PHARM, V89, P190, DOI 10.1016/0041-008X(87)90040-8; Srivastava RK, 1999, MOL CELL BIOL, V19, P5659; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tang DM, 2000, J BIOL CHEM, V275, P9303, DOI 10.1074/jbc.275.13.9303; Urbano A, 1998, J BIOL CHEM, V273, P34820, DOI 10.1074/jbc.273.52.34820; Waring P, 1996, EXP CELL RES, V227, P264, DOI 10.1006/excr.1996.0276; Wertz IE, 2000, J BIOL CHEM, V275, P11470, DOI 10.1074/jbc.275.15.11470; Wuerzberger SM, 1998, CANCER RES, V58, P1876; Yakovlev AG, 2000, J BIOL CHEM, V275, P21302, DOI 10.1074/jbc.M001087200; Yao Y, 1997, J GEN PHYSIOL, V109, P703, DOI 10.1085/jgp.109.6.703	70	131	140	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19150	19159		10.1074/jbc.M100730200	http://dx.doi.org/10.1074/jbc.M100730200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279125	hybrid			2022-12-27	WOS:000169091000070
J	Rangaraj, P; Ruttimann-Johnson, C; Shah, VK; Ludden, PW				Rangaraj, P; Ruttimann-Johnson, C; Shah, VK; Ludden, PW			Accumulation of Fe-55-labeled precursors of the iron-molybdenum cofactor of nitrogenase on NifH and NifX of Azotobacter vinelandii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO BIOSYNTHESIS; ENCODED APODINITROGENASE; NUCLEOTIDE-SEQUENCE; PROTEIN; DINITROGENASE; PURIFICATION; GENE; MATURATION; CLUSTER; EXPRESSION	Iron-molybdenum cofactor (FeMo-co) biosynthesis involves the participation of several proteins. We have used Fe-55-labeled NifB-co, the specific iron and sulfur donor to FeMo-co, to investigate the accumulation of protein-bound precursors of FeMo-co. The Fe-55 label from radiolabeled NifB-co became associated with two major protein bands when the in vitro FeMo-co synthesis reaction was carried out with the extract of an Azotobacter vinelandii mutant lacking apodinitrogenase. One of the bands, termed Fe-55-labeled upper band, was purified and shown to be NifH by immunoblot analysis. The Fe-55-labeled lower band was identified as NifX by N-terminal sequencing, NifX purified from an A. vinelandii nifB strain showed a different electrophoretic mobility on anoxic native gels than did NifX with the FeMo-co precursor bound.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Coll Agr & Life Sci, Ctr Study Nitrogen Fixat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ludden, PW (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Ave, Madison, WI 53706 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035332, R37GM035332] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 35332] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen RM, 1999, J BIOL CHEM, V274, P15869, DOI 10.1074/jbc.274.22.15869; ALLEN RM, 1995, J BIOL CHEM, V270, P26890, DOI 10.1074/jbc.270.45.26890; BRANDNER JP, 1989, J BACTERIOL, V171, P360, DOI 10.1128/jb.171.1.360-368.1989; BRIGLE KE, 1987, J BACTERIOL, V169, P1547, DOI 10.1128/jb.169.4.1547-1553.1987; BULEN WA, 1966, P NATL ACAD SCI USA, V56, P979, DOI 10.1073/pnas.56.3.979; BURRIS RH, 1993, ANNU REV NUTR, V13, P317, DOI 10.1146/annurev.nu.13.070193.001533; Chatterjee R, 1996, J BIOL CHEM, V271, P6819, DOI 10.1074/jbc.271.12.6819; FILLER WA, 1986, EUR J BIOCHEM, V160, P371, DOI 10.1111/j.1432-1033.1986.tb09981.x; GAVINI N, 1992, J BIOL CHEM, V267, P21179; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; HAGEMAN RV, 1978, P NATL ACAD SCI USA, V75, P2699, DOI 10.1073/pnas.75.6.2699; HAUSINGER RP, 1983, J BIOL CHEM, V258, P3486; HOMER MJ, 1995, J BIOL CHEM, V270, P24745, DOI 10.1074/jbc.270.42.24745; HOOVER TR, 1989, BIOCHEMISTRY-US, V28, P2768, DOI 10.1021/bi00433a004; IMPERIAL J, 1987, J BACTERIOL, V169, P1784, DOI 10.1128/jb.169.4.1784-1786.1987; JACOBSON MR, 1989, J BACTERIOL, V171, P1017, DOI 10.1128/jb.171.2.1017-1027.1989; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; JOERGER RD, 1991, J BACTERIOL, V173, P4440, DOI 10.1128/JB.173.14.4440-4446.1991; JOERGER RD, 1988, J BACTERIOL, V170, P1475, DOI 10.1128/jb.170.4.1475-1487.1988; KIM JS, 1992, SCIENCE, V257, P1677, DOI 10.1126/science.1529354; KUO CF, 1988, ANAL BIOCHEM, V170, P183, DOI 10.1016/0003-2697(88)90106-6; PAUSTIAN TD, 1990, BIOCHEMISTRY-US, V29, P3515, DOI 10.1021/bi00466a014; Rangaraj P, 1999, J BIOL CHEM, V274, P19778, DOI 10.1074/jbc.274.28.19778; Rangaraj P, 1997, P NATL ACAD SCI USA, V94, P11250, DOI 10.1073/pnas.94.21.11250; Rangaraj P, 1999, J BIOL CHEM, V274, P29413, DOI 10.1074/jbc.274.41.29413; ROBINSON AC, 1987, J BIOL CHEM, V262, P14327; ROLL JT, 1995, J BIOL CHEM, V270, P4432, DOI 10.1074/jbc.270.9.4432; Ruttimann-Johnson C, 1999, J BIOL CHEM, V274, P18087, DOI 10.1074/jbc.274.25.18087; Shah V. K., 1988, Nitrogen fixation: Hundred years after. Proceedings of the 7th International Congress on Nitrogen Fixation, Koln (Cologne), FRG, March 13-20, 1988., P115; SHAH VK, 1972, BIOCHIM BIOPHYS ACTA, V256, P498, DOI 10.1016/0005-2728(72)90078-3; Shah VK, 1999, J BACTERIOL, V181, P2797, DOI 10.1128/JB.181.9.2797-2801.1999; SHAH VK, 1994, J BIOL CHEM, V269, P1154; SHAH VK, 1973, BIOCHIM BIOPHYS ACTA, V305, P445, DOI 10.1016/0005-2728(73)90190-4; SHAH VK, 1986, P NATL ACAD SCI USA, V83, P1636, DOI 10.1073/pnas.83.6.1636; SHAH VK, 1977, P NATL ACAD SCI USA, V74, P3249, DOI 10.1073/pnas.74.8.3249; STRANDBERG GW, 1968, CAN J MICROBIOL, V14, P14; UGALDE RA, 1984, J BACTERIOL, V159, P888, DOI 10.1128/JB.159.3.888-893.1984; WAUGH SI, 1995, J BACTERIOL, V177, P1505, DOI 10.1128/jb.177.6.1505-1510.1995; WOLFINGER ED, 1991, J BACTERIOL, V173, P7565, DOI 10.1128/jb.173.23.7565-7572.1991; WOLLE D, 1992, SCIENCE, V258, P992, DOI 10.1126/science.1359643	40	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15968	15974		10.1074/jbc.M100907200	http://dx.doi.org/10.1074/jbc.M100907200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279153	hybrid			2022-12-27	WOS:000168623100055
J	Jung, H; Kim, T; Chae, HZ; Kim, KT; Ha, H				Jung, H; Kim, T; Chae, HZ; Kim, KT; Ha, H			Regulation of macrophage migration inhibitory factor and thiol-specific antioxidant protein PAG by direct interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-TERMINAL PROLINE; FACTOR MIF; CRYSTAL-STRUCTURE; PHENYLPYRUVATE TAUTOMERASE; GLUTATHIONE; ACTIVATION; REDUCTASE; MECHANISM; CLONING; CELLS	Macrophage migration inhibitory factor (MIF) is an important mediator that plays a central role in the control of the host immune and inflammatory response. To investigate the molecular mechanism of MIF action, we have used the yeast two-hybrid system and identified PAG, a thiol-specific antioxidant protein, as an interacting partner of MIF. Association of MIF with PAG was found in 293T cells transiently expressing MIF and PAG. The use of PAG mutants (C52S, C71S, and C173S) revealed that this association was significantly affected by C173S, but not C52S and C71S, indicating that a disulfide involving Cys(173) Of PAG is responsible for the formation of MIF.PAG complex. In addition, the interaction was highly dependent on the reducing conditions such as dithiothreitol or beta -mercaptoethanol but not in the presence of H2O2. Analysis of the activities of the interacting proteins showed that the D-dopachrome tautomerase activity of MIF was decreased in a dose-dependent manner by coexpression of wild-type PAG, C52S, and C71S, whereas C173S was almost ineffective, suggesting that the direct interaction may be involved in the control of D-dopachrome tautomerase activity of MIF. Moreover, MIF has been shown to bind to PAG and it also inhibits the antioxidant activity of PAG.	Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea; Chonnam Natl Univ, Coll Sci, Dept Biol, Kwangju 500757, South Korea; Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea	Chungbuk National University; Chonnam National University; Pohang University of Science & Technology (POSTECH)	Ha, H (corresponding author), Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea.			KIM, KYONG-TAI/0000-0001-7292-2627				BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 1998, J MOL MED-JMM, V76, P151, DOI 10.1007/s001090050204; Bucala Richard, 1996, Cytokine and Growth Factor Reviews, V7, P19, DOI 10.1016/1359-6101(96)00008-1; Calandra T, 1997, CRIT REV IMMUNOL, V17, P77, DOI 10.1615/CritRevImmunol.v17.i1.30; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; CALANDRA T, 1994, J EXP MED, V179, P1985; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; CHAE HZ, 1994, BIOFACTORS, V4, P177; CHOOK YM, 1994, J MOL BIOL, V240, P476, DOI 10.1006/jmbi.1994.1462; Jaschke A, 1998, J MOL BIOL, V277, P763, DOI 10.1006/jmbi.1998.1644; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; KALEBIC T, 1991, P NATL ACAD SCI USA, V88, P986, DOI 10.1073/pnas.88.3.986; Kato Y, 1996, P NATL ACAD SCI USA, V93, P3007, DOI 10.1073/pnas.93.7.3007; KIM KW, 1988, J BIOL CHEM, V263, P4704; Kim T, 1999, FEBS LETT, V460, P363, DOI 10.1016/S0014-5793(99)01375-7; Kleemann R, 1998, FEBS LETT, V430, P191, DOI 10.1016/S0014-5793(98)00654-1; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; LIU YC, 1994, P NATL ACAD SCI USA, V91, P11227, DOI 10.1073/pnas.91.23.11227; Lubetsky JB, 1999, BIOCHEMISTRY-US, V38, P7346, DOI 10.1021/bi990306m; Metz CN, 1997, ADV IMMUNOL, V66, P197, DOI 10.1016/S0065-2776(08)60598-2; Mischke R, 1997, FEBS LETT, V414, P226, DOI 10.1016/S0014-5793(97)01039-9; Pennock JL, 1998, BIOCHEM J, V331, P905, DOI 10.1042/bj3310905; PROSPERI MT, 1993, J BIOL CHEM, V268, P11050; PUIG A, 1994, J BIOL CHEM, V269, P19128; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Rosengren E, 1997, FEBS LETT, V417, P85, DOI 10.1016/S0014-5793(97)01261-1; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Stamps SL, 1998, BIOCHEMISTRY-US, V37, P10195, DOI 10.1021/bi9806955; Stivers JT, 1996, BIOCHEMISTRY-US, V35, P803, DOI 10.1021/bi951077g; Subramanya HS, 1996, BIOCHEMISTRY-US, V35, P792, DOI 10.1021/bi951732k; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Suzuki M, 1996, NAT STRUCT BIOL, V3, P259, DOI 10.1038/nsb0396-259; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Swope MD, 1998, J BIOL CHEM, V273, P14877, DOI 10.1074/jbc.273.24.14877; WISTOW GJ, 1993, P NATL ACAD SCI USA, V90, P1272, DOI 10.1073/pnas.90.4.1272; ZHANG M, 1995, FEBS LETT, V373, P203, DOI 10.1016/0014-5793(95)01041-C	38	89	93	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15504	15510		10.1074/jbc.M009620200	http://dx.doi.org/10.1074/jbc.M009620200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11297517	hybrid			2022-12-27	WOS:000168528800129
J	Huang, WH; Yung, BYM; Syu, WJ; Lee, YHW				Huang, WH; Yung, BYM; Syu, WJ; Lee, YHW			The nucleolar phosphoprotein B23 interacts with hepatitis delta antigens and modulates the hepatitis delta virus RNA replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MATRIX PROTEIN; LYMPHOTOXIN-BETA RECEPTOR; BINDING-ACTIVITY; CORE PROTEIN; LOCALIZATION SIGNALS; TRANSCRIPTION FACTOR; GENOME REPLICATION; TARGETING SIGNAL; GENE-EXPRESSION; POLYMERASE-II	Hepatitis delta virus (HDV) encodes two isoforms of delta antigens (HDAgs), The small form of HDAg is required for HDV RNA replication, while the large form of HDAg inhibits the viral replication and is required for virion assembly. In this study, we found that the expression of B23, a nucleolar phosphoprotein involved in disparate functions including nuclear transport, cellular proliferation, and ribosome biogenesis, is up-regulated by these two HDAgs, Using in vivo and in vitro experimental approaches, we have demonstrated that both isoforms of HDAg can interact with B23 and their interaction domains were identified as the NH2-terminal fragment of each molecule encompassing the nuclear localization signal but not the coiled-coil region of HDAg, Sucrose gradient centrifugation analysis indicated that the majority of small HDAg, but a lesser amount of the large HDAg, co-sedimented with B23 and nucleolin in the large nuclear complex. Transient transfection experiments also indicated that introducing exogenous full-length B23, but not a mutated B23 defective in HDAg binding, enhanced HDV RNA replication. All together, our results reveal that HDAg has two distinct effects on nucleolar B23, up-regulation of its gene expression and the complex formation, which in turn regulates HDV RNA replication. Therefore, this work demonstrates the important role of nucleolar protein in regulating the HDV RNA replication through the complex formation with the key positive regulator being small HDAg.	Natl Yang Ming Univ, Inst Biochem, Taipei 112, Taiwan; Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; Chang Gung Univ, Coll Med, Dept Pharmacol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chang Gung University	Lee, YHW (corresponding author), Natl Yang Ming Univ, Inst Biochem, Taipei 112, Taiwan.			Yung, Benjamin Yat Ming/0000-0003-0093-3196; Lee Wu, Yan-Hwa/0000-0001-7299-7354				ADACHI Y, 1993, J BIOL CHEM, V268, P13930; Bell P, 2000, J VIROL, V74, P5329, DOI 10.1128/JVI.74.11.5329-5336.2000; Bichko VV, 1996, J VIROL, V70, P8064, DOI 10.1128/JVI.70.11.8064-8070.1996; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; Brazas R, 1996, SCIENCE, V274, P90, DOI 10.1126/science.274.5284.90; CHAN PK, 1989, CANCER RES, V49, P3271; Chan PK, 1997, NUCLEIC ACIDS RES, V25, P1225, DOI 10.1093/nar/25.6.1225; CHAN WY, 1989, BIOCHEMISTRY-US, V28, P1033, DOI 10.1021/bi00429a017; CHANG FL, 1991, P NATL ACAD SCI USA, V88, P8490, DOI 10.1073/pnas.88.19.8490; CHANG MF, 1988, J VIROL, V62, P2403, DOI 10.1128/JVI.62.7.2403-2410.1988; CHANG MF, 1993, J VIROL, V67, P2529, DOI 10.1128/JVI.67.5.2529-2536.1993; CHANG MF, 1992, J VIROL, V66, P6019, DOI 10.1128/JVI.66.10.6019-6027.1992; CHAO M, 1990, J VIROL, V64, P5066, DOI 10.1128/JVI.64.10.5066-5069.1990; Chen CM, 1997, J VIROL, V71, P9417, DOI 10.1128/JVI.71.12.9417-9426.1997; CHEN CM, 1991, J BIOL CHEM, V266, P7754; CHEN PJ, 1990, P NATL ACAD SCI USA, V87, P5253, DOI 10.1073/pnas.87.14.5253; Chou HC, 1998, J VIROL, V72, P3684, DOI 10.1128/JVI.72.5.3684-3690.1998; Cunha C, 1998, RNA, V4, P680, DOI 10.1017/S135583829898013X; DICKINSON LA, 1995, MOL CELL BIOL, V15, P456, DOI 10.1128/MCB.15.1.456; Dingle K, 1998, J VIROL METHODS, V75, P199, DOI 10.1016/S0166-0934(98)00117-7; DUMBAR TS, 1989, BIOCHEMISTRY-US, V28, P9495, DOI 10.1021/bi00450a037; ERARD MS, 1988, EUR J BIOCHEM, V175, P525, DOI 10.1111/j.1432-1033.1988.tb14224.x; FANKHAUSER C, 1991, MOL CELL BIOL, V11, P2567, DOI 10.1128/MCB.11.5.2567; FEUERSTEIN N, 1988, J CELL BIOL, V107, P1629, DOI 10.1083/jcb.107.5.1629; FEUERSTEIN N, 1987, J BIOL CHEM, V262, P11389; FEUERSTEIN N, 1990, BIOCHIM BIOPHYS ACTA, V1087, P127, DOI 10.1016/0167-4781(90)90196-9; Filipovska J, 2000, RNA, V6, P41, DOI 10.1017/S1355838200991167; FU TB, 1993, J VIROL, V67, P6965, DOI 10.1128/JVI.67.12.6965-6972.1993; GHISOLFI L, 1992, J BIOL CHEM, V267, P2955; GLENN JS, 1991, J VIROL, V65, P2357, DOI 10.1128/JVI.65.5.2357-2361.1991; GLENN JS, 1992, SCIENCE, V256, P1331, DOI 10.1126/science.1598578; GOWANS EJ, 1988, VIROLOGY, V167, P274, DOI 10.1016/0042-6822(88)90078-5; Hanakahi LA, 1997, P NATL ACAD SCI USA, V94, P3605, DOI 10.1073/pnas.94.8.3605; HERRERA JE, 1995, NUCLEIC ACIDS RES, V23, P3974, DOI 10.1093/nar/23.19.3974; Herrera JE, 1996, BIOCHEMISTRY-US, V35, P2668, DOI 10.1021/bi9523320; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; HOFFNAGLE JH, 1989, JAMA-J AM MED ASSOC, V261, P1321; Hu HM, 1996, J VIROL METHODS, V60, P39; Huang ZS, 1998, J BIOL CHEM, V273, P26455, DOI 10.1074/jbc.273.41.26455; HWANG SB, 1993, J VIROL, V67, P7659, DOI 10.1128/JVI.67.12.7659-7662.1993; HWANG SB, 1992, VIROLOGY, V190, P413, DOI 10.1016/0042-6822(92)91227-L; INOUYE CJ, 1994, J BIOL CHEM, V269, P6506; JORDAN G, 1987, NATURE, V329, P489, DOI 10.1038/329489a0; Kondo T, 1997, ONCOGENE, V15, P1275, DOI 10.1038/sj.onc.1201286; KUO MYP, 1989, J VIROL, V63, P1945, DOI 10.1128/JVI.63.5.1945-1950.1989; LAI MMC, 1995, ANNU REV BIOCHEM, V64, P259, DOI 10.1146/annurev.bi.64.070195.001355; LAZINSKI DW, 1993, J VIROL, V67, P2672, DOI 10.1128/JVI.67.5.2672-2680.1993; Lee CH, 1998, J BIOL CHEM, V273, P7650, DOI 10.1074/jbc.273.13.7650; LEE CZ, 1993, J VIROL, V67, P2221, DOI 10.1128/JVI.67.4.2221-2227.1993; Li YP, 1996, EUR J BIOCHEM, V237, P153, DOI 10.1111/j.1432-1033.1996.0153n.x; Li YP, 1997, J VIROL, V71, P4098, DOI 10.1128/JVI.71.5.4098-4102.1997; LIN JH, 1990, J VIROL, V64, P4051, DOI 10.1128/JVI.64.9.4051-4058.1990; LIU QR, 1991, EUR J BIOCHEM, V200, P715, DOI 10.1111/j.1432-1033.1991.tb16236.x; Lo K, 1998, VIROLOGY, V247, P178, DOI 10.1006/viro.1998.9253; LUO GX, 1990, J VIROL, V64, P1021, DOI 10.1128/JVI.64.3.1021-1027.1990; MACNAUGHTON TB, 1991, VIROLOGY, V184, P387, DOI 10.1016/0042-6822(91)90855-6; MACNAUGHTON TB, 1990, J GEN VIROL, V71, P1339, DOI 10.1099/0022-1317-71-6-1339; MACNAUGHTON TB, 1990, VIROLOGY, V177, P692, DOI 10.1016/0042-6822(90)90535-Y; MELESE T, 1995, CURR OPIN CELL BIOL, V7, P319, DOI 10.1016/0955-0674(95)80085-9; Modahl LE, 2000, MOL CELL BIOL, V20, P6030, DOI 10.1128/MCB.20.16.6030-6039.2000; Mu JJ, 1999, J VIROL, V73, P10540, DOI 10.1128/JVI.73.12.10540-10545.1999; PECULIS BA, 1992, J CELL BIOL, V116, P1, DOI 10.1083/jcb.116.1.1; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; PRESTAYKO AW, 1974, BIOCHEMISTRY-US, V13, P1945, DOI 10.1021/bi00706a026; RIZZETTO M, 1983, HEPATOLOGY, V3, P729; RYU WS, 1992, J VIROL, V66, P2310, DOI 10.1128/JVI.66.4.2310-2315.1992; Savkur RS, 1998, NUCLEIC ACIDS RES, V26, P4508, DOI 10.1093/nar/26.19.4508; SCHMIDTZACHMANN MS, 1987, EMBO J, V6, P1881, DOI 10.1002/j.1460-2075.1987.tb02447.x; SHIH CM, 1993, J VIROL, V67, P5823, DOI 10.1128/JVI.67.10.5823-5832.1993; SHIH CM, 1995, J VIROL, V69, P1160, DOI 10.1128/JVI.69.2.1160-1171.1995; SOLLNERWEBB B, 1991, TRENDS BIOCHEM SCI, V16, P58, DOI 10.1016/0968-0004(91)90025-Q; SPECTOR DL, 1984, CHROMOSOMA, V90, P139, DOI 10.1007/BF00292451; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Szebeni A, 1997, BIOCHEMISTRY-US, V36, P3941, DOI 10.1021/bi9627931; SZEBENI A, 1995, BIOCHEMISTRY-US, V34, P8037, DOI 10.1021/bi00025a009; Szebeni A, 1999, PROTEIN SCI, V8, P905; TAYLOR J, 1987, J VIROL, V61, P2891, DOI 10.1128/JVI.61.9.2891-2895.1987; THOMAS PS, 1983, METHOD ENZYMOL, V100, P255; TUTEJA N, 1995, GENE, V160, P143, DOI 10.1016/0378-1119(95)00207-M; VALDEZ BC, 1994, J BIOL CHEM, V269, P23776; WANG DR, 1994, J BIOL CHEM, V269, P30994; WANG JG, 1993, J VIROL, V67, P446, DOI 10.1128/JVI.67.1.446-454.1993; Wei Y, 1998, J VIROL, V72, P2089, DOI 10.1128/JVI.72.3.2089-2096.1998; WEINER AJ, 1988, J VIROL, V62, P594, DOI 10.1128/JVI.62.2.594-599.1988; WU JC, 1992, HEPATOLOGY, V16, P1120; XIA YP, 1992, J VIROL, V66, P6641, DOI 10.1128/JVI.66.11.6641-6648.1992; XIA YP, 1992, J VIROL, V66, P914, DOI 10.1128/JVI.66.2.914-921.1992; YANG TH, 1994, MOL CELL BIOL, V14, P6068, DOI 10.1128/MCB.14.9.6068; Yeh TS, 1998, VIROLOGY, V249, P12, DOI 10.1006/viro.1998.9310; Yeh TS, 1996, J VIROL, V70, P6190, DOI 10.1128/JVI.70.9.6190-6198.1996; You LR, 1999, J VIROL, V73, P1672, DOI 10.1128/JVI.73.2.1672-1681.1999; You LR, 1999, J VIROL, V73, P2841, DOI 10.1128/JVI.73.4.2841-2853.1999; YUNG BYM, 1985, BIOCHIM BIOPHYS ACTA, V826, P167, DOI 10.1016/0167-4781(85)90002-8; YUNG BYM, 1987, BIOCHIM BIOPHYS ACTA, V925, P74, DOI 10.1016/0304-4165(87)90149-8; ZHANG XT, 1989, BIOCHEM BIOPH RES CO, V164, P176, DOI 10.1016/0006-291X(89)91699-9; Zuccola HJ, 1998, STRUCTURE, V6, P821, DOI 10.1016/S0969-2126(98)00084-7	97	75	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					25166	25175		10.1074/jbc.M010087200	http://dx.doi.org/10.1074/jbc.M010087200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11309377	hybrid			2022-12-27	WOS:000169800700099
J	Zaar, A; Eisenreich, W; Bacher, A; Fuchs, G				Zaar, A; Eisenreich, W; Bacher, A; Fuchs, G			A novel pathway of aerobic benzoate catabolism in the bacteria Azoarcus evansii and Bacillus stearothermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENITRIFYING PSEUDOMONAS SP; PHENYLACETYL-COA CATABOLON; COENZYME-A LIGASE; 4-CHLOROBENZOATE DEHALOGENASE; MOLECULAR CHARACTERIZATION; ANAEROBIC DEGRADATION; SP CBS3; ACID; PURIFICATION; OXIDATION	The aerobic catabolism of benzoate was studied in the Gram-negative proteobacterium Azoarcus evansii and in the Gram-positive bacterium Bacillus stearothermophilus, In contrast to earlier proposals, benzoate was not converted into hydroxybenzoate or gentisate, Rather, benzoyl-CoA was a product of benzoate catabolism in both microbial species under aerobic conditions in vivo. Benzoyl-CoA was converted into various CoA thioesters by cell extracts of both species in oxygen- and NADPH-dependent reactions. Using [ring-C-13(6)]benzoyl-CoA as substrate, cis-3,4-[2,3,4,5,6-C-13(5)]dehydroadipyl-CoA, trans-2,3-[2,3,4,5,6-C-13(5)]dehydroadipyl-CoA, the 3,6-lactone of 3-[2,3,4,5,6-C-13(5)]hydroxyadipyl-CoA, and 3-[2,3, 4,5,6-C-13(5)]hydroxyadipyl-CoA were identified as products by MMR spectroscopy. A protein mixture of A. evansii transformed [ring-C-13(6)]benzoyl-CoA in an NADPH- and oxygen-dependent reaction into 6-[2,3,4,5,6-C-13(5)]hydroxy-3-hexenoyl-CoA. The data suggest a novel aerobic pathway of benzoate catabolism via CoA intermediates leading to beta -ketoadipyl-CoA, an intermediate of the known beta -ketoadipate pathway.	Tech Univ Munich, Lehrstuhl Organ Chem & Biochem, D-85747 Garching, Germany; Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany	Technical University of Munich; University of Freiburg	Eisenreich, W (corresponding author), Tech Univ Munich, Lehrstuhl Organ Chem & Biochem, Lichtenbergstr 4, D-85747 Garching, Germany.		Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279				ALTENSCHMIDT U, 1991, J BACTERIOL, V173, P5494, DOI 10.1128/jb.173.17.5494-5501.1991; ALTENSCHMIDT U, 1993, J BACTERIOL, V175, P4851, DOI 10.1128/JB.175.15.4851-4858.1993; ANDERS HJ, 1995, INT J SYST BACTERIOL, V45, P327, DOI 10.1099/00207713-45-2-327; BRAUN K, 1984, APPL ENVIRON MICROB, V48, P102, DOI 10.1128/AEM.48.1.102-107.1984; BUDER R, 1989, EUR J BIOCHEM, V191, P365; BUSWELL JA, 1976, J GEN MICROBIOL, V96, P209, DOI 10.1099/00221287-96-1-209; CHANG KH, 1992, BIOCHEMISTRY-US, V31, P5605, DOI 10.1021/bi00139a025; Clark D. P., 1996, ESCHERICHIA COLI SAL, P343; CLARK JS, 1979, J GEN MICROBIOL, V112, P191, DOI 10.1099/00221287-112-1-191; COLIGAN JE, 1995, CURRENT PROTOCOLS SC; CRAWFORD RL, 1976, J BACTERIOL, V127, P204, DOI 10.1128/JB.127.1.204-210.1976; CROOKS GP, 1994, BIOCHEMISTRY-US, V33, P11645, DOI 10.1021/bi00204a028; Ferrandez A, 1998, J BIOL CHEM, V273, P25974, DOI 10.1074/jbc.273.40.25974; Fu WJ, 1999, EXTREMOPHILES, V3, P45, DOI 10.1007/s007920050098; Garcia B, 1999, J BIOL CHEM, V274, P29228, DOI 10.1074/jbc.274.41.29228; GROSS GG, 1966, Z NATURFORSCH PT B, VB 21, P683; Hartmann S, 1999, P NATL ACAD SCI USA, V96, P7831, DOI 10.1073/pnas.96.14.7831; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Kiemer P, 1996, BIOL FERT SOILS, V23, P307, DOI 10.1007/BF00335959; LOFFLER F, 1995, BIODEGRADATION, V6, P203, DOI 10.1007/BF00700458; LOFFLER F, 1991, FEBS LETT, V290, P224, DOI 10.1016/0014-5793(91)81265-A; MARTINEZBLANCO H, 1990, J BIOL CHEM, V265, P7084; Mohamed ME, 2000, J BACTERIOL, V182, P286, DOI 10.1128/JB.182.2.286-294.2000; NIEMETZ R, 1995, EUR J BIOCHEM, V227, P161, DOI 10.1111/j.1432-1033.1995.tb20372.x; Olivera ER, 1998, P NATL ACAD SCI USA, V95, P6419, DOI 10.1073/pnas.95.11.6419; SCHACHTER D, 1976, J BIOL CHEM, V203, P925; STADTMAN ER, 1957, METHOD ENZYMOL, V3, P931, DOI 10.1016/S0076-6879(57)03481-3; Takami H, 1999, EXTREMOPHILES, V3, P29, DOI 10.1007/s007920050096; Torres RA, 1999, P NATL ACAD SCI USA, V96, P14748, DOI 10.1073/pnas.96.26.14748; TSCHECH A, 1987, ARCH MICROBIOL, V148, P213, DOI 10.1007/BF00414814; VITOVSKI S, 1993, FEMS MICROBIOL LETT, V108, P1; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; ZIEGLER K, 1989, ARCH MICROBIOL, V151, P171, DOI 10.1007/BF00414434	33	48	50	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					24997	25004		10.1074/jbc.M100291200	http://dx.doi.org/10.1074/jbc.M100291200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11306574	hybrid			2022-12-27	WOS:000169800700076
J	Wu, XY; Li, H; Chen, JD				Wu, XY; Li, H; Chen, JD			The human homologue of the yeast DNA repair and TFIIH regulator MMS19 is an AF-1-specific coactivator of estrogen receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; NUCLEAR-RECEPTOR; TRANSCRIPTIONAL COACTIVATOR; SACCHAROMYCES-CEREVISIAE; PAS DOMAIN; ACTIVATION FUNCTION-1; PROTEIN-INTERACTION; STEROID-RECEPTORS; DIOXIN RECEPTOR; AF2 DOMAINS	Steroid/nuclear hormone receptors are ligand-dependent transcriptional regulators that control gene expression in a wide array of biological processes. The transcriptional activity of the receptors is mediated by an N-terminal ligand-independent transcriptional activation function AF-1 and a C-terminal ligand-dependent transcriptional activation function AF-2. The nuclear receptor coactivator RAGS (also known as AIB1/ACTR/ pCIP/TRAM-1/SRC-3) is amplified in breast cancer cells, where it forms a complex with estrogen receptor (ER) and enhances AF-2 activity of the receptor. Here, we identify a putative human homologue of the yeast DNA repair and transcriptional regulator MMS19 as a RAC3-interacting protein. The human MMS19 interacts with the N-terminal PAS-A/B domain of RAC3 in vivo and in vitro through a conserved C-terminal domain, Interestingly, the human MMS19 also interacts with estrogen receptors in a ligand-independent manner but not with retinoic acid receptor or thyroid hormone receptor. Overexpression of the interacting domain of hMMS19 strongly inhibits ER-mediated transcriptional activation, indicating a dominant negative activity. In contrast, over expression of the full-length hMMS19 enhances ER-mediated transcriptional activation. We find that hMMS19 stimulates the AF-1 activity of ER alpha, but not the AF-2 activity, suggesting that hMMS19 may be an AF-1-specific transcriptional coactivator of estrogen receptor.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Chen, JD (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, 55 Lake Ave N, Worcester, MA 01655 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052888] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK052888-03, R01 DK052888-02, DK52888, R01 DK052888-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alers JC, 2000, LAB INVEST, V80, P931, DOI 10.1038/labinvest.3780096; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Cappellen D, 1997, ONCOGENE, V14, P3059, DOI 10.1038/sj.onc.1201154; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Crews ST, 1999, CURR OPIN GENET DEV, V9, P580, DOI 10.1016/S0959-437X(99)00003-9; Endoh H, 1999, MOL CELL BIOL, V19, P5363; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Lauder S, 1996, MOL CELL BIOL, V16, P6783; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Leo C, 2000, J BIOL CHEM, V275, P5976, DOI 10.1074/jbc.275.8.5976; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; LINDEBRO MC, 1995, EMBO J, V14, P3528, DOI 10.1002/j.1460-2075.1995.tb07359.x; Ma H, 1999, MOL CELL BIOL, V19, P6164; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McInerney EM, 1996, P NATL ACAD SCI USA, V93, P10069, DOI 10.1073/pnas.93.19.10069; MILLER RD, 1982, MOL CELL BIOL, V2, P939, DOI 10.1128/MCB.2.8.939; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; ONATE SA, 1995, SCIENCE, V270, P1854; Pongratz I, 1998, MOL CELL BIOL, V18, P4079, DOI 10.1128/MCB.18.7.4079; PRAKASH L, 1977, GENETICS, V86, P33; PRAKASH L, 1979, MOL GEN GENET, V176, P351, DOI 10.1007/BF00333097; Prakash L, 1989, Ann Ist Super Sanita, V25, P99; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Rogatsky I, 1999, J BIOL CHEM, V274, P22296, DOI 10.1074/jbc.274.32.22296; Seroz T, 2000, NUCLEIC ACIDS RES, V28, P4506, DOI 10.1093/nar/28.22.4506; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; TASSET D, 1990, CELL, V62, P1177, DOI 10.1016/0092-8674(90)90394-T; Tikkanen MK, 2000, P NATL ACAD SCI USA, V97, P12536, DOI 10.1073/pnas.220427297; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Tremblay A, 1999, MOL CELL, V3, P513, DOI 10.1016/S1097-2765(00)80479-7; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang ZY, 2000, P NATL ACAD SCI USA, V97, P13549, DOI 10.1073/pnas.260463097; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Zelzer E, 1997, GENE DEV, V11, P2079, DOI 10.1101/gad.11.16.2079	51	54	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23962	23968		10.1074/jbc.M101041200	http://dx.doi.org/10.1074/jbc.M101041200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11279242	hybrid			2022-12-27	WOS:000169531100098
J	Wu, XY; Li, H; Park, EJ; Chen, JD				Wu, XY; Li, H; Park, EJ; Chen, JD			SMRTe inhibits MEF2C transcriptional activation by targeting HDAC4 and 5 to nuclear domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTORS; II HISTONE DEACETYLASES; N-COR; COREPRESSOR COMPLEX; MEDIATED REPRESSION; PROTEIN; INTERACTS; PATHWAY; DIFFERENTIATION; COACTIVATOR	The silencing mediator for retinoic acid and thyroid hormone receptors (SMRT) mediates transcriptional repression by recruiting histone deacetylases (HDACs) to the DNA-bound nuclear receptor complex, The full-length SMRT (SMRTe) contains an N-terminal sequence that is highly conserved to the nuclear receptor corepressor N-CoR To date, Little is known about the activity and function of the full-length SMRTe protein, despite extensive studies on separated receptor interaction and transcriptional repression domains. Here we show that SMRTe inhibits MEF2C transcriptional activation by targeting selective HDACs to unique subnuclear domains. Indirect immunofluorescence studies with anti-SMRTe antibody reveal discrete cytoplasmic and nuclear speckles, which contain RAR alpha in an RA-sensitive manner. Formation of the SMRTe nuclear speckles results in recruitment of several class I and class II HDACs to these subnuclear domains in a process depending on HDAC enzymatic activity. Intriguingly, although HDAC4 is located primarily in the cytoplasm, coexpression of SMRTe dramatically translocates HDAC4 from the cytoplasm into the nucleus, where HDAC4 prevents MEF2C from activating muscle differentiation, SMRTe also translocates HDAC5 from diffusive nucleoplasm into discrete nuclear domains, Accordingly, SMRTe synergizes with HDAC4 and 5 to inhibit MEF2C transactivation of target promoter, suggesting that nuclear domain targeting of HDAC4/5 may be important in preventing muscle cell differentiation. These results highlight an unexpected new function of the nuclear receptor corepressor SMRTe for its role in regulating cellular trafficking of nuclear receptor and selective HDACs that may play an important role in regulation of cell growth and differentiation.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Li, H (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, 55 Lake Ave N, Worcester, MA 01655 USA.				NIDDK NIH HHS [DK52542] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052542] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Bailey P, 1999, MOL ENDOCRINOL, V13, P1155, DOI 10.1210/me.13.7.1155; Chen JD, 1996, P NATL ACAD SCI USA, V93, P7567, DOI 10.1073/pnas.93.15.7567; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Downes M, 2000, P NATL ACAD SCI USA, V97, P10330, DOI 10.1073/pnas.97.19.10330; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Guenther MG, 2000, GENE DEV, V14, P1048; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hollenberg AN, 1996, J BIOL CHEM, V271, P28516, DOI 10.1074/jbc.271.45.28516; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Huang EY, 2000, GENE DEV, V14, P45; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kao HY, 2000, GENE DEV, V14, P55; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li H, 1997, MOL ENDOCRINOL, V11, P2025, DOI 10.1210/me.11.13.2025; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Ordentlich P, 1999, P NATL ACAD SCI USA, V96, P2639, DOI 10.1073/pnas.96.6.2639; Park EJ, 1999, P NATL ACAD SCI USA, V96, P3519, DOI 10.1073/pnas.96.7.3519; Soderstrom M, 1997, MOL ENDOCRINOL, V11, P682, DOI 10.1210/me.11.6.682; Wang AH, 1999, MOL CELL BIOL, V19, P7816; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhu XG, 1998, J BIOL CHEM, V273, P27058, DOI 10.1074/jbc.273.42.27058	38	49	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24177	24185		10.1074/jbc.M100412200	http://dx.doi.org/10.1074/jbc.M100412200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11304536	hybrid			2022-12-27	WOS:000169531100126
J	Keenan, SM; Bellone, C; Baldassare, JJ				Keenan, SM; Bellone, C; Baldassare, JJ			Cyclin-dependent kinase 2 nucleocytoplasmic translocation is regulated by extracellular regulated kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; RETINOBLASTOMA PROTEIN; CELL-CYCLE; SUBCELLULAR-LOCALIZATION; FUNCTIONAL INACTIVATION; NUCLEAR TRANSLOCATION; G(1)/S TRANSITION; D1 EXPRESSION; E GENE; PHOSPHORYLATION	Activation of cyclin-dependent kinase 2 (CDK2)-cyclin E in the late G(1) phase of the cell cycle is important for transit into S phase. In Chinese hamster embryonic fibroblasts (IIC9) phosphatidylinositol 3-kinase and ERK regulate cu-thrombin-induced G, transit by their effects on cyclin D1 protein accumulation (Phillips-Mason, P. J., Raben, D. M., and Baldassare, J. J. (2000) J. Biol. Chem, 275, 18046-18053). Here, we show that ERK also affects CDK2-cyclin E activation by regulating the subcellular localization of CDK2, Ectopic expression of cyclin E rescues the inhibition of alpha -thrombin-induced activation of CDK2-cyclin E and transit into S phase brought about by treat ment of IIC9 cells with LY29004, a selective inhibitor of mitogen stimulation of phosphatidylinositol 3-kinase activity. However, cyclin E expression is ineffectual in rescuing these effects when ERK activation is blocked by treatment with PD98059, a selective inhibitor of MEK activation of ERR. Investigation into the mechanistic reasons for this difference found the following. 1) Although treatment with LY29004 inhibits alpha -thrombin-stimulated nuclear localization, ectopic expression of cyclin E rescues CDK2 translocation. 2) In contrast to treatment with LY29004, ectopic expression of cyclin E fails to restore alpha -thrombin-stimulated nuclear CDK2 translocation in IIC9 cells treated with PD98059. 3) CDK2-cyclin E complexes are not affected by treatment with either inhibitor. These data indicate that, in addition to its effects on cyclin D1 expression, ERK activity is an important controller of the translocation of CDK2 into the nucleus where it is activated.	St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA	Saint Louis University; Saint Louis University	Baldassare, JJ (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.							ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Blanchard DA, 2000, ONCOGENE, V19, P4184, DOI 10.1038/sj.onc.1203761; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; Botz J, 1996, MOL CELL BIOL, V16, P3401; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; FESQUET D, 1993, EMBO J, V12, P3111, DOI 10.1002/j.1460-2075.1993.tb05980.x; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; Geng Y, 1996, ONCOGENE, V12, P1173; GIRARD F, 1992, J CELL BIOL, V118, P785, DOI 10.1083/jcb.118.4.785; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; HATAKEYAMA M, 1994, GENE DEV, V8, P1759, DOI 10.1101/gad.8.15.1759; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; KATO J, 1993, GENE DEV, V7, P331; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; LEW DJ, 1993, CELL, V72, P488, DOI 10.1016/0092-8674(93)90068-2; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; MELOCHE S, 1992, MOL BIOL CELL, V3, P63, DOI 10.1091/mbc.3.1.63; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Phillips-Mason PJ, 2000, J BIOL CHEM, V275, P18046, DOI 10.1074/jbc.M909194199; SEBASTIAN B, 1993, P NATL ACAD SCI USA, V90, P3521, DOI 10.1073/pnas.90.8.3521; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Weber JD, 1997, J BIOL CHEM, V272, P17320, DOI 10.1074/jbc.272.28.17320	37	54	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22404	22409		10.1074/jbc.M100409200	http://dx.doi.org/10.1074/jbc.M100409200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11304535	hybrid			2022-12-27	WOS:000169412700059
J	Patel, NA; Chalfant, CE; Watson, JE; Wyatt, JR; Dean, NM; Eichler, DC; Cooper, DR				Patel, NA; Chalfant, CE; Watson, JE; Wyatt, JR; Dean, NM; Eichler, DC; Cooper, DR			Insulin regulates alternative splicing of protein kinase C beta II through a phosphatidylinositol 3-kinase-dependent pathway involving the nuclear serine/arginine-rich splicing factor, SRp40, in skeletal muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; STIMULATED GLUCOSE-TRANSPORT; RAT ADIPOSE-CELLS; SR PROTEINS; SMOOTH-MUSCLE; SERINE-RICH; TRANSCRIPTION FACTOR; POLYMERASE-II; STAT 5B; PHOSPHORYLATION	Insulin regulates the inclusion of the exon encoding protein kinase C (PKC) PII mRNA In this report, we show that insulin regulates this exon inclusion (alternative splicing) via the phosphatidylinositol 3-kinase (PI 3-kinase) signaling pathway through the phosphorylation state of SRp40, a factor required for insulin-regulated splice site selection for PKC beta II mRNA. By taking advantage of a well known inhibitor of PI S-kinase, LY294002, we demonstrated that pretreatment of L6 myotubes with LY294002 blocked insulin-induced PKC beta II exon inclusion as well as phosphorylation of SRp40. In the absence of LY294002, overexpression of SRp40 in L6 cells mimicked insulin-induced exon inclusion. When antisense oligonucleotides targeted to a putative SRp40-binding sequence in the beta II-betaI intron were transfected into L6 cells, insulin effects on splicing and glucose uptake were blocked. Taken together, these results demonstrate a role for SRp40 in insulin-mediated alternative splicing independent of changes in SRp40 concentration but dependent on serine phosphorylation of SRp40 via a PI 3-kinase signaling pathway. This switch in PKC isozyme expression is important for in creases in the glucose transport effect of insulin. Significantly, insulin regulation of PKCI betaI exon inclusion occurred in the absence of cell growth and differentiation demonstrating that insulin-induced alternative splicing of PKC beta II mRNA in L6 cells occurs in response to a metabolic change.	Univ S Florida, James A Haley Vet Hosp, Coll Med, Dept Biochem & Mol Biol,Res Serv 151, Tampa, FL 33612 USA; ISIS Pharmaceut, Carlsbad, CA 92008 USA	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; Isis Pharmaceuticals Inc	Cooper, DR (corresponding author), Univ S Florida, James A Haley Vet Hosp, Coll Med, Dept Biochem & Mol Biol,Res Serv 151, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.		Patel, Niketa/A-1392-2012; Cooper, Denise R./A-4740-2012; Eichler, Duane/A-1906-2012	Patel, Niketa A./0000-0003-4811-8596				AYANE M, 1991, NUCLEIC ACIDS RES, V19, P1273, DOI 10.1093/nar/19.6.1273; BALY DL, 1987, J BIOL CHEM, V262, P21; Bandyopadhyay G, 1997, ENDOCRINOLOGY, V138, P4721, DOI 10.1210/en.138.11.4721; Bossenmaier B, 1997, DIABETOLOGIA, V40, P863, DOI 10.1007/s001250050761; Braiman L, 1999, DIABETES, V48, P1922, DOI 10.2337/diabetes.48.10.1922; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CACERES JF, 1994, SCIENCE, V265, P1707; Chalfant CE, 1996, MOL ENDOCRINOL, V10, P1273, DOI 10.1210/me.10.10.1273; CHALFANT CE, 1995, J BIOL CHEM, V270, P13326, DOI 10.1074/jbc.270.22.13326; Chalfant CE, 1998, J BIOL CHEM, V273, P910, DOI 10.1074/jbc.273.2.910; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Cooper DR, 1999, ARCH BIOCHEM BIOPHYS, V372, P69, DOI 10.1006/abbi.1999.1472; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; DIAMOND RH, 1993, J BIOL CHEM, V268, P15185; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dirksen WP, 2000, J BIOL CHEM, V275, P29170, DOI 10.1074/jbc.M001126200; DISATNIK MH, 1994, EXP CELL RES, V210, P287, DOI 10.1006/excr.1994.1041; Du C, 1998, MOL CELL, V2, P741, DOI 10.1016/S1097-2765(00)80289-0; Du KY, 1997, MOL CELL BIOL, V17, P4096, DOI 10.1128/MCB.17.7.4096; Du KY, 1998, J BIOL CHEM, V273, P35208, DOI 10.1074/jbc.273.52.35208; FERAMISCO JR, 1980, J BIOL CHEM, V255, P1194; FU XD, 1995, RNA, V1, P663; FU XD, 1993, NATURE, V365, P82, DOI 10.1038/365082a0; GOODE N, 1992, J BIOL CHEM, V267, P16878; Gorman L, 2000, J BIOL CHEM, V275, P35914, DOI 10.1074/jbc.M006259200; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Henry RR, 1996, DIABETES, V45, P400, DOI 10.2337/diabetes.45.4.400; Ishii H, 1996, SCIENCE, V272, P728, DOI 10.1126/science.272.5262.728; JONES TLZ, 1989, J BIOL CHEM, V264, P7874; KLIP A, 1984, AM J PHYSIOL, V247, pE291, DOI 10.1152/ajpendo.1984.247.3.E291; Koizumi J, 1999, J BIOL CHEM, V274, P11125, DOI 10.1074/jbc.274.16.11125; KOSAKI A, 1993, J BIOL CHEM, V268, P21990; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; MATTHAEI S, 1988, BIOCHEM J, V251, P491, DOI 10.1042/bj2510491; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Nayler O, 1998, J BIOL CHEM, V273, P34341, DOI 10.1074/jbc.273.51.34341; Nayler O, 1997, BIOCHEM J, V326, P693, DOI 10.1042/bj3260693; Nikolakaki E, 1996, J BIOL CHEM, V271, P8365, DOI 10.1074/jbc.271.14.8365; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Okamoto Y, 1998, BIOCHEM BIOPH RES CO, V249, P872, DOI 10.1006/bbrc.1998.9247; ONO Y, 1987, SCIENCE, V236, P1116, DOI 10.1126/science.3576226; ONO Y, 1986, FEBS LETT, V206, P347, DOI 10.1016/0014-5793(86)81010-9; Patel NA, 1999, FASEB J, V13, P103, DOI 10.1096/fasebj.13.1.103; Perrotti D, 1998, EMBO J, V17, P4442, DOI 10.1093/emboj/17.15.4442; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Prasad J, 1999, MOL CELL BIOL, V19, P6991; ROTH MB, 1991, J CELL BIOL, V115, P587, DOI 10.1083/jcb.115.3.587; ROTH MB, 1990, J CELL BIOL, V111, P2217, DOI 10.1083/jcb.111.6.2217; Sambrook J., 2002, MOL CLONING LAB MANU; Sawka-Verhelle D, 2000, ENDOCRINOLOGY, V141, P1977, DOI 10.1210/en.141.6.1977; SawkaVerhelle D, 1997, EUR J BIOCHEM, V250, P411, DOI 10.1111/j.1432-1033.1997.0411a.x; SCREATON GR, 1995, EMBO J, V14, P4336, DOI 10.1002/j.1460-2075.1995.tb00108.x; Stark JM, 1998, P NATL ACAD SCI USA, V95, P2163, DOI 10.1073/pnas.95.5.2163; Stark JM, 1999, J BIOL CHEM, V274, P29838, DOI 10.1074/jbc.274.42.29838; Tacke R, 1997, P NATL ACAD SCI USA, V94, P1148, DOI 10.1073/pnas.94.4.1148; Taylor J K, 1999, Curr Opin Drug Discov Devel, V2, P147; Taylor JK, 1999, NAT BIOTECHNOL, V17, P1097, DOI 10.1038/15079; Thorell A, 1999, AM J PHYSIOL-ENDOC M, V277, pE733, DOI 10.1152/ajpendo.1999.277.4.E733; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Vollenweider P, 1999, MOL CELL BIOL, V19, P1081; Wang J, 1996, GENE DEV, V10, P2588, DOI 10.1101/gad.10.20.2588; Wang JM, 1999, MOL CELL BIOL, V19, P6195; Will CL, 1997, CURR OPIN CELL BIOL, V9, P320, DOI 10.1016/S0955-0674(97)80003-8; Withers DJ, 2000, ENDOCRINOLOGY, V141, P1917, DOI 10.1210/en.141.6.1917; WOPPMANN A, 1993, NUCLEIC ACIDS RES, V21, P2815, DOI 10.1093/nar/21.12.2815; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Yamamoto M, 1998, EXP CELL RES, V240, P349, DOI 10.1006/excr.1998.3999; Yamamoto M, 1999, INT J CANCER, V83, P98, DOI 10.1002/(SICI)1097-0215(19990924)83:1<98::AID-IJC18>3.0.CO;2-V; Yeakley JM, 1996, P NATL ACAD SCI USA, V93, P7582, DOI 10.1073/pnas.93.15.7582; Yeakley JM, 1999, J CELL BIOL, V145, P447, DOI 10.1083/jcb.145.3.447; ZAHLER AM, 1993, SCIENCE, V260, P219, DOI 10.1126/science.8385799	75	62	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22648	22654		10.1074/jbc.M101260200	http://dx.doi.org/10.1074/jbc.M101260200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11283022	hybrid			2022-12-27	WOS:000169412700091
J	Swift, LL; Farkas, MH; Major, AS; Valyi-Nagy, K; Linton, MF; Fazio, S				Swift, LL; Farkas, MH; Major, AS; Valyi-Nagy, K; Linton, MF; Fazio, S			A recycling pathway for resecretion of internalized apolipoprotein E in liver cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; CHOLESTEROL EFFLUX; RECEPTOR-BINDING; HEPATIC-UPTAKE; APOPROTEIN-E; E EXPRESSION; BETA-VLDL; SECRETION; MICE; LDL	We have investigated the recycling of apoE in livers of apoE(-/-) mice transplanted with wild type bone marrow (apoE(+/+) --> apoE(-/-)), a model in which circulating apoE is derived exclusively from macrophages. Nascent Gels lipoproteins were recovered from livers of apoE(+/+) --> apoE(-/-) mice 8 weeks after transplantation. ApoE was identified with nascent d < 1.006 and with d 1.006-1.210 g/ml lipoproteins at a level similar to6% that of nascent lipoproteins from C57BL/6 mice. Hepatocytes from apoE(+/+) --> apoE(-/-) mice were isolated and cultured in media free of exogenous apoE, ApoE was found in the media primarily on the d < 1.006 g/ml fraction, indicating a resecretion of internalized apoprotein. Secretion of apoE from C57BL/6 hepatocytes was consistent with constitutive production, whereas the majority of apoE secreted from apoE(+/+) --> apoE(-/-) hepatocytes was recovered in the last 24 h of culture, This suggests that release may be triggered by accumulation of an acceptor, such as very low density lipoproteins, in the media. In agreement with the in vivo data, total recovery of apoE from apoE(+/+) --> apoE(-/-) hepatocytes was similar to6% that of the apoE recovered from C57BL/6 hepatocytes. Since plasma apoE levels in the transplanted mice are similar to 10% of control levels, the findings indicate that up to 60% of the internalized apoE may be reutilized under physiologic conditions. These studies provide definitive evidence for the sparing of apoE and its routing through the secretory pathway and demonstrate that internalized apoE can be resecreted in a quantitatively significant fashion.	Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Swift, LL (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA.	macrae.linton@mcmail.vanderbilt.edu; sergio.fazio@mcmail.vanderbilt.edu		Valyi-Nagy, Klara/0000-0002-3035-6388	NHLBI NIH HHS [HL57984, 5T32 HL07751, HL57986] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057984, R01HL057986, T32HL007751] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BERNSTEIN SE, 1975, BIOL LABORATORY MOUS, P337; DAWSON PA, 1989, J LIPID RES, V30, P403; EHRENREICH JH, 1973, J CELL BIOL, V59, P45, DOI 10.1083/jcb.59.1.45; Fazio S, 1999, J BIOL CHEM, V274, P8247, DOI 10.1074/jbc.274.12.8247; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Heeren J, 1999, J CELL SCI, V112, P349; Horton JD, 1999, J CLIN INVEST, V103, P1067, DOI 10.1172/JCI6246; Huang YD, 1999, ARTERIOSCL THROM VAS, V19, P2952, DOI 10.1161/01.ATV.19.12.2952; INNERARITY TL, 1983, J BIOL CHEM, V258, P2341; JI ZS, 1994, J BIOL CHEM, V269, P2764; Jong MC, 1996, ARTERIOSCL THROM VAS, V16, P934, DOI 10.1161/01.ATV.16.8.934; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; Kinoshita M, 2000, J Atheroscler Thromb, V6, P22; Kuipers F, 1997, J CLIN INVEST, V100, P2915, DOI 10.1172/JCI119841; Langer C, 2000, J MOL MED, V78, P217, DOI 10.1007/s001090000096; Lin CY, 1999, J LIPID RES, V40, P1618; Linton MF, 1998, J CLIN INVEST, V101, P1726, DOI 10.1172/JCI2181; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; Mensenkamp AR, 1999, J BIOL CHEM, V274, P35711, DOI 10.1074/jbc.274.50.35711; PITAS RE, 1979, P NATL ACAD SCI USA, V76, P2311, DOI 10.1073/pnas.76.5.2311; Rensen PCN, 1996, J BIOL CHEM, V271, P14791, DOI 10.1074/jbc.271.25.14791; Rensen PCN, 2000, J BIOL CHEM, V275, P8564, DOI 10.1074/jbc.275.12.8564; SCHWIEGELSHOHN B, 1995, J BIOL CHEM, V270, P1761, DOI 10.1074/jbc.270.4.1761; SHIMANO H, 1994, J CLIN INVEST, V93, P2215, DOI 10.1172/JCI117218; Swift LL, 1996, J BIOL CHEM, V271, P31491; Swift LL, 2001, J LIPID RES, V42, P218; TABAS I, 1991, J CELL BIOL, V115, P1547, DOI 10.1083/jcb.115.6.1547; TABAS I, 1990, J CELL BIOL, V111, P929, DOI 10.1083/jcb.111.3.929; Takahashi Y, 1999, P NATL ACAD SCI USA, V96, P11358, DOI 10.1073/pnas.96.20.11358; Tsukamoto K, 2000, J LIPID RES, V41, P253; WONG L, 1989, J CELL PHYSIOL, V141, P441, DOI 10.1002/jcp.1041410227	32	53	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22965	22970		10.1074/jbc.M100172200	http://dx.doi.org/10.1074/jbc.M100172200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11304532	hybrid			2022-12-27	WOS:000169412700131
J	Zehnulova, J; Kasparkova, J; Farrell, N; Brabec, V				Zehnulova, J; Kasparkova, J; Farrell, N; Brabec, V			Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE-I; DIETHYL PYROCARBONATE; CHEMICAL-REACTIVITY; MAJOR ADDUCT; CISPLATIN; SITE; BINDING; HMG1; TRANS-DIAMMINEDICHLOROPLATINUM(II); CIS-DIAMMINEDICHLOROPLATINUM(II)	`The new antitumor trinuclear platinum compound [[trans-PtCl(NH3)(2)}(2)mu -trans Pt(NH3)(2){H2N(CH2)(2)NH2}(2)](4+) (designated as BBR3464) is currently in phase II clinical trials. DNA is generally considered the major pharmacological target of platinum drugs. As such it is of considerable interest to understand the patterns of DNA damage. The bifunctional DNA binding of BBR3464 is characterized by the rapid formation of long range intra-and interstrand cross links. We examined how the structures of the various types of the intrastrand crosslinks of BBR3464 affect conformational properties of DNA, and how these adducts are recognized by high mobility group 1 protein and removed from DNA during in, vitro nucleotide excision repair reactions. The results have revealed that intrastrand cross-links of BBR3484 create a local conformational distortion, but none of these cross-links results in a stable curvature. In addition, we have observed no recognition of these crosslinks by high mobility group 1 proteins, but we have observed effective removal of these adducts from DNA by nucleotide excision repair. These results suggest that the processing of the intrastrand cross-links of BBR3464 in tumor cells sensitive to this drug may not be relevant to its antitumor effects. Hence, polynuclear platinum compounds apparently represent a novel class of platinum anticancer drugs acting by a different mechanism than cisplatin and its analogues.	Virginia Commonwealth Univ, Dept Chem, Richmond, VA 23284 USA; Acad Sci Czech Republ, Inst Biophys, CZ-61265 Brno, Czech Republic	Virginia Commonwealth University; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Farrell, N (corresponding author), Virginia Commonwealth Univ, Dept Chem, Med Coll Virginia Campus, Richmond, VA 23284 USA.	nfarrell@maill.vcu.edu; brabec@ibp.cz	Brabec, Viktor/H-1946-2014	Brabec, Viktor/0000-0002-8233-1393	NCI NIH HHS [R01-CA78754] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078754] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANIN MF, 1990, NUCLEIC ACIDS RES, V18, P4395, DOI 10.1093/nar/18.15.4395; BAILLY C, 1994, BIOCHEM J, V300, P165, DOI 10.1042/bj3000165; BAILLY C, 1997, DRUG DNA INTERACTION, P51; BELLON SF, 1990, BIOPHYS CHEM, V35, P179, DOI 10.1016/0301-4622(90)80007-T; BELLON SF, 1991, BIOCHEMISTRY-US, V30, P8026, DOI 10.1021/bi00246a021; BRABEC V, 1993, P NATL ACAD SCI USA, V90, P5345, DOI 10.1073/pnas.90.11.5345; BRABEC V, 1993, BIOCHEMISTRY-US, V32, P11676, DOI 10.1021/bi00094a025; Brabec V, 2000, CANC DRUG DISC DEV, V7, P37; Brabec V, 1999, BIOCHEMISTRY-US, V38, P6781, DOI 10.1021/bi990124s; BRABEC V, 1992, BIOCHEMISTRY-US, V31, P12397, DOI 10.1021/bi00164a014; Buschta-Hedayat N, 1999, P NATL ACAD SCI USA, V96, P6090, DOI 10.1073/pnas.96.11.6090; Calvert PM, 1999, CLIN CANCER RES, V5, p3796S; Cohen SM, 2000, BIOCHEMISTRY-US, V39, P11771, DOI 10.1021/bi001352l; COMESS KM, 1990, BIOCHEMISTRY-US, V29, P2102, DOI 10.1021/bi00460a020; Cox JW, 2001, J AM CHEM SOC, V123, P1316, DOI 10.1021/ja0012772; Farrell N, 2000, CANC DRUG DISC DEV, V7, P321; FARRELL N, 1999, CISPLATIN CHEM BIOCH, P479; He Q, 2000, P NATL ACAD SCI USA, V97, P5768, DOI 10.1073/pnas.100108697; He Q, 2000, BIOCHEMISTRY-US, V39, P14426, DOI 10.1021/bi001700j; HERR W, 1985, P NATL ACAD SCI USA, V82, P8009, DOI 10.1073/pnas.82.23.8009; HUANG HF, 1995, SCIENCE, V270, P1842, DOI 10.1126/science.270.5243.1842; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Janus F, 1999, CELL MOL LIFE SCI, V55, P12, DOI 10.1007/s000180050266; Johnson N.P., 1989, PROG CLIN BIOCH MED, V10, P1, DOI [DOI 10.1007/978-3-642-74760-1, 10.1007/978-3-642-74760-1_1, DOI 10.1007/978-3-642-74760-1_1]; JOHNSTON BH, 1985, CELL, V42, P713, DOI 10.1016/0092-8674(85)90268-5; JONES SL, 1994, INT J CANCER, V59, P388, DOI 10.1002/ijc.2910590317; KASPARKOVA J, 1995, BIOCHEMISTRY-US, V34, P12379, DOI 10.1021/bi00038a035; Kasparkova J, 1996, BIOCHEMISTRY-US, V35, P16705, DOI 10.1021/bi961160j; Kasparkova J, 2000, J BIOL CHEM, V275, P15789, DOI 10.1074/jbc.M000777200; Kloster MBG, 1999, BIOCHEMISTRY-US, V38, P14731, DOI 10.1021/bi991202e; Koberle B, 1999, CURR BIOL, V9, P273, DOI 10.1016/S0960-9822(99)80118-3; KOO HS, 1986, NATURE, V320, P501, DOI 10.1038/320501a0; KOO HS, 1988, P NATL ACAD SCI USA, V85, P1763, DOI 10.1073/pnas.85.6.1763; LEMAIRE M, 1990, BIOCHEM J, V267, P431, DOI 10.1042/bj2670431; LEMAIRE MA, 1991, P NATL ACAD SCI USA, V88, P1982, DOI 10.1073/pnas.88.5.1982; LENG M, 1990, BIOPHYS CHEM, V35, P155, DOI 10.1016/0301-4622(90)80005-R; Li MJ, 1999, INT J ONCOL, V15, P1177; MANLEY JL, 1980, P NATL ACAD SCI-BIOL, V77, P3855, DOI 10.1073/pnas.77.7.3855; MARROT L, 1989, BIOCHEMISTRY-US, V28, P1454, DOI 10.1021/bi00430a005; MATSUNAGA T, 1995, J BIOL CHEM, V270, P20862, DOI 10.1074/jbc.270.35.20862; Maxam A M, 1980, Methods Enzymol, V65, P499; MCANULTY MM, 1995, NUCLEIC ACIDS MOL BI, V9, P264; MCCARTHY JG, 1991, NUCLEIC ACIDS RES, V19, P3421, DOI 10.1093/nar/19.12.3421; MCCARTHY JG, 1990, BIOCHEMISTRY-US, V29, P6071, DOI 10.1021/bi00477a027; Moggs JG, 1997, NUCLEIC ACIDS RES, V25, P480, DOI 10.1093/nar/25.3.480; Naegeli H., 1997, MECH DNA DAMAGE RECO; Nielsen P E, 1990, J Mol Recognit, V3, P1, DOI 10.1002/jmr.300030102; O'Dwyer P. J., 1999, CISPLATIN CHEM BIOCH, P31; O'Dwyer PJ, 2000, DRUGS, V59, P19, DOI 10.2165/00003495-200059004-00003; Ohndorf UM, 1999, NATURE, V399, P708, DOI 10.1038/21460; Perego P, 1999, MOL PHARMACOL, V55, P528; Perego P, 1999, J INORG BIOCHEM, V77, P59, DOI 10.1016/S0162-0134(99)00142-7; Pratesi G, 1999, BRIT J CANCER, V80, P1912, DOI 10.1038/sj.bjc.6690620; Qu Y, 2000, J MED CHEM, V43, P3189; Reardon JT, 1999, CANCER RES, V59, P3968; REARDON JT, 1998, ADV DNA DAMAGE REPAI, P377; RICE JA, 1988, P NATL ACAD SCI USA, V85, P4158, DOI 10.1073/pnas.85.12.4158; Roberts JD, 1999, J INORG BIOCHEM, V77, P51, DOI 10.1016/S0162-0134(99)00147-6; Roberts JD, 1999, J INORG BIOCHEM, V77, P47, DOI 10.1016/S0162-0134(99)00137-3; Rosenberg B, 1999, CISPLATIN CHEM BIOCH, P1, DOI DOI 10.1002/9783906390420; Ross SA, 1996, NUCLEIC ACIDS RES, V24, P5062, DOI 10.1093/nar/24.24.5062; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SCHWARTZ A, 1989, BIOCHEMISTRY-US, V28, P7975, DOI 10.1021/bi00446a001; Sessa C, 2000, ANN ONCOL, V11, P977, DOI 10.1023/A:1008302309734; Stros M, 1998, J BIOL CHEM, V273, P10355; Teuben JM, 1999, BIOCHEMISTRY-US, V38, P12305, DOI 10.1021/bi9904757; Whitehead JP, 1996, MET IONS BIOL SYST, V32, P687; Wong E, 1999, CHEM REV, V99, P2451, DOI 10.1021/cr980420v; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031; Zaludova R, 1997, EUR J BIOCHEM, V246, P508, DOI 10.1111/j.1432-1033.1997.00508.x; Zamble DB, 1996, BIOCHEMISTRY-US, V35, P10004, DOI 10.1021/bi960453+; ZAMBLE DB, 1999, CISPLATIN CHEM BIOCH, P73; Zlatanova J, 1998, FASEB J, V12, P791, DOI 10.1096/fasebj.12.10.791	74	88	88	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22191	22199		10.1074/jbc.M103118200	http://dx.doi.org/10.1074/jbc.M103118200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11303029	hybrid			2022-12-27	WOS:000169412700031
J	Christophe, T; Karlsson, A; Dugave, C; Rabiet, MJ; Boulay, F; Dahlgren, C				Christophe, T; Karlsson, A; Dugave, C; Rabiet, MJ; Boulay, F; Dahlgren, C			The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A(4) receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; N-FORMYLPEPTIDE RECEPTOR; NADPH-OXIDASE; PHOSPHORYLATION SITES; PHOSPHOINOSITIDE HYDROLYSIS; CELL-LINE; DESENSITIZATION; IDENTIFICATION; 7-TRANSMEMBRANE; INTERNALIZATION	Neutrophils express the G protein-coupled N-formyl peptide receptor (FPR) and its homologue FPRL1, whereas monocytes express FPR, FPRL1, and FPRL2, an orphan receptor sharing 83% amino acid identity with FPRL1, FPRL1 is a promiscuous receptor activated by serum amyloid A and by different synthetic peptides, including the hexapeptide Trp-Lys-Tyr-Met-Val-D-Met-NH2 (WKYMVm), By measuring calcium flux in HL-60 cells transfected with FPR, FPRL1, or FPRL2, we show that WKYMVm activated all three receptors, whereas the L-conformer WKYMVM activated exclusively FPRL1 and FPRL2, The functionality of FPRL2 was further assessed by the ability of HL-60-FPRL2 cells to migrate toward nanomolar concentrations of hexapeptides. The half-maximal effective concentrations of WKYMVM for calcium mobilization in HL-60-FPRL1 and HL-60-FPRL2 cells were 2 and 80 nM, respectively. Those of WKYMVm were 75 pM and 3 nM, The tritiated peptide WK[3,5-H-3(2)]YMVM bound to FPRL1 (K-D similar to 160 nM), but not to FPR, The two conformers similarly inhibited binding of I-125-labeled WKYMVm to FPRL2-expressing cells (IC50 similar to 2.5-3 muM). Metabolic labeling with orthophosphoric acid revealed that FPRL1 was differentially phosphorylated upon addition of the L- or D-conformer, indicating that it induced different conformational changes. In contrast to FPRL1, FPRL2 was already phosphorylated in the absence of agonist and not evenly distributed in the plasma membrane of unstimulated cells. However, both receptors were internalized upon addition of either of the two conformers. Taken together, the results indicate that neutrophils are activated by WKYMVM through FPRL1 and that FPRL2 is a chemotactic receptor transducing signals in myeloid cells.	Univ Grenoble 1, CEA Grenoble, Dept Biol Mol & Struct Biochim & Biophys Syst Int, CNRS,UMR 5092, F-38054 Grenoble 9, France; Univ Gothenburg, Dept Med Microbiol & Immunol, Phagocyte Res Lab, S-40530 Gothenburg, Sweden; CEA Saclay, Dept Ingn & Etud Prot, F-91191 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Gothenburg; CEA; UDICE-French Research Universities; Universite Paris Saclay	Boulay, F (corresponding author), Univ Grenoble 1, CEA Grenoble, Dept Biol Mol & Struct Biochim & Biophys Syst Int, CNRS,UMR 5092, 17 Rue Martyrs, F-38054 Grenoble 9, France.	fboulay@cea.fr	TEST-GU, TEST-GU/B-5469-2010; Karlsson, Anna/A-4130-2012	Karlsson, Anna/0000-0001-6796-1154				Ali H, 1997, MED CLIN N AM, V81, P1, DOI 10.1016/S0025-7125(05)70503-4; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Baek SH, 1996, J BIOL CHEM, V271, P8170, DOI 10.1074/jbc.271.14.8170; BAO L, 1992, Genomics, V13, P437, DOI 10.1016/0888-7543(92)90265-T; BOKOCH GM, 1995, BLOOD, V86, P1649, DOI 10.1182/blood.V86.5.1649.bloodjournal8651649; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; BOULAY F, 1990, BIOCHEM BIOPH RES CO, V168, P1103, DOI 10.1016/0006-291X(90)91143-G; BOULAY F, 1990, BIOCHEMISTRY-US, V29, P11123, DOI 10.1021/bi00502a016; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Christophe T, 2000, J BIOL CHEM, V275, P1656, DOI 10.1074/jbc.275.3.1656; Clark RB, 1999, TRENDS PHARMACOL SCI, V20, P279, DOI 10.1016/S0165-6147(99)01351-6; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; Deng XY, 1999, BLOOD, V94, P1165, DOI 10.1182/blood.V94.4.1165.416k23_1165_1173; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; DURSTIN M, 1994, BIOCHEM BIOPH RES CO, V201, P174, DOI 10.1006/bbrc.1994.1685; FEATHERSTONE C, 1995, TRENDS CELL BIOL, V5, P388, DOI 10.1016/S0962-8924(00)89081-9; FIORE S, 1994, J EXP MED, V180, P253, DOI 10.1084/jem.180.1.253; Franci C, 1996, J IMMUNOL, V157, P5606; GAO JL, 1993, J BIOL CHEM, V268, P25395; GIANNINI E, 1995, J BIOL CHEM, V270, P19166, DOI 10.1074/jbc.270.32.19166; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hebert TE, 1998, BIOCHEM CELL BIOL, V76, P1, DOI 10.1139/bcb-76-1-1; Hsu MH, 1997, J BIOL CHEM, V272, P29426, DOI 10.1074/jbc.272.47.29426; JESAITIS AJ, 1993, EUR J HAEMATOL, V51, P288; LANG JC, 1993, EMBO J, V12, P2671, DOI 10.1002/j.1460-2075.1993.tb05928.x; Le YY, 2001, J IMMUNOL, V166, P1448, DOI 10.4049/jimmunol.166.3.1448; Le YY, 1999, J IMMUNOL, V163, P6777; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Liu L, 1998, J IMMUNOL, V160, P2463; Lundqvist H, 1996, FREE RADICAL BIO MED, V20, P785, DOI 10.1016/0891-5849(95)02189-2; LUNQVIST H, 1994, BIOCHIM BIOPHYS ACTA, V1224, P43; MURPHY PM, 1992, J BIOL CHEM, V267, P7637; Naik N, 1997, J CELL SCI, V110, P2381; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; Rainger GE, 1997, CURR BIOL, V7, P316, DOI 10.1016/S0960-9822(06)00155-2; SALACINSKI PRP, 1981, ANAL BIOCHEM, V117, P136, DOI 10.1016/0003-2697(81)90703-X; Seo JK, 1997, J IMMUNOL, V158, P1895; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Su SB, 1999, J IMMUNOL, V162, P5924; Tardif M, 1998, J IMMUNOL, V161, P6885; TARDIF M, 1993, J IMMUNOL, V150, P3534; TONETTI DA, 1994, J BIOL CHEM, V269, P23230; Wenzel-Seifert K, 1998, J BIOL CHEM, V273, P24181, DOI 10.1074/jbc.273.37.24181; WENZELSEIFERT K, 1993, J IMMUNOL, V150, P4591; WIENTJES FB, 1995, SEMIN CELL BIOL, V6, P357, DOI 10.1016/S1043-4682(05)80006-6; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Ye R D, 1997, Adv Pharmacol, V39, P221, DOI 10.1016/S1054-3589(08)60073-3; YE RD, 1992, BIOCHEM BIOPH RES CO, V184, P582, DOI 10.1016/0006-291X(92)90629-Y; Yu YK, 1997, J BIOL CHEM, V272, P28869, DOI 10.1074/jbc.272.46.28869; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	54	158	169	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21585	21593		10.1074/jbc.M007769200	http://dx.doi.org/10.1074/jbc.M007769200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11285256	hybrid			2022-12-27	WOS:000169297900105
J	Yamaoka, T; Yano, M; Kondo, M; Sasaki, H; Hino, S; Katashima, R; Moritani, M; Itakura, M				Yamaoka, T; Yano, M; Kondo, M; Sasaki, H; Hino, S; Katashima, R; Moritani, M; Itakura, M			Feedback inhibition of amidophosphoribosyltransferase regulates the rate of cell growth via purine nucleotide, DNA, and protein syntheses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MICE; LEUKEMIA-CELLS; T-LYMPHOCYTES; PHOSPHORIBOSYLPYROPHOSPHATE; PHOSPHORIBOSYLTRANSFERASE; BIOSYNTHESIS; AMIDOTRANSFERASE; BINDING; DENOVO	To clarify the contributions of amidophosphoribosyltransferase (ATase) and its feedback regulation to the rates of purine de novo synthesis, DNA synthesis, protein synthesis, and cell growth, mutated human ATase (mhATase) resistant to feedback inhibition by purine ribonucleotides was engineered by site-directed mutagenesis and expressed in CHO ade (-)A cells (an ATase-deficient cell line of Chinese hamster ovary fibroblasts) and in transgenic mice (mhATase-Tg mice). In Chinese hamster ovary transfectants with mhATase, the following parameters were examined: ATase activity and its subunit structure, the metabolic rates of de novo and salvage pathways, DNA and protein synthesis rates, and the rate of cell growth. In mhATase-Tg mice, ATase activity in the liver and spleen, the metabolic rate of the de novo pathway in the liver, serum uric acid concentration, urinary excretion of purine derivatives, and T lymphocyte proliferation by phytohemagglutinin were examined. We concluded the following. 1) ATase and its feedback inhibition regulate not only the rate of purine de novo synthesis but also DNA and protein synthesis rates and the rate of cell growth in cultured fibroblasts, 2) Suppression of the de novo pathway by the salvage pathway is mainly due to the feedback inhibition of ATase by purine ribonucleotides produced via the salvage pathway, whereas the suppression of the salvage pathway by the de novo pathway is due to consumption of 5-phosphoribosyl 1-pyrophosphate by the de novo pathway. 3) The feedback inhibition of ATase is more important for the regulation of the de novo pathway than that of 5-phosphoribosyl 1-pyrophosphate synthetase, 4) ATase superactivity leads to hyperuricemia and an increased bromodeoxyuridine incorporation in T lymphocytes stimulated by phytohemagglutinin.	Univ Tokushima, Sch Med, Div Genet Informat, Inst Genome Res, Tokushima 7708503, Japan; Univ Tokushima, Sch Med, Otsuka Dept Clin & Mol Nutr, Tokushima 7708503, Japan	Tokushima University; Tokushima University	Yamaoka, T (corresponding author), Univ Tokushima, Sch Med, Div Genet Informat, Inst Genome Res, Tokushima 7708503, Japan.							ALLISON AC, 1975, LANCET, V2, P1179; BECKER MA, 1995, J CLIN INVEST, V96, P2133, DOI 10.1172/JCI118267; BECKER MA, 1987, J BIOL CHEM, V262, P14531; BOSS GR, 1982, J BIOL CHEM, V257, P4242; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROSH S, 1976, J CLIN INVEST, V58, P289, DOI 10.1172/JCI108471; FAIRBANKS LD, 1995, J BIOL CHEM, V270, P29682; Fairbanks LD, 1999, BIOCHEM J, V342, P143, DOI 10.1042/0264-6021:3420143; HOLMES EW, 1973, J BIOL CHEM, V248, P6035; ITAKURA M, 1979, J BIOL CHEM, V254, P333; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; Kondo M, 2000, J BIOCHEM, V128, P57, DOI 10.1093/oxfordjournals.jbchem.a022730; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pelled D, 1999, J NEUROCHEM, V72, P1139, DOI 10.1046/j.1471-4159.1999.0721139.x; SANT ME, 1992, J BIOL CHEM, V267, P11038; Shi RZ, 1998, INT J BIOCHEM CELL B, V30, P885, DOI 10.1016/S1357-2725(98)00053-3; Yamaoka T, 1998, J CLIN INVEST, V102, P294, DOI 10.1172/JCI2769; Yamaoka T, 1997, J BIOL CHEM, V272, P17719, DOI 10.1074/jbc.272.28.17719; ZHOU GC, 1994, J BIOL CHEM, V269, P6784	19	39	39	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21285	21291		10.1074/jbc.M011103200	http://dx.doi.org/10.1074/jbc.M011103200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11290738	hybrid			2022-12-27	WOS:000169297900066
J	Learn, CA; Boger, MS; Li, LW; McCall, CE				Learn, CA; Boger, MS; Li, LW; McCall, CE			The phosphatidylinositol 3-kinase pathway selectively controls sIL-1RA not interleukin-1 beta production in the septic leukocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTOXIN-TOLERANT CELLS; MESSENGER-RNA; SEPSIS; EXPRESSION; MACROPHAGES; CYTOKINE; INHIBITION; KINASE; HUMANS; BLOOD	Microbial components such as bacterial endotoxin lipopolysaccharide (LPS) can trigger highly lethal septic shock, The cardinal features of septic leukocytes include the repressed production of inflammatory cytokines, such as interleukin-1 beta (IL-1 beta), and elevated production of anti-inflammatory cytokines, such as secretory interleukin-1 receptor antagonist (sIL-1RA), Pro- and anti-inflammatory cytokine gene transcriptions are equally repressed in septic leukocytes due to disruption of the LPS signaling pathway at the level of interleukin-1 receptor-associated kinase, The selective elevation of sIL-1RA protein in septic blood is caused by efficient translation of residual sIL-1RA message. In this study, we report that the LPS-inducible phosphatidylinositol 3-kinase (PI3-kinase)-dependent signaling pathway contributes to the elevated translation of sIL-1RA in septic/LPS-adapted leukocytes, We also observe that this pathway is gene specific and does not affect the production of proinflammatory IL-1 beta protein.	Wake Forest Univ, Sch Med, Dept Med, Infect Dis Sect, Winston Salem, NC 27157 USA	Wake Forest University	Li, LW (corresponding author), Wake Forest Univ, Sch Med, Dept Med, Infect Dis Sect, Med Ctr Blvd, Winston Salem, NC 27157 USA.			Li, Liwu/0000-0001-8870-5299	NCI NIH HHS [CA-09422] Funding Source: Medline; NCRR NIH HHS [MM01 RR07122-10] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009422] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; Bone RC, 1996, JAMA-J AM MED ASSOC, V276, P565, DOI 10.1001/jama.276.7.565; Bowling WM, 1996, J SURG RES, V63, P287, DOI 10.1006/jsre.1996.0262; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; CROSS A, 1995, J CLIN INVEST, V96, P676, DOI 10.1172/JCI118110; Diaz-Guerra MJM, 1999, J IMMUNOL, V162, P6184; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; LARUE KEA, 1994, J EXP MED, V180, P2269, DOI 10.1084/jem.180.6.2269; Learn CA, 2000, J BIOL CHEM, V275, P12185, DOI 10.1074/jbc.275.16.12185; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200; MCCALL CE, 1993, J CLIN INVEST, V91, P853, DOI 10.1172/JCI116306; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136; Reddy SAG, 2000, J IMMUNOL, V164, P1355, DOI 10.4049/jimmunol.164.3.1355; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; STONE R, 1994, SCIENCE, V264, P365, DOI 10.1126/science.8153620; vanderPoll T, 1996, J INFECT DIS, V174, P1356, DOI 10.1093/infdis/174.6.1356; Weinstein SL, 2000, J LEUKOCYTE BIOL, V67, P405, DOI 10.1002/jlb.67.3.405; Wenzel RP, 1996, CLIN INFECT DIS, V22, P407, DOI 10.1093/clinids/22.3.407; Yoza BK, 2000, SHOCK, V13, P236, DOI 10.1097/00024382-200003000-00011	21	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20234	20239		10.1074/jbc.M100316200	http://dx.doi.org/10.1074/jbc.M100316200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279236	hybrid			2022-12-27	WOS:000169135100077
J	Mitoma, M; Oho, T; Shimazaki, Y; Koga, T				Mitoma, M; Oho, T; Shimazaki, Y; Koga, T			Inhibitory effect of bovine milk lactoferrin on the interaction between a streptococcal surface protein antigen and human salivary agglutinin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; BIOSPECIFIC INTERACTION ANALYSIS; MUTANS SEROTYPE-C; PLASMON RESONANCE; 3-DIMENSIONAL STRUCTURE; COATED HYDROXYAPATITE; DENTAL-CARIES; BINDING-SITE; ADHERENCE; GLUCOSYLTRANSFERASE	Human whole saliva induces aggregation of Streptococcus mutans cells via an interaction between a surface protein antigen (PAc) of the organism and salivary agglutinin, Bovine milk inhibits the saliva-induced aggregation of S, mutans, In this study, the milk component that possesses inhibitory activity against this aggregation was isolated and found to be lactoferrin, Surface plasmon resonance analysis indicated that bovine lactoferrin binds more strongly to salivary agglutinin, especially to high molecular mass glycoprotein, which is a component of the agglutinin, than to recombinant PAc. The binding of bovine lactoferrin to salivary agglutinin was thermostable, and the optimal pH for binding was 4.0, To identify the saliva-binding region of bovine lactoferrin, 11 truncated bovine lactoferrin fragments were constructed. A fragment corresponding to the C-terminal half of the lactoferrin molecule had a strong inhibitory effect on the saliva-induced aggregation of S. mutans, whereas a fragment corresponding to the N-terminal half had a weak inhibitory effect. Seven shorter fragments corresponding to lactoferrin residues 473-538 also showed a high ability to inhibit the aggregation of S. mutans. These results suggest that residues 473-538 of bovine lactoferrin are important in the inhibition of saliva-induced aggregation of S. mutans.	Kyushu Univ, Fac Dent Sci, Dept Prevent Dent, Fukuoka 8128582, Japan	Kyushu University	Oho, T (corresponding author), Kyushu Univ, Fac Dent Sci, Dept Prevent Dent, Fukuoka 8128582, Japan.	oho@dent.kyushu-u.ac.jp	Abrams, William R/A-5782-2008					Baker EN, 1998, ADV EXP MED BIOL, V443, P1; Baker HM, 2000, INT CONGR SER, V1195, P3; BELLAMY W, 1992, BIOCHIM BIOPHYS ACTA, V1121, P130, DOI 10.1016/0167-4838(92)90346-F; BOWEN WH, 1991, INFECT IMMUN, V59, P4606, DOI 10.1128/IAI.59.12.4606-4609.1991; Brock JH, 1997, EXP BIOL M, V28, P3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CARLEN A, 1995, J DENT RES, V74, P1040, DOI 10.1177/00220345950740040301; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; EBINA T, 1992, J MED VIROL, V38, P117, DOI 10.1002/jmv.1890380209; Freedman DJ, 1998, J INFECT DIS, V177, P662, DOI 10.1086/514227; GIBBONS RJ, 1989, J DENT RES, V68, P750, DOI 10.1177/00220345890680050101; GIBBONS RJ, 1988, INFECT IMMUN, V56, P439, DOI 10.1128/IAI.56.2.439-445.1988; Gong K, 2000, J BIOL CHEM, V275, P8970, DOI 10.1074/jbc.275.12.8970; ISHIDA A, 1992, J NUTR, V122, P1875, DOI 10.1093/jn/122.9.1875; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Kawasaki Y, 2000, BIOSCI BIOTECH BIOCH, V64, P348, DOI 10.1271/bbb.64.348; KOGA T, 1990, INFECT IMMUN, V58, P289, DOI 10.1128/IAI.58.2.289-296.1990; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laloi P, 1996, INFECT IMMUN, V64, P28, DOI 10.1128/IAI.64.1.28-36.1996; LASSITER MO, 1987, J DENT RES, V66, P480, DOI 10.1177/00220345870660021601; LEE SF, 1989, INFECT IMMUN, V57, P3306, DOI 10.1128/IAI.57.11.3306-3313.1989; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHESHWARI P, 1997, BIOCHEM J, V323, P815; Moore SA, 1997, J MOL BIOL, V274, P222, DOI 10.1006/jmbi.1997.1386; Mulvihill DM, 1997, ADV EXP MED BIOL, V415, P77; MUROSAKI S, 1991, J NUTR, V121, P1860, DOI 10.1093/jn/121.11.1860; Oho T, 1998, INFECT IMMUN, V66, P115, DOI 10.1128/IAI.66.1.115-121.1998; Oho T, 1999, J NUTR, V129, P1836, DOI 10.1093/jn/129.10.1836; PAYNE JB, 1991, ORAL MICROBIOL IMMUN, V6, P169, DOI 10.1111/j.1399-302X.1991.tb00472.x; RAJ PA, 1992, J BIOL CHEM, V267, P5968; ROGER V, 1994, CARIES RES, V28, P421, DOI 10.1159/000262015; Russell M W, 1992, Curr Opin Dent, V2, P72; RUSSELL RRB, 1994, CARIES RES, V28, P69, DOI 10.1159/000261625; SAITO H, 1994, ADV EXP MED BIOL, V357, P219; SANCHEZ L, 1992, ARCH DIS CHILD, V67, P657, DOI 10.1136/adc.67.5.657; Senpuku H, 1996, FEMS MICROBIOL LETT, V139, P195, DOI 10.1016/0378-1097(96)00141-3; SHIMAZAKI K, 1993, INT J BIOCHEM, V25, P1653, DOI 10.1016/0020-711X(93)90524-I; SHIMAZAKI K, 1991, COMP BIOCHEM PHYS B, V98, P417, DOI 10.1016/0305-0491(91)90199-N; Shimazaki K, 2000, INT CONGR SER, V1195, P37; SOUKKA T, 1993, ARCH ORAL BIOL, V38, P227, DOI 10.1016/0003-9969(93)90032-H; SOUKKA T, 1994, MICROB ECOL HEALTH D, V7, P139, DOI 10.3109/08910609409141343; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; Tsukioka Y, 1997, J BACTERIOL, V179, P4411, DOI 10.1128/jb.179.13.4411-4414.1997; VACCASMITH AM, 1995, CARIES RES, V29, P498, DOI 10.1159/000262121; VACCASMITH AM, 1994, ARCH ORAL BIOL, V39, P1063, DOI 10.1016/0003-9969(94)90059-0; WINGFIELD PT, 1995, CURRENT PROTOCOLS PR, V1; YAMAUCHI K, 1993, INFECT IMMUN, V61, P719, DOI 10.1128/IAI.61.2.719-728.1993	48	40	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18060	18065		10.1074/jbc.M101459200	http://dx.doi.org/10.1074/jbc.M101459200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279204	hybrid			2022-12-27	WOS:000168866500060
J	Gaburjakova, M; Gaburjakova, J; Reiken, S; Huang, F; Marx, SO; Rosemblit, N; Marks, AR				Gaburjakova, M; Gaburjakova, J; Reiken, S; Huang, F; Marx, SO; Rosemblit, N; Marks, AR			FKBP12 binding modulates ryanodine receptor channel gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; FK506; RAPAMYCIN; PROTEIN; COMPLEX	The ryanodine receptor (RyR1)/calcium release channel on the sarcoplasmic reticulum of skeletal muscle is comprised of four 565,000-dalton RyR1s, each of which binds one FK506 binding protein (FKBP12), RyR1 is required for excitation-contraction coupling in skeletal muscle. FKBP12, a cis-trans peptidyl-prolyl isomerase, is required for the normal gating of the RyR1 channel. In the absence of FKBP12, RyR1 channels Exhibit increased gating frequency, suggesting that FKBP12 "stabilizes" the channel in the open and closed states. We now show that substitution of a Gly, Glu, or Ile for Val(2461) in RyR1 prevents FKBP12 binding to RyR1, resulting in channels with increased gating frequency. In the case of the V2461I mutant RyR1, normal channel function can be restored by adding FKBP12.6, an isoform of FKBP12. These data identify Val(2461) ag a critical residue required for FKBP12 binding to RyR1 and demonstrate the functional role for FKBP12 in the RyR1 channel complex.	Columbia Univ, Coll Phys & Surg, Ctr Mol Cardiol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Marks, AR (corresponding author), Columbia Univ, Coll Phys & Surg, Ctr Mol Cardiol, Rm 9-401,630 W 168th St, New York, NY 10032 USA.	arm42@columbia.edu	Gaburjakova, Jana/HGA-3661-2022; Gaburjakova, Marta/AAV-6066-2021	Gaburjakova, Jana/0000-0001-9540-7169; Gaburjakova, Marta/0000-0002-9300-0688	FIC NIH HHS [R03 TW00949] Funding Source: Medline; NHLBI NIH HHS [R01 HL61503, R01 HL56180] Funding Source: Medline; NIAID NIH HHS [R01 AI39794] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R03TW000949] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061503, R01HL056180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039794] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHERN GP, 1994, FEBS LETT, V352, P369, DOI 10.1016/0014-5793(94)01001-3; Ahern GP, 1997, BIOPHYS J, V72, P146, DOI 10.1016/S0006-3495(97)78654-5; ALBERS MW, 1990, J ORG CHEM, V55, P4984, DOI 10.1021/jo00304a003; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Cameron AM, 1997, J BIOL CHEM, V272, P27582, DOI 10.1074/jbc.272.44.27582; CHEN SRW, 1994, P NATL ACAD SCI USA, V91, P11953, DOI 10.1073/pnas.91.25.11953; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; Kaftan E, 1996, CIRC RES, V78, P990, DOI 10.1161/01.RES.78.6.990; Marks AR, 2000, CIRC RES, V87, P8, DOI 10.1161/01.RES.87.1.8; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; MARKS AR, 1989, P NATL ACAD SCI USA, V86, P8683, DOI 10.1073/pnas.86.22.8683; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Ondrias K, 1996, SOC GEN PHY, V51, P29; ROSEN MK, 1990, SCIENCE, V248, P863, DOI 10.1126/science.1693013; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Shou WN, 1998, NATURE, V391, P489, DOI 10.1038/35146; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; TIMERMAN AP, 1993, J BIOL CHEM, V268, P22992; Xin HB, 2001, BIOPHYS J, V80, p579A	21	139	147	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16931	16935		10.1074/jbc.M100856200	http://dx.doi.org/10.1074/jbc.M100856200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279144	hybrid			2022-12-27	WOS:000168730400044
J	Gilbertson, DG; Duff, ME; West, JW; Kelly, JD; Sheppard, PO; Hofstrand, PD; Gao, ZR; Shoemaker, K; Bukowski, TR; Moore, M; Feldhaus, AL; Humes, JM; Palmer, TE; Hart, CE				Gilbertson, DG; Duff, ME; West, JW; Kelly, JD; Sheppard, PO; Hofstrand, PD; Gao, ZR; Shoemaker, K; Bukowski, TR; Moore, M; Feldhaus, AL; Humes, JM; Palmer, TE; Hart, CE			Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; DIFFERENT ISOFORMS; TYROSINE KINASES; NERVOUS-SYSTEM; FACTOR FGF; TGF-BETA; A-CHAINS; NEUROPILIN; EXPRESSION; FAMILY	We have characterized platelet-derived growth factor (PDGF) C, a novel growth factor belonging to the PDGF family. PDGF-C is a multidomain protein with the N-terminal region homologous-to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and PDGF A-chain (23%). A serum-sensitive cleavage site between the two domains allows release of the GFD from the CUE domain. Competition binding and immunoprecipitation studies on cells bearing both PDGF alpha and beta receptors reveal a high affinity binding of recombinant GFD (PDGF-CC) to PDGF receptor-alpha homodimers and PDGF receptor-alpha/beta heterodimers, PDGF-CC exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than PDGF-AB and PDGF-BB on several mesenchymal cell types. Analysis of PDGF-CC in vivo in a diabetic mouse model of delayed wound healing showed that PDGF-CC significantly enhanced repair of a full-thickness skin excision. Together, these studies describe a third member of the PDGF family (PDGF-C) as a potent mitogen for cells of mesenchymal origin in in vitro and in vivo systems with a binding pattern similar to PDGF-AB.	ZymoGenet Inst, Seattle, WA 98102 USA	Zymogenet Inc.	Gilbertson, DG (corresponding author), 1201 Eastlake Ave E, Seattle, WA 98102 USA.	gilbertd@zgi.com						ABBOUD HE, 1994, J CELL PHYSIOL, V158, P140, DOI 10.1002/jcp.1041580118; Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; ANSEL JC, 1993, J CLIN INVEST, V92, P671, DOI 10.1172/JCI116636; BOWENPOPE DF, 1985, METHOD ENZYMOL, V109, P69; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Clark DA, 1998, INT J BIOCHEM CELL B, V30, P293, DOI 10.1016/S1357-2725(97)00128-3; COLLINS T, 1987, NATURE, V328, P621, DOI 10.1038/328621a0; Coulier F, 1997, J MOL EVOL, V44, P43, DOI 10.1007/PL00006120; FOSTER DC, 1994, Patent No. 5641655; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; GREENWEL P, 1993, LAB INVEST, V69, P210; HART CE, 1987, J BIOL CHEM, V262, P10780; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HART CE, 1990, J INVEST DERMATOL, V94, pS53, DOI 10.1111/1523-1747.ep12875065; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HELDIN CH, 1993, GROWTH FACTORS, V8, P245, DOI 10.3109/08977199308991570; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Joukov V, 1996, EMBO J, V15, P290; KELLY JD, 1991, J BIOL CHEM, V266, P8987; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOYAMA N, 1994, CIRC RES, V75, P682, DOI 10.1161/01.RES.75.4.682; Lepisto J, 1996, CELL TISSUE RES, V286, P449, DOI 10.1007/s004410050714; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Malinda KM, 1999, FASEB J, V13, P53, DOI 10.1096/fasebj.13.1.53; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; NICOSIA RF, 1990, IN VITRO CELL DEV B, V26, P119; Olofsson B, 1998, P NATL ACAD SCI USA, V95, P11709, DOI 10.1073/pnas.95.20.11709; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; RAINES W, 1993, CYTOKINES, V5, P74; Raymond CK, 1999, BIOTECHNIQUES, V26, P134, DOI 10.2144/99261rr02; Rosenkranz S, 1999, GROWTH FACTORS, V16, P201, DOI 10.3109/08977199909002130; RUPP E, 1994, EUR J BIOCHEM, V225, P29, DOI 10.1111/j.1432-1033.1994.00029.x; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; SPRUGEL KH, 1991, PROG CLIN BIOL RES, V365, P327; STROOBANT P, 1984, EMBO J, V3, P2963, DOI 10.1002/j.1460-2075.1984.tb02241.x; Szebenyi G, 1999, INT REV CYTOL, V185, P45; TAKAGI S, 1987, DEV BIOL, V122, P90, DOI 10.1016/0012-1606(87)90335-6; TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208; TIESMAN J, 1993, J BIOL CHEM, V268, P9621; TISCHER E, 1989, BIOCHEM BIOPH RES CO, V165, P1198, DOI 10.1016/0006-291X(89)92729-0; TONG BD, 1987, NATURE, V328, P619, DOI 10.1038/328619a0	46	213	245	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 20	2001	276	29					27406	27414		10.1074/jbc.M101056200	http://dx.doi.org/10.1074/jbc.M101056200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	454HJ	11297552	hybrid			2022-12-27	WOS:000169966900090
J	Quintas, A; Vaz, DC; Cardoso, I; Saraiva, MJM; Brito, RMM				Quintas, A; Vaz, DC; Cardoso, I; Saraiva, MJM; Brito, RMM			Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRIL PROTEIN; POLYNEUROPATHY; FIBRILLOGENESIS; THYROXINE; BINDING; MODEL	Amyloid fibril formation and deposition is a common feature of a wide range of fatal diseases including spongiform encephalopathies, Alzheimer's disease, and familial amyloidotic polyneuropathies (FAP), among many others. In certain forms of FAP, the amyloid fibrils are mostly constituted by variants of transthyretin (TTR), a homotetrameric plasma protein. Recently, we showed that transthyretin in solution may undergo dissociation to a non-native monomer, even under close to physiological conditions of temperature, pH, ionic strength, and protein concentration. We also showed that this non-native monomer is a compact structure, does not behave as a molten globule, and may lead to the formation of partially unfolded monomeric species and high molecular mass soluble aggregates (Quintas, A., Saraiva, M.J.M., and Brito, R.M.M. (1999) J. Biol. Chem. 274, 32943-32949), Here, based on aging experiments of tetrameric TTR and chemically induced protein unfolding experiments of the non-native monomeric forms, we show that tetramer dissociation and partial unfolding of the monomer precedes amyloid fibril formation. We also show that TTR variants with the least thermodynamically stable non-native monomer produce the largest amount of partially unfolded monomeric species and soluble aggregates under conditions that are close to physiological. Additionally, the soluble aggregates formed by the amyloidogenic TTR variants showed morphological and thioflavin-T fluorescence properties characteristic of amyloid. These results allowed us to conclude that amyloid fibril formation by some TTR variants might be triggered by tetramer dissociation to a compact non-native monomer with low conformational stability, which originates partially unfolded monomeric species with a high tendency for ordered aggregation into amyloid fibrils. Thus, partial unfolding and conformational fluctuations of molecular species with marginal thermodynamic stability may play a crucial role on amyloid formation in vivo.	Univ Coimbra, Dept Quim, Fac Ciencias & Tecnol, P-3004535 Coimbra, Portugal; Univ Coimbra, Ctr Neurociencias Coimbra, P-3004517 Coimbra, Portugal; Inst Super Ciencias Saude Sul, P-2825 Monte De Caparica, Portugal; Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4050 Porto, Portugal; Univ Porto, Inst Mol & Cellular Biol, P-4050 Porto, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade do Porto; Universidade do Porto	Brito, RMM (corresponding author), Univ Coimbra, Dept Quim, Fac Ciencias & Tecnol, P-3004535 Coimbra, Portugal.	brito@ci.uc.pt	Cardoso, Isabel/K-3903-2013; Quintas, Alexandre/J-6436-2012; de Moura Cipreste Vaz, Daniela Barroso/W-5725-2019; Vaz, Daniela C./E-2941-2015; Saraiva, Maria João/K-3907-2013	Cardoso, Isabel/0000-0003-2472-7055; Quintas, Alexandre/0000-0002-5188-0453; de Moura Cipreste Vaz, Daniela Barroso/0000-0001-7562-4676; Saraiva, Maria João/0000-0002-3360-6899; Brito, Rui/0000-0001-9128-2557				Almeida MR, 1997, ENDOCRINE, V6, P309, DOI 10.1007/BF02820508; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Connors LH, 2000, AMYLOID, V7, P54, DOI 10.3109/13506120009146826; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; FURUYA H, 1991, BIOCHEMISTRY-US, V30, P2415, DOI 10.1021/bi00223a017; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Inouye H, 1998, AMYLOID, V5, P163, DOI 10.3109/13506129809003842; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Pace C N, 1986, Methods Enzymol, V131, P266; Quintas A, 1999, J BIOL CHEM, V274, P32943, DOI 10.1074/jbc.274.46.32943; Quintas A, 1997, FEBS LETT, V418, P297, DOI 10.1016/S0014-5793(97)01398-7; Raffen R, 1999, PROTEIN SCI, V8, P509; Ramirez-Alvarado M, 2000, P NATL ACAD SCI USA, V97, P8979, DOI 10.1073/pnas.150091797; RAZ A, 1969, J BIOL CHEM, V244, P3230; Redondo C, 2000, J MOL BIOL, V304, P461, DOI 10.1006/jmbi.2000.4220; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Saraiva M J, 1996, J Peripher Nerv Syst, V1, P179; SARAIVA MJM, 1984, J CLIN INVEST, V74, P104, DOI 10.1172/JCI111390; Sebastiao MP, 1998, J BIOL CHEM, V273, P24715, DOI 10.1074/jbc.273.38.24715; Shnyrov VL, 2000, BIOPHYS CHEM, V88, P61, DOI 10.1016/S0301-4622(00)00199-X; SOPRANO DR, 1985, J BIOL CHEM, V260, P1793; STAUDER AJ, 1986, J HISTOCHEM CYTOCHEM, V34, P949, DOI 10.1177/34.7.3458812; TAWARA S, 1981, J LAB CLIN MED, V98, P811; Uversky VN, 1998, P NATL ACAD SCI USA, V95, P5480, DOI 10.1073/pnas.95.10.5480; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364	27	253	264	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2001	276	29					27207	27213		10.1074/jbc.M101024200	http://dx.doi.org/10.1074/jbc.M101024200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	454HJ	11306576	hybrid, Green Published			2022-12-27	WOS:000169966900065
J	Linnell, J; Groeger, G; Hassan, AB				Linnell, J; Groeger, G; Hassan, AB			Real time kinetics of insulin-like growth factor II (IGF-II) interaction with the IGF-II/mannose 6-phosphate receptor - The effects of domain 13 and pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; MANNOSE 6-PHOSPHATE; BINDING-SITE; MANNOSE-6-PHOSPHATE RECEPTOR; PERINATAL LETHALITY; LYSOSOMAL-ENZYMES; LIGAND-BINDING; ORGAN SIZE; G-PROTEINS; EXPRESSION	The interaction of soluble forms of the human cation-independent insulin-like growth factor-II/mannose 6-phosphate receptor (IGF-IIR) with IGFs and mannosylated ligands was analyzed in real time. IGF-IIR proteins containing domains 1-15, 10-13, 11-13, or 11-12 were combined with rat CD4 domains 3 and 4. Following transient expression in 293T cells, secreted protein was immobilized onto biosensor chips. beta -Glucuronidase and latent transforming growth factor-beta1 bound only to domains 1-15. IGF-II bound to all constructs except a control, which contained a point mutation in domain 11. The affinity of domains 1-15, 10-13, 11-13, and 11-12 to IGF-II were 14, 120, 100, and 450 nM, respectively. Our data suggest. that domain 13 acts as an enhancer of IGF-II affinity by slowing the rate of dissociation, but additional enhancement by domains other than 10-13 also occurs. As the receptor functions to transport ligands from either the trans-Golgi network or extracellular space to the endosomes, the interaction of IGF-IIR extracellular domains with IGF-II was analyzed over a pH range of 5.0-7.4, The constructs behaved differently in response to pH and in recovery after low pH exposure, suggesting that pH stability of the extracellular domains depends on domains other than 10-13.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Hassan, AB (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.			Hassan, Andrew/0000-0002-2517-6681				AlShamkhani A, 1997, J BIOL CHEM, V272, P5275, DOI 10.1074/jbc.272.8.5275; Blanchard F, 1999, J BIOL CHEM, V274, P24685, DOI 10.1074/jbc.274.35.24685; BRADY RL, 1993, BIOCHEM SOC T, V21, P958, DOI 10.1042/bst0210958; BROWN MH, 1994, PROTEIN ENG, V7, P515, DOI 10.1093/protein/7.4.515; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Byrd JC, 1999, J BIOL CHEM, V274, P24408, DOI 10.1074/jbc.274.34.24408; Byrd JC, 2000, J BIOL CHEM, V275, P18647, DOI 10.1074/jbc.M001273200; CHISHOLM V, 1995, DNA CLONING PRACTICA; Chorney K M, 1998, J Biocommun, V25, P25; DAHMS NM, 1993, ENDOCRINOLOGY, V133, P440, DOI 10.1210/en.133.2.440; DAVIS SJ, 1990, J BIOL CHEM, V265, P10410; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; Devi GR, 1998, MOL ENDOCRINOL, V12, P1661, DOI 10.1210/me.12.11.1661; FISCHER HD, 1980, J BIOL CHEM, V255, P5069; GALLAHER BW, 1994, EUR J ENDOCRINOL, V131, P398, DOI 10.1530/eje.0.1310398; Garmroudi F, 1996, MOL ENDOCRINOL, V10, P642, DOI 10.1210/me.10.6.642; GELATO MC, 1988, J CLIN ENDOCR METAB, V67, P669, DOI 10.1210/jcem-67-4-669; Gleizes PE, 1997, STEM CELLS, V15, P190, DOI 10.1002/stem.150190; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Hassan AB, 2000, CANCER RES, V60, P1070; HOFLACK B, 1987, J BIOL CHEM, V262, P123; IKEZU T, 1995, J BIOL CHEM, V270, P29224, DOI 10.1074/jbc.270.49.29224; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Kang JX, 1997, P NATL ACAD SCI USA, V94, P13671, DOI 10.1073/pnas.94.25.13671; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; KORNER C, 1995, J BIOL CHEM, V270, P287, DOI 10.1074/jbc.270.1.287; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; LI M, 1991, Glycobiology, V1, P511, DOI 10.1093/glycob/1.5.511; LOBEL P, 1988, J BIOL CHEM, V263, P2563; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Ludwig T, 1996, DEV BIOL, V177, P517, DOI 10.1006/dbio.1996.0182; Marron-Terada PG, 2000, BIOCHEMISTRY-US, V39, P2243, DOI 10.1021/bi992226o; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Motyka B, 2000, CELL, V103, P491, DOI 10.1016/S0092-8674(00)00140-9; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Nykjaer A, 1998, J CELL BIOL, V141, P815, DOI 10.1083/jcb.141.3.815; O'Gorman DB, 1999, CANCER RES, V59, P5692; Ouyang H, 1997, CANCER RES, V57, P1851; PURCHIO AF, 1988, J BIOL CHEM, V263, P14211; ROHRER J, 1995, J CELL BIOL, V130, P1297, DOI 10.1083/jcb.130.6.1297; SAHAGIAN GG, 1983, J BIOL CHEM, V258, P7121; Sambrook J., 2002, MOL CLONING LAB MANU; SCHMIDT B, 1995, J BIOL CHEM, V270, P14975, DOI 10.1074/jbc.270.25.14975; Souza RF, 1996, NAT GENET, V14, P255, DOI 10.1038/ng1196-255; TONG PY, 1988, J BIOL CHEM, V263, P2585; Toretsky JA, 1996, J ENDOCRINOL, V149, P367, DOI 10.1677/joe.0.1490367; Valenzano KJ, 1997, J BIOL CHEM, V272, P4804, DOI 10.1074/jbc.272.8.4804; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; WESTLUND B, 1991, J BIOL CHEM, V266, P23233; Yamada T, 1997, P NATL ACAD SCI USA, V94, P10351, DOI 10.1073/pnas.94.19.10351; York SJ, 1999, J BIOL CHEM, V274, P1164, DOI 10.1074/jbc.274.2.1164; Zaina S, 1998, J BIOL CHEM, V273, P28610, DOI 10.1074/jbc.273.44.28610; Zaina S, 1998, ENDOCRINOLOGY, V139, P3886, DOI 10.1210/en.139.9.3886	54	53	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23986	23991		10.1074/jbc.M100700200	http://dx.doi.org/10.1074/jbc.M100700200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11297550	hybrid			2022-12-27	WOS:000169531100101
J	Loewith, R; Smith, JS; Meijer, M; Williams, TJ; Bachman, N; Boeke, JD; Young, D				Loewith, R; Smith, JS; Meijer, M; Williams, TJ; Bachman, N; Boeke, JD; Young, D			Pho23 is associated with the Rpd3 histone deacetylase and is required for its normal function in regulation of gene expression and silencing in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSION; IN-VIVO; N-COR; NUCLEOSOMAL DNA; RIBOSOMAL DNA; YEAST; COMPLEX; ACETYLATION; CHROMATIN; SIN3	The Rpd8 histone deacetylase (HDAC) functions in a large complex containing many proteins including Sin3 and Sap30, Previous evidence indicates that the pho23, rpd3, sin3, and sap30 mutants exhibit similar defects in PHO5 regulation, We report that pho23 mutants like rpd3, sin3, and sap30 are hypersensitive to cycloheximide and heat shock and exhibit enhanced silencing of rDNA, telomeric, and HMR loci, suggesting that these genes are functionally related. Based on these observations, we explored whether Pho23 is a component of the Rpds HDAC complex. Our results demonstrate that Myc-Pho23 co-immunoprecipitates with HA-Rpd3 and HA-Sap30. Furthermore, similar levels of HDAC activity were detected in immunoprecipitates of HA-Pho23, HA-Rpd3, or HA-Sap30, In contrast, HDAC activity was not detected in immunoprecipitates of HA-Pho23 or HA-Sap30 from strains lacking Rpd3, suggesting that Rpd8 is the HDAC associated with these proteins. However, HDAC activity was detected in immunoprecipitates of HA-Sap30 or HA-Rpd3 from cells lacking Pho23, although levels were significantly lower than those detected in wild-type cells, indicating that Rpd3 activity is compromised in the absence of Pho23, Together, our genetic and biochemical studies provide strong evidence that Pho23 is a component of the Rpd3 HDAC complex, and. is required for the normal function of this complex.	Univ Calgary, Hlth Sci Ctr, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; Univ Calgary, Hlth Sci Ctr, Dept Oncol, Calgary, AB T2N 4N1, Canada; Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Virginia; Johns Hopkins University	Young, D (corresponding author), Univ Calgary, Hlth Sci Ctr, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada.		Loewith, Robbie J/S-6289-2016	Loewith, Robbie J/0000-0002-2482-603X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061692] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM61692-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; Carmen AA, 1999, P NATL ACAD SCI USA, V96, P12356, DOI 10.1073/pnas.96.22.12356; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Cheung WL, 2000, CURR OPIN CELL BIOL, V12, P326, DOI 10.1016/S0955-0674(00)00096-X; Davie JR, 1998, CURR OPIN GENET DEV, V8, P173, DOI 10.1016/S0959-437X(98)80138-X; DeRubertis F, 1996, NATURE, V384, P589; Dorland S, 2000, GENETICS, V154, P573; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Gunduz M, 2000, CANCER RES, V60, P3143; Haber JE, 1999, CELL, V97, P829, DOI 10.1016/S0092-8674(00)80795-3; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HENDZEL MJ, 1991, J BIOL CHEM, V266, P21936; HONG L, 1993, J BIOL CHEM, V268, P305; Hubberstey A, 1996, J CELL BIOCHEM, V61, P459, DOI 10.1002/(SICI)1097-4644(19960601)61:3<459::AID-JCB13>3.0.CO;2-E; Jacobson S, 1999, CURR OPIN GENET DEV, V9, P175, DOI 10.1016/S0959-437X(99)80027-6; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kasten MM, 1997, MOL CELL BIOL, V17, P4852, DOI 10.1128/MCB.17.8.4852; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Kolle D, 1998, METHODS, V15, P323, DOI 10.1006/meth.1998.0636; Kornberg RD, 1999, CURR OPIN GENET DEV, V9, P148, DOI 10.1016/S0959-437X(99)80022-7; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Lau WTW, 1998, GENETICS, V150, P1349; Lechner T, 2000, J BIOL CHEM, V275, P40961, DOI 10.1074/jbc.M005730200; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Loewith R, 2000, MOL CELL BIOL, V20, P3807, DOI 10.1128/MCB.20.11.3807-3816.2000; MATVIW H, 1992, MOL CELL BIOL, V12, P5033, DOI 10.1128/MCB.12.11.5033; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Sambrook J., 2002, MOL CLONING LAB MANU; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; Skowyra D, 2001, J BIOL CHEM, V276, P8734, DOI 10.1074/jbc.M007664200; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1999, MOL CELL BIOL, V19, P3184; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun ZW, 1999, GENETICS, V152, P921; SUSSEL L, 1991, P NATL ACAD SCI USA, V88, P7749, DOI 10.1073/pnas.88.17.7749; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; TO EA, 1973, J BACTERIOL, V113, P727; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Vannier D, 1996, GENETICS, V144, P1343; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; VIDAL M, 1991, MOL CELL BIOL, V11, P6317, DOI 10.1128/MCB.11.12.6317; VIDAL M, 1991, MOL CELL BIOL, V11, P6306, DOI 10.1128/MCB.11.12.6306; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1	66	59	60	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24068	24074		10.1074/jbc.M102176200	http://dx.doi.org/10.1074/jbc.M102176200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11306585	hybrid			2022-12-27	WOS:000169531100112
J	Borisov, VB; Sedelnikova, SE; Poole, RK; Konstantinov, AA				Borisov, VB; Sedelnikova, SE; Poole, RK; Konstantinov, AA			Interaction of cytochrome bd with carbon monoxide at low and room temperatures - Evidence that only a small fraction of heme b(595) reacts with CO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AEROBIC RESPIRATORY-CHAIN; TERMINAL OXIDASE COMPLEX; ESCHERICHIA-COLI; QUINOL OXIDASE; UBIQUINOL OXIDASE; AZOTOBACTER-VINELANDII; OXYGEN; BINDING; PURIFICATION; COMPONENT	Azotobacter vinelandii is an obligately aerobic bacterium in which aerotolerant dinitrogen fixation requires cytochrome bd, This oxidase comprises two polypeptide subunits and three hemes, but no copper, and has been studied extensively. However, there remain apparently conflicting reports on the reactivity of the high spin heme b(595) with ligands. Using purified cytochrome bd, we show that absorption changes induced by CO photodissociation from the fully reduced cytochrome bd at low temperatures demonstrate binding of the ligand with heme b(595). However, the magnitude of these changes corresponds to the reaction with CO of only about 5% of the heme. CO binding with a minor fraction of heme b(595) is also revealed at room temperature by time-resolved studies of CO recombination, The data resolve the apparent discrepancies between conclusions drawn from room and low temperature spectroscopic studies of the CO reaction with cytochrome bd, The results are consistent with the proposal that hemes b(595) and d form a diheme oxygen-reducing center with a binding capacity for a single exogenous ligand molecule that partitions between the hemes d and b(595) in accordance with their intrinsic affinities for the ligand, In this model, the affinity of heme b(595) for CO is about 20-fold lower than that of heme d.	Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia; Univ Sheffield, Krebs Inst Biomolec Res, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	Lomonosov Moscow State University; University of Sheffield	Borisov, VB (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia.	r.poole@sheffield.ac.uk	Borisov, Vitaliy B/C-9504-2012	Borisov, Vitaliy B/0000-0002-3400-9068				ANRAKU Y, 1987, TRENDS BIOCHEM SCI, V12, P262, DOI 10.1016/0968-0004(87)90131-9; Azarkina N, 1999, J BIOL CHEM, V274, P32810, DOI 10.1074/jbc.274.46.32810; Azarkina N, 1997, FEBS LETT, V416, P171, DOI 10.1016/S0014-5793(97)01196-4; Bertsova YV, 1997, FEBS LETT, V414, P369, DOI 10.1016/S0014-5793(97)01047-8; Borisov V, 1999, BIOCHEMISTRY-US, V38, P740, DOI 10.1021/bi981908t; BORISOV VB, 1995, BIOCHEMISTRY-MOSCOW+, V60, P231; CHANCE B, 1975, ANAL BIOCHEM, V67, P552, DOI 10.1016/0003-2697(75)90331-0; DMELLO R, 1994, FEMS MICROBIOL LETT, V121, P115, DOI 10.1111/j.1574-6968.1994.tb07084.x; Dmello R, 1996, MICROBIOL-UK, V142, P755, DOI 10.1099/00221287-142-4-755; DUEWEKE TJ, 1991, BIOCHEMISTRY-US, V30, P3401, DOI 10.1021/bi00228a007; GREEN GN, 1986, BIOCHEMISTRY-US, V25, P2309, DOI 10.1021/bi00357a002; HATATANAKA A, 1987, BIOCHIM BIOPHYS ACTA, V893, P289, DOI 10.1016/0005-2728(87)90050-8; HILL JJ, 1993, P NATL ACAD SCI USA, V90, P5863, DOI 10.1073/pnas.90.12.5863; JUNEMANN S, 1995, J BIOL CHEM, V270, P16213, DOI 10.1074/jbc.270.27.16213; JUNEMANN S, 1995, BIOCHEM SOC T, V23, pS157; Junemann S, 1997, BBA-BIOENERGETICS, V1321, P107, DOI 10.1016/S0005-2728(97)00046-7; Kalnenieks U, 1998, FEMS MICROBIOL LETT, V168, P91; KAYSSER TM, 1995, BIOCHEMISTRY-US, V34, P13491, DOI 10.1021/bi00041a029; KELLY MJS, 1990, J BACTERIOL, V172, P6010, DOI 10.1128/jb.172.10.6010-6019.1990; KITA K, 1984, J BIOL CHEM, V259, P3375; Kobayashi K, 1999, BIOCHEMISTRY-US, V38, P5913, DOI 10.1021/bi982088n; KOLAND JG, 1984, BIOCHEMISTRY-US, V23, P445, DOI 10.1021/bi00298a008; KRASNOSELSKAYA I, 1993, FEBS LETT, V327, P279, DOI 10.1016/0014-5793(93)81004-J; LORENCE RM, 1986, BIOCHEMISTRY-US, V25, P2314, DOI 10.1021/bi00357a003; MILLER MJ, 1985, J BIOL CHEM, V260, P4003; MILLER MJ, 1986, METHOD ENZYMOL, V126, P87; Osborne JP, 1999, BBA-BIOENERGETICS, V1410, P32, DOI 10.1016/S0005-2728(98)00171-6; POOLE RK, 1987, FEBS LETT, V217, P49, DOI 10.1016/0014-5793(87)81240-1; POOLE RK, 1982, FEBS LETT, V141, P237, DOI 10.1016/0014-5793(82)80056-2; POOLE RK, 1981, J GEN MICROBIOL, V125, P431; POOLE RK, 1983, J GEN MICROBIOL, V129, P1345; POOLE RK, 1994, MICROBIOL-SGM, V140, P1027, DOI 10.1099/13500872-140-5-1027; POOLE RK, 1994, ANTON LEEUW INT J G, V65, P289, DOI 10.1007/BF00872215; Poole RK., 1988, BACTERIAL ENERGY TRA, P231; PUUSTINEN A, 1991, BIOCHEMISTRY-US, V30, P3936, DOI 10.1021/bi00230a019; ROTHERY RA, 1987, J GEN MICROBIOL, V133, P3247; Sakamoto J, 1999, BBA-BIOENERGETICS, V1411, P147, DOI 10.1016/S0005-2728(99)00012-2; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; TSUBAKI M, 1995, J BIOL CHEM, V270, P28565, DOI 10.1074/jbc.270.48.28565; VINCENT JC, 1982, ANAL BIOCHEM, V126, P86, DOI 10.1016/0003-2697(82)90112-9; Vos MH, 2000, P NATL ACAD SCI USA, V97, P1554, DOI 10.1073/pnas.030528197; WILSON DF, 1967, ARCH BIOCHEM BIOPHYS, V121, P757, DOI 10.1016/0003-9861(67)90065-3; WOOD PM, 1984, BIOCHIM BIOPHYS ACTA, V768, P293, DOI 10.1016/0304-4173(84)90020-X	43	44	51	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22095	22099		10.1074/jbc.M011542200	http://dx.doi.org/10.1074/jbc.M011542200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11283005	hybrid			2022-12-27	WOS:000169412700017
J	Dobransky, T; Davis, WL; Rylett, RJ				Dobransky, T; Davis, WL; Rylett, RJ			Functional characterization of phosphorylation of 69-kDa human choline acetyltransferase at serine 440 by protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT HIPPOCAMPAL TISSUE; CENTRAL-NERVOUS-SYSTEM; TYROSINE-HYDROXYLASE; O-ACETYLTRANSFERASE; ALZHEIMERS-DISEASE; LOCALIZATION; MEMBRANES; ISOZYMES; TORPEDO; ENZYME	Choline acetyltransferase, the enzyme that synthesizes the transmitter acetylcholine in cholinergic neurons, is a substrate for protein kinase C, In the present study, we used mass spectrometry to identify serine 440 in recombinant human 69-kDa choline acetyltransferase as a protein kinase C phosphorylation site, and site-directed mutagenesis to determine that phosphorylation of this residue is involved in regulation of the enzyme's catalytic activity and binding to subcellular membranes. Incubation of HEK293 cells stably expressing wild-type 69-kDa choline acetyltransferase with the protein kinase C activator phorbol la myristate 13-acetate showed time- and dose-related increases in specific activity of the enzyme; in control and phorbol ester-treated cells, the enzyme was distributed predominantly in cytoplasm (about 88%) with the remainder (about 12%) bound to cellular membranes. Mutation of serine 440 to alanine resulted in localization of the enzyme entirely in cytoplasm, and this was unchanged by phorbol ester treatment. Furthermore, activation of mutant enzyme in phorbol ester-treated HEK293 cells was about 50% that observed for wild-type enzyme, Incubation of immunoaffinity purified wild-type and mutant choline acetyltransferase with protein kinase C under phosphorylating conditions led to incorporation of [P-32]phosphate, with radiolabeling of mutant enzyme being about one-half that of wild-type, indicating that another residue is phosphorylated by protein kinase C, Acetylcholine synthesis in HEK293 cells expressing wild-type choline acetyltransferase, but not mutant enzyme, was increased by about 17% by phorbol ester treatment.	Univ Western Ontario, Dept Physiol, London, ON N6A 5C1, Canada; John P Robarts Res Inst, Neurodegenerat Dis Grp, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Rylett, RJ (corresponding author), Univ Western Ontario, Dept Physiol, Med Sci Bldg, London, ON N6A 5C1, Canada.		Rylett, Rebecca Jane/K-3597-2013	Rylett, Rebecca Jane/0000-0002-9158-9599				ATTERWILL CK, 1978, J NEUROCHEM, V31, P719, DOI 10.1111/j.1471-4159.1978.tb07846.x; BRUCE G, 1989, NEUROCHEM RES, V14, P613, DOI 10.1007/BF00964869; CARROLL PT, 1990, J NEUROCHEM, V54, P1047, DOI 10.1111/j.1471-4159.1990.tb02356.x; CLARK EA, 1991, LAB INVEST, V64, P35; COLE G, 1988, BRAIN RES, V452, P165, DOI 10.1016/0006-8993(88)90021-2; COOPER JR, 1994, J NEUROCHEM, V63, P395; Dobransky T, 2000, BIOCHEM J, V349, P141, DOI 10.1042/0264-6021:3490141; EDERCOLLI L, 1992, BRAIN RES, V573, P284, DOI 10.1016/0006-8993(92)90774-4; EDERCOLLI L, 1985, NEUROSCIENCE, V15, P577, DOI 10.1016/0306-4522(85)90235-0; FONNUM F, 1969, BIOCHEM J, V115, P465, DOI 10.1042/bj1150465; GARRELS JI, 1979, J BIOL CHEM, V254, P7961; GOODNIGHT J, 1995, J BIOL CHEM, V270, P9991, DOI 10.1074/jbc.270.17.9991; HABERT E, 1992, J NEUROCHEM, V58, P1447, DOI 10.1111/j.1471-4159.1992.tb11362.x; Haycock JW, 1998, J NEUROCHEM, V71, P1670; Itagaki C, 1999, BIOCHEMISTRY-US, V38, P15673, DOI 10.1021/bi9914255; Keenan C, 1997, IMMUNOLOGY, V90, P557, DOI 10.1046/j.1365-2567.1997.00198.x; KEENAN C, 1995, EUR J IMMUNOL, V25, P13, DOI 10.1002/eji.1830250104; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MASLIAH E, 1990, J NEUROSCI, V10, P2113; Misawa H, 1997, MOL BRAIN RES, V44, P323, DOI 10.1016/S0169-328X(96)00231-8; ODA Y, 1992, MOL BRAIN RES, V16, P287, DOI 10.1016/0169-328X(92)90237-6; Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017; Pahud G, 1998, EUR J NEUROSCI, V10, P1644, DOI 10.1046/j.1460-9568.1998.00177.x; PISANO M R, 1991, Biomedical and Environmental Sciences, V4, P173; Resendes MC, 1999, J BIOL CHEM, V274, P19417, DOI 10.1074/jbc.274.27.19417; RYLETT RJ, 1993, J NEUROCHEM, V61, P1388, DOI 10.1111/j.1471-4159.1993.tb13632.x; RYLETT RJ, 1989, J NEUROCHEM, V52, P869, DOI 10.1111/j.1471-4159.1989.tb02535.x; SALEM N, 1993, BRAIN RES, V609, P223, DOI 10.1016/0006-8993(93)90876-O; SCHMIDT BM, 1993, J NEUROCHEM, V61, P1774, DOI 10.1111/j.1471-4159.1993.tb09815.x; SCHMIDT BM, 1993, NEUROSCIENCE, V54, P649, DOI 10.1016/0306-4522(93)90236-9; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SMITH LK, 1993, BRAIN RES, V605, P155, DOI 10.1016/0006-8993(93)91367-2	32	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22244	22250		10.1074/jbc.M011702200	http://dx.doi.org/10.1074/jbc.M011702200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11303024	hybrid			2022-12-27	WOS:000169412700038
J	Sweeney, C; Fambrough, D; Huard, C; Diamonti, AJ; Lander, ES; Cantley, LC; Carraway, KL				Sweeney, C; Fambrough, D; Huard, C; Diamonti, AJ; Lander, ES; Cantley, LC; Carraway, KL			Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; DIFFERENTIATION FACTOR; TYROSINE KINASES; BREAST-CANCER; NEURONAL DIFFERENTIATION; NEUREGULIN RECEPTOR; CARDIAC DEVELOPMENT; PC12 CELLS; LIGAND; NETWORK	The mechanisms by which receptor tyrosine kinases (RTKs) utilize intracellular signaling pathways to direct gene expression and cellular response remain unclear. A current question is whether different RTKs within a single cell target similar or different sets of genes. In this study we have used the ErbB receptor network to explore the relationship between RTK activation and gene expression, We profiled growth factor-stimulated signaling pathway usage and broad gene expression patterns in two human mammary tumor cell lines expressing different complements of ErbB receptors. Although the growth factors epidermal growth factor (EGF) and neuregulin (NRG) 1 similarly stimulated Erk1/2 in MDA-MB-361 cells, EGF acting through an EGF receptor/ ErbB2 heterodimer preferentially stimulated protein kinase C, and NRG1 beta acting through an ErbB2/ErbB3 heterodimer preferentially stimulated Akt, The two growth factors regulated partially overlapping yet distinct sets of genes in these cells. In MDA-MB-453 cells, NRG1 beta acting through an ErbB2/ErbB3 heterodimer stimulated prolonged signaling of all pathways examined relative to NRG2 beta acting through the same heterodimeric receptor species, Surprisingly, NRG1 beta and NRG2 beta also regulated partially overlapping but distinct sets of genes in these cells. These results demonstrate that the activation of different RTKs, or activation of the same RTKs with different Iigands, can lead to distinct profiles of gene regulation within a single cell type. Our observations also suggest that the identity and kinetics of signaling pathway usage by RTKs may play a role in the selection of regulated genes.	Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA; Whitehead Inst Biomed Res, Nine Cambridge Ctr, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Sweeney, C (corresponding author), Univ Calif Davis, Ctr Canc, Res Bldg 3,Rm 1400,4645 2nd Ave, Sacramento, CA 95817 USA.		Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653	NCI NIH HHS [CA71702] Funding Source: Medline; NIGMS NIH HHS [GM41890, R01 GM041890] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA071702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890, R37GM041890] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adlkofer K, 2000, GLIA, V29, P104, DOI 10.1002/(SICI)1098-1136(20000115)29:2<104::AID-GLIA2>3.0.CO;2-2; Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; BACUS SS, 1992, CELL GROWTH DIFFER, V3, P401; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.3.CO;2-E; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; CARRAWAY KL, 1995, J BIOL CHEM, V270, P7111, DOI 10.1074/jbc.270.13.7111; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Cohen BD, 1996, J BIOL CHEM, V271, P30897, DOI 10.1074/jbc.271.48.30897; Crovello CS, 1998, J BIOL CHEM, V273, P26954, DOI 10.1074/jbc.273.41.26954; CULOUSCOU JM, 1993, J BIOL CHEM, V268, P18407; Daly JM, 1997, CANCER RES, V57, P3804; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DIKIC I, 1994, CURR BIOL, V4, P702, DOI 10.1016/S0960-9822(00)00155-X; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; FEDI P, 1994, MOL CELL BIOL, V14, P492, DOI 10.1128/MCB.14.1.492; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Gassmann M, 1997, CURR OPIN NEUROBIOL, V7, P87, DOI 10.1016/S0959-4388(97)80125-0; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Grasso AW, 1997, ONCOGENE, V15, P2705, DOI 10.1038/sj.onc.1201447; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; Jones FE, 1996, CELL GROWTH DIFFER, V7, P1031; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Levkowitz G, 1996, ONCOGENE, V12, P1117; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MARGOLIS B, 1992, CELL GROWTH DIFFER, V3, P73; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pawson T, 1999, CELL, V97, P675, DOI 10.1016/S0092-8674(00)80779-5; Pinkas-Kramarski R, 1998, MOL CELL BIOL, V18, P6090, DOI 10.1128/MCB.18.10.6090; PinkasKramarski R, 1996, J BIOL CHEM, V271, P19029, DOI 10.1074/jbc.271.32.19029; RIESE DJ, 1995, MOL CELL BIOL, V15, P5770; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shak S, 1999, SEMIN ONCOL, V26, P71; Simon MA, 2000, CELL, V103, P13, DOI 10.1016/S0092-8674(00)00100-8; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Stambolic V, 1999, ONCOGENE, V18, P6094, DOI 10.1038/sj.onc.1203126; Sweeney C, 2000, J BIOL CHEM, V275, P19803, DOI 10.1074/jbc.C901015199; Syroid DE, 1996, P NATL ACAD SCI USA, V93, P9229, DOI 10.1073/pnas.93.17.9229; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Toker A, 2000, MOL PHARMACOL, V57, P652, DOI 10.1124/mol.57.4.652; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; Winkles JA, 1998, PROG NUCLEIC ACID RE, V58, P41; WOODGETT JR, 1989, BRIT MED BULL, V45, P529, DOI 10.1093/oxfordjournals.bmb.a072340; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0; YANG YM, 1995, J CELL BIOL, V131, P215, DOI 10.1083/jcb.131.1.215	57	98	101	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22685	22698		10.1074/jbc.M100602200	http://dx.doi.org/10.1074/jbc.M100602200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11297548	hybrid			2022-12-27	WOS:000169412700096
J	Aoki, K; Ishida, N; Kawakita, M				Aoki, K; Ishida, N; Kawakita, M			Substrate recognition by UDP-galactose and CMP-sialic acid transporters - Different sets of transmembrane helices are utilized for the specific recognition of UDP-galactose and CMP-sialic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINE TRANSPORTER; NUCLEOTIDE-SUGAR TRANSPORTERS; GOLGI VESICLE MEMBRANES; OVARY CELL MUTANT; MOLECULAR-CLONING; FUNCTIONAL EXPRESSION; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; VRG4 GENE; DEFICIENT	Human UDP-galactose transporter (hUGT1) and CMP-sialic acid transporter (hCST) are related Golgi membrane proteins with 10 transmembrane helices. We have constructed chimeras between these proteins in order to identify submolecular regions responsible for the determination of substrate specificity. To assess the UGT and CST activities, chimeric cDNAs were transiently expressed in either UGT-deficient mutant Lec8 cells or CST-deficient mutant Lec2 cells, and the binding of plant lectins, GS-II or PNA, respectively, to these cells was examined. During the course of analysis of various chimeric transporters, we found that chimeras whose submolecular regions contained helices 1, 8, 9, and 10, and helices 2, 3, and 7 derived from hUGT1 and hCST sequences, respectively, exhibited both UGT and CST activities. The dual substrate specificity for UDP-galactose and CMP-sialic acid of one such representative chimera was directly confirmed by in vitro measurement of the nucleotide sugar transport activity casing a heterologous expression system in the yeast Saccharomyces cerevisiae, These findings indicated that the regions which are critical for determining the substrate specificity of UGT and CST resided in different submolecular sites in the two transporters, and that these different determinants could be present within one protein without interfering with each other's function.	Tokyo Metropolitan Inst Med Sci, Dept Physiol Chem, Bunkyo Ku, Tokyo 1138613, Japan	Tokyo Metropolitan Institute of Medical Science	Kawakita, M (corresponding author), Kogakuin Univ, Dept Appl Chem, Shinjuku Ku, 1-24-2 Nishi Shinjuku, Tokyo 1638677, Japan.	bt13004@ns.kogakuin.ac.jp						Abeijon C, 1996, P NATL ACAD SCI USA, V93, P5963, DOI 10.1073/pnas.93.12.5963; Aoki K, 1999, J BIOCHEM, V126, P940, DOI 10.1093/oxfordjournals.jbchem.a022538; BOSSUYT X, 1994, BIOCHEM J, V302, P261, DOI 10.1042/bj3020261; BRILES EB, 1977, J BIOL CHEM, V252, P1107; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; DESCOTEAUX A, 1995, SCIENCE, V269, P1869, DOI 10.1126/science.7569927; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; Eckhardt M, 1999, J BIOL CHEM, V274, P8779, DOI 10.1074/jbc.274.13.8779; Eckhardt M, 1997, EUR J BIOCHEM, V248, P187, DOI 10.1111/j.1432-1033.1997.00187.x; Eckhardt M, 1996, P NATL ACAD SCI USA, V93, P7572, DOI 10.1073/pnas.93.15.7572; Guillen E, 1998, P NATL ACAD SCI USA, V95, P7888, DOI 10.1073/pnas.95.14.7888; HARA T, 1989, J BIOCHEM-TOKYO, V106, P236, DOI 10.1093/oxfordjournals.jbchem.a122838; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Ishida N, 1996, J BIOCHEM, V120, P1074; Ishida N, 1999, J BIOCHEM, V126, P1107, DOI 10.1093/oxfordjournals.jbchem.a022556; Ishida N, 1998, J BIOCHEM, V124, P171, DOI 10.1093/oxfordjournals.jbchem.a022076; Ishida N, 1999, J BIOCHEM, V126, P68, DOI 10.1093/oxfordjournals.jbchem.a022437; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kawakita M, 1998, J BIOCHEM, V123, P777; Lubke T, 1999, J BIOL CHEM, V274, P25986, DOI 10.1074/jbc.274.37.25986; Ma DQ, 1997, J BIOL CHEM, V272, P3799, DOI 10.1074/jbc.272.6.3799; Miera N, 1996, J BIOCHEM-TOKYO, V120, P236; Poster JB, 1996, J BIOL CHEM, V271, P3837; Segawa H, 1999, FEBS LETT, V451, P295, DOI 10.1016/S0014-5793(99)00596-7; STANLEY P, 1977, SOMAT CELL GENET, V3, P391, DOI 10.1007/BF01542968; Sun-Wada GH, 1998, J BIOCHEM, V123, P912; TAKI T, 1991, CANCER RES, V51, P1701; Wang J, 1997, J BIOL CHEM, V272, P28845, DOI 10.1074/jbc.272.46.28845; Yoshioka S, 1997, J BIOCHEM, V122, P691	30	52	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21555	21561		10.1074/jbc.M101462200	http://dx.doi.org/10.1074/jbc.M101462200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279205	hybrid			2022-12-27	WOS:000169297900101
J	Chattopadhyay, MK; Murakami, Y; Matsufuji, S				Chattopadhyay, MK; Murakami, Y; Matsufuji, S			Antizyme regulates the degradation of ornithine decarboxylase in fission yeast Schizosaccharomyces pombe - Study in the spe2 knockout strains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; SACCHAROMYCES-CEREVISIAE; POLYAMINE SYNTHESIS; MAMMALIAN ANTIZYME; NEUROSPORA-CRASSA; 26S PROTEASOME; BUDDING YEAST; PROTEIN; CELLS; EXPRESSION	The mechanism of the regulatory degradation of ornithine decarboxylase (ODC) by polyamines was studied in fission yeast, Schizosaccharomyces pombe. To regulate cellular spermidine experimentally, we cloned and disrupted S-adenosylmethionine decarboxylase gene (spe2) in S. pombe. The null mutant of spe2 was devoid of spermidine and spermine, accumulated putrescine, and contained a high level of ODC. Addition of spermidine to the culture medium resulted in rapid decrease in the ODC activity caused by the acceleration of ODC degradation, which was dependent on de novo protein synthesis. A fraction of ODC forming an inactive complex concomitantly increased. The accelerated ODC degradation was prevented either by knockout of antizyme gene or by selective inhibitors of proteasome. Thus, unlike budding yeast, mammalian type antizyme-mediated ODC degradation by proteasome is operating in S. pombe.	Jikei Univ, Sch Med, Dept Biochem 2, Minato Ku, Tokyo 1058461, Japan	Jikei University	Matsufuji, S (corresponding author), Jikei Univ, Sch Med, Dept Biochem 2, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	senya@jikei.ac.jp						Bagni N., 1989, PHYSL POLYAMINES, P107; BALASUNDARAM D, 1993, P NATL ACAD SCI USA, V90, P4693, DOI 10.1073/pnas.90.10.4693; BALASUNDARAM D, 1991, P NATL ACAD SCI USA, V88, P5872, DOI 10.1073/pnas.88.13.5872; BARNETT GR, 1988, J BIOL CHEM, V263, P10005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Da'Dara AA, 1998, BIOCHEM J, V336, P545, DOI 10.1042/bj3360545; ELIAS S, 1995, EUR J BIOCHEM, V229, P276, DOI 10.1111/j.1432-1033.1995.0276l.x; FONZI WA, 1989, J BIOL CHEM, V264, P18110; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GRIMM C, 1988, MOL GEN GENET, V215, P81, DOI 10.1007/BF00331307; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; HEBY O, 1990, TRENDS BIOCHEM SCI, V15, P153, DOI 10.1016/0968-0004(90)90216-X; HELLER JS, 1976, P NATL ACAD SCI USA, V73, P1858, DOI 10.1073/pnas.73.6.1858; ICHIBA T, 1994, BIOCHEM BIOPH RES CO, V200, P1721, DOI 10.1006/bbrc.1994.1651; Ivanov IP, 2000, NUCLEIC ACIDS RES, V28, P3185, DOI 10.1093/nar/28.17.3185; Ivanov IP, 2000, EMBO J, V19, P1907, DOI 10.1093/emboj/19.8.1907; Ivanov IP, 1998, RNA, V4, P1230, DOI 10.1017/S1355838298980864; KASHIWAGI K, 1990, J BIOL CHEM, V265, P22321; LI XQ, 1994, MOL CELL BIOL, V14, P87, DOI 10.1128/MCB.14.1.87; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Matsufuji S, 1996, EMBO J, V15, P1360, DOI 10.1002/j.1460-2075.1996.tb00478.x; MIERENDORF RC, 1987, METHOD ENZYMOL, V152, P458; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; MURAKAMI Y, 1985, BIOCHEM J, V225, P689, DOI 10.1042/bj2250689; MURAKAMI Y, 1989, EUR J BIOCHEM, V180, P181, DOI 10.1111/j.1432-1033.1989.tb14630.x; Murakami Y, 1999, MOL CELL BIOL, V19, P7216; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; MURAKAMI Y, 1988, BIOCHEM J, V254, P367, DOI 10.1042/bj2540367; Pegg AE, 1998, BIOCHEM SOC T, V26, P580, DOI 10.1042/bst0260580; PITKIN J, 1990, ARCH BIOCHEM BIOPHYS, V278, P386, DOI 10.1016/0003-9861(90)90275-4; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; Ruan HJ, 1996, J BIOL CHEM, V271, P29576, DOI 10.1074/jbc.271.47.29576; RUSSELL P, 1986, CELL, V45, P781, DOI 10.1016/0092-8674(86)90550-7; Saito T, 2000, BIOCHEM J, V345, P99, DOI 10.1042/0264-6021:3450099; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; Sakata K, 1997, BIOCHEM BIOPH RES CO, V238, P415, DOI 10.1006/bbrc.1997.7266; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SUZUKI T, 1994, P NATL ACAD SCI USA, V91, P8930, DOI 10.1073/pnas.91.19.8930; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Toth C, 1999, J BIOL CHEM, V274, P25921, DOI 10.1074/jbc.274.36.25921; TYAGI AK, 1981, J BIOL CHEM, V256, P2156; Zhu C, 2000, BIOINFORMATICS, V16, P478, DOI 10.1093/bioinformatics/16.5.478	45	20	22	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21235	21241		10.1074/jbc.M010643200	http://dx.doi.org/10.1074/jbc.M010643200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11283013	hybrid			2022-12-27	WOS:000169297900059
J	Mertani, HC; Zhu, T; Goh, ELK; Lee, KO; Morel, G; Lobie, PE				Mertani, HC; Zhu, T; Goh, ELK; Lee, KO; Morel, G; Lobie, PE			Autocrine human growth hormone (hGH) regulation of human mammary carcinoma cell gene expression - Identification of chop as a mediator of hGH-stimulated human mammary carcinoma cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR CHOP; RECEPTOR MESSENGER-RNA; AMINO-ACID LIMITATION; BINDING-PROTEIN; BETA-CATENIN; FACTOR-I; BREAST-CANCER; SKI ONCOGENE; GADD153 GENE; GLAND FACTOR	By use of cDNA array technology we have screened 588 genes to determine the effect of autocrine production of human growth hormone (hGH) on gene expression in human mammary carcinoma cells. We have used a previously described cellular model to study autocrine hGH function in which the hGH gene or a translation-deficient hGH gene was stably transfected into MCF-7 cells. Fifty two of the screened genes were regulated, either positively (24) or negatively (28), by autocrine production of hGH, We have now characterized the role of one of the up-regulated genes, chop (gadd153), in the effect of autocrine production of hGH on mammary carcinoma cell number. The effect of autocrine production of hGH on the level of CHOP mRNA was exerted at the transcriptional level as autocrine hGH increased chloramphenicol acetyltransferase production from a reporter plasmid containing a l-kilobase pair fragment of the chop promoter. The autocrine hGH-stimulated increase in CHOP mRNA also resulted in an increase in CHOP protein. As a consequence, autocrine hGH stimulation of CHOP-mediated transcriptional activation was increased. Stable transfection of human CHOP cDNA into mammary carcinoma cells demonstrated that CHOP functioned not as a mediator of hGH-stimulated mitogenesis but rather enhanced the protection from apoptosis afforded by hGH in a p38 MAPK-dependent manner. Thus transcriptional up-regulation of chop is one mechanism by which hGH regulates mammary carcinoma cell number.	Inst Mol & Cell Biol, Singapore 117609, Singapore; Natl Univ Singapore, Dept Med, Singapore 119074, Singapore; Univ Lyon 1, CNRS, UMR 5578, F-69622 Villeurbanne, France	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Lobie, PE (corresponding author), Inst Mol & Cell Biol, 30 Med Dr, Singapore 117609, Singapore.	mcbpel@imcb.nus.edu.sg	MERTANI, Hichem-Claude/AAR-6415-2020; Lee, Kok-Onn/E-9874-2011; Goh, Eyleen/A-8006-2013	Lee, Kok-Onn/0000-0002-3040-1185; Goh, Eyleen/0000-0002-8244-6959				Abcouwer SF, 1999, J BIOL CHEM, V274, P28645, DOI 10.1074/jbc.274.40.28645; Adelmant G, 1998, J BIOL CHEM, V273, P15574, DOI 10.1074/jbc.273.25.15574; Arnal M, 1999, INT J MOL MED, V4, P545; BARKAS AE, 1986, VIROLOGY, V151, P131, DOI 10.1016/0042-6822(86)90111-X; BARONE MV, 1994, GENE DEV, V8, P453, DOI 10.1101/gad.8.4.453; BARTLETT JD, 1992, J BIOL CHEM, V267, P20465; BATCHVAROVA N, 1995, EMBO J, V14, P4654, DOI 10.1002/j.1460-2075.1995.tb00147.x; Bergad PL, 2000, J BIOL CHEM, V275, P8114, DOI 10.1074/jbc.275.11.8114; Brenner B, 1997, J BIOL CHEM, V272, P22173, DOI 10.1074/jbc.272.35.22173; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736; CHEN Q, 1992, J BIOL CHEM, V267, P8207; Cianfarani S, 1998, EUR J CLIN INVEST, V28, P41; Coutts M, 1999, BLOOD, V93, P3369, DOI 10.1182/blood.V93.10.3369.410k11_3369_3378; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Cui KY, 2000, J BIOL CHEM, V275, P7591, DOI 10.1074/jbc.275.11.7591; Del Bino G, 1999, CELL PROLIFERAT, V32, P25, DOI 10.1046/j.1365-2184.1999.00130.x; ENGERT JC, 1995, NUCLEIC ACIDS RES, V23, P2988, DOI 10.1093/nar/23.15.2988; Fawcett TW, 1997, CELL STRESS CHAPERON, V2, P104, DOI 10.1379/1466-1268(1997)002<0104:POHSIH>2.3.CO;2; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; FELDMAN M, 1993, ENDOCRINOLOGY, V133, P1602, DOI 10.1210/en.133.4.1602; Friedman AD, 1996, CANCER RES, V56, P3250; GIARRE M, 1998, ANN NY ACAD SCI, V23, P43; GLIMM DR, 1990, J ENDOCRINOL, V126, pR5, DOI 10.1677/joe.0.126R005; Goh ELK, 1998, ENDOCRINOLOGY, V139, P4364, DOI 10.1210/en.139.10.4364; Goh ELK, 1997, ENDOCRINOLOGY, V138, P3207, DOI 10.1210/en.138.8.3207; Guyton KZ, 1996, BIOCHEM J, V314, P547, DOI 10.1042/bj3140547; Haeffner A, 1999, EUR J IMMUNOL, V29, P334, DOI 10.1002/(SICI)1521-4141(199901)29:01<334::AID-IMMU334>3.0.CO;2-S; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; HUGUET EL, 1994, CANCER RES, V54, P2615; ILKBAHAR YN, 1995, ENDOCRINOLOGY, V136, P386, DOI 10.1210/en.136.2.386; ISAKSSON OGP, 1985, ANNU REV PHYSIOL, V47, P483, DOI 10.1146/annurev.ph.47.030185.002411; JAMMES H, 1991, MOL CELL ENDOCRINOL, V75, P27, DOI 10.1016/0303-7207(91)90242-K; Kaulsay KK, 1999, EXP CELL RES, V250, P35, DOI 10.1006/excr.1999.4492; Kaulsay KK, 2001, ENDOCRINOLOGY, V142, P767, DOI 10.1210/en.142.2.767; Kaulsay KK, 2000, ENDOCRINOLOGY, V141, P1571, DOI 10.1210/en.141.4.1571; Kim R, 1999, ANTICANCER RES, V19, P1779; Kim R, 1999, ANTICANCER RES, V19, P5399; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lantinga-van Leeuwen IS, 1999, MOL CELL ENDOCRINOL, V150, P121, DOI 10.1016/S0303-7207(99)00010-6; Li H, 1998, ENDOCRINOLOGY, V139, P3855, DOI 10.1210/en.139.9.3855; Lin BH, 1999, CELL DEATH DIFFER, V6, P570, DOI 10.1038/sj.cdd.4400528; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; LINCOLN DT, 1990, ACTA HISTOCHEM, P47; MARTEN NW, 1994, FASEB J, V8, P538, DOI 10.1096/fasebj.8.8.8181673; MEIER VS, 1994, MOL CELL BIOL, V14, P128, DOI 10.1128/MCB.14.1.128; Mertani HC, 1998, INT J CANCER, V79, P202; MERTANI HC, 1995, ENDOCRINE, V3, P135, DOI 10.1007/BF02990065; MOL JA, 1995, J CLIN ENDOCR METAB, V80, P3094, DOI 10.1210/jc.80.10.3094; MOL JA, 1995, J CLIN INVEST, V95, P2028, DOI 10.1172/JCI117888; MOLLER C, 1992, J BIOL CHEM, V267, P23403; MOSER AR, 1993, P NATL ACAD SCI USA, V90, P8977, DOI 10.1073/pnas.90.19.8977; Nam S Y, 2000, Obes Rev, V1, P73, DOI 10.1046/j.1467-789x.2000.00015.x; Nicol R, 1998, J BIOL CHEM, V273, P3588, DOI 10.1074/jbc.273.6.3588; Nicol R, 1999, CELL GROWTH DIFFER, V10, P243; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Orme SM, 1998, J CLIN ENDOCR METAB, V83, P2730, DOI 10.1210/jc.83.8.2730; Outinen PA, 1998, BIOCHEM J, V332, P213, DOI 10.1042/bj3320213; PARK JS, 1992, GENE, V116, P259, DOI 10.1016/0378-1119(92)90523-R; PLAUT K, 1993, ENDOCRINOLOGY, V133, P1843, DOI 10.1210/en.133.4.1843; PRICE BD, 1992, CANCER RES, V52, P3814; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; RAUGHT B, 1994, MOL CELL BIOL, V14, P1752, DOI 10.1128/MCB.14.3.1752; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; RUDICK VL, 1993, J CELL SCI, V104, P509; Schlosshauer PW, 2000, CARCINOGENESIS, V21, P1453, DOI 10.1093/carcin/21.7.1453; Shamu Caroline E., 1994, Trends in Cell Biology, V4, P56, DOI 10.1016/0962-8924(94)90011-6; Shen J, 2000, EXP CELL RES, V259, P274, DOI 10.1006/excr.2000.4963; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; SOBRIER ML, 1993, FEBS LETT, V319, P16, DOI 10.1016/0014-5793(93)80028-S; SUTRAVE P, 1990, MOL CELL BIOL, V10, P3137, DOI 10.1128/MCB.10.6.3137; SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462; Tan MJ, 2000, P NATL ACAD SCI USA, V97, P109, DOI 10.1073/pnas.97.1.109; Ubeda M, 1999, MOL CELL BIOL, V19, P7589; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wennbo H, 2000, ONCOGENE, V19, P1072, DOI 10.1038/sj.onc.1203349; WOOD TJJ, 1995, J BIOL CHEM, V270, P9448, DOI 10.1074/jbc.270.16.9448; Xu WD, 2000, P NATL ACAD SCI USA, V97, P5924, DOI 10.1073/pnas.090097797; Young CS, 1998, MOL CELL BIOL, V18, P2474, DOI 10.1128/MCB.18.5.2474; ZHAN QM, 1994, MOL CELL BIOL, V14, P2361, DOI 10.1128/MCB.14.4.2361; Zhu T, 2000, J BIOL CHEM, V275, P2103, DOI 10.1074/jbc.275.3.2103; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	87	59	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21464	21475		10.1074/jbc.M100437200	http://dx.doi.org/10.1074/jbc.M100437200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11297545	hybrid			2022-12-27	WOS:000169297900090
J	Tang, A; Curthoys, NP				Tang, A; Curthoys, NP			Identification of zeta-crystallin/NADPH : quinone reductase as a renal glutaminase mRNA pH response element-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEGRADATION; PHOSPHATE-DEPENDENT GLUTAMINASE; GUINEA-PIG; METABOLIC-ACIDOSIS; GENE-EXPRESSION; RAT-KIDNEY; LENS; TIAR; RECRUITMENT; STABILITY	Increased renal ammoniagenesis and bicarbonate synthesis from glutamine during chronic metabolic acidosis facilitate the excretion of acids and partially restore normal acid-base balance. This adaptation is sustained, in part, by a cell-specific stabilization of the glutaminase mRNA that leads to an increased synthesis of the mitochondrial glutaminase, A direct repeat of an 8-base AU sequence within the 3'-nontranslated region of the glutaminase mRNA binds a unique protein with high affinity and specificity. Expression of various chimeric mRNAs in LLC-PK1-FBPase(+) cells demonstrated that a single 8-base AU sequence is both necessary and sufficient to function as a pH response element (pH RE). A biotinylated oligoribonucleotide containing the direct repeat was used as an affinity ligand to purify the pH RE-binding protein from a cytosolic extract of rat renal cortex. The purified binding activity retained the same specific binding properties as observed with crude extracts and correlated with the elution of a 36-kDa protein. Microsequencing by mass spectroscopy and Western blot analysis were used to identify this protein as zeta -crystallin/NADPH:quinone reductase, The purified protein contained eight tryptic peptides that were identical to sequences found in mouse zeta -crystallin and three peptides that differed by only a single amino acid. The observed differences may represent substitutions found in the rat homolog. A second protein purified by this protocol was identified as T-cell-restricted intracellular antigen-related protein (TIAR), However, the purified TIAR neither bound nor affected the binding of zeta -crystallin/NADPH:quinone reductase to the pH RE. Further; more, specific antibodies to zeta -crystallin, but not TIAR, blocked the formation of the complex between the pH RE and either the crude cytosolic extract or the purified protein. Thus, zeta -crystallin/NADPH:quinone reductase is a pH response element-binding protein.	Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University	Curthoys, NP (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.				NIDDK NIH HHS [DK-37124] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037124] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBERTA JA, 1994, J BIOL CHEM, V269, P4532; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brosnan JT, 1988, PH HOMEOSTASIS MECHA, P281; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; CURTHOYS NP, 1973, J BIOL CHEM, V248, P162; CURTHOYS NP, 1976, ARCH BIOCHEM BIOPHYS, V172, P162, DOI 10.1016/0003-9861(76)90062-X; Dember LM, 1996, J BIOL CHEM, V271, P2783, DOI 10.1074/jbc.271.5.2783; Gagna CE, 1998, CELL BIOL INT, V22, P217, DOI 10.1006/cbir.1998.0243; GARLAND D, 1991, ARCH BIOCHEM BIOPHYS, V285, P134, DOI 10.1016/0003-9861(91)90339-K; GONZALEZ P, 1994, GENOMICS, V21, P317, DOI 10.1006/geno.1994.1272; GONZALEZ P, 1995, MOL BIOL EVOL, V12, P773; GONZALEZ P, 1994, MOL BIOL EVOL, V11, P305; GSTRAUNTHALER G, 1987, AM J PHYSIOL, V252, pC232, DOI 10.1152/ajpcell.1987.252.2.C232; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hansen WR, 1996, AM J PHYSIOL-RENAL, V271, pF126, DOI 10.1152/ajprenal.1996.271.1.F126; HWANG JJ, 1991, J BIOL CHEM, V266, P9392; HWANG JJ, 1991, BIOCHEMISTRY-US, V30, P7522, DOI 10.1021/bi00244a022; KAWAKAMI A, 1992, P NATL ACAD SCI USA, V89, P8681, DOI 10.1073/pnas.89.18.8681; Laterza OF, 2000, J AM SOC NEPHROL, V11, P1583, DOI 10.1681/ASN.V1191583; Laterza OF, 1997, J BIOL CHEM, V272, P22481, DOI 10.1074/jbc.272.36.22481; Laterza OF, 2000, AM J PHYSIOL-RENAL, V278, pF970, DOI 10.1152/ajprenal.2000.278.6.F970; LEE DC, 1994, J MOL BIOL, V236, P669, DOI 10.1006/jmbi.1994.1178; RAO PV, 1992, BIOCHIM BIOPHYS ACTA, V1117, P315; RAO PV, 1992, J BIOL CHEM, V267, P96; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; SQUIRES EJ, 1976, BIOCHEM J, V160, P125, DOI 10.1042/bj1600125; TANNEN RL, 1992, HDB PHYSL 8, V1, P1017; TAUPIN JL, 1995, P NATL ACAD SCI USA, V92, P1629, DOI 10.1073/pnas.92.5.1629; TONG J, 1987, BIOCHEMISTRY-US, V26, P2773, DOI 10.1021/bi00384a018; TONG J, 1986, BIOCHEM J, V233, P139, DOI 10.1042/bj2330139; Wang ZR, 2000, MOL CELL BIOL, V20, P6334, DOI 10.1128/MCB.20.17.6334-6341.2000; WELBOURNE TC, 1986, AM J PHYSIOL, V250, pF457; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WRIGHT PA, 1990, AM J PHYSIOL, V259, pF961, DOI 10.1152/ajprenal.1990.259.6.F961	39	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21375	21380		10.1074/jbc.M101941200	http://dx.doi.org/10.1074/jbc.M101941200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11294877	hybrid			2022-12-27	WOS:000169297900078
J	Stacey, M; Lin, HH; Hilyard, KL; Gordon, S; McKnight, AJ				Stacey, M; Lin, HH; Hilyard, KL; Gordon, S; McKnight, AJ			Human epidermal growth factor (EGF) module-containing mucin-like hormone receptor 3 is a new member of the EGF-TM7 family that recognizes a ligand on human macrophages and activated neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ALPHA-LATROTOXIN RECEPTOR; MOLECULAR-CLONING; POINT MUTATIONS; MARFAN-SYNDROME; MOUSE CD97; RAT CD2; SURFACE; 7-TRANSMEMBRANE; CD48	The epidermal growth factor (EGF)-TM7 subgroup of G-protein-coupled receptors is composed predominantly of leukocyte-restricted glycoproteins defined by their unique hybrid structure, in which extracellular EGF-like domains are coupled to a seven-span transmembrane moiety via a mucin-like stalk. The EGF-TM7 group comprises mouse F4/80, human EGF module-containing mucin-like hormone receptor (EMR) 1, human EMR2, and human and mouse CD97, the genes for which map to human chromosome 19p13 and the syntenic regions of the mouse genome. In this study we describe the cloning and characterization of EMR3, a novel human EGF-TM7 molecule, and show the existence of its cellular ligand. The EMR3 gene maps closely to the existing members of the EGF-TM7 family on human chromosome 19p13.1 and, in common with other EGF-TM7 genes, is capable of generating different protein isoforms through alternative splicing. Two alternative splice forms have been isolated: one encoding a 652-amino acid cell surface protein consisting of two EGF-like domains, a mucin stalk, and a putative G-protein-coupled receptor domain and the other encoding a truncated soluble form containing only two EGF-like domains. As with other members of the EGF-TM7 family, EMR3 mRNA displays a predominantly leukocyte-restricted expression pattern, with highest levels in neutrophils, monocytes, and macrophages, Through the use of soluble EMR3 multivalent probes we have shown the presence of a ligand at the surface of monocyte-derived macrophages and activated human neutrophils. These interactions suggest a potential role for EMR3 in myeloid-myeloid interactions during immune and inflammatory responses.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Roche Discovery Welwyn, Welwyn Garden City AL7 3AY, Herts, England; Kings Coll London Hosp, Dept Clin Sci, Inst Liver Studies, London SE5 9PJ, England	University of Oxford; Roche Holding; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Stacey, M (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	mstacey@molbiol.ox.ac.uk	LIN, Hsi-Hsien/N-1488-2015					BAUD V, 1995, GENOMICS, V26, P334, DOI 10.1016/0888-7543(95)80218-B; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brown MH, 1995, EUR J IMMUNOL, V25, P3222, DOI 10.1002/eji.1830251204; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Carver EA, 1999, MAMM GENOME, V10, P1039, DOI 10.1007/s003359901157; Chomczynski P, 1997, BIOTECHNIQUES, V22, P550, DOI 10.2144/97223pf01; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; GANDRILLE S, 1995, BLOOD, V85, P130, DOI 10.1182/blood.V85.1.130.bloodjournal851130; Giannelli F, 1996, NUCLEIC ACIDS RES, V24, P103, DOI 10.1093/nar/24.1.103; Gray JX, 1996, J IMMUNOL, V157, P5438; HAMANN J, 1995, J IMMUNOL, V155, P1942; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; Hamann J, 2000, INT IMMUNOL, V12, P439, DOI 10.1093/intimm/12.4.439; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; Lelianova VG, 1997, J BIOL CHEM, V272, P21504, DOI 10.1074/jbc.272.34.21504; Lin HH, 1997, GENOMICS, V41, P301, DOI 10.1006/geno.1997.4674; Lin HH, 2000, GENOMICS, V67, P188, DOI 10.1006/geno.2000.6238; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; McKnight AJ, 1998, J LEUKOCYTE BIOL, V63, P271, DOI 10.1002/jlb.63.3.271; McKnight AJ, 1996, J BIOL CHEM, V271, P486, DOI 10.1074/jbc.271.1.486; Moy GW, 1996, J CELL BIOL, V133, P809, DOI 10.1083/jcb.133.4.809; Qian YM, 1999, IMMUNOLOGY, V98, P303; Stacey M, 2000, TRENDS BIOCHEM SCI, V25, P284, DOI 10.1016/S0968-0004(00)01583-8; Sugita S, 1998, J BIOL CHEM, V273, P32715, DOI 10.1074/jbc.273.49.32715; VANDERMERWE PA, 1993, EMBO J, V12, P4945, DOI 10.1002/j.1460-2075.1993.tb06188.x	28	84	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18863	18870		10.1074/jbc.M101147200	http://dx.doi.org/10.1074/jbc.M101147200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279179	hybrid			2022-12-27	WOS:000169091000030
J	Tuominen, EKJ; Zhu, K; Wallace, CJA; Clark-Lewis, I; Craig, DB; Rytomaa, M; Kinnunen, PKJ				Tuominen, EKJ; Zhu, K; Wallace, CJA; Clark-Lewis, I; Craig, DB; Rytomaa, M; Kinnunen, PKJ			ATP induces a conformational change in lipid-bound cytochrome c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING SITE; PHOSPHOLIPID-VESICLES; CIRCULAR-DICHROISM; FERRICYTOCHROME-C; EMISSION-SPECTRA; LIPOSOMES; OXIDASE; MEMBRANES; MITOCHONDRIA; RESONANCE	Resonance energy transfer studies using a pyrene-labeled phospholipid derivative 1-palmitoyl-2-[10(pyren-1-yl)decanoyl]-sn-glycero-3-phosphoglycerol (donor) and the heme (acceptor) of cytochrome c (cyt c) have indicated that ATP causes changes in the conformation of the lipid-bound protein (Rytomaa, M., Mustonen, P., and Kinnunen, P. K. J. (1992) J. Biol. Chem. 267, 22243-22248). Accordingly, after binding cyt c via its so called C-site to neat phosphatidylglycerol liposomes (mole fraction of PG = 1.0) has commenced, further quenching of donor fluorescence is caused by ATP, saturating at 2 mM nucleotide. ATP-induced conformational changes in liposome-associated cyt c could be directly demonstrated by CD in the Soret band region (380-460 nm). The latter data were further supported by time-resolved spectroscopy using the fluorescent cyt c analog with a Zn2+-substituted heme moiety. A high affinity ATP-binding site has been demonstrated in cyt c (Craig, D. B., and Wallace, C. J. A. (1993) Protein Sci. 2, 966-976) that is compromised by replacing the invariant Arg(91) to norleucine. Although no major effects on conformation and function of cyt c were concluded due to the modification, a significantly reduced effect by ATP on the lipid-bound [Nle(91)]cyt c was evident, implying that this modulation is mediated via the Arg(91)-containing binding site.	Univ Helsinki, Inst Biomed, Dept Med Chem, Helsinki Biophys & Biomembrane Grp, FIN-00014 Helsinki, Finland; Univ British Columbia, Dept Biochem, Vancouver, BC V6T 1W5, Canada; Dalhousie Univ, Dept Biochem, Halifax, NS B3H 4H7, Canada	University of Helsinki; University of British Columbia; Dalhousie University	Kinnunen, PKJ (corresponding author), Univ Helsinki, Inst Biomed, Dept Med Chem, Helsinki Biophys & Biomembrane Grp, POB 63,Haartmaninkatu 8, FIN-00014 Helsinki, Finland.							ANNI H, 1995, BIOCHEMISTRY-US, V34, P5744, DOI 10.1021/bi00017a006; ANTALIK M, 1995, GEN PHYSIOL BIOPHYS, V14, P19; BLAUER G, 1993, BIOCHEMISTRY-US, V32, P6674, DOI 10.1021/bi00077a021; Cortese JD, 1998, BIOCHEMISTRY-US, V37, P6402, DOI 10.1021/bi9730543; CORTHESY BE, 1988, BIOCHEM J, V252, P349, DOI 10.1042/bj2520349; CORTHESY BE, 1986, BIOCHEM J, V236, P359, DOI 10.1042/bj2360359; CRAIG DB, 1995, BIOCHEMISTRY-US, V34, P2686, DOI 10.1021/bi00008a036; CRAIG DB, 1991, BIOCHEM J, V279, P781, DOI 10.1042/bj2790781; CRAIG DB, 1993, PROTEIN SCI, V2, P966, DOI 10.1002/pro.5560020610; DEJONGH HHJ, 1992, BIOCHEMISTRY-US, V31, P1636, DOI 10.1021/bi00121a008; DEJONGH HHJ, 1995, FEBS LETT, V360, P255, DOI 10.1016/0014-5793(95)00115-P; DEKRUIJFF B, 1980, BIOCHIM BIOPHYS ACTA, V602, P477, DOI 10.1016/0005-2736(80)90327-2; DICKERSON RE, 1971, J BIOL CHEM, V246, P1511; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GRATTON E, 1984, ANNU REV BIOPHYS BIO, V13, P105; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HILDEBRANDT P, 1990, EUR BIOPHYS J, V18, P193, DOI 10.1007/BF02427378; Jameson D. M., 1991, BIOPHYSICAL BIOCH AS, P105; Jemmerson R, 1999, BIOCHEMISTRY-US, V38, P3599, DOI 10.1021/bi9809268; KAIHOVAARA P, 1991, BIOCHEMISTRY-US, V30, P8380, DOI 10.1021/bi00098a015; Kinnunen PKJ, 1996, CHEM PHYS LIPIDS, V81, P151, DOI 10.1016/0009-3084(96)02579-0; KINNUNEN PKJ, 1994, CHEM PHYS LIPIDS, V73, P181, DOI 10.1016/0009-3084(94)90181-3; KINNUNEN PKJ, 1993, FLUORESCENCE SPECTRO, P159; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LIN J, 1995, BIOCHEMISTRY-US, V34, P2678, DOI 10.1021/bi00008a035; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; McIntosh DB, 1996, J BIOL CHEM, V271, P18379, DOI 10.1074/jbc.271.31.18379; MUGA A, 1991, BIOCHEMISTRY-US, V30, P7219, DOI 10.1021/bi00243a025; MUSTONEN P, 1987, BIOCHEMISTRY-US, V26, P2991, DOI 10.1021/bi00385a006; MUSTONEN P, 1993, J BIOL CHEM, V268, P1074; MYER YP, 1968, J BIOL CHEM, V243, P2115; Pinheiro TJT, 1997, BIOCHEMISTRY-US, V36, P13122, DOI 10.1021/bi971235z; Rosell FI, 1998, J AM CHEM SOC, V120, P11234, DOI 10.1021/ja971756+; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; RYTOMAA M, 1992, J BIOL CHEM, V267, P22243; RYTOMAA M, 1994, J BIOL CHEM, V269, P1770; Salamon Z, 1996, BIOPHYS J, V71, P848, DOI 10.1016/S0006-3495(96)79286-X; Santucci R, 1997, J INORG BIOCHEM, V68, P211, DOI 10.1016/S0162-0134(97)00100-1; SKOOG L, 1974, J BIOL CHEM, V249, P6434; SMITH L, 1980, BIOCHEMISTRY-US, V19, P1613, DOI 10.1021/bi00549a013; SPECK SH, 1983, FEBS LETT, V164, P379, DOI 10.1016/0014-5793(83)80321-4; SPOONER J, 1992, BIOCHEMISTRY-US, V30, P3880; SPOONER J, 1992, BIOCHEMISTRY-US, V30, P3871; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Subramanian M, 1998, BIOCHEMISTRY-US, V37, P1394, DOI 10.1021/bi9716581; TAANMAN JW, 1994, BIOCHEMISTRY-US, V33, P11833, DOI 10.1021/bi00205a020; Tuominen EKJ, 1997, BIOCHEM BIOPH RES CO, V238, P140, DOI 10.1006/bbrc.1997.7257; VANDERKOOI JM, 1975, EUR J BIOCHEM, V60, P199, DOI 10.1111/j.1432-1033.1975.tb20992.x; VANDERKOOI JM, 1976, EUR J BIOCHEM, V64, P381, DOI 10.1111/j.1432-1033.1976.tb10312.x; VIK SB, 1981, P NATL ACAD SCI-BIOL, V78, P1456, DOI 10.1073/pnas.78.3.1456; WALLACE CJA, 1984, BIOCHEM J, V217, P601, DOI 10.1042/bj2170601; WALLACE CJA, 1983, BIOCHEM J, V215, P651, DOI 10.1042/bj2150651; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	56	46	46	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19356	19362		10.1074/jbc.M100853200	http://dx.doi.org/10.1074/jbc.M100853200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279142	hybrid			2022-12-27	WOS:000169091000096
J	Hackam, DJ; Botelho, RJ; Sjolin, C; Rotstein, OD; Robinson, JM; Schreiber, AD; Grinstein, S				Hackam, DJ; Botelho, RJ; Sjolin, C; Rotstein, OD; Robinson, JM; Schreiber, AD; Grinstein, S			Indirect role for COPI in the completion of Fc gamma receptor-mediated phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; SYK TYROSINE KINASE; PLASMA-MEMBRANE; EPSILON-COP; TRANSFERRIN RECEPTOR; GOLGI MEMBRANES; CELL MUTANT; BREFELDIN-A; CHO CELLS; MACROPHAGES	Recent evidence suggests that extension of pseudopods during phagocytosis requires localized insertion of endomembrane vesicles. The nature of these vesicles and the processes mediating their release and insertion are unknown. COPI plays an essential role in the budding and traffic of membrane vesicles in intracellular compartments. We therefore assessed whether COPI is also involved in phagosome formation. We used IdlF cells, a mutant line derived from Chinese hamster ovary cells that express a temperature-sensitive form of epsilon COP, To confer phagocytic ability to IdlF cells, they were stably transfected with Fc receptors type IIA (Fc gamma RIIA), In the presence of functional COPI, Fc gamma RIIA-transfected IdlF cells effectively internalized opsonized particles. In contrast, phagocytosis was virtually eliminated after incubation at the restrictive temperature. Similar results were obtained impairing COPI function in macrophages using brefeldin A. Notably, loss of COPI function preceded complete inhibition of phagocytosis, suggesting that COPI is indirectly required for phagocytosis, Despite their inability to internalize particles, COPI-deficient cells nevertheless expressed normal levels of Fc gamma RIIA, and signal transduction appeared unimpeded, The opsonized particles adhered normally to COPI-deficient cells and were often found on actin-rich pedestals, but they were not internalized due to the inability of the cells to extend pseudopods. The failure to extend pseudopods was attributed to the inability of COPI-deficient cells to mobilize endomembrane vesicles, including a VAMP3-containing compartment, in response to the phagocytic stimulus.	Hosp Sick Children, Div Cell Biol, Toronto, ON M5G 1X8, Canada; Toronto Gen Hosp, Dept Surg, Toronto, ON M5G 2C4, Canada; Ohio State Univ, Dept Physiol, Columbus, OH 43210 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University System of Ohio; Ohio State University; University of Pennsylvania	Grinstein, S (corresponding author), Hosp Sick Children, Div Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Botelho, Roberto J/B-9145-2013	Botelho, Roberto J/0000-0002-7820-0999; Hackam, David/0000-0001-5195-8807				Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; BERON W, 1995, TRENDS CELL BIOL, V5, P100, DOI 10.1016/S0962-8924(00)88958-8; Blystone SD, 1999, J CELL BIOL, V145, P889, DOI 10.1083/jcb.145.4.889; Botelho RJ, 2000, J BIOL CHEM, V275, P15717, DOI 10.1074/jbc.M910068199; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Cox D, 1996, J BIOL CHEM, V271, P16597, DOI 10.1074/jbc.271.28.16597; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Cox D, 2000, P NATL ACAD SCI USA, V97, P680, DOI 10.1073/pnas.97.2.680; Daro E, 1997, J CELL BIOL, V139, P1747, DOI 10.1083/jcb.139.7.1747; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Downey GP, 1999, J BIOL CHEM, V274, P28436, DOI 10.1074/jbc.274.40.28436; GALLI T, 1994, J CELL BIOL, V125, P1015, DOI 10.1083/jcb.125.5.1015; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GONZALEZROTHI RJ, 1991, EXP LUNG RES, V17, P687, DOI 10.3109/01902149109062873; Greenberg S, 1996, P NATL ACAD SCI USA, V93, P1103, DOI 10.1073/pnas.93.3.1103; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183; GUO Q, 1994, J CELL BIOL, V125, P1213, DOI 10.1083/jcb.125.6.1213; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; Hackam DJ, 1997, J EXP MED, V186, P955, DOI 10.1084/jem.186.6.955; Hackam DJ, 1998, P NATL ACAD SCI USA, V95, P11691, DOI 10.1073/pnas.95.20.11691; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; HOBBIE L, 1994, J BIOL CHEM, V269, P20958; Holevinsky KO, 1998, BIOPHYS J, V75, P2577, DOI 10.1016/S0006-3495(98)77703-3; Jun CD, 1996, CELL IMMUNOL, V174, P25, DOI 10.1006/cimm.1996.0290; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lennartz MR, 1997, J CELL SCI, V110, P2041; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; PARK JG, 1993, J CLIN INVEST, V92, P1967, DOI 10.1172/JCI116790; Prekeris R, 1999, J NEUROSCI, V19, P10324; ROBINSON JM, 1986, J CELL BIOL, V102, P1615, DOI 10.1083/jcb.102.5.1615; ROSALES C, 1991, J IMMUNOL, V146, P3937; ROSALES C, 1992, J BIOL CHEM, V267, P5265; Scales SJ, 2000, INT REV CYTOL, V195, P67; Schnitzler N, 1999, NAT MED, V5, P231, DOI 10.1038/5597; SCHONHORN JE, 1994, MOL CELL BIOCHEM, V135, P159, DOI 10.1007/BF00926519; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; WERB Z, 1972, J BIOL CHEM, V247, P2439; Wieland F, 1999, CURR OPIN CELL BIOL, V11, P440, DOI 10.1016/S0955-0674(99)80063-5; Zhang Q, 1998, J BIOL CHEM, V273, P19977, DOI 10.1074/jbc.273.32.19977; Zimmerli S, 1996, J CELL BIOL, V132, P49, DOI 10.1083/jcb.132.1.49	42	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18200	18208		10.1074/jbc.M102009200	http://dx.doi.org/10.1074/jbc.M102009200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279223	hybrid			2022-12-27	WOS:000168866500079
J	Fujimaki, W; Iwashima, M; Yagi, J; Zhang, H; Yagi, H; Seo, K; Imai, Y; Imanishi, K; Uchiyama, T				Fujimaki, W; Iwashima, M; Yagi, J; Zhang, H; Yagi, H; Seo, K; Imai, Y; Imanishi, K; Uchiyama, T			Functional uncoupling of T-cell receptor engagement and Lck activation in anergic human thymic CD4(+) T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PROTEIN-KINASE; SHOCK-SYNDROME TOXIN-1; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR; INDUCTION; CD45; SUPERANTIGEN; MATURATION; PATHWAYS; CALCIUM	Human thymic CD1a(-)CD4(+) T cells in the final stage of thymic maturation are susceptible to anergy induced by a superantigen, toxic shock syndrome toxin-1 (TSST-1). Thymic CD4(+) T-cell blasts, established by stimulating human thymic CD1a(-)CD4(+) T cells with TSST-1 in vitro, produce a low level of interleukin-2 after restimulation with TSST-1, whereas TSST-1-induced adult peripheral blood (APB) CD4(+) T-cell blasts produce high levels of interleukin-2. The extent of tyrosine phosphorylation of the T-cell receptor zeta chain induced after restimulation with TSST-1 was 2-4-fold higher in APE CD4(+) T-cell blasts than in thymic CD4(+) T-cell blasts. The tyrosine kinase activity of Lck was low in both thymic and APE CD4(+) T-cell blasts before restimulation with TSST-1, After restimulation, the Lck kinase activity increased in APE CD4(+) T-cell blasts but not in thymic CD4(+) T-cell blasts. Surprisingly, Lck was highly tyrosine-phosphorylated in both thymic and APE CD4(+) T-cell blasts before restimulation with TSST-1, After restimulation, it was markedly dephosphorylated in APE CD4(+) T-cell blasts but not in thymic CD4(+) T-cell blasts. Lck fi om APE CD4(+) T-cell blasts bound the peptide containing the phosphotyrosine at the negative regulatory site of Lck-505 indicating that the site of dephosphorylation in TSST-1-activated T-cell blasts is Tyr-505, Confocal microscopy demonstrated that colocalization of Lck and CD45 was induced after restimulation with TSST-1 in APE CD4(+) T-cell blasts but not in thymic CD4(+) T-cell blasts. Further, remarkable accumulation of Lck in the membrane raft was observed in restimulated APE CD4(+) T-cell blasts but not in thymic CD4(+) T-cell blasts. These data indicate that interaction between Lck and CD45 is suppressed physically in thymic CD4(+) T-cell blasts and plays a critical role in sustaining an anergic state.	Tokyo Womens Med Univ, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1628666, Japan; Tokyo Womens Med Univ, Heart Inst Japan, Dept Pediat Cardiovasc Surg, Shinjuku Ku, Tokyo 1628666, Japan; Med Coll Georgia, Inst Mol Med & Genet, Program Mol Immunol, Augusta, GA 30912 USA	Tokyo Women's Medical University; Tokyo Women's Medical University; University System of Georgia; Augusta University	Fujimaki, W (corresponding author), Tokyo Womens Med Univ, Dept Microbiol & Immunol, Shinjuku Ku, 8-1 Kawadacho, Tokyo 1628666, Japan.							AKATSUKA H, 1994, CLIN EXP IMMUNOL, V96, P422; AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHOI YW, 1989, P NATL ACAD SCI USA, V86, P8941, DOI 10.1073/pnas.86.22.8941; DeSilva DR, 1996, J EXP MED, V183, P2017, DOI 10.1084/jem.183.5.2017; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; GAJEWSKI TF, 1995, EUR J IMMUNOL, V25, P1836, DOI 10.1002/eji.1830250707; GAJEWSKI TF, 1994, P NATL ACAD SCI USA, V91, P38, DOI 10.1073/pnas.91.1.38; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Imanishi K, 1998, J IMMUNOL, V160, P112; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; KATO H, 1994, J TOKYO WOM MED COLL, V64, P985; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Leitenberg D, 1999, IMMUNITY, V10, P701, DOI 10.1016/S1074-7613(00)80069-2; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MIGITA K, 1995, J IMMUNOL, V155, P5083; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; MUELLER DL, 1989, J IMMUNOL, V142, P2617; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; Res P, 1997, J EXP MED, V185, P141, DOI 10.1084/jem.185.1.141; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; SIEH M, 1993, EMBO J, V12, P315, DOI 10.1002/j.1460-2075.1993.tb05659.x; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TAKAHASHI N, 1995, J IMMUNOL, V155, P5213; UCHIYAMA T, 1987, CLIN EXP IMMUNOL, V68, P638; VEILLETTE A, 1990, ONCOGENE, V5, P1455; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	32	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17455	17460		10.1074/jbc.M101072200	http://dx.doi.org/10.1074/jbc.M101072200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279170	hybrid			2022-12-27	WOS:000168730400115
J	Chen, Z; Cobb, MH				Chen, Z; Cobb, MH			Regulation of stress-responsive mitogen-activated protein (MAP) kinase pathways by TAO2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; SIGNAL-TRANSDUCTION; STE20-LIKE KINASE; KAPPA-B; IDENTIFICATION; FAMILY; P38; MYOGENESIS; SCAFFOLD; MEMBER	Previous studies demonstrated that in vitro the protein kinase TAO2 activates MAP/ERK kinases (MEKs) 3, 4, and 6 toward their substrates p38 MAP kinase and c-dun N-terminal kinase/stress-activated protein kinase (JNK/SAPK). In this study, we examined the ability of TAO2 to activate stress-sensitive MAP kinase pathways in cells and the relationship between activation of TAO2 and potential downstream pathways. Over-expression of TAO2 activated endogenous JNK/SAPK and p38 but not ERK1/2. Cotransfection experiments suggested that TAO2 selectively activates MEK3 and MEK6 but not MEKs 1, 4, or 7. Coimmunoprecipitation demonstrated that endogenous TAO2 specifically associates with MEK3 and MEK6 providing one mechanism for preferential recognition of MEKs upstream of p38. Sorbitol, and to a lesser extent, sodium chloride, Taxol, and nocodazole increased TAO2 activity toward itself and kinase-dead MEKs 3 and 6, Activation of endogenous TAO2 during differentiation of C2C12 myoblasts paralleled activation of p38 but not JNK/SAPK, consistent with the idea that TAO2 is a physiological regulator of p38 under certain circumstances.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.			Cobb, Melanie/0000-0003-0833-5473	NIGMS NIH HHS [GM53032] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; Chen Z, 1999, J BIOL CHEM, V274, P28803, DOI 10.1074/jbc.274.40.28803; Conejo R, 2001, J CELL PHYSIOL, V186, P82, DOI 10.1002/1097-4652(200101)186:1<82::AID-JCP1001>3.0.CO;2-R; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; English JM, 1999, J BIOL CHEM, V274, P31588, DOI 10.1074/jbc.274.44.31588; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Hutchison M, 1998, J BIOL CHEM, V273, P28625, DOI 10.1074/jbc.273.44.28625; Ishizuka T, 1997, P NATL ACAD SCI USA, V94, P6358, DOI 10.1073/pnas.94.12.6358; Karandikar M, 2000, J BIOL CHEM, V275, P40120, DOI 10.1074/jbc.M005926200; Moore TM, 2000, J BIOL CHEM, V275, P4311, DOI 10.1074/jbc.275.6.4311; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PEARSON G, 2001, IN PRESS ENDOCRINE R; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Swantek JL, 1999, J BIOL CHEM, V274, P11667, DOI 10.1074/jbc.274.17.11667; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tassi E, 1999, J BIOL CHEM, V274, P33287, DOI 10.1074/jbc.274.47.33287; Wang XHSN, 1998, BIOCHEM BIOPH RES CO, V253, P33, DOI 10.1006/bbrc.1998.9749; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Xu BE, 1999, J BIOL CHEM, V274, P34029, DOI 10.1074/jbc.274.48.34029; Xu SC, 1996, P NATL ACAD SCI USA, V93, P5291, DOI 10.1073/pnas.93.11.5291; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Yujiri T, 1999, J BIOL CHEM, V274, P12605, DOI 10.1074/jbc.274.18.12605; Yustein JT, 2000, ONCOGENE, V19, P710, DOI 10.1038/sj.onc.1203342	29	47	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16070	16075		10.1074/jbc.M100681200	http://dx.doi.org/10.1074/jbc.M100681200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279118	hybrid			2022-12-27	WOS:000168623100069
J	La Mar, GN; Asokan, A; Espiritu, B; Yeh, DC; Auclair, K; de Montellano, PRO				La Mar, GN; Asokan, A; Espiritu, B; Yeh, DC; Auclair, K; de Montellano, PRO			Solution H-1 NMR of the active site of substrate-bound, cyanide-inhibited human heme oxygenase - Comparison to the crystal structure of the water-ligated form	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUTION NMR DETERMINATION; SUSCEPTIBILITY TENSOR; ELECTRONIC CONTROL; HYPERFINE SHIFTS; RESONANCE RAMAN; CATALYTIC SITE; MAGNETIC AXES; PROTON NMR; RAT HEME; ORIENTATION	The majority of the active site residues of cyanide-inhibited, substrate-bound human heme oxygenase have been assigned on the basis of two-dimensional NMR using the crystal structure of the water-ligated substrate complex as a guide (Schuller, D. J., Wilks, A., Ortiz de Montellano, P. R., and Poulos, T. L. (1999) Nat. Struct. Biol. 6, 860-867). The proximal helix and the N-terminal portion of the distal helix are found to be identical to those in the crystal except that the heme for the major isomer (similar to 75-80%) in solution is rotated 180 degrees about the alpha-gamma -meso axis relative to the unique orientation in the crystal. The central portion of the distal helix in solution is translated slightly over the heme toward the distal ligand and a distal four-ring aromatic cluster has moved 1-2 Angstrom closer to the heme, which allows for strong hydrogen bonds between the hydroxyls of Tyr-58 and Tyr-137. These latter interactions are proposed to stabilize the closed pocket conducive to the high stereospecificity of the alpha -meso ring opening. The determination of the magnetic axes, for which the major axis is controlled by the Fe-CN orientation, reveals a similar to 20 degrees tilt of the distal ligand from the heme normal in the direction of the alpha -meso bridge, demonstrating that the close placement of the distal helix over the heme exerts control of stereospecificity by both blocking access to the beta, gamma, and delta -meso positions and tilting the axial ligand, a proposed peroxide, toward the alpha -meso position.	Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California Davis; University of California System; University of California San Francisco	La Mar, GN (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	lamar@indigo.ucdavis.edu			NCRR NIH HHS [RR04795, RR11973, RR08206] Funding Source: Medline; NIDDK NIH HHS [DK30297] Funding Source: Medline; NIGMS NIH HHS [GM62830, GM26226] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR004795, S10RR011973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062830, R01GM026226] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANCI L, 1995, J AM CHEM SOC, V117, P8659, DOI 10.1021/ja00138a023; BERTINI I, 1993, CHEM REV, V93, P2833, DOI 10.1021/cr00024a009; BROWN SB, 1981, NATURE, V289, P93, DOI 10.1038/289093a0; BUNDI A, 1979, BIOPOLYMERS, V18, P285, DOI 10.1002/bip.1979.360180206; CHEN ZG, 1994, J AM CHEM SOC, V116, P8772, DOI 10.1021/ja00098a040; CROSS KJ, 1985, J MAGN RESON, V64, P220, DOI 10.1016/0022-2364(85)90346-4; de Montellano P. R. O., 1995, CYTCOCHROME P450 STR, P245; De Montellano PRO, 1998, ACCOUNTS CHEM RES, V31, P543; DUNFORD BH, 2000, HEME PEROXIDASES; EMERSON SD, 1990, BIOCHEMISTRY-US, V29, P1556, DOI 10.1021/bi00458a029; Fujii H, 1998, J AM CHEM SOC, V120, P8251, DOI 10.1021/ja973925w; Gorst CM, 1998, J AM CHEM SOC, V120, P8875, DOI 10.1021/ja9815475; GRIESINGER C, 1988, J AM CHEM SOC, V65, P355; HERNANDEZ G, 1994, BIOCHEMISTRY-US, V33, P6631, DOI 10.1021/bi00187a033; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Kolczak U, 1997, J AM CHEM SOC, V119, P12643, DOI 10.1021/ja9722133; La Mar G.N., 2000, PORPHYRIN HDB, V5, P185; La Mar G.N., 1993, BIOL MAGN RESON, P1; LAMAR GN, 1995, J AM CHEM SOC, V117, P411, DOI 10.1021/ja00106a047; Liu Y, 2000, J BIOL CHEM, V275, P34501, DOI 10.1074/jbc.M004245200; Matera KM, 1997, BIOCHEMISTRY-US, V36, P4909, DOI 10.1021/bi962321m; Migita CT, 1998, J BIOL CHEM, V273, P945, DOI 10.1074/jbc.273.2.945; MULLER RM, 1987, J BIOL CHEM, V262, P6795; Nguyen BD, 1999, J AM CHEM SOC, V121, P208, DOI 10.1021/ja982555o; PEYTON DH, 1988, BIOCHIM BIOPHYS ACTA, V954, P82, DOI 10.1016/0167-4838(88)90058-1; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; QIN J, 1993, J MOL BIOL, V231, P1009, DOI 10.1006/jmbi.1993.1348; RAJARATHNAM K, 1994, BIOCHEMISTRY-US, V33, P5493, DOI 10.1021/bi00184a018; ROTENBERG MO, 1990, J BIOL CHEM, V265, P7501; Sandstrom J., 1982, DYNAMIC NMR SPECTROS; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Shokhirev NV, 1998, J BIOL INORG CHEM, V3, P581, DOI 10.1007/s007750050271; STEIGEMANN W, 1979, J MOL BIOL, V127, P309, DOI 10.1016/0022-2836(79)90332-2; Sugishima M, 2000, FEBS LETT, V471, P61, DOI 10.1016/S0014-5793(00)01353-3; SUN J, 1993, BIOCHEMISTRY-US, V32, P14151, DOI 10.1021/bi00214a012; SUN J, 1994, BIOCHEMISTRY-US, V33, P13734, DOI 10.1021/bi00250a026; TAKAHASHI S, 1994, J BIOL CHEM, V269, P1010; TAKAHASHI S, 1994, BIOCHEMISTRY-US, V33, P5531, DOI 10.1021/bi00184a023; TAKAHASHI S, 1995, J AM CHEM SOC, V117, P6002, DOI 10.1021/ja00127a013; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Torpey J, 1997, J BIOL CHEM, V272, P22008, DOI 10.1074/jbc.272.35.22008; Torpey J, 1996, J BIOL CHEM, V271, P26067, DOI 10.1074/jbc.271.42.26067; WILKS A, 1995, BIOCHEMISTRY-US, V34, P4421, DOI 10.1021/bi00013a034; WILKS A, 1994, J BIOL CHEM, V269, P29553; WILKS A, 1993, J BIOL CHEM, V268, P22357; WILLIAMS G, 1985, J MOL BIOL, V183, P447, DOI 10.1016/0022-2836(85)90013-0; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Wuthrich K, 1986, NMR PROTEINS NUCL AC; YOSHIDA T, 1978, J BIOL CHEM, V253, P4224; YOSHIDA T, 1988, EUR J BIOCHEM, V171, P457, DOI 10.1111/j.1432-1033.1988.tb13811.x	50	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15676	15687		10.1074/jbc.M009974200	http://dx.doi.org/10.1074/jbc.M009974200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11297521	hybrid			2022-12-27	WOS:000168623100016
J	Schmidlin, F; Dery, O; DeFea, KO; Slice, L; Patierno, S; Sternini, C; Grady, EF; Bunnett, NW				Schmidlin, F; Dery, O; DeFea, KO; Slice, L; Patierno, S; Sternini, C; Grady, EF; Bunnett, NW			Dynamin and Rab5a-dependent trafficking and signaling of the neurokinin 1 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTANCE-P RECEPTOR; ACTIVATED PROTEIN-KINASE; MUSCARINIC ACETYLCHOLINE-RECEPTOR; ARRESTIN-DEPENDENT ENDOCYTOSIS; KAPPA-OPIOID RECEPTOR; BETA-ARRESTIN; RAB GTPASES; BETA(2)-ADRENERGIC RECEPTOR; INDUCED INTERNALIZATION; NEUTRAL ENDOPEPTIDASE	Understanding the molecular mechanisms of agonist-induced trafficking of G-protein-coupled receptors is important because of the essential role of trafficking in signal transduction. We examined the role of the GT-Pases dynamin 1 and Rab5a in substance P (SP)-induced trafficking and signaling of the neurokinin 1 receptor (NK1R), an important mediator of pain, depression, and inflammation, by studying transfected cells and enteric neurons that naturally express the NK1R, In unstimulated cells, the NK1R colocalized with dynamin at the plasma membrane, and Rab5a was detected in endosomes, SP induced translocation of the receptor into endosomes containing Rab5a immediately beneath the plasma membrane and then in a perinuclear location. Expression of the dominant negative mutants dynamin 1 K44E and Rab5aS34N inhibited endocytosis of SP by 45 and 32%, respectively. Dynamin K44E caused membrane retention of the NK1R, whereas Rab5aS34N also impeded the translocation of the receptor from superficially located to perinuclear endosomes, Both dynamin K44E and Rab5aS34N strongly inhibited resensitization of SP-induced Ca2+ mobilization by 60 and 85%, respectively, but had no effect on NK1R desensitization. Dynamin K44E but not Rab5aS34N markedly reduced SP-induced phosphorylation of extracellular signal regulated kinases 1 and 2. Thus, dynamin mediates the formation of endosomes containing the NK1R, and Rab5a mediates both endosomal formation and their translocation from a superficial to a perinuclear location. Dynamin and Rab5a-dependent trafficking is essential for NK1R resensitization but is not necessary for desensitization of signaling. Dynamin-dependent but not Rab5a-dependent trafficking is required for coupling of the NK1R to the mitogen-activated protein kinase cascade. These processes may regulate the nociceptive, depressive, and proinflammatory effects of SP.	Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; W Los Angeles Vet Affairs Med Ctr, Digest Dis Res Ctr, CURE, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90073 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bunnett, NW (corresponding author), Univ Calif San Francisco, Dept Surg, 521 Parnassus Ave, San Francisco, CA 94143 USA.			Bunnett, Nigel W./0000-0003-3367-0644	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054155, R01DK035740, R56DK054155, R01DK039957, R56DK043207, R37DK039957, R01DK052388, R01DK043207] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK39957, DK43207, DK52388, DK35740, DK54155] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Barak LS, 1999, J BIOL CHEM, V274, P7565, DOI 10.1074/jbc.274.11.7565; Bohm SK, 1997, BIOCHEM J, V322, P1; Bohm SK, 1996, J BIOL CHEM, V271, P22003; BOWDEN JJ, 1994, P NATL ACAD SCI USA, V91, P8964, DOI 10.1073/pnas.91.19.8964; BRASS LF, 1994, J BIOL CHEM, V269, P2943; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUNNETT NW, 1995, PEPTIDES, V16, P733, DOI 10.1016/0196-9781(95)00042-I; Chu P, 1997, J BIOL CHEM, V272, P27124, DOI 10.1074/jbc.272.43.27124; Daaka Y, 1997, P NATL ACAD SCI USA, V94, P2180, DOI 10.1073/pnas.94.6.2180; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Garland AM, 1996, MOL PHARMACOL, V49, P438; GARLAND AM, 1994, BIOCHEM J, V303, P177, DOI 10.1042/bj3030177; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Grady EF, 1996, J NEUROSCI, V16, P6975, DOI 10.1523/jneurosci.16-21-06975.1996; GRADY EF, 1995, MOL BIOL CELL, V6, P509, DOI 10.1091/mbc.6.5.509; GRADY EF, 1996, NEUROSCIENCE, V16, P1239; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Ignatova EG, 1999, J NEUROSCI, V19, P56, DOI 10.1523/JNEUROSCI.19-01-00056.1999; Iwata K, 1999, EUR J BIOCHEM, V263, P596, DOI 10.1046/j.1432-1327.1999.00549.x; Kramer MS, 1998, SCIENCE, V281, P1640, DOI 10.1126/science.281.5383.1640; Kranenburg O, 1999, J BIOL CHEM, V274, P35301, DOI 10.1074/jbc.274.50.35301; KWATRA MM, 1993, J BIOL CHEM, V268, P9161; Labrousse AM, 1998, MOL BIOL CELL, V9, P3227, DOI 10.1091/mbc.9.11.3227; Lee KB, 1998, J BIOL CHEM, V273, P12967, DOI 10.1074/jbc.273.21.12967; Li JG, 1999, J BIOL CHEM, V274, P12087, DOI 10.1074/jbc.274.17.12087; Li JG, 2000, MOL PHARMACOL, V58, P795, DOI 10.1124/mol.58.4.795; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Lu B, 1997, NAT MED, V3, P904, DOI 10.1038/nm0897-904; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; McClure SJ, 1996, MOL MEMBR BIOL, V13, P189, DOI 10.3109/09687689609160598; McConalogue K, 1999, J BIOL CHEM, V274, P16257, DOI 10.1074/jbc.274.23.16257; McConalogue K, 1999, NEUROSCIENCE, V90, P1051, DOI 10.1016/S0306-4522(98)00514-4; McConalogue K, 1998, MOL BIOL CELL, V9, P2305, DOI 10.1091/mbc.9.8.2305; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Nishimura K, 1998, BIOCHEMISTRY-US, V37, P1192, DOI 10.1021/bi972302s; Olkkonen VM, 1997, INT REV CYTOL, V176, P1, DOI 10.1016/S0074-7696(08)61608-3; OTSUKA M, 1993, PHYSIOL REV, V73, P229, DOI 10.1152/physrev.1993.73.2.229; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; PIPPIG S, 1993, J BIOL CHEM, V268, P3201; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Roberts RL, 1999, J CELL SCI, V112, P3667; Rodman JS, 2000, J CELL SCI, V113, P183; Roush ED, 1999, MOL PHARMACOL, V55, P855; Schramm NL, 1999, J BIOL CHEM, V274, P24935, DOI 10.1074/jbc.274.35.24935; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Sternini C, 2000, NEUROSCIENCE, V98, P233, DOI 10.1016/S0306-4522(00)00118-4; Sturiale S, 1999, P NATL ACAD SCI USA, V96, P11653, DOI 10.1073/pnas.96.20.11653; Trischler M, 1999, J CELL SCI, V112, P4773; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; VIGNA SR, 1994, J NEUROSCI, V14, P834; Vigna SR, 1999, J NEUROCHEM, V73, P1925; Vogler O, 1998, J BIOL CHEM, V273, P12155, DOI 10.1074/jbc.273.20.12155; Vogler O, 1999, J BIOL CHEM, V274, P12333, DOI 10.1074/jbc.274.18.12333; VON ZM, 1992, J BIOL CHEM, V267, P3530; Yang W, 1999, J BIOL CHEM, V274, P11328, DOI 10.1074/jbc.274.16.11328; YU SS, 1993, J BIOL CHEM, V268, P337; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	65	58	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					25427	25437		10.1074/jbc.M101688200	http://dx.doi.org/10.1074/jbc.M101688200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11306580	hybrid			2022-12-27	WOS:000169800700133
J	Marchbank, T; Cox, HM; Goodlad, RA; Giraud, AS; Moss, SF; Poulsom, R; Wright, NA; Jankowski, J; Playford, RJ				Marchbank, T; Cox, HM; Goodlad, RA; Giraud, AS; Moss, SF; Poulsom, R; Wright, NA; Jankowski, J; Playford, RJ			Effect of ectopic expression of rat trefoil factor family 3 (intestinal trefoil factor) in the jejunum of transgenic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; PANCREATIC SPASMOLYTIC POLYPEPTIDE; EPITHELIAL-CELLS; FACTOR RECEPTOR; CELIAC-DISEASE; PEPTIDE; PROTEIN; PS2; SECRETION; STOMACH	To further examine the function of the trefoil factor family (TFF), the expression of which is up-regulated at sites of injury, we have produced transgenic mice that chronically express rat TFF3 within the jejunum (using a rat fatty acid-binding protein promoter). The expression of rat TFF3 was limited to the villi of the jejunum and had no effect on base-line morphology. Rat TFF3 expression did result, however, in a reduced sensitivity to indomethacin (85 mg/kg sulbcutaneously), which only caused a 29% reduction in villus height in transgenics versus 51% reduction in controls (p < 0.01). Indomethacin increased initial intestinal epithelial cell proliferation and migration, but the presence of rat TFF3 caused no additional change in proliferation (bromodeoxyuridine), cell migration ([H-3]thymidine and bromodeoxyuridine), apoptosis (terminal deoxyuridine nucleotidyl nick end labeling), or E-cadherin immunostaining, In vitro studies following changes in resistance of intestinal strips in Ussing chambers (voltage-clamp technique) showed increased base-line resistance in the rat TFF3-expressing region (326 +/- 60 versus 195 +/- 48 ohm.cm(2) in controls, p < 0.05) and reduced the fall in resistance following Hel exposure by about 40% (p < 0.01). Overexpression of TFF3 stabilizes the mucosa against noxious agents, supporting its role in mucosal protection/repair. It may therefore provide a novel approach to the prevention and/or treatment of intestinal ulceration.	Univ London Imperial Coll Sci Technol & Med, Sch Med, Hammersmith Hosp, Dept Gastroenterol, London W12 0NN, England; Kings Coll London, Ctr Neurosci, London SE1 9RT, England; Imperial Canc Res Fund, London WC2A 2PX, England; Univ Melbourne, Melbourne, Vic 3011, Australia; St Lukes Roosevelt Hosp, New York, NY 10025 USA; Univ London Imperial Coll Sci Technol & Med, Sch Med, London W12 0NN, England; Univ Hosp Birmingham, Birmingham B15 2TM, W Midlands, England	Imperial College London; University of London; King's College London; Cancer Research UK; University of Melbourne; Mount Sinai St. Luke's; Mount Sinai West; Imperial College London	Playford, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Med, Hammersmith Hosp, Dept Gastroenterol, Du Cane Rd, London W12 0NN, England.	r.playford@ic.ac.uk	Wright, Nicholas/HHY-7227-2022; Jankowski, Janusz/H-2706-2012; Cox, Helen M/F-2783-2015	Jankowski, Janusz/0000-0003-2130-9181; Goodlad, Robert/0000-0002-7660-4287; Playford, Raymond/0000-0003-1235-8504; Cox, Helen/0000-0001-9024-1497; Wright, Nicholas/0000-0002-5525-3457				ALISON MR, 1995, J PATHOL, V175, P405, DOI 10.1002/path.1711750408; Babyatsky MW, 1996, GASTROENTEROLOGY, V110, P489, DOI 10.1053/gast.1996.v110.pm8566596; Calnan DP, 1999, J PATHOL, V188, P312, DOI 10.1002/(SICI)1096-9896(199907)188:3<312::AID-PATH360>3.0.CO;2-P; CHINERY R, 1995, PEPTIDES, V16, P749, DOI 10.1016/0196-9781(95)00045-L; CHINERY R, 1995, CLIN SCI, V88, P401, DOI 10.1042/cs0880401; CHINERY R, 1995, BRIT J PHARMACOL, V115, P77, DOI 10.1111/j.1476-5381.1995.tb16322.x; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; Efstathiou JA, 1998, P NATL ACAD SCI USA, V95, P3122, DOI 10.1073/pnas.95.6.3122; GOODLAD RA, 1994, CELL BIOL LAB HDB, P205; Gott P, 1996, EUR J HUM GENET, V4, P308; GREGORY H, 1985, J CELL SCI, P11; HANBY AM, 1993, GASTROENTEROLOGY, V105, P1110, DOI 10.1016/0016-5085(93)90956-D; HOOSEIN NM, 1989, FEBS LETT, V247, P303, DOI 10.1016/0014-5793(89)81357-2; JORGENSEN KD, 1982, REGUL PEPTIDES, V3, P231, DOI 10.1016/0167-0115(82)90128-8; Kanai M, 1998, P NATL ACAD SCI USA, V95, P178, DOI 10.1073/pnas.95.1.178; KIDA N, 1989, CANCER RES, V49, P3494; KINDON H, 1995, GASTROENTEROLOGY, V109, P516, DOI 10.1016/0016-5085(95)90340-2; Konturek PC, 1997, REGUL PEPTIDES, V68, P71, DOI 10.1016/S0167-0115(96)02106-4; Lefebvre O, 1996, SCIENCE, V274, P259, DOI 10.1126/science.274.5285.259; LEVI S, 1994, BRIT J RHEUMATOL, V33, P605; Liu D, 1997, LAB INVEST, V77, P557; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; McKenzie C, 1997, AM J PHYSIOL-GASTR L, V273, pG112, DOI 10.1152/ajpgi.1997.273.1.G112; Moss SF, 1996, GUT, V39, P811, DOI 10.1136/gut.39.6.811; Otto WR, 1996, EUR J BIOCHEM, V235, P64, DOI 10.1111/j.1432-1033.1996.00064.x; Perry I, 1999, LAB INVEST, V79, P1489; Playford RJ, 1997, GUT, V40, P286, DOI 10.1136/gut.40.2.286; Playford RJ, 1996, GUT, V39, P262, DOI 10.1136/gut.39.2.262; PLAYFORD RJ, 1995, GASTROENTEROLOGY, V108, P108, DOI 10.1016/0016-5085(95)90014-4; Playford RJ, 1996, P NATL ACAD SCI USA, V93, P2137, DOI 10.1073/pnas.93.5.2137; Playford RJ, 1999, GUT, V44, P653, DOI 10.1136/gut.44.5.653; PODOLSKY DK, 1993, J BIOL CHEM, V268, P6694; Poulsen SS, 1998, GUT, V43, P240, DOI 10.1136/gut.43.2.240; POULSOM R, 1992, SCAND J GASTROENTERO, V27, P17, DOI 10.3109/00365529209095975; RUTTEN MJ, 1984, MECH MUCOSAL PROTECT, P987; Sands BE, 1996, ANNU REV PHYSIOL, V58, P253, DOI 10.1146/annurev.ph.58.030196.001345; SILEN W, 1985, ANNU REV PHYSIOL, V47, P217; SWEETSER DA, 1987, J BIOL CHEM, V262, P16060; Taupin D, 2000, GASTROENTEROLOGY, V118, pA823, DOI 10.1016/S0016-5085(00)85436-0; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; TAUPIN DR, 1995, PEPTIDES, V16, P1001, DOI 10.1016/0196-9781(95)00070-Z; TOMASETTO C, 1990, EMBO J, V9, P407, DOI 10.1002/j.1460-2075.1990.tb08125.x; Tran CP, 1999, GUT, V44, P636, DOI 10.1136/gut.44.5.636; Wong WM, 1999, GUT, V44, P890, DOI 10.1136/gut.44.6.890; WRIGHT NA, 1993, GASTROENTEROLOGY, V104, P12, DOI 10.1016/0016-5085(93)90830-6	45	46	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24088	24096		10.1074/jbc.M101363200	http://dx.doi.org/10.1074/jbc.M101363200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11301329	hybrid			2022-12-27	WOS:000169531100115
J	Marcinkeviciene, J; Luo, Y; Graciani, NR; Combs, AP; Copeland, RA				Marcinkeviciene, J; Luo, Y; Graciani, NR; Combs, AP; Copeland, RA			Mechanism of inhibition of beta-site amyloid precursor protein-cleaving enzyme (BACE) by a statine-based peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 PROTEASE; SECRETASE; BINDING; BRAIN	Inhibition of beta -site amyloid precursor protein-cleaving enzyme by a statine-based inhibitor has been studied using steady state and stopped-sow methods. A slow onset rate of inhibition has been observed under steady state conditions, and a K-i of 22 nM has been derived using progress curves analysis. Simulation of stopped-flow protein fluorescence transients provided an estimate of the K-d for initial inhibitor binding of 660 nM. A two-step inhibition mechanism is proposed, wherein slower "tightening up" of the initial encounter complex occurs, Two hypotheses have been proposed in the literature to address the nature of the slow step in the inhibition of aspartic proteases by peptidomimetic inhibitors: a conformational change related to the "flap" movement and displacement of a catalytic water. We compared substrate and inhibitor binding rates under pre-steady-state conditions. Both ligands are likely to cause flap movement, whereas no catalytic mater replacement occurs during substrate binding. Our results suggest that both ligands bind to the enzyme at a rate significantly lower than the diffusion limit, but there are additional rate limitations involved in inhibitor binding, resulting in a k(on) of 3.5 x 10(4) M-1 s(-1) for the inhibitor compared with 3.5 x 10(5) M-1 s(-1) for the substrate. Even though specific intermediate formation steps might be different in the productive inhibitor and substrate binding to p-site amyloid precursor protein-cleaving enzyme, a similar final optimized conformation is achieved in both cases, as judged by the comparable free energy changes (Delta DeltaG of 2.01 versus 1.97 kcal/mol) going from the initial to the final enzyme-inhibitor or enzyme-substrate complexes.	Dupont Merck Pharmaceut Co, Dept Chem Enzymol, Wilmington, DE 19880 USA; Dupont Merck Pharmaceut Co, Combinatorial Chem Grp, Wilmington, DE 19880 USA	DuPont; DuPont	Marcinkeviciene, J (corresponding author), Dupont Merck Pharmaceut Co, Dept Chem Enzymol, Wilmington, DE 19880 USA.	jovita.marcinkeviciene@dupontpharma.com						Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; BROUWER AC, 1982, BIOCHEMISTRY-US, V21, P1302, DOI 10.1021/bi00535a030; CHO YK, 1994, BIOCHEMISTRY-US, V33, P9637, DOI 10.1021/bi00198a032; ERMOLIEFF J, 1908, BIOCHEMISTRY-US, V39, P12450; Ghosh AK, 2000, J AM CHEM SOC, V122, P3522, DOI 10.1021/ja000300g; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; JOHNSON KA, 1992, ENZYMES, V20, P2; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Mallender WD, 2001, MOL PHARMACOL, V59, P619, DOI 10.1124/mol.59.3.619; MILLER M, 1989, SCIENCE, V246, P1149, DOI 10.1126/science.2686029; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; RICH DH, 1985, J MED CHEM, V28, P263, DOI 10.1021/jm00381a001; RODRIGUEZ EJ, 1993, BIOCHEMISTRY-US, V32, P3557, DOI 10.1021/bi00065a006; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Small DH, 1999, J NEUROCHEM, V73, P443, DOI 10.1046/j.1471-4159.1999.0730443.x; SUGUNA K, 1987, P NATL ACAD SCI USA, V84, P7009, DOI 10.1073/pnas.84.20.7009; TIAN WX, 1982, BIOCHEMISTRY-US, V21, P1028, DOI 10.1021/bi00534a031; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	21	37	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23790	23794		10.1074/jbc.M101896200	http://dx.doi.org/10.1074/jbc.M101896200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11306583	hybrid			2022-12-27	WOS:000169531100077
J	Dorlet, P; Xiong, L; Sayre, RT; Un, S				Dorlet, P; Xiong, L; Sayre, RT; Un, S			High field EPR study of the pheophytin anion radical in wild type and D1-E130 mutants of photosystem II in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-ACCEPTOR; REACTION CENTERS; RESONANCE	The intermediate electron acceptor in photosystem II is a pheophytin molecule. The radical anion of this molecule was studied using high field electron paramagnetic resonance in a series of Chlamydomonas reinhardtii mutants. Glutamic acid 130 of the D1 polypeptide is thought to hydrogen bond the ring V carbonyl group of this radical. Mutations at this site, designed to weaken or remove this hydrogen bond, strongly affected the g tenser of the radical. The upward shift of the g,component followed the decreasing hydro gen bonding capacity of the amino acid introduced. This behavior is similar to that of tyrosyl and semiquinone radicals. It is also consistent with the optical spectra of the pheophytin in similar mutants. Density functional calculations were used to calculate the g tensors and rationalize the observed trend in the variation of the g, value for pheophytin and bacteriopheophytin radical. The theoretical results support the experimental observations and demonstrate the sensitivity of g values to the electrostatic protein environment for these types of radicals.	CEA Saclay, CNRS URA2096, Sect Bioenerget, Dept Biol Cellulaire & Mol, F-91191 Gif Sur Yvette, France; Ohio State Univ, Dept Plant Biol, Columbus, OH 43210 USA	CEA; UDICE-French Research Universities; Universite Paris Saclay; University System of Ohio; Ohio State University	Un, S (corresponding author), CEA Saclay, CNRS URA2096, Sect Bioenerget, Dept Biol Cellulaire & Mol, F-91191 Gif Sur Yvette, France.			Dorlet, Pierre/0000-0001-7394-3374; Sayre, Richard/0000-0002-3153-7084				Baerends EJ, 1973, CHEM PHYS, V2, P41, DOI 10.1016/0301-0104(73)80059-X; Baerends E. J., 1992, J COMPUT PHYS, V99, P84, DOI DOI 10.1016/0021-9991(92)90277-6; BURGHAUS O, 1993, J PHYS CHEM-US, V97, P7639, DOI 10.1021/j100131a037; Dorlet P, 2000, BIOCHEMISTRY-US, V39, P7826, DOI 10.1021/bi000175l; FASANELL.EL, 1969, P NATL ACAD SCI USA, V62, P299, DOI 10.1073/pnas.62.2.299; Giorgi LB, 1996, J BIOL CHEM, V271, P2093, DOI 10.1074/jbc.271.4.2093; Guerra CF, 1998, THEOR CHEM ACC, V99, P391, DOI 10.1007/s002140050021; Knupling M, 1997, CHEM PHYS, V219, P291, DOI 10.1016/S0301-0104(97)00104-3; LUBITZ W, 1989, BIOCHIM BIOPHYS ACTA, V977, P227, DOI 10.1016/S0005-2728(89)80076-3; MOENNELOCCOZ P, 1989, BIOCHEMISTRY-US, V28, P3641, DOI 10.1021/bi00435a003; NABEDRYK E, 1990, BIOCHIM BIOPHYS ACTA, V1016, P49, DOI 10.1016/0005-2728(90)90005-O; O'Malley PJ, 2000, J PHYS CHEM B, V104, P2176, DOI 10.1021/jp993907w; PIMENTEL GC, 1960, HYDROGEN BOND, P157; Schlegel HB., 2009, GAUSSIAN 09 REVISION; STONE AJ, 1963, MOL PHYS, V6, P509, DOI 10.1080/00268976300100571; STONE AJ, 1963, PROC R SOC LON SER-A, V271, P424, DOI 10.1098/rspa.1963.0027; STONE AJ, 1964, MOL PHYS, V7, P311, DOI 10.1080/00268976300101081; SVENSSON B, 1990, EMBO J, V9, P2051, DOI 10.1002/j.1460-2075.1990.tb07372.x; Un S, 1996, BIOCHEMISTRY-US, V35, P679, DOI 10.1021/bi9523769; UN S, 1995, J AM CHEM SOC, V117, P10713, DOI 10.1021/ja00148a013; Un S, 2001, J AM CHEM SOC, V123, P3048, DOI 10.1021/ja003650b; vanLenthe E, 1996, J CHEM PHYS, V105, P6505, DOI 10.1063/1.472460; VERSLUIS L, 1988, J CHEM PHYS, V88, P322, DOI 10.1063/1.454603; *VRIJ U, 1999, AMST DENS FUNCT PROG; Xiong J, 1998, PHOTOSYNTH RES, V56, P229, DOI 10.1023/A:1006061918025; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	26	30	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22313	22316		10.1074/jbc.M102475200	http://dx.doi.org/10.1074/jbc.M102475200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294881	hybrid			2022-12-27	WOS:000169412700047
J	Hoffman, MP; Engbring, JA; Nielsen, PK; Vargas, J; Steinberg, Z; Karmand, AJ; Nomizu, M; Yamada, Y; Kleinman, HK				Hoffman, MP; Engbring, JA; Nielsen, PK; Vargas, J; Steinberg, Z; Karmand, AJ; Nomizu, M; Yamada, Y; Kleinman, HK			Cell type-specific differences in glycosaminoglycans modulate the biological activity of a heparin-binding peptide (RKRLQVQLSIRT) from the G domain of the laminin alpha 1 chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATE PROTEOGLYCANS; CRYSTAL-STRUCTURE; GLOBULAR DOMAIN; IDENTIFICATION; DYSTROGLYCAN; SITE; SEQUENCES; SURFACE; MATRIX; FAMILY	AG73 (RKRLQVQLSIRT), a peptide from the G domain of the laminin alpha1 chain, has diverse biological activities with different cell types, The heparan sulfate side chains of syndecan-1 on human salivary gland cells were previously identified as the cell surface ligand for AG73. We used homologous peptides from the other laminin cu-chains (A2G73-A5G73) to determine whether the bioactivity of the AG73 sequence is conserved. Human salivary gland cells and a mouse melanoma cell line (B16F10) both bind to the peptides, but cell attachment was inhibited by glycosaminoglycans, modified heparin, and sized heparin fragments in a cell type-specific manner. In other assays, AG73, but not the homologous peptides, inhibited branching morphogenesis of salivary glands and B16F10 network formation on Matrigel. We identified residues critical for AG73 bioactivity using peptides with amino acid substitutions and truncations. Fewer residues were critical for inhibiting branching morphogenesis (XKXLXVXXXIRT) than those required to inhibit B16F10 network formation on Matrigel (N-terminal XxRLQVQLSIRT). In addition, surface plasmon resonance analysis identified the C-terminal IRT of the sequence to be important for heparin binding. Structure based sequence alignment predicts AG73 in a P-sheet with the N-terminaI K (Lys(2)) and the C-terminal R (Arg(10)) on the surface of the G domain. In conclusion, we have determined that differences in cell surface glycosaminoglycans and differences in the amino acids in AG73 recognized by cells modulate the biological activity of the peptide and provide a mechanism to explain its cell-specific activities.	NIDCR, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA; Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Hokkaido University	Hoffman, MP (corresponding author), NIDCR, Craniofacial Dev Biol & Regenerat Branch, NIH, 30-430,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	mhoffman@mail.nih.gov						Andac Z, 1999, J MOL BIOL, V287, P253, DOI 10.1006/jmbi.1999.2606; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Caldwell EEO, 1999, ARCH BIOCHEM BIOPHYS, V361, P215, DOI 10.1006/abbi.1998.0996; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; DESAI UR, 1993, ANAL BIOCHEM, V213, P120, DOI 10.1006/abio.1993.1394; Fidler I J, 1978, Adv Cancer Res, V28, P149, DOI 10.1016/S0065-230X(08)60648-X; GALLAGHER JT, 1992, INT J BIOCHEM, V24, P553, DOI 10.1016/0020-711X(92)90326-V; Goldfinger LE, 2000, J BIOL CHEM, V275, P34887, DOI 10.1074/jbc.M006652200; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; HUMPHRIES MJ, 1986, SCIENCE, V233, P467, DOI 10.1126/science.3726541; Kadoya Y, 1999, HISTOCHEM CELL BIOL, V112, P417, DOI 10.1007/s004180050423; Kadoya Y, 1998, DEV DYNAM, V212, P394; Kariya Y, 2000, J BIOL CHEM, V275, P25949, DOI 10.1074/jbc.M004140200; KATO M, 1994, J BIOL CHEM, V269, P18881; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Kim WH, 1998, INT J CANCER, V77, P632, DOI 10.1002/(SICI)1097-0215(19980812)77:4<632::AID-IJC25>3.0.CO;2-6; KRAMER RH, 1986, CANCER RES, V46, P1980; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; Lundin L, 2000, J BIOL CHEM, V275, P24653, DOI 10.1074/jbc.M908930199; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; MOULD AP, 1991, J BIOL CHEM, V266, P3579; Nielsen PK, 2000, J BIOL CHEM, V275, P14517, DOI 10.1074/jbc.275.19.14517; Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198; Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491; NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Richard BL, 1996, EXP CELL RES, V228, P98, DOI 10.1006/excr.1996.0304; Safaiyan F, 2000, BIOCHEMISTRY-US, V39, P10823, DOI 10.1021/bi000411s; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7; Talts JF, 2000, J BIOL CHEM, V275, P35192, DOI 10.1074/jbc.M003261200; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; TURNBULL JE, 1988, BIOCHEM J, V251, P597, DOI 10.1042/bj2510597; WALKER A, 1994, J BIOL CHEM, V269, P931; Weeks BS, 1998, EXP CELL RES, V243, P375, DOI 10.1006/excr.1998.4157; Woods A, 2000, J BIOL CHEM, V275, P24233, DOI 10.1074/jbc.R000001200; Yamaguchi H, 2000, J BIOL CHEM, V275, P29458, DOI 10.1074/jbc.M003103200; Yoshida I, 1999, J CELL PHYSIOL, V179, P18, DOI 10.1002/(SICI)1097-4652(199904)179:1<18::AID-JCP3>3.0.CO;2-K; YURCHENCO PD, 1990, J BIOL CHEM, V265, P3981	48	99	99	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22077	22085		10.1074/jbc.M100774200	http://dx.doi.org/10.1074/jbc.M100774200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11304538	hybrid			2022-12-27	WOS:000169412700014
J	Loewen, CJR; Moritz, OL; Molday, RS				Loewen, CJR; Moritz, OL; Molday, RS			Molecular characterization of peripherin-2 and Rom-1 mutants responsible for digenic retinitis pigmentosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEGENERATION SLOW RDS; RETINAL DEGENERATION; PHOTORECEPTOR PERIPHERIN/RDS; MEMBRANE-PROTEIN; DISK MEMBRANE; ROD PHOTORECEPTORS; COILED-COIL; GENE; MUTATIONS; LOCALIZATION	Peripherin-2 and Rom-l are homologous tetraspanning membrane proteins that assemble into noncovalent tetramers and higher order disulfide-linked oligomers implicated in photoreceptor disc morphogenesis. Individuals who coinherit a L185P peripherin-2 mutation and a null or G113E rom I mutation are afflicted with retinitis pigmentosa, whereas individuals who inherit only one defective gene are normal. We examined the expression, subunit assembly, and disulfide-mediated oligomerization of L185P and L185A peripherin-2 and L188P Rom-l by velocity sedimentation, co-immunoprecipitation, and cross-linking. These mutants formed noncovalent dimers under disulfide-reducing conditions but failed to assemble into core tetramers. Under nonreducing conditions, L185P dimers formed disulfide linked tetramers but not higher order oligomers. L185P coassembled with wild-type peripherin-2 and Rom-l to form tetramers and higher order disulfide-linked oligomers characteristic of the wild-type proteins. The G113E Rom-l mutant expressed 20-fold lower than wildtype Rom-l, indicating that it behaves mechanistically as a null allele. We conclude that Leu(185) of peripherin-2 (Leu(188) of Rom-l) is critical for tetramer but not dimer formation and that the core tetramer has a-fold symmetry. Peripherin-2-containing tetramers are required for higher order disulfide-linked oligomer formation, The level of these oligomers is critical for stable photoreceptor disc formation and the digenic retinitis pigmentosa disease phenotype.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Ophthalmol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Molday, RS (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2146 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	molday@interchange.ubc.ca		Moritz, Orson L/0000-0002-6183-6499	NATIONAL EYE INSTITUTE [R01EY002422] Funding Source: NIH RePORTER; NEI NIH HHS [EY 2422] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; Boesze-Battaglia K, 1998, BIOCHEMISTRY-US, V37, P9477, DOI 10.1021/bi980173p; CASCIO M, 1995, J BIOL CHEM, V270, P18643, DOI 10.1074/jbc.270.31.18643; Clarke G, 2000, NAT GENET, V25, P67, DOI 10.1038/75621; CLARKE S, 1989, METHOD ENZYMOL, V172, P696; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; CONNELL GJ, 1990, BIOCHEMISTRY-US, V29, P4691, DOI 10.1021/bi00471a025; Dryja TP, 1997, INVEST OPHTH VIS SCI, V38, P1972; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; FASMAN GD, 1975, HDB BIOCH MOL BIOL, pL10; Goldberg AFX, 1998, BIOCHEMISTRY-US, V37, P680, DOI 10.1021/bi972036i; Goldberg AFX, 1996, BIOCHEMISTRY-US, V35, P6144, DOI 10.1021/bi960259n; GOLDBERG AFX, 1995, BIOCHEMISTRY-US, V34, P14213, DOI 10.1021/bi00043a028; Goldberg AFX, 1996, P NATL ACAD SCI USA, V93, P13726, DOI 10.1073/pnas.93.24.13726; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; Kammerer RA, 1997, MATRIX BIOL, V15, P555, DOI 10.1016/S0945-053X(97)90031-7; Kedzierski W, 1999, J BIOL CHEM, V274, P29181, DOI 10.1074/jbc.274.41.29181; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; LI Y, 1995, J BIOL CHEM, V270, P1935, DOI 10.1074/jbc.270.4.1935; Loewen CJR, 2000, J BIOL CHEM, V275, P5370, DOI 10.1074/jbc.275.8.5370; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Moritz OL, 1996, INVEST OPHTH VIS SCI, V37, P352; NELSON RM, 1989, ANAL BIOCHEM, V180, P147, DOI 10.1016/0003-2697(89)90103-6; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; SAGA M, 1993, HUM GENET, V92, P519, DOI 10.1007/BF00216463; SANYAL S, 1981, NEUROSCI LETT, V21, P23, DOI 10.1016/0304-3940(81)90051-3; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G; WELEBER RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1531, DOI 10.1001/archopht.1993.01090110097033; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213; *WORTH BIOCH CORP, 1996, WORTH ENZ MAN, P36; WRIGHT MD, 1994, IMMUNOL TODAY, V15, P588, DOI 10.1016/0167-5699(94)90222-4; Wrigley JDJ, 2000, J BIOL CHEM, V275, P13191, DOI 10.1074/jbc.C900853199	39	55	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22388	22396		10.1074/jbc.M011710200	http://dx.doi.org/10.1074/jbc.M011710200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11297544	hybrid			2022-12-27	WOS:000169412700057
J	Lopez, GN; Turck, CW; Schaufele, F; Stallcup, MR; Kushner, PJ				Lopez, GN; Turck, CW; Schaufele, F; Stallcup, MR; Kushner, PJ			Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-INDEPENDENT ACTIVATION; THYROID-HORMONE RECEPTOR; ESTROGEN-RECEPTOR; HISTONE ACETYLTRANSFERASE; NUCLEAR RECEPTORS; CROSS-TALK; BINDING; CBP; PHOSPHORYLATION; TRANSCRIPTION	Promoter-bound steroid receptors activate gene expression by recruiting members of the p160 family of coactivators. Many steroid receptors, most notably the progesterone and estrogen receptors, are regulated both by cognate hormone and independently by growth factors, Here we show that epidermal growth factor regulates the activities of the p160 GRIP1 through the extracellular signal-regulated kinase (ERK) family of mitogen-activated protein kinases. ERKs phosphorylate GRIP1 at a specific site, Ser-736, the integrity of which is required for full growth factor induction of GRIP1 transcriptional activation and coactivator function. We propose that growth factors signal to nuclear receptors in part by targeting the p160 coactivators.	Univ Calif San Francisco, Metab Res Unit, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Southern California	Kushner, PJ (corresponding author), Univ Calif San Francisco, Metab Res Unit, San Francisco, CA 94143 USA.				NATIONAL CANCER INSTITUTE [R01CA080210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051083] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 80210] Funding Source: Medline; NIDDK NIH HHS [R01 DK51083] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bai WL, 1997, J BIOL CHEM, V272, P10457; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hong H, 1999, J BIOL CHEM, V274, P3496, DOI 10.1074/jbc.274.6.3496; IGNARTROWBRIDGE DM, 1995, ENVIRON HEALTH PERSP, V103, P35, DOI 10.2307/3432505; IgnarTrowbridge DM, 1996, ENDOCRINOLOGY, V137, P1735, DOI 10.1210/en.137.5.1735; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kato S, 1998, ONCOLOGY-BASEL, V55, P5, DOI 10.1159/000055253; Lange CA, 1998, J BIOL CHEM, V273, P31308, DOI 10.1074/jbc.273.47.31308; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Liu YZ, 1998, J BIOL CHEM, V273, P32400, DOI 10.1074/jbc.273.49.32400; LOPEZ G, 1993, MOL CELL BIOL, V13, P3042, DOI 10.1128/MCB.13.5.3042; Ma H, 1999, MOL CELL BIOL, V19, P6164; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Saatcioglu F, 1997, MOL CELL BIOL, V17, P4687, DOI 10.1128/MCB.17.8.4687; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shibata H, 1997, RECENT PROG HORM RES, V52, P141; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Swope DL, 1996, J BIOL CHEM, V271, P28138, DOI 10.1074/jbc.271.45.28138; TORA L, 1989, EMBO J, V8, P1981, DOI 10.1002/j.1460-2075.1989.tb03604.x; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; WEBB P, 1992, MOL ENDOCRINOL, V6, P157, DOI 10.1210/me.6.2.157; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443; Weigel NL, 1998, J MOL MED, V76, P469, DOI 10.1007/s001090050241; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5	42	118	122	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22177	22182		10.1074/jbc.M010718200	http://dx.doi.org/10.1074/jbc.M010718200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301320	hybrid			2022-12-27	WOS:000169412700029
J	Morinaga, N; Kaihou, Y; Vitale, N; Moss, J; Noda, M				Morinaga, N; Kaihou, Y; Vitale, N; Moss, J; Noda, M			Involvement of ADP-ribosylation factor 1 in cholera toxin induced morphological changes of Chinese hamster ovary cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING-PROTEIN; ENDOPLASMIC-RETICULUM; BREFELDIN-A; INTRACELLULAR TRAFFICKING; PHOSPHOLIPASE-D; GOLGI; MEMBRANE; SUBUNIT; TRANSPORT; KDEL	ADP-ribosylation factor 1 (ARF1) was originally found as a cofactor in CT-catalyzed ADP-ribosylation of Ga, but is now known to participate in vesicle trafficking. We asked whether ARF1 function in vesicular trafficking is necessary for CT induced morphological changes in Chinese hamster ovary (CHO) cells, which result from increased intracellular cAMCP. Brefeldin A treatment of cells suppressed CT action, confirming a requirement for Golgi integrity. Overexpression of a GFP-ARF1 fusion protein did not affect the morphological changes induced by CT, but changes were reduced in cells over expressing guanine nucleotide exchange-defective ARF1(T31N) or GTP hydrolysis-deficient ARF1(Q71L) mutants. In cells expressing these mutants, 8-bromo-cAMP induced changes similar to those seen in cells transfected with ARF1 or vector. Inhibition of CT action was specific for mutants of ARF1 and not reproduced by analogous mutants of ARF5 or ARF6. ARF1(Q71L) was mostly colocalized with beta COP, but ARF5(Q71L) less so. ARF6(Q67L) did not colocalize with beta COP and was partially associated with the plasma membrane. These data are consistent with the conclusion that ARF1 influenced CT action in cells by its specific function in the vesicular transport pathway used by CT to travel from plasma membrane to Golgi to ER.	Chiba Univ, Sch Med, Dept Microbiol 2, Chuo Ku, Chiba 2608670, Japan; INSERM U338, Ctr Neurochim, F-67084 Strasbourg, France; NHLBI, Pulm Crit Care Med Branch, NIH, Bethesda, MD 20892 USA	Chiba University; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Morinaga, N (corresponding author), Chiba Univ, Sch Med, Dept Microbiol 2, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.		Vitale, Nicolas/G-5967-2014	Vitale, Nicolas/0000-0002-4752-4907	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL000659, ZIAHL000659] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACT T, 1998, EMBO J, V16, P7305; Altschuler Y, 1999, J CELL BIOL, V147, P7, DOI 10.1083/jcb.147.1.7; BALCH WE, 1992, J BIOL CHEM, V267, P13053; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; DASHER C, 1994, J BIOL CHEM, V269, P1437; FENSOME A, 1994, FEBS LETT, V349, P34, DOI 10.1016/0014-5793(94)00634-2; GILL DM, 1975, J BIOL CHEM, V250, P6424; KAHN RA, 1984, J BIOL CHEM, V259, P6228; KAHN RA, 1991, J BIOL CHEM, V266, P2606; KAHN RA, 1986, J BIOL CHEM, V261, P7906; KASSIS S, 1982, J BIOL CHEM, V257, P12141; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; LENCER WI, 1995, J CELL BIOL, V131, P951, DOI 10.1083/jcb.131.4.951; Lencer WI, 1999, BBA-MOL CELL RES, V1450, P177, DOI 10.1016/S0167-4889(99)00070-1; Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601; Majoul I, 1997, FEBS LETT, V401, P104, DOI 10.1016/S0014-5793(96)01447-0; Majoul IV, 1996, J CELL BIOL, V133, P777, DOI 10.1083/jcb.133.4.777; MAKLER V, 1995, J BIOL CHEM, V270, P5232, DOI 10.1074/jbc.270.10.5232; MASSENBURG D, 1994, P NATL ACAD SCI USA, V91, P11718, DOI 10.1073/pnas.91.24.11718; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; MOSS J, 1977, J BIOL CHEM, V252, P2455; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; NANBIAR MP, 1993, J CELL PHYSL, V154, P222; ORLANDI PA, 1993, J BIOL CHEM, V268, P12010; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Robineau S, 2000, P NATL ACAD SCI USA, V97, P9913, DOI 10.1073/pnas.170290597; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Shin OH, 1999, J BIOL CHEM, V274, P36609, DOI 10.1074/jbc.274.51.36609; WEIDMAN PJ, 1994, J CELL BIOL, V127, P1815, DOI 10.1083/jcb.127.6.1815; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289	33	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22838	22843		10.1074/jbc.M101184200	http://dx.doi.org/10.1074/jbc.M101184200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11279243	hybrid			2022-12-27	WOS:000169412700114
J	O'Regan, P; Wilson, C; Townsend, S; Thacker, J				O'Regan, P; Wilson, C; Townsend, S; Thacker, J			XRCC2 is a nuclear RAD51-like protein required for damage-dependent RAD51 focus formation without the need for ATP binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-REPAIR GENE; HOMOLOGOUS RECOMBINATION; CELL-CYCLE; ESCHERICHIA-COLI; RECA PROTEIN; IN-VIVO; P-LOOP; BRCA1; EXPRESSION	The human XRCC2 gene was recently identified by its ability to complement a hamster cell line, irs1, which is sensitive to DNA-damaging agents and shows genetic instability. The XRCC2 protein is highly conserved in mammalian species and has structural features, including a putative ATP-binding domain (P-loop), consistent with membership of the RecA/RAD51 family of recombination-repair proteins. We show that a hybrid XRCC2-green fluorescent protein, which was found to be functional by complementation, localizes to the nucleus. We have established a functional link between XRCC-2 and RAD51 by looking at damage dependent RAD51 focus formation in the irs1 cell line. Little or no formation of RAD51 foci occurred in irs1. This effect was specific to the loss of XRCC2 because transfection of the gene into irs1 restored normal levels of focus formation. Surprisingly, XRCC2 genes carrying site-specific mutations in P-loop residues were found to be able to complement the XRCC2-deficient irs1 line for a number of different end points, We conclude that XRCC2 is important in the early stages of homologous recombination in mammalian cells to facilitate RAD51-dependent recombination repair but that it does not make use of ATP binding to promote this function.	MRC, Radiat & Genome Stabil Unit, Harwell OX11 0RD, Oxon, England		Thacker, J (corresponding author), MRC, Radiat & Genome Stabil Unit, Harwell OX11 0RD, Oxon, England.							Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Bishop DK, 1998, J BIOL CHEM, V273, P21482, DOI 10.1074/jbc.273.34.21482; Braybrooke JP, 2000, J BIOL CHEM, V275, P29100, DOI 10.1074/jbc.M002075200; Cartwright R, 1998, NUCLEIC ACIDS RES, V26, P3084, DOI 10.1093/nar/26.13.3084; Chen FQ, 1997, MUTAT RES-DNA REPAIR, V384, P205, DOI 10.1016/S0921-8777(97)00020-7; Cox MM, 2000, PROG NUCLEIC ACID RE, V63, P311, DOI 10.1016/S0079-6603(08)60726-6; Deans B, 2000, EMBO J, V19, P6675, DOI 10.1093/emboj/19.24.6675; Flygare J, 1996, BBA-MOL CELL RES, V1312, P231, DOI 10.1016/0167-4889(96)00040-7; GAME JC, 1993, SEMIN CANCER BIOL, V4, P73; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Griffin CS, 2000, NAT CELL BIOL, V2, P757, DOI 10.1038/35036399; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Haijema BJ, 1996, MOL MICROBIOL, V21, P989, DOI 10.1046/j.1365-2958.1996.601424.x; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; JOHNSON RD, 1995, MOL CELL BIOL, V15, P4843; JONES NJ, 1987, MUTAT RES, V183, P279, DOI 10.1016/0167-8817(87)90011-3; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Li MJ, 1997, EXP CELL RES, V237, P93, DOI 10.1006/excr.1997.3761; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; LOGAN KM, 1993, J MOL BIOL, V232, P1048, DOI 10.1006/jmbi.1993.1459; Morrison C, 1999, MOL CELL BIOL, V19, P6891; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pittman DL, 2000, GENESIS, V26, P167, DOI 10.1002/(SICI)1526-968X(200003)26:3<167::AID-GENE1>3.0.CO;2-M; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schild D, 2000, J BIOL CHEM, V275, P16443, DOI 10.1074/jbc.M001473200; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shu ZG, 1999, MOL CELL BIOL, V19, P8686; Snouwaert JN, 1999, ONCOGENE, V18, P7900, DOI 10.1038/sj.onc.1203334; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Takata M, 2000, MOL CELL BIOL, V20, P6476, DOI 10.1128/MCB.20.17.6476-6482.2000; Tambini CE, 1997, GENOMICS, V41, P84, DOI 10.1006/geno.1997.4636; Tashiro S, 2000, J CELL BIOL, V150, P283, DOI 10.1083/jcb.150.2.283; Tashiro S, 1996, ONCOGENE, V12, P2165; Thacker J, 1999, TRENDS GENET, V15, P166, DOI 10.1016/S0168-9525(99)01733-3; THACKER J, 1994, MUTAGENESIS, V9, P163, DOI 10.1093/mutage/9.2.163; TUCKER JD, 1991, MUTAT RES, V254, P143, DOI 10.1016/0921-8777(91)90005-A; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yamamoto A, 1996, MOL GEN GENET, V251, P1; Yuan SSF, 1999, CANCER RES, V59, P3547	52	80	80	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22148	22153		10.1074/jbc.M102396200	http://dx.doi.org/10.1074/jbc.M102396200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301337	hybrid			2022-12-27	WOS:000169412700025
J	Mohapatra, S; Agrawal, D; Pledger, WJ				Mohapatra, S; Agrawal, D; Pledger, WJ			P27(Kip1) regulates T cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; HUMAN LYMPHOCYTES-T; GROWTH-FACTOR; INHIBITOR P27(KIP1); MICE LACKING; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; RESTRICTION POINT; GENE-EXPRESSION; CDK INHIBITORS	Our studies addressed the mechanism by which serum acts in conjunction with T cell receptor (TCR) agonists to promote the proliferation of primary splenic T cells. When added to resting splenocytes, TCR agonists initiated G(0)/G(1) traverse and activated cyclin D3-cdk6 complexes in a serum-independent manner. On the other hand, both TCR agonists and 10% serum were required for the activation of cyclin E-cdk2 and cyclin A-cdk2 complexes and the entry of cells into S phase. Serum facilitated cdk2 activation by maximizing the extent and extending the duration of the TCR-initiated down-regulation of the cdk2 inhibitor, p27(Kip1). Although p27(Kip1) levels were reduced (albeit submaximally) in cells stimulated in serum-deficient medium, nearly all of the cdk2 complexes in these cells contained p27(Kip1). I, contrast, in cells receiving TCR agonist and 10% serum, little if any p27(Kip1) was present in cyclin-cdk2 complexes. Unlike wild-type splenocytes, p27(Kip1)-null splenocytes did not require serum for cdk2 activation or S phase entry whereas loss of the related cdk2 inhibitor, p21(Cip1), did not override the serum dependence of these responses. We also found that cdk2 activation was both necessary and sufficient for maximal expression of cdk2 protein. These studies provide a mechanistic basis for the serum dependence of T cell mitogenesis.	Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Oncol, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Biochem & Mol Biol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Pledger, WJ (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, 12902 Magnolia Dr, Tampa, FL 33612 USA.		Mohapatra, Subhra/A-1381-2012		NATIONAL CANCER INSTITUTE [R01CA072694, R01CA067360] Funding Source: NIH RePORTER; NCI NIH HHS [CA67360, CA72694] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agrawal D, 1996, MOL CELL BIOL, V16, P4327; AJCHENBAUM F, 1993, J BIOL CHEM, V268, P4113; Appleman LJ, 2000, J IMMUNOL, V164, P144, DOI 10.4049/jimmunol.164.1.144; Balomenos D, 2000, NAT MED, V6, P171, DOI 10.1038/72272; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Coats S, 1999, CURR BIOL, V9, P163, DOI 10.1016/S0960-9822(99)80086-4; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; FIRPO EJ, 1994, MOL CELL BIOL, V14, P4889, DOI 10.1128/MCB.14.7.4889; Hengst L, 1998, CURR TOP MICROBIOL, V227, P25; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; HERZBERG VL, 1987, J IMMUNOL, V139, P998; Karnitz LM, 1996, ADV IMMUNOL, V61, P147, DOI 10.1016/S0065-2776(08)60867-6; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kwon TK, 1997, J IMMUNOL, V158, P5642; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; LEONARD WJ, 1985, P NATL ACAD SCI USA, V82, P6281, DOI 10.1073/pnas.82.18.6281; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; MEUER SC, 1984, P NATL ACAD SCI-BIOL, V81, P1509, DOI 10.1073/pnas.81.5.1509; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; MODIANO JF, 1994, J BIOL CHEM, V269, P32972; Modiano JF, 1995, ANN NY ACAD SCI, V766, P134, DOI 10.1111/j.1749-6632.1995.tb26657.x; Mohapatra S, 2001, J BIOL CHEM, V276, P21984, DOI 10.1074/jbc.M100037200; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; PlanasSilva MD, 1997, CURR OPIN CELL BIOL, V9, P768, DOI 10.1016/S0955-0674(97)80076-2; Rivard N, 1996, J BIOL CHEM, V271, P18337, DOI 10.1074/jbc.271.31.18337; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; SCHULZE A, 1995, P NATL ACAD SCI USA, V92, P11264, DOI 10.1073/pnas.92.24.11264; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WILLIAMS ME, 1990, J IMMUNOL, V144, P1208; Winston J, 1996, J BIOL CHEM, V271, P11253, DOI 10.1074/jbc.271.19.11253; WINSTON JT, 1993, MOL BIOL CELL, V4, P1133, DOI 10.1091/mbc.4.11.1133; Zhang XH, 2000, MOL BIOL CELL, V11, P2117, DOI 10.1091/mbc.11.6.2117	46	45	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21976	21983		10.1074/jbc.M009788200	http://dx.doi.org/10.1074/jbc.M009788200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11297537	hybrid			2022-12-27	WOS:000169297900153
J	Kupke, T; Hernandez-Acosta, P; Steinbacher, S; Culianez-Macia, FA				Kupke, T; Hernandez-Acosta, P; Steinbacher, S; Culianez-Macia, FA			Arabidopsis thaliana flavoprotein AtHAL3a catalyzes the decarboxylation of 4 '-phosphopantothenoylcysteine to 4 '-phosphopantetheine, a key step in coenzyme A biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE DECARBOXYLATION; SALT TOLERANCE; PRECURSOR PEPTIDE; A BIOSYNTHESIS; PURIFICATION; SUBSTRATE; EPIDERMIN; TRANSPORT; PROTEINS; SUBUNIT	Arabidopsis thaliana flavoprotein AtHAL3a is related to plant growth and salt and osmotic tolerance. AtHAL3a shows sequence homology to the bacterial flavoproteins EpiD and Dfp. EpiD, Dfp, and AtHAL3a are members of the homo-oligomeric flavin-containing Cys decarboxylase (HFCD) protein family. We demonstrate that AtHAL3a catalyzes the decarboxylation of (R)-4 ' -phospho-N-pantothenoylcysteine to 4 ' -phosphopantetheine. This key step in coenzyme A biosynthesis is catalyzed in bacteria by the Dfp proteins. Exchange of His-90 of AtHAL3a for Asn led to complete inactivation of the enzyme. Dfp and AtHAL3a are characterized by a shortened substrate binding clamp compared with EpiD. Exchange of the cysteine residue of the conserved ACGD motif of this binding clamp resulted in loss of (R)-4 ' -phospho-N-pantothenoylcysteine decarboxylase activity. Based on the crystal structures of EpiD H67N with bound substrate peptide and of AtHAL3a, we present a model for the binding of (R)-4 ' -phospho-N-pantothenoylcysteine to AtHAL3a.	Univ Tubingen, Lehrstuhl Mikrobielle Genet, D-72076 Tubingen, Germany; Univ Politecn Valencia, Inst Mol & Celular Plantas, CSIC, Valencia 46022, Spain; Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Planegg Martinsried, Germany	Eberhard Karls University of Tubingen; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; Max Planck Society	Kupke, T (corresponding author), Univ Tubingen, Lehrstuhl Mikrobielle Genet, Morgenstelle 15, D-72076 Tubingen, Germany.	Thomas.Kupke@t-online.de	Zhang, Ning/F-1387-2014	Kupke, Thomas/0000-0003-2341-1710				Abiko Y., 1975, Metabolism of sulphur compounds., P1; Albert A, 2000, STRUCTURE, V8, P961, DOI 10.1016/S0969-2126(00)00187-8; Blaesse M, 2000, EMBO J, V19, P6299, DOI 10.1093/emboj/19.23.6299; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; Clotet J, 1999, MOL CELL BIOL, V19, P2408; de Nadal E, 1998, P NATL ACAD SCI USA, V95, P7357, DOI 10.1073/pnas.95.13.7357; DICOMO CJ, 1995, GENETICS, V139, P95; DUPRE S, 1975, ITAL J BIOCHEM, V24, P369; Espinosa-Ruiz A, 1999, PLANT J, V20, P529, DOI 10.1046/j.1365-313X.1999.00626.x; FALK KL, 1993, ARCH BIOCHEM BIOPHYS, V301, P424, DOI 10.1006/abbi.1993.1166; FERRANDO A, 1995, MOL CELL BIOL, V15, P5470; GRAHAM JE, 1992, J BACTERIOL, V174, P2711, DOI 10.1128/jb.174.8.2711-2716.1992; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; JACKOWSKI S, 1996, ESCHERICHIA COLI SAL, V1, P687; Kempter C, 1996, ANGEW CHEM INT EDIT, V35, P2104, DOI 10.1002/anie.199621041; Kupke T, 1997, J BIOL CHEM, V272, P4759, DOI 10.1074/jbc.272.8.4759; Kupke T, 2000, J BIOL CHEM, V275, P31838, DOI 10.1074/jbc.M004273200; KUPKE T, 1992, J BACTERIOL, V174, P5354, DOI 10.1128/JB.174.16.5354-5361.1992; KUPKE T, 1994, J BIOL CHEM, V269, P5653; Kupke T, 1997, FEMS MICROBIOL LETT, V153, P25, DOI 10.1016/S0378-1097(97)00216-4; KUPKE T, 1995, J BIOL CHEM, V270, P11282, DOI 10.1074/jbc.270.19.11282; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; SPITZER ED, 1988, J BACTERIOL, V170, P872, DOI 10.1128/jb.170.2.872-876.1988; SPITZER ED, 1985, J BACTERIOL, V164, P994, DOI 10.1128/JB.164.3.994-1003.1985; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURK D, 1992, THESIS TU MUNCHEN; YANG HC, 1987, BIOCHEMISTRY-US, V26, P4076, DOI 10.1021/bi00387a050; Zhu JK, 2000, PLANT PHYSIOL, V124, P941, DOI 10.1104/pp.124.3.941	29	43	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19190	19196		10.1074/jbc.M100776200	http://dx.doi.org/10.1074/jbc.M100776200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279129	hybrid			2022-12-27	WOS:000169091000075
J	Numata, M; Orlowski, J				Numata, M; Orlowski, J			Molecular cloning and characterization of a novel (Na+,K+)/H+ exchanger localized to the trans-Golgi network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; NA+/H+ EXCHANGER; HEART-MITOCHONDRIA; BREFELDIN-A; RETROGRADE TRANSPORT; CYTOPLASMIC DOMAIN; PLASMA-MEMBRANE; K+/H+ ANTIPORT; LIVING CELLS; PH	The luminal pH of organelles along the secretory and endocytic pathways of mammalian cells is acidic and tightly regulated, with the [H+] varying up to 100-fold between compartments. Steady-state organellar pH is thought to reflect a balance between the rates of H+ pumping by the vacuolar-type H+-ATPase and H+ efflux through ill-defined pathways. Here, we describe the cloning of a novel gene (NHE7) in humans that is homologous to Na+/H+ exchangers, is ubiquitously expressed, and localizes predominantly to the trans-Golgi network. Significantly, NHE7 mediates the influx of Na+ or K+ in exchange for H+. The activity of NHE7 was also found to be relatively insensitive to inhibition by amiloride but could be antagonized by the analogue benzamil and the unrelated compound quinine. Thus, NHE7 displays unique functional and pharmacological properties and may play an important role in maintaining cation homeostasis of this important organelle.	McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	McGill University	Orlowski, J (corresponding author), McGill Univ, Dept Physiol, McIntyre Med Sci Bldg,3655 Promenade Sir William, Montreal, PQ H3G 1Y6, Canada.			Orlowski, John/0000-0001-7371-175X				ANDERSON RGW, 1985, CELL, V40, P635, DOI 10.1016/0092-8674(85)90212-0; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833; Biemesderfer D, 1998, J BIOL CHEM, V273, P12391, DOI 10.1074/jbc.273.20.12391; BIEMESDERFER D, 1993, AM J PHYSIOL, V265, pF736, DOI 10.1152/ajprenal.1993.265.5.F736; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; BRIERLEY GP, 1984, J BIOL CHEM, V259, P4672; BRIERLEY GP, 1994, J BIOENERG BIOMEMBR, V26, P519, DOI 10.1007/BF00762736; BRIERLEY GP, 1989, BIOCHEMISTRY-US, V28, P4337; COUNILLON L, 1993, BIOCHIM BIOPHYS ACTA, V1172, P343, DOI 10.1016/0167-4781(93)90228-6; COUNILLON L, 1994, BIOCHEMISTRY-US, V33, P10463, DOI 10.1021/bi00200a030; D'Souza S, 1998, J BIOL CHEM, V273, P2035, DOI 10.1074/jbc.273.4.2035; Demaurex N, 1998, J BIOL CHEM, V273, P2044, DOI 10.1074/jbc.273.4.2044; DIRESTA DJ, 1986, AM J PHYSIOL, V251, pR787, DOI 10.1152/ajpregu.1986.251.4.R787; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Farinas J, 1999, J BIOL CHEM, V274, P7603, DOI 10.1074/jbc.274.12.7603; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Garlid KD, 1995, METHOD ENZYMOL, V260, P331, DOI 10.1016/0076-6879(95)60149-X; GARLID KD, 1991, J BIOL CHEM, V266, P6518; GARLID KD, 1978, BIOCHEM BIOPH RES CO, V83, P1450, DOI 10.1016/0006-291X(78)91383-9; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; GLUCK S, 1992, J EXP BIOL, V172, P29; HUMPHREY JS, 1993, J CELL BIOL, V120, P1123, DOI 10.1083/jcb.120.5.1123; JUNG DW, 1992, AM J PHYSIOL, V262, pC1047, DOI 10.1152/ajpcell.1992.262.4.C1047; KAPUS A, 1988, BIOCHIM BIOPHYS ACTA, V944, P383, DOI 10.1016/0005-2736(88)90509-3; Kim JH, 1996, J CELL BIOL, V134, P1387, DOI 10.1083/jcb.134.6.1387; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; MARTIN WH, 1984, J BIOL CHEM, V259, P2062; MELLMAN I, 1992, J EXP BIOL, V172, P39; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; MITCHELL P, 1969, EUR J BIOCHEM, V9, P149, DOI 10.1111/j.1432-1033.1969.tb00588.x; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; Nass R, 1998, J BIOL CHEM, V273, P21054, DOI 10.1074/jbc.273.33.21054; Nath S., 1988, INTEGRATION MITOCHON, P357; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; Numata M, 1998, J BIOL CHEM, V273, P6951, DOI 10.1074/jbc.273.12.6951; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; PUOPOLO K, 1992, J BIOL CHEM, V267, P3696; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; Rybak SL, 1997, BIOPHYS J, V73, P674, DOI 10.1016/S0006-3495(97)78102-5; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; SASTRASINH M, 1995, AM J PHYSIOL-CELL PH, V268, pC1227, DOI 10.1152/ajpcell.1995.268.5.C1227; SCHAFER W, 1995, EMBO J, V14, P2424, DOI 10.1002/j.1460-2075.1995.tb07240.x; Schapiro FB, 2000, J BIOL CHEM, V275, P21025, DOI 10.1074/jbc.M002386200; Shrode LD, 1998, AM J PHYSIOL-CELL PH, V275, pC431, DOI 10.1152/ajpcell.1998.275.2.C431; TSE CM, 1994, BIOCHEMISTRY-US, V33, P12954, DOI 10.1021/bi00248a003; VANWEERT AWM, 1995, J CELL BIOL, V130, P821, DOI 10.1083/jcb.130.4.821; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; WONG SH, 1993, J BIOL CHEM, V268, P22853; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; Yang W, 1998, MOL BIOL CELL, V9, P191, DOI 10.1091/mbc.9.1.191; YUN CHC, 1995, AM J PHYSIOL-GASTR L, V269, pG1, DOI 10.1152/ajpgi.1995.269.1.G1	63	198	205	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17387	17394		10.1074/jbc.M101319200	http://dx.doi.org/10.1074/jbc.M101319200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279194	hybrid			2022-12-27	WOS:000168730400106
J	Jeong, HS; Jeong, KC; Choi, HK; Park, KJ; Lee, KH; Rhee, JH; Choi, SH				Jeong, HS; Jeong, KC; Choi, HK; Park, KJ; Lee, KH; Rhee, JH; Choi, SH			Differential expression of Vibrio vulnificus elastase gene in a growth phase-dependent manner by two different types of promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STATIONARY-PHASE; CYCLIC-AMP; VIRULENCE DETERMINANTS; ELASTOLYTIC PROTEASE; SUICIDE VECTOR; SIGMA-FACTOR; RPOS GENE; CONSTRUCTION; CHOLERAE	Elastase activity of Vibrio vulnificus was highly dependent on growth phase, reached a maximum during the stationary phase, and was regulated at the level of transcription. The stationary phase production of elastase in crp or rpoS mutants, which were constructed by allelic exchanges, decreased about 3- and 10-fold, respectively. However, the promoter activity of vvpE encoding elastase was unaffected by those mutations in the log phase when analyzed using a vvpE-lux fusion, A primer extension analysis revealed that the transcription of vvpE begins at two different sites, consisting of putative promoter L (PL) and promoter S (PS), The PL activity was constitutive through the log and stationary phases, lower than the PS activity, and unaffected by the crp or rpoS mutations. The transcription of PS, induced only in the stationary phase, was dependent on RpoS. The mutation in crp reduced the activity of PS; however, the additional inactivation of crp did not influence the PS activity in the rpoS mutant, indicating that CRP exerted its effects through PS requiring RpoS, These results demonstrate that vvpE expression is differentially directed by PL and PS depending on the growth phase and elevated by RpoS and CRP in the stationary phase.	Chonnam Natl Univ, Inst Biotechnol, Dept Food Sci & Technol, Kwangju 500757, South Korea; Chonnam Natl Univ, Inst Biotechnol, Dept Mol Biotechnol, Kwangju 500757, South Korea; Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin 449791, Kyunggi Do, South Korea; Chonnam Natl Univ, Sch Med, Dept Microbiol, Kwangju 500190, South Korea	Chonnam National University; Chonnam National University; Hankuk University Foreign Studies; Chonnam National University	Choi, SH (corresponding author), Chonnam Natl Univ, Inst Biotechnol, Dept Food Sci & Technol, Kwangju 500757, South Korea.			Choi, Sang Ho/0000-0003-3865-1039				BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; CHEN CY, 1995, J BACTERIOL, V177, P5303, DOI 10.1128/jb.177.18.5303-5309.1995; Choi SH, 2000, APPL ENVIRON MICROB, V66, P3911, DOI 10.1128/AEM.66.9.3911-3916.2000; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; HASE CC, 1993, MICROBIOL REV, V57, P823; Hengge-Aronis R., 1996, ESCHERICHIA COLI SAL, V5, P1497; IRIARTE M, 1995, INFECT IMMUN, V63, P1840, DOI 10.1128/IAI.63.5.1840-1847.1995; Jeong KC, 2000, INFECT IMMUN, V68, P5096, DOI 10.1128/IAI.68.9.5096-5106.2000; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; KOLTER R, 1993, ANNU REV MICROBIOL, V47, P855, DOI 10.1146/annurev.micro.47.1.855; KOTHARY MH, 1987, J GEN MICROBIOL, V133, P1783; LANGE R, 1991, MOL MICROBIOL, V5, P49, DOI 10.1111/j.1365-2958.1991.tb01825.x; Linkous DA, 1999, FEMS MICROBIOL LETT, V174, P207, DOI 10.1111/j.1574-6968.1999.tb13570.x; Loewen PC, 1998, CAN J MICROBIOL, V44, P707, DOI 10.1139/cjm-44-8-707; MEKALANOS JJ, 1992, J BACTERIOL, V174, P1; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; MIYOSHI S, 1988, MICROBIOL IMMUNOL, V32, P1025, DOI 10.1111/j.1348-0421.1988.tb01467.x; Miyoshi S, 1998, INFECT IMMUN, V66, P4851, DOI 10.1128/IAI.66.10.4851-4855.1998; Nagai S, 1998, VET MICROBIOL, V60, P227, DOI 10.1016/S0378-1135(98)00144-8; OBYRNE CP, 1994, J BACTERIOL, V176, P905, DOI 10.1128/jb.176.3.905-912.1994; OKA A, 1981, J MOL BIOL, V147, P217, DOI 10.1016/0022-2836(81)90438-1; Sambrook J., 2002, MOL CLONING LAB MANU; SASSEDWIGHT S, 1991, METHOD ENZYMOL, V208, P146; Shao CP, 2000, INFECT IMMUN, V68, P3569, DOI 10.1128/IAI.68.6.3569-3573.2000; Skorupski K, 1997, P NATL ACAD SCI USA, V94, P265, DOI 10.1073/pnas.94.1.265; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P3511, DOI 10.1073/pnas.90.8.3511; Yildiz FH, 1998, J BACTERIOL, V180, P773, DOI 10.1128/JB.180.4.773-784.1998	28	67	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13875	13880		10.1074/jbc.M010567200	http://dx.doi.org/10.1074/jbc.M010567200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11297524	hybrid			2022-12-27	WOS:000168356600053
J	Ranganathan, AC; Nelson, KK; Rodriguez, AM; Kim, KH; Tower, GB; Rutter, JL; Brinckerhoff, CE; Huang, TT; Epstein, CJ; Jeffrey, JJ; Melendez, JA				Ranganathan, AC; Nelson, KK; Rodriguez, AM; Kim, KH; Tower, GB; Rutter, JL; Brinckerhoff, CE; Huang, TT; Epstein, CJ; Jeffrey, JJ; Melendez, JA			Manganese superoxide dismutase signals matrix metalloproteinase expression via H2O2-dependent ERK1/2 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; INTERLEUKIN-1 MESSENGER-RNA; SMOOTH-MUSCLE CELLS; GASTRIC-CANCER; INTERSTITIAL COLLAGENASE; HYDROGEN-PEROXIDE; GENE-EXPRESSION; OVEREXPRESSION; FIBROBLASTS; TISSUE	Manganese-superoxide dismutase (Sod2) removes mitochondrially derived superoxide (O-2(radical anion)) at near-diffusion limiting rates and is the only antioxidant enzyme whose expression is regulated by numerous stimuli. Here it is shown that Sod2 also serves as a source of the intracellular signaling molecule H2O2. Sod2-dependent increases in the steady-state levels of H2O2 led to ERK1/2 activation and subsequent downstream transcriptional increases in matrix metalloproteinase-1 (MMP-1) expression, which were reversed by expression of the H2O2-detoxifying enzyme, catalase. In addition, a single nucleotide polymorphism has recently been identified (1G/2G) at base pair -1607 that creates an Ets site adjacent to an AP-1 site at base pair -1602 and has been shown to dramatically enhance transcription of the MMP-1 promoter. Luciferase promoter constructs containing either the 1G or 2G variation were 25- or 1000-fold more active when transiently transfected into Sod2-overexpressing cell lines, respectively. The levels of MMP-2, -3, and -7 were also increased in the Sod2-overexpressing cell lines, suggesting that Sod2 may function as a "global" redox regulator of MMP expression. In addition, Sod2(-/+) mouse embryonic fibroblasts failed to respond to the cytokine-mediated induction of the murine functional analog of MMP-1, MMP-13. This study provides evidence that the modulation of Sod2 activity by a wide array of pathogenic and inflammatory stimuli may be utilized by the cell as a primary signaling mechanism leading to matrix metalloproteinase expression.	Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; Dartmouth Coll, Sch Med, Hanover, NH 03755 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	Albany Medical College; Albany Medical College; Dartmouth College; University of California System; University of California San Francisco	Melendez, JA (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, MC151,47 New Scotland Ave, Albany, NY 12208 USA.			Rutter, Joni/0000-0002-6502-2361; Melendez, Juan/0000-0001-8021-3097				Bai JX, 1999, J BIOL CHEM, V274, P26217, DOI 10.1074/jbc.274.37.26217; Birkenkamp KU, 2000, BRIT J PHARMACOL, V131, P99, DOI 10.1038/sj.bjp.0703534; Brenneisen P, 1997, FREE RADICAL BIO MED, V22, P515, DOI 10.1016/S0891-5849(96)00404-2; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; Day BJ, 1999, FREE RADICAL BIO MED, V27, pS59; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dumin J, 1998, J BIOL CHEM, V273, P25488, DOI 10.1074/jbc.273.39.25488; FINI ME, 1998, MATRIX METALLOPROTEI; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; FRUCHART JC, 1994, FREE RADICAL DAMAGE; FUJII J, 1991, J BIOL CHEM, V266, P23142; GOROSPE M, 1993, J BIOL CHEM, V268, P6214; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140; Huang TT, 1997, ARCH BIOCHEM BIOPHYS, V344, P424, DOI 10.1006/abbi.1997.0237; Inoue T, 1999, INT J MOL MED, V4, P73; Janssen AML, 2000, CLIN CANCER RES, V6, P3183; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; KUMAR S, 1992, P NATL ACAD SCI USA, V89, P4683, DOI 10.1073/pnas.89.10.4683; Li N, 1998, J CELL PHYSIOL, V175, P359, DOI 10.1002/(SICI)1097-4652(199806)175:3<359::AID-JCP14>3.0.CO;2-0; Li N, 1998, PROSTATE, V35, P221, DOI 10.1002/(SICI)1097-0045(19980515)35:3<221::AID-PROS8>3.0.CO;2-J; Malafa M, 2000, J SURG RES, V88, P130, DOI 10.1006/jsre.1999.5773; Manzano VM, 1999, J PHARMACOL EXP THER, V289, P123; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Melendez JA, 1996, J BIOL CHEM, V271, P18898, DOI 10.1074/jbc.271.31.18898; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Poswig A, 1999, J INVEST DERMATOL, V112, P13, DOI 10.1046/j.1523-1747.1999.00465.x; Rodriguez AM, 2000, FREE RADICAL BIO MED, V29, P801, DOI 10.1016/S0891-5849(00)00362-2; Rutter JL, 1998, CANCER RES, V58, P5321; Sasaki H, 1997, PHOTOCHEM PHOTOBIOL, V65, P707, DOI 10.1111/j.1751-1097.1997.tb01914.x; SATOMI A, 1995, J GASTROENTEROL, V30, P177, DOI 10.1007/BF02348662; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Toh Y, 2000, INT J ONCOL, V17, P107; TOWER GB, 2000, 91 ANN M AM ASS CANC; VISNER GA, 1990, J BIOL CHEM, V265, P2856; WEBER GF, 1994, MED HYPOTHESES, V43, P223, DOI 10.1016/0306-9877(94)90070-1; Wenk J, 1999, J BIOL CHEM, V274, P25869, DOI 10.1074/jbc.274.36.25869; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; WESTMAYS JA, 1995, P NATL ACAD SCI USA, V92, P6768, DOI 10.1073/pnas.92.15.6768; WILCOX BD, 1994, J BIOL CHEM, V269, P29658; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; ZYAD A, 1994, CANCER RES, V54, P825	45	130	139	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14264	14270		10.1074/jbc.M100199200	http://dx.doi.org/10.1074/jbc.M100199200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11297530	hybrid			2022-12-27	WOS:000168356600100
J	Jackson, MW; Lindstrom, MS; Berberich, SJ				Jackson, MW; Lindstrom, MS; Berberich, SJ			MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; NUCLEOLAR-LOCALIZATION; RETINOBLASTOMA PROTEIN; P53-BINDING PROTEIN; ONCOPROTEIN MDM2; CELL-GROWTH; GENE; P19(ARF); AMPLIFICATION; IDENTIFICATION	Regulation of p53 involves a complex network of protein interactions. The primary regulator of p53 protein stability is the Mdm2 protein. ARF and MdmX are two proteins that have recently been shown to inhibit Mdm2-mediated degradation of p53 via distinct associations with Mdm2, We demonstrate here that ARF is capable of interacting with MdmX and in a manner similar to its association with Mdm2, sequestering MdmX within the nucleolus. The sequestration of MdmX by ARF results in an increase in p53 transactivation, In addition, the redistribution of MdmX by ARF requires that a nucleolar localization signal be present on MdmX Although expression of either MdmX or ARF leads to Mdm2 stabilization, coexpression of both MdmX and ARF results in a decrease in Mdm2 protein levels. Similarly, increasing ARF protein levels in the presence of constant MdmX and Mdm2 leads to a dose-dependent decrease in Mdm2 levels. Under these conditions, ARF can synergistically reverse the ability of Mdm2 and MdmX to inhibit p53-dependent transactivation. Finally, the association and redistribution of MdmX by ARF has no effect on the protein stability of either ARF or MdmX, Taken together, these results demonstrate that the interaction between MdmX and ARF represents a novel pathway for regulating Mdm2 protein levels. Additionally, both MdmX and Mdm2, either individually or together, are capable of antagonizing the effects of the ARF tumor suppressor on p53 activity.	Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; Karolinska Hosp & Inst, Canc Ctr Karolinska, Dept Oncol Pathol, S-17176 Stockholm, Sweden	University System of Ohio; Wright State University Dayton; Karolinska Institutet; Karolinska University Hospital	Berberich, SJ (corresponding author), Wright State Univ, Dept Biochem & Mol Biol, 3640 Colonel Glenn Hwy, Dayton, OH 45435 USA.		Lindström, Mikael S/AAA-1451-2019	Lindström, Mikael S/0000-0003-1148-8497	NATIONAL CANCER INSTITUTE [R29CA064430, R01CA064430] Funding Source: NIH RePORTER; NCI NIH HHS [CA64430, R01 CA064430-08, R01 CA064430] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berberich SJ, 1999, DIFFERENTIATION, V64, P205, DOI 10.1046/j.1432-0436.1999.6440205.x; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FINLAY CA, 1993, MOL CELL BIOL, V13, P301, DOI 10.1128/MCB.13.1.301; HARPER JW, 1993, CELL, V75, P805; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; Jackson MW, 1999, DNA CELL BIOL, V18, P693, DOI 10.1089/104454999314971; Kaelin WG, 1999, BIOESSAYS, V21, P950, DOI 10.1002/(SICI)1521-1878(199911)21:11<950::AID-BIES7>3.0.CO;2-D; Ko JL, 1996, GENE DEV, V10, P1054; Liggett WH, 1996, CANCER RES, V56, P4119; Lindstrom MS, 2000, EXP CELL RES, V256, P400, DOI 10.1006/excr.2000.4854; Lohrum MAE, 2000, NAT CELL BIOL, V2, P179, DOI 10.1038/35004057; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; QUELLE DE, 1995, CELL, V83, P993; QUELLE DE, 1995, ONCOGENE, V11, P635; Riemenschneider MJ, 1999, CANCER RES, V59, P6091; Rizos H, 2000, ONCOGENE, V19, P2978, DOI 10.1038/sj.onc.1203629; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Shvarts A, 1997, GENOMICS, V43, P34, DOI 10.1006/geno.1997.4775; Stad R, 2000, J BIOL CHEM, V275, P28039; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Zhang YP, 1999, MOL CELL, V3, P579, DOI 10.1016/S1097-2765(00)80351-2; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	33	57	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					25336	25341		10.1074/jbc.M010685200	http://dx.doi.org/10.1074/jbc.M010685200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11297540	hybrid			2022-12-27	WOS:000169800700120
J	Noji, H; Bald, D; Yasuda, R; Itoh, H; Yoshida, M; Kinosita, K				Noji, H; Bald, D; Yasuda, R; Itoh, H; Yoshida, M; Kinosita, K			Purine but not pyrimidine nucleotides support rotation of F-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(3)BETA(3)GAMMA COMPLEX; ESCHERICHIA-COLI; CATALYTIC SITE; BETA-SUBUNITS; F1-ATPASE; BINDING	The binding change model for the F-1-ATPase predicts that its rotation is intimately correlated with the changes in the affinities of the three catalytic sites for nucleotides. If so, subtle differences in the nucleotide structure may have pronounced effects on rotation. Here we show by single-molecule imaging that purine nucleotides ATP, GTP, and ITP support rotation but pyrimidine nucleotides UTP and CTP do not, suggesting that the extra ring in purine is indispensable for proper operation of this molecular motor. Although the three purine nucleotides were bound to the enzyme at different rates, all showed similar rotational characteristics: counterclockwise rotation, 120 degrees steps each driven by hydrolysis of one nucleotide molecule, occasional back steps, rotary torque of similar to 40 piconewtons (pN)(.)nm, and mechanical work done in a step of similar to 80 pN(.)nm. These latter characteristics are likely to be determined by the rotational mechanism built in the protein structure, which purine nucleotides can energize. With ATP and GTP, rotation was observed even when the free energy of hydrolysis was -80 pN(.)nm/molecule, indicating similar to 100% efficiency. Reconstituted F0F1-ATPase actively translocated protons by hydrolyzing ATP, GTP, and ITP, but CTP and UTP were not even hydrolyzed. Isolated F-1 very slowly hydrolyzed UTP (but not CTP), suggesting possible uncoupling from rotation.	Teikyo Univ, Biotechnol Res Ctr 3F, Genet Programming Team 13, CREST,Miyamae Ku, Kawasaki, Kanagawa 2160001, Japan; Tokyo Inst Technol, Chem Resources Lab, PRESTO, Yokohama, Kanagawa 2268503, Japan; Hamamatsu Photon KK, Tsukuba Res Lab, Tsukuba, Ibaraki 3002635, Japan; Keio Univ, Fac Sci & Technol, Yokohama, Kanagawa 2238522, Japan	Japan Science & Technology Agency (JST); Teikyo University; Japan Science & Technology Agency (JST); Tokyo Institute of Technology; Hamamatsu Photonics; Keio University	Kinosita, K (corresponding author), Teikyo Univ, Biotechnol Res Ctr 3F, Genet Programming Team 13, CREST,Miyamae Ku, Nogawa 907, Kawasaki, Kanagawa 2160001, Japan.		Yasuda, Ryohei/E-7726-2011	Yasuda, Ryohei/0000-0001-6263-9297				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; AGGELER R, 1995, J BIOL CHEM, V270, P9185, DOI 10.1074/jbc.270.16.9185; Bald D, 1998, J BIOL CHEM, V273, P865, DOI 10.1074/jbc.273.2.865; Boyer PD, 2000, BBA-BIOENERGETICS, V1458, P252, DOI 10.1016/S0005-2728(00)00077-3; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Jault JM, 1995, BIOCHEMISTRY-US, V34, P16412, DOI 10.1021/bi00050a023; Matsui T, 1997, J BIOL CHEM, V272, P8215, DOI 10.1074/jbc.272.13.8215; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Oosawa F, 1986, Adv Biophys, V22, P151, DOI 10.1016/0065-227X(86)90005-5; Papageorgiou S, 1998, J BIOENERG BIOMEMBR, V30, P533, DOI 10.1023/A:1020528432609; PERLIN DS, 1984, BIOCHEMISTRY-US, V23, P4998, DOI 10.1021/bi00316a026; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; SORGATO MC, 1982, BIOCHIM BIOPHYS ACTA, V681, P319, DOI 10.1016/0005-2728(82)90038-X; STRYER L, 1995, BIOCHEMISTRY-US, P443; Tsunoda SP, 1999, J BIOL CHEM, V274, P5701, DOI 10.1074/jbc.274.9.5701; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; YOKOYAMA K, 1989, J BIOL CHEM, V264, P21837	19	44	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					25480	25486		10.1074/jbc.M102200200	http://dx.doi.org/10.1074/jbc.M102200200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11279248	hybrid, Green Published			2022-12-27	WOS:000169800700138
J	Batchu, RB; Shammas, MA; Wang, JY; Munshi, NC				Batchu, RB; Shammas, MA; Wang, JY; Munshi, NC			Dual level inhibition of E2F-1 activity by adeno-associated virus Rep78	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA GENE-PRODUCT; CELL-CYCLE; TRANSCRIPTION FACTOR; SUPPRESSOR PROTEIN; IN-VITRO; DNA; BINDING; TRANSFORMATION; ACTIVATION; AAV	E2F-1, a major cellular transcription factor, plays a pivotal role in regulating the cell cycle. The activity of E2F-1 is negatively regulated by its interaction with retinoblastoma protein (pRB), and disruption of the pRB-E2F-1 complex, a hallmark of cellular transformation by DNA tumor viruses, leads to cell proliferation, Adeno-associated virus-2 (AAV) is known to have oncosuppressive properties against DNA tumor viruses. Here we provide, for the first time, the molecular basis for antioncogenic activity of AAV. Rep78, a major regulatory protein of AAV, interacts at the protein level with E2F-1 and stabilizes the pRB-E2F-1 complex. At the DNA level, Rep78 binds to a putative site on the E2F-1 promoter and down-regulates the adenovirus-induced E2F-1 transcription. This dual level of Rep78 activity leads to decreased cellular levels of free E2F-1, leading to its once-suppressive properties.	Univ Arkansas Med Sci, Cent Arkansas Vet Hlth Care Syst, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Myeloma & Transplantat Res Ctr, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences	Munshi, NC (corresponding author), Univ Arkansas Med Sci, Cent Arkansas Vet Hlth Care Syst, 4301 W Markham,Slot 776, Little Rock, AR 72205 USA.		Munshi, Nikhil/ABE-2338-2021		NATIONAL CANCER INSTITUTE [P01CA055819] Funding Source: NIH RePORTER; NCI NIH HHS [CA55819] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAGCHI S, 1990, CELL, V62, P659, DOI 10.1016/0092-8674(90)90112-R; BAGCHI S, 1989, P NATL ACAD SCI USA, V86, P4352, DOI 10.1073/pnas.86.12.4352; Batchu RB, 1999, CANCER RES, V59, P3592; BATCHU RB, 1994, CANCER LETT, V86, P23, DOI 10.1016/0304-3835(94)90176-7; BATCHU RB, 1995, FEBS LETT, V367, P267, DOI 10.1016/0014-5793(95)00584-V; Beijersbergen RL, 1996, BBA-REV CANCER, V1287, P103, DOI 10.1016/0304-419X(96)00002-9; BERNS KI, 1987, ADV VIRUS RES, V32, P243, DOI 10.1016/S0065-3527(08)60479-0; CASTO BC, 1972, P SOC EXP BIOL MED, V140, P72; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; CHIORINI JA, 1994, J VIROL, V68, P7448, DOI 10.1128/JVI.68.11.7448-7457.1994; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; FARNHAM PJ, 1993, BIOCHIM BIOPHYS ACTA, V1155, P125, DOI 10.1016/0304-419X(93)90001-S; GILDEN RV, 1968, NATURE, V220, P1139, DOI 10.1038/2201139b0; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; HEILBRONN R, 1990, J VIROL, V64, P3012, DOI 10.1128/JVI.64.6.3012-3018.1990; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Hermanns J, 1997, J VIROL, V71, P6020, DOI 10.1128/JVI.71.8.6020-6027.1997; HERMONAT PL, 1989, VIROLOGY, V172, P253, DOI 10.1016/0042-6822(89)90127-X; Hermonat PL, 1997, GYNECOL ONCOL, V66, P487, DOI 10.1006/gyno.1997.4789; Hermonat PL, 1996, CANCER RES, V56, P5299; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; IKEDA MA, 1993, MOL CELL BIOL, V13, P7029, DOI 10.1128/MCB.13.11.7029; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; KHLEIF SN, 1991, VIROLOGY, V181, P738, DOI 10.1016/0042-6822(91)90909-U; KYOSTIO SRM, 1995, J VIROL, V69, P6787; LEVINE AJ, 1990, BIOESSAYS, V12, P60, DOI 10.1002/bies.950120203; MAYOR HD, 1977, CANCER BIOCHEM BIOPH, V2, P25; Mulligan G, 1998, TRENDS GENET, V14, P223, DOI 10.1016/S0168-9525(98)01470-X; MURRAY A, 1994, CURR OPIN CELL BIOL, V6, P872, DOI 10.1016/0955-0674(94)90059-0; NEUMAN E, 1994, MOL CELL BIOL, V14, P6607, DOI 10.1128/MCB.14.10.6607; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; NEVINS JR, 1992, SCIENCE, V258, P424; OSTROVE JM, 1981, VIROLOGY, V113, P521, DOI 10.1016/0042-6822(81)90180-X; PAGANO M, 1992, ONCOGENE, V7, P1681; RAYCHAUDHURI P, 1990, J VIROL, V64, P2702, DOI 10.1128/JVI.64.6.2702-2710.1990; SAMULSKI RJ, 1991, EMBO J, V10, P3941, DOI 10.1002/j.1460-2075.1991.tb04964.x; SCHLEHOFER JR, 1994, MUTAT RES, V305, P303, DOI 10.1016/0027-5107(94)90250-X; TYAGI RK, 1993, ELECTROPHORESIS, V14, P826, DOI 10.1002/elps.11501401130; Walz CM, 1998, VIROLOGY, V247, P97, DOI 10.1006/viro.1998.9226; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WEITZMAN MD, 1994, P NATL ACAD SCI USA, V91, P5808, DOI 10.1073/pnas.91.13.5808; Yamasaki L, 1998, Results Probl Cell Differ, V22, P199; YANG QC, 1992, J VIROL, V66, P6058, DOI 10.1128/JVI.66.10.6058-6069.1992; YANG QC, 1995, VIROLOGY, V207, P246, DOI 10.1006/viro.1995.1072; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111	45	17	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24315	24322		10.1074/jbc.M008154200	http://dx.doi.org/10.1074/jbc.M008154200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11294829	hybrid			2022-12-27	WOS:000169531100143
J	Evanko, DS; Thiyagarajan, MM; Siderovski, DP; Wedegaertner, PB				Evanko, DS; Thiyagarajan, MM; Siderovski, DP; Wedegaertner, PB			G beta gamma isoforms selectively rescue plasma membrane localization and palmitoylation of mutant G alpha(s) and G alpha(q)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; DIFFERENTIAL DISTRIBUTION; ALPHA-SUBUNITS; RAT-BRAIN; RECEPTOR; ACTIVATION; ASSOCIATION; SPECIFICITY; PALMITATE; CHANNELS	Mutation of G alpha (q) or G alpha (s) N-terminal contact sites for G beta gamma resulted in alpha subunits that failed to localize at the plasma membrane or undergo palmitoylation when expressed in HEK293 cells. We now show that overexpression of specific py subunits can recover plasma membrane localization and palmitoylation of the beta gamma -binding-deficient mutants of alpha (s) or alpha (q). Thus, the beta gamma -binding-defective alpha is completely dependent on co-expression of exogenous beta gamma for proper membrane localization. In this report, we examined the ability of beta (1-5) in combination with gamma (2) or gamma (3) to promote proper localization and palmitoylation of mutant alpha (s) or alpha (q). Immunofluorescence localization, cellular fractionation, and palmitate labeling revealed distinct subtype-specific differences in beta gamma interactions with alpha subunits. These studies demonstrate that 1) alpha and beta gamma reciprocally promote the plasma membrane targeting of the other subunit; 2) beta (5), when coexpressed with gamma (2) or gamma (3), fails to localize to the plasma membrane or promote plasma membrane localization of mutant alpha (s) or alpha (q); 3) beta (3) is deficient in promoting plasma membrane localization of mutant alpha (s) and alpha (q), whereas beta (4) is deficient in promoting plasma membrane localization of mutant alpha (q); 4) both palmitoylation and interactions with beta gamma are required for plasma membrane localization of alpha.	Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Inst, Philadelphia, PA 19107 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	Jefferson University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wedegaertner, PB (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Inst, 233 S 10th St,839 BLSB, Philadelphia, PA 19107 USA.		Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210	NIGMS NIH HHS [GM56444] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056444, R56GM056444, R55GM056444] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASANO T, 1995, J NEUROCHEM, V64, P1267; ASANO T, 1993, J BIOL CHEM, V268, P20512; Asano T, 1999, J BIOL CHEM, V274, P21425, DOI 10.1074/jbc.274.30.21425; Bayewitch ML, 1998, J BIOL CHEM, V273, P2273, DOI 10.1074/jbc.273.4.2273; Betty M, 1998, NEUROSCIENCE, V85, P475, DOI 10.1016/S0306-4522(97)00623-4; Brunk I, 1999, EUR J CELL BIOL, V78, P311, DOI 10.1016/S0171-9335(99)80065-X; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; Diverse-Pierluissi M, 2000, J BIOL CHEM, V275, P28380, DOI 10.1074/jbc.M003571200; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; Evanko DS, 2000, J BIOL CHEM, V275, P1327, DOI 10.1074/jbc.275.2.1327; Fishburn CS, 2000, P NATL ACAD SCI USA, V97, P1085, DOI 10.1073/pnas.97.3.1085; Fishburn CS, 1999, J BIOL CHEM, V274, P18793, DOI 10.1074/jbc.274.26.18793; Fletcher JE, 1998, J BIOL CHEM, V273, P636, DOI 10.1074/jbc.273.1.636; Gudermann T, 1997, ADV SEC MESS PHOSPH, V31, P253; HANSEN CA, 1994, J CELL BIOL, V126, P811, DOI 10.1083/jcb.126.3.811; Hou YM, 2000, J BIOL CHEM, V275, P38961, DOI 10.1074/jbc.C000604200; Iiri T, 1996, P NATL ACAD SCI USA, V93, P14592, DOI 10.1073/pnas.93.25.14592; Kalkbrenner F, 1996, BBA-MOL CELL RES, V1314, P125, DOI 10.1016/S0167-4889(96)00072-9; KLEUSS C, 1992, NATURE, V358, P424, DOI 10.1038/358424a0; KLEUSS C, 1993, SCIENCE, V259, P832, DOI 10.1126/science.8094261; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lei QB, 2000, P NATL ACAD SCI USA, V97, P9771, DOI 10.1073/pnas.97.17.9771; Liang JJ, 1998, J NEUROCHEM, V71, P345; Lindorfer MA, 1998, J BIOL CHEM, V273, P34429, DOI 10.1074/jbc.273.51.34429; Maier U, 2000, J BIOL CHEM, V275, P13746, DOI 10.1074/jbc.275.18.13746; Morishita R, 1997, J NEUROCHEM, V68, P820; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; PRONIN AN, 1992, P NATL ACAD SCI USA, V89, P6220, DOI 10.1073/pnas.89.13.6220; Rehm A, 1997, J CELL BIOL, V137, P305, DOI 10.1083/jcb.137.2.305; Richardson M, 1999, J BIOL CHEM, V274, P13525, DOI 10.1074/jbc.274.19.13525; Robillard L, 2000, CELL SIGNAL, V12, P673, DOI 10.1016/S0898-6568(00)00118-2; SCHMIDT CJ, 1992, J BIOL CHEM, V267, P13807; Snow BE, 1999, P NATL ACAD SCI USA, V96, P6489, DOI 10.1073/pnas.96.11.6489; Sondek J, 2001, BIOCHEM PHARMACOL, V61, P1329, DOI 10.1016/S0006-2952(01)00633-5; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang Q, 1999, J BIOL CHEM, V274, P17365, DOI 10.1074/jbc.274.24.17365; Wang YR, 1999, J BIOL CHEM, V274, P37435, DOI 10.1074/jbc.274.52.37435; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Wedegaertner PB, 1998, BIOL SIGNAL RECEPT, V7, P125; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; WILCOX MD, 1995, J BIOL CHEM, V270, P4189, DOI 10.1074/jbc.270.9.4189; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Yan K, 1996, J BIOL CHEM, V271, P7141, DOI 10.1074/jbc.271.12.7141; Zhang JH, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-03-j0004.2000; Zhang SY, 1996, J BIOL CHEM, V271, P33575, DOI 10.1074/jbc.271.52.33575; Zhou JY, 2000, J NEUROSCI, V20, P7143	50	58	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23945	23953		10.1074/jbc.M101154200	http://dx.doi.org/10.1074/jbc.M101154200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11294873	hybrid			2022-12-27	WOS:000169531100096
J	Felizmenio-Quimio, ME; Daly, NL; Craik, DJ				Felizmenio-Quimio, ME; Daly, NL; Craik, DJ			Circular proteins in plants - Solution structure of a novel macrocyclic trypsin inhibitor from Momordica cochinchinensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE KALATA B1; NMR STRUCTURE CALCULATION; TORSION ANGLE DYNAMICS; BOVINE BETA-TRYPSIN; CYSTINE KNOT MOTIF; 3-DIMENSIONAL STRUCTURE; CHASSALIA-PARVIFOLIA; MOLECULAR-DYNAMICS; DISTANCE GEOMETRY; CRYSTAL-STRUCTURE	Much interest has been generated by recent reports on the discovery of circular (i.e. head-to-tail cyclized) proteins in plants. Here we report the three-dimensional structure of one of the newest such circular proteins, MCoTI-II, a novel trypsin inhibitor from Momordica cochinchinensis, a member of the Cucurbitaceae plant family. The structure consists of a small beta -sheet, several turns, and a cystine knot arrangement of the three disulfide bonds. Interestingly, the molecular topology is similar to that of the plant cyclotides (Craik, D. J., Daly, N. L., Bond, T., and Waine, C. (1999) J. Mol. Biol, 294, 1327-1336), which derive from the Rubiaceae and Violaceae plant families, have antimicrobial activities, and exemplify the cyclic cystine knot structural motif as part of their circular backbone. The sequence, biological activity, and plant family of MCoTI-II are all different from known cyclotides. However, given the structural similarity, cyclic backbone, and plant origin of MCoTI-II, we propose that MCoTI-II can be classified as a new member of the cyclotide class of proteins. The expansion of the cyclotides to include trypsin inhibitory activity and a new plant family highlights the importance and functional variability of circular proteins and the fact that they are more common than has previously been believed, Insights into the possible roles of backbone cyclization have been gained by a comparison of the structure of MCoTI-II with the homologous acyclic trypsin inhibitors CMTI-I and EETI-II from the Cucurbitaceae plant family.	Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Queensland	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.		Daly, Norelle L/D-4302-2013; Craik, David/B-1695-2010	Daly, Norelle L/0000-0002-4697-6602; Craik, David/0000-0003-0007-6796				BODE W, 1989, FEBS LETT, V242, P285, DOI 10.1016/0014-5793(89)80486-7; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1996, X PLOR MANUAL VERSIO; CLORE GM, 1986, J MOL BIOL, V191, P523, DOI 10.1016/0022-2836(86)90146-4; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Daly NL, 2000, J BIOL CHEM, V275, P19068, DOI 10.1074/jbc.M000450200; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 1999, J MOL BIOL, V285, P333, DOI 10.1006/jmbi.1998.2276; DiMarco S, 1997, STRUCTURE, V5, P1465; ECCLES C, 1991, Journal of Biomolecular NMR, V1, P111, DOI 10.1007/BF01877224; Evans TC, 1999, J BIOL CHEM, V274, P18359, DOI 10.1074/jbc.274.26.18359; Goransson U, 1999, J NAT PROD, V62, P283, DOI 10.1021/np9803878; Gran L, 2000, J ETHNOPHARMACOL, V70, P197, DOI 10.1016/S0378-8741(99)00175-0; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Gustafson KR, 2000, J NAT PROD, V63, P176, DOI 10.1021/np990432r; Hallock YF, 2000, J ORG CHEM, V65, P124, DOI 10.1021/jo990952r; HEITZ A, 1989, BIOCHEMISTRY-US, V28, P2392, DOI 10.1021/bi00432a009; Helland R, 1999, ACTA CRYSTALLOGR D, V55, P139, DOI 10.1107/S090744499801052X; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; HOLAK TA, 1989, J MOL BIOL, V210, P635, DOI 10.1016/0022-2836(89)90137-X; HUANG QC, 1993, J MOL BIOL, V229, P1022, DOI 10.1006/jmbi.1993.1102; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; Iwai H, 1999, FEBS LETT, V459, P166, DOI 10.1016/S0014-5793(99)01220-X; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LING MH, 1993, J BIOL CHEM, V268, P810; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; Schoepke T., 1993, SCI PHARM, V61, P145; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Stein EG, 1997, J MAGN RESON, V124, P154, DOI 10.1006/jmre.1996.1027; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; U QUEENSLAND, 2000, Patent No. 0015654; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002; Wuthrich K, 1986, NMR PROTEINS NUCL AC	43	199	201	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22875	22882		10.1074/jbc.M101666200	http://dx.doi.org/10.1074/jbc.M101666200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11292835	hybrid			2022-12-27	WOS:000169412700120
J	Huang, AY; Castle, AM; Hinton, BT; Castle, JD				Huang, AY; Castle, AM; Hinton, BT; Castle, JD			Resting (basal) secretion of proteins is provided by the minor regulated and constitutive-like pathways and not granule exocytosis in parotid acinar cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECEPTORS; PHOSPHATIDYLINOSITOL 3-KINASE; MDCK CELLS; LYSOSOMAL-ENZYMES; AMYLASE RELEASE; CARBACHOL; DISTINCT; STORAGE; BIOGENESIS; TRANSPORT	Resting secretion of salivary proteins by the parotid gland is sustained in situ between periods of eating by parasympathetic stimulation and has been assumed to involve low level granule exocytosis. By using parotid lobules from ad libitum fed rats stimulated with low doses of carbachol as an in vitro analog of resting secretion, we deduce from the composition of discharged proteins that secretion does not involve granule exocytosis. Rather, it derives from two other acinar export routes, the constitutive-like (stimulus-independent) pathway and the minor regulated pathway, which responds to low doses of cholinergic or P-adrenergic agonists (Castle, J, D,, and Castle, A. M. (1996) J, Cell Sci, 109, 2591-2599). The protein composition collected in vitro mimics that collected from cannulated ducts of glands given low level stimulation in situ. Analysis of secretory trafficking along the two pathways of resting secretion has indicated that the constitutive-like pathway may pass through endosomes after diverging from the minor regulated pathway at a brefeldin A sensitive branch point. The branch point is deduced to be distal to a common vesicular budding event by which both pathways originate from immature granules. Detectable perturbation of neither pathway in lobules was observed by wortmannin addition, and neither serves as a significant export route for lysosomal procathepsin B. These findings show that parotid acinar cells use low capacity, high sensitivity secretory pathways for resting secretion and reserve granule exocytosis, a high capacity, low sensitivity pathway, for massive salivary protein export during meals, An analogous strategy may be employed in other secretory cell types.	Univ Virginia, Sch Med, Hlth Sci Ctr, Dept Cell Biol, Charlottesville, VA 22908 USA	University of Virginia	Castle, JD (corresponding author), Univ Virginia, Sch Med, Hlth Sci Ctr, Dept Cell Biol, Charlottesville, VA 22908 USA.	jdc4r@virginia.edu	Hinton, Barry/AAT-5786-2021		NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008941] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE08941] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; ASKING B, 1980, ACTA PHYSIOL SCAND, V109, P415, DOI 10.1111/j.1748-1716.1980.tb06614.x; ASKING B, 1980, ACTA PHYSIOL SCAND, V109, P407, DOI 10.1111/j.1748-1716.1980.tb06613.x; BARROSO M, 1994, J CELL BIOL, V124, P83, DOI 10.1083/jcb.124.1.83; BAUM EJ, 1987, J DENT RES, V55, P628; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; BREWER CB, 1995, J CELL SCI, V108, P789; BRIGNONI M, 1995, J CELL SCI, V108, P1931; BROWN WJ, 1995, J CELL BIOL, V130, P781, DOI 10.1083/jcb.130.4.781; Calhoun BC, 1998, AM J PHYSIOL-CELL PH, V275, pC163, DOI 10.1152/ajpcell.1998.275.1.C163; CAMERON RS, 1986, J CELL BIOL, V103, P1299, DOI 10.1083/jcb.103.4.1299; Castle AM, 1997, J CELL BIOL, V138, P45, DOI 10.1083/jcb.138.1.45; CASTLE AM, 1992, J BIOL CHEM, V267, P13093; Castle D, 1998, CRIT REV ORAL BIOL M, V9, P4, DOI 10.1177/10454411980090010301; Castle JD, 1996, J CELL SCI, V109, P2591; Chavez RA, 1996, J CELL BIOL, V133, P1177, DOI 10.1083/jcb.133.6.1177; Christensen BM, 2000, AM J PHYSIOL-RENAL, V278, pF29, DOI 10.1152/ajprenal.2000.278.1.F29; DAVIDSON HW, 1995, J CELL BIOL, V130, P797, DOI 10.1083/jcb.130.4.797; DeLisle RC, 1996, EUR J CELL BIOL, V71, P62; DVORAK AM, 1991, AM J PATHOL, V138, P69; Eaton BA, 2000, J NEUROSCI, V20, P7334; EMMELIN N, 1987, J DENT RES, V66, P509, DOI 10.1177/00220345870660022101; Fernandez CJ, 1997, MOL BIOL CELL, V8, P2171, DOI 10.1091/mbc.8.11.2171; GIRARD LR, 1993, J BIOL CHEM, V268, P26592; HALBAN PA, 1982, ENDOCRINOLOGY, V110, P1183, DOI 10.1210/endo-110-4-1183; HANSEN SH, 1994, J CELL BIOL, V126, P677, DOI 10.1083/jcb.126.3.677; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; HENDRICKS LC, 1992, P NATL ACAD SCI USA, V89, P7242, DOI 10.1073/pnas.89.15.7242; Hirono C, 1998, J MEMBRANE BIOL, V164, P197, DOI 10.1007/s002329900405; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Klumperman J, 1998, J CELL BIOL, V141, P359, DOI 10.1083/jcb.141.2.359; KOMHOFF M, 1994, EUR J CELL BIOL, V63, P192; Kuliawat R, 1997, J CELL BIOL, V137, P595, DOI 10.1083/jcb.137.3.595; KULIAWAT R, 1994, J CELL BIOL, V126, P77, DOI 10.1083/jcb.126.1.77; Kundra A, 1998, J BIOL CHEM, V273, P3848, DOI 10.1074/jbc.273.7.3848; LARSSON O, 1989, ACTA PHYSIOL SCAND, V137, P231, DOI 10.1111/j.1748-1716.1989.tb08743.x; LEONG DA, 1991, J BIOL CHEM, V266, P9016; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Martys JL, 1996, J BIOL CHEM, V271, P10953, DOI 10.1074/jbc.271.18.10953; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Nakajima Y, 1997, MOL BIOL CELL, V8, P577, DOI 10.1091/mbc.8.4.577; PHANEUF S, 1984, CELL TISSUE RES, V235, P699; PHANEUF S, 1985, CELL TISSUE RES, V239, P105, DOI 10.1007/BF00214909; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Salem N, 1998, NAT NEUROSCI, V1, P551, DOI 10.1038/2787; SESSO A, 1980, ACTA ANAT, V108, P521; SHARONI Y, 1976, J CELL BIOL, V71, P107, DOI 10.1083/jcb.71.1.107; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; TAKEMURA H, 1984, JPN J PHARMACOL, V36, P107, DOI 10.1254/jjp.36.107; TEMPLETON D, 1990, PFLUGERS ARCH, V384, P287; Turner MD, 2000, J BIOL CHEM, V275, P14025, DOI 10.1074/jbc.275.19.14025; VONZASTROW M, 1989, J BIOL CHEM, V264, P6566; VONZASTROW M, 1987, J CELL BIOL, V105, P2675, DOI 10.1083/jcb.105.6.2675; WALKER AM, 1980, ENDOCRINOLOGY, V107, P1095, DOI 10.1210/endo-107-4-1095; Wang EI, 2000, TRAFFIC, V1, P480, DOI 10.1034/j.1600-0854.2000.010606.x; YELDHUIS JD, 2000, NOVART FDN SYMP, V227, P1	56	44	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22296	22306		10.1074/jbc.M100211200	http://dx.doi.org/10.1074/jbc.M100211200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301325	hybrid			2022-12-27	WOS:000169412700045
J	Mouton, J; Feltz, A; Maulet, Y				Mouton, J; Feltz, A; Maulet, Y			Interactions of calmodulin with two peptides derived from the C-terminal cytoplasmic domain of the Ca(v)1.2 Ca2+ channel provide evidence for a molecular switch involved in Ca2+-induced inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG VENTRICULAR MYOCYTES; CALCIUM CHANNELS; CA2+-SENSITIVE INACTIVATION; ALPHA(1C) SUBUNIT; CA2+-DEPENDENT INACTIVATION; MOTIF; BINDING; DETERMINANTS; FACILITATION; VOLTAGE	When opened by depolarization, L-type calcium channels are rapidly inactivated by the elevation of Ca2+ concentration on the cytoplasmic side, Recent studies have shown that the interaction of calmodulin with the proximal part of the cytoplasmic C-terminal tail of the channel plays a prominent role in this modulation, Two motifs interacting with calmodulin in a Ca2+-dependent manner have been described: the IQ sequence and more recently the neighboring CB sequence. Here, using synthetic peptides and fusion proteins derived from the Ca(v)1.2 channel combined with biochemical techniques, we show that these two peptides are the only motifs of the cytoplasmic tail susceptible to interact with calmodulin, We determined the K-d of the CB interaction with calmodulin to be 12 nM, i.e, below the K-d of IQ-calmodulin, thereby precluding a competitive displacement of CB by IQ in the presence of Ca2+. In place, we demonstrated that a ternary complex is formed at high Ca2+ concentration, provided that calmodulin and the peptides are initially allowed to interact at a low Ca2+ concentration. These results provide evidence that CB and IQ motifs interacting together with calmodulin constitute a minimal molecular switch leading to Ca2+-induced inactivation. In addition, we suggest that they could also be the tethering site of calmodulin.	CNRS, Lab Neurobiol Cellulaire, FRE 2180, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Maulet, Y (corresponding author), CNRS, Lab Neurobiol Cellulaire, FRE 2180, 5 Rue Blaise Pascal, F-67084 Strasbourg, France.		Maulet, Yves/AAC-3207-2019	Maulet, Yves/0000-0002-3162-0435; mouton, jerome/0000-0002-7984-3996				CAPIOD T, 1989, J PHYSIOL-LONDON, V409, P285, DOI 10.1113/jphysiol.1989.sp017497; Cens T, 1999, FEBS LETT, V450, P17, DOI 10.1016/S0014-5793(99)00463-9; Cens T, 1999, J BIOL CHEM, V274, P5483, DOI 10.1074/jbc.274.9.5483; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; ECKERT R, 1984, PROG BIOPHYS MOL BIO, V44, P215, DOI 10.1016/0079-6107(84)90009-9; GURNEY AM, 1989, NATURE, V341, P65, DOI 10.1038/341065a0; HADLEY RW, 1991, J PHYSIOL-LONDON, V444, P257, DOI 10.1113/jphysiol.1991.sp018876; Hall DR, 1996, ANAL BIOCHEM, V235, P175, DOI 10.1006/abio.1996.0109; Hofer GF, 1997, BIOPHYS J, V73, P1857, DOI 10.1016/S0006-3495(97)78216-X; KLOCKNER U, 1995, J BIOL CHEM, V270, P17306, DOI 10.1074/jbc.270.29.17306; Lakowicz J.R., 1983, PRINC FLUORESC SPECT, P341, DOI [10.1007/978-1-4615-7658-7_11, DOI 10.1007/978-1-4615-7658-7_11]; LANG DG, 1987, PFLUG ARCH EUR J PHY, V410, P614, DOI 10.1007/BF00581321; MARTIN SR, 1996, BIOCHEMISTRY-US, V35, P3506; MAULET Y, 1983, BIOCHEMISTRY-US, V22, P5680, DOI 10.1021/bi00293a035; MORAD M, 1988, SCIENCE, V241, P842, DOI 10.1126/science.2457253; OLWIN BB, 1985, BIOCHEMISTRY-US, V24, P8081, DOI 10.1021/bi00348a037; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; PLANT TD, 1983, J PHYSIOL-LONDON, V334, P189, DOI 10.1113/jphysiol.1983.sp014489; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Restituito S, 2000, J NEUROSCI, V20, P9046; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schuhmann K, 1997, J GEN PHYSIOL, V110, P503, DOI 10.1085/jgp.110.5.503; Slavik KJ, 1997, AM J PHYSIOL-CELL PH, V272, pC1475, DOI 10.1152/ajpcell.1997.272.5.C1475; Soldatov NM, 1998, J BIOL CHEM, V273, P957, DOI 10.1074/jbc.273.2.957; Soldatov NM, 1997, J BIOL CHEM, V272, P3560, DOI 10.1074/jbc.272.6.3560; YAZAWA M, 1987, J BIOL CHEM, V262, P10951; YAZAWA M, 1992, BIOCHEMISTRY-US, V31, P3171, DOI 10.1021/bi00127a018; Zhou JM, 1997, P NATL ACAD SCI USA, V94, P2301, DOI 10.1073/pnas.94.6.2301; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200; ZYGMUNT AC, 1990, J PHYSIOL-LONDON, V428, P653, DOI 10.1113/jphysiol.1990.sp018233	36	43	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22359	22367		10.1074/jbc.M100755200	http://dx.doi.org/10.1074/jbc.M100755200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294864	hybrid			2022-12-27	WOS:000169412700053
J	Salmeron, A; Janzen, J; Soneji, Y; Bump, N; Kamens, J; Allen, H; Ley, SC				Salmeron, A; Janzen, J; Soneji, Y; Bump, N; Kamens, J; Allen, H; Ley, SC			Direct phosphorylation of NF-kappa B1 p105 by the I kappa B kinase complex on serine 927 is essential for signal-induced p105 proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING SUBUNIT; UBIQUITIN LIGASE; IMMUNE-RESPONSE; DIFFERENTIAL REGULATION; TERMINAL SEQUENCES; ALPHA PROTEOLYSIS; INNATE IMMUNITY; PRECURSOR P105; REL PROTEINS; MICE LACKING	The p105 precursor protein of NF-kappa B1 acts as an NF-KB inhibitory protein, retaining associated Rel subunits in the cytoplasm of unstimulated cells. Tumor necrosis factor alpha (TNF alpha) and interleukin-1 alpha (IL-1 alpha) stimulate p105 degradation, releasing associated Rel subunits to translocate into the nucleus. By using knockout embryonic fibroblasts, it was first established that the I kappaB kinase (IKK) complex is essential for these pro-inflammatory cytokines to trigger efficiently p105 degradation. The p105 PEST domain contains a motif (Asp-Ser(927) Gly-Val Glu-Thr), related to the IKK target sequence in I kappaB alpha, which is conserved between human, mouse, rat, and chicken p105. Analysis of a panel of human p105 mutants in which serine/threonine residues within and adjacent to this motif were individually changed to alanine established that only serine 927 is essential for p105 proteolysis triggered by IKK2 overexpression. This residue is also required for TNF alpha and IL-1 alpha to stimulate p105 degradation. By using a specific anti-phosphopeptide antibody, it was confirmed that IKK2 overexpression induces serine 927 phosphorylation of co transfected p105 and that endogenous p105 is also rapidly phosphorylated on this residue after TNF alpha or IL-1 alpha stimulation. lie vitro kinase assays with purified proteins demonstrated that both IKK1 and IKK2 can directly phosphorylate p105 on serine 927. Together these experiments indicate that the IKK complex regulates the signal-induced proteolysis of NF-kappa B1 p105 by direct phosphorylation of serine 927 in its PEST domain.	Natl Inst Med Res, Div Cellular Immunol, London NW7 1AA, England; Abbott Biores Ctr, Worcester, MA 01605 USA	MRC National Institute for Medical Research	Ley, SC (corresponding author), Natl Inst Med Res, Div Cellular Immunol, The Ridgeway,Mill Hill, London NW7 1AA, England.			Soneji, Yasmina/0000-0001-9189-6348; Kamens, Joanne/0000-0002-7000-1477				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Belich MP, 1999, NATURE, V397, P363, DOI 10.1038/16946; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Betts JC, 1996, MOL CELL BIOL, V16, P6363; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; DADAMIO L, 1992, J IMMUNOL, V149, P3550; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; Heissmeyer V, 1999, EMBO J, V18, P4766, DOI 10.1093/emboj/18.17.4766; Heissmeyer V, 2001, MOL CELL BIOL, V21, P1024, DOI 10.1128/MCB.21.4.1024-1035.2001; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Ishikawa H, 1998, J EXP MED, V187, P985, DOI 10.1084/jem.187.7.985; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Lin X, 1999, IMMUNITY, V10, P271, DOI 10.1016/S1074-7613(00)80027-8; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; MacKichan ML, 1996, J BIOL CHEM, V271, P6084, DOI 10.1074/jbc.271.11.6084; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; MELLITS KH, 1993, NUCLEIC ACIDS RES, V21, P5059, DOI 10.1093/nar/21.22.5059; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; Orian A, 2000, EMBO J, V19, P2580, DOI 10.1093/emboj/19.11.2580; Orian A, 1999, MOL CELL BIOL, V19, P3664; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; RICE NR, 1992, CELL, V71, P243, DOI 10.1016/0092-8674(92)90353-E; Rudolph D, 2000, GENE DEV, V14, P854; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Shirane M, 1999, J BIOL CHEM, V274, P28169, DOI 10.1074/jbc.274.40.28169; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; WHITESIDE ST, 1995, MOL CELL BIOL, V15, P5339; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	59	111	119	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22215	22222		10.1074/jbc.M101754200	http://dx.doi.org/10.1074/jbc.M101754200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11297557	hybrid			2022-12-27	WOS:000169412700034
J	Suvorova, ES; Kurten, RC; Lupashin, VV				Suvorova, ES; Kurten, RC; Lupashin, VV			Identification of a human orthologue of Sec34p as a component of the cis-Golgi vesicle tethering machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL MEMBRANE-PROTEIN; GTP-BINDING PROTEINS; RAB5 EFFECTOR EEA1; ENDOPLASMIC-RETICULUM; TRANSPORT VESICLES; COPII VESICLES; SNARE COMPLEX; ER; YEAST; LOCALIZATION	The roles of the components of the Sec34p protein complex in intracellular membrane trafficking, first identified in the yeast Saccharomyces cerevisiae, have yet to be characterized in higher eukaryotes. We cloned a human cDNA whose predicted amino acid sequence showed 41% similarity to yeast Sec34p with homology throughout the entire coding region. Affinity-purified antibodies raised against the human SEC34 protein (hSec34p) recognized a cellular protein of 94 kDa in both soluble and membrane fractions. Like yeast Sec34p, cytosolic hSec34p migrated with an apparent molecular mass of 300 kDa on a glycerol velocity gradient, suggesting that it is part of a protein complex. Immunofluorescence microscopy localized hSec34p to the Golgi compartment in cells of all species examined, where it co-localized well with the cis/medial Golgi marker membrin and partially co-localized with cis-Golgi network marker p115 and trans-Golgi marker TGN38. The co localization with membrin was maintained at 15 degreesC and after microtubule depolymerization with nocodazole. During transport of the tsO45 vesicular stomatitis virus G protein through the Golgi, there was significant overlap with the hSec34p compartment. Green fluorescent protein-hSec34 expressed in HeLa cells was restricted to Golgi cisternae, and its membrane association was sensitive to brefeldin A treatment. Taken together, our findings indicate that hSec34p is part of a peripheral membrane protein complex localized on cis/medial Golgi cisternae where it may participate in tethering intra-Golgi transport vesicles.	Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Lupashin, VV (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, 4301 W Markham,Slot 750, Little Rock, AR 72205 USA.	lupashinvladimirv@uams.edu	Lupashin, Vladimir/AAB-4312-2020; Lupashin, Vladimir/E-3013-2013	Lupashin, Vladimir/0000-0002-2350-1962; Lupashin, Vladimir/0000-0002-2350-1962				Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Alvarez C, 1999, J CELL BIOL, V147, P1205, DOI 10.1083/jcb.147.6.1205; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; BECKERS CJM, 1987, CELL, V50, P523, DOI 10.1016/0092-8674(87)90025-0; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BRENNWALD P, 1993, NATURE, V362, P560, DOI 10.1038/362560a0; Cao H, 2000, J CELL SCI, V113, P1993; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; Chao DS, 1999, J CELL BIOL, V144, P869, DOI 10.1083/jcb.144.5.869; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; FERRONOVICK S, 1993, ANNU REV CELL BIOL, V9, P575; Fleischer B, 1974, Methods Enzymol, V31, P180; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; HUMPHREY JS, 1993, J CELL BIOL, V120, P1123, DOI 10.1083/jcb.120.5.1123; Kim DW, 1999, MOL BIOL CELL, V10, P3317, DOI 10.1091/mbc.10.10.3317; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1995, BIOCHEM SOC T, V23, P544, DOI 10.1042/bst0230544; Lupashin VV, 1996, J CELL BIOL, V132, P277, DOI 10.1083/jcb.132.3.277; Lupashin VV, 1997, MOL BIOL CELL, V8, P2659, DOI 10.1091/mbc.8.12.2659; LUZIO JP, 1990, BIOCHEM J, V270, P97, DOI 10.1042/bj2700097; Morinaga N, 1999, J BIOL CHEM, V274, P17417, DOI 10.1074/jbc.274.25.17417; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nelson DS, 1998, J CELL BIOL, V143, P319, DOI 10.1083/jcb.143.2.319; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; ROGALSKI AA, 1984, J CELL BIOL, V99, P1092, DOI 10.1083/jcb.99.3.1092; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sapperstein SK, 1996, J CELL BIOL, V132, P755, DOI 10.1083/jcb.132.5.755; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SHAYWITZ DA, 1995, J CELL BIOL, V128, P769, DOI 10.1083/jcb.128.5.769; Shugrue CA, 1999, J CELL SCI, V112, P4547; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Spelbrink RG, 1999, MOL BIOL CELL, V10, P4263, DOI 10.1091/mbc.10.12.4263; VanRheenen SM, 1999, J CELL BIOL, V147, P729, DOI 10.1083/jcb.147.4.729; VanRheenen SM, 1998, J CELL BIOL, V141, P1107, DOI 10.1083/jcb.141.5.1107; vonMollard GF, 1997, J CELL BIOL, V137, P1511, DOI 10.1083/jcb.137.7.1511; WATERS MG, 1992, J CELL BIOL, V118, P1015, DOI 10.1083/jcb.118.5.1015; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Wuestehube LJ, 1996, GENETICS, V142, P393	43	53	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22810	22818		10.1074/jbc.M011624200	http://dx.doi.org/10.1074/jbc.M011624200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11292827	hybrid			2022-12-27	WOS:000169412700111
J	Wicksteed, B; Herbert, TP; Alarcon, C; Lingohr, MK; Moss, LG; Rhodes, CJ				Wicksteed, B; Herbert, TP; Alarcon, C; Lingohr, MK; Moss, LG; Rhodes, CJ			Cooperativity between the preproinsulin mRNA untranslated regions is necessary for glucose-stimulated translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; PROINSULIN BIOSYNTHESIS; INSULIN; ISLETS; PC3; CONVERSION; MECHANISM; PROTEINS	Glucose regulates proinsulin biosynthesis via stimulation of the translation of the preproinsulin mRNA in pancreatic beta -cells, However, the mechanism by which this occurs has remained unclear. Using recombinant adenoviruses that express the preproinsulin mRNA with defined alterations, the untranslated regions (UTRs) of the preproinsulin mRNA were examined for elements that specifically control translation of the mRNA in rat pancreatic islets. These studies revealed that the preproinsulin 5 ' -UTR was necessary for glucose stimulation of preproinsulin mRNA translation, whereas the 3 ' -UTR appeared to suppress translation. However, together the 5 '- and 3 ' -UTRs acted cooperatively to markedly increase glucose-induced proinsulin biosynthesis. In primary hepatocytes the presence of the preproinsulin 3 ' -UTR led to reduced mRNA levels compared with the presence of the SV40 3 ' -UTR, consistent with the presence of mRNA stability determinants in the 3 ' -UTR that stabilize the preproinsulin mRNA in a pancreatic beta -cell-specific manner. Translation of these mRNAs in primary hepatocytes was not stimulated by glucose, indicating that regulated translation of the preproinsulin mRNA occurs in a pancreatic beta -cell-specific manner. Thus, the untranslated regions of the preproinsulin mRNA play crucial roles in regulating insulin production and therefore glucose homeostasis by regulating the translation and the stability of the preproinsulin mRNA.	Pacific NW Res Fdn, Inst Res, Seattle, WA 98122 USA; Tufts Univ New England Med Ctr, Dept Med, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Dept Physiol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts Medical Center; Tufts Medical Center; Tufts University	Rhodes, CJ (corresponding author), Pacific NW Res Fdn, Inst Res, 720 Broadway, Seattle, WA 98122 USA.	cjr@pnri.org		Herbert, Terence/0000-0001-5402-0814	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050610, R56DK050610] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK50610] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALARCON C, 1993, J BIOL CHEM, V268, P4276; ALARCON C, 1995, J CLIN INVEST, V95, P1032, DOI 10.1172/JCI117748; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; DECKER CJ, 1995, CURR OPIN CELL BIOL, V7, P386, DOI 10.1016/0955-0674(95)80094-8; DOCHERTY K, 1994, FASEB J, V8, P20, DOI 10.1096/fasebj.8.1.8299887; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Gilligan M, 1996, J BIOL CHEM, V271, P2121, DOI 10.1074/jbc.271.4.2121; Goodge KA, 2000, SEMIN CELL DEV BIOL, V11, P235, DOI 10.1006/scdb.2000.0172; GRIMALDI KA, 1987, BIOCHEM J, V245, P567, DOI 10.1042/bj2450567; GUEST PC, 1989, BIOCHEM J, V257, P431, DOI 10.1042/bj2570431; GUEST PC, 1991, BIOCHEM J, V274, P73, DOI 10.1042/bj2740073; HERBERT TP, 1998, MOL B INT U, V2, P105; HSU CJ, 1992, AM J PHYSIOL, V263, pE1106; ITOH N, 1980, NATURE, V283, P100, DOI 10.1038/283100a0; KNIGHT SW, 1992, J MOL ENDOCRINOL, V8, P225, DOI 10.1677/jme.0.0080225; KOZAK M, 1991, GENE EXPRESSION, V1, P117; LEER RJ, 1984, NUCLEIC ACIDS RES, V12, P6685, DOI 10.1093/nar/12.17.6685; MARTIN SK, 1994, FEBS LETT, V356, P279, DOI 10.1016/0014-5793(94)01284-9; Rhoads RE, 1999, J BIOL CHEM, V274, P30337, DOI 10.1074/jbc.274.43.30337; Rhodes CJ., 2000, DIABETES MELLITUS FU, P20; ROUAULT TA, 1999, TRANSLATIONAL CONTRO, P655; SACHS A, 1999, TRANSLATIONAL CONTRO, P447; SCHPPIN GT, 1995, BIOCHEM J, V313, P259; SEGLEN PO, 1984, IN VITRO BIOL SYSTEM, P231; Skelly RH, 1996, DIABETES, V45, P37, DOI 10.2337/diabetes.45.1.37; Webb GC, 2000, P NATL ACAD SCI USA, V97, P5773, DOI 10.1073/pnas.100126597; WELSH N, 1991, BIOCHEM J, V275, P23, DOI 10.1042/bj2750023; Xu G, 1998, J BIOL CHEM, V273, P4485, DOI 10.1074/jbc.273.8.4485	28	77	77	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22553	22558		10.1074/jbc.M011214200	http://dx.doi.org/10.1074/jbc.M011214200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11297542	hybrid, Green Accepted			2022-12-27	WOS:000169412700078
J	Iwata, H; Tomita, T; Maruyama, K; Iwatsubo, T				Iwata, H; Tomita, T; Maruyama, K; Iwatsubo, T			Subcellular compartment and molecular subdomain of beta-amyloid precursor protein relevant to the A beta 42-promoting effects of Alzheimer mutant presenilin 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE INHIBITORS; ENDOPLASMIC-RETICULUM; PATHOGENIC MUTATION; DISEASE INCREASE; DISTINCT SITES; APP GENE; CLEAVAGE; PEPTIDES; CELLS; GENERATION	Increased production of amyloid beta peptides ending at position 42 (A beta 42) is one of the pathogenic phenotypes caused by mutant forms of presenilins (PS) linked to familial Alzheimer's disease. To identify the subcellular compartment(s) in which familial Alzheimer's disease mutant PS2 (mt PS2) affects the gamma -cleavage of beta APP to increase A beta 42, we co-expressed the C-terminal 99-amino acid fragment of beta APP (C100) tagged with sorting signals to the endoplasmic reticulum (C100/ER) or to the trans-Golgi network (C100/TGN) together with mt PS2 in N2a cells. C100/TGN co-transfected with mt PS2 increased levels or ratios of intracellular as well as secreted A beta 42 at similar levels to those with C100 without signals (C100/WT), whereas C100/ER yielded a negligible level of A beta, which was not affected by co-transfection of mt PS2, To identify the molecular subdomain of beta APP required for the effects of mt PS2, we next co-expressed C100 variously truncated at the C-terminal cytoplasmic domain together with mt PS2, All types of C-terminally truncated C100 variants including that lacking the entire cytoplasmic domain yielded the secreted form of A beta at levels comparable with those from C100/WT, and cotransfection of mt PS2 increased the secretion of A beta 42, These results suggest that (i) late intracellular compartments including TGN are the major sites in which A beta 42 is produced and up-regulated by mt PS2 and that (ii) the anterior half of C100 lacking the entire cytoplasmic domain is sufficient for the overproduction of A beta 42 caused by mt PS2.	Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Bunkyo Ku, Tokyo 1130033, Japan; Saitama Med Sch, Dept Pharmacol, Moroyama, Saitama 3500495, Japan	University of Tokyo; Saitama Medical University	Iwatsubo, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	iwatsubo@mol.f.u-tokyo.ac.jp	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943				Ancolio K, 1999, P NATL ACAD SCI USA, V96, P4119, DOI 10.1073/pnas.96.7.4119; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; De Strooper B, 2000, J CELL SCI, V113, P1857; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; IWATSUBO T, 1995, ANN NEUROL, V37, P294, DOI 10.1002/ana.410370305; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kwok JBJ, 2000, ANN NEUROL, V47, P249, DOI 10.1002/1531-8249(200002)47:2<249::AID-ANA18>3.3.CO;2-#; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; MARUYAMA K, 1990, NATURE, V347, P566, DOI 10.1038/347566a0; Maruyama K, 1996, BIOCHEM BIOPH RES CO, V227, P730, DOI 10.1006/bbrc.1996.1577; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Peraus GC, 1997, J NEUROSCI, V17, P7714; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Soriano S, 1999, J BIOL CHEM, V274, P32295, DOI 10.1074/jbc.274.45.32295; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Sudoh S, 2000, EUR J BIOCHEM, V267, P2036, DOI 10.1046/j.1432-1327.2000.01206.x; Sudoh S, 1998, J NEUROCHEM, V71, P1535; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 1998, J BIOL CHEM, V273, P21153, DOI 10.1074/jbc.273.33.21153; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomita T, 1998, NEUROREPORT, V9, P911, DOI 10.1097/00001756-199803300-00027; USAMI M, 1993, J NEUROCHEM, V61, P239, DOI 10.1111/j.1471-4159.1993.tb03560.x; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia WM, 1998, BIOCHEMISTRY-US, V37, P16465, DOI 10.1021/bi9816195; Yamazaki T, 2001, J BIOL CHEM, V276, P4454, DOI 10.1074/jbc.M009598200	62	54	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21678	21685		10.1074/jbc.M007989200	http://dx.doi.org/10.1074/jbc.M007989200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11283011	hybrid			2022-12-27	WOS:000169297900117
J	Dart, C; Leyland, ML				Dart, C; Leyland, ML			Targeting of an a kinase-anchoring protein, AKAP79, to an inwardly rectifying potassium channel, Kir2.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER K+ CHANNELS; PHOSPHORYLATION; EXPRESSION; RECEPTORS; COMPLEX; RII; CYTOSKELETON; CONDUCTANCE; ASSOCIATION; INHIBITION	Protein kinase A (PKA) is targeted to discrete subcellular locations close to its intended substrates through interaction with A kinase-anchoring proteins (AKAPs), Ion channels represent a diverse and important group of kinase substrates, and it has been shown that membrane targeting of PKA through association with AKAPs facilitates PKA-mediated phosphorylation and regulation of several classes of ion channel. Here, we investigate the effect of AKAP79, a membrane associated multivalent-anchoring protein, upon the function and modulation of the strong inwardly rectifying potassium channel, Kir2.1. Functionally, the presence of AKAP79 enhanced the response of Kir2.1 to elevated intracellular cAMP, suggesting a requirement for a pool of PKA anchored close to the channel. Antibodies directed against a hemagglutinin epitope tag on Kir2.1 coimmunoprecipitated AKAP79, indicating that the two proteins exist together in a complex within intact cells. In support of this, glutathione S-transferase fusion proteins of both the intracellular N and C domains of Kir2.1 isolated AKAP79 from cell lysates, while glutathione S-transferase alone failed to interact with AKAP79. Together, these findings suggest that AKAP79 associates directly with the Kir2.1 ion channel and may serve to anchor kinase enzymes in close proximity to key channel phosphorylation sites.	Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leicester	Dart, C (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, POB 138, Leicester LE1 9HN, Leics, England.			Dart, Caroline/0000-0002-3509-8349				Ali S, 1998, P NATL ACAD SCI USA, V95, P10274, DOI 10.1073/pnas.95.17.10274; CARR DW, 1991, J BIOL CHEM, V266, P14188; CASSOLA AC, 1993, AM J PHYSIOL, V264, pF502, DOI 10.1152/ajprenal.1993.264.3.F502; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Dart C, 1998, J PHYSIOL-LONDON, V511, P15, DOI 10.1111/j.1469-7793.1998.015bi.x; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; DellAcqua ML, 1997, J BIOL CHEM, V272, P12881, DOI 10.1074/jbc.272.20.12881; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; FAKLER B, 1994, NEURON, V13, P1413, DOI 10.1016/0896-6273(94)90426-X; Faux MC, 1996, TRENDS BIOCHEM SCI, V21, P312, DOI 10.1016/0968-0004(96)10040-2; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; GLANTZ SB, 1993, J BIOL CHEM, V268, P12796; Gray PC, 1998, NEURON, V20, P1017, DOI 10.1016/S0896-6273(00)80482-1; Hausken ZE, 1996, J BIOL CHEM, V271, P29016, DOI 10.1074/jbc.271.46.29016; Henry P, 1996, J PHYSIOL-LONDON, V495, P681, DOI 10.1113/jphysiol.1996.sp021625; Hille B, 1992, IONIC CHANNELS EXCIT, P127; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Karschin A, 1999, NEWS PHYSIOL SCI, V14, P215; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Leyland ML, 1999, PFLUG ARCH EUR J PHY, V438, P778, DOI 10.1007/s004240051106; Li Y, 1996, J BIOL CHEM, V271, P16862, DOI 10.1074/jbc.271.28.16862; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Nehring RB, 2000, J NEUROSCI, V20, P156, DOI 10.1523/JNEUROSCI.20-01-00156.2000; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; Ruppersberg JP, 2000, PFLUG ARCH EUR J PHY, V441, P1, DOI 10.1007/s004240000380; WANG WH, 1994, AM J PHYSIOL-RENAL, V267, pF599, DOI 10.1152/ajprenal.1994.267.4.F599; Wang ZW, 1996, AM J PHYSIOL-LUNG C, V271, pL100, DOI 10.1152/ajplung.1996.271.1.L100; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Wischmeyer E, 1996, P NATL ACAD SCI USA, V93, P5819, DOI 10.1073/pnas.93.12.5819	38	54	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20499	20505		10.1074/jbc.M101425200	http://dx.doi.org/10.1074/jbc.M101425200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11287423	hybrid			2022-12-27	WOS:000169135100111
J	Bacolla, A; Jaworski, A; Connors, TD; Wells, RD				Bacolla, A; Jaworski, A; Connors, TD; Wells, RD			PKD1 unusual DNA conformations are recognized by nucleotide excision repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							POLYCYSTIC KIDNEY-DISEASE; LEFT-HANDED DNA; CENTER-DOT-CAG; NONSENSE MUTATION; TRIPLET REPEATS; STRUCTURAL TRANSITIONS; INTRAMOLECULAR TRIPLEX; MOLECULAR-GENETICS; CRYSTAL-STRUCTURE; REPEATED PART	The 2.5-kilobase pair poly(purine pyrimidine) (poly(R.Y)) tract present in intron 21 of the polycystic kidney disease 1 (PKD1) gene has been proposed to contribute to the high mutation frequency of the gene. To evaluate this hypothesis, we investigated the growth rates of II Escherichia coli strains, with mutations in the nucleotide excision repair, SOS, and topoisomerase I and/or gyrase genes, harboring plasmids containing the full-length tract, six 5'-truncations of the tract, and a control plasmid (pSPL3), The full-length poly(R.Y) tract induced dramatic losses of cell viability during the first few hours of growth and lengthened the doubling times of the populations in strains with an inducible SOS response. The extent of cell loss was correlated with the length of the poly(R.Y) tract and the levels of negative supercoiling as modulated by the genotype of the strains or drugs that specifically inhibited DNA gyrase or bound to DNA directly, thereby affecting conformations at specific loci. We conclude that the unusual DNA conformations formed by the PKD1 poly(R.Y) tract under the influence of negative supercoiling induced the SOS response pathway, and they were recognized as lesions by the nucleotide excision repair system and were cleaved, causing delays in cell division and loss of the plasmid, These data support a role for this sequence in the mutation of the PKD1 gene by stimulating repair and/or recombination functions.	Texas A&M Univ, Hlth Sci Ctr, Texas Med Ctr, Inst Biosci & Technol,Ctr Genome Res, Houston, TX 77030 USA; Genzyme Corp, Framingham, MA 01701 USA	Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Sanofi-Aventis; Genzyme Corporation	Wells, RD (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Texas Med Ctr, Inst Biosci & Technol,Ctr Genome Res, 2121 Holcombe Blvd, Houston, TX 77030 USA.	rwells@ibt.tamu.edu	Bacolla, Albino/N-3877-2013; Bacolla, Albino/AAP-1727-2020	Bacolla, Albino/0000-0003-0206-8423; Bacolla, Albino/0000-0003-0206-8423	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM052982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037554] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 52982] Funding Source: Medline; NINDS NIH HHS [NS 37554] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Afzal AR, 1999, HUM GENET, V105, P648, DOI 10.1007/s004390051157; Bacolla A, 1997, J BIOL CHEM, V272, P16783, DOI 10.1074/jbc.272.27.16783; BACOLLA A, 1995, J BIOL CHEM, V270, P24556, DOI 10.1074/jbc.270.41.24556; Badenas C, 1999, KIDNEY INT, V55, P1225, DOI 10.1046/j.1523-1755.1999.00368.x; Bailly Christian, 1992, Journal of Molecular Recognition, V5, P155, DOI 10.1002/jmr.300050406; Barre FX, 2000, P NATL ACAD SCI USA, V97, P3084, DOI 10.1073/pnas.050368997; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bierne H, 1997, MOL MICROBIOL, V26, P557, DOI 10.1046/j.1365-2958.1997.6011973.x; Blaszak RT, 1999, NUCLEIC ACIDS RES, V27, P2610, DOI 10.1093/nar/27.13.2610; Bowater RP, 2001, PROG NUCLEIC ACID RE, V66, P159; Bowater RP, 1996, J MOL BIOL, V264, P82, DOI 10.1006/jmbi.1996.0625; Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; Budavari S., 1989, MERCK INDEX; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; Calvet JP, 1998, J NEPHROL, V11, P24; Chen DR, 1999, J MOL BIOL, V285, P443, DOI 10.1006/jmbi.1998.2358; CHEN FM, 1991, BIOCHEMISTRY-US, V30, P4472, DOI 10.1021/bi00232a014; COLL M, 1989, BIOCHEMISTRY-US, V28, P310, DOI 10.1021/bi00427a042; Courcelle J, 1999, MOL GEN GENET, V262, P543, DOI 10.1007/s004380051116; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cozzarelli N. R., 1990, DNA TOPOLOGY ITS BIO, P139; Daniells C, 1998, HUM GENET, V102, P216, DOI 10.1007/s004390050681; Duong TH, 1997, J BIOMOL STRUCT DYN, V14, P691, DOI 10.1080/07391102.1997.10508172; Freudenreich CH, 1997, MOL CELL BIOL, V17, P2090, DOI 10.1128/MCB.17.4.2090; GEORGE JW, 1994, J MOL BIOL, V235, P424, DOI 10.1006/jmbi.1994.1003; Gilbert DE, 1999, CURR OPIN STRUC BIOL, V9, P305, DOI 10.1016/S0959-440X(99)80041-4; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Grunfeld JP, 1999, J NEPHROL, V12, pS42; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; HANVEY JC, 1988, J BIOL CHEM, V263, P7386; HANVEY JC, 1988, P NATL ACAD SCI USA, V85, P6292, DOI 10.1073/pnas.85.17.6292; Harris PC, 1999, HUM MOL GENET, V8, P1861, DOI 10.1093/hmg/8.10.1861; Herbert A, 1999, GENETICA, V106, P37, DOI 10.1023/A:1003768526018; Ibraghimov-Beskrovnaya O, 2000, HUM MOL GENET, V9, P1641, DOI 10.1093/hmg/9.11.1641; JAWORSKI A, 1987, SCIENCE, V238, P773, DOI 10.1126/science.3313728; JAWORSKI A, 1995, P NATL ACAD SCI USA, V92, P11019, DOI 10.1073/pnas.92.24.11019; JAWORSKI A, 1989, J MOL BIOL, V207, P513, DOI 10.1016/0022-2836(89)90461-0; KAMITORI S, 1992, J MOL BIOL, V225, P445, DOI 10.1016/0022-2836(92)90931-9; KLYSIK J, 1982, J BIOL CHEM, V257, P152; KLYSIK J, 1981, NATURE, V290, P672, DOI 10.1038/290672a0; KOCH WH, 1998, DNA DAMAGE REPAIR, V1, P107; KOPKA ML, 1985, J MOL BIOL, V183, P553, DOI 10.1016/0022-2836(85)90171-8; Koptides M, 1998, HUM GENET, V103, P709, DOI 10.1007/s004390050896; Lewis RJ, 1996, EMBO J, V15, P1412, DOI 10.1002/j.1460-2075.1996.tb00483.x; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MIRAU PA, 1983, NUCLEIC ACIDS RES, V11, P1931, DOI 10.1093/nar/11.6.1931; MIRKIN SM, 1994, ANNU REV BIOPH BIOM, V23, P541, DOI 10.1146/annurev.bb.23.060194.002545; Moolenaar GF, 1998, J BIOL CHEM, V273, P34896, DOI 10.1074/jbc.273.52.34896; Moolenaar GF, 2000, J BACTERIOL, V182, P5706, DOI 10.1128/JB.182.20.5706-5714.2000; Murcia NS, 1998, PEDIATR NEPHROL, V12, P721, DOI 10.1007/s004670050534; Neophytou P, 1996, HUM GENET, V98, P437, DOI 10.1007/s004390050235; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; OSSANNA N, 1989, J BACTERIOL, V171, P303, DOI 10.1128/jb.171.1.303-307.1989; PARK YW, 1992, P NATL ACAD SCI USA, V89, P6653, DOI 10.1073/pnas.89.14.6653; Parniewski P, 1999, NUCLEIC ACIDS RES, V27, P616, DOI 10.1093/nar/27.2.616; Peral B, 1996, HUM MOL GENET, V5, P539, DOI 10.1093/hmg/5.4.539; Peral B, 1996, AM J HUM GENET, V58, P86; Peral B, 1997, AM J HUM GENET, V60, P1399, DOI 10.1086/515467; PERAL B, 1995, HUM MOL GENET, V4, P569, DOI 10.1093/hmg/4.4.569; Perrichot RA, 1999, HUM GENET, V105, P231, DOI 10.1007/s004390051094; Podtelezhnikov AA, 1999, P NATL ACAD SCI USA, V96, P12974, DOI 10.1073/pnas.96.23.12974; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; RAHMOUNI AR, 1992, J MOL BIOL, V223, P131, DOI 10.1016/0022-2836(92)90721-U; Roelfsema JH, 1997, AM J HUM GENET, V61, P1044, DOI 10.1086/301600; ROSCHE WA, 1995, J BACTERIOL, V177, P4385, DOI 10.1128/jb.177.15.4385-4391.1995; Rossetti S, 1996, AM J MED GENET, V65, P155, DOI 10.1002/(SICI)1096-8628(19961016)65:2<155::AID-AJMG15>3.0.CO;2-P; Rybenkov VV, 1997, SCIENCE, V277, P690, DOI 10.1126/science.277.5326.690; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SHIMIZU M, 1989, J BIOL CHEM, V264, P5944; Shimizu M, 1996, J MOL BIOL, V258, P614, DOI 10.1006/jmbi.1996.0273; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; Sinden RR, 1998, ADV GENOM B, V5, P1; Smith BT, 1998, GENETICS, V148, P1599; SNOUNOU G, 1983, J MOL BIOL, V167, P211, DOI 10.1016/S0022-2836(83)80043-6; Soyfer V.N., 1996, TRIPLE HELICAL NUCL; STORL K, 1993, FEBS LETT, V334, P49, DOI 10.1016/0014-5793(93)81678-S; Thomas R, 1999, AM J HUM GENET, V65, P39, DOI 10.1086/302460; Thongnoppakhun A, 2000, Hum Mutat, V15, P115, DOI 10.1002/(SICI)1098-1004(200001)15:1<115::AID-HUMU22>3.0.CO;2-Z; Torra R, 1998, HUM MUTAT, pS117; TRINH TQ, 1993, GENETICS, V134, P409; Tsai FTF, 1997, PROTEINS, V28, P41; TSAO YP, 1989, CELL, V56, P111, DOI 10.1016/0092-8674(89)90989-6; Turco AE, 1997, HUM MUTAT, V10, P164, DOI 10.1002/(SICI)1098-1004(1997)10:2<164::AID-HUMU9>3.3.CO;2-8; TURCO AE, 1995, HUM MOL GENET, V4, P1331, DOI 10.1093/hmg/4.8.1331; van Adelsberg JS, 1999, PEDIATR NEPHROL, V13, P454, DOI 10.1007/s004670050639; Van Raay T J, 1996, Microb Comp Genomics, V1, P317; VOLOGODSKII AV, 1994, ANNU REV BIOPH BIOM, V23, P609, DOI 10.1146/annurev.bb.23.060194.003141; WALKER GT, 1985, BIOCHEMISTRY-US, V24, P7471, DOI 10.1021/bi00346a066; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; WARD CJ, 1994, CELL, V77, P881; WARTELL RM, 1974, J BIOL CHEM, V249, P6719; Watnick T, 1999, AM J HUM GENET, V65, P1561, DOI 10.1086/302657; Watnick TJ, 1997, HUM MOL GENET, V6, P1473, DOI 10.1093/hmg/6.9.1473; Watnick TJ, 1998, HUM MOL GENET, V7, P1239, DOI 10.1093/hmg/7.8.1239; Wells R.D., 1988, UNUSUAL DNA STRUCTUR; WELLS RD, 1970, J MOL BIOL, V49, P319, DOI 10.1016/0022-2836(70)90248-2; White PJ, 1999, MOL CELL BIOL, V19, P5675; Wilson W. D., 1994, Journal of Molecular Recognition, V7, P89, DOI 10.1002/jmr.300070206; Wu GQ, 2000, MOL GENET METAB, V69, P1, DOI 10.1006/mgme.1999.2943; ZACHARIAS W, 1988, P NATL ACAD SCI USA, V85, P7069, DOI 10.1073/pnas.85.19.7069; Zechiedrich EL, 2000, J BIOL CHEM, V275, P8103, DOI 10.1074/jbc.275.11.8103; Zimmer C, 1975, Prog Nucleic Acid Res Mol Biol, V15, P285, DOI 10.1016/S0079-6603(08)60122-1	105	52	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18597	18604		10.1074/jbc.M100845200	http://dx.doi.org/10.1074/jbc.M100845200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279140	hybrid			2022-12-27	WOS:000168866500130
J	Kasparkova, J; Pospisilova, S; Brabec, V				Kasparkova, J; Pospisilova, S; Brabec, V			Different recognition of DNA modified by antitumor cisplatin and its clinically ineffective trans isomer by tumor suppressor protein p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTRAND CROSS-LINKS; SUPERCOILED DNA; MAJOR ADDUCT; PLATINUM; BINDING; DRUG; DUPLEX; SITE; CIS-DIAMMINEDICHLOROPLATINUM(II); SPECIFICITY	The p53 gene encodes a nuclear phosphoprotein that is biologically activated in response to genotoxic stresses including treatment with anticancer platinum drugs. The DNA binding activity of p53 protein is crucial for its tumor suppressor function. DNA interactions of active wild-type human p53 protein with DNA fragments and oligodeoxyribonucleotide duplexes modified by antitumor cisplatin and its clinically ineffective trans isomer (transplatin) were investigated by using a gel mobility shift assay. It was found that DNA adducts of cisplatin reduced binding affinity of the consensus DNA sequence to p53, whereas transplatin adducts did not. This result was interpreted to mean that the precise steric fit required for the formation and stability of the tetrameric complex of p53 with the consensus sequence cannot be attained, as a consequence of severe conformational perturbations induced in DNA by cisplatin adducts. The results also demonstrate an increase of the binding affinity of p53 to DNA lacking the consensus sequence and modified by cisplatin but not by transplatin. In addition, only major 1,2-GG intrastrand crosslinks of cisplatin are responsible for this enhanced binding affinity of p53. The data base on structures of various DNA adducts of cisplatin and transplatin reveals distinctive structural features of 1,2-intrastrand cross-links of cisplatin, suggesting a unique role for this adduct in the binding of p53 to DNA lacking the consensus sequence. The results support the hypothesis that the mechanism of antitumor activity of cisplatin may also be associated with its efficiency to affect the binding affinity of platinated DNA to active p53 protein.	Acad Sci Czech Republ, Inst Biophys, CZ-61265 Brno, Czech Republic; Masaryk Mem Canc Inst, CZ-65653 Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk Memorial Cancer Institute	Brabec, V (corresponding author), Acad Sci Czech Republ, Inst Biophys, Kralovopolska 135, CZ-61265 Brno, Czech Republic.	brabec@ibp.cz	Brabec, Viktor/H-1946-2014; Pospisilova, Sarka/D-7200-2012	Brabec, Viktor/0000-0002-8233-1393; Pospisilova, Sarka/0000-0001-7136-2680				Bates S, 1999, CELL MOL LIFE SCI, V55, P28, DOI 10.1007/s000180050267; BELLON SF, 1991, BIOCHEMISTRY-US, V30, P8026, DOI 10.1021/bi00246a021; BRABEC V, 1990, BIOPHYS CHEM, V35, P129, DOI 10.1016/0301-4622(90)80003-P; BRABEC V, 1993, P NATL ACAD SCI USA, V90, P5345, DOI 10.1073/pnas.90.11.5345; BRABEC V, 1993, BIOCHEMISTRY-US, V32, P11676, DOI 10.1021/bi00094a025; Brabec V, 2000, CANC DRUG DISC DEV, V7, P37; Brabec V, 2000, J BIOL INORG CHEM, V5, P364, DOI 10.1007/PL00010665; BRABEC V, 1992, BIOCHEMISTRY-US, V31, P12397, DOI 10.1021/bi00164a014; Burns TF, 1999, J CELL PHYSIOL, V181, P231, DOI 10.1002/(SICI)1097-4652(199911)181:2<231::AID-JCP5>3.0.CO;2-L; Eastman A., 1999, CISPLATIN CHEM BIOCH, P111, DOI [DOI 10.1002/9783906390420.CH4, 10.1002/9783906390420.ch4]; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Gelasco A, 1998, BIOCHEMISTRY-US, V37, P9230, DOI 10.1021/bi973176v; HUPP TR, 1995, J BIOL CHEM, V270, P18165, DOI 10.1074/jbc.270.30.18165; Imamura T, 2001, J BIOL CHEM, V276, P7534, DOI 10.1074/jbc.M008143200; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Janus F, 1999, CELL MOL LIFE SCI, V55, P12, DOI 10.1007/s000180050266; Jordan P, 2000, CELL MOL LIFE SCI, V57, P1229, DOI 10.1007/PL00000762; KASPARKOVA J, 1995, BIOCHEMISTRY-US, V34, P12379, DOI 10.1021/bi00038a035; Kasparkova J, 2000, J BIOL CHEM, V275, P15789, DOI 10.1074/jbc.M000777200; KECK MV, 1992, J AM CHEM SOC, V114, P3386, DOI 10.1021/ja00035a033; KIM SD, 1990, ANAL LETT, V23, P1505, DOI 10.1080/00032719008052504; LEMAIRE MA, 1991, P NATL ACAD SCI USA, V88, P1982, DOI 10.1073/pnas.88.5.1982; Leng M, 2000, MOL PHARMACOL, V58, P1525, DOI 10.1124/mol.58.6.1525; Leng M, 2000, CANC DRUG DISC DEV, V7, P63; May P, 1999, ONCOGENE, V18, P7621, DOI 10.1038/sj.onc.1203285; Mazur SJ, 1999, J MOL BIOL, V292, P241, DOI 10.1006/jmbi.1999.3064; Nagaich AK, 1999, P NATL ACAD SCI USA, V96, P1875, DOI 10.1073/pnas.96.5.1875; O'Dwyer P. J., 1999, CISPLATIN CHEM BIOCH, P31; OConnor PM, 1997, CANCER RES, V57, P4285; Rosenberg B, 1999, CISPLATIN CHEM BIOCH, P1, DOI DOI 10.1002/9783906390420; Teuben JM, 1999, BIOCHEMISTRY-US, V38, P12305, DOI 10.1021/bi9904757; VOJTESEK B, 1992, J IMMUNOL METHODS, V151, P237, DOI 10.1016/0022-1759(92)90122-A; Wetzel CC, 1998, ONCOL RES, V10, P151; Wong E, 1999, CHEM REV, V99, P2451, DOI 10.1021/cr980420v; YANG DZ, 1995, BIOCHEMISTRY-US, V34, P12912, DOI 10.1021/bi00039a054; Zamble DB, 1998, P NATL ACAD SCI USA, V95, P6163, DOI 10.1073/pnas.95.11.6163; ZAMBLE DB, 1999, CISPLATIN CHEM BIOCH, P73	37	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16064	16069		10.1074/jbc.M101224200	http://dx.doi.org/10.1074/jbc.M101224200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279186	hybrid			2022-12-27	WOS:000168623100068
J	Skov, LK; Mirza, O; Henriksen, A; De Montalk, GP; Remaud-Simeon, M; Sarcabal, P; Willemot, RM; Monsan, P; Gajhede, M				Skov, LK; Mirza, O; Henriksen, A; De Montalk, GP; Remaud-Simeon, M; Sarcabal, P; Willemot, RM; Monsan, P; Gajhede, M			Amylosucrase, a glucan-synthesizing enzyme from the alpha-amylase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-POLYSACCHAREA; CRYSTAL-STRUCTURE; X-RAY; ANGSTROM RESOLUTION; GLYCOSYL HYDROLASES; SEQUENCE; INSIGHTS; GLYCOGEN; RESIDUES; TOOL	Amylosucrase (E,C, 2.4.1.4) is a member of Family 13 of the glycoside hydrolases (the alpha -amylases), although its biological function is the synthesis of amylose-like polymers from sucrose. The structure of amylosucrase from Neisseria polysaccharea is divided into five domains: an all helical N-terminal domain that is not similar to any known fold, a (beta/alpha)(8)-barrel A-domain, B- and B'-domains displaying alpha/beta -structure, and a C-terminal eight-stranded beta -sheet domain. In contrast to other Family 13 hydrolases that have the active site in the bottom of a large cleft, the active site of amylosucrase is at the bottom of a pocket at the molecular surface. A substrate binding site resembling the amylase 2 subsite is not found in amylosucrase, The site is blocked by a salt bridge between residues in the second and eight loops of the (beta/alpha)(8)-barrel. The result is an exo-acting enzyme. Loop 7 in the amylosucrase barrel is prolonged compared with the loop structure found in other hydrolases, and this insertion (forming domain B') is suggested to be important for the polymer synthase activity of the enzyme. The topology of the B'-domain creates an active site entrance with several ravines in the molecular surface that could be used specifically by the substrates/ products (sucrose, glucan polymer, and fructose) that have to get in and out of the active site pocket.	Univ Copenhagen, Dept Chem, Prot Struct Grp, DK-2100 Copenhagen, Denmark; Inst Natl Sci Appl, CNRS, UMR 5504,INRA,UMR 792, Ctr Bioingn G Durand,Dept Genie Biochim & Aliment, F-31077 Toulouse 4, France	University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse	Gajhede, M (corresponding author), Univ Copenhagen, Dept Chem, Prot Struct Grp, Univ Parken 5, DK-2100 Copenhagen, Denmark.			Mirza, Osman Asghar/0000-0001-9435-0690; Gajhede, Michael/0000-0001-9864-2287; Henriksen, Anette/0000-0003-4051-5079				Aghajari N, 1998, STRUCTURE, V6, P1503, DOI 10.1016/S0969-2126(98)00149-X; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i; Buttcher V, 1997, J BACTERIOL, V179, P3324; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; de Montalk GP, 2000, FEMS MICROBIOL LETT, V186, P103; de Montalk GP, 2000, FEBS LETT, V471, P219, DOI 10.1016/S0014-5793(00)01406-X; De Montalk GP, 1999, J BACTERIOL, V181, P375; HEHRE EJ, 1946, J BIOL CHEM, V166, P777; HEHRE EJ, 1949, J BIOL CHEM, V177, P267; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KADZIOLA A, 1994, J MOL BIOL, V239, P104, DOI 10.1006/jmbi.1994.1354; Kamitori S, 1999, J MOL BIOL, V287, P907, DOI 10.1006/jmbi.1999.2647; Kim JS, 1999, J BIOL CHEM, V274, P26279, DOI 10.1074/jbc.274.37.26279; KLEIN C, 1991, J MOL BIOL, V217, P737, DOI 10.1016/0022-2836(91)90530-J; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MACKENZIE CR, 1978, CAN J MICROBIOL, V24, P357, DOI 10.1139/m78-060; MATSUURA Y, 1984, J BIOCHEM-TOKYO, V95, P697, DOI 10.1093/oxfordjournals.jbchem.a134659; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PREISS J, 1994, PROG NUCLEIC ACID RE, V47, P299, DOI 10.1016/S0079-6603(08)60255-X; RIOU JY, 1983, ANN INST PASTEUR MIC, VB134, P257, DOI 10.1016/S0769-2609(83)80038-6; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Sarcabal P, 2000, FEBS LETT, V474, P33, DOI 10.1016/S0014-5793(00)01567-2; Skov LK, 2000, ACTA CRYSTALLOGR D, V56, P203, DOI 10.1107/S0907444999015887; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Watanabe K, 1997, J MOL BIOL, V269, P142, DOI 10.1006/jmbi.1997.1018; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571	38	137	143	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					25273	25278		10.1074/jbc.M010998200	http://dx.doi.org/10.1074/jbc.M010998200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11306569	Green Published, hybrid			2022-12-27	WOS:000169800700112
J	Benaroudj, N; Lee, DH; Goldberg, AL				Benaroudj, N; Lee, DH; Goldberg, AL			Trehalose accumulation during cellular stress protects cells and cellular proteins from damage by oxygen radicals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; MAMMALIAN-CELLS; TREHALOSE-6-PHOSPHATE SYNTHASE; SELECTIVE DEGRADATION; DESICCATION TOLERANCE; TRANSIENT ADAPTATION; MOLECULAR CHAPERONES; MODIFIED HEMOGLOBIN	The disaccharide trehalose, which accumulates dramatically during heat shock and stationary phase in many organisms, enhances thermotolerance and reduces aggregation of denatured proteins. Here we re port a new role for trehalose in protecting cells against oxygen radicals. Exposure of Saccharomyces cerevisiae to a mild heat shock (38 degreesC) or to a proteasome inhibitor (MG132) induced trehalose accumulation and markedly increased the viability of the cells upon exposure to a free radical-generating system (H2O2/iron). When cells were returned to normal growth temperature (28 degreesC) or MG132 was removed from the medium, the trehalose content and resistance to oxygen radicals decreased rapidly, Furthermore, a mutant unable to synthesize trehalose was much more sensitive to killing by oxygen radicals than wild-type cells. Providing trehalose exogenously enhanced the resistance of mutant cells to H2O2. Exposure of cells to H2O2 caused oxidative damage to amino acids in cellular proteins, and trehalose accumulation was found to reduce such damage. After even brief exposure to H2O2, the trehalose-deficient mutant exhibited a much higher content of oxidatively damaged proteins than wild-type cells. Trehalose accumulation decreased the initial appearance of damaged proteins, presumably by acting as a free radical scavenger. Therefore, trehalose accumulation in stressed cells plays a major role in protecting cellular constituents from oxidative damage.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.			Benaroudj, Nadia/0000-0002-6475-0041				ARNES BN, 1993, P NATL ACAD SCI USA, V90, P7915; ATTFIELD PV, 1987, FEBS LETT, V225, P259, DOI 10.1016/0014-5793(87)81170-5; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bell W, 1998, J BIOL CHEM, V273, P33311, DOI 10.1074/jbc.273.50.33311; BELL W, 1992, EUR J BIOCHEM, V209, P951, DOI 10.1111/j.1432-1033.1992.tb17368.x; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; CAVICCHIOLI R, 1986, FEBS LETT, V207, P149, DOI 10.1016/0014-5793(86)80030-8; Chaturvedi V, 1996, J IMMUNOL, V156, P3836; COLLINSON LP, 1992, J GEN MICROBIOL, V138, P329, DOI 10.1099/00221287-138-2-329; COSTA V, 1993, ARCH BIOCHEM BIOPHYS, V300, P608, DOI 10.1006/abbi.1993.1084; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; DAVIES JMS, 1995, ARCH BIOCHEM BIOPHYS, V317, P1, DOI 10.1006/abbi.1995.1128; DAVIES KJA, 1987, J BIOL CHEM, V262, P8227; DEVIRGILIO C, 1993, EUR J BIOCHEM, V212, P315; DEVIRGILIO C, 1994, EUR J BIOCHEM, V219, P179; Dukan S, 1998, GENE DEV, V12, P3431, DOI 10.1101/gad.12.21.3431; Elliott B, 1996, GENETICS, V144, P923; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; GIULIVI C, 1994, ARCH BIOCHEM BIOPHYS, V311, P329, DOI 10.1006/abbi.1994.1245; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; GOUNALAKI N, 1994, EMBO J, V13, P4036, DOI 10.1002/j.1460-2075.1994.tb06720.x; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Guo N, 2000, NAT BIOTECHNOL, V18, P168, DOI 10.1038/72616; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hazell BW, 1995, FEBS LETT, V377, P457, DOI 10.1016/0014-5793(95)01392-X; HENGGEARONIS R, 1991, J BACTERIOL, V173, P7918, DOI 10.1128/jb.173.24.7918-7924.1991; Henle ES, 1997, J BIOL CHEM, V272, P19095, DOI 10.1074/jbc.272.31.19095; HOTTIGER T, 1987, FEBS LETT, V220, P113, DOI 10.1016/0014-5793(87)80886-4; HOTTIGER T, 1994, EUR J BIOCHEM, V219, P187, DOI 10.1111/j.1432-1033.1994.tb19929.x; Jennings DB, 1998, P NATL ACAD SCI USA, V95, P15129, DOI 10.1073/pnas.95.25.15129; KIENLE I, 1993, YEAST, V9, P607, DOI 10.1002/yea.320090607; Lee DH, 1998, MOL CELL BIOL, V18, P30, DOI 10.1128/MCB.18.1.30; Lee J, 1995, MICROBIOL-SGM, V141, P3127, DOI 10.1099/13500872-141-12-3127; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Li SH, 1996, J PHARM SCI, V85, P868, DOI 10.1021/js9504550; LILLIE SH, 1980, J BACTERIOL, V143, P1384, DOI 10.1128/JB.143.3.1384-1394.1980; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LITCHFIELD WJ, 1978, ARCH BIOCHEM BIOPHYS, V188, P26, DOI 10.1016/0003-9861(78)90351-X; Mizisin AP, 1997, NEUROSCI LETT, V229, P53, DOI 10.1016/S0304-3940(97)00416-3; MIZISIN AP, 1996, AM J PHYSIOL, V270, P90; MoradasFerreira P, 1996, MOL MICROBIOL, V19, P651, DOI 10.1046/j.1365-2958.1996.403940.x; PACIFICI RE, 1993, J BIOL CHEM, V268, P15405; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Rego AC, 1996, FREE RADICAL BIO MED, V20, P175, DOI 10.1016/0891-5849(95)02029-2; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; SHERMAN MY, 1998, EXPT BASEL S, V77, P57; Singer MA, 1998, TRENDS BIOTECHNOL, V16, P460, DOI 10.1016/S0167-7799(98)01251-7; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Sitte N, 1998, FEBS LETT, V440, P399, DOI 10.1016/S0014-5793(98)01495-1; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; TAKAHASHI R, 1990, ARCH BIOCHEM BIOPHYS, V277, P228, DOI 10.1016/0003-9861(90)90573-H; Tamarit J, 1998, J BIOL CHEM, V273, P3027, DOI 10.1074/jbc.273.5.3027; TAUBER AI, 1977, J CLIN INVEST, V60, P374, DOI 10.1172/JCI108786; WIESE AG, 1995, ARCH BIOCHEM BIOPHYS, V318, P231, DOI 10.1006/abbi.1995.1225; WIESER R, 1991, J BIOL CHEM, V266, P12406	59	480	519	8	75	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24261	24267		10.1074/jbc.M101487200	http://dx.doi.org/10.1074/jbc.M101487200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11301331	hybrid			2022-12-27	WOS:000169531100135
J	Blader, IJ; Manger, ID; Boothroyd, JC				Blader, IJ; Manger, ID; Boothroyd, JC			Microarray analysis reveals previously unknown changes in Toxoplasma gondii-infected human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; MEDIATED-IMMUNITY; HUMAN FIBROBLASTS; REGULATED GENES; KAPPA-B; IDENTIFICATION; TACHYZOITES; MAINTENANCE; INTERFERON; RESISTANCE	Cells infected with the intracellular protozoan parasite Toxoplasma gondii undergo up-regulation of proinflammatory cytokines, organelle redistribution, and protection from apoptosis, To examine the molecular basis of these and other changes, gene expression pro files of human foreskin fibroblasts infected with Toxoplasma were studied using human cDNA microarrays consisting of similar to 22,000 known genes and uncharacterized expressed sequence tags. Early during infection (1-2 h), <1% of all genes show a significant change in the abundance of their transcripts. Of the 63 known genes in this group, 27 encode proteins associated with the immune response. These genes are also up-regulated by secreted, soluble factors from extracellular parasites indicating that the early response does not require parasite invasion. Later during infection, genes involved in numerous host cell processes, including glucose and mevalonate metabolism, are modulated. Many of these late genes are dependent on the direct presence of the parasite; i.e. secreted products from either the parasite or infected cells are insufficient to induce these changes. These results reveal several previously unknown effects on the host cell and lay the foundation for detailed analysis of their role in the host-pathogen interaction.	Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University	Boothroyd, JC (corresponding author), Stanford Univ, Dept Microbiol & Immunol, 299 Campus Dr, Stanford, CA 94305 USA.	john.boothroyd@Stanford.edu		Boothroyd, John C./0000-0001-9719-745X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI010478] Funding Source: NIH RePORTER; NIAID NIH HHS [1F32AI10478-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexander J, 1997, PHILOS T ROY SOC B, V352, P1355, DOI 10.1098/rstb.1997.0120; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; ANSARI AA, 1981, BIOCHEM BIOPH RES CO, V102, P93, DOI 10.1016/0006-291X(81)91493-5; Boothroyd JC, 1997, PHILOS T ROY SOC B, V352, P1347, DOI 10.1098/rstb.1997.0119; Brenier-Pinchart MP, 2000, MOL CELL BIOCHEM, V209, P79, DOI 10.1023/A:1007075701551; Caamano J, 1999, J IMMUNOL, V163, P4453; Caamano J, 2000, J IMMUNOL, V165, P5720, DOI 10.4049/jimmunol.165.10.5720; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Channon JY, 1999, INFECT IMMUN, V67, P2547, DOI 10.1128/IAI.67.5.2547-2551.1999; Cohen P, 2000, J BIOL CHEM, V275, P11181, DOI 10.1074/jbc.275.15.11181; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; DARCY F, 1988, PARASITE IMMUNOL, V10, P553, DOI 10.1111/j.1365-3024.1988.tb00242.x; DENKERS EY, 1994, J EXP MED, V180, P985, DOI 10.1084/jem.180.3.985; Denney CF, 1999, INFECT IMMUN, V67, P1547; Denton H, 1996, FEMS MICROBIOL LETT, V137, P103, DOI 10.1111/j.1574-6968.1996.tb08090.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Geiss GK, 2000, VIROLOGY, V266, P8, DOI 10.1006/viro.1999.0044; HUNTER CA, 1994, INFECT IMMUN, V62, P2818, DOI 10.1128/IAI.62.7.2818-2824.1994; Ichikawa JK, 2000, P NATL ACAD SCI USA, V97, P9659, DOI 10.1073/pnas.160140297; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; KHAN IA, 1991, J IMMUNOL, V147, P3501; LI ZY, 1994, INFECT IMMUN, V62, P3434, DOI 10.1128/IAI.62.8.3434-3440.1994; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; LUFT BJ, 1991, EUR J CLIN MICROBIOL, V10, P178, DOI 10.1007/BF01964455; Manger ID, 2000, CURR OPIN IMMUNOL, V12, P215, DOI 10.1016/S0952-7915(99)00077-1; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; May MJ, 1997, SEMIN CANCER BIOL, V8, P63, DOI 10.1006/scbi.1997.0057; Rosenberger CM, 2000, J IMMUNOL, V164, P5894, DOI 10.4049/jimmunol.164.11.5894; SCHMITZ JL, 1989, INFECT IMMUN, V57, P3254, DOI 10.1128/IAI.57.10.3254-3256.1989; SCHWARTZMAN JD, 1982, EXP PARASITOL, V53, P77, DOI 10.1016/0014-4894(82)90094-7; Sher A, 1995, CIBA F SYMP, V195, P95; Sinai AP, 1997, J CELL SCI, V110, P2117; Sinai AP, 1997, ANNU REV MICROBIOL, V51, P415, DOI 10.1146/annurev.micro.51.1.415; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Taylor LA, 2000, CIRC RES, V87, P328, DOI 10.1161/01.RES.87.4.328; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; Yap G, 2000, J IMMUNOL, V165, P628, DOI 10.4049/jimmunol.165.2.628; Yap GS, 1999, IMMUNOBIOLOGY, V201, P240, DOI 10.1016/S0171-2985(99)80064-3; Zhu H, 1998, P NATL ACAD SCI USA, V95, P14470, DOI 10.1073/pnas.95.24.14470	41	206	222	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24223	24231		10.1074/jbc.M100951200	http://dx.doi.org/10.1074/jbc.M100951200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11294868	hybrid			2022-12-27	WOS:000169531100131
J	Giulivi, C; Davies, KJA				Giulivi, C; Davies, KJA			Mechanism of the formation and proteolytic release of H2O2-induced dityrosine and tyrosine oxidation products in hemoglobin and red blood cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRIC QUANTIFICATION; HYDROGEN-PEROXIDE; LIPID-PEROXIDATION; ACTIVATED METMYOGLOBIN; SELECTIVE PROTEOLYSIS; MODIFIED PROTEINS; VITAMIN-E; TROLOX-C; MYOGLOBIN; FERRYLMYOGLOBIN	Oxyhemoglobin exposed to a continuous flux of H2O2 underwent oxidative modifications, including limited release of fluorescent fragmentation products. The main fragments formed were identified as oxidation products of tyrosine, including dopamine, dopamine quinone, and dihydroxyindol. Further release of these oxidation products plus dityrosine was only seen after proteolytic degradation of the oxidatively modified hemoprotein. A possible mechanism is proposed to explain the formation of these oxidation products that includes cyclization, decarboxylation, and further oxidation of the intermediates. Release of dityrosine is proposed as a useful technique for evaluating selective proteolysis after an oxidative stress, because dityrosine is metabolically stable, and it is only released after enzymatic hydrolysis of the oxidatively modified protein. The measurement can be accomplished by high performance liquid chromatography with fluorescence detection or by high efficiency thin layer chromatography. Comparable results, in terms of dityrosine release, were obtained using red blood cells of different sources after exposing them to a flux of H2O2. Furthermore, dityrosine has been reported to occur in a wide variety of oxidatively modified proteins. These observations suggest that dityrosine formation and release can be used as a highly specific marker for protein oxidation and selective proteolysis.	Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA; Univ So Calif, Div Mol Biol, Los Angeles, CA 90089 USA; Univ Minnesota, Dept Chem, Duluth, MN 55812 USA; Univ So Calif, Div Mol Biol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Minnesota System; University of Minnesota Duluth; University of Southern California	Davies, KJA (corresponding author), Univ So Calif, Ethel Percy Andrus Gerontol Ctr, 3715 McClintock Ave,Rm 306, Los Angeles, CA 90089 USA.	Kelvin@usc.edu	Giulivi, Cecilia/AAV-6774-2021; Giulivi, Cecilia/ABB-7809-2020	Giulivi, Cecilia/0000-0003-1033-7435; Davies, Kelvin/0000-0001-7790-3003				ALLENTOFF AJ, 1992, J AM CHEM SOC, V114, P9744, DOI 10.1021/ja00051a003; BOVERIS A, 1977, ANAL BIOCHEM, V80, P145, DOI 10.1016/0003-2697(77)90634-0; BRUCKDORFER KR, 1990, BIOCHEM SOC T, V18, P1061, DOI 10.1042/bst0181061; CATALANO CE, 1989, J BIOL CHEM, V264, P10534; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; CHANG JY, 1972, ARCH BIOCHEM BIOPHYS, V148, P505, DOI 10.1016/0003-9861(72)90169-5; COUGHEY WS, 1985, HDB METHODS OXYGEN R, P95; CUDINA I, 1987, RADIAT RES, V109, P206, DOI 10.2307/3576947; DEMONTELLANO PRO, 1985, J BIOL CHEM, V260, P9265; Di Iorio E E, 1981, Methods Enzymol, V76, P57; DIEM K, 1974, SCI TABLES, P574; GALARIS D, 1989, ARCH BIOCHEM BIOPHYS, V273, P497, DOI 10.1016/0003-9861(89)90509-2; GALARIS D, 1988, ARCH BIOCHEM BIOPHYS, V262, P221, DOI 10.1016/0003-9861(88)90184-1; GIBSON JF, 1958, NATURE, V181, P1398, DOI 10.1038/1811398a0; GIULIVI C, 1992, ARCH BIOCHEM BIOPHYS, V299, P302, DOI 10.1016/0003-9861(92)90279-6; GIULIVI C, 1994, METHOD ENZYMOL, V233, P363; GIULIVI C, 1994, ARCH BIOCHEM BIOPHYS, V311, P329, DOI 10.1006/abbi.1994.1245; GIULIVI C, 1994, FREE RADICAL BIO MED, V16, P123, DOI 10.1016/0891-5849(94)90249-6; GIULIVI C, 1990, J BIOL CHEM, V265, P19453; GIULIVI C, 1993, ARCH BIOCHEM BIOPHYS, V303, P152, DOI 10.1006/abbi.1993.1266; GIULIVI C, 1993, FEBS LETT, V332, P287, DOI 10.1016/0014-5793(93)80651-A; Giulivi C, 1998, FREE RADICAL BIO MED, V24, P269, DOI 10.1016/S0891-5849(97)00226-8; Giulivi C, 1998, FREE RADICAL BIO MED, V25, P175, DOI 10.1016/S0891-5849(98)00027-6; GIULIVI C, 1993, J BIOL CHEM, V268, P8752; GROSS AJ, 1959, J BIOL CHEM, V234, P1611; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; GUTTERIDGE JMC, 1986, FEBS LETT, V201, P291, DOI 10.1016/0014-5793(86)80626-3; HARADA K, 1987, J BIOCHEM, V101, P283, DOI 10.1093/oxfordjournals.jbchem.a121903; Heinecke JW, 1999, FASEB J, V13, P1113, DOI 10.1096/fasebj.13.10.1113; HUNTER EPL, 1989, FREE RADICAL BIO MED, V6, P581, DOI 10.1016/0891-5849(89)90064-6; KANNER J, 1985, LIPIDS, V20, P625, DOI 10.1007/BF02534290; KANNER J, 1985, ARCH BIOCHEM BIOPHYS, V237, P314, DOI 10.1016/0003-9861(85)90282-6; KELMAN DJ, 1992, FREE RADICAL RES COM, V16, P27, DOI 10.3109/10715769209049156; KING NK, 1967, BIOCHIM BIOPHYS ACTA, V133, P65; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P3520, DOI 10.1074/jbc.272.6.3520; LEONARD LJ, 1988, BIOCHEMISTRY-US, V27, P6156, DOI 10.1021/bi00416a049; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Malencik DA, 1996, ANAL BIOCHEM, V242, P202, DOI 10.1006/abio.1996.0454; MALENCIK DA, 1987, BIOCHEMISTRY-US, V26, P695, DOI 10.1021/bi00377a006; MARGOLIASH E, 1960, BIOCHEM J, V74, P339, DOI 10.1042/bj0740339; MIKI H, 1989, ARCH BIOCHEM BIOPHYS, V275, P354, DOI 10.1016/0003-9861(89)90382-2; NICHOLLS P, 1962, BIOCHIM BIOPHYS ACTA, V59, P414, DOI 10.1016/0006-3002(62)90191-9; PRUTZ WA, 1983, INT J RADIAT BIOL, V44, P183, DOI 10.1080/09553008314550981; REICHARD P, 1983, SCIENCE, V221, P514, DOI 10.1126/science.6306767; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; SEGURAAGUILAR J, 1989, CHEM-BIOL INTERACT, V72, P309, DOI 10.1016/0009-2797(89)90006-9; SHIGA T, 1985, ARCH BIOCHEM BIOPHYS, V167, P469; SOUPART P, 1962, AMINO ACID POOLS, P263; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; STRYER L, 1981, BIOCHEMISTRY-US, P59; TEPHLY TR, 1961, J PHARMACOL EXP THER, V134, P77; TEW D, 1988, J BIOL CHEM, V263, P17880; TINOCO JI, 1978, PHYSICAL CHEM PRINCI, P282; YONETANI T, 1967, J BIOL CHEM, V242, P1974	54	79	81	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24129	24136		10.1074/jbc.M010697200	http://dx.doi.org/10.1074/jbc.M010697200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11294851	hybrid			2022-12-27	WOS:000169531100120
J	Suzuki, N; Khoo, KH; Chen, HC; Johnson, JR; Lee, YC				Suzuki, N; Khoo, KH; Chen, HC; Johnson, JR; Lee, YC			Isolation and characterization of major glycoproteins of pigeon egg white - Ubiquitous presence of unique N-glycans containing Gal alpha 1-4Gal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; LINKED SUGAR CHAINS; SIALOSYL GALACTOSYL GLOBOSIDE; PREFERRED BINDING-RECEPTOR; AMINO-ACID-SEQUENCE; STREPTOCOCCUS-SUIS; HEN OVALBUMIN; STRUCTURAL CHARACTERIZATION; LIQUID-CHROMATOGRAPHY; BIOSYNTHETIC-PATHWAY	Ovotransferrin (POT), two ovalbumins (POA(hi) and POA(lo)), and ovomucoid (POM) were isolated from pigeon egg white (PEW). Unlike their chicken egg white counterparts, PEW glycoproteins contain terminal Gal alpha1-4Gal, as evidenced by GS-I lectin (specific for terminal alpha -Gal), anti-P-1 (Gal alpha1-4Gal beta1- 4GlcNAc beta1-3Gal beta1-4Glc beta1-1Cer) monoclonal antibody, and P fimbriae on uropathogenic Escherichia coli (specific for Gal alpha1-4Gal). Gal alpha1-4Gal on PEW glycoproteins were found in N-glycans releasable by treatment with glycoamidase F. The respective contents of N-glycans in each glycoprotein were 3.5%, POT; 17%, POA(hi); and 31-37%, POM. POA(hi) has four N-glycosylation sites, in contrast to chicken ovalbumin, which has only one. High performance liquid chromatography analysis showed that N-glycans on POA(hi) were highly heterogeneous. Mass spectrometric analysis revealed that the major N-glycans were monosialylated tri-, tetra-, and penta-antennary oligosaccharides containing terminal Gal alpha1-4Gal with or without bisecting N-acetylglucosamine, Oligo saccharide chains terminating in Gal alpha1-4Gal are rare among N-glycans from the mammals and avians that have been studied, and our finding is the first predominant presence of (Gal alpha1-4Gal)-terminated N-glycans.	Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; NICHD, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA; Univ Minnesota, Dept Med, Minneapolis, MN 55417 USA; Vet Affairs Med Ctr, Dept Med, Minneapolis, MN 55417 USA	Johns Hopkins University; Academia Sinica - Taiwan; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Lee, YC (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.		Khoo, Kay-Hooi/E-1989-2019	Khoo, Kay-Hooi/0000-0003-2906-406X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK009970, R37DK009970, R01DK047504] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARUMUGHAM RG, 1986, BIOCHIM BIOPHYS ACTA, V883, P112, DOI 10.1016/0304-4165(86)90142-X; Awade AC, 1996, Z LEBENSM UNTERS FOR, V202, P1, DOI 10.1007/BF01229676; BEELEY JG, 1976, BIOCHEM J, V159, P335, DOI 10.1042/bj1590335; BEELEY JG, 1971, BIOCHEM J, V123, P399, DOI 10.1042/bj1230399; BOCK K, 1985, J BIOL CHEM, V260, P8545; BROCTEUR J, 1975, Haematologia, V9, P43; CHATTERJEE S, 1995, GLYCOBIOLOGY, V5, P327, DOI 10.1093/glycob/5.3.327; CHEN LM, 1988, FASEB J, V2, P2819, DOI 10.1096/fasebj.2.12.3410198; COSSEY A, 1979, EUR J BIOCHEM, V98, P53, DOI 10.1111/j.1432-1033.1979.tb13159.x; CRACRAFT J, 1986, PALEOBIOLOGY, V12, P383, DOI 10.1017/S0094837300003122; DASILVA MLC, 1995, ARCH BIOCHEM BIOPHYS, V318, P465, DOI 10.1006/abbi.1995.1255; DELL A, 1994, METHOD ENZYMOL, V230, P108; DORLAND L, 1984, BIOCHEM BIOPH RES CO, V122, P859, DOI 10.1016/S0006-291X(84)80113-8; DORLAND L, 1979, EUR J BIOCHEM, V100, P569, DOI 10.1111/j.1432-1033.1979.tb04203.x; FAN JQ, 1994, ANAL BIOCHEM, V219, P375, DOI 10.1006/abio.1994.1280; FRANCOISGERARD C, 1980, REV FR TRANSFUS IMMU, V23, P95, DOI 10.1016/S0338-4535(80)80050-X; FRANCOISGERARD C, 1979, BIOCHEM J, V177, P679, DOI 10.1042/bj1770679; FRANCOISGERARD C, 1980, VOX SANG, V39, P141, DOI 10.1111/j.1423-0410.1980.tb01849.x; FRANCOISGERARD C, 1980, REV FR TRANSFUS IMMU, V23, P579, DOI 10.1016/S0338-4535(80)80161-9; FUJIWARA S, 1988, BIOCHEM J, V252, P453, DOI 10.1042/bj2520453; GAHMBERG CG, 1975, J BIOL CHEM, V250, P2438; Galili U, 1998, TRANSPLANTATION, V65, P1129, DOI 10.1097/00007890-199804270-00020; GILBOAGARBER N, 1994, GLYCOCONJUGATE J, V11, P414, DOI 10.1007/BF00731276; HAATAJA S, 1993, J BIOL CHEM, V268, P4311; HASE S, 1986, J BIOCHEM-TOKYO, V99, P1725, DOI 10.1093/oxfordjournals.jbchem.a135649; HASE S, 1982, J BIOCHEM-TOKYO, V91, P735, DOI 10.1093/oxfordjournals.jbchem.a133748; JOHNSON JR, 1993, INFECT IMMUN, V61, P4902, DOI 10.1128/IAI.61.11.4902-4905.1993; JOHNSON JR, 1992, INFECT IMMUN, V60, P578, DOI 10.1128/IAI.60.2.578-583.1992; KATO I, 1987, BIOCHEMISTRY-US, V26, P193, DOI 10.1021/bi00375a027; Khoo KH, 1997, MOL BIOCHEM PARASIT, V86, P237, DOI 10.1016/S0166-6851(97)00036-4; KORHONEN TK, 1982, INFECT IMMUN, V37, P286, DOI 10.1128/IAI.37.1.286-291.1982; KOTANI M, 1994, ARCH BIOCHEM BIOPHYS, V310, P89, DOI 10.1006/abbi.1994.1144; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE YC, 1962, ARCH BIOCHEM BIOPHYS, V97, P9, DOI 10.1016/0003-9861(62)90037-1; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; LYERLA T, 1986, J CELL PHYSIOL, V129, P390, DOI 10.1002/jcp.1041290318; Mindell David P., 1997, P213, DOI 10.1016/B978-012498315-1/50014-5; Miyake M, 2000, ANAL BIOCHEM, V281, P202, DOI 10.1006/abio.2000.4559; NAKAGAWA H, 1995, ANAL BIOCHEM, V226, P130, DOI 10.1006/abio.1995.1200; NAKAMURA K, 1984, J BIOCHEM-TOKYO, V95, P1137, DOI 10.1093/oxfordjournals.jbchem.a134702; NISBET AD, 1981, EUR J BIOCHEM, V115, P335, DOI 10.1111/j.1432-1033.1981.tb05243.x; RUSSI S, 1974, J IMMUNOL, V112, P1061; SMITH DF, 1990, J BIOL CHEM, V265, P6225; SPIK G, 1979, CR ACAD SCI D NAT, V288, P967; STAPLETON A, 1992, J CLIN INVEST, V90, P965, DOI 10.1172/JCI115973; Stapleton AE, 1998, INFECT IMMUN, V66, P3856, DOI 10.1128/IAI.66.8.3856-3861.1998; Stroud MR, 1998, BIOCHEMISTRY-US, V37, P17420, DOI 10.1021/bi9814639; TAKAHASHI N, 1993, GLYCOCONJUGATE J, V10, P425, DOI 10.1007/BF00737962; Takahashi N, 2001, J BIOL CHEM, V276, P23230, DOI 10.1074/jbc.M101380200; Tikkanen K, 1996, INFECT IMMUN, V64, P3659, DOI 10.1128/IAI.64.9.3659-3665.1996; TIKKANEN K, 1995, J BIOL CHEM, V270, P28874, DOI 10.1074/jbc.270.48.28874; Tomiya N, 1998, ANAL BIOCHEM, V264, P204, DOI 10.1006/abio.1998.2849; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; WIERUSZESKI JM, 1987, J BIOL CHEM, V262, P6650; WILLIAMS J, 1968, BIOCHEM J, V108, P57, DOI 10.1042/bj1080057; YAMASHITA K, 1983, J BIOL CHEM, V258, P3099; YAMASHITA K, 1984, CARBOHYD RES, V130, P271, DOI 10.1016/0008-6215(84)85285-4; YAMASHITA K, 1978, J BIOL CHEM, V253, P3862; YAMASHITA K, 1982, J BIOL CHEM, V257, P2809; YANG ZT, 1994, J BIOL CHEM, V269, P14620; [No title captured]; [No title captured]	63	50	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23221	23229		10.1074/jbc.M101379200	http://dx.doi.org/10.1074/jbc.M101379200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11287422	hybrid			2022-12-27	WOS:000169531100003
J	Brandes, C; Kahr, L; Stockinger, W; Hiesberger, T; Schneider, WJ; Nimpf, J				Brandes, C; Kahr, L; Stockinger, W; Hiesberger, T; Schneider, WJ; Nimpf, J			Alternative splicing in the ligand binding domain of mouse ApoE receptor-2 produces receptor variants binding reelin but not alpha(2)-macroglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-E RECEPTOR-2; CHICKEN OOCYTE RECEPTOR; TYROSINE PHOSPHORYLATION; NEURONAL MIGRATION; CYTOSOLIC ADAPTER; BRAIN-DEVELOPMENT; VLDL RECEPTOR; GENE FAMILY; PROTEIN	LR7/8B and ApoER2 are recently discovered members of the low density lipoprotein (LDL) receptor family, Although structurally different, these two proteins are derived from homologous genes in chicken and man by alternative splicing and contain 7 or 8 LDL receptor ligand binding repeats. Here we present the cDNA for ApoER2 cloned from mouse brain and describe splice variants in the ligand binding domain of this protein, which are distinct from those present in man and chicken, The cloned cDNA is coding for a receptor with only five LDL receptor ligand-binding repeats, i.e. comprising repeats 1-3, 7, and 8. Reverse transcriptase-polymerase chain reaction analysis of mRNA from murine brain revealed the existence of two additional transcripts. One is lacking repeat 8, and in the other repeat 8 is substituted for by a 13-amino acid insertion with a consensus site for furin cleavage arising from an additional small exon present in the murine gene. None of the transcripts in the mouse, however, contain repeats 4-6. In murine placenta only the form containing repeats 1-3 and 7 and the furin cleavage site is detectable. Analysis of the corresponding region of the murine gene showed the existence of 6 exons coding for a total of 8 ligand binding repeats, with one exon encoding repeats 4-6. Exon trapping experiments demonstrated that this exon is constitutively spliced out in all murine transcripts, Thus, the murine ApoER2 gene codes for receptor variants harboring either 4 or 5 binding repeats only. Recombinant expression of the 5-repeat and 4-repeat variants showed that repeats 1-3, 7, and 8 are sufficient for binding of beta -very low density lipoprotein and reelin, but not for recognition of alpha (2)-macroglobulin, which binds to the avian homologue of ApoER2 harboring 8 ligand binding repeats.	Bioctr, Dept Mol Genet, Inst Med Biochem, A-1030 Vienna, Austria; Univ Vienna, A-1030 Vienna, Austria; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA	University of Vienna; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Nimpf, J (corresponding author), Bioctr, Dept Mol Genet, Inst Med Biochem, Dr Bohrgasse 9-2, A-1030 Vienna, Austria.			Nimpf, Johannes/0000-0002-9273-3492				Brandes C, 1997, GENOMICS, V42, P185, DOI 10.1006/geno.1997.4702; Clatworthy AE, 1999, NEUROSCIENCE, V90, P903, DOI 10.1016/S0306-4522(98)00489-8; Cooper JA, 1999, CELL, V97, P671, DOI 10.1016/S0092-8674(00)80778-3; Curran T, 1998, BRAIN RES REV, V26, P285, DOI 10.1016/S0165-0173(97)00035-0; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; HAYASHI K, 1989, J BIOL CHEM, V264, P3131; HEIJNE GV, 1983, EUR J BIOCHEM, V133, P17; HERZ J, 1991, J BIOL CHEM, V266, P21232; HIESBERGER T, 1995, J BIOL CHEM, V270, P18219, DOI 10.1074/jbc.270.31.18219; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1999, MOL CELL BIOL, V19, P5179; JACOBSEN L, 1995, J BIOL CHEM, V270, P6468, DOI 10.1074/jbc.270.12.6468; Kim DH, 1997, J BIOL CHEM, V272, P8498, DOI 10.1074/jbc.272.13.8498; Kim DH, 1996, J BIOL CHEM, V271, P8373, DOI 10.1074/jbc.271.14.8373; Kim HJ, 1998, J BIOCHEM-TOKYO, V124, P451, DOI 10.1093/oxfordjournals.jbchem.a022134; KOVANEN PT, 1981, P NATL ACAD SCI-BIOL, V78, P1396, DOI 10.1073/pnas.78.3.1396; LEUVEN FV, 1981, J BIOL CHEM, V256, P9016; MACLACHLAN I, 1993, J BIOL CHEM, V268, P23222; Novak S, 1996, J BIOL CHEM, V271, P11732, DOI 10.1074/jbc.271.20.11732; SCHNEIDER WJ, 1980, J BIOL CHEM, V255, P1442; Schneider WJ, 1997, CURR OPIN LIPIDOL, V8, P315, DOI 10.1097/00041433-199710000-00011; SCHNEIDER WJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P303, DOI 10.1016/0304-4157(89)90023-3; Schneider Wolfgang J., 1993, Current Opinion in Lipidology, V4, P205, DOI 10.1097/00041433-199306000-00005; SENAPATHY P, 1990, MOL EVOLUTION COMPUT, P183; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Stockinger W, 1998, J BIOL CHEM, V273, P32213, DOI 10.1074/jbc.273.48.32213; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556	35	63	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22160	22169		10.1074/jbc.M102662200	http://dx.doi.org/10.1074/jbc.M102662200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294845	hybrid			2022-12-27	WOS:000169412700027
J	Chetyrkin, SV; Belyaeva, OV; Gough, MH; Kedishvili, NY				Chetyrkin, SV; Belyaeva, OV; Gough, MH; Kedishvili, NY			Characterization of a novel type of human microsomal 3 alpha-hydroxysteroid dehydrogenase - Unique tissue distribution and catalytic properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							11-CIS RETINOL DEHYDROGENASE; CDNA CLONING; 17BETA-HYDROXY-5ALPHA-ANDROSTAN-3-ONE 5ALPHA-DIHYDROTESTOSTERONE; HYDROXYSTEROID DEHYDROGENASES; GENE STRUCTURE; RAT; EXPRESSION; 5ALPHA-ANDROSTANE-3ALPHA,17BETA-DIOL; DIHYDROTESTOSTERONE; OXIDOREDUCTASES	We report characterization of a novel member of the short chain dehydrogenase/reductase superfamily. The 1513-base pair cDNA encodes a 319-amino acid protein. The corresponding gene spans over 26 kilobase pairs on chromosome 2 and contains five exons, The recombinant protein produced using the baculovirus system is localized in the microsomal fraction of Sf9 cells and is an integral membrane protein with cytosolic orientation of its catalytic domain. The enzyme exhibits an oxidoreductase activity toward hydroxysteroids with NAD(+) and NADH as the preferred cofactors, The enzyme is most efficient as a 3 alpha -hydroxysteroid dehydrogenase, converting 3 alpha -tetrahydroprogesterone (allopregnanolone) to dihydroprogesterone and 3 alpha -androstanediol to dihydrotes- tosterone with similar catalytic efficiency (V-max values of 13-14 nmol/min/mg microsomal protein and K-m values of 5-7 muM). Despite similar to 44-47% sequence identity with retinol/ 3 alpha -hydroxysterol dehydrogenases, the enzyme is not active toward retinols, The corresponding message is abundant in human trachea and is present at lower levels in the spinal cord, bone marrow, brain, heart, colon, testis, placenta, lung, and lymph node, Thus, the new short chain dehydrogenase represents a novel type of microsomal NAD(+)-dependent 3 alpha -hydroxysteroid dehydrogenase with unique catalytic properties and tissue distribution.	Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Kedishvili, NY (corresponding author), Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, 5007 Rockhill Rd,103 BSB, Kansas City, MO 64110 USA.	kedishvilin@umkc.edu		Kedishvili, Natalia/0000-0001-6917-4891; Beliaeva, Olga/0000-0003-2512-925X	NIAAA NIH HHS [R01 AA012153-02, AA00221, R01 AA012153, AA12153] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012153] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Biswas MG, 1997, J BIOL CHEM, V272, P15959, DOI 10.1074/jbc.272.25.15959; Chai XY, 1997, J BIOL CHEM, V272, P33125, DOI 10.1074/jbc.272.52.33125; Chetyrkin SV, 2001, ARCH BIOCHEM BIOPHYS, V386, P1, DOI 10.1006/abbi.2000.2203; Dombroski RA, 1997, J STEROID BIOCHEM, V63, P155, DOI 10.1016/S0960-0760(97)00058-7; Gamble MV, 1999, J LIPID RES, V40, P2279; Ge RS, 1999, BIOL REPROD, V60, P855, DOI 10.1095/biolreprod60.4.855; Gough WH, 1998, J BIOL CHEM, V273, P19778, DOI 10.1074/jbc.273.31.19778; Huang XF, 2000, J BIOL CHEM, V275, P29452, DOI 10.1074/jbc.M000562200; Jurukovski V, 1999, MOL GENET METAB, V67, P62, DOI 10.1006/mgme.1999.2840; Kedishvili NY, 2001, CHEM-BIOL INTERACT, V130, P457, DOI 10.1016/S0009-2797(00)00291-X; KHANNA M, 1995, J BIOL CHEM, V270, P20162, DOI 10.1074/jbc.270.34.20162; KRAUSE JE, 1980, J BIOL CHEM, V255, P1807; Labrie F, 1997, STEROIDS, V62, P148, DOI 10.1016/S0039-128X(96)00174-2; Li XD, 1997, J STEROID BIOCHEM, V60, P311, DOI 10.1016/S0960-0760(96)00195-1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mertz JR, 1997, J BIOL CHEM, V272, P11744, DOI 10.1074/jbc.272.18.11744; Odermatt A, 1999, J BIOL CHEM, V274, P28762, DOI 10.1074/jbc.274.40.28762; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Penning TM, 1996, STEROIDS, V61, P508, DOI 10.1016/S0039-128X(96)00093-1; PIROG EC, 1994, STEROIDS, V59, P259, DOI 10.1016/0039-128X(94)90110-4; Pirog EC, 1999, J CLIN ENDOCR METAB, V84, P3217, DOI 10.1210/jc.84.9.3217; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; Simon A, 1996, GENOMICS, V36, P424, DOI 10.1006/geno.1996.0487; Simon A, 1999, J CELL SCI, V112, P549; Span PN, 1996, J STEROID BIOCHEM, V58, P319, DOI 10.1016/0960-0760(96)00036-2; Su J, 1998, J BIOL CHEM, V273, P17910, DOI 10.1074/jbc.273.28.17910; Su J, 1999, ENDOCRINOLOGY, V140, P5275, DOI 10.1210/endo.140.11.7137; TANNIN GM, 1991, J BIOL CHEM, V266, P16653; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; VERHOEVEN G, 1976, EUR J BIOCHEM, V65, P565; VERHOEVEN G, 1977, J STEROID BIOCHEM, V8, P731, DOI 10.1016/0022-4731(77)90004-8; Wang J, 1999, BIOCHEM J, V338, P23, DOI 10.1042/0264-6021:3380023; Yamamoto H, 1999, NAT GENET, V22, P188, DOI 10.1038/9707	33	69	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22278	22286		10.1074/jbc.M102076200	http://dx.doi.org/10.1074/jbc.M102076200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294878	hybrid			2022-12-27	WOS:000169412700043
J	Hagedoorn, PL; Schmidt, PP; Andersson, KK; Hagen, WR; Flatmark, T; Martinez, A				Hagedoorn, PL; Schmidt, PP; Andersson, KK; Hagen, WR; Flatmark, T; Martinez, A			The effect of substrate, dihydrobiopterin, and dopamine on the EPR spectroscopic properties and the midpoint potential of the catalytic iron in recombinant human phenylalanine hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID HYDROXYLASES; H-1-NMR PARAMAGNETIC RELAXATION; HUMAN TYROSINE-HYDROXYLASE; NITRIC-OXIDE SYNTHASE; CRYSTAL-STRUCTURE; ACTIVE-SITE; ESCHERICHIA-COLI; ANGSTROM RESOLUTION; KINETIC-PROPERTIES; ENZYMATIC-ACTIVITY	Phenylalanine hydroxylase (PAH) is a tetrahydrobiopterin (BH4) and non-heme iron-dependent enzyme that hydroxylates L-Phe to L-Tyr. The paramagnetic ferric iron at the active site of recombinant human PAH (hPAH) and its midpoint potential at pH 7.25 (E-m(Fe(III)/Fe(II))) were studied by EPR spectroscopy. Similar EPR spectra were obtained for the tetrameric wild-type (wt-hPAH) and the dimeric truncated hpAH(Gly(103)-Gln(428)) corresponding to the "catalytic domain." A rhombic high spin Fe(III) signal with a g value of 4.3 dominates the EPR spectra at 3.6 K of both enzyme forms. An E-m +207 +/- 10 mV was measured for the iron in wt-hPAH, which seems to be adequate for a thermodynamically feasible electron transfer from BH4 (E-m (quinonoid-BH2/BH4) = +174 mV). The broad EPR features from g = 9.7-4.3 in the spectra of the ligand-free enzyme de creased in intensity upon the addition of L-Phe, whereas more axial type signals were observed upon binding of 7,8-dihydrobiopterin (BH2), the stable oxidized form of BH2, and of dopamine. Ah three ligands induced a decrease in the E-m value of the iron to +123 +/- 4 mV (L-Phe), +110 +/- 20 mV (BH2), and -8 +/- 9 mV (dopamine). On the basis of these data we have calculated that the binding affinities of L-Phe, BH2, and dopamine decrease by 28-, 47-, and 5040-fold, respectively, for the reduced ferrous form of the enzyme, with respect to the ferric form. Interestingly, an E-m value comparable with that of the ligand-free, resting form of wt-hPAH, i.e. +191 +/- 11 mV, was measured upon the simultaneous binding of both L-Phe and BH2, representing an inactive model for the iron environment under turnover conditions. Our findings provide new information on the redox properties of the active site iron relevant for the understanding of the reductive activation of the enzyme and the catalytic mechanism.	Univ Bergen, Dept Biochem & Mol Biol, N-5009 Bergen, Norway; Univ Oslo, Dept Biochem, N-0316 Oslo, Norway; Delft Univ Technol, Kluyver Dept Biotechnol, NL-2628 BC Delft, Netherlands; Univ Oslo, Dept Biochem, N-0316 Oslo, Norway	University of Bergen; University of Oslo; Delft University of Technology; University of Oslo	Martinez, A (corresponding author), Univ Bergen, Dept Biochem & Mol Biol, Arstadveien 19, N-5009 Bergen, Norway.		Martinez, Aurora/M-3088-2019; Hagedoorn, Peter-Leon/C-8535-2014; Andersson, K Kristoffer/F-9624-2010	Martinez, Aurora/0000-0003-1643-6506; Hagedoorn, Peter-Leon/0000-0001-6342-2022; 				AASA R, 1975, J MAGN RESON, V19, P308, DOI 10.1016/0022-2364(75)90045-1; ANDERSSON KK, 1989, FEBS LETT, V258, P9, DOI 10.1016/0014-5793(89)81603-5; ANDERSSON KK, 1988, J BIOL CHEM, V263, P18621; ARCHER MC, 1972, CAN J BIOCHEM CELL B, V50, P1174, DOI 10.1139/o72-160; ARCHER MC, 1970, CAN J BIOCHEM CELL B, V48, P526, DOI 10.1139/o70-086; BAILEY SW, 1983, BIOCHEMISTRY-US, V22, P1790, DOI 10.1021/bi00277a008; BLOOM LM, 1986, BIOCHEMISTRY-US, V25, P4204, DOI 10.1021/bi00363a006; BUBLITZ C, 1971, BIOCHEM PHARMACOL, V20, P2543, DOI 10.1016/0006-2952(71)90162-6; CITRON BA, 1992, PROTEIN EXPRES PURIF, V3, P93, DOI 10.1016/S1046-5928(05)80024-5; COX DD, 1988, J AM CHEM SOC, V110, P2026, DOI 10.1021/ja00215a002; DAVIS MD, 1989, J BIOL CHEM, V264, P8585; DIX TA, 1988, ACCOUNTS CHEM RES, V21, P101, DOI 10.1021/ar00147a002; DOSKELAND AP, 1984, J BIOL CHEM, V259, P1242; EHRENBER.A, 1970, EUR J BIOCHEM, V16, P584, DOI 10.1111/j.1432-1033.1970.tb01121.x; Ellis HR, 2000, BIOCHEMISTRY-US, V39, P4174, DOI 10.1021/bi9928546; Erlandsen H, 2000, BIOCHEMISTRY-US, V39, P2208, DOI 10.1021/bi992531+; Erlandsen H, 1997, NAT STRUCT BIOL, V4, P995, DOI 10.1038/nsb1297-995; Erlandsen H, 1998, BIOCHEMISTRY-US, V37, P15638, DOI 10.1021/bi9815290; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Flatmark T, 1999, EUR J BIOCHEM, V262, P840, DOI 10.1046/j.1432-1327.1999.00445.x; Flatmark T, 1999, CHEM REV, V99, P2137, DOI 10.1021/cr980450y; Francisco WA, 1998, J AM CHEM SOC, V120, P4057, DOI 10.1021/ja973543q; Fusetti F, 1998, J BIOL CHEM, V273, P16962, DOI 10.1074/jbc.273.27.16962; Goodwill KE, 1998, BIOCHEMISTRY-US, V37, P13437, DOI 10.1021/bi981462g; Goodwill KE, 1997, NAT STRUCT BIOL, V4, P578, DOI 10.1038/nsb0797-578; GOTTSCHALL DW, 1982, J BIOL CHEM, V257, P845; HAAVIK J, 1990, FEBS LETT, V262, P363, DOI 10.1016/0014-5793(90)80230-G; HAAVIK J, 1992, EUR J BIOCHEM, V210, P23, DOI 10.1111/j.1432-1033.1992.tb17386.x; HAAVIK J, 1986, EUR J BIOCHEM, V160, P1, DOI 10.1111/j.1432-1033.1986.tb09932.x; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; Kappock TJ, 1995, J BIOL CHEM, V270, P30532, DOI 10.1074/jbc.270.51.30532; Kappock TJ, 1996, CHEM REV, V96, P2659, DOI 10.1021/cr9402034; KAUFMAN S, 1993, ADV ENZYMOL RAMB, V67, P77; Kemsley JN, 1999, J AM CHEM SOC, V121, P1528, DOI 10.1021/ja9833063; Knappskog PM, 1996, EUR J BIOCHEM, V242, P813, DOI 10.1111/j.1432-1033.1996.0813r.x; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Kumer SC, 1996, J NEUROCHEM, V67, P443; Lange SJ, 1998, CURR OPIN CHEM BIOL, V2, P159, DOI 10.1016/S1367-5931(98)80057-4; MAROTA JJA, 1984, BIOCHEMISTRY-US, V23, P1303, DOI 10.1021/bi00301a044; MARTINEZ A, 1995, BIOCHEM J, V306, P589, DOI 10.1042/bj3060589; MARTINEZ A, 1991, EUR J BIOCHEM, V198, P675, DOI 10.1111/j.1432-1033.1991.tb16066.x; MARTINEZ A, 1990, EUR J BIOCHEM, V193, P211, DOI 10.1111/j.1432-1033.1990.tb19325.x; MARTINEZ A, 1993, EUR J BIOCHEM, V211, P259, DOI 10.1111/j.1432-1033.1993.tb19894.x; Martinez A, 1996, J BIOL CHEM, V271, P19737, DOI 10.1074/jbc.271.33.19737; MICHAUDSORET I, 1995, BIOCHEMISTRY-US, V34, P5504, DOI 10.1021/bi00016a022; Noble MA, 1999, BIOCHEMISTRY-US, V38, P16413, DOI 10.1021/bi992150w; Olafsdottir S, 1999, J BIOL CHEM, V274, P6280, DOI 10.1074/jbc.274.10.6280; PARNIAK MA, 1981, J BIOL CHEM, V256, P6876; PHILLIPS RS, 1984, J BIOL CHEM, V259, P271; Presta A, 1998, J AM CHEM SOC, V120, P9460, DOI 10.1021/ja9740374; Que L, 2000, NAT STRUCT BIOL, V7, P182, DOI 10.1038/73270; Ramsey AJ, 1998, BIOCHEMISTRY-US, V37, P8980, DOI 10.1021/bi980582l; Schmidt PP, 2001, J BIOL INORG CHEM, V6, P151, DOI 10.1007/s007750000185; SHIMAN R, 1994, J BIOL CHEM, V269, P24647; SHIMAN R, 1994, J BIOL CHEM, V269, P24637; Teigen K, 1999, J MOL BIOL, V294, P807, DOI 10.1006/jmbi.1999.3288; WALLICK DE, 1984, BIOCHEMISTRY-US, V23, P1295, DOI 10.1021/bi00301a043	57	24	24	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22850	22856		10.1074/jbc.M009458200	http://dx.doi.org/10.1074/jbc.M009458200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301319	hybrid			2022-12-27	WOS:000169412700116
J	Saadi, I; Semina, EV; Amendt, BA; Harris, DJ; Murphy, KP; Murray, JC; Russo, AF				Saadi, I; Semina, EV; Amendt, BA; Harris, DJ; Murphy, KP; Murray, JC; Russo, AF			Identification of a dominant negative homeodomain mutation in Rieger syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEFT-RIGHT ASYMMETRY; HELIX-LOOP-HELIX; SAETHRE-CHOTZEN-SYNDROME; TRANSCRIPTION FACTOR; RECOGNITION HELIX; HOMEOBOX GENE; PITX2; DNA; PROTEIN; DOMAIN	Mutations in the PITX2 bicoid-like homeobox gene cause Rieger syndrome. Rieger syndrome is an autosomal-dominant human disorder characterized by glaucoma as well as dental hypoplasia, mild craniofacial dysmorphism, and umbilical stump abnormalities, PITX2 has also been implicated in the development of multiple organs and left-right asymmetry in the body plan. The PITX2 homeodomain has a lysine at position 50, which has been shown to impart the bicoid-type (TAATCC) DNA binding specificity to other homeodomain proteins. A mutation (R88E), found in a Rieger syndrome patient, changes this lysine to glutamic acid. We were intrigued by the relatively pronounced phenotypic consequences of this R88E mutation, In the initial analyses, the mutant protein appeared to simply be inactive, with essentially no DNA binding and transactivation activities and, unlike the wild type protein, with an inability to synergize with another transcription factor, Pit-1. However, when the K88E DNA was cotransfected with wild type PITX2, analogous to the patient genotype, the K88E mutant suppressed the synergism of wild type PITX2 with Pit-1. In contrast, a different PITX2 homeodomain mutant, T68P, which is also defective in DNA binding, transactivation, and Pit-1 synergism activities, did not suppress the wild type synergism with Pit-1. These results describe the first dominant negative missense mutation in a homeodomain and support a model that may partially explain the phenotypic variation within Rieger syndrome.	Univ Iowa, Genet Program, Iowa City, IA 52242 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Childrens Mercy Hosp, Kansas City, MO 64108 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Children's Mercy Hospital	Russo, AF (corresponding author), Univ Iowa, Genet Program, Iowa City, IA 52242 USA.		Saadi, Irfan/I-5989-2019	Saadi, Irfan/0000-0002-6250-6651; Amendt, Brad A./0000-0001-6524-1006; Russo, Andrew/0000-0002-8156-5649	NEI NIH HHS [EY12384] Funding Source: Medline; NIDCR NIH HHS [DE13076] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P60DE013076] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; BALDWIN CT, 1995, AM J MED GENET, V58, P115, DOI 10.1002/ajmg.1320580205; BELLMANN R, 1992, EMBO J, V11, P3367, DOI 10.1002/j.1460-2075.1992.tb05415.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Dave V, 2000, MOL CELL BIOL, V20, P7673, DOI 10.1128/MCB.20.20.7673-7684.2000; DeStefano AL, 1998, HUM GENET, V102, P499, DOI 10.1007/s004390050732; DUBOULE D, 1994, GUIDEBOOK HOMEOBOX G; El Ghouzzi V, 1999, EUR J HUM GENET, V7, P27, DOI 10.1038/sj.ejhg.5200240; Gage PJ, 1999, DEVELOPMENT, V126, P4643; HANES SD, 1991, SCIENCE, V251, P426, DOI 10.1126/science.1671176; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; Hanson I, 1999, HUM MOL GENET, V8, P165, DOI 10.1093/hmg/8.2.165; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Jacobson EM, 1997, GENE DEV, V11, P198, DOI 10.1101/gad.11.2.198; Kozlowski K, 2000, HUM MOL GENET, V9, P2131, DOI 10.1093/hmg/9.14.2131; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Lanigan TM, 1997, J BIOL CHEM, V272, P18316, DOI 10.1074/jbc.272.29.18316; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; MAURER RA, 1987, MOL CELL BIOL, V7, P4247, DOI 10.1128/MCB.7.12.4247; Prosser J, 1998, HUM MUTAT, V11, P93, DOI 10.1002/(SICI)1098-1004(1998)11:2<93::AID-HUMU1>3.0.CO;2-M; QIAN YQ, 1993, J MOL BIOL, V234, P1070, DOI 10.1006/jmbi.1993.1660; Rhodes S. J., 1996, J ANIM SCI, V74, P94; Rieger H, 1935, Z AUGENHEILKD, V86, P333; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Singh S, 1998, J BIOL CHEM, V273, P21531, DOI 10.1074/jbc.273.34.21531; Stoffers DA, 1998, J CLIN INVEST, V102, P232, DOI 10.1172/JCI2242; Szeto DP, 1996, P NATL ACAD SCI USA, V93, P7706, DOI 10.1073/pnas.93.15.7706; TREISMAN J, 1989, CELL, V59, P553; TVERBERG LA, 1993, J BIOL CHEM, V268, P15965; Yamagata K, 1998, DIABETES, V47, P1231, DOI 10.2337/diabetes.47.8.1231; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7	36	65	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23034	23041		10.1074/jbc.M008592200	http://dx.doi.org/10.1074/jbc.M008592200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301317	hybrid			2022-12-27	WOS:000169412700140
J	Togayachi, A; Akashima, T; Ookubo, R; Kudo, T; Nishihara, S; Iwasaki, H; Natsume, A; Mio, H; Inokuchi, J; Irimura, T; Sasaki, K; Narimatsu, H				Togayachi, A; Akashima, T; Ookubo, R; Kudo, T; Nishihara, S; Iwasaki, H; Natsume, A; Mio, H; Inokuchi, J; Irimura, T; Sasaki, K; Narimatsu, H			Molecular cloning and characterization of UDP-GlcNAc : Lactosylceramide beta 1,3-N-acetylglucosaminyltransferase (beta 3Gn-T5), an essential enzyme for the expression of HNK-1 and Lewis X epitopes on glycolipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLONIC ADENOCARCINOMA; BIOSYNTHESIS IN-VITRO; SULFOGLUCURONYL GLYCOLIPIDS; DEVELOPMENTAL EXPRESSION; BINDING-PROTEIN; CEREBRAL-CORTEX; NERVOUS-SYSTEM; UP-REGULATION; CD15 EPITOPE; CARBOHYDRATE	A new member of the UDP-N-acetylglucosamine:beta -galactose beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T) family having the beta 3Gn-T motifs was cloned from rat and human cDNA libraries and named beta 3Gn-T5 based on its position in a phylogenetic tree. We concluded that beta 3Gn-T5 is the most feasible candidate for lactotriaosylceramide (Lc,Cer) synthase, an important enzyme which plays a key role in the synthesis of lacto- or neolacto-series carbohydrate chains on glycolipids. beta 3Gn-T5 exhibited strong activity to transfer GlcNAc to glycolipid substrates, such as lactosylceramide (LacCer) and neolactotetraosylceramide (nLc(4)Cer; paragloboside), resulting in the synthesis of Lc(3)Cer and neolactopentaosylceramide (nLc(5)Cer), respectively. A marked decrease in LacCer and increase in nLc(4)Cer was detected in Namalwa cells stably expressing beta 3Gn-T5. This indicated that beta 3Gn-T5 exerted activity to synthesize Lc(3)Cer and decrease LacCer, followed by conversion to nLc(4)Cer via endogenous galactosylation. The following four findings further supported that beta 3Gn-T5 is Lc(3)Cer synthase. 1) The beta 3Gn-T5 transcript levels in various cells were consistent with the activity levels of Lc(3)Cer synthase in those cells. 2) The beta 3Gn-T5 transcript was presented in various tissues and cultured cells. 3) The beta 3Gn-T5 expression was up-regulated by stimulation with retinoic acid and down-regulated with 12-O-tetradecanoylphorbol-13-acetate in HL-60 cells. 4) The changes in beta 3Gn-T5 transcript levels during the rat brain development were determined. Points 2, 3, and 4 were consistent with the Lc,Cer synthase activity reported previously.	AIST, Natl Inst Adv Ind Sci & Technol, IMCB, Lab Gene Funct Anal, Tsukuba, Ibaraki 3058568, Japan; Soka Univ, Inst Life Sci, Div Cell Biol, Hachioji, Tokyo 1928577, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Tokyo Univ Agr, Fac Bioind, Lab Anim Resources, Abashiri, Hokkaido 0992422, Japan; Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biomembrane & Biofunct Chem, Kita Ku, Sapporo, Hokkaido 0600812, Japan; Kyowa Hakko Kogyo Co Ltd, Tokyo Res Labs, Machida, Tokyo 1948582, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Soka University; University of Tokyo; Tokyo University of Agriculture; Hokkaido University; Kyowa Kirin Ltd	Narimatsu, H (corresponding author), AIST, Natl Inst Adv Ind Sci & Technol, IMCB, Lab Gene Funct Anal, Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	h.narimatsu@aist.go.jp	Togayachi, Akira/M-4144-2018; Narimatsu, Hisashi/M-4757-2018; Natsume, Atsushi/I-7364-2014; Inokuchi, Jin-ichi/AAW-9964-2020	Togayachi, Akira/0000-0003-3600-9149; Narimatsu, Hisashi/0000-0002-8402-133X; Natsume, Atsushi/0000-0002-9113-0470; Inokuchi, Jin-ichi/0000-0002-0703-5746; Nishihara, Shoko/0000-0002-1668-2603				Allendoerfer KL, 1999, DEV BIOL, V211, P208, DOI 10.1006/dbio.1999.9308; Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; Ashwell KWS, 1997, INT J DEV NEUROSCI, V15, P883, DOI 10.1016/S0736-5748(97)00036-1; Ashwell KWS, 1997, CELL TISSUE RES, V289, P17, DOI 10.1007/s004410050848; BASU M, 1991, CARBOHYD RES, V209, P261, DOI 10.1016/0008-6215(91)80162-G; BASU M, 1984, J BIOL CHEM, V259, P2557; Chou DKH, 1996, GLYCOCONJUGATE J, V13, P295, DOI 10.1007/BF00731504; Chou DKH, 1996, J BIOL CHEM, V271, P28868, DOI 10.1074/jbc.271.46.28868; CHOU DKH, 1993, J BIOL CHEM, V268, P21727; Chou DKH, 1998, J BIOL CHEM, V273, P8508, DOI 10.1074/jbc.273.14.8508; CHOU DKH, 1994, J NEUROCHEM, V62, P307; CHOU DKH, 1991, J BIOL CHEM, V266, P17941; CHOU DKH, 1988, J NEUROCHEM, V50, P1655, DOI 10.1111/j.1471-4159.1988.tb03056.x; CHOU DKH, 1990, J NEUROCHEM, V54, P1589, DOI 10.1111/j.1471-4159.1990.tb01209.x; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; CHOU DKH, 1993, J BIOL CHEM, V268, P330; CHOU KH, 1985, BIOCHEM BIOPH RES CO, V128, P383, DOI 10.1016/0006-291X(85)91690-0; Dasgupta S, 1996, GLYCOCONJUGATE J, V13, P367, DOI 10.1007/BF00731469; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; Gocht A, 1996, HISTOL HISTOPATHOL, V11, P1007; Gotz M, 1996, NEURON, V16, P551, DOI 10.1016/S0896-6273(00)80074-4; HOLMES EH, 1987, J BIOL CHEM, V262, P15649; HOLMES EH, 1988, ARCH BIOCHEM BIOPHYS, V260, P461, DOI 10.1016/0003-9861(88)90470-5; Isshiki S, 1999, J BIOL CHEM, V274, P12499, DOI 10.1074/jbc.274.18.12499; JUNGALWALA FB, 1994, NEUROCHEM RES, V19, P945, DOI 10.1007/BF00968704; Kolbinger F, 1998, J BIOL CHEM, V273, P433, DOI 10.1074/jbc.273.1.433; Kudo T, 1998, J BIOL CHEM, V273, P26729, DOI 10.1074/jbc.273.41.26729; Kudo T, 1998, LAB INVEST, V78, P797; Mai JK, 1999, NEUROSCIENCE, V88, P847, DOI 10.1016/S0306-4522(98)00266-8; Mai JK, 1999, J COMP NEUROL, V404, P197; Nair SM, 1998, NEUROSCIENCE, V85, P759, DOI 10.1016/S0306-4522(97)00666-0; Nair SM, 1997, J NEUROCHEM, V68, P1286; NAIR SM, 1993, J COMP NEUROL, V332, P282, DOI 10.1002/cne.903320303; NAKAMURA M, 1992, J BIOL CHEM, V267, P23507; Nishihara S, 1999, FEBS LETT, V462, P289, DOI 10.1016/S0014-5793(99)01549-5; Oka S, 1998, YAKUGAKU ZASSHI, V118, P431, DOI 10.1248/yakushi1947.118.10_431; PILLER F, 1983, J BIOL CHEM, V258, P2293; PRASADARAO N, 1990, J NEUROCHEM, V55, P2024, DOI 10.1111/j.1471-4159.1990.tb05791.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sajdel-Sulkowska EM, 1998, ACTA BIOCHIM POL, V45, P781, DOI 10.18388/abp.1998_4272; SASAKI K, 1994, J BIOL CHEM, V269, P15950; Sasaki K, 1997, P NATL ACAD SCI USA, V94, P14294, DOI 10.1073/pnas.94.26.14294; SASAKI K, 1993, J BIOL CHEM, V268, P22782; SASAKI K, 1994, J BIOL CHEM, V269, P14730; SASAKI K, 1994, Patent No. 0612759; Shiraishi N, 2001, J BIOL CHEM, V276, P3498, DOI 10.1074/jbc.M004800200; Streit A, 1996, J NEUROCHEM, V66, P834; STULTS CLM, 1993, ARCH BIOCHEM BIOPHYS, V303, P125, DOI 10.1006/abbi.1993.1263; TAGA S, 1995, BBA-LIPID LIPID MET, V1254, P56, DOI 10.1016/0005-2760(94)00167-W; Togayachi A, 1999, INT J CANCER, V83, P70, DOI 10.1002/(SICI)1097-0215(19990924)83:1<70::AID-IJC14>3.0.CO;2-K; Yoshida-Noro C, 1999, GLYCOBIOLOGY, V9, P1323, DOI 10.1093/glycob/9.12.1323; YOUNG WW, 1981, J BIOL CHEM, V256, P967; Zhou DP, 2000, P NATL ACAD SCI USA, V97, P11673; Zhou DP, 1999, P NATL ACAD SCI USA, V96, P406, DOI 10.1073/pnas.96.2.406	54	94	99	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22032	22040		10.1074/jbc.M011369200	http://dx.doi.org/10.1074/jbc.M011369200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11283017	hybrid			2022-12-27	WOS:000169412700008
J	Berwin, B; Reed, RC; Nicchitta, CV				Berwin, B; Reed, RC; Nicchitta, CV			Virally induced lytic cell death elicits the release of immunogenic GRP94/gp96	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; DENDRITIC CELLS; T-CELLS; ENDOPLASMIC-RETICULUM; IN-VIVO; INDUCED APOPTOSIS; CTL RESPONSES; CHAPERONE; CALRETICULIN; PEPTIDES	Necrotic cell death yields the release of cellular components that can function in the initiation of cellular immune responses. Given the established capacity of the endoplasmic reticulum chaperone GRP94 (gp96) to elicit CD8(+) T cell activation, we have investigated the cellular fate and antigenicity of GRP94 in differing scenarios of cell death. Virally induced cell death or mechanical cell death, elicited by freeze/thaw treatment of cell suspensions, yielded GRP94 release into the extracellular space; apoptotic cell death occurring in response to serum deprivation did not elicit GRP94 release. To assess the antigenicity of GRP94 released following virally induced cell death (lethal infection of cells with rVV ES-OVA(Met258-265), a recombinant, ovalbumin epitope-expressing vaccinia virus) or mechanical cell death (freeze/thaw of ovalbumin-expressing cells), tissue culture supernatant fractions were pulsed onto antigen-presenting cells, and antigen re-presentation was assayed as activation of an ovalbumin-specific T cell hybridoma, For both cell death scenarios, released GRP94 elicited a dose-dependent, ovalbumin-specific, hybridoma activation. In contrast, calreticulin derived from rVV ES-OVA(Met258-265)-infected cell extracts did not stimulate B3Z activity. These data identify GRP94 as an antigenic component released upon pathological, but not apoptotic, cell death and provide an assay system far the identification of cellular components of related activity.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Nicchitta, CV (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.			Berwin, Brent/0000-0001-9196-3256	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053058] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK53058] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARNOLD D, 1995, J EXP MED, V182, P885, DOI 10.1084/jem.182.3.885; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Baixeras E, 1998, VIRUS RES, V58, P107, DOI 10.1016/S0168-1702(98)00105-1; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Basu S, 1999, J EXP MED, V189, P797, DOI 10.1084/jem.189.5.797; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; DUVALL E, 1986, IMMUNOL TODAY, V7, P115, DOI 10.1016/0167-5699(86)90152-0; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gillet G, 1996, TRENDS MICROBIOL, V4, P312, DOI 10.1016/0966-842X(96)10047-0; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McConkey DJ, 1998, TOXICOL LETT, V99, P157, DOI 10.1016/S0378-4274(98)00155-6; Melcher A, 1999, J MOL MED-JMM, V77, P824, DOI 10.1007/s001099900066; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Moroi Y, 2000, P NATL ACAD SCI USA, V97, P3485, DOI 10.1073/pnas.070550797; Nair S, 1999, J IMMUNOL, V162, P6426; Nicchitta CV, 1998, CURR OPIN IMMUNOL, V10, P103, DOI 10.1016/S0952-7915(98)80039-3; Reddy RK, 1999, J BIOL CHEM, V274, P28476, DOI 10.1074/jbc.274.40.28476; RESTIFO NP, 1995, J IMMUNOL, V154, P4414; Rodenburg RJT, 2000, BIOESSAYS, V22, P627, DOI 10.1002/1521-1878(200007)22:7<627::AID-BIES5>3.0.CO;2-K; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Singh-Jasuja H, 2000, J EXP MED, V191, P1965, DOI 10.1084/jem.191.11.1965; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; Steinhoff U, 1999, IMMUNITY, V11, P349, DOI 10.1016/S1074-7613(00)80110-7; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; Todryk S, 1999, J IMMUNOL, V163, P1398; Trump BF, 1997, TOXICOL PATHOL, V25, P82, DOI 10.1177/019262339702500116; UDONO H, 1994, P NATL ACAD SCI USA, V91, P3077, DOI 10.1073/pnas.91.8.3077; UDONO H, 1994, J IMMUNOL, V152, P5398; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; Wassenberg JJ, 1999, J CELL SCI, V112, P2167; Wearsch PA, 1996, PROTEIN EXPRES PURIF, V7, P114, DOI 10.1006/prep.1996.0015	38	74	80	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21083	21088		10.1074/jbc.M101836200	http://dx.doi.org/10.1074/jbc.M101836200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279246	hybrid			2022-12-27	WOS:000169297900040
J	Marenstein, DR; Ocampo, MTA; Chan, MK; Altamirano, A; Basu, AK; Boorstein, RJ; Cunningham, RP; Teebor, GW				Marenstein, DR; Ocampo, MTA; Chan, MK; Altamirano, A; Basu, AK; Boorstein, RJ; Cunningham, RP; Teebor, GW			Stimulation of human endonuclease III by Y box-binding protein 1 (DNA-binding protein B) - Interaction between a base excision repair enzyme and a transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; THYMINE GLYCOL; 8-OXOGUANINE-DNA GLYCOSYLASE; CROSS-LINKING; HUMAN HOMOLOG; ABASIC SITE; HUMAN NTH1; IDENTIFICATION; CLONING; YB-1	Human endonuclease III (hNth1) is a DNA glycosylase/ apurinic/apyrimidinic (AP) lyase that initiates base excision repair of pyrimidines modified by reactive oxygen species, ionizing, and ultraviolet radiation. Using duplex 2'-deoxyribose oligonucleotides containing an abasic (AP) site, a thymine glycol, or a 5-hydroxyuracil residue as substrates, we found the AP lyase activity of hNth1 was 7 times slower than its DNA glycosylase activity, similar to results reported for murine and human 8-oxoguanine-DNA glycosylase, which are also members of the endonuclease III family. This difference in rates contrasts with the equality of rates found in Escherichia coli and Saccharomyces cerevisiae endonuclease III homologs, A yeast two-hybrid screen for potential modulators of hNth1 activity revealed interaction with the damage-inducible transcription factor Y box-binding protein 1 (YB-1), also identified as DNA-binding protein B (DbpB). The in vitro addition of His(6)YB-1 to hNth1 increased the rate of DNA glycosylase and AP lyase activity. Analysis revealed that YB-1 affects the steady state equilibrium between the covalent hNth1-AP site Schiff base ES intermediate and the noncovalent ES intermediate containing the AP aldehydic sugar and the epsilon -amino group of the hNth1 active site lysine, This equilibrium may be a checkpoint in modulating hNth1 activity.	NYU, Med Ctr, Dept Pathol, Sch Med, New York, NY 10016 USA; NYU, Sch Med, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA; SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; Univ Connecticut, Dept Chem, Storrs, CT 06269 USA	New York University; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Connecticut	Teebor, GW (corresponding author), NYU, Med Ctr, Dept Pathol, Sch Med, 550 1st Ave, New York, NY 10016 USA.	george.teebor@med.nyu.edu		Teebor, George/0000-0002-7397-2500	NCI NIH HHS [5T32 CA-09161, CA 16669, CA 49869] Funding Source: Medline; NIEHS NIH HHS [NIES-ES 09127] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA016669, R01CA049869, T32CA009161, R37CA016669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009127, R56ES009127] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Asagoshi K, 2000, BIOCHEMISTRY-US, V39, P11389, DOI 10.1021/bi000422l; Aspinwall R, 1997, P NATL ACAD SCI USA, V94, P109, DOI 10.1073/pnas.94.1.109; Bessho T, 1999, NUCLEIC ACIDS RES, V27, P979, DOI 10.1093/nar/27.4.979; CAREY J, 1991, METHOD ENZYMOL, V208, P103; Chen CY, 2000, GENE DEV, V14, P1236; Chernukhin IV, 2000, J BIOL CHEM, V275, P29915, DOI 10.1074/jbc.M001538200; Chheda AD, 2000, METHODS, V22, P180, DOI 10.1006/meth.2000.1059; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; DIDIER DK, 1988, P NATL ACAD SCI USA, V85, P7322, DOI 10.1073/pnas.85.19.7322; Dizdaroglu M, 1999, BIOCHEMISTRY-US, V38, P243, DOI 10.1021/bi9819071; Duh JL, 1995, J BIOL CHEM, V270, P30499, DOI 10.1074/jbc.270.51.30499; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Friedberg EC, 1996, ANNU REV BIOCHEM, V65, P15; GLAZER PM, 1989, P NATL ACAD SCI USA, V86, P1163, DOI 10.1073/pnas.86.4.1163; Hilbert TP, 1996, BIOCHEMISTRY-US, V35, P2505, DOI 10.1021/bi952516e; Hilbert TP, 1997, J BIOL CHEM, V272, P6733, DOI 10.1074/jbc.272.10.6733; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; HORI N, 1992, NUCLEIC ACIDS RES, V20, P4761, DOI 10.1093/nar/20.18.4761; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; Ise T, 1999, CANCER RES, V59, P342; JONES PG, 1994, MOL MICROBIOL, V11, P811, DOI 10.1111/j.1365-2958.1994.tb00359.x; Kenny MK, 2001, J BIOL CHEM, V276, P9532, DOI 10.1074/jbc.M009297200; Klungland A, 1999, MOL CELL, V3, P33, DOI 10.1016/S1097-2765(00)80172-0; Koike K, 1997, FEBS LETT, V417, P390, DOI 10.1016/S0014-5793(97)01296-9; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; McNulty JM, 1998, CHEM RES TOXICOL, V11, P666, DOI 10.1021/tx970225w; Memisoglu A, 2000, MUTAT RES-FUND MOL M, V451, P39, DOI 10.1016/S0027-5107(00)00039-7; Miao F, 2000, J BIOL CHEM, V275, P28433, DOI 10.1074/jbc.M001064200; OHANDLEY S, 1995, BIOCHEMISTRY-US, V34, P2528, DOI 10.1021/bi00008a017; Ohga T, 1998, J BIOL CHEM, V273, P5997, DOI 10.1074/jbc.273.11.5997; Ohga T, 1996, CANCER RES, V56, P4224; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; SABATH DE, 1990, J BIOL CHEM, V265, P12671; SAKURA H, 1988, GENE, V73, P499; Shen QC, 1998, J BIOL CHEM, V273, P5443, DOI 10.1074/jbc.273.10.5443; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Sung JS, 2000, BIOCHEMISTRY-US, V39, P10224, DOI 10.1021/bi0007066; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728; WOLFFE AP, 1992, NEW BIOL, V4, P290; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	41	109	113	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21242	21249		10.1074/jbc.M101594200	http://dx.doi.org/10.1074/jbc.M101594200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11287425	hybrid			2022-12-27	WOS:000169297900060
J	Kawabe, Y; Branzei, D; Hayashi, T; Suzuki, H; Masuko, T; Onoda, F; Heo, SJ; Ikeda, H; Shimamoto, A; Furuichi, Y; Seki, M; Enomoto, T				Kawabe, Y; Branzei, D; Hayashi, T; Suzuki, H; Masuko, T; Onoda, F; Heo, SJ; Ikeda, H; Shimamoto, A; Furuichi, Y; Seki, M; Enomoto, T			A novel protein interacts with the Werner's syndrome gene product physically and functionally	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOMS-SYNDROME GENE; DNA HELICASE; SACCHAROMYCES-CEREVISIAE; SYNDROME CELLS; RECQ FAMILY; SGS1; YEAST; MUTATIONS; HOMOLOG; CLONING	Werner's syndrome (WS) is a rare autosomal recessive disorder characterized by premature aging. The gene responsible for WS encodes a protein homologous to Escherichia coli RecQ. Here we describe a novel Werner helicase interacting protein (WHIP), which interacts with the N-terminal portion of Werner protein (WRN), containing the exonuclease domain. WHIP, which shows homology to replication factor C family proteins, is conserved from E. coli to human. Ectopically expressed WHIP and WRN co-localized in granular structures in the nucleus. The functional relationship between WHIP and WRN was indicated by genetic analysis of yeast cells. Disruptants of the SGS1 gene of Saccharomyces cerevisiae, which is the WRN homologue in yeast, show an accelerated aging phenotype and high sensitivity to methyl methanesulfonate as compared with wild-type cells. Disruption of the yeast WHIP (yWHIP) gene in wild-type cells and sgs1 disruptants resulted in slightly accelerated aging and enhancement of the premature aging phenotype of sgs1 disruptants, respectively. In contrast, disruption of the yWHIP gene partially alleviated the sensitivity to methyl methanesulfonate of sgs1 disruptants.	Tohoku Univ, Grad Sch Pharmaceut Sci, Mol Cell Biol Lab, Aoba Ku, Sendai, Miyagi 9808578, Japan; AGENE Res Inst, Kamakura, Kanagawa 2470063, Japan; Kitasato Inst, Ctr Basic Res, Minato Ku, Tokyo 1088642, Japan	Tohoku University	Enomoto, T (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Mol Cell Biol Lab, Aoba Ku, Sendai, Miyagi 9808578, Japan.		Branzei, Dana/GOG-9093-2022; Branzei, Dana/A-2806-2015	Branzei, Dana/0000-0002-0544-4888; Branzei, Dana/0000-0002-0544-4888				Balajee AS, 1999, MOL BIOL CELL, V10, P2655, DOI 10.1091/mbc.10.8.2655; Blander G, 1999, J BIOL CHEM, V274, P29463, DOI 10.1074/jbc.274.41.29463; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Cooper MP, 2000, GENE DEV, V14, P907; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Frei C, 2000, GENE DEV, V14, P81; FUJIWARA Y, 1977, J CELL PHYSIOL, V92, P365, DOI 10.1002/jcp.1040920305; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gangloff S, 1999, EMBO J, V18, P1701, DOI 10.1093/emboj/18.6.1701; Goto M, 1997, HUM GENET, V99, P191, DOI 10.1007/s004390050336; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; HISHIDA T, 2001, IN PRESS P NATL ACAD; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Kamath-Loeb AS, 2000, P NATL ACAD SCI USA, V97, P4603, DOI 10.1073/pnas.97.9.4603; Kawabe Y, 2000, J BIOL CHEM, V275, P20963, DOI 10.1074/jbc.C000273200; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; Kusano K, 1999, GENETICS, V151, P1027; Lebel M, 1999, J BIOL CHEM, V274, P37795, DOI 10.1074/jbc.274.53.37795; Li BM, 2000, J BIOL CHEM, V275, P28349, DOI 10.1074/jbc.C000289200; MARTIN GM, 1977, AM J PATHOL, V89, P484; Matsumoto T, 1997, NAT GENET, V16, P335, DOI 10.1038/ng0897-335; Miyajima A, 2000, MOL CELL BIOL, V20, P6399, DOI 10.1128/MCB.20.17.6399-6409.2000; NAKAYAMA K, 1985, MOL GEN GENET, V200, P266, DOI 10.1007/BF00425434; Ogburn CE, 1997, HUM GENET, V101, P121, DOI 10.1007/s004390050599; Onoda F, 2001, MOL GEN GENET, V264, P702, DOI 10.1007/s004380000358; ONODA S, 2000, MUTAT RES, V459, P203; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; Schulz VP, 1996, HUM GENET, V97, P750; SEKI M, 1994, NUCLEIC ACIDS RES, V22, P466; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Spillare EA, 1999, GENE DEV, V13, P1355, DOI 10.1101/gad.13.11.1355; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; Suzuki N, 1997, NUCLEIC ACIDS RES, V25, P2973, DOI 10.1093/nar/25.15.2973; TSURIMOTO T, 1990, P NATL ACAD SCI USA, V87, P1023, DOI 10.1073/pnas.87.3.1023; Watt PM, 1996, GENETICS, V144, P935; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733; Yan H, 1998, NAT GENET, V19, P375, DOI 10.1038/1263; Yu CE, 1997, AM J HUM GENET, V60, P330; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	47	50	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20364	20369		10.1074/jbc.C100035200	http://dx.doi.org/10.1074/jbc.C100035200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11301316	hybrid			2022-12-27	WOS:000169135100094
J	Reusch, HP; Schaefer, M; Plum, C; Schultz, G; Paul, M				Reusch, HP; Schaefer, M; Plum, C; Schultz, G; Paul, M			G beta gamma mediate differentiation of vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; EPIDERMAL-GROWTH-FACTOR; HEAVY-CHAIN ISOFORMS; FACTOR RECEPTOR; COUPLED RECEPTORS; ARGININE-VASOPRESSIN; ANGIOTENSIN-II; ALPHA-ACTIN; TRANSCRIPTIONAL REGULATION; DEPENDENT ACTIVATION	Proliferation and subsequent dedifferentiation of vascular smooth muscle (VSM) cells contribute to the pathogenesis of atherosclerosis and postangioplastic restenosis, The dedifferentiation of VSRI cells in vivo or in cell culture is characterized by a loss of contractile proteins such as smooth muscle-specific Lu-actin and myosin heavy chain (SM-MHC). Serum increased the expression of contractile proteins in neonatal rat VSM cells, indicating a redifferentiation process. RNase protection assays defined thrombin as a serum component that increases the abundance of SRI-MHC transcripts. Additionally, serum and thrombin transiently elevated cytosolic Ca2+ concentrations, led to a biphasic extracellular signal-regulated kinase (ERK) phosphorylation, up-regulated a transfected SRI-MHC promoter construct, and induced expression of the contractile proteins SM-MHc and ol-actin, Pertussis toxin, N17-Ras/Raf, and PD98059 prevented both the serum- and thrombin-induced second phase ERK phosphorylation and SM-MHc promoter activation. Constitutively active G alpha (q), G alphai, G alpha (12), and G alpha (13) failed to up-regulate SRI-MHC transcription, whereas G beta gamma concentration-dependently increased the SM-MHC promoter activity. Furthermore, the G beta gamma scavenger beta -adrenergic receptor kinase 1 C-terminal peptide abolished the serum-mediated differentiation. We conclude that receptor-mediated differentiation of VSM cells requires G beta gamma and an intact Ras/Raf/MEK/ERK signaling.	Free Univ Berlin, Inst Klin Pharmakol & Toxikol, Benjamin Franklin Med Ctr, D-14195 Berlin, Germany; Free Univ Berlin, Inst Pharmacol, Benjamin Franklin Med Ctr, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Reusch, HP (corresponding author), Free Univ Berlin, Inst Klin Pharmakol & Toxikol, Benjamin Franklin Med Ctr, Garystr 5, D-14195 Berlin, Germany.		Paul, Martin/K-5425-2015					AIKAWA M, 1995, ANN NY ACAD SCI, V748, P578; Aikawa M, 1997, CIRCULATION, V96, P82; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Garat C, 2000, J BIOL CHEM, V275, P22537, DOI 10.1074/jbc.M003000200; GEISTERFER AAT, 1989, HYPERTENSION, V14, P413, DOI 10.1161/01.HYP.14.4.413; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; Gohla A, 2000, CIRC RES, V87, P221, DOI 10.1161/01.RES.87.3.221; Grosse R, 2000, J BIOL CHEM, V275, P12251, DOI 10.1074/jbc.275.16.12251; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gudermann T, 1996, ANNU REV PHARMACOL, V36, P429; HEDIN U, 1988, J CELL BIOL, V107, P307, DOI 10.1083/jcb.107.1.307; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; IVES HE, 1978, J EXP MED, V148, P1400, DOI 10.1084/jem.148.5.1400; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LINSEMAN DA, 1995, J BIOL CHEM, V270, P12563, DOI 10.1074/jbc.270.21.12563; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Madsen CS, 1997, J BIOL CHEM, V272, P29842, DOI 10.1074/jbc.272.47.29842; Madsen CS, 1997, J BIOL CHEM, V272, P6332, DOI 10.1074/jbc.272.10.6332; MAJESKY MW, 1988, P NATL ACAD SCI USA, V85, P1524, DOI 10.1073/pnas.85.5.1524; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mattingly RR, 1996, NATURE, V382, P268, DOI 10.1038/382268a0; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; NAGAI R, 1989, J BIOL CHEM, V264, P9734; NAGAI R, 1988, P NATL ACAD SCI USA, V85, P1047, DOI 10.1073/pnas.85.4.1047; OWENS GK, 1995, PHYSIOL REV, V75, P487; Piiper A, 2000, MOL PHARMACOL, V58, P608, DOI 10.1124/mol.58.3.608; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; PUMIGLIA KM, 1995, J BIOL CHEM, V270, P14251, DOI 10.1074/jbc.270.24.14251; Racke FK, 1997, J BIOL CHEM, V272, P23366, DOI 10.1074/jbc.272.37.23366; Reusch P, 1996, CIRC RES, V79, P1046, DOI 10.1161/01.RES.79.5.1046; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shanahan CM, 1998, ARTERIOSCL THROM VAS, V18, P333, DOI 10.1161/01.ATV.18.3.333; SHIMIZU RT, 1995, J BIOL CHEM, V270, P7631, DOI 10.1074/jbc.270.13.7631; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; TURLA MB, 1991, CIRC RES, V68, P288, DOI 10.1161/01.RES.68.1.288; VANPUTTEN V, 1994, CIRC RES, V75, P1126, DOI 10.1161/01.RES.75.6.1126; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WILSON E, 1993, J CELL BIOL, V123, P741, DOI 10.1083/jcb.123.3.741; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Zeidan A, 2000, CIRC RES, V87, P228, DOI 10.1161/01.RES.87.3.228; Zwick E, 1999, J BIOL CHEM, V274, P20989, DOI 10.1074/jbc.274.30.20989	53	30	30	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19540	19547		10.1074/jbc.M101963200	http://dx.doi.org/10.1074/jbc.M101963200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279222	hybrid			2022-12-27	WOS:000169091000117
J	Schild-Poulter, C; Pope, L; Giffin, W; Kochan, JC; Ngsee, JK; Traykova-Andonova, M; Hache, RJG				Schild-Poulter, C; Pope, L; Giffin, W; Kochan, JC; Ngsee, JK; Traykova-Andonova, M; Hache, RJG			The binding of Ku antigen to homeodomain proteins promotes their phosphorylation by DNA-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; V(D)J RECOMBINATION; GLUCOCORTICOID RECEPTOR; CATALYTIC SUBUNIT; GENE-PRODUCT; C-ABL; DOMAIN; ACTIVATION; REPAIR; OCT-1	The Ku antigen (70- and 80-kDa subunits) is a regulatory subunit of DNA-dependent protein kinase (DNA-PK) that promotes the recruitment of the catalytic subunit of DNA-PK (DNA-PKcs) to DNA ends and to specific DNA sequences from which the kinase is activated. Ku and DNA-PKcs plays essential roles in double-stranded DNA break repair and V(D)J recombination and have been implicated in the regulation of specific gene transcription. In a yeast two-hybrid screen of a Jurkat T cell cDNA library, we have identified a specific interaction between the 70-kDa subunit of Ku heterodimer and the homeodomain of HOXC4, a homeodomain protein expressed in the hematopoietic system. Unexpectedly, a similar interaction with Ku was observed for several additional homeodomain proteins including octamer transcription factors 1 and 2 and D1x2, suggesting that specific binding to Ku may be a property shared by many homeodomain proteins. Ku-homeodomain binding was mediated through the extreme C terminus of Ku70 and was abrogated by amino acid substitutions at Lys(595)/lys(596). Ku binding allowed the recruitment of the homeodomain to DNA ends and dramatically enhanced the phosphorylation of homeodomain-containing proteins by DNA-PK. These results suggest that Ku functions as a substrate docking protein for signaling by DNA-PK to homeodomain proteins from DNA ends.	Ottawa Hosp, Loeb Hlth Res Inst, Dept Med, Ottawa, ON K1Y 4K9, Canada; Univ Ottawa, Loeb Hlth Res Inst, Dept Cellular & Mol Med, Ottawa Hosp, Ottawa, ON K1Y 4K9, Canada; Univ Ottawa, Loeb Hlth Res Inst, Dept Biochem Microbiol & Immunol, Ottawa Hosp, Ottawa, ON K1Y 4K9, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Hache, RJG (corresponding author), Ottawa Hosp, Loeb Hlth Res Inst, Dept Med, 725 Parkdale Ave, Ottawa, ON K1Y 4K9, Canada.		Hoff, Paulo M. PH/M-7662-2017; Schild-Poulter, Caroline/K-4476-2013	Hoff, Paulo M. PH/0000-0002-0065-2194; 				AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; Anderson CW, 1995, METHODS IN PROTEIN STRUCTURE ANALYSIS, P395; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Barlev NA, 1998, MOL CELL BIOL, V18, P1349, DOI 10.1128/MCB.18.3.1349; Chariot A, 1999, BIOCHEM PHARMACOL, V58, P1851, DOI 10.1016/S0006-2952(99)00234-8; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; EDELMAN GM, 1993, J BIOL CHEM, V268, P20683; Faux MC, 1996, CELL, V85, P9, DOI 10.1016/S0092-8674(00)81075-2; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Giffin W, 1999, MOL CELL BIOL, V19, P4065; Giffin W, 1997, J BIOL CHEM, V272, P5647, DOI 10.1074/jbc.272.9.5647; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; Grande MA, 1997, J CELL SCI, V110, P1781; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Haber JE, 1999, CELL, V97, P829, DOI 10.1016/S0092-8674(00)80795-3; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; HINKLEY CS, 1992, MOL CELL BIOL, V12, P638, DOI 10.1128/MCB.12.2.638; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Imai S, 1997, MOL BIOL CELL, V8, P2407, DOI 10.1091/mbc.8.12.2407; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; Jin SF, 1997, J BIOL CHEM, V272, P24763, DOI 10.1074/jbc.272.40.24763; Jin SF, 1997, CANCER SURV, V29, P221; Kharbanda S, 1997, NATURE, V386, P732, DOI 10.1038/386732a0; Kim MK, 1996, MOL CELL BIOL, V16, P4366; KORNBERG TB, 1993, J BIOL CHEM, V268, P26813; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; LAI JS, 1992, GENE DEV, V6, P2058, DOI 10.1101/gad.6.11.2058; Leber R, 1998, J BIOL CHEM, V273, P1794, DOI 10.1074/jbc.273.3.1794; LeesMiller SP, 1996, BIOCHEM CELL BIOL, V74, P503, DOI 10.1139/o96-054; Li GC, 1998, MOL CELL, V2, P1, DOI 10.1016/S1097-2765(00)80108-2; Lowndes NF, 2000, CURR OPIN GENET DEV, V10, P17, DOI 10.1016/S0959-437X(99)00050-7; MANAK JR, 1994, DEVELOPMENT, P61; Martincic I, 1997, J BIOL CHEM, V272, P26991, DOI 10.1074/jbc.272.43.26991; Meighan-Mantha RL, 1999, MOL CELL BIOCHEM, V199, P209, DOI 10.1023/A:1006958217143; Modesti M, 1999, EMBO J, V18, P2008, DOI 10.1093/emboj/18.7.2008; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Ouyang H, 1997, J EXP MED, V186, P921, DOI 10.1084/jem.186.6.921; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Phelan ML, 1997, J BIOL CHEM, V272, P8635, DOI 10.1074/jbc.272.13.8635; Prefontaine GG, 1998, MOL CELL BIOL, V18, P3416, DOI 10.1128/MCB.18.6.3416; Romero F, 1996, MOL CELL BIOL, V16, P37; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sartorius CA, 2000, J MOL ENDOCRINOL, V24, P165, DOI 10.1677/jme.0.0240165; Scott MP, 1999, NATURE, V397, P649, DOI 10.1038/17685; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Tuteja R, 2000, CRIT REV BIOCHEM MOL, V35, P1, DOI 10.1080/10409230091169177; Vershon AK, 1996, CURR OPIN BIOTECH, V7, P392, DOI 10.1016/S0958-1669(96)80113-3; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Wang JM, 1999, MOL CELL BIOL, V19, P7106; Weaver DT, 1998, CURR BIOL, V8, pR492, DOI 10.1016/S0960-9822(98)70315-X; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8; Zhao HC, 2000, CANCER RES, V60, P6276; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	64	56	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16848	16856		10.1074/jbc.M100768200	http://dx.doi.org/10.1074/jbc.M100768200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279128	hybrid			2022-12-27	WOS:000168730400035
J	Provost, P; Doucet, J; Hammarberg, T; Gerisch, G; Samuelsson, B; Radmark, O				Provost, P; Doucet, J; Hammarberg, T; Gerisch, G; Samuelsson, B; Radmark, O			5-Lipoxygenase interacts with coactosin-like protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN POLYMERIZATION DEPOLYMERIZATION; POLYMORPHONUCLEAR LEUKOCYTES; BINDING MOTIF; IN-VITRO; LEUKOTRIENES; CALCIUM; DOMAIN; TRIGGERS; LIGANDS; NUCLEUS	We have recently identified coactosin-like protein (CLP) in a yeast two-hybrid screen using 5-lipoxygenase (5LO) as a bait. In this report, we demonstrate a direct interaction between 5LO and CLP, 5LO associated with CLP, which was expressed as a glutathione S-transferase fusion protein, in a dose-dependent manner. Coimmunoprecipitation experiments using epitope-tagged 5LO and CLP proteins transiently expressed in human embryonic kidney 293 cells revealed the presence of CLP in 5LO immunoprecipitates, In reciprocal experiments, 5LO was detected in CLP immunoprecipitates. Non-denaturing polyacrylamide gel electrophoresis and cross-linking experiments showed that 5LO binds CLP in a 1:1 molar stoichiometry in a Ca2+-independent manner. Site-directed mutagenesis suggested an important role for lysine 131 of CLP in mediating 5LO binding. In view of the ability of CLP to bind 5LO and filamentous actin (F-actin), we determined whether CLP could physically link 5LO to actin filaments. However, no F-actin-CLP.5LO ternary complex was observed. In contrast, 5LO appeared to compete with F-actin for the binding of CLP. Moreover, 5LO was found to interfere with actin polymerization. Our results indicate that the 5LO-CLP and CLP-F-actin interactions are mutually exclusive and suggest a modulatory role for 5LO in actin dynamics.	Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Max Planck Inst Biochem, D-82152 Martinsried, Germany	Karolinska Institutet; Max Planck Society	Radmark, O (corresponding author), Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	olof.radmark@mbb.ki.se	Provost, Patrick/G-2786-2010	Provost, Patrick/0000-0002-6099-6562				Alberts B., 1994, MOL BIOL CELL; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brock TG, 1997, J BIOL CHEM, V272, P8276, DOI 10.1074/jbc.272.13.8276; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; DEHOSTOS EL, 1993, CELL MOTIL CYTOSKEL, V26, P181, DOI 10.1002/cm.970260302; HAM EA, 1983, P NATL ACAD SCI-BIOL, V80, P4349, DOI 10.1073/pnas.80.14.4349; HAMMARBERG T, 1995, EUR J BIOCHEM, V230, P401; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; HAURAND M, 1989, BIOCHEM PHARMACOL, V38, P2129, DOI 10.1016/0006-2952(89)90067-1; Howard T H, 1994, Curr Opin Hematol, V1, P61; James P, 1996, GENETICS, V144, P1425; JANMEY PA, 1985, BIOCHEMISTRY-US, V24, P3714, DOI 10.1021/bi00335a046; Kang LT, 1998, J LIPID RES, V39, P1476; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LEPLEY RA, 1994, J BIOL CHEM, V269, P24163; Lepley RA, 1996, J BIOL CHEM, V271, P6179, DOI 10.1074/jbc.271.11.6179; Lodish H., 1995, MOL CELL BIOL; MARRIOTT G, 1988, BIOCHEMISTRY-US, V27, P6214, DOI 10.1021/bi00417a004; Massoumi R, 1998, EUR J CELL BIOL, V76, P185, DOI 10.1016/S0171-9335(98)80033-2; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; OMANN GM, 1989, J BIOL CHEM, V264, P16355; OMANN GM, 1995, J IMMUNOL, V155, P5375; Peters-Golden M, 2000, AM J RESP CRIT CARE, V161, pS36, DOI 10.1164/ajrccm.161.supplement_1.ltta-8; PRENDERGAST FG, 1983, J BIOL CHEM, V258, P7541; Provost P, 1999, P NATL ACAD SCI USA, V96, P1881, DOI 10.1073/pnas.96.5.1881; Reddy KV, 2000, BIOCHEMISTRY-US, V39, P1840, DOI 10.1021/bi9919246; REES MK, 1967, J BIOL CHEM, V242, P4449; ROHRIG U, 1995, FEBS LETT, V374, P284, DOI 10.1016/0014-5793(95)01130-7; SAFER D, 1989, ANAL BIOCHEM, V178, P32, DOI 10.1016/0003-2697(89)90351-5; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Turchin A, 1999, BIOTECHNIQUES, V26, P672, DOI 10.2144/99264st02; Wang JHC, 2000, CELL MOTIL CYTOSKEL, V46, P137, DOI 10.1002/1097-0169(200006)46:2<137::AID-CM6>3.0.CO;2-8; Werz O, 2000, P NATL ACAD SCI USA, V97, P5261, DOI 10.1073/pnas.050588997; WOODS JW, 1995, J CLIN INVEST, V95, P2035, DOI 10.1172/JCI117889; ZHANG YY, 1992, P NATL ACAD SCI USA, V89, P485, DOI 10.1073/pnas.89.2.485; Zigmond SH, 1989, CURR OPIN CELL BIOL, V1, P80, DOI 10.1016/S0955-0674(89)80041-9	39	82	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16520	16527		10.1074/jbc.M011205200	http://dx.doi.org/10.1074/jbc.M011205200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11297527	hybrid			2022-12-27	WOS:000168623100126
J	Saydam, N; Georgiev, O; Nakano, MY; Greber, UF; Schaffner, W				Saydam, N; Georgiev, O; Nakano, MY; Greber, UF; Schaffner, W			Nucleo-cytoplasmic trafficking of metal-regulatory transcription factor 1 is regulated by diverse stress signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLOTHIONEIN GENE-EXPRESSION; FACTOR MTF-1; NUCLEAR-LOCALIZATION; RESPONSE ELEMENTS; BINDING-ACTIVITY; DNA-BINDING; FACTOR-I; ACTIVATION; TRANSPORT; PROTEIN	The metal-regulatory transcription factor 1 (MTF-1) is a key regulator of heavy metal-induced transcription of metallothionein I and II and other genes in mammals and other metazoans. Transcriptional activation of genes by MTF-1 is mediated through binding to metal-responsive elements of consensus TGCRCNC in the target gene promoters. In an attempt to further clarify the mechanisms by which certain external signals activate MTF-1 and in turn modulate gene transcription, we show here that human MTF-1 has a dual nuclear and cytoplasmic localization in response to diverse stress stimuli. MTF-1 contains a consensus nuclear localization signal located just N-terminal to the first zinc finger that contributes to but is not essential for nuclear import. MTF-1 also harbors a leucine-rich, nuclear export signal. Under resting conditions, the nuclear export signal is required for cytoplasmic localization of MTF-1 as indicated by mutational analysis and transfer to the heterologous green fluorescent protein. Export from the nucleus was inhibited by leptomycin B, suggesting the involvement of the nuclear export protein CRM1. Our results further show that in addition to the heavy metals zinc and cadmium, heat shock, hydrogen peroxide, low extracellular pH (pH 6.0), inhibition of protein synthesis by cycloheximide, and serum induce nuclear accumulation of MTF-1. However, heavy metals alone land not the other stress conditions) induce a significant transcriptional response via metal-responsive element promoter sequences, implying that nuclear import of MTF-1 is necessary but not sufficient for transcriptional activation. Possible roles for nuclear import under nonmetal stress conditions are discussed.	Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich	Schaffner, W (corresponding author), Univ Zurich, Inst Mol Biol, Winterhurerstr 190, CH-8057 Zurich, Switzerland.	walter.schaffner@molbio.unizh.ch	Greber, Urs F/G-9458-2015; Nakano, Michel Y/H-3528-2014	Greber, Urs F/0000-0003-2278-120X; Nakano, Michel Y/0000-0003-1838-771X				AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bittel D, 1998, J BIOL CHEM, V273, P7127, DOI 10.1074/jbc.273.12.7127; Bittel DC, 2000, J BIOL CHEM, V275, P37194, DOI 10.1074/jbc.M003863200; Dalton TP, 1996, J BIOL CHEM, V271, P26233, DOI 10.1074/jbc.271.42.26233; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Ferrigno P, 1999, ONCOGENE, V18, P6129, DOI 10.1038/sj.onc.1203132; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gatsios P, 1998, J BIOL CHEM, V273, P22962, DOI 10.1074/jbc.273.36.22962; GLANVILLE N, 1981, NATURE, V292, P267, DOI 10.1038/292267a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Greber UF, 1997, EMBO J, V16, P5998, DOI 10.1093/emboj/16.19.5998; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Komeili A, 2000, CURR OPIN CELL BIOL, V12, P355, DOI 10.1016/S0955-0674(00)00100-9; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Lichtlen P, 2001, NUCLEIC ACIDS RES, V29, P1514, DOI 10.1093/nar/29.7.1514; Liu XD, 1997, METHODS, V11, P289, DOI 10.1006/meth.1996.0423; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Moffatt P, 1997, DRUG METAB REV, V29, P261, DOI 10.3109/03602539709037585; Murphy BJ, 1999, CANCER RES, V59, P1315; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; RADTKE F, 1995, NUCLEIC ACIDS RES, V23, P2277, DOI 10.1093/nar/23.12.2277; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Smirnova IV, 2000, J BIOL CHEM, V275, P9377, DOI 10.1074/jbc.275.13.9377; SOLDATI T, 1991, CELL, V66, P277, DOI 10.1016/0092-8674(91)90618-9; THIELE DJ, 1992, NUCLEIC ACIDS RES, V20, P1183, DOI 10.1093/nar/20.6.1183; Vasak M, 2000, CURR OPIN CHEM BIOL, V4, P177, DOI 10.1016/S1367-5931(00)00082-X; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Zhao H, 1998, J BIOL CHEM, V273, P28713, DOI 10.1074/jbc.273.44.28713	40	107	109	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					25487	25495		10.1074/jbc.M009154200	http://dx.doi.org/10.1074/jbc.M009154200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11306562	hybrid, Green Accepted			2022-12-27	WOS:000169800700139
J	Ito, J; Jacobs-Lorena, M				Ito, J; Jacobs-Lorena, M			Functional mapping of destabilizing elements in the protein-coding region of the Drosophila fushi tarazu mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; PAIR-RULE TRANSCRIPTS; ALDOLASE-B GENE; TRANSLATION; INSTABILITY; DEGRADATION; SEQUENCE; TRANSFORMATION; LOCALIZATION; DETERMINANTS	The instability of the fushi tarazu (ftz) mRNA is essential for the proper development of the Drosophila embryo. Previously, we identified a 201-nucleotide instability element (FLE3) in the 3 ' untranslated region (UTR) of the ftz mRNA Here we report on the identification of two additional elements in the protein-coding region of the message: the 83-nucleotide-long FIE5-1 and the 69-nucleotide-long FLE5-2. The function of both elements was position dependent; the same elements destabilized RNAs when present within the coding region but did not when embedded in the 3 ' UTR of the hybrid mRNAs. We conclude that ftz mRNA has three redundant instability elements, two in the protein-coding region and one in the 3 ' UTR. Although each instability element is sufficient to destabilize a heterologous mRNA, the destabilizing activity of the two 5 ' -elements depended on their position within the message.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA	Case Western Reserve University	Jacobs-Lorena, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, 10900 Euclid Ave, Cleveland, OH 44106 USA.							CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; DAVIS I, 1991, CELL, V67, P927, DOI 10.1016/0092-8674(91)90366-7; EDGAR BA, 1987, GENE DEV, V1, P1226, DOI 10.1101/gad.1.10.1226; Fontes AM, 1999, CURR TOP DEV BIOL, V44, P171; GARFINKEL MD, 1983, J MOL BIOL, V168, P765, DOI 10.1016/S0022-2836(83)80074-6; HAFEN E, 1984, CELL, V37, P833, DOI 10.1016/0092-8674(84)90418-5; Hennigan AN, 1996, MOL CELL BIOL, V16, P3833; HIROMI Y, 1987, CELL, V50, P963, DOI 10.1016/0092-8674(87)90523-X; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; Ito JI, 1998, ARCH BIOCHEM BIOPHYS, V350, P291, DOI 10.1006/abbi.1997.0527; KELLERMAN KA, 1990, GENE DEV, V4, P1925; Lall S, 1999, CELL, V98, P171, DOI 10.1016/S0092-8674(00)81012-0; MASON JO, 1988, GENE DEV, V2, P1003, DOI 10.1101/gad.2.8.1003; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; OLIVEIRA CC, 1995, J BIOL CHEM, V270, P8936, DOI 10.1074/jbc.270.15.8936; Pirrotta V, 1988, VECTORS SURVEY MOL C, P437; QIAN S, 1987, NUCLEIC ACIDS RES, V15, P987, DOI 10.1093/nar/15.3.987; Riedl A, 1996, MOL CELL BIOL, V16, P3047; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIAVI SC, 1994, J BIOL CHEM, V269, P3441; SERANO TL, 1994, GENE, V138, P181, DOI 10.1016/0378-1119(94)90804-4; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; STELLER H, 1986, MOL CELL BIOL, V6, P1640, DOI 10.1128/MCB.6.5.1640; Surdej P, 1998, MOL CELL BIOL, V18, P2892, DOI 10.1128/MCB.18.5.2892; TSUTSUMI K, 1985, J MOL BIOL, V181, P153, DOI 10.1016/0022-2836(85)90081-6; TSUTSUMI K, 1984, J BIOL CHEM, V259, P4572; VEYRUNE JL, 1995, ONCOGENE, V11, P2127; WEINER AJ, 1984, CELL, V37, P843, DOI 10.1016/0092-8674(84)90419-7; WEINER MP, 1985, NATURE, V318, P433; WELTE MA, 1995, GENE DEV, V9, P2240, DOI 10.1101/gad.9.18.2240; YU Y, 1995, MECH DEVELOP, V50, P163, DOI 10.1016/0925-4773(94)00333-I; ZAMBETTI G, 1987, P NATL ACAD SCI USA, V84, P2683, DOI 10.1073/pnas.84.9.2683; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	36	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23525	23530		10.1074/jbc.M102965200	http://dx.doi.org/10.1074/jbc.M102965200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11306592	hybrid			2022-12-27	WOS:000169531100042
J	Bacqueville, D; Deleris, P; Mendre, C; Pieraggi, MT; Chap, H; Guillon, G; Perret, B; Breton-Douillon, M				Bacqueville, D; Deleris, P; Mendre, C; Pieraggi, MT; Chap, H; Guillon, G; Perret, B; Breton-Douillon, M			Characterization of a G protein-activated phosphoinositide 3-kinase in vascular smooth muscle cell nuclei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER NUCLEI; BETA-GAMMA-SUBUNITS; SWISS 3T3 CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; GROWTH-FACTOR; KINASE-B; LOCALIZATION SITES; PHOSPHOLIPASE-C; LIPID PRODUCTS; TRANSLOCATION	Recent studies highlight the existence of an autonomous nuclear polyphosphoinositide metabolism related to cellular proliferation and differentiation. However, only few data document the nuclear production of the putative second messengers, the 3-phosphorylated phosphoinositides, by the phosphoinositide 3-kinase (PI3K). In the present paper, we examine whether GTP-binding proteins can directly modulate 3-phosphorylated phosphoinositide metabolism in membrane-free nuclei isolated from pig aorta smooth muscle cells (VSMCs). In vitro PI3K assays performed without the addition of any exogenous substrates revealed that guanosine 5 '-(gamma -thio)triphosphate (GTP gammaS) specifically stimulated the nuclear synthesis of phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3), whereas guanosine 5 '-(beta -thio)diphosphate was ineffective. PI3K inhibitors wortmannin and LY294002 prevented GTP gammaS-induced PtdIns(3,4,5)P-3 synthesis. Moreover, pertussis toxin inhibited partially PtdIns(3,4,5)P-3 accumulation, suggesting that nuclear G(i)/G(0) proteins are involved in the activation of PI3K. Immunoblot experiments showed the presence of G alpha (0), proteins in VSMC nuclei. In contrast with previous reports, immunoblots and indirect immunofluorescence failed to detect the p85 alpha subunit of the heterodimeric PI3K within VSMC nuclei. By contrast, we have detected the presence of a 117-kDa protein immunologically related to the PI3K gamma. These results indicate the existence of a G protein-activated PI3K inside VSMC nucleus that might be involved in the contol of VSMC proliferation and in the pathogenesis of vascular proliferative disorders.	Hop Purpan, INSERM Unite 326, Inst Claude Preval, F-31059 Toulouse, France; CCIPE, INSERM Unite 469, F-34094 Montpellier 5, France; Hop Rangueil, INSERM Unite 466, Inst Louis Bugnard, F-31043 Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Breton-Douillon, M (corresponding author), Hop Purpan, INSERM Unite 326, Inst Claude Preval, F-31059 Toulouse, France.	monique.douillon@purpan.inserm.fr						Bacqueville D, 1998, BIOCHEM BIOPH RES CO, V244, P630, DOI 10.1006/bbrc.1997.7885; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; BRETON M, 1986, EXP CELL RES, V166, P416, DOI 10.1016/0014-4827(86)90487-8; Coffer PJ, 1998, BIOCHEM J, V335, P1; CROUCH MF, 1991, FASEB J, V5, P200, DOI 10.1096/fasebj.5.2.1900794; D'Santos CS, 1998, BBA-MOL CELL BIOL L, V1436, P201, DOI 10.1016/S0005-2760(98)00146-5; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; Domin J, 1997, FEBS LETT, V410, P91, DOI 10.1016/S0014-5793(97)00617-0; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; Iaccarino G, 1999, P NATL ACAD SCI USA, V96, P3945, DOI 10.1073/pnas.96.7.3945; Leopoldt D, 1998, J BIOL CHEM, V273, P7024, DOI 10.1074/jbc.273.12.7024; Lu PJ, 1998, BIOCHEMISTRY-US, V37, P5738, DOI 10.1021/bi972551g; Marchisio M, 1998, BIOCHEM BIOPH RES CO, V253, P346, DOI 10.1006/bbrc.1998.9787; MARTELLI AM, 1992, NATURE, V358, P242, DOI 10.1038/358242a0; Martelli AM, 2000, J BONE MINER RES, V15, P1716, DOI 10.1359/jbmr.2000.15.9.1716; Matteucci A, 1998, CANCER RES, V58, P5057; MAZZOTTI G, 1995, J HISTOCHEM CYTOCHEM, V43, P181, DOI 10.1177/43.2.7822774; Meier R, 1997, J BIOL CHEM, V272, P30491, DOI 10.1074/jbc.272.48.30491; Metjian A, 1999, J BIOL CHEM, V274, P27943, DOI 10.1074/jbc.274.39.27943; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NERI LM, 1994, CELL MOL BIOL, V40, P619; Neri LM, 1999, FASEB J, V13, P2299, DOI 10.1096/fasebj.13.15.2299; PAYRASTRE B, 1994, FEBS LETT, V341, P113, DOI 10.1016/0014-5793(94)80251-3; PAYRASTRE B, 1992, J BIOL CHEM, V267, P5078; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; ROUOT B, 1992, MOL PHARMACOL, V41, P273; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; SULTAN C, 1990, BIOCHEM J, V269, P831, DOI 10.1042/bj2690831; TAKEI Y, 1992, J BIOL CHEM, V267, P5085; Tanaka K, 1999, J BIOL CHEM, V274, P3919, DOI 10.1074/jbc.274.7.3919; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Vann LR, 1997, BIOCHEM J, V327, P569; Viard P, 1999, FASEB J, V13, P685, DOI 10.1096/fasebj.13.6.685; Wang YX, 1999, J BIOL CHEM, V274, P13859, DOI 10.1074/jbc.274.20.13859; WU HC, 1994, LAB INVEST, V71, P175; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8; YORK JD, 1994, J BIOL CHEM, V269, P7847; Zhou GS, 1997, J BIOL CHEM, V272, P31130, DOI 10.1074/jbc.272.49.31130; Zini N, 1996, HISTOCHEM CELL BIOL, V106, P457, DOI 10.1007/BF02473307	50	41	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22170	22176		10.1074/jbc.M011572200	http://dx.doi.org/10.1074/jbc.M011572200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11303021	hybrid			2022-12-27	WOS:000169412700028
J	Brysha, M; Zhang, JG; Bertolino, P; Corbin, JE; Alexander, WS; Nicola, NA; Hilton, DJ; Starr, R				Brysha, M; Zhang, JG; Bertolino, P; Corbin, JE; Alexander, WS; Nicola, NA; Hilton, DJ; Starr, R			Suppressor of cytokine signaling-1 attenuates the duration of interferon gamma signal transduction in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED DISRUPTION; MICE; INHIBITOR; ACTIVATION; LIVER; GENE; CELLS; STAT1; LYMPHOCYTES; PROTEINS	Suppressor of cytokine signaling-1 (SOCS-1) is a cytokine-inducible intracellular protein that functions to negatively regulate cytokine signal transduction pathways. Studies in vitro have shown that constitutive over expression of SOCS-1 inhibits signaling in response to a range of cytokines, including interferons (IFN). Mice lacking SOCS-1 die from a complex disease characterized by liver degeneration and massive inflammation. Whereas there is clear evidence of increased IFN gamma signaling in SOCS-1(-/-) mice, it is unclear to what extent this is due to increased IFN gamma levels or to increased IFN gamma sensitivity. Here we have used SOCS-1(-/-) IFN gamma (-/-) mice, which remain healthy and produce no endogenous IFN gamma to demonstrate that in vitro and in vivo hepatocytes lacking SOCS-1 exhibit a prolonged response to IFN gamma and that this correlates with a dramatically increased sensitivity to the toxic effects of IFN gamma in vivo. Thus, SOCS-1 is required for the timely attenuation of IFN gamma signaling in vivo.	PO Royal Melbourne Hosp, Cooperat Res Ctr Cellular Growth Factors, Melbourne, Vic 3050, Australia; PO Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Centenary Inst Canc Med & Cell Biol, Newtown, NSW 2042, Australia	Royal Melbourne Hospital; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Sydney; Centenary Institute	Starr, R (corresponding author), PO Royal Melbourne Hosp, Cooperat Res Ctr Cellular Growth Factors, Melbourne, Vic 3050, Australia.		Nicola, Nicos/D-2989-2011; Hilton, Douglas J/C-7250-2013	Nicola, Nicos/0000-0003-1054-7889; Hilton, Douglas J/0000-0002-7698-2392; Bertolino, Patrick/0000-0001-8244-7057	NCI NIH HHS [CA-22556] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA022556, R37CA022556] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams TE, 1998, J BIOL CHEM, V273, P1285, DOI 10.1074/jbc.273.3.1285; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Bertolino P, 1998, EUR J IMMUNOL, V28, P221, DOI 10.1002/(SICI)1521-4141(199801)28:01<221::AID-IMMU221>3.3.CO;2-6; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; DALE TC, 1989, P NATL ACAD SCI USA, V86, P1203, DOI 10.1073/pnas.86.4.1203; DAMELL JE, 1994, SCIENCE, V264, P1415; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; GRESSER I, 1981, AM J PATHOL, V102, P396; Gresser I, 1982, Interferon, V4, P95; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Losman JA, 1999, J IMMUNOL, V162, P3770; Marine JC, 1999, CELL, V98, P617, DOI 10.1016/S0092-8674(00)80049-5; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Metcalf D, 1999, LEUKEMIA, V13, P926, DOI 10.1038/sj.leu.2401440; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; NOVAK U, 1995, BLOOD, V86, P2948, DOI 10.1182/blood.V86.8.2948.bloodjournal8682948; Paludan SR, 1998, SCAND J IMMUNOL, V48, P459; Sakamoto H, 1998, BLOOD, V92, P1668, DOI 10.1182/blood.V92.5.1668.417k09_1668_1676; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; TOYONAGA T, 1994, P NATL ACAD SCI USA, V91, P614, DOI 10.1073/pnas.91.2.614; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3	30	91	93	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22086	22089		10.1074/jbc.M102737200	http://dx.doi.org/10.1074/jbc.M102737200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11306591	hybrid			2022-12-27	WOS:000169412700015
J	Huang, CS; Ding, M; Li, JX; Leonard, SS; Rojanasakul, Y; Castranova, V; Vallyathan, V; Ju, G; Shi, XL				Huang, CS; Ding, M; Li, JX; Leonard, SS; Rojanasakul, Y; Castranova, V; Vallyathan, V; Ju, G; Shi, XL			Vanadium-induced nuclear factor of activated T cells activation through hydrogen peroxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CYCLOSPORINE-A; TRANSCRIPTION FACTORS; AP-1 TRANSACTIVATION; PROTEIN-1 ACTIVATION; PLASMA-MEMBRANE; FAMILY; CALCINEURIN; EXPRESSION; TRANSFORMATION	The present study investigated the role of reactive oxygen species (ROS) in activation of nuclear factor of activated T cells (NFAT), a pivotal transcription factor responsible for regulation of cytokines, by vanadium in mouse embryo fibroblast PW cells or mouse epidermal Cl 41 cells. Exposure of cells to vanadium led to the transactivation of NFAT in a time- and dose-dependent manner. Scavenging of vanadium-induced H2O2 with Nacety-L-cyteine (a general antioxidant) or catalase (a specific H2O2 inhibitor) or the chelation of vanadate with deferoxamine, resulted in inhibition of NFAT activation. In contrast, an increase in H2O2 generation by the addition of superoxide dismutase or NADPH enhanced vanadium-induced NEAT activation. This vanadate-mediated H2O2 generation was verified by both electron spin resonance and fluorescence staining assay. These results demonstrate that H2O2 plays an important role in vanadium-induced NFAT transactivation in two different cell types. Furthermore, pretreatment of cells with nifedipine, a calcium channel blocker, inhibited vanadium-induced NFAT activation, whereas A23187 and ionomycin, two calcium ionophores, had synergistic effects with vanadium for NFAT induction, Incubation of cells with cyclosporin A (CsA), a pharmacological inhibitor of the phosphatase calcineurin, blocked vanadium-induced NFAT activation. Ah data show that vanadium induces NFAT activation not only through a calcium-dependent and CsA-sensitive pathway but also involved H2O2 generation, suggesting that H2O2 may be involved in activation of calcium-calcineurin pathways for NFAT activation caused by vanadium exposure.	NIOSH, Hlth Effects Lab Div, NIH, Morgantown, WV 26505 USA; NYU, Sch Med, Nelson Inst Environm Med, New York, NY 10016 USA; Fourth Mil Med Univ, Inst Neurosci, Xian 710032, Peoples R China; W Virginia Univ, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); National Institutes of Health (NIH) - USA; New York University; Air Force Military Medical University; West Virginia University	Shi, XL (corresponding author), NIOSH, Hlth Effects Lab Div, NIH, Morgantown, WV 26505 USA.	xas0@cdc.gov	Shi, Xianglin/B-8588-2012	Huang, Chuanshu/0000-0003-4133-5096; Rojanasakul, Yon/0000-0002-8839-6462				Boss V, 1998, J BIOL CHEM, V273, P19664, DOI 10.1074/jbc.273.31.19664; Carter JD, 1997, TOXICOL APPL PHARM, V146, P180, DOI 10.1006/taap.1997.8254; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COCKERILL GW, 1995, BLOOD, V86, P2689; COHEN MD, 1992, MUTAT RES, V269, P141, DOI 10.1016/0027-5107(92)90169-3; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; Dong W, 1998, TOXICOL APPL PHARM, V146, P180; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; Dye JA, 1999, AM J PHYSIOL-LUNG C, V277, pL498, DOI 10.1152/ajplung.1999.277.3.L498; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; HO AM, 1994, J BIOL CHEM, V269, P28181; HO SN, 1995, J BIOL CHEM, V270, P19898, DOI 10.1074/jbc.270.34.19898; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; Hoyal CR, 1996, J BIOL CHEM, V271, P29205, DOI 10.1074/jbc.271.46.29205; Huang CS, 1998, CANCER RES, V58, P4102; Huang CS, 1998, INT J ONCOL, V13, P711; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Huang CS, 2000, J BIOL CHEM, V275, P32516, DOI 10.1074/jbc.M005366200; Huang CS, 1996, J BIOL CHEM, V271, P31262, DOI 10.1074/jbc.271.49.31262; Huang CS, 1997, P NATL ACAD SCI USA, V94, P11957, DOI 10.1073/pnas.94.22.11957; Huang CS, 1996, MOL CELL BIOL, V16, P6427; Huang CS, 2000, J BIOL CHEM, V275, P9143, DOI 10.1074/jbc.275.13.9143; Huang CS, 1997, J BIOL CHEM, V272, P27753, DOI 10.1074/jbc.272.44.27753; Huang CS, 1998, P NATL ACAD SCI USA, V95, P156, DOI 10.1073/pnas.95.1.156; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JIANG H, 1993, CARCINOGENESIS, V14, P67, DOI 10.1093/carcin/14.1.67; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; Lara-Pezzi E, 1998, EMBO J, V17, P7066, DOI 10.1093/emboj/17.23.7066; Luo C, 1996, MOL CELL BIOL, V16, P3955; MartinezMartinez S, 1997, MOL CELL BIOL, V17, P6437, DOI 10.1128/MCB.17.11.6437; Masuda ES, 1998, CELL SIGNAL, V10, P599, DOI 10.1016/S0898-6568(98)00019-9; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MATTILA PS, 1990, EMBO J, V9, P4425, DOI 10.1002/j.1460-2075.1990.tb07893.x; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; NRIAGU JO, 1988, NATURE, V333, P134, DOI 10.1038/333134a0; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Park JC, 1996, J BIOL CHEM, V271, P20914, DOI 10.1074/jbc.271.34.20914; Pierce LM, 1996, TOXICOL APPL PHARM, V138, P1, DOI 10.1006/taap.1996.9999; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rincon M, 1997, MOL CELL BIOL, V17, P1522, DOI 10.1128/MCB.17.3.1522; Rincon M, 1996, MOL CELL BIOL, V16, P1074; SABBIONI E, 1992, J RADIOAN NUCL CH AR, V160, P493, DOI 10.1007/BF02037125; Saccani S, 1999, EUR J IMMUNOL, V29, P1194, DOI 10.1002/(SICI)1521-4141(199904)29:04&lt;1194::AID-IMMU1194&gt;3.0.CO;2-0; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; SERTLING E, 1995, BIOCHIM BIOPHYS ACTA, V1263, P181; SERTLING E, 1989, EMBO J, V8, P465; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SHEU CW, 1992, FOOD CHEM TOXICOL, V30, P307, DOI 10.1016/0278-6915(92)90008-9; SHI XL, 1992, FREE RADICAL RES COM, V17, P369, DOI 10.3109/10715769209083141; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; SINGH RK, 1995, CANCER RES, V55, P3669; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tsatsanis C, 1998, ONCOGENE, V17, P2609, DOI 10.1038/sj.onc.1202460; Weiss DL, 1996, MOL CELL BIOL, V16, P228; Ye JP, 1999, J BIOL CHEM, V274, P34974, DOI 10.1074/jbc.274.49.34974; Ye JP, 1999, MOL CELL BIOCHEM, V198, P193, DOI 10.1023/A:1006969008056	62	68	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22397	22403		10.1074/jbc.M010828200	http://dx.doi.org/10.1074/jbc.M010828200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11292823	hybrid			2022-12-27	WOS:000169412700058
J	Yarmola, EG; Edison, AS; Lenox, RH; Bubb, MR				Yarmola, EG; Edison, AS; Lenox, RH; Bubb, MR			Actin filament cross-linking by MARCKS - Characterization of two actin-binding sites within the phosphorylation site domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ACANTHAMOEBA ACTOBINDIN; DENDRITIC SPINES; F-ACTIN; SELF-ASSOCIATION; DYNAMICS; BRAIN; MODEL; MACROMOLECULES; IDENTIFICATION	We recently identified conformational changes that occur upon phosphorylation of myristoylated alanine-rich protein kinase C substrate (MARCKS) that preclude efficient cross-linking of actin filaments (Bubb, M. R,, Lenox, R, H., and Edison, A. S, (1999) J; Biol. Chem. 274, 36472-36478), These results implied that the phosphorylation site domain of MARCKS has two actin-binding sites. We now present evidence for the existence of two actin-binding sites that not only mutually compete but also specifically compete with the actin-binding proteins thymosin P, and actobindin to bind to actin. The effects of substitution of alanine for phenylalanine within a repeated hexapeptide segment suggest that the noncharged region of the domain contributes to binding affinity, but the binding affinity of peptides corresponding to each binding site has a steep dependence on salt concentration consistent with presumed electrostatic interactions between these polycationic peptides and the polyanionic N terminus of actin, Phosphorylation decreases the site-specific affinity by no more than 0.7 kcal/mol, which is less than the effect of alanine substitution. However, phosphorylation has a much greater effect than alanine substitution on the loss of actin filament cross-linking activity. These results are consistent with the hypothesis that the compact structure resulting from conformational changes due to phosphorylation, in addition to modest decreases in site-specific affinity, explains the loss of cross-linking activity in phosphorylated MARCKS.	Univ Florida, Dept Med, Gainesville, FL 32610 USA; Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; Malcom Randall Dept Vet Affairs Med Ctr, Res Serv, Gainesville, FL 32608 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Bubb, MR (corresponding author), Univ Florida, Dept Med, Box 100277, Gainesville, FL 32610 USA.	bubb@medicine.ufl.edu		Edison, Arthur/0000-0002-5686-2350				ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; ALBERT KA, 1987, P NATL ACAD SCI USA, V84, P7046, DOI 10.1073/pnas.84.20.7046; Angenstein F, 1999, HIPPOCAMPUS, V9, P173, DOI 10.1002/(SICI)1098-1063(1999)9:2<173::AID-HIPO8>3.0.CO;2-K; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BUBB MR, 1991, J BIOL CHEM, V266, P3820; Bubb MR, 1999, J BIOL CHEM, V274, P36472, DOI 10.1074/jbc.274.51.36472; BUBB MR, 1991, METHOD ENZYMOL, V196, P119; CARLIER MF, 1993, P NATL ACAD SCI USA, V90, P5034, DOI 10.1073/pnas.90.11.5034; CHATELIER RC, 1987, BIOPHYS CHEM, V28, P121, DOI 10.1016/0301-4622(87)80081-9; De La Cruz EM, 2000, BIOPHYS J, V78, P2516, DOI 10.1016/S0006-3495(00)76797-X; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; GRIFFITH LM, 1982, J BIOL CHEM, V257, P9135; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HO MF, 1991, J BIOL CHEM, V266, P5600; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kang F, 1997, BIOCHEMISTRY-US, V36, P8384, DOI 10.1021/bi970065n; KIRSCHNER MW, 1971, BIOCHEMISTRY-US, V10, P1900, DOI 10.1021/bi00786a027; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; LEWIS MS, 1994, MODERN ANAL ULTRACEN, P94; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Lu D, 1998, J CELL BIOL, V142, P217, DOI 10.1083/jcb.142.1.217; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; McNamara RK, 1998, J COMP NEUROL, V397, P337; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; MINTON AP, 1981, MOL PHARMACOL, V19, P1; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Safer D, 1997, BIOCHEMISTRY-US, V36, P5806, DOI 10.1021/bi970185v; SCHOLZ WK, 1991, J NEUROSCI, V11, P2422; Schutt CE, 1997, NAT STRUCT BIOL, V4, P169, DOI 10.1038/nsb0397-169; SELDEN SC, 1986, ANN NY ACAD SCI, V466, P803, DOI 10.1111/j.1749-6632.1986.tb38464.x; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; TORGERSON PM, 1979, BIOCHEMISTRY-US, V18, P3079, DOI 10.1021/bi00581a026; VALTORTA F, 1992, J BIOL CHEM, V267, P7195; VANCOMPERNOLLE K, 1991, J BIOL CHEM, V266, P15427; VANDEKERCKHOVE J, 1990, J BIOL CHEM, V265, P12801; Wohnsland F, 2000, J BIOL CHEM, V275, P20873, DOI 10.1074/jbc.M910298199; WOODY RW, 1983, BIOCHEMISTRY-US, V22, P2186, DOI 10.1021/bi00278a020; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yarmola EG, 2000, J BIOL CHEM, V275, P28120	47	63	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22351	22358		10.1074/jbc.M101457200	http://dx.doi.org/10.1074/jbc.M101457200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294839	hybrid			2022-12-27	WOS:000169412700052
J	Eichhorn, K; Jackson, SP				Eichhorn, K; Jackson, SP			A role for TAF3B2 in the repression of human RNA polymerase III transcription in nonproliferating cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEIC-ACID POLYMERASE; TATA-BINDING PROTEIN; RETINOBLASTOMA PROTEIN; ACCURATE TRANSCRIPTION; MULTIPLE FORMS; FACTOR TFIIIB; GENE; PROMOTER; P53; SEQUENCE	RNA polymerase III (Pol III) synthesizes various small RNA species, including the tRNAs and the 5 S ribosomal RNA,which are involved in protein synthesis. Here, we describe the regulation of human Pol III transcription in response to sustained cell cycle arrest. The experimental system used is a cell line in which cell cycle arrest is induced by the regulated expression of the tumor suppressor protein p53. We show that the capacity of cells to carry out Pol III transcription from various promoter types, when tested in vitro, is severely reduced in response to sustained p53-mediated cell cycle arrest. Furthermore, this effect does not appear to be due to direct inhibition by p53. By using complementation assays, we demonstrate that a subcomponent of the Pol III transcription factor IIIB, which contains the proteins TATA-binding protein and TAF3B2, is the target of repression. Moreover, we reveal that TAF3B2 levels are markedly reduced in extracts from cell cycle-arrested cells because of a decrease in TAF3B2 protein stability. These findings provide a novel mechanism of Pol III regulation and yield insights into how cellular biosynthetic capacity and growth status can be coordinated.	Wellcome Trust & Canc Res Campaign, Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QR, England	University of Cambridge	Jackson, SP (corresponding author), Wellcome Trust & Canc Res Campaign, Inst Canc & Dev Biol, Tennis Court Rd, Cambridge CB2 1QR, England.		Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014	Jackson, Stephen Philip/0000-0001-9317-7937; 				AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; BURATOWSKI S, 1992, CELL, V71, P221, DOI 10.1016/0092-8674(92)90351-C; Cairns CA, 1998, EMBO J, V17, P3112, DOI 10.1093/emboj/17.11.3112; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Chedin S, 1998, COLD SPRING HARB SYM, V63, P381, DOI 10.1101/sqb.1998.63.381; Chesnokov I, 1996, MOL CELL BIOL, V16, P7084; Coligan J.E., 1997, CURRENT PROTOCOLS PR; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ENGELKE DR, 1980, CELL, V19, P717, DOI 10.1016/S0092-8674(80)80048-1; GALLI G, 1981, NATURE, V294, P626, DOI 10.1038/294626a0; GINSBERG AM, 1984, CELL, V39, P479, DOI 10.1016/0092-8674(84)90455-0; GODDARD JP, 1983, NUCLEIC ACIDS RES, V11, P2551, DOI 10.1093/nar/11.9.2551; HARLOW E, 1988, ANTIBODIES LABORATOR, P421; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; KEDINGER C, 1970, BIOCHEM BIOPH RES CO, V38, P165, DOI 10.1016/0006-291X(70)91099-5; KOUZARIDES T, 1995, SEMIN CANCER BIOL, V6, P91, DOI 10.1006/scbi.1995.0012; Larminie CGC, 1998, J MOL MED, V76, P94, DOI 10.1007/s001090050196; LOBO SM, 1992, CELL, V71, P1029, DOI 10.1016/0092-8674(92)90397-U; MACK DH, 1993, NATURE, V363, P281, DOI 10.1038/363281a0; MCLAREN A, 1986, NUCLEIC ACIDS RES, V14, P5938, DOI 10.1093/nar/14.14.5938; Mital R, 1996, MOL CELL BIOL, V16, P7031; MOOREFIELD B, 1994, J BIOL CHEM, V269, P20857; PRUZAN R, 1992, NUCLEIC ACIDS RES, V20, P5705, DOI 10.1093/nar/20.21.5705; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROEDER RG, 1974, J BIOL CHEM, V249, P241; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; ROHAN RM, 1987, J BIOL CHEM, V262, P8500; Rosenwald IB, 1996, BIOESSAYS, V18, P243, DOI 10.1002/bies.950180312; Schramm L, 2000, GENE DEV, V14, P2650, DOI 10.1101/gad.836400; SCHWARTZ LB, 1974, J BIOL CHEM, V249, P5889; SEGALL J, 1980, J BIOL CHEM, V255, P1986; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; SORENSEN PD, 1990, NUCLEIC ACIDS RES, V18, P3060, DOI 10.1093/nar/18.10.3060; TAGGART AKP, 1992, CELL, V71, P1015, DOI 10.1016/0092-8674(92)90396-T; Teichmann M, 2000, P NATL ACAD SCI USA, V97, P14200, DOI 10.1073/pnas.97.26.14200; Wang ZX, 1998, MOL CELL, V1, P749, DOI 10.1016/S1097-2765(00)80074-X; WANG ZX, 1995, P NATL ACAD SCI USA, V92, P7026, DOI 10.1073/pnas.92.15.7026; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WHITE RJ, 1992, CELL, V71, P1041, DOI 10.1016/0092-8674(92)90398-V; WHITE RJ, 1989, CELL, V59, P1081, DOI 10.1016/0092-8674(89)90764-2; White RJ, 1996, NATURE, V382, P88, DOI 10.1038/382088a0; White RJ, 1998, INT J ONCOL, V12, P741; WHITE RJ, 1998, GENE THER MOL BIOL, V1, P613; WHITE RJ, 1994, RNA POLYM 3 TRANSCRI; WILLIS IM, 1993, EUR J BIOCHEM, V212, P1, DOI 10.1111/j.1432-1033.1993.tb17626.x; YOON JB, 1995, MOL CELL BIOL, V15, P2019; YOSHINAGA SK, 1987, P NATL ACAD SCI USA, V84, P3585, DOI 10.1073/pnas.84.11.3585	47	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21158	21165		10.1074/jbc.M102295200	http://dx.doi.org/10.1074/jbc.M102295200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11283026	hybrid			2022-12-27	WOS:000169297900050
J	Kneidinger, B; Graninger, M; Puchberger, M; Kosma, P; Messner, P				Kneidinger, B; Graninger, M; Puchberger, M; Kosma, P; Messner, P			Biosynthesis of nucleotide-activated D-glycero-D-manno-heptose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; D-MANNOHEPTOSE 6-EPIMERASE; SALMONELLA-TYPHIMURIUM; BACILLUS-THERMOAEROPHILUS; PHOSPHOHEPTOSE ISOMERASE; CAMPYLOBACTER-JEJUNI; SHIGELLA-SONNEI; CORE REGION; RFAD GENE; LIPOPOLYSACCHARIDE	The glycan chain repeats of the S-layer glycoprotein of Aneurinibacillus thermoaerophilus DSM 10155 contain D-glycero-D-manno-heptose, which has also been described as constituent of lipopolysaccharide cores of Gram-negative bacteria The four genes required for biosynthesis of the nucleotide-activated form GDP-D-glycero-D-manno-heptose were cloned, sequenced, and overexpressed in Escherichia coli, and the corresponding enzymes GmhA, GmhB, GmhC, and GmhD were purified to homogeneity, The isomerase GmhA catalyzed the conversion of D-sedoheptulose 7-phosphate to D-glycero-D-manno-heptose 7-phosphate, and the phosphokinase GmhB added a phosphate group to form D-glycero-D-manno-heptose 1,7-bisphosphate, The phosphatase GmhC removed the phosphate in the C-7 position, and the intermediate D-glycero-cu-D-manno-heptose :L-phosphate was eventually activated with GTP by the pyrophosphorylase GmhD to yield the final product GDP-D-glycero-alpha -D-manno-heptose. The intermediate and end products were analyzed by high performance liquid chromatography. Nuclear magnetic resonance spectroscopy was used to confirm the structure of these substances. This is the first report of the biosynthesis of GDP-D-glycero-alpha -D-manno-heptose in Gram-positive organisms. In addition, we propose a pathway for biosynthesis of the nucleotide-activated form of L-glycero-D-manno-heptose.	Agr Univ Vienna, Zentrum Ultrastrukturforsch, A-1180 Vienna, Austria; Agr Univ Vienna, Ludwig Boltzmann Inst Mol Nanotechnol, A-1180 Vienna, Austria; Agr Univ Vienna, Inst Chem, A-1190 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; Ludwig Boltzmann Institute; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Messner, P (corresponding author), Agr Univ Vienna, Zentrum Ultrastrukturforsch, Gregor Mendel Str 33, A-1180 Vienna, Austria.		Kosma, Paul/Y-7443-2019; Messner, Paul/Q-5345-2017	Kosma, Paul/0000-0001-5342-7161; Messner, Paul/0000-0002-3246-5801				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAX A, 1983, J MAGN RESON, V55, P301, DOI 10.1016/0022-2364(83)90241-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooke JS, 1996, J BIOL CHEM, V271, P3608; CARLOMAGNO MS, 1988, J MOL BIOL, V203, P585, DOI 10.1016/0022-2836(88)90194-5; Clark MA, 1998, CURR MICROBIOL, V37, P356, DOI 10.1007/s002849900392; COLEMAN WG, 1983, J BIOL CHEM, V258, P1985; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CURTISS R, 1968, BACTERIOL REV, V32, P320, DOI 10.1128/MMBR.32.4_Pt_1.320-348.1968; Deacon AM, 2000, STRUCT FOLD DES, V8, P453, DOI 10.1016/S0969-2126(00)00128-3; DING L, 1994, J BIOL CHEM, V269, P24384; EIDELS L, 1971, P NATL ACAD SCI USA, V68, P1673, DOI 10.1073/pnas.68.8.1673; EIDELS L, 1974, J BIOL CHEM, V249, P5642; GINSBURG V, 1962, J BIOL CHEM, V237, P497; Giraud MF, 2000, CURR OPIN STRUC BIOL, V10, P687, DOI 10.1016/S0959-440X(00)00145-7; Grzeszczyk BG, 1998, CARBOHYD RES, V307, P55, DOI 10.1016/S0008-6215(98)00037-8; HAVEKES LM, 1976, MOL GEN GENET, V146, P43, DOI 10.1007/BF00267981; Heinrichs DE, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P305; Heyndrickx M, 1997, INT J SYST BACTERIOL, V47, P808, DOI 10.1099/00207713-47-3-808; Kneidinger B, 2001, BIOTECHNIQUES, V30, P248, DOI 10.2144/01302bm01; Kneidinger B, 2001, J BIOL CHEM, V276, P5577, DOI 10.1074/jbc.M010027200; Knirel YA, 1999, EUR J BIOCHEM, V266, P123, DOI 10.1046/j.1432-1327.1999.00831.x; KOCSIS B, 1984, J BIOL CHEM, V259, P1858; KONTROHR T, 1981, J BIOL CHEM, V256, P7715; Kosma P, 1995, GLYCOBIOLOGY, V5, P791, DOI 10.1093/glycob/5.8.791; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARUMO K, 1992, EUR J BIOCHEM, V204, P539, DOI 10.1111/j.1432-1033.1992.tb16665.x; MELAUGH W, 1992, J BIOL CHEM, V267, P13434; Messner P, 2000, GLYCOMICROBIOLOGY, P93; NAESS V, 1984, J GEN MICROBIOL, V130, P2783; PALMIERI MJ, 1991, ANAL BIOCHEM, V194, P388, DOI 10.1016/0003-2697(91)90246-P; PAULSEN H, 1994, LIEBIGS ANN CHEM, P389; RADZIEJEWSKALEBRECHT J, 1994, EUR J BIOCHEM, V221, P343, DOI 10.1111/j.1432-1033.1994.tb18746.x; RADZIEJEWSKALEBRECHT J, 1989, EUR J BIOCHEM, V183, P573, DOI 10.1111/j.1432-1033.1989.tb21086.x; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; REEVES PR, 1994, NEW COMPR BIOCH, V27, P271; Sambrook J., 2002, MOL CLONING LAB MANU; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Schaffer C, 1996, MICROB DRUG RESIST, V2, P17, DOI 10.1089/mdr.1996.2.17; SIRISENA DM, 1994, J BACTERIOL, V176, P2379, DOI 10.1128/JB.176.8.2379-2385.1994; SUMMERS MF, 1986, J AM CHEM SOC, V108, P4285, DOI 10.1021/ja00275a008; Susskind M, 1998, J BIOL CHEM, V273, P7006, DOI 10.1074/jbc.273.12.7006; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; TAMAKI S, 1971, J BACTERIOL, V105, P968, DOI 10.1128/JB.105.3.968-975.1971; Valvano MA, 2000, J BACTERIOL, V182, P488, DOI 10.1128/JB.182.2.488-497.2000; WILKINSON SG, 1983, REV INFECT DIS S5, V5, P941; Zamyatina A, 2000, ANGEW CHEM INT EDIT, V39, P4150, DOI 10.1002/1521-3773(20001117)39:22<4150::AID-ANIE4150>3.0.CO;2-A; ZWAHLEN A, 1985, J INFECT DIS, V152, P485, DOI 10.1093/infdis/152.3.485	49	75	83	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20935	20944		10.1074/jbc.M100378200	http://dx.doi.org/10.1074/jbc.M100378200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279237	hybrid			2022-12-27	WOS:000169297900020
J	Liang, CC; Chen, HC				Liang, CC; Chen, HC			Sustained activation of extracellular signal-regulated kinase stimulated by hepatocyte growth factor leads to integrin alpha(2) expression that is involved in cell scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; PROTEIN-TYROSINE-PHOSPHATASE; CANINE KIDNEY-CELLS; MAP KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; MDCK CELLS; MET PROTOONCOGENE; EPITHELIAL-CELLS; RAS; RECEPTOR	We have previously shown that hepatocyte growth factor (HGF) selectively increases the expression of integrin alpha (2) in Madin-Darby canine kidney (MDCK) cells. In this study, we have further investigated the signal transduction pathways responsible for the event and its role in HGF-induced cell scattering. We found that the level of integrin alpha (2)beta (1) expression induced by HGF correlated with the extent of cell scattering and that a functional blocking antibody against integrin alpha (2) at the concentration of 25 mug/ml partially (40%) inhibited the HGF-induced cell scattering, However, in the presence of the specific phosphatidylinositol 3-kinase inhibitor LY294002 or the selective Src family kinase inhibitor PP1, although cells retained their response to HGF for increasing integrin alpha (2) expression, they failed to scatter, indicating that increased expression of integrin alpha (2) alone is not sufficient for cell scattering. Moreover, epidermal growth factor, which induced a transient (1 h) activation of extracellular signal-regulated kinase (ERK) in MDCK cells, only slightly increased integrin alpha (2) expression and failed to trigger cell scattering. Conversely, HGF induced a sustained (at least 12 h) activation of ERK in the cells, Expression of constitutively active ERK kinase (MEK) in MDCK cells led to increased expression of integrin alpha (2) even in the absence of HGF stimulation. In contrast, expression of ERK phosphatase or dominant negative MEK inhibited HGF-induced integrin alpha (2) expression. Taken together, our results suggest that the increased expression of integrin alpha (2)beta (1) by HGF is at least partially required for cell scattering and that the duration of MEK/ERK activation is likely to be a crucial determinant for cells to activate integrin alpha (2) expression and cell scattering.	Natl Chung Hsing Univ, Coll Life Sci, Dept Zool, Taichung 40227, Taiwan	National Chung Hsing University	Chen, HC (corresponding author), Natl Chung Hsing Univ, Coll Life Sci, Dept Zool, Taichung 40227, Taiwan.		Liang, Chun-Chi/D-7986-2016; Liang, Richard Chun-Chi/C-6989-2013	Liang, Chun-Chi/0000-0002-8345-8564; 				ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Chen HC, 1998, J BIOL CHEM, V273, P25777, DOI 10.1074/jbc.273.40.25777; CHIN R, 1988, CELL, V54, P541; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; GUAN KL, 1995, J BIOL CHEM, V270, P7191; HARTMANN G, 1994, J BIOL CHEM, V269, P21936; Herrera R, 1998, J CELL SCI, V111, P1039; Howe AK, 1998, J BIOL CHEM, V273, P27268, DOI 10.1074/jbc.273.42.27268; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Hu XT, 2000, CELL GROWTH DIFFER, V11, P191; Khwaja A, 1998, J BIOL CHEM, V273, P18793, DOI 10.1074/jbc.273.30.18793; Lai JF, 2000, J BIOL CHEM, V275, P7474, DOI 10.1074/jbc.275.11.7474; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; Muda M, 1996, J BIOL CHEM, V271, P4319; NALDINI L, 1991, MOL CELL BIOL, V11, P1793, DOI 10.1128/MCB.11.4.1793; Nissinen L, 1998, EXP CELL RES, V243, P1, DOI 10.1006/excr.1998.4128; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Potempa S, 1998, MOL BIOL CELL, V9, P2185, DOI 10.1091/mbc.9.8.2185; Reiske HR, 1999, J BIOL CHEM, V274, P12361, DOI 10.1074/jbc.274.18.12361; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Rosfjord EC, 1999, EXP CELL RES, V248, P260, DOI 10.1006/excr.1998.4390; ROYAL I, 1995, J BIOL CHEM, V270, P27780, DOI 10.1074/jbc.270.46.27780; SAELMAN EUM, 1995, J CELL SCI, V108, P3531; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; SCHOENENBERGER CA, 1994, J CELL SCI, V107, P527; Schramek H, 1997, J BIOL CHEM, V272, P11426; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sugimoto T, 1998, EMBO J, V17, P1717, DOI 10.1093/emboj/17.6.1717; Takeda H, 1999, EMBO J, V18, P386, DOI 10.1093/emboj/18.2.386; Terauchi R, 2000, EXP CELL RES, V256, P411, DOI 10.1006/excr.2000.4850; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775; Zutter MM, 1997, BLOOD, V90, P678, DOI 10.1182/blood.V90.2.678.678_678_689; ZUTTER MM, 1994, J BIOL CHEM, V269, P463; Zutter MM, 1999, BLOOD, V93, P1600, DOI 10.1182/blood.V93.5.1600.405k04_1600_1611	41	50	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21146	21152		10.1074/jbc.M010669200	http://dx.doi.org/10.1074/jbc.M010669200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11287413	hybrid			2022-12-27	WOS:000169297900048
J	Martel, V; Racaud-Sultan, C; Dupe, S; Marie, C; Paulhe, F; Galmiche, A; Block, MR; Albiges-Rizo, C				Martel, V; Racaud-Sultan, C; Dupe, S; Marie, C; Paulhe, F; Galmiche, A; Block, MR; Albiges-Rizo, C			Conformation, localization, and integrin binding of talin depend on its interaction with phosphoinositides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; PLECKSTRIN HOMOLOGY DOMAINS; CYTOSKELETAL PROTEIN TALIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ACTIN-BINDING; PLASMA-MEMBRANE; ALPHA-ACTININ; INTRAMOLECULAR ASSOCIATION; ALPHA-5-BETA-1 INTEGRIN; SIGNAL-TRANSDUCTION	Talin is a structural component of focal adhesion sites and is thought to be engaged in multiple protein interactions at the cytoplasmic face of cell/matrix contacts. Talin is a major link between integrin and the actin cytoskeleton and was shown to play an important role in focal adhesion assembly. Consistent with the view that talin must be activated at these sites, we found that phosphatidylinositol 4-monophosphate and phosphatidylinositol 4,5-bisphosphate (PI4,5P(2)) bound to talin in cells in suspension or at early stages of adhesion, respectively. When phosphoinositides were associated with phospholipid bilayer, talin/phosphoinositide association was restricted to PI4,5P(2). This association led to a conformational change of the protein. Moreover, the interaction between integrin and talin was greatly enhanced by PI4,5P(2)-induced talin activation. Finally, sequestration of PI4,5P(2) by a specific pleckstrin homology domain confirms that PI4,5P(2) is necessary for proper membrane localization of talin and that this localization is essential for the maintenance of focal adhesions. Our results support a model in which PI4,5P(2) exposes the integrin-binding site on talin, We propose that PI4,5P(2)-dependent signaling modulates assembly of focal adhesions by regulating integrin-talin complexes. These results demonstrate that activation of the integrin-binding activity of talin requires not only integrin engagement to the extracellular matrix but also the binding of PI4,5P(2) to talin, suggesting a possible role of lipid metabolism in organizing the sequential assembly of focal adhesion components.	Fac Med Grenoble, Inst Albert Bonniot, LEDAC,UJF, CNRS,UMR 5538, F-38706 La Tronche, France; Hop Purpan, Inst Federatif Rech Claude de Preval, INSERM, U326, F-31059 Toulouse, France; Fac Med Nice, INSERM, U452, F-06107 Nice, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Martel, V (corresponding author), Fac Med Grenoble, Inst Albert Bonniot, LEDAC,UJF, CNRS,UMR 5538, F-38706 La Tronche, France.		Frachet, Véronique/B-8418-2018; Martel-Frachet, Veronique/B-8657-2014; Albiges-Rizo, Corinne/M-2568-2013	Frachet, Véronique/0000-0001-6739-7901; ALBIGES-RIZO, Corinne/0000-0002-6333-4150; Racaud-Sultan, Claire/0000-0002-6549-1088				ALBIGESRIZO C, 1995, J CELL SCI, V108, P3317; ARROYO AG, 1992, J CELL BIOL, V117, P659, DOI 10.1083/jcb.117.3.659; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; BECKERLE MC, 1987, CELL, V51, P569, DOI 10.1016/0092-8674(87)90126-7; Berditchevski F, 1997, J BIOL CHEM, V272, P2595, DOI 10.1074/jbc.272.5.2595; Borowsky ML, 1998, J CELL BIOL, V143, P429, DOI 10.1083/jcb.143.2.429; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Chockalingam PS, 1999, BIOCHEMISTRY-US, V38, P5596, DOI 10.1021/bi982564+; DEPASQUALE JA, 1987, J CELL BIOL, V105, P2803, DOI 10.1083/jcb.105.6.2803; Derman MP, 1997, J BIOL CHEM, V272, P6465, DOI 10.1074/jbc.272.10.6465; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; EVANS E, 1982, BIOCHEMISTRY-US, V21, P4874, DOI 10.1021/bi00263a007; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; FUKAMI K, 1994, J BIOL CHEM, V269, P1518; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Gironcel D, 1996, FEBS LETT, V389, P253, DOI 10.1016/0014-5793(96)00595-9; GOLDMANN WH, 1994, J STRUCT BIOL, V112, P3, DOI 10.1006/jsbi.1994.1002; GOLDMANN WH, 1992, BIOCHEMISTRY-US, V31, P7665, DOI 10.1021/bi00148a030; GROUX H, 1989, NATURE, V339, P152, DOI 10.1038/339152a0; GUINEBAULT C, 1995, J CELL BIOL, V129, P831, DOI 10.1083/jcb.129.3.831; Hartwig JH, 1996, J BIOL CHEM, V271, P32986, DOI 10.1074/jbc.271.51.32986; HEISE H, 1991, BIOCHIM BIOPHYS ACTA, V1061, P121, DOI 10.1016/0005-2736(91)90276-E; Hemmings L, 1996, J CELL SCI, V109, P2715; Heraud JM, 1998, J BIOL CHEM, V273, P17817, DOI 10.1074/jbc.273.28.17817; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; INGLESE J, 1993, J BIOL CHEM, V268, P23735; Inomata M, 1996, ARCH BIOCHEM BIOPHYS, V328, P129, DOI 10.1006/abbi.1996.0152; Irvine R, 1998, CURR BIOL, V8, pR557, DOI 10.1016/S0960-9822(07)00360-0; Isenberg G, 1996, FEBS LETT, V397, P316, DOI 10.1016/S0014-5793(96)01203-3; Isenberg G., 1995, CYTOSKELETON, V1, P169; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Knezevic I, 1996, J BIOL CHEM, V271, P16416, DOI 10.1074/jbc.271.27.16416; KOVACSOVICS TJ, 1995, J BIOL CHEM, V270, P11358, DOI 10.1074/jbc.270.19.11358; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Loyet KM, 1998, J BIOL CHEM, V273, P8337, DOI 10.1074/jbc.273.14.8337; MCNAMEE HP, 1993, J CELL BIOL, V121, P673, DOI 10.1083/jcb.121.3.673; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; MUGURUMA M, 1990, BIOCHEM BIOPH RES CO, V171, P1217, DOI 10.1016/0006-291X(90)90815-5; Nakamura F, 1999, MOL BIOL CELL, V10, P2669, DOI 10.1091/mbc.10.8.2669; NIGGLI V, 1994, EUR J BIOCHEM, V224, P951, DOI 10.1111/j.1432-1033.1994.00951.x; NUCKOLLS GH, 1992, J CELL SCI, V102, P753; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Patil S, 1999, J BIOL CHEM, V274, P28575, DOI 10.1074/jbc.274.40.28575; PAVALKO FM, 1991, J CELL BIOL, V114, P481, DOI 10.1083/jcb.114.3.481; PIGNATARO OP, 1990, J BIOL CHEM, V265, P1718; RAGHUNATHAN V, 1992, FEBS LETT, V297, P46, DOI 10.1016/0014-5793(92)80324-A; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sakisaka T, 1997, MOL CELL BIOL, V17, P3841, DOI 10.1128/MCB.17.7.3841; Schafer DA, 1995, ANNU REV CELL DEV BI, V11, P497, DOI 10.1146/annurev.cellbio.11.1.497; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Steimle PA, 1999, J BIOL CHEM, V274, P18414, DOI 10.1074/jbc.274.26.18414; Takenawa T, 1999, CHEM PHYS LIPIDS, V98, P13, DOI 10.1016/S0009-3084(99)00014-6; Tall E, 1997, BIOCHEMISTRY-US, V36, P7239, DOI 10.1021/bi9702288; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; TURNER CE, 1989, EUR J CELL BIOL, V49, P202; Udagawa T, 1996, J BIOL CHEM, V271, P12542, DOI 10.1074/jbc.271.21.12542; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; Vignoud L, 1997, J CELL SCI, V110, P1421; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; WENNSTROM S, 1994, ONCOGENE, V9, P651; YU FX, 1992, J BIOL CHEM, V267, P14616	74	252	258	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21217	21227		10.1074/jbc.M102373200	http://dx.doi.org/10.1074/jbc.M102373200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279249	hybrid			2022-12-27	WOS:000169297900057
J	Sauna, ZE; Smith, MM; Muller, M; Ambudkar, SV				Sauna, ZE; Smith, MM; Muller, M; Ambudkar, SV			Functionally similar vanadate-induced 8-azidoadenosine 5 '-[alpha-P-32]diphosphate-trapped transition state intermediates of human P-glycoprotein are generated in the absence and presence of ATP hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; REPAIR PROTEIN MUTS; HAMSTER OVARY CELLS; MULTIDRUG TRANSPORTER; CRYSTAL-STRUCTURE; CATALYTIC SITES; RESISTANCE PUMP; ABC TRANSPORTER; WALKER-A; SUBUNIT	P-glycoprotein (Pgp) is an ATP-dependent drug efflux pump whose overexpression confers multidrug resistance to cancer cells. Pgp exhibits a robust drug substrate-stimulable ATPase activity, and vanadate (Vi) blocks this activity effectively by trapping Pgp nucleotide in a noncovalent stable transition state conformation. In this study we compare Vi-induced [alpha-P-32]8-azido-ADP trapping into Pgp in the presence of [alpha-P-32]8-azido-ATP (with ATP hydrolysis) or [alpha-P-32]8-azido-ADP (without ATP hydrolysis), Vi mimics Pi to trap the nucleotide tenaciously in the Pgp . [alpha-P-32]8-azido-ADP.Vi conformation in either condition. Thus, by using [alpha-P-32]8-azido-ADP we show that the Vi-induced transition state of Pgp can be generated even in the absence of ATP hydrolysis. Furthermore, half-maximal trapping of nucleotide into Pgp in the]presence of Vi occurs at similar concentrations of [(alpha-P-32]8-azido-ATP or [alpha-P-32]8-azido-ADP. The trapped [(alpha-P-32]8-azido-ADP is almost equally distributed between the N- and the C-terminal ATP sites of Pgp in both conditions. Additionally, point mutations in the Walker B domain of either the N- (D555N) or C (D1200N)-terminal ATP sites that arrest ATP hydrolysis and Vi-induced trapping also show abrogation of [alpha-P-32]8-azido-ADP trapping into Pgp in the absence of hydrolysis, These data suggest that both ATP sites are dependent on each other for function and that each site exhibits similar affinity for 8-azido-ATP (ATP) or 8-azido-ADP (ADP), Similarly, Pgp in the transition state conformation generated with either ADP or ATP exhibits drastically reduced affinity for the binding of analogues of drug substrate ([I-125]iodoarylazidoprazosin) as well as nucleotide (2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate). Analyses of Arrhenius plots show that trapping of Pgp with [alpha-P-32]8-azido-ADP tin the, absence of hydrolysis) displays an similar to2.5-fold higher energy of activation (152 kJ/mol) compared with that observed when the transition state intermediate is generated through hydrolysis of [alpha-P-32]8-azido-ATP (62 kJ/mol), In aggregate, these results demonstrate that the Pgp [alpha-P-32]8-azido-ADP (or ADP) Vi transition state complexes generated either in the absence of or accompanying [alpha-P-32]8-azido-ATP hydrolysis are functionally indistinguishable.	NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ambudkar, SV (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37,Rm 1B-22,37 convent Dr, Bethesda, MD 20892 USA.	ambudkar@helix.nih.gov	Sauna, Zuben E./AAA-7149-2019; Ambudkar, Suresh V/B-5964-2008; Ambudkar, Suresh V/L-1317-2016					Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; HIRATSUKA T, 1973, BIOCHIM BIOPHYS ACTA, V320, P635, DOI 10.1016/0304-4165(73)90143-8; Hrycyna CA, 1998, J BIOL CHEM, V273, P16631, DOI 10.1074/jbc.273.27.16631; Hrycyna CA, 1999, BIOCHEMISTRY-US, V38, P13887, DOI 10.1021/bi991115m; Hrycyna CA, 1998, METHOD ENZYMOL, V292, P456; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Liu RH, 1997, BIOCHEMISTRY-US, V36, P2836, DOI 10.1021/bi9627119; Matsuo M, 2000, J BIOL CHEM, V275, P28757, DOI 10.1074/jbc.M004818200; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; Romsicki Y, 1998, EUR J BIOCHEM, V256, P170, DOI 10.1046/j.1432-1327.1998.2560170.x; Sankaran B, 1997, BIOCHEMISTRY-US, V36, P6847, DOI 10.1021/bi970034s; Sankaran B, 1997, ARCH BIOCHEM BIOPHYS, V341, P160, DOI 10.1006/abbi.1997.9944; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Sauna ZE, 2001, J BIOL CHEM, V276, P11653, DOI 10.1074/jbc.M011294200; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SENIOR AE, 1995, J BIOENERG BIOMEMBR, V27, P31, DOI 10.1007/BF02110328; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Senior AE, 1998, BIOCHEMISTRY-US, V37, P831, DOI 10.1021/bi9719962; Senior AE, 1997, SEMIN CANCER BIOL, V8, P143, DOI 10.1006/scbi.1997.0065; Senior AE, 1998, ACTA PHYSIOL SCAND, V163, P213; SHAROM FJ, 1995, BIOCHEM J, V308, P381, DOI 10.1042/bj3080381; Szabo K, 1998, J BIOL CHEM, V273, P10132, DOI 10.1074/jbc.273.17.10132; Szakacs G, 2000, BIOCHEM BIOPH RES CO, V276, P1314, DOI 10.1006/bbrc.2000.3576; Taguchi Y, 1997, FEBS LETT, V401, P11, DOI 10.1016/S0014-5793(96)01421-4; Urbatsch IL, 2000, J BIOL CHEM, V275, P25031, DOI 10.1074/jbc.M003962200; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P11921, DOI 10.1021/bi001220s; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Urbatsch IL, 1998, BIOCHEMISTRY-US, V37, P4592, DOI 10.1021/bi9728001; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956; Weinreich F, 1999, J GEN PHYSIOL, V114, P55, DOI 10.1085/jgp.114.1.55; YOUNT RG, 1992, PHILOS T ROY SOC B, V336, P55, DOI 10.1098/rstb.1992.0044; Zhou TQ, 2000, EMBO J, V19, P4838, DOI 10.1093/emboj/19.17.4838	44	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21199	21208		10.1074/jbc.M100886200	http://dx.doi.org/10.1074/jbc.M100886200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11287418	hybrid			2022-12-27	WOS:000169297900055
J	Lutz, W; Lingle, WL; McCormick, D; Greenwood, TM; Salisbury, JL				Lutz, W; Lingle, WL; McCormick, D; Greenwood, TM; Salisbury, JL			Phosphorylation of centrin during the cell cycle and its role in centriole separation preceding centrosome duplication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE POLE BODY; PROTEIN-KINASE-A; EF-HAND PROTEIN; SACCHAROMYCES-CEREVISIAE; MITOTIC CENTROSOMES; CONTRACTILE FIBERS; MAMMALIAN-CELLS; DIVISION CYCLE; GOLGI-COMPLEX; ANIMAL-CELLS	Once during each cell cycle, mitotic spindle poles arise by separation of newly duplicated centrosomes. Ne report here the involvement of phosphorylation of the centrosomal protein centrin in this process. We show that centrin is phosphorylated at serine residue 170 during the G(2)/M phase of the cell cycle. Indirect immunofluorescence staining of HeLa cells using a phosphocentrin-specific antibody reveals intense labeling of mitotic spindle poles during prophase and metaphase of the cell division cycle, with diminished staining of anaphase and no staining of telophase and interphase centrosomes. Cultured cells undergo a dramatic increase in centrin phosphorylation following the experimental elevation of PKA activity, suggesting that this kinase can phosphorylate centrin tn vivo. Surprisingly, elevated PKA activity also resulted intense phosphocentrin antibody labeling of interphase centrosomes and in the concurrent movement of individual centrioles apart from one another, Taken together, these results suggest that centrin phosphorylation signals the separation of centrosomes at prophase and implicates centrin phosphorylation in centriole separation that normally precedes centrosome duplication.	Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Tumor Biol Program, Rochester, MN 55905 USA	Mayo Clinic	Salisbury, JL (corresponding author), Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Tumor Biol Program, Rochester, MN 55905 USA.	salisbury@mayo.edu		Salisbury, Jeffrey/0000-0001-9257-4578	NCI NIH HHS [CA72836] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072836] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams IR, 2000, TRENDS CELL BIOL, V10, P329, DOI 10.1016/S0962-8924(00)01798-0; ALBADER AA, 1976, EXP CELL RES, V103, P47, DOI 10.1016/0014-4827(76)90239-1; Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Balczon R, 1996, INT REV CYTOL, V169, P25, DOI 10.1016/S0074-7696(08)61984-1; BARON AT, 1995, METHOD CELL BIOL, V47, P341, DOI 10.1016/S0091-679X(08)60828-6; BAUM P, 1988, MOL CELL BIOL, V8, P5386, DOI 10.1128/MCB.8.12.5386; BAUM P, 1986, P NATL ACAD SCI USA, V83, P5512, DOI 10.1073/pnas.83.15.5512; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BREWIS ND, 1993, EMBO J, V12, P987, DOI 10.1002/j.1460-2075.1993.tb05739.x; BURGER MM, 1972, NATURE-NEW BIOL, V239, P161, DOI 10.1038/newbio239161a0; CENTONZE VE, 1990, J CELL SCI, V95, P405; DECAMILLI P, 1986, J CELL BIOL, V103, P189, DOI 10.1083/jcb.103.1.189; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; ERRABOLU R, 1994, J CELL SCI, V107, P9; FANTES P, 1993, CELL CYCLE; Fry AM, 2000, CURR TOP DEV BIOL, V49, P291; Goepfert TM, 2000, CURR TOP DEV BIOL, V49, P331; Hardie G., 1995, PROTEIN KINASE FACTS, P418; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hinchcliffe EH, 1998, J CELL BIOL, V140, P1417, DOI 10.1083/jcb.140.6.1417; HOHMANN P, 1993, CELL PROLIFERAT, V26, P195, DOI 10.1111/j.1365-2184.1993.tb00019.x; HULEN D, 1991, CELL MOTIL CYTOSKEL, V18, P113, DOI 10.1002/cm.970180206; Keryer G, 1999, EXP CELL RES, V249, P131, DOI 10.1006/excr.1999.4447; KURIYAMA R, 1989, CELL MOTIL CYTOSKEL, V12, P90, DOI 10.1002/cm.970120204; Kurokawa K, 1998, CELL STRUCT FUNCT, V23, P357, DOI 10.1247/csf.23.357; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE VD, 1993, P NATL ACAD SCI USA, V90, P11039, DOI 10.1073/pnas.90.23.11039; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; MARTINDALE VE, 1990, J CELL SCI, V96, P395; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; MCFADDEN GI, 1987, J CELL BIOL, V105, P903, DOI 10.1083/jcb.105.2.903; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Middendorp S, 1997, P NATL ACAD SCI USA, V94, P9141, DOI 10.1073/pnas.94.17.9141; MORBECK DE, 1993, MOL CELL ENDOCRINOL, V97, P173, DOI 10.1016/0303-7207(93)90225-9; Mussman JG, 2000, ONCOGENE, V19, P1635, DOI 10.1038/sj.onc.1203460; NIGG EA, 1985, CELL, V41, P1039, DOI 10.1016/S0092-8674(85)80084-2; Oh WJ, 1996, BIOCHEM MOL BIOL INT, V39, P991; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Paoletti A, 1996, J CELL SCI, V109, P3089; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PERICH JW, 1992, INT J PEPT PROT RES, V40, P134; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; RAO PN, 1989, J CELL SCI, V93, P63; SALISBURY JL, 1984, J CELL BIOL, V99, P962, DOI 10.1083/jcb.99.3.962; SALISBURY JL, 1995, CURR OPIN CELL BIOL, V7, P39; SALISBURY JL, 1978, SCIENCE, V202, P975, DOI 10.1126/science.202.4371.975; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHIEBEL E, 1995, TRENDS CELL BIOL, V5, P197, DOI 10.1016/S0962-8924(00)88999-0; SPANG A, 1993, J CELL BIOL, V123, P405, DOI 10.1083/jcb.123.2.405; Stearns T, 1997, CELL, V91, P303, DOI 10.1016/S0092-8674(00)80414-6; Sullivan DS, 1998, J CELL BIOL, V143, P751, DOI 10.1083/jcb.143.3.751; TAILLON BE, 1992, J CELL BIOL, V119, P1613, DOI 10.1083/jcb.119.6.1613; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vandre DD, 2000, MICROSC RES TECHNIQ, V49, P458; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; Witczak O, 1999, EMBO J, V18, P1858, DOI 10.1093/emboj/18.7.1858; ZEILIG CE, 1976, J CELL BIOL, V71, P515, DOI 10.1083/jcb.71.2.515	59	90	94	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20774	20780		10.1074/jbc.M101324200	http://dx.doi.org/10.1074/jbc.M101324200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279195	hybrid			2022-12-27	WOS:000169135100146
J	Thoden, JB; Wohlers, TM; Fridovich-Keil, JL; Holden, HM				Thoden, JB; Wohlers, TM; Fridovich-Keil, JL; Holden, HM			Molecular basis for severe epimerase deficiency galactosemia - X-ray structure of the human V94M-substituted UDP-galactose 4-epimerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAM	Galactosemia is an inherited disorder characterized by an inability to metabolize galactose. Although classical galactosemia results from impairment of the second enzyme of the Leloir pathway, namely galactose-1-phosphate uridylyltransferase, alternate forms of the disorder can occur due to either galactokinase or UDP-galactose 4-epimerase deficiencies. One of the more severe cases of epimerase deficiency galactosemia arises from an amino acid substitution at position 94. It has been previously demonstrated that the V94M protein is impaired relative to the wild-type enzyme predominantly at the level of V-max rather than K-m. To address the molecular consequences the mutation imparts on the three-dimensional architecture of the enzyme, we have solved the structures of the V94M-substituted human epimerase complexed with NADH and UDP-glucose, UDP-galactose, UDP-GlcNAc, or UDP-GalNAc. In the wild-type enzyme, the hydrophobic side chain of Val(94) packs near the aromatic group of the catalytic Tyr(157) and serves as a molecular "fence" to limit the rotation of the glycosyl portions of the UDP-sugar substrates within the active site. The net effect of the V94M substitution is an opening up of the Ala(93) to Glu(96) surface loop, which allows free rotation of the sugars into nonproductive binding modes.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Emory Univ, Sch Med, Grad Program Genet & Mol Biol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Genet, Atlanta, GA 30322 USA	University of Wisconsin System; University of Wisconsin Madison; Emory University; Emory University	Holden, HM (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK047814, R29DK046403, R01DK046403, R01DK047814] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47814, DK46403] Funding Source: Medline; NIGMS NIH HHS [GM08490, T32 GM008490] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANO A, 1997, J INVEST MED, V45, P191; ESNOUF R, 1991, J APPL CRYSTALLOGR, V24, P946; FREY PA, 1987, PYRIDINE NUCLEOTID B, P461; GITZELMANN R, 1972, HELV PAEDIATR ACTA, V27, P125; GITZELMANN R, 1977, HELV PAEDIATR ACTA, V31, P441; GITZELMANN R, 1973, HELV PAEDIATR ACTA, V28, P497; Holton J. B., 2000, METABOLIC MOL BASES, P1553; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MALEY F, 1959, BIOCHIM BIOPHYS ACTA, V31, P577, DOI 10.1016/0006-3002(59)90047-2; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PILLER F, 1983, J BIOL CHEM, V258, P774; ROUSSEL A, 1991, SILICON GRAPHICS GEO; Thoden JB, 2000, BIOCHEMISTRY-US, V39, P5691, DOI 10.1021/bi000215l; Thoden JB, 1996, BIOCHEMISTRY-US, V35, P5137, DOI 10.1021/bi9601114; Thoden JB, 2001, J BIOL CHEM, V276, P15131, DOI 10.1074/jbc.M100220200; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Wohlers TM, 2000, J INHERIT METAB DIS, V23, P713, DOI 10.1023/A:1005682913784; Wohlers TM, 1999, AM J HUM GENET, V64, P462, DOI 10.1086/302263	20	38	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20617	20623		10.1074/jbc.M101304200	http://dx.doi.org/10.1074/jbc.M101304200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279193	hybrid			2022-12-27	WOS:000169135100127
J	Jones, I; Lindberg, C; Jakobsson, S; Hellqvist, A; Hellman, U; Borg, B; Olsson, PE				Jones, I; Lindberg, C; Jakobsson, S; Hellqvist, A; Hellman, U; Borg, B; Olsson, PE			Molecular cloning and characterization of spiggin - An androgen-regulated extraorganismal adhesive with structural similarities to von Willebrand Factor-related proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALE 3-SPINED STICKLEBACK; GASTEROSTEUS-ACULEATUS; VONWILLEBRAND-FACTOR; NEW-GENERATION; SEQUENCE; IDENTIFICATION; KIDNEY; THIOREDOXIN; PREDICTION; CLEAVAGE	One of the most definitive examples of a vertebrate extraorganismal structural protein can be found in three-spined sticklebacks (Gasterosteus aculeatus), In the breeding male the kidney hypertrophies and synthesizes an adhesive protein called "spiggin,'" which is secreted into the urinary bladder from where it is employed as a structural thread for nest building. This paper describes the first molecular characterization of spiggin and demonstrates that this adhesive is a protein complex assembled from a potential of three distinct subunits (alpha, beta, and gamma). These subunits arise by alternative splicing, and 11-ketoandrogens induce their expression in stickleback kidneys. Analysis of the predicted amino acid sequence of each subunit reveals a modular organization whose structural elements display a similarity to the multimerization domains found within von Willebrand Factor-related proteins. These results implicate that spiggin utilizes a conserved multimerization mechanism for the formation of a viscous agglutinate from its constituent subunits in the urinary bladders of male sticklebacks, This novel extraorganismal structural protein is therefore ideally suited to its function as an adhesive thread.	Umea Univ, Dept Cell & Mol Biol, Unit Physiol, SE-90187 Umea, Sweden; Stockholm Univ, Dept Zool, SE-10691 Stockholm, Sweden; Uppsala Biomed Ctr, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden	Umea University; Stockholm University; Ludwig Institute for Cancer Research	Olsson, PE (corresponding author), Umea Univ, Dept Cell & Mol Biol, Unit Physiol, SE-90187 Umea, Sweden.			Olsson, Per-Erik/0000-0001-7336-6335				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; BORG B, 1993, CAN J ZOOL, V71, P2327, DOI 10.1139/z93-326; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DEVORE DP, 1984, COMP BIOCHEM PHYS B, V77, P529, DOI 10.1016/0305-0491(84)90270-0; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Gosline JM, 1999, J EXP BIOL, V202, P3295; GUM JR, 1994, J BIOL CHEM, V269, P2440; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Harada N, 1997, J BIOL CHEM, V272, P15232, DOI 10.1074/jbc.272.24.15232; HARDY DM, 1995, J BIOL CHEM, V270, P26025, DOI 10.1074/jbc.270.44.26025; HOLMGREN A, 1984, METHOD ENZYMOL, V107, P295; HYELLMAN U, 2000, PROTEOMICS FUNCTIONA; HYLLNER SJ, 1995, MOL REPROD DEV, V41, P339, DOI 10.1002/mrd.1080410309; Jakobsson S, 1999, FISH PHYSIOL BIOCHEM, V20, P79, DOI 10.1023/A:1007776016610; Joba W, 1997, J BIOL CHEM, V272, P1805, DOI 10.1074/jbc.272.3.1805; JONGENS TA, 1988, EMBO J, V7, P2559, DOI 10.1002/j.1460-2075.1988.tb03105.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; MAYADAS TN, 1992, P NATL ACAD SCI USA, V89, P3531, DOI 10.1073/pnas.89.8.3531; MAYADAS TN, 1989, J BIOL CHEM, V264, P13497; MAYER I, 1990, GEN COMP ENDOCR, V79, P23, DOI 10.1016/0016-6480(90)90084-Y; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Perez-Vilar J, 1998, J BIOL CHEM, V273, P34527, DOI 10.1074/jbc.273.51.34527; PerezVilar J, 1996, J BIOL CHEM, V271, P9845, DOI 10.1074/jbc.271.16.9845; ROUX KH, 1995, PCR METH APPL, V4, P185; Sambrook J., 2002, MOL CLONING LAB MANU; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOOLE JJ, 1979, CELL, V17, P441, DOI 10.1016/0092-8674(79)90170-3; TSUDA M, 1979, P NATL ACAD SCI USA, V76, P4872, DOI 10.1073/pnas.76.10.4872; Urich K., 1994, COMP ANIMAL BIOCH, P376; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217	35	50	55	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17857	17863		10.1074/jbc.M101142200	http://dx.doi.org/10.1074/jbc.M101142200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279178	hybrid			2022-12-27	WOS:000168866500034
J	Akakura, S; Yoshida, M; Yoneda, Y; Horinouchi, S				Akakura, S; Yoshida, M; Yoneda, Y; Horinouchi, S			A role for Hsc70 in regulating nucleocytoplasmic transport of a temperature-sensitive p53 (p53(Val-135))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; TUMOR-SUPPRESSOR P53; NUCLEAR EXPORT SIGNAL; RING-FINGER DOMAIN; HEAT-SHOCK COGNATE; MUTANT P53; LEPTOMYCIN-B; IN-VIVO; CYTOPLASMIC SEQUESTRATION; SUBCELLULAR-LOCALIZATION	Mouse temperature-sensitive p53(Val-135) accumulates in the nucleus and acts as a "wild-type" at 32 degreesC while it is sequestered in the cytoplasm at 37 degreesC. The cytoplasmic p53(Val-135) relocalized into the nucleus upon inhibition of the nuclear export at 37 degreesC, whereas a mutation in a major bipartite nuclear localization signal (NLS) caused constitutive cytoplasmic localization, indicating that it shuttled between the cytoplasm and the nucleus by its own nuclear export signal and NLS rather than tethered to cytoplasmic structures. Although the full-length p53(Val-135) did not bind the import receptor at 37 degreesC, a C-terminally truncated p53(Val-135) lacking residues 326-390 did bind it. Molecular chaperones such as Hsc70 were associated with p53(Val-135) at 37 degreesC but not at 32 degreesC. When the nuclear export was blocked by leptomycin B, only a fraction lacking Hsc70 was specifically accumulated in the nucleus. Immunodepletion of Hsc70 from the reticulocyte lysate caused p53(Val-135) to bind the import receptor. This binding was blocked by supplying the cell extract containing Hsc70 but not by the addition of recombinant Hsc70 alone. We suggest that the association with the Hsc70-containing complex prevents the NLS from the access of the import receptor through the C-terminal region of p53(Val-135) at 37 degreesC, whereas its dissociation at 32 degreesC allows rapid nuclear import.	Univ Tokyo, Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; Osaka Univ, Sch Med, Dept Anat & Cell Biol, Suita, Osaka 565, Japan; Japan Sci & Technol Corp, CREST Res Project, Saitama 3320012, Japan	University of Tokyo; Osaka University; Japan Science & Technology Agency (JST)	Yoshida, M (corresponding author), Univ Tokyo, Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.		Yoshida, Minoru/C-8049-2014	Yoshida, Minoru/0000-0002-4376-5674				ALI IU, 1994, CANCER RES, V54, P1; Angelidis CE, 1999, EUR J BIOCHEM, V259, P505, DOI 10.1046/j.1432-1327.1999.00078.x; Blagosklonny MV, 1996, P NATL ACAD SCI USA, V93, P8379, DOI 10.1073/pnas.93.16.8379; BOSARI S, 1995, AM J PATHOL, V147, P790; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; CORVI R, 1995, ONCOGENE, V10, P1081; ELKIND NB, 1995, ONCOGENE, V11, P841; Feldman DE, 2000, CURR OPIN STRUC BIOL, V10, P26, DOI 10.1016/S0959-440X(99)00044-5; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; GAITONDESV, 2000, ONCOGENE, V19, P4042; GANNON JV, 1991, NATURE, V349, P802; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; HAMAMOTO T, 1983, J ANTIBIOT, V36, P639, DOI 10.7164/antibiotics.36.639; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; IMAMOTO N, 1992, J CELL BIOL, V119, P1047, DOI 10.1083/jcb.119.5.1047; IMAMOTO N, 1995, FEBS LETT, V368, P415; Jimenez GS, 1999, ONCOGENE, V18, P7656, DOI 10.1038/sj.onc.1203013; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Klotzsche O, 1998, ONCOGENE, V16, P3423, DOI 10.1038/sj.onc.1202155; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; Liang SH, 1998, J BIOL CHEM, V273, P19817, DOI 10.1074/jbc.273.31.19817; Lu WG, 2000, ONCOGENE, V19, P232, DOI 10.1038/sj.onc.1203262; LUNA RMD, 1995, NATURE, V378, P203; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; Merrick BA, 1996, BBA-PROTEIN STRUCT M, V1297, P57; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Middeler G, 1997, ONCOGENE, V14, P1407, DOI 10.1038/sj.onc.1200949; MILNER J, 1990, J MOL BIOL, V216, P481, DOI 10.1016/0022-2836(90)90371-R; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; MILNER J, 1991, MOL CELL BIOL, V11, P12, DOI 10.1128/MCB.11.1.12; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Ostermeyer AG, 1996, P NATL ACAD SCI USA, V93, P15190, DOI 10.1073/pnas.93.26.15190; PINHASIKIMHI O, 1986, NATURE, V320, P182, DOI 10.1038/320182a0; PORTER PL, 1992, AM J PATHOL, V140, P145; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; ROTTER V, 1983, EMBO J, V2, P1041, DOI 10.1002/j.1460-2075.1983.tb01543.x; Schlamp CL, 1997, J NATL CANCER I, V89, P1530, DOI 10.1093/jnci/89.20.1530; Sepehrnia B, 1996, J BIOL CHEM, V271, P15084, DOI 10.1074/jbc.271.25.15084; SHAULSKY G, 1990, MOL CELL BIOL, V10, P6565, DOI 10.1128/MCB.10.12.6565; STENMARKASKMALM M, 1994, EUR J CANCER, V30A, P175, DOI 10.1016/0959-8049(94)90082-5; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; TAKAHASHI K, 1994, ONCOGENE, V9, P183; UEDA H, 1995, NAT GENET, V9, P41, DOI 10.1038/ng0195-41; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; Whitesell L, 1998, MOL CELL BIOL, V18, P1517, DOI 10.1128/MCB.18.3.1517; YEHIELY F, 1992, CELL GROWTH DIFFER, V3, P803; ZERRAHN J, 1992, ONCOGENE, V7, P1371	60	52	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14649	14657		10.1074/jbc.M100200200	http://dx.doi.org/10.1074/jbc.M100200200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11297531	hybrid			2022-12-27	WOS:000168528800019
J	Friedrich, CL; Rozek, A; Patrzykat, A; Hancock, REW				Friedrich, CL; Rozek, A; Patrzykat, A; Hancock, REW			Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; CYTOPLASMIC MEMBRANE; NEUTROPHIL DEFENSIN; CIRCULAR-DICHROISM; DISTANCE GEOMETRY; NMR-SPECTROSCOPY; HELICAL PEPTIDES	Indolicidin, an antimicrobial peptide with a unique amino acid sequence (ILPWKWPWWPWRR-NH2) is found in bovine neutrophils, A derivative of indolicidin, CP10A, has alanine residues substituted for proline residues and has improved activity against Gram-positive organisms. Transmission electron microscopy of Staphylococcus aureus and Staphylococcus epidermidis treated with CP10A showed mesosome-like structures in the cytoplasm, The peptide at a-fold the minimal inhibitory concentration did not show significant killing of S, aureus ISP67 (a histidine, uridine, and thymidine auxotroph) but did show an early effect on histidine and uridine incorporation and, later, an effect on thymidine incorporation. Upon interaction with liposomes, detergents, and lipoteichoic acid, CP10A was shown by circular dichroism spectroscopy to undergo a change in secondary structure. Fluorescence spectroscopy indicated that the tryptophan residues were located at the hydrophobic/hydrophilic interface of liposomes and detergent micelles and were inaccessible to the aqueous quencher KI. The three-dimensional structure of CP10A in the Lipid mimetic dodecylphosphocholine was determined using two-dimensional NMR methods and was characterized as a short, amphipathic helical structure, whereas indolicidin was previously shown to have an extended structure. These studies have introduced a cationic peptide with a unique structure and an ability to interact with membranes and to affect intracellular synthesis of proteins, RNA, and DNA.	Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Hancock, REW (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 300-6174 Univ Blvd, Vancouver, BC V6T 1Z3, Canada.	bob@cmdr.ubc.ca	Hancock, Robert E. W./E-1145-2013	Hancock, Robert E. W./0000-0001-5989-8503				Amsterdam D, 1996, ANTIBIOTICS LAB MED, V4, P52; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BEVERIDGE TJ, 1989, BACTERIA NATURE, V3, P1; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; COCIANCICH S, 1993, J BIOL CHEM, V268, P19239; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; FIOCCO MM, 1994, J MOL BIOL, V235, P709; Friedrich C, 1999, ANTIMICROB AGENTS CH, V43, P1542, DOI 10.1128/AAC.43.7.1542; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Hancock RE, 1995, ADV MICROB PHYSL, V37, P136; HOLZWARTH G, 1965, J AM CHEM SOC, V87, P218, DOI 10.1021/ja01080a015; Huo SH, 1999, PROTEINS, V36, P249; HYBERTS SG, 1992, PROTEIN SCI, V1, P736, DOI 10.1002/pro.5560010606; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; JURETIC D, 1989, FEBS LETT, V249, P219, DOI 10.1016/0014-5793(89)80627-1; KUSZEWSKI J, 1992, J BIOMOL NMR, V2, P33, DOI 10.1007/BF02192799; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; MILLHAUSER GL, 1995, BIOCHEMISTRY-US, V34, P3873, DOI 10.1021/bi00012a001; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; NILGES M, 1991, COMPUTATIONAL ASPECT; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; PETERSON AA, 1987, ANTIMICROB AGENTS CH, V31, P230, DOI 10.1128/AAC.31.2.230; PIERS KL, 1994, MOL MICROBIOL, V12, P951, DOI 10.1111/j.1365-2958.1994.tb01083.x; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Rozek A, 2000, BIOCHEMISTRY-US, V39, P15765, DOI 10.1021/bi000714m; SAWYER JG, 1988, INFECT IMMUN, V56, P693, DOI 10.1128/IAI.56.3.693-698.1988; Scott MG, 1999, INFECT IMMUN, V67, P6445; SELSTED ME, 1992, J BIOL CHEM, V267, P4292; SHIMODA M, 1995, INFECT IMMUN, V63, P2886, DOI 10.1128/IAI.63.8.2886-2891.1995; SIMS PJ, 1974, BIOCHEMISTRY-US, V13, P3315, DOI 10.1021/bi00713a022; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Subbalakshmi C, 1996, FEBS LETT, V395, P48, DOI 10.1016/0014-5793(96)00996-9; WALLACE BA, 1984, ANAL BIOCHEM, V142, P317, DOI 10.1016/0003-2697(84)90471-8; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; WUTHERICH K, 1986, NMR PROTEINS NUCL AC; Xiong YQ, 1999, ANTIMICROB AGENTS CH, V43, P1111, DOI 10.1128/AAC.43.5.1111; Yeaman MR, 1998, J CLIN INVEST, V101, P178, DOI 10.1172/JCI562; Zhang LJ, 1999, BIOCHEMISTRY-US, V38, P8102, DOI 10.1021/bi9904104	45	177	194	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24015	24022		10.1074/jbc.M009691200	http://dx.doi.org/10.1074/jbc.M009691200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11294848	hybrid			2022-12-27	WOS:000169531100105
J	Daniels, M; Brown, DR				Daniels, M; Brown, DR			Astrocytes regulate N-methyl-D-aspartate receptor subunit composition increasing neuronal sensitivity to excitotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE CELLS; GLIAL GLUTAMATE TRANSPORTERS; PRION PROTEIN-FRAGMENT; RAT-BRAIN; COCULTURE SYSTEM; NMDA ANTAGONISTS; EXPRESSION; NEUROTOXICITY; CULTURE; TOXICITY	We have examined the dependence of rat cerebellar granule neurons (CGNs) for protection against glutamate toxicity. Under co-culture conditions, rat CGNs require astrocytes to protect against glutamate. The CGNs become more sensitive to glutamate toxicity in co culture than when grown in cultures with only low numbers of astrocytes. If the protection of the astroyctes was withdrawn or blocked, this sensitivity led to neuronal death. Differing changes in NMDA receptor subunit subtype composition were noted depending on the conditions in which the CGNs were grown. Suppression of individual NMDA subunit subtypes by oligonucleotide knockdown resulted in inhibition of toxicity. This result implies that astrocytes regulate the expression of NMDA receptor subunit subtypes which influence neuronal sensitivity to glutamate toxicity.	Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge	Brown, DR (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.							AUDINAT E, 1994, EUR J NEUROSCI, V6, P1792, DOI 10.1111/j.1460-9568.1994.tb00572.x; Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Beaman-Hall CM, 1998, J NEUROCHEM, V71, P1993; BONDY SC, 1993, BRAIN RES, V610, P229, DOI 10.1016/0006-8993(93)91405-H; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; Brown DR, 1999, J NEUROCHEM, V72, P943, DOI 10.1046/j.1471-4159.1999.0720943.x; Brown DR, 1996, GLIA, V18, P59, DOI 10.1002/(SICI)1098-1136(199609)18:1<59::AID-GLIA6>3.0.CO;2-Z; Brown DR, 2000, MOL CELL NEUROSCI, V15, P465, DOI 10.1006/mcne.2000.0840; Brown DR, 1999, MOL CELL NEUROSCI, V13, P379, DOI 10.1006/mcne.1999.0751; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; CHOI DW, 1988, J NEUROSCI, V8, P185; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; DUMUIS A, 1988, NATURE, V336, P68, DOI 10.1038/336068a0; DURAND GM, 1992, P NATL ACAD SCI USA, V89, P9359, DOI 10.1073/pnas.89.19.9359; FARRANT M, 1994, NATURE, V368, P335, DOI 10.1038/368335a0; GALLO V, 1982, P NATL ACAD SCI-BIOL, V79, P7919, DOI 10.1073/pnas.79.24.7919; Gegelashvili G, 1997, J NEUROCHEM, V69, P2612; GOTTSCHALL PE, 1994, BRAIN RES, V637, P197, DOI 10.1016/0006-8993(94)91233-5; Kreutz MR, 1998, J NEUROSCI, V18, P8278; LEHRE KP, 1995, J NEUROSCI, V15, P1835; LEVY LM, 1995, EUR J NEUROSCI, V7, P2036, DOI 10.1111/j.1460-9568.1995.tb00626.x; MCLENNAN H, 1976, BRAIN RES, V115, P139, DOI 10.1016/0006-8993(76)90828-3; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; NAKANISHI N, 1992, P NATL ACAD SCI USA, V89, P8552, DOI 10.1073/pnas.89.18.8552; OKADA S, 1994, NEUROSCIENCE, V63, P691; ROSENBERG PA, 1992, J NEUROSCI, V12, P56; ROTHMAN SM, 1993, NEUROPHARMACOLOGY, V32, P1279, DOI 10.1016/0028-3908(93)90022-U; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Schinder AF, 1996, J NEUROSCI, V16, P6125; SPELIOTES EK, 1994, J NEUROCHEM, V63, P879; Standaert DG, 1996, J PHARMACOL EXP THER, V276, P342; Swanson RA, 1997, J NEUROSCI, V17, P932; Vallano ML, 1996, J NEUROSCI, V16, P631; Ward MW, 2000, J NEUROSCI, V20, P7208; WATANABE M, 1994, J COMP NEUROL, V343, P513, DOI 10.1002/cne.903430402; WESTERGAARD N, 1994, J NEUROCHEM, V62, P1727; Ye ZC, 1998, GLIA, V22, P237, DOI 10.1002/(SICI)1098-1136(199803)22:3<237::AID-GLIA3>3.0.CO;2-2	37	29	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22446	22452		10.1074/jbc.M101740200	http://dx.doi.org/10.1074/jbc.M101740200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11306581	hybrid			2022-12-27	WOS:000169412700064
J	Han, YP; Tuan, TL; Hughes, M; Wu, HY; Garner, WL				Han, YP; Tuan, TL; Hughes, M; Wu, HY; Garner, WL			Transforming growth factor-beta- and tumor necrosis factor-alpha-mediated induction and proteolytic activation of MMP-9 in human skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV COLLAGENASE GELATINASE; GENE-EXPRESSION; MATRIX METALLOPROTEINASE-9; HYPERTROPHIC SCAR; VII COLLAGEN; CELL-LINES; MESSENGER-RNA; WOUND FLUID; CANCER; GROWTH-FACTOR-BETA-1	Both cytokines and matrix metalloproteinases (MMPs) are active during physiologic and pathologic processes such as cancer metastasis and wound repair. We have systematically studied cytokine-mediated MMP regulation. Cytokine-mediated proteinase induction and activation were initially investigated in organ-cultured human skin followed by determination of underlying cellular and molecular mechanisms using isolated skin cells. In this report we demonstrate that tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta (TGF-beta) synergistically induce pro-MMP-9 in human skin as well as isolated dermal fibroblasts and epidermal keratinocytes. Furthermore, TNF-alpha promotes proteolytic activation of pro-MMP-9 by conversion of the 92-kDa pro-MMP-9 to the 82-kDa active enzyme. This activation occurred only in skin organ culture and not by either isolated fibroblasts or keratinocyte, although the pro-MMP-9 activation could be measured in a cell-free system derived from TNF-alpha -activated skin. The cytokine-mediated induction of pro-MMP-9 in dermal fibroblasts was evident by increased mRNA At the transcription level, we examined the cytokine-mediated transactivation of the 5'-region promoter of the human MMP 9 in dermal fibroblasts. The results demonstrated that TNF-alpha and TGF-beta could independently stimulate the 5'-flanking 670-base pair promoter. A TGF-beta -response element (-474) and an NF-kappaB-binding site (-601) were identified to be the cis-elements for TGF-P or TNF-alpha activation, respectively. Taken together, these findings suggest a specific mechanism whereby multiple cytokines can regulate MMP-9 expression/activation in the cells of human skin. These results imply roles for these cytokines in the regulation of MMP-9 in physiologic and pathologic tissue remodeling.	Univ So Calif, Sch Med, Div Plast & Reconstruct Surg, Los Angeles, CA 90033 USA; Univ So Calif, Childrens Hosp, Sch Med, Dept Surg, Los Angeles, CA 90027 USA	University of Southern California; Children's Hospital Los Angeles; University of Southern California	Garner, WL (corresponding author), Univ So Calif, Sch Med, Div Plast & Reconstruct Surg, 1450 San Pablo St,Ste 2000, Los Angeles, CA 90033 USA.	wgarner@surgery.usc.edu		Hughes, Michael W./0000-0002-8899-9773	NIGMS NIH HHS [R01 GM050967-07, GM55081, GM 50967, R01 GM050967-08] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM050967, R01GM050967] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMENTO EP, 1991, CIBA F SYMP, V157, P115; Beck LS, 1990, GROWTH FACTORS, V3, P267, DOI 10.3109/08977199009003669; BOSHART M, 1992, GENE, V110, P129, DOI 10.1016/0378-1119(92)90456-Y; Cooney R, 1997, J TRAUMA, V42, P415, DOI 10.1097/00005373-199703000-00008; FAJARDO LF, 1992, AM J PATHOL, V140, P539; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; FRIDMAN R, 1995, CANCER RES, V55, P2548; GARNER WL, 1993, J INVEST DERMATOL, V101, P875, DOI 10.1111/1523-1747.ep12371710; GHAHARY A, 1993, J LAB CLIN MED, V122, P465; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; Han YP, 2001, J CELL SCI, V114, P131; HUHTALA P, 1991, J BIOL CHEM, V266, P16485; Iocono JA, 2000, WOUND REPAIR REGEN, V8, P216, DOI 10.1046/j.1524-475x.2000.00216.x; Janowska-Wieczorek A, 1999, BRIT J HAEMATOL, V105, P402, DOI 10.1046/j.1365-2141.1999.01352.x; Karelina TV, 2000, J INVEST DERMATOL, V114, P371, DOI 10.1046/j.1523-1747.2000.00886.x; KERR LD, 1990, CELL, V61, P267, DOI 10.1016/0092-8674(90)90807-Q; Kitzis V, 1999, J SURG RES, V87, P134, DOI 10.1006/jsre.1999.5747; Kon A, 1999, ONCOGENE, V18, P1837, DOI 10.1038/sj.onc.1202495; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Lijnen HR, 1998, BLOOD, V91, P2045, DOI 10.1182/blood.V91.6.2045.2045_2045_2053; LYONS JG, 1993, J BIOL CHEM, V268, P19143; Malik S T, 1992, Semin Cancer Biol, V3, P27; MAUVIEL A, 1993, J CELL BIOCHEM, V53, P288, DOI 10.1002/jcb.240530404; MIYAGI E, 1995, CLIN EXP METASTAS, V13, P89, DOI 10.1007/BF00133613; Moses MA, 1996, J CELL BIOCHEM, V60, P379, DOI 10.1002/(SICI)1097-4644(19960301)60:3<379::AID-JCB9>3.0.CO;2-T; MURPHY G, 1989, BIOCHEM J, V258, P463, DOI 10.1042/bj2580463; Neely AN, 1999, WOUND REPAIR REGEN, V7, P166, DOI 10.1046/j.1524-475X.1999.00166.x; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; OKADA Y, 1990, BIOCHEM BIOPH RES CO, V171, P610, DOI 10.1016/0006-291X(90)91190-4; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Parks WC, 1999, WOUND REPAIR REGEN, V7, P423, DOI 10.1046/j.1524-475X.1999.00423.x; PERUCCIO D, 1994, BURNS, V20, P118, DOI 10.1016/S0305-4179(06)80007-0; PLATZER C, 1995, CYTOKINES PRACTICAL, P57; POLVERINI PJ, 1977, NATURE, V269, P804, DOI 10.1038/269804a0; Rha SY, 1997, BREAST CANCER RES TR, V43, P175; Ritter SJ, 1998, J BIOL CHEM, V273, P12798, DOI 10.1074/jbc.273.21.12798; ROBERTS AB, 1988, BRIT J CANCER, V57, P594, DOI 10.1038/bjc.1988.135; SALO T, 1994, LAB INVEST, V70, P176; SATO H, 1993, J BIOL CHEM, V268, P23460; SATO H, 1993, ONCOGENE, V8, P395; Sehgal I, 1999, MOL BIOL CELL, V10, P407, DOI 10.1091/mbc.10.2.407; Sehgal I, 1996, CANCER RES, V56, P3359; SELTZER JL, 1989, J BIOL CHEM, V264, P3822; Sorsa T, 1997, J BIOL CHEM, V272, P21067, DOI 10.1074/jbc.272.34.21067; SPORN MB, 1993, J CLIN INVEST, V92, P2565, DOI 10.1172/JCI116868; Tarlton JF, 1999, WOUND REPAIR REGEN, V7, P347, DOI 10.1046/j.1524-475X.1999.00347.x; Tarlton JF, 1997, BRIT J DERMATOL, V137, P506, DOI 10.1111/j.1365-2133.1997.tb03779.x; VU TH, 1995, MATRIX METALLOPROTEA, P115; WAHL SM, 1993, P NATL ACAD SCI USA, V90, P4577, DOI 10.1073/pnas.90.10.4577; WYSOCKI AB, 1993, J INVEST DERMATOL, V101, P64, DOI 10.1111/1523-1747.ep12359590; Wysocki AB, 1999, WOUND REPAIR REGEN, V7, P154, DOI 10.1046/j.1524-475X.1999.00154.x; YOUNG PK, 1994, J INVEST DERMATOL, V103, P660, DOI 10.1111/1523-1747.ep12398424; Zeng ZS, 1998, BRIT J CANCER, V78, P349, DOI 10.1038/bjc.1998.497; ZHANG K, 1995, J INVEST DERMATOL, V104, P750, DOI 10.1111/1523-1747.ep12606979	54	137	146	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22341	22350		10.1074/jbc.M010839200	http://dx.doi.org/10.1074/jbc.M010839200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11297541	Green Accepted, hybrid			2022-12-27	WOS:000169412700051
J	Khalyfa, A; Bourbeau, D; Chen, E; Petroulakis, E; Pan, J; Xu, SY; Wang, E				Khalyfa, A; Bourbeau, D; Chen, E; Petroulakis, E; Pan, J; Xu, SY; Wang, E			Characterization of elongation factor-1A (eEF1A-1) and eEF1A-2/S1 protein expression in normal and wasted mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATIONAL FIDELITY; ATAXIA-TELANGIECTASIA; NUCLEOTIDE EXCHANGE; ESCHERICHIA-COLI; FACTOR 1-ALPHA; S1; MOUSE; GENE; CDNA; MUTATIONS	The eEF1A-2 gene (S1) encodes a tissue-specific isoform of peptide elongation factor-1A (eEF1A-1); its mRNA is expressed only in brain, heart, and skeletal muscle, tissues dominated by terminally differentiated, long-lived cells. Homozygous mutant mice exhibit muscle wasting and neurodegeneration, resulting in death around postnatal day 28. eEF1A-2/S1 protein shares 92% identity with eEF1A-1; because specific antibodies for each were not available previously, it was difficult to study the developmental expression patterns of these two peptide elongation factors IA in wasted and wild-type mice. We generated a peptide derived antiserum that recognizes the eEF1A-2/S1 isoform and does not cross-react with eEF1A-1, We characterized the expression profiles of eEF1A-1 and eEF1A-2/S1 during development in wild type (+/+), heterozygous (+/wst), and homozygous (wst/wst) mice. In wild-type and heterozygous animals, eEF1A-2/S1 protein is present only in brain, heart, and muscle; the onset of its expression coincides with a concomitant decrease in the eEF1A-1 protein level, In wasted mutant tissues, even though eEE1A-2/S1 protein is absent, the scheduled decline of eEF1A-1 occurs nonetheless during postnatal development, as it does in wild-type counterparts. In the brain of adult wild-type mice, the eEF1A-2/S1 isoform is localized in neurons, whereas eEF1A-1 is found in non-neuronal cells. In neurons prior to postnatal day 7, eEF1A-1 is the major isoform, but it is later replaced by eEF1A-2/S1, which by postnatal day 14 is the only isoform present, The postdevelopmental appearance of eEF1A-2/S1 protein and the decline in eEF1A-1 expression in brain, heart, and muscle suggest that eEF1A-2/S1 is the adult form of peptide elongation factor, whereas its sister is the embryonic isoform, in these tissues. The absence of eEF1A-2/S1, as well as the on-schedule development-dependent disappearance of its sister gene, eEF1A, in wst/wst mice may result in loss of protein synthesis ability, which may account for the numerous defects and ultimate fatality seen in these mice.	Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3T 1E2, Canada; McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada	University of Louisville; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University	Wang, E (corresponding author), Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA.		Khalyfa, Abdelnaby/M-9498-2017	Chen, Edwin/0000-0003-0742-9734				ANN DK, 1991, J BIOL CHEM, V266, P10429; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; Carr-Schmid A, 1999, J BIOL CHEM, V274, P30297, DOI 10.1074/jbc.274.42.30297; Chambers DM, 1998, P NATL ACAD SCI USA, V95, P4463, DOI 10.1073/pnas.95.8.4463; Gopalkrishnan RV, 1999, INT J BIOCHEM CELL B, V31, P151, DOI 10.1016/S1357-2725(98)00138-1; INOUE T, 1986, CANCER RES, V46, P3979; Inoue T, 1986, Basic Life Sci, V39, P323; Kahns S, 1998, NUCLEIC ACIDS RES, V26, P1884, DOI 10.1093/nar/26.8.1884; KAUR KJ, 1994, J BIOL CHEM, V269, P23045; KNUDSEN SM, 1993, EUR J BIOCHEM, V215, P549, DOI 10.1111/j.1432-1033.1993.tb18064.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LEE S, 1995, EXP CELL RES, V219, P589, DOI 10.1006/excr.1995.1268; LEE S, 1992, J BIOL CHEM, V267, P24064; LEE S, 1993, J BIOL CHEM, V268, P24453; LEE S, 1996, CELLULAR AGING CELL, P139; LIU CHL, 1993, BIOCHEM BIOPH RES CO, V195, P1371, DOI 10.1006/bbrc.1993.2195; LUTSEP HL, 1989, J NEUROPATH EXP NEUR, V48, P519, DOI 10.1097/00005072-198909000-00003; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; SHIINA N, 1994, SCIENCE, V266, P282, DOI 10.1126/science.7939665; SHULTZ LD, 1982, NATURE, V297, P402, DOI 10.1038/297402a0; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; THOMPSON RC, 1982, P NATL ACAD SCI-BIOL, V79, P4922, DOI 10.1073/pnas.79.16.4922; UPRETI GC, 1988, ANAL BIOCHEM, V168, P421, DOI 10.1016/0003-2697(88)90339-9; Welle S, 1997, J GERONTOL A-BIOL, V52, pB235, DOI 10.1093/gerona/52A.5.B235; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0	26	72	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22915	22922		10.1074/jbc.M101011200	http://dx.doi.org/10.1074/jbc.M101011200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294870	hybrid			2022-12-27	WOS:000169412700125
J	Meyer, TN; Schwesinger, C; Ye, JM; Denker, BM; Nigam, SK				Meyer, TN; Schwesinger, C; Ye, JM; Denker, BM; Nigam, SK			Reassembly of the tight junction after oxidative stress depends on tyrosine kinase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULAR EPITHELIAL-CELLS; EPIDERMAL GROWTH-FACTOR; ATP DEPLETION; HYDROGEN-PEROXIDE; INTRACELLULAR CALCIUM; BARRIER FUNCTION; LLC-PK1 CELLS; ADENOSINE-TRIPHOSPHATE; ACTIN CYTOSKELETON; OXIDANT INJURY	Oxidative stress compromises the tight junction, but the mechanisms underlying its recovery remain unclear. We developed a model in which oxidative stress reversibly disrupts the tight junction. Exposure of Madin-Darby canine kidney cells to hydrogen peroxide markedly reduced transepithelial resistance and disrupted the staining patterns of the tight junction proteins ZO-1 and occludin. These changes were reversed by catalase. The short-term reassembly of tight junctions was not dependent on new protein synthesis, suggesting that recovery occurs through re-utilization of existing proteins. Although ATP levels were reduced, the reduction was insufficient to explain the observed changes, since a comparable reduction of ATP levels (with a-deoxy-D-glucose) did not induce these changes. The intracellular hydrogen peroxide scavenger pyruvate protected Madin-Darby canine kidney cells front loss of transepithelial resistance as did the heavy metal scavenger N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine. Of a wide variety of agents examined, only tyrosine kinase inhibitors and protein kinase C inhibitors markedly inhibited tight junction reassembly. During reassembly, tyrosine phosphorylation in or near the lateral membrane, was detected by immunofluorescence. The tyrosine kinase inhibitors genistein and PP-2 inhibited the recovery of transepithelial resistance and perturbed the relocalization of ZO-1 and occludin to the tight junction, indicating that tyrosine kinases, possibly members of the Src family, are critical for reassembly after oxidative stress.	Univ Calif San Diego, Dept Pediat & Med, Div Nephrol & Hypertens, La Jolla, CA 92093 USA; Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Childrens Hosp, Dept Surg, Boston, MA 02115 USA	University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Nigam, SK (corresponding author), Univ Calif San Diego, Dept Pediat, Div Nephrol & Hypertens, 9500 Gilman Dr, La Jolla, CA 92093 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055223, R29GM055223] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK53507] Funding Source: Medline; NIGMS NIH HHS [GM55223] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aito H, 1999, AM J PHYSIOL-CELL PH, V277, pC878, DOI 10.1152/ajpcell.1999.277.5.C878; ANDREOLI SP, 1990, KIDNEY INT, V38, P785, DOI 10.1038/ki.1990.272; ANDREOLI SP, 1993, AM J PHYSIOL, V265, pF377, DOI 10.1152/ajprenal.1993.265.3.F377; BACALLAO R, 1994, J CELL SCI, V107, P3301; BAKER RD, 1995, DIGEST DIS SCI, V40, P510, DOI 10.1007/BF02064358; BALDA MS, 1991, J MEMBRANE BIOL, V122, P193, DOI 10.1007/BF01871420; BALDA MS, 1993, J CELL BIOL, V123, P293, DOI 10.1083/jcb.123.2.293; CANFIELD PE, 1991, AM J PHYSIOL, V261, pF1038, DOI 10.1152/ajprenal.1991.261.6.F1038; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; Chen YH, 2000, MOL BIOL CELL, V11, P849, DOI 10.1091/mbc.11.3.849; Collares-Buzato CB, 1998, EUR J CELL BIOL, V76, P85, DOI 10.1016/S0171-9335(98)80020-4; Cui XL, 1997, P NATL ACAD SCI USA, V94, P3771, DOI 10.1073/pnas.94.8.3771; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; DOCTOR RB, 1994, AM J PHYSIOL, V266, pC1803, DOI 10.1152/ajpcell.1994.266.6.C1803; Filipovic DM, 1999, AM J PHYSIOL-RENAL, V277, pF428, DOI 10.1152/ajprenal.1999.277.3.F428; GOLIGORSKY MS, 1993, ARCH BIOCHEM BIOPHYS, V301, P119, DOI 10.1006/abbi.1993.1123; HECHT D, 1992, BIOCHEM BIOPH RES CO, V188, P773, DOI 10.1016/0006-291X(92)91123-8; HINSHAW DB, 1989, J SURG RES, V46, P339, DOI 10.1016/0022-4804(89)90199-6; Hirase T, 2001, J BIOL CHEM, V276, P10423, DOI 10.1074/jbc.M007136200; Hopkins AM, 2000, ADV DRUG DELIVER REV, V41, P329, DOI 10.1016/S0169-409X(00)00050-8; HYSLOP PA, 1988, J BIOL CHEM, V263, P1665; KAUFMAN DS, 1993, ARCH BIOCHEM BIOPHYS, V302, P245, DOI 10.1006/abbi.1993.1206; Kevil CG, 2000, AM J PHYSIOL-CELL PH, V279, pC21, DOI 10.1152/ajpcell.2000.279.1.C21; KROSHIAN VM, 1994, AM J PHYSIOL, V266, pF21, DOI 10.1152/ajprenal.1994.266.1.F21; KURIHARA H, 1995, AM J PHYSIOL-RENAL, V268, pF514, DOI 10.1152/ajprenal.1995.268.3.F514; MANDEL LJ, 1994, J CELL SCI, V107, P3315; Meng XM, 2000, AM J PHYSIOL-RENAL, V278, pF83, DOI 10.1152/ajprenal.2000.278.1.F83; Molitoris BA, 1997, PEDIATR NEPHROL, V11, P761, DOI 10.1007/s004670050385; NIGAM SK, 1991, BIOCHEM BIOPH RES CO, V181, P548, DOI 10.1016/0006-291X(91)91224-Z; Rao R, 1999, BIOCHEM PHARMACOL, V57, P685, DOI 10.1016/S0006-2952(98)00333-5; Rao RK, 1997, AM J PHYSIOL-GASTR L, V273, pG812, DOI 10.1152/ajpgi.1997.273.4.G812; Rao RK, 2000, AM J PHYSIOL-GASTR L, V279, pG332, DOI 10.1152/ajpgi.2000.279.2.G332; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; SALAHUDEEN AK, 1991, J CLIN INVEST, V88, P1886, DOI 10.1172/JCI115511; SHASBY DM, 1985, BLOOD, V65, P605; SHASBY DM, 1988, AM J PHYSIOL, V255, pC781, DOI 10.1152/ajpcell.1988.255.6.C781; STADDON JM, 1995, J CELL SCI, V108, P609; STUART RO, 1994, J CELL PHYSIOL, V159, P423, DOI 10.1002/jcp.1041590306; STUART RO, 1995, P NATL ACAD SCI USA, V92, P6072, DOI 10.1073/pnas.92.13.6072; Takeda M, 1999, NEPHRON, V81, P234, DOI 10.1159/000045282; Tsukamoto T, 1999, AM J PHYSIOL-RENAL, V276, pF737, DOI 10.1152/ajprenal.1999.276.5.F737; Tsukamoto T, 1997, J BIOL CHEM, V272, P16133, DOI 10.1074/jbc.272.26.16133; UEDA N, 1992, AM J PHYSIOL, V263, pF214, DOI 10.1152/ajprenal.1992.263.2.F214; UEDA N, 1992, J CLIN INVEST, V90, P2593, DOI 10.1172/JCI116154; VANITALLIE CM, 1995, J CELL SCI, V108, P1735; WELSH MJ, 1985, J CLIN INVEST, V76, P1155, DOI 10.1172/JCI112071; WILSON J, 1990, BLOOD, V76, P2578; WINTER M, 1990, AM J RESP CELL MOL, V2, P355, DOI 10.1165/ajrcmb/2.4.355; YAMAYA M, 1995, AM J PHYSIOL-LUNG C, V268, pL284, DOI 10.1152/ajplung.1995.268.2.L284; Ye JM, 1999, AM J PHYSIOL-RENAL, V277, pF524, DOI 10.1152/ajprenal.1999.277.4.F524; Zager RA, 1996, J AM SOC NEPHROL, V7, P2327	51	104	107	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22048	22055		10.1074/jbc.M011477200	http://dx.doi.org/10.1074/jbc.M011477200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11294856	hybrid			2022-12-27	WOS:000169412700010
J	Moog-Lutz, C; Peterson, EJ; Lutz, PG; Eliason, S; Cave-Riant, F; Singer, A; Di Gioia, Y; Dmowski, S; Kamens, J; Cayre, YE; Koretzky, G				Moog-Lutz, C; Peterson, EJ; Lutz, PG; Eliason, S; Cave-Riant, F; Singer, A; Di Gioia, Y; Dmowski, S; Kamens, J; Cayre, YE; Koretzky, G			PRAM-1 is a novel adaptor protein regulated by retinoic acid (RA) and promyelocytic leukemia (PML)-RA receptor alpha in acute promyelocytic leukemia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASES; T-CELLS; GRANULOCYTIC DIFFERENTIATION; MOLECULAR-CLONING; MAMMALIAN-CELLS; SLP-76; GENE; EXPRESSION; BINDING; TRANSLOCATION	The t(15;17) translocation, found in 95% of acute promyelocytic leukemia, encodes a promyelocytic leukemia (PML)-retinoic acid receptor alpha (RAR alpha) fusion protein. Complete remission of acute promyelocytic leukemia can be obtained by treating patients with all-trans retinoic acid, and PML-RAR alpha plays a major role in mediating retinoic acid effects in leukemia cells. A main model proposed for acute promyelocytic leukemia is that PML-RAR alpha exerts its oncogenic effects by repressing the expression of retinoic acid-inducible genes critical to myeloid differentiation. By applying subtraction cloning to acute promyelocytic leukemia cells, we identified a retinoic acid-induced gene, PRAM-1 ((P) under bar ML-RAR alpha target gene encoding an (A) under bar daptor (M) under bar olecule-1), which encodes a novel adaptor protein sharing structural homologies with the SLAP-130/fyb adaptor. PRAM-1 is expressed and regulated during normal human myelopoiesis. In U937 myeloid precursor cells, PRAM-1 expression is inhibited by expression of PML-RAR alpha in the absence of ligand and de novo superinduced by retinoic acid. PRAM-1 associates with other adaptors, SLP-76 and SKAP-55HOM, in myeloid cell lines and with protein tyrosine kinase lyn. By providing the first evidence that PML-RAR alpha dysregulates expression of an adaptor protein, our data open new insights into signaling events that are disrupted during transformation by PML-RAR alpha and induced by retinoic acid during de novo differentiation of acute promyelocytic leukemia cells.	Hop St Antoine, INSERM U417, F-75012 Paris, France; Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; BASF Biores Corp, Worcester, MA 01605 USA; Thomas Jefferson Univ, Kimmel Canc Inst, Dept Immunol Microbiol, Philadelphia, PA 19107 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; BASF; Jefferson University	Cayre, YE (corresponding author), Hop St Antoine, INSERM U417, F-75012 Paris, France.	cayre@st-antoine.inserm.fr	MOOG-LUTZ, Christel/F-1975-2011; Koretzky, Gary/AAU-5381-2021; Peterson, Erik/M-9365-2013; Lutz, Pierre/B-8822-2009	Kamens, Joanne/0000-0002-7000-1477; Lutz, Pierre/0000-0003-0590-9101				Boerth NJ, 2000, J BIOL CHEM, V275, P5143, DOI 10.1074/jbc.275.7.5143; BORROW J, 1990, SCIENCE, V249, P1577, DOI 10.1126/science.2218500; Botling J, 1997, J BIOL CHEM, V272, P9443; BREITMAN TR, 1990, METHOD ENZYMOL, V190, P118; CASTAIGNE S, 1990, BLOOD, V76, P1704; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOMIENNE C, 1990, BLOOD, V76, P1710; CHOO KH, 1986, DNA-J MOLEC CELL BIO, V5, P529, DOI 10.1089/dna.1.1986.5.529; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; DERMIME S, 1993, BLOOD, V82, P1573; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Geng LP, 1999, J IMMUNOL, V163, P5753; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Grignani F, 2000, BLOOD, V96, P1531, DOI 10.1182/blood.V96.4.1531.h8001531_1531_1537; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; He LZ, 1999, ONCOGENE, V18, P5278, DOI 10.1038/sj.onc.1203088; HendricksTaylor LR, 1997, J BIOL CHEM, V272, P1363, DOI 10.1074/jbc.272.2.1363; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Katagiri K, 1996, J BIOL CHEM, V271, P11557, DOI 10.1074/jbc.271.19.11557; Kogan SC, 1999, ONCOGENE, V18, P5261, DOI 10.1038/sj.onc.1202996; Kouroku Y, 1998, BIOCHEM BIOPH RES CO, V252, P738, DOI 10.1006/bbrc.1998.9637; KOZAK M, 1990, NUCLEIC ACIDS RES, V18, P2828, DOI 10.1093/nar/18.9.2828; LANOTTE M, 1991, BLOOD, V77, P1080; Lin RJ, 1999, TRENDS GENET, V15, P179, DOI 10.1016/S0168-9525(99)01710-2; Liu J, 1998, P NATL ACAD SCI USA, V95, P8779, DOI 10.1073/pnas.95.15.8779; Liu TX, 2000, BLOOD, V96, P1496, DOI 10.1182/blood.V96.4.1496.h8001496_1496_1504; Lutz P, 1997, J VIROL, V71, P5102, DOI 10.1128/JVI.71.7.5102-5109.1997; Lutz PG, 2000, P NATL ACAD SCI USA, V97, P1601, DOI 10.1073/pnas.97.4.1601; Marie-Cardine A, 1998, FEBS LETT, V435, P55, DOI 10.1016/S0014-5793(98)01040-0; Marie-Cardine A, 1998, J BIOL CHEM, V273, P25789, DOI 10.1074/jbc.273.40.25789; MAYER BJ, 1995, CURR BIOL, V5, P364, DOI 10.1016/S0960-9822(95)00073-X; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Motto DG, 1996, J EXP MED, V183, P1937, DOI 10.1084/jem.183.4.1937; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; Myung PS, 2000, CURR OPIN IMMUNOL, V12, P256, DOI 10.1016/S0952-7915(00)00085-6; PANDOLFI PP, 1991, ONCOGENE, V6, P1285; PATWARDHAN S, 1991, ONCOGENE, V6, P917; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; ROWLEY JD, 1977, LANCET, V1, P549; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Timms JF, 1999, CURR BIOL, V9, P927, DOI 10.1016/S0960-9822(99)80401-1; WARRELL RP, 1991, NEW ENGL J MED, V324, P1385, DOI 10.1056/NEJM199105163242002; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P6462, DOI 10.1073/pnas.94.12.6462; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	49	40	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22375	22381		10.1074/jbc.M011683200	http://dx.doi.org/10.1074/jbc.M011683200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11301322	hybrid			2022-12-27	WOS:000169412700055
J	Zhou, ZH; Liao, WC; Cheng, RH; Lawson, JE; McCarthy, DB; Reed, LJ; Stoops, JK				Zhou, ZH; Liao, WC; Cheng, RH; Lawson, JE; McCarthy, DB; Reed, LJ; Stoops, JK			Direct evidence for the size and conformational variability of the pyruvate dehydrogenase complex revealed by three-dimensional electron microscopy - The "breathing" core and its functional relationship to protein dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLAMINE TUNGSTATE STAIN; X-RAY CRYSTALLOGRAPHY; BUTVAR SUPPORT FILM; CRYOELECTRON MICROSCOPY; STRUCTURAL-ANALYSIS; BINDING PROTEIN; CUBIC CORE; RECONSTRUCTION; CRYSTALLIZATION; MACROMOLECULES	Structural studies by three-dimensional electron microscopy of the Saccharomyces cerevisiae truncated dihydrolipoamide acetyltransferase (tE(2)) component of the pyruvate dehydrogenase complex reveal an extraordinary example of protein dynamics. The tE(2) forms a 60-subunit core with the morphology of a pentagonal dodecahedron and consists of 20 cone-shaped trimers interconnected by 30 bridges. Frozen-hydrated and stained molecules of tE(2) in the same field vary in size similar to 20%, Analyses of the data show that the size distribution is bell-shaped, and there is an approximately 40-Angstrom difference in the diameter of the smallest and largest structures that corresponds to similar to 14 Angstrom of variation in the length of the bridge between interconnected trimers, Companion studies of mature E-2 show that the complex of the intact subunit exhibits a similar size variation, The x-ray structure of Bacillus stearothermophilus tE(2) shows that there is an similar to 10-Angstrom gap between adjacent trimers and that the trimers are interconnected by the potentially flexible C-terminal ends of two adjacent subunits. We propose that this springlike feature is involved in a thermally driven expansion and contraction of the core and, since it appears to be a common feature in the phylogeny of pyruvate dehydrogenase complexes, protein dynamics is an integral component of the function of these multienzyme complexes.	Univ Texas, Houston Med Sch, Dept Pathol & Lab Med, Houston, TX 77030 USA; Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden; Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Health Science Center Houston; Karolinska Institutet; University of Texas System; University of Texas Austin	Stoops, JK (corresponding author), Univ Texas, Houston Med Sch, Dept Pathol & Lab Med, Houston, TX 77030 USA.	James.K.Stoops@uth.tmc.edu	Cheng, Holland/A-8973-2008; Zhou, Z Hong/HDN-0747-2022		NIAID NIH HHS [AI46420] Funding Source: Medline; NIGMS NIH HHS [GM06590] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046420] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALDROUBI A, 1992, ULTRAMICROSCOPY, V46, P175, DOI 10.1016/0304-3991(92)90013-A; Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; Balabin IA, 2000, SCIENCE, V290, P114, DOI 10.1126/science.290.5489.114; BOSMA HJ, 1984, EUR J BIOCHEM, V142, P541, DOI 10.1111/j.1432-1033.1984.tb08320.x; Bothner B, 1998, J BIOL CHEM, V273, P673, DOI 10.1074/jbc.273.2.673; BrõndÚn CI., 1991, INTRO PROTEIN STRUCT; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CHENG RH, 1995, CELL, V80, P621; CROWTHER RA, 1970, PROC R SOC LON SER-A, V317, P319, DOI 10.1098/rspa.1970.0119; CROWTHER RA, 1971, PHILOS T R SOC B, V261, P221, DOI 10.1098/rstb.1971.0054; DEROSIER DJ, 1971, P NATL ACAD SCI USA, V68, P1135, DOI 10.1073/pnas.68.6.1135; DOUGHERTY MT, 1998, MICROSC MICROANAL, P452; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; FULLER CC, 1979, BIOCHEM BIOPH RES CO, V90, P431, DOI 10.1016/0006-291X(79)91253-1; Fuller SD, 1996, J STRUCT BIOL, V116, P48, DOI 10.1006/jsbi.1996.0009; GUEST JR, 1989, ANN N Y ACAD SCI, V573, P76; HACKERT ML, 1989, BIOCHEMISTRY-US, V28, P6816, DOI 10.1021/bi00443a006; Hall C. E., 1966, INTRO ELECT MICROSCO, V2nd; Izard T, 1999, P NATL ACAD SCI USA, V96, P1240, DOI 10.1073/pnas.96.4.1240; Johnson O, 1997, FOURTH INTERNATIONAL CONFERENCE ON HIGH-PERFORMANCE COMPUTING, PROCEEDINGS, P517, DOI 10.1109/HIPC.1997.634540; Jones M, 2000, J BIOL CHEM, V275, P21349, DOI 10.1074/jbc.M001564200; Knapp JE, 1998, J MOL BIOL, V280, P655, DOI 10.1006/jmbi.1998.1924; Knapp JE, 2000, PROTEIN SCI, V9, P37; Kolodziej SJ, 1997, J STRUCT BIOL, V120, P158, DOI 10.1006/jsbi.1997.3911; Lata R, 2000, CELL, V100, P253, DOI 10.1016/S0092-8674(00)81563-9; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Lu GY, 1998, J VIROL, V72, P8541, DOI 10.1128/JVI.72.11.8541-8549.1998; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MAENG CY, 1994, BIOCHEMISTRY-US, V33, P13801, DOI 10.1021/bi00250a034; Maeng CY, 1996, BIOCHEMISTRY-US, V35, P5879, DOI 10.1021/bi9600254; MATTEVI A, 1992, SCIENCE, V255, P1544, DOI 10.1126/science.1549782; OLSON NH, 1992, J STRUCT BIOL, V108, P168, DOI 10.1016/1047-8477(92)90016-4; Orlova EV, 1996, NAT STRUCT BIOL, V3, P547, DOI 10.1038/nsb0696-547; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; REED LJ, 1990, J BIOL CHEM, V265, P8971; Schulten K, 2000, SCIENCE, V290, P61, DOI 10.1126/science.290.5489.61; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; Stoops James K., 1998, Microscopy and Microanalysis, V4, P954, DOI 10.1017/S1431927600024892; STOOPS JK, 1992, J BIOL CHEM, V267, P24769; Stoops JK, 1997, J BIOL CHEM, V272, P5757, DOI 10.1074/jbc.272.9.5757; STOOPS JK, 1991, J ELECTRON MICR TECH, V18, P157, DOI 10.1002/jemt.1060180210; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wilson EK, 2000, CHEM ENG NEWS, V78, P42, DOI 10.1021/cen-v078n029.p042; Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604; Zhou ZH, 1999, J VIROL, V73, P3210, DOI 10.1128/JVI.73.4.3210-3218.1999; Zhou ZH, 1998, BIOPHYS J, V74, P576, DOI 10.1016/S0006-3495(98)77816-6; Zhou ZH, 1996, J STRUCT BIOL, V116, P216, DOI 10.1006/jsbi.1996.0033; ZHOU ZH, 1995, THESIS BAYLOR COLL M	50	48	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21704	21713		10.1074/jbc.M101765200	http://dx.doi.org/10.1074/jbc.M101765200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11285267	hybrid			2022-12-27	WOS:000169297900121
J	Keller, SH; Lindstrom, J; Ellisman, M; Taylor, P				Keller, SH; Lindstrom, J; Ellisman, M; Taylor, P			Adjacent basic amino acid residues recognized by the COPI complex and ubiquitination govern endoplasmic reticulum to cell surface trafficking of the nicotinic acetylcholine receptor alpha-subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFECTIVE PROTEIN TRAFFICKING; PLASMA-MEMBRANE; SECRETORY PATHWAY; POTASSIUM CHANNEL; BINDING-SITE; ENDOCYTOSIS; RETRIEVAL; CALNEXIN; SIGNAL; GAMMA	The nicotinic acetylcholine receptor in muscle is a ligand-gated ion channel with an ordered subunit arrangement of alpha-gamma-alpha-delta-beta. The subunits are sequestered in the endoplasmic reticulum (ER) and assembled into the pentameric arrangement prior to their exit to the cell surface. Mutating the Arg(313)-Lys(314) sequence in the large cytoplasmic loop of the alpha -subunit to K314Q promotes the trafficking of the mutant unassembled alpha -subunit from the ER to the Golgi in transfected HEK cells, identifying an important determinant that modulates the ER to Golgi trafficking of the subunit, The association of the K314Q alpha -subunit with gamma -COP, a component of COP I coats implicated in Golgi to ER anterograde transport, is diminished to a level comparable to that observed for wild-type alpha -subunits when co-expressed with the beta-, delta-, and gamma -subunits. This suggests that the Arg(313)-Lys(314) sequence is masked when the subunits assemble, thereby enabling ER to Golgi trafficking of the alpha -subunit, Although unassembled K314Q alpha -subunits accumulate in the Golgi, they are not detected at the cell surface, suggesting that a second post-Golgi level of capture exists, Expressing the K314Q alpha -subunit in the absence of the other subunits in ubiquitinating deficient cells (ts20) results in detecting this subunit at the cell surface, indicating that ubiquitination functions as a post-Golgi modulator of trafficking. Taken together, our findings support the hypothesis that subunit assembly sterically occludes the trafficking signals and ubiquitination at specific sites. Following the masking of these signals, the assembled ion channel expresses at the cell surface.	Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of Pennsylvania; University of California System; University of California San Diego; University of Pennsylvania; University of California System; University of California San Diego	Keller, SH (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	shkeller@ucsd.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018360, R01GM018360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011323] Funding Source: NIH RePORTER; NCRR NIH HHS [RR P41-04050] Funding Source: Medline; NIGMS NIH HHS [GM18360] Funding Source: Medline; NINDS NIH HHS [NS11323] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andersson H, 1999, J BIOL CHEM, V274, P15080, DOI 10.1074/jbc.274.21.15080; BLOUNT P, 1988, J BIOL CHEM, V263, P1072; BOULTER J, 1985, J NEUROSCI, V5, P2545; Chang W, 1997, J BIOL CHEM, V272, P28925, DOI 10.1074/jbc.272.46.28925; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; DAS MK, 1991, BIOCHEMISTRY-US, V30, P2470, DOI 10.1021/bi00223a025; DENNING GM, 1992, J CELL BIOL, V118, P551, DOI 10.1083/jcb.118.3.551; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; GU Y, 1991, J CELL BIOL, V114, P799, DOI 10.1083/jcb.114.4.799; Harter C, 1996, P NATL ACAD SCI USA, V93, P1902, DOI 10.1073/pnas.93.5.1902; Harter C, 1998, P NATL ACAD SCI USA, V95, P11649, DOI 10.1073/pnas.95.20.11649; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Keller SH, 1996, J BIOL CHEM, V271, P22871, DOI 10.1074/jbc.271.37.22871; Keller SH, 1998, J BIOL CHEM, V273, P17064, DOI 10.1074/jbc.273.27.17064; KELLER SH, 1995, J BIOL CHEM, V270, P4165, DOI 10.1074/jbc.270.8.4165; KREIENKAMP HJ, 1995, NEURON, V14, P635, DOI 10.1016/0896-6273(95)90320-8; KULKA RG, 1988, J BIOL CHEM, V263, P15726; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lindstrom J, 1996, Ion Channels, V4, P377; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Nakatsu F, 2000, J BIOL CHEM, V275, P26213, DOI 10.1074/jbc.M907720199; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; SMITH MM, 1987, J BIOL CHEM, V262, P4367; Stang E, 2000, J BIOL CHEM, V275, P13940, DOI 10.1074/jbc.275.18.13940; Strous GJ, 1997, J BIOL CHEM, V272, P40; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; Sugiyama N, 1996, J BIOL CHEM, V271, P26575, DOI 10.1074/jbc.271.43.26575; Vincent MJ, 1998, J BIOL CHEM, V273, P950, DOI 10.1074/jbc.273.2.950; WELSH MJ, 1993, J CELL SCI, P235; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	37	67	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18384	18391		10.1074/jbc.M100691200	http://dx.doi.org/10.1074/jbc.M100691200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279119	hybrid			2022-12-27	WOS:000168866500102
J	Burgess, BR; Richardson, JP				Burgess, BR; Richardson, JP			Transcription factor Rho does not require a free end to act as an RNA-DNA helicase on an RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINATION FACTOR-RHO; CRO MESSENGER-RNA; SINGLE-STRANDED-DNA; PROTEIN HEXAMER; KINETICS; BINDING; COMPLEX; ACID; ATP	Escherichia coli Rho factor is a ring-shaped, homohexameric protein that terminates synthesis of RNA through interactions with the nascent RNA transcript, Because its mechanism of action may involve translocation of the RNA transcript through the hole in its ring structure, its action could depend on the availability of a free 5' terminus. To determine whether Rho's activity is 5'-end-dependent, its ability to bind to and function on a circular derivative of A cro mRNA was investigated. The circular derivative was made in vitro by action of RNA ligase on a derivative of A cro RNA containing an extra 10-nucleotide sequence near the 5'-end that was complementary to a sequence located near the 3'-end. Rho bound nearly as tightly to the circular derivative RNA as to the standard cro transcript, Rho was also able to readily dissociate a DNA oligonucleotide from its helical complex with the circular RNA in an ATP-dependent reaction. Thus, the action of Rho on a transcript does not depend on the availability of a free 5' terminus.	Indiana Univ, Dept Chem, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Richardson, JP (corresponding author), Indiana Univ, Dept Chem, 800 E Kirkwood Ave, Bloomington, IN 47405 USA.	richardj@indiana.edu			NIGMS NIH HHS [GM 56095] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEAUDRY D, 1995, NUCLEIC ACIDS RES, V23, P3064; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; Burgess BR, 2001, J BIOL CHEM, V276, P4182, DOI 10.1074/jbc.M007066200; CAREY J, 1983, BIOCHEMISTRY-US, V22, P2601, DOI 10.1021/bi00280a002; CHEN CYA, 1986, CELL, V46, P1023, DOI 10.1016/0092-8674(86)90701-4; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; FAUS I, 1989, BIOCHEMISTRY-US, V28, P3510, DOI 10.1021/bi00434a054; FAUS I, 1990, J MOL BIOL, V212, P53, DOI 10.1016/0022-2836(90)90304-5; Gan E, 1999, BIOCHEMISTRY-US, V38, P16882, DOI 10.1021/bi991559i; GOGOL EP, 1991, J MOL BIOL, V221, P1127, DOI 10.1016/0022-2836(91)80116-C; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MIWA Y, 1995, J MOL BIOL, V254, P815, DOI 10.1006/jmbi.1995.0658; ODA T, 1972, J MOL BIOL, V71, P799; RICHARDSON JP, 1991, CELL, V64, P1047, DOI 10.1016/0092-8674(91)90257-Y; Richardson JP, 1996, J BIOL CHEM, V271, P1251, DOI 10.1074/jbc.271.3.1251; RICHARDSON JP, 1996, ESCHERICHIA COLI SAL, P882; ROBERTS JW, 1969, NATURE, V224, P1168, DOI 10.1038/2241168a0; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7993, DOI 10.1021/bi963180r; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7980, DOI 10.1021/bi963179s; Yu X, 1997, NAT STRUCT BIOL, V4, P101, DOI 10.1038/nsb0297-101	21	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17106	17110		10.1074/jbc.M101856200	http://dx.doi.org/10.1074/jbc.M101856200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279220	hybrid			2022-12-27	WOS:000168730400068
